PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Clayton, NS; Fox, M; Vicente-Garcia, JJ; Schroeder, CM; Littlewood, TD; Wilde, JI; Krishnan, K; Brown, MJB; Crafter, C; Mott, HR; Owen, D				Clayton, Natasha S.; Fox, Millie; Vicente-Garcia, Jose J.; Schroeder, Courtney M.; Littlewood, Trevor D.; Wilde, Jonathon, I; Krishnan, Kadalmani; Brown, Murray J. B.; Crafter, Claire; Mott, Helen R.; Owen, Darerca			Assembly of nuclear dimers of PI3K regulatory subunits is regulated by the Cdc42-activated tyrosine kinase ACK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						signal; tyrosine kinase domain; Src homology-3 (SH3) domain	ANDROGEN RECEPTOR; TUMOR-SUPPRESSOR; GTPASE ACTIVITY; P85-ALPHA; CANCER; 3-KINASE; P85; PHOSPHORYLATION; ACTIVATION; MECHANISMS	Activated Cdc42-associated kinase (ACK) is an oncogenic nonreceptor tyrosine kinase associated with poor prognosis in several human cancers. ACK promotes proliferation, in part by contributing to the activation of Akt, the major effector of class 1A phosphoinositide 3-kinases (PI3Ks), which transduce signals via membrane phosphoinositol lipids. We now show that ACK also interacts with other key components of class 1A PI3K signaling, the PI3K regulatory subunits. We demonstrate ACK binds to all five PI3K regulatory subunit isoforms and directly phosphorylates p85 alpha, p85/1, p50 alpha, and p55 alpha on Tyr607 (or analogous residues). We found that phosphorylation of p85/1 promotes cell proliferation in HEK293T cells. We demonstrate that ACK interacts with p85 alpha exclusively in nuclear-enriched cell fractions, where p85 alpha phosphorylated at Tyr607 (pTyr607) also resides, and identify an interaction between pTyr607 and the N-terminal SH2 domain that supports dimerization of the regulatory subunits. We infer from this that ACK targets p110-independent p85 and further postulate that these regulatory subunit dimers undertake novel nuclear functions underpinning ACK activity. We conclude that these dimers represent a previously undescribed mode of regulation for the class1A PI3K regulatory subunits and potentially reveal additional avenues for therapeutic intervention.	[Clayton, Natasha S.; Fox, Millie; Vicente-Garcia, Jose J.; Schroeder, Courtney M.; Littlewood, Trevor D.; Krishnan, Kadalmani; Mott, Helen R.; Owen, Darerca] Univ Cambridge, Dept Biochem, Cambridge, England; [Wilde, Jonathon, I; Brown, Murray J. B.] GlaxoSmithKline Med Res Ctr, Screening & Compound Profiling, Stevenage, Herts, England; [Crafter, Claire] AstraZeneca, Biosci, Oncol R&D, Res & Early Dev, Cambridge, England; [Clayton, Natasha S.] Sch Cellular & Mol Med, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England; [Fox, Millie] Astrazeneca, Cell Engn, Discovery Sci, Cambridge, England; [Vicente-Garcia, Jose J.] GlaxoSmithKline, Stockley Pk West,1 3 Ironbridge Rd, Uxbridge UB11 1BT, Middx, England; [Schroeder, Courtney M.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA; [Wilde, Jonathon, I] Veracyte, Suite 300,6000 Shoreline Court, San Francisco, CA 94080 USA; [Krishnan, Kadalmani] Levim Biotech, 501 506,TICEL Biopk Phase 2,CSIR Rd, Chennai 600113, Tamil Nadu, India	University of Cambridge; GlaxoSmithKline; AstraZeneca; University of Bristol; AstraZeneca; GlaxoSmithKline; Fred Hutchinson Cancer Center	Mott, HR; Owen, D (corresponding author), Univ Cambridge, Dept Biochem, Cambridge, England.	hrm28@cam.ac.uk; do202@cam.ac.uk			BBSRC DTG/A studentships [BB/F017464/1, BB/A517685/1]; MRC iCASE [MR/N018354/1]; Churchill Scholarship by the Winston Churchill Foundation of the United States; CR-UK [C4750/A19013, C11309/A5148]; National Over-seas Scholarship, Government of India; Cambridge Commonwealth Scholarship	BBSRC DTG/A studentships; MRC iCASE; Churchill Scholarship by the Winston Churchill Foundation of the United States; CR-UK(Cancer Research UK); National Over-seas Scholarship, Government of India; Cambridge Commonwealth Scholarship	This research was supported by BBSRC DTG/A studentships (BB/F017464/1 and BB/A517685/1) to N. S. C. and J.V.-G.; an MRC iCASE (MR/N018354/1) to D.O. and C.C.; a Churchill Scholarship (awarded by the Winston Churchill Foundation of the United States) to C.S.; a CR-UK (C4750/A19013) programme grant to T. D. L.; a National Over-seas Scholarship, Government of India, and a Cambridge Commonwealth Scholarship to K. K. and a CR-UK project grant (C11309/A5148) to D. O. and H. R. M.	Ahmed I, 2004, BIOCHEM BIOPH RES CO, V314, P571, DOI 10.1016/j.bbrc.2003.12.137; Bandyopadhyay GK, 2005, DIABETES, V54, P2351, DOI 10.2337/diabetes.54.8.2351; Barber Domingo F, 2006, Sci STKE, V2006, ppe49, DOI 10.1126/stke.3622006pe49; Burke JE, 2012, P NATL ACAD SCI USA, V109, P15259, DOI 10.1073/pnas.1205508109; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; Chamberlain MD, 2010, CELL SIGNAL, V22, P1562, DOI 10.1016/j.cellsig.2010.05.025; Chamberlain MD, 2004, J BIOL CHEM, V279, P48607, DOI 10.1074/jbc.M409769200; Cheung LWT, 2015, ELIFE, V4, DOI 10.7554/eLife.06866; Chiu YH, 2014, MOL CELL, V54, P193, DOI 10.1016/j.molcel.2014.02.016; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; Fox M, 2020, BIOCHEM SOC T, V48, P1397, DOI 10.1042/BST20190845; Fox M, 2019, BIOCHEM SOC T, V47, P1715, DOI 10.1042/BST20190176; Galisteo ML, 2006, P NATL ACAD SCI USA, V103, P9796, DOI 10.1073/pnas.0603714103; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Harpur AG, 1999, J BIOL CHEM, V274, P12323, DOI 10.1074/jbc.274.18.12323; HAYASHI H, 1993, J BIOL CHEM, V268, P7107; Honorato RV, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.729513; Hoxhaj G, 2020, NAT REV CANCER, V20, P74, DOI 10.1038/s41568-019-0216-7; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Inaba S, 2017, J BIOL CHEM, V292, P1052, DOI 10.1074/jbc.M116.755173; LoPiccolo J, 2015, J BIOL CHEM, V290, P30390, DOI 10.1074/jbc.M115.689604; Luck K, 2020, NATURE, V580, P402, DOI 10.1038/s41586-020-2188-x; Mahajan K, 2017, CANCER CELL, V31, P790, DOI 10.1016/j.ccell.2017.05.003; Mahajan K, 2012, J BIOL CHEM, V287, P22112, DOI 10.1074/jbc.M112.357384; Mahajan K, 2010, J CELL PHYSIOL, V224, P327, DOI 10.1002/jcp.22162; Mahajan K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009646; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Mellor P, 2012, BIOCHEM J, V441, P23, DOI 10.1042/BJ20111164; Mundi PS, 2016, BRIT J CLIN PHARMACO, V82, P943, DOI 10.1111/bcp.13021; Park SW, 2014, CELL METAB, V20, P73, DOI 10.1016/j.cmet.2014.04.006; Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099; Prieto-Echague V, 2010, J BIOL CHEM, V285, P10605, DOI 10.1074/jbc.M109.060459; Shen F, 2007, MOL BIOL CELL, V18, P732, DOI 10.1091/mbc.E06-02-0142; Siegal G, 1998, J MOL BIOL, V276, P461, DOI 10.1006/jmbi.1997.1562; Song L, 2011, ONCOGENE, V30, P1360, DOI 10.1038/onc.2010.506; Thorpe LM, 2015, NAT REV CANCER, V15, P7, DOI 10.1038/nrc3860; Tsolakos N, 2018, P NATL ACAD SCI USA, V115, P12176, DOI 10.1073/pnas.1803446115; Ueki K, 2002, MOL CELL BIOL, V22, P965, DOI 10.1128/MCB.22.3.965-977.2002; Urick ME, 2011, CANCER RES, V71, P4061, DOI 10.1158/0008-5472.CAN-11-0549; van der Horst EH, 2005, P NATL ACAD SCI USA, V102, P15901, DOI 10.1073/pnas.0508014102; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Yap TA, 2015, CURR OPIN PHARMACOL, V23, P98, DOI 10.1016/j.coph.2015.05.016; Yin YX, 1998, NATURE, V391, P707, DOI 10.1038/35648; Yokoyama N, 2006, METHOD ENZYMOL, V406, P250, DOI 10.1016/S0076-6879(06)06018-6	46	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101916	10.1016/j.jbc.2022.101916	http://dx.doi.org/10.1016/j.jbc.2022.101916			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9OQ	35429500	gold, Green Published			2022-12-26	WOS:000807778400002
J	Johnson, TA; Gordon-Evans, WJ; Lascelles, BDX; Conzemius, MG				Johnson, Tiffany A.; Gordon-Evans, Wanda J.; Lascelles, B. Duncan X.; Conzemius, Michael G.			Determination of the center of mass in a heterogeneous population of dogs	PLOS ONE			English	Article							ANIMAL-MODELS; WRIST-WORN; WAIST	The center of mass (CoM) is the location in a body where mass distribution is balanced. It has a fundamental role in balance and motion which has been poorly described in the dog. The objective of this study was to estimate the variance of the center of mass (CoM) in a heterogeneous population of client-owned dogs and to describe the relationship between CoM, subject morphometrics and an inertial measurement unit (IMU) box positioned ventrally on a neck collar. A single force platform and a reaction board were used to determine CoM in the transverse, sagittal and dorsal planes in thirty-one healthy adult dogs. A series of morphometric measurements were acquired with each dog standing, including distances relative to an IMU box positioned ventrally on a neck collar. Mean transverse plane CoM was 48% the distance from ischium to the IMU box, near the xiphoid process. Mean sagittal place CoM was 59% the width of the chest on the left side. Mean dorsal plane CoM was 41% the distance from the most dorsal to the most ventral aspect of the body. Dog length was the primary variable required to maximize the relationship between three-dimensional CoM and identifiable variables measured. A CoM based normalization procedure should be considered to normalize mass or motion based outcome measure output (e.g., ground reaction forces, vector acceleration) in a heterogeneous population of dogs. Future research will be needed to determine if CoM-based normalization procedures reduce variance in outcome measures affected by subject morphometrics.	[Johnson, Tiffany A.; Gordon-Evans, Wanda J.; Conzemius, Michael G.] Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA; [Lascelles, B. Duncan X.] North Carolina State Univ, Coll Vet Med, Translat Res Pain Comparat Pain Res & Educ Ctr, Dept Clin Sci, Raleigh, NC USA	University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; North Carolina State University	Conzemius, MG (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA.	conze012@umn.edu		Gordon-Evans, Wanda/0000-0003-1356-8327; Lascelles, B. Duncan X./0000-0002-2950-9009	University of Minnesota Tata Group Endowment	University of Minnesota Tata Group Endowment	This work was supported by the University of Minnesota Tata Group Endowment.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphe M, 2017, MECH ENG, V21Mechanics, P485; Almeida CWL, 2011, GAIT POSTURE, V34, P208, DOI 10.1016/j.gaitpost.2011.04.013; Baker R, 2007, GAIT POSTURE, V26, P331, DOI 10.1016/j.gaitpost.2006.10.014; Chambers RD, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11061549; Chiu KW, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58499-1; Conzemius MG, 2022, VET SURG, V51, P385, DOI 10.1111/vsu.13772; Damavandi M, 2013, MED ENG PHYS, V35, P1607, DOI 10.1016/j.medengphy.2013.05.010; Damavandi M, 2009, MED ENG PHYS, V31, P1187, DOI 10.1016/j.medengphy.2009.07.015; Erdman W., 2018, MOJ APPL BIONICS BIO, V2, DOI 10.15406/mojabb.2018.02.00057; Eskander BS, 2020, CAN J VET RES, V84, P44; Kamada M, 2016, GAIT POSTURE, V44, P23, DOI 10.1016/j.gaitpost.2015.11.005; Kobayashi T, 2012, TOP STROKE REHABIL, V19, P338, DOI 10.1310/tsr1904-338; Lascelles BDX, 2019, VET J, V252, DOI 10.1016/j.tvjl.2019.105370; Lascelles BDX, 2018, OSTEOARTHR CARTILAGE, V26, P175, DOI 10.1016/j.joca.2017.11.011; Lee DV, 2011, J EXP BIOL, V214, P402, DOI 10.1242/jeb.044487; Loprinzi PD, 2017, J PHYS ACT HEALTH, V14, P539, DOI 10.1123/jpah.2016-0211; Lynn R., 2020, J MEASUREMENT PHYS B, V3, P197; Matthews CE, 2005, MED SCI SPORT EXER, V37, pS512, DOI 10.1249/01.mss.0000185659.11982.3d; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; Meeson RL, 2019, NAT REV RHEUMATOL, V15, P273, DOI 10.1038/s41584-019-0202-1; Mejia S, 2019, VET J, V252, DOI 10.1016/j.tvjl.2019.105355; MONTOYE HJ, 1983, MED SCI SPORT EXER, V15, P403; Park Se Jin, 1999, Applied Human Science, V18, P91; Pataky TC, 2003, CLIN BIOMECH, V18, P364, DOI 10.1016/S0268-0033(03)00015-9; Piel MJ, 2014, GENE, V537, P184, DOI 10.1016/j.gene.2013.11.091; Scott RM, 2017, VET COMP ORTHOPAED, V30, P318, DOI [10.3415/vcot-17-02-0020, 10.3415/VCOT-17-02-0020]; Tesio L., 2021, CLIN BIOMECH, V88; Tesio L, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00999; Troiano RP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093546; Tudor-Locke C, 2015, MED SCI SPORT EXER, V47, P839, DOI 10.1249/MSS.0000000000000476; Vainio O, 2012, SCAND J PAIN, V3, P84, DOI 10.1016/j.sjpain.2011.11.007; Virmavirta M, 2014, J BIOMECH, V47, P1909, DOI 10.1016/j.jbiomech.2014.04.001; Voss K, 2010, VET SURG, V39, P863, DOI 10.1111/j.1532-950X.2010.00729.x	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267361	10.1371/journal.pone.0267361	http://dx.doi.org/10.1371/journal.pone.0267361			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476847	gold, Green Published			2022-12-26	WOS:000840124300036
J	Bushen, G; Merga, H; Tessema, F				Bushen, Gedamu; Merga, Hailu; Tessema, Fasil			Effects of community-led total sanitation and hygiene implementation on diarrheal diseases prevention in children less than five years of age in South Western Ethiopia: A quasi- experimental study	PLOS ONE			English	Article							HEALTH; WATER; PREVALENCE; PREDICTORS; GROWTH	BackgroundLack of improved sanitation is the most important contributing factor to diarrheal disease among under-five children in low and middle-income countries. There was no study to identify the effect of Community-Led Total Sanitation and Hygiene intervention on diarrheal diseases in the study area. Hence, this study was designed with the aim of finding the effects of Community-led Total Sanitation and Hygiene implementation for preventing diarrhea among under-five children. MethodsA community-based Quasi-Experimental study was conducted among a sample of 846 households selected from intervention (kersa) and comparison (mana) districts using the four-stage random cluster-sampling method. A Semi-structured questionnaire was used to collect data. The collected data was cleaned, coded, and entered into EpiData version 3.1 and exported to SPSS version 20 for analysis. Difference-in Difference method with McNemar's tests was used to compare the prevalence of diarrhea between the intervention and comparison districts, and the significance of change between the pre-test and post-test was declared at p-value less than 0.05 with 95% confidence interval. ResultsThe intervention led to decreased diarrhea prevalence [pp = -8.2, 95% CI: -15.9, -0.5], increased latrine ownership [pp = 5.6, 95% CI: 0.5, 10.8], and increased latrine utilization [pp = 10.7, 95% CI: 4.7, 16.6] in intervention district at post-test compared to the baseline; while the presence of handwashing facility near the latrine, home-based water treatment, and proper water storage and handling practice were decreased at post-test compared to the baseline. ConclusionImplementation of Community-Led Total Sanitation improved sanitation and hygiene status of community that resulted in the reduction of diarrhea diseases in under-five children. Further implementation, evaluation, and scale-up of the interventions are needed to reduce diarrheal disease in under-five children.	[Bushen, Gedamu] South West Sewa Hlth Dept, MPH Filed Epidemiol, Oromia Region, Waliso, Ethiopia; [Merga, Hailu; Tessema, Fasil] Jimma Univ, Inst Hlth, Dept Epidemiol, Jimma, Ethiopia	Jimma University	Merga, H (corresponding author), Jimma Univ, Inst Hlth, Dept Epidemiol, Jimma, Ethiopia.	hailu.merga2014@gmail.com		Merga, Hailu/0000-0001-7536-4755				[Anonymous], 2017, WORLD HLTH STAT 2017; Anteneh ZA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4021-5; Anthonj C, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102112; Azage M, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0090-z; Bitew BD, 2017, ITAL J PEDIATR, V43, DOI 10.1186/s13052-017-0412-6; Central Statistical Agency, 2008, 2007 NAT CENS PREL R; Cha S, 2017, AM J TROP MED HYG, V97, P460, DOI 10.4269/ajtmh.16-0361; Crocker J, 2017, INT J HYG ENVIR HEAL, V220, P551, DOI 10.1016/j.ijheh.2017.02.011; Danquah Leslie., 2014, SCI J PUBLIC HLTH, V2, P119, DOI [10.11648/j.sjph.20140202.21, DOI 10.11648/J.SJPH.20140202.21]; Degebasa MZ, 2018, PEDIATR HEALTH MED T, V9, P109, DOI 10.2147/PHMT.S159366; Dreibelbis R, 2014, AM J PUBLIC HEALTH, V104, pE91, DOI 10.2105/AJPH.2013.301412; Eshete N, 2015, SCI J PUBLIC HLTH, V3, P669, DOI DOI 10.11648/j.sjph.20150305.22; Florence Nwaoha Adanma, 2017, Cuadernos de Investigación UNED, V9, P7; Gebremariam B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203458; Gebru T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-395; Geremew A, 2018, ENVIRON HEALTH PREV, V23, DOI 10.1186/s12199-018-0737-9; Gizaw Z, 2019, ENVIRON HEALTH PREV, V24, DOI 10.1186/s12199-019-0801-0; Harris M, 2017, ENVIRON SCI TECHNOL, V51, P7219, DOI 10.1021/acs.est.7b00178; Harter M, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5287-y; Hurlimann E, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2642-x; Jung S, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1319-z; Jung YT, 2017, PLOS ONE, V12, DOI [10.1371/Journal.pone.0173808, 10.1371/journal.pone.0173808]; Kakulu RemidiusKamuhabwa., 2012, MUHIMBILI U HLTH ALL; Kar K, 2008, HDB COMMUNITY LED TO; Larsen DA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005591; Mihrete TS, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-102; Ministry of Health of Uganda, 2018, COMM LED TOT SAN FAC, P128; Ayalew AM, 2018, J ENVIRON PUBLIC HEA, V2018, DOI 10.1155/2018/4271915; Patil SR, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001709; Pickering AJ, 2015, LANCET GLOB HEALTH, V3, pE701, DOI 10.1016/S2214-109X(15)00144-8; Roushdy R., 2012, IMPACT WATER SUPPLY, P1, DOI [10.23846/wss1.4-egypt-gfr, DOI 10.23846/WSS1.4-EGYPT-GFR]; Solomon Islands Government Ministry of Health, 2016, COMM LED TOT SAN CLT, P170; Tadesse A, 2022, BMC HEALTH SERV RES, V22, DOI 10.1186/s12913-022-07565-7; UNICEF, 2016, COMM LED TOT SAN TRA, P1104; Walker CLF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-220; Warsame HA, 2016, MORBIDITY DIARRHEAL, P192; World Health Organization and United Nations Childrens Fund Joint Monitoring Programme for Water Supply and Sanitation (JMP), 2008, PROGR DRINKING WATER; World Health Organization (WHO), 2018, GUID SAN HLTH	38	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0265804	10.1371/journal.pone.0265804	http://dx.doi.org/10.1371/journal.pone.0265804			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D9PO	35468143	Green Submitted, Green Published, gold			2022-12-26	WOS:000794129600017
J	Cochrane, A; Ruba, AL; Lovely, A; Kane-Grade, FE; Duerst, A; Pollak, SD				Cochrane, Aaron; Ruba, Ashley L.; Lovely, Alyssa; Kane-Grade, Finola E.; Duerst, Abigail; Pollak, Seth D.			Perceptual learning is robust to manipulations of valence and arousal in childhood and adulthood	PLOS ONE			English	Article							PSYCHOMETRIC FUNCTION; POSITIVE AFFECT; STRESS; ORIENTATION; SPECIFICITY; PLASTICITY; ATTENTION; NETWORKS; TRIAL; LAW	Despite clear links between affective processes in many areas of cognition and perception, the influence of affective valence and arousal on low-level perceptual learning have remained largely unexplored. Such influences could have the potential to disrupt or enhance learning that would have long-term consequences for young learners. The current study manipulated 8- to 11-year-old children's and young adults' mood using video clips (to induce a positive mood) or a psychosocial stressor (to induce a negative mood). Each participant then completed one session of a low-level visual learning task (visual texture paradigm). Using novel computational methods, we did not observe evidence for the modulation of visual perceptual learning by manipulations of emotional arousal or valence in either children or adults. The majority of results supported a model of perceptual learning that is overwhelmingly constrained to the task itself and independent from external factors such as variations in learners' affect.	[Cochrane, Aaron] Univ Geneva, Fac Psychol & Educ Sci, Geneva, Switzerland; [Ruba, Ashley L.; Lovely, Alyssa; Pollak, Seth D.] Univ Wisconsin Madison, Dept Psychol, Madison, WI USA; [Kane-Grade, Finola E.] Univ Minnesota, Inst Child Dev, Minneapolis, MN USA; [Duerst, Abigail] Western Michigan Univ, Homer Stryker MD Sch Med, Kalamazoo, MI USA	University of Geneva; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities; Western Michigan University	Cochrane, A (corresponding author), Univ Geneva, Fac Psychol & Educ Sci, Geneva, Switzerland.	aaron.cochrane@unige.ch	Cochrane, Aaron/AAH-7967-2020	Cochrane, Aaron/0000-0001-6691-9149	National Institute of Mental Health; National Institute of Child Health and Human Development [P50HD105353, T32 MH018931]; Hilldale Undergraduate Research Fellowship from the University of Wisconsin - Madison	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Hilldale Undergraduate Research Fellowship from the University of Wisconsin - Madison	This work was supported by the National Institute of Mental Health (www.nimh.nih.gov/) (R01 MH61285), and a core grant to the Waisman Center from the National Institute of Child Health and Human Development (www.nichd.nih.gov/) (P50HD105353) to SDP. ALR was supported by an Emotion Research Training Grant (T32 MH018931) from the National Institute of Mental Health (www.nimh.nih.gov/). The study was also supported by a Hilldale Undergraduate Research Fellowship from the University of Wisconsin - Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Ahissar M, 2000, VISION RES, V40, P1349, DOI 10.1016/S0042-6989(00)00002-X; Ahmadi M, 2018, VISION RES, V152, P101, DOI 10.1016/j.visres.2017.08.008; Ashby FG, 1999, PSYCHOL REV, V106, P529, DOI 10.1037/0033-295X.106.3.529; BALL K, 1987, VISION RES, V27, P953, DOI 10.1016/0042-6989(87)90011-3; Barrett LF, 1999, CURR DIR PSYCHOL SCI, V8, P10, DOI 10.1111/1467-8721.00003; Bejjanki VR, 2011, NAT NEUROSCI, V14, P642, DOI 10.1038/nn.2796; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Bryan T, 1996, LEARN DISABILITY Q, V19, P153, DOI 10.2307/1511058; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Burkner PC, 2020, BRIT J MATH STAT PSY, V73, P420, DOI 10.1111/bmsp.12195; BuskeKirschbaum A, 1997, PSYCHOSOM MED, V59, P419, DOI 10.1097/00006842-199707000-00012; Clewett D, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0108-18.2019; Cochrane A, 2021, J VISION, V21, P1, DOI 10.1167/jov.21.13.5; Cochrane A, 2021, NPJ SCI LEARN, V6, DOI 10.1038/s41539-021-00111-w; Cochrane A, 2019, ATTEN PERCEPT PSYCHO, V81, P621, DOI 10.3758/s13414-018-01636-w; Dale G, 2021, ATTEN PERCEPT PSYCHO, V83, P2241, DOI 10.3758/s13414-021-02268-3; Dehaene S, 2000, PROG BRAIN RES, V126, P217; Dehaene S, 2010, SCIENCE, V330, P1359, DOI 10.1126/science.1194140; Deveau Jenni, 2013, Curr Trends Neurol, V7, P39; Deveau J, 2014, VISION RES, V99, P134, DOI 10.1016/j.visres.2013.12.015; Dosher BA, 2007, PSYCHOL SCI, V18, P531, DOI 10.1111/j.1467-9280.2007.01934.x; FAHLE M, 1993, VISION RES, V33, P397, DOI 10.1016/0042-6989(93)90094-D; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; Gronau QF, 2020, J STAT SOFTW, V92, P1, DOI 10.18637/jss.v092.i10; Hawkey DJC, 2004, NAT NEUROSCI, V7, P1055, DOI 10.1038/nn1315; Heathcote A, 2000, PSYCHON B REV, V7, P185, DOI 10.3758/BF03212979; HEBB DO, 1955, PSYCHOL REV, V62, P243, DOI 10.1037/h0041823; Johnston IA, 2020, J VISION, V20, DOI 10.1167/jov.20.8.16; Kang DW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23487-z; Kattner F, 2017, J VISION, V17, DOI 10.1167/17.11.3; Kattner F, 2017, CURR BIOL, V27, P840, DOI 10.1016/j.cub.2017.01.046; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Klein SA, 2001, PERCEPT PSYCHOPHYS, V63, P1421, DOI 10.3758/BF03194552; Lee TH, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00241; Lupien SJ, 2007, BRAIN COGNITION, V65, P209, DOI 10.1016/j.bandc.2007.02.007; Markant J, 2018, CURR DIR PSYCHOL SCI, V27, P163, DOI 10.1177/0963721418769884; Palmeri TJ, 2004, TRENDS COGN SCI, V8, P378, DOI 10.1016/j.tics.2004.06.001; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; QUICK RF, 1974, KYBERNETIK, V16, P65, DOI 10.1007/BF00271628; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; Rubin N, 1997, CURR BIOL, V7, P461, DOI 10.1016/S0960-9822(06)00217-X; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Saxton BT, 2020, PSYCHOL RES-PSYCH FO, V84, P259, DOI 10.1007/s00426-018-0995-6; Seitz AR, 2007, CURR OPIN NEUROBIOL, V17, P148, DOI 10.1016/j.conb.2007.02.004; Shibata K, 2016, CEREB CORTEX, V26, P3681, DOI 10.1093/cercor/bhw176; Smith KE, 2020, PSYCHONEUROENDOCRINO, V122, DOI 10.1016/j.psyneuen.2020.104873; TEIGEN KH, 1994, THEOR PSYCHOL, V4, P525, DOI 10.1177/0959354394044004; Thorndike EL, 1901, PSYCHOL REV, V8, P247, DOI 10.1037/h0071363; Tiferet-Dweck C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154622; Watanabe T, 2015, ANNU REV PSYCHOL, V66, P197, DOI 10.1146/annurev-psych-010814-015214; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544	54	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266258	10.1371/journal.pone.0266258	http://dx.doi.org/10.1371/journal.pone.0266258			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7VA	35439260	gold, Green Published			2022-12-26	WOS:000791280100025
J	Gros, A; Menguy, S; Bobee, V; Ducharme, O; Cassaigne, IC; Vergier, B; Parrens, M; Beylot-Barry, M; Pham-Ledard, A; Ruminy, P; Jardin, F; Merlio, JP				Gros, Audrey; Menguy, Sarah; Bobee, Victor; Ducharme, Oceane; Cassaigne, Isabelle Cirilo; Vergier, Beatrice; Parrens, Marie; Beylot-Barry, Marie; Pham-Ledard, Anne; Ruminy, Philippe; Jardin, Fabrice; Merlio, Jean-Philippe			Integrative diagnosis of primary cutaneous large B-cell lymphomas supports the relevance of cell of origin profiling	PLOS ONE			English	Article							CLASSIFICATION; SURVIVAL	Primary cutaneous large B-cell lymphomas (PCLBCL) represent a diagnostic challenge because they are classified as PCLBCL, leg type (PCLBCL, LT) or primary cutaneous follicle centre lymphoma, large cell (PCFCL, LC), which differ by prognosis and therapeutic requirement. Unclassified cases with discordant clinical presentations, morphologies, and immunophenotypes may be classified into the not otherwise specified (PCLBCL, NOS) category based on ancillary molecular analyses. Cell-of-origin profiling as germinal centre (GC) type or non-GC type by immunohistochemistry is not considered reproducible because of variable CD10 expression. In a series of 55 PCLBCL cases with > 80% large cells, we reported 21 PCFCL, LC cases as GC-type and 27 PCLBCL, LT as non-GC-type; 7 cases were considered PCLBCL, NOS. Here, we demonstrate the accuracy of molecular profiling of PCLBCL as GC or non-GC type using a reverse transcriptase multiplex ligation assay (RT-MLPA). RT-MLPA classified the seven PCLBCL, NOS cases in accordance with their mutational profile. An integrative principal component analysis confirmed the main criteria and the relevance of genomic profiling of PCFCL, LC as GC-derived, and PCLBCL, LT as non-GC-derived. Both the cell-of-origin classification of PCLBCL and the integrative analysis identified two clinically relevant subgroups according to overall survival, which may help to standardize PCLBCL diagnosis and patient management.	[Gros, Audrey; Cassaigne, Isabelle Cirilo; Merlio, Jean-Philippe] Univ Hosp Bordeaux, Tumor Biol & Tumor Bank Dept, Bordeaux, France; [Gros, Audrey; Menguy, Sarah; Ducharme, Oceane; Vergier, Beatrice; Parrens, Marie; Beylot-Barry, Marie; Pham-Ledard, Anne; Merlio, Jean-Philippe] Univ Bordeaux, Team 5, BRIC, INSERM,U1213, Bordeaux, France; [Menguy, Sarah; Vergier, Beatrice; Parrens, Marie] Univ Hosp Bordeaux, Pathol Dept, Bordeaux, France; [Bobee, Victor] Univ Hosp Rouen, Hematol Dept, Rouen, France; [Ducharme, Oceane; Beylot-Barry, Marie; Pham-Ledard, Anne] Univ Hosp Bordeaux, Dermatol Dept, Bordeaux, France; [Ruminy, Philippe; Jardin, Fabrice] Univ Normandie, Ctr Henri Becquerel, INSERM, U1245, Rouen, France	CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; CHU de Rouen; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Henri Becquerel	Merlio, JP (corresponding author), Univ Hosp Bordeaux, Tumor Biol & Tumor Bank Dept, Bordeaux, France.; Merlio, JP (corresponding author), Univ Bordeaux, Team 5, BRIC, INSERM,U1213, Bordeaux, France.	jp.merlio@u-bordeaux.fr			PROTEOM grant from the Groupe Interregional de Recherche Clinique et Innovation Canceropole Grand SudOuest CHU de Bordeaux [2018/78]; Societe Francaise de Dermatologie	PROTEOM grant from the Groupe Interregional de Recherche Clinique et Innovation Canceropole Grand SudOuest CHU de Bordeaux; Societe Francaise de Dermatologie	This work was supported by a PROTEOM grant from the Groupe Interregional de Recherche Clinique et Innovation Canceropole Grand SudOuest CHU de Bordeaux 2018/78 awarded to Audrey Gros, and a 2018 PROTEOM grant from the Societe Francaise de Dermatologie awarded to Oceane Ducharme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barasch NJK, 2020, HUM PATHOL, V106, P93, DOI 10.1016/j.humpath.2020.09.014; Bobee V., 2020, BLOOD CANCER J, P10, DOI [10.1038/s41408-020-0281-x, DOI 10.1038/S41408-020-0281-X]; Bobee V, 2017, J MOL DIAGN, V19, P892, DOI 10.1016/j.jmoldx.2017.07.007; Carlsen ED, 2019, AM J SURG PATHOL, V43, P1403, DOI 10.1097/PAS.0000000000001363; Chapuy B, 2018, NAT MED, V24, P679, DOI 10.1038/s41591-018-0016-8; Dubois S, 2016, CLIN CANCER RES, V22, P2919, DOI 10.1158/1078-0432.CCR-15-2305; Ducharme O., 2019, J INVEST DERMATOL, DOI [10.1159/000503605, DOI 10.1159/000503605]; Grange F, 2014, JAMA DERMATOL, V150, P535, DOI 10.1001/jamadermatol.2013.7452; Hoefnagel JJ, 2005, BLOOD, V105, P3671, DOI 10.1182/blood-2004-04-1594; Hristov AC, 2020, AM J HEMATOL, V95, P1209, DOI 10.1002/ajh.25970; Hu SM, 2013, BLOOD, V121, P2715, DOI 10.1182/blood-2012-10-461848; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Mareschal S, 2017, J INVEST DERMATOL, V137, P1984, DOI 10.1016/j.jid.2017.04.010; Menguy S, 2019, HISTOPATHOLOGY, V74, P1067, DOI 10.1111/his.13832; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Schmitz R, 2018, NEW ENGL J MED, V378, P1396, DOI 10.1056/NEJMoa1801445; Schrader AMR, 2022, VIRCHOWS ARCH, V480, P667, DOI 10.1007/s00428-021-03265-5; Schrader AMR, 2018, AM J SURG PATHOL, V42, P1488, DOI 10.1097/PAS.0000000000001132; Scott DW, 2018, BLOOD, V131, P2060, DOI 10.1182/blood-2017-12-820605; Senff NJ, 2008, BLOOD, V112, P1600, DOI 10.1182/blood-2008-04-152850; Swerdlow SH., 2017, WHO CLASSIFICATION T, V4th; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Willemze R, 2018, ANN ONCOL, V29, P30, DOI 10.1093/annonc/mdy133; Willemze R, 2005, BLOOD, V105, P3768, DOI 10.1182/blood-2004-09-3502; Willemze R., 2018, WHO CLASSIFICATION S, V4th, P258; Willemze R., 2018, WHO CLASSIFICATION S, V4th, P260; Willemze R, 2019, BLOOD, V133, P1703, DOI 10.1182/blood-2018-11-881268; Xu-Monette ZY, 2020, BLOOD ADV, V4, P28, DOI 10.1182/bloodadvances.2020001949; Zhou XA., 2021, GENOMIC LANDSCAPE CU, V5, P13; Zhou XA, 2018, J INVEST DERMATOL, V138, P2365, DOI 10.1016/j.jid.2018.04.038	32	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266978	10.1371/journal.pone.0266978	http://dx.doi.org/10.1371/journal.pone.0266978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C1KV	35452489	Green Published, gold			2022-12-26	WOS:000792887700031
J	Hagiya, H; Hasegawa, K; Otsuka, F				Hagiya, Hideharu; Hasegawa, Kou; Otsuka, Fumio			Fear of an unprecedented, invisible enemy: Difficulties experienced in establishing criteria for the release of COVID-19 patients from isolation in a Japanese University Hospital	PLOS ONE			English	Article								Introduction The novel coronavirus disease 2019 (COVID-19) has emerged as a global pandemic, and the United States and European authorities established criteria for the release of COVID-19 patients from isolation in October 2020. However, a huge discrepancy exists between the hospital-discharge protocol for COVID-19 patients and the release of patients from in-hospital isolation. Our initially proposed criteria for in-hospital release from isolation was not adhered to by healthcare workers (HCWs) due to prevailing concerns regarding disease infectivity. Herein, we report difficulties encountered in attempting to establish a common understanding of the management of emerging infections. Methods We performed a Google Form-based questionnaire survey targeting HCWs from Okayama University Hospital, Japan, via e-mail on January 21-28, 2021. The anonymous investigation required respondents to provide information regarding their background as well as perceptions regarding the requirement, level of understanding, and readiness for developing release criteria. Results We obtained 150 eligible responses, including 57 (38.0%) from medical doctors and 53 (35.3%) from nurses. Most HCWs managing COVID-19 patients advocated for the implementation of the criteria, whereas those not working in that capacity did not (p<0.001). Over half of the HCWs indicated discomfort at seeing COVID-19 patients transitioning to general management even after meeting the criteria. Conclusions It was challenging to establish a common understanding regarding the ideal criteria for in-hospital release of COVID-19 patients from isolation in our hospital. The dissemination of our experiences and multifaceted discussions with HCWs would be of great value as a countermeasure against the emergent pandemic.	[Hagiya, Hideharu; Hasegawa, Kou; Otsuka, Fumio] Okayama Univ, Dept Gen Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan	Okayama University	Hagiya, H (corresponding author), Okayama Univ, Dept Gen Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	hagiya@okayama-u.ac.jp		Hagiya, Hideharu/0000-0002-5086-1891				Asai A, 2022, ASIAN BIOETHICS REV, V14, P133, DOI 10.1007/s41649-021-00201-2; Centers for Disease Control and Prevention, INT GUID DUR IS PREC; European Centre for Disease Prevention and Control, GUID DISCH END IS PE; Karako K, 2021, BIOSCI TRENDS, V15, P1, DOI 10.5582/bst.2021.01019; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Lee K, 2009, GLOB INST, P1; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3	7	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266853	10.1371/journal.pone.0266853	http://dx.doi.org/10.1371/journal.pone.0266853			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421155	Green Published, gold			2022-12-26	WOS:000795453600071
J	Horhat, R; Miclos-Balica, M; Muntean, P; Popa, S; Sima, I; Glisici, B; Cirja, O; Neagu, A; Neagu, M				Horhat, Raluca; Miclos-Balica, Monica; Muntean, Paul; Popa, Sandra; Sima, Irina; Glisici, Bogdan; Cirja, Onisim; Neagu, Adrian; Neagu, Monica			The impact of subject positioning on body composition assessments by air displacement plethysmography evaluated in a heterogeneous sample	PLOS ONE			English	Article							RELIABILITY; FAT; VALIDATION; ADULTS; VALIDITY; CHILDREN; OBESE; POD	Introduction This study sought to evaluate the impact of subject positioning on body composition assessments by air displacement plethysmography using the BOD POD (R). Methods Eighty-two adults (42 men and 40 women), aged 26.1 +/- 8.4 y (mean +/- standard deviation), body mass index = 23.6 +/- 4.8 kg/m(2), were assessed by repeated measurements in two different positions: relaxed (legs apart, back away from the rear) and compact (legs together, arms near the body, back touching the rear). We relied on Bland-Altman analysis to quantify the agreement between results recorded in the two positions. Using body surface charts, we tested the hypothesis that posture-induced variability stems from differences in exposed skin area. Results Switching from compact to relaxed position resulted in a bias of -197 mL for body volume, -1.53% for percent body fat, and 1.085 kg for fat-free mass. The body surface area in contact with air was larger in relaxed position by 3632 +/- 522 cm(2). When body volume was expressed in terms of the actual area of exposed skin in the compact position, the percent body fat bias became 0.08%, with a 95% confidence interval of (-0.14, 0.29)%. Conclusions Subject posture is a source of significant variability in air displacement plethysmography. The disagreement between results obtained in different positions can be eliminated by adjusting the surface area artifact, suggesting that subject positioning in the BOD POD (R) should be controlled to avoid changes in the amount of air maintained under isothermal conditions by the body.	[Horhat, Raluca; Miclos-Balica, Monica; Muntean, Paul; Popa, Sandra; Sima, Irina; Glisici, Bogdan; Cirja, Onisim; Neagu, Adrian; Neagu, Monica] Victor Babes Univ Med & Pharm, Dept Funct Sci, Timisoara, Romania; [Horhat, Raluca; Neagu, Adrian; Neagu, Monica] Victor Babes Univ Med & Pharm, Ctr Modeling Biol Syst & Data Anal, Timisoara, Romania; [Neagu, Adrian] Univ Missouri, Dept Phys & Astron, Columbia, MO 65211 USA	Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara; University of Missouri System; University of Missouri Columbia	Neagu, M (corresponding author), Victor Babes Univ Med & Pharm, Dept Funct Sci, Timisoara, Romania.; Neagu, M (corresponding author), Victor Babes Univ Med & Pharm, Ctr Modeling Biol Syst & Data Anal, Timisoara, Romania.	neagu.monica@umft.ro	Horhat, Raluca/GVT-1732-2022; Neagu, Adrian/H-6377-2018	Neagu, Adrian/0000-0003-3871-2188				Anderson DE, 2007, J STRENGTH COND RES, V21, P169, DOI 10.1519/00124278-200702000-00030; Biaggi RR, 1999, AM J CLIN NUTR, V69, P898; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Borhani-Khomani K, 2017, J PLAST SURG HAND SU, V51, P375, DOI 10.1080/2000656X.2017.1310732; Cheah AKW, 2018, BURNS TRAUMA, V6, DOI 10.1186/s41038-018-0109-0; Claros Geo, 2005, BMC Pediatr, V5, P37, DOI 10.1186/1471-2431-5-37; Collins AL, 2003, EUR J CLIN NUTR, V57, P770, DOI 10.1038/sj.ejcn.1601609; DEMPSTER P, 1995, MED SCI SPORT EXER, V27, P1692; Fields DA, 2004, CURR OPIN CLIN NUTR, V7, P11, DOI 10.1097/00075197-200401000-00003; Fields DA, 2002, AM J CLIN NUTR, V75, P453, DOI 10.1093/ajcn/75.3.453; Fields DA, 2000, INT J OBESITY, V24, P200, DOI 10.1038/sj.ijo.0801113; Giretzlehner M, 2021, MEDICINA-LITHUANIA, V57, DOI 10.3390/medicina57030242; King GA, 2006, J STRENGTH COND RES, V20, P95; Levenhagen DK, 1999, JPEN-PARENTER ENTER, V23, P293, DOI 10.1177/0148607199023005293; Lund CC., SURG GYNECOL OBSTET, V79, P352; Mance M, 2020, BURNS, V46, P868, DOI 10.1016/j.burns.2019.10.015; MCCRORY MA, 1995, MED SCI SPORT EXER, V27, P1686; Neaman KC, 2011, J BURN CARE RES, V32, P421, DOI 10.1097/BCR.0b013e318217f8c6; Noreen EE, 2006, MED SCI SPORT EXER, V38, P1505, DOI 10.1249/01.mss.0000228950.60097.01; Nunez C, 1999, EUR J CLIN NUTR, V53, P382, DOI 10.1038/sj.ejcn.1600735; Peeters MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032722; Peeters MW, 2011, J SPORT SCI, V29, P191, DOI 10.1080/02640414.2010.530677; Peeters MW., 2009, INT J BODY COMPOSITI, V7, P123; Perle-Jones G., 2020, INT J EXERC SCI, V8; R Core Team, 2021, R LANG ENV STAT; Shafer KJ, 2008, NUTRITION, V24, P148, DOI 10.1016/j.nut.2007.10.015; SIRI WE, 1993, NUTRITION, V9, P481; Tinsley GM, 2020, EUR J CLIN NUTR, V74, P1054, DOI 10.1038/s41430-019-0526-6; Tucker LA, 2014, PERCEPT MOTOR SKILL, V118, P563, DOI 10.2466/03.PMS.118k15w5; Vescovi JD, 2002, MED SCI SPORT EXER, V34, P282, DOI 10.1097/00005768-200202000-00016; WALLACE AB, 1951, LANCET, V260, P501, DOI 10.1016/S0140-6736(51)91975-7; Yee AJ, 2001, AM J CLIN NUTR, V74, P637	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267089	10.1371/journal.pone.0267089	http://dx.doi.org/10.1371/journal.pone.0267089			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1E2NP	35427395	gold, Green Published			2022-12-26	WOS:000794332400036
J	Li, GM; Hui, X; Zhao, Y; Zhai, W; Purswell, JL; Porter, Z; Poudel, S; Jia, LA; Zhang, B; Chesser, GD				Li, Guoming; Hui, Xue; Zhao, Yang; Zhai, Wei; Purswell, Joseph L.; Porter, Zach; Poudel, Sabin; Jia, Linan; Zhang, Bo; Chesser, Gary D.			Effects of ground robot manipulation on hen floor egg reduction, production performance, stress response, bone quality, and behavior	PLOS ONE			English	Article							LAYING HENS; CORTICOSTERONE; WELFARE; FREQUENCY; DENSITY; PERCHES; LITTER	Reducing floor eggs in cage-free (CF) housing systems is among primary concerns for egg producers. The objective of this research was to evaluate the effects of ground robot manipulation on reduction of floor eggs. In addition, the effects of ground robot manipulation on production performance, stress response, bone quality, and behavior were also investigated. Two successive flocks of 180 Hy-Line Brown hens at 34 weeks of this age were used. The treatment structure for each flock consisted of six pens with three treatments (without robot running, with one-week robot running, and with two-weeks robot running), resulting in two replicates per treatment per flock and four replicates per treatment with two flocks. Two phases were involved with each flock. Phase 1 (weeks 35-38) mimicked the normal scenario, and phase 2 (weeks 40-43) mimicked a scenario after inadvertent restriction to nest box access. Results indicate that the floor egg reduction rate in the first two weeks of phase 1 was 11.0% without the robot treatment, 18.9% with the one-week robot treatment, and 34.0% with the two-week robot treatment. The effect of robot operation on floor egg production was not significant when the two phases of data were included in the analysis. Other tested parameters were similar among the treatments, including hen-day egg production, feed intake, feed conversion ratio, live body weight, plasma corticosterone concentration, bone breaking force, ash percentage, and time spent in nest boxes. In conclusion, ground robot operation in CF settings may help to reduce floor egg production to a certain degree for a short period right after being introduced. Additionally, robot operation does not seem to negatively affect hen production performance and well-being.	[Li, Guoming; Porter, Zach; Chesser, Gary D.] Mississippi State Univ, Dept Agr & Biol Engn, Mississippi State, MS 39762 USA; [Li, Guoming] Iowa State Univ, Dept Agr & Biosyst Engn, Ames, IA USA; [Hui, Xue] Henan Univ Anim Husb & Econ, Coll Energy & Intelligent Engn, Zhengzhou, Henan, Peoples R China; [Zhao, Yang] Univ Tennessee, Dept Anim Sci, Knoxville, TN 37901 USA; [Zhai, Wei; Poudel, Sabin; Jia, Linan; Zhang, Bo] Mississippi State Univ, Dept Poultry Sci, Mississippi State, MS 39762 USA; [Purswell, Joseph L.] ARS, USDA, Poultry Res Unit, Mississippi State, MS USA	Mississippi State University; Iowa State University; Henan University of Animal Husbandry & Economy; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Mississippi State University; Mississippi State University; United States Department of Agriculture (USDA)	Chesser, GD (corresponding author), Mississippi State Univ, Dept Agr & Biol Engn, Mississippi State, MS 39762 USA.; Zhao, Y (corresponding author), Univ Tennessee, Dept Anim Sci, Knoxville, TN 37901 USA.	yzhao@utk.edu; dchesser@abe.msstate.edu	Jia, Linan/GVR-9863-2022	Purswell, Joseph/0000-0001-9541-6858; Li, Guoming/0000-0001-7624-8051; poudel, sabin/0000-0001-5421-4256				[Anonymous], 2012, S3583 ASAE; APPLEBY MC, 1984, WORLD POULTRY SCI J, V40, P241, DOI 10.1079/WPS19840019; ASAE Standarts, 2003, S459DEC01 ASAE ANSI; AVMA Guidelines, AVMA GUIDELINES EUTH; Campbell DLM, 2017, ANIMAL, V11, P1036, DOI 10.1017/S1751731116002342; Compendio JDZ., 2018, PHILIPPINE J VET ANI, V42, P91; Cordiner LS, 2001, APPL ANIM BEHAV SCI, V71, P305, DOI 10.1016/S0168-1591(00)00186-6; Cox W., 2011, PROBLEM FLOOR EGGS; CRAIG JV, 1986, POULTRY SCI, V65, P856, DOI 10.3382/ps.0650856; Cronin GM, 2012, ANIM PROD SCI, V52, P398, DOI 10.1071/AN11258; Dennis IC, 2020, BRIT POULTRY SCI, V61, P483, DOI 10.1080/00071668.2020.1759785; GROSS WB, 1985, POULTRY SCI, V64, P2230, DOI 10.3382/ps.0642230; Gunnarsson S, 1999, BRIT POULTRY SCI, V40, P12, DOI 10.1080/00071669987773; Hartcher KM, 2017, WORLD POULTRY SCI J, V73, P767, DOI [10.1017/S0043933917000812, 10.1017/s0043933917000812]; Hunniford ME, 2018, APPL ANIM BEHAV SCI, V201, P7, DOI 10.1016/j.applanim.2017.12.020; Hy-Line, COMM MAN GUID 2020; Hy-Line, UND NEST BEH MAN FEW; Janczak AM, 2015, POULTRY SCI, V94, P1454, DOI 10.3382/ps/pev123; Kang HK, 2016, POULTRY SCI, V95, P2764, DOI 10.3382/ps/pew264; Lei TJ, 2020, IEEE C EVOL COMPUTAT; Li G, 2019, ANIMAL, V13, P2060, DOI [10.1017/S1751731118003440, 10.1017/s1751731118003440]; Li GM, 2020, CAN J ANIM SCI, V100, P37, DOI 10.1139/cjas-2019-0009; Li GM, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20020332; Lundberg A, 1999, APPL ANIM BEHAV SCI, V64, P57, DOI 10.1016/S0168-1591(99)00020-9; Mashaly MM, 2004, POULTRY SCI, V83, P889, DOI 10.1093/ps/83.6.889; MCGIBBON WH, 1976, POULTRY SCI, V55, P765, DOI 10.3382/ps.0550765; Mendez S, 2019, OSF J, P1, DOI [10.31219/OSF.IO/WTA3Q, DOI 10.31219/OSF.IO/WTA3Q]; Mishra A, 2005, POULTRY SCI, V84, P979, DOI 10.1093/ps/84.7.979; MYBIOSOURCE, MYASSAYS DAT AN SOFT; Ochs D, 2019, FOOD POLICY, V87, DOI 10.1016/j.foodpol.2019.101743; Oliveira JL, 2019, INT J AGR BIOL ENG, V12, P7, DOI 10.25165/j.ijabe.20191206.5129; Oliveira JL, 2019, POULTRY SCI, V98, P1664, DOI 10.3382/ps/pey525; Olsson IAS, 2000, APPL ANIM BEHAV SCI, V68, P243, DOI 10.1016/S0168-1591(00)00097-6; Parajuli P, 2020, T ASABE, V63, P477, DOI 10.13031/trans.13644; Park SY, 2003, POULTRY SCI, V82, P1688, DOI 10.1093/ps/82.11.1688; Philippe FX, 2020, LIVEST SCI, V232, DOI 10.1016/j.livsci.2020.103917; Ralph CR, 2015, DOMEST ANIM ENDOCRIN, V50, P72, DOI 10.1016/j.domaniend.2014.09.002; Riczu CM, 2004, POULTRY SCI, V83, P375, DOI 10.1093/ps/83.3.375; Ringgenberg N, 2014, APPL ANIM BEHAV SCI, V155, P66, DOI 10.1016/j.applanim.2014.02.012; SHERWIN CM, 1993, APPL ANIM BEHAV SCI, V36, P211, DOI 10.1016/0168-1591(93)90011-D; Thaxton JP, 2005, J APPL POULTRY RES, V14, P745, DOI 10.1093/japr/14.4.745; Wang G, 1998, BRIT POULTRY SCI, V39, P191, DOI 10.1080/00071669889114; Wechsler B, 2007, APPL ANIM BEHAV SCI, V108, P197, DOI 10.1016/j.applanim.2007.03.012; Welfare Quality R, 2009, WELFARE QUALITY R AS; Yang X, 2020, T ASABE, V63, P1981, DOI 10.13031/trans.14115; Zhang BF, 1997, POULTRY SCI, V76, P1698, DOI 10.1093/ps/76.12.1698; Zhao Y, 2015, POULTRY SCI, V94, P475, DOI 10.3382/ps/peu077	47	0	0	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267568	10.1371/journal.pone.0267568	http://dx.doi.org/10.1371/journal.pone.0267568			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C1KV	35452500	Green Published, gold			2022-12-26	WOS:000792887700034
J	Mirmiran, P; Zahedi, AS; Koochakpour, G; Hosseini-Esfahani, F; Akbarzadeh, M; Daneshpour, MS; Azizi, F				Mirmiran, Parvin; Zahedi, Asiyeh Sadat; Koochakpour, Glareh; Hosseini-Esfahani, Firoozeh; Akbarzadeh, Mahdi; Daneshpour, Maryam S.; Azizi, Fereidoun			Resemblance of nutrient intakes in three generations of parent-offspring pairs: Tehran lipid and Glucose Study	PLOS ONE			English	Article							DIETARY-INTAKE; FAMILY RESEMBLANCE; RELATIVE VALIDITY; CHILDREN; RELIABILITY; VEGETABLES; FAT	The degree of maintaining nutrient intake patterns, conformed in the family, for offspring into adulthood is unknown. The aim of this study was to investigate the correlation between nutrient intakes in three younger-middle-older generations of Tehranian adults by sex. Of individuals who participated in 2012-15 phase of the Tehran Lipid and Glucose Study, 1286 families (4685 subjects), who had at least two members of the family with complete data in two or three generations were entered in this cross-sectional study. The energy and nutrient intakes of parents and their young or adult offspring or grandparents-grandson/granddaughter dyads were compared. The differences were estimated using pairwise t-test and partial correlation. Data of parents with their offspring were paired based on living arrangement. There were 857 fathers (mean age: 55.4 +/- 11.1) and 1394 mothers (mean age: 50.1 +/- 11.4). The mean age of grandfathers and grandmothers were 69.4 +/- 7.9 and 63.7 +/- 8.5 respectively. The significant correlation in fathers-sons and father-daughter (living with their parents) pairs were observed for 9 and 7 nutrients, respectively. Correlations for most nutrients were significant for mother-daughter or sons (living with their parents) dyads. The mean percentage of energy from total fat and trans-fatty acids of sons or daughters (living with their parents) were higher than their parents. For most nutrients, there were no significant adjusted correlations between parents-adult offspring (living independent of their parents) dyads. Also few nutrient intakes of grandparents-grandson or granddaughter dyads were correlated. The nutrient intakes of adult offspring were not associated with their parents; this correlation for younger and older generations disappeared. There were weak to moderate correlation between nutrient intakes of parent-offspring dyads that lived with their parents. The resemblance was higher for mother-offspring than father-offspring. Overall, total fat and trans-fatty acid intakes of young offspring were higher than their parents.	[Mirmiran, Parvin; Hosseini-Esfahani, Firoozeh] Shahid Beheshti Univ Med Sci, Nutr & Endocrine Res Ctr, Res Inst Endocrine Sci, Tehran, Iran; [Zahedi, Asiyeh Sadat; Akbarzadeh, Mahdi; Daneshpour, Maryam S.] Shahid Beheshti Univ Med Sci, Cellular & Mol Endocrine Res Ctr, Res Inst Endocrine Sci, Tehran, Iran; [Koochakpour, Glareh] Maragheh Univ Med Sci, Maragheh, Iran; [Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Endocrine Res Ctr, Res Inst Endocrine Sci, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Hosseini-Esfahani, F (corresponding author), Shahid Beheshti Univ Med Sci, Nutr & Endocrine Res Ctr, Res Inst Endocrine Sci, Tehran, Iran.	f.hosseini@sbmu.ac.ir	Mirmiran, Parvin/V-1433-2019; Azizi, Fereidoun/ABD-4136-2021	Azizi, Fereidoun/0000-0002-6470-2517	Shahid Beheshti University of Medical Sciences, Tehran, Iran [15361]	Shahid Beheshti University of Medical Sciences, Tehran, Iran	This study was supported by Shahid Beheshti University of Medical Sciences, Tehran, Iran (Grant no. 15361). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azizi F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-5; Beydoun MA, 2009, SOC SCI MED, V68, P2137, DOI 10.1016/j.socscimed.2009.03.029; Bogl LH, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080892; Brown R, 2004, HEALTH EDUC RES, V19, P261, DOI 10.1093/her/cyg040; Cullen KW, 2003, HEALTH EDUC BEHAV, V30, P615, DOI 10.1177/1090198103257254; Dong F, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0445-z; Draxten M, 2014, APPETITE, V78, P1, DOI 10.1016/j.appet.2014.02.017; Esfahani FH, 2010, J EPIDEMIOL, V20, P150, DOI 10.2188/jea.JE20090083; Esmailli M., 2016, IRANIAN FOOD COMPOSI, DOI [10.3109/01480545.2016.1157810, DOI 10.3109/01480545.2016.1157810]; Feunekes GIJ, 1997, EUR J CLIN NUTR, V51, P793, DOI 10.1038/sj.ejcn.1600494; Food composition table (FCT), 2010, FOOD COMP TABL FCT; Gillman MW, 2000, ARCH FAM MED, V9, P235, DOI 10.1001/archfami.9.3.235; Hebestreit A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020126; Hosseini-Esfahani F, 2018, INT J ENDOCRINOL MET, V16, DOI 10.5812/ijem.84772; Hosseini-Esfahani F, 2018, INT J ENDOCRINOL MET, V16, DOI 10.5812/ijem.84791; Jahns L, 2001, J PEDIATR-US, V138, P493, DOI 10.1067/mpd.2001.112162; Lahmann PH, 2017, AM J CLIN NUTR, V105, P185, DOI 10.3945/ajcn.116.137539; Mirmiran P, 2010, PUBLIC HEALTH NUTR, V13, P654, DOI 10.1017/S1368980009991698; Momenan AA, 2012, ARCH IRAN MED, V15, P279, DOI 012155/AIM.007; Montazeri S, 2016, J ENVIRON PUBLIC HEA, V2016, DOI 10.1155/2016/8615929; Park HS, 2004, ANN EPIDEMIOL, V14, P486, DOI 10.1016/j.annepidem.2003.10.007; Rahill S, 2020, APPETITE, V147, DOI 10.1016/j.appet.2019.104540; Robinson LN, 2015, J HUM NUTR DIET, V28, P443, DOI 10.1111/jhn.12261; Roemmich JN, 2010, APPETITE, V55, P325, DOI 10.1016/j.appet.2010.07.004; Shrivastava A, 2013, PUBLIC HEALTH NUTR, V16, P1476, DOI 10.1017/S1368980012003667; STAFLEU A, 1994, PREV MED, V23, P474, DOI 10.1006/pmed.1994.1065; Vagstrand K, 2010, BRIT J NUTR, V103, P1205, DOI 10.1017/S0007114509992972; Vepsalainen H, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-018-0693-1; Vivarini P, 2019, BMJ OPEN, V9, P147, DOI 10.1136/bmjopen-2017-020898; Wang Y, 2011, J EPIDEMIOL COMMUN H, V65, P177, DOI 10.1136/jech.2009.095901; Wang YF, 2009, J AM DIET ASSOC, V109, P52, DOI 10.1016/j.jada.2008.10.009; Wroten KC, 2012, APPETITE, V59, P316, DOI 10.1016/j.appet.2012.05.014; Yee AZH, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0501-3	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266941	10.1371/journal.pone.0266941	http://dx.doi.org/10.1371/journal.pone.0266941			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1E2NP	35427388	gold, Green Published			2022-12-26	WOS:000794332400008
J	Ovando-Garay, V; Gonzalez-Gomez, R; Zarza, E; Castillo-Vera, A; de Coss-Flores, ME				Ovando-Garay, Vivian; Gonzalez-Gomez, Rebeca; Zarza, Eugenia; Castillo-Vera, Alfredo; Elena de Coss-Flores, Martha			Morphological and genetic characterization of the broad mite Polyphagotarsonemus latus Banks (Acari: Tarsonemidae) from two Mexican populations	PLOS ONE			English	Article							CYTOCHROME-OXIDASE-I; PRIMERS	Polyphagotarsonemus latus Banks is considered a polyphagous pest of diverse agricultural and ornamental crops of global economic significance. Its distribution, host range, variety of symptoms, morphological differences, chaetotaxy and several ontogeny reports have advanced the idea of P. latus as a species complex. Correct pest identification leads to suitable control treatment. Therefore, the objective of this study was the identification of mites collected in two different geographic regions in Mexico (Chiapas and Guanajuato) that had been tentatively designated as Polyphagotarsonemus sp. Biometric differences on the morphology of adults as well the genetic variability were determined by taxonomical and molecular (mitochondrial COI gene) characterization techniques. The identity of the mites from both populations was confirmed as P. latus based on taxonomic characters. Biometric parameter variations were found between both populations (70.58% and 53.84% for females and males, respectively). The average sequenced fragment size was 447 bp (both populations). A homology search against six P. latus sequences available in the GenBank database revealed that sequence KM580507.1 (from India) shows 83.0-86.41% and 99.26-99.52% similarity with the sequences from Guanajuato and Chiapas, respectively. Molecular data indicated a significant divergence between the populations. The genetic distance demonstrates the population from Chiapas has a higher genetic correspondence (0.010) to the sequence from India (KM580507.1) whereas the population from Guanajuato is more distant (0.191). The genetic distance between the populations of this study and other GenBank sequences is even larger. We consider our results strengthen the hypothesis of P. latus consisting of a species-complex. However, it is essential to extend the study to other regions including its country of origin (Sri Lanka), and to include ultrastructural features.	[Ovando-Garay, Vivian; Gonzalez-Gomez, Rebeca; Castillo-Vera, Alfredo] Colegio la Frontera Sur, Dept Agr Soc & Ambiente, Ecol Artropodos & Manejo Plagas, Tapachula, Chiapas, Mexico; [Gonzalez-Gomez, Rebeca; Zarza, Eugenia] Consejo Nacl Ciencia & Technol, Investigadoras & Invest Mexico, Ciudad De Mexico, Mexico; [Zarza, Eugenia] Colegio la Frontera Sur, Dept Ciencias Sustentabilidad, Biotecnol Ambiental, Tapachula, Chiapas, Mexico; [Elena de Coss-Flores, Martha] Empresa Innovadora Sect Salud & Agr, MEKOSS, Tapachula, Chiapas, Mexico		Gonzalez-Gomez, R (corresponding author), Colegio la Frontera Sur, Dept Agr Soc & Ambiente, Ecol Artropodos & Manejo Plagas, Tapachula, Chiapas, Mexico.; Gonzalez-Gomez, R (corresponding author), Consejo Nacl Ciencia & Technol, Investigadoras & Invest Mexico, Ciudad De Mexico, Mexico.	rgonzalez@ecosur.mx	Zarza, Eugenia/AAG-3651-2020; Castillo, Alfredo/B-5491-2016	Zarza, Eugenia/0000-0001-7702-8579; GONZALEZ-GOMEZ, REBECA/0000-0002-3896-6762; Castillo, Alfredo/0000-0003-1452-0026	Consejo Nacional de Ciencia y Tecnologia (CONACYT) Mexico [869920]	Consejo Nacional de Ciencia y Tecnologia (CONACYT) Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	VOG received a scholarship from Consejo Nacional de Ciencia y Tecnologia (CONACYT) Mexico, 869920, Master Thesis Support Program-2019 and complementary supports to facilitate non-presential work ECOSUR-2020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade-Cetto A, 2005, J ETHNOPHARMACOL, V99, P325, DOI 10.1016/j.jep.2005.04.019; Beer RE., 1965, B ZOOL AGRIE BACHIC, V11, P19; Breda MO, 2017, PEST MANAG SCI, V73, P2054, DOI 10.1002/ps.4571; Cabedo-Lopez M, 2021, AGR FOREST ENTOMOL, V23, P411, DOI 10.1111/afe.12442; Childers CC, 1994, PEST MANAGEMENT SUBT; CROSS JV, 1982, PLANT PATHOL, V31, P391, DOI 10.1111/j.1365-3059.1982.tb01291.x; De Coss FME, 1999, MORFOLOGA EXTERNA CA; de Coss-Romero M, 1998, FLA ENTOMOL, V81, P515, DOI 10.2307/3495950; DEJONG D, 1982, ANNU REV ENTOMOL, V27, P229, DOI 10.1146/annurev.en.27.010182.001305; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; GERSON U, 1992, EXP APPL ACAROL, V13, P163, DOI 10.1007/BF01194934; Ruiz MCG, 2020, MADERA BOSQUES, V26, DOI 10.21829/myb.2020.2632055; Hanson P., 1993, MANEJO INTEGR PLAGAS, V29, P48; Hugon R, 1983, NEUFCHATEAU, V38, P635; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kaewmongkol G, 2011, INFECT GENET EVOL, V11, P1868, DOI 10.1016/j.meegid.2011.07.021; KARL E., 1965, BIOL ZENTRALBL, V84, P331; Krantz GW., 2009, MANUAL ACAROLOGY, V3rd; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; LINDQUIST EE, 1986, MEM ENTOMOL SOC CAN, P1, DOI 10.4039/entm118136fv; LINDQUIST EE, 1986, EXP APPL ACAROL, V2, P323, DOI 10.1007/BF01193898; Linquist EE., 2009, MANUAL ACAROLOGY, VThird, P807; Lopez-Laredo AR, 2009, IN VITRO CELL DEV-PL, V45, P550, DOI 10.1007/s11627-009-9250-6; Lunt DH, 1996, INSECT MOL BIOL, V5, P153, DOI 10.1111/j.1365-2583.1996.tb00049.x; Magalhaes S, 2007, EXP APPL ACAROL, V42, P225, DOI 10.1007/s10493-007-9091-0; Montero-Pau J, 2008, LIMNOL OCEANOGR-METH, V6, P218, DOI 10.4319/lom.2008.6.218; Nasrin M, 2021, ENTOMOL RES, V51, P273, DOI 10.1111/1748-5967.12491; Navajas M, 1996, B ENTOMOL RES, V86, P407, DOI 10.1017/S0007485300034994; OCHOA R, 1991, International Journal of Acarology, V17, P41; Pelton J., 1964, Butler University Botanical Studies, V14, P53; PENA JE, 1990, J ECON ENTOMOL, V83, P2008, DOI 10.1093/jee/83.5.2008; R Core Team, 2021, R LANG ENV STAT; Ramos M., 1988, Revista de Proteccion Vegetal, V3, P183; Rodríguez Isaura Viviana, 2017, Acta Agron., V66, P633, DOI 10.15446/acag.v66n4.59922; Sabino-Lopez J. E., 2021, Agroproductividad, V14, P87, DOI 10.32854/agrop.v14i2.1969; Schaarschmidt L., 1959, P713; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Maanen R, 2010, EXP APPL ACAROL, V52, P29, DOI 10.1007/s10493-010-9343-2; Venzon M, 2008, CROP PROT, V27, P869, DOI 10.1016/j.cropro.2007.10.001	40	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266335	10.1371/journal.pone.0266335	http://dx.doi.org/10.1371/journal.pone.0266335			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446869	Green Published, gold			2022-12-26	WOS:000795468200027
J	Qeadan, F; Tingey, B; Egbert, J; Pezzolesi, MG; Burge, MR; Peterson, KA; Honda, T				Qeadan, Fares; Tingey, Benjamin; Egbert, Jamie; Pezzolesi, Marcus G.; Burge, Mark R.; Peterson, Kathryn A.; Honda, Trenton			The associations between COVID-19 diagnosis, type 1 diabetes, and the risk of diabetic ketoacidosis: A nationwide cohort from the US using the Cerner Real-World Data	PLOS ONE			English	Article							PEDIATRIC-PATIENTS; MELLITUS; AUTOIMMUNITY; CHILDREN; CORONAVIRUS; MORTALITY; INFECTION; LOCKDOWN	ObjectiveTo assess the risk of new-onset type 1 diabetes mellitus (T1D) diagnosis following COVID-19 diagnosis and the impact of COVID-19 diagnosis on the risk of diabetic ketoacidosis (DKA) in patients with prior T1D diagnosis. Research design and methodsRetrospective data consisting of 27,292,879 patients from the Cerner Real-World Data were used. Odds ratios, overall and stratified by demographic predictors, were calculated to assess associations between COVID-19 and T1D. Odds ratios from multivariable logistic regression models, adjusted for demographic and clinical predictors, were calculated to assess adjusted associations between COVID-19 and DKA. Multiple imputation with multivariate imputation by chained equations (MICE) was used to account for missing data. ResultsThe odds of developing new-onset T1D significantly increased in patients with COVID-19 diagnosis (OR: 1.42, 95% CI: 1.38, 1.46) compared to those without COVID-19. Risk varied by demographic groups, with the largest risk among pediatric patients ages 0-1 years (OR: 6.84, 95% CI: 2.75, 17.02) American Indian/Alaskan Natives (OR: 2.30, 95% CI: 1.86, 2.82), Asian or Pacific Islanders (OR: 2.01, 95% CI: 1.61, 2.53), older adult patients ages 51-65 years (OR: 1.77, 95% CI: 1.66, 1.88), those living in the Northeast (OR: 1.71, 95% CI: 1.61, 1.81), those living in the West (OR: 1.65, 95% CI: 1.56, 1.74), and Black patients (OR: 1.59, 95% CI: 1.47, 1.71). Among patients with diagnosed T1D at baseline (n = 55,359), 26.7% (n = 14,759) were diagnosed with COVID-19 over the study period. The odds of developing DKA for those with COVID-19 were significantly higher (OR 2.26, 95% CI: 2.04, 2.50) than those without COVID-19, and the largest risk was among patients with higher Elixhauser Comorbidity Index. ConclusionsCOVID-19 diagnosis is associated with significantly increased risk of new-onset T1D, and American Indian/Alaskan Native, Asian/Pacific Islander, and Black populations are disproportionately at risk. In patients with pre-existing T1D, the risk of developing DKA is significantly increased following COVID-19 diagnosis.	[Qeadan, Fares; Tingey, Benjamin; Egbert, Jamie] Loyola Univ Chicago, Parkinson Sch Hlth Sci & Publ Hlth, Maywood, IL USA; [Pezzolesi, Marcus G.] Univ Utah, Dept Internal Med, Sch Med, Salt Lake City, UT USA; [Burge, Mark R.] Univ New Mex Hosp, Dept Internal Med, Albuquerque, NM USA; [Peterson, Kathryn A.] Univ Utah, Dept Gastroenterol, Sch Med, Salt Lake City, UT USA; [Honda, Trenton] Northeastern Univ, Bouve Coll Hlth Sci, Sch Clin & Rehabil Sci, Boston, MA USA	Loyola University Chicago; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Northeastern University	Qeadan, F (corresponding author), Loyola Univ Chicago, Parkinson Sch Hlth Sci & Publ Hlth, Maywood, IL USA.	fqeadan@luc.edu	Qeadan, Fares/B-9482-2014	Qeadan, Fares/0000-0002-3376-220X				Beliard K, 2021, J DIABETES, V13, P270, DOI 10.1111/1753-0407.13141; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; Bian X, 2016, DIABETES, V65, P285, DOI 10.2337/db15-0179; Boddu SK, 2020, DIABETES METAB SYND, V14, P2211, DOI 10.1016/j.dsx.2020.11.012; Buggs-Saxton C, 2021, PEDIATR CLIN N AM, V68, P1093, DOI 10.1016/j.pcl.2021.05.014; Cerner, 2020, COVID 19 DEID DAT CO; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chee YJ, 2020, DIABETES RES CLIN PR, V164, DOI 10.1016/j.diabres.2020.108166; Coate KC, 2020, CELL METAB, V32, DOI 10.1016/j.cmet.2020.11.006; Ditkowsky J, 2021, WEST J EMERG MED, V22, P599, DOI 10.5811/westjem.2021.2.49634; Divers J, 2020, MMWR-MORBID MORTAL W, V69, P161, DOI 10.15585/mmwr.mm6906a3; Ebekozien O, 2021, J CLIN ENDOCR METAB, V106, pE1755, DOI 10.1210/clinem/dgaa920; Eberle C, 2021, DIABETOL METAB SYNDR, V13, DOI 10.1186/s13098-021-00705-9; Gasparini A., 2020, COMORBIDITY SCORES; Goldman N, 2020, DIABETES RES CLIN PR, V166, DOI 10.1016/j.diabres.2020.108291; Gosmanov AR, 2014, DIABET METAB SYND OB, V7, P255, DOI 10.2147/DMSO.S50516; Haller MJ, 2005, PEDIATR CLIN N AM, V52, P1553, DOI 10.1016/j.pcl.2005.07.006; Hiemstra HS, 2001, P NATL ACAD SCI USA, V98, P3988, DOI 10.1073/pnas.071050898; Kountouri A, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10050752; Kumar A, 2020, DIABETES METAB SYND, V14, P535, DOI 10.1016/j.dsx.2020.04.044; Laitinen OH, 2014, DIABETES, V63, P446, DOI 10.2337/db13-0619; Li JY, 2020, DIABETES OBES METAB, V22, P1935, DOI 10.1111/dom.14057; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Marchand L, 2020, ACTA DIABETOL, V57, P1265, DOI 10.1007/s00592-020-01570-0; Torres-Espindola LM, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00048; Miles A, 2016, SOCIOL METHOD RES, V45, P175, DOI 10.1177/0049124115610345; Moltchanova EV, 2009, DIABETIC MED, V26, P673, DOI 10.1111/j.1464-5491.2009.02743.x; Nassar M, 2021, DIABETES METAB SYND, V15, P447, DOI 10.1016/j.dsx.2021.02.009; Pennington Audrey F, 2021, Open Forum Infect Dis, V8, pofaa638, DOI 10.1093/ofid/ofaa638; Qeadan F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176295; Rabbone I, 2020, DIABETES CARE, V43, P2870, DOI 10.2337/dc20-1321; Ramondetti F, 2012, DIABETIC MED, V29, P761, DOI 10.1111/j.1464-5491.2011.03529.x; Ramos-Yataco A., 2021, J ENDOCR SOC, V5, pA403, DOI [10.1210/jendso/bvab048.821, DOI 10.1210/JENDSO/BVAB048.821]; Reddy PK, 2020, DIABETES METAB SYND, V14, P1459, DOI 10.1016/j.dsx.2020.07.050; Rubin DB., 2004, MULTIPLE IMPUTATION; Rubin R, 2020, JAMA-J AM MED ASSOC, V324, P321, DOI 10.1001/jama.2020.11254; Saleem M., 2021, J ENDOCR SOC, V5, pA338, DOI [10.1210/jendso/bvab048.690, DOI 10.1210/JENDSO/BVAB048.690]; Shyu, 1992, STAT MODELS; Somasundaram NP, 2020, J ENDOCR SOC, V4, DOI 10.1210/jendso/bvaa082; Stene LC, 2010, DIABETES, V59, P3174, DOI 10.2337/db10-0866; Tang XM, 2021, CELL METAB, V33, P1577, DOI 10.1016/j.cmet.2021.05.015; Taplin CE, 2008, AUTOIMMUNITY, V41, P11, DOI 10.1080/08916930701619169; Thunander M, 2008, DIABETES RES CLIN PR, V82, P247, DOI 10.1016/j.diabres.2008.07.022; Tittel SR, 2020, DIABETES CARE, V43, pE172, DOI 10.2337/dc20-1633; Unsworth R, 2020, DIABETES CARE, V43, pE170, DOI 10.2337/dc20-1551; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wu CT, 2021, CELL METAB, V33, P1565, DOI 10.1016/j.cmet.2021.05.013; Yang JK, 2010, ACTA DIABETOL, V47, P193, DOI 10.1007/s00592-009-0109-4; Yu I., 2021, J ENDOCR SOC, V5, pA400, DOI [10.1210/jendso/bvab048.814, DOI 10.1210/JENDSO/BVAB048.814]	50	9	9	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266809	10.1371/journal.pone.0266809	http://dx.doi.org/10.1371/journal.pone.0266809			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7VA	35439266	gold, Green Published			2022-12-26	WOS:000791280100030
J	Richardson, JR; Gotz, R; Mayr, V; Lohse, MJ; Holthoff, HP; Ungerer, M				Richardson, Jennifer R.; Goetz, Ralph; Mayr, Vanessa; Lohse, Martin J.; Holthoff, Hans-Peter; Ungerer, Martin			SARS-CoV2 wild type and mutant specific humoral and T cell immunity is superior after vaccination than after natural infection	PLOS ONE			English	Article							PROTECTION	ObjectiveWe investigated blood samples from fully SARS-CoV2-vaccinated subjects and from previously positive tested patients up to one year after infection with SARS-CoV2, and compared short- and long-term T cell and antibody responses, with a special focus on the recently emerged delta variant (B.1.617.2). Methods and resultsIn 23 vaccinated subjects, we documented high anti-SARS-CoV2 spike protein receptor binding domain (RBD) antibody titers. Average virus neutralization by antibodies, assessed as inhibition of ACE2 binding to RBD, was 2.2-fold reduced for delta mutant vs. wild type (wt) RBD. The mean specific antibody titers were lower one year after natural infection than after vaccination; ACE2 binding to delta mutant vs. wt RBD was 1.65-fold reduced. In an additional group, omicron RBD binding was reduced compared to delta. Specific CD4+ T cell responses were measured after stimulation with peptides pools from wt, alpha, beta, gamma, or delta variant SARS-CoV2 spike proteins by flow cytometric intracellular cytokine staining. There was no significant difference in cytokine production of IFN-gamma, TNF-alpha, or IL-2 between vaccinated subjects. T cell responses to wt or mutant SARS-CoV2 spike were significantly weaker after natural occurring infections compared to those in vaccinated individuals. ConclusionAntibody neutralisation of the delta mutant was reduced compared to wt, as assessed in a novel inhibition assay with a finger prick blood drop. Strong CD4 T cell responses were present against wt and mutant SARS-CoV2 variants, including the delta (B.1.617.2) strain, in fully vaccinated individuals, whereas they were partly weaker 1 year after natural infection. Hence, immune responses after vaccination are stronger compared to those after naturally occurring infection, pointing out the need of the vaccine to overcome the pandemic.	[Richardson, Jennifer R.; Goetz, Ralph; Mayr, Vanessa; Lohse, Martin J.; Holthoff, Hans-Peter; Ungerer, Martin] ISAR Biosci, Planegg, Germany		Holthoff, HP; Ungerer, M (corresponding author), ISAR Biosci, Planegg, Germany.	hans-peter.holthoff@isarbioscience.de; martin.ungerer@isarbioscience.de	Lohse, Martin J/A-7160-2012	Lohse, Martin J/0000-0002-0599-3510				Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; Bilich T, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf7517; Bosnjak B, 2021, CELL MOL IMMUNOL, V18, P936, DOI 10.1038/s41423-020-00573-9; Carreno J.M., 2021, REDUCED NEUTRALIZING, DOI [10.1101/2021.07.21.21260961, DOI 10.1101/2021.07.21.21260961]; Choi A, 2021, J VIROL, V95, DOI 10.1128/JVI.01313-21; Gooch KE, 2019, SCI REP-UK, V9, P1, DOI [10.1038/s41598-018-37186-2, DOI 10.1038/S41598-018-37186-2]; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Jo DH, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9101145; Kim S, 2021, J CHEM THEORY COMPUT, V17, P7972, DOI [10.1021/acs.jctc.1c00965, 10.1101/2021.07.23.453598]; Krammer F, 2020, NATURE, V586, P516, DOI 10.1038/s41586-020-2798-3; Kreer C, 2020, CELL, V182, P843, DOI 10.1016/j.cell.2020.06.044; Liu JY, 2021, NATURE, V596, P273, DOI 10.1038/s41586-021-03693-y; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Lumley SF, 2021, NEW ENGL J MED, V384, P533, DOI 10.1056/NEJMoa2034545; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; Nelde A, 2021, NAT IMMUNOL, V22, P74, DOI 10.1038/s41590-020-00808-x; Ogbe A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21856-3; Payne RP, 2021, PREPUBLICATION; Pilishvili T, 2021, NEW ENGL J MED, V385, DOI 10.1056/NEJMoa2106599; Planas D, 2021, NATURE, V596, P276, DOI 10.1038/s41586-021-03777-9; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Rodda LB, 2021, CELL, V184, P169, DOI [10.1016/j.cell.2020.11.029, 10.21203/rs.3.rs-57112/v1, 10.1101/2020.08.11.20171843]; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Skelly DT., 2021, RES SQ, V12, P1, DOI [10.21203/rs.3.rs-226857, DOI 10.21203/RS.3.RS-226857]; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Volz E, 2021, CELL, V184, P64, DOI 10.1016/j.cell.2020.11.020; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang ZJ, 2021, NATURE, V595, P426, DOI 10.1038/s41586-021-03696-9; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612	32	4	4	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266701	10.1371/journal.pone.0266701	http://dx.doi.org/10.1371/journal.pone.0266701			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D9PO	35468147	gold, Green Published			2022-12-26	WOS:000794129600015
J	Soudy, R; Kimura, R; Fu, W; Patel, A; Jhamandas, J				Soudy, Rania; Kimura, Ryoichi; Fu, Wen; Patel, Aarti; Jhamandas, Jack			Extracellular vesicles enriched with amylin receptor are cytoprotective against the A beta toxicity in vitro	PLOS ONE			English	Article							AMYLOID-BETA; ALZHEIMERS-DISEASE; EXOSOMES; PROTEIN; MODEL; VIVO	Extracellular vesicles (EVs) are double membrane structures released by all cell types with identified roles in the generation, transportation, and degradation of amyloid-beta protein (A beta) oligomers in Alzheimer's disease (AD). EVs are thus increasingly recognized to play a neuroprotective role in AD, through their ability to counteract the neurotoxic effects of A beta, possibly through interactions with specific receptors on cell membranes. Our previous studies have identified the amylin receptor (AMY), particularly AMY3 subtype, as a mediator of the deleterious actions of A beta in vitro and in vivo experimental paradigms. In the present study, we demonstrate that AMY3 enriched EVs can bind soluble oligomers of A beta and protect N2a cells against toxic effects of this peptide. The effect was specific to amylin receptor as it was blocked in the presence of amylin receptor antagonist AC253. This notion was supported by reduced A beta binding to EVs from AMY depleted mice compared to those from wild type (Wt) mice. Finally, application of AMY3, but not Wt derived, EVs to hippocampal brain slices improved A beta-induced reduction of long-term potentiation, a cellular surrogate of memory. Collectively, our observations support the role of AMY receptors, particularly AMY3, in EVs as a potential therapeutic target for AD.	[Soudy, Rania; Kimura, Ryoichi; Fu, Wen; Patel, Aarti; Jhamandas, Jack] Univ Alberta, Neurosci & Mental Hlth Inst, Dept Med Neurol, Edmonton, AB, Canada; [Soudy, Rania] Cairo Univ, Fac Pharm, Cairo, Egypt; [Kimura, Ryoichi] Sanyo Onoda City Univ, Ctr Liberal Arts & Sci, Yamaguchi, Japan	University of Alberta; Egyptian Knowledge Bank (EKB); Cairo University	Jhamandas, J (corresponding author), Univ Alberta, Neurosci & Mental Hlth Inst, Dept Med Neurol, Edmonton, AB, Canada.	jack.jhamandas@ualberta.ca			Alzheimer's Society of Alberta and Northwest Territories; University Hospital Foundation; Canadian Institutes of Health Research [PS 159746]	Alzheimer's Society of Alberta and Northwest Territories; University Hospital Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by grants from the Alzheimer's Society of Alberta and Northwest Territories (https://alzheimer.ca/ab/en? gclid=Cj0KCQjww4OMBhCUARIsAILndv4jBWGZ luVCzDZTsHL7-dar-1Ts8mtoqPceJpXu94qnv0Ke QVCMRmgaAmV_EALw_wcB), and the University Hospital Foundation(https://givetouhf.ca/) to the SynAD Group at the University of Alberta as a part of the Hope for Tomorrow Project and the Canadian Institutes of Health Research (PS 159746; https://cihr-irsc.gc.ca/e/193.html) to JHJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrova LR, 2020, MOL BRAIN, V13, DOI 10.1186/s13041-020-00627-z; An K, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-47; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; D'Acunzo P, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe5085; Davey RA, 2008, J BONE MINER RES, V23, P1182, DOI 10.1359/JBMR.080310; Dinkins MB, 2014, NEUROBIOL AGING, V35, P1792, DOI 10.1016/j.neurobiolaging.2014.02.012; Doyle LM, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070727; Faruqu FN, 2018, JOVE-J VIS EXP, DOI 10.3791/58814; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fu W, 2012, J BIOL CHEM, V287, P18820, DOI 10.1074/jbc.M111.331181; Gimenez-Llort L, 2007, NEUROSCI BIOBEHAV R, V31, P125, DOI 10.1016/j.neubiorev.2006.07.007; Hay DL, 2015, PHARMACOL REV, V67, P564, DOI 10.1124/pr.115.010629; Hong S, 2014, NEURON, V82, P308, DOI 10.1016/j.neuron.2014.02.027; Jhamandas JH, 2011, AM J PATHOL, V178, P140, DOI 10.1016/j.ajpath.2010.11.022; Jiang LQ, 2019, MED SCI MONITOR, V25, P3329, DOI 10.12659/MSM.914027; Joshi P, 2015, INT J MOL SCI, V16, P4800, DOI 10.3390/ijms16034800; Kimura R, 2012, J NEUROSCI, V32, P17401, DOI 10.1523/JNEUROSCI.3028-12.2012; Lord A, 2006, NEUROBIOL AGING, V27, P67, DOI 10.1016/j.neurobiolaging.2004.12.007; Patel A, 2021, MOL NEUROBIOL, V58, P5369, DOI 10.1007/s12035-021-02490-y; Paul PS, 2022, J NANOBIOTECHNOL, V20, DOI 10.1186/s12951-022-01269-0; Perez-Gonzalez R, 2020, FASEB J, V34, P12922, DOI 10.1096/fj.202000823R; Perez-Gonzalez R, 2017, METHODS MOL BIOL, V1545, P139, DOI 10.1007/978-1-4939-6728-5_10; Rastogi S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010440; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Sinha MS, 2018, ACTA NEUROPATHOL, V136, P41, DOI 10.1007/s00401-018-1868-1; Soudy Rania, 2017, Alzheimers Dement (N Y), V3, P44, DOI 10.1016/j.trci.2016.11.005; Sudkamp N, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.591735; Tailor B., 2019, ALZHEIMERS DIS; Vilanova-Perez T, 2020, NANOMEDICINE-UK, V15, P1965, DOI 10.2217/nnm-2020-0056; Weller Jason, 2018, F1000Res, V7, DOI 10.12688/f1000research.14506.1; Yuyama K, 2014, J BIOL CHEM, V289, P24488, DOI 10.1074/jbc.M114.577213; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616; Zhu Haihao, 2017, Alzheimers Dement (N Y), V3, P33, DOI 10.1016/j.trci.2016.12.002	33	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267164	10.1371/journal.pone.0267164	http://dx.doi.org/10.1371/journal.pone.0267164			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421203	Green Published, gold			2022-12-26	WOS:000795453600115
J	Swift, CL; Isanovic, M; Velez, KEC; Sellers, SC; Norman, RS				Swift, Candice L.; Isanovic, Mirza; Velez, Karlen E. Correa; Sellers, Sarah C.; Norman, R. Sean			Wastewater surveillance of SARS-CoV-2 mutational profiles at a university and its surrounding community reveals a 20G outbreak on campus	PLOS ONE			English	Article								Wastewater surveillance of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been leveraged during the Coronavirus Disease 2019 (COVID-19) pandemic as a public health tool at the community and building level. In this study, we compare the sequence diversity of SARS-CoV-2 amplified from wastewater influent to the Columbia, South Carolina, metropolitan wastewater treatment plant (WWTP) and the University of South Carolina campus during September 2020, which represents the peak of COVID-19 cases at the university during 2020. A total of 92 unique mutations were detected across all WWTP influent and campus samples, with the highest frequency mutations corresponding to the SARS-CoV-2 20C and 20G clades. Signature mutations for the 20G Glade dominated SARS-CoV-2 sequences amplified from localized wastewater samples collected at the University of South Carolina, suggesting that the peak in COVID-19 cases during early September 2020 was caused by an outbreak of the 20G lineage. Thirteen mutations were shared between the university building-level wastewater samples and the WWTP influent collected in September 2020, 62% of which were nonsynonymous substitutions. Co-occurrence of mutations was used as a similarity metric to compare wastewater samples. Three pairs of mutations co-occurred in university wastewater and WWTP influent during September 2020. Thirty percent of the detected mutations, including 12 pairs of concurrent mutations, were only detected in university samples. This report affirms the close relationship between the prevalent SARS-CoV-2 genotypes of the student population at a university campus and those of the surrounding community. However, this study also suggests that wastewater surveillance at the building-level at a university offers important insight by capturing sequence diversity that was not apparent in the WWTP influent, thus offering a balance between the community-level wastewater and clinical sequencing.	[Swift, Candice L.; Isanovic, Mirza; Velez, Karlen E. Correa; Sellers, Sarah C.; Norman, R. Sean] Univ South Carolina, Dept Environm Hlth Sci, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia	Norman, RS (corresponding author), Univ South Carolina, Dept Environm Hlth Sci, Columbia, SC 29208 USA.	rsnorman@sc.edu		Norman, Sean/0000-0003-4766-4376; Sellers, Sarah/0000-0002-9676-3197; Swift, Candice/0000-0002-5860-6203	Centers for Disease Control and Prevention [75D-301-18C-02903]; South Carolina Department of Health and Environmental Control [EQ-0-654]; University of South Carolina	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); South Carolina Department of Health and Environmental Control; University of South Carolina	Funding sources to RSN: Centers for Disease Control and Prevention (https://www.cdc.gov/) #75D-301-18C-02903, South Carolina Department of Health and Environmental Control (https://scdhec.gov/) #EQ-0-654, and the University of South Carolina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A. P.Sabin, 2020, medRxiv, DOI 10.1101/2020.10.12.20210294; Ahmed F, 2021, SCI TOTAL ENVIRON, V776, DOI 10.1016/j.scitotenv.2021.145724; [Anonymous], 2021, NATL WASTEWATER SURV; [Anonymous], UOFSC ENROLLMENT INC; [Anonymous], US CENSUS BUREAU QUI; Bureau UC, ZIP CODE TABULATION; Crits-Christoph A., 2020, GENOME SEQUENCING SE, DOI [10.1101/2020.09.13.20193805, DOI 10.1101/2020.09.13.20193805]; Fang SY, 2021, NUCLEIC ACIDS RES, V49, pD706, DOI 10.1093/nar/gkaa808; Fontenele RS, 2021, WATER RES, V205, DOI [10.1016/j.watres.2021.117710, 10.1101/2021.01.22.21250320]; Gibas C, 2021, SCI TOTAL ENVIRON, V782, DOI 10.1016/j.scitotenv.2021.146749; Griffith DM, 2016, J STAT SOFTW, V69, P1; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Harris-Lovett S, 2021, INT J ENV RES PUB HE, V18, DOI [10.3390/ijerph18094455, 10.1101/2021.02.01.21250952]; Jahn K., 2021, INFECT DIS EXCEPT HI, V801, P1499757, DOI [10.1101/ 2021.01.08.21249379, DOI 10.1101/2021.01.08.21249379, 10.1101/2021.01.08.21249379]; Kumar M, 2020, SCI TOTAL ENVIRON, V746, DOI 10.1016/j.scitotenv.2020.141326; La Rosa G, 2020, SCI TOTAL ENVIRON, V736, DOI 10.1016/j.scitotenv.2020.139652; Leidner AJ, 2021, MMWR-MORBID MORTAL W, V70, P14, DOI 10.15585/mmwr.mm7001a4; Li BS, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28089-y; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Loman N, 2020, ARTIC NETWORK, P14; M. S. Andersen, 2022, medRxiv, DOI 10.1101/2020.09.22.20196048; McClary, PREPRINT, V2021, P121, DOI [10.20944/preprints202104.0167.v1, DOI 10.20944/PREPRINTS202104.0167.V1]; Quick J., 2020, PROTOCOLSIO, DOI [10.17504/protocols.io.bbmuik6w.https://doi.org/10.17504/protocols.io.bbmuik6w, DOI 10.17504/PROTOCOLS.IO.BBMUIK6W.HTTPS://DOI.ORG/10.17504/PROTOCOLS.IO.BBMUIK6W]; R Core Team, 2020, R LANG ENV STAT COMP; Rennert L, 2022, CLIN INFECT DIS, V74, P719, DOI 10.1093/cid/ciab454; Scott LC, 2021, ENVIRON RES, V200, DOI 10.1016/j.envres.2021.111374; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Swift CL, 2021, SCI TOTAL ENVIRON, V801, DOI 10.1016/j.scitotenv.2021.149691; UP. University of PennsylvaniaProfile, 2020, US NEWS 0918; Veech JA, 2013, GLOBAL ECOL BIOGEOGR, V22, P252, DOI 10.1111/j.1466-8238.2012.00789.x; Wu FQ, 2022, SCI TOTAL ENVIRON, V805, DOI 10.1016/j.scitotenv.2021.150121; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418; Zhang W, 2020, EMERG MICROBES INFEC, V9, DOI 10.1080/22221751.2020.1729071	34	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266407	10.1371/journal.pone.0266407	http://dx.doi.org/10.1371/journal.pone.0266407			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421164	gold, Green Published			2022-12-26	WOS:000795453600045
J	West, EG; McDermott, C; Chess-Williams, R; Sellers, DJ				West, Eliza G.; McDermott, Catherine; Chess-Williams, Russ; Sellers, Donna J.			Partial recovery of voiding function in female mice following repeated psychological stress exposure	PLOS ONE			English	Article							WATER AVOIDANCE STRESS; BLADDER SMOOTH-MUSCLE; PHASIC ACTIVITY; RAT; ACETYLCHOLINE; HYPERSENSITIVITY; UROTHELIUM; COMPONENTS; RESPONSES; RECEPTOR	Psychological stress causes bladder dysfunction in humans and in rodent models, with increased urinary frequency and altered contractile responses evident following repeated environmental stress exposure. However, whether these changes persist after removal of the stressor is unknown, and the aim of this study was to determine if stress-induced changes in voiding behaviour and bladder function recover following removal of the stressor. Adult female mice were allocated to three groups: Unstressed, Stressed or Stressed + Recovery. Animals in the stressed groups were exposed to water avoidance stress for 1h/day for 10-days, with unstressed animals age-matched and housed under normal conditions. For recovery studies, animals were housed without stress exposure for an additional 10-days. Voiding behaviour was assessed periodically and animals sacrificed on day 10 (Unstressed and Stressed) or day 20 (Unstressed and Stressed + Recovery). Isolated whole bladder studies were used to assess compliance, urothelial mediator release and contractile responses. Exposure to stress increased plasma corticosterone levels almost three-fold (P<0.05) but this returned to baseline during the recovery period. Contractile responses of the bladder to carbachol and KCl were also increased following stress, and again fully recovered after a 10-day stress-free period. In contrast, stress increased urinary frequency four-fold (P<0.001), but this did not return fully to baseline during the recovery period. Bladder compliance was unchanged by stress; however, it was increased in the stressed + recovery group (P<0.05). Thus, following a stress-free period there is partial recovery of voiding behaviour, with an increase in bladder compliance possibly contributing to the compensatory mechanisms.	[West, Eliza G.; McDermott, Catherine; Chess-Williams, Russ; Sellers, Donna J.] Bond Univ, Fac Hlth Sci & Med, Ctr Urol Res, Gold Coast, Australia	Bond University	Sellers, DJ (corresponding author), Bond Univ, Fac Hlth Sci & Med, Ctr Urol Res, Gold Coast, Australia.	dsellers@bond.edu.au		McDermott, Catherine/0000-0003-3118-3084				Avgustinovich D F, 2005, Neurosci Behav Physiol, V35, P917, DOI 10.1007/s11055-005-0146-6; Banks FCL, 2006, BJU INT, V97, P372, DOI 10.1111/j.1464-410X.2006.06010.x; Bradesi S, 2005, AM J PHYSIOL-GASTR L, V289, pG42, DOI 10.1152/ajpgi.00500.2004; Buckner SA, 2002, BRIT J PHARMACOL, V135, P639, DOI 10.1038/sj.bjp.0704499; Burke HM, 2005, PSYCHONEUROENDOCRINO, V30, P846, DOI 10.1016/j.psyneuen.2005.02.010; Butler S, 2018, PHYSIOL BEHAV, V183, P10, DOI 10.1016/j.physbeh.2017.09.020; Chatkoff DK, 2010, INT J PSYCHOPHYSIOL, V77, P150, DOI 10.1016/j.ijpsycho.2010.05.008; Daly DM, 2010, EUR UROL, V58, P22, DOI 10.1016/j.eururo.2009.12.030; De Wachter S, 2003, J UROLOGY, V169, P1892, DOI 10.1097/01.ju.0000049903.60057.4b; Divyashree S, 2018, REPROD FERT DEVELOP, V30, P380, DOI 10.1071/RD17082; Gao YL, 2018, NEUROUROL URODYNAM, V37, P673, DOI 10.1002/nau.23374; Gray JD, 2014, MOL PSYCHIATR, V19, P1171, DOI 10.1038/mp.2013.175; Grundy L, 2020, AM J PHYSIOL-RENAL, V318, pF298, DOI 10.1152/ajprenal.00435.2019; Han DY, 2015, LUTS, V7, P56, DOI 10.1111/luts.12048; Hanna-Mitchell AT, 2007, LIFE SCI, V80, P2298, DOI 10.1016/j.lfs.2007.02.010; Hassan AM, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00386; Hawthorn MH, 2000, BRIT J PHARMACOL, V129, P416, DOI 10.1038/sj.bjp.0703068; Iijima K, 2007, EUR UROL, V52, P842, DOI 10.1016/j.eururo.2007.02.057; Inaba M, 2007, UROL INT, V78, P270, DOI 10.1159/000099351; LEVIN RM, 1986, J UROLOGY, V136, P517, DOI 10.1016/S0022-5347(17)44934-2; Lips KS, 2007, EUR UROL, V51, P1042, DOI 10.1016/j.eururo.2006.10.028; Mann EA, 2015, PHYSIOL BEHAV, V150, P83, DOI 10.1016/j.physbeh.2015.02.021; MASINI E, 1985, INT ARCH ALLER A IMM, V77, P184, DOI 10.1159/000233780; McGonagle E, 2012, NEUROUROL URODYNAM, V31, P1185, DOI 10.1002/nau.22207; Mills IW, 2000, J UROLOGY, V163, P646, DOI 10.1016/S0022-5347(05)67951-7; Mills KA, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-97053-5; Ortiz JB, 2018, FRONT NEUROENDOCRIN, V49, P114, DOI 10.1016/j.yfrne.2018.02.005; PAVCOVICH LA, 1995, NEUROSCI LETT, V196, P185, DOI 10.1016/0304-3940(95)11873-U; Pierce AN, 2016, BRAIN RES, V1639, P58, DOI 10.1016/j.brainres.2016.02.039; Smith AL, 2011, UROLOGY, V78, DOI 10.1016/j.urology.2011.06.041; Spanos C, 1997, J UROLOGY, V157, P669, DOI 10.1016/S0022-5347(01)65247-9; Stevenson K, 2006, MOL CELL BIOCHEM, V283, P107, DOI 10.1007/s11010-006-2388-1; Stromberga Z, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40384-1; Templeman L, 2002, J UROLOGY, V167, P742, DOI 10.1016/S0022-5347(01)69137-7; Vahabi B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058611; Vahabi B, 2011, EUR J PHARMACOL, V660, P431, DOI 10.1016/j.ejphar.2011.03.053; Wang Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182976; West EG, 2021, LIFE SCI, V278, DOI 10.1016/j.lfs.2021.119598; West EG, 2021, LIFE SCI, V265, DOI 10.1016/j.lfs.2020.118735; West EG, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00247; West EG, 2018, J PHARMACOL EXP THER, V366, P282, DOI 10.1124/jpet.118.248989; Yoon H, 2010, KOREAN J UROL, V51, P132, DOI 10.4111/kju.2010.51.2.132	42	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266458	10.1371/journal.pone.0266458	http://dx.doi.org/10.1371/journal.pone.0266458			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446874	Green Published, gold			2022-12-26	WOS:000795468200032
J	Zhan, H; Liu, HZ; Wang, TC; Liu, L; Ai, WF; Lu, XJ				Zhan, Hao; Liu, Hanzhang; Wang, Tianchong; Liu, Lin; Ai, Wanfeng; Lu, Xiujun			Selection and validation of reference genes for quantitative real-time PCR of Quercus mongolica Fisch. ex Ledeb under abiotic stresses	PLOS ONE			English	Article							SUITABLE REFERENCE GENES; RT-PCR; ACCURATE NORMALIZATION; WIDE IDENTIFICATION; EXPRESSION ANALYSIS; QPCR; ACCUMULATION; STRATEGIES; FRUITS	Quercus mongolica Fisch. ex Ledeb is the main species of coniferous and broadleaved mixed forests in northeast and north China, which has high ornamental, economic, and ecological value. The appropriate reference genes must be selected for quantitative real-time PCR to reveal the molecular mechanisms of stress responses and their contribution to breeding of Q. mongolica. In the present study, we chose 11 candidate reference genes (TUA, CYP18, HIS4, RPS13, ACT97, TUB1, UBQ10, UBC5, SAND, PP2A, and SAMDC) and used four programs (GeNorm, NormFinder, BestKeeper, and RefFinder) to assess the expression stability of the above genes in roots, stems, and leaves under five abiotic stress factors (cold, salt, drought, weak light, and heavy metal). The findings revealed that under various experimental environments, the most stable genes were different; CYP18, ACT97, and RPS13 ranked the highest under most experimental environments. Moreover, two genes induced by stress, CMO and P5CS2, were chosen to demonstrate the reliability of the selected reference genes in various tissues under various stress conditions. Our research provides a significant basis for subsequent gene function studies of Q. mongolica.	[Zhan, Hao; Ai, Wanfeng] Shenyang Agr Univ, Coll Hort, Shenyang, Peoples R China; [Liu, Hanzhang; Wang, Tianchong; Liu, Lin; Lu, Xiujun] Shenyang Agr Univ, Coll Forestry, Shenyang, Peoples R China; [Lu, Xiujun] Key Lab Forest Tree Genet Breeding & Cultivat Lia, Shenyang, Peoples R China	Shenyang Agricultural University; Shenyang Agricultural University	Lu, XJ (corresponding author), Shenyang Agr Univ, Coll Forestry, Shenyang, Peoples R China.; Lu, XJ (corresponding author), Key Lab Forest Tree Genet Breeding & Cultivat Lia, Shenyang, Peoples R China.	lxjsyau@syau.edu.cn			National Key Research and Development Program of China [2017YFD0600602]	National Key Research and Development Program of China	This research was funded by National Key Research and Development Program of China (Grant Numbers 2017YFD0600602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroise V, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174210; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Annunziata MG, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00230; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Borges AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111399; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Chen X, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00637; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Deng Y, 2020, FEBS OPEN BIO, V10, P1418, DOI 10.1002/2211-5463.12903; Galli V, 2015, GENE, V554, P205, DOI 10.1016/j.gene.2014.10.049; Gao D, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4643-8; Guobao Wang, 2020, Acta Sericologica Sinica, P560, DOI 10.13441/j.cnki.cykx.2020.05.005; Heng YQ, 2019, P NATL ACAD SCI USA, V116, P26049, DOI 10.1073/pnas.1915149116; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Ji YR, 2020, NEW PHYTOL, V228, P1914, DOI 10.1111/nph.16805; Jiang YiRen, 2019, Acta Sericologica Sinica, P577; Kanakachari M, 2016, APPL BIOCHEM BIOTECH, V178, P433, DOI 10.1007/s12010-015-1884-8; Kim SJ, 2020, PHYSIOL MOL BIOL PLA, V26, P2103, DOI 10.1007/s12298-020-00874-3; Kotrade P, 2019, TREE GENET GENOMES, V15, DOI 10.1007/s11295-019-1347-4; Li CQ, 2019, MOL BIOL REP, V46, P6003, DOI 10.1007/s11033-019-05036-7; Li L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63917-5; Li L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226168; Li MY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01481; Li ZY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225926; Lv Y, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.586098; Marum L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035113; Niu LJ, 2015, INT J MOL SCI, V16, P12513, DOI 10.3390/ijms160612513; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pihur V, 2007, BIOINFORMATICS, V23, P1607, DOI 10.1093/bioinformatics/btm158; Pu Q, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9080996; Qu RJ, 2019, BMC MOL BIOL, V20, DOI 10.1186/s12867-019-0126-y; Shivhare R, 2016, SCI REP-UK, V6, DOI 10.1038/srep23036; Song HY, 2020, BMC PLANT BIOL, V20, DOI 10.1186/s12870-020-02670-3; Torre S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112487; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang F, 2020, PLANT BIOTECHNOL J, V18, P1041, DOI 10.1111/pbi.13272; Wu JY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00780; Xu LF, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00669; Xu ZJ, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01469; Yamada N, 2015, PLANT PHYSIOL BIOCH, V96, P217, DOI 10.1016/j.plaphy.2015.06.014; Yang ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119569; Ye J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33342-w; Zhang K, 2019, ECOTOX ENVIRON SAFE, V168, P127, DOI 10.1016/j.ecoenv.2018.10.049; Zhang MF, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15027982; Zhang M, 2013, FOREST ECOL MANAG, V306, P234, DOI 10.1016/j.foreco.2013.06.031; Zhang SW, 2016, SCI REP-UK, V6, DOI 10.1038/srep30363; Zhang YT, 2018, BMC MOL BIOL, V19, DOI 10.1186/s12867-018-0109-4; Zhao DD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43438-6; Zhao JM, 2020, GENES-BASEL, V11, DOI 10.3390/genes11050502	49	1	1	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267126	10.1371/journal.pone.0267126	http://dx.doi.org/10.1371/journal.pone.0267126			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D8GY	35482686	Green Published, gold			2022-12-26	WOS:000794035700111
J	Meyer, MJ; Schreier, PCF; Basaran, M; Vlasova, S; Seitz, T; Brockmoeller, J; Zdrazil, B; Tzvetkov, MV				Meyer, Marleen J.; Schreier, Pascale C. F.; Basaran, Mert; Vlasova, Stefaniia; Seitz, Tina; Brockmoeller, Juergen; Zdrazil, Barbara; V. Tzvetkov, Mladen			Amino acids in transmembrane helix 1 confer major functional differences between human and mouse orthologs of the polyspecific membrane transporter OCT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC CATION TRANSPORTERS; SPECIES-DIFFERENCES; SUBSTRATE; RAT; EXPRESSION; POLYMORPHISMS; CLONING; ROCT1; PHARMACOKINETICS; IDENTIFICATION	Organic cation transporter 1 (OCT1) is a membrane transporter that affects hepatic uptake of cationic and weakly basic drugs. OCT1 transports structurally highly diverse substrates. The mechanisms conferring this polyspecificity are unknown. Here, we analyzed differences in transport kinetics between human and mouse OCT1 orthologs to identify amino acids that contribute to the polyspecificity of OCT1. Following stable transfection of HEK293 cells, we observed more than twofold differences in the transport kinetics of 22 out of 28 tested substrates. We found that the /12-adrenergic drug fenoterol was transported with eightfold higher affinity but at ninefold lower capacity by human OCT1. In contrast, the anticholinergic drug trospium was transported with 11-fold higher affinity but at ninefold lower capacity by mouse Oct1. Using human-mouse chimeric constructs and site-directed mutagenesis, we identified nonconserved amino acids Cys36 and Phe32 as responsible for the species-specific differences in fenoterol and trospium uptake. Substitution of Cys36 (human) to Tyr36 (mouse) caused a reversal of the affinity and capacity of fenoterol but not trospium uptake. Substitution of Phe32 to Leu32 caused reversal of trospium but not fenoterol uptake kinetics. Comparison of the uptake of structurally similar /12-adrenergics and molecular docking analyses indicated the second phenol ring, 3.3 to 4.8 angstrom from the protonated amino group, as essential for the affinity for fenoterol conferred by Cys36. This is the first study to report single amino acids as determinants of OCT1 polyspecificity. Our findings suggest ferrable between substrates or species.	[Meyer, Marleen J.; Schreier, Pascale C. F.; V. Tzvetkov, Mladen] Univ Med Greifswald, Inst Pharmacol, Ctr Drug Absorpt & Transport C DAT, Dept Gen Pharmacol, Greifswald, Germany; [Basaran, Mert; Vlasova, Stefaniia; Zdrazil, Barbara] Univ Vienna, Dept Pharmaceut Sci, Div Pharmaceut Chem, Vienna, Austria; [Brockmoeller, Juergen] Univ Med Ctr Gottingen, Inst Clin Pharmacol, Gottingen, Germany	Greifswald Medical School; University of Vienna; University of Gottingen	Tzvetkov, MV (corresponding author), Univ Med Greifswald, Inst Pharmacol, Ctr Drug Absorpt & Transport C DAT, Dept Gen Pharmacol, Greifswald, Germany.	mladen.tzvetkov@uni-greifswald.de	; Zdrazil, Barbara/F-1021-2013	Tzvetkov, Mladen/0000-0003-1670-5534; Zdrazil, Barbara/0000-0001-9395-1515	Department of General Pharmacology, Institute of Pharmacology, University MedicineGreifswald; DFG (German Research Foundation); University of Greifwald	Department of General Pharmacology, Institute of Pharmacology, University MedicineGreifswald; DFG (German Research Foundation)(German Research Foundation (DFG)); University of Greifwald	This article contains supporting information. Acknowledgments-We acknowledge Kerstin Schmidt and Tina Sonnenberger (Greifswald) for their technical support in construct generation and uptake experiments. We further acknowledge Alz-beta Tuerkova for the technical support during initial computa-tional modeling efforts and Helen Massy for the support in the initial cloning of mouse and human orthologs and the generation of the low-resolution chimeras. We acknowledge Chemaxon, Budapest, Hungary (https:// www.chemaxon.com ) for providing the academic license for MarvinSketch. This project was funded by internal institutional resources of the Department of General Pharmacology, Institute of Pharmacology, University MedicineGreifswald. We acknowledge support for the articel processing charge from the DFG (German Research Foundation) and the Open Access Publication Fund of the University of Greifwald.	Abebe BT, 2020, J CLIN PHARMACOL, V60, P312, DOI 10.1002/jcph.1523; Ahlin G, 2008, J MED CHEM, V51, P5932, DOI 10.1021/jm8003152; Beaudoin JJ, 2020, PHARMACOL THERAPEUT, V211, DOI 10.1016/j.pharmthera.2020.107542; Born SL, 1997, DRUG METAB DISPOS, V25, P1318; Boxberger KH, 2018, BIOCHEM PHARMACOL, V156, P371, DOI 10.1016/j.bcp.2018.08.028; Brosseau N, 2019, DRUG METAB REV, V51, P389, DOI 10.1080/03602532.2019.1670204; Burckhardt G, 2005, MOL PHARMACOL, V67, P1391, DOI 10.1124/mol.105.012161; Chen EC, 2017, J MED CHEM, V60, P2685, DOI 10.1021/acs.jmedchem.6b01317; Chen JY, 2017, BIOL CHEM, V398, P813, DOI 10.1515/hsz-2017-0129; Chen LG, 2014, P NATL ACAD SCI USA, V111, P9983, DOI 10.1073/pnas.1314939111; Chu XY, 2013, EXPERT OPIN DRUG MET, V9, P237, DOI 10.1517/17425255.2013.741589; Dresser MJ, 2000, J PHARMACOL EXP THER, V292, P1146; Gebauer L, 2022, BIOCHEM PHARMACOL, V197, DOI 10.1016/j.bcp.2021.114871; Gorboulev V, 1999, MOL PHARMACOL, V56, P1254, DOI 10.1124/mol.56.6.1254; Gorboulev V, 2005, MOL PHARMACOL, V67, P1612, DOI 10.1124/mol.104.008821; Gorboulev V, 1997, DNA CELL BIOL, V16, P871, DOI 10.1089/dna.1997.16.871; Gorboulev V, 2018, MOL PHARMACOL, V93, P402, DOI 10.1124/mol.117.110767; Green RM, 1999, HEPATOLOGY, V29, P1556, DOI 10.1002/hep.510290530; Haberkorn B, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.662535; Hendrickx R, 2013, J MED CHEM, V56, P7232, DOI 10.1021/jm400966v; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Ioannides C., 1996, CYTOCHROMES P450 MET; Jensen O, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.674559; Jensen O, 2021, J MED CHEM, V64, P2762, DOI 10.1021/acs.jmedchem.0c02047; Jonker JW, 2003, MOL CELL BIOL, V23, P7902, DOI 10.1128/MCB.23.21.7902-7908.2003; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Keller T, 2019, MOL PHARMACOL, V95, P169, DOI 10.1124/mol.118.113498; Koepsell H, 2020, PHARMACOL REV, V72, P253, DOI 10.1124/pr.118.015578; Koepsell H, 2019, BIOL CHEM, V400, P195, DOI 10.1515/hsz-2018-0191; Koepsell H, 2011, BIOL CHEM, V392, P95, DOI 10.1515/BC.2011.009; Matthaei J, 2016, CLIN PHARMACOL THER, V99, P633, DOI 10.1002/cpt.317; Meyer MJ, 2020, DRUG METAB DISPOS, V48, P1380, DOI 10.1124/dmd.120.000170; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morse BL, 2020, DRUG METAB DISPOS, V48, P93, DOI 10.1124/dmd.119.088781; Nies AT, 2009, HEPATOLOGY, V50, P1227, DOI 10.1002/hep.23103; OHMORI S, 1993, XENOBIOTICA, V23, P419, DOI 10.3109/00498259309057030; Pedersen BP, 2013, NATURE, V496, P533, DOI 10.1038/nature12042; Popp C, 2005, MOL PHARMACOL, V67, P1600, DOI 10.1124/mol.104.008839; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmitt A, 2003, J NEUROSCI RES, V71, P701, DOI 10.1002/jnr.10521; Seitz T, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0172-0; Shu Y, 2008, CLIN PHARMACOL THER, V83, P273, DOI 10.1038/sj.clpt.6100275; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sturm A, 2007, AM J PHYSIOL-RENAL, V293, pF767, DOI 10.1152/ajprenal.00106.2007; Sundelin EIO, 2017, CLIN PHARMACOL THER, V102, P841, DOI 10.1002/cpt.701; Takekuma Y, 2007, J PHARM PHARM SCI, V10, P71; Tzvetkov MV, 2012, PHARMACOGENOMICS J, V12, P22, DOI 10.1038/tpj.2010.75; Tzvetkov MV, 2009, CLIN PHARMACOL THER, V86, P299, DOI 10.1038/clpt.2009.92; Tzvetkov MV, 2018, CLIN PHARMACOL THER, V103, P868, DOI 10.1002/cpt.812; Tzvetkov MV, 2013, BIOCHEM PHARMACOL, V86, P666, DOI 10.1016/j.bcp.2013.06.019; Varadi M., 2021, NUCL ACIDS RES; Volk C, 2009, MOL PHARMACOL, V76, P275, DOI 10.1124/mol.109.054783; Wang DS, 2002, J PHARMACOL EXP THER, V302, P510, DOI 10.1124/jpet.102.034140; Wang L, 2015, DRUG METAB DISPOS, V43, P367, DOI 10.1124/dmd.114.061580; Zhang L, 1997, MOL PHARMACOL, V51, P913, DOI 10.1124/mol.51.6.913	56	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101974	10.1016/j.jbc.2022.101974	http://dx.doi.org/10.1016/j.jbc.2022.101974			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9DZ	35469921	gold, Green Published			2022-12-26	WOS:000807750700014
J	Readnour, BM; Ayinuola, YA; Russo, BT; Liang, Z; Lee, SW; Ploplis, VA; Fischetti, VA; Castellino, FJ				Readnour, Bradley M.; Ayinuola, Yetunde A.; Russo, Brady T.; Liang, Zhong; Lee, Shaun W.; Ploplis, Victoria A.; Fischetti, Vincent A.; Castellino, Francis J.			Evolution of Streptococcus pyogenes has maximized the efficiency of the Sortase A cleavage motif for cell wall transpeptidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCI; SURFACE-PROTEINS; STAPHYLOCOCCUS-AUREUS; HUMAN-PLASMINOGEN; BACKBONE DYNAMICS; VIRULENCE FACTORS; HTRA; SECRETION; SEQUENCE; STREPTOKINASES	Trafficking of M-protein (Mprt) from the cytosol of Group A Streptococcus pyogenes (GAS) occurs via Sec translocase membrane channels that associate with Sortase A (SrtA), an enzyme that catalyzes cleavage of Mprt at the proximal C-terminal [-LPST(355*)GEAA-] motif and subsequent transpeptidation of the Mprt-containing product to the cell wall (CW). These steps facilitate stable exposure of the N-terminus of Mprt to the extracellular milieu where it interacts with ligands. Previously, we found that inactivation of SrtA in GAS cells eliminated Mprt CW transpeptidation but effected little reduction in its cell surface exposure, indicating that the C-terminus of Mprt retained in the cytoplasmic membrane (CM) extends its N-terminus to the cell surface. Herein, we assessed the effects of mutating the Thr(355) residue in the WT SrtA consensus sequence (LPST(355*)GEAA-) in a specific Mprt, PAM. In vitro, we found that synthetic peptides with mutations (LPSX(355)GEAA) in the SrtA cleavage site displayed slower cleavage activities with rSrtA than the WT peptide. Aromatic residues at X had the lowest activities. Nonetheless, PAM/[Y(355)G] still transpeptidated the CW in vivo. However, when using isolated CMs from srtA-inactivated GAS cells, rapid cleavage of PAM/[LPSY(355)GEAA] occurred at E-357* but transpeptidation did not take place. These results show that another CM-resident enzyme nonproductively cleaved PAM/[LPSYGE(357*)AA]. However, SrtA associated with the translocon channel in vivo cleaved and transpeptidated PAM/ [LPSX(355*)GEAA] variants. These CM features allow diverse cleavage site variants to covalently attach to the CW despite the presence of other potent nonproductive CM proteases.	[Readnour, Bradley M.; Ayinuola, Yetunde A.; Russo, Brady T.; Liang, Zhong; Lee, Shaun W.; Ploplis, Victoria A.; Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; [Readnour, Bradley M.; Russo, Brady T.; Ploplis, Victoria A.; Castellino, Francis J.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Lee, Shaun W.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Fischetti, Vincent A.] Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, 1230 York Ave, New York, NY 10021 USA	University of Notre Dame; University of Notre Dame; University of Notre Dame; Rockefeller University	Castellino, FJ (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.; Castellino, FJ (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	fcasteli@nd.edu			NIH [HL013423]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Grant HL013423 by the NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bae T, 2003, J BACTERIOL, V185, P2910, DOI 10.1128/JB.185.9.2910-2919.2003; Bao YJ, 2016, J BACTERIOL, V198, P1712, DOI 10.1128/JB.01019-15; Biagini M, 2015, MOL CELL PROTEOMICS, V14, P2138, DOI 10.1074/mcp.M114.045880; Carlsson F, 2006, NATURE, V442, P943, DOI 10.1038/nature05021; CHIBBER BAK, 1985, BIOCHEMISTRY-US, V24, P3429, DOI 10.1021/bi00335a006; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Cole JN, 2007, PROTEOMICS, V7, P4488, DOI 10.1002/pmic.200700626; Dale JB, 2013, VACCINE, V31, pB216, DOI 10.1016/j.vaccine.2012.09.045; Denks K, 2014, MOL MEMBR BIOL, V31, P58, DOI 10.3109/09687688.2014.907455; FISCHETTI VA, 1990, MOL MICROBIOL, V4, P1603, DOI 10.1111/j.1365-2958.1990.tb02072.x; Fischetti VA., 2016, STREPTOCOCCUS PYOGEN; Fischetti VA, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.GPP3-0010-2018; Grandi Guido, 2010, F1000 Biol Rep, V2, DOI 10.3410/B2-36; Hu P, 2008, ARCH ORAL BIOL, V53, P150, DOI 10.1016/j.archoralbio.2007.08.008; Jacobitz AW, 2017, ADV PROTEIN CHEM STR, V109, P223, DOI 10.1016/bs.apcsb.2017.04.008; Jeffery CJ, 2018, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0523; Kumari P, 2021, BIOTECHNOL BIOENG, V118, P4577, DOI 10.1002/bit.27935; LAWRENCE PI, 1970, J BIOL CHEM, V245, P3660; Lee SG, 2006, J BACTERIOL, V188, P389, DOI 10.1128/JB.188.2.389-398.2006; Lee SG, 2002, J BIOL CHEM, V277, P46912, DOI 10.1074/jbc.M208660200; Liang Z, 2013, J BIOL CHEM, V288, P6561, DOI 10.1074/jbc.M112.442657; Lyon WR, 2004, INFECT IMMUN, V72, P1618, DOI 10.1128/IAI.72.3.1618-1625.2004; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Muller M, 2001, PROG NUCLEIC ACID RE, V66, P107; Nilsen SL, 1999, PROTEIN EXPRES PURIF, V16, P136, DOI 10.1006/prep.1999.1045; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Poquet I, 2000, MOL MICROBIOL, V35, P1042, DOI 10.1046/j.1365-2958.2000.01757.x; Qiu CJ, 2019, J STRUCT BIOL, V206, P193, DOI 10.1016/j.jsb.2019.03.003; Raines RT, 2000, METHOD ENZYMOL, V326, P362; Raz A, 2008, P NATL ACAD SCI USA, V105, P18549, DOI 10.1073/pnas.0808301105; Rosch J, 2004, SCIENCE, V304, P1513, DOI 10.1126/science.1097404; Russo BT, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00096-20; Schneewind O, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.PSIB-0004-2018; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; TOKUNAGA M, 1982, P NATL ACAD SCI-BIOL, V79, P2255, DOI 10.1073/pnas.79.7.2255; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; VONHEIJNE G, 1989, PROTEIN ENG, V2, P531, DOI 10.1093/protein/2.7.531; Wang CC, 2009, J BIOL CHEM, V284, P10957, DOI 10.1074/jbc.M807624200; Wang M, 2010, BIOPHYS J, V99, P302, DOI 10.1016/j.bpj.2010.04.019; Zhang YL, 2013, FEBS LETT, V587, P1304, DOI 10.1016/j.febslet.2013.02.033; Zhang YL, 2012, J BIOL CHEM, V287, P42093, DOI 10.1074/jbc.M112.417808	45	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101940	10.1016/j.jbc.2022.101940	http://dx.doi.org/10.1016/j.jbc.2022.101940			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3R4NR	35430253	gold, Green Published			2022-12-26	WOS:000838892100003
J	Vigil, W; Tran, J; Niks, D; Schut, GJ; Ge, XX; Adams, MWW; Hille, R				Vigil, Wayne, Jr.; Tran, Jessica; Niks, Dimitri; Schut, Gerrit J.; Ge, Xiaoxuan; Adams, Michael W. W.; Hille, Russ			The reductive half-reaction of two bifurcating electron-transferring flavoproteins: Evidence for changes in flavin reduction potentials mediated by specific conformational changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURIFICATION; FERREDOXIN; MECHANISM; SULFITE; COMPLEX; OXYGEN; NADH	The EtfAB components of two bifurcating flavoprotein systems, the crotonyl-CoA-dependent NADH:ferredoxin oxidoreductase from the bacterium Megasphaera elsdenii and the menaquinone-dependent NADH:ferredoxin oxidoreductase from the archaeon Pyrobaculum aerophilum, have been investigated. With both proteins, we find that removal of the electron-transferring flavin adenine dinucleotide (FAD) moiety from both proteins results in an uncrossing of the reduction potentials of the remaining bifurcating FAD; this significantly stabilizes the otherwise very unstable semiquinone state, which accumulates over the course of reductive titrations with sodium dithionite. Furthermore, reduction of both EtfABs depleted of their electron-transferring FAD by NADH was monophasic with a hyperbolic dependence of reaction rate on the concentration of NADH. On the other hand, NADH reduction of the replete proteins containing the electron-transferring FAD was multiphasic, consisting of a fast phase comparable to that seen with the depleted proteins followed by an intermediate phase that involves significant accumulation of FAD.-, again reflecting uncrossing of the half-potentials of the bifurcating FAD. This is then followed by a slow phase that represents the slow reduction of the electron-transferring FAD to FADH-, with reduction of the now fully reoxidized bifurcating FAD by a second equivalent of NADH. We suggest that the crossing and uncrossing of the reduction half-potentials of the bifurcating FAD is due to specific conformational changes that have been structurally characterized.	[Vigil, Wayne, Jr.; Tran, Jessica; Niks, Dimitri; Hille, Russ] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Schut, Gerrit J.; Ge, Xiaoxuan; Adams, Michael W. W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University of California System; University of California Riverside; University System of Georgia; University of Georgia	Hille, R (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	russ.hille@ucr.edu		Vigil Jr, Wayne/0000-0001-7021-1960	National Institutes of Health, United States [GM 135088]; National Science Foundation, United States [CHE 2101672]	National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation, United States(National Science Foundation (NSF))	Work with the P. aerophilum EtfAB was supported by the National Institutes of Health, United States grant GM 135088 (to M. W. W. A. and R. H.); work with the M. elsdenii EtfAB was supported by the National Science Foundation, United States award CHE 2101672 (to R. H.).The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aliverti A, 1999, METH MOL B, V131, P9; BALLOU DP, 1974, ANAL CHEM, V46, P1248, DOI 10.1021/ac60345a034; Brereton PS, 1998, BIOCHEMISTRY-US, V37, P7351, DOI 10.1021/bi972864b; Buckel W, 2018, CHEM REV, V118, P3862, DOI 10.1021/acs.chemrev.7b00707; Buckel W, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00401; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; Chowdhury NP, 2015, FEBS J, V282, P3149, DOI 10.1111/febs.13308; Chowdhury NP, 2014, J BIOL CHEM, V289, P5145, DOI 10.1074/jbc.M113.521013; Demmer JK, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01746-3; Feng X, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2016978118; Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07; Hoben JP, 2017, J BIOL CHEM, V292, P14039, DOI 10.1074/jbc.M117.794214; KOZIOL J., 1971, Methods in Enzymology, V18B, P253, DOI 10.1016/S0076-6879(71)18089-5; Li F, 2008, J BACTERIOL, V190, P843, DOI 10.1128/JB.01417-07; MASSEY V, 1969, J BIOL CHEM, V244, P3999; MULLER F, 1969, J BIOL CHEM, V244, P4007; Niks D, 2019, METHODS MOL BIOL, V1876, P55, DOI 10.1007/978-1-4939-8864-8_4; PACE CP, 1987, BIOCHIM BIOPHYS ACTA, V911, P267, DOI 10.1016/0167-4838(87)90067-7; Palmer G., 1971, P 3 INT S FLAVINS FL; Sato K, 2003, J BIOCHEM, V134, P719, DOI 10.1093/jb/mvg199; Sato K, 2013, J BIOCHEM, V153, P565, DOI 10.1093/jb/mvt026; Schut GJ, 2019, J BIOL CHEM, V294, P3271, DOI 10.1074/jbc.RA118.005653; Sucharitakul J, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.016017; Sucharitakul J, 2021, FEBS J, V288, P1008, DOI 10.1111/febs.15343; TAYLOR MF, 1990, BIOCHEMISTRY-US, V29, P6911, DOI 10.1021/bi00481a022; Toogood HS, 2007, FEBS J, V274, P5481, DOI 10.1111/j.1742-4658.2007.06107.x; Vigil W, 2021, ARCH BIOCHEM BIOPHYS, V701, DOI 10.1016/j.abb.2021.108793; WHITFIELD C, 1972, Federation Proceedings, V31, P447; WHITFIELD CD, 1974, J BIOL CHEM, V249, P2801	29	1	1	7	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101927	10.1016/j.jbc.2022.101927	http://dx.doi.org/10.1016/j.jbc.2022.101927			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9FR	35429498	Green Published, gold			2022-12-26	WOS:000807755100003
J	Shao, R; Liao, XM; Lan, YW; Zhang, H; Jiao, L; Du, QY; Han, D; Ai, QH; Mai, KS; Wan, M				Shao, Rui; Liao, Xinmeng; Lan, Yawen; Zhang, Hui; Jiao, Lin; Du, Qingyang; Han, Dong; Ai, Qinghui; Mai, Kangsen; Wan, Min			Vitamin D regulates insulin pathway and glucose metabolism in zebrafish (Danio rerio)	FASEB JOURNAL			English	Article						1; 25(OH)(2)D-3; diabetes; glucose homeostasis; hyperglycemia; insulin; insulin receptor; vitamin D-3	GLYCOGEN-SYNTHESIS; MUSCLE; RESISTANCE; TRANSPORT; STIMULATION; EXPRESSION; RECEPTORS; LIVER; LEADS	1,25-dihydroxyvitamin D-3 [1,25(OH)(2)D-3], the most active vitamin D (VD) metabolite, is a steroid hormone playing an important role in many physiological functions in addition to maintaining mineral homeostasis. In this study, we explored the mechanism that the VD regulated insulin pathway and glucose metabolism in zebrafish in vitro and in vivo. Our results show that 1,25(OH)(2)D-3 significantly enhances the expression of insulin receptor a (insra), insulin receptor substrate 1 (irs1) and glucose transporter 2 (glut2), and promotes glycolysis and glycogenesis, while suppressing gluconeogenesis in zebrafish liver cell line (ZFL) under the condition of high glucose (20 mM), instead of the normal glucose (10 mM). Moreover, consistent results were obtained from the zebrafish fed with VD3-deficient diet, as well as the cyp2r1(-/-) zebrafish, in which endogenous VD metabolism is blocked. Furthermore, results from dual-luciferase reporting system exhibited that 1,25(OH)(2)D-3 directly activated the transcription of insra, rather than insrb in zebrafish by binding to vitamin D response element (VDRE) located at -181 to -167 bp in the promoter region of insra. Importantly, the 1,25(OH)(2)D-3 treatment significantly alleviated the symptoms of hyperglycemia in diabetic zebrafish. In conclusion, our study demonstrated that VD activates VDRE located in the promoter area of insra in zebrafish to promote insulin/insra signaling pathway, thereby contributing to the maintenance of glucose homeostasis.	[Shao, Rui; Liao, Xinmeng; Lan, Yawen; Zhang, Hui; Jiao, Lin; Du, Qingyang; Ai, Qinghui; Mai, Kangsen; Wan, Min] Ocean Univ China, Coll Fisheries, Key Lab Aquaculture Nutr & Feed, Minist Agr, Qingdao 266003, Peoples R China; [Shao, Rui; Liao, Xinmeng; Lan, Yawen; Zhang, Hui; Jiao, Lin; Du, Qingyang; Ai, Qinghui; Mai, Kangsen; Wan, Min] Ocean Univ China, Coll Fisheries, Minist Educ, Key Lab Mariculture, Qingdao 266003, Peoples R China; [Han, Dong] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China; [Ai, Qinghui; Mai, Kangsen; Wan, Min] Pilot Natl Lab Marine Sci & Technol, Qingdao, Peoples R China	Ministry of Agriculture & Rural Affairs; Ocean University of China; Ocean University of China; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Qingdao National Laboratory for Marine Science & Technology	Wan, M (corresponding author), Ocean Univ China, Coll Fisheries, Key Lab Aquaculture Nutr & Feed, Minist Agr, Qingdao 266003, Peoples R China.; Wan, M (corresponding author), Ocean Univ China, Coll Fisheries, Minist Educ, Key Lab Mariculture, Qingdao 266003, Peoples R China.	Wanmin@ouc.edu.cn		Shao, Rui/0000-0002-1774-6461	National Natural Science Foundation of China (NSFC) [31972802]; National Key R&D Program of China [2018YFD0900400]; Natural Science Foundation of Shandong Province (Natural Science Foundation of Shandong) [ZR2019MC041]; Fundamental Research Funds for the Central Universities [202161026]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Natural Science Foundation of Shandong Province (Natural Science Foundation of Shandong); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31972802; National Key R&D Program of China, Grant/Award Number: 2018YFD0900400; Natural Science Foundation of Shandong Province (Natural Science Foundation of Shandong):, Grant/Award Number: ZR2019MC041; Fundamental Research Funds for the Central Universities, Grant/Award Number: 202161026	Alcaraz-Perez F, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-81; Barbarawi M, 2020, J CLIN ENDOCR METAB, V105, P2857, DOI 10.1210/clinem/dgaa335; Bouskila M, 2008, AM J PHYSIOL-ENDOC M, V294, pE28, DOI 10.1152/ajpendo.00481.2007; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Capiotti KM, 2014, COMP BIOCHEM PHYS B, V171, P58, DOI 10.1016/j.cbpb.2014.03.005; Carlberg C, 2013, STEROIDS, V78, P127, DOI 10.1016/j.steroids.2012.10.019; Caruso MA, 2011, GEN COMP ENDOCR, V173, P227, DOI 10.1016/j.ygcen.2011.06.014; Chen SC, 2016, J BONE MINER RES, V31, P585, DOI 10.1002/jbmr.2729; Christakos S, 2016, PHYSIOL REV, V96, P365, DOI 10.1152/physrev.00014.2015; Colotta F, 2017, J AUTOIMMUN, V85, P78, DOI 10.1016/j.jaut.2017.07.007; Contreras-Bolivar V, 2021, NUTRIENTS, V13, DOI 10.3390/nu13103491; Dimitriadis G, 2011, DIABETES RES CLIN PR, V93, pS52, DOI 10.1016/S0168-8227(11)70014-6; Gong YL, 2018, GEN COMP ENDOCR, V269, P33, DOI 10.1016/j.ygcen.2018.08.012; Haeusler RA, 2018, NAT REV MOL CELL BIO, V19, P31, DOI 10.1038/nrm.2017.89; Hatting M, 2018, ANN NY ACAD SCI, V1411, P21, DOI 10.1111/nyas.13435; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Li SL, 2018, FISH PHYSIOL BIOCHEM, V44, P1185, DOI 10.1007/s10695-018-0508-y; Liao XM, 2022, J INNATE IMMUN, V14, P229, DOI 10.1159/000519183; Maestro B, 2000, ENDOCR J, V47, P383, DOI 10.1507/endocrj.47.383; Manna P, 2012, J BIOL CHEM, V287, P42324, DOI 10.1074/jbc.M112.407833; Melguizo-Rodriguez L, 2021, NUTRIENTS, V13, DOI 10.3390/nu13030830; Merz KE, 2020, COMPR PHYSIOL, V10, P785, DOI 10.1002/cphy.c190029; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Morro M, 2020, DIABETES, V69, P927, DOI 10.2337/db19-0757; Nackiewicz D, 2014, DIABETOLOGIA, V57, P1645, DOI 10.1007/s00125-014-3249-1; Nozaki Y, 2020, P NATL ACAD SCI USA, V117, P8166, DOI 10.1073/pnas.1921694117; Ojuka EO, 2004, P NUTR SOC, V63, P275, DOI 10.1079/PNS2004339; Peng XY, 2017, CELL REP, V19, P1444, DOI 10.1016/j.celrep.2017.04.066; Pittas AG, 2019, NEW ENGL J MED, V381, P520, DOI 10.1056/NEJMoa1900906; Polakof S, 2016, COMP BIOCHEM PHYS B, V199, P43, DOI 10.1016/j.cbpb.2015.11.001; Polakof S, 2012, J COMP PHYSIOL B, V182, P1015, DOI 10.1007/s00360-012-0658-7; Roder PV, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.6; Salehpour A, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.652061; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sassi F, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111656; Shao R, 2022, BRIT J NUTR, V128, P2083, DOI 10.1017/S0007114522000125; Singh A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41009-3; Tai K, 2008, NUTRITION, V24, P279, DOI 10.1016/j.nut.2007.11.006; Thorens B, 2015, DIABETOLOGIA, V58, P221, DOI 10.1007/s00125-014-3451-1; Toyoshima Y, 2008, ENDOCRINOLOGY, V149, P5996, DOI 10.1210/en.2008-0329; Uno K, 2006, SCIENCE, V312, P1656, DOI 10.1126/science.1126010; Wei Z, 2018, CELL, V173, P1135, DOI 10.1016/j.cell.2018.04.013; Wright DC, 2004, DIABETES, V53, P330, DOI 10.2337/diabetes.53.2.330; Yang BY, 2018, AM J PHYSIOL-ENDOC M, V315, pE38, DOI 10.1152/ajpendo.00227.2017; Yang BY, 2017, SCI BULL, V62, P486, DOI 10.1016/j.scib.2017.03.001; Yki-Jarvinen H, 2005, ANN MED, V37, P347, DOI 10.1080/07853890510037383; Zeitz U, 2003, FASEB J, V17, P509, DOI 10.1096/fj.02-0424fje; Zhang DF, 2019, IMMUNITY, V51, P671, DOI 10.1016/j.immuni.2019.08.001; Zheng JS, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003394	50	1	1	23	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22330	10.1096/fj.202200334RR	http://dx.doi.org/10.1096/fj.202200334RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0U6CL	35474468				2022-12-26	WOS:000787737000001
J	DelPozo-Banos, M; Lee, SC; Friedmann, Y; Akbari, A; Torabi, F; Lloyd, K; Lyons, RA; John, A				DelPozo-Banos, M.; Lee, S. C.; Friedmann, Y.; Akbari, A.; Torabi, F.; Lloyd, K.; Lyons, R. A.; John, A.			Healthcare contacts with self-harm during COVID-19: An e-cohort whole-population-based study using individual-level linked routine electronic health records in Wales, UK, 2016-March 2021	PLOS ONE			English	Article							MENTAL-HEALTH; UNITED-STATES; SUICIDE; DIFFERENCE; EPISODES; CHILDREN; POLICY	Introduction Reduced rates of help seeking by those who self-harmed during the COVID-19 pandemic have been reported. Objectives To understand changes in healthcare service contacts for self-harm during the COVID-19 pandemic across primary, emergency and secondary care. Methods This retrospective cohort study used routine electronic healthcare data for Wales, United Kingdom, from 2016 to March 14, 2021. Population-based data from primary care, emergency departments and hospital admissions were linked at individual-level. All Welsh residents aged >= 10 years over the study period were included in the study. Primary, emergency and secondary care contacts with self-harm at any time between 2016 and March 14, 2021 were identified. Outcomes were counts, incidence, prevalence and proportion of self-harm contacts relative to all contacts in each and all settings, as well as the proportion of people contacting one or more settings with self-harm. Weekly trends were modelled using generalised estimated equations, with differences between 2020 (to March 2021) and comparison years 2016-2018 (to March 2017-2019) quantified using difference in differences, from which mean rate of odds ratios (mu ROR) across years was reported. Results The study included 3,552,210 individuals over the study period. Self-harm contacts reduced across services in March and December 2020 compared to previous years. Primary care contacts with self-harm reduced disproportionately compared to non-self-harm contacts (mu ROR = 0.7, p<0.05), while their proportion increased in emergency departments during April 2020 (mu ROR = 1.3, p<0.05 in 2/3 comparison years) and hospital admissions during April-May 2020 (mu ROR = 1.2, p<0.05 in 2/3 comparison years). Despite this, those who self-harmed in April 2020 were more likely to be seen in primary care than other settings compared to previous years (mu ROR = 1.2, p<0.05). A lower proportion of those with self-harm contacts in emergency departments were subsequently admitted to hospital in December 2020 compared to previous years (mu ROR = 0.5, p<0.05). Conclusions These findings suggest that those who self-harmed during the COVID-19 pandemic may have been less likely to seek help, and those who did so faced more stringent criteria for admission. Communications encouraging those who self-harm to seek help during pandemics may be beneficial. However, this needs to be supported by maintained provision of mental health services.	[DelPozo-Banos, M.; Lee, S. C.; Friedmann, Y.; Lloyd, K.; Lyons, R. A.; John, A.] Swansea Univ, Sch Med, Swansea, W Glam, Wales; [Akbari, A.; Torabi, F.] Swansea Univ, Sch Med, Populat Data Sci, Swansea, W Glam, Wales	Swansea University; Swansea University	John, A (corresponding author), Swansea Univ, Sch Med, Swansea, W Glam, Wales.	a.john@swansea.ac.uk		Akbari, Ashley/0000-0003-0814-0801; John, Ann/0000-0002-5657-6995	Welsh Government through Health and Care Research Wales [CA04]; Con-COV team - Medical Research Council [MR/V028367/1]; Health Data Research UK from HDR UK Ltd - UK Medical Research Council [HDR-9006]; Engineering and Physical Sciences Research Council; Economic and Social Research Council; Department of Health and Social Care (England); Chief Scientist Office of the Scottish Government Health and Social Care Directorates; Health and Social Care Research and Development Division (Welsh Government); Public Health Agency (Northern Ireland); British Heart Foundation (BHF); Wellcome Trust; ADR Wales programme; ADR UK [ES/S007393/1]; Wales COVID-19 Evidence Centre - Health and Care Research Wales	Welsh Government through Health and Care Research Wales; Con-COV team - Medical Research Council; Health Data Research UK from HDR UK Ltd - UK Medical Research Council; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department of Health and Social Care (England); Chief Scientist Office of the Scottish Government Health and Social Care Directorates; Health and Social Care Research and Development Division (Welsh Government); Public Health Agency (Northern Ireland); British Heart Foundation (BHF)(British Heart Foundation); Wellcome Trust(Wellcome Trust); ADR Wales programme; ADR UK; Wales COVID-19 Evidence Centre - Health and Care Research Wales	This work was supported by the Welsh Government through Health and Care Research Wales (Grant awarded to The National Centre for Mental Health, No.: CA04) [AJ, MDPB and LL] and by the Con-COV team funded by the Medical Research Council (grant number: MR/V028367/1). This work was also supported by Health Data Research UK, which receives its funding from HDR UK Ltd (HDR-9006) funded by the UK Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Department of Health and Social Care (England), Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (Northern Ireland), British Heart Foundation (BHF) and the Wellcome Trust. This work was supported by the ADR Wales programme of work. The ADR Wales programme of work is aligned to the priority themes as identified in the Welsh Government's national strategy: Prosperity for All. ADR Wales brings together data science experts at Swansea University Medical School, staff from the Wales Institute of Social and Economic Research, Data and Methods (WISERD) at Cardiff University and specialist teams within the Welsh Government to develop new evidence which supports Prosperity for All by using the SAIL Databank at Swansea University, to link and analyse anonymized data. ADR Wales is part of the Economic and Social Research Council (part of UK Research and Innovation) funded ADR UK (grant ES/S007393/1). This work was supported by the Wales COVID-19 Evidence Centre, funded by Health and Care Research Wales.	[Anonymous], WRITT STAT COR COVID; [Anonymous], WAL POP MID YEAR EST; [Anonymous], 2014, WELSH INDEX MULTIPLE; [Anonymous], COR TIM RESP WAL; Batchelor S, 2021, J ADOLESCENT HEALTH, V68, P1067, DOI 10.1016/j.jadohealth.2021.03.015; Capuzzi E, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113463; Carr MJ, 2021, LANCET PUBLIC HEALTH, V6, pe124, DOI 10.1016/S2468-2667(20)30288-7; Chang SS, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5239; Cybulski L, 2021, BMC PSYCHIATRY, V21, DOI 10.1186/s12888-021-03235-w; Czeisler ME, 2020, MMWR-MORBID MORTAL W, V69, P1049, DOI [10.1101/2020.04.22.20076141v1, 10.15585/mmwr.mm6932a1]; Dimick JB, 2014, JAMA-J AM MED ASSOC, V312, P2401, DOI 10.1001/jama.2014.16153; Epstein S, 2020, EUR CHILD ADOLES PSY, V29, P1175, DOI 10.1007/s00787-019-01327-3; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; Goncalves-Pinho M, 2021, PSYCHIAT QUART, V92, P621, DOI 10.1007/s11126-020-09837-z; Gunnell D, 2020, LANCET PSYCHIAT, V7, P468, DOI 10.1016/S2215-0366(20)30171-1; Iob E, 2020, BRIT J PSYCHIAT, V217, P543, DOI 10.1192/bjp.2020.130; John A, 2022, LANCET PSYCHIAT, V9, P23, DOI 10.1016/S2215-0366(21)00367-9; John Ann, 2020, F1000Res, V9, P1097, DOI 10.12688/f1000research.25522.1; John A, 2020, BRIT J PSYCHIAT, V217, P717, DOI 10.1192/bjp.2020.137; Jollant F, 2021, LANCET REG HEALTH-EU, V6, DOI 10.1016/j.lanepe.2021.100102; Karakasi MV, 2020, PSYCHIAT CLIN NEUROS, V74, P613, DOI 10.1111/pcn.13136; Lo YF, 2021, LANCET PSYCHIAT, V8, P179, DOI 10.1016/S2215-0366(20)30565-4; Lyons J, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-043010; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Ma L, 2021, J AFFECT DISORDERS, V293, P78, DOI 10.1016/j.jad.2021.06.021; Mansfield KE, 2021, LANCET DIGIT HEALTH, V3, pE217, DOI [10.1016/S2589-7500(21)00017-0, 10.1016/S2589-7500(21)00017-0ac.uk]; Marchant A, 2020, ARCH DIS CHILD, V105, P347, DOI 10.1136/archdischild-2019-317248; McIntyre A, 2021, IRISH J PSYCHOL MED, V38, P116, DOI 10.1017/ipm.2020.116; Miller M, 2013, AM J PUBLIC HEALTH, V103, pE61, DOI 10.2105/AJPH.2013.301326; Niederkrotenthaler T, 2020, CRISIS, V41, P321, DOI 10.1027/0227-5910/a000731; O'Connor RC, 2021, BRIT J PSYCHIAT, V218, P326, DOI 10.1192/bjp.2020.212; Ougrin D, 2022, EUR CHILD ADOLES PSY, V31, DOI 10.1007/s00787-021-01741-6; Pirkis J, 2021, LANCET PSYCHIAT, V8, P579, DOI 10.1016/S2215-0366(21)00091-2; Pirkis J, 2020, EPIDEMIOL PSYCH SCI, V29, DOI 10.1017/S2045796019000581; Pritchard R., PERCEPTIONS RISK ATT, DOI [10.21203/rs.3.rs-72263/v1, DOI 10.21203/RS.3.RS-72263/V1]; Rhodes HX, 2020, CUREUS, V12, DOI 10.7759/cureus.9811; Samji H, 2022, CHILD ADOL MENT H-UK, V27, P173, DOI 10.1111/camh.12501; Saunders NR, 2022, JAMA PEDIATR, V176, DOI 10.1001/jamapediatrics.2021.6298; Sinyor M, 2017, CURR OPIN PSYCHIATR, V30, P1, DOI 10.1097/YCO.0000000000000296; Steeg S, 2022, BMJ OPEN, V12, DOI 10.1136/bmjopen-2021-052613; Thomas KH, 2013, BRIT J CLIN PHARMACO, V76, P145, DOI 10.1111/bcp.12059; Walker LE, 2020, MAYO CLIN PROC, V95, P2395, DOI 10.1016/j.mayocp.2020.09.019; Wing C, 2018, ANNU REV PUBL HEALTH, V39, P453, DOI 10.1146/annurev-publhealth-040617-013507; Yard E, 2021, MMWR-MORBID MORTAL W, V70, P888, DOI 10.15585/mmwr.mm7024e1; Yolken R, 2021, LANCET PSYCHIAT, V8, P89, DOI 10.1016/S2215-0366(20)30479-X; Zortea TC, 2021, CRISIS, V42, P474, DOI 10.1027/0227-5910/a000753	46	2	2	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0266967	10.1371/journal.pone.0266967	http://dx.doi.org/10.1371/journal.pone.0266967			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476839	gold, Green Published			2022-12-26	WOS:000840124300024
J	Denora, M; Amato, M; Brunetti, G; De Mastro, F; Perniola, M				Denora, Michele; Amato, Mariana; Brunetti, Gennaro; De Mastro, Francesco; Perniola, Michele			Geophysical field zoning for nitrogen fertilization in durum wheat (Triticum durum Desf.)	PLOS ONE			English	Article							YIELD RESPONSE; GRAIN-YIELD; MANAGEMENT; VARIABILITY; TECHNOLOGY; EFFICIENCY; WATER; NDVI	The current social context requires an increase in food production, improvement of its quality characteristics and greater environmental sustainability in the management of agricultural systems. Technological innovation plays a great role in making agriculture more efficient and sustainable. One of the main aims of precision farming (PF) is optimizing yield and its quality, while minimizing environmental impacts and improving the efficient use of resources. Variable rate techniques (VRT) are amongst the main management options for PF, and they require spatial information. This work incorporates maps of soil properties from low induction electromagnetic measurements into nitrogen (N) balance calculations for a field application of VRT nitrogen fertilization of (Triticum durum Desf., var. Tirex). The trial was conducted in 2018-19 at Genzano di Lucania (PZ, Italy) geologically located on the clayey hillsides of the Bradanica pit and the Sant'Arcangelo basin. Three soil homogeneous areas were detected through low induction electromagnetic measurements and used as uniform management zones. The amount of nitrogen fertilizer to be applied by VRT was calculated on the base of estimated crop nitrogen uptake and soil characteristics of each homogeneous area. Crop response to VRT was compared to uniform nitrogen application (UA) on the whole field. The application of VRT resulted in a reduction of 25% nitrogen fertilizer with the same level of yield respect to UA. Grain protein content, as well as gluten content and N content, were significantly higher in VRT than in UA. As a consequence of lower nitrogen input and higher levels of N removal, VRT reached a higher nitrogen use efficiency than UA, and this indicates a lower environmental impact and a higher economic profitability.	[Denora, Michele; Perniola, Michele] Univ Basilicata, Dipartimento Culture Europee & Mediterraneo, Matera, Italy; [Amato, Mariana] Univ Basilicata, Scuola Sci Agr Forestali Alimentari & Ambientali, Potenza, Italy; [Brunetti, Gennaro; De Mastro, Francesco] Univ Bari, Dipartimento Sci Suolo Pianta & Alimenti, Bari, Italy	University of Basilicata; University of Basilicata; Universita degli Studi di Bari Aldo Moro	Perniola, M (corresponding author), Univ Basilicata, Dipartimento Culture Europee & Mediterraneo, Matera, Italy.	michele.perniola@unibas.it		Michele, Denora/0000-0001-7218-1953	"LUCAN CEREALS project" (Rural Development Program of the Basilicata Region) [mis. 16.1. CUP B44G18000020002]	"LUCAN CEREALS project" (Rural Development Program of the Basilicata Region)	This work was partly funded by the "LUCAN CEREALS project" (Rural Development Program of the Basilicata Region - mis. 16.1. CUP B44G18000020002), in particular the funds were used for laboratory analyzes and soil study and management. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balafoutis A, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9081339; Basso B, 2009, J AGRON CROP SCI, V195, P301, DOI 10.1111/j.1439-037X.2008.00351.x; Basso B, 2013, EUR J AGRON, V51, P65, DOI 10.1016/j.eja.2013.06.007; Benincasa P, 2018, EXP AGR, V54, P604, DOI 10.1017/S0014479717000278; Bitella G., 2015, SUSTAINABILITY AGRO, P353, DOI [10.1007/978-3-319-16357-4_23, DOI 10.1007/978-3-319-16357-4_23]; Blandino M, 2016, ITAL J AGRON, V11, P107, DOI 10.4081/ija.2016.745; De Mastro F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219099; De Mastro F, 2019, SOIL RES, V57, P365, DOI 10.1071/SR18297; Diacono M., 2011, World Journal of Agricultural Sciences, V7, P286; Diacono M, 2013, AGRON SUSTAIN DEV, V33, P219, DOI 10.1007/s13593-012-0111-z; Elmetwalli AH, 2020, AGR WATER MANAGE, V242, DOI 10.1016/j.agwat.2020.106413; Fabbri C, 2020, EUR J AGRON, V120, DOI 10.1016/j.eja.2020.126148; Fabiani S, 2020, ENVIRON SCI POLICY, V114, P366, DOI 10.1016/j.envsci.2020.08.019; Gandorfer M., 2017, PRECISION AGR TECHNO, P79, DOI [10.1007/978-3-319-68715-5_3, DOI 10.1007/978-3-319-68715-5_3]; Guerrero A, 2021, SOIL TILL RES, V205, DOI 10.1016/j.still.2020.104789; Guerrini L, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10020233; Hawkesford MJ, 2014, J CEREAL SCI, V59, P276, DOI 10.1016/j.jcs.2013.12.001; Hirel B, 2007, J EXP BOT, V58, P2369, DOI 10.1093/jxb/erm097; Karatay YN, 2020, PRECIS AGRIC, V21, P449, DOI 10.1007/s11119-019-09677-3; Kitchen NR, 2010, AGRON J, V102, P71, DOI 10.2134/agronj2009.0114; Liu YY, 2006, AM J AGR ECON, V88, P471, DOI 10.1111/j.1467-8276.2006.00872.x; Mateo-Marin N, 2020, J PLANT NUTR SOIL SC, V183, P567, DOI 10.1002/jpln.201900561; MIPAAF, 2015, LIN GUID SVIL AGR PR; MOLL RH, 1982, AGRON J, V74, P562, DOI 10.2134/agronj1982.00021962007400030037x; Morari F, 2009, COMPUT ELECTRON AGR, V68, P97, DOI 10.1016/j.compag.2009.05.003; Mori M., 2012, GUIDA CONCIMAZIONE M; OECD, 2016, OECD GREEN GROWTH ST, DOI [10.1787/9789264238657-en, DOI 10.1787/9789264238657-EN]; Page A, 1965, METHODS SOIL ANAL; Passioura JB, 2002, FUNCT PLANT BIOL, V29, P537, DOI 10.1071/FP02020; Pollice A, 2019, STOCH ENV RES RISK A, V33, P747, DOI 10.1007/s00477-019-01667-1; R Core Team, 2020, R LANG ENV STAT COMP; Rathore VS, 2017, AGR WATER MANAGE, V187, P232, DOI 10.1016/j.agwat.2017.03.031; Rogovska N, 2019, PRECIS AGRIC, V20, P40, DOI 10.1007/s11119-018-9579-0; Rossi R, 2018, J APPL GEOPHYS, V159, P146, DOI 10.1016/j.jappgeo.2018.08.008; Rossi R, 2013, INT AGROPHYS, V27, P211, DOI 10.2478/v10247-012-0087-6; Rutting T, 2018, NUTR CYCL AGROECOSYS, V110, P1, DOI 10.1007/s10705-017-9900-8; SOIL SURVEY STAFF, 2014, KEYS SOIL TAXONOMY, V12th; Song XY, 2009, PRECIS AGRIC, V10, P471, DOI 10.1007/s11119-009-9108-2; Yost MA, 2019, PRECIS AGRIC, V20, P1177, DOI 10.1007/s11119-019-09649-7	39	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267219	10.1371/journal.pone.0267219	http://dx.doi.org/10.1371/journal.pone.0267219			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476844	Green Published, gold			2022-12-26	WOS:000840124300029
J	Song, DK; Hong, YS; Sung, YA; Lee, H				Song, Do Kyeong; Hong, Young Sun; Sung, Yeon-Ah; Lee, Hyejin			Waist circumference and mortality or cardiovascular events in a general Korean population	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; BODY-MASS INDEX; FAT DISTRIBUTION; ASSOCIATION; OBESITY; RISK; MEN; METAANALYSIS; PREDICTORS; OVERWEIGHT	Background Obesity is associated with cardiovascular diseases and is a risk factor for all-cause mortality. Until now, the associations between abdominal obesity and mortality or cardiovascular disease (CVD) incidence have not been conclusive. We aimed to evaluate the associations between waist circumference (WC) and mortality or CVD incidence in a general Korean population. Methods We analyzed a total of 204,068 adults older than 40 years of age who had undergone a national health examination at least once from 2009 to 2018 in the Korean National Health Insurance Service Cohort. WC was divided into five categories (< 80, 80-84.9, 85-89.9, 90-94.9, >= 95 cm). Hazard ratios for death and CVD incidence were calculated using Cox proportional hazards models. Results In men, WC and overall mortality showed a reverse J-shaped association. In women, the association between WC and overall mortality was not significant. For both men and women, WC was not associated with the risk of cardiovascular mortality. Contrary to the mortality trend, CVD incidence was positively associated with WC in both men and women, and the risk of the CVD incidence was the lowest in subjects with a WC < 80 cm. Conclusions WC exhibited a significant J-shaped association with overall mortality in men, where subjects who had central obesity showed a lower rate of mortality than those in the lowest or highest WC group. The risk of incident CVD showed a positive association with central obesity, where the lowest risk was observed for subjects in the lowest WC group in a general Korean population.	[Song, Do Kyeong; Hong, Young Sun; Sung, Yeon-Ah; Lee, Hyejin] Ewha Womans Univ, Dept Internal Med, Sch Med, Seoul, South Korea	Ewha Womans University	Lee, H (corresponding author), Ewha Womans Univ, Dept Internal Med, Sch Med, Seoul, South Korea.	hyejinlee@ewha.ac.kr						Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Aune D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2156; Bhaskaran K, 2018, LANCET DIABETES ENDO, V6, P944, DOI [10.1016/S2213-8587(18)30288-2, 10.1016/s2213-8587(18)30288-2]; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; Bluher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc; Canoy D, 2004, J HYPERTENS, V22, P2067, DOI 10.1097/00004872-200411000-00007; Carmienke S, 2013, EUR J CLIN NUTR, V67, P573, DOI 10.1038/ejcn.2013.61; Chen YJ, 2019, OBESITY, V27, P662, DOI 10.1002/oby.22423; Cheng KK., 2020, SCI REP-UK, V10, P1, DOI [10.1038/s41598-019-56847-4, DOI 10.1038/S41598-019-56847-4]; Cho GJ, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1114-7; de Hollander EL, 2012, INT J EPIDEMIOL, V41, P805, DOI 10.1093/ije/dys008; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Jacobs EJ, 2010, ARCH INTERN MED, V170, P1293, DOI 10.1001/archinternmed.2010.201; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Kim YH, 2019, J CLIN MED, V8, DOI 10.3390/jcm8010072; Klein S, 2007, OBESITY, V15, P1061, DOI 10.1038/oby.2007.632; Kong KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185024; Koster A, 2008, AM J EPIDEMIOL, V167, P1465, DOI 10.1093/aje/kwn079; Kuk JL, 2005, AM J CLIN NUTR, V81, P1330; Lee SW, 2018, DIABETES OBES METAB, V20, P141, DOI 10.1111/dom.13050; Leitzmann MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018582; Lv YB, 2018, J AM MED DIR ASSOC, V19, P672, DOI 10.1016/j.jamda.2018.03.015; Saito I, 2012, CIRC J, V76, P2867, DOI 10.1253/circj.CJ-11-1259; Seidell JC, 2010, EUR J CLIN NUTR, V64, P35, DOI 10.1038/ejcn.2009.71; Seidell JC, 2000, EUR J CLIN NUTR, V54, pS33, DOI 10.1038/sj.ejcn.1601023; Simpson JA, 2007, OBESITY, V15, P994, DOI 10.1038/oby.2007.622; Snijder MB, 2006, INT J EPIDEMIOL, V35, P83, DOI 10.1093/ije/dyi253; Staiano AE, 2012, INT J OBESITY, V36, P1450, DOI 10.1038/ijo.2011.268	31	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267597	10.1371/journal.pone.0267597	http://dx.doi.org/10.1371/journal.pone.0267597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476723	Green Submitted, Green Published, gold			2022-12-26	WOS:000840124300055
J	Song, MH; Jo, Y; Kim, YK; Kook, H; Jeong, D; Park, WJ				Song, Min Ho; Jo, Yongjoon; Kim, Young-Kook; Kook, Hyun; Jeong, Dongtak; Park, Woo Jin			The TSP-1 domain of the matricellular protein CCN5 is essential for its nuclear localization and anti-fibrotic function	PLOS ONE			English	Article							ARREST-SPECIFIC GENE; CELLULAR INTERNALIZATION; FAMILY; RECEPTOR; PROLIFERATION; CANCER; THROMBOSPONDIN-1; WISP-2/CCN5; DEGRADATION	The matricellular protein CCN5 exerts anti-fibrotic activity in hearts partly by inducing reverse trans-differentiation of myofibroblasts (MyoFBs) to fibroblasts (FBs). CCN5 consists of three structural domains: an insulin-like growth factor binding protein (IGFBP), a von Willebrand factor type C (VWC), and a thrombospondin type 1 (TSP-1). In this study, we set out to elucidate the roles of these domains in the context of the reverse trans-differentiation of MyoFBs to FBs. First, human cardiac FBs were trans-differentiated to MyoFBs by treatment with TGF-beta; this was then reversed by treatment with recombinant human CCN5 protein or various recombinant proteins comprising individual or paired CCN5 domains. Subcellular localization of these recombinant proteins was analyzed by immunocytochemistry, cellular fractionation, and western blotting. Anti-fibrotic activity was also evaluated by examining expression of MyoFB-specific markers, alpha-SMA and fibronectin. Our data show that CCN5 is taken up by FBs and MyoFBs mainly via clathrin-mediated endocytosis, which is essential for the function of CCN5 during the reverse trans-differentiation of MyoFBs. Furthermore, we showed that the TSP-1 domain is essential and sufficient for endocytosis and nuclear localization of CCN5. However, the TSP-1 domain alone is not sufficient for the anti-fibrotic function of CCN5; either the IGFBP or VWC domain is needed in addition to the TSP-1 domain.	[Song, Min Ho; Jo, Yongjoon; Park, Woo Jin] Gwangju Inst Sci & Technol, Coll Life Sci, Gwangju, South Korea; [Kim, Young-Kook] Chonnam Natl Univ, Dept Biochem, Med Sch, Hwasun, Jeollanam Do, South Korea; [Kook, Hyun] Chonnam Natl Univ, Sch Med, Dept Pharmacol, Hwasun, Jeollanam Do, South Korea; [Jeong, Dongtak] Hanyang Univ, ERICA, Coll Sci & Convergence Technol, Dept Mol & Life Sci, Ansan, Gyeonggi Do, South Korea	Gwangju Institute of Science & Technology (GIST); Chonnam National University; Chonnam National University; Hanyang University	Park, WJ (corresponding author), Gwangju Inst Sci & Technol, Coll Life Sci, Gwangju, South Korea.; Jeong, D (corresponding author), Hanyang Univ, ERICA, Coll Sci & Convergence Technol, Dept Mol & Life Sci, Ansan, Gyeonggi Do, South Korea.	woojinpark@icloud.com; woojinpark@icloud.com	Dongtak, Jeong/AGZ-5435-2022; Jeong, Dongtak/K-2623-2015	Song, Min Ho/0000-0003-4191-8160; Jeong, Dongtak/0000-0003-4153-3498	National Research Foundation of Korea [2019R1A2C2085457, 2019R1A4A1028534]; Korean Government (MSIP); Hanyang University [HY-202000000002749]	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government (MSIP); Hanyang University	D.J. was supported by grants from the National Research Foundation of Korea (2021R1A2C1008058 and 2021R1A4A5032463) funded by the Korean Government (MSIP) and Hanyang University (HY-202000000002749). W.J. P. was supported by grants from the National Research Foundation of Korea (2019R1A2C2085457, 2019R1A4A1028534) funded by the Korean Government (MSIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2007, CANCER BIOL THER, V6, P454, DOI 10.4161/cbt.6.3.3630; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Das A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00916-z; Dhar G, 2007, CANCER LETT, V254, P63, DOI 10.1016/j.canlet.2007.02.012; Dorn LE, 2018, J MOL CELL CARDIOL, V121, P205, DOI 10.1016/j.yjmcc.2018.07.130; Ferrand N, 2012, BIOCHEM J, V447, P71, DOI 10.1042/BJ20120311; Fiaturi N, 2018, J CELL COMMUN SIGNAL, V12, P217, DOI 10.1007/s12079-017-0443-1; Fritah A, 2008, MOL CELL BIOL, V28, P1114, DOI 10.1128/MCB.01335-07; GODYNA S, 1995, J CELL BIOL, V129, P1403, DOI 10.1083/jcb.129.5.1403; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Inadera H, 2009, BIOCHEM BIOPH RES CO, V379, P969, DOI 10.1016/j.bbrc.2008.12.185; Iruela-Arispe ML, 1999, CIRCULATION, V100, P1423, DOI 10.1161/01.CIR.100.13.1423; Jeong D, 2016, J AM COLL CARDIOL, V67, P1556, DOI 10.1016/j.jacc.2016.01.030; Kaasboll OJ, 2018, J BIOL CHEM, V293, P17953, DOI 10.1074/jbc.RA118.004559; Kim Y, 2018, BIOCHEM BIOPH RES CO, V495, P2573, DOI 10.1016/j.bbrc.2017.12.128; Kyurkchiev Stanimir, 2004, Cell Commun Signal, V2, P9, DOI 10.1186/1478-811X-2-9; Lake AC, 2003, AM J PATHOL, V162, P219, DOI 10.1016/S0002-9440(10)63813-8; Lau LF, 2016, J CELL COMMUN SIGNAL, V10, P121, DOI 10.1007/s12079-016-0324-z; Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Mason HR, 2004, MOL HUM REPROD, V10, P181, DOI 10.1093/molehr/gah028; Mikhailenko I, 1997, J BIOL CHEM, V272, P6784, DOI 10.1074/jbc.272.10.6784; MIKHAILENKO I, 1995, J BIOL CHEM, V270, P9543, DOI 10.1074/jbc.270.16.9543; Niwa Y, 2015, FEBS LETT, V589, P3287, DOI 10.1016/j.febslet.2015.09.012; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P57, DOI 10.1136/mp.54.2.57; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Perbal B, 2013, J CELL COMMUN SIGNAL, V7, P169, DOI 10.1007/s12079-013-0193-7; Planque N, 2006, J CELL BIOCHEM, V99, P105, DOI 10.1002/jcb.20887; Rachfal AW, 2005, VITAM HORM, V70, P69, DOI 10.1016/S0083-6729(05)70003-0; Sabbah M, 2011, MOL CELL BIOL, V31, P1459, DOI 10.1128/MCB.01316-10; Tamura I, 2001, AM J PHYSIOL-CELL PH, V281, pC1524, DOI 10.1152/ajpcell.2001.281.5.C1524; Wahab NA, 2001, BIOCHEM J, V359, P89, DOI 10.1042/0264-6021:3590089; Wiesman KC, 2010, J CELL COMMUN SIGNAL, V4, P91, DOI 10.1007/s12079-010-0087-x; Yoon A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208897; Yoon PO, 2010, J MOL CELL CARDIOL, V49, P294, DOI 10.1016/j.yjmcc.2010.04.010	36	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267629	10.1371/journal.pone.0267629	http://dx.doi.org/10.1371/journal.pone.0267629			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476850	Green Published, gold			2022-12-26	WOS:000840124300057
J	Amissah, RQ; Vogt, NA; Chen, CY; Urban, K; Khokhar, J				Amissah, Richard Quansah; Vogt, Nadine A.; Chen, Chuyun; Urban, Karolina; Khokhar, Jibran			Prevalence and characteristics of cannabis-induced toxicoses in pets: Results from a survey of veterinarians in North America	PLOS ONE			English	Article							CONSTITUENT CANNABIDIOL; RECEPTOR AGONISTS; CB1 RECEPTORS; MARIJUANA; INGESTION; DOGS; TOXICITY; BRAIN; RAT; BRADYCARDIA	Cannabis legalization in North America has coincided with an increase in reports of cannabis-induced toxicosis in pets, but the magnitude of this problem, as well as outcomes of these incidents remain unknown. Therefore, we examined the frequency, diagnostic criteria, clinical signs, and prognoses of cannabis toxicoses in pets in North America. We conducted an online survey between January, 2021 and April, 2021 targeting veterinarians practicing in Canada and the United States (US). Out of the 251 study participants, 191 practiced in Canada. Cannabis toxicosis was most commonly reported in dogs (n = 226 veterinarians), and the number of toxicosis cases increased significantly in Canada (p<0.0001) and the US (p = 0.002) after October, 2018. Frequently reported clinical signs of cannabis toxicosis included: urinary incontinence (n = 195), disorientation (n = 182), ataxia (n = 178), lethargy (n = 150), hyperesthesia (n = 134), and bradycardia (n = 112). Edibles were most commonly suspected to be the cause of toxicosis (n = 116). The most common route of exposure was ingestion (n = 135), while the most cited reason was ingestion while unattended (n = 135). Cannabis toxicosis was mostly diagnosed using supportive clinical signs (n = 229), the most common treatment was outpatient monitoring (n = 182), and pets were most often treated as out-patients (n = 103). The legalization of cannabis use in Canada and the US is likely an important factor associated with the increased cannabis toxicosis cases in pets; however, the legal status may also increase reporting. The medicinal use of cannabis by pet-owners for pets may also contribute to a portion of the reported toxicoses. Most pets that experienced cannabis toxicosis recovered completely, suggesting that most cannabis toxicoses do not result in long-term ill effects. Even though some deaths (n = 16) were reported in association with cannabis toxicosis, the presence of confounders such as toxins, and underlying conditions cannot be ruled out, emphasizing the need for rigorous controlled laboratory studies to investigate this important issue.	[Amissah, Richard Quansah; Chen, Chuyun; Khokhar, Jibran] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON, Canada; [Vogt, Nadine A.] Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON, Canada; [Urban, Karolina] Avicanna Inc, Toronto, ON, Canada	University of Guelph; University of Guelph	Khokhar, J (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON, Canada.	jkhokhar@uoguelph.ca	Khokhar, Jibran Younis/AAI-4010-2021	Khokhar, Jibran Younis/0000-0002-2169-2275	Natural Sciences and Engineering Research Council Alliance Grant [ALLRP 549529]; MITACS Accelerate Fellowship [IT27597]	Natural Sciences and Engineering Research Council Alliance Grant; MITACS Accelerate Fellowship	This research was funded by a Natural Sciences and Engineering Research Council Alliance Grant (ALLRP 549529 to JYK; https://www.nserccrsng.gc.ca/innovate-innover/alliancealliance/index_eng.asp) and a MITACS Accelerate Fellowship (IT27597 to RQA and JYK; https://www.mitacs.ca/en/programs/accelerate/fellowship) in partnership with Avicanna Inc. The funders had no role in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	Animal Medicines Australia, 2019, PETS AUSTR NAT SURV; ASPCA, 2021, TIMES LONDON 0617; Atakan Z, 2012, THER ADV PSYCHOPHARM, V2, P241, DOI 10.1177/2045125312457586; Bonz A, 2003, J CARDIOVASC PHARM, V41, P657, DOI 10.1097/00005344-200304000-00020; Bouchard JF, 2003, LIFE SCI, V72, P1859, DOI 10.1016/S0024-3205(02)02474-8; Brutlag A, 2018, VET CLIN N AM-SMALL, V48, P1087, DOI 10.1016/j.cvsm.2018.07.008; Canadian Animal Health Institute, 2021, 2020 CAN PET POP FIG; Canadian Veterinary Medical Association, 2019, NEWS REL NAT VET ASS; Chicoine A, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.583404; Cone EJ, 1998, J ANAL TOXICOL, V22, P460, DOI 10.1093/jat/22.6.460; Costa B, 2007, EUR J PHARMACOL, V556, P75, DOI 10.1016/j.ejphar.2006.11.006; Currie S, 2008, J MOL CELL CARDIOL, V45, P804, DOI 10.1016/j.yjmcc.2008.07.005; De Briyne N, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11030892; Donaldson CW, 2002, VET MED-US, V97, P437; Ettinger SJ., 2017, TXB VET INTERNAL MED, V39, P1483; Fitzgerald KT, 2013, TOP COMPANION ANIM M, V28, P8, DOI 10.1053/j.tcam.2013.03.004; Freundt-Revilla J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181064; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Girling SJ, 2011, J SMALL ANIM PRACT, V52, P113, DOI 10.1111/j.1748-5827.2010.01017.x; Glass M, 1997, NEUROSCIENCE, V77, P299, DOI 10.1016/S0306-4522(96)00428-9; GODBOLD JC, 1979, J AM VET MED ASSOC, V175, P1101; Grotenhermen F, 2016, CRIT REV PLANT SCI, V35, P378, DOI 10.1080/07352689.2016.1265360; HANASONO GK, 1987, FUND APPL TOXICOL, V9, P185, DOI 10.1016/0272-0590(87)90042-X; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Howard-Azzeh M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250323; Huestis MA, 2007, CHEM BIODIVERS, V4, P1770, DOI 10.1002/cbdv.200790152; ICHISE M, 1992, NUCL MED COMMUN, V13, P767, DOI 10.1097/00006231-199213100-00011; Janczyk P, 2004, VET HUM TOXICOL, V46, P19; Janeczek A, 2018, ACTA VET SCAND, V60, DOI 10.1186/s13028-018-0398-0; Kim SI, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00098; Kogan LR, 2019, CAN VET J, V60, P749; Kuratsune H, 1997, BIOCHEM BIOPH RES CO, V231, P488, DOI 10.1006/bbrc.1996.5919; Lake KD, 1997, J PHARMACOL EXP THER, V281, P1030; Lauinger CA, 2022, AUST VET J, V100, P90, DOI 10.1111/avj.13134; Malfait AM, 2000, P NATL ACAD SCI USA, V97, P9561, DOI 10.1073/pnas.160105897; Martin RS, 2000, BRIT J PHARMACOL, V129, P1707, DOI 10.1038/sj.bjp.0703229; Meola SD, 2012, J VET EMERG CRIT CAR, V22, P690, DOI 10.1111/j.1476-4431.2012.00818.x; Obafemi AI, 2015, J MED TOXICOL, V11, P426, DOI 10.1007/s13181-015-0482-z; Patel S, 2001, J PHARMACOL EXP THER, V297, P629; Peer M, 2015, P NATL ACAD SCI USA, V112, P11072, DOI 10.1073/pnas.1504242112; Pertwee RG, 1996, BRIT J PHARMACOL, V118, P2053, DOI 10.1111/j.1476-5381.1996.tb15643.x; Richards JR., 2017, TOXICOLOGY COMMUNICA, V1, P29; ROLLINS DE, 1990, CLIN CHEM, V36, P602; Schmid PC, 2000, CHEM PHYS LIPIDS, V104, P185, DOI 10.1016/S0009-3084(99)00124-3; SMITH RA, 1988, VET HUM TOXICOL, V30, P486; Talcott M.S., 2013, SMALL ANIMAL TOXICOL, V3rd; Teitler JB, 2009, J AM ANIM HOSP ASSOC, V45, P59, DOI 10.5326/0450059; THACH WT, 1992, ANNU REV NEUROSCI, V15, P403, DOI 10.1146/annurev.neuro.15.1.403; THOMPSON GR, 1973, TOXICOL APPL PHARM, V25, P363, DOI 10.1016/0041-008X(73)90310-4; Trouve R, 1999, MARIHUANA AND MEDICINE, P291; Tyagi V, 2009, J UROLOGY, V181, P1932, DOI 10.1016/j.juro.2008.11.078; United Nations Office on Drugs and Crime, 2019, WORLD DRUG REP, P76; Van-de-Velde M, 2017, CLIN TOXICOL, V55, P414; Vogt NA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219430; VOLLMER RR, 1974, J PHARM PHARMACOL, V26, P186, DOI 10.1111/j.2042-7158.1974.tb09252.x; Vuckovic S, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01259; Wang PF, 2012, J CARDIOVASC PHARM, V59, P301, DOI 10.1097/FJC.0b013e3182418997; Williams K, 2015, J VET EMERG CRIT CAR, V25, P739, DOI 10.1111/vec.12378	58	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0261909	10.1371/journal.pone.0261909	http://dx.doi.org/10.1371/journal.pone.0261909			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35442991	Green Submitted, gold, Green Published			2022-12-26	WOS:000822608900004
J	Banga, R; Banga, V; Eltalla, A; Shahin, L; Parag, S; Naim, M; Iyer, E; Kumrah, N; Zacharias, B; Nathanson, L; Beljanski, V				Banga, Rajkaran; Banga, Veerkaran; Eltalla, Amr; Shahin, Lauren; Parag, Sonam; Naim, Maha; Iyer, Easha; Kumrah, Neha; Zacharias, Brian; Nathanson, Lubov; Beljanski, Vladimir			Effects of autophagy modulators tamoxifen and chloroquine on the expression profiles of long non-coding RNAs in MIAMI cells exposed to IFN gamma	PLOS ONE			English	Article							STEM-CELLS; INFLAMMATION; CXCL13; IMMUNOMODULATION; DIFFERENTIATION; MECHANISMS; FERRITIN; PROMOTES	Mesenchymal stromal cells (MSCs) can be utilized clinically for treatment of conditions that result from excessive inflammation. In a pro-inflammatory environment, MSCs adopt an anti-inflammatory phenotype resulting in immunomodulation. A sub-type of MSCs referred to as "marrow-isolated adult multilineage inducible" (MIAMI) cells, which were isolated from bone marrow, were utilized to show that the addition of autophagy modulators, tamoxifen (TX) or chloroquine (CQ), can alter how MIAMI cells respond to IFN gamma exposure in vitro resulting in an increased immunoregulatory capacity of the MIAMI cells. Molecularly, it was also shown that TX and CQ each alter both the levels of immunomodulatory genes and microRNAs which target such genes. However, the role of other non-coding RNAs (ncRNAs) such as long non-coding RNAs (lncRNAs) in regulating the response of MSCs to inflammation has been poorly studied. Here, we utilized transcriptomics and data mining to analyze the putative roles of various differentially regulated lncRNAs in MIAMI cells exposed to IFN gamma with (or without) TX or CQ. The aim of this study was to investigate how the addition of TX and CQ alters lncRNA levels and evaluate how such changes could alter previously observed TX- and CQ-driven changes to the immunomodulatory properties of MIAMI cells. Data analysis revealed 693 long intergenic non-coding RNAS (lincRNAs), 480 pseudogenes, and 642 antisense RNAs that were differentially regulated with IFN gamma, IFN gamma+TX and IFN gamma+CQ treatments. Further analysis of these RNA species based on the existing literature data revealed 6 antisense RNAs, 2 pseudogenes, and 5 lincRNAs that have the potential to modulate MIAMI cell's response to IFN gamma treatment. Functional analysis of these genomic species based on current literature linking inflammatory response and ncRNAs indicated their potential for regulation of several key pro- and anti-inflammatory responses, including NF kappa B signaling, cytokine secretion and auto-immune responses. Overall, this work found potential involvement of multiple pro-and anti-inflammatory pathways and molecules in modulating MIAMI cells' response to inflammation.	[Banga, Rajkaran; Banga, Veerkaran; Eltalla, Amr; Parag, Sonam; Beljanski, Vladimir] Nova Southeastern Univ, Dr Kiran C Patel Coll Allopath Med, Davie, FL USA; [Shahin, Lauren; Nathanson, Lubov] Nova Southeastern Univ, Dr Kiran C Patel Coll Osteopath Med, Davie, FL USA; [Naim, Maha; Iyer, Easha; Kumrah, Neha; Zacharias, Brian] Nova Southeastern Univ, Halmos Coll Arts & Sci, Dept Biol Sci, Davie, FL USA; [Nathanson, Lubov] Nova Southeastern Univ, Inst Neuroimmune Med, Dr Kiran C Patel Coll Osteopath Med, Davie, FL USA; [Beljanski, Vladimir] Nova Southeastern Univ, Cell Therapy Inst, Dr Kiran C Patel Coll Allopath Med, Davie, FL USA	Nova Southeastern University; Nova Southeastern University; Nova Southeastern University; Nova Southeastern University; Nova Southeastern University	Beljanski, V (corresponding author), Nova Southeastern Univ, Dr Kiran C Patel Coll Allopath Med, Davie, FL USA.; Beljanski, V (corresponding author), Nova Southeastern Univ, Cell Therapy Inst, Dr Kiran C Patel Coll Allopath Med, Davie, FL USA.	vbeljanski@nova.edu			Nova Southeastern University (NSU); NSU	Nova Southeastern University (NSU); NSU	This research was supported, in part, by funding from Nova Southeastern University (NSU) provided to The Cell Therapy Institute and by a NSU's President's Faculty Research and Development Grant (https://www.nova.edu/academic-affairs/faculty-research-grant/index. html) to V.B.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Barriocanal M, 2015, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00655; Brantl S, 2002, BBA-GENE STRUCT EXPR, V1575, P15, DOI 10.1016/S0167-4781(02)00280-4; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Carlsen HS, 2004, BLOOD, V104, P3021, DOI 10.1182/blood-2004-02-0701; Ceccarelli S, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00236; Chan JJ, 2018, NUCLEIC ACIDS RES, V46, P1998, DOI 10.1093/nar/gkx1248; Cheetham SW, 2020, NAT REV GENET, V21, P191, DOI 10.1038/s41576-019-0196-1; Chen J, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.08.37; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fernandes JCR, 2019, NON-CODING RNA, V5, DOI 10.3390/ncrna5010017; Ferns G, 2006, INT J EXP PATHOL, V87, P253, DOI 10.1111/j.1365-2613.2006.00484.x; Finch DK, 2013, EUR J CLIN INVEST, V43, P501, DOI 10.1111/eci.12063; Fishilevich S, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax028; Gabbs M, 2015, ADV NUTR, V6, P513, DOI 10.3945/an.114.007732; Gao Y, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.83; Gomes AQ, 2013, INT J MOL SCI, V14, P16010, DOI 10.3390/ijms140816010; Gong YY, 2018, EUR REV MED PHARMACO, V22, P8805, DOI 10.26355/eurrev_201812_16648; Gonzalez-Moro I, 2020, P NATL ACAD SCI USA, V117, P9022, DOI 10.1073/pnas.1914353117; Han Y, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080886; Hu WH, 2013, MOL MED REP, V7, P689, DOI 10.3892/mmr.2012.1207; Hung J, 2020, ARTERIOSCL THROM VAS, V40, P697, DOI 10.1161/ATVBAHA.119.313430; Huynh M, 2018, J BIOL CHEM, V293, P2452, DOI 10.1074/jbc.RA117.000667; Jiang GM, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0944-z; Jin XH, 2020, HUM CELL, V33, P683, DOI 10.1007/s13577-020-00336-8; Kaikkonen MU, 2011, CARDIOVASC RES, V90, P430, DOI 10.1093/cvr/cvr097; Karantalis V, 2015, J AM COLL CARDIOL, V66, P1990, DOI 10.1016/j.jacc.2015.08.879; Kazanietz MG, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00471; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Levy O, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba6884; Li H, 2017, ONCOTARGET, V8, P114568, DOI [10.18632/oncotarget.23059, 10.18632/oncotarget.21603]; Li Y, 2017, INT J MOL MED, V39, P775, DOI 10.3892/ijmm.2017.2912; Long YC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao2110; Lv H, 2018, HYPERTENSION, V71, P648, DOI 10.1161/HYPERTENSIONAHA.117.10084; Ma LN, 2013, RNA BIOL, V10, P925, DOI 10.4161/rna.24604; Marinic M, 2021, ELIFE, V10, DOI 10.7554/eLife.61257; Mariotti B, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00100; Mendt M, 2019, BONE MARROW TRANSPL, V54, P789, DOI 10.1038/s41409-019-0616-z; Mosanya CH, 2019, ANN RHEUM DIS, V78, P297, DOI 10.1136/annrheumdis-2018-214024; Neri S, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10020340; Netea-Maier RT, 2016, AUTOPHAGY, V12, P245, DOI 10.1080/15548627.2015.1071759; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Pittenger MF, 2019, NPJ REGEN MED, V4, DOI 10.1038/s41536-019-0083-6; Rossi F, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1515-3; Salari S, 2013, CELL STRESS CHAPERON, V18, P53, DOI 10.1007/s12192-012-0356-0; Song N, 2020, TRENDS PHARMACOL SCI, V41, P653, DOI 10.1016/j.tips.2020.06.009; Statello L, 2021, NAT REV MOL CELL BIO, V22, P96, DOI 10.1038/s41580-020-00315-9; Terra XM, 2011, EUR J ENDOCRINOL, V164, P539, DOI 10.1530/EJE-10-1195; Tsuji Y, 2000, MOL CELL BIOL, V20, P5818, DOI 10.1128/MCB.20.16.5818-5827.2000; van de Vyver M, 2021, ADV EXP MED BIOL, V1286, P163, DOI 10.1007/978-3-030-55035-6_12; Weiss ARR, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01191; Wight TN, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00512; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yarani R, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0188-9; Yin ZY, 2016, MICROB CELL, V3, P457, DOI 10.15698/mic2016.12.546; Yu B, 2013, GENET EPIDEMIOL, V37, P840, DOI 10.1002/gepi.21752; Zhang H, 2018, INT J IMMUNOPATH PH, V32, DOI 10.1177/2058738418772652; Zhou T, 2021, J HEMATOL ONCOL, V14, DOI 10.1186/s13045-021-01037-x	58	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266179	10.1371/journal.pone.0266179	http://dx.doi.org/10.1371/journal.pone.0266179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446871	Green Published, gold			2022-12-26	WOS:000795468200024
J	Enguix, V; Easson, K; Gilbert, G; Saint-Martin, C; Rohlicek, C; Luck, D; Lodygensky, GA; Brossard-Racine, M				Enguix, Vincente; Easson, Kaitlyn; Gilbert, Guillaume; Saint-Martin, Christine; Rohlicek, Charles; Luck, David; Lodygensky, Gregory Anton; Brossard-Racine, Marie			Altered resting state functional connectivity in youth with congenital heart disease operated during infancy	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; WHITE-MATTER INTEGRITY; EXECUTIVE FUNCTION; D-TRANSPOSITION; ADOLESCENTS; BRAIN; AMYGDALA; MEMORY; ADULTS; MRI	Congenital heart disease (CHD) has been associated with structural brain growth and long-term developmental impairments, including deficits in learning, memory, and executive functions. Altered functional connectivity has been shown to be altered in neonates born with CHD; however, it is unclear if these early life alterations are also present during adulthood. Therefore, this study aimed to compare resting state functional connectivity networks associated with executive function deficits between youth (16 to 24 years old) with complex CHD (mean age = 20.13; SD = 2.35) who underwent open-heart surgery during infancy and age- and sex-matched controls (mean age = 20.41; SD = 2.05). Using the Behavior Rating Inventory of Executive Function-Adult Version questionnaire, we found that participants with CHD presented with poorer performance on the inhibit, initiate, emotional control, working memory, self-monitor, and organization of materials clinical scales than healthy controls. We then compared the resting state networks theoretically corresponding to these impaired functions, namely the default mode, dorsal attention, fronto-parietal, fronto-orbital, and amygdalar networks, between the two groups. Participants with CHD presented with decreased functional connectivity between the fronto-orbital cortex and the hippocampal regions and between the amygdala and the frontal pole. Increased functional connectivity was observed within the default mode network, the dorsal attention network, and the fronto-parietal network. Overall, our results suggest that youth with CHD present with disrupted resting state functional connectivity in widespread networks and regions associated with altered executive functioning.	[Enguix, Vincente; Luck, David; Lodygensky, Gregory Anton] Canadian Neonatal Brain Platform, Montreal, PQ, Canada; [Enguix, Vincente; Luck, David; Lodygensky, Gregory Anton] Univ Montreal, Dept Pediat, CHU St Justine Res Ctr, Montreal, PQ, Canada; [Easson, Kaitlyn] McGill Univ, Adv Brain & Child Dev ABCD Res Lab, Res Inst, Hlth Ctr, Montreal, PQ, Canada; [Easson, Kaitlyn] McGill Univ, Fac Med, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Gilbert, Guillaume] Philips Healthcare, MR Clin Sci, Markham, ON, Canada; [Saint-Martin, Christine; Brossard-Racine, Marie] Montreal Childrens Hosp, Dept Med Imaging, Div Pediat Radiol, Montreal, PQ, Canada; [Rohlicek, Charles; Brossard-Racine, Marie] Montreal Childrens Hosp, Dept Pediat, Div Cardiol, Montreal, PQ, Canada; [Brossard-Racine, Marie] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Brossard-Racine, Marie] Montreal Childrens Hosp, Dept Pediat, Div Neonatol, Montreal, PQ, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; McGill University; McGill University; Philips; Philips Healthcare; McGill University; McGill University; McGill University; McGill University	Brossard-Racine, M (corresponding author), Montreal Childrens Hosp, Dept Med Imaging, Div Pediat Radiol, Montreal, PQ, Canada.; Brossard-Racine, M (corresponding author), Montreal Childrens Hosp, Dept Pediat, Div Cardiol, Montreal, PQ, Canada.; Brossard-Racine, M (corresponding author), McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada.; Brossard-Racine, M (corresponding author), Montreal Childrens Hosp, Dept Pediat, Div Neonatol, Montreal, PQ, Canada.	marie.brossardracine@mcgill.ca			Philips Healthcare	Philips Healthcare	Guillaume Gilbert is an employee of Philips Healthcare who per our institutional agreement provided support during the implementation of the MRI acquisition protocol. Philips Healthcare provided support in the form of salaries for one author [G.G] but did not fund or sponsor the study and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonazi BK, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1168; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bagge CN, 2018, CIRCULATION, V137, P1912, DOI 10.1161/CIRCULATIONAHA.117.029686; Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Barbey AK, 2011, CEREB CORTEX, V21, P789, DOI 10.1093/cercor/bhq153; Batra AS, 2012, PEDIATR CARDIOL, V33, P394, DOI 10.1007/s00246-012-0162-6; Bauml JG, 2019, BIOL PSYCHIAT-COGN N, V4, P333, DOI 10.1016/j.bpsc.2018.11.005; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Bernier Pierre-Luc, 2010, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V13, P26, DOI 10.1053/j.pcsu.2010.02.005; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blackford JU, 2014, BIOL PSYCHOL, V99, P15, DOI 10.1016/j.biopsycho.2014.02.003; Bolduc ME, 2018, DEV MED CHILD NEUROL, V60, P1209, DOI 10.1111/dmcn.13975; Bozhilova NS, 2018, NEUROSCI BIOBEHAV R, V92, P464, DOI 10.1016/j.neubiorev.2018.07.010; Brewster RC, 2015, J INT NEUROPSYCH SOC, V21, P22, DOI 10.1017/S135561771400109X; Brossard-Racine M, 2016, AM J NEURORADIOL, V37, P1338, DOI 10.3174/ajnr.A4716; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Calderon J, 2015, CARDIOL YOUNG, V25, P1238, DOI 10.1017/S1047951115001134; Cassidy AR, 2015, J INT NEUROPSYCH SOC, V21, P34, DOI 10.1017/S1355617714001027; Cullen KR, 2014, JAMA PSYCHIAT, V71, P1138, DOI 10.1001/jamapsychiatry.2014.1087; Davey CG, 2016, NEUROIMAGE, V132, P390, DOI 10.1016/j.neuroimage.2016.02.022; De Asis-Cruz J, 2018, NEUROIMAGE-CLIN, V17, P31, DOI 10.1016/j.nicl.2017.09.020; DeMaso DR, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2241; Easson K, 2020, NEUROIMAGE, V205, DOI 10.1016/j.neuroimage.2019.116255; Easson K, 2019, J PEDIATR-US, V207, P34, DOI 10.1016/j.jpeds.2018.11.002; Ehrler M, 2020, NEUROIMAGE-CLIN, V25, DOI 10.1016/j.nicl.2019.102123; Figueroa CA, 2017, SOC COGN AFFECT NEUR, V12, P1803, DOI 10.1093/scan/nsx108; Figueroa-Vargas A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66279-0; Fontes K, 2020, AM J NEURORADIOL, V41, P1503, DOI 10.3174/ajnr.A6667; Fontes K, 2019, HUM BRAIN MAPP, V40, P3548, DOI 10.1002/hbm.24615; Frank DW, 2014, NEUROSCI BIOBEHAV R, V45, P202, DOI 10.1016/j.neubiorev.2014.06.010; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Gao ZN, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73679-9; Gardini S, 2015, J ALZHEIMERS DIS, V45, P457, DOI 10.3233/JAD-142547; Hojjati SH, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00904; Hollingshead A.B, 1975, 4 FACTOR INDEX SOCIA, V24, P2; Holst LM, 2020, CARDIOL YOUNG, V30, P180, DOI 10.1017/S1047951119003184; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Keir M, 2019, CAN J CARDIOL, V35, P1675, DOI 10.1016/j.cjca.2019.06.020; Latal B, 2016, PEDIATR RES, V80, P531, DOI 10.1038/pr.2016.122; LeDoux J, 2007, CURR BIOL, V17, pR868, DOI 10.1016/j.cub.2007.08.005; Lee MH, 2013, AM J NEURORADIOL, V34, P1866, DOI 10.3174/ajnr.A3263; Lindquist MA, 2008, HUM BRAIN MAPP, V29, P1276, DOI 10.1002/hbm.20475; Liu WY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55002-3; Marelli A, 2016, CIRCULATION, V133, P1951, DOI 10.1161/CIRCULATIONAHA.115.019881; Motoyama Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49360-1; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Muschelli J, 2014, NEUROIMAGE, V96, P22, DOI 10.1016/j.neuroimage.2014.03.028; Pierick AR, 2021, CARDIOL YOUNG, V31, P969, DOI 10.1017/S1047951120004965; Pike NA, 2018, J NEUROSCI RES, V96, P1104, DOI 10.1002/jnr.24215; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Reid GJ, 2006, J AM COLL CARDIOL, V48, P349, DOI 10.1016/j.jacc.2006.03.041; Rivkin MJ, 2013, J THORAC CARDIOV SUR, V146, P543, DOI 10.1016/j.jtcvs.2012.12.006; Rohr CS, 2017, CEREB CORTEX, V27, P4350, DOI 10.1093/cercor/bhw236; Ross RS, 2013, COGN AFFECT BEHAV NE, V13, P900, DOI 10.3758/s13415-013-0170-x; Rouel M, 2016, EAT BEHAV, V23, P58, DOI 10.1016/j.eatbeh.2016.07.010; Sheffield JM, 2016, NEUROSCI BIOBEHAV R, V61, P108, DOI 10.1016/j.neubiorev.2015.12.007; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Skoczek Adrianna, 2019, Wiad Lek, V72, P2135; Tang S, 2018, EBIOMEDICINE, V36, P436, DOI 10.1016/j.ebiom.2018.09.010; Tomiyama H, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.102004; Tyagi M, 2017, CARDIOL YOUNG, V27, P851, DOI 10.1017/S1047951116001396; von Rhein M, 2014, BRAIN, V137, P268, DOI 10.1093/brain/awt322; Wang Y, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01006; Watson CG, 2018, J PEDIATR-US, V200, P140, DOI 10.1016/j.jpeds.2018.04.022; Watson CG, 2016, J PEDIATR-US, V169, P36, DOI 10.1016/j.jpeds.2015.09.084; Wehrle FM, 2018, NEUROIMAGE-CLIN, V20, P1148, DOI 10.1016/j.nicl.2018.10.002; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Zhang LW, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63540-4	69	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0264781	10.1371/journal.pone.0264781	http://dx.doi.org/10.1371/journal.pone.0264781			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1E2NP	35427374	Green Published, gold			2022-12-26	WOS:000794332400024
J	Ji, AL; Trumbauer, AC; Noffsinger, VP; Jeon, H; Patrick, AC; De Beer, FC; Webb, NR; Tannock, LR; Shridas, P				Ji, Ailing; Trumbauer, Andrea C.; Noffsinger, Victoria P.; Jeon, Hayce; Patrick, Avery C.; De Beer, Frederick C.; Webb, Nancy R.; Tannock, Lisa R.; Shridas, Preetha			Serum Amyloid A is not obligatory for high-fat, high-sucrose, cholesterol-fed diet-induced obesity and its metabolic and inflammatory complications	PLOS ONE			English	Article							ADIPOSE-TISSUE; INSULIN-RESISTANCE; PROTEIN; SAA; A3; EXPRESSION; ADIPOCYTE; LIPOPROTEINS; INFILTRATION; DEFICIENCY	Several studies in the past have reported positive correlations between circulating Serum amyloid A (SAA) levels and obesity. However, based on limited number of studies involving appropriate mouse models, the role of SAA in the development of obesity and obesity-related metabolic consequences has not been established. Accordingly, herein, we have examined the role of SAA in the development of obesity and its associated metabolic complications in vivo using mice deficient for all three inducible forms of SAA: SAA1.1, SAA2.1 and SAA3 (TKO). Male and female mice were rendered obese by feeding a high fat, high sucrose diet with added cholesterol (HFHSC) and control mice were fed rodent chow diet. Here, we show that the deletion of SAA does not affect diet-induced obesity, hepatic lipid metabolism or adipose tissue inflammation. However, there was a modest effect on glucose metabolism. The results of this study confirm previous findings that SAA levels are elevated in adipose tissues as well as in the circulation in diet-induced obese mice. However, the three acute phase SAAs do not play a causative role in the development of obesity or obesity-associated adipose tissue inflammation and dyslipidemia.	[Ji, Ailing; Noffsinger, Victoria P.; De Beer, Frederick C.; Tannock, Lisa R.; Shridas, Preetha] Univ Kentucky, Dept Internal Med, Lexington, KY 40506 USA; [Ji, Ailing; Trumbauer, Andrea C.; Noffsinger, Victoria P.; De Beer, Frederick C.; Webb, Nancy R.; Tannock, Lisa R.; Shridas, Preetha] Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY 40506 USA; [Jeon, Hayce; Patrick, Avery C.; Webb, Nancy R.] Univ Kentucky, Pharmacol & Nutr Sci, Lexington, KY USA; [Jeon, Hayce] Univ Kentucky, Dept Obstet & Gynecol, Lexington, KY USA; [De Beer, Frederick C.; Webb, Nancy R.; Tannock, Lisa R.; Shridas, Preetha] Univ Kentucky, Barnstable Brown Diabet Ctr, Lexington, KY 40506 USA; [Tannock, Lisa R.] Dept Vet Affairs LRT, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Shridas, P (corresponding author), Univ Kentucky, Dept Internal Med, Lexington, KY 40506 USA.; Shridas, P (corresponding author), Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY 40506 USA.; Shridas, P (corresponding author), Univ Kentucky, Barnstable Brown Diabet Ctr, Lexington, KY 40506 USA.	pshri2@uky.edu		shridas, Preetha/0000-0002-2532-4007	Diabetes Research Center at Washington University in St. Louis of the National Institutes of Health [P30DK020579]; National Institutes of Health [HL147381, HL134731]; Department of Veterans Affairs [BX004275]; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P30 GM127211]	Diabetes Research Center at Washington University in St. Louis of the National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health(General Electric)	This study was funded by the Diabetes Research Center at Washington University in St. Louis of the National Institutes of Health in the form of a grant (No. P30DK020579) to PS. This study was also funded by the National Institutes of Health Grants in the form of grants to PS and LT (No. HL147381), and NW and FD (No. HL134731). This study was also funded by the Department of Veterans Affairs in the form of a grant to LT (No. BX004275). This study was also supported with resources and facilities provided by the Centers of Biomedical Research Excellence (COBRE) at the University of Kentucky, which was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under a grant (No. P30 GM127211). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Salama SA, 2021, IMMUNOLOGY, V163, P115, DOI 10.1111/imm.13295; Ahlin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072204; Ather JL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192352; BADOLATO R, 1994, J EXP MED, V180, P203, DOI 10.1084/jem.180.1.203; Bang YJ, 2021, SCIENCE, V373, P1323, DOI 10.1126/science.abf9232; Bjorkman L, 2010, ARTHRITIS RHEUM-US, V62, P1660, DOI 10.1002/art.27440; Calabro P., 2013, EUR HEART J, V34, DOI [10.1093/eurheartj/eht309.P4160, DOI 10.1093/EURHEARTJ/EHT309.P4160]; Chiba T, 2009, J LIPID RES, V50, P1353, DOI 10.1194/jlr.M900089-JLR200; Christenson K, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00092; de Beer MC, 2010, J LIPID RES, V51, P3117, DOI 10.1194/jlr.M005413; De Buck M, 2016, CURR MED CHEM, V23, P1725, DOI 10.2174/0929867323666160418114600; de Oliveira EM, 2016, DIABETOLOGIA, V59, P1760, DOI 10.1007/s00125-016-3970-z; DEBEER MC, 1995, J LIPID RES, V36, P526; den Hartigh LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108564; Derebe MG, 2014, ELIFE, V3, DOI 10.7554/eLife.03206; Dong Z, 2011, MOL MED, V17, P1357, DOI 10.2119/molmed.2011.00186; Eklund KK, 2012, CRIT REV IMMUNOL, V32, P335; Filippin-Monteiro FB, 2012, INT J OBESITY, V36, P1032, DOI 10.1038/ijo.2011.193; FOLCH J, 1957, J BIOL CHEM, V226, P497; Franco AG, 2011, MEM I OSWALDO CRUZ, V106, P986, DOI 10.1590/S0074-02762011000800014; Furlaneto CJ, 2000, BIOCHEM BIOPH RES CO, V268, P405, DOI 10.1006/bbrc.2000.2143; Gomez-Ambrosi J, 2006, OBES SURG, V16, P262, DOI 10.1381/096089206776116525; Hatanaka E, 2003, FEMS IMMUNOL MED MIC, V38, P81, DOI 10.1016/S0928-8244(03)00112-3; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hu ZH, 2019, P NATL ACAD SCI USA, V116, P19077, DOI 10.1073/pnas.1910713116; Jahangiri A, 2013, OBESITY, V21, P993, DOI 10.1002/oby.20126; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kim MH, 2013, CYTOKINE, V61, P506, DOI 10.1016/j.cyto.2012.10.019; King VL, 2010, OBESITY, V18, P35, DOI 10.1038/oby.2009.176; KLUVEBECKERMAN B, 1991, DNA CELL BIOL, V10, P651, DOI 10.1089/dna.1991.10.651; Lee JY, 2020, CELL, V180, P79, DOI 10.1016/j.cell.2019.11.026; Marzi C, 2013, DIABETES CARE, V36, P1321, DOI 10.2337/dc12-1514; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; O'Brien KD, 2005, J CLIN ENDOCR METAB, V90, P2244, DOI 10.1210/jc.2004-1011; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Poitou C, 2005, DIABETOLOGIA, V48, P519, DOI 10.1007/s00125-004-1654-6; Poitou C, 2006, OBESITY, V14, P309, DOI 10.1038/oby.2006.40; Sack GH, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0047-0; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; Shridas P, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11121883; Shridas P, 2019, CURR OPIN LIPIDOL, V30, P320, DOI 10.1097/MOL.0000000000000616; Shridas P, 2018, J BIOL CHEM, V293, P13257, DOI 10.1074/jbc.RA118.002428; Shridas P, 2014, J BIOL CHEM, V289, P27410, DOI 10.1074/jbc.M114.591735; Simons JP, 2013, P NATL ACAD SCI USA, V110, P16115, DOI 10.1073/pnas.1306621110; Sjoholm K, 2005, J CLIN ENDOCR METAB, V90, P2233, DOI 10.1210/jc.2004-1830; Sjoholm K, 2009, CYTOKINE, V48, P260, DOI 10.1016/j.cyto.2009.08.005; Softic S, 2018, J CLIN INVEST, V128, P1199, DOI 10.1172/JCI99009; Steel DM, 1996, SCAND J IMMUNOL, V44, P493, DOI 10.1046/j.1365-3083.1996.d01-341.x; Subramanian S, 2008, ARTERIOSCL THROM VAS, V28, P685, DOI 10.1161/ATVBAHA.107.157685; Tannock LR, 2018, J LIPID RES, V59, P339, DOI 10.1194/jlr.M080887; Thompson JC, 2018, ATHEROSCLEROSIS, V268, P32, DOI 10.1016/j.atherosclerosis.2017.11.011; Thompson JC, 2015, J LIPID RES, V56, P286, DOI 10.1194/jlr.M054015; van Dielen FMH, 2001, INT J OBESITY, V25, P1759, DOI 10.1038/sj.ijo.0801825; Vercalsteren E, 2021, ADIPOCYTE, V10, P242, DOI 10.1080/21623945.2021.1916220; Webb NR, 2021, CURR ATHEROSCLER REP, V23, DOI 10.1007/s11883-020-00901-4; Webb NR, 2015, ARTERIOSCL THROM VAS, V35, P1156, DOI 10.1161/ATVBAHA.114.304776; WHITEHEAD AS, 1992, J BIOL CHEM, V267, P3862; Yamada T, 2001, CLIN CHEM LAB MED, V39, P7, DOI 10.1515/CCLM.2001.003; YAMAMOTO KI, 1987, J IMMUNOL, V139, P1683; Yang RZ, 2006, PLOS MED, V3, P884, DOI 10.1371/journal.pmed.0030287; Yu J, 2000, LAB INVEST, V80, P1797, DOI 10.1038/labinvest.3780191; Zhou JL, 2018, POSTGRAD MED J, V94, P499, DOI 10.1136/postgradmedj-2018-136004	62	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266688	10.1371/journal.pone.0266688	http://dx.doi.org/10.1371/journal.pone.0266688			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7MW	35436297	gold, Green Published			2022-12-26	WOS:000791258900012
J	Johansson, M; Holtermann, A; Marott, J; Prescott, E; Schnohr, P; Korshoj, M; Sogaard, K				Johansson, Melker; Holtermann, Andreas; Marott, Jacob; Prescott, Eva; Schnohr, Peter; Korshoj, Mette; Sogaard, Karen			The physical activity health paradox and risk factors for cardiovascular disease: A cross-sectional compositional data analysis in the Copenhagen City Heart Study	PLOS ONE			English	Article							BLOOD-PRESSURE; LEISURE-TIME; SEDENTARY BEHAVIOR; VASCULAR MORTALITY; EUROPEAN-SOCIETY; INDIVIDUAL DATA; TASK-FORCE; ALL-CAUSE; METAANALYSIS; ADULTS	BackgroundStudies indicate that physical activity during leisure and work have opposite associations with cardiovascular disease (CVD) risk factors, referred to as the physical activity health paradox. We investigated how sedentary behaviour and physical activity types during leisure and work are associated with systolic blood pressure (SBP), waist circumference (WC), and low-density lipoprotein cholesterol (LDL-C) in an adult general population sample using compositional data analysis. MethodsParticipants wore accelerometers for 7 days (right thigh and iliac crest; 24 h/day) and had their SBP, WC, and LDL-C measured. Accelerometer data was analysed using the software Acti4 to derive daily time spent in sedentary behaviour and physical activity types. The measure of association was quantified by reallocating time between sedentary behaviour and 1) walking, and 2) high-intensity physical activity (HIPA; sum of climbing stairs, running, cycling, and rowing), during both domains. ResultsIn total, 652 participants were included in the analyses (median wear time: 6 days, 23.8 h/day). During leisure, the results indicated that less sedentary behaviour and more walking or more HIPA was associated with lower SBP, while during work, the findings indicated an association with higher SBP. During both domains, the findings indicated that less sedentary behaviour and more HIPA was associated with a smaller WC and lower LDL-C. However, the findings indicated less sedentary behaviour and more walking to be associated with a larger WC and higher LDL-C, regardless of domain. ConclusionsDuring leisure, less sedentary behaviour and more walking or HIPA seems to be associated with a lower SBP, but, during work, it seems to be associated with a higher SBP. No consistent differences between domains were observed for WC and LDL-C. These findings highlight the importance of considering the physical activity health paradox, at least for some risk factors for CVD.	[Johansson, Melker; Holtermann, Andreas; Korshoj, Mette] Natl Res Ctr Working Environm, Musculoskeletal Disorders & Phys Workload, Copenhagen, Denmark; [Johansson, Melker; Holtermann, Andreas; Sogaard, Karen] Univ Southern Denmark, Dept Sports Sci & Clin Biomech, Odense, Denmark; [Marott, Jacob; Prescott, Eva; Schnohr, Peter] Bispebjerg & Frederiksberg Hosp, Copenhagen City Heart Study, Frederiksberg, Denmark; [Prescott, Eva] Bispebjerg Hosp, Dept Cardiol, Copenhagen, Denmark; [Korshoj, Mette] Holbaek Cent Hosp, Dept Occupat & Social Med, Holbaek, Denmark; [Sogaard, Karen] Univ Southern Denmark, Dept Clin Res, Odense, Denmark	National Research Centre for the Working Environment; University of Southern Denmark; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital; Holbaek Hospital; University of Southern Denmark	Johansson, M (corresponding author), Natl Res Ctr Working Environm, Musculoskeletal Disorders & Phys Workload, Copenhagen, Denmark.; Johansson, M (corresponding author), Univ Southern Denmark, Dept Sports Sci & Clin Biomech, Odense, Denmark.	msjohansson@health.sdu.dk	; Sogaard, Karen/B-7933-2008	Johansson, Melker Staffan/0000-0002-2745-2870; Sogaard, Karen/0000-0003-3968-6364; Korshoj, Mette/0000-0001-8422-9969	Danish Heart Foundation; Beckett Foundation; Danish Lung Association; IMK - Almene Fond; Helene and Viggo Bruun's Foundation; Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark; National Research Centre for the Working Environment, Copenhagen, Denmark	Danish Heart Foundation; Beckett Foundation; Danish Lung Association; IMK - Almene Fond; Helene and Viggo Bruun's Foundation; Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark; National Research Centre for the Working Environment, Copenhagen, Denmark	The Danish Heart Foundation, the Beckett Foundation, the Danish Lung Association, the IMK - Almene Fond, and Helene and Viggo Bruun's Foundation funded the fifth examination of the CCHS. The funders were not involved in the design and management of the study, in the collection, analysis or the interpretation of data, in the preparation of the manuscript, or in the decision to submit the manuscript for publication. MSJ received funding from the Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark (Faculty Scholarship), and the National Research Centre for the Working Environment, Copenhagen, Denmark (internal funding). The remaining authors received no specific funding for this work.	Allesoe K, 2015, EUR J PREV CARDIOL, V22, P1601, DOI 10.1177/2047487314554866; Beenackers MA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-116; Cillekens B, 2022, SCAND J WORK ENV HEA, V48, P86, DOI 10.5271/sjweh.3993; Clays E, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1002; Coenen P, 2018, BRIT J SPORT MED, V52, P1320, DOI 10.1136/bjsports-2017-098540; Dempsey PC, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-018-0748-3; Dowd KP, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-017-0636-2; Dumuid D, 2018, STAT METHODS MED RES, V27, P3726, DOI 10.1177/0962280217710835; Dumuid D, 2019, STAT METHODS MED RES, V28, P846, DOI 10.1177/0962280217737805; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Gibbs BB, 2020, INT J OBESITY, V44, P559, DOI 10.1038/s41366-019-0443-8; Gram B, 2012, SCAND J WORK ENV HEA, V38, P467, DOI 10.5271/sjweh.3260; Grgic J, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-018-0691-3; Grundy SM., 2019, REPORT AM COLL CARDI, V73, P285; Gupta N, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-018-0766-1; Gupta N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154935; Gupta N, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2803-9; Hall C, 2019, SCAND J WORK ENV HEA, V45, P267, DOI 10.5271/sjweh.3787; Hamer M, 2008, BRIT J SPORT MED, V42, P238, DOI 10.1136/bjsm.2007.039974; Hansen TW, 2007, J HYPERTENS, V25, P1554, DOI 10.1097/HJH.0b013e3281c49da5; Hanson S, 2015, BRIT J SPORT MED, V49, P710, DOI 10.1136/bjsports-2014-094157; Hernan MA, 2018, AM J PUBLIC HEALTH, V108, P616, DOI 10.2105/AJPH.2018.304337; Holtermann A, 2012, BRIT J SPORT MED, V46, P291, DOI 10.1136/bjsm.2010.079582; Holtermann Andreas, 2021, Eur Heart J, V42, P1499, DOI 10.1093/eurheartj/ehab087; Holtermann A, 2018, BRIT J SPORT MED, V52, P149, DOI 10.1136/bjsports-2017-097965; Honda T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1307; Hron K, 2017, MATH GEOSCI, V49, P797, DOI 10.1007/s11004-017-9684-z; Jesus TS, 2020, PHYSIOTHER CAN, V72, P122, DOI 10.3138/ptc-2018-0065; Johansson MS, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7679-z; Katzmarzyk PT, 2019, MED SCI SPORT EXER, V51, P1227, DOI 10.1249/MSS.0000000000001935; Keating SE, 2017, OBES REV, V18, P943, DOI 10.1111/obr.12536; Kelly P, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0132-x; Korshoj M, 2020, SCAND J WORK ENV HEA, V46, P188, DOI 10.5271/sjweh.3850; Korshoj M, 2015, SCAND J WORK ENV HEA, V41, P140, DOI 10.5271/sjweh.3475; Kraus WE, 2019, MED SCI SPORT EXER, V51, P1270, DOI 10.1249/MSS.0000000000001939; Lee PH, 2015, SPORTS MED, V45, P867, DOI 10.1007/s40279-015-0322-y; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lidegaard M, 2018, INT ARCH OCC ENV HEA, V91, P225, DOI 10.1007/s00420-017-1274-3; Lloyd CD, 2012, ANN ASSOC AM GEOGR, V102, P1251, DOI 10.1080/00045608.2011.652855; Mach F, 2019, ATHEROSCLEROSIS, V290, P140, DOI [10.1016/j.atherosclerosis.2019.08.014, 10.1093/eurheartj/ehz455]; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Maillard F, 2018, SPORTS MED, V48, P269, DOI 10.1007/s40279-017-0807-y; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Masala G, 2017, NUTR METAB CARDIOVAS, V27, P670, DOI 10.1016/j.numecd.2017.06.003; McArdle W.D., 2015, EXERCISE PHYSL NUTR; MCMICHAEL AJ, 1976, J OCCUP ENVIRON MED, V18, P165, DOI 10.1097/00043764-197603000-00009; Naci H, 2019, BRIT J SPORT MED, V53, P859, DOI 10.1136/bjsports-2018-099921; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Nordengen S, 2019, BRIT J SPORT MED, V53, P879, DOI 10.1136/bjsports-2018-099778; Nordengen S, 2019, BRIT J SPORT MED, V53, P870, DOI 10.1136/bjsports-2018-099099; Nordestgaard BG, 2016, EUR HEART J, V37, P1944, DOI 10.1093/eurheartj/ehw152; Oja P, 2018, BRIT J SPORT MED, V52, P769, DOI 10.1136/bjsports-2017-098558; Olsen MH, 2016, LANCET, V388, P2665, DOI 10.1016/S0140-6736(16)31134-5; Pawlowsky-Glahn V., 2015, STAT PRACTICE MODELI; Pedisic Z, 2020, BRIT J SPORT MED, V54, P898, DOI 10.1136/bjsports-2018-100493; Piepoli MF, 2016, ATHEROSCLEROSIS, V252, P207, DOI [10.1177/2047487316653709, 10.1016/j.atherosclerosis.2016.05.037]; Piercy KL, 2018, JAMA-J AM MED ASSOC, V320, P2020, DOI 10.1001/jama.2018.14854; Poggio R, 2018, J OCCUP ENVIRON MED, V60, pE470, DOI 10.1097/JOM.0000000000001398; R Core Team, 2021, R LANGUAGE ENV STAT; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Rothman KJ, 2014, J GEN INTERN MED, V29, P1060, DOI 10.1007/s11606-013-2755-z; Rothman KJ, 2013, INT J EPIDEMIOL, V42, P1012, DOI 10.1093/ije/dys223; Rstudio T, 2020, RSTUDIO INT DEV R; Saidj M, 2016, EUR J PREV CARDIOL, V23, P1321, DOI 10.1177/2047487315619559; Saidj M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070213; Schnohr P, 2001, EUR HEART J SUPPL, V3, pH1; Shephard RJ, 2019, BRIT J SPORT MED, V53, P1557, DOI 10.1136/bjsports-2018-100344; Skotte J, 2014, J PHYS ACT HEALTH, V11, P76, DOI 10.1123/jpah.2011-0347; Smith P, 2018, AM J EPIDEMIOL, V187, P27, DOI 10.1093/aje/kwx298; Stemland I, 2015, ERGONOMICS, V58, P953, DOI 10.1080/00140139.2014.998724; Tang KL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010137; Templ M, 2011, COMPOSITIONAL DATA ANALYSIS: THEORY AND APPLICATIONS, P341; Unger T, 2020, HYPERTENSION, V75, P1334, DOI 10.1161/HYPERTENSIONAHA.120.15026; Vaara JP, 2014, J PHYS ACT HEALTH, V11, P1482, DOI 10.1123/jpah.2012-0504; van den Boogaart KG, 2018, COMPOSITIONS COMPOSI; Verweij LM, 2013, PUBLIC HEALTH NUTR, V16, P281, DOI 10.1017/S1368980012002741; Wewege M, 2017, OBES REV, V18, P635, DOI 10.1111/obr.12532; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Wu D, 2020, INT J ACCOUNT INF MA, V28, P184, DOI [10.1108/IJAIM-12-2018-0148, 10.1016/j.ijid.2020.03.004]; Zhou B, 2018, INT J EPIDEMIOL, V47, P872, DOI 10.1093/ije/dyy016	81	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267427	10.1371/journal.pone.0267427	http://dx.doi.org/10.1371/journal.pone.0267427			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1F9GM	35446893	gold, Green Published			2022-12-26	WOS:000795468200025
J	Kim, DHC; Williams, LJ; Hernandez-Fernandez, M; Bjornson, BH				Kim, Danny H. C.; Williams, Lynne J.; Hernandez-Fernandez, Moises; Bjornson, Bruce H.			Comparison of CPU and GPU bayesian estimates of fibre orientations from diffusion MRI	PLOS ONE			English	Article							RANDOM NUMBER GENERATORS; TRACTOGRAPHY; ACCELERATION; OPTIMIZATION; REGISTRATION; ROBUST	BackgroundThe correct estimation of fibre orientations is a crucial step for reconstructing human brain tracts. Bayesian Estimation of Diffusion Parameters Obtained using Sampling Techniques (bedpostx) is able to estimate several fibre orientations and their diffusion parameters per voxel using Markov Chain Monte Carlo (MCMC) in a whole brain diffusion MRI data, and it is capable of running on GPUs, achieving speed-up of over 100 times compared to CPUs. However, few studies have looked at whether the results from the CPU and GPU algorithms differ. In this study, we compared CPU and GPU bedpostx outputs by running multiple trials of both algorithms on the same whole brain diffusion data and compared each distribution of output using Kolmogorov-Smirnov tests. ResultsWe show that distributions of fibre fraction parameters and principal diffusion direction angles from bedpostx and bedpostx_gpu display few statistically significant differences in shape and are localized sparsely throughout the whole brain. Average output differences are small in magnitude compared to underlying uncertainty. ConclusionsDespite small amount of differences in output between CPU and GPU bedpostx algorithms, results are comparable given the difference in operation order and library usage between CPU and GPU bedpostx.	[Kim, Danny H. C.; Williams, Lynne J.; Bjornson, Bruce H.] BC Childrens Hosp, Brain Mapping Neuroinformat & Neurotechnol Lab, Vancouver, BC, Canada; [Williams, Lynne J.; Bjornson, Bruce H.] BC Childrens Hosp, MRI Res Facil, Vancouver, BC, Canada; [Hernandez-Fernandez, Moises] Univ Oxford, Wellcome Ctr Integrat Neuroimaging WIN, Ctr Funct Magnet Resonance Imaging Brain FMRIB, Oxford, England; [Bjornson, Bruce H.] Univ British Columbia, Fac Med, Dept Pediat, Div Neurol, Vancouver, BC, Canada	BC Childrens Hospital; University of British Columbia; BC Childrens Hospital; University of British Columbia; University of Oxford; University of British Columbia	Kim, DHC (corresponding author), BC Childrens Hosp, Brain Mapping Neuroinformat & Neurotechnol Lab, Vancouver, BC, Canada.	dkim@bcchr.ca			Canadian Foundation for Innovation [20494]	Canadian Foundation for Innovation(Canada Foundation for Innovation)	DK LW -Canadian Foundation for Innovation (Project number: 20494) -The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Chang LC, 2014, NEUROCOMPUTING, V135, P328, DOI 10.1016/j.neucom.2013.12.035; Colberg PH, 2011, COMPUT PHYS COMMUN, V182, P1120, DOI 10.1016/j.cpc.2011.01.009; Eklund A, 2013, MED IMAGE ANAL, V17, P1073, DOI 10.1016/j.media.2013.05.008; Eklund A, 2013, COGN AFFECT BEHAV NE, V13, P587, DOI 10.3758/s13415-013-0165-7; Garyfallidis E, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00008; Gruber B, 2018, J MAGN RESON IMAGING, V48, P590, DOI 10.1002/jmri.26187; Hellekalek P, 1998, MATH COMPUT SIMULAT, V46, P485, DOI 10.1016/S0378-4754(98)00078-0; Hernandez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061892; Hernandez-Fernandez M, 2019, NEUROIMAGE, V188, P598, DOI 10.1016/j.neuroimage.2018.12.015; HOLM S, 1979, SCAND J STAT, V6, P65; Jbabdi S, 2010, NEUROIMAGE, V49, P247, DOI 10.1016/j.neuroimage.2009.08.039; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Johansen-Berg H, 2009, ANNU REV NEUROSCI, V32, P75, DOI 10.1146/annurev.neuro.051508.135735; Laguna I, 2019, LECT NOTES COMPUT SC, V11501, P227, DOI 10.1007/978-3-030-20656-7_12; Lee J, 2013, INT J IMAG SYST TECH, V23, P256, DOI 10.1002/ima.22059; Lerner A, 2014, WORLD NEUROSURG, V82, P96, DOI 10.1016/j.wneu.2013.07.083; Luizi PCS, 2010, COMPUT ECON, V36, P57, DOI 10.1007/s10614-010-9210-6; McGraw T, 2007, IEEE T VIS COMPUT GR, V13, P1504, DOI 10.1109/TVCG.2007.70597; Miller KL, 2016, NAT NEUROSCI, V19, P1523, DOI 10.1038/nn.4393; PARK SK, 1988, COMMUN ACM, V31, P1192, DOI 10.1145/63039.63042; Sotiropoulos SN, 2013, NEUROIMAGE, V80, P125, DOI 10.1016/j.neuroimage.2013.05.057; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Veraart J, 2016, NEUROIMAGE, V142, P384, DOI 10.1016/j.neuroimage.2016.08.016; Whitehead N., 2011, PRECISION PERFORMANC, V21, P18749; Wiggins GC, 2006, MAGN RESON MED, V56, P216, DOI 10.1002/mrm.20925; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	31	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0252736	10.1371/journal.pone.0252736	http://dx.doi.org/10.1371/journal.pone.0252736			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446840	gold, Green Published, Green Submitted			2022-12-26	WOS:000795468200007
J	Miller, RA; Kutmon, M; Bohler, A; Waagmeester, A; Evelo, CT; Willighagen, EL				Miller, Ryan A.; Kutmon, Martina; Bohler, Anwesha; Waagmeester, Andra; Evelo, Chris T.; Willighagen, Egon L.			Understanding signaling and metabolic paths using semantified and harmonized information about biological interactions	PLOS ONE			English	Article							SPHINGOLIPID BIOSYNTHESIS; RETT-SYNDROME; PROTEIN; MUTATIONS; DATABASE	To grasp the complexity of biological processes, the biological knowledge is often translated into schematic diagrams of, for example, signalling and metabolic pathways. These pathway diagrams describe relevant connections between biological entities and incorporate domain knowledge in a visual format making it easier for humans to interpret. Still, these diagrams can be represented in machine readable formats, as done in the KEGG, Reactome, and WikiPathways databases. However, while humans are good at interpreting the message of the creators of diagrams, algorithms struggle when the diversity in drawing approaches increases. WikiPathways supports multiple drawing styles which need harmonizing to offer semantically enriched access. Particularly challenging, here, are the interactions between the biological entities that underlie the biological causality. These interactions provide information about the biological process (metabolic conversion, inhibition, etc.), the direction, and the participating entities. Availability of the interactions in a semantic and harmonized format is essential for searching the full network of biological interactions. We here study how the graphically-modelled biological knowledge in diagrams can be semantified and harmonized, and exemplify how the resulting data is used to programmatically answer biological questions. We find that we can translate graphically modelled knowledge to a sufficient degree into a semantic model and discuss some of the current limitations. We then use this to show that reproducible notebooks can be used to explore up- and downstream targets of MECP2 and to analyse the sphingolipid metabolism. Our results demonstrate that most of the graphical biological knowledge from WikiPathways is modelled into the semantic layer with the semantic information intact and connectivity information preserved. Being able to evaluate how biological elements affect each other is useful and allows, for example, the identification of up or downstream targets that will have a similar effect when modified.	[Miller, Ryan A.; Kutmon, Martina; Bohler, Anwesha; Waagmeester, Andra; Evelo, Chris T.; Willighagen, Egon L.] Maastricht Univ, Dept Bioinformat BiGCaT, NUTRIM, Maastricht, Netherlands; [Kutmon, Martina; Evelo, Chris T.] Maastricht Univ, Maastricht Ctr Syst Biol MaCSBio, Maastricht, Netherlands; [Waagmeester, Andra] Micellio, Antwerp, Belgium	Maastricht University; Maastricht University	Miller, RA (corresponding author), Maastricht Univ, Dept Bioinformat BiGCaT, NUTRIM, Maastricht, Netherlands.	ryan.miller@maastrichtuniversity.nl		Willighagen, Egon/0000-0001-7542-0286	European Union's Horizon 2020 research and innovation programme under the EJP RD COFUND-EJP [825575]	European Union's Horizon 2020 research and innovation programme under the EJP RD COFUND-EJP	C.E. work is supported by the funding from the European Union's Horizon 2020 research and innovation programme under the EJP RD COFUND-EJP N degrees 825575. https://cordis.europa.eu/project/id/825575.	Azzaoui K, 2013, DRUG DISCOV TODAY, V18, P843, DOI 10.1016/j.drudis.2013.05.008; Bohler A, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004941; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Ehrhart F, 2020, WORLD J BIOL PSYCHIA, V21, P712, DOI 10.1080/15622975.2019.1593501; Gault Christopher R, 2010, Adv Exp Med Biol, V688, P1; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hucka M, 2019, J INTEGR BIOINFORMAT, V16, DOI 10.1515/jib-2019-0021; Karp PD, 2021, BMC GENOMICS, V22, DOI 10.1186/s12864-021-07502-8; Kikugawa S, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S2-S7; Kluyver T, 2016, POSITIONING AND POWER IN ACADEMIC PUBLISHING: PLAYERS, AGENTS AND AGENDAS, P87, DOI 10.3233/978-1-61499-649-1-87; Kolter T, 2006, BBA-BIOMEMBRANES, V1758, P2057, DOI 10.1016/j.bbamem.2006.05.027; Kraut R., 2012, FLUORESCENCE CORRELA, V108, P395; Kutmon M, 2016, NUCLEIC ACIDS RES, V44, pD488, DOI 10.1093/nar/gkv1024; Kutmon M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004085; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Luna A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-167; Meldal BHM, 2019, NUCLEIC ACIDS RES, V47, pD550, DOI 10.1093/nar/gky1001; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Miller RA, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00059; Miller Ryan A, 2018, F1000Res, V7, P75, DOI 10.12688/f1000research.13197.1; Moog UTE, 2003, EUR J PAEDIATR NEURO, V7, P5, DOI 10.1016/S1090-3798(02)00134-4; Neul JL, 2008, NEUROLOGY, V70, P1313, DOI 10.1212/01.wnl.0000291011.54508.aa; Piovesan A, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4343-8; Prudhommeaux E, 2014, SEM14 P 10 INT C SEM, P3240; Slenter DN, 2018, NUCLEIC ACIDS RES, V46, pD661, DOI 10.1093/nar/gkx1064; Staworko S, 2015, LEIBNIZ INT P INFORM; Thornton K, 2019, LECT NOTES COMPUT SC, V11503, P606, DOI 10.1007/978-3-030-21348-0_39; Tidhar R, 2013, BBA-MOL CELL RES, V1833, P2511, DOI 10.1016/j.bbamcr.2013.04.010; Waagmeester A, 2021, BMC BIOL, V19, DOI 10.1186/s12915-020-00940-y; Waagmeester A, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004989; Wan MM, 1999, AM J HUM GENET, V65, P1520, DOI 10.1086/302690; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0263057	10.1371/journal.pone.0263057	http://dx.doi.org/10.1371/journal.pone.0263057			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7MW	35436299	Green Submitted, gold, Green Published			2022-12-26	WOS:000791258900009
J	Nakubulwa, MA; Greenfield, G; Pizzo, E; Magusin, A; Maconochie, I; Blair, M; Bell, D; Majeed, A; Sathyamoorthy, G; Woodcock, T				Nakubulwa, Mable Angela; Greenfield, Geva; Pizzo, Elena; Magusin, Andreas; Maconochie, Ian; Blair, Mitch; Bell, Derek; Majeed, Azeem; Sathyamoorthy, Ganesh; Woodcock, Thomas			To what extent do callers follow the advice given by a non-emergency medical helpline (NHS 111): A retrospective cohort study	PLOS ONE			English	Article							TELEPHONE TRIAGE ADVICE; SERVICE; CARE	National Health Service (NHS) 111 helpline was set up to improve access to urgent care in England, efficiency and cost-effectiveness of first-contact health services. Following trusted, authoritative advice is crucial for improved clinical outcomes. We examine patient and call-related characteristics associated with compliance with advice given in NHS 111 calls. The importance of health interactions that are not face-to-face has recently been highlighted by COVID-19 pandemic. In this retrospective cohort study, NHS 111 call records were linked to urgent and emergency care services data. We analysed data of 3,864,362 calls made between October 2013 and September 2017 relating to 1,964,726 callers across London. A multiple logistic regression was used to investigate associations between compliance with advice given and patient and call characteristics. Caller's action is 'compliant with advice given if first subsequent service interaction following contact with NHS 111 is consistent with advice given. We found that most calls were made by women (58%), adults aged 30-59 years (33%) and people in the white ethnic category (36%). The most common advice was for caller to contact their General Practitioner (GP) or other local services (18.2%) with varying times scales. Overall, callers followed advice given in 49% of calls. Compliance with triage advice was more likely in calls for children aged <16 years, women, those from Asian/Asian British ethnicity, and calls made out of hours. The highest compliance was among callers advised to self-care without the need to contact any other healthcare service. This is one of the largest studies to describe pathway adherence following telephone advice and associated clinical and demographic features. These results could inform attempts to improve caller compliance with advice given by NHS 111, and as the NHS moves to more hybrid way of working, the lessons from this study are key to the development of remote healthcare services going forward.	[Nakubulwa, Mable Angela; Greenfield, Geva; Blair, Mitch; Bell, Derek; Majeed, Azeem; Sathyamoorthy, Ganesh; Woodcock, Thomas] Imperial Coll London, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London, England; [Pizzo, Elena] UCL, Dept Appl Hlth Res, London, England; [Magusin, Andreas] NHS North & East London Commissioning Support Unit, London, England; [Maconochie, Ian] St Marys Hosp, Imperial Coll NHS Healthcare Trust, Dept Paediat Emergency Med, Div Med, London, England	Imperial College London; University of London; University College London; Imperial College London	Woodcock, T (corresponding author), Imperial Coll London, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London, England.	thomas.woodcock99@imperial.ac.uk	Woodcock, Thomas/GXZ-9374-2022	Woodcock, Thomas/0000-0002-4735-4856; Pizzo, Elena/0000-0003-0790-7505; Majeed, Azeem/0000-0002-2357-9858; Maconochie, Ian/0000-0001-6319-8550	National Institute for Health Research Applied Research Collaboration Northwest London; Healthy London Partnership [NIHR200180]	National Institute for Health Research Applied Research Collaboration Northwest London; Healthy London Partnership	This report is independent research supported by the National Institute for Health Research Applied Research Collaboration Northwest London. Healthy London Partnership also provided funding contributing to this study. The views expressed in this publication are those of the authors and not necessarily those of the National Institute for Health Research or the Department of Health and Social Care. Grant No. NIHR200180. AM is an NIHR Senior Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belman S, 2005, ARCH PEDIAT ADOL MED, V159, P145, DOI 10.1001/archpedi.159.2.145; Blank L, 2012, J ADV NURS, V68, P2610, DOI 10.1111/j.1365-2648.2012.06052.x; Dale J, 1997, J ACCID EMERG MED, V14, P21; Tran DT, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2458-y; Egan M, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-032043; Gibson A, 2018, HEALTH SERV RES, V53, P1137, DOI 10.1111/1475-6773.12692; Kempe A, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.6.e111; Kempe A, 2006, PEDIATRICS, V118, P457, DOI 10.1542/peds.2005-3073; Knowles E, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011846; Knowles E, 2014, J HEALTH SERV RES PO, V19, P224, DOI 10.1177/1355819614535571; Lee TJ, 2003, CLIN PEDIATR, V42, P613, DOI 10.1177/000992280304200707; Lewis J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251362; Li L, 2016, STUD HEALTH TECHNOL, V227, P87, DOI 10.3233/978-1-61499-666-8-87; McCulloch P., 1990, GEN LINEAR MODELS, V2nd; Mckew Matthew, 2017, Emerg Nurse, V24, P8, DOI 10.7748/en.24.10.8.s8; Niemann S, 2004, SWISS MED WKLY, V134, P126; O'Cathain A, 2014, FAM PRACT, V31, P193, DOI 10.1093/fampra/cmt078; Purc-Stephenson RJ, 2012, PATIENT EDUC COUNS, V87, P135, DOI 10.1016/j.pec.2011.08.019; Robinson Cicely, 2017, Clin Med (Lond), V17, ps13, DOI 10.7861/clinmedicine.17-3-s13; Staub GM, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-110; Stewart B, 2006, EMERG MED J, V23, P911, DOI 10.1136/emj.2006.039339; Turner J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003451; Turner J., 2021, HLTH SERV DELIV RES, V9, P1, DOI [10.3310/hsdr09210, DOI 10.3310/HSDR09210]	23	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267052	10.1371/journal.pone.0267052	http://dx.doi.org/10.1371/journal.pone.0267052			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446886	Green Published, gold			2022-12-26	WOS:000795468200044
J	Xiao, GF; Zhao, YL; Huang, WY; Hu, LQ; Wang, GQ; Luo, HY				Xiao, Gefei; Zhao, Yanling; Huang, Wuyan; Hu, Liqing; Wang, Guoqing; Luo, Huayu			Health economic evaluation of noninvasive prenatal testing and serum screening for down syndrome	PLOS ONE			English	Article							FETAL DNA	Background Down syndrome (DS), also known as trisomy 21 (T21), is the most common genetic disorder associated with intellectual disability. There are two methods commonly used for prenatal testing of DS: serum screening (SS) for biomarkers in maternal serum and noninvasive prenatal testing (NIPT) for aneuploidy by cell-free DNA (cfDNA) in maternal plasma. However, cost-effectiveness analyses of these two methods are mostly based on data derived from simulations with various models, with theoretical values calculated. In this study, we statistically analyzed clinical DS screening data and pregnancy outcomes during the follow-up of pregnant women in Zhuhai City, China. The economics of the two mainstream prenatal DS screening methods was evaluated from a public health perspective. Methods A retrospective analysis was performed on the data of 17,363 pregnant women who received SS and NIPT during gestation in Zhuhai from 2018 to 2019, and a cost-effectiveness analysis was performed with four screening strategies. In strategy I, all pregnant women received SS, and those with T21 risk >= 1/270 had invasive prenatal diagnosis (IPD). In strategy II, all pregnant women received SS, those with T21 risk >= 1/270 had IPD, and those with 1/270 > T21 risk >= 1/1,000 had NIPT; then, women at high risk based on NIPT also had IPD. In strategy III, all pregnant women received SS, and those with T21 risk >= 1,000 had NIPT; then, women at high risk based on NIPT results had IPD. In strategy IV, all pregnant women received NIPT and those at high risk based on NIPT results had IPD. Finally, to assess the cost and effectiveness of DS screening, the total costs were calculated as the sum of screening and diagnosis as well as the direct and indirect economic burden during the average life cycle of DS patients. Results A total of 22 of the 17,363 (1/789) pregnant women had DS, of which only one woman was over 35 years of age. SS detected 1,024 cases at high risk of T21 (>= 1/270), 8 cases were true positive, with a positive predictive value of 0.78% and a detection rate of 36.4%. NIPT detected 27 cases at high risk of T21 (Z >= 3) and 22 cases of DS, with a positive predictive value of 81.5% and a detection rate of 100%. Strategy I had the largest total cost of 65.54 million CNY, strategy II and III had similar total costs of 40 million CNY, and strategy IV had the lowest total cost of 14.91 million CNY. By comparison, the screening strategy with NIPT alone had the highest health economic value for DS. Conclusions SS was greatly affected by nuchal translucency and the accuracy of gestational age measured by ultrasonography. Unstandardized ultrasonography was an important reason for the low DS detection rate with SS. The influence of interfering factors on NIPT was much lower than in SS. NIPT can be used as an alternative to SS and as a primary screening strategy of prenatal DS screening for secondary prevention and control of birth defects. NIPT greatly decreased the frequency of IPD and the miscarriages associated with IPD, saved the limited medical and health resources, and greatly increased DS detection rate. Therefore, NIPT has great social and economic benefits.	[Xiao, Gefei; Zhao, Yanling; Huang, Wuyan; Hu, Liqing; Wang, Guoqing; Luo, Huayu] Zhuhai Ctr Maternal & Child Healthcare, Inst Med Genet, Dept Clin Lab, Zhuhai, Guangdong, Peoples R China		Xiao, GF (corresponding author), Zhuhai Ctr Maternal & Child Healthcare, Inst Med Genet, Dept Clin Lab, Zhuhai, Guangdong, Peoples R China.	xgf8111_cn@hotmail.com		Gefei, Xiao/0000-0002-6990-8901	Science and Technology planning projects of Zhuhai	Science and Technology planning projects of Zhuhai	Funding is provided by: Science and Technology planning projects of Zhuhai (Project No. ZH2202200063HJL).This project manager is the corresponding author of this manuscript.	Ayres AC, 2014, AUST NZ J OBSTET GYN, V54, P412, DOI 10.1111/ajo.12223; Beulen L, 2014, EUR J OBSTET GYN R B, V182, P53, DOI 10.1016/j.ejogrb.2014.08.028; Bull MJ, 2020, NEW ENGL J MED, V382, P2344, DOI 10.1056/NEJMra1706537; Coppede F, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00223; CUCKLE HS, 1984, LANCET, V1, P926; Evans MI, 2015, ULTRASOUND OBST GYN, V45, P74, DOI 10.1002/uog.14693; General Office of National Health and Family Planning Commission PC, 2016, NOT GEN OFF NAT HLTH; Gil MM, 2015, ULTRASOUND OBST GYN, V45, P249, DOI 10.1002/uog.14791; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lowy I, 2022, SOC SCI MED, V304, DOI 10.1016/j.socscimed.2020.113064; Ministry of Health of the Peoples Republic of China, REP BIRTH DEF PREV C; Morris S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093559; National Bureau of Statistics, 2019, CHINA STAT YB; WALD NJ, 1992, BRIT J OBSTET GYNAEC, V99, P144, DOI 10.1111/j.1471-0528.1992.tb14474.x; Wald NJ, 1999, NEW ENGL J MED, V341, P461, DOI 10.1056/NEJM199908123410701; Xu Y, 2019, INT J TECHNOL ASSESS, V35, P237, DOI 10.1017/S0266462319000308; Zeng F., 2012, THESIS CENTRAL S U; Zhang W, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225281	18	0	0	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266718	10.1371/journal.pone.0266718	http://dx.doi.org/10.1371/journal.pone.0266718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421148	gold, Green Published			2022-12-26	WOS:000795453600063
J	Kweon, OJ; Lim, YK; Lee, MK; Kim, HR				Kweon, Oh Joo; Lim, Yong Kwan; Lee, Mi-Kyung; Kim, Hye Ryoun			Red and white blood cell morphology characterization and hands-on time analysis by the digital cell imaging analyzer DI-60	PLOS ONE			English	Article							PERIPHERAL-BLOOD; ICSH RECOMMENDATIONS	Background The Sysmex DI-60 digital morphology analyzer is a fully automated, cell-locating image analysis system. This study aimed to evaluate the analytical performance of DI-60. Methods A total of 822 peripheral blood smears were used. The diagnostic performance of DI-60 in terms of red blood cell (RBC) morphology characterization, white blood cell (WBC) differentials, and the total assay time including hands-on time was evaluated. Results In comparison with manual slide review, DI-60 demonstrated acceptable accuracy in recognizing polychromasia, target cells, and ovalocytes. However, for schistocytes, DI-60 demonstrated low specificity (10.4%) despite the high sensitivity (97.2%). In the precision analysis of RBC morphology characterization, borderline samples harboring specific RBCs showed inconsistencies in the positive results among 20 replicates. Particularly, 6 of 10 samples showed inconsistencies in the precision for schistocytes. For WBC differentials, the overall agreement between pre-classification results and user-verified results was 89.4%. Except for basophils, normal WBCs showed a good correlation between DI-60 (after user verification) and manual counts. The sensitivities in detecting immature granulocytes, blasts, atypical lymphocytes, and normoblasts were 85.9%, 92.0%, 37.5%, and 77.6%, respectively. Although the total assay time of DI-60 was longer than that of manual review, the hands-on time was considerably shorter with a difference of 144.1 s/slide for abnormal samples. Conclusion DI-60 demonstrated acceptable performance for normal samples. However, for abnormal WBC differentials and RBC morphology characterization, it should be utilized carefully. DI-60 may contribute to an improvement in laboratory efficiency with increased feasibility.	[Kweon, Oh Joo; Lim, Yong Kwan; Lee, Mi-Kyung; Kim, Hye Ryoun] Chung Ang Univ, Coll Med, Dept Lab Med, Seoul, South Korea	Chung Ang University; Chung Ang University Hospital	Kim, HR (corresponding author), Chung Ang Univ, Coll Med, Dept Lab Med, Seoul, South Korea.	hyekim@cau.ac.kr		Lim, Yong Kwan/0000-0002-4300-8964	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2021R1A2C2013359]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2021R1A2C2013359). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briggs C, 2009, INT J LAB HEMATOL, V31, P48, DOI 10.1111/j.1751-553X.2007.01002.x; Ceelie H, 2007, J CLIN PATHOL, V60, P72, DOI 10.1136/jcp.2005.035402; CLSI, 2014, EP5A3 CLSI; CLSI, 2007, H20A2 CLSI, VSecond; Criel M, 2016, INT J LAB HEMATOL, V38, P366, DOI 10.1111/ijlh.12497; Gao Yuon, 2013, J Pathol Inform, V4, P16, DOI 10.4103/2153-3539.114207; Herishanu Y, 2014, LEUKEMIA RES, V38, P484, DOI 10.1016/j.leukres.2014.01.008; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee Lik Hang, 2013, J Pathol Inform, V4, P14, DOI 10.4103/2153-3539.114205; Lesesve JF, 2015, INT J LAB HEMATOL, V37, P583, DOI 10.1111/ijlh.12364; Maenhout TM, 2014, J CLIN PATHOL, V67, P648, DOI 10.1136/jclinpath-2014-202223; Palmer L, 2015, INT J LAB HEMATOL, V37, P287, DOI 10.1111/ijlh.12327; Rosetti M, 2021, CLIN CHEM LAB MED, V59, pE161, DOI 10.1515/cclm-2020-0627; RUMKE CL, 1985, BLOOD CELLS, V11, P311; Tabe Y, 2015, CLIN CHEM LAB MED, V53, P281, DOI 10.1515/cclm-2014-0445; Zini G, 2012, INT J LAB HEMATOL, V34, P107, DOI 10.1111/j.1751-553X.2011.01380.x	16	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267638	10.1371/journal.pone.0267638	http://dx.doi.org/10.1371/journal.pone.0267638			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476704	gold, Green Published			2022-12-26	WOS:000840124300058
J	Peng, W; Shi, S; Zhong, JC; Liang, HH; Hou, JB; Hu, XS; Wang, F; Zhang, JY; Geng, SJ; Sun, XC; Zhong, D; Cui, HJ				Peng, Wen; Shi, Shuang; Zhong, Jiacheng; Liang, Hanghua; Hou, Jianbin; Hu, Xiaosong; Wang, Feng; Zhang, Jiayi; Geng, Shengjun; Sun, Xiaochuan; Zhong, Dong; Cui, Hongjuan			CBX3 accelerates the malignant progression of glioblastoma multiforme by stabilizing EGFR expression	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; LUNG ADENOCARCINOMA; CANCER PROGRESSION; TUMOR-SUPPRESSOR; HISTONE H3; LYSINE 9; PARKIN; P53; PROLIFERATION; GENE	CBX3, also known as HP1 gamma, is a major isoform of heterochromatin protein 1, whose deregulation has been reported to promote the development of human cancers. However, the molecular mechanism of CBX3 in glioblastoma multiforme (GBM) are unclear. Our study reported the identification of CBX3 as a potential therapeutic target for GBM. Briefly, we found that, CBX3 is significantly upregulated in GBM and reduces patient survival. In addition, functional assays demonstrated that CBX3 significantly promote the proliferation, invasion and tumorigenesis of GBM cells in vitro and in vivo. Mechanistically, Erlotinib, a small molecule targeting epidermal growth factor receptor (EGFR) tyrosine kinase, was used to demonstrate that CBX3 direct the malignant progression of GBM are EGFR dependent. Previous studies have shown that PARK2(Parkin) and STUB1(Carboxy Terminus of Hsp70-Interacting Protein) are EGFR-specific E3 ligases. Notably, we verified that CBX3 directly suppressed PARK2 and STUB1 at the transcriptional level through its CD domain to reduce the ubiquitination of EGFR. Moreover, the CSD domain of CBX3 interacted with PARK2 and regulated its ubiquitination to further reduce its protein level. Collectively, these results revealed an unknown mechanism underlying the pathogenesis of GBM and confirmed that CBX3 is a promising therapeutic target.	[Peng, Wen; Liang, Hanghua; Hou, Jianbin; Hu, Xiaosong; Wang, Feng; Zhang, Jiayi; Geng, Shengjun; Cui, Hongjuan] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China; [Peng, Wen; Liang, Hanghua; Hou, Jianbin; Hu, Xiaosong; Wang, Feng; Zhang, Jiayi; Geng, Shengjun; Cui, Hongjuan] Southwest Univ, Med Res Inst, Canc Ctr, Chongqing 400716, Peoples R China; [Shi, Shuang; Zhong, Jiacheng; Sun, Xiaochuan; Zhong, Dong] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing 400016, Peoples R China	Southwest University - China; Southwest University - China; Chongqing Medical University	Cui, HJ (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China.; Cui, HJ (corresponding author), Southwest Univ, Med Res Inst, Canc Ctr, Chongqing 400716, Peoples R China.; Zhong, D (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing 400016, Peoples R China.	zhongdongdp@sina.com; hcui@swu.edu.cn	Hu, Xiao/GQI-0007-2022	Hu, Xiao/0000-0003-1128-4099	Natural Science Foundation of Chongqing [cstc2019jcyj-zdxmX0033]; Chongqing Doctoral Research and Innovation Project [CYB21131]	Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing); Chongqing Doctoral Research and Innovation Project	This research was supported by the Natural Science Foundation of Chongqing (cstc2019jcyj-zdxmX0033) and Chongqing Doctoral Research and Innovation Project (CYB21131).	Akaike Y, 2015, ONCOGENE, V34, P3463, DOI 10.1038/onc.2014.278; Alam H, 2018, CANCER RES, V78, P3834, DOI 10.1158/0008-5472.CAN-17-3571; Aldape K, 2015, ACTA NEUROPATHOL, V129, P829, DOI 10.1007/s00401-015-1432-1; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bhuripanyo K, 2018, SCI ADV, V4, DOI 10.1126/sciadv.1701393; Brandes AA, 2008, CLIN CANCER RES, V14, P957, DOI 10.1158/1078-0432.CCR-07-1810; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cai HP, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03247-6; Caillier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015507; Chakravarti A, 2013, INT J RADIAT ONCOL, V85, P1206, DOI 10.1016/j.ijrobp.2012.10.008; Chang SC, 2018, ASIA-PAC J CLIN ONCO, V14, pe283, DOI 10.1111/ajco.12820; Chen CY, 2013, CANCER RES, V73, P4009, DOI 10.1158/0008-5472.CAN-12-4066; Chen LY, 2018, BIOCHEM BIOPH RES CO, V500, P691, DOI 10.1016/j.bbrc.2018.04.137; Choi Jae Duk, 2013, Genomics & Informatics, V11, P164, DOI 10.5808/GI.2013.11.4.164; da Costa CA, 2009, NAT CELL BIOL, V11, P1370, DOI 10.1038/ncb1981; Dialynas GK, 2008, MUTAT RES-FUND MOL M, V647, P13, DOI 10.1016/j.mrfmmm.2008.09.007; England B, 2013, TUMOR BIOL, V34, P2063, DOI 10.1007/s13277-013-0871-3; Eskilsson E, 2018, NEURO-ONCOLOGY, V20, P743, DOI 10.1093/neuonc/nox191; Furnari FB, 2015, NAT REV CANCER, V15, P302, DOI 10.1038/nrc3918; Gao FQ, 2020, GENE, V726, DOI 10.1016/j.gene.2019.144196; Guimaraes DP, 2002, BIOCHIMIE, V84, P83, DOI 10.1016/S0300-9084(01)01356-6; Hegi ME, 2011, MOL CANCER THER, V10, P1102, DOI 10.1158/1535-7163.MCT-11-0048; Hou J, 2017, ONCOGENE, V36, P1134, DOI 10.1038/onc.2016.280; Karpel-Massler G, 2009, MOL CANCER RES, V7, P1000, DOI 10.1158/1541-7786.MCR-08-0479; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Li Q, 2021, TRANSL LUNG CANCER R, V10, P936, DOI 10.21037/tlcr-21-147; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Lim M, 2018, NAT REV CLIN ONCOL, V15, P422, DOI 10.1038/s41571-018-0003-5; Lin DC, 2015, CANCER RES, V75, P1815, DOI 10.1158/0008-5472.CAN-14-1433; Liu M, 2015, CANCER RES, V75, P4593, DOI 10.1158/0008-5472.CAN-14-3735; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Maugeri G, 2015, INT J ONCOL, V47, P1282, DOI 10.3892/ijo.2015.3105; Okorokov AL, 2009, CURR OPIN STRUC BIOL, V19, P197, DOI 10.1016/j.sbi.2009.02.003; Osuka S, 2017, J CLIN INVEST, V127, P415, DOI 10.1172/JCI89587; Reardon DA, 2014, NEURO-ONCOLOGY, V16, pviii7, DOI 10.1093/neuonc/nou232; Roth P, 2014, NEURO-ONCOLOGY, V16, pviii14, DOI 10.1093/neuonc/nou222; Shao GB, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0784-2; Sridharan R, 2013, NAT CELL BIOL, V15, P872, DOI 10.1038/ncb2768; Stathias V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07659-z; Sunico CR, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-29; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Viotti J, 2014, ONCOGENE, V33, P1764, DOI 10.1038/onc.2013.124; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang FM, 2021, MOL NEUROBIOL, V58, P3362, DOI 10.1007/s12035-021-02337-6; Wang SQ, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1930-3; Wang TX, 2014, ONCOTARGET, V5, P1969, DOI 10.18632/oncotarget.1890; Weisz L, 2007, ONCOGENE, V26, P2202, DOI 10.1038/sj.onc.1210294; Weller M, 2017, LANCET ONCOL, V18, pE315, DOI 10.1016/S1470-2045(17)30194-8; Wong SC, 2021, NUTRIENTS, V13, DOI 10.3390/nu13030950; Xuan F, 2016, NEURO-ONCOLOGY, V18, P819, DOI 10.1093/neuonc/nov281; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yeo CWS, 2012, CANCER RES, V72, P2543, DOI 10.1158/0008-5472.CAN-11-3060; Zhang C, 2011, P NATL ACAD SCI USA, V108, P16259, DOI 10.1073/pnas.1113884108; Zhang Y, 2018, CANCERS, V10, DOI 10.3390/cancers10090297; Zhao SP, 2019, J NEURO-ONCOL, V145, P35, DOI 10.1007/s11060-019-03286-w; Zhao YZ, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0137-7; Zhong XP, 2019, AGING-US, V11, P5483, DOI 10.18632/aging.102132	58	3	3	10	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 27	2022	41	22					3051	3063		10.1038/s41388-022-02296-9	http://dx.doi.org/10.1038/s41388-022-02296-9		APR 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	1U7PG	35459780				2022-12-26	WOS:000787474100005
J	Abatedaga, I; Mora, BP; Tuttobene, M; Muller, G; Biancotti, D; Borsarelli, CD; Valle, L; Mussi, MA				Abatedaga, Ines; Perez Mora, Barbara; Tuttobene, Marisel; Muller, Gabriela; Biancotti, Daiana; Borsarelli, Claudio D.; Valle, Lorena; Mussi, Maria A.			Characterization of BLUF-photoreceptors present in Acinetobacter nosocomialis	PLOS ONE			English	Article							TRANSFER-RNA; SHIGELLA-FLEXNERI; VIRULENCE; BAUMANNII; EXPRESSION; PATHOGEN; TEMPERATURE; METABOLISM; INFECTION; KINETICS	Acinetobacter nosocomialis is a Gram-negative opportunistic pathogen, whose ability to cause disease in humans is well recognized. Blue light has been shown to modulate important physiological traits related to persistence and virulence in this microorganism. In this work, we characterized the three Blue Light sensing Using FAD (BLUF) domain-containing proteins encoded in the A. nosocomialis genome, which account for the only canonical light sensors present in this microorganism. By focusing on a light-modulated bacterial process such as motility, the temperature dependence of light regulation was studied, as well as the expression pattern and spectroscopic characteristics of the different A. nosocomialis BLUFs. Our results show that the BLUF-containing proteins AnBLUF65 and AnBLUF46 encode active photoreceptors in the light-regulatory temperature range when expressed recombinantly. In fact, AnBLUF65 is an active photoreceptor in the temperature range from 15 degrees C to 37 degrees C, while AnBLUF46 between 15 degrees C to 32 degrees C, in vitro. In vivo, only the Acinetobacter baumannii BlsA's ortholog AnBLUF65 was expressed in A. nosocomialis cells recovered from motility plates. Moreover, complementation assays showed that AnBLUF65 is able to mediate light regulation of motility in A. baumannii Delta blsA strain at 30 degrees C, confirming its role as photoreceptor and in modulation of motility by light. Intra-protein interactions analyzed using 3D models built based on A. baumannii ' s BlsA photoreceptor, show that hydrophobic/aromatic intra-protein interactions may contribute to the stability of dark/light- adapted states of the studied proteins, reinforcing the previous notion on the importance of these interactions in BLUF photoreceptors. Overall, the results presented here reveal the presence of BLUF photoreceptors in A. nosocomialis with idiosyncratic characteristics respect to the previously characterized A. baumannii's BlsA, both regarding the photoactivity temperature-dependency as well as expression patterns, contributing thus to broaden our knowledge on the BLUF family.	[Abatedaga, Ines; Borsarelli, Claudio D.; Valle, Lorena] Univ Nacl Santiago del Estero UNSE, CONICET, Inst Bionanotecnol NOA INBIONATEC, Santiago Del Estero, Argentina; [Perez Mora, Barbara; Tuttobene, Marisel; Muller, Gabriela; Biancotti, Daiana; Mussi, Maria A.] Univ Nacl Rosario UNR, CONICET, Ctr Estudios Fotosintet & Bioquim CEFOBI, Rosario, Argentina; [Borsarelli, Claudio D.; Valle, Lorena] UNSE, Fac Agron & Agroindustrias FAyA, Inst Ciencias Quim ICQ, Santiago Del Estero, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Valle, L (corresponding author), Univ Nacl Santiago del Estero UNSE, CONICET, Inst Bionanotecnol NOA INBIONATEC, Santiago Del Estero, Argentina.; Mussi, MA (corresponding author), Univ Nacl Rosario UNR, CONICET, Ctr Estudios Fotosintet & Bioquim CEFOBI, Rosario, Argentina.; Valle, L (corresponding author), UNSE, Fac Agron & Agroindustrias FAyA, Inst Ciencias Quim ICQ, Santiago Del Estero, Argentina.	lvalle@unse.edu.ar; mussi@cefobi-conicet.gov.ar		Abatedaga, Ines/0000-0002-3046-4426; Valle, Lorena/0000-0002-3497-479X	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2018-00793]; ASaCTeI, Ministerio de Ciencia, Tecnologia e Innovacion Productiva de la Provincia de Santa Fe [IO-021-18]; Consejo Nacional de Investigaciones Cientificas y Tecnologicas [PIP 2017-0493]; Facultad de Agronomia y Agroindustrias (FAyA) of Universidad Nacional de Santiago del Estero	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); ASaCTeI, Ministerio de Ciencia, Tecnologia e Innovacion Productiva de la Provincia de Santa Fe; Consejo Nacional de Investigaciones Cientificas y Tecnologicas; Facultad de Agronomia y Agroindustrias (FAyA) of Universidad Nacional de Santiago del Estero	This work was funded by Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2018-00793) and ASaCTeI, Ministerio de Ciencia, Tecnologia e Innovacion Productiva de la Provincia de Santa Fe (IO-021-18) by MAM. IA recieved funding from Consejo Nacional de Investigaciones Cientificas y Tecnologicas (PIP 2017-0493). LV recieved funding by Facultad de Agronomia y Agroindustrias (FAyA) of Universidad Nacional de Santiago del Estero. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatedaga I, 2017, PHOTOCHEM PHOTOBIOL, V93, P805, DOI 10.1111/php.12760; Arias M, 1976, GLUTATHIONE METABOLI, P175; Bhuiyan MS, 2016, P NATL ACAD SCI USA, V113, P9599, DOI 10.1073/pnas.1523116113; Bitrian M, 2013, MICROBIOL-SGM, V159, P1828, DOI 10.1099/mic.0.069153-0; BURNS RO, 1963, BIOCHEMISTRY-US, V2, P1053, DOI 10.1021/bi00905a024; Cerqueira GM, 2014, J INFECT DIS, V210, P46, DOI 10.1093/infdis/jiu024; Chitrakar I, 2020, ACS INFECT DIS, V6, P2592, DOI 10.1021/acsinfecdis.0c00156; Christgen SL, 2019, ANTIOXID REDOX SIGN, V30, P683, DOI 10.1089/ars.2017.7335; Chusri S, 2014, ANTIMICROB AGENTS CH, V58, P4172, DOI 10.1128/AAC.02992-14; Cress BF, 2014, FEMS MICROBIOL REV, V38, P660, DOI [10.1111/1574-6976.12056, 10.1111/1574-69]; Csonka Laszlo N, 2007, EcoSal Plus, V2, DOI 10.1128/ecosalplus.3.6.1.4; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Durand JMB, 1997, J BACTERIOL, V179, P5777, DOI 10.1128/jb.179.18.5777-5782.1997; Durand JMB, 2000, MOL MICROBIOL, V35, P924, DOI 10.1046/j.1365-2958.2000.01767.x; Fujisawa Tomotsumi, 2018, Biophys Rev, V10, P327, DOI 10.1007/s12551-017-0355-6; Golic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055059; Golic AE, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01925; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; HOBBS G, 1990, J GEN MICROBIOL, V136, P2291, DOI 10.1099/00221287-136-11-2291; Huang L, 2014, J MICROBIOL IMMUNOL, V47, P311, DOI 10.1016/j.jmii.2013.02.002; Hurlburt NK, 2020, ACTA CRYSTALLOGR F, V76, P557, DOI [10.1017/S2053230X20013680, 10.1107/S2053230X20013680]; Khrenova MG, 2017, CHEM PHYS LETT, V676, P25, DOI 10.1016/j.cplett.2017.03.035; Kilstrup M, 2005, FEMS MICROBIOL REV, V29, P555, DOI 10.1016/j.femsre.2005.04.006; Klein K, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00100; Knight DB, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01902; Kraft BJ, 2003, BIOCHEMISTRY-US, V42, P6726, DOI 10.1021/bi030055o; LaMarre JM, 2011, ANTIMICROB AGENTS CH, V55, P2989, DOI 10.1128/AAC.00183-11; Lanzarotti E, 2011, J CHEM INF MODEL, V51, P1623, DOI 10.1021/ci200062e; Lee K, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw104; Liiv A, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-18; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mann PA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005585; MCFARLAND WC, 1987, MICROB PATHOGENESIS, V3, P129, DOI 10.1016/0882-4010(87)90071-4; Mei JM, 1997, MOL MICROBIOL, V26, P399, DOI 10.1046/j.1365-2958.1997.5911966.x; Morris RC, 2001, MOL GENET METAB, V74, P147, DOI 10.1006/mgme.2001.3216; Muller GL, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00011-17; Mussi MA, 2010, J BACTERIOL, V192, P6336, DOI 10.1128/JB.00917-10; Navone L, 2014, APPL MICROBIOL BIOT, V98, P351, DOI 10.1007/s00253-013-5372-1; Nemec A, 2011, RES MICROBIOL, V162, P393, DOI 10.1016/j.resmic.2011.02.006; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Park YJ, 2007, FEMS MICROBIOL LETT, V276, P55, DOI 10.1111/j.1574-6968.2007.00909.x; Pezza A, 2019, PHOTOCH PHOTOBIO SCI, V18, P2363, DOI 10.1039/c9pp00261h; Piovesan D, 2016, NUCLEIC ACIDS RES, V44, pW367, DOI 10.1093/nar/gkw315; Potron A, 2009, ANTIMICROB AGENTS CH, V53, P3010, DOI 10.1128/AAC.01164-08; Tuttobene MR, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01376; Samant S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040037; Samuel J, 2002, NAT PROD REP, V19, P261, DOI 10.1039/b100492l; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schramm STJ, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01375; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Ramirez MS, 2015, J MED MICROBIOL, V64, P525, DOI 10.1099/jmm.0.000048; Tanwar M, 2016, FEBS LETT, V590, P2146, DOI 10.1002/1873-3468.12227; Trovato M, 2019, OSMOPROTECTANT-MEDIATED ABIOTIC STRESS TOLERANCE IN PLANTS: RECENT ADVANCES AND FUTURE PERSPECTIVES, P41, DOI 10.1007/978-3-030-27423-8_2; Tuttobene M., 2020, J BACTERIOL; Tuttobene MR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26127-8; Valle L, 2012, PHOTOCH PHOTOBIO SCI, V11, P1051, DOI 10.1039/c2pp05385c; Valle L, 2015, CHEMPHYSCHEM, V16, P872, DOI 10.1002/cphc.201402774; Velloso LM, 2008, EMBO REP, V9, P199, DOI 10.1038/sj.embor.7401154; Villegas JM, 2014, BBA-PROTEINS PROTEOM, V1844, P576, DOI 10.1016/j.bbapap.2013.12.021; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Webb-Robertson BJM, 2015, J PROTEOME RES, V14, P1993, DOI 10.1021/pr501138h; Wisplinghoff H, 2012, J INFECTION, V64, P282, DOI 10.1016/j.jinf.2011.12.008; Wood CR, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00442-18; Xie RQ, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0038-9	66	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0254291	10.1371/journal.pone.0254291	http://dx.doi.org/10.1371/journal.pone.0254291			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35442978	gold, Green Submitted, Green Published			2022-12-26	WOS:000822608900001
J	Xia, J; Wang, JH; Chen, H; Zhuang, J; Cao, ZB; Chen, PJ				Xia, Jun; Wang, Jihong; Chen, Hua; Zhuang, Jie; Cao, Zhenbo; Chen, Peijie			An unsupervised machine learning approach to evaluate sports facilities condition in primary school	PLOS ONE			English	Article							FUZZY C-MEANS; PHYSICAL-ACTIVITY LEVELS; ENVIRONMENT; CLASSIFICATION; CHILDREN; ASSOCIATIONS; ADOLESCENTS; YOUTH; AVAILABILITY; PREVALENCE	Sports facilities have been acknowledged as one of the crucial environmental factors for children's physical education, physical fitness, and participation in physical activity. Finding a solution for the effective and objective evaluation of the condition of sports facilities in schools (SSFs) with the responding quantitative magnitude is an uncertain task. This paper describes the utilization of an unsupervised machine learning method to objectively evaluate the condition of sports facilities in primary school (PSSFC). The statistical data of 845 samples with nine PSSFC indicators (indoor and outdoor included) were collected from the Sixth National Sports Facility Census in mainland China (NSFC), an official nationwide quinquennial census. The Fuzzy C-means (FCM) algorithm was applied to cluster the samples in accordance with the similarity of PSSFC. The clustered data were visualized by using t-stochastic neighbor embedding (t-SNE). The statistics results showed that the application of t-SNE and FCM led to the acceptable performance of clustering SSFs data into three types with differences in PSSFC. The effects of school category, location factors, and the interaction on PSSFC were analyzed by two-way analysis of covariance, which indicated that regional PSSFC has geographical and typological characteristics: schools in the suburbs are superior to those in the inner city, schools with more grades of students are configured with better variety and larger size of sports facilities. In conclusion, we have developed a combinatorial machine learning clustering approach that is suitable for objective evaluation on PSSFC and indicates its characteristics.	[Xia, Jun; Wang, Jihong; Zhuang, Jie; Cao, Zhenbo; Chen, Peijie] Shanghai Univ Sport, Sch Kinesiol, Shanghai, Peoples R China; [Chen, Hua] Tongji Univ, Inst Urban Dev & Management, Shanghai, Peoples R China	Shanghai University of Sport; Tongji University	Chen, PJ (corresponding author), Shanghai Univ Sport, Sch Kinesiol, Shanghai, Peoples R China.	chenpeijie@sus.edu.cn		Xia, Jun/0000-0003-0645-7389	Science and Technology Commission of Shanghai Municipality [20080502700, 19080503000]; Ministry of Science and Technology [2018YFF0300505]; China Postdoctoral Science Foundation [2018M632148]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	Research Project from the Science and Technology Commission of Shanghai Municipality (No. 19080503000). J Z. http://svc.stcsm.sh.gov.cn/Research Project from the Science and Technology Commission of Shanghai Municipality (No. 20080502700). JH W, J X. http://svc.stcsm.sh.gov.cn/National Key Research and Development Project of China from the Ministry of Science and Technology (No. 2018YFF0300505). J X, JH W. http://service.most.gov.cn Grand-in-Aid for Postdoctoral Scientific Research from the China Postdoctoral Science Foundation (No. 2018M632148). J Z, PJ C, J X. http://jj.chinapostdoctor.org.cn/All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], STAND CONSTR SCHOOL; Anter AM, 2020, SOFT COMPUT, V24, P1565, DOI 10.1007/s00500-019-03988-3; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Beighle A, 2006, J SCHOOL HEALTH, V76, P516, DOI 10.1111/j.1746-1561.2006.00151.x; Bevans KB, 2010, J SCHOOL HEALTH, V80, P573, DOI 10.1111/j.1746-1561.2010.00544.x; BEZDEK JC, 1984, COMPUT GEOSCI, V10, P191, DOI 10.1016/0098-3004(84)90020-7; Bhatia V, 2018, KNOWL INF SYST, V57, P159, DOI 10.1007/s10115-018-1156-3; Biddle SJH, 2004, J SPORT SCI, V22, P679, DOI 10.1080/02640410410001712412; Caron M, 2018, LECT NOTES COMPUT SC, V11218, P139, DOI 10.1007/978-3-030-01264-9_9; Celebi ME, 2013, EXPERT SYST APPL, V40, P200, DOI 10.1016/j.eswa.2012.07.021; Chen JL, 2008, INT NURS REV, V55, P81, DOI 10.1111/j.1466-7657.2007.00588.x; Chen JL, 2018, SENSOR ACTUAT A-PHYS, V284, P52, DOI 10.1016/j.sna.2018.10.021; Chopde NR., 2013, INT J INNOVATIVE RES, V1, P298, DOI DOI 10.15680/IJIRCCE; Choudhry MS, 2016, PROCEDIA COMPUT SCI, V89, P749, DOI 10.1016/j.procs.2016.06.052; Gordon-Larsen P, 2004, AM J CLIN NUTR, V80, P569; Guo MF, 2017, INT J ELEC POWER, V93, P97, DOI 10.1016/j.ijepes.2017.05.014; Haldar NA, 2017, NEUROCOMPUTING, V220, P221, DOI 10.1016/j.neucom.2016.08.042; Haug E, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-47; Haug E, 2010, HEALTH EDUC RES, V25, P248, DOI 10.1093/her/cyn050; Haug E, 2010, HEALTH PROMOT INT, V25, P63, DOI 10.1093/heapro/dap040; Heil J, 2019, GEODERMA, V337, P11, DOI 10.1016/j.geoderma.2018.09.004; Hobin EP, 2013, J SCHOOL HEALTH, V83, P357, DOI 10.1111/josh.12039; Huang J, 2015, HABITAT INT, V49, P538, DOI 10.1016/j.habitatint.2015.07.006; Ishii K, 2014, INT J ENV RES PUB HE, V11, P7195, DOI 10.3390/ijerph110707195; Izakian H, 2011, EXPERT SYST APPL, V38, P1835, DOI 10.1016/j.eswa.2010.07.112; Jago R, 2004, PREV MED, V39, P157, DOI 10.1016/j.ypmed.2004.01.014; Kelly IR, 2010, J PHYS ACT HEALTH, V7, P333, DOI 10.1123/jpah.7.3.333; Kirby J, 2012, HEALTH EDUC RES, V27, P101, DOI 10.1093/her/cyr090; Lai DTC, 2013, INT J BIOMED ENG TEC, V13, P303, DOI 10.1504/IJBET.2013.058535; Lo KY, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14010083; de Rezende LFM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131342; Mahela OP, 2016, INT J ELEC POWER, V83, P229, DOI 10.1016/j.ijepes.2016.04.011; Mahfouz A, 2015, METHODS, V73, P79, DOI 10.1016/j.ymeth.2014.10.004; McGrath LJ, 2015, SPORTS MED, V45, P841, DOI 10.1007/s40279-015-0301-3; Nayak J, 2015, SMART INNOV SYST TEC, V32, P133, DOI 10.1007/978-81-322-2208-8_14; Niclasen B, 2012, SCAND J PUBLIC HEALT, V40, P614, DOI 10.1177/1403494812459815; O'Malley PM, 2009, J ADOLESCENT HEALTH, V45, pS71, DOI 10.1016/j.jadohealth.2009.04.008; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Oliveira FHM, 2019, IFMBE PROC, V68, P421, DOI 10.1007/978-981-10-9035-6_78; Pagels P, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-803; Parrish AM, 2012, HEALTH EDUC RES, V27, P269, DOI 10.1093/her/cyr049; Prins RG, 2011, HEALTH PLACE, V17, P1228, DOI 10.1016/j.healthplace.2011.07.012; Reimers AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093059; Robertson-Wilson JE, 2008, J ADOLESCENT HEALTH, V42, P486, DOI 10.1016/j.jadohealth.2007.10.006; Schelker M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02289-3; Slyper AH, 2004, J CLIN ENDOCR METAB, V89, P2540, DOI 10.1210/jc.2003-031449; Song WJ, 2019, MULTIMED TOOLS APPL, V78, P4311, DOI 10.1007/s11042-018-5715-0; Stanley RM, 2012, J SCI MED SPORT, V15, P44, DOI 10.1016/j.jsams.2011.08.002; The Statistics Bureau of Shanghai, 2019, SHANGH STAT YB 2018, P154; Thompson JL, 2001, J COMMUN HEALTH, V26, P423, DOI 10.1023/A:1012507323784; Troiano RP, 1999, INT J OBESITY, V23, pS22, DOI 10.1038/sj.ijo.0800855; Van Der Maaten L. J. P., 2008, J MACH LEARN RES, V9, P2579; van der Maaten L, 2014, J MACH LEARN RES, V15, P3221; Vo NP, 2017, APPL INTELL, V46, P717, DOI 10.1007/s10489-016-0858-z; Wong BYM, 2010, INT J PEDIATR OBES, V5, P169, DOI 10.3109/17477160903159432; World Health Organization, 2010, Global recommendations on physical activity for health; Wu KL, 2005, PATTERN RECOGN LETT, V26, P1275, DOI 10.1016/j.patrec.2004.11.022; Zeng Z., 2014, LECT NOTES ELECT ENG, V269, P579, DOI [10.1007/978-94-007-7618-0_56, DOI 10.1007/978-94-007-7618-0_56]	58	0	0	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0267009	10.1371/journal.pone.0267009	http://dx.doi.org/10.1371/journal.pone.0267009			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35443011	gold, Green Published			2022-12-26	WOS:000822608900038
J	Bebber, MR; Buchanan, B; Holland-Lulewicz, J				Bebber, Michelle R.; Buchanan, Briggs; Holland-Lulewicz, Jacob			Refining the chronology of North America's copper using traditions: A macroscalar approach via Bayesian modeling	PLOS ONE			English	Article							NATIVE COPPER; RADIOCARBON; CULTURE; ARTIFACTS; REGION; ERA	North America's ancient copper use, predicted to originate as early as 9000 cal BP, represents the earliest use of native copper for utilitarian tool production in the world. Although recent work has focused on establishing the first use of copper in the western Great Lakes region, little attention has been paid to determining the age ranges of subsequent copper using groups or to the identification of broader trends in copper use during the Archaic Period (10,000-3000 RCYBP). Here we address this issue by applying Bayesian modeling to a comprehensive suite of 76 radiocarbon dates directly associated with copper use. Our results identified two distinct peaks in copper usage, ca. 5500 cal BP and ca. 3300 cal BP. Age ranges for the three Archaic Period traditions and practices associated with copper use of the western Great Lakes are revised using modern calibration curves. Bayesian revisions of age ranges from sites where copper tools and/or production debris have been found provide insight into the historical relationships between, and cultural interactions among, these early copper using groups. This study provides an updated, refined chronology based on the most recent calibration curve (IntCal20) for the varied cultural contexts of copper use across the western Great Lakes.	[Bebber, Michelle R.] Kent State Univ, Dept Anthropol, Kent, OH 44240 USA; [Buchanan, Briggs] Univ Tulsa, Dept Anthropol, Tulsa, OK USA; [Holland-Lulewicz, Jacob] Washington Univ St Louis, Dept Anthropol, St Louis, MO USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University of Tulsa; Washington University (WUSTL)	Bebber, MR (corresponding author), Kent State Univ, Dept Anthropol, Kent, OH 44240 USA.	mbebber@kent.edu		Bebber, Michelle/0000-0002-6084-8420; Buchanan, Briggs/0000-0002-5684-9615; Lulewicz, Jacob/0000-0002-0389-9846				Baerreis D. A., 1954, WISCONSIN ARCHEOLOGI, V35, P1; Barrier CR, 2017, J ARCHAEOL SCI-REP, V11, P523, DOI 10.1016/j.jasrep.2016.12.027; Bayliss A., 2007, VERNAC ARCHIT, V38, P75, DOI DOI 10.1179/174962907X248074; Bayliss A, 2007, CAMB ARCHAEOL J, V17, P1, DOI 10.1017/S0959774307000145; Bayliss A, 2015, WORLD ARCHAEOL, V47, P677, DOI 10.1080/00438243.2015.1067640; Bayliss A, 2009, RADIOCARBON, V51, P123, DOI 10.1017/S0033822200033750; Beaubien PL, 1953, AM ANTIQUITY, V19, P56, DOI 10.2307/276413; Bebber MR, 2019, J ARCHAEOL SCI-REP, V26, DOI 10.1016/j.jasrep.2019.101917; Bebber MR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42185-y; Bebber MR, 2018, J ARCHAEOL SCI, V98, P34, DOI 10.1016/j.jas.2018.08.001; Bebber MR., AM ANTIQUITY; Bebber MR., 2021, J ARCHAEOL METHOD TH, P1; BEUKENS RP, 1992, RADIOCARBON, V34, P890, DOI 10.1017/S0033822200064213; BINFORD LR, 1962, AM ANTIQUITY, V28, P217, DOI 10.2307/278380; Bronk Ramsey C, 2021, OXCAL PROGRAM VERSIO; Buchanan B, 2021, PALEOAMERICA, V7, P133, DOI 10.1080/20555563.2021.1890401; Buchner AP., 1990, DECIDING OTHERS ETHI, P51; Buck CE, 1998, J ARCHAEOL SCI, V25, P303, DOI 10.1006/jasc.1997.0207; Buck CE., 1996, BAYESIAN APPROACH IN, P382; Christen JA, 1998, J ROY STAT SOC C-APP, V47, P543, DOI 10.1111/1467-9876.00127; Clark CP., 1989, MICHIGAN ARCHAEOLOGI, P88; Clermont N., 2003, COLLECTION PAL O QU; Clermont N., 1998, COLLECTION PAL O QU; Crane H. R., 1964, Radiocarbon, V6, P1; CRANE HR, 1965, RADIOCARBON, V7, P123, DOI 10.1017/S0033822200037115; CRANE HR, 1956, SCIENCE, V124, P664, DOI 10.1126/science.124.3224.664; Ehrhardt KL, 2009, J WORLD PREHIST, V22, P213, DOI 10.1007/s10963-009-9020-8; Emerson T. E., 2012, ARCHAIC SOC DIVERSIT; Esarey D., 1986, KAMPSVILLE SERIES AR, P213; Freeman JE., 1966, WISCONSIN ARCHEOLOGI, V47, P33; Fregni G., 2009, MINN ARCHAEOL, V67, P121; Griffin JB., 1959, RADIOCARBON, V1, P173; Griffin JB, 1961, ANTHR PAPERS; HANCOCK RGV, 1991, ARCHAEOMETRY, V33, P69, DOI 10.1111/j.1475-4754.1991.tb00686.x; Harrison C, 1995, U MINNESOTA INTERDIS, V4; Hill, 1994, OTTAWA NATL FOREST C, V6; Hill MA., 2011, WIS ARCHEOL, V92, P85; Hill MA, 2006, MIDCONT J ARCHAEOL, V31, P213, DOI 10.1179/mca.2006.011; Hill MA, 2012, AM ANTIQUITY, V77, P279, DOI 10.7183/0002-7316.77.2.279; Holland-Lulewicz J., 2021, ADV ARCHAEOL PRACT, V15, P1; Holland-Lulewicz J, 2021, J ARCHAEOL RES, V29, P537, DOI 10.1007/s10814-020-09154-w; Hruska R., 1967, WISCONSIN ARCHEOLOGI, V48, P145; Hunzicker DA., 2002, WISCONSIN ARCHEOLOGI, V83, P45; Johnson E., 1964, MINNESOTA ARCHAEOLOG, V26, P4; Kennedy, 1967, NATL MUSEUM CANADA B, P100; Kennedy CC., 1970, UPPER OTTAWA VALLEY; Krus AM, 2018, AM ANTIQUITY, V83, P302, DOI 10.1017/aaq.2018.1; Kuehn SR, 1998, AM ANTIQUITY, V63, P457, DOI 10.2307/2694630; Laronge M, 2001, N AM ARCHAEOL, V22, P371, DOI 10.2190/2JLE-YM32-AB1V-0DHY; Lee S, 2012, RADIOCARBON, V54, P107, DOI 10.2458/azu_js_rc.v54i1.12397; Levine MA, 2007, J ARCHAEOL SCI, V34, P572, DOI 10.1016/j.jas.2006.06.015; LIBBY WF, 1954, SCIENCE, V120, P733, DOI 10.1126/science.120.3123.733; Lovis WA, 2009, ARCHAIC SOC DIVERSIT, P725; Lovis WA., 1999, B CRANBROOK I SCI, P83; Lynn M., 1991, PSYCHOL MARK, V8, P43, DOI [10.1002/mar.4220080105, DOI 10.1002/MAR.4220080105]; Manning SW, 2019, AM ANTIQUITY, V84, P684, DOI 10.1017/aaq.2019.60; Marois R., 1987, RECH AMERINDIEN QUE, V17, P7; Martin, 1999, WONDERFUL POWER STOR; Martin, 1993, MICH ARCHAEOL, V39, P4; Martin SR, 1999, TAMING THE TAXONOMY, P61; Mason R.J., 1981, GREAT LAKES ARCHAEOL; Mauk JL, 1998, ARCHAEOMETRY, V40, P97, DOI 10.1111/j.1475-4754.1998.tb00826.x; McHugh, 1973, WISCONSIN ARCHAEOLOG, V48, P145; McKern WC., 1942, WIS MAG HIST, V26, P153; Meinholz NM., 1996, DEADMAN SLOUGH SITE; Miles SW, 1951, AM ANTIQUITY, V16, P240, DOI 10.2307/276784; Moffatt C. R., 1999, WISCONSIN ARCHEOLOGI, V80, P111; Paquette, 1988, WISCONSIN ARCHEOLOGI, V69, P101; Penman J, 1977, WISCONSIN ARCHEOLOGI, V58, P3; Peterson David H., 2003, CENTRAL STATES ARCHA, V50, P168; Peterson DH., 2003, CENTRAL STATES ARCHA, V50, P102; Phillips GB, 1925, AM ANTHROPOL, V27, P284, DOI 10.1525/aa.1925.27.2.02a00030; Pilon JL., 2009, 170 CAN MUS CIV ARCH, P181; Pleger TC., 2000, MIDCONTINENTAL J ARC, V1, P169; Pleger TC, 2009, ARCHAIC SOC DIVERSIT, P697; Pompeani DP, 2021, RADIOCARBON, V63, P513, DOI 10.1017/RDC.2021.7; Pompeani DP, 2013, ENVIRON SCI TECHNOL, V47, P5545, DOI 10.1021/es304499c; Prufer O.H., 2001, ARCHAIC TRANSITIONS; Quimby GI, 1957, FIELDIANA ANTHR, V36, P189; Quinn CP, 2020, ANTIQUITY, V94, P44, DOI 10.15184/aqy.2019.231; Ramsey CB, 2017, RADIOCARBON, V59, P1809, DOI 10.1017/RDC.2017.108; Ramsey CB, 2009, RADIOCARBON, V51, P1023, DOI 10.1017/S0033822200034093; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; RAPP G, 1980, JOM-J MIN MET MAT S, V32, P35, DOI 10.1007/BF03354542; Reardon B., 2014, WISCONSIN ARCHEOLOGI, V95, P86; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Ritzenthaler R. E., 1957, OLD COPPER CULTURE W; Ritzenthaler R. E, 1946, WISCONSIN ARCHEOLOGI, V27, P53; Ritzenthaler R. E., 1962, FIELDIANA ANTHR, V36, P243; Ritzenthaler RE, 1970, WISCONSIN ARCHEOLOGI, V51, P77; Ritzenthaler RE., 1952, OCONTO SITE OLD COPP, DOI [10.1016/0002-9378(52)90073-2, DOI 10.1016/0002-9378(52)90073-2]; Ritzenthaler RE., 1958, WIS ARCHEOL, P173; RUBIN M, 1956, SCIENCE, V123, P442, DOI 10.1126/science.123.3194.442; Salzer RJ., 1974, ASPECTS UPPER GREAT, P40; Sassaman Kenneth E, 2010, E ARCHAIC, DOI [10.1212/WNL.0b013e3181c7197b, DOI 10.1212/WNL.0B013E3181C7197B]; STEINBRING J, 1966, AM ANTIQUITY, V31, P567, DOI 10.2307/2694392; Steinbring J., 1968, MANITOBA ARCHAEOLOGI, V5, P3; STEVENTON RL, 1986, RADIOCARBON, V28, P1206, DOI 10.1017/S003382220002021X; Vickery K, 2008, TRANSITIONS ARCHAIC, P1; Whittle A., 2011, GATHERING TIME DATIN; WITTRY WL, 1956, AM ANTIQUITY, V21, P244, DOI 10.2307/277196; Wittry WL, 1951, WISCONSIN ARCHEOLOGI, V32, P1	102	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266908	10.1371/journal.pone.0266908	http://dx.doi.org/10.1371/journal.pone.0266908			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35472064	gold, Green Published			2022-12-26	WOS:000816171900036
J	Berke, A; Doorley, R; Alonso, L; Arroyo, V; Pons, M; Larson, K				Berke, Alex; Doorley, Ronan; Alonso, Luis; Arroyo, Vanesa; Pons, Marc; Larson, Kent			Using mobile phone data to estimate dynamic population changes and improve the understanding of a pandemic: A case study in Andorra	PLOS ONE			English	Article							TRANSMISSION	Compartmental models are often used to understand and predict the progression of an infectious disease such as COVID-19. The most basic of these models consider the total population of a region to be closed. Many incorporate human mobility into their transmission dynamics, usually based on static and aggregated data. However, mobility can change dramatically during a global pandemic as seen with COVID-19, making static data unsuitable. Recently, large mobility datasets derived from mobile devices have been used, along with COVID-19 infections data, to better understand the relationship between mobility and COVID-19. However, studies to date have relied on data that represent only a fraction of their target populations, and the data from mobile devices have been used for measuring mobility within the study region, without considering changes to the population as people enter and leave the region. This work presents a unique case study in Andorra, with comprehensive datasets that include telecoms data covering 100% of mobile subscribers in the country, and results from a serology testing program that more than 90% of the population voluntarily participated in. We use the telecoms data to both measure mobility within the country and to provide a real-time census of people entering, leaving and remaining in the country. We develop multiple SEIR (compartmental) models parameterized on these metrics and show how dynamic population metrics can improve the models. We find that total daily trips did not have predictive value in the SEIR models while country entrances did. As a secondary contribution of this work, we show how Andorra's serology testing program was likely impacted by people leaving the country. Overall, this case study suggests how using mobile phone data to measure dynamic population changes could improve studies that rely on more commonly used mobility metrics and the overall understanding of a pandemic.	[Berke, Alex; Doorley, Ronan; Alonso, Luis; Larson, Kent] MIT, Media Lab, Cambridge, MA 02139 USA; [Arroyo, Vanesa; Pons, Marc] Andorra Recerca Innovacio, St Julia De Loria, Andorra	Massachusetts Institute of Technology (MIT)	Berke, A (corresponding author), MIT, Media Lab, Cambridge, MA 02139 USA.	aberke@mit.edu	Pons, Marc/GYR-1419-2022	Pons, Marc/0000-0001-9105-0772; Berke, Alex/0000-0001-5996-0557	Andorra Recerca + Innovacio	Andorra Recerca + Innovacio	Andorra Recerca + Innovacio provided financial support to the City Science Group at MIT Media Lab. The authors Alex Berke, Ronan Doorley, Luis Alonso, Kent Larson are affiliated with the City Science Group. The other authors are affiliated with Andorra Recerca + Innovacio.	Adjodah D, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252315; [Anonymous], 2020, ELS TESTS DANTICOSSO; Arroyo-Marioli F, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244474; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Baidu Inc, 2020, BAIDU AI OPEN PLATFO; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Brauner JM, 2021, SCIENCE, V371, P802, DOI 10.1126/science.abd9338; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Camacho A., 2015, PLOS CURR, V7, P1, DOI DOI 10.1371/CURRENTS.OUTBREAKS.406AE55E83EC0B5193E3085; Chaves LF, 2020, MATH MODEL NAT PHENO, V15, DOI 10.1051/mmnp/2020019; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; CIA, 2021, WORLD FACTB ANDORRA; City Mapper, 2021, CIT MOB IND; Colak S, 2015, TRANSPORT RES REC, P126, DOI 10.3141/2526-14; Delamater PL, 2019, EMERG INFECT DIS, V25, P1, DOI 10.3201/eid2501.171901; Departament-d'Estadistica, 2020, EST POBL GEN 2020 A0, P1; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Doorley R, 2020, 2020 IEEE 23 INT C I, P1; Doorley R, 2022, IEEE J BIOMED HEALTH, V26, P183, DOI 10.1109/JBHI.2021.3121165; Facebook, 2021, DAT COVID 19 COR OUR; FRIEDMAN J, 2021, NAT COMMUN, V12, DOI DOI 10.1038/S41467-021-22457-W; Giattino C, 2020, OUR WORLD DATA; Gilbert M, 2020, LANCET, V395, P871, DOI 10.1016/S0140-6736(20)30411-6; Google LLC, 2021, GOOGL COVID 19 COMM; Gu Y., 2021, COVID 19 PROJECTIONS; Guan G, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253865; Hancean MG, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.200780; Haug N, 2020, NAT HUM BEHAV, V4, DOI 10.1038/s41562-020-01009-0; IHME, 2021, COVID 19 EST HIST TI; Ilin C, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92892-8; Keeling M.J., 2011, MODELING INFECT DIS, DOI 10.1111/j.1541-0420.2008.01082-_}7.x; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kounchev O, 2020, ARXIV PREPRINT ARXIV; Kraemer MUG, 2021, SCIENCE, V373, P889, DOI 10.1126/science.abj0113; Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218; Kung KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096180; Li ML., 2021, MEDRXIV, P2020; Li Q, 2008, P 16 ACM SIGSPATIAL, P1, DOI [10.1145/1463434.1463477, DOI 10.1145/1463434.1463477]; Los Alamos national Laboratory COVID-19 Team, 2020, COVID 19 CONFIRMED F; Mathieu E, 2021, NAT HUM BEHAV, V5, P947, DOI 10.1038/s41562-021-01122-8; Mazzoli M, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1009326; Mazzoli M, 2021, J TRAVEL MED, V28, DOI 10.1093/jtm/taab129; MCNEIL BJ, 1976, J NUCL MED, V17, P439; Pei S, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd6370; Pei S, 2018, P NATL ACAD SCI USA, V115, P2752, DOI 10.1073/pnas.1708856115; Pepe E., 2020, COVID 19 OUTBREAK RE, DOI DOI 10.1101/2020.03.22.20039933; Petr K, 2020, SWISS MED WKLY, V150, DOI 10.4414/smw.2020.20313; Reiner RC, 2021, NAT MED, V27, P94, DOI 10.1038/s41591-020-1132-9; Reuters Staff, REUTERS; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Royo-Cebrecos C, 2021, LANCET REG HEALTH-EU, V5, DOI 10.1016/j.lanepe.2021.100119; Ryan Fox Squire S, 2019, SAFE GRAPH IDEAS INT; Safegraph, 2021, SHELTER PLACE INDEX; Skillman MS, 2020, ARXIV PREPRINT ARXIV; Soucy J.P.R., 2020, MEDRXIV, DOI [10.1101/2020.04.05.20054288, DOI 10.1101/2020.04.05.20054288]; Srivastava A., ARXIV PREPRINT ARXIV; Tariq A, 2020, BMC MED, V18, DOI [10.1186/s12916-020-01615-9, 10.1101/2020.02.21.20026435]; Thompson RN, 2019, EPIDEMICS-NETH, V29, DOI 10.1016/j.epidem.2019.100356; TULJAPURKAR S, 1991, SCIENCE, V254, P591, DOI 10.1126/science.254.5031.591; Viceconte G, 2020, COVID 19 R0 MAGIC NU; Walker PGT, 2020, SCIENCE, V369, P413, DOI 10.1126/science.abc0035; WHO Collaborating Centre for Infectious Disease Modelling MRC Centre for Global Infectious Disease Analysis Abdul Latif Jameel Institute for Disease and Emergency Analytics Imperial College London, 2020, 9 WHO COLL CTR INF D	63	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0264860	10.1371/journal.pone.0264860	http://dx.doi.org/10.1371/journal.pone.0264860			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35472092	gold, Green Published, Green Submitted			2022-12-26	WOS:000816171900012
J	Couturier, M; Touvrey-Loiodice, M; Terrapon, N; Drula, E; Buon, L; Chirat, C; Henrissat, B; Helbert, W				Couturier, Marie; Touvrey-Loiodice, Melanie; Terrapon, Nicolas; Drula, Elodie; Buon, Laurine; Chirat, Christine; Henrissat, Bernard; Helbert, William			Functional exploration of the glycoside hydrolase family GH113	PLOS ONE			English	Article							CELLULOSIC STRUCTURAL POLYSACCHARIDES; ALGAL CELL-WALLS; CATALYTIC MECHANISM; MANNAN; BETA-1,4-MANNANASE; ALIGNMENT; ACCURATE; DATABASE	beta-Mannans are a heterogeneous group of polysaccharides with a common main chain of beta-1,4-linked mannopyranoside residues. The cleavage of beta-mannan chains is catalyzed by glycoside hydrolases called beta-mannanases. In the CAZy database, beta-mannanases are grouped by sequence similarity in families GH5, GH26, GH113 and GH134. Family GH113 has been under-explored so far with six enzymes characterized, all from the Firmicutes phylum. We undertook the functional characterization of 14 enzymes from a selection of 31 covering the diversity of the family GH113. Our observations suggest that GH113 is a family with specificity towards mannans, with variations in the product profiles and modes of action. We were able to assign mannanase and mannosidase activities to four out of the five clades of the family, increasing by 200% the number of characterized GH113 members, and expanding the toolbox for fine-tuning of mannooligosaccharides.	[Couturier, Marie; Touvrey-Loiodice, Melanie; Buon, Laurine; Helbert, William] Univ Grenoble Alpes, CNRS, CERMAV, Grenoble, France; [Terrapon, Nicolas; Drula, Elodie] Aix Marseille Univ, AFMB, UMR CNRS 7257, USC INRAE 1408, Marseille, France; [Drula, Elodie] INRAE, Biodiversite & Biotechnol Fong, UMR 1163, Marseille, France; [Chirat, Christine] Univ Grenoble Alpes, Inst Engn Grenoble INP, CNRS, LGP2, Grenoble, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah, Saudi Arabia; [Henrissat, Bernard] Tech Univ Denmark, DTU Bioengn, Lyngby, Denmark	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); INRAE; UDICE-French Research Universities; Aix-Marseille Universite; INRAE; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Grenoble Alpes (UGA); King Abdulaziz University; Technical University of Denmark	Couturier, M (corresponding author), Univ Grenoble Alpes, CNRS, CERMAV, Grenoble, France.	marie.couturier@cermav.cnrs.fr	Terrapon, Nicolas/O-3630-2014; Henrissat, Bernard/J-2475-2012	Terrapon, Nicolas/0000-0002-3693-6017; Henrissat, Bernard/0000-0002-3434-8588; Couturier, Marie/0000-0002-0032-1280	Institut Carnot PolyNat [ANR-17-CARN-0025-0]; Glyco@Alps Cross-Disciplinary Program [ANR-15-IDEX-02]; Labex ARCANE [ANR-11-LABX-0003]; Grenoble Graduate School in Chemistry, Biology [ANR-17-EURE-0003]	Institut Carnot PolyNat; Glyco@Alps Cross-Disciplinary Program; Labex ARCANE; Grenoble Graduate School in Chemistry, Biology	This work was financially supported by the Institut Carnot Poly Nat (ANR-17-CARN-0025-0). Support was received from the Glyco@ AlpsCross-Disciplinary Program (GrantANR-15-IDEX-02), Labex ARCANE(GrantANR-11-LABX-0003), and Grenoble Graduate School in Chemistry, Biology, and Health(GrantANR-17-EURE-0003).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; CHANZY H, 1987, MACROMOLECULES, V20, P2407, DOI 10.1021/ma00176a014; CHANZY HD, 1984, PLANTA, V161, P320, DOI 10.1007/BF00398722; Rodriguez-Gacio MDC, 2012, J EXP BOT, V63, P3975, DOI 10.1093/jxb/ers096; Deloule V, 2020, J FUNCT FOODS, V64, DOI 10.1016/j.jff.2019.103688; Dierckx S., 2002, BIOPOLYMERS, P321; Drula E, 2022, NUCLEIC ACIDS RES, V50, pD571, DOI 10.1093/nar/gkab1045; Dunn EK, 2007, PLANT CELL PHYSIOL, V48, P122, DOI 10.1093/pcp/pcl053; FREI E, 1968, PROC R SOC SER B-BIO, V169, P127, DOI 10.1098/rspb.1968.0001; FREI E, 1964, PROC R SOC SER B-BIO, V160, P314, DOI 10.1098/rspb.1964.0042; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Helbert W, 2019, P NATL ACAD SCI USA, V116, P6063, DOI 10.1073/pnas.1815791116; Jin Y, 2016, ACS CENTRAL SCI, V2, P896, DOI 10.1021/acscentsci.6b00232; Kalidas NR, 2017, FOOD CHEM, V234, P348, DOI 10.1016/j.foodchem.2017.04.159; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; KIDBY DK, 1973, ANAL BIOCHEM, V55, P321, DOI 10.1016/0003-2697(73)90323-0; La Rosa SL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08812-y; La Rosa SL, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00554-18; Lefort V, 2015, MOL BIOL EVOL, V32, P2798, DOI 10.1093/molbev/msv150; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lindstad LJ, 2021, MBIO, V12, DOI 10.1128/mBio.03628-20; Lopez M, 2020, POLYMERS-BASEL, V12, DOI 10.3390/polym12061215; Mary PR, 2019, CARBOHYD RES, V486, DOI 10.1016/j.carres.2019.107822; Mathieu S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159415; Michalak L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19585-0; Rajan K, 2020, CELLULOSE, V27, P3693, DOI 10.1007/s10570-020-03018-8; Shimizu M, 2015, J BIOL CHEM, V290, P27914, DOI 10.1074/jbc.M115.661645; Song YJ, 2018, J AGR FOOD CHEM, V66, P11055, DOI 10.1021/acs.jafc.8b03878; Terrapon N, 2018, NUCLEIC ACIDS RES, V46, pD677, DOI 10.1093/nar/gkx1022; Terrett OM., 2020, NAT COMMUN, V11, P5773, DOI [10.1038/s41467-020-19585-0, DOI 10.1038/S41467-020-19585-0]; Valoppi F, 2019, GREEN CHEM, V21, P4691, DOI [10.1039/c9gc02007a, 10.1039/C9GC02007A]; Xia W, 2016, APPL ENVIRON MICROB, V82, P2718, DOI 10.1128/AEM.04071-15; You X, 2018, J BIOL CHEM, V293, P11746, DOI 10.1074/jbc.RA118.002363; Zhang YL, 2008, J BIOL CHEM, V283, P31551, DOI 10.1074/jbc.M803409200	35	1	1	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267509	10.1371/journal.pone.0267509	http://dx.doi.org/10.1371/journal.pone.0267509			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C1KV	35452491	Green Published, gold			2022-12-26	WOS:000792887700019
J	Fung, KW; Baik, SH; Baye, F; Zheng, ZN; Huser, V; McDonald, CJ				Fung, Kin Wah; Baik, Seo H.; Baye, Fitsum; Zheng, Zhaonian; Huser, Vojtech; McDonald, Clement J.			Effect of common maintenance drugs on the risk and severity of COVID-19 in elderly patients	PLOS ONE			English	Article							RECEPTOR BLOCKERS; CORONAVIRUS; ACE2; INHIBITION; INFECTION; THERAPY; RAAS	BackgroundMaintenance drugs are used to treat chronic conditions. Several classes of maintenance drugs have attracted attention because of their potential to affect susceptibility to and severity of COVID-19. MethodsUsing claims data on 20% random sample of Part D Medicare enrollees from April to December 2020, we identified patients diagnosed with COVID-19. Using a nested case-control design, non-COVID-19 controls were identified by 1:5 matching on age, race, sex, dual-eligibility status, and geographical region. We identified usage of angiotensin-converting enzyme inhibitors (ACEI), angiotensin-receptor blockers (ARB), statins, warfarin, direct factor Xa inhibitors, P2Y12 inhibitors, famotidine and hydroxychloroquine based on Medicare prescription claims data. Using extended Cox regression models with time-varying propensity score adjustment we examined the independent effect of each study drug on contracting COVID-19. For severity of COVID-19, we performed extended Cox regressions on all COVID-19 patients, using COVID-19-related hospitalization and all-cause mortality as outcomes. Covariates included gender, age, race, geographic region, low-income indicator, and co-morbidities. To compensate for indication bias related to the use of hydroxychloroquine for the prophylaxis or treatment of COVID-19, we censored patients who only started on hydroxychloroquine in 2020. ResultsUp to December 2020, our sample contained 374,229 Medicare patients over 65 who were diagnosed with COVID-19. Among the COVID-19 patients, 278,912 (74.6%) were on at least one study drug. The three most common study drugs among COVID-19 patients were statins 187,374 (50.1%), ACEI 97,843 (26.2%) and ARB 83,290 (22.3%). For all three outcomes (diagnosis, hospitalization and death), current users of ACEI, ARB, statins, warfarin, direct factor Xa inhibitors and P2Y12 inhibitors were associated with reduced risks, compared to never users. Famotidine did not show consistent significant effects. Hydroxychloroquine did not show significant effects after censoring of recent starters. ConclusionMaintenance use of ACEI, ARB, warfarin, statins, direct factor Xa inhibitors and P2Y12 inhibitors was associated with reduction in risk of acquiring COVID-19 and dying from it.	[Fung, Kin Wah; Baik, Seo H.; Baye, Fitsum; Zheng, Zhaonian; Huser, Vojtech; McDonald, Clement J.] NIH, Lister Hill Natl Ctr Biomed Commun, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Fung, KW (corresponding author), NIH, Lister Hill Natl Ctr Biomed Commun, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	kfung@mail.nih.gov		Fung, Kin Wah/0000-0003-0593-5377	Intramural Research Program of the NIH, National Library of Medicine	Intramural Research Program of the NIH, National Library of Medicine	This research was supported in part by the Intramural Research Program of the NIH, National Library of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administration on AgingU.S. Department of Health and Human Services, 2018, PROF OLD AM; An J, 2021, INT J CARDIOL HYPER, V9, DOI 10.1016/j.ijchy.2021.100088; Arshad S, 2020, INT J INFECT DIS, V97, P396, DOI 10.1016/j.ijid.2020.06.099; Azzato EM, 2009, BRIT J CANCER, V100, P1806, DOI 10.1038/sj.bjc.6605062; Barochiner J, 2020, J CLIN PHARM THER, V45, P1244, DOI 10.1111/jcpt.13246; Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031; Bourinbaiar Aldar S., 1996, Life Sciences, V59, pPL365, DOI 10.1016/S0024-3205(96)00553-X; Bozkurt B, 2020, J CARD FAIL, V26, P370, DOI 10.1016/j.cardfail.2020.04.013; Centers for Disease Control and Prevention, 2020, COVID 19 RESP COVID; Csizmadi I, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P791; Cubeddu LX, 2006, PHARMACOTHERAPY, V26, P1288, DOI 10.1592/phco.26.9.1288; Cui SP, 2020, J THROMB HAEMOST, V18, P1421, DOI 10.1111/jth.14830; Elshafei A, 2021, SAUDI J BIOL SCI, V28, P6465, DOI 10.1016/j.sjbs.2021.07.003; ERNSTER VL, 1994, PREV MED, V23, P587, DOI 10.1006/pmed.1994.1093; Ferrario CM, 2005, CIRCULATION, V111, P2605, DOI 10.1161/CIRCULATIONAHA.104.510461; Fontelo Paul, 2021, Thromb J, V19, P47, DOI 10.1186/s12959-021-00298-3; Fosbol EL, 2020, JAMA-J AM MED ASSOC, V324, P168, DOI 10.1001/jama.2020.11301; Freedberg DE, 2020, GASTROENTEROLOGY, V159, P1129, DOI 10.1053/j.gastro.2020.05.053; Guo XM, 2020, HYPERTENSION, V76, pE13, DOI 10.1161/HYPERTENSIONAHA.120.15572; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Inama G, 2020, J CARDIOVASC MED, V21, P765, DOI 10.2459/JCM.0000000000001066; Janowitz T, 2020, GUT, V69, P1592, DOI 10.1136/gutjnl-2020-321852; Keyaerts E, 2004, BIOCHEM BIOPH RES CO, V323, P264, DOI 10.1016/j.bbrc.2004.08.085; Klok FA, 2020, THROMB RES, V191, P145, DOI [10.1016/j.thromres.2020.04.013, 10.1016/j.thromres.2020.04.041]; Li JY, 2020, JAMA CARDIOL, V5, P825, DOI 10.1001/jamacardio.2020.1624; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Mancia G, 2020, NEW ENGL J MED, V382, P2431, DOI 10.1056/NEJMoa2006923; Pal R, 2022, POSTGRAD MED J, V98, P354, DOI 10.1136/postgradmedj-2020-139172; Pawlos A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22084177; Permana H, 2021, PHARMACOL REP, V73, P769, DOI 10.1007/s43440-021-00233-3; Pourhoseingholi Mohamad Amin, 2012, Gastroenterol Hepatol Bed Bench, V5, P79; Research Data Assistance Center (ResDAC), CMS VRDC; Reynolds HR, 2020, NEW ENGL J MED, V382, P2441, DOI 10.1056/NEJMoa2008975; Rico-Mesa JS, 2020, CURR CARDIOL REP, V22, DOI 10.1007/s11886-020-01328-8; Rodrigues-Diez RR, 2020, BRIT J PHARMACOL, V177, P4873, DOI 10.1111/bph.15166; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rossi R, 2020, EUR J INTERN MED, V77, P158, DOI 10.1016/j.ejim.2020.06.006; Russo V, 2020, PHARMACOL RES, V159, DOI 10.1016/j.phrs.2020.104965; Sinha N, 2020, POSTGRAD MED J, V96, P550, DOI 10.1136/postgradmedj-2020-137785; Sivaloganathan H, 2020, BRIT J HAEMATOL, V190, pE192, DOI 10.1111/bjh.16968; Soler MJ, 2008, CURR HYPERTENS REP, V10, P410, DOI 10.1007/s11906-008-0076-0; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768; The Chronic Condition Warehouse, CHRON COND DAT WAR C; Tremblay D, 2020, BLOOD, V136, P144, DOI 10.1182/blood.2020006941; Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; World Health Organization, 2020, COVID 19 US ANG CONV; Wu CR, 2020, ACTA PHARM SIN B, V10, P766, DOI 10.1016/j.apsb.2020.02.008; Wyss R, 2020, EPIDEMIOLOGY, V31, P82, DOI 10.1097/EDE.0000000000001107; Zhang Y, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2007575	52	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266922	10.1371/journal.pone.0266922	http://dx.doi.org/10.1371/journal.pone.0266922			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7MW	35436293	Green Submitted, Green Published, gold			2022-12-26	WOS:000791258900008
J	Goh, RMV; Pua, A; Luro, F; Ee, KH; Huang, YL; Marchi, E; Liu, SQ; Lassabliere, B; Yu, B				Goh, Rui Min Vivian; Pua, Aileen; Luro, Francois; Ee, Kim Huey; Huang, Yunle; Marchi, Elodie; Liu, Shao Quan; Lassabliere, Benjamin; Yu, Bin			Distinguishing citrus varieties based on genetic and compositional analyses	PLOS ONE			English	Article							VOLATILE COMPOUNDS; GC-MS; ESSENTIAL OILS; FRUIT-GROWTH; DIVERSITY; PEEL; AUTHENTICATION; COMPONENTS; EVOLUTION; MARKERS	Simple sequence repeats (SSR) markers and secondary metabolite composition were used in combination to study seven varieties of citrus for the first time. With reference to established accessions of citrus, two of the varieties (Chanh Giay and Ma Nao Pan) were predicted to be Mexican key limes, while three were mandarin hybrids (Nagpur, Pontianak and Dalandan) and the remaining two (Qicheng and Mosambi) were related to the sweet orange. Notably, Dalandan was genetically more like a mandarin despite often referred to as an orange locally, whereas Mosambi was more likely to be a sweet orange hybrid although it has also been called a sweet lime due to its green peel and small size. Several key secondary metabolites such as polymethoxyflavones (sinensetin, tangeretin etc.), furanocoumarins (bergapten, citropten etc.) and volatiles (citronellol, alpha-sinensal etc.) were identified to be potential biomarkers for separation of citrus species. However, despite having similar genetic profiles, variations in the volatile profile of the two limes were observed; similarly, there were differences in the secondary metabolite profiles of the three mandarin hybrids despite having a common ancestral parent, highlighting the usefulness of genetic and compositional analyses in combination for revealing both origins and flavour profiles especially in citrus hybrids. This knowledge would be crucial for variety screening and selection for use in flavour or fragrance creation and application.	[Goh, Rui Min Vivian; Pua, Aileen; Huang, Yunle; Liu, Shao Quan] Natl Univ Singapore, Dept Food Sci & Technol, Singapore, Singapore; [Pua, Aileen; Ee, Kim Huey; Huang, Yunle; Lassabliere, Benjamin; Yu, Bin] Mane SEA PTE LTD, Singapore, Singapore; [Luro, Francois; Marchi, Elodie] Univ Montpellier, UMR AGAP Inst, Inst Agro, CIRAD,INRAE, Montpellier, France	National University of Singapore; CIRAD; INRAE; Institut Agro; Universite de Montpellier	Liu, SQ (corresponding author), Natl Univ Singapore, Dept Food Sci & Technol, Singapore, Singapore.; Yu, B (corresponding author), Mane SEA PTE LTD, Singapore, Singapore.	gsgpbiy@gmail.com; fstlsq@nus.edu.sg		Yu, Bin/0000-0002-3867-5447				Abbate L, 2012, FOOD RES INT, V48, P284, DOI 10.1016/j.foodres.2012.04.007; Barkley NA, 2006, THEOR APPL GENET, V112, P1519, DOI 10.1007/s00122-006-0255-9; Brendel R, 2021, J AGR FOOD CHEM, V69, P1727, DOI 10.1021/acs.jafc.0c07447; Gonzalez-Mas MC, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00012; Chalhoub BA, 1997, BIOTECHNIQUES, V22, P216, DOI 10.2144/97222bm03; Chisholm MG, 2003, FLAVOUR FRAG J, V18, P106, DOI 10.1002/ffj.1172; Curk F, 2016, ANN BOT-LONDON, V117, P565, DOI 10.1093/aob/mcw005; Dharmawan J, 2007, FLAVOUR FRAG J, V22, P228, DOI 10.1002/ffj.1790; Garcia-Lor A, 2012, MOL GENET GENOMICS, V287, P77, DOI 10.1007/s00438-011-0658-4; Gattuso G, 2007, MOLECULES, V12, P1641, DOI 10.3390/12081641; Goh RMV, 2021, FOOD RES INT, V148, DOI 10.1016/j.foodres.2021.110607; Goh RMV, 2019, LWT-FOOD SCI TECHNOL, V99, P328, DOI 10.1016/j.lwt.2018.09.073; Jandric Z, 2017, FOOD CONTROL, V72, P181, DOI 10.1016/j.foodcont.2015.10.044; Jungen M, 2021, FOOD CHEM, V359, DOI 10.1016/j.foodchem.2021.129804; Khan A. A., 2016, Journal of Chemical and Pharmaceutical Research, V8, P555; Langgut D, 2017, HORTSCIENCE, V52, P814, DOI [10.21273/HORTSCI11023-16, 10.21273/hortsci11023-16]; Ledesma-Escobar CA, 2017, FOOD CHEM, V234, P262, DOI 10.1016/j.foodchem.2017.05.009; Lota ML, 2002, J AGR FOOD CHEM, V50, P796, DOI 10.1021/jf010924l; Rambla JL, 2014, J AGR FOOD CHEM, V62, P11312, DOI 10.1021/jf5043079; Luro F., 2017, PUBLICATIONS CTR JEA, P243; Luro F, 2011, PLANT GENET RESOUR-C, V9, P218, DOI 10.1017/S1479262111000189; Manners GD, 2007, J AGR FOOD CHEM, V55, P8285, DOI 10.1021/jf071797h; Ollitrault P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-593; Perrier X., 2006, DARWIN SOFTWARE; Qiao Y, 2008, MOLECULES, V13, P1333, DOI 10.3390/molecules13061333; Ren JN, 2015, FOOD CHEM, V185, P25, DOI 10.1016/j.foodchem.2015.03.142; Sawamura M, 2004, BIOSCI BIOTECH BIOCH, V68, P1690, DOI 10.1271/bbb.68.1690; Shi YS, 2020, J FUNCT FOODS, V75, DOI 10.1016/j.jff.2020.104213; Singh B, 2020, FOOD RES INT, V132, DOI 10.1016/j.foodres.2020.109114; Spadaro F, 2012, NAT PROD COMMUN, V7, P1523; Sun CD, 2005, FOOD CHEM, V93, P599, DOI 10.1016/j.foodchem.2004.10.037; Tisserand R., 2014, CHURCHILL LIVINGSTON, V2nd; Wang P, 2019, RSC ADV, V9, P23373, DOI 10.1039/c9ra03740c; Wang SX, 2017, SCI REP-UK, V7, DOI [10.1038/s41598-017-04692-8, 10.1038/s41598-017-10970-2]; Wu GA, 2018, NATURE, V554, P311, DOI 10.1038/nature25447; Yi KU, 2021, HORTIC SCI TECHNOL, V39, P96, DOI 10.7235/HORT.20210009; Yu Y, 2018, J SCI FOOD AGR, V98, P1124, DOI 10.1002/jsfa.8563; Zhang HP, 2019, MOLECULES, V24, DOI 10.3390/molecules24244550; Zhang HP, 2017, FOOD CHEM, V230, P316, DOI 10.1016/j.foodchem.2017.03.040	39	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267007	10.1371/journal.pone.0267007	http://dx.doi.org/10.1371/journal.pone.0267007			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7MW	35436309	Green Published, gold			2022-12-26	WOS:000791258900027
J	Herre, C; Nshdejan, A; Klopfleisch, R; Corte, GM; Bahramsoltani, M				Herre, Christina; Nshdejan, Arpenik; Klopfleisch, Robert; Corte, Giuliano Mario; Bahramsoltani, Mahtab			Expression of vimentin, TPI and MAT2A in human dermal microvascular endothelial cells during angiogenesis in vitro	PLOS ONE			English	Article							S-ADENOSYLMETHIONINE; TRIOSEPHOSPHATE ISOMERASE; QUANTITATION; GROWTH; MECHANISMS; DYNAMICS; ADHESION	IntroductionIn vitro assays of angiogenesis face immense problems considering their reproducibility based on the inhomogeneous characters of endothelial cells (ECs). It is necessary to detect influencing factors, which affect the angiogenic potency of ECs. ObjectiveThis study aimed to analyse expression profiles of vimentin (VIM), triosephosphate isomerase (TPI) and adenosylmethionine synthetase isoform type-2 (MAT2A) during the whole angiogenic cascade in vitro. Furthermore, the impact of knocking down vimentin (VIM) on angiogenesis in vitro was evaluated, while monitoring TPI and MAT2A expression. MethodsA long-term cultivation and angiogenic stimulation of human dermal microvascular ECs was performed. Cells were characterized via VEGFR-1 and VEGFR-2 expression and a shRNA-mediated knockdown of VIM was performed. The process of angiogenesis in vitro was quantified via morphological staging and mRNA-and protein-levels of all proteins were analysed. ResultsWhile native cells ran through the angiogenic cascade chronologically, knockdown cells only entered beginning stages of angiogenesis and died eventually. Cell cultures showing a higher VEGFR-1 expression survived exclusively and displayed an upregulation of MAT2A and TPI expression. Native cells highly expressed VIM in early stages, MAT2A mainly in the beginning and TPI during the course of angiogenesis in vitro. ConclusionVIM knockdown led to a deceleration of angiogenesis in vitro and knockdown cells displayed expressional changes in TPI and MAT2A. Cell populations with a higher number of stalk cells emerged as being more stable against manipulations and native expression profiles provided an indication of VIM and MAT2A being relevant predominantly in beginning stages and TPI during the whole angiogenic cascade in vitro.	[Herre, Christina; Nshdejan, Arpenik; Corte, Giuliano Mario; Bahramsoltani, Mahtab] Free Univ Berlin, Inst Vet Anat, Dept Vet Med, Berlin, Germany; [Klopfleisch, Robert] Free Univ Berlin, Inst Vet Pathol, Dept Vet Med, Berlin, Germany	Free University of Berlin; Free University of Berlin	Herre, C (corresponding author), Free Univ Berlin, Inst Vet Anat, Dept Vet Med, Berlin, Germany.	christina.herre@fu-berlin.de		Herre, Christina/0000-0003-3189-5882				[Anonymous], 1960, MED J AUSTRALIA, V1, P500, DOI [10.5694/j.1326-5377.1960.tb73127.x, DOI 10.5694/J.1326-5377.1960.TB73127.X]; Antfolk D, 2017, P NATL ACAD SCI USA, V114, pE4574, DOI 10.1073/pnas.1703057114; Arboleda-Velasquez JF, 2014, CELLULAR MOL PATHOBI, P181, DOI [10.1016/B978-0-12-405206-2.00010-7, DOI 10.1016/B978-0-12-405206-2.00010]; Bahramsoltani M, 2004, ALTEX-ALTERN TIEREXP, V21, P227; Bahramsoltani M, 2007, APMIS, V115, P30, DOI 10.1111/j.1600-0463.2007.apm_405.x; Bahramsoltani M, 2016, METHODS MOL BIOL, V1464, P185, DOI 10.1007/978-1-4939-3999-2_17; Bahramsoltani M, 2013, CLIN HEMORHEOL MICRO, V55, P255, DOI 10.3233/CH-2012-1631; Bahramsoltani M, 2010, CLIN HEMORHEOL MICRO, V46, P189, DOI 10.3233/CH-2010-1345; Banerjee S, 2010, EXP CELL RES, V316, P172, DOI 10.1016/j.yexcr.2009.08.011; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Chappell JC., 2010, VASCULAR DEV, V1st, P43, DOI [10.1016/S0070-2153(10)90002-1, DOI 10.1016/S0070-2153(10)90002-1]; Danielsson F, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7100147; Dave JM, 2014, MICROCIRCULATION, V21, P333, DOI 10.1111/micc.12111; De Cesari C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072354; De Spiegelaere W, 2011, CLIN HEMORHEOL MICRO, V48, P15, DOI 10.3233/CH-2011-1393; Doke SK, 2015, SAUDI PHARM J, V23, P223, DOI 10.1016/j.jsps.2013.11.002; Eekels JJM, 2012, GENE THER, V19, P1058, DOI 10.1038/gt.2011.191; Firestone RS, 2017, J AM CHEM SOC, V139, P13754, DOI 10.1021/jacs.7b05803; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gomez-Escudero J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50866-x; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Iqbal F, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0631-1; Kist M, 2021, EMBO J, V40, DOI 10.15252/embj.2020106700; Liu TG, 2010, AM J PHYSIOL-CELL PH, V299, pC363, DOI 10.1152/ajpcell.00057.2010; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lu SC, 2008, J GASTROEN HEPATOL, V23, pS73, DOI 10.1111/j.1440-1746.2007.05289.x; Nosrati H, 2021, J NANOBIOTECHNOL, V19, DOI 10.1186/s12951-020-00755-7; Nowak-Sliwinska P, 2018, ANGIOGENESIS, V21, P425, DOI 10.1007/s10456-018-9613-x; Olias P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099678; Omorphos NP, 2021, MOL BIOL REP, V48, P941, DOI 10.1007/s11033-020-06108-9; Orosz F, 2009, BBA-MOL BASIS DIS, V1792, P1168, DOI 10.1016/j.bbadis.2009.09.012; Patan S, 2000, J NEURO-ONCOL, V50, P1, DOI 10.1023/A:1006493130855; Patteson AE, 2020, BIOESSAYS, V42, DOI 10.1002/bies.202000078; Qiu J, 2007, BIOL PHARM BULL, V30, P247, DOI 10.1248/bpb.30.247; Ribatti D, 2012, DEV BIOL, V372, P157, DOI 10.1016/j.ydbio.2012.09.018; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Robert A, 2016, BIOESSAYS, V38, P232, DOI 10.1002/bies.201500142; Rusu MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115853; Sahin M, 2010, CANCER METAST REV, V29, P655, DOI 10.1007/s10555-010-9253-0; Shafqat N, 2013, BIOCHEM J, V452, P27, DOI 10.1042/BJ20121580; Stryker ZI, 2019, BIOMEDICINES, V7, DOI 10.3390/biomedicines7020037; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Tahergorabi Z, 2012, IRAN J BASIC MED SCI, V15, P1110; Tanase CE, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/025002; Tsuruta D, 2003, J CELL SCI, V116, P4977, DOI 10.1242/jcs.00823; van Beijnum JR, 2006, BLOOD, V108, P2339, DOI 10.1182/blood-2006-02-004291; Wang XH, 2017, POLYMERS-BASEL, V9, DOI 10.3390/polym9110575; Wierenga RK, 2010, CELL MOL LIFE SCI, V67, P3961, DOI 10.1007/s00018-010-0473-9; Yamaji R, 2004, ARCH BIOCHEM BIOPHYS, V423, P332, DOI 10.1016/j.abb.2004.01.003; Yetkin-Arik B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48676-2	50	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266774	10.1371/journal.pone.0266774	http://dx.doi.org/10.1371/journal.pone.0266774			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D8GY	35482724	gold, Green Published			2022-12-26	WOS:000794035700022
J	Hu, HP; Qiao, SC; Hao, Y; Bai, YP; Cheng, R; Zhang, WD; Zhang, GJ				Hu, Hongping; Qiao, Shichang; Hao, Yan; Bai, Yanping; Cheng, Rong; Zhang, Wendong; Zhang, Guojun			Breast cancer histopathological images recognition based on two-stage nuclei segmentation strategy	PLOS ONE			English	Article							CLASSIFICATION; DIAGNOSIS; MODEL	Pathological examination is the gold standard for breast cancer diagnosis. The recognition of histopathological images of breast cancer has attracted a lot of attention in the field of medical image processing. In this paper, on the base of the Bioimaging 2015 dataset, a two-stage nuclei segmentation strategy, that is, a method of watershed segmentation based on histopathological images after stain separation, is proposed to make the dataset recognized to be the carcinoma and non-carcinoma recognition. Firstly, stain separation is performed on breast cancer histopathological images. Then the marker-based watershed segmentation method is used for images obtained from stain separation to achieve the nuclei segmentation target. Next, the completed local binary pattern is used to extract texture features from the nuclei regions (images after nuclei segmentation), and color features were extracted by using the color auto-correlation method on the stain-separated images. Finally, the two kinds of features were fused and the support vector machine was used for carcinoma and non-carcinoma recognition. The experimental results show that the two-stage nuclei segmentation strategy proposed in this paper has significant advantages in the recognition of carcinoma and non-carcinoma on breast cancer histopathological images, and the recognition accuracy arrives at 91.67%. The proposed method is also applied to the ICIAR 2018 dataset to realize the automatic recognition of carcinoma and non-carcinoma, and the recognition accuracy arrives at 92.50%.	[Hu, Hongping; Qiao, Shichang; Bai, Yanping; Cheng, Rong] North Univ China, Sch Sci, Taiyuan, Peoples R China; [Hao, Yan] North Univ China, Sch Informat & Commun Engn, Taiyuan, Peoples R China; [Zhang, Wendong; Zhang, Guojun] North Univ China, Sch Instrument & Elect, State Key Lab Dynam Testing Technol, Taiyuan, Peoples R China	North University of China; North University of China; North University of China	Hu, HP (corresponding author), North Univ China, Sch Sci, Taiyuan, Peoples R China.	hhp92@163.com			Fundamental Research Program of Shanxi Province [202103021223189, 20210302123019]; Shanxi Scholarship Council of China [2020-104]; National Natural Science Foundation of China [61774137, 51875535]; Key Research and Development Projects of Shanxi Province [201903D121156]; National Key Research and Development Project [2019YFC019800]; National Natural Science Foundation of China as National Major Scientific Instruments Development Project [61927807]; Shanxi '1331 Project' Key Subject Construction and Innovation Special Zone Project	Fundamental Research Program of Shanxi Province; Shanxi Scholarship Council of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Projects of Shanxi Province; National Key Research and Development Project; National Natural Science Foundation of China as National Major Scientific Instruments Development Project; Shanxi '1331 Project' Key Subject Construction and Innovation Special Zone Project	This work was supported in part by Fundamental Research Program of Shanxi Province (Grant Number 20210302123019), and the Shanxi Scholarship Council of China (Grant number 2020-104) both awarded to HH. This work was also funded by the National Natural Science Foundation of China (Grant numbers 61774137) awarded to YB and (grant number 51875535) awarded to WZ. This work was also funded by the Key Research and Development Projects of Shanxi Province (Grant number 201903D121156) awarded to YB, National Key Research and Development Project (Grant number 2019YFC019800) awarded to GZ and the National Natural Science Foundation of China as National Major Scientific Instruments Development Project (Grant number 61927807) awarded to WZ. Finally, this work was also funded by the Shanxi `1331 Project' Key Subject Construction and Innovation Special Zone Project awarded to WZ and the Fundamental Research Program of Shanxi Province (Grant Number 202103021223189) awarded to RC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta R, 2009, P IEEE COMPUTER SOC; Alom MZ, 2019, J DIGIT IMAGING, V32, P605, DOI 10.1007/s10278-019-00182-7; Araujo T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177544; Aresta G, 2019, MED IMAGE ANAL, V56, P122, DOI 10.1016/j.media.2019.05.010; Belsare AD, 2015, TENCON 20152015 IEEE, P15; Brancati N, 2018, LECT NOTES COMPUT SC, V10882, P771, DOI 10.1007/978-3-319-93000-8_87; Chan A, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160558; Das A, 2019, IEEE T IMAGE PROCESS, V28, P1248, DOI 10.1109/TIP.2018.2877337; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Elelimy E, 2018, P 2018 13 INT C COMP; Gavrilovic M, 2013, IEEE T MED IMAGING, V32, P983, DOI 10.1109/TMI.2013.2239655; GRAPS A, 1995, IEEE COMPUT SCI ENG, V2, P50, DOI 10.1109/99.388960; Guo ZH, 2010, IEEE T IMAGE PROCESS, V19, P1657, DOI 10.1109/TIP.2010.2044957; Han ZY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04075-z; Hao Y, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.657560; He HL, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.614174; Hossin M., 2015, INT J DATA MIN KNOWL, V5, P1, DOI [10.5121/ijdkp.2015.5201, DOI 10.5121/IJDKP.2015.5201]; Huang J, 1999, INT J COMPUT VISION, V35, P245, DOI 10.1023/A:1008108327226; Kassani S H, P 29 ANN INT C COMPU; Kaushal C, 2019, IRBM, V40, P211, DOI 10.1016/j.irbm.2019.06.001; Kowal M, 2013, COMPUT BIOL MED, V43, P1563, DOI 10.1016/j.compbiomed.2013.08.003; Kumar Rajesh, 2015, J Med Eng, V2015, P457906, DOI 10.1155/2015/457906; Li X, 2020, J VIS COMMUN IMAGE R, V70, DOI 10.1016/j.jvcir.2020.102799; Lian JG, 2020, CLIN BREAST CANCER, V20, P283, DOI 10.1016/j.clbc.2020.03.004; Pang B, P 2010 CHINESE C PAT, P1; Rakhlin A, 2018, LECT NOTES COMPUT SC, V10882, P737, DOI 10.1007/978-3-319-93000-8_83; Reis S, 2017, IEEE T BIO-MED ENG, V64, P2344, DOI 10.1109/TBME.2017.2665602; Robertson S, 2018, TRANSL RES, V194, P19, DOI 10.1016/j.trsl.2017.10.010; Roy K, 2019, COMPUT MED IMAG GRAP, V71, P90, DOI 10.1016/j.compmedimag.2018.11.003; Saha M, 2018, COMPUT MED IMAG GRAP, V64, P29, DOI 10.1016/j.compmedimag.2017.12.001; Saini M, 2020, APPL SOFT COMPUT, V97, DOI 10.1016/j.asoc.2020.106759; Shukla K.K., 2017, BIOMED PHARMACOL J, V10, DOI [DOI 10.13005/bpj/1116, 10.13005/bpj/1116]; Soh LK, 1999, IEEE T GEOSCI REMOTE, V37, P780, DOI 10.1109/36.752194; Spanhol FA, 2016, P INT JOINT C NEURAL; Spanhol FA, 2016, IEEE T BIO-MED ENG, V63, P1455, DOI 10.1109/TBME.2015.2496264; Srinivas U, 2014, IEEE T MED IMAGING, V33, P1163, DOI 10.1109/TMI.2014.2306173; Sudharshan PJ, 2019, EXPERT SYST APPL, V117, P103, DOI 10.1016/j.eswa.2018.09.049; Tamura H., 1978, IEEE Transactions on Systems, Man and Cybernetics, VSMC-8, P460, DOI 10.1109/TSMC.1978.4309999; Vahadane A, 2016, IEEE T MED IMAGING, V35, P1962, DOI 10.1109/TMI.2016.2529665; Wang Y, LECT NOTES COMPUTER, P845; Wang ZQ, 2019, IEEE ACCESS, V7, P105146, DOI 10.1109/ACCESS.2019.2892795; World Health Organization (WHO), WORLD CANC REPORT 20; Xu J, 2016, IEEE T MED IMAGING, V35, P119, DOI 10.1109/TMI.2015.2458702; Zheng YS, 2017, PATTERN RECOGN, V71, P14, DOI 10.1016/j.patcog.2017.05.010	44	0	0	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266973	10.1371/journal.pone.0266973	http://dx.doi.org/10.1371/journal.pone.0266973			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D8GY	35482728	gold, Green Published			2022-12-26	WOS:000794035700091
J	Johnson, KM; Jiao, BS; Bender, MA; Ramsey, SD; Devine, B; Basu, A				Johnson, Kate M.; Jiao, Boshen; Bender, M. A.; Ramsey, Scott D.; Devine, Beth; Basu, Anirban			Development of a conceptual model for evaluating new non-curative and curative therapies for sickle cell disease	PLOS ONE			English	Article							COST-EFFECTIVENESS ANALYSIS; QUALITY-OF-LIFE; STRUCTURAL UNCERTAINTY; ECONOMIC-EVALUATION; HEALTH; TRANSPLANTATION; MANAGEMENT; PAIN; ALLOIMMUNIZATION; ANEMIA	BackgroundSickle cell disease (SCD) is a clinically heterogeneous disease with many acute and chronic complications driven by ongoing vaso-occlusion and hemolysis. It causes a disproportionate burden on Black and Hispanic communities. Our objective was to follow the SMDM/ISPOR Task Force recommendations for good practices and create a conceptual model of the progression of SCD under current clinical practice to inform cost-effectiveness analyses (CEA) of promising curative therapies in the pipeline over a lifetime horizon. MethodsWe used consultations with experts, providers, and patients to identify acute events and chronic conditions in the conceptual model. We compared our model structure to previous CEA models of interventions for SCD, assessed the prevalence of the identified disease attributes in Medicaid and Medicare claims databases, and identified relevant outcomes following the 2(nd) Panel in CEA. We determined an appropriate modeling technique and relevant data sources for parameterizing the model. ResultsThe conceptual model structure included four dimensions of disease: chronic pain, acute events, chronic conditions, and treatment complications, spanning 26 disease attributes with significant impacts on health-related quality of life and resource. We modeled chronic pain separately to reflect its importance to patients and interaction with all other disease attributes. We identified additional data sources for health state utilities and non-medical costs and benefits of SCD. We will use a microsimulation model with age- and sex-specific transitions between health states predicted by patient demographic characteristics and disease history. ConclusionDeveloping the model structure through an explicit process of model conceptualization can increase the transparency and accuracy of results. We will populate the conceptual model with the data sources described and evaluate the cost-effectiveness of curative therapies.	[Johnson, Kate M.] Univ British Columbia, Fac Pharmaceut Sci, Collaborat Outcomes Res & Evaluat CORE, Vancouver, BC, Canada; [Johnson, Kate M.] Univ British Columbia, Fac Med, Div Resp Med, Vancouver, BC, Canada; [Johnson, Kate M.; Jiao, Boshen; Ramsey, Scott D.; Devine, Beth; Basu, Anirban] Univ Washington, Comparat Hlth Outcomes Policy & Econ CHOICE Inst, Seattle, WA 98195 USA; [Bender, M. A.] Univ Washington, Fred Hutchinson Canc Res Ctr, Dept Pediat, Clin Res Div, Seattle, WA 98195 USA; [Ramsey, Scott D.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Ramsey, Scott D.] Fred Hutchinson Canc Res Ctr, Hutchinson Inst Canc Outcomes Res, 1124 Columbia St, Seattle, WA 98104 USA; [Basu, Anirban] Univ Washington, Dept Hlth Syst & Populat Hlth, Seattle, WA 98195 USA; [Basu, Anirban] Univ Washington, Dept Econ, Seattle, WA 98195 USA	University of British Columbia; University of British Columbia; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Basu, A (corresponding author), Univ Washington, Comparat Hlth Outcomes Policy & Econ CHOICE Inst, Seattle, WA 98195 USA.; Basu, A (corresponding author), Univ Washington, Dept Hlth Syst & Populat Hlth, Seattle, WA 98195 USA.; Basu, A (corresponding author), Univ Washington, Dept Econ, Seattle, WA 98195 USA.	basua@uw.edu		Basu, Anirban/0000-0003-4238-7402	National Institutes of Health (NIH) [OT3HL152448, OT3HL151434]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded in part by the National Institutes of Health (NIH) Agreements OT3HL152448 and OT3HL151434. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzali HHA, 2021, VALUE HEALTH, V24, P755, DOI 10.1016/j.jval.2020.12.013; Afzali HHA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222049; [Anonymous], 2021, LONG TERM FOLL UP HE; Arnold SD, 2016, BRIT J HAEMATOL, V174, P515, DOI 10.1111/bjh.14167; Baldwin Zach., PHARMACOECONOMICS OP; Barlow JF, 2019, VALUE HEALTH, V22, P642, DOI 10.1016/j.jval.2018.12.004; Basu A., 2016, COST EFFECTIVENESS H, P201, DOI [DOI 10.1093/ACPROF:OSO/9780190492939.003.0008, 10.1093/acprof:oso/9780190492939.003.0008]; Beasley D., 2019, REUTERS HLTH NEWS; Bojke L, 2009, VALUE HEALTH, V12, P739, DOI 10.1111/j.1524-4733.2008.00502.x; Bradt P., 2020, I CLIN EC REV; Brisson M, 2006, MED DECIS MAKING, V26, P434, DOI 10.1177/0272989X06290485; Bryan S, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X601325; Businesswire, 2021, BLUEB BIOANN TEMP SU; Castilla-Rodriguez I, 2016, EXPERT OPIN ORPHAN D, V4, P567, DOI 10.1080/21678707.2016.1179572; Centers for Disease Control and Prevention, 2020, DAT STAT SICKL CELL; Cherry MG., 2012, CLIN EFFECTIVENESS C; DeMartino P, 2021, JAMA PEDIATR, V175, P617, DOI 10.1001/jamapediatrics.2020.7140; Drummond MF, 2019, VALUE HEALTH, V22, P661, DOI 10.1016/j.jval.2019.03.012; Esrick EB, 2018, SEMIN HEMATOL, V55, P76, DOI 10.1053/j.seminhematol.2018.04.014; Frederix GWJ, 2014, PHARMACOECONOMICS, V32, P47, DOI 10.1007/s40273-013-0106-x; Hankins JS, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.27228; Harrison C, 2019, NAT BIOTECHNOL, V37, P1102, DOI 10.1038/d41587-019-00026-3; Holdford D, 2021, VALUE HEALTH, V24, P1095, DOI 10.1016/j.jval.2021.02.014; Hsieh MM, 2009, NEW ENGL J MED, V361, P2309, DOI 10.1056/NEJMoa0904971; Husbands S, 2017, PHARMACOECONOMICS, V35, P607, DOI 10.1007/s40273-017-0499-z; IJzerman MJ, 2017, PHARMACOECONOMICS, V35, P727, DOI 10.1007/s40273-017-0509-1; Jiao B., 2021, QUAL LIFE RES; Jiao Bohsen., ASSOCIATING HL UNPUB; Jiao BS, 2022, VALUE HEALTH, V25, P276, DOI 10.1016/j.jval.2021.08.002; Jiao BS, 2021, PHARMACOECONOMICS, V39, P1225, DOI 10.1007/s40273-021-01072-z; Jiao BS, 2021, VALUE HEALTH, V24, P957, DOI 10.1016/j.jval.2021.03.006; Kacker S, 2014, TRANSFUSION, V54, P2034, DOI 10.1111/trf.12585; Kacker S, 2014, TRANSFUSION, V54, P86, DOI 10.1111/trf.12250; Kapoor S, 2018, MAYO CLIN PROC, V93, P1810, DOI 10.1016/j.mayocp.2018.08.001; Kuznik A, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1572-6; Lubeck D, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.15374; Madani BM, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-1009-5; McGann PT, 2015, J PEDIATR-US, V167, P1314, DOI 10.1016/j.jpeds.2015.08.068; McLeod C, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13010; Osunkwo I, 2020, HEMATOL-AM SOC HEMAT, P562, DOI 10.1182/hematology.2020000143; Panepinto JA, 2012, PEDIATR BLOOD CANCER, V59, P377, DOI 10.1002/pbc.24176; Quach D., 2021, EXPERT REV PHARM OUT; Quinn C, 2019, VALUE HEALTH, V22, P621, DOI 10.1016/j.jval.2019.03.014; Ramos GFP, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-150; Reeves S, 2014, ACAD PEDIATR, V14, pS61, DOI 10.1016/j.acap.2014.02.008; Roberts M, 2012, MED DECIS MAKING, V32, P678, DOI [10.1177/0272989X12454941, 10.1016/j.jval.2012.06.016]; Roth JA, 2018, J MED ECON, V21, P1238, DOI 10.1080/13696998.2018.1529674; Salcedo J, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90405-1; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Shah NR, 2020, J MED ECON, V23, P1345, DOI 10.1080/13696998.2020.1813144; Smith WR, 2008, ANN INTERN MED, V148, P94, DOI 10.7326/0003-4819-148-2-200801150-00004; Smith WR, 2005, J NATL MED ASSOC, V97, P183; Spackman E, 2014, EUR J HAEMATOL, V92, P249, DOI 10.1111/ejh.12232; Squires H, 2016, VALUE HEALTH, V19, P588, DOI 10.1016/j.jval.2016.02.011; Tabberer M, 2017, MED DECIS MAKING, V37, P440, DOI 10.1177/0272989X16662009; Tappenden P, 2013, VALUE HEALTH, V16, P542, DOI 10.1016/j.jval.2013.02.012; Varni J., PEDSQL TM MEASUREMEN; WALTERS MC, 1995, BLOOD, V85, P879, DOI 10.1182/blood.V85.4.879.bloodjournal854879; Ware RE, 2017, LANCET, V390, P311, DOI 10.1016/S0140-6736(17)30193-9; Yawn BP, 2014, JAMA-J AM MED ASSOC, V312, P1033, DOI 10.1001/jama.2014.10517	60	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267448	10.1371/journal.pone.0267448	http://dx.doi.org/10.1371/journal.pone.0267448			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D8GY	35482721	Green Published, gold			2022-12-26	WOS:000794035700058
J	Makeswaran, P; Shah, SA; Safian, N; Muhamad, NA; Harith, AA				Makeswaran, Punitha; Shah, Shamsul Azhar; Safian, Nazarudin; Muhamad, Nor Asiah; Harith, Abdul Aziz			Determinants of delayed tuberculosis treatment among patients in Selangor: A study protocol	PLOS ONE			English	Article								The high prevalence rate and ever-increasing incidence of tuberculosis (TB) worldwide remain a significant issue in healthcare. In Malaysia, the incidence and mortality rate of TB is increasing due to the delayed presentation of TB patients to healthcare facilities. However, there is a lack of local studies on the contributing factors of delayed presentation of TB patients in Malaysia. This study aims to establish a social epidemiology framework by analysing social factors including socio-epidemiological, socio-cultural, and health-seeking behaviours associated with the delay in seeking TB treatment among patients in Selangor, Malaysia. A sequential exploratory mixed-method study design that combines qualitative and quantitative research methods will be employed. This study will recruit adult patients who have been diagnosed with TB using chest X-ray and sputum smear microscopy. Four districts with the highest recorded cases in the state of Selangor will be selected as study locations. The qualitative study will involve a Focus Group Discussion (FGD) to explore six components, namely demographic, socio-cultural, health-seeking behaviours, social support and resources, previous knowledge and experience with illness, and treatment pathway. Meanwhile, the quantitative study will incorporate a structured survey that will be developed based on the themes identified in the qualitative phase and a review of several studies in the literature. Several quality control measures will be taken while ensuring that the survey questionnaires are anonymised and participants' confidentiality is maintained. The data obtained from both qualitative and quantitative approaches will be combined to provide a more robust assessment of the study. Given that this study will focus on districts with high recorded cases of TB in Selangor, the findings might assist to address TB-related issues such as the increasing incidence and mortality rates, which are mainly attributed to the delayed presentation of TB patients to healthcare facilities.	[Makeswaran, Punitha; Shah, Shamsul Azhar; Safian, Nazarudin] UKM Med Ctr, Dept Community Med, Kuala Lumpur, Malaysia; [Muhamad, Nor Asiah] Minist Hlth, Natl Inst Hlth, Evidence Based Healthcare Med Sect, Shah Alam, Selangor, Malaysia; [Harith, Abdul Aziz] Minist Hlth Malaysia, Inst Publ Hlth, Occupat Hlth Res Ctr, Shah Alam, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia	Shah, SA (corresponding author), UKM Med Ctr, Dept Community Med, Kuala Lumpur, Malaysia.	drsham@ppukm.ukm.edu.my		Shah, Shamsul Azhar/0000-0003-0635-1816	Ministry of Health Malaysia	Ministry of Health Malaysia	This work forms part of the first author's PhD. PM is supported by the Ministry of Health Malaysia.	Abdelbary BE, 2016, TUBERCULOSIS, V101, pS124, DOI 10.1016/j.tube.2016.09.024; Aday LA, 2006, DESIGNING CONDUCTING; Alene KA, 2020, TROP MED INFECT DIS, V5, DOI 10.3390/tropicalmed5030123; Alvarez JL, 2011, INT J TUBERC LUNG D, V15, P1461, DOI 10.5588/ijtld.10.0252; Ariffin F, 2015, Malays Fam Physician, V10, P26; Creswell J.W., 2007, DESIGNING CONDUCTING; Fleiss J.L., 2013, STAT METHODS RATES P; Gupta A, 2011, RECENT TRENDS BIOTEC, P261; MacNeil A, 2017, MMWR-MORBID MORTAL W, V69, P281; MacNeil A, 2019, MMWR-MORBID MORTAL W, V68, P263, DOI 10.15585/mmwr.mm6811a3; Maiga M, 2012, INDIAN J MED RES, V135, P731; Narasimhan P, 2013, PULM MED, V2013, DOI 10.1155/2013/828939; Phan MN, 2016, INT J INFECT DIS, V53, P1, DOI 10.1016/j.ijid.2016.09.006; Portal-Celhay C., 2019, PRINCIPLES PRACTICE, P491, DOI [10.1007/978-1-4939-9034-4_29, DOI 10.1007/978-1-4939-9034-4_29]; Prasad A, 2016, T ROY SOC TROP MED H, V110, P151, DOI 10.1093/trstmh/trw004; Sandhu GK, 2011, J GLOB INFECT DIS, V3, P143, DOI 10.4103/0974-777X.81691; Senanayake MGB, 2018, MULTIDISCIP RESP MED, V13, DOI 10.1186/s40248-018-0121-z; Tamhane A, 2012, INT J PREVENTIVE MED, V3, P569; Tsai HYS, 2016, COMPUT SECUR, V59, P138, DOI 10.1016/j.cose.2016.02.009; Van Crevel R., 2017, TUBERCULOSIS INFECT, P271, DOI [10.4103/ijmr.IJMR_177_16, DOI 10.4103/IJMR.IJMR_177_16]; World Health Organisation, 2019, GLOB TUB REP; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization, 2018, GLOB TUB REP 2018; World Health Organization, 2013, WHOHTMTB201311; Yew WW, 2011, EUR RESPIR J, V37, P441, DOI 10.1183/09031936.00033010	25	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266746	10.1371/journal.pone.0266746	http://dx.doi.org/10.1371/journal.pone.0266746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D9PO	35468167	gold, Green Published			2022-12-26	WOS:000794129600014
J	Nguyen, TB; Do, DN; Nguyen, TTP; Nguyen, TL; Nguyen-Thanh, T; Nguyen, H				Nguyen, Thong Ba; Do, Duy Ngoc; Nguyen, Thuy T. P.; Nguyen, Truc Ly; Nguyen-Thanh, Tung; Nguyen, Ha Thi			Immune-related biomarkers shared by inflammatory bowel disease and liver cancer	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; C-SRC; COLORECTAL-CANCER; TUMOR-SUPPRESSOR; GENE-EXPRESSION; CROHN-DISEASE; RISK; PROMOTES; METASTASIS; HCC	It has been indicated that there is an association between inflammatory bowel disease (IBD) and hepatocellular carcinoma (HCC). However, the molecular mechanism underlying the risk of developing HCC among patients with IBD is not well understood. The current study aimed to identify shared genes and potential pathways and regulators between IBD and HCC using a system biology approach. By performing the different gene expression analyses, we identified 871 common differentially expressed genes (DEGs) between IBD and HCC. Of these, 112 genes overlapped with immune genes were subjected to subsequent bioinformatics analyses. The results revealed four hub genes (CXCL2, MMP9, SPP1 and SRC) and several other key regulators including six transcription factors (FOXC1, FOXL1, GATA2, YY1, ZNF354C and TP53) and five microRNAs (miR-124-3p, miR-34a-5p, miR-1-3p, miR-7-5p and miR-99b-5p) for these disease networks. Protein-drug interaction analysis discovered the interaction of the hub genes with 46 SRC-related and 11 MMP9- related drugs that may have a therapeutic effect on IBD and HCC. In conclusion, this study sheds light on the potential connecting mechanisms of HCC and IBD.	[Nguyen, Thong Ba] Univ Hawaii Manoa, John A Burns Sch Med, Dept Anat Biochem & Physiol, Honolulu, HI 96822 USA; [Do, Duy Ngoc] Dalhousie Univ, Dept Anim Sci & Aquaculture, Truro, NS, Canada; [Nguyen, Thuy T. P.] Chonnam Natl Univ, Dept Anim Sci, Gwangju, South Korea; [Nguyen, Truc Ly] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Nguyen, Truc Ly] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Nguyen-Thanh, Tung] Hue Univ, Hue Univ Med & Pharm, Inst Biomed, Hue, Vietnam; [Nguyen-Thanh, Tung] Hue Univ, Hue Univ Med & Pharm, Fac Basic Sci, Hue, Vietnam; [Nguyen, Ha Thi] Duy Tan Univ, Coll Med & Pharm, Ctr Mol Biol, Danang, Vietnam	University of Hawaii System; University of Hawaii Manoa; Dalhousie University; Chonnam National University; Seoul National University (SNU); Seoul National University (SNU); Hue University; Hue University; Duy Tan University	Nguyen, TB (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Anat Biochem & Physiol, Honolulu, HI 96822 USA.; Nguyen, H (corresponding author), Duy Tan Univ, Coll Med & Pharm, Ctr Mol Biol, Danang, Vietnam.	nguyenb7@hawaii.edu; hangth.bio@gmail.com	Nguyen, Thong/ADQ-2780-2022	Nguyen, Thong/0000-0001-9647-534X; Nguyen-Thanh, Tung/0000-0002-5215-383X; NGUYEN, THUY/0000-0002-3507-2309; NGUYEN, Ha/0000-0001-9222-632X				Al-Alwan LA, 2013, J IMMUNOL, V191, P2731, DOI 10.4049/jimmunol.1203421; Al-Mustanjid M, 2020, GENOMICS, V112, P3416, DOI 10.1016/j.ygeno.2020.06.001; Altaf-Ul-Amin M, 2020, BMC MED GENOMICS, V13, DOI 10.1186/s12920-020-0660-y; Annese V, 2015, J CROHNS COLITIS, V9, P945, DOI 10.1093/ecco-jcc/jjv141; Arii S, 1996, HEPATOLOGY, V24, P316; Askling J, 2005, GUT, V54, P617, DOI 10.1136/gut.2004.051771; Baldelli V, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9040697; Bhattacharya S, 2014, IMMUNOL RES, V58, P234, DOI 10.1007/s12026-014-8516-1; Bittencourt VZ, 2021, INFLAMM BOWEL DIS, V27, P1684, DOI 10.1093/ibd/izab024; Botros Y, 2015, CASE REP GASTROINTES, V2015, DOI 10.1155/2015/939136; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cai QQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40733; Caron de Fromentel C., 2020, HEPATOMA RES, V6, P80, DOI [10.20517/2394-5079.2020.77, DOI 10.20517/2394-5079.2020.77]; CARTWRIGHT CA, 1994, J CLIN INVEST, V93, P509, DOI 10.1172/JCI117000; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chen JWC, 2009, HPB, V11, P81, DOI 10.1111/j.1477-2574.2009.00022.x; Chen RX, 2012, ANN SURG ONCOL, V19, pS375, DOI 10.1245/s10434-011-1836-7; Chen YH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21175999; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; Danese S, 2010, ONCOGENE, V29, P3313, DOI 10.1038/onc.2010.109; Ding J, 2018, BMB REP, V51, P630, DOI 10.5483/BMBRep.2018.51.12.140; Dohan A, 2015, DIAGN INTERV IMAG, V96, P871, DOI 10.1016/j.diii.2015.02.009; Erichsen R, 2021, CANCER EPIDEM BIOMAR, V30, P886, DOI 10.1158/1055-9965.EPI-20-1241; Fang YX, 2012, HEPATOLOGY, V55, P1852, DOI 10.1002/hep.25576; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Galon J, 2014, J PATHOL, V232, P199, DOI 10.1002/path.4287; Gassler N, 2002, SCAND J GASTROENTERO, V37, P1286, DOI 10.1080/003655202761020560; Geremia A, 2014, AUTOIMMUN REV, V13, P3, DOI 10.1016/j.autrev.2013.06.004; Grainge MJ, 2010, LANCET, V375, P657, DOI 10.1016/S0140-6736(09)61963-2; Greuter T, 2020, DIGESTION, V101, P136, DOI 10.1159/000509544; Guo J, 2019, INFLAMMATION, V42, P2267, DOI 10.1007/s10753-019-01091-1; Guo J, 2017, MOL MED REP, V16, P1200, DOI 10.3892/mmr.2017.6730; Han JX, 2019, CANCER RES, V79, P1451, DOI 10.1158/0008-5472.CAN-18-2238; Hemminki K, 2009, ANN ONCOL, V20, P574, DOI 10.1093/annonc/mdn595; Higuchi T, 2016, J BIOL CHEM, V291, P21074, DOI 10.1074/jbc.M116.748210; Hsu CN, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-66; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang L, 2020, AGING CELL, V19, DOI 10.1111/acel.13252; Huerta-Yepez Sara, 2006, Proceedings of the American Association for Cancer Research Annual Meeting, V47, P215; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; Jiang XW, 2018, ONCOL LETT, V15, P2625, DOI 10.3892/ol.2017.7534; Kappelman MD, 2014, CLIN GASTROENTEROL H, V12, P265, DOI 10.1016/j.cgh.2013.03.034; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Koberle V, 2013, EUR J CANCER, V49, P3442, DOI 10.1016/j.ejca.2013.06.002; Kong DQ, 2020, AM J CANCER RES, V10, P1522; Kourepini E, 2014, P NATL ACAD SCI USA, V111, pE856, DOI 10.1073/pnas.1316447111; Kwon Oh Sang, 2015, Korean J Gastroenterol, V66, P320, DOI 10.4166/kjg.2015.66.6.320; Lee SH, 2018, INTEST RES, V16, P26, DOI 10.5217/ir.2018.16.1.26; Levine Jonathan S, 2011, Gastroenterol Hepatol (N Y), V7, P235; Li B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1028-7; Li QJ, 2021, MOL THER-NUCL ACIDS, V26, P222, DOI 10.1016/j.omtn.2021.07.009; Li WH, 2015, ONCOTARGET, V6, P24448, DOI 10.18632/oncotarget.4423; Li YJ, 2019, THERANOSTICS, V9, P7599, DOI 10.7150/thno.34931; Li YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087505; Li Z, 2021, HEPATOLOGY, V73, P1764, DOI 10.1002/hep.31530; Lin ZY, 2021, J EXP CLIN CANC RES, V40, DOI 10.1186/s13046-021-01829-6; Long JY, 2019, THERANOSTICS, V9, P7251, DOI 10.7150/thno.31155; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lv BJ, 2018, BIOMED PHARMACOTHER, V98, P783, DOI 10.1016/j.biopha.2018.01.013; Ma C, 2018, SCIENCE, V360, DOI 10.1126/science.aan5931; Majid A, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00223; Moni MA, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-333; Ni J, 2017, NAT REV GASTRO HEPAT, V14, P573, DOI 10.1038/nrgastro.2017.88; Pedersen N, 2010, AM J GASTROENTEROL, V105, P1480, DOI 10.1038/ajg.2009.760; Pinero J, 2017, NUCLEIC ACIDS RES, V45, pD833, DOI 10.1093/nar/gkw943; Puleston J, 2005, ALIMENT PHARM THER, V21, P109, DOI 10.1111/j.1365-2036.2004.02262.x; Ramos GP, 2019, MAYO CLIN PROC, V94, P155, DOI 10.1016/j.mayocp.2018.09.013; Ren H, 2016, OPEN LIFE SCI, V11, P513, DOI 10.1515/biol-2016-0067; Rong ZH, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-01551-9; Sackett SD, 2009, LAB INVEST, V89, P1387, DOI 10.1038/labinvest.2009.103; Schwabe RF, 2020, J HEPATOL, V72, P230, DOI 10.1016/j.jhep.2019.08.016; Shin HD, 2007, INT J EPIDEMIOL, V36, P1001, DOI 10.1093/ije/dym093; Singh S, 2014, CLIN GASTROENTEROL H, V12, P382, DOI 10.1016/j.cgh.2013.08.023; Tabei Y, 2019, BMC SYST BIOL, V13, DOI 10.1186/s12918-019-0691-1; Tili E, 2017, CURR OPIN PHARMACOL, V37, P142, DOI 10.1016/j.coph.2017.10.010; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vandenbulcke H, 2016, J HEPATOL, V65, P543, DOI 10.1016/j.jhep.2016.04.031; Villanueva A, 2011, J HEPATOL, V55, P724, DOI 10.1016/j.jhep.2011.03.018; Wang DC, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00342; Wang JQ, 2019, AM J TRANSL RES, V11, P6924; Wang YG, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1128-9; Wei W, 2018, ONCOL LETT, V16, P6960, DOI 10.3892/ol.2018.9555; Wheeler DL, 2009, ONCOLOGIST, V14, P667, DOI 10.1634/theoncologist.2009-0009; Wilson JC, 2016, J CROHNS COLITIS, V10, P186, DOI 10.1093/ecco-jcc/jjv193; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037; Wong SW, 2018, JGH OPEN, V2, P235, DOI 10.1002/jgh3.12070; Wu G, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2863902; Wu WZ, 2017, CANCER CELL INT, V17, DOI 10.1186/s12935-017-0386-x; Xia JG, 2015, NAT PROTOC, V10, P823, DOI 10.1038/nprot.2015.052; Xia LM, 2013, HEPATOLOGY, V57, P610, DOI 10.1002/hep.26029; Xiong L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08245-z; Yablecovitch D, 2019, THER ADV GASTROENTER, V12, DOI 10.1177/1756284819881590; Yang JH, 2015, ONCOL REP, V34, P1415, DOI 10.3892/or.2015.4104; Yang J, 2021, LIFE SCI, V264, DOI 10.1016/j.lfs.2020.118711; Zamor PJ, 2017, J GASTROINTEST ONCOL, V8, P229, DOI 10.21037/jgo.2017.03.14; Zhang HF, 2018, MOL MED REP, V17, P4483, DOI 10.3892/mmr.2018.8399; Zhang H, 2019, ONCOTARGETS THER, V12, P2149, DOI 10.2147/OTT.S197326; Zhang SJ, 2012, J MOL MED, V90, P1069, DOI 10.1007/s00109-012-0879-y; Zhao S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1401-z; Zheng F, 2012, GUT, V61, P278, DOI 10.1136/gut.2011.239145; Zhou GX, 2017, J DIGEST DIS, V18, P495, DOI 10.1111/1751-2980.12540	103	3	3	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267358	10.1371/journal.pone.0267358	http://dx.doi.org/10.1371/journal.pone.0267358			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C1KV	35452485	gold, Green Published			2022-12-26	WOS:000792887700016
J	Padakandla, SR; Das, T; Prashanthi, GS; Angadi, KK; Reddy, SS; Reddy, GB; Shivaji, S				Padakandla, Shalem Raj; Das, Taraprasad; Prashanthi, Gumpili Sai; Angadi, Kiran Kumar; Reddy, S. Sreenivasa; Reddy, G. Bhanuprakash; Shivaji, Sisinthy			Gut mycobiome dysbiosis in rats showing retinal changes indicative of diabetic retinopathy	PLOS ONE			English	Article							FUNGAL MICROBIOTA; ANTIDIABETIC ACTIVITY; INFLAMMATORY DISEASE; COMMENSAL FUNGI; CHILDREN; TYPE-1; AUTOIMMUNITY; PATHOGENESIS; ASSOCIATION; BACTERIAL	The current study compared the gut mycobiomes of diabetic rats generated by a streptozotocin chemical challenge, diabetic rats with retinal changes and normal control rats over a period of 4 months. Sustained increase in blood sugar levels (>150 mg/dL) confirmed the induction of diabetes. Histology and immunohistochemistry were used to identify changes in the retinal tissues in the diabetic rats indicative of the animals progressing into diabetic retinopathy. Gut mycobiomes generated using faecal DNA, indicated dysbiosis at the genus level in both diabetic (DM) and diabetic rats with retinal changes (DRC) when compared with the control rats. In Tables 3-6 the specific genera that were significantly increased/decreased in DM1 and DM2 and in DRC1 and DRC2 respectively compared to the respective controls CT1-CT4 rats are listed. Further, the mycobiomes of the DM and DRC rats separated into distinct clusters following heat-map analysis of the discriminating genera. In addition, beta-diversity analysis separated the mycobiomes of DM and DRC rats from that of the control rats, but the mycobiomes of diabetic rats and diabetic rats with retinal changes showed an overlap. Based on the inferred functions of the discriminating genera in the mycobiomes, we speculated that increase in pathogenic fungi might contribute to the inflammatory status both in diabetic rats and rats showing retinal changes.	[Padakandla, Shalem Raj; Prashanthi, Gumpili Sai; Shivaji, Sisinthy] LV Prasad Eye Inst, Brien Holden Eye Res Ctr, Kallam Anji Reddy Campus, Hyderabad, Telangana, India; [Das, Taraprasad] LV Prasad Eye Inst, Kanuri Santhamma Ctr Vitreo Retinal Dis, Hyderabad, Telangana, India; [Angadi, Kiran Kumar; Reddy, S. Sreenivasa; Reddy, G. Bhanuprakash] Natl Inst Nutr, Biochem Div, ICMR, Hyderabad, Telangana, India	L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN)	Shivaji, S (corresponding author), LV Prasad Eye Inst, Brien Holden Eye Res Ctr, Kallam Anji Reddy Campus, Hyderabad, Telangana, India.	shivas@lvpei.org		Reddy, G. Bhanuprakash/0000-0003-4787-3944; Das, Taraprasad/0000-0002-1295-4528	Brien Holden Eye Research Centre and Hyderabad eye research foundation; Department of Science and Technology, Government of India, India [EMR/2017/000815]	Brien Holden Eye Research Centre and Hyderabad eye research foundation; Department of Science and Technology, Government of India, India(Department of Science & Technology (India))	This research was funded by the Brien Holden Eye Research Centre and Hyderabad eye research foundation, L V Prasad Eye Institute, Hyderabad 500034, India, and the Department of Science and Technology, Government of India (grant No: EMR/2017/000815, August 2018), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K., 2020, **DATA OBJECT**, DOI 10.15156/BIO/786387; Beli E, 2018, DIABETES, V67, P1867, DOI 10.2337/db18-0158; Bharti SK, 2013, FOOD CHEM, V136, P813, DOI 10.1016/j.foodchem.2012.08.083; Botschuijver S, 2017, GASTROENTEROLOGY, V153, P1026, DOI 10.1053/j.gastro.2017.06.004; Cai J, 2002, EYE, V16, P242, DOI 10.1038/sj.eye.6700133; Chakravarthy SK, 2018, INDIAN J MICROBIOL, V58, P457, DOI 10.1007/s12088-018-0746-9; Chakravarthy SK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199640; Chehoud C, 2015, INFLAMM BOWEL DIS, V21, P1948, DOI 10.1097/MIB.0000000000000454; Chen Y, 2011, DIAGN MICR INFEC DIS, V70, P492, DOI 10.1016/j.diagmicrobio.2010.04.005; Cui LJ, 2013, GENOME MED, V5, DOI 10.1186/gm467; Das T, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82538-0; Dong Y., 2014, Biomed Res Int, V2014, P160980, DOI 10.1155/2014/160980; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; El Mouzan M, 2017, J CROHNS COLITIS, V11, P586, DOI 10.1093/ecco-jcc/jjw197; Faust Karoline, 2016, F1000Res, V5, P1519; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Fujimura KE, 2016, NAT MED, V22, P1187, DOI 10.1038/nm.4176; Gosiewski T, 2014, GUT PATHOG, V6, DOI 10.1186/s13099-014-0043-z; Gouba Nina, 2014, BMC Res Notes, V7, P33, DOI 10.1186/1756-0500-7-33; Hartley AJ, 2009, FEMS MICROBIOL LETT, V297, P24, DOI 10.1111/j.1574-6968.2009.01656.x; Heisel T, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00351-17, 10.1128/msphere.00351-17]; Hoffmann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066019; Horai R, 2015, IMMUNITY, V43, P343, DOI 10.1016/j.immuni.2015.07.014; Huffnagle GB, 2013, TRENDS MICROBIOL, V21, P334, DOI 10.1016/j.tim.2013.04.002; Huseyin CE, 2017, FEMS MICROBIOL REV, V41, P479, DOI 10.1093/femsre/fuw047; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Jayasudha R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243077; Jayasudha R, 2019, INVEST OPHTH VIS SCI, V60, P1384, DOI 10.1167/iovs.18-26426; Jayasudha R, 2018, J BIOSCIENCES, V43, P835, DOI 10.1007/s12038-018-9798-6; Jones EE, 2012, PLANT DIS, V96, P144, DOI 10.1094/PDIS-04-11-0347; Kasonga T.K., 2021, FUNGI BIOPROSPECTS S, P213, DOI 10.1016/b978-0-12-821925-6.00011-3; Knudsen H, 2008, FUNGA NORDICA AGARIC; Kowalewska B, 2016, PATIENT PREFER ADHER, V10, P591, DOI 10.2147/PPA.S97852; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Kumar K, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7020039; Lai AKW, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/106594; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Li JY, 2018, MICROB ECOL, V75, P821, DOI 10.1007/s00248-017-1105-9; Li QR, 2014, J CLIN GASTROENTEROL, V48, P513, DOI 10.1097/MCG.0000000000000035; Lombard L, 2015, STUD MYCOL, P189, DOI 10.1016/j.simyco.2014.12.002; Luan CG, 2015, SCI REP-UK, V5, DOI 10.1038/srep07980; Lyke KE, 2001, CLIN INFECT DIS, V32, P1178, DOI 10.1086/319751; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mar JS, 2016, MBIO, V7, DOI 10.1128/mBio.01072-16; Rodriguez MM, 2015, SCI REP-UK, V5, DOI 10.1038/srep14600; Marinucci V, 2022, J PHARM PRACT, V35, P311, DOI 10.1177/0897190020966196; Mukhopadhya I, 2015, MICROBES INFECT, V17, P304, DOI 10.1016/j.micinf.2014.12.001; Nakamura YK, 2016, INVEST OPHTH VIS SCI, V57, P3747, DOI 10.1167/iovs.16-19733; Narula Himanshu, 2020, Curr Med Mycol, V6, P51, DOI 10.18502/cmm.6.1.2510; Nash AK, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0373-4; Olivares AM, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0913-0; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; Ott SJ, 2008, SCAND J GASTROENTERO, V43, P831, DOI 10.1080/00365520801935434; Padakandla SR, 2021, INVEST OPHTH VIS SCI, V62, DOI 10.1167/iovs.62.10.31; Paterson MJ, 2017, CURR OPIN MICROBIOL, V40, P131, DOI 10.1016/j.mib.2017.11.012; Pichon M, 2020, INFECTION, V48, P193, DOI 10.1007/s15010-020-01394-8; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Raghu G, 2017, J FOOD SCI TECH MYS, V54, P2411, DOI 10.1007/s13197-017-2683-8; Raimondi S, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01575; Richard ML, 2019, NAT REV GASTRO HEPAT, V16, P331, DOI 10.1038/s41575-019-0121-2; Rodrigues CF, 2019, J CLIN MED, V8, DOI 10.3390/jcm8010076; Saeedi P, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107843; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Seed PC, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a019810; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shruthi K, 2017, ARCH BIOCHEM BIOPHYS, V627, P10, DOI 10.1016/j.abb.2017.06.006; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Soyucen E, 2014, PEDIATR INT, V56, P336, DOI 10.1111/ped.12243; Strati F, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0185-y; Suh SH, 2019, EMBO REP, V20, DOI 10.15252/embr.201846927; Suhr MJ, 2016, LETT APPL MICROBIOL, V62, P209, DOI 10.1111/lam.12539; Suhr MJ, 2015, MYCOLOGIA, V107, P1057, DOI 10.3852/15-147; Quang TH, 2020, VIETNAM J CHEM, V58, P752, DOI 10.1002/vjch.202000067; Uzor PF, 2017, DRUG RES, V67, P308, DOI 10.1055/s-0042-122777; Vollmeister E, 2012, FEMS MICROBIOL REV, V36, P59, DOI 10.1111/j.1574-6976.2011.00296.x; Wang C, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/1390418; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wijesuriya T M, 2015, Indian J Endocrinol Metab, V19, P811, DOI 10.4103/2230-8210.167565; Yang AM, 2017, J CLIN INVEST, V127, P2829, DOI 10.1172/JCI90562; Yang BH, 2009, INT J INFECT DIS, V13, pE493, DOI 10.1016/j.ijid.2009.02.003; Zuo T, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02247	83	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267080	10.1371/journal.pone.0267080	http://dx.doi.org/10.1371/journal.pone.0267080			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7VA	35439275	Green Published, gold			2022-12-26	WOS:000791280100035
J	Sargent, RH; Laurie, S; Moncada, L; Weakland, LF; Lavery, JV; Salmon, DA; Orenstein, WA; Breiman, RF				Sargent, Rikki H.; Laurie, Shaelyn; Moncada, Leah; Weakland, Leo F.; Lavery, James V.; Salmon, Daniel A.; Orenstein, Walter A.; Breiman, Robert F.			Masks, money, and mandates: A national survey on efforts to increase COVID-19 vaccination intentions in the United States	PLOS ONE			English	Article								Various efforts to increase COVID-19 vaccination rates have been employed in the United States. We sought to rapidly investigate public reactions to these efforts to increase vaccination, including self-reported responses to widespread reduced masking behavior, monetary incentive programs to get vaccinated, and work vaccination requirements. Using a unique method for data collection (Random Domain Intercept Technology), we captured a large (N = 14,152), broad-based sample of the United States Web-using population (data collected from June 30 -July 26, 2021). About 3/4 of respondents reported being vaccinated. The likelihood of vaccination and vaccination intention differed across various demographic indicators (e.g., gender, age, income, political leaning). We observed mixed reactions to efforts aimed at increasing vaccination rates among unvaccinated respondents. While some reported that specific efforts would increase their likelihood of getting vaccinated (between 16% and 32%), others reported that efforts would decrease their likelihood of getting vaccinated (between 17% and 42%). Reactions differed by general vaccination intention, as well as other demographic indicators (e.g., race, education). Our results highlight the need to fully understand reactions to policy changes, programs, and mandates before they are communicated to the public and employed. Moreover, the results emphasize the importance of understanding how reactions differ across groups, as this information can assist in targeting intervention efforts and minimizing potentially differential negative impact.	[Sargent, Rikki H.; Laurie, Shaelyn; Moncada, Leah] RIWI Corp, Toronto, ON, Canada; [Weakland, Leo F.; Breiman, Robert F.] Ctr Global Hlth Innovat, Atlanta, GA USA; [Lavery, James V.; Orenstein, Walter A.; Breiman, Robert F.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA USA; [Lavery, James V.] Emory Univ, Ctr Ethics, Atlanta, GA USA; [Salmon, Daniel A.] Johns Hopkins Bloomberg Sch Publ Hlth, Inst Vaccine Safety, Baltimore, MD USA; [Salmon, Daniel A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Salmon, Daniel A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Orenstein, Walter A.; Breiman, Robert F.] Emory Univ, Sch Med, Atlanta, GA USA	Emory University; Rollins School Public Health; Emory University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Emory University	Breiman, RF (corresponding author), Ctr Global Hlth Innovat, Atlanta, GA USA.; Breiman, RF (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA USA.; Breiman, RF (corresponding author), Emory Univ, Sch Med, Atlanta, GA USA.	rfbreiman@emory.edu		Sargent, Rikki/0000-0002-5247-0181; Breiman, Robert/0000-0002-7099-2936	United States Centers for Disease Control and Prevention (CDC) [6 NU51IP000873-05-02]; Task Force for Global Health [6 NU51IP000873-05-02]	United States Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Task Force for Global Health	This project was made possible by a grant from the United States Centers for Disease Control and Prevention (CDC) in collaboration with the Task Force for Global Health under Award#6 NU51IP000873-05-02 which supported the project related activities of all authors, including the financial support provided to RIWI Corp., the commercial affiliation of authors RHS, SL, and LM. The funder provided support in the form of percentages of salaries for RHS, SL, LM, LFW, JVL, DAS, WAO, and RFB, but did not have any additional role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abusaid S, ATLANTA J CONSTITUTI; Centers for Disease Control and Prevention, 2022, COVID 19 VACC US JUR; Centers for Disease Control and Prevention, 2022, COVID DATA TRACKER; Cooper H., 2021, NEW YORK TIMES; Elevyst RIWI Corp. PRO-A, 2021, ADDR DRUG US REC STI; Fowlkes A, 2021, MMWR-MORBID MORTAL W, V70, P1167, DOI 10.15585/mmwr.mm7034e4; Hamel L., 2021, KFF COVID 19 VACCINE; Khubchandani J, 2021, J COMMUN HEALTH, V46, P270, DOI 10.1007/s10900-020-00958-x; Kim J., 2021, INT J QUAL HEALTH C, V33, P1, DOI [10.1093/intqhc/mzab110, DOI 10.1093/INTQHC/MZAB110]; Largent EA, 2021, JAMA-J AM MED ASSOC, V325, P534, DOI 10.1001/jama.2020.27121; Largent EA, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.33324; Messenger M., 2021, NBC NEWS 0803; Nguyen LH., 2021, PREPRINT, DOI [10.1101/2021.02.25.21252402, DOI 10.1101/2021.02.25.21252402V1]; Phillips N, 2021, NATURE, V590, P382, DOI 10.1038/d41586-021-00396-2; Roder-DeWan S, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2019-002205; Roder-DeWan S, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002879; Roy B., 2021, COVID 19 VACCINE INC; Schonlau M, 2017, STAT SCI, V32, P279, DOI 10.1214/16-STS597; Seeman N, 2016, J AFFECT DISORDERS, V190, P115, DOI 10.1016/j.jad.2015.10.011; Seeman N, 2015, NATURE, V528, P309, DOI 10.1038/528309a; Seeman Neil, 2010, Healthc Q, V13 Spec No, P8; Seeman NL., 2020, SAGE RES METHODS CAS, DOI [10.4135/9781529719260, DOI 10.4135/9781529719260]; Siegler AJ, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.26882; Sprengholz P, 2021, J MED ETHICS, V47, P547, DOI 10.1136/medethics-2020-107122; Tartof SY, 2021, LANCET, V398, P1407, DOI 10.1016/S0140-6736(21)02183-8	25	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267154	10.1371/journal.pone.0267154	http://dx.doi.org/10.1371/journal.pone.0267154			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1F9GM	35446922	Green Published, gold			2022-12-26	WOS:000795468200004
J	Son, S; Park, YC; Cho, MY; Kang, U				Son, Sangjun; Park, Yong-Chan; Cho, Minyong; Kang, U.			DAO-CP: Data-Adaptive Online CP decomposition for tensor stream	PLOS ONE			English	Article								How can we accurately and efficiently decompose a tensor stream? Tensor decomposition is a crucial task in a wide range of applications and plays a significant role in latent feature extraction and estimation of unobserved entries of data. The problem of efficiently decomposing tensor streams has been of great interest because many real-world data dynamically change over time. However, existing methods for dynamic tensor decomposition sacrifice the accuracy too much, which limits their usages in practice. Moreover, the accuracy loss becomes even more serious when the tensor stream has an inconsistent temporal pattern since the current methods cannot adapt quickly to a sudden change in data. In this paper, we propose DAO-CP, an accurate and efficient online CP decomposition method which adapts to data changes. DAO-CP tracks local error norms of the tensor streams, detecting a change point of the error norms. It then chooses the best strategy depending on the degree of changes to balance the trade-off between speed and accuracy. Specifically, DAO-CP decides whether to (1) reuse the previous factor matrices for the fast running time or (2) discard them and restart the decomposition to increase the accuracy. Experimental results show that DAO-CP achieves the state-of-the-art accuracy without noticeable loss of speed compared to existing methods.	[Son, Sangjun; Park, Yong-Chan; Cho, Minyong; Kang, U.] Seoul Natl Univ, Seoul, South Korea	Seoul National University (SNU)	Kang, U (corresponding author), Seoul Natl Univ, Seoul, South Korea.	ukang@snu.ac.kr		Son, Sangjun/0000-0002-1046-6192	National Research Foundation of Korea(NRF) - MSIT [2022R1A2C3007921]; Institute of Information & communications Technology Planning & Evaluation (IITP) - Korea government(MSIT) [2021-0-02068, 2021-0-01343]; MSIT [MSIT 2019R1A2C2004990]	National Research Foundation of Korea(NRF) - MSIT(National Research Foundation of KoreaMinistry of Science & ICT (MSIT), Republic of Korea); Institute of Information & communications Technology Planning & Evaluation (IITP) - Korea government(MSIT)(Institute for Information & Communication Technology Planning & Evaluation (IITP), Republic of KoreaMinistry of Science & ICT (MSIT), Republic of Korea); MSIT(Ministry of Science & ICT (MSIT), Republic of Korea)	This work was partly supported by the National Research Foundation of Korea(NRF) funded by MSIT(2022R1A2C3007921) and MSIT 2019R1A2C2004990). This work was partly supported by Institute of Information & communications Technology Planning & Evaluation (IITP) grant funded by the Korea government(MSIT) [NO.2021-0-02068, Artificial Intelligence Innovation Hub (Artificial Intelligence Institute, Seoul National University)] and [NO.2021-0-01343, Artificial Intelligence Graduate School Program (Seoul National University)]. The Institute of Engineering Research and ICT at Seoul National University provided research facilities for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar E, 2011, CHEMOMETR INTELL LAB, V106, P41, DOI 10.1016/j.chemolab.2010.08.004; [Anonymous], 2006, MULTILINEAR OPERATOR; Battaglino C, 2018, SIAM J MATRIX ANAL A, V39, P876, DOI 10.1137/17M1112303; Cai YJ, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P79, DOI 10.1145/2783258.2783348; Cichocki A, 2015, IEEE SIGNAL PROC MAG, V32, P145, DOI 10.1109/MSP.2013.2297439; Cong FY, 2015, J NEUROSCI METH, V248, P59, DOI 10.1016/j.jneumeth.2015.03.018; Govindu VM, 2005, PROC CVPR IEEE, P1150; Kang U, 2012, P 18 ACM SIGKDD INT, P316, DOI 10.1145/2339530.2339583; Kasai H, 2016, INT CONF ACOUST SPEE, P2519, DOI 10.1109/ICASSP.2016.7472131; Kolda T., 2006, PROC WORKSHOP LINK A, V7, P26; Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X; Kolda TG, 2005, FIFTH IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P242, DOI 10.1109/ICDM.2005.77; LING RF, 1974, J AM STAT ASSOC, V69, P859, DOI 10.2307/2286154; Mardani M, 2015, IEEE T SIGNAL PROCES, V63, P2663, DOI 10.1109/TSP.2015.2417491; Najafi M, 2019, PROCEEDINGS OF THE TWENTY-EIGHTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P3187; Oh S, 2019, IEEE T PARALL DISTR, V30, P2237, DOI 10.1109/TPDS.2019.2908639; Pasricha R, 2018, JOINT EUROPEAN C MAC; Sedghi Hanie, 2018, T ASSOC COMPUT LING, V6, P197; Shakeri M, 2019, PROC CVPR IEEE, P7214, DOI 10.1109/CVPR.2019.00739; Sidiropoulos ND, 2017, IEEE T SIGNAL PROCES, V65, P3551, DOI 10.1109/TSP.2017.2690524; Smith S, 2018, P 2018 SIAM INT C DA, P8189; Song QQ, 2017, KDD'17: PROCEEDINGS OF THE 23RD ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P435, DOI 10.1145/3097983.3098007; Sun J., 2006, ACM SIGKDD INT C KNO, P374, DOI DOI 10.1145/1150402.1150445; WELFORD BP, 1962, TECHNOMETRICS, V4, P419, DOI 10.2307/1266577; Ye JM, 2018, PROC CVPR IEEE, P9378, DOI 10.1109/CVPR.2018.00977; Zhang SY, 2017, P ROY SOC A-MATH PHY, V473, DOI 10.1098/rspa.2017.0457; Zhou S, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1375, DOI 10.1145/2939672.2939763	27	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267091	10.1371/journal.pone.0267091	http://dx.doi.org/10.1371/journal.pone.0267091			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421202	gold, Green Published			2022-12-26	WOS:000795453600107
J	Tejada, D; Juanbeltz, R; Rivero, M; San Miguel, R; Capdevila, F; Beloqui, JJ; Sarobe, M				Tejada, Diana; Juanbeltz, Regina; Rivero, Maria; San Miguel, Ramon; Capdevila, Ferran; Jose Beloqui, Juan; Sarobe, Maite			Clinical course of patients with severe COVID-19 pneumonia treated with remdesivir: A real-life study	PLOS ONE			English	Article								BackgroundThere is currently much uncertainty regarding the most optimal treatment for COVID-19. This study analyze the change in the clinical condition of patients hospitalized for severe COVID-19 pneumonia and treated with remdesivir in a real-life setting, based on the WHO Ordinal Scale. Clinical complications, treatment safety, and impact of other associated drugs were also analyzed. MethodsWe conducted an observational, retrospective study including patients treated with remdesivir. The need for admission to the ICU, the length of ICU and hospital stay, and the need for ventilatory support were analyzed. The laboratory parameters, drugs administered concomitantly, and difference in the length of hospital stay according to the concomitant treatment received were also evaluated. A univariate and multivariate Cox regression analysis was performed to analyze associated factors. ResultsA total of 92 patients were included. The mean length of hospital stay was 15 days, and 90% of the patients had been discharged from the hospital 28 days after starting treatment with remdesivir. The likelihood of hospital discharge among patients not presenting with hypertension as a comorbidity was significantly higher than that of those with this condition (HR = 3.19, P = 0.008). Nineteen patients had to be admitted to the ICU (mean of 18 days). Approximately 11% required invasive mechanical ventilation (mean of 22 days). Almost 37% of the patients received high-flow oxygen therapy and 14% non-invasive mechanical ventilation. Four deaths were recorded within the first week. Main adverse events were increases in transaminase and creatinine levels. Nosocomial infections were more frequent when remdesivir was combined with immunosuppressive drugs. ConclusionsPatients with severe COVID-19 pneumonia and treated with remdesivir require relatively prolonged hospital stays, many with a need for ventilatory support and, in a considerable proportion of cases, admission to the ICU. However, the observed survival rate is high, and the drug is well tolerated.	[Tejada, Diana; Juanbeltz, Regina; San Miguel, Ramon; Capdevila, Ferran; Jose Beloqui, Juan; Sarobe, Maite] Hosp Univ Navarra, Dept Hosp Pharm, Navarra, Spain; [Tejada, Diana; Juanbeltz, Regina; Rivero, Maria; San Miguel, Ramon; Capdevila, Ferran; Sarobe, Maite] Navarre Inst Hlth Res IdiSNA, Navarra, Spain; [Juanbeltz, Regina] CIBER Epidemiol & Salud Publ CIBERESP, Navarra, Spain; [Rivero, Maria] Complejo Hosp Navarra, Infect Dis Unit, Navarra, Spain; [Jose Beloqui, Juan] Ctr Invest Med Navarrabiomed, Navarra, Spain	Servicio Navarro de Salud - Osasunbidea; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Servicio Navarro de Salud - Osasunbidea; Navarrabiomed	Juanbeltz, R (corresponding author), Hosp Univ Navarra, Dept Hosp Pharm, Navarra, Spain.; Juanbeltz, R (corresponding author), Navarre Inst Hlth Res IdiSNA, Navarra, Spain.; Juanbeltz, R (corresponding author), CIBER Epidemiol & Salud Publ CIBERESP, Navarra, Spain.	regina.juanbeltz.zurbano@navarra.es		Capdevila Bastons, Ferran/0000-0002-7970-3213; Sarobe, Maite/0000-0002-2375-0053; BELOQUI LIZASO, JUAN JOSE/0000-0003-1290-4050	Spanish AIDS Research Network (Red Espanola de Investigacion en SIDA) [RD16/0025/0044]; Carlos III Institute of Health; European Regional Development Fund [JR19/00044]	Spanish AIDS Research Network (Red Espanola de Investigacion en SIDA); Carlos III Institute of Health(Instituto de Salud Carlos III); European Regional Development Fund(European Commission)	This study was funded by the Spanish AIDS Research Network (Red Espanola de Investigacio ' n en SIDA), RD16/0025/0044. Regina Juanbeltz received research grant from Carlos III Institute of Health with the European Regional Development Fund, during the conduct of the study (JR19/00044). These institutions played no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2022, AEMPS WEBSITE; Antinori S, 2020, PHARMACOL RES, V158, DOI 10.1016/j.phrs.2020.104899; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Berenguer J, 2020, CLIN MICROBIOL INFEC, V26, P1525, DOI 10.1016/j.cmi.2020.07.024; Cancer Therapy Evaluation Program (CTEP), 2017, CANC THER EVAL PROGR, P155; Cucchiari D, 2020, MED CLIN-BARCELONA, V155, P502, DOI [10.1016/j.medcli.2020.05.022, 10.1016/j.medcle.2020.05.028]; Deeks ED, 2021, DRUGS, V81, P2047, DOI 10.1007/s40265-021-01620-z; Fung M, 2021, CLIN INFECT DIS, V72, P340, DOI 10.1093/cid/ciaa863; Garcia-Vidal C, 2021, LANCET REG HEALTH-EU, V3, DOI 10.1016/j.lanepe.2021.100041; Goldman JD, 2020, NEW ENGL J MED, V383, P1827, DOI 10.1056/NEJMoa2015301; Gupta A, 2021, NEW ENGL J MED, V385, P1941, DOI 10.1056/NEJMoa2107934; Kooshkaki O, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.572329; Lee TC, 2021, INT J INFECT DIS, V104, P671, DOI 10.1016/j.ijid.2021.01.065; Malin JJ, 2021, CLIN MICROBIOL REV, V34, DOI 10.1128/CMR.00162-20; Ministerio de Sanidad, 2020, AEMPS WEBSITE; Regas VHL, 2020, MED CLIN-BARCELONA, V155, P448, DOI 10.1016/j.medcli.2020.06.019; Solimando AG, 2021, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.625176; Spinner CD, 2020, JAMA-J AM MED ASSOC, V324, P1048, DOI 10.1001/jama.2020.16349; Terap IDEP, 2015, INFORME POSICIONAMIE, V223, P1; Vu CA, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05701-4; Wang B, 2020, EUR J CLIN MICROBIOL, V39, P2309, DOI 10.1007/s10096-020-03927-3; Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0; Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9; WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839; Williamson BN, 2020, NATURE, V585, P273, DOI 10.1038/s41586-020-2423-5	26	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267283	10.1371/journal.pone.0267283	http://dx.doi.org/10.1371/journal.pone.0267283			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D8GY	35482685	Green Published, gold			2022-12-26	WOS:000794035700052
J	Tepper, AWJW; Chu, G; Klaren, VNA; Kalin, JH; Molina-Ortiz, P; Impagliazzo, A				Tepper, Armand W. J. W.; Chu, Gerald; Klaren, Vincent N. A.; Kalin, Jay H.; Molina-Ortiz, Patricia; Impagliazzo, Antonietta			Development and characterization of rabbit monoclonal antibodies that recognize human spermine oxidase and application to immunohistochemistry of human cancer tissues	PLOS ONE			English	Article							POLYAMINE OXIDASE; EXPRESSION; RISK	The enzyme spermine oxidase (SMOX) is involved in polyamine catabolism and converts spermine to spermidine. The enzymatic reaction generates reactive hydrogen peroxide and aldehydes as by-products that can damage DNA and other biomolecules. Increased expression of SMOX is frequently found in lung, prostate, colon, stomach and liver cancer models, and the enzyme also appears to play a role in neuronal dysfunction and vascular retinopathy. Because of growing evidence that links SMOX activity with DNA damage, inflammation, and carcinogenesis, the enzyme has come into view as a potential drug target. A major challenge in cancer research is the lack of characterization of antibodies used for identification of target proteins. To overcome this limitation, we generated a panel of high-affinity rabbit monoclonal antibodies against various SMOX epitopes and selected antibodies for use in immunoblotting, SMOX quantification assays, immunofluorescence microscopy and immunohistochemistry. Immunohistochemistry analysis with the antibody SMAB10 in normal and transformed tissues confirms that SMOX is upregulated in several different cancers. Together, the panel of antibodies generated herein adds to the toolbox of high-quality reagents to study SMOX biology and to facilitate SMOX drug development.	[Tepper, Armand W. J. W.; Klaren, Vincent N. A.; Impagliazzo, Antonietta] Janssen Vaccine & Prevent, Leiden, Netherlands; [Chu, Gerald; Kalin, Jay H.] Janssen Res & Dev, Spring House, PA USA; [Molina-Ortiz, Patricia] UK Labs, Precis Med, Royston, England; [Impagliazzo, Antonietta] Genmab BV Uppsalalaan, Utrecht, Netherlands	Johnson & Johnson; Janssen Pharmaceuticals	Impagliazzo, A (corresponding author), Janssen Vaccine & Prevent, Leiden, Netherlands.; Impagliazzo, A (corresponding author), Genmab BV Uppsalalaan, Utrecht, Netherlands.	anim@genmab.com						Babbar N, 2006, CANCER RES, V66, P11125, DOI 10.1158/0008-5472.CAN-06-3174; Battaglia V, 2014, AMINO ACIDS, V46, P511, DOI 10.1007/s00726-013-1529-6; Casero RA., 2009, POLYAMINE CATABOLISM, V338, P338, DOI [10.1042/BJ20090598, DOI 10.1042/BJ20090598]; Casero RA, 2018, NAT REV CANCER, V18, P681, DOI 10.1038/s41568-018-0050-3; Chaturvedi R, 2015, ONCOGENE, V34, P3429, DOI 10.1038/onc.2014.273; Chaturvedi R, 2011, GASTROENTEROLOGY, V141, P1696, DOI 10.1053/j.gastro.2011.07.045; Damiani E, 2018, METHODS MOL BIOL, V1694, P469, DOI 10.1007/978-1-4939-7398-9_39; Ghandi M, 2019, NATURE, V569, P503, DOI 10.1038/s41586-019-1186-3; Goodwin AC, 2008, PROSTATE, V68, P766, DOI 10.1002/pros.20735; Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108; Hong SKS, 2010, INFLAMM BOWEL DIS, V16, P1557, DOI 10.1002/ibd.21224; Karlsson M, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abh2169; Leonetti A, 2017, BIOCHEM J, V474, P4253, DOI 10.1042/BCJ20170744; Liu F, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020340; Mahajan UV, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003439; Makletsova MG., 2019, J NEUROL RES, V9, P1, DOI [10.14740/jnr509, DOI 10.14740/JNR509]; McCloskey DE, 1999, J BIOL CHEM, V274, P6175, DOI 10.1074/jbc.274.10.6175; Murray-Stewart T, 2008, FEBS J, V275, P2795, DOI 10.1111/j.1742-4658.2008.06419.x; Narayanan SP, 2019, PHARMACOL RES, V147, DOI 10.1016/j.phrs.2019.104299; Patel C, 2016, BBA-MOL BASIS DIS, V1862, P1628, DOI 10.1016/j.bbadis.2016.05.020; Pichavaram P, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00956; Pledgie A, 2005, J BIOL CHEM, V280, P39843, DOI 10.1074/jbc.M508177200; Seiler N, 2000, NEUROCHEM RES, V25, P471, DOI 10.1023/A:1007508008731; Takano K, 2005, CURR NEUROVASC RES, V2, P213, DOI 10.2174/1567202054368335; Wang YL, 2001, CANCER RES, V61, P5370; Weber J, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.23; Wu D, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.6.52	27	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267046	10.1371/journal.pone.0267046	http://dx.doi.org/10.1371/journal.pone.0267046			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C1KV	35452470	gold, Green Published			2022-12-26	WOS:000792887700025
J	Tomura, H				Tomura, Hajime			Associations between components of household expenditures and the rate of change in the number of new confirmed cases of COVID-19 in Japan: Time-series analysis	PLOS ONE			English	Article							NONPHARMACEUTICAL INTERVENTIONS	Background Social distancing measures to prevent the spread of COVID-19 included restrictions on retail services in many countries. In some countries, the governments also subsidized consumer spending on part of retail services to help struggling businesses. To evaluate the costs and benefits of government interventions in retail services, it is necessary to measure the infectiousness of each type of consumer activity. Methods This study regresses the log difference over seven days in the number of new confirmed cases of COVID-19 in Japan on lagged values of household expenditures per household on eating out, traveling, admissions to entertainment facilities, clothing and footwear, and the other items, as well as a measure of mobility in public transportation in the past 14 days. The sample period of the dependent variable is set from March 1, 2020, to February 1, 2021, in order to avoid a possible structural break due to the spread of mutant strains in 2021. The regression model is estimated by the Bayesian method with a non-informative (improper) prior. The estimated model is evaluated by out-of-sample forecast performance from February 2, 2021, onward. Results The out-of-sample forecasts of the regression by the posterior means of regression coefficients perform well before the spread of the Delta variant in Japan since June 2021. R-2 for the out-of-sample forecasts from February 2, 2021, to June 30, 2021, is 0.60. The dependent variable of the regression overshot the out-of-sample forecasts from mid-June to August 2021. Then, the out-of-sample forecasts overpredicted the dependent variable for the rest of 2021. Conclusion The estimated model can be potentially useful in simulating changes in the number of new confirmed cases due to household spending on retail services, if it can be adjusted to real-time developments of mutant strains and vaccinations. Such simulations would help in designing cost-efficient government interventions.	[Tomura, Hajime] Waseda Univ, Fac Polit Sci & Econ, Shinjyuku Ku, Tokyo, Japan	Waseda University	Tomura, H (corresponding author), Waseda Univ, Fac Polit Sci & Econ, Shinjyuku Ku, Tokyo, Japan.	htomura@waseda.jp						Acemoglu D., 2020, MULTIRISK SIR MODEL, DOI [10.3386/w27102, DOI 10.3386/W27102]; [Anonymous], 2021, JAPAN TIMES 1225; [Anonymous], 2021, MAINICHI SHINBU 0220; [Anonymous], CURRENT POPULATION E; [Anonymous], [Kako no kisho data, Past weather data]; [Anonymous], 1996, CONS PRIC IND; [Anonymous], 2020, HEN I KABU SCREENING; [Anonymous], SURVEY HOUSEHOLD EC; [Anonymous], 2021, COVID 19 COMMUNITY M; [Anonymous], FAMILY INCOME EXPEND; [Anonymous], 2020, VISUALIZING DATA INF; [Anonymous], 2019, TOKYO NOVEL CORONAVI; [Anonymous], SHIN GATA CORONA VAC; Bongaerts D, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251373; Bukhari Q, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155399; Chang S, 2021, NATURE, V589, P82, DOI 10.1038/s41586-020-2923-3; Chung PC, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0255873; Cori A, 2013, AM J EPIDEMIOL, V178, P1505, DOI 10.1093/aje/kwt133; Cowling BJ, 2020, LANCET PUBLIC HEALTH, V5, pE279, DOI 10.1016/S2468-2667(20)30090-6; Davies NG, 2020, LANCET PUBLIC HEALTH, V5, pE375, DOI 10.1016/S2468-2667(20)30133-X; Davies RET, 2020, JAPAN TIMES 1018; Davies RET, 2020, JAPAN TIMES 1020; Di Domenico L, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01698-4; Eichenbaum MS, 2020, NATL BUREAU EC RES W, Vw26882; Fetzer T., 2021, EC J LONDON; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Guerrieri V, 2022, AM ECON REV, V112, P1437, DOI 10.1257/aer.20201063; Hale T, 2021, NAT HUM BEHAV, V5, P529, DOI 10.1038/s41562-021-01079-8; hutton georgina, 2020, EAT OUT HELP OUT SCH; International Monetary Fund, POL RESP COVID 19; Islam N, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2743; J. Kurita, 2021, medRxiv, DOI 10.1101/2020.12.29.20248977; Jiji Press, 2020, JAPAN TIMES 1114; Jung SM, 2021, INT J INFECT DIS, V113, P47, DOI 10.1016/j.ijid.2021.10.007; Kajitani Y, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247186; Kaplan G, 2020, NATL BUREAU EC RES W, Vw27794; Kato Yasuyuki, 2020, CLIN MANAGEMENT PATI; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P1151, DOI 10.1016/S1473-3099(20)30457-6; Kurita J, 2021, JMIR PUBLIC HLTH SUR, V7, DOI 10.2196/20335; Larrosa JMC, 2021, J MED VIROL, V93, P2252, DOI 10.1002/jmv.26659; Lemaitre Joseph C, 2020, Swiss Med Wkly, V150, pw20295, DOI 10.4414/smw.2020.20295; Li Y, 2021, LANCET INFECT DIS, V21, P193, DOI 10.1016/S1473-3099(20)30785-4; McClymont H, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020396; Miyawaki A, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-049069; Nakanishi M, 2021, JMIR MHEALTH UHEALTH, V9, DOI 10.2196/27342; NHK WORLDJAPAN, 2020, WILL STAT EM DECL AF; NHK WORLDJAPAN, 2021, OL BE HELD TOK 4 COR; NHK WORLDJAPAN, 2021, DOES JAP STAT EM AFF; NHK WORLDJAPAN, 2021, WILL JAP 2 STAT EM A; Nottmeyer LN, 2021, ENVIRON RES, V196, DOI 10.1016/j.envres.2021.110977; Pan A, 2020, JAMA-J AM MED ASSOC, V323, P1915, DOI 10.1001/jama.2020.6130; Petr K, 2020, SWISS MED WKLY, V150, DOI 10.4414/smw.2020.20313; R Core Team, 2021, R LANGUAGE ENV STAT; Ryu S, 2020, EMERG INFECT DIS, V26, P2406, DOI 10.3201/eid2610.201886; Smith-Spark L, 2020, CABLE NEWS NETW 1009; Stan Development Team, 2021, CMDSTAN VERS 2 28 1; Sugishita Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239455; Tariq A, 2020, BMC MED, V18, DOI [10.1186/s12916-020-01615-9, 10.1101/2020.02.21.20026435]; Vardavas R., 2020, HLTH EC IMPACTS NONP; Wheeler C, TERRITORIAL IMPACT C; Yabe T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75033-5	61	1	1	9	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266963	10.1371/journal.pone.0266963	http://dx.doi.org/10.1371/journal.pone.0266963			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421195	Green Published, gold			2022-12-26	WOS:000795453600088
J	Truong, M; Dreier, T; Wasselius, J; Sundius, L; Persson, A; Lovric, G; Bonnin, A; Goncalves, I; Bech, M				Truong, My; Dreier, Till; Wasselius, Johan; Sundius, Lena; Persson, Ana; Lovric, Goran; Bonnin, Anne; Goncalves, Isabel; Bech, Martin			Sub-micrometer morphology of human atherosclerotic plaque revealed by synchrotron radiation-based mu CT-A comparison with histology	PLOS ONE			English	Article							PHASE-CONTRAST; TOMOGRAPHY; IMAGE	Histology is a long standing and well-established gold standard for pathological characterizations. In recent years however, synchrotron radiation-based micro-computed tomography (SR mu CT) has become a tool for extending the imaging of two-dimensional thin sections into three-dimensional imaging of tissue blocks, enabling so-called virtual histology with arbitrary clipping planes, volumetric rendering and automatic segmentation. In this study, we present a thorough characterization of human carotid plaques after endarterectomy of patients with stroke or transient ischemic attack (TIA), investigating several different pathologic structures using both SR mu CT and histology. Phase-contrast SR mu CT was performed with two different magnifications (voxel sizes 6.5 mu m and 0.65 mu m, respectively), and histology was performed with multiple different stainings (Alpha-actin, Glycophorin A, von Kossa, Movat, CD68). The 0.65 mu m high-resolution SR mu CT was performed on selected areas with plaque typical relevant morphology, identified on the 6.5 mu m low-resolution SR mu CT. The tomography datasets were reconstructed with additional 3D volume rendering and compared to histology. In total, nine different regions with typical pathologic structures were identified and imaged with high-resolution SR mu CT. The results show many characteristics typical for advanced atherosclerotic plaques, clinically relevant, namely ruptures with thrombosis, neo-vascularization, inflammatory infiltrates in shoulder regions, lipid rich necrotic cores (LRNC), thin fibrous cap, calcifications, lumen irregularities, and changes in vessel wall structures such as the internal elastic membrane. This method's non-destructive nature renders details of micro-structures with an excellent visual likeness to histology, with the additional strength of multiplanar and 3D visualization and the possibility of multiple re-scans.	[Truong, My; Wasselius, Johan] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Diagnost Radiol, Lund, Sweden; [Dreier, Till; Bech, Martin] Lund Univ, Dept Med Radiat Phys, Clin Sci Lund, Lund, Sweden; [Dreier, Till] Excillum AB, Kista, Sweden; [Sundius, Lena; Persson, Ana] Lund Univ, Clin Sci Malmo, Malmo, Sweden; [Lovric, Goran] Ecole Polytech Fed Lausanne, Ctr Biomed Imaging, Lausanne, Switzerland; [Lovric, Goran; Bonnin, Anne] Paul Scherrer Inst, Swiss Light Source, Villigen, Switzerland; [Goncalves, Isabel] Skane Univ Hosp, Cardiol, Lund, Sweden; [Goncalves, Isabel] Lund Univ, Dept Clin Sci Malmo, Lund, Sweden	Lund University; Skane University Hospital; Lund University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Lund University; Skane University Hospital; Lund University	Bech, M (corresponding author), Lund Univ, Dept Med Radiat Phys, Clin Sci Lund, Lund, Sweden.	martin.bech@med.lu.se	Goncalves, Isabel/AAD-4654-2022; Lovric, Goran/J-9358-2013	Lovric, Goran/0000-0002-0833-4043; Wasselius, Johan/0000-0003-1896-381X; Dreier, Till/0000-0002-6632-402X; Goncalves, Isabel/0000-0002-2935-0181	Crafoordska Stiftelsen [20180610]; Region Skane [I-ALF 47447, YF-ALF 43435]; Swedish research council [2014-06054, 2018-06197, 2019-01260]; Hjart-Lungfonden grant [20200403]; Skanes Universitetssjukhus grant [2020-O000028]; Swedish Foundation for Strategic Research [IRC15-0067]	Crafoordska Stiftelsen; Region Skane; Swedish research council(Swedish Research CouncilEuropean Commission); Hjart-Lungfonden grant; Skanes Universitetssjukhus grant; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	JW: Crafoordska Stiftelsen grant 20180610 JW: Region Skane grants I-ALF 47447 and YF-ALF 43435 IG: Swedish research council grant 2019-01260 IG: Hjart-Lungfonden grant 20200403 IG: Skanes Universitetssjukhus grant 2020-O000028 IG: Swedish Foundation for Strategic Research, grant IRC15-0067 MB: Swedish research council grants 2014-06054 and 2018-06197 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyildiz AC, 2017, J STRUCT BIOL, V200, P28, DOI 10.1016/j.jsb.2017.08.003; Barrett HE, 2019, J BIOMECH, V87, P1, DOI 10.1016/j.jbiomech.2019.03.005; Buscema M., 2016, HISTOLOGY VALIDATED; Feigin VL, 2017, CIRC RES, V120, P439, DOI 10.1161/CIRCRESAHA.116.308413; Hetterich H, 2016, EUR RADIOL, V26, P3223, DOI 10.1007/s00330-015-4143-z; Hetterich H, 2014, RADIOLOGY, V271, P870, DOI 10.1148/radiol.14131554; Hetterich H, 2013, Z MED PHYS, V23, P194, DOI 10.1016/j.zemedi.2012.12.001; Hillman H, 2000, MED HYPOTHESES, V54, P553, DOI 10.1054/mehy.1999.0894; Holme MN, 2014, NAT PROTOC, V9, P1401, DOI 10.1038/nprot.2014.091; Libby P, 2019, NAT REV DIS PRIMERS, V5, DOI [10.1038/s41572-019-0116-x, 10.1038/s41572-019-0106-z]; Liuzzo G, 2001, Rays, V26, P221; Mayo SC, 2002, J MICROSC-OXFORD, V207, P79, DOI 10.1046/j.1365-2818.2002.01046.x; Meletta R, 2015, INT J CARDIOVAS IMAG, V31, P1425, DOI 10.1007/s10554-015-0706-y; Miettinen A, 2019, BIOINFORMATICS, V35, P5290, DOI 10.1093/bioinformatics/btz423; Nguyen DT, 2021, J MICROSC-OXFORD, V283, P9, DOI 10.1111/jmi.13003; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; Qin GP, 2020, INT J CLIN EXP PATHO, V13, P764; RAINES EW, 1993, BRIT HEART J, V69, pS30; Redgrave JNE, 2006, CIRCULATION, V113, P2320, DOI 10.1161/CIRCULATIONAHA.105.589044; Rodgers G, 2021, J NEUROSCI METH, V364, DOI 10.1016/j.jneumeth.2021.109354; Saam T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073513; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Vagberg W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29344-3; Wintermark M, 2008, AM J NEURORADIOL, V29, P875, DOI 10.3174/ajnr.A0950	24	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0265598	10.1371/journal.pone.0265598	http://dx.doi.org/10.1371/journal.pone.0265598			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35471989	Green Published, gold			2022-12-26	WOS:000816171900011
J	Tabassum, Z; Tseng, JH; Isemann, C; Tian, X; Chen, YJ; Herring, LE; Cohen, TJ				Tabassum, Zarin; Tseng, Jui-Heng; Isemann, Camryn; Tian, Xu; Chen, Youjun; Herring, Laura E.; Cohen, Todd J.			Identification of a reciprocal negative feedback loop between tau-modifying proteins MARK2 kinase and CBP acetyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-ASSOCIATED DOMAINS; POSTTRANSLATIONAL MODIFICATIONS; LYSINE METHYLATION; PHOSPHORYLATION; ACETYLATION; AGGREGATION; ACTIVATION; BINDING; SITES; NEUROTOXICITY	The posttranslational regulation of the neuronal proteome is critical for brain homeostasis but becomes dysregulated in the aged or diseased brain, in which abnormal posttranslational modifications (PTMs) are frequently observed. While the full extent of modified substrates that comprise the PTM-ome are slowly emerging, how the upstream enzymes catalyzing these processes are regulated themselves is not well understood, particularly in the context of neurodegeneration. Here, we describe the reciprocal regulation of a kinase, the micro tubule affinity-regulating kinase 2 (MARK2), and an acetyltransferase, CREB-binding protein (CBP), two enzymes known to extensively modify tau proteins in the progression of Alzheimer's disease. We found that MARK2 negatively regulates CBP and, conversely, CBP directly acetylates and inhibits MARK2 kinase activity. These findings highlight a reciprocal negative feedback loop between a kinase and an acetyltransferase, which has implications for how PTM interplay is coordinated on substrates including tau. Our study suggests that PTM profiles occur through the posttranslational control of the master PTM themselves.	[Tabassum, Zarin; Tseng, Jui-Heng; Isemann, Camryn; Tian, Xu; Chen, Youjun; Cohen, Todd J.] Univ N Carolina, Dept Neurol, UNC Neurosci Ctr, Chapel Hill, NC 27515 USA; [Herring, Laura E.] Univ N Carolina, Dept Pharmacol, UNC Prote Core Facil, Chapel Hill, NC 27515 USA; [Cohen, Todd J.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Cohen, TJ (corresponding author), Univ N Carolina, Dept Neurol, UNC Neurosci Ctr, Chapel Hill, NC 27515 USA.; Cohen, TJ (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA.	toddcohen@neurology.unc.edu		Tabassum, Zarin/0000-0001-9007-2566	National Institutes of Health (NIH) [R01AG061188, R01NS105981, R21AG058080]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This work is supported by the National Institutes of Health (NIH) grants R01AG061188, R01NS105981, and R21AG058080 (to T. J. C.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahrari S, 2014, MOL BIOL RES COMMUN, V3, P149; Alam J, 2019, CURR DRUG TARGETS, V20, P316, DOI 10.2174/1389450119666180820104723; Alquezar C, 2021, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.595532; Annadurai N, 2017, CELL MOL LIFE SCI, V74, P4159, DOI 10.1007/s00018-017-2574-1; Arakhamia T, 2020, CELL, V180, P633, DOI 10.1016/j.cell.2020.01.027; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Blank MF, 2017, NUCLEIC ACIDS RES, V45, P2675, DOI 10.1093/nar/gkx053; Carlonnagno Y, 2017, J BIOL CHEM, V292, P15277, DOI 10.1074/jbc.M117.794602; Chen X, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-019-0354-0; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; Cho JH, 2003, J BIOL CHEM, V278, P187, DOI 10.1074/jbc.M206236200; Cohen TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1255; Cook C, 2014, HUM MOL GENET, V23, P104, DOI 10.1093/hmg/ddt402; Cripps D, 2006, J BIOL CHEM, V281, P10825, DOI 10.1074/jbc.M512786200; Dorval V, 2006, J BIOL CHEM, V281, P9919, DOI 10.1074/jbc.M510127200; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Farina S, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.693325; Fenton TR, 2010, INT J BIOCHEM CELL B, V42, P359, DOI 10.1016/j.biocel.2009.11.022; Funk KE, 2014, BIOCHEM J, V462, P77, DOI 10.1042/BJ20140372; Gu GJ, 2013, J ALZHEIMERS DIS, V33, P699, DOI 10.3233/JAD-2012-121357; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Huseby CJ, 2019, J ALZHEIMERS DIS, V71, P979, DOI 10.3233/JAD-190604; Hwang AW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168913; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Kamah A, 2014, BIOCHEMISTRY-US, V53, P3020, DOI 10.1021/bi500006v; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Lee J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31785-9; Lee J, 2014, BIOCHEM BIOPH RES CO, V447, P121, DOI 10.1016/j.bbrc.2014.03.118; Liu SJ, 2004, J BIOL CHEM, V279, P50078, DOI 10.1074/jbc.M406109200; Lontay B, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124282; Lu YN, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001096; Lund H, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-22; Luo HB, 2014, P NATL ACAD SCI USA, V111, P16586, DOI 10.1073/pnas.1417548111; Malikov V, 2017, CELL REP, V20, P2792, DOI 10.1016/j.celrep.2017.08.076; Manzanza ND, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.690293; Marx A, 2006, J BIOL CHEM, V281, P27586, DOI 10.1074/jbc.M604865200; Mateo F, 2009, NUCLEIC ACIDS RES, V37, P7072, DOI 10.1093/nar/gkp777; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; MORISHIMAKAWASHIMA M, 1993, NEURON, V10, P1151, DOI 10.1016/0896-6273(93)90063-W; Morris M, 2015, NAT NEUROSCI, V18, P1183, DOI 10.1038/nn.4067; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Naqvi AA, 2020, CURR TOP MED CHEM, V20, P1059, DOI 10.2174/1568026620666200106125910; Nativio R, 2020, NAT GENET, V52, P1024, DOI 10.1038/s41588-020-0696-0; Nativio R, 2018, NAT NEUROSCI, V21, P497, DOI 10.1038/s41593-018-0101-9; Oba T, 2020, J BIOL CHEM, V295, P17138, DOI 10.1074/jbc.RA120.014420; Olzscha H, 2017, CELL CHEM BIOL, V24, P9, DOI 10.1016/j.chembiol.2016.11.009; Panneerselvam S, 2006, STRUCTURE, V14, P173, DOI 10.1016/j.str.2005.09.022; Portillo M, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109035; Ramazi S, 2020, J BIOSCIENCES, V45, DOI 10.1007/s12038-020-00099-2; Rankin CA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-12; Rouaux C, 2003, EMBO J, V22, P6537, DOI 10.1093/emboj/cdg615; Sabo A, 2008, MOL CELL BIOL, V28, P2201, DOI 10.1128/MCB.01557-07; Saha P, 2019, MECH AGEING DEV, V178, P72, DOI 10.1016/j.mad.2019.01.007; Santos AL, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5716409; Schaffert LN, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10040232; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; Shafi S, 2021, CNS NEUROL DISORD-DR, V20, P54, DOI 10.2174/1871527319666200903162200; Steinhilb ML, 2007, MOL BIOL CELL, V18, P5060, DOI 10.1091/mbc.E07-04-0327; Steinhilb ML, 2007, J NEUROSCI RES, V85, P1271, DOI 10.1002/jnr.21232; Sternburg EL, 2022, TRENDS BIOCHEM SCI, V47, P6, DOI 10.1016/j.tibs.2021.07.004; Taylor BC, 2021, BIOCHEM J, V478, P511, DOI 10.1042/BCJ20200170; Thomas SN, 2012, ACTA NEUROPATHOL, V123, P105, DOI 10.1007/s00401-011-0893-0; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Timm T, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S9; Trosky JE, 2007, J BIOL CHEM, V282, P34299, DOI 10.1074/jbc.M706970200; Wen J, 2021, J MOL CELL BIOL, V13, P774, DOI 10.1093/jmcb/mjab047; Wesseling H, 2020, CELL, V183, P1699, DOI 10.1016/j.cell.2020.10.029; Wu Z, 2019, ARCH BIOCHEM BIOPHYS, V676, DOI 10.1016/j.abb.2019.108138; Yang FC, 2013, J BIOL CHEM, V288, P6227, DOI 10.1074/jbc.M112.431239; Yoshimura Y, 2010, MOL CELL BIOL, V30, P2206, DOI 10.1128/MCB.01181-09; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	72	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101977	10.1016/j.jbc.2022.101977	http://dx.doi.org/10.1016/j.jbc.2022.101977			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9OQ	35469920	gold, Green Published			2022-12-26	WOS:000807778400004
J	Barley, TJ; Murphy, PR; Wang, XT; Bowman, BA; Mormol, JM; Mager, CE; Kirk, SG; Cash, CJ; Linn, SC; Meng, XM; Nelin, LD; Chen, BRDT; Hafner, M; Zhang, J; Liu, YS				Barley, Timothy J.; Murphy, Parker R.; Wang, Xiantao; Bowman, Bridget A.; Mormol, Justin M.; Mager, Carli E.; Kirk, Sean G.; Cash, Charles J.; Linn, Sarah C.; Meng, Xiaomei; Nelin, Leif D.; Chen, Bernadette; Hafner, Markus; Zhang, Jian; Liu, Yusen			Mitogen-activated protein kinase phosphatase-1 controls PD-L1 expression by regulating type I interferon during systemic Escherichia coli infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE SYNTHASE; ANTIINFLAMMATORY CYTOKINES; MAPK PHOSPHATASE-1; KUPFFER CELLS; IFN-GAMMA; ALPHA; MKP-1; MACROPHAGES; MECHANISMS	Mitogen-activated protein kinase phosphatase 1 (Mkp-1) KO mice produce elevated cytokines and exhibit increased mortality and bacterial burden following systemic Escherichia coli infection. To understand how Mkp-1 affects immune defense, we analyzed the RNA-Seq datasets previously generated from control and E. coli-infected Mkp-1(+/+) and Mkp-1(-/-) mice. We found that E. coli infection markedly induced programmed death-ligand 1 (PD-L1) expression and that Mkp-1 deficiency further amplified PD-L1 expression. Administration of a PD L1-neutralizing monoclonal antibody (mAb) to Mkp-1(-/-) mice increased the mortality of the animals following E. coli infection, although bacterial burden was decreased. In addition, the PD-L1-neutralizing mAb increased serum interferon (IFN)-gamma and tumor necrosis factor alpha, as well as lung-and liver inducible nitric oxide synthase levels, suggesting an enhanced inflammatory response. Interestingly, neutralization of IFN-alpha/beta receptor 1 blocked PD-L1 induction in Mkp-1(-/-) mice following E. coli infection. PD-L1 was potently induced in macrophages by E. coli and lipopolysaccharide in vitro, and Mkp-1 deficiency exacerbated PD-L1 induction with little effect on the half-life of PD-L1 mRNA. In contrast, inhibitors of Janus kinase 1/2 and tyrosine kinase 2, as well as the IFN-alpha/beta receptor 1-neutralizing mAb, markedly attenuated PD-L1 induction. These results suggest that the beneficial effect of type I IFNs in E. coli-infected Mkp-1(-/-) mice is, at least in part, mediated by Janus kinase/signal transducer and activator of transcription-driven PD-L1 induction. Our studies also support the notion that enhanced PD-L1 expression contributes to the bactericidal defect of Mkp-1(-/-) mice.	[Barley, Timothy J.; Murphy, Parker R.; Bowman, Bridget A.; Mormol, Justin M.; Mager, Carli E.; Kirk, Sean G.; Cash, Charles J.; Meng, Xiaomei; Nelin, Leif D.; Chen, Bernadette; Liu, Yusen] Nat Wide Childrens Hosp, Abigail Wexner Res Inst, Ctr Perinatal Res, Columbus, OH 43215 USA; [Wang, Xiantao; Hafner, Markus] Natl Inst Arthrit & Musculoskeletal & Skin Dis, NIH, Lab Muscle Stem Cells & Gene Regulat, Bethesda, MD USA; [Linn, Sarah C.] Ohio State Univ Coll Vet Med, Dept Vet Biosci, Combined Anat Pathol Residency Grad Program, Columbus, OH USA; [Linn, Sarah C.] Nat Wide Childrens Hosp, Abigail Wexner Res Inst, Kidney & Urinary Tract Ctr, Columbus, OH USA; [Nelin, Leif D.; Chen, Bernadette; Liu, Yusen] Ohio State Univ Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Zhang, Jian] Univ Iowa Carver Coll Med, Dept Pathol, Iowa City, IA USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University of Iowa	Liu, YS (corresponding author), Nat Wide Childrens Hosp, Abigail Wexner Res Inst, Ctr Perinatal Res, Columbus, OH 43215 USA.; Liu, YS (corresponding author), Ohio State Univ Coll Med, Dept Pediat, Columbus, OH 43210 USA.	yusen.liu@nationwidechildrens.org		Linn, Sarah/0000-0003-4337-2966; Mormol, Justin/0000-0001-6324-4393; Barley, Timothy/0000-0002-7005-6187	National Institutes of Health [AI124029, AI142885, AI121196, AI123253]; Genentech Veterinary Pathology Fellowship through Genentech, Inc; Ohio State University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genentech Veterinary Pathology Fellowship through Genentech, Inc; Ohio State University(Ohio State University)	This work was supported by grants from the National Institutes of Health (grant nos.: AI124029 and AI142885 [to Y. L.] and AI121196 and AI123253 [to J. Z.] ) . S. C. L. is supported by a Genentech Veterinary Pathology Fellowship through Genentech, Inc and The Ohio State University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aparicio-Vergara M, 2017, METHODS MOL BIOL, V1639, P161, DOI 10.1007/978-1-4939-7163-3_16; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Bazhin AV, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02129; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P419, DOI 10.1016/S0952-7915(00)00111-4; Borchers A, 2010, GENES-BASEL, V1, P413, DOI 10.3390/genes1030413; Boxx GM, 2016, CELL HOST MICROBE, V19, P760, DOI 10.1016/j.chom.2016.05.016; Chang KC, 2013, CRIT CARE, V17, DOI 10.1186/cc12711; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Clark A, 2009, FRONT BIOSCI-LANDMRK, V14, P847, DOI 10.2741/3282; Dinarello CA, 1997, CHEST, V112, p321S, DOI 10.1378/chest.112.6_Supplement.321S; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Dorfman K, 1996, ONCOGENE, V13, P925; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; Frazier WJ, 2009, J IMMUNOL, V183, P7411, DOI 10.4049/jimmunol.0804343; Gao JJ, 1997, J BIOL CHEM, V272, P1226, DOI 10.1074/jbc.272.2.1226; Garcia-Diaz A, 2017, CELL REP, V19, P1189, DOI 10.1016/j.celrep.2017.04.031; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Guignant C, 2011, CRIT CARE, V15, DOI 10.1186/cc10112; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Hammer M, 2010, IMMUNOLOGY, V131, P395, DOI 10.1111/j.1365-2567.2010.03313.x; Hutchins NA, 2013, J LEUKOCYTE BIOL, V94, P963, DOI 10.1189/jlb.0113051; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Janeway CA, 2005, IMMUNOBIOLOGY; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Kim VY, 2019, J IMMUNOL, V203, P2239, DOI 10.4049/jimmunol.1701686; Kirk SG, 2021, J IMMUNOL, V206, P2966, DOI 10.4049/jimmunol.2001468; KONO Y, 1994, ARCH BIOCHEM BIOPHYS, V311, P153, DOI 10.1006/abbi.1994.1220; Kovarik P, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00652; Kumar A, 2001, J CARDIOTHOR VASC AN, V15, P485, DOI 10.1053/jcan.2001.25003; Landry DW, 2001, NEW ENGL J MED, V345, P588, DOI 10.1056/NEJMra002709; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Lazar-Molnar E, 2008, P NATL ACAD SCI USA, V105, P2658, DOI 10.1073/pnas.0711918105; Lee SY, 2011, J IMMUNOL, V186, P3226, DOI 10.4049/jimmunol.1003587; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Lu CW, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1291106; MARTIN E, 1994, J EXP MED, V180, P977, DOI 10.1084/jem.180.3.977; Matziouridou C, 2018, MUCOSAL IMMUNOL, V11, P774, DOI 10.1038/mi.2017.106; McMullin Bevin B, 2005, Respir Care, V50, P1451; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Morimoto Y, 2018, BIOCHEM BIOPH RES CO, V507, P330, DOI 10.1016/j.bbrc.2018.11.035; Muhlbauer M, 2006, J HEPATOL, V45, P520, DOI 10.1016/j.jhep.2006.05.007; Osum KC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26471-9; PARRILLO JE, 1993, NEW ENGL J MED, V328, P1471, DOI 10.1056/nejm199305203282008; Rothfuchs AG, 2001, J IMMUNOL, V167, P6453, DOI 10.4049/jimmunol.167.11.6453; Roussey JA, 2017, J IMMUNOL, V199, P3535, DOI 10.4049/jimmunol.1700840; Salkowski CA, 1997, J IMMUNOL, V158, P905; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Shepherd EG, 2004, J BIOL CHEM, V279, P54023, DOI 10.1074/jbc.M408444200; Song W, 2000, CARDIOVASC RES, V45, P595, DOI 10.1016/S0008-6363(99)00395-8; Stanciu LA, 2006, J INFECT DIS, V193, P404, DOI 10.1086/499275; Stenzel W, 2005, J NEUROPATH EXP NEUR, V64, P27, DOI 10.1093/jnen/64.1.27; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Triantafyllou E, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI140196; Tsiodras S, 2008, MAYO CLIN PROC, V83, P181; Wang JF, 2015, ANESTHESIOLOGY, V122, P852, DOI 10.1097/ALN.0000000000000525; WANG SD, 1994, J IMMUNOL, V152, P5014; Wang XX, 2007, J IMMUNOL, V178, P5312, DOI 10.4049/jimmunol.178.8.5312; Wang XX, 2009, J BIOL CHEM, V284, P27123, DOI 10.1074/jbc.M109.051235; Whibley N, 2015, J IMMUNOL, V195, P3781, DOI 10.4049/jimmunol.1500870; Xiao W, 2018, J IMMUNOL, V201, P264, DOI 10.4049/jimmunol.1800129; Yu H, 2011, CYTOKINE, V56, P245, DOI 10.1016/j.cyto.2011.06.006; Zhang Y, 2010, CRIT CARE, V14, DOI 10.1186/cc9354; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zhao Q, 2005, J BIOL CHEM, V280, P8101, DOI 10.1074/jbc.M411760200; Zhu WM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/361501	68	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101938	10.1016/j.jbc.2022.101938	http://dx.doi.org/10.1016/j.jbc.2022.101938			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L7CP	35429501	Green Published, gold			2022-12-26	WOS:000817175700014
J	Zhu, MY; Wang, H; Ding, YL; Yang, YY; Xu, Z; Shi, L; Zhang, NX				Zhu, Mengying; Wang, Hui; Ding, Yiluan; Yang, Yuanyuan; Xu, Zhuo; Shi, Li; Zhang, Naixia			Ribonucleotide reductase holoenzyme inhibitor COH29 interacts with deubiquitinase ubiquitin-specific protease 2 and downregulates its substrate protein cyclin D1	FASEB JOURNAL			English	Article						COH29; cyclin D1; deubiquitinase; inhibitor; USP2	CANCER-CELL GROWTH; PATHWAY; TARGET; DEGRADATION; METASTASIS; STABILIZES; MECHANISMS; DISCOVERY; DISTINCT; ARREST	USP2 contributes to the quality control of multiple oncogenic proteins including cyclin D1, Mdm2, Aurora-A, etc., and it is a potential target for anti-cancer drug development. However, currently only a few inhibitors with moderate inhibition activities against USP2 have been discovered. USP2-targeted active compounds with either new scaffolds or enhanced activities are in need. Here in this study, Ub-AMC hydrolysis assay-based screening against similar to 4000 commercially available drugs and drug candidates was performed to identify USP2-targeted inhibitors. COH29, which was originally developed as an anti-cancer agent by blocking the function of human ribonucleotide reductase (RNR, IC50 = 16 mu M), was found to exhibit an inhibition activity against USP2 with the IC50 value at 2.02 +/- 0.16 mu M. The following conducted biophysical and biochemical experiments demonstrated that COH29 could specifically interact with USP2 and inhibit its enzymatic activity in a noncompetitive inhibition mode (K-i = 1.73 +/- 0.14 mu M). Since COH29 shows similar inhibitory potencies against RNR (RRM2) and USP2, USP2 inhibition-dependent cellular consequences of COH29 are expected. The results of cellular assays confirmed that the application of COH29 could downregulate the level of cyclin D1 by enhancing its degradation via ubiquitin-proteasome system (UPS), and the modulation effect of COH29 on cyclin D1 is independent of RRM2. Since cyclin D1 acts as an oncogenic driver in human cancer, our findings suggest that USP2 might be a promising therapeutic target for cyclin D1-addicted cancers, and COH29 could serve as a starting compound for high selectivity inhibitor development against USP2.	[Zhu, Mengying; Wang, Hui; Ding, Yiluan; Yang, Yuanyuan; Xu, Zhuo; Shi, Li; Zhang, Naixia] Chinese Acad Sci, Analyt Res Ctr Organ & Biol Mol, Shanghai Inst Mat Med, 555 Zu Chong Zhi Rd, Shanghai 201203, Peoples R China; [Zhu, Mengying; Xu, Zhuo; Zhang, Naixia] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Shi, L; Zhang, NX (corresponding author), Chinese Acad Sci, Analyt Res Ctr Organ & Biol Mol, Shanghai Inst Mat Med, 555 Zu Chong Zhi Rd, Shanghai 201203, Peoples R China.	shili@simm.ac.cn; nxzhang@simm.ac.cn		Zhang, Naixia/0000-0003-4824-5819; Shi, Li/0000-0003-2013-5511	National Natural Science Foundation of China (NSFC) [21977105, 32000890, 32171220, 22107111]; Shanghai Municipal Science and Technology Major Project	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology Major Project	National Natural Science Foundation of China (NSFC), Grant/Award Number: 21977105, 32000890, 32171220 and 22107111; Shanghai Municipal Science and Technology Major Project	Allende-Vega N, 2010, ONCOGENE, V29, P432, DOI 10.1038/onc.2009.330; Altun M, 2011, CHEM BIOL, V18, P1401, DOI 10.1016/j.chembiol.2011.08.018; Ande SR, 2009, EUR J PHARMACOL, V625, P199, DOI 10.1016/j.ejphar.2009.08.042; Castaneda CA, 2016, STRUCTURE, V24, P423, DOI 10.1016/j.str.2016.01.007; Chen MC, 2015, MOL PHARMACOL, V87, P996, DOI 10.1124/mol.114.094987; Cheng J, 2019, BBA-REV CANCER, V1872, DOI 10.1016/j.bbcan.2019.188312; Chuang SJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21476-w; Copeland RA, 2013, EVALUATION OF ENZYME INHIBITORS IN DRUG DISCOVERY: A GUIDE FOR MEDICINAL CHEMISTS AND PHARMACOLOGISTS, 2ND EDITION, P1, DOI 10.1002/9781118540398; D'Arcy P, 2015, PHARMACOL THERAPEUT, V147, P32, DOI 10.1016/j.pharmthera.2014.11.002; Davis MI, 2016, J BIOL CHEM, V291, P24628, DOI 10.1074/jbc.M116.738567; Fang Y, 2017, CANCER METAST REV, V36, P669, DOI 10.1007/s10555-017-9702-0; Fricker LD, 2020, ANNU REV PHARMACOL, V60, P457, DOI 10.1146/annurev-pharmtox-010919-023603; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Harrigan JA, 2018, NAT REV DRUG DISCOV, V17, P57, DOI 10.1038/nrd.2017.152; He JB, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1512-6; Ikeda F, 2010, CELL, V143, P677, DOI 10.1016/j.cell.2010.10.026; Kim JC, 2018, AM J CANCER RES, V8, P1823; Kitamura H, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22031209; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kwasna D, 2018, MOL CELL, V70, P150, DOI 10.1016/j.molcel.2018.02.023; Lee JT, 2010, CELL CYCLE, V9, P857, DOI 10.4161/cc.9.5.11175; Li WY, 2020, GENE DEV, V34, P1310, DOI 10.1101/gad.339804.120; Liu Z, 2013, ONCOGENE, V32, P1660, DOI 10.1038/onc.2012.188; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; Magiera K, 2017, CELL CHEM BIOL, V24, P458, DOI 10.1016/j.chembiol.2017.03.002; Mazzu YZ, 2019, CLIN CANCER RES, V25, P4480, DOI 10.1158/1078-0432.CCR-18-4046; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Pozhidaeva A, 2019, DNA REPAIR, V76, P30, DOI 10.1016/j.dnarep.2019.02.005; Priolo C, 2006, CANCER RES, V66, P8625, DOI 10.1158/0008-5472.CAN-06-1374; Raasi Shahri, 2005, V301, P47; Rehman SAA, 2016, MOL CELL, V63, P146, DOI 10.1016/j.molcel.2016.05.009; Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012; Ruiz EJ, 2021, ELIFE, V10, DOI [10.7554/eLife.71596, 10.7554/eLife.71596.sa1, 10.7554/eLife.71596.sa2]; Sacco JJ, 2010, IUBMB LIFE, V62, P140, DOI 10.1002/iub.300; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Shi Y, 2011, J BIOL CHEM, V286, P38960, DOI 10.1074/jbc.M111.231498; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; Tedesco AC, 2004, J MAGN MAGN MATER, V272, P2404, DOI 10.1016/j.jmmm.2003.12.375; Tomala MD, 2018, EUR J MED CHEM, V150, P261, DOI 10.1016/j.ejmech.2018.03.009; Tong X, 2012, J BIOL CHEM, V287, P25280, DOI 10.1074/jbc.M112.340786; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wang H, 2021, FEBS J, V288, P1325, DOI 10.1111/febs.15461; Wang XF, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0208-z; Wertz IE, 2019, CELL CHEM BIOL, V26, P156, DOI 10.1016/j.chembiol.2018.10.022; Yang GF, 2021, CANCER CELL INT, V21, DOI 10.1186/s12935-021-02160-y; Yang YY, 2019, PROTEIN SCI, V28, P1606, DOI 10.1002/pro.3675; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304; Zhang W, 2014, FEBS LETT, V588, P356, DOI 10.1016/j.febslet.2013.11.003; Zhao Y, 2018, CELL REP, V22, P2442, DOI 10.1016/j.celrep.2018.02.007; Zhou BS, 2013, CANCER RES, V73, P6484, DOI 10.1158/0008-5472.CAN-13-1094; Zhu HQ, 2017, INT J BIOL SCI, V13, P1489, DOI 10.7150/ijbs.21637	55	0	0	8	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22329	10.1096/fj.202101914RR	http://dx.doi.org/10.1096/fj.202101914RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0U8DF	35476303				2022-12-26	WOS:000787876900001
J	Piesanen, J; Valjakka, J; Niemela, S; Borgenstrom, M; Nikkari, S; Hytonen, V; Maatta, J; Kunnas, T				Piesanen, Jaakko; Valjakka, Jarkko; Niemela, Sanna; Borgenstrom, Marjut; Nikkari, Seppo; Hytonen, Vesa; Maatta, Juha; Kunnas, Tarja			Hepcidin is potential regulator for renin activity	PLOS ONE			English	Article							INCREASED SERUM FERRITIN; HEART-FAILURE; ACUTE-PHASE; IRON; HYPERTENSION; EXPRESSION; LOCALIZATION; PROTEINS; DOCKING; SERVER	An association between genetic variants in the genes HFE, HJV, BMP4 and arterial hypertension has been shown earlier. Proteins encoded by these genes participate in the signalling routes leading eventually to the production of the peptide hormone hepcidin. Mutations in these genes have been associated with the abnormal production of hepcidin in the body. This finding led to studies exploring the possible role of hepcidin in regulating the activity of blood pressure related renin-angiotensin system enzymes. We used molecular modelling to find out if it is possible for hepcidin to bind to the active site of the renin-angiotensin system enzymes, especially renin. Fluorometric assays were used to evaluate the inhibitory effect of hepcidin on renin as well as angiotensin converting enzymes 1 and 2. Finally, bio-layer interferometry technique was used to study hepcidin binding to renin. The molecular modelling showed that hepcidin seems to have similar binding properties to the renin active site as angiotensinogen does. Based on fluorometric enzyme activity assay, hepcidin has an inhibitory effect on renin in vitro, too. However, angiotensin converting enzymes 1 and 2 were not inhibited remarkably by hepcidin-25. In bio-layer interferometry analysis hepcidin-renin binding was concentration dependent. Our results suggest that hepcidin could act as an inhibitor to the renin. Nowadays, there is no known biological inhibitor for renin in vivo and our finding may thus have important clinical implications.	[Piesanen, Jaakko; Valjakka, Jarkko; Niemela, Sanna; Nikkari, Seppo; Hytonen, Vesa; Maatta, Juha; Kunnas, Tarja] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland; [Borgenstrom, Marjut] Patendo Oy, Pargas, Finland	Tampere University	Kunnas, T (corresponding author), Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland.	tarja.kunnas@tuni.fi	Hytonen, Vesa P./E-8855-2013	Hytonen, Vesa P./0000-0002-9357-1480; Piesanen, Jaakko/0000-0002-3657-1169; Kunnas, Tarja/0000-0002-9647-642X				Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Campostrini N, 2012, J PROTEOMICS, V76, P28, DOI 10.1016/j.jprot.2012.08.006; Choi B, 2015, ENVIRON TOXICOL, V30, P101, DOI 10.1002/tox.21899; Ellervik C, 2010, J INTERN MED, V268, P252, DOI 10.1111/j.1365-2796.2010.02217.x; Suarez-Ortegon MF, 2015, ARCH MED RES, V46, P507, DOI 10.1016/j.arcmed.2015.07.007; Galesloot TE, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0246-4; Galesloot TE, 2014, ARTERIOSCL THROM VAS, V34, P446, DOI 10.1161/ATVBAHA.113.302381; Giese T., 2015, **DATA OBJECT**, DOI 10.2210/pdb4QAE/pdb; Girelli D, 2016, BLOOD, V127, P2809, DOI 10.1182/blood-2015-12-639112; Grammer TB, 2019, CLIN CHEM, V65, P849, DOI 10.1373/clinchem.2018.297242; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Houschyar KS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-54; Ishizaka N, 2007, HYPERTENS RES, V30, P195, DOI 10.1291/hypres.30.195; Jankowska EA, 2016, EUR J HEART FAIL, V18, P786, DOI 10.1002/ejhf.473; Kim MK, 2012, AM J HYPERTENS, V25, P492, DOI 10.1038/ajh.2011.241; Klip IT, 2013, AM HEART J, V165, P575, DOI 10.1016/j.ahj.2013.01.017; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Kulaksiz H, 2005, J ENDOCRINOL, V184, P361, DOI 10.1677/joe.1.05729; Kurcinski M, 2015, NUCLEIC ACIDS RES, V43, pW419, DOI 10.1093/nar/gkv456; Liu QD, 2012, J CLIN INVEST, V122, P4635, DOI 10.1172/JCI63924; Maatta KM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000464; Mastrogiannaki M, 2012, HAEMATOL-HEMATOL J, V97, P827, DOI 10.3324/haematol.2011.056119; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nikkari ST, 2017, MEDICINE, V96, DOI [10.1097/md.0000000000006052, 10.1097/MD.0000000000006052]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Piesanen JVI, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000009362, 10.1097/md.0000000000009362]; Piperno A, 2002, J HYPERTENS, V20, P1513, DOI 10.1097/00004872-200208000-00013; Ponikowska B, 2013, DIABETES CARE, V36, P4147, DOI 10.2337/dc13-0528; Ryoo JH, 2015, INT J CARDIOL, V183, P258, DOI 10.1016/j.ijcard.2014.10.152; Sangkhae V, 2017, ADV NUTR, V8, P126, DOI 10.3945/an.116.013961; Scindia Y, 2019, SEMIN NEPHROL, V39, P76, DOI 10.1016/j.semnephrol.2018.10.006; Selvaraj S, 2019, HYPERTENSION, V73, P68, DOI 10.1161/HYPERTENSIONAHA.118.11730; Silva B, 2015, BBA-MOL BASIS DIS, V1852, P1347, DOI 10.1016/j.bbadis.2015.03.011; Suzuki H, 2009, TOHOKU J EXP MED, V218, P93, DOI 10.1620/tjem.218.93; Tajima S, 2015, EUR J NUTR, V54, P709, DOI 10.1007/s00394-014-0749-1; Valenti L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134635; Vyoral D, 2017, PHARMACOL RES, V115, P242, DOI 10.1016/j.phrs.2016.11.010; Wunderer F, 2020, PHARMACOL RES, V153, DOI 10.1016/j.phrs.2020.104664; Yan YH, 2019, J BIOL CHEM, V294, P2353, DOI 10.1074/jbc.RA118.006608	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0267343	10.1371/journal.pone.0267343	http://dx.doi.org/10.1371/journal.pone.0267343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35442992	gold, Green Published			2022-12-26	WOS:000822608900052
J	Ratze, MAK; Koorman, T; Sijnesael, T; Bassey-Archibong, B; van de Ven, R; Enserink, L; Visser, D; Jaksani, S; Viciano, I; Bakker, ERM; Richard, F; Tutt, A; O'Leary, L; Fitzpatrick, A; Roca-Cusachs, P; van Diest, PJ; Desmedt, C; Daniel, JM; Isacke, CM; Derksen, PWB				Ratze, Max A. K.; Koorman, Thijs; Sijnesael, Thijmen; Bassey-Archibong, Blessing; van de Ven, Robert; Enserink, Lotte; Visser, Daan; Jaksani, Sridevi; Viciano, Ignacio; Bakker, Elvira R. M.; Richard, Francois; Tutt, Andrew; O'Leary, Lynda; Fitzpatrick, Amanda; Roca-Cusachs, Pere; van Diest, Paul J.; Desmedt, Christine; Daniel, Juliet M.; Isacke, Clare M.; Derksen, Patrick W. B.			Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer	ONCOGENE			English	Article							MAMMARY EPITHELIAL-CELLS; ANOIKIS RESISTANCE; GENE-EXPRESSION; CARCINOMA; ID2; GROWTH; D1; PROLIFERATION; DIFFERENTIATION; REPRESSION	Invasive lobular breast carcinoma (ILC) is characterized by proliferative indolence and long-term latency relapses. This study aimed to identify how disseminating ILC cells control the balance between quiescence and cell cycle re-entry. In the absence of anchorage, ILC cells undergo a sustained cell cycle arrest in G0/G1 while maintaining viability. From the genes that are upregulated in anchorage independent ILC cells, we selected Inhibitor of DNA binding 2 (Id2), a mediator of cell cycle progression. Using loss-of-function experiments, we demonstrate that Id2 is essential for anchorage independent survival (anoikis resistance) in vitro and lung colonization in mice. Importantly, we find that under anchorage independent conditions, E-cadherin loss promotes expression of Id2 in multiple mouse and (organotypic) human models of ILC, an event that is caused by a direct p120-catenin/Kaiso-dependent transcriptional de-repression of the canonical Kaiso binding sequence TCCTGCNA. Conversely, stable inducible restoration of E-cadherin expression in the ILC cell line SUM44PE inhibits Id2 expression and anoikis resistance. We show evidence that Id2 accumulates in the cytosol, where it induces a sustained and CDK4/6-dependent G0/G1 cell cycle arrest through interaction with hypo-phosphorylated Rb. Finally, we find that Id2 is indeed enriched in ILC when compared to other breast cancers, and confirm cytosolic Id2 protein expression in primary ILC samples. In sum, we have linked mutational inactivation of E-cadherin to direct inhibition of cell cycle progression. Our work indicates that loss of E-cadherin and subsequent expression of Id2 drive indolence and dissemination of ILC. As such, E-cadherin and Id2 are promising candidates to stratify low and intermediate grade invasive breast cancers for the use of clinical cell cycle intervention drugs.	[Ratze, Max A. K.; Koorman, Thijs; Sijnesael, Thijmen; van de Ven, Robert; Enserink, Lotte; Visser, Daan; Jaksani, Sridevi; Bakker, Elvira R. M.; van Diest, Paul J.; Derksen, Patrick W. B.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Bassey-Archibong, Blessing; Daniel, Juliet M.] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Viciano, Ignacio; Roca-Cusachs, Pere] Barcelona Inst Technol BIST, Inst Bioengn Catalonia IBEC, Barcelona, Spain; [Richard, Francois; Desmedt, Christine] Katholieke Univ Leuven, Lab Translat Breast Canc Res, Leuven, Belgium; [Tutt, Andrew] Kings Coll London, Breast Canc Now Res Unit, London, England; [Tutt, Andrew; O'Leary, Lynda; Fitzpatrick, Amanda; Isacke, Clare M.] Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, London, England	Utrecht University; Utrecht University Medical Center; McMaster University; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; KU Leuven; University of London; King's College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Derksen, PWB (corresponding author), Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands.	p.w.b.derksen@umcutrecht.nl	Derksen, Patrick/C-6643-2008; Desmedt, Christine/P-7438-2017	Derksen, Patrick/0000-0003-0732-7762; Sijnesael, Thijmen/0000-0003-2248-9786; Desmedt, Christine/0000-0002-5223-5579; Koorman, Thijs/0000-0002-6064-3353; Isacke, Clare/0000-0002-9222-3345; Tutt, Andrew/0000-0001-8715-2901	NHS; St Thomas' NHS Foundation Trust and King's College London; Royal Marsden NHS Foundation Trust; Canadian Breast Cancer Foundation; Juravinski Hospital and Cancer Center Foundation; Schlumberger Faculty for the Future Fellowship; Breast Cancer Now [2018NovPCC1297]; NC3Rs [NC/P001262/1]; Medical Research Council Clinical Research Training Fellowship; Netherlands Organization for Scientific Research [NWO/ZonMW-VIDI 016.096.318]; Dutch Cancer Society [KWF-UU-2011-5230, KWF-UU-2014-7201, KWF-UU-2016-10456]; Pfizer; European Union [731957, CA19138]; COST (European Cooperation in Science and Technology)	NHS; St Thomas' NHS Foundation Trust and King's College London; Royal Marsden NHS Foundation Trust(Royal Society of New ZealandMarsden Fund (NZ)); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Juravinski Hospital and Cancer Center Foundation; Schlumberger Faculty for the Future Fellowship(Schlumberger); Breast Cancer Now; NC3Rs(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); Medical Research Council Clinical Research Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding); Pfizer(Pfizer); European Union(European Commission); COST (European Cooperation in Science and Technology)(European Cooperation in Science and Technology (COST))	We thank Jonathan R. Keller (National Cancer Institute, Frederick, MA, USA) for the Id2 reporter, and Livio Kleij and Nikki Kolsters for technical support. Members from the De Bruin and Daniel laboratories are acknowledged for input and fruitful discussions. We thank the UMC Utrecht Cell Microscopy Center for imaging support. Rebecca Marlow and Eleanor Knight (BCN Organoid Facility) for their advice on the ILC PDO generation and Angela Clifford (KCL) in her role as BTBC trial coordinator. We acknowledge NHS funding to the NIHR Biomedical Research Centres at both Guy's and St Thomas' NHS Foundation Trust and King's College London, and the Royal Marsden NHS Foundation Trust and the Canadian Breast Cancer Foundation, the Juravinski Hospital and Cancer Center Foundation (JHCCF). BIB-A was partly supported by a Schlumberger Faculty for the Future Fellowship. We received financial support by Breast Cancer Now (CTR-Q4-Y3), NC3Rs (NC/P001262/1) (CMI/AT) and a Medical Research Council Clinical Research Training Fellowship (AF), grants from the Netherlands Organization for Scientific Research (NWO/ZonMW-VIDI 016.096.318), the Dutch Cancer Society (KWF-UU-2011-5230, KWF-UU-2014-7201 and KWF-UU-2016-10456), Breast Cancer Now (2018NovPCC1297) which is supported by funding from Pfizer, and the European Union's Horizon 2020 FET Proactive program under the grant agreement No. 731957 (MECHANO-CONTROL). This publication is based upon work from COST action LOBSTERPOT (CA19138), supported by COST (European Cooperation in Science and Technology).	Annunziato S, 2016, GENE DEV, V30, P1470, DOI 10.1101/gad.279190.116; Arpino G, 2004, BREAST CANCER RES, V6, pR149, DOI 10.1186/bcr767; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Berx G, 1995, EMBO J, V14, P6107, DOI 10.1002/j.1460-2075.1995.tb00301.x; Boelens MC, 2016, CELL REP, V16, P2087, DOI 10.1016/j.celrep.2016.07.059; Booij TH, 2016, J BIOMOL SCREEN, V21, P912, DOI 10.1177/1087057116657269; Bruner HC, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029330; Christgen M, 2021, CANCERS, V13, DOI 10.3390/cancers13153695; Christgen M, 2016, PATHOL RES PRACT, V212, P583, DOI 10.1016/j.prp.2016.05.002; Coma S, 2010, CANCER RES, V70, P3823, DOI 10.1158/0008-5472.CAN-09-3048; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Derksen PWB, 2011, DIS MODEL MECH, V4, P347, DOI 10.1242/dmm.006395; Desmedt C, 2017, SEMIN CANCER BIOL, V44, P98, DOI 10.1016/j.semcancer.2017.03.007; Di Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109688; Engel J, 2003, EUR J CANCER, V39, P1794, DOI 10.1016/S0959-8049(03)00422-2; Engelstaedter Verena, 2011, Arch Gynecol Obstet, V283 Suppl 1, P93, DOI 10.1007/s00404-011-1843-8; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gainer SM, 2012, J SURG RES, V177, P93, DOI 10.1016/j.jss.2012.03.014; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gray MJ, 2008, ONCOGENE, V27, P7192, DOI 10.1038/onc.2008.356; Guiu S, 2014, CRIT REV ONCOL HEMAT, V92, P235, DOI 10.1016/j.critrevonc.2014.07.003; Herold MJ, 2008, P NATL ACAD SCI USA, V105, P18507, DOI 10.1073/pnas.0806213105; Hornsveld M, 2016, CELL DEATH DIFFER, V23, P1483, DOI 10.1038/cdd.2016.33; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; IAVARONE A, 1994, GENE DEV, V8, P1270, DOI 10.1101/gad.8.11.1270; Jares P, 1997, J PATHOL, V182, P160; Johnson J, 2016, ONCOGENE, V35, P4829, DOI 10.1038/onc.2016.32; KAELIN WG, 1991, CELL, V64, P521, DOI 10.1016/0092-8674(91)90236-R; Kijewska M, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-018-1093-9; Kim NS, 2011, MOL CELL BIOL, V31, P4775, DOI 10.1128/MCB.05646-11; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Korhonen T, 2013, BREAST, V22, P1119, DOI 10.1016/j.breast.2013.06.001; Lasorella A, 1996, MOL CELL BIOL, V16, P2570; Li HJ, 2010, BLOOD, V116, P1060, DOI 10.1182/blood-2009-11-255075; Liu Y, 2019, BREAST CANCER RES TR, V175, P77, DOI 10.1007/s10549-018-05126-3; Mandoli A, 2014, GENOM DATA, V2, P170, DOI 10.1016/j.gdata.2014.06.014; Manning AL, 2012, NAT REV CANCER, V12, P220, DOI 10.1038/nrc3216; Mathieu MC, 2004, EUR J CANCER, V40, P342, DOI 10.1016/j.ejca.2003.08.015; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Meng YG, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-75; Metzger O, 2013, ANN ONCOL, V24, P377, DOI 10.1093/annonc/mds280; Michaut M, 2016, SCI REP-UK, V6, DOI 10.1038/srep18517; NEWSTEAD GM, 1992, RADIOLOGY, V184, P623, DOI 10.1148/radiology.184.3.1324506; O'Brien N, 2018, MOL CANCER THER, V17, P897, DOI 10.1158/1535-7163.MCT-17-0290; Oyama T, 1998, CANCER RES, V58, P2876; Parrinello S, 2001, J BIOL CHEM, V276, P39213, DOI 10.1074/jbc.M104473200; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Pestalozzi BC, 2008, J CLIN ONCOL, V26, P3006, DOI 10.1200/JCO.2007.14.9336; Pierre CC, 2015, BBA-GENE REGUL MECH, V1849, P1432, DOI 10.1016/j.bbagrm.2015.10.018; Pinto Proenca Rita, 2018, BMJ Case Rep, V2018, DOI 10.1136/bcr-2017-223542; Rollin J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004158; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sandercock AM, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0415-0; Schackmann RCJ, 2013, CANCER RES, V73, P4937, DOI 10.1158/0008-5472.CAN-13-0180; Schackmann RCJ, 2011, J CLIN INVEST, V121, P3176, DOI 10.1172/JCI41695; Shapiro GI, 2000, CELL BIOCHEM BIOPHYS, V33, P189, DOI 10.1385/CBB:33:2:189; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Teo K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33525-5; Tobin NP, 2012, HUM PATHOL, V43, P2053, DOI 10.1016/j.humpath.2012.02.015; Troyanovsky RB, 2003, MOL CELL BIOL, V23, P7965, DOI 10.1128/MCB.23.22.7965-7972.2003; van de Ven RAH, 2015, DIS MODEL MECH, V8, P373, DOI 10.1242/dmm.018648; vanDiest PJ, 1997, AM J PATHOL, V150, P705; Vlug EJ, 2013, CELL ONCOL, V36, P375, DOI 10.1007/s13402-013-0143-7; Wazir U, 2013, ANTICANCER RES, V33, P2179; Zhou JD, 2017, ONCOTARGET, V8, P91979, DOI 10.18632/oncotarget.20559	67	2	2	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 20	2022	41	21					2932	2944		10.1038/s41388-022-02314-w	http://dx.doi.org/10.1038/s41388-022-02314-w		APR 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	1L8MU	35437308	hybrid, Green Published			2022-12-26	WOS:000784068300002
J	Bakht, MP; Salam, Z; Bhatti, AR; Sheikh, UU; Khan, N; Anjum, W				Bakht, Muhammad Paend; Salam, Zainal; Bhatti, Abdul Rauf; Sheikh, Usman Ullah; Khan, Nuzhat; Anjum, Waqas			Techno-economic modelling of hybrid energy system to overcome the load shedding problem: A case study of Pakistan	PLOS ONE			English	Article							RURAL ELECTRIFICATION; POWER-GENERATION; OPTIMIZATION; ELECTRICITY; FEASIBILITY; MANAGEMENT; BIOMASS; PV	This paper demonstrates the application of hybrid energy system (HES) that comprises of photovoltaic (PV) array, battery storage system (BSS) and stand-by diesel generator (DGen) to mitigate the problem of load shedding. The main work involves techno-economic modelling to optimize the size of HES such that the levelized cost of electricity (LCOE) is minimized. The particle swarm optimization (PSO) algorithm is used to determine the optimum size of the components (PV, BSS). Simulations are performed in MATLAB using real dataset of irradiance, temperature and load shedding schedule of the small residential community situated in the city of Quetta, Pakistan. The LCOE for the HES system under study is 8.32 cents/kWh-which is lower than the conventional load shedding solution, namely the uninterruptable power supply (UPS) (13.06 cents/kWh) and diesel and generator system (29.19 cents/kWh). In fact, the LCOE of the HRES is lower than the grid electricity price of Pakistan (9.3 cents/kWh). Besides that, the HES alleviates the grid burden by 47.9% and 13.1% compared to the solution using the UPS and generator, respectively. The outcomes of the study suggests that HES is able to improve reliability and availability of electric power for regions that is affected by the load shedding issue.	[Bakht, Muhammad Paend; Salam, Zainal; Sheikh, Usman Ullah; Anjum, Waqas] Univ Teknol Malaysia UTM, Ctr Elect Energy Syst, Sch Elect Engn, Johor Baharu, Malaysia; [Bakht, Muhammad Paend] Balochistan Univ Informat Technol Engn & Managemen, Dept Elect Engn, Quetta, Pakistan; [Bhatti, Abdul Rauf] Govt Coll Univ Faisalabad GCUF, Dept Elect Engn, Faisalabad, Pakistan; [Khan, Nuzhat] Univ Sains Malaysia USM, George Town, Malaysia; [Anjum, Waqas] Islamia Univ Bahawalpur, Bahawalpur, Pakistan	Universiti Teknologi Malaysia; Government College University Faisalabad; Universiti Sains Malaysia; Islamia University of Bahawalpur	Bakht, MP (corresponding author), Univ Teknol Malaysia UTM, Ctr Elect Energy Syst, Sch Elect Engn, Johor Baharu, Malaysia.; Bakht, MP (corresponding author), Balochistan Univ Informat Technol Engn & Managemen, Dept Elect Engn, Quetta, Pakistan.	muhammad.paend@buitms.edu.pk	Bhatti, Abdul Rauf/P-8244-2017; Bakht, Muhammad Paend/HDM-7159-2022; Sheikh, Usman Ullah/GRO-0863-2022	Bhatti, Abdul Rauf/0000-0001-9609-4563; Bakht, Muhammad Paend/0000-0001-8833-4563; 				Adefarati T, 2019, APPL ENERG, V236, P1089, DOI 10.1016/j.apenergy.2018.12.050; Ahmad J, 2018, ENERGY, V148, P208, DOI 10.1016/j.energy.2018.01.133; Ahmed J, 2015, APPL ENERG, V150, P97, DOI 10.1016/j.apenergy.2015.04.006; Akella AK, 2009, RENEW ENERG, V34, P390, DOI 10.1016/j.renene.2008.05.002; Ali F, 2021, ENERGY, V215, DOI 10.1016/j.energy.2020.119103; Ali M, 2020, 2020 INT C ENG EMERG; Badescu V, 2016, THEOR APPL CLIMATOL, V124, P141, DOI 10.1007/s00704-015-1400-7; Bakht MP, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11104601; Bakht MP, 2018, 2018 IEEE 7TH INTERNATIONAL CONFERENCE ON POWER AND ENERGY (PECON), P35, DOI 10.1109/PECON.2018.8684040; Bevrani H., 2010, WORLD ACAD SCI ENG T, V65, P199; Bhatti AR, 2019, INT J ENERG RES, V43, P500, DOI 10.1002/er.4287; Bukar AL, 2020, ENERG CONVERS MANAGE, V221, DOI 10.1016/j.enconman.2020.113161; Bukar AL, 2019, SOL ENERGY, V188, P685, DOI 10.1016/j.solener.2019.06.050; Chermat F, 2018, ENG TECHNOL APPL SCI, V8, P3421; Chin VJ, 2015, APPL ENERG, V154, P500, DOI 10.1016/j.apenergy.2015.05.035; Das Valasai G, 2017, RENEW SUST ENERG REV, V72, P734, DOI 10.1016/j.rser.2017.01.097; Divya KC, 2009, ELECTR POW SYST RES, V79, P511, DOI 10.1016/j.epsr.2008.09.017; Engerer, 2020, HIST TMY; Ghasemi M, 2019, SOFT COMPUT, V23, P9701, DOI 10.1007/s00500-018-3536-8; Habib HUR, 2019, IEEE ACCESS, V7, P117369, DOI 10.1109/ACCESS.2019.2936789; HABIB M, FREQUENCY CONTROL OF; IESCO) Iesc, SCHED EL TAR; Javid Z, 2020, TEH VJESN, V27, P781, DOI 10.17559/TV-20181219042529; Jumani TA, 2020, IEEE ACCESS, V8, P75986, DOI 10.1109/ACCESS.2020.2989133; Jung TY, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10114045; Khalid A, 2013, RENEW ENERG, V50, P253, DOI 10.1016/j.renene.2012.06.040; Khawaja Y, 2019, APPL ENERG, V250, P257, DOI 10.1016/j.apenergy.2019.04.185; Lai CS, 2017, APPL ENERG, V190, P191, DOI 10.1016/j.apenergy.2016.12.153; Li XJ, 2013, IEEE T SUSTAIN ENERG, V4, P464, DOI 10.1109/TSTE.2013.2247428; Maleki A, 2015, RENEW ENERG, V80, P552, DOI 10.1016/j.renene.2015.02.045; MoEP, LOAD MANAGEMENT PORT; Mohamed MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159702; Barbosa LDNS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173820; Odeh S, 2018, J POWER ENERGY ENG, V06, P59; Ou P, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8070687; Power, 2019, MP P SERIES POWERED; Rehman SU, 2019, ENVIRON PROG SUSTAIN, V38, DOI 10.1002/ep.13031; Shahzad MK, 2017, RENEW ENERG, V106, P264, DOI 10.1016/j.renene.2017.01.033; Shakeel SR, 2016, RENEW SUST ENERG REV, V64, P421, DOI 10.1016/j.rser.2016.06.016; Shezan SA, 2019, ENVIRON PROG SUSTAIN, V38, DOI 10.1002/ep.13340; Shi BY, 2015, INT J ELEC POWER, V67, P582, DOI 10.1016/j.ijepes.2014.12.041; Shrestha R.S., 2010, HYDRO NEPAL J WATER, V6, P7, DOI [10.3126/hn.v6i0.4187, DOI 10.3126/HN.V6I0.4187]; SolarDesignTool,, KYOCERA KD325GX LFB; Tomar V, 2017, RENEW SUST ENERG REV, V70, P822, DOI 10.1016/j.rser.2016.11.263; Unbreen A., 2019, PAK J SCI, V71, P50; Xu Cai, 2014, 2014 International Power Electronics Conference (IPEC-Hiroshima 2014 - ECCE ASIA), P1842, DOI 10.1109/IPEC.2014.6869835; Yimen N, 2020, PROCESSES, V8, DOI 10.3390/pr8111381; Zafar U, 2018, RENEW SUST ENERG REV, V82, P654, DOI 10.1016/j.rser.2017.09.034; Zahid H, 2020, INT J PHOTOENERGY, V2020, DOI 10.1155/2020/4135860; Zameer H, 2018, RENEW SUST ENERG REV, V82, P886, DOI 10.1016/j.rser.2017.09.089; Zeng M, 2013, ENERG POLICY, V61, P610, DOI 10.1016/j.enpol.2013.06.116; Zhang L, 2014, APPL ENERG, V136, P480, DOI 10.1016/j.apenergy.2014.08.106; Zubair M, 2021, ENERG POLICY, V151, DOI 10.1016/j.enpol.2021.112194	53	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266660	10.1371/journal.pone.0266660	http://dx.doi.org/10.1371/journal.pone.0266660			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35471991	Green Published, gold			2022-12-26	WOS:000816171900002
J	Cruz, J; Yang, J				Cruz, Jazmin; Yang, James			Improved heat coefficients for joint-space metabolic energy expenditure model during level, uphill, and downhill walking	PLOS ONE			English	Article							MECHANICAL DETERMINANTS; MUSCLE MODEL; COST; EFFICIENCY	A previously developed joint-space metabolic energy expenditure (MEE) model includes subject-specific parameters and was validated using level walking gait data. In this work, we determine how well this joint-space model performs during various walking grades (-8%, 0%, and 8%) at 0.8 m.s(-1) and 1.3 m.s(-1) using published gait data in the literature. In response to those results, we formulate an optimization problem and solve it through the particle swam method plus fmincon function in MATLAB to identify a new optimal weighting parameter set for each grade that produces more accurate predicted MEE and we compare our new findings with seven other MEE models in the literature. The current study matched the measured MEE the best with the lowest RMSE values for level (0.45 J.kg(-1).m(-1)) and downhill (0.82 J.kg(-1).m(-1)) walking and the third lowest RMSE value for uphill (1.56 J.kg(-1).m(-1)) walking, where another MEE model, Looney et al., had the lowest RMSE for uphill (1.27 J.kg(-1).m(-1)) walking. Bland-Altman plots and three independent-samples t-tests show that there was no statistical significant difference between experimentally measured MEE and estimated MEE during the three walking conditions, meaning that the three new optimal weighting parameter sets can be used with 6 degree of freedom (DOF) lower extremity motion data to better estimate whole body MEE in those scenarios. We believe that this work is a step towards identifying a single robust parameter set that allows for accurate estimation of MEE during any task, with the potential to mitigate a limitation of indirect calorimetry requiring lengthy steady state motion.	[Cruz, Jazmin; Yang, James] Texas Tech Univ, Dept Mech Engn, Human Centr Design Res Lab, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Yang, J (corresponding author), Texas Tech Univ, Dept Mech Engn, Human Centr Design Res Lab, Lubbock, TX 79409 USA.	james.yang@ttu.edu			National Science Foundation [CBET1703093]; US Army Medical Research and Development Command [W81XWH18C0102]; Texas Tech University Presidential Graduate Fellowship	National Science Foundation(National Science Foundation (NSF)); US Army Medical Research and Development Command(United States Department of DefenseUnited States ArmyUnited States Army Medical Research & Development Command (USAMRDC)); Texas Tech University Presidential Graduate Fellowship	JY: National Science Foundation (CBET1703093), US Army Medical Research and Development Command (W81XWH18C0102) JC: Texas Tech University Presidential Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson FRANK C., 1999, Comput Methods Biomech Biomed Engin, V2, P201, DOI 10.1080/10255849908907988; Ardigo LP, 2003, EUR J APPL PHYSIOL, V90, P365, DOI 10.1007/s00421-003-0882-7; Bhargava LJ, 2004, J BIOMECH, V37, P81, DOI 10.1016/S0021-9290(03)00239-2; De Groote F, 2016, ANN BIOMED ENG, V44, P2922, DOI 10.1007/s10439-016-1591-9; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; Glass S., 2006, ACSMS METABOLIC CALC, P1; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; Houdijk H, 2006, J BIOMECH, V39, P536, DOI 10.1016/j.jbiomech.2004.11.033; Kim JH, 2015, INT J NUMER METH BIO, V31, DOI 10.1002/cnm.2721; Koelewijn AD., 2018, DATASET METABOLIC CO; Koelewijn AD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222037; Lichtwark GA, 2005, J EXP BIOL, V208, P2831, DOI 10.1242/jeb.01709; Looney DP, 2019, MED SCI SPORT EXER, V51, P1954, DOI 10.1249/MSS.0000000000002002; Ludlow LW, 2017, J APPL PHYSIOL, V123, P1288, DOI 10.1152/japplphysiol.00504.2017; Margaria R, 1968, Int Z Angew Physiol, V25, P339; MINETTI AE, 1993, J PHYSIOL-LONDON, V472, P725, DOI 10.1113/jphysiol.1993.sp019969; MINETTI AE, 1994, J EXP BIOL, V195, P211; Minetti AE, 2002, J APPL PHYSIOL, V93, P1039, DOI 10.1152/japplphysiol.01177.2001; Gonabadi AM, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1008280; PANDOLF KB, 1977, J APPL PHYSIOL, V43, P577, DOI 10.1152/jappl.1977.43.4.577; Roberts D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168070; Santee W. R., 2003, LOAD CARRIAGE MODEL; Statistics Laerd., 2017, STAT TUT SOFTW GUID; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Umberger Brian R., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P99, DOI 10.1080/1025584031000091678; Uth N, 2004, EUR J APPL PHYSIOL, V91, P111, DOI 10.1007/s00421-003-0988-y; Winters JA., 1990, MULTIPLE MUSCLE SYST, P69, DOI DOI 10.1007/978-1-4613-9030-5_5	27	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267120	10.1371/journal.pone.0267120	http://dx.doi.org/10.1371/journal.pone.0267120			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421206	gold, Green Published			2022-12-26	WOS:000795453600112
J	Papadimitriou, C; Weaver, J; Guernon, A; Walsh, E; Mallinson, T; Pape, TLB				Papadimitriou, Christina; Weaver, Jennifer; Guernon, Ann; Walsh, Elyse; Mallinson, Trudy; Pape, Theresa L. Bender			"Fluctuation is the norm": Rehabilitation practitioner perspectives on ambiguity and uncertainty in their work with persons in disordered states of consciousness after traumatic brain injury	PLOS ONE			English	Article							NATIONAL INSTITUTE; DECISION-MAKING; DISABILITY; RECOVERY; PHYSIOTHERAPISTS; PHENOMENOLOGY; CONNECTIVITY; DISRUPTION; DIAGNOSIS; SEARCH	The purpose of this study is to describe the clinical lifeworld of rehabilitation practitioners who work with patients in disordered states of consciousness (DoC) after severe traumatic brain injury (TBI). We interviewed 21 practitioners using narrative interviewing methods from two specialty health systems that admit patients in DoC to inpatient rehabilitation. The overarching theme arising from the interview data is "Experiencing ambiguity and uncertainty in clinical reasoning about consciousness" when treating persons in DoC. We describe practitioners' practices of looking for consistency, making sense of ambiguous and hard to explain patient responses, and using trial and error or "tinkering" to care for patients. Due to scientific uncertainty about diagnosis and prognosis in DoC and ambiguity about interpretation of patient responses, working in the field of DoC disrupts the canonical meaning-making processes that practitioners have been trained in. Studying the lifeworld of rehabilitation practitioners through their story-making and story-telling uncovers taken-for-granted assumptions and normative structures that may exist in rehabilitation medical and scientific culture, including practitioner training. We are interested in understanding these canonical breaches in order to make visible how practitioners make meaning while treating patients.	[Papadimitriou, Christina] Oakland Univ, Dept Interdisciplinary Hlth Sci & Sociol, Rochester, MI 48309 USA; [Weaver, Jennifer] Ft Collins Colorado State Univ, Dept Occupat Therapy, Ft Collins, CO USA; [Guernon, Ann] Lewis Univ, Speech Language Pathol Dept, Romeoville, IL USA; [Walsh, Elyse; Pape, Theresa L. Bender] Res Serv, Edward Hines Jr VA, Res Serv, Hines, IL USA; [Walsh, Elyse; Mallinson, Trudy; Pape, Theresa L. Bender] George Washington Univ, Dept Clin Research& Leadership, Washington, DC USA; [Pape, Theresa L. Bender] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL USA; Edward Hines Jr VA, Ctr Innovat Complex Chron Hlth care, Hines, IL USA	Oakland University; Lewis University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; George Washington University; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Papadimitriou, C (corresponding author), Oakland Univ, Dept Interdisciplinary Hlth Sci & Sociol, Rochester, MI 48309 USA.	cpapadimitriou@oakland.edu	Weaver, Jennifer/GPS-4261-2022; Weaver, Jennifer/M-1478-2017	Weaver, Jennifer/0000-0002-3964-1441; Papadimitriou, Christina/0000-0002-6021-9288	Congressionally Directed Medical Research Programs (CDMRP); Joint Warfighter Medical Research Programs (JWFMRP) of United States Department of Defense [CDMRP W81XWH-14-1-0568, JWFMRP W81Xwh-16-2-0023]	Congressionally Directed Medical Research Programs (CDMRP)(United States Department of Defense); Joint Warfighter Medical Research Programs (JWFMRP) of United States Department of Defense(United States Department of Defense)	Funding for this project came from the Congressionally Directed Medical Research Programs (CDMRP) and Joint Warfighter Medical Research Programs (JWFMRP) of the United States Department of Defense. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific award names and numbers are: CDMRP W81XWH-14-1-0568 and JWFMRP W81Xwh-16-2-0023.	Achard S, 2012, P NATL ACAD SCI USA, V109, P20608, DOI 10.1073/pnas.1208933109; Ahlsen B, 2018, MED HUMANIT, V44, P40, DOI 10.1136/medhum-2017-011229; Ajjawi R, 2007, QUAL REP, V12, P612; American Occupational Therapy Association (AOTA), 2020, 2019 WORKF SOL SURV; American Physical Therapy Association, 2020, APTA PHYS THERAP WOR; American Speech-Language-Hearing Association, 2019, ASHA LEADER, V24, P32; Bayne T, 2017, ANN NEUROL, V82, P866, DOI 10.1002/ana.25088; Beck Christine E, 2012, US Army Med Dep J, P38; Berg K, 2019, INT J SPEECH-LANG PA, V21, P493, DOI 10.1080/17549507.2017.1413134; Blain-Moraes S, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00306; Bruner J. S., 1990, ACTS MEANING; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Bylander J., 2020, NARRATIVE MATTERS WR; Cassell E., 2004, HDB PRIMARY CARE PSY; Charmaz K., 2006, CONSTRUCTING GROUNDE; Crone JS, 2018, J NEUROSCI RES, V96, P671, DOI 10.1002/jnr.24115; Cruse D, 2012, NEUROLOGY, V78, P816, DOI 10.1212/WNL.0b013e318249f764; Cruse D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049933; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Csordas TJ, 2010, CULT MED PSYCHIAT, V34, P29, DOI 10.1007/s11013-009-9160-4; Demertzi A, 2015, BRAIN, V138, P2619, DOI 10.1093/brain/awv169; Demertzi A, 2014, CORTEX, V52, P35, DOI 10.1016/j.cortex.2013.11.005; Denzin NK, 2002, QUAL INQ; Di Perri C, 2016, LANCET NEUROL, V15, P830, DOI 10.1016/S1474-4422(16)00111-3; Doyle S, 2013, BRIT J OCCUP THER, V76, P254, DOI 10.4276/030802213X13706169932789; Edlow BL, 2013, J NEUROPATH EXP NEUR, V72, P505, DOI 10.1097/NEN.0b013e3182945bf6; Edmondson R, 2009, THEOR MED BIOETH, V30, P231, DOI 10.1007/s11017-009-9108-2; Fischer DB, 2016, NEUROLOGY, V87, P2427, DOI 10.1212/WNL.0000000000003404; Fleming A., 2020, SCI FOCUS; Fricker M, 2008, THEORIA-SPAIN, V23, P69; Geertz C, 1973, INTERPRETATION CULTU; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino JT, 2020, ARCH PHYS MED REHAB, V101, P1072, DOI 10.1016/j.apmr.2020.01.013; Giacino JT, 2018, ARCH PHYS MED REHAB, V99, P1710, DOI 10.1016/j.apmr.2018.07.002; Giacino JT, 2018, ARCH PHYS MED REHAB, V99, P1699, DOI 10.1016/j.apmr.2018.07.001; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2004, NEUROREHABILITATION, V19, P293; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gibson BE, 2020, DISABIL REHABIL, V42, P1529, DOI 10.1080/09638288.2019.1587793; Gibson BE, 2016, REHABILITATION POSTC, P27; GLASER BG, 1965, SOC PROBL, V12, P436, DOI 10.1525/sp.1965.12.4.03a00070; Green J., 2014, QUALITATIVE METHODS, V3rd; Greenhalgh T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3725; Hammell, 2006, PERSPECTIVES DISABIL; Hammell K., 2004, QUALITATIVE RES EVID, P14; Hammond FM, 2019, J NEUROTRAUM, V36, P1136, DOI 10.1089/neu.2018.5954; Holdar U, 2013, PHYSIOTHER RES INT, V18, P220, DOI 10.1002/pri.1551; Johnson LSM., 2018, AJOB NEUROSCI, V9, P76, DOI DOI 10.1080/21507740.2018.1459933; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; LEDER D, 1990, THEOR MED, V11, P9, DOI 10.1007/BF00489234; Lewis S, 2015, HEALTH PROMOT PRACT, V16, P473, DOI 10.1177/1524839915580941; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mattingly C, 2010, PARADOX OF HOPE: JOURNEYS THROUGH A CLINICAL BORDERLAND, P1; Mattingly C, 1998, MED ANTHROPOL Q, V12, P273, DOI 10.1525/maq.1998.12.3.273; Mattingly C., 1994, CLIN REASONING FORMS; Mattingly C, 2008, ETHOS, V36, P1, DOI 10.1111/j.1548-1352.2008.00001.x; Maynard DW, 2017, SOC PSYCHOL QUART, V80, P254, DOI 10.1177/0190272517720683; Mol A., CARE PRACTICE TINKER, P7; Montgomery K, 2006, DOCTORS THINK CLIN J; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Overbeek BUH, 2018, J NEUROL, V265, P1957, DOI 10.1007/s00415-018-8788-9; Papadimitriou C, 2008, DISABIL REHABIL, V30, P365, DOI 10.1080/09638280701336306; Papadimitriou C, 2012, PHYS THER REV, V17, P409, DOI 10.1179/1743288X12Y.0000000031; Papadimitriou C, 2012, OTJR-OCCUP PART HEAL, V32, pS2, DOI 10.3928/15394492-20111005-01; Papadimitriou C, 2011, DISABIL REHABIL, V33, P2121, DOI 10.3109/09638288.2011.555597; Papadimitriou C, 2008, SPORT ETHICS PHILOS, V2, P216, DOI 10.1080/17511320802223733; Peterson A, 2020, BRAIN INJURY, V34, P390, DOI 10.1080/02699052.2019.1706000; Rappaport M, 2005, NEUROPSYCHOL REHABIL, V15, P442, DOI 10.1080/09602010443000335; Rappaport M., 2000, COMA NEAR COMA SCALE; Rodrigue Catherine, 2013, Narrat Inq Bioeth, V3, P261, DOI 10.1353/nib.2013.0059; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Saldana J., 2021, CODING MANUAL QUALIT, P1; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Siegel JS, 2016, P NATL ACAD SCI USA, V113, pE4367, DOI 10.1073/pnas.1521083113; Silva S, 2015, NEUROLOGY, V85, P2036, DOI 10.1212/WNL.0000000000002196; Smiley RA, 2018, J NURS REGUL, V9, pS4, DOI 10.1016/S2155-8256(18)30131-5; Starks H, 2007, QUAL HEALTH RES, V17, P1372, DOI 10.1177/1049732307307031; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Van Maanen J., 2011, TALES FIELD WRITING; Weaver J., 2019, ARCH PHYS MED REHABI, V100, pe102, DOI [10.1016/j.apmr.2019.08.296, DOI 10.1016/J.APMR.2019.08.296]; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041; Winance M., ANNEMARIE MOL; Wu XH, 2015, J NEUROSCI, V35, P12932, DOI 10.1523/JNEUROSCI.0415-15.2015; Yao S, 2015, J NEUROL SCI, V356, P168, DOI 10.1016/j.jns.2015.06.044; Yelden K., 2018, NEUROREHAB NEURAL RE, V32, P478, DOI [10.1080/09602011.2017.1310657, DOI 10.1080/09602011.2017.1310657]; Yin R.K., 2017, APPL CASE STUDY RES	91	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267194	10.1371/journal.pone.0267194	http://dx.doi.org/10.1371/journal.pone.0267194			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1F9GM	35446897	Green Published, gold			2022-12-26	WOS:000795468200017
J	Urrego, DM; Vanegas, JM; Jimenez, JN				Urrego, Daniela Montoya; Vanegas, Johanna M.; Jimenez, J. Natalia			The remarkable genetic relationship between Staphylococcus aureus isolates from hemodialysis patients and their household contacts: Homes as an important source of colonization and dissemination	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; NASAL COLONIZATION; MULTIPLEX PCR; TRANSMISSION; PREVALENCE; CARRIAGE; RISK; MEC; IDENTIFICATION; POPULATION	IntroductionStaphylococcus aureus is a successful pathogen in hospital and community. Hemodialysis patients have high colonization rates. Interactions between them and their household contacts, are an opportunity to understand the S. aureus colonization between hospitals and community. This study aims to determine the clinical and epidemiological characteristics of S. aureus colonization in hemodialysis patients and their household contacts, as well as the genetic relationship between their isolates. MethodsA cross-sectional study was conducted on hemodialysis patients from hospital-associated dialysis center in Medellin-Colombia, and their household contacts between 2019 and 2020. Colonization was assessed in the nostrils for household contacts and nostrils and skin around the catheter insertion for hemodialysis patients. Epidemiological information was obtained, and colonization was evaluated in their pets' oral cavities. Bacterial identification and susceptibility were assessed using phenotypic and molecular methods. Molecular typing included SCCmec typing, pulsed-field gel electrophoresis (PFGE), spa typing, and virulence factor detection. ResultsColonization frequency was 35.6% (n = 16/45) in patients (87.5% MSSA- 12.5% MRSA) and 43.1% (n = 53/123) in household contacts (88.7% MSSA-11.3% MRSA). Of 45 homes, 77.8% presented colonized people. Colonization was detected in at least two household members in 46.7% of homes, of which 52.4% had a genetic relationship. Colonization was 16% (n = 4/25) in pets (75% MRSA-25% MSSA). The most frequent clonal complex was CC8 (15.6%), and the spa typing revealed high diversity. ConclusionThis study shows a high frequency of colonization by S. aureus in both hemodialysis patients and their household contacts and a significant genetic relationship between their isolates. This demonstrates an exchange of this bacterium and that homes are an important source of colonization to patients, highlighting the need for prevention strategies outside the hospital to avoid future infections, and the importance of the populations with permanent transit between the two environments.	[Urrego, Daniela Montoya; Vanegas, Johanna M.; Jimenez, J. Natalia] Univ Antioquia, Escuela Microbiol, Grp Invest Microbiol Bas & Aplicada MICROBA, Medellin, Colombia; [Vanegas, Johanna M.] Univ Pontificia Bolivariana, Escuela Ciencias Salud, Grp Invest Salud Publ, Medellin, Colombia	Universidad de Antioquia; Universidad Pontificia Bolivariana	Jimenez, JN (corresponding author), Univ Antioquia, Escuela Microbiol, Grp Invest Microbiol Bas & Aplicada MICROBA, Medellin, Colombia.	jnatalia.jimenez@udea.edu.co		Jimenez, J Natalia/0000-0002-9183-1912; Montoya Urrego, Daniela/0000-0002-9326-4341	Departamento Administrativo de Ciencia, Tecnologia e innovacion (MinCiencias Project) [111577756947]; Comite para el Desarrollo de la Investigacion CODI, Universidad de Antioquia [2017-15526]	Departamento Administrativo de Ciencia, Tecnologia e innovacion (MinCiencias Project); Comite para el Desarrollo de la Investigacion CODI, Universidad de Antioquia	This work was supported by Departamento Administrativo de Ciencia, Tecnologia e innovacion (MinCiencias Project: 111577756947), and Comite para el Desarrollo de la Investigacion CODI, Universidad de Antioquia, project: 2017-15526. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aponte-Gonzalez J, 2019, PHARM PRACT-GRANADA, V17, DOI [10.18549/pharmpract.2019.1.1394, 10.18549/PharmPract.2019.1.1394]; Bettin A, 2012, BRAZ J INFECT DIS, V16, P329, DOI 10.1016/j.bjid.2012.06.017; BRAKSTAD OG, 1992, J CLIN MICROBIOL, V30, P1654, DOI 10.1128/JCM.30.7.1654-1660.1992; Calfee DP, 2013, SEMIN DIALYSIS, V26, P447, DOI 10.1111/sdi.12094; Chmielowiec-Korzeniowska A, 2020, POSTEP DERM ALERGOL, V37, P184, DOI 10.5114/ada.2020.94837; Clinical and Laboratory Standards Institute, 2019, CLSI SUPPLEMENT M100, V28th; Conceicao T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077812; Davis MF, 2012, LANCET INFECT DIS, V12, P703, DOI 10.1016/S1473-3099(12)70156-1; Hogan PG, 2019, J INFECTION, V78, P200, DOI 10.1016/j.jinf.2018.11.006; Kanwar A, 2019, AM J INFECT CONTROL, V47, P577, DOI 10.1016/j.ajic.2019.01.028; Knox J, 2015, TRENDS MICROBIOL, V23, P437, DOI 10.1016/j.tim.2015.03.007; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; Lakhundi S, 2018, CLIN MICROBIOL REV, V31, DOI [10.1128/CMR.00020-18, 10.1128/cmr.00020-18]; Lu PL, 2008, NEPHROL DIAL TRANSPL, V23, P1659, DOI 10.1093/ndt/gfm806; Mathema Barun, 2008, V431, P285; Mehrotra M, 2000, J CLIN MICROBIOL, V38, P1032, DOI 10.1128/JCM.38.3.1032-1035.2000; Melles DC, 2004, J CLIN INVEST, V114, P1732, DOI 10.1172/JCI200423083; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Miller LG, 2012, CLIN INFECT DIS, V54, P1523, DOI 10.1093/cid/cis213; Mizumachi E, 2011, J APPL MICROBIOL, V110, P562, DOI 10.1111/j.1365-2672.2010.04910.x; Monaco M, 2017, CURR TOP MICROBIOL, V409, P21, DOI 10.1007/82_2016_3; Mork RL, 2020, LANCET INFECT DIS, V20, P188, DOI 10.1016/S1473-3099(19)30570-5; Mulvey MR, 2001, J CLIN MICROBIOL, V39, P3481, DOI 10.1128/JCM.39.10.3481-3485.2001; Jimenez JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038576; Ng W, 2017, INFECT CONT HOSP EP, V38, P61, DOI 10.1017/ice.2016.245; Nouwen JL., 2004, DETERMINANTS RISKS D, pIV; Patel G, 2011, INFECT CONT HOSP EP, V32, P881, DOI 10.1086/661598; Peters C, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021204; Rodriguez EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101417; Rozenbaum R, 2006, INFECT CONT HOSP EP, V27, P1041, DOI 10.1086/507921; Salgado CD, 2003, CLIN INFECT DIS, V36, P131, DOI 10.1086/345436; Scheuch M, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1332-z; Vanegas JM, 2021, AM J INFECT CONTROL, V49, P215, DOI 10.1016/j.ajic.2020.05.031; Vanegas JM, 2021, INT J MED MICROBIOL, V311, DOI 10.1016/j.ijmm.2020.151471; World Health Organization, 2018, HOUS HLTH GUID; Yan X, 2015, CLIN MICROBIOL INFEC, V21, P157, DOI 10.1016/j.cmi.2014.08.023; Zafar U, 2007, INFECT CONT HOSP EP, V28, P966, DOI 10.1086/518965; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	39	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267276	10.1371/journal.pone.0267276	http://dx.doi.org/10.1371/journal.pone.0267276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7VA	35439257	Green Published, gold			2022-12-26	WOS:000791280100005
J	Wilke, ABB; Vasquez, C; Carvajal, A; Moreno, M; Petrie, WD; Beier, JC				Wilke, Andre B. B.; Vasquez, Chalmers; Carvajal, Augusto; Moreno, Maday; Petrie, William D.; Beier, John C.			Mosquito surveillance in maritime entry ports in Miami-Dade County, Florida to increase preparedness and allow the early detection of invasive mosquito species	PLOS ONE			English	Article							CULEX-CORONATOR; AEDES-AEGYPTI; ZIKA VIRUS; INTRODUCTIONS; ESTABLISHMENT; ALBOPICTUS; FEVER	Invasive mosquito vector species have been inadvertently transported to new areas by humans for decades. Strong evidence supports that monitoring maritime, terrestrial, and aerial points of entry is an essential part of the effort to curb the invasion and establishment of invasive vector mosquito species. Miami-Dade County, Florida is an important operational hub for the cruise ship industry and leisure boats that routinely visit nearby areas in the Caribbean, and freight cargo ships transporting goods from Miami-Dade to Caribbean countries and vice versa. To deal with the increasing public health concern, we hypothesized that mosquito surveillance in small- and medium-sized maritime ports of entry in Miami-Dade is crucial to allow the early detection of invasive mosquito species. Therefore, we have selected 12 small- and medium-sized maritime ports of entry in Miami-Dade County with an increased flow of people and commodities that were not covered by the current mosquito surveillance system. Collection sites were comprised of two distinct environments, four marinas with international traffic of leisure boats, and eight maintenance and commercial freight cargo ship ports. Mosquitoes were collected weekly at each of the 12 collection sites for 24 hours for 6 weeks in the Spring and then for 6 additional weeks in the Summer using BG-Sentinel traps. A total of 32,590 mosquitoes were collected, with Culex quinquefasciatus and Aedes aegypti being the most abundant species totaling 19,987 and 11,247 specimens collected, respectively. Our results show that important mosquito vector species were present in great numbers in all of the 12 maritime ports of entry surveyed during this study. The relative abundance of Cx. quinquefasciatus and Ae. aegypti was substantially higher in the commercial freight cargo ship ports than in the marinas. These results indicate that even though both areas are conducive for the proliferation of vector mosquitoes, the port area in the Miami River is especially suitable for the proliferation of vector mosquitoes. Therefore, this potentially allows the establishment of invasive mosquito species inadvertently brought in by cargo freights.	[Wilke, Andre B. B.; Beier, John C.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Vasquez, Chalmers; Carvajal, Augusto; Moreno, Maday; Petrie, William D.] Miami Dade Cty Mosquito Control Div, Miami, FL USA	University of Miami	Wilke, ABB (corresponding author), Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.	axb1737@med.miami.edu	Wilke, Andre B B/J-9973-2014	Wilke, Andre B B/0000-0002-6629-7666	JCB Miami-Dade Mosquito Control Division Miami-Dade Mosquito Control Division JCB CDC [1U01CK000510-05]	JCB Miami-Dade Mosquito Control Division Miami-Dade Mosquito Control Division JCB CDC	JCB Miami-Dade Mosquito Control Division Miami-Dade Mosquito Control Division JCB CDC (https://www.cdc.gov/) grant 1U01CK000510-05: Southeastern Regional Center of Excellence in Vector-Borne Diseases: The Gateway Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon-Elbal PM, 2020, J MED ENTOMOL, V57, P2016, DOI 10.1093/jme/tjaa128; Alencar J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122268; Alto BW, 2014, VECTOR-BORNE ZOONOT, V14, P606, DOI 10.1089/vbz.2013.1501; Ammar SE, 2019, TROP MED INFECT DIS, V4, DOI 10.3390/tropicalmed4030101; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Benelli G, 2020, TRENDS PARASITOL, V36, P942, DOI 10.1016/j.pt.2020.01.001; Bureau of Transportation Statistics, 2017, 2016 ANN DEC US AIRL; Centers for Disease Control and Prevention, NAT ARB SURV SYST; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Darsie RF, 2000, KEYS ADULT FEMALES 4; Davalos-Becerril E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212987; Florida Department of Health, 2020, US; Florida Department of Health, 2016, FLOR ARB SURV; Fuehrer HP, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008433; Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2; Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x; Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Ibanez-Justicia A, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2555-0; Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35; Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1; Monaghan AJ, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007369; Muller P, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008705; Mutebi J., 2018, ZIKA VIRUS MB16 23 M, V24, P6; Osorio HC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040820; Pagac BB, 2021, ACTA TROP, V213, DOI 10.1016/j.actatropica.2020.105739; Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860; Reiter P, 1998, J AM MOSQUITO CONTR, V14, P83; Ricotta C, 2017, ECOL COMPLEX, V31, P201, DOI 10.1016/j.ecocom.2017.07.003; Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189; Schmidt TL, 2019, EVOL APPL, V12, P1136, DOI 10.1111/eva.12787; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; WHO, 2020, VECT DIS; Wilke ABB, 2021, TRENDS PARASITOL, V37, P1027, DOI 10.1016/j.pt.2021.09.013; Wilke ABB, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-94202-8; Wilke ABB, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0007864; Wilke ABB, 2019, CURR OPIN INSECT SCI, V35, P1, DOI 10.1016/j.cois.2019.06.002; Wilke ABB, 2019, TRENDS PARASITOL, V35, P607, DOI 10.1016/j.pt.2019.05.009; Wilke ABB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45337-2; Wilke ABB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212688	40	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267224	10.1371/journal.pone.0267224	http://dx.doi.org/10.1371/journal.pone.0267224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1E2NP	35427409	Green Published, gold			2022-12-26	WOS:000794332400010
J	Worku, M; Belay, G; Tigabu, A				Worku, Minichil; Belay, Gizeaddis; Tigabu, Abiye			Bacterial profile and antimicrobial susceptibility patterns in cancer patients	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; VIRULENCE FACTORS; PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC-RESISTANCE; FEBRILE NEUTROPENIA; MICROBIAL SPECTRUM; EPIDEMIOLOGY; CHEMOTHERAPY; BACTEREMIA; SEPTICEMIA	BackgroundBloodstream infections have been the leading complications in cancer patients because they are at high risk for antibiotic-resistant bacterial infections. There is increasing evidence from different parts of the world of the high prevalence of antimicrobial-resistant bacterial strains in cancer patients. The burden of the infection is high in developing countries, especially in Ethiopia. Data on bacterial profile and antimicrobial susceptibility patterns among cancer patients in Ethiopia is limited. Thus, this study aimed to determine the predominant bacterial species causing bacteremia and their antibiotic resistance pattern among cancer patients at University of Gondar comprehensive specialized hospital. MethodsA hospital-based, cross-sectional study was conducted on 200 study participants from March to July 2021. All cancer patients who developed a fever at the time of hospital visit were included in this study, and their socio-demographic and clinical data were collected using a structured questionnaire. Blood samples (10 mL for adults and 4 mL for children) were collected from each patient, and the collected blood samples were transferred into sterile tryptic soy broth, then incubated at 37 degrees C for 7 days. Tryptic soy broth which showed signs of growth were Gram-stained and sub-cultured on blood agar, chocolate agar, MacConkey agar, and mannitol salt agar. The inoculated plates were then aerobically incubated at 37 degrees C for 18-24 hours and the isolates obtained were identified using standard microbiological methods. Antimicrobial susceptibility tests were done using a modified Kirby-Bauer disk diffusion technique following CLSI 2021 guidelines. Data were entered using EPI data version 4.6 and analyzed with SPSS version 20. ResultsIn this study, out of 200 cancer patients included and 67.5% (135/200) of them were males. The majorities of study participants, 56% (113/200) of cancer patients were pediatrics and 26.5% (53/200) of them belong under five years of age. Out of 200 patient samples that had undergone culture, 27% (54/200) samples had bacterial growth. Gram-positive bacterial isolates were predominant, 61.1%, and S. aureus was the predominant Gram-positive isolate, (51.5.6%), followed by coagulase-negative staphylococci (48.5%). Moreover, K. pneumoniae (47%) and P. aeruginosa (29.5%) were the most common Gram-negative bacterial isolates. Among patients who had BSIs, the highest prevalence of BSIs was observed among males (66.7%), and in pediatrics cancer patients (44.2%). Pediatric study participants were more venerable to bloodstream infection (P = 0.000) compared to adult participants. Meropenem (100%), amikacin (100%), piperacillin/tazobactam (72.3%), and ceftazidime (73.5%) were effective against for Gram-negative isolates while cefoxitin (81.2%) and penicillin (70.5%) were effective for Gram-positive isolates. Additionally, most Gram-negative and Gram-positive bacterial isolates were sensitive for gentamycin (75.9%). Multidrug resistance was seen among 17.1% bacterial isolates, and MDR in Gram-negative and Gram-positive bacteria were 83.3% and 16.7%, respectively. Gram-negative bacterial isolates showed a high prevalence of MDR than Gram-positive isolates. Conclusions and recommendationBSI's remains an important health problem in cancer patients, and Gram-positive bacteria were more common as etiologic agents of BSIs in cancer patients. S. aureus was the dominant bacteria followed by CoNS, K. pneumoniae, and P. aeruginosa. Multidrug-resistant isolates found in cancer patients and routine bacterial surveillance and study of their resistance patterns may guide successful antimicrobial therapy and improve the quality of care. Therefore, strict regulation of antibiotic stewardship and infection control programs should be considered in the study area.	[Worku, Minichil; Belay, Gizeaddis; Tigabu, Abiye] Univ Gondar, Sch Biomed & Lab Sci, Dept Med Microbiol, Gondar, Ethiopia	University of Gondar	Tigabu, A (corresponding author), Univ Gondar, Sch Biomed & Lab Sci, Dept Med Microbiol, Gondar, Ethiopia.	abty12@gmail.com		worku, minichil/0000-0002-5952-1658; Tigabu, Abiye/0000-0002-4160-1094				Abolghait SK, 2020, INT J FOOD MICROBIOL, V328, DOI 10.1016/j.ijfoodmicro.2020.108669; Akova M, 2016, VIRULENCE, V7, P252, DOI 10.1080/21505594.2016.1159366; Al-Asady FM, 2020, J INFECT DEV COUNTR, V14, P1387, DOI 10.3855/jidc.13089; Al-Mulla NA, 2014, INFECT DRUG RESIST, V7, P289, DOI 10.2147/IDR.S70486; Algammal AM, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88861-w; Algammal AM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75914-9; Algammal AM, 2020, INFECT DRUG RESIST, V13, P3255, DOI 10.2147/IDR.S272733; Algammal AM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72264-4; Algammal AM, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9050362; Alghamdi S, 2021, CELL MOL BIOL, V67, P190, DOI 10.14715/cmb/2021.67.3.30; Anatoliotaki M, 2004, INFECTION, V32, P65, DOI 10.1007/s15010-004-3049-5; Arega B, 2018, INFECT DRUG RESIST, V11, P1511, DOI 10.2147/IDR.S168867; Arega B, 2017, INFECT AGENTS CANCER, V12, DOI 10.1186/s13027-017-0150-9; Aust C, 2013, SCAND J INFECT DIS, V45, P285, DOI 10.3109/00365548.2012.735372; Baskaran ND, 2007, INT J INFECT DIS, V11, P513, DOI 10.1016/j.ijid.2007.02.002; Bhabhor H., 2018, INDIAN J MICROBIOL, V5, P368, DOI [10.18231/2394-5478.2018.0077, DOI 10.18231/2394-5478.2018.0077]; Bhat S, 2021, INT J MICROBIOL, V2021, DOI 10.1155/2021/8883700; Butt Tariq, 2004, J Ayub Med Coll Abbottabad, V16, P18; Candan ED, 2015, ACTA BIOCHIM POL, V62, P867, DOI 10.18388/abp.2015_1148; Cattaneo C, 2018, ANN HEMATOL, V97, P1717, DOI 10.1007/s00277-018-3341-6; Cheung GYC, 2021, VIRULENCE, V12, P547, DOI 10.1080/21505594.2021.1878688; Chinowaita F, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-4886-2; Compain F, 2014, J CLIN MICROBIOL, V52, P4377, DOI 10.1128/JCM.02316-14; Dagnew Mulat, 2013, BMC Res Notes, V6, P283, DOI 10.1186/1756-0500-6-283; El-Mahallawy HA, 2011, PEDIATR BLOOD CANCER, V57, P283, DOI 10.1002/pbc.22926; Elseady NSM, 2021, INT J CLIN PRACT, DOI 10.1111/ijcp.14617; Elseed YIM., 2015, CLIN MED J, V1, P122; Feld R, 2008, INT J ANTIMICROB AG, V32, pS30, DOI 10.1016/j.ijantimicag.2008.06.017; Firesbhat A, 2021, BMC MICROBIOL, V21, DOI 10.1186/s12866-021-02378-w; FRIEDMAN H, 1978, AM J PATHOL, V93, P499; Gonsalves Mateus Demarchi, 2010, Curr Infect Dis Rep, V12, P329, DOI 10.1007/s11908-010-0122-3; Gonzalez-Barca E, 1999, EUR J CLIN MICROBIOL, V18, P539, DOI 10.1007/s100960050345; GUNTHER G, 1991, SCAND J INFECT DIS, V23, P589, DOI 10.3109/00365549109105183; Jung J, 2016, ANTIMICROB AGENTS CH, V60, P2012, DOI 10.1128/AAC.02651-15; Kanamaru A, 2004, CLIN INFECT DIS, V39, pS7, DOI 10.1086/383042; Kang CI, 2012, SUPPORT CARE CANCER, V20, P2371, DOI 10.1007/s00520-011-1353-z; Kara O, 2015, INFECT DIS-NOR, V47, P686, DOI 10.3109/23744235.2015.1051105; Karanwal AB, 2013, INDIAN J MED PAEDIAT, V34, P85, DOI 10.4103/0971-5851.116184; Kaya M, 2012, WORLD J GASTROENTERO, V18, P3585, DOI 10.3748/wjg.v18.i27.3585; Kuo FC, 2017, J MICROBIOL IMMUNOL, V50, P507, DOI 10.1016/j.jmii.2015.08.013; Kurtaran BCA., 2010, ARCH CLIN MICROBIOL, V1, P4; Levene I, 2018, PEDIATR INFECT DIS J, V37, P495, DOI 10.1097/INF.0000000000001938; Liu GY, 2009, PEDIATR RES, V65, p71R, DOI 10.1203/PDR.0b013e31819dc44d; Lubwama M, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4520-9; Makharita RR, 2020, INFECT DRUG RESIST, V13, P3991, DOI 10.2147/IDR.S276975; Mangaraj JBD., 2017, INT J CURR MICROBIOL, V6, P1137; Mangaraj OBD., 2017, INT J CONT MED RES, V4, P1599; Moghnieh R, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00011; Montassier E, 2013, EUR J CLIN MICROBIOL, V32, P841, DOI 10.1007/s10096-013-1819-7; Montazeri EA, 2020, INFECT DRUG RESIST, V13, P1319, DOI 10.2147/IDR.S254357; Mutnick AH, 2003, ANN PHARMACOTHER, V37, P47; Mvalo T, 2018, INT J INFECT DIS, V77, P40, DOI 10.1016/j.ijid.2018.09.012; Nesher L, 2014, INFECTION, V42, P5, DOI 10.1007/s15010-013-0525-9; Obeng-Nkrumah Noah, 2015, BMC Res Notes, V8, P742, DOI 10.1186/s13104-015-1701-z; Olejnickova K, 2014, PATHOG DIS, V72, P87, DOI 10.1111/2049-632X.12188; Oogai Y, 2011, APPL ENVIRON MICROB, V77, P8097, DOI 10.1128/AEM.05316-11; Persat A, 2015, P NATL ACAD SCI USA, V112, P7563, DOI 10.1073/pnas.1502025112; Powers ME, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003871; Prabhash K, 2010, INDIAN J CANCER, V47, P184, DOI 10.4103/0019-509X.63019; Rabirad N, 2014, J Prev Med Hyg, V55, P23; Rolston KVI, 2005, CLIN INFECT DIS, V40, pS246, DOI 10.1086/427331; RUBIO M, 1994, INFECT CONT HOSP EP, V15, P101; Safdar A, 2007, CLIN INFECT DIS, V45, P1602, DOI 10.1086/522998; Saghir S, 2009, INDIAN J MED MICROBI, V27, P341, DOI 10.4103/0255-0857.55454; Saito T, 2008, EUR J CLIN MICROBIOL, V27, P209, DOI 10.1007/s10096-007-0428-8; Singh R, 2014, INDIAN J CANCER, V51, P477, DOI 10.4103/0019-509X.175305; Strateva T, 2011, ANN MICROBIOL, V61, P717, DOI 10.1007/s13213-011-0273-y; Subedi D, 2018, CLIN EXP OPTOM, V101, P162, DOI 10.1111/cxo.12621; Taj M, 2015, J ONCOL, V2015, DOI 10.1155/2015/596504; Tigabu A., 2018, ADV PREVENTIVE MED, V2018; Uso RS., 2021, ZANCO J PURE APPL SC, V33, P70; vonKnorring N., 2019, S AFR J ONCOL, V3, P1; Yu VL, 2007, EMERG INFECT DIS, V13, P986, DOI 10.3201/eid1307.070187; Zinner SH, 1999, CLIN INFECT DIS, V29, P490, DOI 10.1086/598620	75	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266919	10.1371/journal.pone.0266919	http://dx.doi.org/10.1371/journal.pone.0266919			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1E2NP	35427384	Green Published, gold			2022-12-26	WOS:000794332400032
J	Delgado, M; Rainwater, RR; Heflin, B; Urbaniak, A; Butler, K; Davidson, M; Protacio, RM; Baldini, G; Edwards, A; Reed, MR; Raney, KD; Chambers, TC				Delgado, Magdalena; Rainwater, Randall R.; Heflin, Billie; Urbaniak, Alicja; Butler, Kaitlynn; Davidson, Mari; Protacio, Reine M.; Baldini, Giulia; Edwards, Andrea; Reed, Megan R.; Raney, Kevin D.; Chambers, Timothy C.			Primary acute lymphoblastic leukemia cells are susceptible to microtubule depolymerization in G1 and M phases through distinct cell death pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASPASE-ACTIVATED DNASE; MITOTIC ARREST; GREAT DRUGS; INDUCED APOPTOSIS; KEY ROLE; BCL-XL; CANCER; PHOSPHORYLATION; MECHANISMS; MITOSIS	Microtubule targeting agents (MTAs) are widely used cancer chemotherapeutics which conventionally exert their effects during mitosis, leading to mitotic or postmitotic death. However, accumulating evidence suggests that MTAs can also generate death signals during interphase, which may represent a key mechanism in the clinical setting. We reported previously that vincristine and other microtubule destabilizers induce death not only in M phase but also in G1 phase in primary acute lymphoblastic leukemia cells. Here, we sought to investigate and compare the pathways responsible for phase-specific cell death. Primary acute lymphoblastic leukemia cells were subjected to centrifugal elutriation, and cell populations enriched in G1 phase (97%) or G2/M phases (80%) were obtained and treated with vincristine. We found death of M phase cells was associated with established features of mitochondrial-mediated apoptosis, including Bax activation, loss of mitochondrial transmembrane potential, caspase-3 activation, and nucleosomal DNA fragmentation. In contrast, death of G1 phase cells was not associated with pronounced Bax or caspase-3 activation but was associated with loss of mitochondrial transmembrane potential, parylation, nuclear translocation of apoptosis-inducing factor and endonuclease G, and supra-nucleosomal DNA fragmentation, which was enhanced by inhibition of autophagy. The results indicate that microtubule depolymerization induces distinct cell death pathways depending on during which phase of the cell cycle microtubule perturbation occurs. The observation that a specific type of drug can enter a single cell type and induce two different modes of death is novel and intriguing. These findings provide a basis for advancing knowledge of clinical mechanisms of MTAs.	[Delgado, Magdalena; Rainwater, Randall R.; Heflin, Billie; Urbaniak, Alicja; Butler, Kaitlynn; Davidson, Mari; Protacio, Reine M.; Baldini, Giulia; Edwards, Andrea; Reed, Megan R.; Raney, Kevin D.; Chambers, Timothy C.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Delgado, Magdalena] UTSW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; [Edwards, Andrea] UTSW Med Ctr, Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chambers, TC (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	chamberstimothyc@uams.edu	Urbaniak, Alicja Joanna/J-2555-2019	Urbaniak, Alicja Joanna/0000-0002-0807-1263; Davidson, Mari/0000-0003-3949-8347; Reed, Megan/0000-0001-5086-7938; Protacio, Reine/0000-0003-4091-8724; Heflin, Billie/0000-0001-8774-4579	Winthrop P. Rockefeller Cancer Institute; NIH [GM081766]; Center for Microbial Pathogenesis and Host Inflammatory Responses grant through the NIGMS Centers of Biomedical Research Excellence [P20GM103625]	Winthrop P. Rockefeller Cancer Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Microbial Pathogenesis and Host Inflammatory Responses grant through the NIGMS Centers of Biomedical Research Excellence	This work was supported by funds from the Winthrop P. Rockefeller Cancer Institute (T. C. C.), and in part by NIH Grant GM081766 and by the Center for Microbial Pathogenesis and Host Inflammatory Responses grant P20GM103625 through the NIGMS Centers of Biomedical Research Excellence.	Alford SE, 2015, CANCER RES, V75, P1366, DOI 10.1158/0008-5472.CAN-14-1849; Bah N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.251; Bochum Sylvia, 2018, Recent Results Cancer Res, V211, P217, DOI 10.1007/978-3-319-91442-8_15; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Carlson K, 2011, CLIN BREAST CANCER, V11, P73, DOI 10.1016/j.clbc.2011.03.006; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Choi ME, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.128834; Chu R, 2016, ONCOTARGET, V7, P78958, DOI 10.18632/oncotarget.12586; Chu R, 2012, BIOCHEM PHARMACOL, V83, P199, DOI 10.1016/j.bcp.2011.10.008; Clarke PR, 2018, MOL CELL ONCOL, V5, DOI 10.1080/23723556.2018.1516450; COMPTON MM, 1992, CANCER METAST REV, V11, P105, DOI 10.1007/BF00048058; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Delgado M, 2019, BIOCHEM PHARMACOL, V162, P213, DOI 10.1016/j.bcp.2018.12.015; Delgado M, 2018, CELL CYCLE, V17, P1784, DOI 10.1080/15384101.2018.1496746; Delgado M, 2017, JOVE-J VIS EXP, DOI 10.3791/56418; Du LH, 2005, ONCOGENE, V24, P107, DOI 10.1038/sj.onc.1208189; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Eichhorn JM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.360; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fatokun AA, 2014, BRIT J PHARMACOL, V171, P2000, DOI 10.1111/bph.12416; Furst R, 2013, PHARMAZIE, V68, P478, DOI 10.1691/ph.2013.6509; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Giannakakou P, 2000, NAT CELL BIOL, V2, P709, DOI 10.1038/35036335; Golstein P, 2005, CELL DEATH DIFFER, V12, P1490, DOI 10.1038/sj.cdd.4401607; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Kitagawa K, 2011, NAT REV CLIN ONCOL, V8, P228, DOI 10.1038/nrclinonc.2010.228-c1; Komlodi-Pasztor E, 2013, CLIN CANCER RES, V19, P1304, DOI 10.1158/1078-0432.CCR-12-2058; Komlodi-Pasztor E, 2012, CLIN CANCER RES, V18, P51, DOI 10.1158/1078-0432.CCR-11-0999; Komlodi-Pasztor E, 2011, NAT REV CLIN ONCOL, V8, DOI 10.1038/nrclinonc.2010.228-c2; Kothari A, 2016, CANCER RES, V76, P3553, DOI 10.1158/0008-5472.CAN-15-2104; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Larsen BD, 2017, FEBS J, V284, P1160, DOI 10.1111/febs.13970; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Manchado E, 2012, CELL DEATH DIFFER, V19, P369, DOI 10.1038/cdd.2011.197; Mathiassen SG, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00051; Mauvezin C, 2015, AUTOPHAGY, V11, P1437, DOI 10.1080/15548627.2015.1066957; Mitchison TJ, 2012, MOL BIOL CELL, V23, P1, DOI 10.1091/mbc.E10-04-0335; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nijimeijer BA, 2009, EXP HEMATOL, V37, P376, DOI 10.1016/j.exphem.2008.11.002; Poruchynsky MS, 2015, P NATL ACAD SCI USA, V112, P1571, DOI 10.1073/pnas.1416418112; Pradelli LA, 2010, CELL MOL LIFE SCI, V67, P1589, DOI 10.1007/s00018-010-0285-y; Roth DM, 2007, TRAFFIC, V8, P673, DOI 10.1111/j.1600-0854.2007.00564.x; ROWINSKY EK, 1993, SEMIN ONCOL, V20, P1; Sakurikar N, 2014, CANCER LETT, V343, P232, DOI 10.1016/j.canlet.2013.09.036; Sakurikar N, 2012, J BIOL CHEM, V287, P39193, DOI 10.1074/jbc.M112.391854; Shalini S, 2015, CELL DEATH DIFFER, V22, P526, DOI 10.1038/cdd.2014.216; Shoemaker AR, 2008, CLIN CANCER RES, V14, P3268, DOI 10.1158/1078-0432.CCR-07-4622; Singh R, 2019, NAT REV MOL CELL BIO, V20, P175, DOI 10.1038/s41580-018-0089-8; Sloss O, 2016, ONCOTARGET, V7, P5176, DOI 10.18632/oncotarget.6894; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Steinmetz MO, 2018, TRENDS CELL BIOL, V28, P776, DOI 10.1016/j.tcb.2018.05.001; Terrano DT, 2010, MOL CELL BIOL, V30, P640, DOI 10.1128/MCB.00882-09; Topham CH, 2013, CURR OPIN CELL BIOL, V25, P780, DOI 10.1016/j.ceb.2013.07.003; Tunquist BJ, 2013, CLIN CANCER RES, V19, P1302, DOI 10.1158/1078-0432.CCR-12-1041; Upreti M, 2008, MOL CANCER THER, V7, P2224, DOI 10.1158/1535-7163.MCT-07-2299; Upreti M, 2006, J BIOL CHEM, V281, P15941, DOI 10.1074/jbc.M512586200; Upreti M, 2008, J BIOL CHEM, V283, P35517, DOI 10.1074/jbc.M805019200; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Whitaker RH, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040346; Wissing MD, 2013, CLIN CANCER RES, V19, P1303, DOI 10.1158/1078-0432.CCR-12-2695	61	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101939	10.1016/j.jbc.2022.101939	http://dx.doi.org/10.1016/j.jbc.2022.101939			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3R4NR	35436470	Green Published, gold			2022-12-26	WOS:000838892100002
J	El Kharbili, M; Aviszus, K; Sasse, SK; Zhao, XY; Serban, KA; Majka, SM; Gerber, AN; Gally, F				El Kharbili, Manale; Aviszus, Katja; Sasse, Sarah K.; Zhao, Xiaoyun; Serban, Karina A.; Majka, Susan M.; Gerber, Anthony N.; Gally, Fabienne			Macrophage programming is regulated by a cooperative interaction between fatty acid binding protein 5 and peroxisome proliferator-activated receptor gamma	FASEB JOURNAL			English	Article						FABP5; macrophage polarization; PPAR gamma; resolution of inflammation	OBSTRUCTIVE PULMONARY-DISEASE; PPAR-GAMMA; GENE-EXPRESSION; INDUCED SPUTUM; POLARIZATION; INFLAMMATION; DEFICIENCY; RESOLUTION; AGONIST; SYSTEM	Resolution of inflammation is an active process that is tightly regulated to achieve repair and tissue homeostasis. In the absence of resolution, persistent inflammation underlies the pathogenesis of chronic lung disease such as chronic obstructive pulmonary disease (COPD) with recurrent exacerbations. Over the course of inflammation, macrophage programming transitions from pro-inflammatory to pro-resolving, which is in part regulated by the nuclear receptor Peroxisome Proliferator-Activated Receptor gamma (PPAR gamma). Our previous work demonstrated an association between Fatty Acid Binding Protein 5 (FABP5) expression and PPAR gamma activity in peripheral blood mononuclear cells of healthy and COPD patients. However, a role for FABP5 in macrophage programming has not been examined. Here, using a combination of in vitro and in vivo approaches, we demonstrate that FABP5 is necessary for PPAR gamma activation. In turn, PPAR gamma acts directly to increase FABP5 expression in primary human alveolar macrophages. We further illustrate that lack of FABP5 expression promotes a pro-inflammatory macrophage programming with increased secretion of pro-inflammatory cytokines and increased chromatin accessibility for pro-inflammatory transcription factors (e.g., NF-kappa B and MAPK). And finally, real-time cell metabolic analysis using the Seahorse technology shows an inhibition of oxidative phosphorylation in FABP5-deficient macrophages. Taken together, our data indicate that FABP5 and PPAR gamma reciprocally regulate each other's expression and function, consistent with a novel positive feedback loop between the two factors that mediates macrophage pro-resolving programming. Our studies highlight the importance of defining targets and regulatory mechanisms that control the resolution of inflammation and may serve to inform novel interventional strategies directed towards COPD.	[El Kharbili, Manale; Aviszus, Katja; Zhao, Xiaoyun; Majka, Susan M.; Gerber, Anthony N.; Gally, Fabienne] Natl Jewish Hlth, Dept Immunol & Genom Med, 1400 Jackson St,Room K827, Denver, CO 80206 USA; [Sasse, Sarah K.; Serban, Karina A.; Majka, Susan M.; Gerber, Anthony N.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Serban, Karina A.; Majka, Susan M.; Gerber, Anthony N.; Gally, Fabienne] Univ Colorado, Dept Med, Aurora, CO USA	National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Gally, F (corresponding author), Natl Jewish Hlth, Dept Immunol & Genom Med, 1400 Jackson St,Room K827, Denver, CO 80206 USA.	gallyf@njhealth.org			HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [R01HL141264]	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: R01HL141264	Antunes ARP, 2021, NAT NEUROSCI, V24, P595, DOI 10.1038/s41593-020-00789-y; Auwerx J, 1999, CELL, V97, P161; Bashir S, 2016, INFLAMM RES, V65, P1, DOI 10.1007/s00011-015-0874-1; Bewley MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163139; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; de Groot LES, 2019, AM J PHYSIOL-LUNG C, V316, pL369, DOI 10.1152/ajplung.00456.2018; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Eapen MS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13888-x; Ferroni P, 2013, CURR VASC PHARMACOL, V11, P338, DOI 10.2174/1570161111311030008; Frankenberger M, 2004, CLIN EXP IMMUNOL, V138, P507, DOI 10.1111/j.1365-2249.2004.02637.x; Gally F, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.144294; Gally F, 2013, AM J PHYSIOL-LUNG C, V305, pL64, DOI 10.1152/ajplung.00276.2012; Gally F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051784; Gautier EL, 2012, J IMMUNOL, V189, P2614, DOI 10.4049/jimmunol.1200495; Green RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006860; Gupta A, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101147; Helledie T, 2000, J LIPID RES, V41, P1740; Hertzel AV, 1998, MOL CELL BIOCHEM, V188, P33; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kapellos TS, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/2349045; Kim JH, 2014, CELL DEATH DIFFER, V21, P594, DOI 10.1038/cdd.2013.181; Kim WJ, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/206937; Kunz LIZ, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-34; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Lakshmi SP, 2017, INT J CHRONIC OBSTR, V12, P2141, DOI 10.2147/COPD.S121416; Lakshmi SP, 2014, J BIOL CHEM, V289, P6383, DOI 10.1074/jbc.M113.536805; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Liu PS, 2019, METHODS MOL BIOL, V1862, P173, DOI 10.1007/978-1-4939-8769-6_13; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Petrusca DN, 2010, J BIOL CHEM, V285, P40322, DOI 10.1074/jbc.M110.137604; Rao DM, 2019, J INNATE IMMUN, V11, P469, DOI 10.1159/000496405; Rao DM, 2019, CLIN TRANSL MED, V8, DOI 10.1186/s40169-019-0227-8; Reynolds JM, 2007, J IMMUNOL, V179, P313, DOI 10.4049/jimmunol.179.1.313; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rubin JD, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02153-7; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; TEAGUE SV, 1994, INHAL TOXICOL, V6, P79, DOI 10.3109/08958379409029697; Tripodi IJ, 2018, MOLECULES, V23, DOI 10.3390/molecules23051136; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Viola A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01462; Wei W, 2010, CELL METAB, V11, P503, DOI 10.1016/j.cmet.2010.04.015; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898; Yoon YS, 2015, MUCOSAL IMMUNOL, V8, P1031, DOI 10.1038/mi.2014.130; Zimmerman AW, 2001, BIOCHEM J, V360, P159, DOI 10.1042/0264-6021:3600159	51	0	0	4	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22300	10.1096/fj.202200128R	http://dx.doi.org/10.1096/fj.202200128R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0O7OA	35436029	hybrid, Green Published			2022-12-26	WOS:000783712500001
J	Zhang, Y; Chang, HM; Zhu, H; Leung, PCK				Zhang, Yu; Chang, Hsun-Ming; Zhu, Hua; Leung, Peter C. K.			BMP2 suppresses the production of pentraxin 3 in human endometrial stromal and decidual stromal cells	FASEB JOURNAL			English	Article						BMP2; decidual stromal cells; decidualization; endometrial stromal cell; PTX3	GROWTH-DIFFERENTIATION FACTOR-8; SIGNALING PATHWAY; LONG PENTRAXIN-3; INNATE IMMUNITY; DOWN-REGULATION; EXPRESSION; PREGNANCY; PTX3; STEROIDOGENESIS; TISSUE	Bone morphogenetic protein 2 (BMP2) has been shown to act as a critical regulator in the processes of embryo implantation and endometrial decidualization. The expression and production of pentraxin 3 (PTX3) is essential for successful pregnancy, and aberrant production of PTX3 is involved in the pathogenesis of several vascular complications during pregnancy. Studies have shown that several transforming growth factor beta superfamily members, including BMP2, can regulate female reproductive function by modulating the expression of PTX3 in human granulosa cells. However, to date, whether BMP2 can regulate the production of PTX3 during endometrial decidualization remains to be elucidated. In this study, we aimed to explore the effect of BMP2 on the expression and production of PTX3 and the underlying molecular mechanisms using immortalized human endometrial stromal cells (I-HESCs) and human decidual stromal cells (HDSCs). We demonstrated that treatment with exogenous BMP2 significantly suppressed PTX3 production by decreasing the mRNA level of PTX3 in both I-HESCs and HDSCs. The results also showed that BMP2 activated SMAD signaling by inducing an increase in the protein levels of phosphorylated SMAD1/5/8, and this effect could be abolished by pretreatment with the ALK2/3 inhibitor DMH-1 but not with the ALK1/4/7 inhibitor SB431542. Additionally, combined knockdown of ALK2 and ALK3 completely reversed the BMP2-induced suppressive effect on PTX3 expression, while concomitant knockdown of SMAD1 and SMAD5 or knockdown of SMAD4 completely reversed the BMP2-induced suppressive effect on PTX3 expression. Taken together, these results indicate that BMP2 suppressed PTX3 production by decreasing PTX expression, which is mediated by a canonical ALK2/3-mediated SMAD1/5-SMAD4-dependent signaling pathway. Our findings suggest that BMP2 may potentially regulate the process of endometrial decidualization by suppressing the production of PTX3 in humans.	[Zhang, Yu] Hangzhou Med Coll, Sch Nursing, 8 Yikang St, Hangzhou 311399, Peoples R China; [Zhang, Yu; Chang, Hsun-Ming; Zhu, Hua; Leung, Peter C. K.] Univ British Columbia, BC Childrens Hosp Res Inst, Dept Obstet & Gynaecol, Room 317,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada; [Chang, Hsun-Ming] China Med Univ Hosp, Reprod Med Ctr, Dept Obstet & Gynecol, Taichung, Taiwan	Hangzhou Medical College; University of British Columbia; China Medical University Taiwan; China Medical University Hospital - Taiwan	Zhang, Y (corresponding author), Hangzhou Med Coll, Sch Nursing, 8 Yikang St, Hangzhou 311399, Peoples R China.; Zhang, Y; Leung, PCK (corresponding author), Univ British Columbia, BC Childrens Hosp Res Inst, Dept Obstet & Gynaecol, Room 317,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada.	zhangy@hmc.edu.cn; peter.leung@ubc.ca		Leung, Peter/0000-0003-3152-3800	CARE program at the BC Women's Hospital	CARE program at the BC Women's Hospital	We thank the patients and staff of the CARE program at the BC Women's Hospital and Health Centre for providing placental samples used in this study.	Bai L, 2017, ENDOCRINOLOGY, V158, P3501, DOI 10.1210/en.2017-00436; Cetin I, 2006, AM J OBSTET GYNECOL, V194, P1347, DOI 10.1016/j.ajog.2005.11.018; Chang HM, 2017, HUM REPROD UPDATE, V23, P1, DOI 10.1093/humupd/dmw039; Chang HM, 2016, FERTIL STERIL, V105, P520, DOI 10.1016/j.fertnstert.2015.10.034; Chang HM, 2015, MOL CELL ENDOCRINOL, V404, P82, DOI 10.1016/j.mce.2015.01.036; Chang HM, 2015, J CLIN ENDOCR METAB, V100, pE365, DOI 10.1210/jc.2014-2496; Chang HM, 2014, J CLIN ENDOCR METAB, V99, pE1922, DOI 10.1210/jc.2014-1223; Colmenares-Mejia CC, 2020, HYPERTENS RES, V43, P884, DOI 10.1038/s41440-020-0434-0; Derynck R, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav5183; Doni A, 2006, J LEUKOCYTE BIOL, V79, P797, DOI 10.1189/jlb.0905493; Goodman Adam R., 1996, Cytokine and Growth Factor Reviews, V7, P191, DOI 10.1016/1359-6101(96)00019-6; Hamed S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2606-3; Holtzhausen A, 2014, FASEB J, V28, P1248, DOI 10.1096/fj.13-239178; Larsson A, 2011, INFLAMMATION, V34, P448, DOI 10.1007/s10753-010-9252-x; Lee KY, 2007, MOL CELL BIOL, V27, P5468, DOI 10.1128/MCB.00342-07; Li H, 2018, ENDOCRINOLOGY, V159, P1644, DOI 10.1210/en.2017-03127; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Li QX, 2013, ENDOCRINOLOGY, V154, P446, DOI 10.1210/en.2012-1585; Liu C, 2019, MOL CELL ENDOCRINOL, V493, DOI 10.1016/j.mce.2019.110485; Luo J, 2020, FASEB J, V34, P15462, DOI 10.1096/fj.202000508R; Nagashima T, 2013, J CLIN INVEST, V123, P2539, DOI 10.1172/JCI65710; Popovici RM, 2008, ENDOCRINOLOGY, V149, P1136, DOI 10.1210/en.2007-1302; Rovere-Querini P, 2006, OBSTET GYNECOL, V108, P148, DOI 10.1097/01.AOG.0000224607.46622.bc; Stoikos CJ, 2008, HUM REPROD, V23, P1447, DOI 10.1093/humrep/den110; Susperregui ARG, 2011, MOL ENDOCRINOL, V25, P1006, DOI 10.1210/me.2010-0515; Todoric J, 2013, EUR J CLIN INVEST, V43, P341, DOI 10.1111/eci.12051; Tranguch S, 2007, BIOL REPROD, V77, P425, DOI 10.1095/biolreprod.107.062414; Wisniewski HG, 2004, CYTOKINE GROWTH F R, V15, P129, DOI 10.1016/j.cytogfr.2004.01.005; You JL, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.607332; Yu N, 2021, TAIWAN J OBSTET GYNE, V60, P816, DOI 10.1016/j.tjog.2021.07.006; Zeybek S, 2019, BALK J MED GENET, V22, P21, DOI 10.2478/bjmg-2019-0002; Zhang Y, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.573028; Zhao HJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0230-1; Zhou P, 2012, INFLAMM RES, V61, P1005, DOI 10.1007/s00011-012-0507-x	34	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22319	10.1096/fj.202200081RR	http://dx.doi.org/10.1096/fj.202200081RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0N3EM	35429060				2022-12-26	WOS:000782725200001
J	Nakakido, M; Tanaka, N; Shimojo, A; Miyamae, N; Tsumoto, K				Nakakido, Makoto; Tanaka, Naoki; Shimojo, Ayako; Miyamae, Nobuhiro; Tsumoto, Kouhei			Development of a high-throughput method to screen novel antiviral materials	PLOS ONE			English	Article							PHAGE DISPLAY	Respiratory infectious diseases pose a serious threat worldwide, and novel antiviral materials are highly demanded. Photocatalytic nanoparticles have been developed to inhibit indirect transmission of pathogens by acting as surface coating materials. During development of such antiviral materials, researchers use bacteriophages as model viruses due to their safety and experimental efficiency. Screening methods are used to identify potential antiviral materials, and better screening technologies will accelerate the discovery of antiviral treatments. In this study, we constructed a novel platform to evaluate antiviral activity of surface coating materials using the M13 bacteriophage and phagemid system derived from phage display technology. The evaluation results generated by this system for the two tested antiviral materials were comparable to those for the materials tested on the Q beta bacteriophage and influenza virus using traditional screening methods. The experimental system developed in this study provides rapid and effective screening and can be applied to the development of novel antiviral materials.	[Nakakido, Makoto; Tsumoto, Kouhei] Univ Tokyo, Dept Bioengn, Sch Engn, Bunkyo Ku, Tokyo, Japan; [Nakakido, Makoto; Tsumoto, Kouhei] Univ Tokyo, Dept Chem & Biotechnol, Sch Engn, Bunkyo Ku, Tokyo, Japan; [Tanaka, Naoki; Shimojo, Ayako; Miyamae, Nobuhiro] Nippon Paint Co LTD, Shinagawa Ku, Tokyo, Japan; [Tsumoto, Kouhei] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Nakakido, M; Tsumoto, K (corresponding author), Univ Tokyo, Dept Bioengn, Sch Engn, Bunkyo Ku, Tokyo, Japan.; Nakakido, M; Tsumoto, K (corresponding author), Univ Tokyo, Dept Chem & Biotechnol, Sch Engn, Bunkyo Ku, Tokyo, Japan.; Tsumoto, K (corresponding author), Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo, Japan.	nakakido@g.ecc.u-tokyo.ac.jp; tsumoto@bioeng.t.u-tokyo.ac.jp			Nippon paint Co. LTD.	Nippon paint Co. LTD.	This study was funded by Nippon paint Co. LTD.	Byrne JA, 2015, MOLECULES, V20, P5574, DOI 10.3390/molecules20045574; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Ebrahimizadeh W, 2014, CURR MICROBIOL, V69, P109, DOI 10.1007/s00284-014-0557-0; Kehoe JW, 2005, CHEM REV, V105, P4056, DOI 10.1021/cr000261r; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Lee CMY, 2007, NAT PROTOC, V2, P3001, DOI 10.1038/nprot.2007.448; Leung NHL, 2021, NAT REV MICROBIOL, V19, P528, DOI 10.1038/s41579-021-00535-6; Liu M, 2015, J MATER CHEM A, V3, P17312, DOI 10.1039/c5ta03756e; Ly-Chatain MH, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00046; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Minoshima M, 2016, J HAZARD MATER, V312, P1, DOI 10.1016/j.jhazmat.2016.03.023; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Pelaez M, 2012, APPL CATAL B-ENVIRON, V125, P331, DOI 10.1016/j.apcatb.2012.05.036; Qiu XQ, 2012, ACS NANO, V6, P1609, DOI 10.1021/nn2045888; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Weiss C, 2020, ACS NANO, V14, P6383, DOI 10.1021/acsnano.0c03697; World Health Organization, WHO COR COVID 19 DAS	19	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0266474	10.1371/journal.pone.0266474	http://dx.doi.org/10.1371/journal.pone.0266474			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476790	gold, Green Published, Green Submitted			2022-12-26	WOS:000840124300011
J	Arnaout, R; Arnaout, R				Arnaout, Ramy; Arnaout, Rima			Visualizing omicron: COVID-19 deaths vs. cases over time	PLOS ONE			English	Article								For most of the COVID-19 pandemic, the daily focus has been on the number of cases, and secondarily, deaths. The most recent wave was caused by the omicron variant, first identified at the end of 2021 and the dominant variant through the first part of 2022. South Africa, one of the first countries to experience and report data regarding omicron (variant 21.K), reported far fewer deaths, even as the number of reported cases rapidly eclipsed previous peaks. However, as the omicron wave has progressed, time series show that it has been markedly different from prior waves. To more readily visualize the dynamics of cases and deaths, it is natural to plot deaths per million against cases per million. Unlike the time-series plots of cases or deaths that have become daily features of pandemic updates during the pandemic, which have time as the x-axis, in a plot of deaths vs. cases, time is implicit, and is indicated in relation to the starting point. Here we present and briefly examine such plots from a number of countries and from the world as a whole, illustrating how they summarize features of the pandemic in ways that illustrate how, in most places, the omicron wave is very different from those that came before. Code for generating these plots for any country is provided in an automatically updating GitHub repository.	[Arnaout, Ramy] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Div Clin Pathol, Boston, MA USA; [Arnaout, Ramy] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Clin Informat, Boston, MA USA; [Arnaout, Rima] Univ Calif San Francisco, Bakar Computat Hlth Sci Inst, Dept Med, Biol & Med Informat Grad Program,Div Cardiol,Chan, San Francisco, CA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of California System; University of California San Francisco	Arnaout, R (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Div Clin Pathol, Boston, MA USA.; Arnaout, R (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Clin Informat, Boston, MA USA.	rarnaout@bidmc.harvard.edu			NIH [1R01AI148747, 1R01HL150394]; Gordon and Betty Moore Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This work would not have been possible without expert data collection and curation at all levels, together with the selfless commitment to openness and sharing that resulted in this data being publicly available.	[Anonymous], JOHNS HOPKINS CORONA; [Anonymous], 2020, EXPLORING US COVID 1; [Anonymous], 2021, ATTR; [Anonymous], 2021, PHAS PORTR; Beaumont P., 2021, GUARDIAN 1222; Bentley E., 2021, SARS COV 2 OMICRON B, DOI DOI 10.1101/2021.12.26.474085; Cao Y., 2022, NATURE, V602, P657, DOI [10.1038/s41586-021-04385-3, DOI 10.1038/S41586-021-04385-3]; CDC, 2022, COVID DAT TRACK; Hodcroft E. B, 2021, COVARIANTS SARS COV; Hui KPY, 2022, NATURE, V603, P715, DOI 10.1038/s41586-022-04479-6; Ito K, 2022, J MED VIROL, V94, P2265, DOI 10.1002/jmv.27560; J. Zahradnik, 2021, bioRxiv, DOI 10.1101/2021.12.03.471045; Papanikolaou V, 2022, GENE, V814, DOI 10.1016/j.gene.2021.146134; prograft, 2020, SCATT CHART ACTIVE C; Ritchie Hannah, 2020, CORONAVIRUS PANDEMIC; Sheikh A., 2021, SEVERITY OMICRON VAR; Tarke A., 2021, BIORXIV, DOI [10.1101/2021.12.28.474333, DOI 10.1101/2021.12.28.474333]	17	1	1	7	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0265233	10.1371/journal.pone.0265233	http://dx.doi.org/10.1371/journal.pone.0265233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7VA	35439253	Green Submitted, Green Published, gold			2022-12-26	WOS:000791280100006
J	Chomczynski, PW; Vires, KM; Rymaszewski, M; Heiny, JA				Chomczynski, Peter W.; Vires, Kianna M.; Rymaszewski, Michal; Heiny, Judith A.			A real-time PCR method to genotype mutant mouse models with altered affinity for cardiotonic steroids on the Na,K-ATPase	PLOS ONE			English	Article							OUABAIN-SENSITIVE ALPHA-1-NA,K-ATPASE; ENDOGENOUS OUABAIN; ALPHA-1 ISOFORM; NA+/K+-ATPASE; SITE; K+	The highly conserved, cardiotonic steroid binding site (also termed ouabain binding site) on the primary alpha subunit of Na,K-ATPase plays a receptor signaling role in a range of vital cell processes and is a therapeutic target for human disease. Mouse lines with altered affinity for cardiotonic steroids on the alpha 1 or alpha 2 subunit isoform of Na,K-ATPase, without any change in pump activity, were developed by the late Jerry B Lingrel and are a valuable tool for studying its physiological roles and drug actions. In one model, the normally ouabain resistant alpha 1 isoform was rendered sensitive to ouabain binding. In a second model, the normally sensitive alpha 2 isoform was rendered resistant to ouabain binding. Additional useful models are obtained by mating these mice. To further advance their use, we developed a rapid, real-time PCR method that detects mutant alleles using specific primers and fluorescent probes. PCR is performed in fast mode with up to 15 samples processed in 40 min. The method was validated by Sanger sequencing using mice of known genotype, and by comparing results with a previous two-step method that used PCR amplification followed by gel electrophoresis. In addition, we clarified inconsistencies in published sequences, updated numbering to current reference sequences, and confirmed the continued presence of the mutations in the colony. It is expected that a wider availability of these models and a more efficient genotyping protocol will advance studies of the Na,K-ATPase and its cardiotonic steroid receptor.	[Chomczynski, Peter W.; Vires, Kianna M.; Rymaszewski, Michal; Heiny, Judith A.] Mol Res Ctr, Cincinnati, OH 45212 USA; [Heiny, Judith A.] Univ Cincinnati, Dept Pharmacol & Syst Physiol, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Heiny, JA (corresponding author), Mol Res Ctr, Cincinnati, OH 45212 USA.; Heiny, JA (corresponding author), Univ Cincinnati, Dept Pharmacol & Syst Physiol, Cincinnati, OH 45221 USA.	heinyja@ucmail.uc.edu		Chomczynski, Peter/0000-0001-7570-6663	University of Cincinnati; MRC, Inc	University of Cincinnati; MRC, Inc	JH received funding from the Physiology Research Fund, University of Cincinnati. PWC, KMV, and MR are employed by Molecular Research Center, Inc., https://nam11.safelinks. protection.outlook.com/?url=https%3A%2F% 2Fwww.mrcgene.com%2F & data=04%7C01% <ITALIC><BOLD> </BOLD></ITALIC>7Cheinyja%40ucmail.uc.edu%7C36d690f385d64 a6aa81f08da1973b4d0%7Cf5222e6c5fc648eb 8f0373db18203b63%7C1%7C0%7C63785028 2022118272%7CUnknown%7CTWFpbGZsb3d8 eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBT iI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000 & sdata= BvwsSW4H72vu4d9RnYDxyELPwOJTiqqR Uojzzr6bx8M%3D & reserved=0. MRC, Inc. funded this study. MRC, Inc. had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	[Anonymous], 2021, NCBI REF SEQ NP 6591; [Anonymous], BLAST; [Anonymous], 2020, REAL TIME PCR GUIDE; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Blaustein MP, 2020, CELL CALCIUM, V86, DOI 10.1016/j.ceca.2020.102159; Blaustein MP, 2016, J PHYSIOL-LONDON, V594, P6079, DOI 10.1113/JP272419; Clausen MV, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00371; Cui XY, 2017, MOLECULES, V22, DOI 10.3390/molecules22060990; Despa S, 2012, CARDIOVASC RES, V95, P480, DOI 10.1093/cvr/cvs213; Dostanic I, 2004, J BIOL CHEM, V279, P54053, DOI 10.1074/jbc.M410737200; Dostanic I, 2003, J BIOL CHEM, V278, P53026, DOI 10.1074/jbc.M308547200; Dostanic-Larson I, 2006, AM J PHYSIOL-REG I, V290, pR524, DOI 10.1152/ajpregu.00838.2005; Hamlyn JM, 2016, HYPERTENSION, V68, P526, DOI 10.1161/HYPERTENSIONAHA.116.06599; JOHNSON CL, 1995, BIOCHEM J, V309, P187, DOI 10.1042/bj3090187; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Klimanova EA, 2017, SCI REP-UK, V7, DOI 10.1038/srep45403; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; Loreaux EL, 2008, J AM SOC NEPHROL, V19, P1947, DOI 10.1681/ASN.2008020174; Norman N, 2021, bioRxiv, DOI 10.1101/2021.10.14.454503; OBRIEN WJ, 1994, ARCH BIOCHEM BIOPHYS, V310, P32, DOI 10.1006/abbi.1994.1136; Owczarzy R, 2008, NUCLEIC ACIDS RES, V36, pW163, DOI 10.1093/nar/gkn198; Pratt RD, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092600; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; Shattock MJ, 2015, J PHYSIOL-LONDON, V593, P1361, DOI 10.1113/jphysiol.2014.282319; Upmanyu N, 2016, BBA-MOL CELL RES, V1863, P2809, DOI 10.1016/j.bbamcr.2016.09.001; Wansapura AN, 2011, AM J PHYSIOL-HEART C, V300, pH347, DOI 10.1152/ajpheart.00625.2010; You Y, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl175	27	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267348	10.1371/journal.pone.0267348	http://dx.doi.org/10.1371/journal.pone.0267348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446892	gold, Green Published			2022-12-26	WOS:000795468200029
J	Elhassanny, AEM; Abutaleb, NS; Seleem, MN				Elhassanny, Ahmed E. M.; Abutaleb, Nader S.; Seleem, Mohamed N.			Auranofin exerts antibacterial activity against Neisseria gonorrhoeae in a female mouse model of genital tract infection	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; REPURPOSING AURANOFIN; GONOCOCCAL-INFECTION; IMMUNE-RESPONSES; GOLD COMPOUND; IN-VITRO; EFFICACY; SUSCEPTIBILITY; MUTATIONS; MECHANISM	Neisseria gonorrhoeae has been classified by the U.S. Centers for Disease Control and Prevention as an urgent threat due to the rapid development of antibiotic resistance to currently available antibiotics. Therefore, there is an urgent need to find new antibiotics to treat gonococcal infections. In our previous study, the gold-containing drug auranofin demonstrated potent in vitro activity against clinical isolates of N. gonorrhoeae, including multidrug-resistant strains. Therefore, the aim of this study was to investigate the in vivo activity of auranofin against N. gonorrhoeae using a murine model of vaginal infection. A significant reduction in N. gonorrhoeae recovered from the vagina was observed for infected mice treated with auranofin compared to the vehicle over the course of treatment. Relative to the vehicle, after three and five days of treatment with auranofin, a 1.04 (91%) and 1.40 (96%) average log(10)-reduction of recovered N. gonorrhoeae was observed. In conclusion, auranofin has the potential to be further investigated as a novel, safe anti-gonococcal agent to help meet the urgent need for new antimicrobial agents for N. gonorrhoeae infection.	[Elhassanny, Ahmed E. M.; Abutaleb, Nader S.; Seleem, Mohamed N.] Virginia Polytech Inst & State Univ, Virginia Maryland Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA; [Seleem, Mohamed N.] Virginia Polytech Inst & State Univ, Ctr Emerging Zoonot & Arthropod Borne Pathogens, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Seleem, MN (corresponding author), Virginia Polytech Inst & State Univ, Virginia Maryland Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.; Seleem, MN (corresponding author), Virginia Polytech Inst & State Univ, Ctr Emerging Zoonot & Arthropod Borne Pathogens, Blacksburg, VA 24061 USA.	seleem@vt.edu	Seleem, Mohamed/H-2774-2018	Seleem, Mohamed/0000-0003-0939-0458; Elhassanny, Ahmed/0000-0003-4807-4327	National Institutes of Health [R01AI130186]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	M.N.S. received funding from National Institutes of Health (Grant No. R01AI130186) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelKhalek A, 2019, INT J ANTIMICROB AG, V53, P54, DOI 10.1016/j.ijantimicag.2018.09.018; AbdelKhalek A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26674-0; Abutaleb NS, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86595-3; Abutaleb NS, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64882-9; Abutaleb NS, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2019.10.009; Aguinagalde L, 2015, J ANTIMICROB CHEMOTH, V70, P2608, DOI 10.1093/jac/dkv163; Alhashimi M, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01225-19; BLODGETT RC, 1986, SCAND J RHEUMATOL, P67; Bradford PA, 2020, ACS INFECT DIS, V6, P1332, DOI 10.1021/acsinfecdis.0c00021; Butler MM, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00325-18, 10.1128/aac.00325-18]; Camara J, 2012, J ANTIMICROB CHEMOTH, V67, P1858, DOI 10.1093/jac/dks162; CDC, 2019, ANTIBIOTIC RESISTANC, DOI [DOI 10.15620/CDC:82532, 10.15620/cdc:82532]; Centers for Disease Control and Prevention, 2019, SEX TRANSM DIS SURV; Elkashif A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62696-3; FINKELSTEIN AE, 1976, ANN RHEUM DIS, V35, P251, DOI 10.1136/ard.35.3.251; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Foerster S, 2020, APMIS, V128, P242, DOI 10.1111/apm.13014; FURST DE, 1983, PHARMACOTHERAPY, V3, P284; Gulati S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003559; Harbut MB, 2015, P NATL ACAD SCI USA, V112, P4453, DOI 10.1073/pnas.1504022112; Hewitt CS, 2021, ACS INFECT DIS, V7, P1969, DOI 10.1021/acsinfecdis.1c00055; Jefferson Amber, 2021, Medicines (Basel), V8, DOI 10.3390/medicines8020011; Jerse AE, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00107; Kunz AN, 2012, J INFECT DIS, V205, P1821, DOI 10.1093/infdis/jis277; Liu Y, 2017, MUCOSAL IMMUNOL, V10, P1594, DOI 10.1038/mi.2017.11; Liu Y, 2014, MUCOSAL IMMUNOL, V7, P165, DOI 10.1038/mi.2013.36; Lovett A, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03187; Mohammad H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64352-2; Naclerio GA, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052427; Ohnishi M, 2011, ANTIMICROB AGENTS CH, V55, P3538, DOI 10.1128/AAC.00325-11; Picker MA, 2020, MMWR-MORBID MORTAL W, V69, P1876, DOI 10.15585/mmwr.mm6949a5; Raterman EL, 2019, METHODS MOL BIOL, V1997, P413, DOI 10.1007/978-1-4939-9496-0_24; Rowley J, 2019, B WORLD HEALTH ORGAN, V97, P548, DOI 10.2471/BLT.18.228486; Scangarella-Oman NE, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01221-18; Schmitt DM, 2016, INT J ANTIMICROB AG, V48, P367, DOI 10.1016/j.ijantimicag.2016.06.009; Seong YJ, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.02206-19; Shaughnessy J, 2016, J IMMUNOL, V196, P1732, DOI 10.4049/jimmunol.1500292; Spencer SE, 2004, J INFECT DIS, V189, P410, DOI 10.1086/381125; St Cyr S, 2020, MMWR-MORBID MORTAL W, V69, P1911, DOI 10.15585/mmwr.mm6950a6; Stevens JS, 2018, CURR OPIN HEMATOL, V25, P13, DOI 10.1097/MOH.0000000000000394; STREETER PR, 1981, INFECT IMMUN, V32, P105, DOI 10.1128/IAI.32.1.105-110.1981; TAYLORROBINSON D, 1990, MICROB PATHOGENESIS, V9, P369, DOI 10.1016/0882-4010(90)90071-W; Thangamani S, 2016, INT J ANTIMICROB AG, V47, P195, DOI 10.1016/j.ijantimicag.2015.12.016; Thangamani S, 2016, SCI REP-UK, V6, DOI 10.1038/srep22571; Unemo M, 2021, J ANTIMICROB CHEMOTH, V76, P1221, DOI 10.1093/jac/dkab024; Unemo M, 2014, CLIN MICROBIOL REV, V27, P587, DOI 10.1128/CMR.00010-14; Unemo M, 2012, ANTIMICROB AGENTS CH, V56, P1273, DOI 10.1128/AAC.05760-11; Warner DM, 2008, MOL MICROBIOL, V70, P462, DOI 10.1111/j.1365-2958.2008.06424.x; Woods Charles R, 2005, Semin Pediatr Infect Dis, V16, P258, DOI 10.1053/j.spid.2005.06.006	49	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266764	10.1371/journal.pone.0266764	http://dx.doi.org/10.1371/journal.pone.0266764			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446884	Green Published, gold			2022-12-26	WOS:000795468200050
J	Furukawa, D; Yamanaka, Y; Kasai, H; Urushibara, T; Ishiwata, T; Muranishi, S				Furukawa, Daisuke; Yamanaka, Yoshitaka; Kasai, Hajime; Urushibara, Takashi; Ishiwata, Tomokazu; Muranishi, Sachiyo			Temporal characteristics of aspiration pneumonia in elderly inpatients: From resumption of oral intake to onset	PLOS ONE			English	Article							FRAIL OLDER-PEOPLE; RISK-FACTORS; ACQUIRED PNEUMONIA; DYSPHAGIA; CARE; FREQUENCY	Background Elderly inpatients who develop fevers after resumption of oral intake are often considered to have aspiration pneumonia (AP) and be tentatively fasted. Fasting has been associated with prolonged hospital stays and decreased swallowing ability. The purpose of this study was to compare AP and other infections after resumption of oral intake in elderly inpatients and to identify the clinical characteristics. Patients and methods The records of patients who were admitted to a public tertiary hospital and referred for evaluation of swallowing disability were retrospectively reviewed to identify those who had developed AP, non-AP, or urinary tract infection (UTI) after resumption of oral intake. Eligible patients were enrolled consecutively in the study. The patient characteristics, physical findings, laboratory data, oral intake status at the time of onset of symptoms, and rate of discontinuation of oral intake after onset of infection were compared between the three types of infection. Results A total of 193 patients developed an infectious illness after resuming oral intake. Among them, 114 patients had a diagnosis of AP (n = 45), non-AP (n = 24), or UTI (n = 45). There were no significant differences in patient characteristics, physical findings or laboratory data between the group with AP and the other two groups. AP developed at a median of 6 (range 1 16) days after resumption of oral intake. The rate of discontinuation of oral intake was 91.1% in the AP group, 58.3% in the non-AP group, and 26.7% in the UTI group, respectively. Conclusion Infectious diseases other than AP should be considered in the differential diagnosis when nosocomial fever develops in elderly inpatients more than 17 days after resuming oral intake. Furthermore, nosocomial fever after resuming oral intake has many causes other than AP, and discontinuation of oral intake should be carefully considered.	[Furukawa, Daisuke; Yamanaka, Yoshitaka; Ishiwata, Tomokazu; Muranishi, Sachiyo] Kimitsu Chuo Hosp, Dept Rehabil, Kisarazu, Japan; [Yamanaka, Yoshitaka] Chiba Univ Hosp, Urayasu Rehabil Educ Ctr, Dept Neurol, Chiba, Japan; [Kasai, Hajime; Urushibara, Takashi] Kimitsu Chuo Hosp, Dept Respirol, Kisarazu, Japan; [Kasai, Hajime] Chiba Univ, Grad Sch Med, Dept Respirol, Chiba, Japan	Chiba University; Chiba University	Furukawa, D (corresponding author), Kimitsu Chuo Hosp, Dept Rehabil, Kisarazu, Japan.	daisuke.furukawa01@gmail.com		Kasai, Hajime/0000-0002-6759-2026; Furukawa, Daisuke/0000-0002-3454-5493				[Anonymous], 2009, RESPIROLOGY, V14, pS59, DOI [10.1111/j.1400-1843.2009.1578.x, 10.1111/j.1440-1843.2009.01578.x]; Avci M, 2012, ARCH GERONTOL GERIAT, V54, P247, DOI 10.1016/j.archger.2011.03.014; Blomqvist A., 2013, INT J MICROBIOL IMMU, V2, P37; Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049; El-Solh AA, 2010, CURR MED RES OPIN, V26, P2707, DOI 10.1185/03007995.2010.530154; Fujita K, 2019, ANAEROBE, V57, P86, DOI 10.1016/j.anaerobe.2019.04.002; Ito M, 2018, GERIATR GERONTOL INT, V18, P1469, DOI 10.1111/ggi.13514; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kenzaka T, 2017, CLIN INTERV AGING, V12, P283, DOI 10.2147/CIA.S122309; Lakshminarayan K, 2010, STROKE, V41, P2849, DOI 10.1161/STROKEAHA.110.597039; Langmore SE, 2002, DYSPHAGIA, V17, P298, DOI 10.1007/s00455-002-0072-5; Lapa S, 2021, DYSPHAGIA, V36, P882, DOI 10.1007/s00455-020-10204-0; Maeda K, 2016, CLIN NUTR, V35, P1147, DOI 10.1016/j.clnu.2015.09.011; Mandell LA, 2019, NEW ENGL J MED, V380, P651, DOI 10.1056/NEJMra1714562; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908; Momosaki R, 2016, GERIATR GERONTOL INT, V16, P556, DOI 10.1111/ggi.12506; Morimoto K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122247; Murray J, 1996, DYSPHAGIA, V11, P99, DOI 10.1007/BF00417898; Noguchi S, 2017, CLIN INTERV AGING, V12, P2087, DOI 10.2147/CIA.S150499; Oguchi K., 2000, JPN J REHAB MED, V38, P383, DOI [10.2490/jjrm1963.37.383, DOI 10.2490/jjrm1963.37.383, DOI 10.2490/JJRM1963.37.383]; Oka H, 2017, GERIATR GERONTOL INT, V17, P1076, DOI 10.1111/ggi.12830; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Rosenbek JC, 1996, DYSPHAGIA, V11, P93, DOI 10.1007/BF00417897; Teramoto S, 2008, J AM GERIATR SOC, V56, P577, DOI 10.1111/j.1532-5415.2008.01597.x; Tohara H, 2003, DYSPHAGIA, V18, P126, DOI 10.1007/s00455-002-0095-y; Trivalle C, 1998, ARCH INTERN MED, V158, P1560, DOI 10.1001/archinte.158.14.1560; van der Maarel-Wierink CD, 2011, J DENT RES, V90, P1398, DOI 10.1177/0022034511422909; van der Maarel-Wierink CD, 2013, GERODONTOLOGY, V30, P3, DOI 10.1111/j.1741-2358.2012.00637.x; van der Maarel-Wierink CD, 2011, J AM MED DIR ASSOC, V12, P344, DOI 10.1016/j.jamda.2010.12.099; Watanabe S, 2020, ODONTOLOGY, V108, P117, DOI 10.1007/s10266-019-00431-9; Yamazoe M, 2019, J INFECT CHEMOTHER, V25, P950, DOI 10.1016/j.jiac.2019.05.016; Yoneyama T, 2002, J AM GERIATR SOC, V50, P430, DOI 10.1046/j.1532-5415.2002.50106.x	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267119	10.1371/journal.pone.0267119	http://dx.doi.org/10.1371/journal.pone.0267119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421190	gold, Green Published			2022-12-26	WOS:000795453600111
J	Gabriel, FC; Stein, AT; de Melo, DO; Fontes-Mota, GCH; dos Santos, IB; Rodrigues, CD; Rodrigues, MC; Fraguas, R; Florez, ID; Correia, DT; Ribeiro, E				Gabriel, Franciele Cordeiro; Stein, Airton Tetelbom; de Melo, Daniela Oliveira; Fontes-Mota, Gessica Caroline Henrique; dos Santos, Itamires Benicio; Rodrigues, Camila da Silva; Rodrigues, Monica Cristiane; Fraguas, Renerio; Florez, Ivan D.; Correia, Diogo Telles; Ribeiro, Eliane			Recommendations for the pharmacological treatment of treatment-resistant depression: A systematic review protocol	PLOS ONE			English	Review							CLINICAL-PRACTICE GUIDELINES; AGREE II; LONG-TERM; QUALITY; MANAGEMENT; INSTRUMENT; APPRAISAL; DISEASE; TOOL	IntroductionDepression is a serious and widespread mental health disorder. Although effective treatment does exist, a significant proportion of patients with depression fail to respond to antidepressant treatment trials, a condition named treatment-resistant depression. Efficient approach should be given this condition in order to revert the burden caused by depression. Clinical practice guidelines (CPGs) are evidence-based health promotion instruments to improve diagnosis and treatment. CPGs recommendations for treatment-resistant depression must be trustworthy. The objective of the proposed study is to systematically identify, appraise the quality of CPGs for the treatment of depression and elaborate a synthesis of recommendations for treatment-resistant depression of CPGs considered to be of high quality and with high quality recommendations. Methods and analysisWe will search the databases of organizations, such as PubMed, Embase, Cochrane Library, PsycInfo, and the Virtual Health Library, and organizations that develop CPGs. Three independent researchers will assess the quality of the CPGs and their recommendations using the AGREE II and AGREE-REX instruments, respectively. Given the identification of divergences and convergences as well as weak and strong points among high quality CPGs, our work may help developers, clinicians and eventually patients. Ethics and disseminationNo ethical approval is required for a systematic review, as no patient data will be used. The research results will be disseminated in conferences and submitted to a peer reviewed journal.	[Gabriel, Franciele Cordeiro; Fontes-Mota, Gessica Caroline Henrique; Ribeiro, Eliane] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Farm, Sao Paulo, SP, Brazil; [Stein, Airton Tetelbom] Univ Fed Ciencias Saude Porto Alegre, Dept Saude Colet, Porto Alegre, RS, Brazil; [Stein, Airton Tetelbom] Hosp Conceicao, Curso Posgrad Avaliacaode Tecnol Saude, Porto Alegre, RS, Brazil; [de Melo, Daniela Oliveira; dos Santos, Itamires Benicio; Rodrigues, Camila da Silva] Univ Fed Sao Paulo, Dept Ciencias Farmaceut, Inst Ciencias Ambientais Quim & Farmaceut, Diadema, SP, Brazil; [Rodrigues, Monica Cristiane] Univ Sao Paulo, Fac Saude Publ, Sao Paulo, SP, Brazil; [Fraguas, Renerio] Univ Sao Paulo, Hosp Univ, Hosp Clin, Fac Med,Lab Neuroimagem Psiquiatria LIM 21,Dept P, Sao Paulo, Brazil; [Fraguas, Renerio] Univ Sao Paulo, Hosp Univ, Hosp Clin, Hosp Clin,Inst Psiquiatria,Div Psiquiatria & Psic, Sao Paulo, Brazil; [Fraguas, Renerio; Florez, Ivan D.] Mc Master Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Florez, Ivan D.] Univ Antioquia, Dept Pediat, Medellin, Colombia; [Florez, Ivan D.] Unit Clin Las Amer AUNA, Pediat Intens Care, Medellin, Colombia; [Correia, Diogo Telles] Univ Lisbon, Dept Psiquiatria & Psicol, Fac Med, Lisbon, Portugal	Universidade de Sao Paulo; Universidade Federal de Ciencias da Saude de Porto Alegre; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; McMaster University; Universidad de Antioquia; Universidade de Lisboa	Gabriel, FC (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Farm, Sao Paulo, SP, Brazil.	francordegabriel@gmail.com	Florez, Ivan D./K-3536-2015; Stein, Airton/Q-2218-2015	Florez, Ivan D./0000-0002-0751-8932; Stein, Airton/0000-0002-8756-8699; Benicio dos santos, Itamires/0000-0002-8693-3121	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [141811/2020-0]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Initials of the authors who received each award: FCG Award Number: 141811/2020-0 The full name of each funder: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico URL of each funder website: https://www.gov.br/cnpq/ptbr Have or will the sponsors or funders play any role in the study design, data collection (when applicable) and analysis, decision to publish, or preparation of the manuscript? The funders had not and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Initials of the authors who received each award: FCG.	Acuna-Izcaray A, 2013, CHEST, V144, P390, DOI 10.1378/chest.12-2005; AGREE Next Steps Consortium, 2017, AGREE 2 INSTR; AGREE-REX Research Team, 2019, APPR GUID RES EV REC; Agreetrust, 2010, AGR RES TRUST; Alonso-Coello P, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2010.042077; Arevalo-Rodriguez I, 2013, AM J ALZHEIMERS DIS, V28, P111, DOI 10.1177/1533317512470209; Bahn RS, 2011, THYROID, V21, P593, DOI 10.1089/thy.2010.0417; Bayes AJ, 2018, ACTA PSYCHIAT SCAND, V137, P459, DOI 10.1111/acps.12878; Brouwers MC, 2020, J CLIN EPIDEMIOL, V125, P191, DOI 10.1016/j.jclinepi.2020.05.025; Brouwers MC, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.5535; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Cipriani Andrea, 2018, Focus (Am Psychiatr Publ), V16, P420, DOI 10.1176/appi.focus.16407; Colunga-Lozano LE, 2021, J EVAL CLIN PRACT, V27, P385, DOI 10.1111/jep.13447; Consrcio AGREE, 2009, INSTR AV DIR CLNIC; Khan GSC, 2014, CAD SAUDE PUBLICA, V30, P1111, DOI 10.1590/0102-311X00174912; Dunner DL, 2006, J CLIN PSYCHIAT, V67, P688, DOI 10.4088/JCP.v67n0501; Fekadu A, 2009, J CLIN PSYCHIAT, V70, P177, DOI 10.4088/JCP.08m04309; Fekadu A, 2009, J AFFECT DISORDERS, V116, P4, DOI 10.1016/j.jad.2008.10.014; Gabriel FC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231700; Zafra-Tanaka JH, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2057-z; Hoffmann-Esser W, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-2954-8; Institute of Medicine, 2011, CLIN PRACTICE GUIDEL; Knai C, 2012, HEALTH POLICY, V107, P157, DOI 10.1016/j.healthpol.2012.06.004; Kung J, 2012, ARCH INTERN MED, V172, P1628, DOI 10.1001/2013.jamainternmed.56; Legido-Quigley H, 2012, HEALTH POLICY, V107, P146, DOI 10.1016/j.healthpol.2012.08.004; MacQueen G, 2017, CAN J PSYCHIAT, V62, P11, DOI 10.1177/0706743716664885; Ministrio da Sade (BR), 2012, PORT NO 1083 OUT 201; Ministrio da Sade (BR), 2014, PORT NO 1266 14 NOV; Mota DM, 2020, CIENC SAUDE COLETIVA, V25, P1955, DOI 10.1590/1413-81232020255.19522018; Murcia Paya JF., 2000, MED CLIN BARC, V114, P14; National Institute for Health and Care Excellence, 2006, OB PREV CLIN GUID; Nemeroff CB, 2007, J CLIN PSYCHIAT, V68, P17; Ouzzani M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0384-4; Page MJ, 2021, BMJ-BRIT MED J, V372, DOI [10.1136/bmj.n71, 10.1016/j.ijsu.2021.105906]; Molino CDRC, 2019, JAMA INTERN MED, V179, P553, DOI 10.1001/jamainternmed.2018.7529; Ronsoni RD, 2015, CAD SAUDE PUBLICA, V31, P1157, DOI 10.1590/0102-311X00118814; Rush AJ, 2004, CONTROL CLIN TRIALS, V25, P119, DOI 10.1016/S0197-2456(03)00112-0; Semlitsch T, 2015, DTSCH ARZTEBL INT, V112, P471, DOI 10.3238/arztebl.2015.0471; Siering U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082915; Taylor DM, 2018, MAUDSLEY PRESCRIBING; Thompson C., 2010, AFFECTIVE DISORD; Urinary Tract Infection Guideline Team, 2011, URINARY TRACT INFECT; Watine J, 2006, CLIN CHEM, V52, P65, DOI 10.1373/clinchem.2005.056952; Wooderson SC, 2011, J AFFECT DISORDERS, V131, P92, DOI 10.1016/j.jad.2010.11.002; World Health Organization, 2017, DEPR OTH COMM MENT I	45	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267323	10.1371/journal.pone.0267323	http://dx.doi.org/10.1371/journal.pone.0267323			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7VA	35439270	Green Published, gold			2022-12-26	WOS:000791280100013
J	Gutierrez, A; Schneider, KR				Gutierrez, Alan; Schneider, Keith R.			Survival and inactivation kinetics of Salmonella enterica serovar Typhimurium in irradiated and natural poultry litter microcosms	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; LISTERIA-MONOCYTOGENES; CHICKEN MANURE; WATER ACTIVITY; THERMAL INACTIVATION; WEIBULL MODEL; RISK-FACTORS; BACTERIAL; CONTAMINATION; SPP.	The use of poultry litter as a biological soil amendment presents a risk for the preharvest contamination of fresh produce by Salmonella. In order to properly assess this risk, it is important to understand the factors influencing the persistence of Salmonella in poultry litter. This research was performed to investigate the influence of indigenous microflora on the survival of Salmonella Typhimurium in poultry litter. Microcosms of irradiated (sterilized) and natural poultry litter were inoculated with S. Typhimurium, adjusted to pH 8.0, 0.92 water activity (a(w)), and stored at 30 degrees C for 6 days. S. Typhimurium populations (log CFU g(-1)) declined in both litter treatments and there were no significant differences (P > 0.05) in recovery between litter treatments on any sampling days (0 to 6). The pH of the natural litter significantly increased (P < 0.05) from 8.42 on day 0 to 9.00 on day 6. By day 6, S. Typhimurium populations in both litter treatments fell below the limit of detection (1 log CFU g(-1)). The inactivation kinetics of S. Typhimurium in both litter treatments were described by the Weibull model. Under the experimental conditions (pH 8.0, 0.92 a(w), 30 degrees C), the presence or absence of poultry litter microflora did not significantly influence the survival of S. Typhimurium. This study demonstrates that the mere presence of poultry litter microflora will not inhibit Salmonella survival. Instead, inhibitory interactions between various microorganisms in litter and Salmonella are likely dependent on more favorable environmental conditions (e.g., a(w), pH) for growth and competition.	[Gutierrez, Alan] Univ Florida, Emerging Pathogens Inst, Dept Anim Sci, Gainesville, FL USA; [Schneider, Keith R.] Univ Florida, Food Sci & Human Nutr Dept, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Schneider, KR (corresponding author), Univ Florida, Food Sci & Human Nutr Dept, Gainesville, FL USA.	keiths29@ufl.edu		Gutierrez, Alan/0000-0002-2710-434X				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albert I, 2005, INT J FOOD MICROBIOL, V100, P197, DOI 10.1016/j.ijfoodmicro.2004.10.016; ALEXANDE.DC, 1968, CANADIAN VET J, V9, P127; Baty F., 2014, NLSMICROBIO NONLINEA; Bigelow WD, 1920, J INFECT DIS, V27, P602, DOI 10.1093/infdis/27.6.602; Bolan NS, 2010, WORLD POULTRY SCI J, V66, P673, DOI 10.1017/S0043933910000656; Bucher MG, 2020, J ENVIRON QUAL, V49, P869, DOI 10.1002/jeq2.20081; CARR LE, 1995, AVIAN DIS, V39, P39, DOI 10.2307/1591980; CERF O, 1977, J APPL BACTERIOL, V42, P1, DOI 10.1111/j.1365-2672.1977.tb00665.x; Chen Z, 2015, APPL ENVIRON MICROB, V81, P6883, DOI 10.1128/AEM.01876-15; Chen Z, 2014, AGRICULTURE-BASEL, V4, P1, DOI 10.3390/agriculture4010001; Chen Z, 2013, APPL ENVIRON MICROB, V79, P7013, DOI 10.1128/AEM.01969-13; Chinivasagam HN, 2012, FOOD RES INT, V45, P891, DOI 10.1016/j.foodres.2011.06.014; CHURCHILL SW, 1972, AICHE J, V18, P1121, DOI 10.1002/aic.690180606; Combs S., 2003, RECOMMENDED METHODS; Coroller L, 2006, APPL ENVIRON MICROB, V72, P6493, DOI 10.1128/AEM.00876-06; Crippen TL, 2021, SCI TOTAL ENVIRON, V780, DOI 10.1016/j.scitotenv.2021.146413; Dumas MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024785; Erickson M.C., 2014, AGR FOOD ANAL BACTER, V4, P224; Erickson MC, 2004, J FOOD PROTECT, V67, P685, DOI 10.4315/0362-028X-67.4.685; Eriksson CL, 2001, J APPL POULTRY RES, V10, P245, DOI 10.1093/japr/10.3.245; Fries R, 2005, BRIT POULTRY SCI, V46, P668, DOI 10.1080/00071660500395483; Geeraerd AH, 2000, INT J FOOD MICROBIOL, V59, P185, DOI 10.1016/S0168-1605(00)00362-7; Geeraerd AH, 2005, INT J FOOD MICROBIOL, V102, P95, DOI 10.1016/j.ijfoodmicro.2004.11.038; Gu GY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02868; Gutierrez A, 2020, J FOOD PROTECT, V83, P2179, DOI 10.4315/JFP-20-215; HALBROOK ER, 1951, POULTRY SCI, V30, P381, DOI 10.3382/ps.0300381; Hayes JR, 2000, POULTRY SCI, V79, P1557, DOI 10.1093/ps/79.11.1557; Himathongkham S, 1999, FEMS MICROBIOL LETT, V172, P159, DOI 10.1111/j.1574-6968.1999.tb13464.x; Himathongkham S, 1999, FEMS MICROBIOL LETT, V171, P179, DOI 10.1111/j.1574-6968.1999.tb13430.x; Islam M, 2004, APPL ENVIRON MICROB, V70, P2497, DOI 10.1128/AEM.70.4.2497-2502.2004; Islam Mahbub, 2004, Foodborne Pathog Dis, V1, P27, DOI 10.1089/153531404772914437; Koziel JA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176825; Kyakuwaire M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16193521; Li JR, 2003, APPL ENVIRON MICROB, V69, P901, DOI 10.1128/AEM.69.2.901-908.2003; Locatelli A, 2017, J APPL POULTRY RES, V26, P325, DOI 10.3382/japr/pfw076; Mafart P, 2002, INT J FOOD MICROBIOL, V72, P107, DOI 10.1016/S0168-1605(01)00624-9; MOORE PA, 1995, J SOIL WATER CONSERV, V50, P321; Muniz E, 2014, REV COLOMB CIENC PEC, V27, P12; Natvig EE, 2002, APPL ENVIRON MICROB, V68, P2737, DOI 10.1128/AEM.68.6.2737-2744.2002; Ongeng D, 2014, J FOOD SCI, V79, pR421, DOI 10.1111/1750-3841.12392; OPARA OO, 1992, AVIAN DIS, V36, P664, DOI 10.2307/1591762; Pachepsky YA, 2006, AGR WATER MANAGE, V86, P81, DOI 10.1016/j.agwat.2006.06.010; Park S, 2012, J FOOD PROTECT, V75, P2055, DOI 10.4315/0362-028X.JFP-12-160; Payne JB, 2007, POULTRY SCI, V86, P191, DOI 10.1093/ps/86.1.191; Payne J.B., 2006, INT J POULT SCI, V5, P1102, DOI DOI 10.3923/IJPS.2006.1102.1109; Payne JB, 2002, J APPL POULTRY RES, V11, P239, DOI 10.1093/japr/11.3.239; Pradhan AK, 2019, FOOD MICROBIOLOGY, 5 EDITION, P989, DOI 10.1128/9781555819972.ch39; R Core Team, 2021, R LANGUAGE ENV STAT; REECE FN, 1979, POULTRY SCI, V58, P754, DOI 10.3382/ps.0580754; Roll VFB, 2011, POULTRY SCI, V90, P2257, DOI 10.3382/ps.2011-01583; SCHEFFERLE HE, 1965, J APPL BACTERIOL, V28, P403, DOI 10.1111/j.1365-2672.1965.tb02170.x; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sepehrnia N, 2017, J ENVIRON MANAGE, V201, P388, DOI 10.1016/j.jenvman.2017.07.009; Singh R, 2012, J APPL MICROBIOL, V112, P927, DOI 10.1111/j.1365-2672.2012.05268.x; Stocker MD, 2020, J ENVIRON QUAL, V49, P1633, DOI 10.1002/jeq2.20164; Strawn LK, 2013, APPL ENVIRON MICROB, V79, P7618, DOI 10.1128/AEM.02831-13; Terzich M, 2000, J APPL POULTRY RES, V9, P287, DOI 10.1093/japr/9.3.287; TURNBULL PC, 1973, AVIAN DIS, V17, P72, DOI 10.2307/1588921; U.S. Food and Drug Administration, 2021, BAM SALM; Van Boeijen IKH, 2008, J FOOD PROTECT, V71, P2007, DOI 10.4315/0362-028X-71.10.2007; van Boekel MAJS, 2002, INT J FOOD MICROBIOL, V74, P139, DOI 10.1016/S0168-1605(01)00742-5; van der Waal Z., 2017, GINAFIT A USER GUIDE; Wadud S, 2012, BRIT POULTRY SCI, V53, P561, DOI 10.1080/00071668.2012.723802; Wang D, 2018, CAN J MICROBIOL, V64, P979, DOI 10.1139/cjm-2018-0234; Wilkinson KG, 2011, POULTRY SCI, V90, P10, DOI 10.3382/ps.2010-01023; WILLIAMS JE, 1978, AVIAN DIS, V22, P742, DOI 10.2307/1589652; Zwietering MH, 2011, FOOD MICROBIOL, V28, P818, DOI 10.1016/j.fm.2010.04.015	68	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267178	10.1371/journal.pone.0267178	http://dx.doi.org/10.1371/journal.pone.0267178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7VA	35439271	gold, Green Published			2022-12-26	WOS:000791280100008
J	Khonsari, RH; Oranger, M; Francois, PM; Mendoza-Ruiz, A; Leroux, K; Boussaid, G; Prieur, D; Hodge, JP; Belle, A; Midler, V; Morelot-Panzini, C; Patout, M; Gonzalez-Bermejo, J				Khonsari, Roman Hossein; Oranger, Mathilde; Francois, Pierre-Marc; Mendoza-Ruiz, Alexis; Leroux, Karl; Boussaid, Ghilas; Prieur, Delphine; Hodge, Jean-Pierre; Belle, Antoine; Midler, Vincent; Morelot-Panzini, Capucine; Patout, Maxime; Gonzalez-Bermejo, Jesus			Quality versus emergency: How good were ventilation fittings produced by additive manufacturing to address shortages during the COVID19 pandemic?	PLOS ONE			English	Article							NONINVASIVE VENTILATION; LEAKS; SARS-COV-2; DISPERSION; MASKS; MOUTH	ObjectiveThe coronavirus disease pandemic (COVID-19) increased the risk of shortage in intensive care devices, including fittings with intentional leaks. 3D-printing has been used worldwide to produce missing devices. Here we provide key elements towards better quality control of 3D-printed ventilation fittings in a context of sanitary crisis. Material and methodsFive 3D-printed designs were assessed for non-intentional (junctional and parietal) and intentional leaks: 4 fittings 3D-printed in-house using FDeposition Modelling (FDM), 1 FDM 3D-printed fitting provided by an independent maker, and 2 fittings 3D-printed in-house using Polyjet technology. Five industrial models were included as controls. Two values of wall thickness and the use of coating were tested for in-house FDM-printed devices. ResultsIndustrial and Polyjet-printed fittings had no parietal and junctional leaks, and satisfactory intentional leaks. In-house FDM-printed fittings had constant parietal leaks without coating, but this post-treatment method was efficient in controlling parietal sealing, even in devices with thinner walls (0.7 mm vs 2.3 mm). Nevertheless, the use of coating systematically induced absent or insufficient intentional leaks. Junctional leaks were constant with FDM-printed fittings but could be controlled using rubber junctions rather than usual rigid junctions. The properties of Polyjet-printed and FDM-printed fittings were stable over a period of 18 months. Conclusions3D-printing is a valid technology to produce ventilation devices but requires care in the choice of printing methods, raw materials, and post-treatment procedures. Even in a context of sanitary crisis, devices produced outside hospitals should be used only after professional quality control, with precise data available on printing protocols. The mechanical properties of ventilation devices are crucial for efficient ventilation, avoiding rebreathing of CO2, and preventing the dispersion of viral particles that can contaminate health professionals. Specific norms are still required to formalise quality control procedures for ventilation fittings, with the rise of 3D-printing initiatives and the perspective of new pandemics.	[Khonsari, Roman Hossein] Hop Necker Enfants Malad, AP HP, Serv Chirurg Maxillofaciale & Chirurg Plast, Paris, France; [Khonsari, Roman Hossein] Univ Paris Cite, Fac Med, Paris, France; [Khonsari, Roman Hossein; Prieur, Delphine] AP HP, Delegat Interdept Dev Fabricat Addit DIDDFA, Direct Gen, Paris, France; [Oranger, Mathilde; Boussaid, Ghilas; Gonzalez-Bermejo, Jesus] Hop La Pitie Salpetriere, AP HP, Serv Rehabil Resp Dept R3S, Paris, France; [Oranger, Mathilde; Morelot-Panzini, Capucine; Patout, Maxime; Gonzalez-Bermejo, Jesus] Sorbonne Univ, Fac Med, Paris, France; [Francois, Pierre-Marc] BONE 3D, Paris, France; [Mendoza-Ruiz, Alexis; Leroux, Karl; Hodge, Jean-Pierre] ASV Sante, Gennevilliers, France; [Belle, Antoine] Ctr Hosp Intercommunal Compiegne Noyon, Serv Pneumol, Compiegne, France; [Midler, Vincent] AP HP, Dept Maitrise Ouvrage & Polit Tech DEFIP, Paris, France; [Morelot-Panzini, Capucine; Patout, Maxime; Gonzalez-Bermejo, Jesus] INSERM UMRS1158, Neurophysiol Resp Expt & Clin, Paris, France; [Patout, Maxime] Hop La Pitie Salpetriere, AP HP, Serv Pathol Sommeil Dept R3S, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Khonsari, RH (corresponding author), Hop Necker Enfants Malad, AP HP, Serv Chirurg Maxillofaciale & Chirurg Plast, Paris, France.; Khonsari, RH (corresponding author), Univ Paris Cite, Fac Med, Paris, France.; Khonsari, RH (corresponding author), AP HP, Delegat Interdept Dev Fabricat Addit DIDDFA, Direct Gen, Paris, France.	roman.khonsari@aphp.fr	Khonsari, Roman Hossein/H-7460-2017	Khonsari, Roman Hossein/0000-0002-0649-1432				Advincula RC, 2020, MRS COMMUN, V10, P413, DOI 10.1557/mrc.2020.57; Amza CG, 2021, POLYMERS-BASEL, V13, DOI 10.3390/polym13244467; Anwari V, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247575; Aydin A, 2021, EMERGENT MATER, V4, P363, DOI 10.1007/s42247-021-00164-y; Bernardo T, 2021, JMIR PUBLIC HLTH SUR, V7, DOI 10.2196/25935; Bharti N, 2020, ACS CHEM HEALTH SAFE, V27, P335, DOI 10.1021/acs.chas.0c00089; Blad T, 2020, APPL BIOSAF, V25, P161, DOI 10.1177/1535676020947284; Borel JC, 2009, CHEST, V135, P669, DOI 10.1378/chest.08-1340; Budinoff HD, 2021, J MANUF SYST, V60, P799, DOI 10.1016/j.jmsy.2021.07.010; Calderini E, 1999, INTENS CARE MED, V25, P662, DOI 10.1007/s001340050927; Cantero C, 2020, CHEST, V158, P279, DOI 10.1016/j.chest.2020.02.064; Delbarre M., 2021, ANN 3D PRINTED MED, V1; Delorme M, 2021, ARCH BRONCONEUMOL, V57, P28, DOI 10.1016/j.arbres.2021.01.012; Din AR, 2021, SURG-J R COLL SURG E, V19, pE281, DOI 10.1016/j.surge.2020.12.008; Fillat-Goma F, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05891-2; Francois PM, 2021, J STOMATOL ORAL MAXI, V122, P381, DOI 10.1016/j.jormas.2020.06.010; Goda I, 2022, P I MECH ENG H, V236, P613, DOI 10.1177/09544119211070373; Gonzalez J, 2003, INTENS CARE MED, V29, P596, DOI 10.1007/s00134-003-1659-5; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Hui DS, 2009, CHEST, V136, P998, DOI 10.1378/chest.09-0434; Ishack S, 2020, AM J MED, V133, pE385, DOI 10.1016/j.amjmed.2020.04.002; Lalieve L., 2021, ANN 3D PRINTED MED, V1; Lemarteleur V, 2021, AM J INFECT CONTROL, V49, P389, DOI 10.1016/j.ajic.2020.08.005; Louis B, 2010, EUR RESPIR J, V35, P627, DOI 10.1183/09031936.00188708; Manero A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134634; Martin-Noguerol T, 2021, AM J EMERG MED, V46, P659, DOI 10.1016/j.ajem.2020.08.010; Meyer TJ, 1997, SLEEP, V20, P561, DOI 10.1093/sleep/20.7.561; Ogbuoji EA, 2021, POLYMERS-BASEL, V13, DOI 10.3390/polym13121998; Oranger M, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01692-2020; Patout M, 2021, CHEST, V160, P175, DOI 10.1016/j.chest.2021.02.047; Perez-Mananes R, 2021, 3D PRINT MED, V7, DOI 10.1186/s41205-021-00097-6; Rendeki S, 2020, POLYMERS-BASEL, V12, DOI 10.3390/polym12112703; Spake CSL, 2021, ANN BIOMED ENG, V49, P3666, DOI 10.1007/s10439-021-02859-z; Tareq MS, 2021, J MANUF SYST, V60, P787, DOI 10.1016/j.jmsy.2020.12.021; Teschler H, 1999, EUR RESPIR J, V14, P1251, DOI 10.1183/09031936.99.14612519; Throckmorton AL, 2021, ANN BIOMED ENG, V49, P950, DOI 10.1007/s10439-021-02743-w; Vallatos Antoine, 2021, Front Med Technol, V3, P702526, DOI 10.3389/fmedt.2021.702526; Vanhooydonck A, 2021, J MANUF SYST, V60, P876, DOI 10.1016/j.jmsy.2021.03.016; Zannin E, 2021, PEDIATR RES, V89, P1322, DOI 10.1038/s41390-020-1102-4	39	1	1	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0263808	10.1371/journal.pone.0263808	http://dx.doi.org/10.1371/journal.pone.0263808			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446853	gold, Green Published			2022-12-26	WOS:000795468200052
J	Kuipers, YJ; Bleijenbergh, R; Van den Branden, L; van Gils, Y; Rimaux, S; Brosens, C; Claerbout, A; Mestdagh, E				Kuipers, Yvonne J.; Bleijenbergh, Roxanne; Van den Branden, Laura; van Gils, Yannic; Rimaux, Sophie; Brosens, Charlotte; Claerbout, Astrid; Mestdagh, Eveline			Psychological health of pregnant and postpartum women before and during the COVID-19 Pandemic	PLOS ONE			English	Article							PRIMARY-CARE; DEPRESSION; ANXIETY; PREVALENCE; RESILIENCE; DISORDERS	Background The COVID-19 pandemic is likely to influence psychological health of pregnant and postpartum women. Methods We conducted a non-concurrent cross-sectional study among 1145 women living in the Dutch-speaking part of Belgium, 541 pregnant and 604 postpartum women. We measured psychological health with the Whooley questions, Generalized Anxiety Disorder 2-item (GAD-2) and the Edinburgh Postnatal Depression Scale (EPDS) and compared the scores of pregnant and postpartum women before and during the COVID-19 pandemic. Results No differences were observed in the Whooley, GAD-2 or EPDS scores among pregnant women. The postpartum total GAD-2 scores before vs during the pandemic showed significant differences. Controlling for confounders, we observed a small main positive effect of having an infant during time of COVID-19 (F(1.13) = 5.06, p.025, d.27). The effect was significantly larger for women with (a history of) perinatal psychological problems (F(1.12) = 51.44, p< .001, d.82). Emotional support was significantly related to GAD-2 scores of postpartum women during the pandemic (F(1.90) = 35.54, p < .001). Postpartum women reported significant higher effects of the pandemic on their behavior compared to pregnant women (p.034). Conclusion The COVID-19 pandemic seems to have a positive effect on postpartum women during the first year postpartum, in particular for women with (a history of) perinatal psychological problems and for those women who experienced emotional support. The findings suggest that less external stimuli caused by lockdown restrictions might have a positive effect on postpartum women's emotional wellbeing. The sample consisted of white, educated women in a relationship and information regarding the extent of exposure to adverse COVID-19 consequences was lacking. We relied on self-selection and self-report. The postpartum pandemic sample was small.	[Kuipers, Yvonne J.; Bleijenbergh, Roxanne; Van den Branden, Laura; van Gils, Yannic; Rimaux, Sophie; Brosens, Charlotte; Claerbout, Astrid; Mestdagh, Eveline] AP Univ Coll, Sch Midwifery, Dept Hlth & Social Care, Antwerp, Belgium; [Kuipers, Yvonne J.] Edinburgh Napier Univ, Sch Hlth & Social Care, Edinburgh, Midlothian, Scotland; [Bleijenbergh, Roxanne; Van den Branden, Laura; van Gils, Yannic; Mestdagh, Eveline] Antwerp Univ, Fac Med & Hlth Sci, Antwerp, Belgium	Edinburgh Napier University; University of Antwerp	Kuipers, YJ (corresponding author), AP Univ Coll, Sch Midwifery, Dept Hlth & Social Care, Antwerp, Belgium.; Kuipers, YJ (corresponding author), Edinburgh Napier Univ, Sch Hlth & Social Care, Edinburgh, Midlothian, Scotland.	yvonne.fontein-kuipers@ap.be	Mestdagh, Eveline/AAJ-6963-2021; Kuipers, Yvonne/AAT-3998-2020	Mestdagh, Eveline/0000-0003-0116-0738; Kuipers, Yvonne/0000-0002-4200-0522; Bleijenbergh, Roxanne/0000-0001-6534-7169; van Gils, Yannic/0000-0001-7917-4684	Interreg 2 Seas Mers Zeeen [2S05-002]; Province Antwerp Service for Europe, Department of Economy, Local Policies and Europe [BBSPATH 1564468860780]	Interreg 2 Seas Mers Zeeen; Province Antwerp Service for Europe, Department of Economy, Local Policies and Europe	The work was funded by Interreg 2 Seas Mers Zeee<spacing diaeresis>n https://www.interreg2seas.eu/nl [grant number 2S05-002, 2019] and Province Antwerp Service for Europe, Department of Economy, Local Policies and Europe [grant number BBSPATH 1564468860780, 2019]. The sponsors had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari EH, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.29256; Akhtar H, 2020, GYNECOL OBSTET INVES, V85, P295, DOI 10.1159/000509290; Almeida M, 2020, ARCH WOMEN MENT HLTH, V23, P741, DOI 10.1007/s00737-020-01092-2; B-OSS, 2021, NAT OBST SURV SYST I; Baumann S, 2021, MIDWIFERY, V94, DOI 10.1016/j.midw.2020.102918; Bergink V, 2011, J PSYCHOSOM RES, V70, P385, DOI 10.1016/j.jpsychores.2010.07.008; Beutels P, 2020, GROTE CORONONA STUDI; Boushra MN, 2021, AM J EMERG MED, V40, P193, DOI 10.1016/j.ajem.2020.10.055; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Brown A, 2021, MATERN CHILD NUTR, V17, DOI 10.1111/mcn.13088; Ceulemans M, 2021, ACTA OBSTET GYN SCAN, V100, P1219, DOI 10.1111/aogs.14092; Davenport Margie H, 2020, Front Glob Womens Health, V1, P1, DOI 10.3389/fgwh.2020.00001; Davis-Floyd R, 2020, MED ANTHROPOL, V39, P413, DOI 10.1080/01459740.2020.1761804; Donker T, 2011, PSYCHIAT RES, V188, P58, DOI 10.1016/j.psychres.2011.01.016; Durankus F, 2022, J MATERN-FETAL NEO M, V35, P205, DOI 10.1080/14767058.2020.1763946; Fallon V, 2021, J PSYCHIATR RES, V136, P157, DOI 10.1016/j.jpsychires.2021.01.048; Fan S, 2021, ASIAN J PSYCHIATR, V56, DOI 10.1016/j.ajp.2020.102533; Fergusson DM, 2014, JAMA PSYCHIAT, V71, P1025, DOI 10.1001/jamapsychiatry.2014.652; Fontein-Kuipers Y, 2019, J MENT HEALTH TRAIN, V14, P33, DOI 10.1108/JMHTEP-06-2018-0034; Fontein-Kuipers YJ, 2016, ARCH WOMEN MENT HLTH, V19, P779, DOI 10.1007/s00737-016-0614-8; Gao M, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2583-1; Ghorayeb J, 2018, QUAL HEALTH RES, V28, P1283, DOI 10.1177/1049732318763114; Guo J, 2021, PSYCHOL MED, DOI [10.1017/S0033291720005504, 10.1109/ICETCI53161.2021.9563561]; Harville EW, 2010, WOMEN HEALTH ISS, V20, P20, DOI 10.1016/j.whi.2009.10.002; Heiman T, 2002, J DEV PHYS DISABIL, V14, P159, DOI 10.1023/A:1015219514621; Hessami K, 2022, J MATERN-FETAL NEO M, V35, P4014, DOI 10.1080/14767058.2020.1843155; Kalcev G., 2020, OPEN ACCESS MACED J, V8, P245; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Lebel C, 2020, J AFFECT DISORDERS, V277, P5, DOI 10.1016/j.jad.2020.07.126; Levis B, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4022; Lopez-Morales H, 2021, PSYCHIAT RES, V295, DOI 10.1016/j.psychres.2020.113567; Matthies LM, 2020, ARCH GYNECOL OBSTET, V301, P107, DOI 10.1007/s00404-019-05402-7; Matvienko-Sikar K, 2021, WOMEN BIRTH, V34, P447, DOI 10.1016/j.wombi.2020.10.010; Montagnoli C, 2021, MIDWIFERY, V94, DOI 10.1016/j.midw.2020.102916; Moyer CA, 2020, ARCH WOMEN MENT HLTH, V23, P757, DOI 10.1007/s00737-020-01073-5; Mucci F, 2020, CLIN NEUROPSYCHIATR, V17, P63, DOI 10.36131/CN20200205; Murray D, 1990, J REPROD INFANT PSYC, V8, P99, DOI DOI 10.1080/02646839008403615; Nath S, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023766; Nelson A, 2021, MED LAW REV, V29, P661, DOI 10.1093/medlaw/fwab040; Ollivier R, 2021, MIDWIFERY, V94, DOI 10.1016/j.midw.2020.102902; Osborne LM, 2021, MATERN CHILD HLTH J, V25, P349, DOI 10.1007/s10995-020-03114-y; Pariente G, 2020, ARCH WOMEN MENT HLTH, V23, P767, DOI 10.1007/s00737-020-01075-3; Paul Elise, 2020, Wellcome Open Res, V5, P108, DOI 10.12688/wellcomeopenres.15925.1; POP VJ, 1992, J AFFECT DISORDERS, V26, P105, DOI 10.1016/0165-0327(92)90041-4; Roesch E, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1712; Sciensano, 2021, COVID 19 EP; Sibley CG, 2020, AM PSYCHOL, V75, P618, DOI 10.1037/amp0000662; Silverman ME, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-79564-9; Silverman ME, 2020, ARCH WOMEN MENT HLTH, V23, P779, DOI 10.1007/s00737-020-01061-9; Spijker J, 2013, MULTIDISCIPLINAIRE R; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Thapa SB, 2020, ACTA OBSTET GYN SCAN, V99, P817, DOI 10.1111/aogs.13894; Topalidou A., 2020, COVID 19 MATERNAL ME, DOI [10.1101/2020.03.30.20047969, DOI 10.1101/2020.03.30.20047969]; Vasilevski V, 2022, WOMEN BIRTH, V35, P298, DOI 10.1016/j.wombi.2021.04.012; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Yang X, 2021, J MED INTERNET RES, V23, DOI 10.2196/24495; Zanardo V, 2020, INT J GYNECOL OBSTET, V150, P184, DOI 10.1002/ijgo.13249	58	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267042	10.1371/journal.pone.0267042	http://dx.doi.org/10.1371/journal.pone.0267042			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421171	Green Published, gold			2022-12-26	WOS:000795453600098
J	Loffreda, A; Schlame, M; Butikofer, P				Loffreda, Alessio; Schlame, Michael; Buetikofer, Peter			StaR-related lipid transfer-like domain-containing protein CLDP43 affects cardiolipin synthesis and mitochondrial function in Trypanosoma brucei	PLOS ONE			English	Article							ESCHERICHIA-COLI; CYTOCHROME-C; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; INNER MEMBRANE; BLOOD-STREAM; COMPLEX-III; REQUIREMENT; SYNTHASE; PHOSPHATIDYLETHANOLAMINE	Cardiolipin is known to interact with bacterial and mitochondrial proteins and protein complexes. Unlike in Escherichia coli and Saccharomyces cerevisiae, the synthesis of cardiolipin is essential for growth of Trypanosoma brucei parasites in culture. Inhibition of cardiolipin production has been shown to result in major changes in the T. brucei proteome and energy metabolism, with CLDP43, a mitochondrial protein containing a StaR-related lipid transfer (START)-like domain, being depleted in a cardiolipin-dependent way. We now show that in T. brucei procyclic forms lacking CLDP43, cardiolipin metabolism and mitochondrial function are affected. Using quantitative and qualitative lipid analyses, we found that while steady-state levels of cardiolipin were elevated in CLDP43 knock-out parasites compared to parental cells, de novo formation of cardiolipin was down-regulated. In addition, depletion of CLDP43 resulted in partial loss of mitochondrial membrane potential and decreased ATP production via substrate level phosphorylation. Recombinant CLDP43 was found to bind cardiolipin and phosphatidic acid in lipid overlay experiments, suggesting that it may be involved in transport or synthesis of cardiolipin or its precursors in T. brucei.	[Loffreda, Alessio; Buetikofer, Peter] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland; [Loffreda, Alessio] Univ Bern, Grad Sch Cellular & Biochem Studies, Bern, Switzerland; [Schlame, Michael] NYU, Dept Cell Biol, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA	University of Bern; University of Bern; New York University; NYU Langone Medical Center	Butikofer, P (corresponding author), Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland.	peter.buetikofer@ibmm.unibe.ch			Swiss National Science Foundation [169355]; National Institutes of Health [R01 GM115593]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	PB -Swiss National Science Foundation grant 169355 MS -National Institutes of Health grant R01 GM115593 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; AhYoung AP, 2019, METHODS MOL BIOL, V1949, P213, DOI 10.1007/978-1-4939-9136-5_16; Allemann N, 2000, MOL BIOCHEM PARASIT, V111, P87, DOI 10.1016/S0166-6851(00)00303-0; Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Alpy F, 2014, BIOCHIMIE, V96, P85, DOI 10.1016/j.biochi.2013.09.015; Andersen MH, 1997, BIOCHEMISTRY-US, V36, P5441, DOI 10.1021/bi963119m; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Beltran-Heredia E, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0471-x; Beneke T, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170095; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Charriere F, 2006, P NATL ACAD SCI USA, V103, P6847, DOI 10.1073/pnas.0602362103; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; Das K, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009551; Fiedorczuk K, 2016, NATURE, V538, P406, DOI 10.1038/nature19794; Friedman JR, 2015, ELIFE, V4, DOI 10.7554/eLife.07739; FRY M, 1980, BIOCHEM BIOPH RES CO, V93, P1238, DOI 10.1016/0006-291X(80)90622-1; FRY M, 1981, J BIOL CHEM, V256, P1874; Hill RJ, 2016, J BIOL CHEM, V291, P24280, DOI 10.1074/jbc.M116.740506; HIRSCHBERG CB, 1972, P NATL ACAD SCI USA, V69, P648, DOI 10.1073/pnas.69.3.648; HOFFMANN B, 1994, J BIOL CHEM, V269, P1940; HOSTETLER KY, 1971, BIOCHIM BIOPHYS ACTA, V239, P113, DOI 10.1016/0005-2760(71)90201-3; Jenni A, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100977; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; Joshi AS, 2021, MOL BIOL CELL, V32, P1147, DOI 10.1091/mbc.E20-09-0590; KADENBACH B, 1982, FEBS LETT, V139, P109, DOI 10.1016/0014-5793(82)80498-5; Kasahara T, 2020, FASEB J, V34, P1465, DOI 10.1096/fj.201901598R; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lykidis A, 2007, PROG LIPID RES, V46, P171, DOI 10.1016/j.plipres.2007.03.003; Mahtha SK., 2021, IDENTIFICATION DOWNS, P325; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Nakabayashi M, 2005, ACTA CRYSTALLOGR F, V61, P1027, DOI 10.1107/S1744309105035372; NISHIJIMA S, 1988, J BACTERIOL, V170, P775, DOI 10.1128/jb.170.2.775-780.1988; PATNAIK PK, 1993, MOL BIOCHEM PARASIT, V58, P97, DOI 10.1016/0166-6851(93)90094-E; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Ponting CP, 1999, TRENDS BIOCHEM SCI, V24, P130, DOI 10.1016/S0968-0004(99)01362-6; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; Richmond GS, 2010, PARASITOLOGY, V137, P1357, DOI 10.1017/S0031182010000715; Roderick SL, 2002, NAT STRUCT BIOL, V9, P507, DOI 10.1038/nsb812; Romanowski MJ, 2002, P NATL ACAD SCI USA, V99, P6949, DOI 10.1073/pnas.052140699; Roth GE, 2004, P NATL ACAD SCI USA, V101, P1601, DOI 10.1073/pnas.0308212100; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Schadeli D, 2019, FASEB J, V33, P13161, DOI 10.1096/fj.201901184RR; SCHLAME M, 1993, J BIOL CHEM, V268, P74; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Schlame M, 2017, BBA-MOL CELL BIOL L, V1862, P3, DOI 10.1016/j.bbalip.2016.08.010; Schrick K, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0070-8; Sedlak E, 1999, BIOCHEMISTRY-US, V38, P14966, DOI 10.1021/bi9914053; Serricchio M, 2021, FASEB J, V35, DOI 10.1096/fj.202001579RR; Serricchio M, 2013, MOL MICROBIOL, V87, P569, DOI 10.1111/mmi.12116; Serricchio M, 2012, P NATL ACAD SCI USA, V109, pE954, DOI 10.1073/pnas.1121528109; Shao C, 2008, J BIOL CHEM, V283, P7230, DOI 10.1074/jbc.M705195200; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Signorell A, 2008, J BIOL CHEM, V283, P23636, DOI 10.1074/jbc.M803600200; Signorell A, 2008, J BIOL CHEM, V283, P20320, DOI 10.1074/jbc.M802430200; Smith JT, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00204-18; Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; Starr ML, 2019, METHODS MOL BIOL, V1860, P211, DOI 10.1007/978-1-4939-8760-3_13; Sustarsic EG, 2018, CELL METAB, V28, P159, DOI 10.1016/j.cmet.2018.05.003; Tan BK, 2012, P NATL ACAD SCI USA, V109, P16504, DOI 10.1073/pnas.1212797109; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	63	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0259752	10.1371/journal.pone.0259752	http://dx.doi.org/10.1371/journal.pone.0259752			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C1KV	35452450	gold, Green Published			2022-12-26	WOS:000792887700021
J	Raina, R; Mawby, I; Chakraborty, R; Sethi, SK; Mathur, K; Mahesh, S; Forbes, M; Jia, ZJ				Raina, Rupesh; Mawby, Isabelle; Chakraborty, Ronith; Sethi, Sidharth Kumar; Mathur, Kashin; Mahesh, Shefali; Forbes, Michael; Jia, Zhanjun			Acute kidney injury in COVID-19 pediatric patients in North America: Analysis of the virtual pediatric systems data	PLOS ONE			English	Article								BackgroundDespite extensive research into acute kidney injury (AKI) in adults, research into the epidemiology, associated risk factors, treatment, and mortality of AKI in pediatric COVID-19 patients is understudied. Advancing understanding of this disease is crucial to further developing treatment and preventative care strategies to reduce morbidity and mortality. MethodsThis is a retrospective analysis of 2,546 COVID-19 pediatric patients (age <= 21 years) who were admitted the ICU in North America. Analysis of the Virtual Pediatric Systems (VPS) COVID-19 database was conducted between January 1, 2020, and June 30, 2021. ResultsOut of a total of 2,546 COVID positive pediatric patients, 10.8% (n = 274) were diagnosed with AKI. Significantly higher continuous and categorical outcomes in the AKI subset compared to the non-AKI cohort included: length of stay at the hospital (LOS) [9.04 (5.11-16.66) vs. 5.09 (2.58-9.94) days], Pediatric Index of Mortality (PIM) 2 probability of death [1.20 (0.86-3.83) vs. 0.96 (0.79-1.72)], PIM 3 probability of death [0.98 (0.72-2.93) vs. 0.78 (0.69-1.26)], mortality [crude OR (95% CI): 5.01 (2.89-8.70)], airway and respiratory support [1.63 (1.27-2.10)], cardio-respiratory support [3.57 (1.55-8.23)], kidney support [12.52 (5.30-29.58)], and vascular access [4.84 (3.70-6.32)]. ConclusionsThis is one of the first large scale studies to analyze AKI among pediatric COVID-19 patients admitted to the ICU in North America. Although the course of the COVID-19 virus appears milder in the pediatric population, renal complications may result, increasing the risk of disease complication and mortality.	[Raina, Rupesh; Chakraborty, Ronith; Mahesh, Shefali] Akron Childrens Hosp, Dept Nephrol, Akron, OH USA; [Raina, Rupesh; Chakraborty, Ronith] Akron Nephrol Associates, Dept Nephrol, Cleveland Clin, Akron Gen Med Ctr, Akron, OH USA; [Mawby, Isabelle] North East Ohio Med Univ, Dept Med, Rootstown, OH USA; [Sethi, Sidharth Kumar] Med Hosp, Kidney & Urol Inst, Pediat Nephrol & Pediat Kidney Transplantat, Medanta, Gurgaon, India; [Mathur, Kashin] Akron Nephrol Associates, Cleveland Clin, Akron Gen Med Ctr, Akron, OH USA; [Forbes, Michael] Akron Childrens Hosp, Dept Pediat, Akron, OH USA	Akron Children's Hospital; Akron General Medical Center; Cleveland Clinic Foundation; Akron General Medical Center; Cleveland Clinic Foundation; Akron Children's Hospital	Raina, R (corresponding author), Akron Childrens Hosp, Dept Nephrol, Akron, OH USA.; Raina, R (corresponding author), Akron Nephrol Associates, Dept Nephrol, Cleveland Clin, Akron Gen Med Ctr, Akron, OH USA.	rraina@akronchildrens.org		Mawby, Isabelle/0000-0002-7155-4620				Basu RK, 2022, PEDIATR RES, V91, P1787, DOI 10.1038/s41390-021-01667-4; Bialek S, 2020, MMWR-MORBID MORTAL W, V69, P422, DOI 10.15585/mmwr.mm6914e4; Bjornstad EC, 2021, CLIN J AM SOC NEPHRO, V16, P446, DOI 10.2215/CJN.11470720; Chan LL, 2021, J AM SOC NEPHROL, V32, P151, DOI [10.33982/clr.2021.11.30.151, 10.1681/ASN.2020050615]; Derespina KR, 2020, J PEDIATR-US, V226, P55, DOI 10.1016/j.jpeds.2020.07.039; Dionne A, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-009704; Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Fiser DH, 2000, CRIT CARE MED, V28, P1173, DOI 10.1097/00003246-200004000-00043; Gao YD, 2021, ALLERGY, V76, P428, DOI 10.1111/all.14657; Godfred-Cato S, 2020, MMWR-MORBID MORTAL W, V69, P1074, DOI 10.15585/mmwr.mm6932e2; Grimaud M, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00690-8; Kari JA, 2021, BMC NEPHROL, V22, DOI 10.1186/s12882-021-02389-9; Lee K, 2009, GLOB INST, P1; Lee PI, 2020, J MICROBIOL IMMUNOL, V53, P371, DOI 10.1016/j.jmii.2020.02.011; Livingston Edward, 2020, JAMA, V323, P1335, DOI 10.1001/jama.2020.4344; Mamishi S, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S095026882000196X; Marin BG, 2021, REV MED VIROL, V31, DOI 10.1002/rmv.2146; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Raina R, 2021, PEDIATR NEPHROL, V36, P2627, DOI 10.1007/s00467-021-05084-x; South AM, 2020, HYPERTENSION, V76, P16, DOI 10.1161/HYPERTENSIONAHA.120.15291; Stewart DJ, 2020, LANCET CHILD ADOLESC, V4, pE28, DOI 10.1016/S2352-4642(20)30178-4; Straney L, 2013, PEDIATR CRIT CARE ME, V14, P673, DOI 10.1097/PCC.0b013e31829760cf; Tagarro A, 2021, JAMA PEDIATR, V175, P316, DOI 10.1001/jamapediatrics.2020.1346; Toubiana J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2094; Vanderwall C, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1160-5; Wang XW, 2021, PEDIATR NEPHROL, V36, P163, DOI 10.1007/s00467-020-04715-z; Whittaker E, 2020, JAMA-J AM MED ASSOC, V324, P259, DOI 10.1001/jama.2020.10369; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648	30	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266737	10.1371/journal.pone.0266737	http://dx.doi.org/10.1371/journal.pone.0266737			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35472149	gold, Green Published			2022-12-26	WOS:000816171900032
J	Sano, M; Hirosawa, T; Kikuchi, M; Hasegawa, C; Tanaka, S; Yoshimura, Y				Sano, Masuhiko; Hirosawa, Tetsu; Kikuchi, Mitsuru; Hasegawa, Chiaki; Tanaka, Sanae; Yoshimura, Yuko			Relation between acquisition of lexical concept and joint attention in children with autism spectrum disorder without severe intellectual disability	PLOS ONE			English	Article							LANGUAGE	In children with autism spectrum disorder (ASD), impairment of joint attention and language function are observed frequently from early childhood. Earlier reports have described these two phenomena as mutually related. For this study, developing past research, the relation between joint attention and the ability of conceptual inference is examined in 113 Japanese children (67.9 months mean age, 75% male) with ASD. We calculated Pearson's correlation coefficients between their Joint attention abnormality evaluated by ADOS-2 and "Riddle" subscale in K-ABC, then they are negatively correlated: r (104) = -.285. A larger abnormality of joint attention is associated with a lower ability of conceptual inference. New findings were obtained indicating that, in children of this age group with ASD, the degree of joint attention impairment is correlated negatively with conceptual inference ability, but not with expressive and receptive language abilities. Consideration of the mechanism of this relation is presented in this report.	[Sano, Masuhiko; Hirosawa, Tetsu; Kikuchi, Mitsuru] Kanazawa Univ, Grad Sch Med Sci, Dept Psychiat & Neurobiol, Kanazawa, Ishikawa, Japan; [Hirosawa, Tetsu; Kikuchi, Mitsuru; Hasegawa, Chiaki; Tanaka, Sanae; Yoshimura, Yuko] Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa, Japan; [Yoshimura, Yuko] Kanazawa Univ, Fac Educ, Inst Human & Social Sci, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University; Kanazawa University	Yoshimura, Y (corresponding author), Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa, Japan.; Yoshimura, Y (corresponding author), Kanazawa Univ, Fac Educ, Inst Human & Social Sci, Kanazawa, Ishikawa, Japan.	yukuchen@staff.kanazawa-u.ac.jp	Hasegawa, Chiaki/HHS-2658-2022	Yoshimura, Yuko/0000-0001-9226-4561	Center of Innovation Program of the Japan Science and Technology Agency, JST, JSPS KAKENHI [20H04993, 19K02952]	Center of Innovation Program of the Japan Science and Technology Agency, JST, JSPS KAKENHI	This study was supported by the Center of Innovation Program of the Japan Science and Technology Agency, JST, JSPS KAKENHI Grant Numbers 20H04993 and 19K02952. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson LB, 2009, J AUTISM DEV DISORD, V39, P84, DOI 10.1007/s10803-008-0601-7; American Psychiatric Association, 2013, DSM 5 TASK FORCE DIA, DOI DOI 10.1176/APPI.BOOKS.9780890425596; BAKEMAN R, 1984, CHILD DEV, V55, P1278, DOI 10.2307/1129997; Bottema-Beutel K, 2016, AUTISM RES, V9, P1021, DOI 10.1002/aur.1624; Dawson G, 2004, DEV PSYCHOL, V40, P271, DOI 10.1037/0012-1649.40.2.271; Delbruck E, 2019, BRAIN RES, V1706, P157, DOI 10.1016/j.brainres.2018.10.029; Goelman G, 2019, NEUROIMAGE, V198, P242, DOI 10.1016/j.neuroimage.2019.05.028; Gotham K, 2007, J AUTISM DEV DISORD, V37, P613, DOI 10.1007/s10803-006-0280-1; Kasari C, 2006, J CHILD PSYCHOL PSYC, V47, P611, DOI 10.1111/j.1469-7610.2005.01567.x; Kaufman A. S, 2004, KAUFMAN BRIEF INTELL; Kikuchi M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01139; Langacker R.W., 1987, FDN COGNITIVE GRAMMA; Lord C., 2012, AUTISM DIAGNOSTIC OB; Mack JT, 2021, PSYCHOPATHOLOGY, DOI 10.1159/000520957; Matsuo Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125573; MUNDY P, 1995, DEV PSYCHOPATHOL, V7, P63, DOI 10.1017/S0954579400006349; MUNDY P, 1990, J AUTISM DEV DISORD, V20, P115, DOI 10.1007/BF02206861; OSTERLING J, 1994, J AUTISM DEV DISORD, V24, P247, DOI 10.1007/BF02172225; Robins DL, 2014, PEDIATRICS, V133, P37, DOI 10.1542/peds.2013-1813; Rogers S. J., 2010, EARLY START DENVER M; Siller M, 2002, J AUTISM DEV DISORD, V32, P77, DOI 10.1023/A:1014884404276; Tager-Flusberg H., 2005, DIAGNOSIS DEV NEUROB, V1, P335; Wing L, 2002, J CHILD PSYCHOL PSYC, V43, P307, DOI 10.1111/1469-7610.00023; Zhang YX, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16034-w	24	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266953	10.1371/journal.pone.0266953	http://dx.doi.org/10.1371/journal.pone.0266953			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1F9AX	35421165	gold, Green Published			2022-12-26	WOS:000795453600086
J	Szkwarko, D; Kim, S; Carter, EJ; Goldman, RE				Szkwarko, Daria; Kim, Steven; Carter, E. Jane; Goldman, Roberta E.			Primary care providers' and nurses' knowledge, attitudes, and skills regarding latent TB infection testing and treatment: A qualitative study from Rhode Island	PLOS ONE			English	Article							TUBERCULOSIS INFECTION; ADULTS; HEALTH; IMPACT	BackgroundUntreated latent tuberculosis infection (LTBI) is a major source of active tuberculosis disease in the United States. In 2016, the United States Preventive Services Task Force (USPSTF) recommended that screening for latent tuberculosis infection among individuals at increased risk be performed as routine preventive care. Traditionally, LTBI management-including both testing and treatment-has been conducted by specialists in the United States. It is believed that knowledge gaps among primary care team members and discomfort with LTBI treatment are significant barriers to LTBI management being conducted in primary care. Methods and objectivesThis qualitative study sought to evaluate the knowledge, attitudes, and skills of primary care team members regarding the LTBI care cascade, and to identify each stepwise barrier limiting primary care teams in following the USPSTF recommendations. ResultsWe conducted 24 key informant interviews with primary care providers and nurses in Rhode Island. Our results demonstrate that overall, few primary care providers and nurses felt comfortable with LTBI management, and their confidence and comfort decreased throughout the cascade. Participants felt least confident with LTBI treatment and held misconceptions about LTBI testing, such as high cost. Although participants were not confident about LTBI treatment, most were enthusiastic about treating patients if provided additional training. Participants suggested that their lack of knowledge regarding LTBI treatment led to high rates of referral to specialist providers. ConclusionThe gaps revealed in this study can inform training curricula for primary care team members in Rhode Island and nationally to shift the USPSTF policy into practice, and, ultimately, contribute to TB elimination in the United States.	[Szkwarko, Daria; Goldman, Roberta E.] Brown Univ, Warren Alpert Med Sch, Dept Family Med, Providence, RI 02912 USA; [Kim, Steven] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Carter, E. Jane] Brown Univ, Dept Med, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University; Brown University; Brown University	Szkwarko, D (corresponding author), Brown Univ, Warren Alpert Med Sch, Dept Family Med, Providence, RI 02912 USA.	Szkwarkd@gmail.com		Szkwarko, Daria/0000-0001-5864-9011	National Institute of General Medical Sciences of the National Institutes of Health [U54GM115677]; NIH/NIAID [R25AI140490]	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	DS is partially supported by an internal Institutional Development Award Number U54GM115677 funded by the National Institute of General Medical Sciences of the National Institutes of Health, which funds Advance Clinical and Translational Research (Advance-CTR https://www.brown.edu/initiatives/translational-research/home).Advance-CTR funded this research and members of their team provided mentorship to authors regarding Nvivo use. SK is supported by an internal program that is funded by the NIH/NIAID under R25AI140490 -Emerging Infectious Disease Scholars (EIDS https://www.brown.edu/academics/medical/plme/current-students/enrichment-activities/research-opportunities/emerging-infectious-diseases-scholars-) Program at Brown University. EIDs provided funding to support SK's time, but otherwise did not support the research in any other way. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, Advance-CTR, or EIDS.	Alsdurf H, 2016, LANCET INFECT DIS, V16, P1269, DOI 10.1016/S1473-3099(16)30216-X; [Anonymous], 2017, NVIVO; [Anonymous], 2021, RISE CLIN TUBERCULOS; Bertrand Tom, CHIEF CTR HIV STDS V; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P962, DOI 10.1001/jama.2016.11046; Borkan J, 1999, DOING QUALITATIVE RE, V2nd, P179; Centers for Disease Control and Prevention, 2018, CDC FACT SHEET TB US; Centers for Disease Control and Prevention, 2021, TEST TB INF; Centers for Disease Control and Prevention, 2018, TB US SNAPSH; Centers for Disease Control and Prevention, 2021, HLTH DISP TB; Centers for Disease Control and Prevention, 2021, CDCS TB WORK SAV LIV; Crabtree B.F., 1999, DOING QUALITATIVE RE; Iqbal AZ, 2014, PUBLIC HEALTH NURS, V31, P144, DOI 10.1111/phn.12083; Katrak S, 2018, AM J PUBLIC HEALTH, V108, pS242, DOI [10.2105/AJPH.2018.304529, 10.2105/ajph.2018.304529]; Kattakuzhy S, 2017, ANN INTERN MED, V167, P311, DOI [10.7326/M17-0118, 10.7326/m17-0118]; Kerse N, 2004, ANN FAM MED, V2, P455, DOI 10.1370/afm.139; KUZEL AJ, 1992, RES METH PR, V3, P31; Parriott A, 2020, PUBLIC HEALTH REP, V135, p172S, DOI 10.1177/0033354920927845; Robertshaw L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-015981; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; State of Rhode Island Department of Health, 2021, INF DIS NUMB 2021; Sterling TR, 2006, AM J RESP CRIT CARE, V173, P927, DOI 10.1164/rccm.200510-1563OC; U.S. Preventive Services Task Force, USPSTF WHO WE AR WE, P6; UpToDate, ABOUT AS; Yeh YP, 2005, T ROY SOC TROP MED H, V99, P509, DOI 10.1016/j.trstmh.2005.03.001	25	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267029	10.1371/journal.pone.0267029	http://dx.doi.org/10.1371/journal.pone.0267029			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1E2NP	35427377	gold, Green Published			2022-12-26	WOS:000794332400016
J	Uhe, T; Stegmann, T; Langhammer, R; Dagres, N; Laufs, U; Wachter, R				Uhe, Tobias; Stegmann, Tina; Langhammer, Romy; Dagres, Nikolaos; Laufs, Ulrich; Wachter, Rolf			Signs of left atrial disease and 10-year risk of atrial fibrillation	PLOS ONE			English	Article							P-WAVE INDEXES; NATRIURETIC PEPTIDE; CRYPTOGENIC STROKE; ATHEROSCLEROSIS RISK; PREMATURE BEATS; ISCHEMIC-STROKE; PREDICTORS; COHORT; VOLUME	BackgroundThe contribution of left atrial disease and excessive supraventricular ectopic activity (ESVEA) to the risk for incident atrial fibrillation (AF) is incompletely understood. ObjectiveTo analyse the ten-year risk to develop AF in patients with cardiovascular risk factors and to define the impact of parameters of left atrial disease and ESVEA on AF risk. Methods148 patients from the Diast-CHF trial with at least one cardiovascular risk factor and free of AF at baseline were followed for 10 years. Left atrial disease was defined as left atrial volume index (LAVI) >35 ml/m(2), P-terminal force in lead V-1 (PTFV1) >4000 ms*mu V or elevated N-terminal pro-B-type natriuretic peptide (NT-proBNP) >250 pg/ml. We analyzed the association of these parameters and ESVEA (either >720 premature atrial contractions (PAC) or one atrial run >20 beats per day) on AF-free survival. ResultsAfter ten years, AF was newly detected in twelve patients (13.4%) with signs of left atrial disease and two patients (3.4%) without signs of left atrial disease (p = 0.04). LAVI (p = 0.005), ESVEA (p = 0.016) and NT-proBNP (p = 0.010) were significantly associated with AF-free survival in univariate analysis. A combined Cox model of left atrial disease parameters showed associations for NT-proBNP (HR 3.56; 95%CI 1.33-5.31; p = 0.04) and PAC (HR 2.66; 95%CI 1.25-10.15; p = 0.01) but not for LAVI or PTFV1 with AF-free survival. ConclusionThe risk for AF is higher in patients with cardiovascular risk factors and signs of left atrial disease. NT-proBNP and premature atrial contractions independently predict AF-free survival. The role of excessive supraventricular ectopic activity for the assessment of AF risk may be underestimated and requires further study.	[Uhe, Tobias; Stegmann, Tina; Langhammer, Romy; Laufs, Ulrich; Wachter, Rolf] Univ Klinikum Leipzig, Klin & Poliklin Kardiol, Leipzig, Germany; [Dagres, Nikolaos] Herzzentrum Leipzig, Abt Rhythmol, Leipzig, Germany	Leipzig University; Heart Center Leipzig GMBH	Uhe, T (corresponding author), Univ Klinikum Leipzig, Klin & Poliklin Kardiol, Leipzig, Germany.	Tobias.Uhe@medizin.uni-leipzig.de	Uhe, Tobias/AAW-7581-2021	Uhe, Tobias/0000-0003-2543-2427; Stegmann, Tina/0000-0002-9678-6196				Abbasi SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164914; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Binici Z, 2010, CIRCULATION, V121, P1904, DOI 10.1161/CIRCULATIONAHA.109.874982; Conen D, 2012, CIRCULATION, V126, P2302, DOI 10.1161/CIRCULATIONAHA.112.112300; D'Andrea A, 2013, ECHOCARDIOGR-J CARD, V30, P1001, DOI 10.1111/echo.12217; Fradley MG, 2011, AM J CARDIOL, V108, P1341, DOI 10.1016/j.amjcard.2011.06.057; Gladstone DJ, 2015, STROKE, V46, P936, DOI 10.1161/STROKEAHA.115.008714; Goette A, 2017, HEART RHYTHM, V14, pE3, DOI 10.1016/j.hrthm.2016.05.028; Hindricks G, 2021, EUR HEART J, V42, P546, DOI 10.1093/eurheartj/ehaa945; Huang ZH, 2020, ANN NONINVAS ELECTRO, V25, DOI 10.1111/anec.12739; Kamel H, 2019, INT J STROKE, V14, P207, DOI 10.1177/1747493018799981; Kamel H, 2018, STROKE, V49, P980, DOI 10.1161/STROKEAHA.117.020059; Kamel H, 2014, STROKE, V45, P2786, DOI 10.1161/STROKEAHA.114.006364; Kochhauser S, 2014, STROKE, V45, P884, DOI 10.1161/STROKEAHA.113.003788; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Magnani JW, 2015, AM HEART J, V169, P53, DOI 10.1016/j.ahj.2014.10.009; Magnani JW, 2010, ANN NONINVAS ELECTRO, V15, P77, DOI 10.1111/j.1542-474X.2009.00343.x; Okin PM, 2016, J HYPERTENS, V34, P1831, DOI 10.1097/HJH.0000000000000989; Pagola J, 2021, TRANSL STROKE RES, V12, P735, DOI 10.1007/s12975-020-00873-2; Patton KK, 2009, CIRCULATION, V120, P1768, DOI 10.1161/CIRCULATIONAHA.109.873265; Poli S, 2016, EUR J NEUROL, V23, P375, DOI 10.1111/ene.12843; Psaty BM, 1997, CIRCULATION, V96, P2455; Rasmussen MU, 2020, ANN NONINVAS ELECTRO, V25, DOI 10.1111/anec.12751; Sajeev JK, 2019, J ELECTROCARDIOL, V52, P47, DOI 10.1016/j.jelectrocard.2018.11.007; Schnabel RB, 2010, CIRCULATION, V121, P200, DOI 10.1161/CIRCULATIONAHA.109.882241; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Seegers J, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2014-000182; Soliman EZ, 2009, STROKE, V40, P1204, DOI 10.1161/STROKEAHA.108.534735; Stahrenberg R, 2010, DIABETOLOGIA, V53, P1331, DOI 10.1007/s00125-010-1718-8; Tsang TSM, 2001, MAYO CLIN PROC, V76, P467, DOI 10.4065/76.5.467; VAZIRI SM, 1994, CIRCULATION, V89, P724, DOI 10.1161/01.CIR.89.2.724; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Wasser K, 2020, STROKE, V51, P395, DOI 10.1161/STROKEAHA.119.026496; Weber-Kruger M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067602; Xiao J, 2021, BMC CARDIOVASC DISOR, V21, DOI 10.1186/s12872-021-01942-6	35	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266848	10.1371/journal.pone.0266848	http://dx.doi.org/10.1371/journal.pone.0266848			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C1KV	35452471	gold, Green Published			2022-12-26	WOS:000792887700038
J	Valente, L; Le, ND; Pitton, MM; Chiffi, GR; Grandgirard, D; Jakob, S; Cameron, DL; Resch, G; Que, YA; Leib, S				Valente, Luca; Le, Ngoc Dung; Pitton, Melissa M.; Chiffi, Gabriele R.; Grandgirard, Denis; Jakob, Stephan; Cameron, David L.; Resch, Gregory; Que, Yok-Ai; Leib, Stephen			Efficacy assessment of a novel endolysin PlyAZ3a(T) for the treatment of ceftriaxone-resistant pneumococcal meningitis in an infant rat model	PLOS ONE			English	Article							PHAGE LYTIC ENZYMES; STREPTOCOCCUS-PNEUMONIAE; STAPHYLOCOCCUS-AUREUS; CONJUGATE VACCINE; BRAIN-DAMAGE; ANTIMICROBIAL RESISTANCE; CPL-1; LYSIN; PREVENTION; DISEASE	BackgroundTreatment failure in pneumococcal meningitis due to antibiotic resistance is an increasing clinical challenge and alternatives to antibiotics warrant investigation. Phage-derived endolysins efficiently kill gram-positive bacteria including multi-drug resistant strains, making them attractive therapeutic candidates. The current study assessed the therapeutic potential of the novel endolysin PlyAZ3a(T) in an infant rat model of ceftriaxone-resistant pneumococcal meningitis. MethodsEfficacy of PlyAZ3a(T) was assessed in a randomized, blinded and controlled experimental study in infant Wistar rats. Meningitis was induced by intracisternal infection with 5 x 10(7) CFU/ml of a ceftriaxone-resistant clinical strain of S. pneumoniae, serotype 19A. Seventeen hours post infection (hpi), animals were randomized into 3 treatment groups and received either (i) placebo (phosphate buffered saline [PBS], n = 8), (ii) 50 mg/kg vancomycin (n = 10) or (iii) 400 mg/kg PlyAZ3a(T) (n = 8) via intraperitoneal injection. Treatments were repeated after 12 h. Survival at 42 hpi was the primary outcome; bacterial loads in cerebrospinal fluid (CSF) and blood were secondary outcomes. Additionally, pharmacokinetics of PlyAZ3a(T) in serum and CSF was assessed. ResultsPlyAZ3a(T) did not improve survival compared to PBS, while survival for vancomycin treated animals was 70% which is a significant improvement when compared to PBS or PlyAZ3a(T) (p<0.05 each). PlyAZ3a(T) was not able to control the infection, reflected by the inability to reduce bacterial loads in the CSF, whereas Vancomycin sterilized the CSF and within 25 h. Pharmacokinetic studies indicated that PlyAZ3a(T) did not cross the blood brain barrier (BBB). In support, PlyAZ3a(T) showed a peak concentration of 785 mu g/ml in serum 2 h after intraperitoneal injection but could not be detected in CSF. ConclusionIn experimental pneumococcal meningitis, PlyAZ3a(T) failed to cure the infection due to an inability to reach the CSF. Optimization of the galenic formulation e.g. using liposomes might enable crossing of the BBB and improve treatment efficacy.	[Valente, Luca; Le, Ngoc Dung; Chiffi, Gabriele R.; Grandgirard, Denis; Leib, Stephen] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Valente, Luca; Pitton, Melissa M.; Jakob, Stephan; Cameron, David L.; Que, Yok-Ai] Univ Bern, Bern Univ Hosp, Dept Intens Care Med, Inselspital, Bern, Switzerland; [Valente, Luca; Le, Ngoc Dung; Pitton, Melissa M.; Chiffi, Gabriele R.] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Resch, Gregory] Lausanne Univ Hosp, Ctr Res & Innovat Clin Pharmaceut Sci, Lausanne, Switzerland	University of Bern; University of Bern; University Hospital of Bern; University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Leib, S (corresponding author), Univ Bern, Inst Infect Dis, Bern, Switzerland.	stephen.leib@ifik.unibe.ch	Grandgirard, Denis/AAB-8786-2020	Grandgirard, Denis/0000-0002-4151-5196; /0000-0002-1106-6123; Que, Yok-Ai/0000-0001-9443-6101	Swiss National Science Foundation [176216, 166124, 189136]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We acknowledge the outstanding technical assistance of Maria Erhardt, Sandra Nansoz, Franziska Simon, Romano Josi and Jonathan Save. We thank Carlo Casanova and Markus Hilty from the Swiss National Center for Pneumococci (https://www.ifik.unibe.ch/services/pneumococcal_center/index_eng.html) for generously providing us a ceftriaxone-resistant S. pneumoniae (serotype 19A). We thank Andrea Zbinden for having kindly provided us with the Streptococcus tigurinus strain AZ3aT.	Aiba H, 2021, PEDIATR INT, V63, P1133, DOI 10.1111/ped.14569; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Becker SC, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnu019; CDC, 2013, ANTIBIOTIC RESISTANC, DOI [DOI 10.15620/CDC:82532, 10.15620/cdc:82532]; de Wit J, 2019, J ALLERGY CLIN IMMUN, V144, P860, DOI 10.1016/j.jaci.2019.05.020; Diez-Martinez R, 2015, J ANTIMICROB CHEMOTH, V70, P1763, DOI 10.1093/jac/dkv038; Doehn JM, 2013, J ANTIMICROB CHEMOTH, V68, P2111, DOI 10.1093/jac/dkt131; Donovan DM, 2008, FEMS MICROBIOL LETT, V287, P22, DOI 10.1111/j.1574-6968.2008.01287.x; Entenza JM, 2005, ANTIMICROB AGENTS CH, V49, P4789, DOI 10.1128/AAC.49.11.4789-4792.2005; Grandgirard D, 2008, J INFECT DIS, V197, P1519, DOI 10.1086/587942; Grandgirard D, 2007, ACTA NEUROPATHOL, V114, P609, DOI 10.1007/s00401-007-0304-8; Grandgirard D, 2012, ANTIMICROB AGENTS CH, V56, P4289, DOI 10.1128/AAC.00674-12; Hampton LM, 2012, J INFECT DIS, V205, P401, DOI 10.1093/infdis/jir755; Jado I, 2003, J ANTIMICROB CHEMOTH, V52, P967, DOI 10.1093/jac/dkg485; Jun SY, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02629-16, 10.1128/aac.02629-16]; Kaplan SL, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-0567; Kaplan SL, 2013, PEDIATR INFECT DIS J, V32, P203, DOI 10.1097/INF.0b013e318275614b; Le ND, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01966-3; Leib SL, 2000, INFECT IMMUN, V68, P615, DOI 10.1128/IAI.68.2.615-620.2000; Liechti FD, 2014, INFECT IMMUN, V82, P1710, DOI 10.1128/IAI.00073-14; Linares J, 2010, CLIN MICROBIOL INFEC, V16, P402, DOI 10.1111/j.1469-0691.2010.03182.x; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Loeffler JM, 2003, ANTIMICROB AGENTS CH, V47, P375, DOI 10.1128/AAC.47.1.375-377.2003; Loeffler JM, 2003, INFECT IMMUN, V71, P6199, DOI 10.1128/IAI.71.11.6199-6204.2003; McCullers JA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030028; Meichtry J, 2014, VACCINE, V32, P5185, DOI 10.1016/j.vaccine.2014.07.060; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Muri L, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1549-6; Muri L, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.00220-19, 10.1128/aac.00220-19]; Muri L, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1272-8; Nelson D, 2001, P NATL ACAD SCI USA, V98, P4107, DOI 10.1073/pnas.061038398; Obeso JM, 2008, INT J FOOD MICROBIOL, V128, P212, DOI 10.1016/j.ijfoodmicro.2008.08.010; Olarte L, 2015, CLIN INFECT DIS, V61, P767, DOI 10.1093/cid/civ368; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Rashel M, 2007, J INFECT DIS, V196, P1237, DOI 10.1086/521305; Resch G, 2011, INT J ANTIMICROB AG, V38, P516, DOI 10.1016/j.ijantimicag.2011.08.009; Richter SS, 2014, ANTIMICROB AGENTS CH, V58, P6484, DOI 10.1128/AAC.03344-14; Rodriguez-Rubio L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064671; Son B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-33; Tomczyk S, 2016, CLIN INFECT DIS, V62, P1119, DOI 10.1093/cid/ciw067; Totte JEE, 2017, CASE REP DERMATOL, V9, P19, DOI 10.1159/000473872; Ugorcakova J, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv098; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; van de Beek D, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.74; Zbinden A, 2012, INT J SYST EVOL MICR, V62, P2941, DOI 10.1099/ijs.0.038299-0	45	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266928	10.1371/journal.pone.0266928	http://dx.doi.org/10.1371/journal.pone.0266928			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35472061	gold, Green Published			2022-12-26	WOS:000816171900040
J	Vellani, SS; Puts, M; Iaboni, A; McGilton, K				Vellani, Shirin S.; Puts, Martine; Iaboni, Andrea; McGilton, Katherine			Acceptability of the voice your values, an advance care planning intervention in persons living with mild dementia using videoconferencing technology	PLOS ONE			English	Article							BEHAVIORAL TREATMENTS; INDIVIDUALS; PHARMACOTHERAPY; TELEHEALTH; RATINGS; PEOPLE; LIFE	Advance care planning (ACP) can improve outcomes for persons living with dementia (PLwD). Clinicians see the lack of acceptability of these conversations as a barrier to ACP in individuals with mild dementia. COVID-19 pandemic has magnified the need for ACP discussions in older adults, particularly for those living with dementia. In light of the pandemic, much of the healthcare is provided virtually, but little evidence exists on how to best implement ACP virtually. We designed Voice Your Values (VYV), a tailored ACP intervention for persons living with mild dementia and their trusted individuals such as friends or family. Purpose Determine the acceptability of the VYV intervention, in terms of its content and the potential utility of videoconferencing to deliver it. Methods For this pilot study, we recruited 21 dyads of older adults with mild dementia and their trusted individuals from five geriatric clinics in Ontario, Canada. The tailored VYV intervention was delivered to dyads over two sessions over videoconferencing. Acceptability was assessed using scores on a modified Treatment Evaluation Inventory. The interventionist diary and Researcher Virtual Experience Questionnaire were used to examine facilitators and barriers, whereas Participant Virtual Experience Questionnaire was used to understand their experience. Qualitative data was analyzed using inductive content analysis. Results 100% of the participants rated VYV as acceptable. Participants and researcher rated video and sound quality highly. PLwD who lived with their trusted individuals were more likely to find the intervention acceptable (t = 3.559, p = 0.001, beta = 0.323). Five interrelated themes were established that describe the acceptability of the virtually delivered VYV intervention. All PLwD were able to articulate their values and wishes related to being in a terminal and vegetative states and had them documented. Conclusion The virtual VYV intervention was an acceptable approach to ACP in older adults with mild dementia and their trusted individuals.	[Vellani, Shirin S.] McMaster Univ, Fac Hlth Sci, Sch Nursing, Hamilton, ON, Canada; [Puts, Martine; McGilton, Katherine] Univ Toronto, LawrenceS Bloomberg Fac Nursing, Toronto, ON, Canada; [Iaboni, Andrea; McGilton, Katherine] Univ Hlth Network, Toronto Rehabil Inst, KITE, Toronto, ON, Canada; [Iaboni, Andrea] Univ Toronto, Dept Psychiat, Toronto, ON, Canada	McMaster University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto	Vellani, SS (corresponding author), McMaster Univ, Fac Hlth Sci, Sch Nursing, Hamilton, ON, Canada.	shirin.vellani@mail.utoronto.ca		Vellani, Shirin/0000-0001-6032-0266				Archibald MM, 2019, INT J QUAL METH, V18, DOI 10.1177/1609406919874596; BURGIO LD, 1990, GERONTOLOGIST, V30, P811, DOI 10.1093/geront/30.6.811; BURGIO LD, 1995, GERONTOLOGIST, V35, P630, DOI 10.1093/geront/35.5.630; De Vleminck A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084905; Dening KH, 2013, PALLIATIVE MED, V27, P409, DOI 10.1177/0269216312464094; Donovan HS, 2007, J NURS SCHOLARSHIP, V39, P259, DOI 10.1111/j.1547-5069.2007.00178.x; Eakin JM, 2020, INT J QUAL METH, V19, DOI 10.1177/1609406920949333; Fried TR, 2021, J AM GERIATR SOC, V69, P932, DOI 10.1111/jgs.16953; Fulmer T, 2018, J AM GERIATR SOC, V66, P1201, DOI 10.1111/jgs.15374; Garand L, 2011, AM J GERIAT PSYCHIAT, V19, P712, DOI 10.1097/JGP.0b013e3181faebef; Gilissen J, 2017, INT J NURS STUD, V66, P47, DOI 10.1016/j.ijnurstu.2016.12.003; Harrison Dening Karen, 2019, Palliat Care, V12, p1178224219826579, DOI 10.1177/1178224219826579; Hilgeman MM, 2014, AGING MENT HEALTH, V18, P411, DOI 10.1080/13607863.2013.868403; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Houben CHM, 2014, J AM MED DIR ASSOC, V15, P477, DOI 10.1016/j.jamda.2014.01.008; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Kokorelias KM, 2021, DEMENTIA-LONDON, V20, P2851, DOI 10.1177/14713012211019502; Landreville P, 1998, CAN J AGING, V17, P414, DOI 10.1017/S071498080001268X; Law S, 2021, BMC GERIATR, V21, DOI 10.1186/s12877-021-02354-z; Lawrence V, 2011, GERONTOLOGIST, V51, P39, DOI 10.1093/geront/gnq073; Lee L, 2019, J PALLIAT CARE, V34, P248, DOI 10.1177/0825859718812463; Leventhal H., 1991, MENTAL REPRESENTATIO, P245; Leventhal H., 1984, ILLNESS REPRESENTATI, P221; Lewis M, 2015, AGE AGEING, V44, P1045, DOI 10.1093/ageing/afv138; Mitchell Susan L, 2009, N Engl J Med, V361, P1529, DOI 10.1056/NEJMoa0902234; Montero-Odasso Manuel, 2020, Can Geriatr J, V23, P152, DOI 10.5770/cgj.23.452; Morgan DG, 2011, J APPL GERONTOL, V30, P304, DOI 10.1177/0733464810366564; Noble Helen, 2019, Evid Based Nurs, V22, P67, DOI 10.1136/ebnurs-2019-103145; O'Connell ME, 2021, J MED INTERNET RES, V23, DOI 10.2196/24098; O'Connell ME, 2014, DEMENTIA-LONDON, V13, P382, DOI 10.1177/1471301212474143; Orkin AM, 2021, JAMA-J AM MED ASSOC, V326, P257, DOI 10.1001/jama.2021.9941; Orsulic-Jeras S, 2019, DEMENTIA-LONDON, V18, P360, DOI 10.1177/1471301216673455; Piers R, 2018, BMC PALLIAT CARE, V17, DOI 10.1186/s12904-018-0332-2; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Sampson EL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007209.pub2; Shelton W, 2019, AM J ALZHEIMERS DIS, V34, P131, DOI 10.1177/1533317518817614; Song MK, 2019, J PALLIAT MED, V22, P1410, DOI 10.1089/jpm.2019.0088; Song MK, 2018, CONTEMP CLIN TRIALS, V64, P188, DOI 10.1016/j.cct.2017.10.005; Song MK, 2015, J NURS SCHOLARSHIP, V47, P389, DOI 10.1111/jnu.12156; Sudore RL, 2017, JAMA INTERN MED, V177, P1102, DOI 10.1001/jamainternmed.2017.1607; Tilburgs B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198535; van der Steen JT, 2014, PALLIATIVE MED, V28, P197, DOI 10.1177/0269216313493685; Vellani S., 2021, VOICE YOUR VALUES; Vellani S, 2022, CAN J AGING, V41, P404, DOI 10.1017/S0714980821000349; Wendrich-van Dael A, 2020, INT J NURS STUD, V107, DOI 10.1016/j.ijnurstu.2020.103576	45	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266826	10.1371/journal.pone.0266826	http://dx.doi.org/10.1371/journal.pone.0266826			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35472150	gold, Green Published			2022-12-26	WOS:000816171900038
J	Tang, MF; Chen, Z; Wang, C; Feng, X; Lee, N; Huang, M; Zhang, HM; Li, ST; Xiong, Y; Chen, JJ				Tang, Mengfan; Chen, Zhen; Wang, Chao; Feng, Xu; Lee, Namsoo; Huang, Min; Zhang, Huimin; Li, Siting; Xiong, Yun; Chen, Junjie			Histone chaperone ASF1 acts with RIF1 to promote DNA end joining in BRCA1-deficient cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAK REPAIR PATHWAY; HOMOLOGOUS RECOMBINATION; TELOMERE LENGTH; 53BP1; REPLICATION; RESECTION; PROTEIN; BRCA2; COMPLEX; RAD51	Replication timing regulatory factor 1 (RIF1) acts downstream of p53-binding protein 53BP1 to inhibit the resection of DNA broken ends, which plays critical roles in determining the DNA double-strand break repair pathway choice between nonhomologous end joining and homologous recombination (HR). However, the mechanism by which this choice is made is not yet clear. In this study, we identified that histone chaperone protein ASF1 associates with RIF1 and regulates RIF1-dependent functions in the DNA damage response. Similar to loss of RIF1, we found that loss of ASF1 resulted in resistance to poly (ADP-ribose) polymerase (PARP) inhibition in BRCA1-deficient cells with restored HR and decreased telomere fusion in telomeric repeat-binding protein 2 (TRF2)-depleted cells. Moreover, we showed that these functions of ASF1 are dependent on its interaction with RIF1 but not on its histone chaperone activity. Thus, our study supports a new role for ASF1 in dictating double-strand break repair choice. Considering that the status of 53BP1-RIF1 axis is important in determining the outcome of PARP inhibitor-based therapy in BRCA1- or HR-deficient cancers, the identification of ASF1 function in this critical pathway uncovers an interesting connection between these S-phase events, which may reveal new strategies to overcome PARP inhibitor resistance.	[Tang, Mengfan; Chen, Zhen; Wang, Chao; Feng, Xu; Lee, Namsoo; Huang, Min; Zhang, Huimin; Li, Siting; Xiong, Yun; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Unit 1052, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Unit 1052, Houston, TX 77030 USA.	jchen8@mdanderson.org			Cancer Prevention and Research Institute of Texas [RP160667, RP180813]; National Institutes of Health [R01CA210929, R01CA216911, R01CA216437]; Pamela and Wayne Garrison Distinguished Chair in Cancer Research	Cancer Prevention and Research Institute of Texas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pamela and Wayne Garrison Distinguished Chair in Cancer Research	This work was supported in part by the Cancer Prevention and Research Institute of Texas award RP180813 (to J. C.). In addition, many reagents used in this study were obtained in part with the support of the Cancer Prevention and Research Institute of Texas award RP160667 and National Institutes of Health grants (R01CA210929, R01CA216911, and R01CA216437) (to J. C.). J. C. also received support from the Pamela and Wayne Garrison Distinguished Chair in Cancer Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agez M, 2007, STRUCTURE, V15, P191, DOI 10.1016/j.str.2007.01.002; Batenburg NL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02114-x; Bhowmick R, 2019, CURR BIOL, V29, P1232, DOI 10.1016/j.cub.2019.02.037; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; Carreira A, 2009, CELL, V136, P1032, DOI 10.1016/j.cell.2009.02.019; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Chapman JR, 2012, J CELL SCI, V125, P3529, DOI 10.1242/jcs.105353; Charier G, 2004, STRUCTURE, V12, P1551, DOI 10.1016/j.str.2004.06.014; Daley JM, 2013, MOL CELL, V49, P840, DOI 10.1016/j.molcel.2013.02.019; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Dave A, 2014, CELL REP, V7, P53, DOI 10.1016/j.celrep.2014.02.019; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Davis AJ, 2013, TRANSL CANCER RES, V2, P130, DOI 10.3978/j.issn.2218-676X.2013.04.02; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Dev H, 2018, NAT CELL BIOL, V20, P954, DOI 10.1038/s41556-018-0140-1; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Feng L, 2013, J BIOL CHEM, V288, P11135, DOI 10.1074/jbc.M113.457440; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Garzon J, 2019, CELL REP, V27, P2558, DOI 10.1016/j.celrep.2019.05.002; Ghezraoui H, 2018, NATURE, V560, P122, DOI 10.1038/s41586-018-0362-1; Gupta R, 2018, CELL, V173, P972, DOI 10.1016/j.cell.2018.03.050; Haber JE, 2016, ANNU REV GENET, V50, P1, DOI 10.1146/annurev-genet-120215-035043; Hakem R, 2008, EMBO J, V27, P589, DOI 10.1038/emboj.2008.15; Hammond CM, 2017, NAT REV MOL CELL BIO, V18, P141, DOI 10.1038/nrm.2016.159; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hiraga S, 2017, EMBO REP, V18, P403, DOI 10.15252/embr.201641983; Huang TH, 2020, MOL CELL, V77, P1153, DOI 10.1016/j.molcel.2020.02.019; Huang TH, 2018, CELL CYCLE, V17, P1413, DOI 10.1080/15384101.2018.1486165; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jaspers JE, 2013, CANCER DISCOV, V3, P68, DOI 10.1158/2159-8290.CD-12-0049; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Kedziora S, 2018, NUCLEIC ACIDS RES, V46, P3993, DOI 10.1093/nar/gky132; Klein KN, 2021, SCIENCE, V372, P371, DOI 10.1126/science.aba5545; Lee KY, 2017, MOL CELL, V68, P61, DOI 10.1016/j.molcel.2017.08.021; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; Liu T, 2016, GENOM PROTEOM BIOINF, V14, P126, DOI 10.1016/j.gpb.2016.05.002; Marcand S, 1998, CIBA F SYMP, V211, P76; Mello JA, 2002, EMBO REP, V3, P329, DOI 10.1093/embo-reports/kvf068; Mimitou EP, 2011, DNA REPAIR, V10, P344, DOI 10.1016/j.dnarep.2010.12.004; Mirman Z, 2018, NATURE, V560, P112, DOI 10.1038/s41586-018-0324-7; Munoz IM, 2007, NUCLEIC ACIDS RES, V35, P5312, DOI 10.1093/nar/gkm493; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Noordermeer SM, 2018, NATURE, V560, P117, DOI 10.1038/s41586-018-0340-7; O'Driscoll M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012773; O'Sullivan RJ, 2014, NAT STRUCT MOL BIOL, V21, P167, DOI 10.1038/nsmb.2754; Renkawitz J, 2014, NAT REV MOL CELL BIO, V15, P369, DOI 10.1038/nrm3805; Sillje HHW, 2001, CURR BIOL, V11, P1068, DOI 10.1016/S0960-9822(01)00298-6; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Sreesankar E, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-255; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tang MF, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108018; Tang Y, 2006, NAT STRUCT MOL BIOL, V13, P921, DOI 10.1038/nsmb1147; Taylor MRG, 2015, CELL, V162, P271, DOI 10.1016/j.cell.2015.06.015; Thorslund T, 2010, NAT STRUCT MOL BIOL, V17, P1263, DOI 10.1038/nsmb.1905; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Tyler JK, 2001, MOL CELL BIOL, V21, P6574, DOI 10.1128/MCB.21.19.6574-6584.2001; Wang C, 2020, DNA REPAIR, V95, DOI 10.1016/j.dnarep.2020.102946; Wang JD, 2014, GENE DEV, V28, P2693, DOI 10.1101/gad.252478.114; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Xu DY, 2010, EMBO J, V29, P3140, DOI 10.1038/emboj.2010.186; Xu GT, 2015, NATURE, V521, P541, DOI 10.1038/nature14328; Xu LF, 2004, J CELL BIOL, V167, P819, DOI 10.1083/jcb.200408181; Yamazaki S, 2012, EMBO J, V31, P3667, DOI 10.1038/emboj.2012.180; Zhao WX, 2015, MOL CELL, V59, P176, DOI 10.1016/j.molcel.2015.05.032; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	73	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101979	10.1016/j.jbc.2022.101979	http://dx.doi.org/10.1016/j.jbc.2022.101979			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9FR	35472331	Green Published, gold			2022-12-26	WOS:000807755100005
J	McGrath, SL; Huang, SH; Kobryn, K				McGrath, Siobhan L.; Huang, Shu Hui; Kobryn, Kerri			The N-terminal domain of the Agrobacterium tumefaciens telomere resolvase, TelA, regulates its DNA cleavage and rejoining activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYME-DISEASE SPIROCHETE; BORRELIA-BURGDORFERI; BIDIRECTIONAL REPLICATION; ESCHERICHIA-COLI; PLASMID PROPHAGE; REST; PROTELOMERASE; RECOMBINASE; SEQUENCE; GENOME	Linear replicons can be found in a minority of prokaryotic organisms, including Borrelia species and Agrobacterium tumefaciens. The problem with replicating the lagging strand end of linear DNAs is circumvented in these organisms by the presence of covalently closed DNA hairpin telomeres at the DNA termini. Telomere resolvases are enzymes responsible for generating these hairpin telomeres from a dimeric replication intermediate through a two-step DNA cleavage and rejoining reaction referred to as telomere resolution. It was previously shown that the agrobacterial telomere resolvase, TelA, possesses ssDNA annealing activity in addition to telomere resolution activity. The annealing activity derives, chiefly, from the N-terminal domain. This domain is dispensable for telomere resolution. In this study, we used activity analyses of an N-terminal domain deletion mutant, domain add back experiments, and protein-protein interaction studies and we report that the N-terminal domain of TelA is involved in inhibitory interactions with the remainder of TelA that are relieved by the binding of divalent metal ions. We also found that the regulation of telomere resolution by the N-terminal domain of TelA extends to suppression of inappropriate enzymatic activity, including hairpin telomere fusion (reaction reversal) and recombination between replicated telomeres to form a Holliday junction.	[McGrath, Siobhan L.; Huang, Shu Hui; Kobryn, Kerri] Univ Saskatchewan, Coll Med, Dept Biochem Microbiol & Immunol, Saskatoon, SK, Canada	University of Saskatchewan	Kobryn, K (corresponding author), Univ Saskatchewan, Coll Med, Dept Biochem Microbiol & Immunol, Saskatoon, SK, Canada.				University of Saskatchewan CoMRAD award; NSERC Discovery Grant [RGPIN 04382-2017]	University of Saskatchewan CoMRAD award; NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	FS. L. M. was supported by a University of Saskatchewan CoMRAD award. K. K. was supported by an NSERC Discovery Grant (RGPIN 04382-2017) .	Aihara H, 2007, MOL CELL, V27, P901, DOI 10.1016/j.molcel.2007.07.026; Bandy NJ, 2014, J BACTERIOL, V196, P2396, DOI 10.1128/JB.01435-13; Bankhead T, 2004, P NATL ACAD SCI USA, V101, P13768, DOI 10.1073/pnas.0405762101; Bankhead T, 2006, MOL MICROBIOL, V62, P895, DOI 10.1111/j.1365-2958.2006.05423.x; BARBOUR AG, 1987, SCIENCE, V237, P409, DOI 10.1126/science.3603026; Casjens S, 1997, MOL MICROBIOL, V26, P581, DOI 10.1046/j.1365-2958.1997.6051963.x; Chaconas G, 2001, EMBO J, V20, P3229, DOI 10.1093/emboj/20.12.3229; Cui TL, 2007, EMBO REP, V8, P181, DOI 10.1038/sj.embor.7400880; Deneke J, 2004, J BIOL CHEM, V279, P53699, DOI 10.1074/jbc.M409001200; Deneke J, 2000, P NATL ACAD SCI USA, V97, P7721, DOI 10.1073/pnas.97.14.7721; Dorokhov B. D., 2004, Molekulyarnaya Genetika Mikrobiologiya i Virusologiya, P28; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Godiska R, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1181; Goodner B, 2001, SCIENCE, V294, P2323, DOI 10.1126/science.1066803; Hertwig S, 2003, MOL MICROBIOL, V48, P989, DOI 10.1046/j.1365-2958.2003.03458.x; Huang SH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187382; Huang SH, 2016, NUCLEIC ACIDS RES, V44, P5288, DOI 10.1093/nar/gkw344; Huang WM, 2012, J BIOL CHEM, V287, P25551, DOI 10.1074/jbc.M112.369488; Huang WM, 2004, J MOL BIOL, V337, P77, DOI 10.1016/j.jmb.2004.01.012; Kashammer L, 2019, MOL CELL, V76, P382, DOI 10.1016/j.molcel.2019.07.035; Kobryn K, 2005, MOL CELL, V17, P783, DOI 10.1016/j.molcel.2005.02.025; Kobryn K, 2002, MOL CELL, V9, P195, DOI 10.1016/S1097-2765(01)00433-6; Kobryn K, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MDNA3-0023-2014; Kobryn K, 2009, MOL MICROBIOL, V71, P1117, DOI 10.1111/j.1365-2958.2008.06584.x; Lu C, 2015, CELL REP, V10, P29, DOI 10.1016/j.celrep.2014.12.001; Lucyshyn D, 2015, NUCLEIC ACIDS RES, V43, P6062, DOI 10.1093/nar/gkv497; McGrath SL, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246212; Mir T, 2013, NUCLEIC ACIDS RES, V41, P10438, DOI 10.1093/nar/gkt832; Ohki R, 2001, MOL CELL BIOL, V21, P5753, DOI 10.1128/MCB.21.17.5753-5766.2001; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Picardeau M, 1999, MOL MICROBIOL, V32, P437, DOI 10.1046/j.1365-2958.1999.01368.x; Ravin NV, 2003, NUCLEIC ACIDS RES, V31, P6552, DOI 10.1093/nar/gkg856; Rybchin VN, 1999, MOL MICROBIOL, V33, P895, DOI 10.1046/j.1365-2958.1999.01533.x; Shi K, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001472; Tourand Y, 2007, MOL MICROBIOL, V64, P580, DOI 10.1111/j.1365-2958.2007.05691.x; Unnikrishnan A, 2020, P NATL ACAD SCI USA, V117, P24849, DOI 10.1073/pnas.2011448117	36	0	0	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101951	10.1016/j.jbc.2022.101951	http://dx.doi.org/10.1016/j.jbc.2022.101951			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L7CP	35447111	Green Published, gold			2022-12-26	WOS:000817175700008
J	Al-Shaalan, NH; Nasr, JJ; Shalan, S; El-Mahdy, AM				Al-Shaalan, Nora H.; Nasr, Jenny Jeehan; Shalan, Shereen; El-Mahdy, Areej M.			Inspection of antimicrobial remains in bovine milk in Egypt and Saudi Arabia employing a bacteriological test kit and HPLC-MS/MS with estimation of risk to human health	PLOS ONE			English	Article							ANTIBIOTIC-RESIDUES; EXTRACTION; SAMPLES; QUINOLONE; VIETNAM; PORK; MEAT; COW	Veterinary medicine uses antibiotics randomly for treatment and growth promotion. Milk of dairy animals contains substantial quantities of antibiotics that have harmful effects on health. It is therefore necessary to test commercially available milk using immunological, chromatographic, or microbiological methods to confirm the absence of antibiotic residues. This study aims to perform a microbiological test, followed by a quantitative confirmation analysis, on raw milk to assess the presence of antibiotic residues. Tests were conducted on 200 milk samples collected from markets and farms in Saudi Arabia and Egypt. The microbial inhibitor test (Delvotest SP-NT) revealed that 40 samples were positive for antibiotic residues. The positive samples were further tested using liquid chromatography-tandem mass spectrometry (LC-MS/MS) as a confirmatory quantitative test for 29 antibiotics that belong to five groups: tetracyclines, sulfonamides, fluoroquinolones, macrolides, and lactamases. Only four samples tested positive for oxytetracycline residues above the maximum residue limit. Based on these results, researchers suggest a monitoring system that considers both microbial and HPLC-MS/MS methods when detecting antibiotic residues in bovine milk. The analysis of risk to human health revealed that antibiotic residues at the detected levels do not pose any health risks to consumers.	[Al-Shaalan, Nora H.] Princess Nourah Bint Abdulrahman Univ, Coll Sci, Dept Chem, Riyadh, Saudi Arabia; [Nasr, Jenny Jeehan; Shalan, Shereen] Mansoura Univ, Fac Pharm, Dept Pharmaceut Analyt Chem, Mansoura, Egypt; [El-Mahdy, Areej M.] Princess Nourah Bint Abdulrahman Univ, Coll Pharm, Dept Pharmaceut Sci, Riyadh, Saudi Arabia; [El-Mahdy, Areej M.] Mansoura Univ, Fac Pharm, Dept Microbiol & Immunol, Mansoura, Egypt	Princess Nourah bint Abdulrahman University; Egyptian Knowledge Bank (EKB); Mansoura University; Princess Nourah bint Abdulrahman University; Egyptian Knowledge Bank (EKB); Mansoura University	El-Mahdy, AM (corresponding author), Princess Nourah Bint Abdulrahman Univ, Coll Pharm, Dept Pharmaceut Sci, Riyadh, Saudi Arabia.; El-Mahdy, AM (corresponding author), Mansoura Univ, Fac Pharm, Dept Microbiol & Immunol, Mansoura, Egypt.	amalkasaby@pnu.edu.sa	Nasr, Jenny Jeehan Mohamed/AEO-8604-2022	Nasr, Jenny Jeehan Mohamed/0000-0002-2423-7315	Deanship of Scientific Research at Princess Nourah bint Abdulrahman University, through the Research Funding Program [FRP-1440-26]	Deanship of Scientific Research at Princess Nourah bint Abdulrahman University, through the Research Funding Program(Princess Nourah bint Abdulrahman University)	This research was funded by The Deanship of Scientific Research at Princess Nourah bint Abdulrahman University, through the Research Funding Program (Grant No#FRP-1440-26).	Aggad H, 2009, REV MED VET-TOULOUSE, V160, P590; Australian Pesticides and Veterinary Medicines Authority, ACC DAIL INT AGR VET; Ben YJ, 2019, ENVIRON RES, V169, P483, DOI 10.1016/j.envres.2018.11.040; Ben-Mahdi M., 2009, EUR J SCI RES, V36, P357; Bilandzic N, 2011, FOOD CONTROL, V22, P1941, DOI 10.1016/j.foodcont.2011.05.007; Bohm DA, 2009, J CHROMATOGR A, V1216, P8217, DOI 10.1016/j.chroma.2009.06.058; Boultif L., 2015, THESIS U MENTOURI CO; Chen J, 2019, J AGR FOOD CHEM, V67, P7569, DOI 10.1021/acs.jafc.9b01334; Chung HH, 2009, FOOD CHEM, V113, P297, DOI 10.1016/j.foodchem.2008.07.021; Collignon P, 2005, CLIN INFECT DIS, V41, P1007, DOI 10.1086/433191; de Zayas-Blanco F, 2004, FOOD CONTROL, V15, P375, DOI 10.1016/S0956-7135(03)00100-2; Dorival-Garcia N, 2016, FOOD CONTROL, V60, P382, DOI 10.1016/j.foodcont.2015.08.008; Food and Agriculture Organization of the United Nations, MAXIMUM RESIDUE LIMI; Food and Agriculture Organization of the United Nations, CODEXALIMENTARIUS FA; Furusawa N, 1999, J CHROMATOGR A, V839, P247, DOI 10.1016/S0021-9673(99)00150-8; Hakem A., 2012, B USAMV VET MED, V69, P1; Hillerton JE, 1999, J DAIRY SCI, V82, P704, DOI 10.3168/jds.S0022-0302(99)75287-2; Joint FAO/WHO Expert Committee on Food Additives, 2016, MOD 2 SCI GUID PREP; Juan C, 2010, FOOD CONTROL, V21, P1703, DOI 10.1016/j.foodcont.2010.05.004; Layada S., 2016, International Journal of Food Contamination, V3, DOI 10.1186/s40550-016-0042-6; Li H, 2012, J CHROMATOGR B, V900, P59, DOI 10.1016/j.jchromb.2012.05.031; Ngoc MH, 2016, FOOD CONTROL, V69, P262, DOI 10.1016/j.foodcont.2016.05.004; Martins MT, 2014, TALANTA, V129, P374, DOI 10.1016/j.talanta.2014.04.049; Mensah S. E. P., 2014, Journal of Applied Biosciences, V80, P7102, DOI 10.4314/jab.v80i1.9; Moudgil P, 2019, J FOOD SAFETY, V39, DOI 10.1111/jfs.12643; Peris-Vicente J, 2019, ANTIBIOTICS-BASEL, V8, DOI 10.3390/antibiotics8040226; Petrovic JM, 2008, FOOD ANAL METHOD, V1, P119, DOI 10.1007/s12161-007-9007-y; Pikkemaat MG, 2009, ANAL BIOANAL CHEM, V395, P893, DOI 10.1007/s00216-009-2841-6; Pikkemaata MG., 2009, ANAL CHIM ACTA, V637, P1; Rahman M., 2020, PREPRINT; Ramirez A, 2003, J CHROMATOGR B, V784, P315, DOI 10.1016/S1570-0232(02)00819-X; Stead S, 2011, CHEM ANAL ANTIBIOT, P153; Stead SL, 2008, INT DAIRY J, V18, P3, DOI 10.1016/j.idairyj.2007.06.006; SUHREN G, 1995, MILCHWISSENSCHAFT, V50, P467; Tadesse T., 2017, PUBLIC HLTH IMPACTS; Tarzaali D, 2008, 6EMES JOURNEES SCIEN, P23; Titouche Y., 2013, Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca. Veterinary Medicine, V70, P83; United States Department of Agriculture, MAXIMUM RESIDUE LIMI; Yamaguchi T, 2015, J AGR FOOD CHEM, V63, P5141, DOI 10.1021/jf505254y; Zvirdauskiene R, 2007, FOOD CONTROL, V18, P541, DOI 10.1016/j.foodcont.2006.01.003	40	0	0	8	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267717	10.1371/journal.pone.0267717	http://dx.doi.org/10.1371/journal.pone.0267717			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476746	Green Published, gold			2022-12-26	WOS:000840124300064
J	Feio, MJ; Mantas, AI; Serra, SRQ; Calapez, AR; Almeida, SFP; Sales, MC; Montenegro, M; Moreira, F				Feio, Maria Joao; Mantas, Ana Isabel; Serra, Sonia R. Q.; Calapez, Ana Raquel; Almeida, Salome F. P.; Sales, Manuela C.; Montenegro, Mario; Moreira, Francisca			Effect of environmental education on the knowledge of aquatic ecosystems and reconnection with nature in early childhood	PLOS ONE			English	Article							WATER BODY CHALLENGES; CHILDREN; STREAM; CATCHMENT; IMPACT; STATE	Blue and green ecosystems are considered a key for the improvement of cities sustainability, providing numerous ecosystem services and habitat for many species. However, urban streams are still neglected and degraded, specially in southern European countries. One important step towards the rehabilitation of these ecosystems is the awareness of their importance by citizens. This study aimed to assess the effect of 1-year of activities (field and laboratory) of an environmental education project on primary school children, in improving their knowledge on urban stream ecosystems and their problems. We analyzed students' questionnaires before and after field and laboratory activities, drawings and group interviews. Initially, most children had incipient contact with rivers and streams, showing fears and lack of knowledge about them. As the project progressed, their perceptions changed, with a clear increase in the proportion of students recognizing the biodiversity associated to rivers (e.g., names of riparian trees, aquatic plants and invertebrates). Also, their fears decreased significantly, while their awareness to the impacts of artificialization and lack of riparian vegetation increased. Our results show that direct contact with nature have a positive role in the way it is understood by children, as well as promoting responsible and sustainable behaviors, being effective from the early primary-school years.	[Feio, Maria Joao; Mantas, Ana Isabel; Serra, Sonia R. Q.; Calapez, Ana Raquel] Univ Coimbra, Fac Sci & Technol, Marine & Environm Sci Ctr, Coimbra, Portugal; [Almeida, Salome F. P.; Sales, Manuela C.] Univ Aveiro, GeoBioTec GeoBioSci GeoTechnol & GeoEngn Res Ctr, Dept Biol, Aveiro, Portugal; [Montenegro, Mario] Univ Coimbra, CEIS20 Ctr Interdisciplinary Studies, Fac Arts & Humanities, Coimbra, Portugal; [Montenegro, Mario] Univ Coimbra, MARIONET Assoc Cultural, Fac Arts & Humanities, Coimbra, Portugal; [Montenegro, Mario; Moreira, Francisca] MARIONET Assoc Cultural, Coimbra, Portugal	Universidade de Coimbra; Universidade de Aveiro; Universidade de Coimbra; Universidade de Coimbra	Feio, MJ (corresponding author), Univ Coimbra, Fac Sci & Technol, Marine & Environm Sci Ctr, Coimbra, Portugal.	mjf@ci.uc.pt	Almeida, Salomé/U-9484-2019	Almeida, Salomé/0000-0001-7240-7967; Serra, Sonia/0000-0003-4426-465X; Montenegro, Mario/0000-0001-7292-9685; Feio, Maria/0000-0003-0362-6802	post-doc grant in the Project "PHARA-ON: Pilots for Healthy and Active Ageing" - European Union [H2020-SC1-FA-DTS-2018-2]; posdoc grant of project RIVEAL -RIparian forest Values and Ecosystem services in uncertain freshwater futures and Altered Landscapes [LISBOA-01-0145-FEDER-029790]	post-doc grant in the Project "PHARA-ON: Pilots for Healthy and Active Ageing" - European Union; posdoc grant of project RIVEAL -RIparian forest Values and Ecosystem services in uncertain freshwater futures and Altered Landscapes	SRQS was financed by a post-doc grant in the Project "PHARA-ON: Pilots for Healthy and Active Ageing" funded by the European Union's Horizon 2020 research and innovation programme (H2020-SC1-FA-DTS-2018-2); ARC by a posdoc grant of project RIVEAL -RIparian forest Values and Ecosystem services in uncertain freshwater futures and Altered Landscapes (LISBOA-01-0145FEDER-029790; FCT). MJF by FCT through Norma Transitoria do DL 57/2016 changed by law 57/2017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham A, 2010, INT J PUBLIC HEALTH, V55, P59, DOI 10.1007/s00038-009-0069-z; Almeida A, 2013, INT J SCI EDUC, V35, P312, DOI 10.1080/09500693.2011.608387; Aslanimehr P, 2018, CHILD PHILOS, V14, P483, DOI 10.12957/childphilo.2018.30037; Athanasiadou EA, 2018, THESSALONIKI P, V2, P576, DOI [10.3390/proceedings2110576, DOI 10.3390/PROCEEDINGS2110576]; Bates C., 2020, CHILD GEOGR, V18, P364, DOI [10.1080/14733285.2019.1673880, DOI 10.1080/14733285.2019.1673880]; Bentsen P, 2022, SCAND J PUBLIC HEALT, V50, P303, DOI 10.1177/1403494821993715; Caplin A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09155-4; Chanse V, 2017, J ENVIRON EDUC, V48, P109, DOI 10.1080/00958964.2016.1256260; Chawla L., 2016, GROWING URBANIZING W, DOI [10.4324/9781315541365, DOI 10.4324/9781315541365]; Collado S, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01885; Collado S, 2016, CHILD GEOGR, V14, P716, DOI 10.1080/14733285.2016.1190812; Derr V., 2012, CHILD YOUTH ENV, V22, P112, DOI [10.7721/chilyoutenvi.22.2.0112, DOI 10.7721/CHILYOUTENVI.22.2.0112]; Dillon J., 2006, SCH SCI REV, V87, P107; Donnell A., 2015, CHILD YOUTH ENV, V25, P62, DOI [https%3A//doi.org/10.7721/chilyoutenvi.25.3.0062, DOI 10.7721/CHILYOUTENVI.25.3.0062]; Dopko RL, 2019, J ENVIRON PSYCHOL, V63, P134, DOI 10.1016/j.jenvp.2019.05.002; Egner LE, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186792; Feio M.J., 2021, CLEAN WATER SANITATI, DOI [10.1007/978-3-319-70061-8_188-1, DOI 10.1007/978-3-319-70061-8_188-1]; Feio MJ, 2019, INVESTIGACAO, P335, DOI 10.14195/978-989-26-1624-7_14; Barrera-Hernandez LF, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00276; Freeman C., 2018, CHILDREN NATURE CITI; Giusti M, 2018, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.02283; Harvey DJ, 2020, J ENVIRON PSYCHOL, V67, DOI 10.1016/j.jenvp.2019.101381; Huang JM, 2020, P NATL ACAD SCI USA, V117, P4609, DOI 10.1073/pnas.1914221117; Hughes RM, 2014, FISHERIES, V39, P18, DOI 10.1080/03632415.2013.836500; Hughes RM, 2014, FISHERIES, V39, P30, DOI 10.1080/03632415.2014.866507; Del Arco AI, 2012, LIMNETICA, V31, P141; Janeczko E, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11113007; Jansson W, 2016, URBAN FOR URBAN GREE, V18, P228, DOI 10.1016/j.ufug.2016.06.014; Ji O., 2014, RES EARLY CHILDHOOD, P58; Khan M, 2020, ENVIRON BEHAV, V52, P1079, DOI 10.1177/0013916519860868; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lehmann S., 2019, EMERALD OPEN RES, V1, P2, DOI [10.12688/emeraldopenres.12960.1, DOI 10.12688/EMERALDOPENRES.12960.1]; Louv R., 2008, Last child in the woods: saving our children from nature-deficit disorder; Lynch K., 1977, GROWING CITIES; Mahidin AMM, 2012, PROCD SOC BEHV, V38, P324, DOI 10.1016/j.sbspro.2012.03.354; Marketing England., 2009, CHILDH NATURE SURVEY; Marques TS, 2005, GEOGRAFIA PORTUGAL S, P191; McCormick R, 2017, J PEDIATR NURS, V37, P3, DOI 10.1016/j.pedn.2017.08.027; Mena-Garcia A, 2020, PSYECOLOGY, V11, P21, DOI 10.1080/21711976.2019.1643663; Nieuwenhuijsen MJ, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0108-1; Olivos-Jara P, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00511; R Core Team, 2021, R LANG ENV STAT; Ranta E, 2021, ECOL INDIC, V121, DOI 10.1016/j.ecolind.2020.106980; Serra SRQ, 2019, URBAN ECOSYST, V22, P1173, DOI 10.1007/s11252-019-00892-4; Shaw B., 2015, POLICY STU I; Szlavecz K, 2011, ECOL STUD-ANAL SYNTH, V214, P75, DOI 10.1007/978-3-642-16707-2_6; Tsevreni I., 2015, INT J CRIT PEDAGOG, V6, P149; Veselinovska SS, 2010, PROCD SOC BEHV, V2, P2244, DOI 10.1016/j.sbspro.2010.03.316; Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI 10.1899/04-020.1; Wang MT, 2017, EDUC PSYCHOL REV, V29, P119, DOI 10.1007/s10648-015-9355-x; Wenger SJ, 2009, J N AM BENTHOL SOC, V28, P1080, DOI 10.1899/08-186.1; White MP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44097-3; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yli-Pelkonen V, 2006, MANAG ENVIRON QUAL, V17, P673, DOI 10.1108/14777830610702511	54	1	1	8	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0266776	10.1371/journal.pone.0266776	http://dx.doi.org/10.1371/journal.pone.0266776			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476808	gold, Green Published			2022-12-26	WOS:000840124300016
J	Shembo, AKP; Musumari, PM; Srithanaviboonchai, K; Tangmunkongvorakul, A; Dalleur, O				Shembo, Aurelie Koho Pungu; Musumari, Patou Masika; Srithanaviboonchai, Kriengkrai; Tangmunkongvorakul, Arunrat; Dalleur, Olivia			A qualitative study on community use of antibiotics in Kinshasa, Democratic Republic of Congo	PLOS ONE			English	Article							SELF-MEDICATION PRACTICES; KNOWLEDGE; RESISTANCE	Background Resistance to antibiotics is an increasing and major threat to global health. While the large majority of antimicrobial use occurs in the community where antibiotics are available without prescription, we did not find any studies investigating community-level factors influencing the inappropriate use of antibiotics in the Democratic Republic of Congo (DRC), where nonprescription antibiotic use is prevalent. Methods This qualitative study was conducted from April 1st 2019 to May 5th 2019 and consisting of in-depth semi-structured interviews, utilizing purposive and snowball sampling schemes to recruit adult heads of households in the Pakadjuma slum, in Kinshasa, DRC. Participants with differing medical and educational backgrounds were selected. We employed a thematic analysis approach to explore community knowledge and use of antibiotics in the sampled population. Results A total of 18 participants with a median age of 35 years were interviewed. The majority was female (77.7%), had at least a secondary education (83.4%), and unemployed (61.1%). We found that participants were familiar with the term "antibiotics", but had limited knowledge of the indications and risks of antibiotics, including the risk of antibiotic resistance. Inappropriate use of antibiotics was common and there was frequent self-medication of non-prescribed medicines for a range of non-indicated conditions such as menstruation. Having limited income was the most commonly reported reason for not visiting a health facility for appropriate health care. Conclusion Inappropriate use of antibiotics is a widespread practice and is influenced by lack of adequate knowledge of antibiotic use, indications and risks, prevalent self-medication, and financial barriers to accessing appropriate health care. There is need for both community education as well as structural interventions addressing poverty in order to reduce the inappropriate use of antibiotics in the Pakadjuma slum in Kinshasa.	[Shembo, Aurelie Koho Pungu] Univ Catholique Louvain UCLouvain, Ecole Sante Publ, Brussels, Belgium; [Musumari, Patou Masika] Kyoto Univ, Ctr Promot Interdisciplinary Educ & Res, Global Hlth Interdisciplinary Unit, Sakyo Ku, Kyoto, Japan; [Musumari, Patou Masika; Srithanaviboonchai, Kriengkrai; Tangmunkongvorakul, Arunrat] Chiang Mai Univ, Res Inst Hlth Sci, Sriphum, Muang Chiang Mai, Thailand; [Srithanaviboonchai, Kriengkrai] Chiang Mai Univ, Fac Med, Dept Community Med, Sriphum, Chiang Mai, Thailand; [Dalleur, Olivia] Univ Catholique Louvain UCLouvain, Louvain Drug Res Inst, Clin Pharm, Brussels, Belgium	Kyoto University; Chiang Mai University; Chiang Mai University	Srithanaviboonchai, K (corresponding author), Chiang Mai Univ, Res Inst Hlth Sci, Sriphum, Muang Chiang Mai, Thailand.; Srithanaviboonchai, K (corresponding author), Chiang Mai Univ, Fac Med, Dept Community Med, Sriphum, Chiang Mai, Thailand.	kriengkrai.s@cmu.ac.th						Afari-Asiedu S, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09204-4; Afari-Asiedu S, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00090; Afari-Asiedu S, 2018, J PHARM POLICY PRACT, V11, DOI 10.1186/s40545-018-0158-6; [Anonymous], 2014, INVESTING UNIVERSAL; Atif M, 2018, INT J PHARM SCI RES, V9, P2140, DOI 10.13040/IJPSR.0975-8232.9(5).2140-48; Awad AI, 2007, ANN PHARMACOTHER, V41, P1249, DOI 10.1345/aph.1K068; Awad AI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117910; Bax RP, 1998, NAT MED, V4, P545, DOI 10.1038/nm0598-545; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Cambaco O, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09243-x; Cespedes A, 2006, AM J INFECT CONTROL, V34, P495, DOI 10.1016/j.ajic.2006.01.005; ConfederationSuisse, 2014, FOC RD CONG SYST SAN; Cortez J, 2017, INT J INFECT DIS, V60, P83, DOI 10.1016/j.ijid.2017.05.011; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Didier B, 2021, BMC INFECT DIS; Nga DTT, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-6; Donkor ES, 2012, INT J ENV RES PUB HE, V9, P3519, DOI 10.3390/ijerph9103519; Duffy E, 2018, J CLIN PHARM THER, V43, P59, DOI 10.1111/jcpt.12610; Fiston Mbutiwi Ikwa Ndol, 2013, SANTE PUBLIQUE, V25, P233; Franco Beatriz Espinosa, 2009, Infect Drug Resist, V2, P1; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Hertz JT, 2019, T ROY SOC TROP MED H, V113, P183, DOI 10.1093/trstmh/try138; Horumpende PG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207465; Hounsa A, 2010, MED MALADIES INFECT, V40, P333, DOI 10.1016/j.medmal.2009.10.002; J ON, 2016, TACKL DRUG RES INF G; Jamhour A, 2017, AM J INFECT CONTROL, V45, P384, DOI 10.1016/j.ajic.2016.11.026; Krockow EM, 2019, BIOETHICS, V33, P756, DOI 10.1111/bioe.12604; Ministere de la Sante Publique Secretariat General., RAPP NARR PROF PHARM; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084177; Ocan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092323; Omulo S, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-014-0041-4; Planta MB, 2007, J AM BOARD FAM MED, V20, P533, DOI 10.3122/jabfm.2007.06.070019; Suleman S, 2009, RES SOC ADMIN PHARM, V5, P76, DOI 10.1016/j.sapharm.2008.04.002; Tenover FC, 2006, AM J MED, V119, pS3, DOI 10.1016/j.amjmed.2006.03.011; Togoobaatar G, 2010, B WORLD HEALTH ORGAN, V88, P930, DOI 10.2471/BLT.10.079004; Watkins JA, 2019, AM J TROP MED HYG, V100, P1378, DOI 10.4269/ajtmh.18-0171; WHO, 2015, GLOB ANT RES SURV SY; World Bank, 2008, DEM REP CONG GROWTH; World Health Organization, 2015, 68 WORLD HLTH ASS; World Health Organization, 2019, WHO COUNTR PROGR IMP; World Health Organization, 2000, REP INF DIS OV ANT R; World Health Organization, 2017, ANTIMICROBIAL RESIST; World Health Organization, 2003, GUID GOOD STOR PRACT; World Health Organization (WHO), 2017, 1 10 MED PROD DEV CO; Yu M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-112	46	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267544	10.1371/journal.pone.0267544	http://dx.doi.org/10.1371/journal.pone.0267544			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476752	Green Published, gold			2022-12-26	WOS:000840124300049
J	Vecchio, R; Pomarici, E; Giampietri, E; Borrello, M				Vecchio, Riccardo; Pomarici, Eugenio; Giampietri, Elisa; Borrello, Massimiliano			Consumer acceptance of fungus-resistant grape wines: Evidence from Italy, the UK, and the USA	PLOS ONE			English	Article							NEOPHOBIA; TECHNOLOGIES; PERCEPTION; BENEFITS; DESIGN; SCALE; BIAS	While there is evidence of consumers' interest in wine sustainability, acceptance of innovations in wine production is not guaranteed. The current study addresses this issue by analyzing consumers' acceptance of fungus-resistant grape (FRG) wines, a sustainable innovation that can substantially reduce the need for chemical inputs in viticulture. To do so, by means of an online survey including large samples of regular wine drinkers in Italy (N = 752), the UK (N = 858) and the USA (N = 856), the study compares individuals' preferences for conventional wines with preferences for FRG wines. The study also explores whether FRG wine acceptance is influenced by informal or formal purchase occasion, by different types of information regarding the product, and by individual attitudinal characteristics. The findings show a general acceptance of FRG wines among consumers. In particular, consumers' preferences for FRG wines on formal occasions are not significantly different from their preferences for conventional wine, whereas on informal occasions, consumers prefer FRG wines over conventional wines. Regarding the impact of information on participant choice, participants informed about the potential effects of FRG on sensory wine characteristics had lower preferences for FRG wines than those who read an information script regarding crop biodiversity. Last, individuals' sustainability concerns and food technology neophobia had positive and negative influences on FRG acceptance, respectively. Overall, this research provides wineries, nurseries and policy-makers with important insights concerning the market potential of FRG wines in three key markets.	[Vecchio, Riccardo; Borrello, Massimiliano] Univ Naples Federico II, Dept Agr Sci, Naples, Italy; [Pomarici, Eugenio; Giampietri, Elisa] Univ Padua, Dept Land Environm Agr & Forestry, Padua, Italy	University of Naples Federico II; University of Padua	Giampietri, E (corresponding author), Univ Padua, Dept Land Environm Agr & Forestry, Padua, Italy.	elisa.giampietri@unipd.it	Vecchio, Riccardo/I-8357-2012	Vecchio, Riccardo/0000-0003-2790-597X; GIAMPIETRI, ELISA/0000-0002-1523-1739; Borrello, Massimiliano/0000-0003-1508-713X	EP POR FESR [10063685]	EP POR FESR	EP POR FESR 2014-2020 Regional Project "Innovativi modelli di sviluppo, sperimentazione ed applicazione di protocolli di sostenibilita della vitivinicoltura veneta" -VIT-VIVE (Gran Agreement no.10063685) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi L, 2021, FOOD QUAL PREFER, V90, DOI 10.1016/j.foodqual.2021.104175; Bavaresco L, 2019, ACTA HORTIC, V1248, P7, DOI 10.17660/ActaHortic.2019.1248.2; Bir C, 2021, AGRIC RESOUR ECON RE, V50, P99, DOI 10.1017/age.2020.12; Boncinelli F, 2019, FOOD QUAL PREFER, V71, P270, DOI 10.1016/j.foodqual.2018.07.013; Borrello M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0255130; Borrello M, 2021, J CLEAN PROD, V307, DOI 10.1016/j.jclepro.2021.127318; Carsana L, 2017, J CONSUM MARK, V34, P255, DOI 10.1108/JCM-07-2016-1869; Casanova-Gascon J, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9110738; Charters S, 2007, FOOD QUAL PREFER, V18, P997, DOI 10.1016/j.foodqual.2007.04.003; Ciubotaru RM, 2021, FRONT PLANT SCI, V12, DOI 10.3389/fpls.2021.693887; Cox DN, 2008, FOOD QUAL PREFER, V19, P704, DOI 10.1016/j.foodqual.2008.04.005; Cummings RG, 1999, AM ECON REV, V89, P649, DOI 10.1257/aer.89.3.649; Escudier JL, 2017, 40 OIV M; Espinoza AF, 2018, OENO ONE, V52, P247, DOI 10.20870/oeno-one.2018.52.3.2316; EU Commission Implementing Regulation, 2018, REN APPR ACT SUBST C, P16; European Commission,, DAT EUR; Fanasch P, 2020, J CLEAN PROD, V249, DOI 10.1016/j.jclepro.2019.119415; FISHER RJ, 1993, J CONSUM RES, V20, P303, DOI 10.1086/209351; Gillison S, 2016, J CONSUM MARK, V33, P225, DOI 10.1108/JCM-04-2015-1401; Giordano S, 2018, INT J GASTRON FOOD S, V11, P1, DOI 10.1016/j.ijgfs.2017.10.001; Grunert KG, 2014, FOOD POLICY, V44, P177, DOI 10.1016/j.foodpol.2013.12.001; Guimier S, 2019, ACTA HORTIC, V1248, P21, DOI 10.17660/ActaHortic.2019.1248.4; Hall John., 2001, INT J WINE MARKET, V13, P36, DOI [10.1108/eb043369, DOI 10.1108/EB043369]; Jourjon Frederique, 2016, Recent Pat Food Nutr Agric, V8, P138, DOI 10.2174/2212798408666160524141500; Lamichhane JR, 2018, AGRON SUSTAIN DEV, V38, DOI 10.1007/s13593-018-0503-9; Lusk JL, 2004, AM J AGR ECON, V86, P467, DOI 10.1111/j.0092-5853.2004.00592.x; Mas L., 2018, B LASSOCIATION GEOGR; MITTAL B, 1989, J ECON PSYCHOL, V10, P363, DOI 10.1016/0167-4870(89)90030-5; Montaigne Etienne, 2016, Wine Economics and Policy, V5, P73, DOI 10.1016/j.wep.2016.11.002; Murphy JJ, 2005, ENVIRON RESOUR ECON, V30, P313, DOI 10.1007/s10640-004-3332-z; Nesselhauf L, 2019, INT J WINE BUS RES, V32, P96, DOI 10.1108/IJWBR-09-2018-0049; OIV, 2021, STAT WORLD VIT SECT; Ojeda H., 2017, GIESCO INT M; Olsen J.E., 2003, INT J WINE MARK, V15, P40, DOI [10.1108/eb008762, DOI 10.1108/EB008762]; Paiola A, 2020, SCI TOTAL ENVIRON, V706, DOI 10.1016/j.scitotenv.2019.135839; Pedneault K, 2016, SCI HORTIC-AMSTERDAM, V208, P57, DOI 10.1016/j.scienta.2016.03.016; Pomarici E., 2019, WINE EC POLICY, V8, P1, DOI [10.1016/j.wep.2019.05.001, DOI 10.1016/J.WEP.2019.05.001]; Pomarici E, 2015, SUSTAINABILITY-BASEL, V7, P16164, DOI 10.3390/su71215806; Rabadan A, 2021, FOOD QUAL PREFER, V93, DOI 10.1016/j.foodqual.2021.104241; Rowe RD, 1996, J ENVIRON ECON MANAG, V31, P178, DOI 10.1006/jeem.1996.0039; Santos JA, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10093092; Schaufele I, 2017, J CLEAN PROD, V147, P379, DOI 10.1016/j.jclepro.2017.01.118; Schnettler B, 2017, FOOD RES INT, V96, P198, DOI 10.1016/j.foodres.2017.04.003; Urdapilleta I, 2021, FOOD QUAL PREFER, V87, DOI 10.1016/j.foodqual.2020.104034; van Doorn J, 2011, INT J RES MARK, V28, P167, DOI 10.1016/j.ijresmar.2011.02.005; Wiedmann KP, 2014, BRIT FOOD J, V116, P197, DOI 10.1108/BFJ-04-2012-0090; Wooldridge J.M., 2006, INTRO ECONOMETRICS M; Zini E, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143526	49	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267198	10.1371/journal.pone.0267198	http://dx.doi.org/10.1371/journal.pone.0267198			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476798	Green Published, gold			2022-12-26	WOS:000840124300027
J	Baez, S; Fadrique, B; Feeley, K; Homeier, J				Baez, Selene; Fadrique, Belen; Feeley, Kenneth; Homeier, Juergen			Changes in tree functional composition across topographic gradients and through time in a tropical montane forest	PLOS ONE			English	Article							CLIMATE-CHANGE; TRAITS; PATTERNS; SHIFTS; DIVERSITY; DYNAMICS; DRIVER; PRODUCTIVITY; TEMPERATURE; IMPACT	Understanding variation in tree functional traits along topographic gradients and through time provides insights into the processes that will shape community composition and determine ecosystem functioning. In montane environments, complex topography is known to affect forest structure and composition, yet its role in determining trait composition, indices on community climatic tolerances, and responses to changing environmental conditions has not been fully explored. This study investigates how functional trait composition (characterized as community-weighted moments) and community climatic indices vary for the tree community as a whole and for its separate demographic components (i.e., dying, surviving, recruiting trees) over eight years in a topographically complex tropical Andean forest in southern Ecuador. We identified a strong influence of topography on functional composition and on species' climatic optima, such that communities at lower topographic positions were dominated by acquisitive species adapted to both warmer and wetter conditions compared to communities at upper topographic positions which were dominated by conservative cold adapted species, possibly due to differences in soil conditions and hydrology. Forest functional and climatic composition remained stable through time; and we found limited evidence for trait-based responses to environmental change among demographic groups. Our findings confirm that fine-scale environmental conditions are a critical factor structuring plant communities in tropical forests, and suggest that slow environmental warming and community-based processes may promote short-term community functional stability. This study highlights the need to explore how diverse aspects of community trait composition vary in tropical montane forests, and to further investigate thresholds of forest response to environmental change.	[Baez, Selene] Escuela Politecn Nacl Ecuador, Dept Biol, Quito, Ecuador; [Fadrique, Belen] Univ Leeds, Sch Geog, Leeds, W Yorkshire, England; [Feeley, Kenneth] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA; [Homeier, Juergen] Univ Goettingen, Dept Plant Ecol, Gottingen, Germany; [Feeley, Kenneth] Fairchild Trop Bot Garden, Coral Gables, FL USA; [Homeier, Juergen] Univ Goettingen, Ctr Biodivers & Sustainable Land Use CBL, Gottingen, Germany; [Homeier, Juergen] HAWK Univ Appl Sci & Arts, Fac Resource Management, Gottingen, Germany	Escuela Politecnica Nacional Ecuador; University of Leeds; University of Miami; University of Gottingen; University of Gottingen; HAWK University of Applied Sciences & Arts Hildesheim Holzminden Gottingen	Baez, S (corresponding author), Escuela Politecn Nacl Ecuador, Dept Biol, Quito, Ecuador.	selene.baez@epn.edu.ec		Baez, Selene/0000-0002-7236-6242	Escuela Politecnica Nacional del Ecuador [PII-ICB-01-2017]; German Science Foundation [Ho3296-2, Ho3296-4]	Escuela Politecnica Nacional del Ecuador; German Science Foundation(German Research Foundation (DFG))	SB, Grant Project PII-ICB-01-2017, Escuela Politecnica Nacional del Ecuador. www.epn.edu.ec JH, Grants Ho3296-2 and Ho3296-4 from The German Science Foundation, https://www.dfg.de The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Allie E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141488; Baez S, 2018, GLOBAL CHANGE BIOL, V24, P399, DOI 10.1111/gcb.13905; Baez S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126594; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Blundo C, 2021, BIOL CONSERV, V260, DOI 10.1016/j.biocon.2020.108849; Brown CD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1779; Bueno de Mesquita CP., 2018, ARCT ANTARCT ALP RES, V50, DOI [10.1080/15230430.2018.1504492, DOI 10.1080/15230430.2018.1504492]; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; Davis FW, 2019, AGR FOREST METEOROL, V269, P192, DOI 10.1016/j.agrformet.2019.02.015; De Frenne P, 2021, GLOBAL CHANGE BIOL, V27, P2279, DOI 10.1111/gcb.15569; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Duque A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22459-8; Duque A, 2015, P NATL ACAD SCI USA, V112, P10744, DOI 10.1073/pnas.1506570112; Enquist B.J., 2009, BOT INFORM ECOLOGY N; Enquist BJ, 2015, ADV ECOL RES, V52, P249, DOI 10.1016/bs.aecr.2015.02.001; Fadrique B, 2018, NATURE, V564, P207, DOI 10.1038/s41586-018-0715-9; Feeley KJ, 2020, NAT CLIM CHANGE, V10, P965, DOI 10.1038/s41558-020-0873-2; Feeley KJ, 2013, GLOBAL CHANGE BIOL, V19, P3472, DOI 10.1111/gcb.12300; Feeley KJ, 2011, J BIOGEOGR, V38, P783, DOI 10.1111/j.1365-2699.2010.02444.x; Fortunel C, 2018, ECOLOGY, V99, P2272, DOI 10.1002/ecy.2441; Freeman BG, 2018, GLOBAL ECOL BIOGEOGR, V27, P1268, DOI 10.1111/geb.12774; He SY, 2017, SCI REP-UK, V7, DOI 10.1038/srep40387; Homeier J., 2008, V198, P87; Homeier J, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-89190-8; Homeier J, 2010, BIOTROPICA, V42, P140, DOI 10.1111/j.1744-7429.2009.00547.x; Jucker T, 2018, ECOL LETT, V21, P989, DOI 10.1111/ele.12964; Karger DN, 2021, NAT ECOL EVOL, V5, P854, DOI 10.1038/s41559-021-01450-y; Karger DN, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.122; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Krishnaswamy J, 2014, GLOBAL CHANGE BIOL, V20, P203, DOI 10.1111/gcb.12362; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lembrechts JJ, 2019, ECOGRAPHY, V42, P1267, DOI 10.1111/ecog.03947; Lenoir J, 2015, ECOGRAPHY, V38, P15, DOI 10.1111/ecog.00967; Lenoir J, 2017, ECOGRAPHY, V40, DOI 10.1111/ecog.02788; Link R, 2018, CALCULATION TOPOGRAP; Lippok D, 2014, J VEG SCI, V25, P724, DOI 10.1111/jvs.12132; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Maclean IMD, 2017, GLOBAL CHANGE BIOL, V23, P256, DOI 10.1111/gcb.13343; Madani N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21172-9; Mage SM, 2013, ECOSYSTEMS, V16, P284, DOI 10.1007/s10021-012-9612-5; Malhi Y, 2004, PHILOS T R SOC B, V359, P549, DOI 10.1098/rstb.2003.1449; McCain CM, 2011, ECOL LETT, V14, P1236, DOI 10.1111/j.1461-0248.2011.01695.x; Mclaughlin BC, 2017, GLOBAL CHANGE BIOL, V23, P2941, DOI 10.1111/gcb.13629; Mendez-Toribio M, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa717b; Mendez-Toribio M, 2016, J VEG SCI, V27, P1094, DOI 10.1111/jvs.12455; Moeslund JE, 2013, NORD J BOT, V31, P129, DOI 10.1111/j.1756-1051.2013.00082.x; Muscarella R, 2017, ECOLOGY, V98, P2743, DOI 10.1002/ecy.1990; Nunez PA, 2021, INT J REMOTE SENS, V42, P2940, DOI 10.1080/01431161.2020.1864058; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Pena MA, 2018, PLANT ECOL, V219, P1481, DOI 10.1007/s11258-018-0895-2; Peters T, 2013, ECOSYSTEM SERVICES B, V221, P19, DOI [10.1007/978-3-642-38137-9_2, DOI 10.1007/978-3-642-38137-9_2]; Pierick K, 2021, NEW PHYTOL, V230, P129, DOI 10.1111/nph.17136; R Core Team, 2021, R LANGUAGE ENV STAT; Rahbek C, 2019, SCIENCE, V365, P1108, DOI 10.1126/science.aax0149; Rehm E., 2016, FRONTIERS BIOGEOGRAP, V8, pe27788, DOI [10.21425/F5FBG27788, DOI 10.21425/F5FBG27788]; Reich PB, 2014, J ECOL, V102, P275, DOI 10.1111/1365-2745.12211; Robroek BJM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01350-5; Rohde R., 2013, GEOINFOR GEOSTAT OVE, V1, P1, DOI [10.4172/2327-4581.1000101, 10.4172/gigs.1000101]; Romoleroux K, 2018, BASE DATOS HERBARIO; Ruiz-Benito P, 2017, GLOBAL ECOL BIOGEOGR, V26, P128, DOI 10.1111/geb.12515; Rumpf SB, 2018, P NATL ACAD SCI USA, V115, P1848, DOI 10.1073/pnas.1713936115; Sanchez-Martinez P, 2020, ECOL LETT, V23, P1599, DOI 10.1111/ele.13584; Schweiger AH, 2016, GLOBAL ECOL BIOGEOGR, V25, P1013, DOI 10.1111/geb.12463; Sheldon KS, 2011, ECOL LETT, V14, P1191, DOI 10.1111/j.1461-0248.2011.01689.x; Simova I, 2018, J BIOGEOGR, V45, P895, DOI 10.1111/jbi.13171; Sonnier G, 2014, GLOBAL ECOL BIOGEOGR, V23, P894, DOI 10.1111/geb.12164; Steinbauer MJ, 2018, NATURE, V556, P231, DOI 10.1038/s41586-018-0005-6; Stephenson NL, 2005, ECOL LETT, V8, P524, DOI 10.1111/j.1461-0248.2005.00746.x; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Ungerechts L, 2010, DEM 10M TRIANG AER P; Urrutia R, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011021; Valencia R, 2009, J TROP ECOL, V25, P473, DOI 10.1017/S0266467409990095; van der Sande MT, 2016, ECOL MONOGR, V86, P228, DOI 10.1890/15-1815.1; Vuille M, 2015, J GEOPHYS RES-ATMOS, V120, P3745, DOI 10.1002/2015JD023126; Weiss A., 2001, P ESRI US C; Werner FA, 2015, FUNCT ECOL, V29, P430, DOI 10.1111/1365-2435.12351; White HJ, 2018, ECOL EVOL, V8, P7365, DOI 10.1002/ece3.4267; Wieczynski DJ, 2019, P NATL ACAD SCI USA, V116, P587, DOI 10.1073/pnas.1813723116; Wiens JJ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2001104; Wilcke W, 2008, J PLANT NUTR SOIL SC, V171, P220, DOI 10.1002/jpln.200625210; Wilcke W, 2019, J GEOPHYS RES-BIOGEO, V124, P1370, DOI 10.1029/2018JG004942; Wilcke W, 2013, GLOBAL BIOGEOCHEM CY, V27, P1194, DOI 10.1002/2012GB004471; Wolf K, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003876	85	3	3	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0263508	10.1371/journal.pone.0263508	http://dx.doi.org/10.1371/journal.pone.0263508			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35442987	Green Published, gold			2022-12-26	WOS:000822608900005
J	Sunarno, S; Sofiah, SN; Amalia, N; Hartoyo, Y; Rizki, A; Puspandari, N; Saraswati, RD; Febriyana, D; Febrianti, T; Susanti, I; Khariri, K; Sariadji, K; Muna, F; Rukminiati, Y; Sulistyaningrum, N; Riana, DA; Maha, MS; Fitriana, F; Voronika, V; Muslih, M; Kamal, M; Setiawaty, V				Sunarno, Sunarno; Sofiah, Sundari Nur; Amalia, Novi; Hartoyo, Yudi; Rizki, Aulia; Puspandari, Nelly; Saraswati, Ratih Dian; Febriyana, Dwi; Febrianti, Tati; Susanti, Ida; Khariri, Khariri; Sariadji, Kambang; Muna, Fauzul; Rukminiati, Yuni; Sulistyaningrum, Novi; Riana, Dyah Armi; Maha, Masri Sembiring; Fitriana, Fitriana; Voronika, Vivi; Muslih, Muamar; Kamal, Mushtofa; Setiawaty, Vivi			Laboratory and epidemiology data of pertussis cases and close contacts: A 5-year case-based surveillance of pertussis in Indonesia, 2016-2020	PLOS ONE			English	Article							DIAGNOSIS; INFANTS; DISEASE; INFECTION; OUTBREAK; ENGLAND	Pertussis cases have been reported most frequently in developed countries, but they are predicted to be the most prevalent in developing countries. Indonesia, a developing country, routinely conducts case-based surveillance for pertussis. We reviewed the data on pertussis cases and close contacts based on clinical sample documents examined in the National Reference Laboratory for pertussis, Indonesia (2016-2020). Our objective was to analyze the laboratory and epidemiological aspects of pertussis cases and close contacts, particularly to evaluate the implementation of a 5-year case-based surveillance of pertussis in Indonesia. Data were collected from sample documents and annual laboratory reports between January 2016 and December 2020. We analyzed the proportion of pertussis cases and close contacts by geographic region, year, age, and sex. We used the chi(2) test to correlate the laboratory and epidemiological data. In total, 274 clinical cases of pertussis and 491 close contacts were recorded in 15 provinces. The peak number of cases occurred in 2019, with a positivity rate (percentage of laboratory-confirmed cases) of 41.23% (47/114). Clinical cases were dominated by infants aged <1 year (55.5%), and 52.9% of them were aged <6 months. Similarly, 72.3% (68/94) of the laboratory-confirmed cases were infants. Both clinical cases and positivity rates tended to be higher in females (155 cases, 38.1%) than in males (119 cases, 29.4%). No confirmed cases were found in children aged >= 10 years, although positive results still occurred in close contact. Age-group and laboratory-confirmed cases were correlated (p = 0.00). Clinical and confirmed cases of pertussis occurred mostly in the early age group and may be lower in those aged >= 10 years, especially in confirmed cases. New policies are needed for pertussis prevention at an early age, as well as the application of serology tests to increase laboratory-confirmed cases in children aged >= 10 years.	[Sunarno, Sunarno; Sofiah, Sundari Nur; Amalia, Novi; Hartoyo, Yudi; Rizki, Aulia; Puspandari, Nelly; Saraswati, Ratih Dian; Febriyana, Dwi; Febrianti, Tati; Susanti, Ida; Khariri, Khariri; Sariadji, Kambang; Muna, Fauzul; Rukminiati, Yuni; Sulistyaningrum, Novi; Riana, Dyah Armi; Maha, Masri Sembiring; Setiawaty, Vivi] Natl Inst Hlth Res & Dev, Ctr Res & Dev Biomed & Basic Hlth Technol, Jakarta, Indonesia; [Sunarno, Sunarno; Khariri, Khariri; Maha, Masri Sembiring; Fitriana, Fitriana] Natl Res & Innovat Agcy BRIN, Jakarta, Indonesia; [Fitriana, Fitriana] Natl Inst Hlth Res & Dev, Ctr Res & Dev Hlth Resources & Serv, Jakarta, Indonesia; [Voronika, Vivi; Muslih, Muamar] Minist Hlth, Directorate Gen Dis Prevent & Control, Jakarta, Indonesia; [Kamal, Mushtofa] WHO, Country Off Indonesia, Jakarta, Indonesia; [Setiawaty, Vivi] Sulianti Saroso Hosp, Jakarta, Indonesia	National Institute of Health Research & Development - Indonesia; National Institute of Health Research & Development - Indonesia; Ministry of Health - Indonesia; World Health Organization	Sunarno, S (corresponding author), Natl Inst Hlth Res & Dev, Ctr Res & Dev Biomed & Basic Hlth Technol, Jakarta, Indonesia.; Sunarno, S (corresponding author), Natl Res & Innovat Agcy BRIN, Jakarta, Indonesia.	no_nar@yahoo.com		Sulistyaningrum, Novi/0000-0002-8993-3709; sunarno, sunarno/0000-0002-7012-2738				[Anonymous], 2012, EUR CTR DIS PREV CON; [Anonymous], 2017, PER MENT KES REP IND; Argondizo-Correia C, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/7134168; Ben Fraj I, 2019, J MED MICROBIOL, V68, P241, DOI 10.1099/jmm.0.000892; Bhatti MM, 2017, J PEDIATR INFECT DIS, V6, P91, DOI 10.1093/jpids/piv079; Campbell H, 2018, J MED MICROBIOL, V67, P1426, DOI 10.1099/jmm.0.000829; Campbell H, 2014, EMERG INFECT DIS, V20, P968, DOI 10.3201/eid2006.131069; Craig R, 2019, ASYMPTOMATIC INFECT; Ebell MH, 2017, J AM BOARD FAM MED, V30, P308, DOI 10.3122/jabfm.2017.03.160330; Gkentzi D, 2017, ARCH DIS CHILD-FETAL, V102, pF456, DOI 10.1136/archdischild-2016-312341; Horby P, 2005, EPIDEMIOL INFECT, V133, P229, DOI 10.1017/S0950268804003401; Jackson DW, 2014, EPIDEMIOL INFECT, V142, P672, DOI 10.1017/S0950268812003093; Kandeil W, 2020, EXPERT REV VACCINES, V19, P621, DOI 10.1080/14760584.2020.1791092; Kara EO, 2017, PEDIATR INFECT DIS J, V36, P140, DOI 10.1097/INF.0000000000001378; Kilgore PE, 2016, CLIN MICROBIOL REV, V29, P449, DOI 10.1128/CMR.00083-15; Klein NP, 2013, PEDIATRICS, V131, pE1716, DOI 10.1542/peds.2012-3836; Lee AD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195979; Nataprawira HM, 2015, J ACUTE DIS, V4, P147, DOI 10.1016/S2221-6189(15)30025-1; Peer V, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231570; Pillsbury A, 2014, COMMUN DIS INTELL, V38, pE179; Public Health England, 2019, HEAL PROT REP, V13; van der Zee A, 2015, CLIN MICROBIOL REV, V28, P1005, DOI 10.1128/CMR.00031-15; Vygen-Bonnet S, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-4824-3; Wendelboe AM, 2006, EXPERT REV MOL DIAGN, V6, P857, DOI 10.1586/14737159.6.6.857; Wood N, 2008, PAEDIATR RESPIR REV, V9, P201, DOI 10.1016/j.prrv.2008.05.010; World Health Organization, 2002, GLOB BURD DIS EST 20; World Health Organization, 2020, VACCINE PREVENTABLE, P1; World Health Organization, 2018, VACC PREV DIS SURV S	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0266033	10.1371/journal.pone.0266033	http://dx.doi.org/10.1371/journal.pone.0266033			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35442946	Green Published, gold			2022-12-26	WOS:000822608900017
J	Djade, CD; Diorio, C; Laurin, D; Dionne, CE				Djade, Codjo Djignefa; Diorio, Caroline; Laurin, Danielle; Dionne, Clermont E.			An exploratory identification of biological markers of chronic musculoskeletal pain in the low back, neck, and shoulders	PLOS ONE			English	Article							GLOBAL BURDEN; ISOTRETINOIN THERAPY; CADMIUM EXPOSURE; VITAMIN-C; DEFINITIONS; DISEASE; HOMOCYSTEINE; CONSUMPTION; OVERWEIGHT; MERCURY	ObjectivesThis study was an in-depth exploration of unique data from a nationally representative sample of adults living in the United States to identify biomarkers associated with musculoskeletal pain. MethodsWe performed secondary analyses of 2003-2004 NHANES data. After a first screening of 187 markers, analyses of 31 biomarkers were conducted on participants aged >= 20 years identified in all counties using the 2000 Census Bureau data (n = 4,742). To assess the association of each biomarker with each pain outcome (acute, subacute and chronic low back, neck, and shoulder pain), analyses were carried out using multivariable logistic regression with adjustments for sex, age and body mass index. Biomarkers were considered as continuous variables and categorized at the median of their distributions. ResultsPain at any site for >= 24 hours during the past month was reported by 1,214 participants. Of these, 779 mentioned that the pain had lasted for >= 3 months ("chronic pain"). alpha-carotene, ascorbic acid, beta-carotene, mercury and total protein had a statistically significant, inverse association with >= 2 chronic pain sites. Acrylamide, alkaline phosphatase, cadmium, cotinine, glycidamide, homocysteine, retinol, triglycerides and white blood cell count were positively associated with >= 2 chronic pain sites. Few biological markers were associated with acute and subacute pain. ConclusionsThis study identified some biomarkers that were strongly and consistently associated with musculoskeletal pain. These results raise new hypotheses and could have tremendous implications for advancing knowledge in the field. Research on musculoskeletal pain needs to put more effort on the biological dimension of the biopsychosocial model of pain.	[Djade, Codjo Djignefa; Diorio, Caroline; Dionne, Clermont E.] Univ Laval, Dept Social & Prevent Med, Quebec City, PQ, Canada; [Djade, Codjo Djignefa; Diorio, Caroline; Laurin, Danielle; Dionne, Clermont E.] Univ Laval, Ctr Rech, CHU Quebec, Quebec City, PQ, Canada; [Djade, Codjo Djignefa; Laurin, Danielle; Dionne, Clermont E.] Ctr Rech Sante Durable VITAM, Ctr Excellence Sur Vieillissement Quebec CEVQ, Quebec City, PQ, Canada; [Laurin, Danielle] Univ Laval, Fac Pharm, Quebec City, PQ, Canada; [Dionne, Clermont E.] Univ Laval, Fac Med, Dept Rehabil, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; Laval University	Dionne, CE (corresponding author), Univ Laval, Dept Social & Prevent Med, Quebec City, PQ, Canada.; Dionne, CE (corresponding author), Univ Laval, Ctr Rech, CHU Quebec, Quebec City, PQ, Canada.; Dionne, CE (corresponding author), Ctr Rech Sante Durable VITAM, Ctr Excellence Sur Vieillissement Quebec CEVQ, Quebec City, PQ, Canada.; Dionne, CE (corresponding author), Univ Laval, Fac Med, Dept Rehabil, Quebec City, PQ, Canada.	clermont.dionne@crchudequebec.ulaval.ca		Laurin, Danielle/0000-0001-5032-2452; DIONNE, Clermont/0000-0003-0806-5573				Abdullah M., 2022, STATPEARLS; Ahluwalia N, 2016, ADV NUTR, V7, P121, DOI 10.3945/an.115.009258; Baineni R, 2017, ARCH DIS CHILD, V102, P556, DOI 10.1136/archdischild-2016-310631; Batista ED, 2016, REV BRAS REUMATOL, V56, P105, DOI 10.1016/j.rbre.2015.08.015; Blyth FM, 2019, AM J PUBLIC HEALTH, V109, P35, DOI 10.2105/AJPH.2018.304747; Buchbinder R, 2018, LANCET, V391, P2384, DOI 10.1016/S0140-6736(18)30488-4; Cao WT, 2018, BONE, V111, P116, DOI 10.1016/j.bone.2018.03.023; Carter Jene Andrea, 2019, Integr Med (Encinitas), V18, P49; Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS), 2006, EX SURV AN REP GUID; Croft P, 2005, ARTHRITIS RHEUM-US, V52, P2350, DOI 10.1002/art.21218; Curtin Lester R, 2012, Vital Health Stat 2, P1; Dionne CE, 2008, SPINE, V33, P95, DOI 10.1097/BRS.0b013e31815e7f94; Dionne CE, 2018, SPINE, V43, pE712, DOI 10.1097/BRS.0000000000002466; Dionne CE, 2016, PAIN, V157, P2527, DOI 10.1097/j.pain.0000000000000671; Douketis JD, 2005, CAN MED ASSOC J, V172, P995, DOI 10.1503/cmaj.045170; Elliott AM, 1999, LANCET, V354, P1248, DOI 10.1016/S0140-6736(99)03057-3; Faroon O., 2012, TOXICOLOGICAL PROFIL; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Griffith LE, 2007, J CLIN EPIDEMIOL, V60, P625, DOI 10.1016/j.jclinepi.2006.09.005; Guallar E, 2006, AM J EPIDEMIOL, V163, P700, DOI 10.1093/aje/kwj090; Hayhoe RPG, 2017, BRIT J NUTR, V117, P1439, DOI 10.1017/S0007114517001180; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Hoy DG, 2014, ANN RHEUM DIS, V73, P982, DOI 10.1136/annrheumdis-2013-204344; Inaba T, 2005, TOXICOL LETT, V159, P192, DOI 10.1016/j.toxlet.2005.05.011; Ireland P, 1994, Asia Pac J Clin Nutr, V3, P169; JARVIS MJ, 1988, AM J PUBLIC HEALTH, V78, P696, DOI 10.2105/AJPH.78.6.696; Johnson Clifford L, 2013, Vital Health Stat 2, P1; Kang MY, 2013, OCCUP ENVIRON MED, V70, P268, DOI 10.1136/oemed-2012-101063; KARAKAYA A, 1994, HUM EXP TOXICOL, V13, P73, DOI 10.1177/096032719401300202; Karaosmanoglu N, 2020, BMC MUSCULOSKEL DIS, V21, DOI 10.1186/s12891-020-03656-w; Kroger E, 2009, AM J CLIN NUTR, V90, P184, DOI 10.3945/ajcn.2008.26987; La-Up A, 2018, ENVIRON SCI POLLUT R, V25, P14182, DOI 10.1007/s11356-018-1665-3; Lee YH, 2016, JAMA DERMATOL, V152, P35, DOI 10.1001/jamadermatol.2015.3091; Lovasova E, 2013, J TOXICOL ENV HEAL A, V76, P1033, DOI 10.1080/15287394.2013.828249; Ma SY, 2022, ENVIRON SCI POLLUT R, V29, P1836, DOI 10.1007/s11356-021-15732-2; Maher C, 2017, LANCET, V389, P736, DOI 10.1016/S0140-6736(16)30970-9; Masur LC, 2011, ALTERN MED REV, V16, P314; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Natvig B, 2001, J REHABIL MED, V33, P21; NHANES, NHANES 20032004 LAB; Penniston KL, 2006, AM J CLIN NUTR, V83, P191; Petrova MV, 2020, CHEMOSPHERE, V258, DOI 10.1016/j.chemosphere.2020.127232; Polat M, 2008, J DERMATOL TREAT, V19, P229, DOI 10.1080/09546630701846079; Pruser Kaci N, 2011, Front Biosci (Schol Ed), V3, P41, DOI 10.2741/s130; Puntmann VO, 2009, POSTGRAD MED J, V85, P538, DOI 10.1136/pgmj.2008.073759; Rogalska J, 2009, CHEM-BIOL INTERACT, V177, P142, DOI 10.1016/j.cbi.2008.09.011; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rubin M, 2021, SYNTHESE, V199, P10969, DOI 10.1007/s11229-021-03276-4; Samarghandian Saeed, 2015, Interdiscip Toxicol, V8, P151, DOI 10.1515/intox-2015-0023; SAS Institute Inc, SAS SYSTEM SUN OS; Satarug Soisungwan, 2011, Ciênc. saúde coletiva, V16, P2587, DOI 10.1590/S1413-81232011000500029; Spencer P. S., 1975, ENV HLTH PERSPECT, V11, P129, DOI [10.1289/ehp.7511129, DOI 10.1289/EHP.7511129]; Thomas E, 1999, BRIT MED J, V318, P1662, DOI 10.1136/bmj.318.7199.1662; Treede RD, 2019, PAIN, V160, P19, DOI 10.1097/j.pain.0000000000001384; van den Berg R, 2018, SPINE J, V18, P2140, DOI 10.1016/j.spinee.2018.06.349; WADDELL G, 1987, SPINE, V12, P632, DOI 10.1097/00007632-198709000-00002	56	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266999	10.1371/journal.pone.0266999	http://dx.doi.org/10.1371/journal.pone.0266999			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1E2NP	35427389	Green Published, gold			2022-12-26	WOS:000794332400043
J	Hernandez, K; Madeira, C				Hernandez, Karla; Madeira, Carlos			The impact of climate change on economic output across industries in Chile	PLOS ONE			English	Article							TEMPERATURE; GROWTH	Using region-industry panel data for Chile over the period 1985 to 2017, we find no effect of precipitation changes on GDP and a negative impact of higher summer temperatures on Agriculture-Silviculture and Fishing. An increase of one Celsius degree in the month of January implies a 3% and 12% GDP reduction in Agriculture and Fishing, respectively. There is also a negative effect of higher temperatures in January on Construction and Electricity, Gas, and Water. Our analysis suggests that climate change did not have a big impact on the Chilean economy during this period. Stress test exercises that select only the negative and statistically significant coefficients imply that the Chilean GDP would fall between -14.8% and -9% in 2050 and between -29.6% and -16.8% in 2100, according to our model.	[Hernandez, Karla] Univ Wisconsin, Madison, WI USA; [Madeira, Carlos] Cent Bank Chile, Santiago, Chile	University of Wisconsin System; University of Wisconsin Madison; Central Bank of Chile	Madeira, C (corresponding author), Cent Bank Chile, Santiago, Chile.	cmadeira@bcentral.cl		Madeira, Carlos/0000-0003-4645-2099				Albagli E., 2021, LMITES PLANETARIOS C; [Anonymous], 2019, GLOBAL CLIMATE RISK; Avils-Lucero F., 2021, EC STAT WORKING PAPE, V135; Baltagi B.H., 2021, ECONOMETRIC ANAL PAN; Brcena A., 2019, EMERGENCIA CAMBIO CL; Burke M, 2016, AM ECON J-ECON POLIC, V8, P106, DOI 10.1257/pol.20130025; Burke M, 2015, NATURE, V527, P235, DOI 10.1038/nature15725; Cachon G., 2012, COLUMBIA BUSINESS SC; Cavallo E, 2020, CLIMATE CHANGE IS TH; Central Bank of Chile, 2019, BASE DATOS ESTADSTIC; Colacito R, 2019, J MONEY CREDIT BANK, V51, P313, DOI 10.1111/jmcb.12574; Collins M., 2013, CLIMATE CHANGE 2013, P1029; Dell M, 2012, AM ECON J-MACROECON, V4, P66, DOI 10.1257/mac.4.3.66; Di Bella G., 2015, IMF WP 1530; Diffenbaugh NS, 2019, P NATL ACAD SCI USA, V116, P9808, DOI 10.1073/pnas.1816020116; Fernandes ECM., 2012, CLIMATE CHANGE AGR L; Gerten D, 2011, J HYDROMETEOROL, V12, P885, DOI 10.1175/2011JHM1328.1; Hernndez K., 2021, DTBC933 CENTR BANK C; Hoffmann B., 2020, IDBPB338; Hornbeck R, 2012, AM ECON REV, V102, P1477, DOI 10.1257/aer.102.4.1477; HSBC, 2018, FRAG PLAN SCOR CLIM; IMF, 2021, FINANC DEV, V58; IPCC, 2021, IPCC WORK GROUP I WG; IPCC, 2014, AR5 SCEN DAT; Kahn ME, 2021, ENERG ECON, V104, DOI 10.1016/j.eneco.2021.105624; Madeira C., 2022, **DATA OBJECT**, VV1, DOI [10.17632/zyrdg56hzr.1, DOI 10.17632/ZYRDG56HZR.1]; Mendelsohn R., 1999, IMPACT CLIMATE CHANG; Mendelsohn R., 2009, WORLD BANK WORKING P; NGFS, 2021, NGFS CLIM SCEN CENTR; Olmstead AL, 2011, P NATL ACAD SCI USA, V108, P480, DOI 10.1073/pnas.1008279108; Organization for Economic Co-operation and Development (OECD), 2015, EC CONS CLIM CHANG; Stern N, 2008, AM ECON REV, V98, P1, DOI 10.1257/aer.98.2.1; University of Delaware, 2019, U DEL AIR TEMP PREC; Vergara W., 2013, CLIMATE DEV CHALLENG; Watts N, 2019, LANCET, V394, P1836, DOI 10.1016/S0140-6736(19)32596-6; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; Zivin JG, 2014, J LABOR ECON, V32, P1, DOI 10.1086/671766	37	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266811	10.1371/journal.pone.0266811	http://dx.doi.org/10.1371/journal.pone.0266811			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1D8GY	35482718	Green Published, gold			2022-12-26	WOS:000794035700019
J	Hooykaas, MJD; Schilthuizen, M; Albers, CJ; Smeets, I				Hooykaas, Michiel Jan Dirk; Schilthuizen, Menno; Albers, Casper Johannes; Smeets, Ionica			Species identification skills predict in-depth knowledge about species	PLOS ONE			English	Article							HEALTH; OVERESTIMATION; BIODIVERSITY; ORGANISMS; STUDENTS	To raise biodiversity awareness effectively, communicators should be aware of knowledge levels in their audiences. Species identification skills have been used in the past as a measure of what people know about species, yet it is not known whether they serve as good indicators. To study the link between species identification and in-depth species knowledge, we presented an animal knowledge test to an online audience of over 7,000 Dutch adults, and used correlation and regression analyses to determine the extent to which species identification predicts in-depth knowledge about species' origin, habitat, diet, and behavior. We found that in-depth knowledge was higher in those who correctly identified species as compared with those who did not correctly identify species, for all four types of in-depth knowledge. Moreover, as compared to alternative variables (work, age, gender, and educational level), species identification was by far the best predictor for in-depth knowledge about species. However, species identification levels were generally higher than levels of in-depth knowledge, and knowledge gaps and misconceptions were uncovered. The results confirm the value of species identification tests, but also highlight limitations and challenges that should be taken into account when establishing knowledge levels and communicating biodiversity.	[Hooykaas, Michiel Jan Dirk; Schilthuizen, Menno; Smeets, Ionica] Leiden Univ, Sci Commun & Soc, Leiden, Netherlands; [Schilthuizen, Menno] Nat Biodivers Ctr, Leiden, Netherlands; [Albers, Casper Johannes] Univ Groningen, Heymans Inst Psychol Res, Groningen, Netherlands	Leiden University; Leiden University - Excl LUMC; Naturalis Biodiversity Center; University of Groningen	Hooykaas, MJD (corresponding author), Leiden Univ, Sci Commun & Soc, Leiden, Netherlands.	m.j.d.hooykaas@biology.leidenuniv.nl	Schilthuizen, Menno/B-5156-2009	Schilthuizen, Menno/0000-0001-6229-0347; Albers, Casper/0000-0002-9213-6743; Hooykaas, Michiel/0000-0001-8586-3849				Albert C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199149; Almeida A, 2020, J BIOL EDUC, V54, P17, DOI 10.1080/00219266.2018.1538017; Ballouard JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023152; Balmford A, 2002, SCIENCE, V295, P2367; Barker S, 1998, INT J SCI EDUC, V20, P479, DOI 10.1080/0950069980200407; Buijs Arjen E., 2008, International Journal of Biodiversity Science & Management, V4, P65, DOI 10.3843/Biodiv.4.2:1; Burgman MA., 2016, TRUSTING JUDGEMENTS; Corbett SW, 2005, AM J EMERG MED, V23, P759, DOI 10.1016/j.ajem.2005.03.008; Courchamp F, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003997; Davies T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203694; Dickens C, 2013, J HEALTH COMMUN, V18, P62, DOI 10.1080/10810730.2013.825670; Dixon S. P., 2005, Transactions of the Natural History Society of Northumbria, V64, P121; Elder J., 1998, ENGAGING PUBLIC BIOD; Gerl T, 2021, INT J SCI EDUC, V43, P928, DOI 10.1080/09500693.2021.1892232; Greene HW, 2005, TRENDS ECOL EVOL, V20, P23, DOI 10.1016/j.tree.2004.11.005; Hailikari T, 2008, AM J PHARM EDUC, V72, DOI 10.5688/aj7205113; Hooykaas MJD, 2019, BIOL CONSERV, V238, DOI 10.1016/j.biocon.2019.108202; Hooykaas MJD., 2021, CHILDRENS SPECIES LI, P1; Horwitz P, 2001, ECOSYST HEALTH, V7, P253, DOI 10.1046/j.1526-0992.2001.01044.x; Huxham M, 2006, J BIOL EDUC, V41, P9, DOI 10.1080/00219266.2006.9656050; Kai Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086598; Kelly PA, 2007, PATIENT EDUC COUNS, V66, P119, DOI 10.1016/j.pec.2006.10.007; Kubiatko M., 2007, J BALT SCI EDUC, V6, P5; Leather SR, 2009, J BIOL EDUC, V43, P51, DOI 10.1080/00219266.2009.9656151; Lindemann-Matthies P, 2005, INT J SCI EDUC, V27, P655, DOI 10.1080/09500690500038116; Mohneke M., 2016, J EMERGENT SCI, P11; Mortimer JAJ, 2019, NEW ZEAL J ZOOL, V46, P201, DOI 10.1080/03014223.2018.1536068; Novacek MJ, 2008, P NATL ACAD SCI USA, V105, P11571, DOI 10.1073/pnas.0802599105; Nyhus PJ, 2003, ENVIRON CONSERV, V30, P192, DOI 10.1017/S0376892903000183; Perrenet JC, 2010, EDUC INF TECHNOL, V15, P87, DOI 10.1007/s10639-009-9098-8; Peterson M. N., 2008, HUM DIMENS WILDL INT, V13, P339; Pilgrim S, 2007, ECOL APPL, V17, P1742, DOI 10.1890/06-1358.1; Randler C., 2010, EURASIA J MATH SCI T, V6, P237, DOI [10.12973/ejmste/75244, DOI 10.12973/EJMSTE/75244]; Randler C, 2007, ANTHROZOOS, V20, P65, DOI 10.2752/089279307780216696; Randler C, 2010, J BALT SCI EDUC, V9, P135; Randler C, 2008, J BALT SCI EDUC, V7, P48; Remmele M., 2018, EURASIA J MATH SCI T, V14, DOI DOI 10.29333/EJMSTE/92287; Tetlock PE., 2015, SUPERFORECASTING AMS, P318; Thompson RA, 2003, TEACH PSYCHOL, V30, P96, DOI 10.1207/S15328023TOP3002_02; Torkar G., 2016, INT J BIOL ED, V5, P1; Tunnicliffe SD, 1999, J BIOL EDUC, V33, P142, DOI 10.1080/00219266.1999.9655654; V?zquez-Plass E., 2010, J CARIBBEAN ORNITHOL, V23, P93; Wilson C, 2005, BIRD CONSERV INT, V15, P225, DOI 10.1017/S0959270905000419; Yli-Panula E, 2014, J BALT SCI EDUC, V13, P559	44	1	1	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266972	10.1371/journal.pone.0266972	http://dx.doi.org/10.1371/journal.pone.0266972			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0Z7MW	35436302	Green Published, gold			2022-12-26	WOS:000791258900031
J	Scotti, F; Pierri, F; Bonaccorsi, G; Flori, A				Scotti, Francesco; Pierri, Francesco; Bonaccorsi, Giovanni; Flori, Andrea			Responsiveness of open innovation to COVID-19 pandemic: The case of data for good	PLOS ONE			English	Article							PRIVATE-COLLECTIVE INNOVATION; GRAND CHALLENGES; HUMAN MOBILITY; KNOWLEDGE	Due to the COVID-19 pandemic, countries around the world are facing one of the most severe health and economic crises of recent history and human society is called to figure out effective responses. However, as current measures have not produced valuable solutions, a multidisciplinary and open approach, enabling collaborations across private and public organizations, is crucial to unleash successful contributions against the disease. Indeed, the COVID-19 represents a Grand Challenge to which joint forces and extension of disciplinary boundaries have been recognized as main imperatives. As a consequence, Open Innovation represents a promising solution to provide a fast recovery. In this paper we present a practical application of this approach, showing how knowledge sharing constitutes one of the main drivers to tackle pressing social needs. To demonstrate this, we propose a case study regarding a data sharing initiative promoted by Facebook, the Data For Good program. We leverage a large-scale dataset provided by Facebook to the research community to offer a representation of the evolution of the Italian mobility during the lockdown. We show that this repository allows to capture different patterns of movements on the territory with increasing levels of detail. We integrate this information with Open Data provided by the Lombardy region to illustrate how data sharing can also provide insights for private businesses and local authorities. Finally, we show how to interpret Data For Good initiatives in light of the Open Innovation Framework and discuss the barriers to adoption faced by public administrations regarding these practices.	[Scotti, Francesco; Bonaccorsi, Giovanni; Flori, Andrea] Politecn Milan, Dept Management Econ & Ind Engn, Milan, Italy; [Pierri, Francesco] Politecn Milan, Dept Elect Informat & Bioengn, Milan, Italy	Polytechnic University of Milan; Polytechnic University of Milan	Scotti, F (corresponding author), Politecn Milan, Dept Management Econ & Ind Engn, Milan, Italy.	francesco.scotti@polimi.it		Bonaccorsi, Giovanni/0000-0002-5600-6271; Flori, Andrea/0000-0002-9861-3598; Pierri, Francesco/0000-0002-9339-7566	EU [101016233]	EU(European Commission)	FP is supported in part by EU H2020 Periscope (Grant 101016233). No additional external funding was received for this study.	Ahn JM, 2019, R&D MANAGE, V49, P267, DOI 10.1111/radm.12373; Alessandretti L, 2022, NAT REV PHYS, V4, P12, DOI 10.1038/s42254-021-00407-1; Aleta A, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01619-5; [Anonymous], POL RESP COVID19; [Anonymous], OPEN DATA REGIONE LO; [Anonymous], DIGITAL CONTACT TRAC; [Anonymous], 2020, CLOSING DATA DIVIDE; [Anonymous], COVID 19 MOBILITY RE; [Anonymous], COVID 19 COMMUNITY M; [Anonymous], DATA GOOD; Baker S. R., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts); Baldwin C, 2011, ORGAN SCI, V22, P1399, DOI 10.1287/orsc.1100.0618; Baldwin CY, 2006, MANAGE SCI, V52, P1116, DOI 10.1287/mnsc.1060.0546; Bertello A, 2022, R&D MANAGE, V52, P178, DOI 10.1111/radm.12456; Blasco A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222165; Blasimme Alessandro, 2021, Front Digit Health, V3, P660823, DOI 10.3389/fdgth.2021.660823; Bommert B., 2010, INT PUBLIC MANAG REV, V11, P15, DOI DOI 10.1017/CBO9781316105337.006; Bonaccorsi G, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-99548-7; Bonaccorsi G, 2020, P NATL ACAD SCI USA, V117, P15530, DOI 10.1073/pnas.2007658117; Boudreau KJ, 2011, MANAGE SCI, V57, P843, DOI 10.1287/mnsc.1110.1322; Brunswicker S, 2018, RES TECHNOL MANAGE, V61, P35, DOI 10.1080/08956308.2018.1399022; Brunswicker S, 2015, J SMALL BUS MANAGE, V53, P1241, DOI 10.1111/jsbm.12120; Buckee CO, 2020, SCIENCE, V368, P145, DOI 10.1126/science.abb8021; Chang MC, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10260-7; Chesbrough H., 2014, NEW FRONTIERS OPEN I, P301, DOI DOI 10.1093/ACPROF:OSO/9780199682461.003.0009; Chesbrough H.W., 2006, OPEN INNOVATION NEW, P272, DOI DOI 10.1111/J.1467-8691.2008.00502.X; Chesbrough H, 2020, IND MARKET MANAG, V88, P410, DOI 10.1016/j.indmarman.2020.04.010; Chesbrough H, 2012, RES TECHNOL MANAGE, V55, P20, DOI 10.5437/08956308X5504085; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Chiou L., 2020, W26982 NAT BUR EC RE; Chretien JP, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002109; Christensen L., 2013, IMPACT DATA PROTECTI, P90; Cinar E, 2021, PUBLIC MANAG REV, V23, P326, DOI 10.1080/14719037.2019.1668470; Cinar E, 2019, PUBLIC MANAG REV, V21, P264, DOI 10.1080/14719037.2018.1473477; Dahlander L, 2010, RES POLICY, V39, P699, DOI 10.1016/j.respol.2010.01.013; Dahlberg M., 2020, ARXIV PREPRINT ARXIV; de Graaf R, 2013, PROCD SOC BEHV, V75, P139, DOI 10.1016/j.sbspro.2013.04.016; DPCM, 2020, GAZZETTA UFFICIALE, V62; DPCM, 2020, GAZZETTA UFFICIALE, V59; Drew DA, 2020, SCIENCE, V368, P1362, DOI 10.1126/science.abc0473; Dutta R, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1009236; Dye C, 2016, B WORLD HEALTH ORGAN, V94, P158, DOI 10.2471/BLT.16.170860; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Eisenhardt KM, 2016, ACAD MANAGE J, V59, P1113, DOI 10.5465/amj.2016.4004; Enkel E, 2009, R&D MANAGE, V39, P311, DOI 10.1111/j.1467-9310.2009.00570.x; Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x; European Commission, 2020, OFFICIAL J EUROPEAN, V63, P1; European Union, 2016, OFFICIAL J EUROPEAN, DOI DOI 10.2873/84730; Ferraro F, 2015, ORGAN STUD, V36, P363, DOI 10.1177/0170840614563742; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Gachter S, 2010, RES POLICY, V39, P893, DOI 10.1016/j.respol.2010.04.010; Galeazzi A., 2021, HUMAN MOBILITY RESPO, V11, P1; Garcia-Cremades S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-94696-2; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Huber F, 2020, R&D MANAGE, V50, P31, DOI 10.1111/radm.12347; Hughes B, 2010, R&D MANAGE, V40, P324, DOI 10.1111/j.1467-9310.2010.00594.x; Ienca M, 2020, NAT MED, V26, P463, DOI 10.1038/s41591-020-0832-5; International Monetary Fund, 2020, WORLD EC OUTL WEO DA; Khan K.I., 2021, J OPEN INNOV TECHNOL, V7, P30, DOI [10.3390/joitmc7010030, DOI 10.3390/JOITMC7010030]; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Kleihaus Burkhard, 2020, arXiv; Kokshagina O, 2022, R&D MANAGE, V52, P206, DOI 10.1111/radm.12470; Kotlar J., 2018, INT J MANAG REV, V20, P3, DOI [DOI 10.1111/IJMR.12170, 10.1111/ijmr.12170]; Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218; Kuhlmann S., 2014, CHALLENGE ADDRESSING; Lee K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223405; Lerner J, 2002, J IND ECON, V50, P197, DOI 10.1111/1467-6451.00174; Loo BPY, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84089-w; Maas P, 2019, P 16 INT C INFORM SY; Mirvis P, 2016, J BUS RES, V69, P5014, DOI 10.1016/j.jbusres.2016.04.073; Moorthy V, 2020, B WORLD HEALTH ORGAN, V98, P150, DOI 10.2471/BLT.20.251561; Moro, 2020, EFFECTIVENESS SOCIAL; Muller P, 2006, J EVOL ECON, V16, P85, DOI 10.1007/s00191-005-0009-x; Nurhayati I., 2021, J OPEN INNOV-TECHNOL, V7, P56, DOI [10.3390/joitmc7010056, DOI 10.3390/JOITMC7010056]; OECD, 2020, GUID PAYM LAND BUILD; OECD. OECD Interim Economic Assessment, 2020, COR WORLD EC RISK; Oliver N, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc0764; Ong A.K.S., 2021, J OPEN INNOV TECHNOL, V7, P211, DOI [10.3390/joitmc7040211, DOI 10.3390/JOITMC7040211]; Patrucco AS, 2022, R&D MANAGE, V52, P273, DOI 10.1111/radm.12495; Pedersen K, 2020, GOV INFORM Q, V37, DOI 10.1016/j.giq.2020.101459; Pepe E, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-00575-2; Persson J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2100664118; Pisano GP, 2008, HARVARD BUS REV, V86, P78; Porter ME, 2002, HARVARD BUS REV, V80, P56; Powell WW, 2012, HBK ECON, V1, P575, DOI 10.1016/S0169-7218(10)01013-0; Prasetyo Y.T., 2021, J OPEN INNOV-TECHNOL, V7, P76, DOI [10.3390/joitmc7010076, DOI 10.3390/JOITMC7010076]; Radziwon A, 2022, R&D MANAGE, V52, P376, DOI 10.1111/radm.12512; Ramadi KB, 2021, NPJ DIGIT MED, V4, DOI 10.1038/s41746-021-00397-5; Roper S, 2013, RES POLICY, V42, P1544, DOI 10.1016/j.respol.2013.05.006; Shim E, 2020, INT J INFECT DIS, V93, P339, DOI 10.1016/j.ijid.2020.03.031; Smolinski A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88470-7; Spelta A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73949-6; Stempeck Matt, 2014, HARVARD BUS REV; Stuermer M, 2009, R&D MANAGE, V39, P170, DOI 10.1111/j.1467-9310.2009.00548.x; Tejedor S., 2021, J OPEN INNOV-TECHNOL, V7, P43, DOI [10.3390/joitmc7010043, DOI 10.3390/JOITMC7010043]; Turon K., 2021, J OPEN INNOV TECHNOL, V7, P195, DOI [10.3390/joitmc7030195, DOI 10.3390/JOITMC7030195]; Vanhaverbeke W, 2017, MANAGING OPEN INNOVATION IN SMES, P1, DOI 10.1017/9781139680981; Vanhaverbeke W., 2008, CREAT INNOV MANAG, V17, P251, DOI [10.1111/j.1467-8691.2008.00499.x, DOI 10.1111/J.1467-8691.2008.00499.X]; Vermicelli S, 2021, R&D MANAGE, V51, P183, DOI 10.1111/radm.12443; Vollmer M, 2020, IMP COLL LOND, DOI [10.25561/78677, DOI 10.25561/78677]; von Krogh G, 2003, MIT SLOAN MANAGE REV, V44, P14; Wang Y, 2012, TECHNOL FORECAST SOC, V79, P419, DOI 10.1016/j.techfore.2011.08.009; West J, 2006, R&D MANAGE, V36, P319, DOI 10.1111/j.1467-9310.2006.00436.x; Xiong CF, 2020, P NATL ACAD SCI USA, V117, P27087, DOI 10.1073/pnas.2010836117; Xu B, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0448-0; Yoda T, 2016, R&D MANAGE, V46, P193, DOI 10.1111/radm.12131	106	1	1	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267100	10.1371/journal.pone.0267100	http://dx.doi.org/10.1371/journal.pone.0267100			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35472151	gold, Green Published, Green Submitted			2022-12-26	WOS:000816171900023
J	Sunderhaus, A; Imran, R; Enoh, E; Adedeji, A; Obafemi, T; Aziz, MAH				Sunderhaus, Allison; Imran, Ramsha; Enoh, Elanzou; Adedeji, Adesola; Obafemi, Taiye; Abdel Aziz, May H.			Comparative expression of soluble, active human kinases in specialized bacterial strains	PLOS ONE			English	Article							RECOMBINANT PROTEIN EXPRESSION; ESCHERICHIA-COLI; DOMAIN; RECEPTOR; ACTIVATION; MECHANISM; YIELDS	Kinases act as molecular switches for cellular functions and are involved in multiple human pathogeneses, most notably cancer. There is a continuous need for soluble and active kinases for in-vitro drug discovery and structural biology purposes. Kinases remain challenging to express using Escherichia coli, the most widely utilized host for heterologous expression. In this work, four bacterial strains, BL21 (DE3), BL21 (DE3) pLysS, Rosetta, and Arctic Express, were chosen for parallel expression trials along with BL21 (DE3) complemented with folding chaperones DnaJ/K and GroEL/ES to compare their performance in producing soluble and active human kinases. Three representative diverse kinases were studied, Epidermal Growth Factor Receptor kinase domain, Aurora Kinase A kinase domain, and Mitogen-activated protein Kinase Kinase. The genes encoding the kinases were subcloned into pET15b bacterial plasmid and transformed into the bacterial strains. Soluble kinase expression was tested using different IPTG concentrations (1-0.05 mM) at varying temperatures (37 degrees C- 10 degrees C) and induction times (3-24 hours). The optimum conditions for each kinase in all strains were then used for 1L large scale cultures from which each kinase was purified to compare yield, purity, oligomerization status, and activity. Although using specialized strains achieved improvements in yield and/or activity for the three kinases, none of the tested strains was universally superior, highlighting the individuality in kinase expression.	[Sunderhaus, Allison; Imran, Ramsha; Enoh, Elanzou; Adedeji, Adesola; Obafemi, Taiye; Abdel Aziz, May H.] Univ Texas Tyler, Fisch Coll Pharm, Dept Pharmaceut Sci & Hlth Outcomes, Tyler, TX USA	University of Texas System; University of Texas at Tyler	Aziz, MAH (corresponding author), Univ Texas Tyler, Fisch Coll Pharm, Dept Pharmaceut Sci & Hlth Outcomes, Tyler, TX USA.	mabdelaziz@uttyler.edu		Abdelaziz, May/0000-0002-4852-9806	American Association of University Women Research Publication Grant in Engineering, Medicine, and Science to MHA	American Association of University Women Research Publication Grant in Engineering, Medicine, and Science to MHA	Funding: This work was supported by the American Association of University Women Research Publication Grant in Engineering, Medicine, and Science to MHA (https://www.aauw. org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akritopoulou-Zanze I, 2009, DRUG DISCOV TODAY, V14, P291, DOI 10.1016/j.drudis.2008.12.002; Aziz MHA, 2021, PROTEIN EXPRES PURIF, V179, DOI 10.1016/j.pep.2020.105780; Brignola PS, 2002, J BIOL CHEM, V277, P1576, DOI 10.1074/jbc.M105907200; de Marco A, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-32; Dodson CA, 2017, METHODS MOL BIOL, V1586, P251, DOI 10.1007/978-1-4939-6887-9_16; Francis Dana M, 2010, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0524s61; Galicia MED, 2019, METHOD ENZYMOL, V621, P131, DOI 10.1016/bs.mie.2019.02.027; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; Gutierrez-Gonzalez M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53200-7; Haacke A, 2009, PROTEIN EXPRES PURIF, V64, P185, DOI 10.1016/j.pep.2008.10.022; Janecek M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28528; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Klaeger S, 2017, SCIENCE, V358, DOI 10.1126/science.aan4368; Klesmith JR, 2017, P NATL ACAD SCI USA, V114, P2265, DOI 10.1073/pnas.1614437114; Makino T, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-32; Mathea S, 2019, METHODS MOL BIOL, V2025, P191, DOI 10.1007/978-1-4939-9624-7_8; McCutcheon SR, 2018, BIOTECHNOL J, V13, DOI 10.1002/biot.201700167; McDonald OB, 1999, ANAL BIOCHEM, V268, P318, DOI 10.1006/abio.1998.3030; Muhlmann M, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0832-4; Pacheco B, 2012, PROTEIN EXPRES PURIF, V81, P33, DOI 10.1016/j.pep.2011.08.030; Pengelley SC, 2006, PROTEIN EXPRES PURIF, V48, P173, DOI 10.1016/j.pep.2006.04.016; Rosano GL, 2019, PROTEIN SCI, V28, P1412, DOI 10.1002/pro.3668; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; Seetaha S, 2019, APPL MICROBIOL BIOT, V103, P8427, DOI 10.1007/s00253-019-10116-6; Sunderhaus A, 2021, BIOTECHNOL BIOENG, V118, P1466, DOI 10.1002/bit.27659; Vermeulen JG, 2018, PROTEIN EXPRES PURIF, V151, P62, DOI 10.1016/j.pep.2018.06.005; Vettath SK, 2018, INT J BIOL MACROMOL, V110, P582, DOI 10.1016/j.ijbiomac.2017.12.145; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	29	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267226	10.1371/journal.pone.0267226	http://dx.doi.org/10.1371/journal.pone.0267226			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7VA	35439268	gold, Green Published			2022-12-26	WOS:000791280100029
J	Utura, T; Fikrie, A				Utura, Takala; Fikrie, Anteneh			Prevalence and associated factors of diabetes mellitus among Governmental Civil Servants at Guji Zone, Oromia Region, Ethiopia, 2021. A community-based cross-sectional study	PLOS ONE			English	Article								BackgroundDespite it being easily preventable, still diabetes mellitus is found in every population in the world and all regions, with the greatest escalation in low and middle-income countries. Moreover, undiagnosed or poorly controlled diabetes can lead to lower limb amputation, blindness, and kidney disease. However, there is a paucity of information on the magnitude and associated factors among adult populations in rural pastoral areas. Therefore, this study aimed to assess the magnitude of diabetes mellitus and associated factors among Guji Zone Government Civil Servants, Southern Ethiopia. MethodsCross-sectional study was conducted from March 1-14/2018, among 437 randomly selected Government employees of Guji Zone. A self-administered questionnaire was used to collect data. Data were coded and entered using Epi-data version 3.1 and exported to SPSS version 20 for analysis. Multivariable logistic regression analysis was done to identify significant factors associated with the magnitude of DM. PResultThe median (+/- IQR) age of participants was 33 (+/- 14) years of age. Overall, the prevalence of DM in the study population was found to be 16 (3.9%) [95% CI: 2.2-5.6%]. The prevalence of DM among males and females was 3.8% and 4.2% respectively. Age (<35 years) [0.21 (0.04-0.94)], increasing salt amount in dietary feeding [14.31(1.28-159.2)], Consumption of vegetable &fruit once per week [23.38(2.01-269.17)], diagnosed with HTN [21.35(2.28-199.37)], and Family history of DM [9.42(1.72-51.42)] were significantly associated with DM. ConclusionComparably lower prevalence of previously undiagnosed DM was found by this study. Being old, excess salt consumption, intake of vegetables & fruit once per week, hypertension, and family history of DM were significantly associated with DM. Therefore, the zonal Health department should enhance and strengthen the provision of health education programs and counseling about nutrition, weight control, and appropriate physical activity and advised the communities for mass screening for diabetes.	[Utura, Takala; Fikrie, Anteneh] Bule Hora Univ, Sch Publ Hlth, Inst Hlth, Bule Hora, Ethiopia		Utura, T (corresponding author), Bule Hora Univ, Sch Publ Hlth, Inst Hlth, Bule Hora, Ethiopia.	takekerrofamily@gmail.com	Fikrie, Anteneh/ABB-2068-2021					Abdelbagi O, 2021, BMC CARDIOVASC DISOR, V21, DOI 10.1186/s12872-021-01983-x; Abebe N, 2017, AFR J DIABETES MED, V25, P7; Atlas IDF., 2019, INT DIABETES FED; Aynalem SB, 2018, INT J ENDOCRINOL, V2018, DOI 10.1155/2018/9317987; Bahareh Rasouli, 2017, DIABETOLOGIA; Bull Fiona C, 2020, Br J Sports Med, V54, P1451, DOI 10.1136/bjsports-2020-102955; Cho NH, 2017, IDF DIABETES ATLAS, VEight; Demilew YM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216446; Dereje N, 2020, ANN GLOB HEALTH, V86, DOI 10.5334/aogh.2663; Du H, 2016, LANCET DIABETES ENDO, V4, pS12, DOI [10.1016/s2213-8587(16)30367-9, DOI 10.1016/S2213-8587(16)30367-9]; Endris T, 2019, DIABET METAB SYND OB, V12, P2799, DOI 10.2147/DMSO.S225854; Feldstein CA, 2002, J HUM HYPERTENS, V16, pS48, DOI 10.1038/sj.jhh.1001342; FMOH, 2014, ETH NAT STRAT ACT PL, V1, P265; Gatimu SM, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3845-8; Gebreyes YF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194819; Gyening KN., 2018, MED J ZAMBIA, V45, P117; International Diabetes Federation, 2017, IDF DIAB ATL AFR HIG; International Diabetes Federation, 2021, IDF DIABETES ATLAS, V10th; International Diabetes Federation, 2011, GLOB DIAB PLAN 20112, P120; International Diabetes Federation (IDF), 2015, INT DIABETES FED, V29; Jianhua Zhang, 2015, 2015 IEEE Power & Energy Society General Meeting, P1, DOI 10.1109/PESGM.2015.7286038; Kassa Andargachew, 2019, Int J Chronic Dis, V2019, P2509242, DOI 10.1155/2019/2509242; Kiber M, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4431-9; Mawaw PM, 2017, PAN AFR MED J, V28, DOI 10.11604/pamj.2017.28.282.14361; Melaku YA, 2016, INT J BEHAV NUTR PHY, P13, DOI [10.1186/s12966-016-0337-2, DOI 10.1186/S12966-016-0337-2]; Sabir AA, 2018, SAHEL MED J, V21, P168, DOI [10.4103/smj.smj, DOI 10.4103/SMJ.SMJ]; Seifu W, 2019, PREVALENCE RISK FACT, DOI [10.15406/mojph.2015.02.00035, DOI 10.15406/MOJPH.2015.02.00035]; Seifu Y, 2020, DIABET METAB SYND OB, V13, P4571, DOI 10.2147/DMSO.S275230; Wang PY, 2016, J DIABETES INVEST, V7, P56, DOI 10.1111/jdi.12376; Wolde HF, 2018, BMC ENDOCR DISORD, V18, DOI 10.1186/s12902-018-0280-0; Woldesemayat B., 2019, J BIOMED MAT RES, V7, P8, DOI [10.11648/j.ijbmr.20190701.12, DOI 10.11648/J.IJBMR.20190701.12]; Wondemagegn AT, 2017, J PUBLIC HEALTH RES, V6, P18, DOI 10.4081/jphr.2017.834; Yunka TT, 2020, DIABET METAB SYND OB, V13, P2925, DOI 10.2147/DMSO.S269386; Zekewos A, 2018, ETHIOP J HEALTH SCI, V28, P451, DOI 10.4314/ejhs.v28i4.11	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267231	10.1371/journal.pone.0267231	http://dx.doi.org/10.1371/journal.pone.0267231			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1E2NP	35427392	gold, Green Published			2022-12-26	WOS:000794332400004
J	Wang, JQ; Sugiyama, A; Yokota, H; Hirano, S; Cooper, G; Mukai, H; Ohira, K; Koide, K; Ito, S; Finke, C; Brandt, AU; Paul, F; Kuwabara, S				Wang, Jiaqi; Sugiyama, Atsuhiko; Yokota, Hajime; Hirano, Shigeki; Cooper, Graham; Mukai, Hiroki; Ohira, Kenji; Koide, Kyosuke; Ito, Shoichi; Finke, Carsten; Brandt, Alexander U.; Paul, Friedemann; Kuwabara, Satoshi			Diagnostic efficacy of the magnetic resonance T1w/T2w ratio for the middle cerebellar peduncle in multiple system atrophy and spinocerebellar ataxia: A preliminary study	PLOS ONE			English	Article							MACHADO-JOSEPH-DISEASE; IMAGING FINDINGS; CLINICAL-FEATURES; T(1)W/T(2)W RATIO; MYELIN CONTENT; CRITERIA; CORTEX; MRI	BackgroundThe standardized T1-weighted/T2-weighted (sT1w/T2w) ratio for the middle cerebellar peduncle (MCP) has been reported to be sensitive for detecting degenerative changes in the cerebellar subtype of multiple system atrophy (MSA-C), even in the early stages. We aimed to investigate the diagnostic value of the MCP sT1w/T2w ratio for differentiating between MSA-C and spinocerebellar ataxia (SCA). MethodsWe included 32 MSA-C, 8 SCA type 3 (SCA3), 16 SCA type 6 (SCA6) patients, and 17 controls, and the MCP sT1w/T2w ratio was analyzed using a region-of-interest approach. The diagnostic performance of the MCP sT1w/T2w ratio in discriminating among MSA-C, SCA3, and SCA6 was assessed and compared with diagnosis based on visual interpretation of MCP hyperintensities and the "hot cross bun" (HCB) sign. ResultsMCP sT1w/T2w ratio values were markedly lower in patients with MSA-C than in those with SCA3, those with SCA6, and controls (p < 0.001). The MCP sT1w/T2w ratio showed high diagnostic accuracy for distinguishing MSA-C from SCA3 (area under curve = 0.934), SCA6 (area under curve = 0.965), and controls (area under curve = 0.980). The diagnostic accuracy of the MCP sT1w/T2w ratio for differentiating MSA-C from SCA3 or SCA6 (90.0% for MSA-C vs. SCA3, and 91.7% for MSA-C vs. SCA6) was comparable to or superior than that of visual interpretation of MCP hyperintensities (80.0-87.5% in MSA-C vs. SCA3 and 87.6-97.9% in MSA-C vs. SCA6) or the HCB sign (72.5-80.0% in MSA-C vs. SCA3 and 77.1-93.8% in MSA-C vs. SCA6). ConclusionsThe MCP sT1w/T2w ratio might be a sensitive imaging-based marker for detecting MSA-C-related changes and differentiating MSA-C from SCA3 or SCA6.	[Wang, Jiaqi; Sugiyama, Atsuhiko; Hirano, Shigeki; Koide, Kyosuke; Ito, Shoichi; Kuwabara, Satoshi] Chiba Univ, Grad Sch Med, Dept Neurol, Chiba, Japan; [Yokota, Hajime] Chiba Univ, Grad Sch Med, Dept Diagnost Radiol & Radiat Oncol, Chiba, Japan; [Cooper, Graham; Paul, Friedemann] Max Delbrueck Ctr Mol Med, Expt & Clin Res Ctr, Berlin, Germany; [Cooper, Graham; Paul, Friedemann] Charite Univ Med Berlin, Berlin, Germany; [Cooper, Graham; Paul, Friedemann] Free Univ Berlin, Berlin, Germany; [Cooper, Graham; Paul, Friedemann] Humboldt Univ, Berlin, Germany; [Cooper, Graham; Paul, Friedemann] Berlin Inst Hlth, Berlin, Germany; [Cooper, Graham; Brandt, Alexander U.; Paul, Friedemann] Charite Univ Med Berlin, NeuroCure Clin Res Ctr, Berlin, Germany; [Cooper, Graham; Finke, Carsten; Paul, Friedemann] Einstein Ctr Neurosci, Berlin, Germany; [Cooper, Graham] Charite Univ Med Berlin, Dept Expt Neurol, Berlin, Germany; [Cooper, Graham] Charite Univ Med Berlin, Ctr Stroke Res, Berlin, Germany; [Cooper, Graham; Finke, Carsten] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany; [Mukai, Hiroki; Ohira, Kenji] Chiba Univ Hosp, Dept Radiol, Chiba, Japan; [Ito, Shoichi] Chiba Univ, Grad Sch Med, Dept Med Educ, Chiba, Japan; [Finke, Carsten] Humboldt Univ, Berlin Sch Mind & Brain, Berlin, Germany; [Brandt, Alexander U.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA	Chiba University; Chiba University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Chiba University; Chiba University; Humboldt University of Berlin; University of California System; University of California Irvine	Sugiyama, A (corresponding author), Chiba Univ, Grad Sch Med, Dept Neurol, Chiba, Japan.	asugiyama@chiba-u.jp		Yokota, Hajime/0000-0003-2389-0299	Research Committee of Ataxia, Health Labor Sciences Research Grant, the Ministry of Health, Labor and Welfare, Japan [JPMH20FC1041]	Research Committee of Ataxia, Health Labor Sciences Research Grant, the Ministry of Health, Labor and Welfare, Japan	This work was partly supported by Grants-in-Aid from the Research Committee of Ataxia, Health Labor Sciences Research Grant, the Ministry of Health, Labor and Welfare, Japan (JPMH20FC1041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arshad M, 2017, HUM BRAIN MAPP, V38, P1780, DOI 10.1002/hbm.23481; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; BARNES D, 1988, BRAIN, V111, P83, DOI 10.1093/brain/111.1.83; Bhattacharya K, 2002, ARCH NEUROL-CHICAGO, V59, P835, DOI 10.1001/archneur.59.5.835; Brettschneider J, 2017, NEUROPATH APPL NEURO, V43, P315, DOI 10.1111/nan.12362; Brooks DJ, 2009, MOVEMENT DISORD, V24, P949, DOI 10.1002/mds.22413; Burk K, 2005, ARCH NEUROL-CHICAGO, V62, P981, DOI 10.1001/archneur.62.6.981; Carre G, 2020, J NEUROL, V267, P1269, DOI 10.1007/s00415-020-09702-w; Cooper G, 2021, MULT SCLER J, V27, P2180, DOI 10.1177/13524585211003479; Cooper G, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00334; Du GW, 2019, ANN NEUROL, V85, P96, DOI 10.1002/ana.25376; Durr A, 1996, ANN NEUROL, V39, P490, DOI 10.1002/ana.410390411; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Gierga K, 2009, NEUROPATH APPL NEURO, V35, P515, DOI 10.1111/j.1365-2990.2009.01015.x; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Glasser MF, 2014, NEUROIMAGE, V93, P165, DOI 10.1016/j.neuroimage.2013.03.060; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Gomez CM, 1997, ANN NEUROL, V42, P933, DOI 10.1002/ana.410420616; Hagiwara A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28852-6; Holmes WC, 1998, MED CARE, V36, P237, DOI 10.1097/00005650-199802000-00012; Ishikawa K, 1999, J NEUROL NEUROSUR PS, V67, P86, DOI 10.1136/jnnp.67.1.86; Itoh K, 2014, NEUROPATHOLOGY, V34, P309, DOI 10.1111/neup.12092; Jellinger KA, 2005, MOVEMENT DISORD, V20, pS29, DOI 10.1002/mds.20537; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kim M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53980-y; Kon T, 2013, NEUROPATHOLOGY, V33, P667, DOI 10.1111/neup.12037; Lee EA, 2004, PARKINSONISM RELAT D, V10, P363, DOI 10.1016/j.parkreldis.2004.04.008; Misaki M, 2015, MAGN RESON MED, V74, P1609, DOI 10.1002/mrm.25560; Murata Y, 1998, ARCH NEUROL-CHICAGO, V55, P33, DOI 10.1001/archneur.55.1.33; Murata Y, 1998, ARCH NEUROL-CHICAGO, V55, P1348, DOI 10.1001/archneur.55.10.1348; Naka H, 2002, NEURORADIOLOGY, V44, P204, DOI 10.1007/s00234-001-0713-7; Nakamura K, 2017, ANN NEUROL, V82, P635, DOI 10.1002/ana.25019; Righart R, 2017, ANN NEUROL, V82, P519, DOI 10.1002/ana.25020; Rub U, 2013, PROG NEUROBIOL, V104, P38, DOI 10.1016/j.pneurobio.2013.01.001; SAVOIARDO M, 1990, RADIOLOGY, V174, P693, DOI 10.1148/radiology.174.3.2305051; Schols L, 2004, LANCET NEUROL, V3, P291, DOI 10.1016/S1474-4422(04)00737-9; Schrag A, 1998, J NEUROL NEUROSUR PS, V65, P65, DOI 10.1136/jnnp.65.1.65; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stefanova N, 2009, LANCET NEUROL, V8, P1172, DOI 10.1016/S1474-4422(09)70288-1; Sugiyama A, 2021, EUR RADIOL, V31, P4277, DOI 10.1007/s00330-020-07521-1; Sugiyama A, 2020, BMC NEUROL, V20, DOI 10.1186/s12883-020-01738-9; Tokumaru AM, 2003, J COMPUT ASSIST TOMO, V27, P241, DOI 10.1097/00004728-200303000-00023; Trojanowski JQ, 2007, NEUROPATH APPL NEURO, V33, P615, DOI 10.1111/j.1365-2990.2007.00907.x; Tsuji S, 2008, CEREBELLUM, V7, P189, DOI 10.1007/s12311-008-0028-x; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Uddin MN, 2018, NMR BIOMED, V31, DOI 10.1002/nbm.3868; van Baarsen KM, 2016, NEUROIMAGE, V124, P724, DOI 10.1016/j.neuroimage.2015.09.014; YUASA T, 1986, ANN NEUROL, V19, P152, DOI 10.1002/ana.410190207; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	49	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267024	10.1371/journal.pone.0267024	http://dx.doi.org/10.1371/journal.pone.0267024			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1E2NP	35427382	Green Published, Green Accepted, gold			2022-12-26	WOS:000794332400012
J	Wasay, SA; Jan, SU; Akhtar, M; Noreen, S; Gul, R				Wasay, Syed Abdul; Jan, Syed Umer; Akhtar, Muhammad; Noreen, Sobia; Gul, Rahman			Developed meloxicam loaded microparticles for colon targeted delivery: Statistical optimization, physicochemical characterization, and in-vivo toxicity study	PLOS ONE			English	Article							POLYMETHACRYLATE MICROSPHERES; DRUG-DELIVERY; RS 100; RELEASE; VITRO; POLYMER; SYSTEM; CANCER; NANOPARTICLES; FORMULATIONS	The study aimed to fabricate and evaluate Meloxicam (MLX) loaded Hydroxypropyl Methylcellulose (HPMC) microparticles for colon targeting because MLX is a potent analgesic used in the treatment of pain and inflammation associated with colorectal cancer (CRC). Nevertheless, its efficiency is limited by poor solubility and gastrointestinal tracts (GIT) associated side effects. Seventeen formulations of MLX loaded HPMC microparticles were fabricated by the oil-in-oil (O/O)/ emulsion solvent evaporation (ESE) technique. A 3-factor, 3-level Box Behnken (BBD) statistical design was used to estimate the combined effects of the independent variables on the dependent variables (responses), such as the percent yield (R-1), the entrapment efficiency (EE) (R-2), mean particle size (R-3) and in vitro percentage of cumulative drug release (R-4). For physicochemical characterization FTIR, XRD, DSC, and SEM analyses were performed. Biocompatibility and non-toxicity were confirmed by in-vivo acute oral toxicity determination. The percentage yield and EE were 65.75-90.71%, and 70.62-88.37%, respectively. However, the mean particle size was 62.89-284.55 mu m, and the in vitro cumulative drug release percentage was 74.25-92.64% for 24 hours. FTIR analysis showed that the composition of the particles was completely compatible, while XRD analysis confirmed the crystalline nature of the pure drug and its transition into an amorphous state after formulation. DSC analysis revealed the thermal stability of the formulations. The SEM analysis showed dense spherical particles. The toxicity study in albino rabbits showed no toxicity and was found biocompatible. The histopathological evaluation showed no signs of altered patterns. Results of this study highlighted a standard colonic drug delivery system with the ability to improve patient adherence and reduce GIT drug-associated side effects in CRC treatment.	[Wasay, Syed Abdul; Jan, Syed Umer; Gul, Rahman] Univ Balochistan, Fac Pharm & Hlth Sci, Dept Pharmaceut, Quetta, Pakistan; [Akhtar, Muhammad; Noreen, Sobia] Islamia Univ Bahawalpur, Fac Pharm, Dept Pharmaceut, Bahawalpur, Pakistan; [Akhtar, Muhammad] Islamia Univ Bahawalpur, Fac Med & Allied Hlth Sci, Dept Med Lab Technol, Bahawalpur, Pakistan	University of Balochistan; Islamia University of Bahawalpur; Islamia University of Bahawalpur	Jan, SU (corresponding author), Univ Balochistan, Fac Pharm & Hlth Sci, Dept Pharmaceut, Quetta, Pakistan.	umer.pharm@um.uob.edu.pk	Noreen, Sobia/AAT-8296-2021	Noreen, Sobia/0000-0002-4407-6002; Akhtar, Muhammad/0000-0003-1759-8224; Jan, Syed Umer/0000-0002-7584-5740				Abadi SAH, 2022, INT J ENVIRON AN CH, V102, P546, DOI 10.1080/03067319.2020.1724983; Abd Elbary A, 2012, B FACULTY PHARM, V50, P89; Abdalla M. E., 2012, Journal of Biology, Agriculture and Healthcare, V2, P6; Al Hussein SM, 2017, REV CHIM-BUCHAREST, V68, P937; Ali L, 2015, CELL CHEM TECHNOL, V49, P143; Alvi Z, 2021, POLYMERS-BASEL, V13, DOI 10.3390/polym13244350; Ambrus R, 2009, INT J PHARMACEUT, V381, P153, DOI 10.1016/j.ijpharm.2009.07.009; Behera BC, 2008, TROP J PHARM RES, V7, P879; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cardoso CG, 2020, RES VET SCI, V128, P177, DOI 10.1016/j.rvsc.2019.11.016; Chaisri Wasana, 2009, Current Drug Delivery, V6, P69; Chime S.A., 2013, RES J PHARM BIO CHEM, V4, P97, DOI DOI 10.1517/17425241003602259; Ciardiello D, 2019, CANCER TREAT REV, V76, P22, DOI 10.1016/j.ctrv.2019.04.003; Costa P, 2001, EUR J PHARM SCI, V13, P123, DOI 10.1016/S0928-0987(01)00095-1; da Silveira LM, 2018, EUR J PHARM SCI, V112, P146, DOI 10.1016/j.ejps.2017.11.015; Deshmukh RK, 2014, MAT SCI ENG C-MATER, V36, P320, DOI 10.1016/j.msec.2013.12.024; El-Badry M, 2008, B PHARM SCI, V31, P123; El-Bagory IM., 2007, SAUDI PHARM J, V15, P213; Emam MF, 2021, DRUG DEV IND PHARM, V47, P163, DOI 10.1080/03639045.2020.1862175; Eroglu H., 2009, HACETTEPE U J FACULT, P115; Fathanah Ana, 2019, J Basic Clin Physiol Pharmacol, V30, DOI 10.1515/jbcpp-2019-0249; Floyd JA, 2015, ADV DRUG DELIVER REV, V91, P23, DOI 10.1016/j.addr.2015.04.008; Freitas MN, 2005, INT J PHARMACEUT, V295, P201, DOI 10.1016/j.ijpharm.2005.03.003; Fu XC, 2004, J CONTROL RELEASE, V95, P209, DOI 10.1016/j.jconrel.2003.11.007; Gomez-Gaete C, 2017, EUR J PHARM SCI, V96, P390, DOI 10.1016/j.ejps.2016.10.010; Govender S, 2005, INT J PHARMACEUT, V306, P24, DOI 10.1016/j.ijpharm.2005.07.026; Hnatyszyn A, 2019, HERED CANCER CLIN PR, V17, DOI 10.1186/s13053-019-0118-4; Hong Y, 2005, POLYM ADVAN TECHNOL, V16, P622, DOI 10.1002/pat.629; Hussain Z, 2021, J CONTROL RELEASE, V335, P130, DOI 10.1016/j.jconrel.2021.05.018; Jayaramudu T, 2021, CARBOHYD POLYM, V254, DOI 10.1016/j.carbpol.2020.117302; Jose S., 2011, BIOINTERFACES, DOI [10.1016/j.colsurfb.2010.11.033, DOI 10.1016/J.COLSURFB.2010.11.033]; Kashif PM, 2017, AAPS PHARMSCITECH, V18, P1810, DOI 10.1208/s12249-016-0653-5; Khalil NY, 2020, PROF DRUG SUB EXCIP, V45, P159, DOI 10.1016/bs.podrm.2019.10.006; Khan KU, 2021, DRUG DEV IND PHARM, V47, P465, DOI 10.1080/03639045.2021.1892738; Kilicarslan M, 2003, INT J PHARM, V252, P99, DOI 10.1016/S0378-5173(02)00630-0; Kim BK, 2002, J MICROENCAPSUL, V19, P811, DOI 10.1080/0265204021000022770; Krishnamachari Y, 2007, INT J PHARM, V338, P238, DOI 10.1016/j.ijpharm.2007.02.015; Li CL, 2005, J PHARM PHARMACOL, V57, P533, DOI 10.1211/0022357055957; LIPMAN NS, 1990, LAB ANIM SCI, V40, P395; Maqbool I, 2020, EUR J PHARM SCI, V146, DOI 10.1016/j.ejps.2020.105254; Marmol I, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010197; Martindale W., 2009, COMPLETE DRUG REFERE, V36 Edn.; Maskova E, 2020, J CONTROL RELEASE, V324, P695, DOI 10.1016/j.jconrel.2020.05.045; Meng FB, 2017, POWDER TECHNOL, V320, P405, DOI 10.1016/j.powtec.2017.07.073; Montejo C, 2010, INT J PHARMACEUT, V387, P223, DOI 10.1016/j.ijpharm.2009.11.036; Mujtaba A, 2014, CHEM ENG RES DES, V92, P156, DOI 10.1016/j.cherd.2013.05.032; Nagai N, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12040313; Naidu NB, 2004, J PHARMACEUT BIOMED, V35, P75, DOI 10.1016/j.jpba.2004.01.003; Nanaki SG, 2012, CARBOHYD POLYM, V87, P1286, DOI 10.1016/j.carbpol.2011.09.013; Nandy BC, 2014, CURR DRUG DELIV, V11, P621, DOI 10.2174/1567201811666140519161628; Nhire N., 2014, PHARMA INNOVATION, V2; Nidhi, 2016, SAUDI PHARM J, V24, P458, DOI 10.1016/j.jsps.2014.10.001; Nielsen SS, 2020, EFSA J, V18, DOI 10.2903/j.efsa.2020.5943; Nohemann L, 2017, BRAZ J PHARM SCI, V53, DOI 10.1590/s2175-97902017000115218; Noreen S, 2021, PHARMACEUTICALS-BASE, V14, DOI 10.3390/ph14060557; Oecd O, 2004, SECTION, V1, P1, DOI [10.1177/026119290403200304, DOI 10.1177/026119290403200304]; Osmani RAM, 2015, ASIAN J PHARM SCI, V10, P442, DOI 10.1016/j.ajps.2015.06.003; Padmavathy J., 2011, INT J PHARM PHARM SC, V3, P170; Patel MM, 2017, DRUG DELIV TRANSL RE, V7, P312, DOI 10.1007/s13346-017-0358-7; Patel MM, 2011, CARBOHYD POLYM, V86, P536, DOI 10.1016/j.carbpol.2011.04.068; Patel MM, 2009, PHARM DEV TECHNOL, V14, P62, DOI 10.1080/10837450802409412; Perumal D, 2001, INT J PHARM, V218, P1, DOI 10.1016/S0378-5173(00)00686-4; Prabu PC, 2013, PHYTOTHER RES, V27, P1169, DOI 10.1002/ptr.4854; Rai G, 2016, DRUG DELIV, V23, P328, DOI 10.3109/10717544.2014.913733; Raj, 2016, RES REV J DRUG FORMU, V3, P15; Reverchon E, 2008, J SUPERCRIT FLUID, V46, P185, DOI 10.1016/j.supflu.2008.04.010; Sadaquat H, 2021, INT J PHARMACEUT, V598, DOI 10.1016/j.ijpharm.2021.120363; Sadeghi M, 2010, TURK J CHEM, V34, P739, DOI 10.3906/kim-0910-21; Sanche L, 2016, RADIAT PHYS CHEM, V128, P36, DOI 10.1016/j.radphyschem.2016.05.008; Shahzad Y, 2018, INT J BIOL MACROMOL, V109, P963, DOI 10.1016/j.ijbiomac.2017.11.089; Shi YL, 2017, MAT SCI ENG C-MATER, V76, P975, DOI 10.1016/j.msec.2017.03.163; Sienel W, 2007, EUR J CARDIO-THORAC, V31, P522, DOI 10.1016/j.ejcts.2006.12.018; Siepmann J, 2008, INT J PHARMACEUT, V364, P328, DOI 10.1016/j.ijpharm.2008.09.004; Sun L, 2017, ASIAN J PHARM SCI, V12, P418, DOI 10.1016/j.ajps.2017.04.002; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Thakkar H, 2004, J DRUG TARGET, V12, P549, DOI 10.1080/10611860400010630; Tuynman JB, 2004, CRIT REV ONCOL HEMAT, V52, P81, DOI 10.1016/j.critrevonc.2004.08.004; Udeh NE, 2018, AM J RES MED SCI, V3, P7; Vilos C, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/672760; Wahab AA., 2013, INT J PHARM SCI REV, V21, P38; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407; Yu Q, 2018, ASIAN J PHARM SCI, V13, P518, DOI 10.1016/j.ajps.2017.10.004; Zhang L, 2011, J MICROENCAPSUL, V28, P659, DOI 10.3109/02652048.2011.604436	83	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267306	10.1371/journal.pone.0267306	http://dx.doi.org/10.1371/journal.pone.0267306			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D9PO	35468155	gold, Green Published			2022-12-26	WOS:000794129600027
J	Yang, L; Zhong, BR; Xu, XH; Liang, ZJ				Yang Li; Zhong Baorong; Xu Xiaohong; Liang Zijun			Application of a semivariogram based on a deep neural network to Ordinary Kriging interpolation of elevation data	PLOS ONE			English	Article								The Ordinary Kriging method is a common spatial interpolation algorithm in geostatistics. Because the semivariogram required for kriging interpolation greatly influences this process, optimal fitting of the semivariogram is of major significance for improving the theoretical accuracy of spatial interpolation. A deep neural network is a machine learning algorithm that can, in principle, be applied to any function, including a semivariogram. Accordingly, a novel spatial interpolation method based on a deep neural network and Ordinary Kriging was proposed in this research, and elevation data were used as a case study. Compared with the semivariogram fitted by the traditional exponential model, spherical model, and Gaussian model, the kriging variance in the proposed method is smaller, which means that the interpolation results are closer to the theoretical results of Ordinary Kriging interpolation. At the same time, this research can simplify processes for a variety of semivariogram analyses.	[Yang Li; Xu Xiaohong] Yangtze Univ, Sch Geosci, Wuhan, Hubei, Peoples R China; [Zhong Baorong] Yangtze Univ, Sch Comp Sci, Jingzhou, Hubei, Peoples R China; [Liang Zijun] Data Co Xinjiang Oilfield Co PETROCHINA, Karamay, Xinjiang, Peoples R China	Yangtze University; Yangtze University	Zhong, BR (corresponding author), Yangtze Univ, Sch Comp Sci, Jingzhou, Hubei, Peoples R China.	barry@yangtzeu.edu.cn	li, yang/GXM-7093-2022	li, yang/0000-0002-9442-7704	National Science and Technology Major Projects of China [2016ZX05055]	National Science and Technology Major Projects of China	This research was funded by the National Science and Technology Major Projects of China (2016ZX05055).	Altman N, 2000, AUST NZ J STAT, V42, P441, DOI 10.1111/1467-842X.00141; Amri NA., 2017, ARPN J ENG APPL SCI, V12, P990; Aretouyap Z, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2142-4; CRESSIE N, 1990, MATH GEOL, V22, P239, DOI 10.1007/BF00889887; Rodriguez JD, 2010, IEEE T PATTERN ANAL, V32, P569, DOI 10.1109/TPAMI.2009.187; Eze PN, 2019, SCI AFR, V5, DOI 10.1016/j.sciaf.2019.e00110; Fushiki T, 2011, STAT COMPUT, V21, P137, DOI 10.1007/s11222-009-9153-8; Giraldo R, 2011, ENVIRON ECOL STAT, V18, P411, DOI 10.1007/s10651-010-0143-y; Goodchild MF, 2004, ANN ASSOC AM GEOGR, V94, P300, DOI 10.1111/j.1467-8306.2004.09402008.x; GOTWAY CA, 1991, COMPUT GEOSCI, V17, P171, DOI 10.1016/0098-3004(91)90085-R; HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8; Jo H, 2022, MATH GEOSCI, V54, P177, DOI 10.1007/s11004-021-09962-w; Lophaven SN., 2002, METHODS ESTIMATING S, P128; Matheron G., 1973, Advances in Applied Probability, V5, P439, DOI 10.2307/1425829; Matheron G., 1963, ECON GEOL, V58, P1246, DOI [DOI 10.2113/GSECONGEO.58.8.1246, 10.2113/gsecongeo.58.8.1246]; Mazzella A, 2013, J ENG-NY, V2013, DOI 10.1155/2013/960105; Olea R. A., 1994, AAPG COMPUTER APPL G, P27; Olea RA, 2006, STOCH ENV RES RISK A, V20, P307, DOI 10.1007/s00477-005-0026-1; Panday D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206350; Setiyoko A, 2020, IEEE ACCESS, V8, P82054, DOI 10.1109/ACCESS.2020.2991428; Sui DZ, 2004, ANN ASSOC AM GEOGR, V94, P269, DOI 10.1111/j.1467-8306.2004.09402003.x; Telgarsky M, 2017, PR MACH LEARN RES, V70; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Usman F., 2021, J PHYS C SERIES, V2123; Vieira Sidney Rosa, 2010, Bragantia, V69, P97, DOI 10.1590/S0006-87052010000500011; Nguyen XT, 2015, J INF PROCESS SYST, V11, P134, DOI 10.3745/JIPS.02.0016; Yao XL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056537, 10.1371/journal.pone.0054660]	27	0	0	13	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266942	10.1371/journal.pone.0266942	http://dx.doi.org/10.1371/journal.pone.0266942			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C1KV	35452466	gold, Green Published			2022-12-26	WOS:000792887700013
J	Zakiyah, N; Tuytten, R; Baker, PN; Kenny, LC; Postma, MJ; van Asselt, ADI				Zakiyah, Neily; Tuytten, Robin; Baker, Philip N.; Kenny, Louise C.; Postma, Maarten J.; van Asselt, Antoinette D., I		IMPROvED Consortium	Early cost-effectiveness analysis of screening for preeclampsia in nulliparous women: A modelling approach in European high-income settings	PLOS ONE			English	Article							LOW-DOSE ASPIRIN; EARLY-PREGNANCY PREDICTION; RISK; PREVENTION; CARE; METAANALYSIS; MORTALITY; BIRTH	BackgroundPreeclampsia causes substantial maternal and perinatal morbidity and mortality and significant societal economic impact. Effective screening would facilitate timely and appropriate prevention and management of preeclampsia. ObjectivesTo develop an early cost-effectiveness analysis to assess both costs and health outcomes of a new screening test for preeclampsia from a healthcare payer perspective, in the United Kingdom (UK), Ireland, the Netherlands and Sweden. MethodsA decision tree over a 9-month time horizon was developed to explore the cost-effectiveness of the new screening test for preeclampsia compared to the current screening strategy. The new test strategy is being developed so that it can stratify healthy low risk nulliparous women early in pregnancy to either a high-risk group with a risk of 1 in 6 or more of developing preeclampsia, or a low-risk group with a risk of 1 in 100 or less. The model simulated 25 plausible scenarios in a hypothetical cohort of 100,000 pregnant women, in which the sensitivity and specificity of the new test were varied to set a benchmark for the minimum test performance that is needed for the test to become cost-effective. The input parameters and costs were mainly derived from published literature. The main outcome was incremental costs per preeclampsia case averted, expressed as an incremental cost-effectiveness ratio (ICER). Deterministic and probabilistic sensitivity analyses were conducted to assess uncertainty. ResultsBase case results showed that the new test strategy would be more effective and less costly compared to the current situation in the UK. In the Netherlands, the majority of scenarios would be cost-effective from a threshold of euro50,000 per preeclampsia case averted, while in Ireland and Sweden, the vast majority of scenarios would be considered cost-effective only when a threshold of euro100,000 was used. In the best case analyses, ICERs were more favourable in all four participating countries. Aspirin effectiveness, prevalence of preeclampsia, accuracy of the new screening test and cost of regular antenatal care were identified as driving factors for the cost-effectiveness of screening for preeclampsia. ConclusionThe results indicate that the new screening test for preeclampsia has potential to be cost-effective. Further studies based on proven accuracy of the test will confirm whether the new screening test is a cost-effective additional option to the current situation.	[Zakiyah, Neily; Postma, Maarten J.; van Asselt, Antoinette D., I] Univ Groningen, Dept Pharm, Unit PharmacoTherapy Epidemiol & Econ PTE2, Groningen, Netherlands; [Zakiyah, Neily] Univ Padjadjaran, Fac Pharm, Dept Pharmacol & Clin Pharm, Bandung, Indonesia; [Zakiyah, Neily; Postma, Maarten J.] Univ Padjadjaran, Ctr Excellence Higher Educ Pharmaceut Care Innova, Bandung, Indonesia; [Tuytten, Robin] Metabol Diagnost, Res & Dev, Little Isl, Ireland; [Baker, Philip N.] Univ Leicester, Coll Life Sci, Leicester, Leics, England; [Kenny, Louise C.] Univ Liverpool, Fac Hlth & Life Sci, Dept Womens & Childrens Hlth, Liverpool, Merseyside, England; [Postma, Maarten J.; van Asselt, Antoinette D., I] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Unit Global Hlth, Groningen, Netherlands; [Postma, Maarten J.] Univ Groningen, Fac Econ & Business, Dept Econ Econometr & Finance, Groningen, Netherlands; [van Asselt, Antoinette D., I] Univ Groningen, Univ Med Ctr Groningen, Unit Patient Ctr Hlth Technol Assessment, Dept Epidemiol, Groningen, Netherlands	University of Groningen; Universitas Padjadjaran; Universitas Padjadjaran; University of Leicester; University of Liverpool; University of Groningen; University of Groningen; University of Groningen	Zakiyah, N (corresponding author), Univ Groningen, Dept Pharm, Unit PharmacoTherapy Epidemiol & Econ PTE2, Groningen, Netherlands.; Zakiyah, N (corresponding author), Univ Padjadjaran, Fac Pharm, Dept Pharmacol & Clin Pharm, Bandung, Indonesia.; Zakiyah, N (corresponding author), Univ Padjadjaran, Ctr Excellence Higher Educ Pharmaceut Care Innova, Bandung, Indonesia.	neily.zakiyah@unpad.ac.id	Kenny, Louise/G-1112-2011	Kenny, Louise/0000-0002-9011-759X; Tuytten, Robin/0000-0002-8734-7335; Postma, Maarten/0000-0002-6306-3653; Zakiyah, Neily/0000-0002-9630-5567				[Anonymous], 2019, Obstet Gynecol, V133, P1, DOI 10.1097/AOG.0000000000003018; [Anonymous], 2017, REG PRIS ERS SODR SJ; [Anonymous], 2016, PER ZORG NED 2015; Askie LM, 2007, LANCET, V369, P1791, DOI 10.1016/S0140-6736(07)60712-0; Black RE, 2016, LANCET, V388, P2811, DOI 10.1016/S0140-6736(16)00738-8; Boghossian NS, 2014, ANN EPIDEMIOL, V24, P871, DOI 10.1016/j.annepidem.2014.10.003; Bolten N, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1130-6; Brown MA, 2018, PREGNANCY HYPERTENS, V13, P291, DOI 10.1016/j.preghy.2018.05.004; Buisman LR, 2016, INT J TECHNOL ASSESS, V32, P46, DOI 10.1017/S0266462316000064; Bujold E, 2010, OBSTET GYNECOL, V116, P402, DOI 10.1097/AOG.0b013e3181e9322a; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Cosh E, 2007, J COMMER BIOTECHNOL, V13, P263, DOI DOI 10.1057/PALGRAVE.JCB.3050062; Cusimano MC, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.12.001; Danyliv A, 2016, DIABETOLOGIA, V59, P436, DOI 10.1007/s00125-015-3824-0; Department of Health Commercial Medicines Unit (CMU), 2016, DRUGS PHARM EL MARK; Duley L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004659.pub2; Duley L., 2007, COCHRANE LIB; Duley L, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004659.pub3; Fawsitt C., 2015, THESIS U COLL CORK I; Fisher SJ, 2015, AM J OBSTET GYNECOL, V213, pS115, DOI 10.1016/j.ajog.2015.08.042; Fox A, 2017, HYPERTENSION, V70, P1243, DOI 10.1161/HYPERTENSIONAHA.117.09499; Hadker Nandini, 2010, J Med Econ, V13, P728, DOI 10.3111/13696998.2010.535285; Hakkaart-van Roijen L, 2015, OPDRACHT ZORGINSTITU, P12; Heintz E, 2008, BJOG-INT J OBSTET GY, V115, P1676, DOI 10.1111/j.1471-0528.2008.01935.x; Henderson JT, 2014, ANN INTERN MED, V160, P695, DOI 10.7326/M13-2844; Hendrix MJC, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-211; Hernandez-Diaz Sonia, 2009, BMJ, V338, pb2255, DOI 10.1136/bmj.b2255; Husereau D, 2013, VALUE HEALTH, V16, pE1, DOI 10.1016/j.jval.2013.02.010; Hyde C, 2013, BJOG-INT J OBSTET GY, V120, P1168, DOI 10.1111/1471-0528.12309; IMproved Pregnancy Outcomes by Early Detection (IMPROvED), PERS MED PREGN WOM N; Institute of Obstetricians and Gynaecologists Health Service Executive Royal College of Physicians of Ireland & Clinical Strategy and Programmes Division, 2016, CLIN PRACTICE GUIDEL; Kenny LC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244369; Kenny LC, 2014, HYPERTENSION, V64, P644, DOI 10.1161/HYPERTENSIONAHA.114.03578; Kenny LC, 2010, HYPERTENSION, V56, P741, DOI 10.1161/HYPERTENSIONAHA.110.157297; Koninklijke Nederlandse Organisatie van Verloskundigen (KNOV), 2020, ROYAL DUTCH ORG MIDW; Leitich H, 1997, BRIT J OBSTET GYNAEC, V104, P450, DOI 10.1111/j.1471-0528.1997.tb11497.x; Ling DI, 2019, J COMP EFFECT RES, V8, P7, DOI 10.2217/cer-2018-0033; Lutomski JE, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-13; Mallampati D, 2019, OBSTET GYNECOL, V134, P537, DOI 10.1097/AOG.0000000000003413; McDonald SD, 2008, AM HEART J, V156, P918, DOI 10.1016/j.ahj.2008.06.042; Meads C A, 2008, Health Technol Assess, V12, piii; Mone F, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022056; National Health Service (NHS), 2020, NHS REF COSTS 2017 1; National Institute for Clinical Excellence, 2008, NICE CLIN GUID; National Institute for Health and Care Excellence, 2019, HYPERTENSION PREGNAN; Navaratnam K, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-226; Nederlandse Vereniging voor Obstetrie en Gynaecologie (NVOG), 2015, 10 NVOG; Nederlandse Zorgautoriteit, 2020, OP DIS DAT; Nordic Federation of Societies of Obstetrics and Gynecology (NFOG), 2015, HYPERTENSIVE DISORDE; North RA., 2011, BMJ, V342, pd1875, DOI [10.1136/bmj.d187521474517, DOI 10.1136/BMJ.D187521474517]; Ogge G, 2011, J PERINAT MED, V39, P641, DOI [10.1515/JPM.2011.098, 10.1515/jpm.2011.098]; Ortved D, 2019, ULTRASOUND OBST GYN, V53, P239, DOI 10.1002/uog.19076; Park F, 2021, ULTRASOUND OBST GYN, V58, P688, DOI 10.1002/uog.22193; Roberge S, 2017, AM J OBSTET GYNECOL, V216, P110, DOI 10.1016/j.ajog.2016.09.076; Roberge S, 2016, AM J PERINAT, V33, P781, DOI 10.1055/s-0036-1572495; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Rolnik DL, 2017, ULTRASOUND OBST GYN, V50, P492, DOI 10.1002/uog.18816; Say Lale, 2014, Lancet Glob Health, V2, pe323, DOI 10.1016/S2214-109X(14)70227-X; Sentilhes L, 2017, NEW ENGL J MED, V377, P2399, DOI [10.1056/NEJMc1713798, 10.1056/NEJMoa1704559]; Shaw D, 2016, LANCET, V388, P2282, DOI 10.1016/S0140-6736(16)31527-6; Shmueli A, 2012, PRENATAL DIAG, V32, P29, DOI 10.1002/pd.2871; Skne Region, 2021, KVINN FRLOSSN VRDRIK; Soto E., 2012, LATE ONSET PREECLAMP, V25, p498 507, DOI [10.3109/14767058.2011.591461, DOI 10.3109/14767058.2011.591461]; Tan MY, 2018, ULTRASOUND OBST GYN, V52, P186, DOI 10.1002/uog.19112; Thomas G., NOVEL METHOD INTERRO, DOI [10.1186/s41512-017-0017-y, DOI 10.1186/S41512-017-0017-Y]; von Schmidt auf Altenstadt Joost F, 2013, PLoS One, V8, pe81959, DOI 10.1371/journal.pone.0081959; Wang HD, 2016, LANCET, V388, P1725, DOI 10.1016/S0140-6736(16)31575-6; Werner EF, 2015, OBSTET GYNECOL, V126, P1242, DOI 10.1097/AOG.0000000000001115; World Health Organization, 2011, WHO REC PREV TREATM; Wright D, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.08.110; Wright D, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.02.018; Zakiyah N, 2015, PHARMACOECONOMICS, V33, P1069, DOI 10.1007/s40273-015-0291-x; Zorginstituut Nederland, 2017, MED	73	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267313	10.1371/journal.pone.0267313	http://dx.doi.org/10.1371/journal.pone.0267313			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446907	Green Published, gold			2022-12-26	WOS:000795468200013
J	Liu, JH; Zhao, Y; Ding, Z; Zhao, Y; Chen, TT; Ge, WH; Zhang, JF				Liu, Junhao; Zhao, Yang; Ding, Zhao; Zhao, Yue; Chen, Tingting; Ge, Wenhao; Zhang, Jianfa			Iron accumulation with age alters metabolic pattern and circadian clock gene expression through the reduction of AMP-modulated histone methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALORIC RESTRICTION; LIPID-PEROXIDATION; OXIDATIVE STRESS; SLEEP DISORDERS; BLOOD-DONATION; HEME; OVERLOAD; HEPCIDIN; DISRUPTION; DEFICIENCY	Iron accumulates with age in mammals, and its possible implications in altering metabolic responses are not fully understood. Here, we report that both high-iron diet and advanced age in mice consistently altered gene expression of many pathways, including those governing the oxidative stress response and the circadian clock. We used a metabolomic approach to reveal similarities between metabolic profiles and the daily oscillation of clock genes in old and iron-overloaded mouse livers. In addition, we show that phlebotomy decreased iron accumulation in old mice, partially restoring the metabolic patterns and amplitudes of the oscillatory expression of clock genes Per1 and Per2. We further identified that the transcriptional regulation of iron occurred through a reduction in AMPmodulated methylation of histone H3K9 in the Per1 and H3K4 in the Per2 promoters, respectively. Taken together, our results indicate that iron accumulation with age can affect metabolic patterns and the circadian clock.	[Liu, Junhao; Zhao, Yang; Ding, Zhao; Chen, Tingting; Ge, Wenhao; Zhang, Jianfa] Nanjing Univ Sci & Technol, Ctr Mol Metab, Nanjing, Peoples R China; [Zhao, Yue] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore	Nanjing University of Science & Technology; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Zhang, JF (corresponding author), Nanjing Univ Sci & Technol, Ctr Mol Metab, Nanjing, Peoples R China.	jfzhang@njust.edu.cn	Zhao, Yue/AAJ-4026-2021	Zhao, Yue/0000-0003-2869-5257	National Natural Science Foundation of China fund [31861163004, 31871178]; Fundamental Research Funds for the Central Universities [30920031102]	National Natural Science Foundation of China fund(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research work was supported by the National Natural Science Foundation of China fund (grant nos.: 31861163004 and 31871178) and the Fundamental Research Funds for the Central Universities (grant nos.: 30920031102).	ABRAHAM NG, 1985, EXP GERONTOL, V20, P277, DOI 10.1016/0531-5565(85)90053-1; Amer J, 2003, EUR J HAEMATOL, V70, P84, DOI 10.1034/j.1600-0609.2003.00011.x; Amer J, 2004, CYTOM PART A, V60A, P73, DOI 10.1002/cyto.a.20017; Ancoli-Israel S, 2006, AM J GERIAT PSYCHIAT, V14, P95, DOI 10.1097/01.JGP.0000196627.12010.d1; Andrews NC, 2008, BLOOD, V112, P219, DOI 10.1182/blood-2007-12-077388; Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Arezzini B, 2003, INT J BIOCHEM CELL B, V35, P486, DOI 10.1016/S1357-2725(02)00298-4; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Beard JL, 2001, J NUTR, V131, p568S, DOI 10.1093/jn/131.2.568S; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Berdoukas V, 2015, FREE RADICAL BIO MED, V88, P3, DOI 10.1016/j.freeradbiomed.2015.07.019; BLIWISE DL, 1993, SLEEP, V16, P40, DOI 10.1093/sleep/16.1.40; Boult J, 2008, CLIN CANCER RES, V14, P379, DOI 10.1158/1078-0432.CCR-07-1054; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Camaschella C, 2005, BLOOD, V106, P3710, DOI 10.1182/blood-2005-05-1857; Castro-Caraballo F, 1992, Invest Clin, V33, P121; Chen YW, 2013, CANCER-AM CANCER SOC, V119, P4259, DOI 10.1002/cncr.28356; Constante M, 2006, AM J PHYSIOL-GASTR L, V291, pG229, DOI 10.1152/ajpgi.00092.2006; Cook CI, 1998, MECH AGEING DEV, V102, P1, DOI 10.1016/S0047-6374(98)00005-0; Crow JP, 1997, NITRIC OXIDE-BIOL CH, V1, P145, DOI 10.1006/niox.1996.0113; Crowley K, 2011, NEUROPSYCHOL REV, V21, P41, DOI 10.1007/s11065-010-9154-6; Doi R, 2010, J BIOL CHEM, V285, P22114, DOI 10.1074/jbc.M110.110361; Ellervik C, 2013, DIABETES CARE, V36, P2646, DOI 10.2337/dc12-2032; Equitani F, 2008, DIABETES CARE, V31, P3, DOI 10.2337/dc07-0939; ETHIER MF, 1989, MECH AGEING DEV, V50, P159, DOI 10.1016/0047-6374(89)90011-0; Fenton RA, 2012, J CELL PHYSIOL, V227, P3709, DOI 10.1002/jcp.24079; Fernandez-Real JM, 2002, DIABETES CARE, V25, P2249, DOI 10.2337/diacare.25.12.2249; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Gonzalez-Cuyar LF, 2008, NEUROPATHOLOGY, V28, P466, DOI 10.1111/j.1440-1789.2008.00901.x; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Horl WH, 2014, NEPHROL DIAL TRANSPL, V29, P1141, DOI 10.1093/ndt/gft467; Hofman MA, 2006, AGEING RES REV, V5, P33, DOI 10.1016/j.arr.2005.07.001; Huang D, 2018, ANDROLOGIA, V50, DOI 10.1111/and.12816; Huang YL, 2002, PHYSIOL BEHAV, V76, P597, DOI 10.1016/S0031-9384(02)00733-3; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Jian JL, 2009, ANTIOXID REDOX SIGN, V11, P2939, DOI [10.1089/ars.2009.2576, 10.1089/ARS.2009.2576]; Jung M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01171; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kalpravidh RW, 2013, SCI WORLD J, DOI 10.1155/2013/543973; Kawabata H, 2005, BLOOD, V105, P376, DOI 10.1182/blood-2004-04-1416; Kijima H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-167; Kitanishi K, 2008, BIOCHEMISTRY-US, V47, P6157, DOI 10.1021/bi7023892; KNUDSEN TB, 1992, TERATOLOGY, V45, P91, DOI 10.1002/tera.1420450109; Knutson MD, 2000, J NUTR, V130, P621, DOI 10.1093/jn/130.3.621; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Korolnek T, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00126; Krebs NF, 2000, J NUTR, V130, p358S, DOI 10.1093/jn/130.2.358S; Larson K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002473; Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0; Lynch G, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00143; Madeddu C, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01294; MASSIE HR, 1983, EXP GERONTOL, V18, P277, DOI 10.1016/0531-5565(83)90038-4; McKie AT, 2001, SCIENCE, V291, P1755, DOI 10.1126/science.1057206; Mehta KJ, 2019, WORLD J GASTROENTERO, V25, P521, DOI 10.3748/wjg.v25.i5.521; Mercadante CJ, 2019, HAEMATOLOGICA, V104, P678, DOI 10.3324/haematol.2018.198382; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Mpoya A, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1112-4; Parayath NN, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19486-2; Pra D, 2009, NUTR CANCER, V61, P415, DOI 10.1080/01635580902803701; Praharaj SK, 2018, INDIAN J PSYCHIAT, V60, P383, DOI 10.4103/0019-5545.224477; Prajapati M, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100835; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rigas AS, 2019, TRANSFUSION MED, V29, P65, DOI 10.1111/tme.12478; Salminen A, 2008, AGEING RES REV, V7, P83, DOI 10.1016/j.arr.2007.09.002; Salonen JT, 1998, AM J EPIDEMIOL, V148, P445; Santos MM, 2000, AM J PATHOL, V157, P1883, DOI 10.1016/S0002-9440(10)64827-4; Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009; Schoenfeld JD, 2017, CANCER CELL, V31, P487, DOI 10.1016/j.ccell.2017.02.018; Schwartz AJ, 2019, J CLIN INVEST, V129, P336, DOI 10.1172/JCI122359; Silva RH, 2004, NEUROPHARMACOLOGY, V46, P895, DOI 10.1016/j.neuropharm.2003.11.032; Simcox JA, 2015, DIABETES, V64, P1108, DOI 10.2337/db14-0646; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; SMOLENSKI RT, 1990, J CHROMATOGR-BIOMED, V527, P414, DOI 10.1016/S0378-4347(00)82125-8; Sohal RS, 1999, FREE RADICAL BIO MED, V27, P287, DOI 10.1016/S0891-5849(99)00052-0; Spencer VA, 2003, METHODS, V31, P67, DOI 10.1016/S1046-2023(03)00089-6; Stoltzfus Rebecca J., 2003, Food and Nutrition Bulletin, V24, pS99; Tarasiuk A, 2003, ARCH PEDIAT ADOL MED, V157, P463, DOI 10.1001/archpedi.157.5.463; Terman DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052543; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Toyokuni S, 2011, FREE RADICAL RES, V45, P906, DOI 10.3109/10715762.2011.564170; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; TUREK FW, 1995, NEUROSCI BIOBEHAV R, V19, P53, DOI 10.1016/0149-7634(94)00030-5; Ullum H, 2015, TRANSFUSION, V55, P2479, DOI 10.1111/trf.13205; Vahidnia F, 2013, J CANCER EPIDEMIOL, V2013, DOI 10.1155/2013/814842; van Jaarsveld H, 2002, ATHEROSCLEROSIS, V161, P395, DOI 10.1016/S0021-9150(01)00638-4; Van Someren EJW, 2000, EXP GERONTOL, V35, P1229, DOI 10.1016/S0531-5565(00)00191-1; Voss P, 2006, FREE RADICAL RES, V40, P1339, DOI 10.1080/10715760600953859; Wallen GR, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-207; Wood JG, 2010, AGING CELL, V9, P971, DOI 10.1111/j.1474-9726.2010.00624.x; Xia L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118101; Xu JZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002865; Xu JZ, 2012, INT J MOL SCI, V13, P2368, DOI 10.3390/ijms13022368; Yang X, 2019, DIABETOLOGIA, V62, P2106, DOI 10.1007/s00125-019-04971-1; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Yunce Muharrem, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P653, DOI 10.1515/jbcpp-2015-0111; Zhou YF, 2018, HEPATOLOGY, V67, P21, DOI 10.1002/hep.29499	99	0	0	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101968	10.1016/j.jbc.2022.101968	http://dx.doi.org/10.1016/j.jbc.2022.101968			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3R4NR	35460695	Green Published, gold			2022-12-26	WOS:000838892100014
J	Moran, AL; Carter, SP; Kaylor, JJ; Jiang, ZC; Broekman, S; Dillon, ET; Sanchez, AG; Minhas, SK; van Wijk, E; Radu, RA; Travis, GH; Carey, M; Blacque, OE; Kennedy, BN				Moran, Ailis L.; Carter, Stephen P.; Kaylor, Joanna J.; Jiang, Zhichun; Broekman, Sanne; Dillon, Eugene T.; Sanchez, Alicia Gomez; Minhas, Sajal K.; van Wijk, Erwin; Radu, Roxana A.; Travis, Gabriel H.; Carey, Michelle; Blacque, Oliver E.; Kennedy, Breandan N.			Dawn and dusk peaks of outer segment phagocytosis, and visual cycle function require Rab28	FASEB JOURNAL			English	Article						bisretinoids; cilia; ciliopathy; cone-rod dystrophy; outer segment; phagocytosis; Rab28; retinoids; visual cycle; zebrafish	COMPUTATIONAL PLATFORM; CONE PHOTORECEPTOR; ROD; GENE; RPE; MUTATIONS; CYTOSCAPE; IDENTIFICATION; FLUOROPHORE; PHAGOSOMES	RAB28 is a farnesylated, ciliary G-protein. Patient variants in RAB28 are causative of autosomal recessive cone-rod dystrophy (CRD), an inherited human blindness. In rodent and zebrafish models, the absence of Rab28 results in diminished dawn, photoreceptor, outer segment phagocytosis (OSP). Here, we demonstrate that Rab28 is also required for dusk peaks of OSP, but not for basal OSP levels. This study further elucidated the molecular mechanisms by which Rab28 controls OSP and inherited blindness. Proteomic profiling identified factors whose expression in the eye or whose expression at dawn and dusk peaks of OSP is dysregulated by loss of Rab28. Notably, transgenic overexpression of Rab28, solely in zebrafish cones, rescues the OSP defect in rab28 KO fish, suggesting rab28 gene replacement in cone photoreceptors is sufficient to regulate Rab28-OSP. Rab28 loss also perturbs function of the visual cycle as retinoid levels of 11-cRAL, 11cRP, and atRP are significantly reduced in larval and adult rab28 KO retinae (p < .05). These data give further understanding on the molecular mechanisms of RAB28-associated CRD, highlighting roles of Rab28 in both peaks of OSP, in vitamin A metabolism and in retinoid recycling.	[Moran, Ailis L.; Carter, Stephen P.; Blacque, Oliver E.; Kennedy, Breandan N.] Univ Coll Dublin, UCD Sch Biomol & Biomed Sci, Dublin, Ireland; [Moran, Ailis L.; Carter, Stephen P.; Dillon, Eugene T.; Sanchez, Alicia Gomez; Blacque, Oliver E.; Kennedy, Breandan N.] Univ Coll Dublin, UCD Conway Inst, Dublin, Ireland; [Kaylor, Joanna J.; Jiang, Zhichun; Radu, Roxana A.; Travis, Gabriel H.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Stein Eye Inst, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Broekman, Sanne; van Wijk, Erwin] Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol, Nijmegen, Netherlands; [Broekman, Sanne; van Wijk, Erwin] Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Sanchez, Alicia Gomez] Univ Complutense Madrid, Fac Opt & Optometry, Ocupharm Diagnost Grp Res, Madrid, Spain; [Minhas, Sajal K.; Carey, Michelle] Univ Coll Dublin, UCD Sch Math & Stat, Dublin, Ireland; [Travis, Gabriel H.] Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90024 USA	University College Dublin; University College Dublin; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Radboud University Nijmegen; Radboud University Nijmegen; Complutense University of Madrid; University College Dublin; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kennedy, BN (corresponding author), Univ Coll Dublin, F062 UCD Conway Inst, Dublin 4, Ireland.	brendan.kennedy@ucd.ie	Travis, Gabriel Harvey/AIF-1062-2022	Travis, Gabriel Harvey/0000-0003-4020-9493; Van Wijk, Erwin/0000-0002-5702-3460; Moran, Ailis/0000-0002-8706-9777; Kennedy, Breandan/0000-0001-7991-4689; Radu, Roxana/0000-0002-5064-6403; Carter, Stephen/0000-0002-0562-8783	Irish Research Council [EPS2019/526]; Science Foundation Ireland [18/CRT/6049, 20/FFP-P/8538]; European Union [734907, 101007931]; Research to Prevent Blindness, Inc. (RPB, New York)	Irish Research Council(Irish Research Council for Science, Engineering and Technology); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Union(European Commission); Research to Prevent Blindness, Inc. (RPB, New York)(Research to Prevent Blindness (RPB))	This project received funding from: the Irish Research Council grant EPS2019/526. This publication has emanated from research supported in part by grants from Science Foundation Ireland under grant numbers 18/CRT/6049 and 20/FFP-P/8538. The European Union's Horizon 2020 Research and Innovation Programme under grant agreement numbers 734907 (3DNEONET) and 101007931 (CRYSTAL<SUP>3</SUP>). A UCLA Stein Eye Institute, unrestricted grant from Research to Prevent Blindness, Inc. (RPB, New York).	Akella JS, 2020, ELIFE, V9, DOI 10.7554/eLife.50580; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Angueyra JM, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00110; BASINGER S, 1976, SCIENCE, V194, P1074, DOI 10.1126/science.1086510; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bujakowska KM, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028274; Carter SP, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00136; Carter SP, 2019, CURR OPIN CELL BIOL, V59, P133, DOI 10.1016/j.ceb.2019.04.007; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Scortecci JF, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26161-7; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Gomez Sanchez A., 2021, OPEN RES EUROPE, V1, P92; Guadagno NA, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080909; Hu KP, 2019, BIOMED CIRC SYST C; Iarossi G, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010381; Inana G, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1434-6; Jensen VL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006469; Jespersgaard C, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.2.29; Jiang M, 2015, J CELL BIOL, V210, P595, DOI 10.1083/jcb.201410112; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kennedy BN, 2007, INVEST OPHTH VIS SCI, V48, P522, DOI 10.1167/iovs.06-0975; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Khan M, 2020, KLIN MONATSBL AUGENH, V237, P267, DOI 10.1055/a-1057-9939; Kim JY, 2013, CELL, V154, P365, DOI 10.1016/j.cell.2013.06.012; Kim SR, 2006, EXP EYE RES, V82, P828, DOI 10.1016/j.exer.2005.10.004; Lakkaraju A, 2020, PROG RETIN EYE RES, V78, DOI 10.1016/j.preteyeres.2020.100846; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; LAVAIL MM, 1980, INVEST OPHTH VIS SCI, V19, P407; LAVAIL MM, 1978, INVEST OPHTH VIS SCI, V17, P1189; Lee GI, 2017, OPHTHALMIC GENET, V38, P587, DOI 10.1080/13816810.2017.1301965; Lenis TL, 2018, P NATL ACAD SCI USA, V115, pE11120, DOI 10.1073/pnas.1802519115; Lewis TR, 2018, BMC CELL BIOL, V19, DOI 10.1186/s12860-018-0177-9; Li LJ, 2015, CYTOSKELETON, V72, P447, DOI 10.1002/cm.21255; Liu JH, 2000, J BIOL CHEM, V275, P29354, DOI 10.1074/jbc.M910191199; Lorach H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29631-z; Mazzoni F, 2014, EXP EYE RES, V126, P51, DOI 10.1016/j.exer.2014.01.010; Milicevic N, 2021, FASEB J, V35, DOI 10.1096/fj.202100293RR; Molday RS, 2015, J CELL SCI, V128, P4039, DOI 10.1242/jcs.175687; Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447; Nandrot EF, 2014, ADV EXP MED BIOL, V801, P77, DOI 10.1007/978-1-4614-3209-8_10; Quint WH, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02185-z; Radu RA, 2008, INVEST OPHTH VIS SCI, V49, P3821, DOI 10.1167/iovs.07-1470; Riveiro-Alvarez R, 2015, JAMA OPHTHALMOL, V133, P133, DOI 10.1001/jamaophthalmol.2014.4266; Roosing S, 2013, AM J HUM GENET, V93, P110, DOI 10.1016/j.ajhg.2013.05.005; Salinas RY, 2017, J CELL BIOL, V216, P1489, DOI 10.1083/jcb.201608081; Shadrach KG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067983; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; Spencer WJ, 2019, P NATL ACAD SCI USA, V116, P27043, DOI 10.1073/pnas.1913518117; Hoang T, 2020, SCIENCE, V370, P934, DOI 10.1126/science.abb8598; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Valapala M, 2014, AUTOPHAGY, V10, P480, DOI 10.4161/auto.27292; Vieira OV, 2003, MOL CELL BIOL, V23, P2501, DOI 10.1128/MCB.23.7.2501-2514.2003; Villanueva-Mendoza C, 2021, GENES-BASEL, V12, DOI 10.3390/genes12111824; Ward R, 2020, J BIOL CHEM, V295, P6482, DOI 10.1074/jbc.RA119.011374; Ying GX, 2018, J BIOL CHEM, V293, P17546, DOI 10.1074/jbc.RA118.005484; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; YOUNG RW, 1970, INVEST OPHTH VISUAL, V9, P524; Yu C, 2019, J CELL SCI, V132, DOI 10.1242/jcs.232439; Yu SS, 2017, HUM MOL GENET, V26, P2335, DOI 10.1093/hmg/ddx137; Zhang HB, 2015, FASEB J, V29, P932, DOI 10.1096/fj.14-257915	65	2	2	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22309	10.1096/fj.202101897R	http://dx.doi.org/10.1096/fj.202101897R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0U0KU	35471581	Green Published			2022-12-26	WOS:000787349300001
J	Qian, LL; Ji, JJ; Jiang, Y; Guo, JQ; Wu, Y; Yang, ZW; Ma, GS; Yao, YY				Qian, Ling Lin; Ji, Jing Jing; Jiang, Yu; Guo, Jia Qi; Wu, Ya; Yang, Ziwei; Ma, Gen Shan; Yao, Yu Yu			Serpina3c deficiency induced necroptosis promotes non-alcoholic fatty liver disease through beta-catenin/Foxo1/TLR4 signaling	FASEB JOURNAL			English	Article							CELL-DEATH; INFLAMMATION; SUPPRESSES; ACTIVATION; INHIBITOR; APOPTOSIS; PATHWAY	Non-alcoholic fatty liver disease (NAFLD) is a public health challenge and an increasing cause of chronic liver disease worldwide. However, the underlying molecular mechanism remains unclear. The aim of this study was to determine the precise role of serpina3c in the process of NAFLD. Male Apoe(-/-)/serpina3c(-/-) double knockout (DKO) and Apoe(-/-) mice were fed a high-fat diet (HFD) for 12 weeks. Several markers of steatosis and inflammation were evaluated. In vitro cell models induced by palmitic acid (PA) treatment were used to evaluate the beneficial effect of serpina3c on necroptosis and the underlying molecular mechanism. Compared with Apoe(-/-) mice, DKO mice exhibited a significantly exacerbated hepatic steatosis, increased hepatic triglyceride content and expression of genes involved in lipid metabolism (SREBP1c and SCD1), promoted hepatic inflammation and fibrosis, promoted necroptosis by increasing expression of receptor-interacting protein 3 (RIP3), phosphorylated mixed lineage kinase domain-like (MLKL) and high mobility group box 1 (HMGB1). Notably, serpina3c deficiency increased beta-catenin, Foxo1, and Toll-like receptor 4 (TLR4) protein expression. In vitro , serpina3c knockdown promoted necroptosis and lipid droplet formation under condition of lipotoxicity. However, these phenomena were reversed by the overexpression of serpina3c. Mechanistically, downregulation of serpina3c expression promoted Foxo1 and beta-catenin colocalized in the nucleus under condition of lipotoxicity, consequently upregulating the expression of TLR4. Conversely, disruption of Foxo1-beta/catenin by Foxo1 and beta-catenin inhibitors decreased TLR4 expression and ameliorated hepatic necroptosis in vitro. This study highlights a novel mechanism that serpina3c modulates NAFLD development by inhibiting necroptosis via beta-catenin/Foxo1/TLR4.	[Qian, Ling Lin; Ji, Jing Jing; Jiang, Yu; Guo, Jia Qi; Wu, Ya; Yang, Ziwei; Ma, Gen Shan; Yao, Yu Yu] Southeast Univ, Zhongda Hosp, Sch Med, Dept Cardiol, 87 Dingjiaqiao, Nanjing 210009, Jiangsu, Peoples R China	Southeast University - China	Yao, YY (corresponding author), Southeast Univ, Zhongda Hosp, Sch Med, Dept Cardiol, 87 Dingjiaqiao, Nanjing 210009, Jiangsu, Peoples R China.	yaoyuyunj@hotmail.com	Guo, Jiaqi/GSO-0702-2022		National Natural Science Foundation of China (NSFC) [81770452]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	We would like to thank Bing Li for reviewing the draft. This work was supported by the National Natural Science Foundation of China (NSFC) 81770452.	Afonso MB, 2015, CLIN SCI, V129, P721, DOI 10.1042/CS20140732; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Cazanave SC, 2010, CLIN LIPIDOL, V5, P71, DOI 10.2217/CLP.09.85; Choi Y, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100961; Dela Pena A, 2005, GASTROENTEROLOGY, V129, P1663, DOI 10.1053/j.gastro.2005.09.004; Dewidar B, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111419; Fan WQ, 2010, EMBO J, V29, P4223, DOI 10.1038/emboj.2010.268; Farrell G, 2019, HEPATOLOGY, V69, P2241, DOI 10.1002/hep.30333; Guicciardi ME, 2013, COMPR PHYSIOL, V3, P977, DOI 10.1002/cphy.c120020; Harrison Stephen A, 2020, J Hepatol, V72, P816, DOI 10.1016/j.jhep.2019.11.024; He YC, 2020, CARDIOVASC DIAGN THE, V10, P107, DOI 10.21037/cdt.2019.12.08; Ji JJ, 2020, CELL SIGNAL, V75, DOI 10.1016/j.cellsig.2020.109745; Jorgensen I, 2017, NAT REV IMMUNOL, V17, P151, DOI 10.1038/nri.2016.147; Ju C, 2016, CELL MOL IMMUNOL, V13, P316, DOI 10.1038/cmi.2015.104; Kamo N, 2013, HEPATOLOGY, V57, P289, DOI 10.1002/hep.25958; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Larter CZ, 2008, J HEPATOL, V49, P407, DOI 10.1016/j.jhep.2008.03.026; Leclercq IA, 2002, J HEPATOL, V37, P206, DOI 10.1016/S0168-8278(02)00102-2; Lee T, 2019, MOL CELL ENDOCRINOL, V486, P96, DOI 10.1016/j.mce.2019.03.001; Li B, 2019, HUM GENE THER, V30, P339, DOI 10.1089/hum.2018.084; Li CY, 2021, CELL DEATH DIFFER, V28, P1705, DOI 10.1038/s41418-020-00695-7; Lindenmeyer CC, 2018, CLIN LIVER DIS, V22, P11, DOI 10.1016/j.cld.2017.08.003; Majdi A, 2020, J HEPATOL, V72, P627, DOI 10.1016/j.jhep.2019.11.008; Mendez-Sanchez N, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.02.184; Ming M, 2012, J BIOL CHEM, V287, P22683, DOI 10.1074/jbc.M112.342089; Mularczyk M, 2021, BIOMED PHARMACOTHER, V139, DOI 10.1016/j.biopha.2021.111560; Noureddin Mazen, 2018, Curr Hepatol Rep, V17, P350, DOI 10.1007/s11901-018-0425-7; Qian Ling-Lin, 2021, Clin Sci (Lond), V135, P447, DOI 10.1042/CS20201235; Schierwagen R, 2015, SCI REP-UK, V5, DOI 10.1038/srep12931; Shojaie L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249682; Wang XB, 2016, CELL METAB, V24, P848, DOI 10.1016/j.cmet.2016.09.016; Wilson RB, 2020, PHARMACOL RES, V161, DOI 10.1016/j.phrs.2020.105208; Wree A, 2019, SEMIN LIVER DIS, V39, P275, DOI 10.1055/s-0039-1685515; Wu XQ, 2020, J HEPATOL, V73, P617, DOI 10.1016/j.jhep.2020.03.023; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zang SF, 2016, CLIN EXP PHARMACOL P, V43, P13, DOI 10.1111/1440-1681.12499; Zhang B, 2010, P NATL ACAD SCI USA, V107, P6900, DOI 10.1073/pnas.0906764107; Zhang YZ, 2018, ATHEROSCLEROSIS, V274, P128, DOI 10.1016/j.atherosclerosis.2018.04.031; Zheng XL, 2017, INVEST OPHTH VIS SCI, V58, P2874, DOI 10.1167/iovs.17-21544; Zhou T, 2014, INVEST OPHTH VIS SCI, V55, P4863, DOI 10.1167/iovs.14-14023	40	0	0	5	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22316	10.1096/fj.202101345RRR	http://dx.doi.org/10.1096/fj.202101345RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0N3EU	35429042				2022-12-26	WOS:000782726000001
J	Van den Bergh, G; Van den Branden, A; Opdebeeck, B; Fransen, P; Neven, E; De Meyer, G; D'Haese, PC; Verhulst, A				Van den Bergh, Geoffrey; Van den Branden, Astrid; Opdebeeck, Britt; Fransen, Paul; Neven, Ellen; De Meyer, Guido; D'Haese, Patrick C.; Verhulst, Anja			Endothelial dysfunction aggravates arterial media calcification in warfarin administered rats	FASEB JOURNAL			English	Article						endothelium; medial calcific sclerosis; nitric oxide; vascular calcification; vascular stiffness	NITRIC-OXIDE SYNTHASE; VASCULAR CALCIFICATION; BASAL; SEGMENTS; AORTA; MICE; NO	Arterial media calcification is an active cell process. This encompasses osteochondrogenic transdifferentiation of vascular smooth muscle cells followed by the deposition of calcium-phosphate crystals. Increasing evidence suggests a significant role for endothelial cells (ECs) in the development of arterial media calcification. This manuscript explores a role for endothelial dysfunction in the disease progression of arterial media calcification. Male rats were randomly assigned to four different groups. The first group received standard chow. The second group was given L-NAME (approximate to 50 mg kg(-1) center dot d(-1)), to induce endothelial dysfunction, in addition to standard chow. The third group and fourth group received a warfarin-supplemented diet to induce mild calcification and the latter group was co-administered L-NAME. Prior to sacrifice, non-invasive measurement of aortic distensibility was performed. Animals were sacrificed after 6 weeks. Arterial media calcification was quantified by measuring aortic calcium and visualized on paraffin-embedded slices by the Von Kossa method. Arterial stiffness and aortic reactivity was assessed on isolated carotid segments using specialized organ chamber setups. Warfarin administration induced mineralization. Simultaneous administration of warfarin and L-NAME aggravated the arterial media calcification process. Through organ chamber experiments an increased vessel tonus was found, which could be linked to reduced basal NO availability, in arteries of warfarin-treated animals. Furthermore, increased calcification because of L-NAME administration was related to a further compromised endothelial function (next to deteriorated basal NO release also deteriorated stimulated NO release). Our findings suggest early EC changes to impact the disease progression of arterial media calcification.	[Van den Bergh, Geoffrey; Van den Branden, Astrid; Opdebeeck, Britt; Neven, Ellen; D'Haese, Patrick C.; Verhulst, Anja] Univ Antwerp, Dept Biomed Sci, Lab Pathophysiol, Univ Pl 1,Campus Drie Eiken, Antwerp, Belgium; [Fransen, Paul; De Meyer, Guido] Univ Antwerp, Dept Pharmaceut Sci, Lab Physiopharmacol, Antwerp, Belgium	University of Antwerp; University of Antwerp	Verhulst, A (corresponding author), Univ Antwerp, Dept Biomed Sci, Lab Pathophysiol, Univ Pl 1,Campus Drie Eiken, Antwerp, Belgium.	anja.verhulst@uantwerpen.be	Opdebeeck, Britt/GQA-8470-2022; Neven, Ellen/GVR-7948-2022	Van den Bergh, Geoffrey/0000-0002-8870-1965; Van den Branden, Astrid/0000-0001-6325-4997; Fransen, Paul/0000-0002-4577-3416	Fonds Wetenschappelijk Onderzoek (FWO) [1S18818N, G045120N]; Universiteit Antwerpen (GOA-BOF) [33932]	Fonds Wetenschappelijk Onderzoek (FWO)(FWO); Universiteit Antwerpen (GOA-BOF)	Fonds Wetenschappelijk Onderzoek (FWO), Grant/Award Number: 1S18818N and G045120N; Universiteit Antwerpen (GOA-BOF), Grant/Award Number: 33932	Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Alique M, 2020, COMPUT STRUCT BIOTEC, V18, P953, DOI 10.1016/j.csbj.2020.04.006; [Anonymous], 2018, VP, DOI DOI 10.20517/2574-1209.2018.51; Cahill PA, 2016, ATHEROSCLEROSIS, V248, P97, DOI 10.1016/j.atherosclerosis.2016.03.007; Campos-Staffico AM, 2020, ATHEROSCLEROSIS, V292, P70, DOI 10.1016/j.atherosclerosis.2019.11.007; Cau SBA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00218; Charytan DM, 2015, AM J KIDNEY DIS, V66, P196, DOI 10.1053/j.ajkd.2014.12.016; Csonka C, 2015, BRIT J PHARMACOL, V172, P1620, DOI 10.1111/bph.12832; De Mare A, 2019, TOXINS, V11, DOI 10.3390/toxins11070428; De Moudt S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00157; Dowell FJ, 1999, EUR J PHARMACOL, V379, P175, DOI 10.1016/S0014-2999(99)00511-7; Durham AL, 2018, CARDIOVASC RES, V114, P590, DOI 10.1093/cvr/cvy010; Farrar EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123257; Fransen P, 2008, PFLUG ARCH EUR J PHY, V455, P811, DOI 10.1007/s00424-007-0337-9; Fuglerud BM., 2021, BIORXIV2020091129399, DOI [10.1101/2020.09.11.293993, DOI 10.1101/2020.09.11.293993]; Godia EC, 2007, J ULTRAS MED, V26, P1157, DOI 10.7863/jum.2007.26.9.1157; Guo J., 2016, CIRCULATION, V133, pAMP66; Guo JC, 2017, HYPERTENSION, V69, P102, DOI 10.1161/HYPERTENSIONAHA.116.08459; Hadi HAR, 2005, VASC HEALTH RISK MAN, V1, P183; Kanno Y, 2008, CARDIOVASC RES, V77, P221, DOI 10.1093/cvr/cvm049; Knapp M, 2019, ACTA PHARMACOL SIN, V40, P1, DOI 10.1038/s41401-018-0042-6; KUNG CF, 1995, HYPERTENSION, V26, P744, DOI 10.1161/01.HYP.26.5.744; Lanzer P, 2014, EUR HEART J, V35, P1515, DOI 10.1093/eurheartj/ehu163; Lee JS, 2012, ATHEROSCLEROSIS, V224, P340, DOI 10.1016/j.atherosclerosis.2012.07.023; Leloup A, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00858; Leloup AJA, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.13934; Leloup AJA, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00582; Leloup AJA, 2016, J PHYSIOL-LONDON, V594, P6105, DOI 10.1113/JP272623; Li HG, 2002, NITRIC OXIDE-BIOL CH, V7, P149, DOI 10.1016/S1089-8603(02)00111-8; Oe Y, 2021, AM J PATHOL, V191, P283, DOI 10.1016/j.ajpath.2020.10.012; Ozkor MA, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/156146; Pechanova Olga, 2020, Pathophysiology, V27, P46, DOI 10.3390/pathophysiology27010007; Proudfoot D, 2006, NEPHROLOGY, V11, P455, DOI 10.1111/j.1440-1797.2006.00660.x; Richards J, 2013, AM J PATHOL, V182, P1922, DOI 10.1016/j.ajpath.2013.01.037; Roumeliotis S, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082359; Sambe T, 2018, BIOMED PHARMACOTHER, V98, P149, DOI 10.1016/j.biopha.2017.12.023; Sanchez-Duffhues G, 2019, J PATHOL, V247, P333, DOI 10.1002/path.5193; Sandoo A, 2010, OPEN CARDIOVASC MED, V4, P302, DOI 10.2174/1874192401004010302; Schantl AE, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14091-4; Schantl AE, 2019, ADV THER-GERMANY, V2, DOI 10.1002/adtp.201800094; Shanahan CM, 1999, CIRCULATION, V100, P2168, DOI 10.1161/01.CIR.100.21.2168; Simionescu A, 2005, BIOCHEM BIOPH RES CO, V334, P524, DOI 10.1016/j.bbrc.2005.06.119; Van den Bergh G, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222111615; Van den Bergh G, 2019, TRENDS MOL MED, V25, P1133, DOI 10.1016/j.molmed.2019.08.006; van Langen J, 2012, EUR J PHARMACOL, V696, P111, DOI 10.1016/j.ejphar.2012.09.016; Wilkinson IB, 2002, BRIT J CLIN PHARMACO, V53, P189, DOI 10.1046/j.1365-2125.2002.1528adoc.x; Yuan C, 2021, MICROVASC RES, V134, DOI 10.1016/j.mvr.2020.104105; Zhang XY, 2016, VASC PHARMACOL, V81, P83, DOI 10.1016/j.vph.2016.01.002; Zhang YX, 2021, CELL PROLIFERAT, V54, DOI 10.1111/cpr.12980; Zhao JL, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22717-9	50	1	1	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22315	10.1096/fj.202101919R	http://dx.doi.org/10.1096/fj.202101919R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0N3HL	35429059	hybrid			2022-12-26	WOS:000782732900001
J	Davis, JC; Hsu, CL; Barha, C; Jehu, DA; Chan, P; Ghag, C; Jacova, P; Adjetey, C; Dian, L; Parmar, N; Madden, K; Liu-Ambrose, T				Davis, Jennifer C.; Hsu, Chun Liang; Barha, Cindy; Jehu, Deborah A.; Chan, Patrick; Ghag, Cheyenne; Jacova, Patrizio; Adjetey, Cassandra; Dian, Larry; Parmar, Naaz; Madden, Kenneth; Liu-Ambrose, Teresa			Comparing the cost-effectiveness of the Otago Exercise Programme among older women and men: A secondary analysis of a randomized controlled trial	PLOS ONE			English	Article							HOME-BASED EXERCISE; PREVENT FALLS; ECONOMIC EVALUATIONS; NONFATAL FALLS; ADULTS; COMMUNITY; FRAILTY; PEOPLE; INJURIES; STRENGTH	Objective Using stratified analyses, we examined the cost-effectiveness of the Otago Exercise Programme (OEP), from a health care system perspective, among older women and men who have previously fallen. Methods This study was a secondary stratified analysis (by women and men), of a 12-month prospective economic evaluation of a randomized clinical trial (OEP compared with usual care). Three hundred and forty four community-dwelling older adults (>= 70; 172 OEP (110 women; 62 men), 172 usual care (119 women; 53 men)) who sustained a fall in the past 12 months and received a baseline assessment at the Vancouver Falls Prevention Clinic, Canada were included. A gender by OEP/usual care interaction was examined for the falls incidence rate ratio (IRR). Outcome measures stratified by gender included: falls IRR, incremental cost-per fall prevented (ICER), incremental cost per quality adjusted life year (QALY, ICUR) gained, and mean total health care resource utilization costs. Results Men were frailer than women at baseline. Men incurred higher mean total healthcare costs $6794 (SD: $11906)). There was no significant gender by OEP/usual care interaction on falls IRR. The efficacy of the OEP did not vary by gender. The adjusted IRR for the OEP group demonstrated a 39% (IRR: 0.61, CI: 0.40-0.93) significant reduction in falls among men but not women (32% reduction (IRR: 0.69, CI: 0.47-1.02)). The ICER showed the OEP was effective in preventing falls and less costly for men, while it was costlier for women by $42. The ICUR showed the OEP did not impact quality of life. Conclusion Future studies should explore gender factors (i.e., health seeking behaviours, gender related frailty) that may explain observed variation in the cost-effectiveness of the OEP as a secondary falls prevention strategy.	[Davis, Jennifer C.; Hsu, Chun Liang; Barha, Cindy; Chan, Patrick; Ghag, Cheyenne; Jacova, Patrizio; Liu-Ambrose, Teresa] Univ British Columbia, Dept Phys Therapy, Aging Mobil & Cognit Neurosci Lab, Vancouver, BC, Canada; [Davis, Jennifer C.; Hsu, Chun Liang; Barha, Cindy; Chan, Patrick; Ghag, Cheyenne; Jacova, Patrizio; Liu-Ambrose, Teresa] Vancouver Coastal Hlth Res Inst, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada; [Davis, Jennifer C.; Hsu, Chun Liang; Barha, Cindy; Chan, Patrick; Ghag, Cheyenne; Jacova, Patrizio; Liu-Ambrose, Teresa] Vancouver Coastal Hlth Res Inst, Ctr Hip Hlth & Mobil, Vancouver, BC, Canada; [Davis, Jennifer C.; Adjetey, Cassandra] Univ British Columbia, Fac Management, Social & Econ Change Lab, Kelowna, BC, Canada; [Hsu, Chun Liang] Hebrew SeniorLife, Hinda & Arthur Marcus Inst Aging Res, Roslindale, MA USA; [Jehu, Deborah A.] Augusta Univ, Interdisciplinary Hlth Sci Dept, Augusta, GA USA; [Dian, Larry; Parmar, Naaz; Madden, Kenneth] Univ British Columbia, Fac Med, Dept Med, Div Geriatr Med, Vancouver, BC, Canada	University of British Columbia; Vancouver Coastal Health Research Institute; Vancouver Coastal Health Research Institute; University of British Columbia; Harvard University; Hebrew SeniorLife; University System of Georgia; Augusta University; University of British Columbia	Davis, JC (corresponding author), Univ British Columbia, Dept Phys Therapy, Aging Mobil & Cognit Neurosci Lab, Vancouver, BC, Canada.; Davis, JC (corresponding author), Vancouver Coastal Hlth Res Inst, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada.; Davis, JC (corresponding author), Vancouver Coastal Hlth Res Inst, Ctr Hip Hlth & Mobil, Vancouver, BC, Canada.; Davis, JC (corresponding author), Univ British Columbia, Fac Management, Social & Econ Change Lab, Kelowna, BC, Canada.	jennifer.davis@ubc.ca		Hsu, Chun Liang/0000-0003-2090-1001; Davis, Jennifer/0000-0002-5274-4293	Canadian Institutes of Health Research (CIHR) [MOP110954, MAT_92025]; CIHR; MSFHR; Alzheimer's Associated; Brain Canada Postdoctoral Award; CIHR Postdoctoral Award	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); MSFHR(Michael Smith Foundation for Health Research); Alzheimer's Associated; Brain Canada Postdoctoral Award; CIHR Postdoctoral Award(Canadian Institutes of Health Research (CIHR))	This study is funded by the Canadian Institutes of Health Research to TLA (CIHR, MOP110954, CIHR, MAT_92025). TLA is a Canada Research Chair in Physical Activity, Mobility, and Cognitive Neuroscience. JCD was funded by a CIHR and MSFHR Postdoctoral Fellowship for part of this trial. JCD is a MSFHR Career Scholar and a Canada Research Chair in Applied Health Economics. CB is funded by the Alzheimer's Associated and Brain Canada Postdoctoral Award. CLH was funded by a CIHR Postdoctoral Award.	Aging PHAoCDo Seniors, 2005, REP SEM FALLS CAN DI; Albornos-Munoz L, 2018, J ADV NURS, V74, P1700, DOI 10.1111/jan.13583; ALEXANDER BH, 1992, AM J PUBLIC HEALTH, V82, P1020, DOI 10.2105/AJPH.82.7.1020; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Briggs A, 2003, HEALTH ECON, V12, P377, DOI 10.1002/hec.766; Briggs AH, 1999, HLTH TECHNOLOGY ASSE, V3, P1, DOI DOI 10.3310/hta3020; Burns ER, 2016, J SAFETY RES, V58, P99, DOI 10.1016/j.jsr.2016.05.001; Butler AA, 2015, J GERONTOL A-BIOL, V70, P628, DOI 10.1093/gerona/glu201; Campbell AJ, 1997, BMJ-BRIT MED J, V315, P1065, DOI 10.1136/bmj.315.7115.1065; Davis JC, 2010, OSTEOPOROSIS INT, V21, P1295, DOI 10.1007/s00198-009-1162-0; Davis JC, 2010, BRIT J SPORT MED, V44, P80, DOI 10.1136/bjsm.2008.060988; Davis JC, 2020, J AM GERIATR SOC, V68, P1988, DOI 10.1111/jgs.16476; Drummond M, 2005, INT J TECHNOL ASSESS, V21, P165, DOI 10.1017/S0266462305050221; Florence CS, 2018, J AM GERIATR SOC, V66, P693, DOI 10.1111/jgs.15304; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gill TM, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i245; Gillespie LD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007146.pub3; Goossens MEJB, 2000, J CLIN EPIDEMIOL, V53, P688, DOI 10.1016/S0895-4356(99)00177-8; Groll DL, 2005, J CLIN EPIDEMIOL, V58, P595, DOI 10.1016/j.jclinepi.2004.10.018; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Hartholt KA, 2011, J TRAUMA, V71, P255, DOI 10.1097/TA.0b013e31821c36e7; Hendrie Delia, 2004, Aust Health Rev, V28, P363; Jehu DA, 2022, GERONTOLOGY, V68, P272, DOI 10.1159/000516260; Johnson Shanthi, 2015, Inj Epidemiol, V2, P24; Kane AE, 2021, MECH AGEING DEV, V198, DOI 10.1016/j.mad.2021.111546; Laska EM, 1997, HEALTH ECON, V6, P229, DOI 10.1002/(SICI)1099-1050(199705)6:3<229::AID-HEC268>3.3.CO;2-D; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Leurent B, 2018, HEALTH ECON, V27, P1024, DOI 10.1002/hec.3654; Liu-Ambrose T, 2008, J AM GERIATR SOC, V56, P1821, DOI [10.1111/j.1532-5415.2008.01931.x, 10.1111/j.1532-5415.2008.01984.x]; Liu-Ambrose T, 2019, JAMA-J AM MED ASSOC, V321, P2092, DOI 10.1001/jama.2019.5795; Liu-Ambrose T, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0648-7; Liu-Ambrose T, 2010, ARCH INTERN MED, V170, P170, DOI 10.1001/archinternmed.2009.494; Lord S., 2001, FALLS OLDER PEOPLE R, P221; Ma LN, 2018, J AM GERIATR SOC, V66, P559, DOI 10.1111/jgs.15214; Manca A, 2005, APPL HEALTH ECON HEA, V4, P65, DOI 10.2165/00148365-200504020-00001; Miyamoto J M, 1985, Med Decis Making, V5, P191, DOI 10.1177/0272989X8500500208; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Oostenbrink JB, 2003, PHARMACOECONOMICS, V21, P1103, DOI 10.2165/00019053-200321150-00004; Oostenbrink JB, 2005, HEALTH ECON, V14, P763, DOI 10.1002/hed.966; Patton S, 2022, HEALTH PROMOT PRACT, V23, P785, DOI 10.1177/15248399211009783; Redondo-Sendino A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-155; Robertson MC, 2002, J AM GERIATR SOC, V50, P905, DOI 10.1046/j.1532-5415.2002.50218.x; Robertson MC, 2001, BRIT MED J, V322, P697, DOI 10.1136/bmj.322.7288.697; Robertson MC, 2001, BRIT MED J, V322, P701, DOI 10.1136/bmj.322.7288.701; Screen W., ROLE NUTR EXERCISE M; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Spreen O, 1998, COMPENDIUM NEUROPSYC; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Stevens J.A., 2015, CDC COMPENDIUM EFFEC; Towne SD, 2022, J AGING SOC POLICY, V34, P515, DOI 10.1080/08959420.2020.1740639; VANMARWIJK HWJ, 1995, BRIT J GEN PRACT, V45, P195; Whitney JC, 2005, AGE AGEING, V34, P567, DOI 10.1093/ageing/afi178; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	54	1	1	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0267247	10.1371/journal.pone.0267247	http://dx.doi.org/10.1371/journal.pone.0267247			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35442974	gold, Green Published			2022-12-26	WOS:000822608900046
J	Alamneh, TS; Teshale, AB; Yeshaw, Y; Alem, AZ; Ayalew, HG; Liyew, AM; Tessema, ZT; Tesema, GA; Worku, MG				Alamneh, Tesfa Sewunet; Teshale, Achamyeleh Birhanu; Yeshaw, Yigizie; Alem, Adugnaw Zeleke; Ayalew, Hiwotie Getaneh; Liyew, Alemneh Mekuriaw; Tessema, Zemenu Tadesse; Tesema, Getayeneh Antehunegn; Worku, Misganaw Gebrie			Barriers for health care access affects maternal continuum of care utilization in Ethiopia; spatial analysis and generalized estimating equation	PLOS ONE			English	Article							3 DELAYS; PAKISTAN; TRENDS	BackgroundAlthough Ethiopia had made a significant change in maternal morbidity and mortality over the past decades, it remains a major public health concern. World Health Organization designed maternal continuum of care to reduce maternal morbidity and mortality. However, majority of the mothers didn't utilize the maternal continuum of care. Therefore, this study aimed to assess the spatial distribution of incomplete utilization of maternal continuum of care and its associated factors in Ethiopia. MethodsThis study was based on 2016 Demographic and Health Survey data of Ethiopia. A total weighted sample of 4,772 reproductive aged women were included. The study used ArcGIS and SaTScan software to explore the spatial distribution of incomplete utilization of maternal continuum of care. Besides, multivariable Generalized Estimating Equation was fitted to identify the associated factors of incomplete utilization of maternal continuum of care using STATA software. Model comparison was made based on Quasi Information Criteria. An adjusted odds ratio with 95% confidence interval of the selected model was reported to identify significantly associated factors of incomplete utilization of maternal continuum of care. ResultsThe spatial analysis revealed that incomplete utilization of maternal continuum of care had significant spatial variation across the country. Primary clusters were detected at Somali, North-Eastern part of Oromia, and East part of Southern Nation Nationalities while secondary clusters were detected in the Central Amhara region. In multivariate GEE, rural residency, secondary education, higher education, Protestant religious follower's, Muslim religious follower's, poorer wealth index, richer wealth index, richest wealth index, currently working, having barriers for accessing health care, and exposure for mass media were significantly associated with incomplete utilization maternal continuum of care. ConclusionIncomplete utilization of maternal continuum of care had significant spatial variations in Ethiopia. Residence, wealth index, education, religion, and barriers for health care access, mass media exposure, and currently working were significantly associated with incomplete utilization of maternal continuum of care. Therefore, public health interventions targeted to enhance maternal service utilization and women empowerment in hotspot areas of incomplete utilization of maternal continuum of care are crucial for reducing maternal morbidity and mortality.	[Alamneh, Tesfa Sewunet; Teshale, Achamyeleh Birhanu; Yeshaw, Yigizie; Alem, Adugnaw Zeleke; Liyew, Alemneh Mekuriaw; Tessema, Zemenu Tadesse; Tesema, Getayeneh Antehunegn] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia; [Yeshaw, Yigizie] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Physiol, Gondar, Ethiopia; [Ayalew, Hiwotie Getaneh] Wollo Univ, Coll Med & Hlth Sci, Sch Nursing & Midwifery, Dept Midwifery, Dessie, Ethiopia; [Worku, Misganaw Gebrie] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Human Anat, Gondar, Ethiopia	University of Gondar; University of Gondar; University of Gondar	Alamneh, TS (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia.	tesfasewunet23@gmail.com	Teshale, Achamyeleh/HHN-8416-2022	Alemneh, Tesfa Sewunet/0000-0002-4830-931X				Adedini SA, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23499; Akinyemi JO, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1083-9; Alkema Leontine, 2016, Lancet, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Amare NS, 2019, BIORXIV; ANSELIN L, 1992, ANN REGIONAL SCI, V26, P19, DOI 10.1007/BF01581478; Assembly, 2015, SDGS TRANSFORM OUR W, DOI DOI 10.1186/S12916-015-0342-3; Atnafu A, 2020, J PREGNANCY, V2020, DOI 10.1155/2020/4318197; Babalola S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-43; Berhan Y, 2014, ETHIOP J HEALTH SCI, V24, P137, DOI 10.4314/ejhs.v24i0.12S; Bhunia G. S., 2018, Journal of the Saudi Society of Agricultural Sciences, V17, P114, DOI 10.1016/j.jssas.2016.02.001; Chaka EE, 2019, INT J PREVENTIVE MED, V10, DOI 10.4103/ijpvm.IJPVM_26_19; Croft TN, 2018, GUIDE DHS STAT; Defar A, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-1079-y; Directorate for Sub-Saharan Africa, 2021, GEN COUNTR OR INF RE; Emiru AA, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-02953-5; Esscher A, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-141; Estimation UNIGfCM, 2017, LEVELS TRENDS CHILD; Haile D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0221670; Hamed A. F., 2018, International Journal of Medical Science and Public Health, V7, P417; Haque A., 2016, INT J BUS SOC SCI, V7, P78; Iqbal S, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2111-9; Joliat GR, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3824-0; Kikuchi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139288; Kulldorff M, 2018, SATSCANTM USER GUIDE; Lipsitz S, 2017, J COMPUT GRAPH STAT, V26, P734, DOI 10.1080/10618600.2017.1321552; Liu X., 2015, APPL ORDINAL LOGISTI; Macro O: Central Statistical Agency, 2006, ETH DEM HLTH SURV 20; Mainuddin Akm, 2015, J Family Reprod Health, V9, P65; McMaughan DJ, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00231; MOH E, 2014, FED DEM REP ETH MIN; Mohan D, 2017, HEALTH POLICY PLANN, V32, P791, DOI 10.1093/heapol/czx005; Muluneh AG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234741; Okwaraji YB, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1161-0; Sakuma S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215635; Saxena D, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.19652; Shah N, 2009, JCPSP-J COLL PHYSICI, V19, P95, DOI 02.2009/JCPSP.9598; Shaikh BT, 2005, J PUBLIC HEALTH-UK, V27, P49, DOI 10.1093/pubmed/fdh207; Shibanuma A, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000786; Singh K, 2016, MATERN CHILD HLTH J, V20, P281, DOI 10.1007/s10995-015-1827-6; Singh R, 2019, J HEALTH POPUL NUTR, V38, DOI 10.1186/s41043-019-0173-5; Tamang TM, 2017, INT POP C; Tamirat KS, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05485-y; Waldhor T, 1996, STAT MED, V15, P887, DOI 10.1002/(SICI)1097-0258(19960415)15:7/9<887::AID-SIM257>3.3.CO;2-5; Wang WJ, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0497-0; WHO, 2019, TRENDS MAT MORT 2000; Wieczorek WF, 2009, WILEY INTERDISCIP RE, V1, P167, DOI 10.1002/wics.21; World Health Organization, 2019, POL BRIEF HLTH RED I; Wulandari RD, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232550; wwwworldometersinfo, ETHIOPIA POPULATION; Yeji F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142849	50	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266490	10.1371/journal.pone.0266490	http://dx.doi.org/10.1371/journal.pone.0266490			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C1KV	35452475	Green Published, gold			2022-12-26	WOS:000792887700040
J	Asante-Afari, K; Doku, DT; Darteh, EKM				Asante-Afari, Kwadwo; Doku, David Teye; Darteh, Eugene K. M.			Transition to motherhood following the use of assisted reproductive technologies: Experiences of women in Ghana	PLOS ONE			English	Article							INFERTILITY; CARE	As a result of the significance of childbearing in the Ghanaian culture, couples would go to all lengths to have biological children. One of the means that has made it possible for childless couples to have children is through the use of various assisted reproductive technologies. Using a qualitative research design, the paper explores the experiences of 40 women who have delivered following the use of assisted reproductive technology in Ghana. A semi-structured interview guide was utilised to explore women's experiences and results were analysed thematically. The study revealed that childless women faced hostile treatment but the birth of a child ceased the hostility, giving couples social recognition. The study also revealed that the transition to motherhood is characterised by excitement, high self-esteem, recognition and acceptance into spouses' families. It was a source of anxiety for other women due to society's perception of children born following the use of assisted reproductive technologies. However, women perceived that having a second or third child could change society's perception about the use of assisted reproductive technologies to have children. Based on these assumptions, there is a need for public education to change the societal perception about women who utilise assisted reproductive technologies to meet their parenthood desires as well as children who are born following the use of assisted reproductive technologies.	[Asante-Afari, Kwadwo] Ghana Hlth Serv, Hlth Promot Div, Accra, Ghana; [Doku, David Teye; Darteh, Eugene K. M.] Univ Cape Coast, Dept Populat & Hlth, Cape Coast, Ghana	Ghana Health Service; University of Cape Coast	Asante-Afari, K (corresponding author), Ghana Hlth Serv, Hlth Promot Div, Accra, Ghana.	akwadwo2003@yahoo.com	Darteh, Eugene Kofuor Maafo/H-1670-2015	Darteh, Eugene Kofuor Maafo/0000-0003-4689-8891				Addai I, 2014, J HAPPINESS STUD, V15, P869, DOI 10.1007/s10902-013-9454-7; Asemota OA, 2015, SEMIN REPROD MED, V33, P17, DOI 10.1055/s-0034-1395274; Bardaweel SK., 2013, BMC COMPLEM ALTERN M, P13, DOI [10.1186/1472-6882-13-13, DOI 10.1186/1472-6882-13-13]; Bharadwaj A, 2003, SOC SCI MED, V56, P1867, DOI 10.1016/S0277-9536(02)00210-1; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Cui Weiyuan, 2010, Bull World Health Organ, V88, P881, DOI 10.2471/BLT.10.011210; Donkor ES, 2008, AFR J NURS MIDWIFERY, V10, P22; Fledderjohann JJ, 2012, HUM REPROD, V27, P1383, DOI 10.1093/humrep/des035; Geelhoed DW, 2002, INT J GYNECOL OBSTET, V79, P137, DOI 10.1016/S0020-7292(02)00237-0; Gerrits T, 1997, PATIENT EDUC COUNS, V31, P39, DOI 10.1016/S0738-3991(97)01018-5; Gerrits Trudie, 2016, Reprod Biomed Soc Online, V2, P32, DOI 10.1016/j.rbms.2016.05.002; Gillet E, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/362518; Greil AL., 2011, J HLTH SOCIAL BEHAV, P52493; Gwandure C, 2012, ANTHROPOLOGIST, V14, P415, DOI 10.1080/09720073.2012.11891264; Hollos M, 2014, HUM FERTIL, V17, P188, DOI 10.3109/14647273.2014.936052; Horbst Viola, 2010, FVV OBGYN MONOGRAPH, P22; Inhorn MC, 2015, HUM REPROD UPDATE, V21, P411, DOI 10.1093/humupd/dmv016; Jones HW, INT FEDERATION FERTI; Klock SC, 2000, FERTIL STERIL, V73, P1159, DOI 10.1016/S0015-0282(00)00530-6; Ludford I, 2012, AUST NZ J OBSTET GYN, V52, P235, DOI 10.1111/j.1479-828X.2012.01442.x; Mascarenhas MN, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001356; Morshed-Behbahani B, 2012, IRAN RED CRESCENT ME, V14, P382; Naab F, 2018, SAJOG-S AFR J OBSTET, V24, P45, DOI 10.7196/sajog.1278; Naab F, 2013, J NURS SCHOLARSHIP, V45, P132, DOI 10.1111/jnu.12013; Nahar P., 2000, REPROD HEALTH MATTER, V33, P44, DOI [10.1016/s0968-8080(00)90004-1, DOI 10.1016/S0968-8080(00)90004-1]; Nahar P, 2010, FVVIN OBGYN, P30; Nahar P, 2012, FV V OBGYN, P28; Nahar Papreen, 2011, Anthropol Med, V18, P327, DOI 10.1080/13648470.2011.615911; Noumi E., 2011, INT J PHARM BIOMEDIC, V2, P42; Ola TM, 2012, INT J SOCIAL SCI HUM, P2; Ombelet V, 2019, FACTS VIEWS VIS OBGY, V11, P65; Ranjbar F, 2020, INT J REPROD BIOMED, V18, P145, DOI 10.18502/ijrm.v18i2.6425; Shaw C, 2008, INT J NURS STUD, V45, P1516, DOI 10.1016/j.ijnurstu.2007.11.005; Slauson-Blevins Kathleen, 2011, SOCIOLOGY DEP FACULT, V234; Soladoye M. O., 2014, Ethnobotany Research and Applications, V12, P81; Sullivan EA, 2010, BIRTH-ISS PERINAT C, V37, P184, DOI 10.1111/j.1523-536X.2010.00405.x; Suwanrath C, 2021, BMC PREGNANCY CHILDB, V21, DOI 10.1186/s12884-020-03525-3; Tabi MM, 2010, INT NURS REV, V57, P121, DOI 10.1111/j.1466-7657.2009.00762.x; Tabong PTN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054429; Talaulikar VS, 2012, OBSTET GYNECOL SURV, V67, P566, DOI 10.1097/OGX.0b013e31826a5d4a; White L, 2006, FERTIL STERIL, V85, P853, DOI 10.1016/j.fertnstert.2005.11.039; Yakass MB, 2016, J BRAS REPROD ASSIST, V20, P132, DOI 10.5935/1518-0557.20160030; Zegers-Hochschild F, 2017, HUM REPROD, V32, P1786, DOI 10.1093/humrep/dex234; Zhao Y., 2013, INT J CLIN MED, V04, P395, DOI [10.4236/ijcm.2013.49071, DOI 10.4236/IJCM.2013.49071]	44	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266721	10.1371/journal.pone.0266721	http://dx.doi.org/10.1371/journal.pone.0266721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1C1KV	35452460	Green Published, gold			2022-12-26	WOS:000792887700017
J	Bizuneh, H; Mohammed, S; Yesuf, A				Bizuneh, Hailemichael; Mohammed, Shikur; Yesuf, Aman			COVID-19 precautionary practices and associated factors among clients visiting a tertiary hospital, Addis Ababa, Ethiopia	PLOS ONE			English	Article								BackgroundDespite efforts to contain the spread of COVID-19, Addis Ababa, the country's COVID-19 epicenter, is experiencing a sharp increase in the number of cases and death rate. While poor public adherence to COVID-19 precautionary practices is evident, factors associated with it are not well studied. We aimed to assess the level of practice of COVID-19 precaution and associated factors. MethodsThis was a hospital-based cross-sectional study conducted from February 1(st) to 15(th), 2021 at Saint Paul's Hospital Millennium Medical College, a tertiary teaching hospital in Addis Ababa, Ethiopia. We used a structured questionnaire to conduct a face-to-face exit interview with clients visiting the hospital. Systematic random sampling was employed to recruit study participants. Binary and multivariable logistic regressions were implemented to examine factors associated with precautionary practices. Statistical significance was declared at p-value <0.05. The Crude odds ratio (COR) and Adjusted odds ratio (AOR) were reported with a 95% confidence interval. ResultsWe analyzed data obtained from 262 participants. The mean age of participants was 36 (SD+12) years. The majority (207, 79%) of the study participants had a favorable attitude towards prevention and control measures of COVID-19. A little over half (116, 55.7%) of the respondents had a satisfactory level of practice of COVID-19 precautions. Living in an area with strict enforcement of COVID-19 precautionary measures [AOR: 2.25, 95% CI (1.22-4.15)], and having a favorable attitude of COVID-19 prevention [AOR: 4.88, 95% CI (2.08-11.68)] were significantly associated with satisfactory COVID-19 precautionary practices. ConclusionsThe level of practice of COVID-19 precaution was unsatisfactory. Favorable attitude and stricter enforcement of COVID-19 preventive measures might have contributed more to adherence to precautionary practices. The findings highlight the need for a public health education strategy targeted at improving attitudes of the community on COVID-19 focusing on the effectiveness of preventive measures.	[Bizuneh, Hailemichael; Mohammed, Shikur; Yesuf, Aman] SaintPauls Hosp Millennium Med Coll, Epidemiol & Biostat Dept, Schoolof Publ Hlth, AddisAbaba, Ethiopia		Bizuneh, H (corresponding author), SaintPauls Hosp Millennium Med Coll, Epidemiol & Biostat Dept, Schoolof Publ Hlth, AddisAbaba, Ethiopia.	hailemichaelbiz@gmail.com	Dadi, Hailemichael Bizuneh/D-4088-2019	Dadi, Hailemichael Bizuneh/0000-0003-0586-7562				Karim SAS, 2021, NEW ENGL J MED, V384, P1866, DOI 10.1056/NEJMc2100362; Azene ZN, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244265; Bekele D, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0234585; Biccard BM, 2021, LANCET, V397, P1885, DOI 10.1016/S0140-6736(21)00441-4; Birhanu Z, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10939-x; Chang CT., 2021, INT J ENV RES PUBLIC, P18, DOI [10.3390/ijerph19010018, DOI 10.3390/IJERPH19010018]; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Duong MC, 2021, J COMMUN HEALTH, V46, P975, DOI 10.1007/s10900-021-00981-6; Fan Y., 2018, BMC INFECT DIS, V18, P1, DOI [10.1186/s12879-017-2892-9, DOI 10.1186/S12879-017-2892-9]; Ferdous MZ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239254; Gebreselassie AF, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247848; Gudina EK, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-046764; Gutu B, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251062; Hills S, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10379-7; Howard J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2014564118; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Jang GJ, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052259; Kebede Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233744; Lee M, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10285-y; Luo Y, 2020, PUBLIC HEALTH, V185, P298, DOI 10.1016/j.puhe.2020.06.057; Lyu W, 2020, HEALTH AFFAIR, V39, P1419, DOI 10.1377/hlthaff.2020.00818; Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181; Sallam M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243264; Suarez-Lledo V, 2021, J MED INTERNET RES, V23, DOI 10.2196/17187; WHO, 2021, INT REC US MOD MRNA, P1; World Health Organization, 2020, SURV TOOL GUID RAP S; World Health Organization, 2021, COVID19 WEEKL EP UPD, P1	27	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267000	10.1371/journal.pone.0267000	http://dx.doi.org/10.1371/journal.pone.0267000			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7MW	35436310	gold, Green Published			2022-12-26	WOS:000791258900019
J	De Lorenzo, R; Sciorati, C; Ramirez, GA; Colombo, B; Lore, NI; Capobianco, A; Tresoldi, C; Cirillo, D; Ciceri, FM; Corti, A; Rovere-Querini, P; Manfredi, A; Grp, ABAFCBSA				De Lorenzo, Rebecca; Sciorati, Clara; Ramirez, Giuseppe A.; Colombo, Barbara; Lore, Nicola I.; Capobianco, Annalisa; Tresoldi, Cristina; Cirillo, Daniela; Ciceri, Fabio M.; Corti, Angelo; Rovere-Querini, Patrizia; Manfredi, Angelo; Bio Angels for COVID-BioB Study Grp, Angelo A.			Chromogranin A plasma levels predict mortality in COVID-19	PLOS ONE			English	Article							CLINICAL-OUTCOMES; PEPTIDES; VASOSTATIN; OMEPRAZOLE; CATESTATIN; ADMISSION; FRAGMENT; CALCIUM; DISEASE	BackgroundChromogranin A (CgA) and its fragment vasostatin I (VS-I) are secreted in the blood by endocrine/neuroendocrine cells and regulate stress responses. Their involvement in Coronavirus 2019 disease (COVID-19) has not been investigated. MethodsCgA and VS-I plasma concentrations were measured at hospital admission from March to May 2020 in 190 patients. 40 age- and sex-matched healthy volunteers served as controls. CgA and VS-I levels relationship with demographics, comorbidities and disease severity was assessed through Mann Whitney U test or Spearman correlation test. Cox regression analysis and Kaplan Meier survival curves were performed to investigate the impact of the CgA and VS-I levels on in-hospital mortality. ResultsMedian CgA and VS-I levels were higher in patients than in healthy controls (CgA: 0.558 nM [interquartile range, IQR 0.358-1.046] vs 0.368 nM [IQR 0.288-0.490] respectively, p = 0.0017; VS-I: 0.357 nM [IQR 0.196-0.465] vs 0.144 nM [0.144-0.156] respectively, p<0.0001). Concentration of CgA, but not of VS-I, significantly increased in patients who died (n = 47) than in survivors (n = 143) (median 0.948 nM [IQR 0.514-1.754] vs 0.507 nM [IQR 0.343-0.785], p = 0.00026). Levels of CgA were independent predictors of in-hospital mortality (hazard ratio 1.28 [95% confidence interval 1.077-1.522], p = 0.005) when adjusted for age, number of comorbidities, respiratory insufficiency degree, C-reactive protein levels and time from symptom onset to sampling. Kaplan Meier curves revealed a significantly increased mortality rate in patients with CgA levels above 0.558 nM (median value, log rank test, p = 0.001). ConclusionPlasma CgA levels increase in COVID-19 patients and represent an early independent predictor of mortality.	[De Lorenzo, Rebecca; Sciorati, Clara; Ramirez, Giuseppe A.; Lore, Nicola I.; Capobianco, Annalisa; Cirillo, Daniela; Rovere-Querini, Patrizia; Manfredi, Angelo] IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, Milan, Italy; [De Lorenzo, Rebecca; Ramirez, Giuseppe A.; Ciceri, Fabio M.; Corti, Angelo; Rovere-Querini, Patrizia; Manfredi, Angelo; Bio Angels for COVID-BioB Study Grp, Angelo A.] Univ Vita Salute San Raffaele, Milan, Italy; [Colombo, Barbara; Corti, Angelo] IRCCS San Raffaele Sci Inst, Div Expt Oncol, Tumor Biol & Vasc Targeting Unit, Milan, Italy; [Lore, Nicola I.; Cirillo, Daniela] IRCCS San Raffaele Sci Inst, Emerging Bacterial Pathogens Unit, Milan, Italy; [Tresoldi, Cristina] IRCCS San Raffaele Sci Inst, Hematol & Bone Marrow Transplant, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Sciorati, C (corresponding author), IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, Milan, Italy.	sciorati.clara@hsr.it	Ramirez, Giuseppe Alvise/K-4923-2018; Manfredi, Angelo A./C-7018-2014; De Lorenzo, Rebecca/GQH-7329-2022	Ramirez, Giuseppe Alvise/0000-0002-2889-366X; Manfredi, Angelo A./0000-0001-8370-6970; Tresoldi, Cristina/0000-0001-7711-5621	Italian Ministero della Salute [COVID-2020-12371617]	Italian Ministero della Salute(Ministry of Health, Italy)	The study was supported by the Italian Ministero della Salute (COVID-2020-12371617) and by COVID-19 donations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARDAL S, 1992, REGUL PEPTIDES, V41, P9, DOI 10.1016/0167-0115(92)90509-S; Ackermann M, 2021, CELL DEATH DIFFER, V28, P3125, DOI 10.1038/s41418-021-00805-z; Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Ahern DJ, 2022, CELL, V185, P916, DOI 10.1016/j.cell.2022.01.012; Al-Musa A, 2022, J ALLERGY CLIN IMMUN, V149, P569, DOI 10.1016/j.jaci.2021.12.775; Anderberg SB, 2021, CYTOKINE, V138, DOI 10.1016/j.cyto.2020.155389; BLASCHKO H, 1967, NATURE, V215, P58, DOI 10.1038/215058a0; Bouton MC, 2012, BLOOD, V119, P2452, DOI 10.1182/blood-2011-10-387464; Castro P, 2022, CARDIOVASC DRUG THER, V36, P547, DOI 10.1007/s10557-021-07207-w; Ciceri F, 2020, CLIN IMMUNOL, V217, DOI 10.1016/j.clim.2020.108509; Corsello A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196858; Corti A, 2018, PFLUG ARCH EUR J PHY, V470, P199, DOI 10.1007/s00424-017-2030-y; Crippa L, 2013, BLOOD, V121, P392, DOI 10.1182/blood-2012-05-430314; Curnis F, 2016, ONCOTARGET, V7, P72716, DOI 10.18632/oncotarget.12237; D'amico MA, 2014, ENDOCR CONNECT, V3, pR45, DOI 10.1530/EC-14-0027; Darnell MER, 2006, TRANSFUSION, V46, P1770, DOI 10.1111/j.1537-2995.2006.00976.x; De Lorenzo R, 2021, J NEUROL, V268, P4436, DOI 10.1007/s00415-021-10595-6; Di Comite G, 2009, J LEUKOCYTE BIOL, V85, P81, DOI 10.1189/jlb.0608358; Dittadi R, 2004, CLIN CHEM LAB MED, V42, P109, DOI 10.1515/CCLM.2004.022; Egger M, 2008, EUR J PHARMACOL, V598, P104, DOI 10.1016/j.ejphar.2008.09.016; Eissa N, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21217976; Farina N, 2020, PHARMACOL RES, V161, DOI 10.1016/j.phrs.2020.105114; Giusti M, 2004, EUR J ENDOCRINOL, V150, P299, DOI 10.1530/eje.0.1500299; Gorog DA, 2022, NAT REV CARDIOL, V19, P475, DOI 10.1038/s41569-021-00665-7; Helle KB, 2007, CELL MOL LIFE SCI, V64, P2863, DOI 10.1007/s00018-007-7254-0; Helle KB, 2018, PFLUG ARCH EUR J PHY, V470, P143, DOI 10.1007/s00424-017-2027-6; Helle KB, 2010, CARDIOVASC RES, V85, P9, DOI 10.1093/cvr/cvp266; Loh YP, 2012, J MOL NEUROSCI, V48, P347, DOI 10.1007/s12031-012-9728-2; Lore NI, 2021, MOL MED, V27, DOI 10.1186/s10020-021-00390-4; Lugardon K, 2000, J BIOL CHEM, V275, P10745, DOI 10.1074/jbc.275.15.10745; Maguire D, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251924; Mahatat SK, 2019, ANN NY ACAD SCI, V1455, P34, DOI 10.1111/nyas.14249; Maugeri N, 2022, J THROMB HAEMOST, V20, P434, DOI 10.1111/jth.15575; Meizlish Matthew L, 2020, medRxiv, DOI 10.1101/2020.06.29.20140376; Mokhtari T, 2020, J MOL HISTOL, V51, P613, DOI 10.1007/s10735-020-09915-3; Muller JA, 2021, NAT METAB, V3, P149, DOI 10.1038/s42255-021-00347-1; OCONNOR DT, 1984, NEW ENGL J MED, V311, P764, DOI 10.1056/NEJM198409203111204; Pieroni M, 2007, EUR HEART J, V28, P1117, DOI 10.1093/eurheartj/ehm022; Polidoro RB, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01626; Ramirez GA, 2022, MINERVA MED, V113, P695, DOI 10.23736/S0026-4806.21.07331-6; Rovere-querini P, 2022, PANMINERVA MED, V64, P244, DOI 10.23736/S0031-0808.20.04168-3; Schneider F, 2012, INTENS CARE MED, V38, P1514, DOI 10.1007/s00134-012-2611-3; Selbonne S, 2012, MOL CELL BIOL, V32, P1496, DOI 10.1128/MCB.06554-11; TAKIYYUDDIN MA, 1991, AM J PHYSIOL, V261, pR939, DOI 10.1152/ajpregu.1991.261.4.R939; Tasiemski A, 2002, BLOOD, V100, P553, DOI 10.1182/blood.V100.2.553; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Theurl M, 2010, CIRC RES, V107, P1326, DOI 10.1161/CIRCRESAHA.110.219493; Tian WJ, 2020, J MED VIROL, V92, P1875, DOI 10.1002/jmv.26050; Tombetti E, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1082-2; Venturini S, 2021, INTERN MED J, V51, P506, DOI 10.1111/imj.15140; Waldum HL, 1996, GUT, V39, P649, DOI 10.1136/gut.39.5.649; Wanhella KJ, 2022, AGEING RES REV, V73, DOI 10.1016/j.arr.2021.101513; Zhang D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004501; Zhang D, 2009, ANN MED, V41, P38, DOI 10.1080/07853890802199791	54	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267235	10.1371/journal.pone.0267235	http://dx.doi.org/10.1371/journal.pone.0267235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D9PO	35468164	gold, Green Published			2022-12-26	WOS:000794129600002
J	Gavaravarapu, SM; Seal, A; Banerjee, P; Reddy, T; Pittla, N				Gavaravarapu, SubbaRao M.; Seal, Ananya; Banerjee, Paromita; Reddy, Thirupathi; Pittla, Naresh			Impact of 'infodemic in pandemic' on food and nutrition related perceptions and practices of Indian internet users	PLOS ONE			English	Article								The uncontrolled spread of (mis)information, news and propaganda related to COVID 19 created an 'infodemic' leading to panic and unscientific practices among the mass. With the largest number of internet users in the world, India has witnessed a steep rise in the number of people seeking information on social media related to COVID-19, which reached a staggering 22.3 million by March, 2020. This study aimed to evaluate the trend of COVID-19 associated food and nutrition news search by Indian internet users between 27(th) January 2020 to 30(th) June 2021 (time period between the first detected COVID-19 case and the end of the second wave in India) and its impact on their perceptions and practices. The association between the change in Relative Search Volume (RSV) on Google Trends (GT) of 34 popularly searched keywords classified by the researchers under 5 different categories-"Immunity", "Eating behavior", "Food safety", "Food scares and concerns" and "Covid scare" showed a steep rise in search for immunity boosters, vitamin supplement brands "ayush kadha (ayurvedic decoction) during the first wave (April- August 2020). With a brief period of decline in the search trend, it again hiked correspondingly with the growing number of positive cases during the second wave in India. An online survey conducted on adult Indian internet users (n = 572) reported high (71.9%) consumption of Vitamin C rich fruits as well as Vitamin C (68.2%) and Zinc (61.4%) supplements to boost immunity. Traditional Indian spices like ginger and garlic were used by 62.9% and 50.9% respondents respectively. Most respondents reported to rely on social media for gathering COVID-19 associated tips for boosting immunity, however those with history of COVID-19 infection reported to rely more on doctors and health professionals for information. This study highlights the need of media and health literacy to advocate for the use of health information cautiously.	[Gavaravarapu, SubbaRao M.; Seal, Ananya; Banerjee, Paromita; Pittla, Naresh] ICMR Natl Inst Nutr, Nutr Informat Commun & Hlth Educ NICHE Div, Hyderabad, Telangana, India; [Reddy, Thirupathi] ICMR Natl Inst Nutr, Biostat Div, Hyderabad, Telangana, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN)	Gavaravarapu, SM (corresponding author), ICMR Natl Inst Nutr, Nutr Informat Commun & Hlth Educ NICHE Div, Hyderabad, Telangana, India.	subbarao.gm@icmr.gov.in		Reddy Mokalla, Thirupathi/0000-0002-6329-7206				Ahmed I, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243706; [Anonymous], 2020, DESK LIFESTYLE; Banerjee S., 2020, ADV RES J MED CLIN S, V6, P207; Ceniti C, 2021, MICROBIOL RES-ITALY, V12, P53, DOI 10.3390/microbiolres12010006; Daikeler J, 2020, J SURV STAT METHODOL, V8, P513, DOI 10.1093/jssam/smz008; Feldmann A., 2021, 15 ITG S, P1; Gavaravarapu SM., 2021, COMMUNICATING COVID, P185; Hamulka J, 2021, NUTRIENTS, V13, DOI 10.3390/nu13010054; Johnson C, 2012, INFORM DIET CASE CON; Johnson J., 2021, GOOGLE SEARCH ENGINE; Kanozia Rubal, MEDIA ASIA, V48, P58, DOI [10.1080/01296612.2021.1881286, DOI 10.1080/01296612.2021.1881286]; KumaraSwamy V., 2020, NEW INDIAN EXPR 0927; Mallica J., 2020, RESIDENTS 72 HOUSES; Mukim M., 2020, INDONES J PHARM CLIN, V3, P18; Muscogiuri G, 2020, EUR J CLIN NUTR, V74, P850, DOI 10.1038/s41430-020-0635-2; Rachul C, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-040989; Rovetta A, 2020, JMIR PUBLIC HLTH SUR, V6, DOI 10.2196/19374; Shih TH, 2009, EDUC RES REV-NETH, V4, P26, DOI 10.1016/j.edurev.2008.01.003; Sukhwani V, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165710; Tangcharoensathien V, 2020, J MED INTERNET RES, V22, DOI 10.2196/19659; Tasnim Samia, 2020, J Prev Med Public Health, V53, P171, DOI 10.3961/jpmph.20.094; UN India Hindi, 2020, UN NATIOOS IND BLOG; Verma R., 2021, ACAD MARKETING STUDI, V25, P1; World Health Organization, INDIA WHO CORONAVIRU; Wright KB, 2005, J COMPUT-MEDIAT COMM, V10; Cuan-Baltazar JY, 2020, JMIR PUBLIC HLTH SUR, V6, P176, DOI 10.2196/18444	26	1	1	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266705	10.1371/journal.pone.0266705	http://dx.doi.org/10.1371/journal.pone.0266705			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446865	Green Published, gold			2022-12-26	WOS:000795468200073
J	Mundagowa, PT; Tozivepi, SN; Chiyaka, ET; Mukora-Mutseyekwa, F; Makurumidze, R				Mundagowa, Paddington Tinashe; Tozivepi, Samantha Nokuthula; Chiyaka, Edward Tafumaneyi; Mukora-Mutseyekwa, Fadzai; Makurumidze, Richard			Assessment of COVID-19 vaccine hesitancy among Zimbabweans: A rapid national survey	PLOS ONE			English	Article							ACCEPTANCE	BackgroundAs a way of minimising the devastating effects of the coronavirus disease 2019 (COVID-19) pandemic, scientists hastily developed a vaccine. However, the scale-up of the vaccine is likely to be hindered by the widespread social media misinformation. We therefore conducted a study to assess the COVID-19 vaccine hesitancy among Zimbabweans. MethodsWe conducted a descriptive online cross-sectional survey using a self-administered questionnaire among adults. The questionnaire assessed willingness to be vaccinated; socio-demographic characteristics, individual attitudes and perceptions, effectiveness and safety of the vaccine. Multivariable logistic regression analysis was utilized to examine the independent factors associated with vaccine uptake. ResultsWe analysed data for 1168 participants, age range of 19-89 years with the majority being females (57.5%). Half (49.9%) of the participants reported that they would accept the COVID-19 vaccine. Majority were uncertain about the effectiveness of the vaccine (76.0%) and its safety (55.0%). About half lacked trust in the government's ability to ensure availability of an effective vaccine and 61.0% mentioned that they would seek advice from a healthcare worker to vaccinate. Chronic disease [vs no chronic disease-Adjusted Odds Ratio (AOR): 1.50, 95% Confidence Interval (CI)I: 1.10-2.03], males [vs females-AOR: 1.83, 95%CI: 1.37-2.44] and being a healthcare worker [vs not being a health worker-AOR: 1.59, 95%CI: 1.18-2.14] were associated with increased likelihood to vaccinate. ConclusionWe found half of the participants willing to vaccinate against COVID-19. The majority lacked trust in the government and were uncertain about vaccine effectiveness and safety. The policy makers should consider targeting geographical and demographic groups which were unlikely to vaccinate with vaccine information, education and communication to improve uptake.	[Mundagowa, Paddington Tinashe; Tozivepi, Samantha Nokuthula; Mukora-Mutseyekwa, Fadzai] Africa Univ, Coll Hlth Agr & Nat Sci, Clin Res Ctr, Mutare, Zimbabwe; [Chiyaka, Edward Tafumaneyi] Kent State Univ, Coll Publ Hlth, Dept Hlth Policy & Management, Kent, OH 44242 USA; [Mukora-Mutseyekwa, Fadzai; Makurumidze, Richard] Zimbabwe Coll Publ Hlth Phys, Harare, Zimbabwe; [Makurumidze, Richard] Univ Zimbabwe, Fac Med & Hlth Sci, Publ & Global Hlth Unit, Harare, Zimbabwe; [Makurumidze, Richard] Inst Trop Med, Clin Sci Dept, Antwerp, Belgium; [Makurumidze, Richard] Free Univ Brussels VUB, Fac Med & Pharm, Gerontol, Brussels, Belgium	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University of Zimbabwe; Institute of Tropical Medicine (ITM); Vrije Universiteit Brussel	Mundagowa, PT (corresponding author), Africa Univ, Coll Hlth Agr & Nat Sci, Clin Res Ctr, Mutare, Zimbabwe.	mundagowap@africau.edu	Makurumidze, Richard/AAC-9621-2021	Makurumidze, Richard/0000-0001-6490-1818; mundagowa, paddington/0000-0002-7788-4874	Africa University, College of Health, Agriculture & Natural Science, Clinical Research Centre	Africa University, College of Health, Agriculture & Natural Science, Clinical Research Centre	The study received funding for ethical approval from the Africa University, College of Health, Agriculture & Natural Science, Clinical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ., 2020, CLIN INFECT DIS, V2, DOI [10.1093/cid/ciaa1846 33315061, DOI 10.1093/CID/CIAA184633315061]; Africa Centres for Disease Control and Prevention London School of Hygiene and Tropical Medicines Vaccine Confidence Project Orb International, 2021, COVID 19 VACC PERC 1, P170; Alqudeimat Y, 2021, MED PRIN PRACT, V30, P262, DOI 10.1159/000514636; Anderson RM, 2020, LANCET, V396, P1614, DOI 10.1016/S0140-6736(20)32318-7; CDC, 2021, COVID 19 VACC PREGN; Chandler RE, 2020, NAT REV IMMUNOL, V20, P451, DOI 10.1038/s41577-020-0372-8; COVID Collaborative, 2020, COR VACC HES BLACK L; Ditekemena JD, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020153; Dula J., 2021, VACCINES-BASEL, V9, P1; Edridge AWD, 2020, NAT MED, V26, P1691, DOI 10.1038/s41591-020-1083-1; El-Elimat T, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250555; Everington K, 2021, TAIWAN NEWS 0111; Ferdinand KC, 2020, J NATL MED ASSOC, V112, P681, DOI 10.1016/j.jnma.2020.11.001; Fisher KA, 2020, ANN INTERN MED, V173, P964, DOI 10.7326/M20-3569; Gayle HD., 2020, FRAMEWORK EQUITABLE; Gur-Arie R, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2020-004877; Halabi S, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2030600; Jahanshahi AA, 2020, BRAIN BEHAV IMMUN, V87, P124, DOI 10.1016/j.bbi.2020.04.081; Jarrett C, 2015, VACCINE, V33, P4180, DOI 10.1016/j.vaccine.2015.04.040; Karombo T., 2017, QUARTZ AFRICA; Khubchandani J, 2021, J COMMUN HEALTH, V46, P270, DOI 10.1007/s10900-020-00958-x; Lee K, 2009, GLOB INST, P1; Letizia AG, 2021, LANCET RESP MED, V9, P712, DOI 10.1016/S2213-2600(21)00158-2; Lin C, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010016; Liu K, 2020, J INFECTION, V80, pE14, DOI 10.1016/j.jinf.2020.03.005; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Malik AA, 2020, ECLINICALMEDICINE, V26, DOI 10.1016/j.eclinm.2020.100495; Mavhunga C., 2021, VOA NEWS 0213; McMahon A, 2020, JMIR PUBLIC HLTH SUR, V6, P279, DOI 10.2196/21168; Ministry of Health and Child Care(MoHCC), 2021, SIT REP COVID 19; MoHCC, 2021, COVID 19 VACC GETS T; Monama T., 2021, 71 S AFRICANS ARE WI; Morgantini Luca A, 2020, medRxiv, DOI 10.1101/2020.05.17.20101915; Mufunda Esther, 2012, Open Nurs J, V6, P117, DOI 10.2174/1874434601206010117; Mukaetova-Ladinska EB, 2021, EUR ARCH PSY CLIN N, V271, P235, DOI 10.1007/s00406-020-01210-2; Mutambudzi M, 2021, OCCUP ENVIRON MED, V78, P307, DOI 10.1136/oemed-2020-106731; NapoleonCat, 2022, FAC US S AFR MAY 202; Pogue K, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8040582; Quinn SC, 2021, AM J PUBLIC HEALTH, V111, P355, DOI 10.2105/AJPH.2020.306036; Shah A, 2020, JAMA-J AM MED ASSOC, V324, P931, DOI 10.1001/jama.2020.15725; Shaw J, 2021, CLIN INFECT DIS, V73, P1776, DOI 10.1093/cid/ciab054; Soares P, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030300; Tillett RL, 2021, LANCET INFECT DIS, V21, P52, DOI 10.1016/S1473-3099(20)30764-7; Tobin EA., 2021, CENT AFR J PUBLIC HL, V5, P1; Topline Research Solutions, 2020, ZIMB OP SURV BEST AS; Wang W, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4704; WHO, 2020, INF MAN INF; Wong LP, 2020, HUM VACC IMMUNOTHER, V16, P2204, DOI 10.1080/21645515.2020.1790279; World Health Organization, 2021, DRAFT LANDSC COVID 1; World Health Organization, 2021, 10 THREATS GLOB HLTH; Worldometer, 2021, ZIMB POP 2021; Zimbabwe National Statistics Agency (Zimstat), 2012, CENS 2012 PREL REP	52	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266724	10.1371/journal.pone.0266724	http://dx.doi.org/10.1371/journal.pone.0266724			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446850	Green Published, gold, Green Submitted			2022-12-26	WOS:000795468200045
J	Sheng, SY; Su, WZ; Mao, DS; Li, CH; Hu, XY; Deng, WY; Yao, Y; Ji, YS				Sheng, Shuyan; Su, Wenzhuo; Mao, Deshen; Li, Conghan; Hu, Xinyang; Deng, Wanyu; Yao, Yong; Ji, Yongsheng			MicroRNA-21 induces cisplatin resistance in head and neck squamous cell carcinoma	PLOS ONE			English	Article							BREAST-CANCER; MIR-21; TARGET; PDCD4; EPIDEMIOLOGY; STATISTICS; ACTIVATION; INVASION; PATHWAY; TONGUE	Drug resistance, either intrinsic or acquired, can impair treatment effects and result in increased cell motility and death. MicroRNA-21 (miR-21), a proto-oncogene, may facilitate the development or maintenance of drug resistance in cancer cells. Restoring drug sensitivity can improve therapeutic strategies, a possibility that requires functional evaluation and mechanistic exploration. For miR-21 detection, matched tissue samples from 30 head and neck squamous cell carcinoma (HNSCC) patients and 8 head and neck cancer (HNC) cell lines were obtained. Reverse transcription-PCR to detect expression, MTT and clonogenic assays to evaluate cell proliferation, apoptosis assays, resazurin cell viability assays, western blot and luciferase reporter assays to detect protein expression, and flow cytometry to analyse the cell cycle were adopted. Compared to the corresponding normal control (NC) tissues, 25 cancer tissues had miR-21 upregulation among the 30 matched pair tissues (25/30, 83.8%); furthermore, among the 8 HNC cell lines, miR-21 expression that was notably upregulated in three: UPCI-4B, UMSCC-1, and UPCI-15B. In both the UMSCC-1 and UPCI-4B cell lines, the miR-21 mimic enhanced cell proliferation with reduced apoptosis and increased viability, whereas the miR-21 inhibitor resulted in the opposite effects (all P<0.001); additionally, miR-21 directly targeted the tumour suppressor phosphatase and tensin homologue (PTEN) and inhibited PTEN expression. Furthermore, the miR-21 mimic induced cisplatin resistance, while the miR-21 inhibitor restored cisplatin sensitivity. Overexpression of miR-21 can enhance cell proliferation, reduce apoptosis, and induce drug resistance by inhibiting PTEN expression. Targeting miR-21 may facilitate cancer diagnosis, restore drug sensitivity, and improve therapeutic effects.	[Sheng, Shuyan; Mao, Deshen; Li, Conghan; Hu, Xinyang; Deng, Wanyu] Anhui Med Univ, Clin Med Coll 1, Hefei, Peoples R China; [Su, Wenzhuo] Anhui Med Univ, Clin Med Coll 2, Hefei, Peoples R China; [Yao, Yong] Anhui Med Univ, Coll Life Sci, Hefei, Peoples R China; [Ji, Yongsheng] Univ Sci & Technol China, Div Life Sci & Med, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Ji, YS (corresponding author), Univ Sci & Technol China, Div Life Sci & Med, Hefei, Anhui, Peoples R China.	jiys2020@ustc.edu.cn		Ji, Yongsheng/0000-0002-3273-5947	National Natural Science Foundation of China [81802026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the National Natural Science Foundation of China (Y Ji, Grant #81802026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bai HT, 2011, FEBS LETT, V585, P402, DOI 10.1016/j.febslet.2010.12.027; Basu A, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/201367; Bhattacharyya T, 2018, WORLD J ONCOL, V9, P39, DOI 10.14740/wjon1105w; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Cancer Genome Atlas Network, 2015, NATURE, V517, P576, DOI DOI 10.1038/NATURE14129; Carissimi C, 2014, BIOCHIMIE, V107, P319, DOI 10.1016/j.biochi.2014.09.021; Costa PM, 2013, HUM MOL GENET, V22, P904, DOI 10.1093/hmg/dds496; Cramm M, 2016, MOL NEUROBIOL, V53, P1896, DOI 10.1007/s12035-015-9133-2; Curado MP, 2009, CURR OPIN ONCOL, V21, P194, DOI 10.1097/CCO.0b013e32832a68ca; Du J, 2009, CELL RES, V19, P487, DOI 10.1038/cr.2009.34; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gaur AB, 2011, NEURO-ONCOLOGY, V13, P580, DOI 10.1093/neuonc/nor033; Gong C, 2011, J BIOL CHEM, V286, P19127, DOI 10.1074/jbc.M110.216887; Hopkins BD, 2014, TRENDS BIOCHEM SCI, V39, P183, DOI 10.1016/j.tibs.2014.02.006; Huang Y, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0376-8; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; John K, 2013, INT J DENT, V2013, DOI 10.1155/2013/650218; Jung HM, 2012, J BIOL CHEM, V287, P29261, DOI 10.1074/jbc.M112.366518; Kawakita A, 2014, PATHOL ONCOL RES, V20, P253, DOI 10.1007/s12253-013-9689-y; Kumarswamy R, 2011, RNA BIOL, V8, P706, DOI 10.4161/rna.8.5.16154; Lee S, 2005, GYNECOL ONCOL, V97, P26, DOI 10.1016/j.ygyno.2004.11.051; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Li Y, 2009, BRAIN RES, V1286, P13, DOI 10.1016/j.brainres.2009.06.053; Mydlarz W, 2014, CLIN CANCER RES, V20, P868, DOI 10.1158/1078-0432.CCR-13-2675; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Pozarowski Piotr, 2004, Methods Mol Biol, V281, P301; Sankaranarayanan R, 1998, ANTICANCER RES, V18, P4779; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Sen M, 2015, NEOPLASIA, V17, P256, DOI 10.1016/j.neo.2015.01.003; Shiboski CH, 2005, CANCER-AM CANCER SOC, V103, P1843, DOI 10.1002/cncr.20998; Siegel Rebecca L, 2019, CA Cancer J Clin, V69, P7, DOI 10.3322/caac.21551; Taheri M, 2021, EXP MOL PATHOL, V123, DOI 10.1016/j.yexmp.2021.104602; Tao Ye, 2021, Cell Death Discov, V7, P144, DOI 10.1038/s41420-021-00529-6; Tao Y, 2018, CLIN CANCER RES, V24, P2225, DOI 10.1158/1078-0432.CCR-17-1904; Tao Y, 2018, INT J CANCER, V143, P1327, DOI 10.1002/ijc.31530; Toiyama Y, 2013, JNCI-J NATL CANCER I, V105, P849, DOI 10.1093/jnci/djt101; Vigneswaran N, 2014, ORAL MAXIL SURG CLIN, V26, P123, DOI 10.1016/j.coms.2014.01.001; Wang ZX, 2011, ARCH MED RES, V42, P281, DOI 10.1016/j.arcmed.2011.06.008; Wang Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115855; Zhang LY, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4965-6; Zheng J, 2011, J CELL BIOCHEM, V112, P872, DOI 10.1002/jcb.22995	45	2	2	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267017	10.1371/journal.pone.0267017	http://dx.doi.org/10.1371/journal.pone.0267017			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421166	Green Published, gold			2022-12-26	WOS:000795453600094
J	Shiraishi, K; Chiba, K; Watanabe, K; Oki, N; Iwamoto, N; Amano, S; Yonekura, A; Tomita, M; Uetani, M; Kawakami, A; Osaki, M				Shiraishi, Kazuteru; Chiba, Ko; Watanabe, Kounosuke; Oki, Nozomi; Iwamoto, Naoki; Amano, Shoken; Yonekura, Akihiko; Tomita, Masato; Uetani, Masataka; Kawakami, Atsushi; Osaki, Makoto			Analysis of bone erosions in rheumatoid arthritis using HR-pQCT: Development of a measurement algorithm and assessment of longitudinal changes	PLOS ONE			English	Article							QUANTITATIVE COMPUTED-TOMOGRAPHY; METACARPOPHALANGEAL JOINTS; DENSITY; REPAIR	PurposeThe purpose of this study was to establish an algorithm for measuring bone erosions at metacarpophalangeal (MCP) joints using high-resolution peripheral quantitative computed tomography (HR-pQCT), to investigate the precision of measurements, and to assess longitudinal changes in bone erosions among patients with rheumatoid arthritis (RA). MethodsThe 2nd and 3rd MCP joints were scanned at a voxel size of 60.7 mu m using second-generation HR-pQCT. Bone erosions on MCP joints were identified using a semi-automated algorithm we developed, and each erosion parameter was measured. Measurement reproducibility was evaluated in 19 healthy subjects using intraclass correlation coefficients (ICCs) and root mean square percent coefficient of variance (RMS%CV). Finally, longitudinal changes in bone erosions over a period of 12 months were assessed in 26 patients with RA based on the calculated least significant change (LSC). ResultsReproducibilities for measurement parameters regarding bone erosions with our algorithm were good (all ICCs >= 0.98; all RMS%CVs < 5%). No erosion parameters showed significant changes after 12 months of treatment in terms of median values in all erosions, while both progression and repair of erosions were observed individually (e.g., erosion volume: progression, 26% (+0.62 mm(3)); repair, 34% (-0.85 mm(3)); no change, 40%). ConclusionsThe measurement algorithm developed for bone erosions at MCP joints showed good reproducibility. Both progression and repair of bone erosions were observed in patients with RA even after 12 months of appropriate treatment. Our algorithm may be useful to investigate the etiology of RA and assess drug efficacy.	[Shiraishi, Kazuteru; Chiba, Ko; Watanabe, Kounosuke; Amano, Shoken; Yonekura, Akihiko; Tomita, Masato; Osaki, Makoto] Nagasaki Univ, Dept Orthoped Surg, Grad Sch Biomed Sci, Nagasaki, Japan; [Oki, Nozomi; Uetani, Masataka] Nagasaki Univ, Dept Radiol Sci, Grad Sch Biomed Sci, Nagasaki, Japan; [Iwamoto, Naoki; Kawakami, Atsushi] Nagasaki Univ, Dept Immunol & Rheumatol, Div Adv Prevent Med Sci, Grad Sch Biomed Sci, Nagasaki, Japan	Nagasaki University; Nagasaki University; Nagasaki University	Chiba, K (corresponding author), Nagasaki Univ, Dept Orthoped Surg, Grad Sch Biomed Sci, Nagasaki, Japan.	kohchiba@estate.ocn.ne.jp		Chiba, Ko/0000-0003-2285-5264				Baillet A, 2011, RHEUMATOLOGY, V50, P1137, DOI 10.1093/rheumatology/keq437; Barnabe C, 2016, J RHEUMATOL, V43, P1935, DOI 10.3899/jrheum.160648; Barnabe C, 2012, J RHEUMATOL, V39, P1494, DOI 10.3899/jrheum.120218; Berlin A, 2019, OSTEOARTHR CARTILAGE, V27, P1043, DOI 10.1016/j.joca.2019.01.019; Burghardt AJ, 2011, CLIN ORTHOP RELAT R, V469, P2179, DOI 10.1007/s11999-010-1766-x; Combe B, 2001, ARTHRITIS RHEUM, V44, P1736, DOI 10.1002/1529-0131(200108)44:8<1736::AID-ART308>3.0.CO;2-I; Combe Bernard, 2009, Best Pract Res Clin Rheumatol, V23, P59, DOI 10.1016/j.berh.2008.11.006; Finzel S, 2019, ANN RHEUM DIS, V78, P1186, DOI 10.1136/annrheumdis-2018-214894; Finzel S, 2013, ANN RHEUM DIS, V72, P396, DOI 10.1136/annrheumdis-2011-201075; Finzel S, 2011, ANN RHEUM DIS, V70, P1587, DOI 10.1136/ard.2010.148395; Fouque-Aubert A, 2010, ANN RHEUM DIS, V69, P1671, DOI 10.1136/ard.2009.114512; Gluer CC, 1999, J BONE MINER RES, V14, P1952, DOI 10.1359/jbmr.1999.14.11.1952; GLUER CC, 1995, OSTEOPOROSIS INT, V5, P262, DOI 10.1007/BF01774016; Hecht C, 2015, ANN RHEUM DIS, V74, P2151, DOI 10.1136/annrheumdis-2014-205428; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Lee CH, 2015, INT J RHEUM DIS, V18, P628, DOI 10.1111/1756-185X.12495; Lespessailles E, 2018, JOINT BONE SPINE, V85, P301, DOI 10.1016/j.jbspin.2017.04.012; Lespessailles E, 2016, BONEKEY REP, V5, DOI 10.1038/bonekey.2016.59; Nishiyama KK, 2013, CURR OSTEOPOROS REP, V11, P147, DOI 10.1007/s11914-013-0142-7; Peters M, 2019, CALCIFIED TISSUE INT, V104, P571, DOI 10.1007/s00223-019-00523-2; Peters M, 2018, BMC MED IMAGING, V18, DOI 10.1186/s12880-018-0255-7; Pialat JB, 2012, BONE, V50, P111, DOI 10.1016/j.bone.2011.10.003; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Shimizu T, 2019, J RHEUMATOL, V46, P676, DOI 10.3899/jrheum.180496; Shimizu T, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1430-x; Smolen JS, 2016, LANCET, V388, P2023, DOI 10.1016/S0140-6736(16)30173-8; Stach CM, 2010, ARTHRITIS RHEUM-US, V62, P330, DOI 10.1002/art.27252; Topfer D, 2015, RHEUMATOLOGY, V54, P2171, DOI 10.1093/rheumatology/kev256; Topfer D, 2014, RHEUMATOLOGY, V53, P65, DOI 10.1093/rheumatology/ket259; Yue J, 2019, INT J RHEUM DIS, V22, P1724, DOI 10.1111/1756-185X.13644; Yue J, 2018, SEMIN ARTHRITIS RHEU, V48, P374, DOI 10.1016/j.semarthrit.2018.05.001; Yue J, 2017, ARTHRIT CARE RES, V69, P1156, DOI 10.1002/acr.23133	32	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0265833	10.1371/journal.pone.0265833	http://dx.doi.org/10.1371/journal.pone.0265833			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35472146	gold, Green Published			2022-12-26	WOS:000816171900007
J	Stamp, E; Clarke, G; Wright, P; Velikova, G; Crossfield, SSR; Zucker, K; McInerney, C; Bojke, C; Martin, A; Baxter, P; Woroncow, B; Wilson, D; Warrington, L; Absolom, K; Burke, D; Stables, GI; Mitra, A; Hutson, R; Glaser, AW; Hall, G				Stamp, Elizabeth; Clarke, Gemma; Wright, Penny; Velikova, Galina; Crossfield, Samantha S. R.; Zucker, Kieran; McInerney, Ciaran; Bojke, Chris; Martin, Adam; Baxter, Paul; Woroncow, Barbara; Wilson, David; Warrington, Lorraine; Absolom, Kate; Burke, Dermot; Stables, Graeme, I; Mitra, Angana; Hutson, Richard; Glaser, Adam W.; Hall, Geoff			Collection of cancer Patient Reported Outcome Measures (PROMS) to link with primary and secondary electronic care records to understand and improve long term cancer outcomes: A protocol paper	PLOS ONE			English	Article							QUALITY-OF-LIFE; OVARIAN-CANCER; COLORECTAL-CANCER; PHYSICAL-ACTIVITY; UTILITY SCORES; SURVIVORS; BREAST; HEALTH; BARRIERS; QUESTIONNAIRE	IntroductionMore people are living with and beyond a cancer diagnosis. There is limited understanding of the long-term effects of cancer and cancer treatment on quality of life and personal and household finances when compared to people without cancer. In a separate protocol we have proposed to link de-identified data from electronic primary care and hospital records for a large population of cancer survivors and matched controls. In this current protocol, we propose the linkage of Patient Reported Outcomes Measures data to the above data for a subset of this population. The aim of this study is to investigate the full impact of living with and beyond a cancer diagnosis compared to age and gender matched controls. A secondary aim is to test the feasibility of the collection of Patient Reported Outcomes Measures (PROMS) data and the linkage procedures of the PROMs data to electronic health records data. Materials and methodsThis is a cross-sectional study, aiming to recruit participants treated at the Leeds Teaching Hospitals National Health Service Trust. Eligible patients will be cancer survivors at around 5 years post-diagnosis (breast, colorectal and ovarian cancer) and non-cancer patient matched controls attending dermatology out-patient clinics. They will be identified by running a query on the Leeds Teaching Hospitals Trust patient records system. Approximately 6000 patients (2000 cases and 4000 controls) will be invited to participate via post. Participants will be invited to complete PROMs assessing factors such as quality of life and finances, which can be completed on paper or online (surveys includes established instruments, and bespoke instruments (demographics, financial costs). This PROMs data will then be linked to routinely collected de-identified data from patient's electronic primary care and hospital records. DiscussionThis innovative work aims to create a truly 'comprehensive patient record' to provide a broad picture of what happens to cancer patients across their cancer pathway, and the long-term impact of cancer treatment. Comparisons can be made between the cases and controls, to identify the aspects of life that has had the greatest impact following a cancer diagnosis. The feasibility of linking PROMs data to electronic health records can also be assessed. This work can inform future support offered to people living with and beyond a cancer diagnosis, clinical practice, and future research methodologies.	[Stamp, Elizabeth; Clarke, Gemma; Wright, Penny; Velikova, Galina; Zucker, Kieran; Woroncow, Barbara; Wilson, David; Warrington, Lorraine; Absolom, Kate; Glaser, Adam W.; Hall, Geoff] Univ Leeds, Leeds Inst Med Res St Jamess, Leeds, W Yorkshire, England; [Stamp, Elizabeth] Loughborough Univ, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England; [Clarke, Gemma] Univ Leeds, Acad Unit Palliat Care, Sch Med, Leeds, W Yorkshire, England; [Crossfield, Samantha S. R.] Univ Leeds, Leeds Inst Data Analyt, Leeds, W Yorkshire, England; [McInerney, Ciaran] Univ Leeds, Sch Comp, Leeds, W Yorkshire, England; [Bojke, Chris; Martin, Adam] Univ Leeds, Acad Unit Hlth Econ, Sch Med, Leeds, W Yorkshire, England; [Baxter, Paul] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, England; [Burke, Dermot; Stables, Graeme, I; Mitra, Angana; Hutson, Richard; Glaser, Adam W.; Hall, Geoff] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England	University of Leeds; Loughborough University; University of Leeds; University of Leeds; University of Leeds; University of Leeds; University of Leeds; University of Leeds	Stamp, E (corresponding author), Univ Leeds, Leeds Inst Med Res St Jamess, Leeds, W Yorkshire, England.; Stamp, E (corresponding author), Loughborough Univ, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England.	e.stamp@lboro.ac.uk		Martin, Adam/0000-0002-2559-6483; Baxter, Paul/0000-0003-2699-3103; McInerney, Ciaran D./0000-0001-7620-7110; Crossfield, Samantha/0000-0001-7337-3527; Clarke, Gemma/0000-0001-8438-7131; Burke, Dermot/0000-0002-4342-7464	Macmillan Cancer Support [4757730]	Macmillan Cancer Support	GH and AG are the Principal Investigators and received the funding for this study. This research is funded by Macmillan Cancer Support (URL: https://www.macmillan.org.uk/) (Grant number: 4757730). The funders had no role in study design, decision to publish, or preparation of the manuscript.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Ahmed-Lecheheb D, 2016, J CANCER SURVIV, V10, P789, DOI 10.1007/s11764-016-0525-8; Akbari Kamrani AA, 2014, IRAN J PUBLIC HEALTH, V43, P362; Arndt V, 2005, J CLIN ONCOL, V23, P4945, DOI 10.1200/JCO.2005.03.475; Ashley L, 2011, BRIT J CANCER, V105, pS74, DOI 10.1038/bjc.2011.424; Avis NE, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-92; Avis NE, 2005, QUAL LIFE RES, V14, P1007, DOI 10.1007/s11136-004-2147-2; Basch E, 2006, LANCET ONCOL, V7, P903, DOI 10.1016/S1470-2045(06)70910-X; Basch E, 2009, JNCI-J NATL CANCER I, V101, P1624, DOI 10.1093/jnci/djp386; Bellizzi Keith M, 2007, J Cancer Surviv, V1, P44, DOI 10.1007/s11764-007-0005-2; Black N, 2013, BMJ-BRIT MED J, V346, pf167, DOI [DOI 10.1136/BMJ.F167, 10.1136/bmj.f167]; Enriquez-Reyna MC, 2017, REV LAT-AM ENFERM, V25, DOI 10.1590/1518-8345.1566.2902; Crossfield SSR, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0262609; Dawson J, 2010, BMJ-BRIT MED J, V340, pc186, DOI DOI 10.1136/BMJ.C186; Deimling GT, 2007, CANCER INVEST, V25, P758, DOI 10.1080/07357900600896323; Department of Health, 2019, NHS LONG TERM PLAN; DH, 2010, EQ EXC LIB NHS; DoH, 2013, LIV CANC TAK ACT IMP; DoH Macmillan, 2010, NAT CANC SURV IN VIS; Donnelly DW, 2018, BJU INT, V122, P845, DOI 10.1111/bju.14182; Downing A, 2019, LANCET ONCOL, V20, P436, DOI 10.1016/S1470-2045(18)30780-0; Downing A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013555; Downing A, 2015, J CLIN ONCOL, V33, P616, DOI 10.1200/JCO.2014.56.6539; Farkkila N, 2013, COLORECTAL DIS, V15, pE215, DOI 10.1111/codi.12143; Friedlander M, 2018, ANN ONCOL, V29, P737, DOI 10.1093/annonc/mdx796; Glaser AW, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002317; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Grace SL, 2008, EUR J CARDIOV PREV R, V15, P548, DOI 10.1097/HJR.0b013e328305df05; Harrison SE, 2011, J CLIN ONCOL, V29, P2091, DOI 10.1200/JCO.2010.32.5167; Hippisley-Cox J., 2017, OPEN PSEUDONYMISER 2; Hsu T, 2013, J CLIN ONCOL, V31, P3540, DOI 10.1200/JCO.2012.48.1903; Independent Cancer Taskforce, 2015, ACH WORLD CLASS CANC; International Organization for Standardization, 2017, 252372017 ISO; Jansen L, 2011, J CLIN ONCOL, V29, P3263, DOI 10.1200/JCO.2010.31.4013; Jefford M, 2013, BRIT J CANCER, V108, P14, DOI 10.1038/bjc.2012.554; Kerleau C, 2016, EUR J CANCER, V63, P143, DOI 10.1016/j.ejca.2016.05.020; Khan NF, 2011, BRIT J CANCER, V105, pS29, DOI 10.1038/bjc.2011.420; Kim SH, 2012, SUPPORT CARE CANCER, V20, P3155, DOI 10.1007/s00520-012-1457-0; Kim SH, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0399-x; Klein D, 2011, BREAST CANCER RES TR, V129, P125, DOI 10.1007/s10549-011-1408-3; Koch L, 2013, ACTA ONCOL, V52, P1119, DOI 10.3109/0284186X.2013.774461; Liu RDK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-30; Lutgendorf SK, 2017, GYNECOL ONCOL, V146, P101, DOI 10.1016/j.ygyno.2017.05.008; Macmillan, 2018, CANC VOIC; Macmillan, 2015, BURD CANC OTH LONG T; Macmillan, 2011, LIV DIAGN MED CANC S; Macmillan, 2013, THROW LIGHT CONS CAN; Macmillan, 2019, STAT FACTSH; Marti J, 2016, PSYCHO-ONCOLOGY, V25, P77, DOI 10.1002/pon.3877; Martin A, 2017, BREAST CARE, V12, P78, DOI 10.1159/000475656; Meeske K, 2007, QUAL LIFE RES, V16, P947, DOI 10.1007/s11136-007-9215-3; Mols F, 2005, EUR J CANCER, V41, P2613, DOI 10.1016/j.ejca.2005.05.017; Montemurro F, 2016, JAMA ONCOL, V2, P445, DOI 10.1001/jamaoncol.2015.4720; Naik H, 2017, PATIENT, V10, P105, DOI 10.1007/s40271-016-0190-z; National Cancer Institute, 2021, US; National Institute for Health and Care Excellence, 2013, GUID METH TECHN APPR; Ney M, 2017, SAUDI J GASTROENTERO, V23, P97, DOI 10.4103/1319-3767.203357; Park CL, 2009, J GEN INTERN MED, V24, P430, DOI 10.1007/s11606-009-0993-x; Pearce NJM, 2008, PSYCHO-ONCOLOGY, V17, P629, DOI 10.1002/pon.1281; Pickard AS, 2012, VALUE HEALTH, V15, P305, DOI 10.1016/j.jval.2011.11.029; Richards M, 2011, BRIT J CANCER, V105, pS1, DOI 10.1038/bjc.2011.416; Roland KB, 2013, PSYCHO-ONCOLOGY, V22, P2408, DOI 10.1002/pon.3322; SECHRIST KR, 1987, RES NURS HEALTH, V10, P357, DOI 10.1002/nur.4770100603; Sjors C, 2014, INTERACT J MED RES, V3, P2, DOI 10.2196/ijmr.3191; Stamp E, 2019, PSYCHO-ONCOLOGY, V28, P22; Stroud N, 2009, DISABIL REHABIL, V31, P2216, DOI 10.3109/09638280902980928; Su CC, 2014, J CANCER SURVIV, V8, P205, DOI 10.1007/s11764-013-0325-3; Szende A, 2014, SELF REPORTED POPULA, DOI DOI 10.1007/978-94-007-7596-1; TPP, 2018, RESEARCHONE; TPP, 2013, 20 TPP; Tritter JQ, 2002, EUR J CANCER CARE, V11, P161, DOI 10.1046/j.1365-2354.2002.00345.x; University of Leeds, COMPR PAT REC CANC O; UseMYData, 2018, USE MY DAT MOV PAT R; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Young JM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-298	75	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266804	10.1371/journal.pone.0266804	http://dx.doi.org/10.1371/journal.pone.0266804			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1E2NP	35427401	Green Published, Green Accepted, gold			2022-12-26	WOS:000794332400020
J	Whitbourne, SB; Nguyen, XMT; Song, RJ; Lord, E; Lyden, M; Harrington, KM; Ward, R; Li, YP; Brewer, JVV; Cho, KM; Djousse, L; Muralidhar, S; Tsao, PS; Gaziano, JM; Casas, JP				Whitbourne, Stacey B.; Nguyen, Xuan-Mai T.; Song, Rebecca J.; Lord, Emily; Lyden, Michelle; Harrington, Kelly M.; Ward, Rachel; Li, Yanping; Brewer, Jessica V. V.; Cho, Kelly M.; Djousse, Luc; Muralidhar, Sumitra; Tsao, Philip S.; Gaziano, J. Michael; Casas, Juan P.		MVP COVID-19 Sci Program	Million Veteran Program's response to COVID-19: Survey development and preliminary findings	PLOS ONE			English	Article							HEALTH	BackgroundIn response to the novel Coronavirus Disease 2019 (COVID-19) pandemic, the Department of Veterans Affairs (VA) Million Veteran Program (MVP) organized efforts to better understand the impact of COVID-19 on Veterans by developing and deploying a self-reported survey. MethodsThe MVP COVID-19 Survey was developed to collect COVID-19 specific elements including symptoms, diagnosis, hospitalization, behavioral and psychosocial factors and to augment existing MVP data with longitudinal collection of key domains in physical and mental health. Due to the rapidly evolving nature of the pandemic, a multipronged strategy was implemented to widely disseminate the COVID-19 Survey and capture data using both the online platform and mailings. ResultsWe limited the findings of this paper to the initial phase of survey dissemination which began in May 2020. A total of 729,625 eligible MVP Veterans were invited to complete version 1 of the COVID-19 Survey. As of October 31, 2020, 58,159 surveys have been returned. The mean and standard deviation (SD) age of responders was 71 (11) years, 8.6% were female, 8.2% were Black, 5.6% were Hispanic, and 446 (0.8%) self-reported a COVID-19 diagnosis. Over 90% of responders reported wearing masks, practicing social distancing, and frequent hand washing. ConclusionThe MVP COVID-19 Survey provides a systematic collection of data regarding COVID-19 behaviors among Veterans and represents one of the first large-scale, national surveillance efforts of COVID-19 in the Veteran population. Continued work will examine the overall response to the survey with comparison to available VA health record data.	[Whitbourne, Stacey B.; Nguyen, Xuan-Mai T.; Song, Rebecca J.; Lord, Emily; Lyden, Michelle; Harrington, Kelly M.; Ward, Rachel; Li, Yanping; Brewer, Jessica V. V.; Cho, Kelly M.; Djousse, Luc; Gaziano, J. Michael; Casas, Juan P.] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr Ma, Boston, MA 02130 USA; [Whitbourne, Stacey B.; Cho, Kelly M.; Djousse, Luc; Gaziano, J. Michael; Casas, Juan P.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Whitbourne, Stacey B.; Cho, Kelly M.; Djousse, Luc; Gaziano, J. Michael; Casas, Juan P.] Brigham & Womens Hosp, Dept Med, Div Aging, 75 Francis St, Boston, MA 02115 USA; [Nguyen, Xuan-Mai T.] Univ Illinois, Carle Illinois Coll Med, Champaign, IL 61820 USA; [Song, Rebecca J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Harrington, Kelly M.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Ward, Rachel; Djousse, Luc] VA Boston Healthcare Syst, New England Geriatr Res Educ & Clin Ctr GRECC, Boston, MA USA; [Ward, Rachel] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Muralidhar, Sumitra] Vet Hlth Adm, Off Res & Dev, Washington, DC USA; [Tsao, Philip S.] VA Palo Alto Hlth Care Syst, VA Palo Alto Epidemiol Res & Informat Ctr Genom, Palo Alto, CA USA; [Tsao, Philip S.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Tsao, Philip S.] Stanford Univ, Stanford Cardiovasc Inst, Sch Med, Stanford, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Illinois System; University of Illinois Urbana-Champaign; Boston University; Boston University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University	Whitbourne, SB (corresponding author), VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr Ma, Boston, MA 02130 USA.; Whitbourne, SB (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Whitbourne, SB (corresponding author), Brigham & Womens Hosp, Dept Med, Div Aging, 75 Francis St, Boston, MA 02115 USA.	Stacey.whitbourne@va.gov	li, yan/GTI-4638-2022	, Stacey/0000-0002-3472-3464	Million Veteran Program, Office of Research and Development, Veterans Health Administration [MVP000, MVP035]	Million Veteran Program, Office of Research and Development, Veterans Health Administration	This research is based on data from the Million Veteran Program, Office of Research and Development, Veterans Health Administration, and was funded by awards #MVP000 and MVP035. None of the authors have financial conflicts of interest with the work reported in this manuscript. This publication does not represent the views of the Department of Veterans Affairs or the United States Government.	[Anonymous], 2020, WHO COR DIS COVID 19; [Anonymous], 2020, NIH PUBL HLTH EM DIS; [Anonymous], 2014, CORP DAT WAR CDW; Benight CC, 2002, J TRAUMA STRESS, V15, P177, DOI 10.1023/A:1015295025950; Boni MF, 2020, NAT MICROBIOL, V5, P1408, DOI 10.1038/s41564-020-0771-4; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Chan AT, 2020, CANCER EPIDEM BIOMAR, V29, P1283, DOI 10.1158/1055-9965.EPI-20-0606; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Czeisler ME, 2020, MMWR-MORBID MORTAL W, V69, P751, DOI 10.15585/mmwr.mm6924e1; Davis JP, 2021, ADDICT BEHAV, V122, DOI 10.1016/j.addbeh.2021.107052; DiClemente RJ, 2022, J PUBLIC HEALTH-HEID, V30, P2069, DOI 10.1007/s10389-021-01564-4; Domingo JL, 2021, ENVIRON RES, V200, DOI 10.1016/j.envres.2021.111785; Eastman M., 2020, INNOV AGING, V4, P934, DOI [10.1093/geroni/igaa057.3422, DOI 10.1093/GERONI/IGAA057.3422]; Fatollahi JJ, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph182211923; Fisher KA., 2020, FACTORS ASS CLOTH FA; Gaziano JM, 2016, J CLIN EPIDEMIOL, V70, P214, DOI 10.1016/j.jclinepi.2015.09.016; Grasso DJ., 2020, EPIDEMIC PANDEMIC IM; Harrington KM, 2019, WOMEN HEALTH ISS, V29, pS56, DOI 10.1016/j.whi.2019.04.012; Knell G, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176268; Kopel J, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00418; Lewnard JA, 2020, LANCET INFECT DIS, V20, P631, DOI 10.1016/S1473-3099(20)30190-0; Lowe B, 2010, J AFFECT DISORDERS, V122, P86, DOI 10.1016/j.jad.2009.06.019; Makarenkov V, 2021, BMC ECOL EVOL, V21, DOI 10.1186/s12862-020-01732-2; National Center for Health Statistics, 2020, NAT HLTH INT SURV; Nguyen Xuan-Mai T, 2018, J Health Res Rev Dev Ctries, V5, P98; Okten IO., 2020, GENDER DIFFERENCES P; Song RJ, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251651; Wang Y, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002794; Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598; Wolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	31	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266381	10.1371/journal.pone.0266381	http://dx.doi.org/10.1371/journal.pone.0266381			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1D9PO	35468170	gold, Green Published			2022-12-26	WOS:000794129600009
J	Zhang, HP; Wang, JF; Yu, TY; Wang, JM; Lu, J; Yu, ZY				Zhang, Heping; Wang, Jingfang; Yu, Taoyuan; Wang, Jingmin; Lu, Jun; Yu, Zongyang			Silencing LncRNA CASC9 inhibits proliferation and invasion of colorectal cancer cells by MiR-542-3p/ILK	PLOS ONE			English	Article							LONG NONCODING RNA; LINKED KINASE ILK; MIGRATION; GROWTH	Colorectal cancer (CRC) ranks the third in cancers and the second in the reasons of cancer-related death. More evidence indicates that long non-coding RNA participates in tumor initiation and progression. It's known that cancer susceptibility candidate 9 is an oncogenic long non-coding RNA in CRC. miR-542-3p is a negative regulator of CRC, while integrin-linked kinase could contribute to tumor progression and chemoresistance. However, the correlation among long non-coding RNA cancer susceptibility candidate 9, miR-542-3p and integrin-linked kinase in CRC is still unclear. We demonstrated long non-coding RNA cancer susceptibility candidate 9 in CRC specimens and cell lines overexpressed via real-time quantitative polymerase chain reaction. Once long non-coding RNA cancer susceptibility candidate 9 was knocked down, it significantly inhibited proliferation, invasion, and migration of CRC cells in real-time quantitative polymerase chain reaction, cell counting kit-8, 5-ethynyl-2'-deoxyuridine, and transwell assays, which also was validated in vivo. Long non-coding RNA cancer susceptibility candidate 9 negatively regulates miR-542-3p in a targeted manner, and the function of up-regulated miR-542-3p was confirmed similarly. While miR-542-3p negatively regulates integrin-linked kinase. Thus, we further verified that overexpression of integrin-linked kinase on down-regulated long non-coding RNA cancer susceptibility candidate 9 or up-regulated miR-542-3p significantly restored CRC cell proliferation via bioinformatic analysis, dual-luciferase report assay, real-time quantitative polymerase chain reaction, RNA immunoprecipitation, and western blot. This study testified that silencing long non-coding RNA cancer susceptibility candidate 9 could inhibit proliferation and invasion of CRC cells by miR-542-3p/integrin-linked kinase.	[Zhang, Heping] Peoples Hosp Jiaozuo, Dept Anorectal, Jiaozuo, Henan, Peoples R China; [Wang, Jingfang] Fujian Univ Tradit Chinese Med, Med Coll Rehabil, Fuzhou, Fujian, Peoples R China; [Yu, Taoyuan] Beijing Univ Chem Technol, Inst Int Educ, Beijing, Peoples R China; [Wang, Jingmin] Peoples Hosp Jiaozuo, Infertil Clin, Jiaozuo, Henan, Peoples R China; [Lu, Jun] 900th Hosp Joint Logist Team, Basic Med Lab, Fuzhou, Fujian, Peoples R China; [Yu, Zongyang] 900th Hosp Joint Logist Team, Pulm & Crit Care Med, Fuzhou, Fujian, Peoples R China	Fujian University of Traditional Chinese Medicine; Beijing University of Chemical Technology	Yu, ZY (corresponding author), 900th Hosp Joint Logist Team, Pulm & Crit Care Med, Fuzhou, Fujian, Peoples R China.	yuzy527@sina.com	Zhang, He/GXN-0028-2022	Zhang, Heping/0000-0001-7030-3398				Abuderman AA, 2020, WSPOLCZESNA ONKOL, V24, P183, DOI 10.5114/wo.2020.100281; Albasri A, 2011, ONCOGENE, V30, P2997, DOI 10.1038/onc.2011.26; Cai JC, 2015, J BIOL CHEM, V290, P24678, DOI 10.1074/jbc.M115.649004; Cai W, 2019, AGING-US, V11, P18, DOI 10.18632/aging.101698; Chadla P, 2021, DIGEST DIS SCI, V66, P1510, DOI 10.1007/s10620-020-06364-6; Chen BB, 2015, J CANCER RES THER, V11, pC24, DOI 10.4103/0973-1482.163834; Duan HY, 2020, EXP THER MED, V20, P3823, DOI 10.3892/etm.2020.9096; He JH, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.632834; Khan MZI, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.627022; Li R, 2013, J MOL HISTOL, V44, P183, DOI 10.1007/s10735-012-9463-6; Liu HZ, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-00352-5; Liu QL, 2021, DIAGN PATHOL, V16, DOI 10.1186/s13000-021-01101-7; Long HC, 2016, INT J MOL MED, V37, P1112, DOI 10.3892/ijmm.2016.2505; Luo KL, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1263-3; Qiao B, 2017, ONCOTARGET, V8, P70761, DOI 10.18632/oncotarget.19986; Sharma U, 2020, TRANSL ONCOL, V13, DOI 10.1016/j.tranon.2020.100774; Sun J, 2020, MOL MED REP, V21, P35, DOI 10.3892/mmr.2019.10836; Tsoumas D, 2018, CANCER GENOM PROTEOM, V15, P127, DOI 10.21873/cgp.20071; Wu YS, 2018, ONCOL LETT, V15, P6895, DOI 10.3892/ol.2018.8238; Xiao L, 2014, J RECEPT SIG TRANSD, V34, P64, DOI 10.3109/10799893.2013.862271; Yan ZP, 2014, ACTA HISTOCHEM, V116, P527, DOI 10.1016/j.acthis.2013.11.001; Yang C, 2017, ONCOL REP, V38, P3545, DOI 10.3892/or.2017.6054; Yang YF, 2021, CANCER LETT, V504, P67, DOI 10.1016/j.canlet.2021.01.009; Yuan L, 2017, AM J CANCER RES, V7, P159; Zhang WT, 2021, WORLD J SURG ONCOL, V19, DOI 10.1186/s12957-021-02173-x	25	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0265901	10.1371/journal.pone.0265901	http://dx.doi.org/10.1371/journal.pone.0265901			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1E2NP	35427373	Green Published, gold			2022-12-26	WOS:000794332400041
J	Bahng, S; Kumar, R; Marians, KJ				Bahng, Soon; Kumar, Rupesh; Marians, Kenneth J.			Intersubunit and intrasubunit interactions driving the MukBEF ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CHROMOSOME; TOPOISOMERASE IV INTERACTION; CONDENSIN COMPLEX; HUMAN COHESIN; COMPACTS DNA; PROTEIN; LOCALIZATION; ORGANIZATION; HOMODIMER; MUKF	MukBEF, a structural maintenance of chromosome-like protein complex consisting of an ATPase, MukB, and two interacting subunits, MukE and MukF, functions as the bacterial condensin. It is likely that MukBEF compacts DNA via an ATP hydrolysis-dependent DNA loop-extrusion reaction similar to that demonstrated for the yeast structural maintenance of chromosome proteins condensin and cohesin. MukB also interacts with the ParC subunit of the cellular chromosomal decatenase topoisomerase IV, an interaction that is required for proper chromosome condensation and segregation in Escherichia coli, although it suppresses the MukB ATPase activity. Other structural determinants and interactions that regulate the ATPase activity of MukBEF are not clear. Here, we have investigated the MukBEF ATPase activity, identifying intersubunit and intrasubunit interactions by protein-protein crosslinking and site-specific mutagenesis. We show that interactions between the hinge of MukB and its neck region are essential for the ATPase activity, that the ParC subunit of topoisomerase IV inhibits the MukB ATPase by preventing this interaction, that MukE interaction with DNA is likely essential for viability, and that interactions between MukF and the MukB neck region are necessary for ATPase activity and viability.	[Bahng, Soon; Kumar, Rupesh; Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Mol Biol Program, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Marians, KJ (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Biol Program, 1275 York Ave, New York, NY 10021 USA.	kmarians@sloankettering.edu	Kumar, Rupesh/A-2077-2019	Kumar, Rupesh/0000-0001-5661-8828	National Institutes of Health [R35 GM126907]; Cancer Center Support grant (National Cancer Institute) [P30CA008748]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support grant (National Cancer Institute)	These studies were supported by the National Institutes of Health grant (R35 GM126907; to K. J. M.) and the Cancer Center Support grant (National Cancer Institute grant number: P30CA008748; to Memorial Sloan Kettering Cancer Center). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Badrinarayanan A, 2012, SCIENCE, V338, P528, DOI 10.1126/science.1227126; Bahng S, 2016, J BIOL CHEM, V291, P23999, DOI 10.1074/jbc.M116.749994; Burmann F, 2013, NAT STRUCT MOL BIOL, V20, P371, DOI 10.1038/nsmb.2488; Burmann F, 2021, MOL CELL, V81, P4891, DOI 10.1016/j.molcel.2021.10.011; Burmann F, 2019, NAT STRUCT MOL BIOL, V26, P227, DOI 10.1038/s41594-019-0196-z; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; C. H. Haering, 2021, bioRxiv, DOI 10.1101/2021.10.29.466147; Chen N, 2008, J BACTERIOL, V190, P3731, DOI 10.1128/JB.01863-07; Davidson IF, 2021, NAT REV MOL CELL BIO, V22, P445, DOI 10.1038/s41580-021-00349-7; Davidson IF, 2019, SCIENCE, V366, P1338, DOI 10.1126/science.aaz3418; Davidson IF, 2016, EMBO J, V35, P2671, DOI 10.15252/embj.201695402; El Sayyed H, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006025; Ganji M, 2018, SCIENCE, V360, P102, DOI 10.1126/science.aar7831; Gligoris TG, 2014, SCIENCE, V346, P963, DOI 10.1126/science.1256917; Graham M., 2019, BIORXIV, DOI [10.1101/561829, DOI 10.1101/561829]; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; Hayama Ryo, 2010, Proc Natl Acad Sci U S A, V107, P18826, DOI 10.1073/pnas.1008140107; Hirano M, 1998, EMBO J, V17, P7139, DOI 10.1093/emboj/17.23.7139; Kim E, 2020, NATURE, V579, P438, DOI 10.1038/s41586-020-2067-5; Kim Y, 2019, SCIENCE, V366, P1345, DOI 10.1126/science.aaz4475; Kumar R, 2022, NUCLEIC ACIDS RES, V50, P2621, DOI 10.1093/nar/gkab1027; Kumar R, 2017, J BIOL CHEM, V292, P16921, DOI 10.1074/jbc.M117.803346; Kumar R, 2017, J BIOL CHEM, V292, P16904, DOI 10.1074/jbc.M117.803312; Li YY, 2010, P NATL ACAD SCI USA, V107, P18832, DOI 10.1073/pnas.1008678107; Luijsterburg MS, 2008, CRIT REV BIOCHEM MOL, V43, P393, DOI [10.1080/10409230802528488, 10.1080/10409230802528488 ]; Makela J, 2020, MOL CELL, V78, P250, DOI 10.1016/j.molcel.2020.02.003; Matoba K, 2005, BIOCHEM BIOPH RES CO, V333, P694, DOI 10.1016/j.bbrc.2005.05.163; Mercier R, 2008, CELL, V135, P475, DOI 10.1016/j.cell.2008.08.031; Nasmyth K, 2005, PHILOS T R SOC B, V360, P483, DOI 10.1098/rstb.2004.1604; Nicolas E, 2014, MBIO, V5, DOI 10.1128/mBio.01001-13; NIKI H, 1992, EMBO J, V11, P5101, DOI 10.1002/j.1460-2075.1992.tb05617.x; NIKI H, 1991, EMBO J, V10, P183, DOI 10.1002/j.1460-2075.1991.tb07935.x; Petrushenko ZM, 2006, J BIOL CHEM, V281, P4606, DOI 10.1074/jbc.M504754200; Pong H, 1999, METH MOL B, V94, P163; Prince Josh P, 2021, Nat Commun, V12, P6721, DOI 10.1038/s41467-021-27107-9; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Terakawa T, 2017, SCIENCE, V358, P672, DOI 10.1126/science.aan6516; Uhlmann F, 2016, NAT REV MOL CELL BIO, V17, P399, DOI 10.1038/nrm.2016.30; Vos SM, 2013, EMBO J, V32, P2950, DOI 10.1038/emboj.2013.218; Wells JN, 2017, CURR BIOL, V27, pR17, DOI 10.1016/j.cub.2016.11.050; Woo JS, 2009, CELL, V136, P85, DOI 10.1016/j.cell.2008.10.050; Yamanaka K, 1996, MOL GEN GENET, V250, P241; Yamazoe M, 1999, EMBO J, V18, P5873, DOI 10.1093/emboj/18.21.5873; Zawadzka K, 2018, ELIFE, V7, DOI 10.7554/eLife.31522; Zawadzki P, 2015, CELL REP, V13, P2587, DOI 10.1016/j.celrep.2015.11.034	45	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101964	10.1016/j.jbc.2022.101964	http://dx.doi.org/10.1016/j.jbc.2022.101964			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3R4NR	35452680	Green Published, gold, Green Submitted			2022-12-26	WOS:000838892100013
J	Chung, YH; Kim, JR; Choi, SJ; Joo, EY				Chung, Yeon Hak; Kim, Jae Rim; Choi, Su Jung; Joo, Eun Yeon			Prevalence and predictive factors of nocturia in patients with obstructive sleep apnea syndrome: A retrospective cross-sectional study	PLOS ONE			English	Article							KOREAN VERSION; RISK-FACTORS; MEN; DISEASE; WOMEN; AGE	Objectives Many patients with obstructive sleep apnea syndrome (OSAS) have nocturia. However, the predictive index of nocturia in patients with OSAS is currently not well known. We aimed to investigate the prevalence of nocturia in patients with OSAS and determine the factors that could predict nocturia in these patients. Methods In this retrospective cross-sectional study, we enrolled 1,264 untreated patients with OSAS (Apnea-Hypopnea Index, AHI >= 5/h on polysomnography [PSG]) from January 2017 to January 2020. Participants completed the Beck Depression Inventory-II (BDI-II), Pittsburgh Sleep Quality Index (PSQI), Insomnia Severity Index (ISI), and Epworth Sleepiness Scale. Participants were divided by sex and then subdivided into nocturia and non-nocturia groups according to the following question, "Do you go to the bathroom two times or more during your sleep?" Participants' characteristics and underlying disease were investigated, and all information, including PSG data, was compared between the two groups using the t-test or chi-square test. Results Overall, 35.2% (337/958) of male participants with OSAS and 59.8% (183/306) of female participants with OSAS had nocturia. The nocturia group was older; scored higher on the BDI-II, PSQI, and ISI; and had more underlying disease in both sexes. There was no difference in the AHI between the two groups among both sexes, but the hypoxia-related PSG parameters and sleep quality parameters, such as higher 90% oxygen desaturation index (90% ODI), lesser N3 sleep, and higher wakefulness after sleep onset, were worse among male participants with OSAS in the nocturia group than in the non-nocturia group. In multivariate logistic analysis, 90% ODI was an independent risk factor associated with nocturia in male participants with OSAS. Conclusions Considerable number of patients with OSAS had nocturia and poor sleep quality. Nocturia should be evaluated in male OSAS patients with severe hypoxia observed during sleep.	[Chung, Yeon Hak; Kim, Jae Rim; Choi, Su Jung; Joo, Eun Yeon] Sungkyunkwan Univ, Dept Neurol, Neurosci Ctr, Samsung Med Ctr,Sch Med, Seoul, South Korea; [Choi, Su Jung] Sungkyunkwan Univ, Grad Sch Clin Nursing Sci, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU)	Joo, EY (corresponding author), Sungkyunkwan Univ, Dept Neurol, Neurosci Ctr, Samsung Med Ctr,Sch Med, Seoul, South Korea.	eunyeon.joo@gmail.com		JOO, EUN YEON/0000-0003-1233-959X; Chung, Yeon Hak/0000-0002-7052-2432	Samsung Medical Center Grant [OTC1190671]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HR21C0885]	Samsung Medical Center Grant(Samsung); Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This study was granted by Samsung Medical Center Grant (OTC1190671), and Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HR21C0885). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslan B, 2019, LUTS, V11, P139, DOI 10.1111/luts.12250; Berry RB, 2017, J CLIN SLEEP MED, V13, P665, DOI 10.5664/jcsm.6576; Cho YW, 2014, J CLIN NEUROL, V10, P210, DOI 10.3988/jcn.2014.10.3.210; Cho YW, 2011, SLEEP BREATH, V15, P377, DOI 10.1007/s11325-010-0343-6; Chung JH, 2019, INT NEUROUROL J, V23, P161, DOI 10.5213/inj.1938026.013; Cohn JA, 2017, EXPERT REV CLIN PHAR, V10, P1281, DOI 10.1080/17512433.2017.1394185; Doyle-McClam M, 2021, AM J LIFESTYLE MED, V15, P260, DOI 10.1177/1559827618782657; Endeshaw YW, 2004, J AM GERIATR SOC, V52, P957, DOI 10.1111/j.1532-5415.2004.52264.x; FitzGerald MP, 2007, J UROLOGY, V177, P1385, DOI 10.1016/j.juro.2006.11.057; Hajduk IA, 2003, SLEEP, V26, P61; Hamada S, 2021, SLEEP MED, V77, P288, DOI 10.1016/j.sleep.2020.09.007; Hoshiyama F, 2014, UROLOGY, V84, P892, DOI 10.1016/j.urology.2014.02.073; Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605; Iannella G, 2022, AM J OTOLARYNG, V43, DOI 10.1016/j.amjoto.2021.103197; 성형모, 2008, [Journal of the Korean Society of Biological Therapies in Psychiatry, 생물치료정신의학], V14, P201; Lin CM, 2008, SLEEP MED REV, V12, P481, DOI 10.1016/j.smrv.2007.11.003; Margel D, 2006, UROLOGY, V67, P974, DOI 10.1016/j.urology.2005.11.054; Moriyarna Y, 2008, UROLOGY, V71, P1096, DOI 10.1016/j.urology.2008.02.038; O'Leary K, 2017, COGNITION EMOTION, V31, P1698, DOI 10.1080/02699931.2016.1247035; Pace A, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56090454; Pollicina I, 2021, BEHAV SCI-BASEL, V11, DOI 10.3390/bs11120180; Sateia MJ, 2014, CHEST, V146, P1387, DOI 10.1378/chest.14-0970; Sohn SI, 2012, SLEEP BREATH, V16, P803, DOI 10.1007/s11325-011-0579-9; Tikkinen KAO, 2006, J UROLOGY, V175, P596, DOI 10.1016/S0022-5347(05)00245-4; Tikkinen KAO, 2010, EUR UROL, V57, P488, DOI 10.1016/j.eururo.2009.03.080; Umlauf MG, 2003, SLEEP MED REV, V7, P403, DOI 10.1053/smrv.2002.0273; van Kerrebroeck P, 2002, NEUROUROL URODYNAM, V21, P179, DOI 10.1002/nau.10053; Vrooman OPJ, 2020, NEUROUROL URODYNAM, V39, P1124, DOI 10.1002/nau.24329; Weiss JP, 2019, UROLOGY, V133, P24, DOI 10.1016/j.urology.2019.09.022; Witthaus MW, 2015, J UROLOGY, V193, P1692, DOI 10.1016/j.juro.2014.11.055; Yoshimura K, 2004, INT J UROL, V11, P282, DOI 10.1111/j.1442-2042.2004.00791.x; Yoshimura K, 2012, INT J UROL, V19, P317, DOI 10.1111/j.1442-2042.2011.02956.x; Zhou JT, 2020, SLEEP BREATH, V24, P1293, DOI 10.1007/s11325-019-01981-6	33	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267441	10.1371/journal.pone.0267441	http://dx.doi.org/10.1371/journal.pone.0267441			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476719	gold, Green Published			2022-12-26	WOS:000840124300042
J	Kanamori, R; Kawakami, Y; Nojiri, S; Miyazawa, S; Kuroki, M; Nishizaki, Y				Kanamori, Rie; Kawakami, Yuta; Nojiri, Shuko; Miyazawa, Satoshi; Kuroki, Manabu; Nishizaki, Yuji			Changes in social environment due to the state of emergency and Go To campaign during the COVID-19 pandemic in Japan: An ecological study	PLOS ONE			English	Article							CHINA	Background During the coronavirus disease 2019 (COVID-19) pandemic in Japan, the state of emergency, as a public health measure to control the spread of COVID-19, and the Go To campaign, which included the Go To Travel and Go To Eat campaigns and was purposed to stimulate economic activities, were implemented. This study investigated the impact of these government policies on COVID-19 spread. Methods This ecological study included all 47 prefectures in Japan as samples between February 3 and December 27, 2020. We used COVID-19 cases and mobility as variables. Additionally, places where social contacts could accrue, defined as restaurants, companies, transportation, and tourist spots; mean temperature and humidity; the number of inhabitants in their twenties to fifties; and the number of COVID-19 cases in the previous period, which were factors or covariates in the graphical modeling analysis, were divided into five periods according to the timing of the implementation of the state of emergency and Go To campaign. Results Graphical changes occurred throughout all five periods of COVID-19. During the state of emergency (period 2), a correlation between COVID-19 cases and those before the state of emergency (period 1) was observed, although this correlation was not significant in the period after the state of emergency was lifted (period 3). During the implementation of Go To Travel and the Go To Eat campaigns (period 5), the number of places where social contacts could accrue was correlated with COVID-19 cases, with complex associations and mobility. Conclusions This study confirms that the state of emergency affected the control of COVID-19 spread and that the Go To campaign led to increased COVID-19 cases due to increased mobility by changing behavior in the social environment where social contacts potentially accrue.	[Kanamori, Rie; Nojiri, Shuko; Nishizaki, Yuji] Juntendo Univ, Grad Sch Med, Clin Translat Sci, Tokyo, Japan; [Kawakami, Yuta] Yokohama Natl Univ, Grad Sch Engn Sci, Dept Math Phys Elect Engn & Comp Sci, Yokohama, Kanagawa, Japan; [Nojiri, Shuko] Juntendo Univ, Med Technol Innovat Ctr, Tokyo, Japan; [Miyazawa, Satoshi] LocationMind Inc, Tokyo, Japan; [Kuroki, Manabu] Yokohama Natl Univ, Fac Engn, Yokohama, Kanagawa, Japan	Juntendo University; Yokohama National University; Juntendo University; Yokohama National University	Nojiri, S (corresponding author), Juntendo Univ, Grad Sch Med, Clin Translat Sci, Tokyo, Japan.; Nojiri, S (corresponding author), Juntendo Univ, Med Technol Innovat Ctr, Tokyo, Japan.	s-nojiri@juntendo.ac.jp		Kanamori, Rie/0000-0002-4284-0169				Aleta A, 2020, NAT HUM BEHAV, V4, P964, DOI 10.1038/s41562-020-0931-9; [Anonymous], COVID 19 WEEKLY EPID; [Anonymous], 3 DAYS NEEDED REPORT; [Anonymous], T F SUBSIDIZING SPRE; [Anonymous], JUSE STATWORKS V5; Anzai A, 2021, J CLIN MED, V10, DOI 10.3390/jcm10030398; Arimura Mikiharu, 2020, Transp Res Interdiscip Perspect, V7, P100212, DOI 10.1016/j.trip.2020.100212; Azuma K, 2020, ENVIRON RES, V190, DOI 10.1016/j.envres.2020.110042; Badr HS, 2020, LANCET INFECT DIS, V20, P1247, DOI 10.1016/S1473-3099(20)30553-3; Block P, 2020, NAT HUM BEHAV, V4, P588, DOI 10.1038/s41562-020-0898-6; Brauner JM, 2021, SCIENCE, V371, P802, DOI 10.1126/science.abd9338; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chang S, 2021, NATURE, V589, P82, DOI 10.1038/s41586-020-2923-3; Furuse Y, 2020, JPN J INFECT DIS, V73, P391, DOI 10.7883/yoken.JJID.2020.271; Gao S, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.20485; GOV.UK, GET DISC EAT OUT HEL; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Japan Tourism Agency, GO TRAV CAMP; Japan Tourism Agency Ministry of Land Infrastructure Transport and Tourism Japan, PRESS REL UPD FEBR 1; Jordan MI, 2004, STAT SCI, V19, P140, DOI 10.1214/088342304000000026; Keizai Toyo, COR DIS COVID 19 SIT; Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218; Kuniya T, 2020, INFECT DIS MODEL, V5, P580, DOI 10.1016/j.idm.2020.08.004; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Lauritzen S.L.., 1996, GRAPHICAL MODELS; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Li XJ, 2020, PREV CHRONIC DIS, V17, DOI 10.5888/pcd17.200241; Liu JY, 2020, EMERG INFECT DIS, V26, P1320, DOI 10.3201/eid2606.200239; Liu M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77292-8; Ministry of Health Labour and Welfare Japan, SIT REP; Nagata S, 2021, J EPIDEMIOL, V31, P387, DOI 10.2188/jea.JE20200625; Nguyen TD, 2021, SOUTH ECON J, V88, P458, DOI 10.1002/soej.12538; Pagnini F, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.15821; Pan YX, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77751-2; Prime Minister's Office of Japan, COVID 19 CONTR HEADQ; Purwanto P, 2021, ISPRS INT J GEO-INF, V10, DOI 10.3390/ijgi10030133; Shaw R, 2020, PROG DISASTER SCI, V6, DOI 10.1016/j.pdisas.2020.100090; Siedner MJ, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003244; Stromgren M, 2017, EPIDEMIOL INFECT, V145, P2582, DOI 10.1017/S0950268817001169; Thorpe A, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.33538; Thorsson S, 2007, ENVIRON BEHAV, V39, P660, DOI 10.1177/0013916506294937; WHO, 2020, EM PREP RESP PNEUM U; Wise T, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.200742; World Health Organization, WHO DIR GEN OP REM M; Yabe T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75033-5; Zhou Y, 2020, LANCET DIGIT HEALTH, V2, pE417, DOI 10.1016/S2589-7500(20)30165-5	46	1	1	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267395	10.1371/journal.pone.0267395	http://dx.doi.org/10.1371/journal.pone.0267395			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476643	gold, Green Published			2022-12-26	WOS:000840124300037
J	Nieman, AE; Rozemeijer, W; Savelkoul, PHM; Schade, RP				Nieman, An-Emmie; Rozemeijer, Wouter; Savelkoul, Paul H. M.; Schade, Rogier P.			Bacterial DNA load in Staphylococcus aureus bacteremia is significantly higher in intravascular infections	PLOS ONE			English	Article							MORTALITY; TIME; POSITIVITY; MANAGEMENT; DIAGNOSIS; SEVERITY; BLOOD	Objectives Determination of pathogen-specific bacterial DNA load (BDL) in blood has been shown to be directly correlated with severity of infection in patients with bacteremia. In the diagnostic work-up of patients with Staphylococcus aureus bacteremia (SAB), determination of the primary focus is imperative, because of implications for treatment duration, and ultimately prognosis. Here we investigate whether measurement of BDL in patients with SAB can distinguish between intravascular and extravascular foci of infection. Methods In a consecutive cohort of 43 patients with positive blood cultures with Staphylococcus aureus, we performed a quantitative PCR on whole blood to detect the bacterial DNA load. Infections were classified into 3 categories: i) soft tissue infections and phlebitis, ii) deep-seated infections and iii) endocarditis and other intravascular infections. Bacterial DNA loads and inflammatory parameters in the three categories were analyzed and compared. Results Median BDL in patients with endocarditis and other intravascular infections was 1015 cfu/ml, significantly higher than BDL in the other two categories (28 and 31 cfu/ml respectively). In contrast, CRP and leukocytes were not significantly different between the three patient categories. BDL could be detected in all patients with intravascular causes and levels were generally 10-30 times higher than in the other infection categories. Median BDL in non-survivors was 85 cfu/ml, which was higher than in survivors with a median BDL of 29 cfu/ml, although not significant. Conclusions In Staphylococcus aureus bacteremia pathogen-specific BDL is distinctly higher in patients with intravascular infections compared to extravascular origins. As measurement of BDL by PCR can easily be implemented in routine diagnostics, it can improve the diagnostic work-up of SAB by rapidly identifying the subset of patients who need higher dosages of antibiotics and additional measures to improve outcome.	[Nieman, An-Emmie; Rozemeijer, Wouter; Savelkoul, Paul H. M.; Schade, Rogier P.] Univ Amsterdam, Dept Med Microbiol & Infect Control, Med Ctr, Amsterdam, Netherlands; [Savelkoul, Paul H. M.] Maastricht Univ, Sch Nutr & Translat Res Metab NUTRIM, Dept Med Microbiol, Maastricht, Netherlands; [Nieman, An-Emmie] Jeroen Bosch Hosp, Dept Med Microbiol, sHertogenbosch, Netherlands; [Rozemeijer, Wouter] Noordwest Ziekenhuisgrp, Dept Med Microbiol, Alkmaar, Netherlands	University of Amsterdam; Maastricht University; Jeroen Bosch Ziekenhuis; Medical Center Of Alkmaar	Nieman, AE (corresponding author), Univ Amsterdam, Dept Med Microbiol & Infect Control, Med Ctr, Amsterdam, Netherlands.; Nieman, AE (corresponding author), Jeroen Bosch Hosp, Dept Med Microbiol, sHertogenbosch, Netherlands.	a.nieman@jbz.nl						Al-Hasan MN, 2020, CLIN INFECT DIS, V70, P1834, DOI 10.1093/cid/ciz535; Darton T, 2009, CLIN INFECT DIS, V48, P587, DOI 10.1086/596707; Fowler VG, 2003, ARCH INTERN MED, V163, P2066, DOI 10.1001/archinte.163.17.2066; Guimaraes AO, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz126; Habib G, 2015, EUR HEART J, V36, P3075, DOI [10.1093/eurheartj/ehv319, 10.5603/KP.2015.0227]; Hassan MM, 2018, BIOSENS BIOELECTRON, V99, P150, DOI 10.1016/j.bios.2017.07.057; Ho YC, 2009, J CLIN MICROBIOL, V47, P1443, DOI 10.1128/JCM.01197-08; Kahn F, 2021, CLIN MICROBIOL INFEC, V27, DOI 10.1016/j.cmi.2020.11.007; Khatib R, 2005, CLIN INFECT DIS, V41, P594, DOI 10.1086/432472; Landman Gijs W D, 2011, Ned Tijdschr Geneeskd, V155, pA3376; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Loonen AJM, 2017, EUR J CLIN MICROBIOL, V36, P1541, DOI 10.1007/s10096-017-2963-2; Loonen AJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072349; Marra AR, 2006, J CLIN MICROBIOL, V44, P1342, DOI 10.1128/JCM.44.4.1342-1346.2006; Martineau F, 1998, J CLIN MICROBIOL, V36, P618, DOI 10.1128/JCM.36.3.618-623.1998; Melzer M, 2013, J HOSP INFECT, V84, P143, DOI 10.1016/j.jhin.2012.12.013; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Rello J, 2009, CHEST, V136, P832, DOI 10.1378/chest.09-0258; Society D., 2018, SWAB GUIDELINES ANTI; SWAB., 2010, STICHT WERKGR ANT, V49; van den Brand M, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2010-4; Wang A, 2018, JAMA-J AM MED ASSOC, V320, P72, DOI 10.1001/jama.2018.7596; Ziegler I, 2019, INFECT DIS-NOR, V51, P216, DOI 10.1080/23744235.2018.1562205	23	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0266869	10.1371/journal.pone.0266869	http://dx.doi.org/10.1371/journal.pone.0266869			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35443013	gold, Green Published			2022-12-26	WOS:000822608900035
J	Ashtiani, MTH; Rad, PS; Asnaashari, K; Shahhosseini, A; Berenji, F; Mamishi, S				Ashtiani, Mohammad Taghi Haghi; Rad, Parisa Sadeghi; Asnaashari, Kosar; Shahhosseini, Alireza; Berenji, Fatemeh; Mamishi, Setareh			Role of serology tests in COVID-19 non-hospitalized patients: A cross-sectional study	PLOS ONE			English	Article							ANTIBODIES	Introduction Severe acute respiratory syndrome coronavirus (SARS-CoV2) has imposed catastrophic impressions on the world. After all the focused researches conducted in the COVID-19 area, many features remain obscure. We have surveyed 1,363 outpatients with suspected COVID-19 in Tehran, Iran. The analysis emphasized on characteristics of patients with positive PCR or serology of SARS-CoV-2. Methods The nasopharyngeal swabs were tested for SARS-CoV2 PCR. Serum specimens were tested for SARS-CoV2 IgG and IgM. Clinical presentations of the patients, history of chronic diseases or drug use, contact with a possible COVID-19 patient and previous infection with SARS-COV2 were investigated. Results Of the total 1,363 investigated patients, 22% had positive SARS-CoV-2 PCRs, 82% had positive IgG, 38% had positive IgM, and 31% had both positive IgM and IgG values. Positive serologic tests were significantly associated with a positive PCR test obtained previously in the course of the current disease (P value<0.001). IgG and IgM antibody values were significantly associated with underlying disease, cough, fever, chills, fatigue, and myalgia (all P values <0.001). Dyspnea was significantly associated with IgG levels (P value = 0.01), yet it was not associated with IgM serology (P value = 0.2). Positive serology tests were not associated with symptoms of coryza. GI symptoms were not associated with positive IgG test (P value = 0.1), yet it did show an association with positive IgM test (P value = 0.02). Cough, fever, chills, myalgia fatigue, dyspnea, and GI symptoms were all significantly associated with positive PCR (all P values <0.001), and symptoms of coryza did not show a significant relationship (P value = 0.8). Conclusion Assessing antibody titers in outpatients is invaluable due to the epidemiological importance of investigations in mild or even asymptomatic cases. Since the number of such studies in non-hospitalized patients is not high, the current study can be used as a comparison model.	[Ashtiani, Mohammad Taghi Haghi; Rad, Parisa Sadeghi; Asnaashari, Kosar; Shahhosseini, Alireza; Berenji, Fatemeh; Mamishi, Setareh] Univ Tehran Med Sci, Childrens Med Ctr, Tehran, Iran; [Ashtiani, Mohammad Taghi Haghi; Rad, Parisa Sadeghi; Asnaashari, Kosar; Mamishi, Setareh] Univ Tehran Med Sci, Pediat Grp, Fac Med, Tehran, Iran; [Asnaashari, Kosar] Universal Sci Educ & Res Network USERN, Network Immun Infect Malignancy & Autoimmun NIIMA, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Universal Scientific Education & Research Network (USERN)	Asnaashari, K (corresponding author), Univ Tehran Med Sci, Childrens Med Ctr, Tehran, Iran.; Asnaashari, K (corresponding author), Univ Tehran Med Sci, Pediat Grp, Fac Med, Tehran, Iran.; Asnaashari, K (corresponding author), Universal Sci Educ & Res Network USERN, Network Immun Infect Malignancy & Autoimmun NIIMA, Tehran, Iran.	kosar.asna@gmail.com	ashari, kosar asna/AAW-3521-2021	ashari, kosar asna/0000-0002-9711-7189				[Anonymous], 2020, NAT MED, DOI [10.1038/s41591-020-0897-1, DOI 10.1038/S41591-020-0897-1]; Chen ZF, 2021, CLIN CHIM ACTA, V519, P172, DOI 10.1016/j.cca.2021.04.022; de Oliveira MS, 2021, AM J INFECT CONTROL, V49, P1197, DOI 10.1016/j.ajic.2021.03.010; Deeks JJ, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013652; Deng W, 2020, SCIENCE, V369, P818, DOI 10.1126/science.abc5343; Garcia-Beltran WF, 2021, CELL, V184, P476, DOI 10.1016/j.cell.2020.12.015; Gautier JF, 2020, OBESITY, V28, P848, DOI 10.1002/oby.22809; Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0; Gupta A, 2020, NAT MED, V26, P1017, DOI 10.1038/s41591-020-0968-3; Hassan AO, 2020, CELL, V182, P744, DOI 10.1016/j.cell.2020.06.011; Hendren NS, 2020, CIRCULATION, V141, P1903, DOI 10.1161/CIRCULATIONAHA.120.047349; Jiang F, 2020, J GEN INTERN MED, V35, P1545, DOI 10.1007/s11606-020-05762-w; Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924; Lee WS, 2020, NAT MICROBIOL, V5, P1185, DOI 10.1038/s41564-020-00789-5; Li LQ, 2020, J MED VIROL, V92, P577, DOI 10.1002/jmv.25757; Li YC, 2020, J MED VIROL, V92, P552, DOI 10.1002/jmv.25728; Lombardi A, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-047216; Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]; Patel R, 2020, MBIO, V11, DOI 10.1128/mBio.00722-20; Trougakos IP, 2021, J BIOMED SCI, V28, DOI 10.1186/s12929-020-00703-5; Wajnberg A, 2020, SCIENCE, V370, P1227, DOI 10.1126/science.abd7728; Wellinghausen N, 2020, J CLIN VIROL, V130, DOI 10.1016/j.jcv.2020.104542; Whitman JD, 2020, NAT BIOTECHNOL, V38, P1174, DOI [10.1038/s41587-020-0659-0, 10.1101/2020.04.25.20074856]; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; World Health Organization, COR DIS COVID 19 PAN; World Health Organization, DIAGN TEST SARS COV; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Zhang JL, 2021, GENES DIS, V8, P385, DOI 10.1016/j.gendis.2020.08.013	29	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266923	10.1371/journal.pone.0266923	http://dx.doi.org/10.1371/journal.pone.0266923			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421183	gold, Green Published			2022-12-26	WOS:000795453600083
J	Li, F; Zhang, S				Li, Fang; Zhang, Sheng			Does financial crisis change the relationship between bank development and economic growth? Evidence from US states	PLOS ONE			English	Article							CAUSALITY; LIBERALIZATION; COUNTRIES; MARKETS	This paper investigates the causal relationship between bank development and economic growth in the US before and after the financial crisis in 2008. Based on the quarterly panel data of US states for 2002Q1-2012Q4, this paper uses two-step system GMM method to test the long-term and short-term impact of bank on growth. In addition, panel Granger causality test is used to verify the causality between bank and growth in different periods. The study finds that banks have played a significant role in the long-run economic growth process and there exists a bidirectional causality between bank and growth among US states. In the short term, the financial crisis has corrected the short-run relationship between bank and growth. The relationship between bank and growth has changed from one-way causality before the crisis to two-way causality after the crisis. Before the crisis, economic growth promotes bank credit, but bank development does not promote growth. After the crisis, banks play the role of economic driver through credit, savings and services, and economic growth drives bank savings and scale expansion. The financial intermediary service functions of banks, especially credit to private sector and absorbing savings to transfer loans, determine the role of bank development in economic growth. Policy makers should support bank development in the long run to establish a mature financial intermediary system and promote regional economic development.	[Li, Fang] Nanjing Univ Sci & Technol, Sch Intellectual Property, Nanjing, Jiangsu, Peoples R China; [Zhang, Sheng] Xi An Jiao Tong Univ, Sch Publ Policy & Adm, Xian, Shaanxi, Peoples R China	Nanjing University of Science & Technology; Xi'an Jiaotong University	Li, F (corresponding author), Nanjing Univ Sci & Technol, Sch Intellectual Property, Nanjing, Jiangsu, Peoples R China.	532296776@qq.com						AKINLO AE, 2010, REV FINANCE BANKING, V2, P17; Al-Awad M., 2005, APPL FINANCIAL EC, V15, P1041; Ang JB, 2007, J DEV ECON, V84, P215, DOI 10.1016/j.jdeveco.2006.11.006; Apergis N, 2007, REV WORLD ECON, V143, P179, DOI 10.1007/s10290-007-0102-3; Ashcraft Adam B., 2008, FDN TRENDS FINANCE, V2, P191, DOI DOI 10.1561/0500000024; Bangake C, 2011, ECON SYST, V35, P176, DOI 10.1016/j.ecosys.2010.07.001; Beck T, 2000, J FINANC ECON, V58, P261, DOI 10.1016/S0304-405X(00)00072-6; Bekaert G, 2005, J FINANC ECON, V77, P3, DOI 10.1016/j.jfineco.2004.05.007; Ben Rejeb A, 2015, BORSA ISTANB REV, V15, P161, DOI 10.1016/j.bir.2015.04.003; Calderon C, 2003, J DEV ECON, V72, P321, DOI 10.1016/S0304-3878(03)00079-8; Caporale GM, 2015, INT J FINANC ECON, V20, P48, DOI 10.1002/ijfe.1498; CHANDAVARKAR A, 1992, WORLD DEV, V20, P133, DOI 10.1016/0305-750X(92)90142-I; Cheng XQ, 2010, J FINANC SERV RES, V37, P179, DOI 10.1007/s10693-009-0077-4; Cyree KB, 2016, J FINANC RES, V39, P389, DOI 10.1111/jfir.12112; Dehejia R, 2007, J LAW ECON, V50, P239, DOI 10.1086/511322; Dell'Ariccia G, 2006, J FINANC ECON, V79, P401, DOI 10.1016/j.jfineco.2005.02.003; Dell'Ariccia G, 2004, J FINANC ECON, V72, P185, DOI 10.1016/S0304-405X(03)00210-1; Dell'Ariccia G, 2008, J FINANC INTERMED, V17, P89, DOI 10.1016/j.jfi.2007.06.001; Dumitrescu EI, 2012, ECON MODEL, V29, P1450, DOI 10.1016/j.econmod.2012.02.014; Ghirmay T, 2004, AFR DEV REV, V16, P415, DOI 10.1111/j.1017-6772.2004.00098.x; GURLEY JG, 1956, J FINANC, V11, P257, DOI 10.2307/2976705; Handa J., 2008, APPL FINANCIAL EC, V18, P1033, DOI [10.1080/09603100701477275, DOI 10.1080/09603100701477275]; Hasan I, 2009, J BANK FINANC, V33, P157, DOI 10.1016/j.jbankfin.2007.11.016; Hassan MK, 2011, Q REV ECON FINANC, V51, P88, DOI 10.1016/j.qref.2010.09.001; Kar M, 2011, ECON MODEL, V28, P685, DOI 10.1016/j.econmod.2010.05.015; Khan MS, 2003, J AFR ECON, V12, P89; Kiser EK, 2016, J FINANC SERV RES, V50, P163, DOI 10.1007/s10693-015-0226-x; Kroszner RS, 2007, J FINANC ECON, V84, P187, DOI 10.1016/j.jfineco.2006.05.001; La Porta R, 2002, J FINANC, V57, P265, DOI 10.1111/1540-6261.00422; Levine R, 1998, AM ECON REV, V88, P537; Levine R, 1997, J ECON LIT, V35, P688; Levine R, 1999, J FINANC INTERMED, V8, P8, DOI 10.1006/jfin.1998.0255; Levine R, 2000, J MONETARY ECON, V46, P31, DOI 10.1016/S0304-3932(00)00017-9; Levine Ross., 2009, 4943 WORLD BANK; Loayza NV, 2006, J MONEY CREDIT BANK, V38, P1051, DOI 10.1353/mcb.2006.0060; Lu WL, 2020, AM J BUS, V35, P25, DOI 10.1108/AJB-03-2019-0017; Lu WL, 2013, J FINAN ECON POLICY, V5, P281, DOI 10.1108/JFEP-02-2013-0006; LUCAS RE, 1988, J MONETARY ECON, V22, P3, DOI 10.1016/0304-3932(88)90168-7; MATHIESON DJ, 1980, J DEV ECON, V7, P359, DOI 10.1016/0304-3878(80)90017-6; Odhiambo NM, 2008, ECON MODEL, V25, P704, DOI 10.1016/j.econmod.2007.10.009; PAGANO M, 1993, EUR ECON REV, V37, P613, DOI 10.1016/0014-2921(93)90051-B; Pan HR, 2013, J BANK FINANC, V37, P1720, DOI 10.1016/j.jbankfin.2013.01.018; PATRICK HT, 1966, ECON DEV CULT CHANGE, V14, P174, DOI 10.1086/450153; Pradhan RP., 2010, ASIAN J SOC SCI, V6, P114, DOI [10.5539/ass.v6n9p114, DOI 10.5539/ASS.V6N9P114]; Rafindadi AA., 2013, WORLD APPL SCI J, V28, P182; Rafindadi AA, 2015, INT J EC FINANCIAL I, V5, P716; RAFINDADI AA, 2013, WORLD APPL SCI J, V28, P147; Rafindadi AA, 2016, RENEW SUST ENERG REV, V54, P1073, DOI 10.1016/j.rser.2015.10.023; Rafindadi AA, 2015, QUAL QUANT, V49, P365, DOI 10.1007/s11135-014-9991-0; Rana RH., 2015, ASIAN EC FINANC REV, V5, P1159, DOI [10.18488/journal.aefr/2015.5.10/102.10.1159.1173, DOI 10.18488/JOURNAL.AEFR/2015.5.10/102.10.1159.1173]; Rioja F, 2004, J DEV ECON, V74, P429, DOI 10.1016/j.jdeveco.2003.06.006; Rioja F, 2004, ECON INQ, V42, P127, DOI 10.1093/ei/cbh049; Rousseau PL, 2011, ECON INQ, V49, P276, DOI 10.1111/j.1465-7295.2009.00197.x; Shan J.Z., 2001, REV INT ECON, V9, P443, DOI [DOI 10.1111/1467-9396.00291, 10.1111/1467-9396.00291]; Westerlund J, 2007, OXFORD B ECON STAT, V69, P709, DOI 10.1111/j.1468-0084.2007.00477.x; Wu JL, 2010, J MACROECON, V32, P879, DOI 10.1016/j.jmacro.2009.09.003; Yeh CC, 2013, ECON MODEL, V35, P391, DOI 10.1016/j.econmod.2013.07.034; Yusof, 2013, INT J EC EMPIRICAL R, V1, P99; Zhang J, 2012, J COMP ECON, V40, P393, DOI 10.1016/j.jce.2012.01.001	59	1	1	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267394	10.1371/journal.pone.0267394	http://dx.doi.org/10.1371/journal.pone.0267394			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1F9GM	35446878	Green Published, gold			2022-12-26	WOS:000795468200008
J	Maurer, L; Puishys, L; Ho, NKP; Dahlgren, C; Kamerman, TY; Martin, S; Stamper, MA				Maurer, Leah; Puishys, Lauren; Ho, Nancy Kim Pham; Dahlgren, Craig; Kamerman, Tanya Y.; Martin, Scott; Stamper, M. Andrew			Acropora cervicornis and Acropora palmata cultured on a low maintenance line nursery design in The Bahamas	PLOS ONE			English	Article							CORAL-REEF RESTORATION; GARDENING CONCEPT; GROWTH-RATES; FRAGMENTATION; PROPAGATION; SUCCESS; LAMARCK	Acroporid corals are one of the most important corals in the Caribbean because of their role in building coral reefs. Unfortunately, Acropora corals have suffered a severe decline in the last 50 years thus prompting the development of many restoration practices, such as coral nurseries, to increase the abundance of these species. However, many coral nursery designs require constant visits and maintenance limiting restoration to more convenient sites. Additionally, most studies lack the details required for practitioners to make informed decisions about replicating nursery designs. Two line nurseries were monitored for three years in The Bahamas to assess the survival of corals, Acropora cervicornis and Acropora palmata, as well as evaluate the durability and cost effectiveness of the nursery design. Survivorship ranged from 70 to 97% with one location experiencing significantly higher survivorship. The initial year build-out cost was high for a nursery, $22.97 per coral, but each nursery was comprised of specific materials that could withstand high storm conditions. Some unique aspects of the design included the use of longline clips and large-diameter monofilament lines which allowed for easier adjustments and more vigorous cleaning. The design proved to be very durable with materials showing a life expectancy of five years or more. Additionally, the design was able to withstand multiple hurricanes and winter storm conditions with little to no damage. Only two maintenance visits a year were required reducing costs after construction. After three years, this nursery design showed promising durability of materials and survivorship of both Acropora cervicornis and Acropora palmata despite being serviced just twice a year.	[Maurer, Leah; Puishys, Lauren; Ho, Nancy Kim Pham; Martin, Scott; Stamper, M. Andrew] Disneys Anim Sci & Environm, Lake Buena Vista, FL 32830 USA; [Maurer, Leah; Puishys, Lauren] New Coll Florida, Sarasota, FL 34243 USA; [Dahlgren, Craig] Perry Inst Marine Sci, Waitsfield, VT USA; [Kamerman, Tanya Y.] Nova Southeastern Univ, Oceanog Ctr, Dania, FL USA	State University System of Florida; New College Florida; Nova Southeastern University	Maurer, L (corresponding author), Disneys Anim Sci & Environm, Lake Buena Vista, FL 32830 USA.; Maurer, L (corresponding author), New Coll Florida, Sarasota, FL 34243 USA.	Leah.M.Maurer@disney.com			Walt Disney Company	Walt Disney Company	The Walt Disney Company funded the project.	Albright R, 2010, P NATL ACAD SCI USA, V107, P20400, DOI 10.1073/pnas.1007273107; Amar KO, 2007, MAR BIOL, V151, P713, DOI 10.1007/s00227-006-0512-0; [Anonymous], 2018, TROPICAL CYCLONE REP; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Aronson RB, 2002, ECOL MONOGR, V72, P233, DOI 10.1890/0012-9615(2002)072[0233:TESOST]2.0.CO;2; Avila LA, 2020, TROPICAL CYCLONE REP; Bak RPM, 2009, B MAR SCI, V84, P287; Baums IB, 2005, MAR ECOL PROG SER, V288, P115, DOI 10.3354/meps288115; Bayraktarov E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228477; Bostrom-Einarsson L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226631; Boulon R., 2005, ATLANTIC ACROPORA ST; Bowden-Kerby A, 2001, B MAR SCI, V69, P915; Brown DP, 2018, TROPICAL CYCLONE REP; Bruckner A., 2002, P 9 INT COR REEF S A; Drury C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174000; Edwards A., 2010, REEF REHABILITATION, P164; Edwards AJ., 2010, REEF REHABILITATION, P113; Fogarty ND, 2012, MAR ECOL PROG SER, V446, P145, DOI 10.3354/meps09469; Fris-Torres S., 2018, NATURE SEYCHELLES MA; GLADFELTER EH, 1978, B MAR SCI, V28, P728; Gledhill DK, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004629; Goergen EA, 2018, PEERJ, V6, DOI 10.7717/peerj.4433; GOREAU TF, 1959, ECOLOGY, V40, P67, DOI 10.2307/1929924; GOREAU TF, 1959, BIOL BULL, V117, P239, DOI 10.2307/1538903; Griffin S, 2012, P 8 INT SPAC SYNT S; Hernandez-Delgado Edwin A., 2014, Open Journal of Ecology, V4, P918, DOI 10.4236/oje.2014.414077; HernuYndez-Delgado EA., 2018, CORALS CHANGING WORL, P213, DOI [10.5772/intechopen.73151, DOI 10.5772/INTECHOPEN.73151]; HIGHSMITH RC, 1982, MAR ECOL PROG SER, V7, P207, DOI 10.3354/meps007207; Hightshoe MV, 2018, THESIS NOVA SE U; Jaap WC, 2000, ECOL ENG, V15, P345, DOI 10.1016/S0925-8574(00)00085-9; Johnson ME., 2011, NAT CONSERV; Kojis BL, 2001, B MAR SCI, V69, P967; Levy G, 2010, ECOL ENG, V36, P560, DOI 10.1016/j.ecoleng.2009.12.003; Lirman D, 2016, PEERJ, V4, DOI 10.7717/peerj.2597; Lirman D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107253; Lohr KE, 2017, J EXP MAR BIOL ECOL, V486, P87, DOI 10.1016/j.jembe.2016.10.005; Mbije NEJ, 2010, ECOL ENG, V36, P713, DOI 10.1016/j.ecoleng.2009.12.018; McWilliams JP, 2005, ECOLOGY, V86, P2055, DOI 10.1890/04-1657; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Nedimyer Kenneth, 2011, AACL Bioflux, V4, P442; O'Donnell KE, 2017, J EXP MAR BIOL ECOL, V487, P53, DOI 10.1016/j.jembe.2016.11.013; Osinga R, 2011, MAR BIOTECHNOL, V13, P658, DOI 10.1007/s10126-011-9382-7; Park S, 2008, EXCEL MICROSATELLITE; Pasch RJ, 2018, TROPICAL CYCLONE REP; PORTER JW, 1992, AM ZOOL, V32, P625; Quinn Norman J, 2006, Rev. biol. trop, V54, P105; R Core Team, 2021, R LANG ENV STAT; Rinkevich B, 2008, MAR POLLUT BULL, V56, P1821, DOI 10.1016/j.marpolbul.2008.08.014; Rinkevich B, 2015, J ENVIRON MANAGE, V162, P199, DOI 10.1016/j.jenvman.2015.07.028; Shafir S., 2010, REEF REHABILITATION, P49; Shafir S, 2006, MAR BIOL, V149, P679, DOI 10.1007/s00227-005-0236-6; Shaish L, 2008, J EXP MAR BIOL ECOL, V358, P86, DOI 10.1016/j.jembe.2008.01.024; Shearer TL, 2009, CORAL REEFS, V28, P727, DOI 10.1007/s00338-009-0520-x; Soong K, 2003, RESTOR ECOL, V11, P62, DOI 10.1046/j.1526-100X.2003.00100.x; Spurgeon JPG, 2001, B MAR SCI, V69, P1031; TUNNICLIFFE V, 1981, P NATL ACAD SCI-BIOL, V78, P2427, DOI 10.1073/pnas.78.4.2427; US Department of Commerce National Oceanic and Atmospheric Administration, TROP CYCL CLIM; Wapnick CM, 2004, ECOL LETT, V7, P354, DOI 10.1111/j.1461-0248.2004.00586.x; Young CN, 2012, B MAR SCI, V88, P1075, DOI 10.5343/bms.2011.1143	59	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267034	10.1371/journal.pone.0267034	http://dx.doi.org/10.1371/journal.pone.0267034			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D9PO	35468162	Green Published, gold			2022-12-26	WOS:000794129600004
J	Morales-Arraez, D; Hernandez, A; Hernandez-Bustabad, A; Amaral, C; Reygosa, C; Nicolas-Perez, D; Gimeno-Garcia, AZ; Hernandez-Guerra, M				Morales-Arraez, Dalia; Hernandez, Anjara; Hernandez-Bustabad, Alberto; Amaral, Carla; Reygosa, Cristina; Nicolas-Perez, David; Zebenzui Gimeno-Garcia, Antonio; Hernandez-Guerra, Manuel			Appropriateness of high-priority criteria and safety of endoscopy procedures during the COVID-19 lockdown	PLOS ONE			English	Article							COLORECTAL-CANCER; COLONOSCOPY; RISK	BackgroundDuring the coronavirus-19 disease (COVID-19) pandemic, gastroenterology guidelines recommended the suspension or reduction of non-urgent endoscopy. We aimed to assess the appropriateness and safety of endoscopic activity during the pandemic first wave lockdown using European Society of Gastrointestinal Endoscopy (ESGE) recommendations. MethodsWe identified scheduled patients from the onset of the lockdown in Spain since March 16, 2020) to April 14, 2020. Daily hospital COVID-19-related burden was also registered. A similar cohort from a period immediately before the lockdown was studied (pre-lockdown cohort) to compare appropriateness. Results454 endoscopy procedures were performed during the studied period, comprising a 49.7% reduction compared to the pre-lockdown cohort (n = 913). There was a significant increase in ESGE high-priority indications (62.1% vs. 45.6%, p<0.001) associated with an increase in relevant endoscopic findings (p = 0.006), advanced neoplasia/cancer (p = 0.004) and cancer detection rate (p = 0.010). There were no differences in the rate of admissions or infection among scheduled patients in the lockdown cohort. None of the staff members tested positive for COVID-19 in the 7 days after the adoption of protective measures. ConclusionA prioritized endoscopic activity is not associated with higher contagion after adopting protective measures. In addition, a triage of procedures that follow the ESGE criteria increases the rate of relevant endoscopic findings. These considerations may reduce the impact of the delays of diagnosis after the pandemic.	[Morales-Arraez, Dalia; Hernandez, Anjara; Hernandez-Bustabad, Alberto; Amaral, Carla; Reygosa, Cristina; Nicolas-Perez, David; Zebenzui Gimeno-Garcia, Antonio; Hernandez-Guerra, Manuel] Hosp Univ Canarias, Gastroenterol & Hepatol Dept, Tenerife, Spain; [Hernandez-Guerra, Manuel] Univ La Laguna, Inst Univ Tecnol Biomed CIBICAN, Dept Med Interna Psiquiatria & Dermatol, Tenerife, Spain	Universidad de la Laguna; Universidad de la Laguna	Hernandez-Guerra, M (corresponding author), Hosp Univ Canarias, Gastroenterol & Hepatol Dept, Tenerife, Spain.; Hernandez-Guerra, M (corresponding author), Univ La Laguna, Inst Univ Tecnol Biomed CIBICAN, Dept Med Interna Psiquiatria & Dermatol, Tenerife, Spain.	mhernand@ull.edu.es		Hdez Perez, M. Anjara/0000-0003-2548-6767	Fondo Europeo de Desarrollo Regional (FEDER); Instituto de Salud Carlos III [PI19/01756]	Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This study was supported in part by grants from Fondo Europeo de Desarrollo Regional (FEDER). Dr. M. Hernandez-Guerra is the recipient of a grant from Instituto de Salud Carlos III (PI19/01756). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Abreu I, 2017, DIS COLON RECTUM, V60, P837, DOI 10.1097/DCR.0000000000000863; Auge JM, 2014, GASTROENTEROLOGY, V147, P628, DOI 10.1053/j.gastro.2014.06.008; Bedford J, 2020, LANCET, V395, P1015, DOI 10.1016/S0140-6736(20)30673-5; Castro EC, 2020, GASTROINTEST ENDOSC, V92, P440, DOI 10.1016/j.gie.2020.03.3854; Corley DA, 2017, JAMA-J AM MED ASSOC, V317, P1631, DOI 10.1001/jama.2017.3634; Crespo J, 2021, J GASTROEN HEPATOL, V36, P1627, DOI 10.1111/jgh.15340; Crespo J, 2020, REV ESP ENFERM DIG, V112, P389, DOI 10.17235/reed.2020.7128/2020; Fuccio L, 2019, GASTROENTEROLOGY, V156, P1309, DOI 10.1053/j.gastro.2018.12.006; Garbr J, 2020, GASTROENTEROLOGY, V159, P778, DOI 10.1053/j.gastro.2020.04.061; Gimeno-Garcia AZ, 2021, ENDOSCOPY, V53, P662, DOI 10.1055/a-1453-0206; Gisbert JP., 2012, GASTROENT HEPAT-BARC, V35; Gralnek IM, 2020, NAT REV GASTRO HEPAT, V17, P444, DOI 10.1038/s41575-020-0312-x; Gralnek IM, 2020, ENDOSCOPY, V52, P483, DOI 10.1055/a-1155-6229; Gu JY, 2020, GASTROENTEROLOGY, V158, P1518, DOI 10.1053/j.gastro.2020.02.054; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hassan C, 2019, ENDOSCOPY, V51, P266, DOI 10.1055/a-0831-2522; Imperatore N, 2020, GUT, V69, P1544, DOI 10.1136/gutjnl-2020-321646; Johnston ER, 2019, GASTROINTEST ENDOSC, V89, P818, DOI 10.1016/j.gie.2018.10.034; Kennedy NA, 2020, GUT, V69, P984, DOI 10.1136/gutjnl-2020-321244; Lee YC, 2019, CLIN GASTROENTEROL H, V17, P1332, DOI 10.1016/j.cgh.2018.10.041; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Mahadev S, 2020, GASTROINTEST ENDOSC, V92, P788, DOI 10.1016/j.gie.2020.04.047; Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9; Repici A, 2020, GUT, V69, P1925, DOI 10.1136/gutjnl-2020-321341; Repici A, 2020, GASTROINTEST ENDOSC, V92, P192, DOI 10.1016/j.gie.2020.03.019; Selby K, 2019, GASTROENTEROLOGY, V157, P1494, DOI 10.1053/j.gastro.2019.08.023; Sultan S, 2020, GASTROENTEROLOGY, V159, P739, DOI 10.1053/j.gastro.2020.03.072; Taylor S, 2020, J ANXIETY DISORD, V72, DOI 10.1016/j.janxdis.2020.102232; Tian Y, 2020, ALIMENT PHARM THER, V51, P843, DOI 10.1111/apt.15731; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Xiao F, 2020, GASTROENTEROLOGY, V158, P1831, DOI 10.1053/j.gastro.2020.02.055; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267112	10.1371/journal.pone.0267112	http://dx.doi.org/10.1371/journal.pone.0267112			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D8GY	35482716	Green Published, gold			2022-12-26	WOS:000794035700002
J	Rattay, F; Tanzer, T				Rattay, Frank; Tanzer, Thomas			A simple model considering spiking probability during extracellular axon stimulation	PLOS ONE			English	Article							ACTION-POTENTIALS; AUDITORY-NERVE; ELECTRICAL-STIMULATION; MEMBRANE CURRENTS; ELECTROSTIMULATION; NOISE; NODE; FLUCTUATIONS; SIMULATION; THRESHOLD	The spiking probability of an electrically stimulated axon as a function of stimulus amplitude increases in a sigmoidal dependency from 0 to 1. However, most computer simulation studies for neuroprosthetic applications calculate thresholds for neural targets with a deterministic model and by reducing the sigmoid curve to a step function, they miss an important information about the control signal, namely how the spiking efficiency increases with stimulus intensity. Here, this spiking efficiency is taken into account in a compartment model of the Hodgkin Huxley type where a noise current is added in every compartment with an active membrane. A key parameter of the model is a common factor knoise which defines the ion current fluctuations across the cell membrane for every compartment by its maximum sodium ion conductance. In the standard model Gaussian signals are changed every 2.5 mu s as a compromise of accuracy and computational costs. Additionally, a formula for other noise transmission times is presented and numerically tested. Spiking probability as a function of stimulus intensity can be approximated by the cumulative distribution function of the normal distribution with RS = sigma/mu. Relative spread RS, introduced by Verveen, is a measure for the spread (normalized by the threshold intensity mu), that decreases inversely with axon diameter. Dynamic range, a related measure used in neuroprosthetic studies, defines the intensity range between 10% and 90% spiking probability. We show that (i) the dynamic range normalized by threshold is 2.56 times RS, (ii) RS increases with electrode-axon distance and (iii) we present knoise values for myelinated and unmyelinated axon models in agreement with recoded RS data. The presented method is applicable for other membrane models and can be extended to whole neurons that are described by multi-compartment models.	[Rattay, Frank; Tanzer, Thomas] Vienna Univ Technol, Inst Anal & Sci Comp, Vienna, Austria	Technische Universitat Wien	Rattay, F (corresponding author), Vienna Univ Technol, Inst Anal & Sci Comp, Vienna, Austria.	frank.rattay@tuwien.ac.at	Rattay, Frank/A-2231-2015	Rattay, Frank/0000-0002-2819-8827	Austrian Science Fund (FWF) [29650]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF), grant no. 29650. The fund supported publication costs but the authors received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badenhorst W, 2016, BIOL CYBERN, V110, P403, DOI 10.1007/s00422-016-0694-6; Boinagrov D, 2012, J NEUROPHYSIOL, V108, P3233, DOI 10.1152/jn.01058.2011; Bruce IC, 1999, IEEE T BIO-MED ENG, V46, P630, DOI 10.1109/10.764939; CHIU SY, 1979, J PHYSIOL-LONDON, V292, P149, DOI 10.1113/jphysiol.1979.sp012843; Chow CC, 1996, BIOPHYS J, V71, P3013, DOI 10.1016/S0006-3495(96)79494-8; Dynes S. B. C., 1996, THESIS MASSACHUSETTS; Eiber CD, 2021, J NEURAL ENG, V18, DOI 10.1088/1741-2552/ac36e2; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Fohlmeister JF, 2010, J NEUROPHYSIOL, V103, P1357, DOI 10.1152/jn.00123.2009; Goldwyn JH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002247; Goldwyn JH, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.041908; Greiner N, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20703-1; Heshmat A, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.599868; HOCHMAIRDESOYER IJ, 1984, NEUROSCIENCE, V13, P553, DOI 10.1016/0306-4522(84)90248-3; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Kreft HA, 2004, J ACOUST SOC AM, V116, P2258, DOI 10.1121/1.1786871; Kumaravelu K, 2022, BRAIN STIMUL, V15, P141, DOI 10.1016/j.brs.2021.11.015; Ladenbauer J, 2010, IEEE T NEUR SYS REH, V18, P637, DOI 10.1109/TNSRE.2010.2054112; McIntyre CC, 2002, J NEUROPHYSIOL, V87, P995, DOI 10.1152/jn.00353.2001; Meng K, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aabb7d; Miller CA, 1999, HEARING RES, V130, P197, DOI 10.1016/S0378-5955(99)00012-X; Mino H, 2002, ANN BIOMED ENG, V30, P578, DOI 10.1114/1.1475343; MOORE JW, 1978, BIOPHYS J, V21, P147, DOI 10.1016/S0006-3495(78)85515-5; MOTZ H, 1986, NEUROSCIENCE, V18, P699, DOI 10.1016/0306-4522(86)90064-3; PORTER R, 1963, J PHYSIOL-LONDON, V169, P630, DOI 10.1113/jphysiol.1963.sp007285; Potrusil T, 2020, HEARING RES, V393, DOI 10.1016/j.heares.2020.108001; Rattay F, 1999, NEUROSCIENCE, V89, P335, DOI 10.1016/S0306-4522(98)00330-3; RATTAY F, 1993, IEEE T BIO-MED ENG, V40, P1201, DOI 10.1109/10.250575; Rattay F, 1997, Z ANGEW MATH MECH, V77, P935, DOI 10.1002/zamm.19970771212; Rattay F, 2010, NEUROSCIENCE, V170, P399, DOI 10.1016/j.neuroscience.2010.07.032; Rattay F, 2001, HEARING RES, V153, P43, DOI 10.1016/S0378-5955(00)00256-2; RATTAY F, 1986, J THEOR BIOL, V123, P45, DOI 10.1016/S0022-5193(86)80234-X; Rattay F, 2000, CHAOS SOLITON FRACT, V11, P1875, DOI 10.1016/S0960-0779(99)00124-1; Rattay F., 1990, ELECT NERVE STIMULAT, DOI [10.1121/1.399883, DOI 10.1121/1.399883]; Rattay F., 2002, HDB NEUROPROSTHETIC, P39; Rattay F, 2022, J NEURAL ENG, V19, DOI 10.1088/1741-2552/ac50bf; Rattay Frank, 2021, Minerva Med, DOI 10.23736/S0026-4806.21.07588-1; Rattay F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079256; Romeni S, 2020, NAT PROTOC, V15, P3129, DOI 10.1038/s41596-020-0377-6; RUBINSTEIN JT, 1995, BIOPHYS J, V68, P779, DOI 10.1016/S0006-3495(95)80252-3; SCHWARZ JR, 1995, PFLUG ARCH EUR J PHY, V430, P283, DOI 10.1007/BF00374660; Shepherd RK, 1997, HEARING RES, V108, P112, DOI 10.1016/S0378-5955(97)00046-4; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; SOLOMONOW M, 1984, IEEE T BIO-MED ENG, V31, P752, DOI 10.1109/TBME.1984.325235; Sweeney J. D., 1987, IEEE 9 ANN C ENG MED, V3; Tai CF, 2011, J COMPUT NEUROSCI, V31, P615, DOI 10.1007/s10827-011-0329-9; Tanzer T., 2021, THESIS VIENNA U TECH; Verveen A.A., 1960, STRUCTURE FUNCTION C, P282; Vilkhu RS, 2021, J NEURAL ENG, V18, DOI 10.1088/1741-2552/ac3450; Werginz P, 2014, NEUROSCIENCE, V266, P162, DOI 10.1016/j.neuroscience.2014.01.067; White JA, 2000, TRENDS NEUROSCI, V23, P131, DOI 10.1016/S0166-2236(99)01521-0; WILSON BS, 1991, NATURE, V352, P236, DOI 10.1038/352236a0	52	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0264735	10.1371/journal.pone.0264735	http://dx.doi.org/10.1371/journal.pone.0264735			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446861	Green Published, gold			2022-12-26	WOS:000795468200064
J	Shahbari, NAE; Gesser-Edelsburg, A; Davidovitch, N; Brammli-Greenberg, S; Mesch, GS				Shahbari, Nour Abed Elhadi; Gesser-Edelsburg, Anat; Davidovitch, Nadav; Brammli-Greenberg, Shuli; Mesch, Gustavo S.			Risk perceptions regarding inclusion of seasonal influenza vaccinations in the school immunization program in Israel: Arab vs. Jewish mothers	PLOS ONE			English	Article							PARENTAL ATTITUDES; CHILDREN; KNOWLEDGE; COVERAGE; ELEMENTARY; PREDICTORS; VACCINES; NEED	BackgroundThe issue of whether to include seasonal influenza vaccinations in school-located vaccination programs (SLIV) has been examined in many countries, mainly in the context of economic effectiveness and morbidity prevention. Yet not enough studies have examined the impact of parental risk perceptions, health literacy and SLIV on parental vaccination uptake. ObjectivesThe most recent statistics in Israel point to a higher rate of seasonal influenza vaccination among Arab children (aged 7-9 years) than among Jewish children in the same age group. The present study attempts to explain this high vaccination uptake among mothers from Arab society by comparing their risk perceptions regarding seasonal influenza vaccination and disease to those of Jewish mothers. The study further examines the impact of SLIV on parental risk perceptions and influenza vaccination uptake. MethodsThis cross-sectional study included mothers of children in the second and third grades faced with the decision of whether their children should receive the seasonal influenza vaccination at school. The study population included a stratified sample of Jewish mothers (n = 159) and Arab mothers from all the Arab population sub-groups: Muslim, Christian, Druse and Bedouin (n = 534). ResultsA comparison of the Arab and Jewish populations revealed a significant difference in vaccination rates; 61.7% among Arab mothers compared to 33.5% among Jewish mothers (chi(2)(1) = 39.15, P<0.0001). Moreover, significant differences emerged between the Arab and Jewish populations in health literacy and ability to seek information regarding the seasonal influenza vaccination (t (691) = -5.81, p < 0.0001). While no differences emerged in mothers' perceptions regarding influenza as a disease (t (691) = 1.20, p = 0.2318), Arab mothers perceived the vaccination to be safer than Jewish mothers (t (691) = 2.74, p = 0.0063) and saw its inclusion in the school-located vaccination program as providing more legitimacy (Z = -6.6719, P < .0001). ConclusionThis study showed that the factors influencing vaccination uptake among both the Arab and the Jewish populations include perceived influenza risk, perceived vaccination risk, inclusion in the school-located vaccination program and health literacy. Moreover, influenza vaccination uptake is higher among those who have positive attitudes toward vaccinations, low risk perceptions regarding the vaccine, and low health literacy that impedes their ability to seek information. The research also points to the need for education and tools to boost health literacy among minority groups so that mothers can make independent and informed decisions about whether or not to vaccinate their children.	[Shahbari, Nour Abed Elhadi; Gesser-Edelsburg, Anat] Univ Haifa, Sch Publ Hlth, Haifa, Israel; [Gesser-Edelsburg, Anat] Univ Haifa, Hlth & Risk Commun Lab, Haifa, Israel; [Davidovitch, Nadav] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Hlth Syst Management, Beer Sheva, Israel; [Brammli-Greenberg, Shuli] Hebrew Univ Jerusalem, Braun Sch Publ Hlth & Community Med, Jerusalem, Israel; [Mesch, Gustavo S.] Univ Haifa, Dept Sociol & Anthropol, Haifa, Israel; [Gesser-Edelsburg, Anat; Mesch, Gustavo S.] Univ Haifa, Haifa, Israel; [Davidovitch, Nadav] Ben Gurion Univ Negev, Beer Sheva, Israel; [Brammli-Greenberg, Shuli] Hebrew Univ Jerusalem, Jerusalem, Israel	University of Haifa; University of Haifa; Ben Gurion University; Hebrew University of Jerusalem; University of Haifa; University of Haifa; Ben Gurion University; Hebrew University of Jerusalem	Shahbari, NAE (corresponding author), Univ Haifa, Sch Publ Hlth, Haifa, Israel.	nonoshahbary@gmail.com		Gesser-Edelsburg, PhD, Prof. Anat/0000-0003-4467-8799				Aharon AA, 2020, J RACIAL ETHN HEALTH, V7, P298, DOI 10.1007/s40615-019-00658-w; Al-lela OQB, 2011, J PUBLIC HEALTH-HEID, V19, P497, DOI 10.1007/s10389-011-0411-9; Allison MA, 2010, PEDIATR INFECT DIS J, V29, P751, DOI 10.1097/INF.0b013e3181d8562c; Assaf AM, 2016, VIRAL IMMUNOL, V29, P516, DOI 10.1089/vim.2015.0135; Bekkat-Berkani R, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0420-8; Ben Natan M, 2016, J PEDIATR NURS, V31, P293, DOI 10.1016/j.pedn.2015.12.014; Bukhsh A, 2018, HUM VACC IMMUNOTHER, V14, P952, DOI 10.1080/21645515.2017.1415686; Cheung S, 2015, INFLUENZA OTHER RESP, V9, P255, DOI 10.1111/irv.12332; Cho A, 2016, CURR OPIN VIROL, V17, P110, DOI 10.1016/j.coviro.2016.03.002; Daley MF, 2006, PEDIATRICS, V117, pE268, DOI 10.1542/peds.2005-1752; Elran B, 2018, VACCINE, V36, P8062, DOI 10.1016/j.vaccine.2018.10.078; Fairbrother G, 2010, VACCINE, V28, P4913, DOI 10.1016/j.vaccine.2010.05.036; Fiore AE., 2010, PREVENTION CONTROL I; Ganczak M, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14060665; Gesser-Edelsburg A., 2016, RISK COMMUNICATION I; Gesser-Edelsburg A, 2017, AM J INFECT CONTROL, V45, P267, DOI 10.1016/j.ajic.2016.10.009; Gesser-Edelsburg A, 2016, J RISK RES, V19, P405, DOI 10.1080/13669877.2014.983947; Ghebrehewet S, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6258; Glatman-Freedman A, 2019, ISR J HEALTH POLICY, V8, DOI 10.1186/s13584-019-0349-x; Grohskopf LA, 2019, MMWR RECOMM REP, V68, P1, DOI 10.15585/mmwr.rr6803a1; Heikkinen T, 2013, PEDIATR INFECT DIS J, V32, P881, DOI 10.1097/INF.0b013e3182918168; Jackson SL., 2015, RES METHODS STAT CRI; Jefferson T, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004879.pub5; Kalligeros M, 2020, VACCINE, V38, P2893, DOI 10.1016/j.vaccine.2020.02.049; Malosh R, 2014, VACCINE, V32, P1841, DOI 10.1016/j.vaccine.2014.01.075; Mereckiene J, 2010, EUROSURVEILLANCE, V15, P11; Ministry of Health, 2020, 1 PRZYP KOR POLSC MI; Nakayama T, 2013, J INFECT CHEMOTHER, V19, P787, DOI 10.1007/s10156-013-0641-6; National Health Commission of the People's Republic of China, 2018, Chinese Journal of Viral Diseases, V8, P347; Norman DA, 2019, VACCINE, V37, P2244, DOI 10.1016/j.vaccine.2019.02.077; Omer SB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000441; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Paules CI, 2018, NEW ENGL J MED, V378, P7, DOI 10.1056/NEJMp1714916; Paxton GA, 2011, J PAEDIATR CHILD H, V47, P888, DOI 10.1111/j.1440-1754.2011.02099.x; Pebody R, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES.2015.20.36.30013; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Ramprasad C, 2017, WORLD J PEDIATR, V13, P84, DOI 10.1007/s12519-016-0053-7; Sarndal C.-E., 2003, MODEL ASSISTED SURVE; Schmid P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170550; Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99; Segaloff HE, 2019, CLIN INFECT DIS, V69, P2153, DOI 10.1093/cid/ciz125; Shahbari NAE, 2020, VACCINE, V38, P29, DOI 10.1016/j.vaccine.2019.10.002; Shahbari NAE, 2019, J MED INTERNET RES, V21, DOI 10.2196/13373; Shuaib FMB, 2010, W INDIAN MED J, V59, P549; Stein Y, 2018, CLIN INFECT DIS, V66, P1383, DOI 10.1093/cid/cix1013; Weinstein ND, 2007, HEALTH PSYCHOL, V26, P146, DOI 10.1037/0278-6133.26.2.146; Yoo BK, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4228-5; Zamir CS, 2017, MATERN CHILD HLTH J, V21, P1010, DOI 10.1007/s10995-017-2272-5; Zeraiq L, 2015, SCAND J PUBLIC HEALT, V43, P408, DOI 10.1177/1403494815569105	49	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267279	10.1371/journal.pone.0267279	http://dx.doi.org/10.1371/journal.pone.0267279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7MW	35436312	gold, Green Published			2022-12-26	WOS:000791258900003
J	Erath, J; Djuranovic, S				Erath, Jessey; Djuranovic, Sergej			Association of the receptor for activated C-kinase 1 with ribosomes in Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; MALARIA PARASITES; HOST ERYTHROCYTE; QUALITY-CONTROL; SWISS-MODEL; RACK1; TRANSLATION; DATABASE; RNA; PREDICTION	The receptor for activated C-kinase 1 (RACK1), a highly conserved eukaryotic protein, is known to have many varying biological roles and functions. Previous work has established RACK1 as a ribosomal protein, with defined regions important for ribosome binding in eukaryotic cells. In Plasmodium falciparum, RACK1 has been shown to be required for parasite growth, however, conflicting evidence has been presented about RACK1 ribosome binding and its role in mRNA translation. Given the importance of RACK1 as a regulatory component of mRNA translation and ribosome quality control, the case could be made in parasites that RACK1 either binds or does not bind the ribosome. Here, we used bioinformatics and transcription analyses to further characterize the P. falciparum RACK1 protein. Based on homology modeling and structural analyses, we generated a model of P. falciparum RACK1. We then explored mutant and chimeric human and P. falciparum RACK1 protein binding properties to the human and P. falciparum ribosome. We found that WT, chimeric, and mutant RACK1 exhibit distinct ribosome interactions suggesting different binding characteristics for P. falciparum and human RACK1 proteins. The ribosomal binding of RACK1 variants in human and parasite cells shown here demonstrates that although RACK1 proteins have highly conserved sequences and structures across species, ribosomal binding is affected by species-specific alterations to this protein. In conclusion, we show that in the case of P. falciparum, contrary to the structural data, RACK1 is found to bind ribosomes and actively translating polysomes in parasite cells.	[Erath, Jessey; Djuranovic, Sergej] Washington Univ Sch Med, Dept Cell Biol & Physiol, St Louis, MO USA	Washington University (WUSTL)	Djuranovic, S (corresponding author), Washington Univ Sch Med, Dept Cell Biol & Physiol, St Louis, MO USA.	sergej.djuranovic@wustl.edu		Erath, Jessey/0000-0001-8802-635X; Djuranovic, Sergej/0000-0002-9417-0822	NIH [R01 GM112824, R01 GM136823]; NIH [R01 GM112824, R01 GM136823, R01 MH116999, T32 GM007067]; Washington University LEAP Gap Fund [1014]; Washington University Institute of Clinical and Translational Sciences; NIH/National Center for Advancing Translational Sciences (NCATS) [UL1TR002345]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University LEAP Gap Fund; Washington University Institute of Clinical and Translational Sciences; NIH/National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The authors thank Slavica Pavlovic Djuranovic, and members of Daniel Goldberg?s and Sergej Djuranovic?s lab for helpful comments. Funding and additional information: This work is supported by NIH R01 GM112824, NIH R01 GM136823, and NIMH R01 MH116999 to S. D., and NIH T32 GM007067 and NIMH R01 MH116999 to J. E. We are also thankful to WUCCI center of Washington University on the help with this project. The Washington University LEAP Gap Fund supported this project through the Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship under award number #1014, the Washington University Institute of Clinical and Translational Sciences, and the NIH/National Center for Advancing Translational Sciences (NCATS) grant UL1TR002345. The content is solely the re-sponsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arthur LL, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500154; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bertoni M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09654-8; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Blomqvist K, 2017, MOL BIOCHEM PARASIT, V211, P62, DOI 10.1016/j.molbiopara.2016.10.002; Bradford W, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003768; Brown A, 2015, NATURE, V524, P493, DOI 10.1038/nature14896; Bunnik EM, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1014-0; Caro F, 2014, ELIFE, V3, DOI 10.7554/eLife.04106; Carrillo DR, 2012, ACTA CRYSTALLOGR F, V68, P867, DOI 10.1107/S1744309112027480; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Gallo S, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00230-18; Glushakova S, 2009, CELL MICROBIOL, V11, P95, DOI 10.1111/j.1462-5822.2008.01242.x; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hale VL, 2017, P NATL ACAD SCI USA, V114, P3439, DOI 10.1073/pnas.1619441114; Hanson J, 2017, BIOINFORMATICS, V33, P685, DOI 10.1093/bioinformatics/btw678; Heffernan R, 2017, BIOINFORMATICS, V33, P2842, DOI 10.1093/bioinformatics/btx218; Ikeuchi K, 2016, FEBS LETT, V590, P3254, DOI 10.1002/1873-3468.12366; Jain BP, 2018, PROTEIN J, V37, P391, DOI 10.1007/s10930-018-9785-7; Jha S, 2017, NATURE, V546, P651, DOI 10.1038/nature22814; Joazeiro CAP, 2017, ANNU REV CELL DEV BI, V33, P343, DOI 10.1146/annurev-cellbio-111315-125249; Johnson AG, 2019, RNA, V25, P881, DOI 10.1261/rna.071217.119; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Klausen MS, 2019, PROTEINS, V87, P520, DOI 10.1002/prot.25674; Kouba T, 2012, NUCLEIC ACIDS RES, V40, P2683, DOI 10.1093/nar/gkr1083; Kuroha K, 2010, EMBO REP, V11, P956, DOI 10.1038/embor.2010.169; Lacsina JR, 2011, MOL BIOCHEM PARASIT, V179, P42, DOI 10.1016/j.molbiopara.2011.05.003; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Lopez-Barragan MJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-587; McGlincy NJ, 2017, METHODS, V126, P112, DOI 10.1016/j.ymeth.2017.05.028; Nielsen MH, 2017, CELL SIGNAL, V35, P272, DOI 10.1016/j.cellsig.2017.01.026; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Pease BN, 2013, J PROTEOME RES, V12, P4028, DOI 10.1021/pr400394g; Regmi S, 2008, MOL MICROBIOL, V70, P724, DOI 10.1111/j.1365-2958.2008.06443.x; Rollins MG, 2019, J CELL SCI, V132, DOI 10.1242/jcs.228908; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Salmon BL, 2001, P NATL ACAD SCI USA, V98, P271, DOI 10.1073/pnas.011413198; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; SMITH BL, 1992, BIOCHEM BIOPH RES CO, V188, P1235, DOI 10.1016/0006-291X(92)91363-U; Studer G, 2020, BIOINFORMATICS, V36, P1765, DOI 10.1093/bioinformatics/btz828; Sugiyama T, 2019, CELL REP, V26, P3400, DOI 10.1016/j.celrep.2019.02.067; Sun M, 2015, NUCLEIC ACIDS RES, V43, P10515, DOI 10.1093/nar/gkv991; Sundaramoorthy E, 2017, MOL CELL, V65, P751, DOI 10.1016/j.molcel.2016.12.026; Thompson MK, 2016, ELIFE, V5, DOI 10.7554/eLife.11154; Trager W, 2005, J PARASITOL, V91, P484, DOI 10.1645/0022-3395(2005)091[0484:HMPICC]2.0.CO;2; Varadi M, 2022, NUCLEIC ACIDS RES, V50, pD439, DOI 10.1093/nar/gkab1061; Vincensini L, 2005, MOL CELL PROTEOMICS, V4, P582, DOI 10.1074/mcp.M400176-MCP200; von Bohl A, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0967-x; WARNER JR, 1977, J MOL BIOL, V115, P315, DOI 10.1016/0022-2836(77)90157-7; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wong W, 2014, ELIFE, V3, DOI 10.7554/eLife.03080; Yan RX, 2013, SCI REP-UK, V3, DOI 10.1038/srep02619; Yuan L, 2017, FUNGAL GENET BIOL, V99, P52, DOI 10.1016/j.fgb.2017.01.003; Zanghi G, 2018, CELL REP, V22, P2951, DOI 10.1016/j.celrep.2018.02.075; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	63	1	1	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101954	10.1016/j.jbc.2022.101954	http://dx.doi.org/10.1016/j.jbc.2022.101954			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T5WI	35452681	Green Published, gold			2022-12-26	WOS:000804798000003
J	Nagata, K; Hishikawa, D; Sagara, H; Saito, M; Watanabe, S; Shimizu, T; Shindou, H				Nagata, Katsuyuki; Hishikawa, Daisuke; Sagara, Hiroshi; Saito, Masamichi; Watanabe, Sumiko; Shimizu, Takao; Shindou, Hideo			Lysophosphatidylcholine acyltransferase 1 controls mitochondrial reactive oxygen species generation and survival of retinal photoreceptor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYSICAL-PROPERTIES; ACYL-COA; DEGENERATION; METABOLISM; RHODOPSIN; PROLIFERATION; DESATURASE; EXPRESSION; RECEPTORS; PROTECTS	Due to their high energy demands and characteristic morphology, retinal photoreceptor cells require a specialized lipid metabolism for survival and function. Accordingly, dysregulation of lipid metabolism leads to the photoreceptor cell death and retinal degeneration. Mice bearing a frameshift mutation in the gene encoding lysophosphatidylcholine acyltransferase 1 (Lpcat1), which produces saturated phosphatidylcholine (PC) composed of two saturated fatty acids, has been reported to cause spontaneous retinal degeneration in mice; however, the mechanism by which this mutation affects degeneration is unclear. In this study, we performed a detailed characterization of LPCAT1 in the retina and found that genetic deletion of Lpcat1 induces light-independent and photoreceptor-specific apoptosis in mice. Lipidomic analyses of the retina and isolated photoreceptor outer segment (OS) suggested that loss of Lpcat1 not only decreased saturated PC production but also affected membrane lipid composition, presumably by altering saturated fatty acyl-CoA availability. Furthermore, we demonstrated that Lpcat1 deletion led to increased mitochondrial reactive oxygen species levels in photoreceptor cells, but not in other retinal cells, and did not affect the OS structure or trafficking of OS-localized proteins. These results suggest that the LPCAT1-dependent production of saturated PC plays critical roles in photoreceptor maturation. Our findings highlight the therapeutic potential of saturated fatty acid metabolism in photoreceptor cell degeneration-related retinal diseases.	[Nagata, Katsuyuki; Hishikawa, Daisuke; Shimizu, Takao; Shindou, Hideo] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Shinjuku Ku, Tokyo, Japan; [Sagara, Hiroshi] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo, Japan; [Saito, Masamichi] Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo, Japan; [Watanabe, Sumiko] Univ Tokyo, Inst Med Sci, Div Mol & Dev Biol, Minato Ku, Tokyo, Japan; [Shindou, Hideo] Univ Tokyo, Grad Sch Med, Dept Lipid Sci, Bunkyo Ku, Tokyo, Japan	National Center for Global Health & Medicine - Japan; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Shindou, H (corresponding author), Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Shinjuku Ku, Tokyo, Japan.; Shindou, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Lipid Sci, Bunkyo Ku, Tokyo, Japan.	hshindou@ri.ncgm.go.jp	Sagara, Hiroshi/GRX-7740-2022	Sagara, Hiroshi/0000-0001-8456-8362; Sagara, HIroshi/0000-0003-3473-9850	AMED-CREST, Japan [21gm0910011]; AMED-PCREATE, Japan [21cm0106116]; AMED Program for Basic and Clinical Research on Hepatitis [21fk0210091h]; Takeda Science Foundation, Japan [15668360]	AMED-CREST, Japan; AMED-PCREATE, Japan; AMED Program for Basic and Clinical Research on Hepatitis; Takeda Science Foundation, Japan(Takeda Science Foundation (TSF))	This study was supported by AMED-CREST, Japan 21gm0910011 (Hideo Shindou), AMED-PCREATE, Japan 21cm0106116 (Hideo Shindou), AMED Program for Basic and Clinical Research on Hepatitis 21fk0210091h (Hideo Shindou), and Takeda Science Foundation, Japan 15668360 (T. S.).	Akagi S, 2016, FASEB J, V30, P2027, DOI 10.1096/fj.201500149; Ariyama H, 2010, J BIOL CHEM, V285, P22027, DOI 10.1074/jbc.M110.126870; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Bi JF, 2019, CELL METAB, V30, P525, DOI 10.1016/j.cmet.2019.06.014; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bridges JP, 2010, J CLIN INVEST, V120, P1736, DOI 10.1172/JCI38061; Chang B, 2007, VISION RES, V47, P624, DOI 10.1016/j.visres.2006.11.020; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Chen L, 2016, SCI REP-UK, V6, DOI 10.1038/srep19665; Cheng X, 2020, CELL METAB, V32, P229, DOI 10.1016/j.cmet.2020.06.002; Dai XF, 2014, INVEST OPHTH VIS SCI, V55, P1724, DOI 10.1167/iovs.13-13654; Eberle D, 2011, INVEST OPHTH VIS SCI, V52, P6462, DOI 10.1167/iovs.11-7399; Egnatchik RA, 2014, METABOLISM, V63, P283, DOI 10.1016/j.metabol.2013.10.009; Estadella D, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/137579; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; Friedman JS, 2010, P NATL ACAD SCI USA, V107, P15523, DOI 10.1073/pnas.1002897107; Fu ZJ, 2021, J LIPID RES, V62, DOI 10.1194/jlr.TR120000618; Fu ZJ, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201910473; Geller SF, 2003, ADV EXP MED BIOL, V533, P249; Grunin M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29046; Hamano F, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100303; Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40; Harayama T, 2008, J BIOL CHEM, V283, P11097, DOI 10.1074/jbc.M708909200; Harayama T, 2018, NAT REV MOL CELL BIO, V19, P281, DOI 10.1038/nrm.2017.138; Harayama T, 2014, CELL METAB, V20, P295, DOI 10.1016/j.cmet.2014.05.019; Joyal JS, 2016, NAT MED, V22, P439, DOI 10.1038/nm.4059; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Koso H, 2009, INVEST OPHTH VIS SCI, V50, P5411, DOI 10.1167/iovs.08-3246; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; LOLLEY R N, 1976, Annals of Ophthalmology, V8, P469; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Ogiso H, 2014, METABOLITES, V4, P98, DOI 10.3390/metabo4010098; Pan WW, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-01765-3; Sander CL, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202101063; Scaglia N, 2005, J BIOL CHEM, V280, P25339, DOI 10.1074/jbc.M501159200; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Shindou H, 2017, J BIOL CHEM, V292, P12054, DOI [10.1074/jbc.M117.790568, 10.1074/jbc.m117.790568]; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Uematsu M, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02679-w; Valentine WJ, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2021.101470; Volmer R, 2015, CURR OPIN CELL BIOL, V33, P67, DOI 10.1016/j.ceb.2014.12.002; Yanagida K, 2020, DEV CELL, V52, P779, DOI 10.1016/j.devcel.2020.01.016	49	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101958	10.1016/j.jbc.2022.101958	http://dx.doi.org/10.1016/j.jbc.2022.101958			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9FR	35452679	Green Published, Green Submitted, gold			2022-12-26	WOS:000807755100012
J	Shen, BB; Zhang, YX				Shen, Beibei; Zhang, Yunxin			A mechanochemical model of the forward/backward movement of motor protein kinesin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECK LINKER; 8-NM STEP; FORCE; MECHANISM; DYNAMICS; BINDING; CYCLE; ATP	Kinesin-1 is an ATP-driven, two-headed motor protein that transports intracellular cargoes (loads) along microtubules. The movement of kinesin-1 has generally been modeled according to its correlation with ATP cleavage (forward movement), synthesis (backward movement), or unproductive cleavage (futile consumption). Based on recent experimental observations, we formulate a mechanochemical model for this movement in which the forward/backward/futile cycle can be realized through multiple biochemical pathways. Our results show that the backward motion of kinesin-1 occurs mainly through backward sliding along the microtubule and is usually also coupled with ATP hydrolysis. We also found that with a low external load, about 80% of ATP is wasted (futile consumption) by kinesin-1. Furthermore, at high ATP concentrations or under high external loads, both heads of kinesin-1 are always in the ATP- or ADP . Pi-binding state and tightly bound to the microtubule, while at low ATP concentrations and low loads, kinesin-1 is mainly in the one-head-bound state. Unless the external load is near the stall force, the motion of kinesin-1 is almost deterministic.	[Shen, Beibei; Zhang, Yunxin] Fudan Univ, Sch Math Sci, Shanghai Key Lab Contemporary Appl Math, Shanghai, Peoples R China	Fudan University	Zhang, YX (corresponding author), Fudan Univ, Sch Math Sci, Shanghai Key Lab Contemporary Appl Math, Shanghai, Peoples R China.	xyz@fudan.edu.cn						Al-Bassam J, 2003, J CELL BIOL, V163, P743, DOI 10.1083/jcb.200308020; Ariga T, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.218101; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; Block SM, 2003, P NATL ACAD SCI USA, V100, P2351, DOI 10.1073/pnas.0436709100; Block SM, 2007, BIOPHYS J, V92, P2986, DOI 10.1529/biophysj.106.100677; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Case RB, 2000, CURR BIOL, V10, P157, DOI 10.1016/S0960-9822(00)00316-X; Chowdhury D, 2013, PHYS REP, V529, P1, DOI 10.1016/j.physrep.2013.03.005; Clancy BE, 2011, NAT STRUCT MOL BIOL, V18, P1020, DOI 10.1038/nsmb.2104; Coppin CM, 1997, P NATL ACAD SCI USA, V94, P8539, DOI 10.1073/pnas.94.16.8539; Coppin CM, 1996, P NATL ACAD SCI USA, V93, P1913, DOI 10.1073/pnas.93.5.1913; Coy DL, 1999, J BIOL CHEM, V274, P3667, DOI 10.1074/jbc.274.6.3667; Fisher ME, 2001, P NATL ACAD SCI USA, V98, P7748, DOI 10.1073/pnas.141080498; Gardiner C., 2010, STOCHASTIC METHODS H; Guydosh NR, 2009, NATURE, V461, P125, DOI 10.1038/nature08259; Hariharan V, 2009, CELL MOL BIOENG, V2, P177, DOI 10.1007/s12195-009-0059-5; Higuchi H, 2004, EMBO J, V23, P2993, DOI 10.1038/sj.emboj.7600306; Howard J., 2001, MECH MOTOR PROTEINS; Kalchishkova N, 2008, J MOL BIOL, V382, P127, DOI 10.1016/j.jmb.2008.06.092; Kampen NGV, 2007, STOCHASTIC PROCESSES, V3; Kolomeisky AB, 2015, MOTOR PROTEINS AND MOLECULAR MOTORS, P1, DOI 10.1201/b18426; Kolomeisky AB, 2007, ANNU REV PHYS CHEM, V58, P675, DOI 10.1146/annurev.physchem.58.032806.104532; Muller MJI, 2008, P NATL ACAD SCI USA, V105, P4609, DOI 10.1073/pnas.0706825105; Mugnai ML, 2020, REV MOD PHYS, V92, DOI 10.1103/RevModPhys.92.025001; Nishiyama M, 2001, NAT CELL BIOL, V3, P425, DOI 10.1038/35070116; Parrondo JMR, 2002, APPL PHYS A-MATER, V75, P179, DOI 10.1007/s003390201332; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Schnitzer MJ, 2000, NAT CELL BIOL, V2, P718, DOI 10.1038/35036345; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Toleikis A, 2020, BIOPHYS J, V119, P1984, DOI 10.1016/j.bpj.2020.09.034; Tomishige M, 2006, NAT STRUCT MOL BIOL, V13, P887, DOI 10.1038/nsmb1151; Toprak E, 2009, P NATL ACAD SCI USA, V106, P12717, DOI 10.1073/pnas.0808396106; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Zhang YX, 2008, BIOPHYS CHEM, V136, P19, DOI 10.1016/j.bpc.2008.04.002; Zhang YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032717; Zhang YX, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011923	42	0	0	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101948	10.1016/j.jbc.2022.101948	http://dx.doi.org/10.1016/j.jbc.2022.101948			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3R4NR	35447112	Green Published, gold			2022-12-26	WOS:000838892100007
J	Hsiao, PF; Huang, YT; Lu, PH; Chiu, LY; Weng, TH; Hung, CF; Wu, NL				Hsiao, Pa-Fan; Huang, Yi-Ting; Lu, Po-Hsuan; Chiu, Ling-Ya; Weng, Tzu-Han; Hung, Chi-Feng; Wu, Nan-Lin			Thioredoxin-interacting protein regulates keratinocyte differentiation: Implication of its role in psoriasis	FASEB JOURNAL			English	Article						differentiation; EGFR; keratinocyte; psoriasis; TXNIP	HUMAN EPIDERMAL-KERATINOCYTES; INVOLUCRIN EXPRESSION; FACTOR-ALPHA; SKIN; TXNIP; ACTIVATION; GENE; P63; PATHOGENESIS; CONTRIBUTES	Thioredoxin-interacting protein (TXNIP), also known as Vitamin-D upregulated protein-1 (VDUP-1), interacts with thioredoxin to regulate redox responses and participates in diverse disorders including metabolic, cardiovascular, inflammatory and malignant diseases. Psoriasis is characterized by chronic skin inflammation and an aberrant pattern of keratinocyte differentiation. Clinically, psoriasis is associated with various cardiometabolic comorbidities but studies on TXNIP's biological role in skin disorders are limited. In this study, we investigated TXNIP expression in psoriasis and its regulation in normal human epidermal keratinocytes (NHEKs), and then explored how TXNIP regulated skin keratinocyte differentiation to determine its role in psoriasis pathogenesis. Our immunohistochemical study demonstrated extensive TXNIP expression in the upper and lower epidermis of psoriasis compared to predominant TXNIP expression in the basal layer of normal skin. 1, 25-dihydroxyvitamin D-3 suppressed but TGF-alpha and EGF enhanced TXNIP expression in NHEKs. An inducer of keratinocyte differentiation, phorbol 12-myristate 13-acetate (PMA), also diminished TXNIP expression, which was reversed by PKC-delta knockdown. TXNIP knockdown reduced PMA-induced involucrin and transglutaminse-1 expression, and increased p63 expression in NHEKs but did not significantly affect cell proliferation. H2O2-induced ROS production and EGFR phosphorylation decreased in NHEKs with TXNIP knockdown. Furthermore, PMA-induced PKC-delta phosphorylation, TGF-alpha, and EGF-triggered EGFR phosphorylation were attenuated by TXNIP knockdown. Our results unraveled the regulation and function of TXNIP expression in skin keratinocytes and the cross-regulation between TXNIP and EGFR signaling. These findings imply a role of TXNIP in psoriasis and provide insight into the possible impact of TXNIP regulators on the skin or psoriasis.	[Hsiao, Pa-Fan; Lu, Po-Hsuan; Wu, Nan-Lin] MacKay Mem Hosp, Dept Dermatol, 92,Sec 2,Zhongshan N Rd, Taipei 10449, Taiwan; [Hsiao, Pa-Fan; Lu, Po-Hsuan; Wu, Nan-Lin] MacKay Med Coll, Dept Med, New Taipei, Taiwan; [Hsiao, Pa-Fan; Wu, Nan-Lin] MacKay Jr Coll Med Nursing & Management, Taipei, Taiwan; [Huang, Yi-Ting; Chiu, Ling-Ya] MacKay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Chiu, Ling-Ya] Natl Taiwan Univ, Coll Med, Dept Pharmacol, Taipei, Taiwan; [Weng, Tzu-Han] MacKay Mem Hosp, Dept Med Educ, Taipei, Taiwan; [Hung, Chi-Feng] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Hung, Chi-Feng] Fu Jen Catholic Univ, Grad Inst Biomed & Pharmaceut Sci, New Taipei, Taiwan; [Wu, Nan-Lin] MacKay Med Coll, Inst Biomed Sci, New Taipei, Taiwan	Mackay Memorial Hospital; Mackay Medical College; Mackay Junior College of Medicine, Nursing & Management; Mackay Memorial Hospital; National Taiwan University; Mackay Memorial Hospital; Fu Jen Catholic University; Fu Jen Catholic University; Mackay Medical College	Wu, NL (corresponding author), MacKay Mem Hosp, Dept Dermatol, 92,Sec 2,Zhongshan N Rd, Taipei 10449, Taiwan.	alvinwu.alvinwu@gmail.com	huang, yiting/HDM-3648-2022		Ministry of Science and Technology, Taiwan (MOST) [MOST 106-2314-B-195-003-, MOST 105-2314-B-195-006-MY3]; MacKay Medical College [1081A03]; MacKay Memorial Hospital [MMH107-19]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan); MacKay Medical College; MacKay Memorial Hospital	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: MOST 106-2314-B-195-003- and MOST 105-2314-B-195-006-MY3; MacKay Medical College, Grant/Award Number: 1081A03; MacKay Memorial Hospital, Grant/Award Number: MMH107-19	Abu el Maaty MA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030796; Abu el Maaty MA, 2017, BBA-MOL CELL RES, V1864, P1618, DOI 10.1016/j.bbamcr.2017.06.019; Alhawiti NM, 2017, CURR DRUG TARGETS, V18, P1095, DOI 10.2174/1389450118666170130145514; BERNARD BA, 1988, J INVEST DERMATOL, V90, P801, DOI 10.1111/1523-1747.ep12462014; BOURKE JF, 1993, BRIT J DERMATOL, V129, P74, DOI 10.1111/j.1365-2133.1993.tb03315.x; Cadenas C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2599; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Champliaud MF, 2003, J INVEST DERMATOL, V121, P781, DOI 10.1046/j.1523-1747.2003.12539.x; CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9; Chew YC, 2013, J BIOL CHEM, V288, P17759, DOI 10.1074/jbc.M113.477133; Chong CR, 2014, CARDIOVASC DRUG THER, V28, P347, DOI 10.1007/s10557-014-6538-5; Denning MF, 2010, J INVEST DERMATOL, V130, P1968, DOI 10.1038/jid.2010.194; Deucher A, 2002, J BIOL CHEM, V277, P17032, DOI 10.1074/jbc.M109076200; Domingues A, 2020, ANGIOGENESIS, V23, P249, DOI 10.1007/s10456-019-09704-x; Duvic M, 1998, J AM ACAD DERMATOL, V39, pS129, DOI 10.1016/S0190-9622(98)70309-3; ELDER JT, 1989, SCIENCE, V243, P811, DOI 10.1126/science.2916128; Elmets CA, 2019, J AM ACAD DERMATOL, V80, P1073, DOI 10.1016/j.jaad.2018.11.058; Gegotek A, 2019, PROTEOM CLIN APPL, V13, DOI 10.1002/prca.201800119; Griffiths CEM, 2021, LANCET, V397, P1301, DOI 10.1016/S0140-6736(20)32549-6; Guttman-Yassky E, 2011, J ALLERGY CLIN IMMUN, V127, P1110, DOI 10.1016/j.jaci.2011.01.053; Higashiyama Mari, 1994, Journal of Dermatological Science, V7, P45, DOI 10.1016/0923-1811(94)90021-3; Hu JH, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4582130; Iqbal MA, 2021, FEBS J, V288, P471, DOI 10.1111/febs.15353; ISHIDAYAMAMOTO A, 1995, J INVEST DERMATOL, V104, P391, DOI 10.1111/1523-1747.ep12665870; Jo SH, 2013, DIABETOLOGIA, V56, P2723, DOI 10.1007/s00125-013-3050-6; Kadam DP, 2010, INDIAN J CLIN BIOCHE, V25, P388, DOI 10.1007/s12291-010-0043-9; King KE, 2007, MOL CARCINOGEN, V46, P716, DOI 10.1002/mc.20337; Kostera MI, 2004, J DERMATOL SCI, V34, P3, DOI 10.1016/j.jdermsci.2003.10.003; Lee YS, 1998, J INVEST DERMATOL, V111, P762, DOI 10.1046/j.1523-1747.1998.00365.x; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Meszaros M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-96220-y; Moreci RS, 2020, CURR BIOL, V30, pR144, DOI 10.1016/j.cub.2020.01.004; Mustacich D, 2004, CARCINOGENESIS, V25, P1983, DOI 10.1093/carcin/bgh195; NANNEY LB, 1986, J INVEST DERMATOL, V86, P260, DOI 10.1111/1523-1747.ep12285389; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Ohba M, 1998, MOL CELL BIOL, V18, P5199, DOI 10.1128/MCB.18.9.5199; Plenkowska J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176206; Pomari E, 2015, FASEB J, V29, P508, DOI 10.1096/fj.14-251363; Qayyum N, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052754; Rizova E, 2001, BRIT J DERMATOL, V144, P3, DOI 10.1046/j.1365-2133.2001.00041.x; Samidurai M, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.661505; Tian H, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00269; Truong AB, 2007, CELL CYCLE, V6, P295, DOI 10.4161/cc.6.3.3753; Tsubaki H, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249357; WAKITA H, 1992, J INVEST DERMATOL, V99, P101, DOI 10.1111/1523-1747.ep12611882; Wang JY, 2020, J DERMATOL SCI, V98, P119, DOI 10.1016/j.jdermsci.2020.03.007; Wang SJ, 2019, AM J TRANSL RES, V11, P520; Wang YL, 2002, J BIOL CHEM, V277, P26496, DOI 10.1074/jbc.M202133200; Wang Z, 2006, ONCOGENE, V25, P1903, DOI 10.1038/sj.onc.1209218; Wu NL, 2016, J INVEST DERMATOL, V136, P192, DOI 10.1038/JID.2015.381; Wu NL, 2013, BBA-MOL BASIS DIS, V1832, P1538, DOI 10.1016/j.bbadis.2013.05.020; Wu NL, 2011, J INVEST DERMATOL, V131, P874, DOI 10.1038/jid.2010.402; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yoshihara E, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00514; Young CN, 2008, J INVEST DERMATOL, V128, P2606, DOI 10.1038/jid.2008.122; Zhou Q, 2009, FREE RADICAL BIO MED, V47, P891, DOI 10.1016/j.freeradbiomed.2009.06.033; Zhu L, 2008, J INVEST DERMATOL, V128, P833, DOI 10.1038/sj.jid.5701103	58	1	1	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22313	10.1096/fj.202101772R	http://dx.doi.org/10.1096/fj.202101772R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0U0KQ	35471587				2022-12-26	WOS:000787348900001
J	Zeid, AM; Lamontagne, JO; Zhang, H; Marneros, AG				Zeid, Alia M.; Lamontagne, Joseph O.; Zhang, Hui; Marneros, Alexander G.			Epidermal growth factor deficiency predisposes to progressive renal disease	FASEB JOURNAL			English	Article						epidermal growth factor; glomerulonephritis; kidney; renal failure; renal fibrosis	EGF RECEPTOR; KIDNEY; EXPRESSION; SEX	Epidermal growth factor (EGF) is produced in the kidney by thick ascending limbs of the loop of Henle and by distal convoluted tubules (DCTs). Reduced urinary EGF levels have been associated with chronic kidney disease but it is not known whether physiological levels of EGF protect the kidney from progressive renal disease. Here, we show that EGF-deficient mice on a mixed genetic background had increased urinary microalbumin, and a subset of these mice developed severe progressive renal disease with azotemia that was not seen in WT or TGF alpha-deficient littermates with this mixed genetic background. These azotemic EGF-deficient mice developed crescentic glomerulonephritis linked to HB-EGF/EGFR hyperactivation in glomeruli, as well as attenuation of the proximal tubule brush border, distal convoluted tubule (DCT) dilatation, and kidney fibrosis associated with renal beta-catenin/mTOR hyperactivation. The observation of these severe renal pathologies only in a subset of EGF-deficient mice suggests that independent segregation of strain-specific modifier alleles contributes to the severity of the renal abnormalities that only manifest when EGF is lacking. These findings link the lack of EGF to renal pathologies in the adult mammalian kidney, in support of a role of physiological levels of EGF for maintaining the function of glomeruli, proximal tubules, and DCTs. These observations suggest that diminished EGF levels predispose kidneys to progressive renal disease.	[Zeid, Alia M.; Lamontagne, Joseph O.; Zhang, Hui; Marneros, Alexander G.] Harvard Med Sch, Cutaneous Biol Res Ctr, Massachusetts Gen Hosp, Dept Dermatol, CNY 149,Rm 3-215B,13th St, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Marneros, AG (corresponding author), Harvard Med Sch, Cutaneous Biol Res Ctr, Massachusetts Gen Hosp, Dept Dermatol, CNY 149,Rm 3-215B,13th St, Charlestown, MA 02129 USA.	amarneros@mgh.harvard.edu		Zhang, Hui/0000-0002-4936-4791	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK118134, R01DK121178]; HHS | NIH | National Institute on Aging (NIA) [R21AG063377]	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); HHS | NIH | National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/ Award Number: R01DK118134 and R01DK121178; HHS | NIH | National Institute on Aging (NIA), Grant/Award Number: R21AG063377	Bollee G, 2011, NAT MED, V17, P1242, DOI 10.1038/nm.2491; CALLEGARI C, 1988, EUR J APPL PHYSIOL, V58, P26, DOI 10.1007/BF00636599; Chou JS, 1997, ANN CLIN LAB SCI, V27, P116; GATTONE VH, 1995, DEV BIOL, V169, P504, DOI 10.1006/dbio.1995.1164; Gesualdo L, 1996, KIDNEY INT, V49, P656, DOI 10.1038/ki.1996.94; Groenestege WMT, 2007, J CLIN INVEST, V117, P2260, DOI 10.1172/JCI31680; HUMES HD, 1989, J CLIN INVEST, V84, P1757, DOI 10.1172/JCI114359; Ju WJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7071; Jung JY, 2005, AM J PHYSIOL-RENAL, V288, pF227, DOI 10.1152/ajprenal.00058.2004; Lanktree MB, 2019, KIDNEY INT REP, V4, P995, DOI 10.1016/j.ekir.2019.04.018; Levchenko V, 2010, J CELL PHYSIOL, V223, P252, DOI 10.1002/jcp.22033; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Marneros AG, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108616; Marneros AG, 2020, DEV CELL, V54, P348, DOI 10.1016/j.devcel.2020.05.026; Meybosch S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211212; Napolitano G, 2020, NATURE, V585, P597, DOI 10.1038/s41586-020-2444-0; Norvik JV, 2021, NEPHROL DIAL TRANSPL, V36, P1882, DOI 10.1093/ndt/gfaa208; Pavlov TS, 2013, J AM SOC NEPHROL, V24, P1053, DOI 10.1681/ASN.2012080839; PERHEENTUPA J, 1985, PEDIATR RES, V19, P428, DOI 10.1203/00006450-198505000-00004; RAABERG L, 1988, HISTOCHEMISTRY, V89, P351, DOI 10.1007/BF00500636; Ransick A, 2019, DEV CELL, V51, P399, DOI 10.1016/j.devcel.2019.10.005; Rossetti S, 2007, J AM SOC NEPHROL, V18, P1374, DOI 10.1681/ASN.2007010125; Staruschenko A, 2013, AM J PHYSIOL-RENAL, V305, pF12, DOI 10.1152/ajprenal.00112.2013; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084	24	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22286	10.1096/fj.202101837R	http://dx.doi.org/10.1096/fj.202101837R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0P5AC	35442545	Green Accepted			2022-12-26	WOS:000784231400001
J	Chen, J; Li, ZQ; Jia, X; Song, WF; Wu, H; Zhu, H; Xuan, ZF; Du, YH; Zhu, XX; Song, GY; Dong, HJ; Bian, SC; Wang, S; Zhao, YC; Xie, HY; Zheng, SS; Song, PH				Chen, Jian; Li, Zequn; Jia, Xing; Song, Wenfeng; Wu, Hao; Zhu, Hai; Xuan, Zefeng; Du, Yehui; Zhu, Xingxin; Song, Guangyuan; Dong, Haijiang; Bian, Suchen; Wang, Shuo; Zhao, Yongchao; Xie, Haiyang; Zheng, Shusen; Song, Penghong			Targeting anillin inhibits tumorigenesis and tumor growth in hepatocellular carcinoma via impairing cytokinesis fidelity	ONCOGENE			English	Article							ANLN; CANCER; PLAYS; RHOA	Targeting cytokinesis can suppress tumor growth by blocking cell division and promoting apoptosis. We aimed to characterize key cytokinesis regulator in hepatocellular carcinoma (HCC) progression, providing insights into identifying promising HCC therapeutic targets. The unbiased bioinformatic screening identified Anillin actin binding protein (ANLN) as a critical cytokinesis regulator involved in HCC development. Functional assay demonstrated that knockdown of ANLN inhibited HCC growth by inducing cytokinesis failure and DNA damage, leading to multinucleation and mitotic catastrophe. Mechanistically, ANLN acts as a scaffold to strengthen interaction between RACGAP1 and PLK1. ANLN promotes PLK1-mediated RACGAP1 phosphorylation and RhoA activation to ensure cytokinesis fidelity. To explore the function of ANLN in HCC tumorigenesis, we hydrodynamically transfected c-Myc and NRAS plasmids into Anln(+/+), Anln(+/-), and Anln(-/-) mice through tail vein injection. Hepatic Anln ablation significantly impaired c-Myc/NRAS-driven hepatocarcinogenesis. Moreover, enhanced hepatic polyploidization was observed in Anln ablation mice, manifesting as increasing proportion of cellular and nuclear polyploidy. Clinically, ANLN is upregulated in human HCC tissues and high level of ANLN is correlated with poor patients' prognosis. Additionally, the proportion of cellular polyploidy decreases during HCC progression and ANLN level is significantly correlated with cellular polyploidy proportion in human HCC samples. In conclusion, ANLN is identified as a key cytokinesis regulator contributing to HCC initiation and progression. Our findings revealed a novel mechanism of ANLN in the regulation of cytokinesis to promote HCC tumorigenesis and growth, suggesting targeting ANLN to inhibit cytokinesis may be a promising therapeutic strategy for HCC.	[Chen, Jian; Li, Zequn; Jia, Xing; Song, Wenfeng; Wu, Hao; Zhu, Hai; Zhu, Xingxin; Song, Guangyuan; Dong, Haijiang; Bian, Suchen; Wang, Shuo; Xie, Haiyang; Zheng, Shusen; Song, Penghong] Zhejiang Univ, Affiliated Hosp 1, Dept Surg, Div Hepatobiliary & Pancreat Surg,Sch Med, Hangzhou, Peoples R China; [Chen, Jian; Li, Zequn; Jia, Xing; Song, Wenfeng; Wu, Hao; Zhu, Hai; Zhu, Xingxin; Song, Guangyuan; Dong, Haijiang; Bian, Suchen; Zhao, Yongchao; Xie, Haiyang; Zheng, Shusen; Song, Penghong] NHC Key Lab Combined Multiorgan Transplantat, Hangzhou, Peoples R China; [Chen, Jian; Li, Zequn; Jia, Xing; Song, Wenfeng; Wu, Hao; Zhu, Hai; Zhu, Xingxin; Song, Guangyuan; Dong, Haijiang; Bian, Suchen; Xie, Haiyang; Zheng, Shusen; Song, Penghong] Chinese Acad Med Sci 2019RU019, Res Unit Collaborat Diag & Treatment Hepatobiliar, Key Lab Diag & Treatment Organ Transplantat, Hangzhou, Peoples R China; [Chen, Jian; Li, Zequn; Jia, Xing; Song, Wenfeng; Wu, Hao; Zhu, Hai; Zhu, Xingxin; Song, Guangyuan; Dong, Haijiang; Bian, Suchen; Xie, Haiyang; Zheng, Shusen; Song, Penghong] Res Ctr Diag & Treatment Hepatobiliary Dis, Key Lab Organ Transplantat, Hangzhou, Zhejiang, Peoples R China; [Xuan, Zefeng] Zhejiang Univ, Affiliated Hosp 1, Div Breast Surg, Sch Med, Hangzhou, Peoples R China; [Du, Yehui] Zhejiang Univ, Affiliated Hosp 1, Div Thyroid Surg, Sch Med, Hangzhou, Peoples R China; [Zhao, Yongchao] Zhejiang Univ, Inst Translat Med, Sch Med, Hangzhou, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Zheng, SS; Song, PH (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Surg, Div Hepatobiliary & Pancreat Surg,Sch Med, Hangzhou, Peoples R China.; Zheng, SS; Song, PH (corresponding author), NHC Key Lab Combined Multiorgan Transplantat, Hangzhou, Peoples R China.; Zheng, SS; Song, PH (corresponding author), Chinese Acad Med Sci 2019RU019, Res Unit Collaborat Diag & Treatment Hepatobiliar, Key Lab Diag & Treatment Organ Transplantat, Hangzhou, Peoples R China.; Zheng, SS; Song, PH (corresponding author), Res Ctr Diag & Treatment Hepatobiliary Dis, Key Lab Organ Transplantat, Hangzhou, Zhejiang, Peoples R China.	shusenzheng@zju.edu.cn; songpenghong@zju.edu.cn			Key Research and Development Plan of Zhejiang Province [2019C03050]; National Natural Science Foundation of China [81870434, 82070652]; Innovative Research Groups of National Natural Science Foundation of China [81721091]	Key Research and Development Plan of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Research Groups of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the grants from the Key Research and Development Plan of Zhejiang Province (No. 2020C04003), the National Natural Science Foundation of China (No. 81870434 and No. 82070652), the Innovative Research Groups of National Natural Science Foundation of China (No. 81721091) and the Key Research and Development Plan of Zhejiang Province (No. 2019C03050).	Basant A, 2018, CURR BIOL, V28, pR570, DOI 10.1016/j.cub.2018.03.045; Budnar S, 2019, DEV CELL, V49, P894, DOI 10.1016/j.devcel.2019.04.031; Burkard ME, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000111; Chaikovsky AC, 2021, NATURE, V592, P794, DOI 10.1038/s41586-021-03474-7; Chen J, 2021, BIOCHEM PHARMACOL, V188, DOI 10.1016/j.bcp.2021.114494; Chen J, 2021, ONCOGENE, V40, P163, DOI 10.1038/s41388-020-01522-6; Donne R, 2020, NAT REV GASTRO HEPAT, V17, P391, DOI 10.1038/s41575-020-0284-x; Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414; Gentric G, 2014, AM J PATHOL, V184, P322, DOI 10.1016/j.ajpath.2013.06.035; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hodge RG, 2016, NAT REV MOL CELL BIO, V17, P496, DOI 10.1038/nrm.2016.67; Lens SMA, 2019, NAT REV CANCER, V19, P32, DOI 10.1038/s41568-018-0084-6; Li Z, 2019, HEPATOB PANCREAT DIS, V18, P303, DOI 10.1016/j.hbpd.2019.05.013; Lian YF, 2018, AGING-US, V10, P1884, DOI 10.18632/aging.101510; Lin Heng, 2021, Nat Commun, V12, P645, DOI 10.1038/s41467-020-20572-8; Lulli M, 2021, CANCER RES, V81, P2861, DOI 10.1158/0008-5472.CAN-20-3134; Ma H, 2022, HEPATOLOGY, DOI 10.1002/hep.32335; Maiani E, 2021, NATURE, V592, P799, DOI 10.1038/s41586-021-03422-5; Matsumoto T, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-20916-y; Pallavicini G, 2018, CANCER RES, V78, P4599, DOI 10.1158/0008-5472.CAN-17-4060; Piekny AJ, 2010, SEMIN CELL DEV BIOL, V21, P881, DOI 10.1016/j.semcdb.2010.08.002; Qiao YT, 2021, EXP BIOL MED, V246, P1343, DOI 10.1177/15353702211008380; Rebouissou S, 2020, J HEPATOL, V72, P215, DOI 10.1016/j.jhep.2019.08.017; Sarveazad A, 2019, J RES MED SCI, V24, DOI 10.4103/jrms.JRMS_1017_18; Simoneschi D, 2021, NATURE, V592, P789, DOI 10.1038/s41586-021-03445-y; Su KC, 2011, DEV CELL, V21, P1104, DOI 10.1016/j.devcel.2011.11.003; Suzuki C, 2005, CANCER RES, V65, P11314, DOI 10.1158/0008-5472.CAN-05-1507; Tuan NM, 2020, CANCERS, V12, DOI 10.3390/cancers12061600; Wang AB, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1340-7; Wilkinson PD, 2019, HEPATOLOGY, V69, P1242, DOI 10.1002/hep.30286; Wolfe BA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000110; Xu M, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1020-4; Yang XM, 2018, GASTROENTEROLOGY, V155, P1233, DOI 10.1053/j.gastro.2018.07.010; Zhang L, 2010, CURR BIOL, V20, pR135, DOI 10.1016/j.cub.2009.12.017; Zhang SY, 2018, GASTROENTEROLOGY, V154, P1421, DOI 10.1053/j.gastro.2017.12.013; Zhang SY, 2018, DEV CELL, V44, P447, DOI 10.1016/j.devcel.2018.01.010; Zhao WM, 2005, P NATL ACAD SCI USA, V102, P13158, DOI 10.1073/pnas.0504145102; Zhou WB, 2015, MOL CELL BIOCHEM, V398, P11, DOI 10.1007/s11010-014-2200-6	38	1	1	4	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 27	2022	41	22					3118	3130		10.1038/s41388-022-02274-1	http://dx.doi.org/10.1038/s41388-022-02274-1		APR 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	1U7PG	35477750				2022-12-26	WOS:000794881300001
J	Leal, W; Barbir, J; Abubakar, IR; Paco, A; Stasiskiene, Z; Hornbogen, M; Fendt, MTC; Voronova, V; Kloga, M				Leal Filho, Walter; Barbir, Jelena; Abubakar, Ismaila Rimi; Paco, Arminda; Stasiskiene, Zaneta; Hornbogen, Marie; Christin Fendt, Maren Theresa; Voronova, Viktoria; Kloga, Marija			Consumer attitudes and concerns with bioplastics use: An international study	PLOS ONE			English	Article							PLASTICS; PRODUCTS	The world production of plastic exceeded 360 million tonnes in 2020 alone, a considerable amount of which is not properly disposed of. The significant pressures and damages posed by conventional plastic to human and environmental health suggest that alternatives are urgently needed. One of them is "bioplastic", which is defined as bio-based plastic that is (or not) biodegradable. This paper reports on a study on the perceptions of bioplastics among consumers in 42 countries to identify their levels of information and concerns. The results suggest that most respondents have positive expectations regarding the future of bioplastics to replace conventional plastics fully or partially, especially for food containers, kitchenware, and boxes and bags for packaging. They also reported that the low costs and increased availability of bioplastic products on the market are likely to be the main drivers for their wide-scale adoption. However, many participants are unsure whether they would buy bio-based and biodegradable products if they are expensive. Overall, whereas a rather positive attitude to bioplastics has been identified, greater efforts are needed to address the many information needs of consumers towards upscaling the adoption of bioplastics. Relevant policies are therefore needed to encourage investments in the large-scale manufacture and market uptake of bioplastics. The paper reports on an initial study of consumer behavior, in a sample of countries spread across all geographical regions.	[Leal Filho, Walter; Barbir, Jelena; Hornbogen, Marie; Christin Fendt, Maren Theresa] Hamburg Univ Appl Sci, Fac Life Sci, Res & Transfer Ctr Sustainable Dev & Climate Chan, Hamburg, Germany; [Abubakar, Ismaila Rimi] Imam Abdulrahman Bin Faisal Univ, Coll Architecture & Planning, Dammam, Saudi Arabia; [Paco, Arminda] Univ Beira Interior, Dept Management & Econ, Nucleo Estudos Ciencias Empresariais NECEUBI, Rua Marques Avila & Bolama, Covilha, Portugal; [Stasiskiene, Zaneta] Kaunas Univ Technol, Inst Environm Engn, Kaunas, Lithuania; [Voronova, Viktoria; Kloga, Marija] Tallinn Univ Technol, Dept Civil Engn & Architecture, Tallinn, Estonia	Hochschule Angewandte Wissenschaft Hamburg; Imam Abdulrahman Bin Faisal University; Universidade da Beira Interior; Kaunas University of Technology; Tallinn University of Technology	Barbir, J (corresponding author), Hamburg Univ Appl Sci, Fac Life Sci, Res & Transfer Ctr Sustainable Dev & Climate Chan, Hamburg, Germany.	jelena.barbir@haw-hamburg.de	Abubakar, Ismaila Rimi/A-4417-2015; Voronova, Viktoria/B-7118-2019	Abubakar, Ismaila Rimi/0000-0002-7994-2302; Voronova, Viktoria/0000-0002-4140-412X; Fendt, Maren Theresa Christin/0000-0002-5133-1067; Leal Filho, Walter/0000-0002-1241-5225; Kloga, Marija/0000-0001-6483-2605	European Union's Horizon 2020 research and innovation programme through the research project BIO-PLASTICS EUROPE [860407]	European Union's Horizon 2020 research and innovation programme through the research project BIO-PLASTICS EUROPE	This study has received funding from the European Union's Horizon 2020 research and innovation programme through the research project BIO-PLASTICS EUROPE, under grant agreement No. 860407.	Abubakar IR, 2017, J ENVIRON PUBLIC HEA, V2017, DOI 10.1155/2017/5314840; Alessi E., 2018, OUT PLASTIC TRAP SAV; Almulhim AI, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su131810157; AlQahtany AM, 2020, INT J DISAST RISK RE, V44, DOI 10.1016/j.ijdrr.2019.101422; Amin M.R., 2012, J CHEM ENG, V26, P38, DOI [10.3329/jce.v26i1.10180, DOI 10.3329/JCE.V26I1.10180]; [Anonymous], FOCUS FOOD PACKAGING; Bhagwat G, 2020, J POLYM ENVIRON, V28, P3055, DOI 10.1007/s10924-020-01830-8; Carus M, 2017, BIOBASED DROP IN SMA; Chen GQ, 2016, SYN SYST BIOTECHNO, V1, P236, DOI 10.1016/j.synbio.2016.09.006; Confente I, 2020, J BUS RES, V112, P431, DOI 10.1016/j.jbusres.2019.10.030; Dilkes-Hoffman L, 2019, RESOUR CONSERV RECY, V151, DOI 10.1016/j.resconrec.2019.104479; Eriksen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111913; Eriksen MK, 2019, J IND ECOL, V23, P156, DOI 10.1111/jiec.12822; European Bioplastics, 2019, BIOPLASTICS MARKET D; European-Bioplastics, 2016, DRIVING EVOLUTION PL; European-Bioplastics, 2016, FACT SHEETEUROPEAN B; European-Bioplastics, 2016, BIOPLASTIC MARKET DA; Harris AM, 2008, J APPL POLYM SCI, V107, P2246, DOI 10.1002/app.27261; Herbes C, 2018, J CLEAN PROD, V194, P203, DOI 10.1016/j.jclepro.2018.05.106; Jabeen Nafisa, 2015, Cogent Food & Agriculture, V1, DOI 10.1080/23311932.2015.1117749; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; Jeswani H, 2021, SCI TOTAL ENVIRON, V769, DOI 10.1016/j.scitotenv.2020.144483; Kennouche S, 2016, EUR POLYM J, V75, P142, DOI 10.1016/j.eurpolymj.2015.12.009; Koenig-Lewis N, 2014, J ENVIRON PSYCHOL, V37, P94, DOI 10.1016/j.jenvp.2013.11.009; Leal W, 2021, SCI TOTAL ENVIRON, V755, DOI 10.1016/j.scitotenv.2020.142732; Lebreton LCM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15611; Li WC, 2016, SCI TOTAL ENVIRON, V566, P333, DOI 10.1016/j.scitotenv.2016.05.084; Liu F, 2019, IOP C SER EARTH ENV, V344, DOI 10.1088/1755-1315/344/1/012071; Macfadyen G., 2009, FAO Fisheries and Aquaculture Technical Paper; Mendes AC, 2021, TRENDS FOOD SCI TECH, V112, P839, DOI 10.1016/j.tifs.2021.03.049; Mofokeng JP, 2015, J MATER SCI, V50, P3812, DOI 10.1007/s10853-015-8950-z; Mu'azu ND, 2020, SCI TOTAL ENVIRON, V721, DOI 10.1016/j.scitotenv.2020.137659; Naveena B., 2020, INT J CURR MICROBIOL, V9, P1428, DOI [10.20546/ijcmas.2020.905.163, DOI 10.20546/IJCMAS.2020.905.163]; Plastics Europe, 2020, PLAST FACTS 2019; PlasticsEurope, 2021, PLASTICS THE FACTS 2; Reinders MJ, 2017, J CLEAN PROD, V162, P1169, DOI 10.1016/j.jclepro.2017.06.126; Ritchie H., 2018, URBANIZATION OUR WOR; Ryberg M.W., 2018, MAPPING GLOBAL PLAST; Scherer C, 2018, J CLEAN PROD, V203, P1085, DOI 10.1016/j.jclepro.2018.08.298; Shen MC, 2020, ENVIRON POLLUT, V263, DOI 10.1016/j.envpol.2020.114469; Sidek IS., 2019, TECH MAG, V1, P3, DOI [10.26480/itechmag.01.2019.03.08, DOI 10.26480/ITECHMAG.01.2019.03.08]; Sijtsema SJ, 2016, NJAS-WAGEN J LIFE SC, V77, P61, DOI 10.1016/j.njas.2016.03.007; Song JH, 2009, PHILOS T R SOC B, V364, P2127, DOI 10.1098/rstb.2008.0289; Zhao L., 2020, HDB ENV CHEM MICROPL, V95, P423, DOI [10.1007/698_2020_462, DOI 10.1007/698_2020_462]; Zwicker MV, 2020, J ENVIRON PSYCHOL, V69, DOI 10.1016/j.jenvp.2020.101433	46	2	2	9	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0266918	10.1371/journal.pone.0266918	http://dx.doi.org/10.1371/journal.pone.0266918			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476711	gold, Green Published			2022-12-26	WOS:000840124300022
J	Lim, JS; Lee, KW; Ko, KP; Jeong, SI; Ryu, BK; Lee, MG; Chi, SG				Lim, Ji-Sun; Lee, Kyung-Woo; Ko, Kyung-Phil; Jeong, Seong-In; Ryu, Byung-Kyu; Lee, Min-Goo; Chi, Sung-Gil			XAF1 destabilizes estrogen receptor alpha through the assembly of a BRCA1-mediated destruction complex and promotes estrogen-induced apoptosis	ONCOGENE			English	Article							XIAP-ASSOCIATED FACTOR-1; ESTRADIOL-INDUCED APOPTOSIS; BREAST-CANCER; LIGASE ACTIVITY; EXPRESSION; BRCA1; IDENTIFICATION; GENE; GROWTH; SWITCH	X-linked inhibitor of apoptosis-associated factor 1 (XAF1) is a pro-apoptotic tumor suppressor that is frequently inactivated in multiple human cancers. However, its candidacy as a suppressor in the pathogenesis of breast cancer remains undefined. Here, we report that XAF1 acts as a molecular switch in estrogen (E2)-mediated cell-fate decisions favoring apoptosis over cell proliferation. XAF1 promoter hypermethylation is observed predominantly in estrogen receptor alpha (ER alpha)-positive versus ER alpha-negative tumor cells and associated with attenuated apoptotic response to E2. XAF1 is activated by E2 through a G protein-coupled estrogen receptor-mediated non-genomic pathway and induces ER alpha degradation and apoptosis while it is repressed by ER alpha for E2 stimulation of cell proliferation. The XAF1-ER alpha mutual antagonism dictates the outcomes of E2 signaling and its alteration is linked to the development of E2-resistant tumors. Mechanistically, XAF1 destabilizes ER alpha through the assembly of breast cancer-associated gene 1 (BRCA1)-mediated destruction complex. XAF1 interacts with ER alpha and BRCA1 via the zinc finger (ZF) domains 5/6 and 4, respectively, and the mutants lacking either of these domains fail to drive ER alpha ubiquitination and apoptosis. E2-induced regression of XAF1(+/+) tumors is abolished by XAF1 depletion while XAF1(-/-) tumors recover E2 response by XAF1 restoration. XAF1 and ER alpha expression show an inverse correlation in primary breast tumors, and XAF1 expression is associated with the overall survival of patients with ER alpha-positive but not ER alpha-negative cancer. Together, this study uncovers an important role for the XAF1-ER alpha antagonism as a linchpin to govern E2-mediated cell-fate decisions, illuminating the mechanistic consequence of XAF1 alteration in breast tumorigenesis.	[Lim, Ji-Sun; Lee, Kyung-Woo; Ko, Kyung-Phil; Jeong, Seong-In; Ryu, Byung-Kyu; Lee, Min-Goo; Chi, Sung-Gil] Korea Univ, Coll Life Sci & Technol, Dept Life Sci, Seoul 02841, South Korea; [Ryu, Byung-Kyu] Korea Univ, Sch Med, Dept Neurosurg, Seoul 02841, South Korea	Korea University; Korea University; Korea University Medicine (KU Medicine)	Chi, SG (corresponding author), Korea Univ, Coll Life Sci & Technol, Dept Life Sci, Seoul 02841, South Korea.	chi6302@korea.ac.kr			National Cancer Center [HA17C0034]; National Research Foundation of Korea [NRF-2021R1A2B03002487]; Korea University Grant, Republic of Korea [K2006781]	National Cancer Center; National Research Foundation of Korea(National Research Foundation of Korea); Korea University Grant, Republic of Korea	This work was supported in part by the National Cancer Center (HA17C0034, SGC), the National Research Foundation of Korea (NRF-2021R1A2B03002487, SGC), and Korea University Grant (K2006781, SGC), Republic of Korea.	Acconcia F, 2017, MOL CELL ENDOCRINOL, V457, P3, DOI 10.1016/j.mce.2016.10.033; Altiok N, 2007, BREAST CANCER RES TR, V105, P247, DOI 10.1007/s10549-006-9451-1; Altiok N, 2011, ONCOL LETT, V2, P1281, DOI 10.3892/ol.2011.385; Bennink HJTC, 2017, MATURITAS, V95, P11, DOI 10.1016/j.maturitas.2016.10.010; Burns KA, 2012, ARCH TOXICOL, V86, P1491, DOI 10.1007/s00204-012-0868-5; Byun DS, 2003, CANCER RES, V63, P7068; Carmeci C, 1997, GENOMICS, V45, P607, DOI 10.1006/geno.1997.4972; Carroll JS, 2016, EUR J ENDOCRINOL, V175, pR41, DOI 10.1530/EJE-16-0124; Chi D, 2019, P NATL ACAD SCI USA, V116, P11437, DOI 10.1073/pnas.1819155116; Chung SK, 2007, GASTROENTEROLOGY, V132, P2459, DOI 10.1053/j.gastro.2007.04.024; Deng Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57819-9; Dizin E, 2010, INT J BIOCHEM CELL B, V42, P693, DOI 10.1016/j.biocel.2009.12.025; Eakin CM, 2007, P NATL ACAD SCI USA, V104, P5794, DOI 10.1073/pnas.0610887104; Ellis MJ, 2009, JAMA-J AM MED ASSOC, V302, P774, DOI 10.1001/jama.2009.1204; Fan SJ, 2002, CANCER RES, V62, P141; Fang XL, 2006, INT J CANCER, V118, P2485, DOI 10.1002/ijc.21636; Fong WG, 2000, GENOMICS, V70, P113, DOI 10.1006/geno.2000.6364; Han J, 2013, CELL DEATH DIFFER, V20, P1055, DOI 10.1038/cdd.2013.33; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Jeong SI, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0867-4; Jeselsohn R, 2014, CLIN CANCER RES, V20, P1757, DOI 10.1158/1078-0432.CCR-13-2332; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Kota K, 2017, CUREUS, V9, DOI 10.7759/cureus.1434; Leaman DW, 2002, J BIOL CHEM, V277, P28504, DOI 10.1074/jbc.M204851200; Leclercq G, 2006, CURR CANCER DRUG TAR, V6, P39, DOI 10.2174/156800906775471716; Lee MG, 2006, ONCOGENE, V25, P5807, DOI 10.1038/sj.onc.1209867; Lee MG, 2014, P NATL ACAD SCI USA, V111, P15532, DOI 10.1073/pnas.1411746111; Lewis JS, 2005, JNCI-J NATL CANCER I, V97, P1746, DOI 10.1093/jnci/dji400; Lewis-Wambi JS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2255; Liston P, 2001, NAT CELL BIOL, V3, P128, DOI 10.1038/35055027; Ma YX, 2010, MOL ENDOCRINOL, V24, P76, DOI 10.1210/me.2009-0218; Micali OC, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-52; Monteiro ANA, 2000, TRENDS BIOCHEM SCI, V25, P469, DOI 10.1016/S0968-0004(00)01632-7; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Osborne CK, 2001, CLIN CANCER RES, V7, p4338S; Pedram A, 2002, J BIOL CHEM, V277, P50768, DOI 10.1074/jbc.M210106200; Rahman Syed Azizur, 2019, Asian Pac J Cancer Prev, V20, P1901, DOI 10.31557/APJCP.2019.20.6.1901; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Seval Y, 2006, J CLIN ENDOCR METAB, V91, P2349, DOI 10.1210/jc.2005-2132; Shin CH, 2017, P NATL ACAD SCI USA, V114, P5683, DOI 10.1073/pnas.1700861114; Sun M, 2012, MOL ENDOCRINOL, V26, P736, DOI 10.1210/me.2011-1158; Sun PH, 2011, CANCER LETT, V310, P170, DOI 10.1016/j.canlet.2011.06.037; Thangaraju M, 2000, J BIOL CHEM, V275, P33487, DOI 10.1074/jbc.M005824200; Tu SP, 2010, CANCER-AM CANCER SOC, V116, P1252, DOI 10.1002/cncr.24814; Wang J, 2009, CARCINOGENESIS, V30, P1507, DOI 10.1093/carcin/bgp155; Wang RH, 2004, P NATL ACAD SCI USA, V101, P17108, DOI 10.1073/pnas.0407585101; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200; Xia Y, 2006, MOL CELL BIOCHEM, V286, P67, DOI 10.1007/s11010-005-9094-2; Zhou W, 2014, NAT REV CANCER, V14, P26, DOI 10.1038/nrc3622; Zhu LM, 2014, ONCOTARGET, V5, P5403, DOI 10.18632/oncotarget.2114	51	0	0	1	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 13	2022	41	20					2897	2908		10.1038/s41388-022-02315-9	http://dx.doi.org/10.1038/s41388-022-02315-9		APR 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	1F4TJ	35430604				2022-12-26	WOS:000782888200002
J	Barmpounakis, P; Demiris, N; Kontoyiannis, I; Pavlakis, GN; Sypsa, V				Barmpounakis, Petros; Demiris, Nikolaos; Kontoyiannis, Ioannis; Pavlakis, George N.; Sypsa, Vana			Evaluating the effects of second-dose vaccine-delay policies in European countries: A simulation study based on data from Greece	PLOS ONE			English	Article							SARS-COV-2 INFECTION; COVID-19; BNT162B2; TRANSMISSION; CHINA	The results of a simulation-based evaluation of several policies for vaccine rollout are reported, particularly focusing on the effects of delaying the second dose of two-dose vaccines. In the presence of limited vaccine supply, the specific policy choice is a pressing issue for several countries worldwide, and the adopted course of action will affect the extension or easing of non-pharmaceutical interventions in the next months. We employ a suitably generalised, age-structure, stochastic SEIR (Susceptible -> Exposed -> Infectious -> Removed) epidemic model that can accommodate quantitative descriptions of the major effects resulting from distinct vaccination strategies. The different rates of social contacts among distinct age-groups (as well as some other model parameters) are informed by a recent survey conducted in Greece, but the conclusions are much more widely applicable. The results are summarised and evaluated in terms of the total number of deaths and infections as well as life years lost. The optimal strategy is found to be one based on fully vaccinating the elderly/at risk as quickly as possible, while extending the time-interval between the two vaccine doses to 12 weeks for all individuals below 75 years old, in agreement with epidemic theory which suggests targeting a combination of susceptibility and infectivity. This policy, which is similar to the approaches adopted in the UK and in Canada, is found to be effective in reducing deaths and life years lost in the period while vaccination is still being carried out.	[Barmpounakis, Petros; Demiris, Nikolaos] Athens Univ Econ & Business, Dept Stat, Athens, Greece; [Kontoyiannis, Ioannis] Univ Cambridge, Dept Pure Math & Math Stat, Cambridge, England; [Pavlakis, George N.] NCI, Human Retrovirus Sect, VB, Frederick, MD 21701 USA; [Sypsa, Vana] Natl & Kapodistrian Univ Athens, Med Sch, Dept Hyg, Athens, Greece; [Sypsa, Vana] Natl & Kapodistrian Univ Athens, Med Sch, Dept Epidemiol, Athens, Greece; [Sypsa, Vana] Natl & Kapodistrian Univ Athens, Med Sch, Dept Med Stat, Athens, Greece	Athens University of Economics & Business; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National & Kapodistrian University of Athens; National & Kapodistrian University of Athens; National & Kapodistrian University of Athens	Barmpounakis, P (corresponding author), Athens Univ Econ & Business, Dept Stat, Athens, Greece.	barmpounakis@aueb.gr		Barmpounakis, Petros/0000-0002-1020-3886				Amit S, 2021, LANCET, V397, P875, DOI 10.1016/S0140-6736(21)00448-7; Andersson H., 2000, STOCHASTIC EPIDEMIC, V151; [Anonymous], GREEK STAT AUTH; [Anonymous], OFFICIAL STATEMENT D; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bi QF, 2020, LANCET INFECT DIS, V20, P911, DOI 10.1016/S1473-3099(20)30287-5; Bollyky TJ, 2021, ANN INTERN MED, V174, P558, DOI 10.7326/M20-8280; Bubar KM, 2021, SCIENCE, V371, P916, DOI 10.1126/science.abe6959; CDC, 2021, COV 19 PAND PLANN SC; Cereda D., 2020, ARXIV E PRINTS ARXIV; Diekmann O, MATH TOOLS UNDERSTAN, V516; Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114; FDA, 2020, FDA BRIEF DOC MOD CO; Ferreira, 2021, MEDRXIV 2021, DOI [10.1101/2021.07.28.21261200, DOI 10.1101/2021.07.28.21261200V1, 10.1101/2021.07.28.21261200v1]; Ganyani T, 2020, EUROSURVEILLANCE, V25, P12, DOI 10.2807/1560-7917.ES.2020.25.17.2000257; Haas EJ, 2021, LANCET, V397, P1819, DOI 10.1016/S0140-6736(21)00947-8; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Koh WC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240205; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Lavezzo E, 2020, NATURE, V584, P425, DOI 10.1038/s41586-020-2488-1; Lewnard JA, 2020, LANCET INFECT DIS, V20, P631, DOI 10.1016/S1473-3099(20)30190-0; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Matrajt L., 2021, MEDRXIV; Matrajt Laura, 2020, medRxiv, DOI [10.1126/sciadv.abf1374, 10.1101/2020.08.14.20175257]; Moghadas SM, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001211; Moore S, 2021, LANCET INFECT DIS, V21, P793, DOI 10.1016/S1473-3099(21)00143-2; Paltiel A.D, 2021, HEALTH AFFAIR, P10; Paltiel AD, 2021, ANN INTERN MED, V174, P568, DOI 10.7326/M20-7866; Parino F, 2021, INT J ROBUST NONLIN, DOI 10.1002/rnc.5728; Persad G, 2009, LANCET, V373, P423, DOI 10.1016/S0140-6736(09)60137-9; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Romero-Brufau S, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1087; Silva PJS, 2021, P NATL ACAD SCI USA, V118, DOI [10.1073/pnas.2104640118|1of6, 10.1073/pnas.2104640118]; Skowronski DM, 2021, NEW ENGL J MED, V384, P1576, DOI 10.1056/NEJMc2036242; Sypsa V., 2021, MEDRXIV, DOI 2021.06.23.21259376; Sypsa V, 2021, EMERG INFECT DIS, V27, P452, DOI 10.3201/eid2702.203412; Taipale J., 2021, ARXIV210406857 Q BIO; Thompson MG, 2021, MMWR-MORBID MORTAL W, V70, P495, DOI 10.15585/mmwr.mm7013e3; Tuite AR, 2021, ANN INTERN MED, V174, P570, DOI 10.7326/M20-8137; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Wang W, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4704; Xue J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0521-0	43	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0263977	10.1371/journal.pone.0263977	http://dx.doi.org/10.1371/journal.pone.0263977			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446847	Green Published, gold			2022-12-26	WOS:000795468200035
J	Chaiyakulsil, C; Sritipsukho, P; Satdhabudha, A; Bunjoungmanee, P; Tangsathapornpong, A; Sinlapamongkolkul, P; Sritipsukho, N				Chaiyakulsil, Chanapai; Sritipsukho, Paskorn; Satdhabudha, Araya; Bunjoungmanee, Pornumpa; Tangsathapornpong, Auchara; Sinlapamongkolkul, Phakatip; Sritipsukho, Naiyana			An epidemiological study of pediatric COVID-19 in the era of the variant of concern	PLOS ONE			English	Article								BackgroundThere were limited epidemiological data of pediatric COVID-19 in Asia outside China, especially during the era of the variants of concern such as the Delta and Alpha variants. The objective was to describe the clinical epidemiology of pediatric COVID-19 in a tertiary care center in Thailand from April to August 2021. The identification of risk factors for the development of pneumonia in these children was also performed. MethodsThis retrospective cohort study was conducted by retrospective chart review of all children aged 0-15 years admitted to Thammasat University Hospital care system during the study period. The risk factors for the development of pneumonia were analyzed using logistic regression. ResultsA total of 698 children were included for analysis, of which 52% were male. The mean age of the cohort was 7.2 + 4.5 years old. Radiographic pneumonia was identified in 100 children (14.3%) and a total of 16 children (2.3%) were diagnosed with severe and critical diseases. The mortality rate was 0.1%. Children younger than 1 year and children with comorbidity were at higher risk of developing pneumonia (Adjusted odds ratios 2.99 (95% confidence interval (CI): 1.56-5.74) and 2.32 (95% CI: 1.15-4.67), respectively). ConclusionIn the era of the variants of concern, the proportion of children with severe and critical diseases remained low. However, prudence must be taken in caring for younger children and children with comorbidity.	[Chaiyakulsil, Chanapai] Thammasat Univ, Thammasat Univ Hosp, Fac Med, Div Pediat Crit Care,Dept Pediat, Pathum Thani, Thailand; [Sritipsukho, Paskorn] Thammasat Univ, Fac Med, Dept Pediat, Div Pediat Allergy & Immunol, Pathum Thani, Thailand; [Sritipsukho, Paskorn] Thammasat Univ, Ctr Excellence Appl Epidemiol, Pathum Thani, Thailand; [Satdhabudha, Araya] Thammasat Univ, Fac Med, Dept Pediat, Div Pediat Pulmonol, Pathum Thani, Thailand; [Bunjoungmanee, Pornumpa; Tangsathapornpong, Auchara] Thammasat Univ, Fac Med, Dept Pediat, Div Pediat Infect Dis, Pathum Thani, Thailand; [Sinlapamongkolkul, Phakatip] Thammasat Univ, Fac Med, Dept Pediat, Div Pediat Hematol & Oncol, Pathum Thani, Thailand; [Sritipsukho, Naiyana] Thammasat Univ, Thammasat Postdoctoral Fellowship, Pathum Thani, Thailand	Thammasat University; Thammasat University; Thammasat University; Thammasat University; Thammasat University; Thammasat University; Thammasat University	Chaiyakulsil, C (corresponding author), Thammasat Univ, Thammasat Univ Hosp, Fac Med, Div Pediat Crit Care,Dept Pediat, Pathum Thani, Thailand.	chanapai.chai@hotmail.com		Chaiyakulsil, Chanapai/0000-0003-4677-4223; Sinlapamongkolkul, Phakatip/0000-0001-9602-4768	Thammasat University	Thammasat University	This study was supported by Thammasat Postdoctoral Fellowship, Thammasat University.	Agrawal Umang, 2020, Med J Armed Forces India, V76, P370, DOI 10.1016/j.mjafi.2020.08.004; Bellino S, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-009399; Center for Disease Control and Prevention, 2021, SARS COV2 VAR CLASS; Cui XJ, 2021, J MED VIROL, V93, P1057, DOI 10.1002/jmv.26398; Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702; Hoang A, 2020, ECLINICALMEDICINE, V24, DOI 10.1016/j.eclinm.2020.100433; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Lee K, 2009, GLOB INST, P1; Li Q., 2020, NEW ENGL J MED, V382, P1199; Ministry of Public Health, 2021, THAI GUID COVID 19; Ozsurekci Y, 2021, PEDIATR NEPHROL, V36, P3771, DOI 10.1007/s00467-021-05111-x; Tsankov BK, 2021, INT J INFECT DIS, V103, P246, DOI 10.1016/j.ijid.2020.11.163; Wong JJM, 2021, AM J TROP MED HYG, V105, P413, DOI 10.4269/ajtmh.21-0299	13	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267035	10.1371/journal.pone.0267035	http://dx.doi.org/10.1371/journal.pone.0267035			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1E2NP	35427379	gold, Green Published			2022-12-26	WOS:000794332400002
J	Cofsky, JA; Knott, G; Gee, C; Doudna, J				Cofsky, Joshua A.; Knott, Gavin; Gee, Christine; Doudna, Jennifer			Crystal structure of an RNA/DNA strand exchange junction	PLOS ONE			English	Article							MOLECULAR-STRUCTURE; OKAZAKI FRAGMENT; 2-HYDROXYL GROUP; B-DNA; RNA; HYBRID; DUPLEX; R(GCG)D(TATACGC); CONFORMATIONS; ASSIGNMENT	Short segments of RNA displace one strand of a DNA duplex during diverse processes including transcription and CRISPR-mediated immunity and genome editing. These strand exchange events involve the intersection of two geometrically distinct helix types-an RNA:DNA hybrid (A-form) and a DNA:DNA homoduplex (B-form). Although previous evidence suggests that these two helices can stack on each other, it is unknown what local geometric adjustments could enable A-on-B stacking. Here we report the X-ray crystal structure of an RNA-5 '/DNA-3 ' strand exchange junction at an anisotropic resolution of 1.6 to 2.2 angstrom. The structure reveals that the A-to-B helical transition involves a combination of helical axis misalignment, helical axis tilting and compression of the DNA strand within the RNA:DNA helix, where nucleotides exhibit a mixture of A- and B-form geometry. These structural principles explain previous observations of conformational stability in RNA/DNA exchange junctions, enabling a nucleic acid architecture that is repeatedly populated during biological strand exchange events.	[Cofsky, Joshua A.; Gee, Christine; Doudna, Jennifer] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Knott, Gavin] Monash Univ, Monash Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton city, Vic, Australia; [Gee, Christine; Doudna, Jennifer] Univ Calif Berkeley, Calif Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA; [Gee, Christine; Doudna, Jennifer] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [Doudna, Jennifer] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; Monash University; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco; The J David Gladstone Institutes	Doudna, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.; Doudna, J (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA.; Doudna, J (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Doudna, J (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Doudna, J (corresponding author), Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA.; Doudna, J (corresponding author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.; Doudna, J (corresponding author), Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA.	doudna@berkeley.edu		Gee, Christine/0000-0002-2632-6418; Cofsky, Joshua/0000-0001-5403-8555	NSF Graduate Research Fellowship; NHMRC Investigator Grant [1175568, U01AI142817-02]; Howard Hughes Medical Institute; National Science Foundation [1817593]; Centers for Excellence in Genomic Science of the National Institutes of Health [RM1HG009490]; Somatic Cell Genome Editing Program of the Common Fund of the National Institutes of Health [DE-AC02-05CH11231]; U.S. DOE Office of Science User Facility [P30 GM124169-01]; National Institutes of Health, National Institute of General Medical Sciences [EL1]	NSF Graduate Research Fellowship(National Science Foundation (NSF)); NHMRC Investigator Grant(National Health and Medical Research Council (NHMRC) of Australia); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); Centers for Excellence in Genomic Science of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Somatic Cell Genome Editing Program of the Common Fund of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. DOE Office of Science User Facility(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	J.C.C. is a recipient of the NSF Graduate Research Fellowship (https://www.nsfgrfp.org/). G. J.K was supported by an NHMRC Investigator Grant (EL1, 1175568) (https://www.nhmrc.gov.au/ ). This work was supported by the Howard Hughes Medical Institute (https://www.hhmi.org/), the National Science Foundation under award number 1817593 (https://www.nsf.gov/), the Centers for Excellence in Genomic Science of the National Institutes of Health under award number RM1HG009490 (https://www.genome.gov/ Funded-Programs-Projects/Centers-of-Excellence-in-Genomic-Science), and the Somatic Cell Genome Editing Program of the Common Fund of the National Institutes of Health under award number U01AI142817-02 (https://commonfund. nih.gov/editing). J.A.D. is an HHMI investigator. Beamline 8.3.1 of the Advanced Light Source, a U. S. DOE Office of Science User Facility under Contract No. DE-AC02-05CH11231, is supported in part by the ALS-ENABLE program (http://als-enable.lbl.gov/) funded by the National Institutes of Health, National Institute of General Medical Sciences, grant P30 GM124169-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altae-Tran H, 2021, SCIENCE, V374, P57, DOI 10.1126/science.abj6856; AYMAMI J, 1990, P NATL ACAD SCI USA, V87, P2526, DOI 10.1073/pnas.87.7.2526; BAN C, 1994, J MOL BIOL, V236, P275, DOI 10.1006/jmbi.1994.1134; Broadwater DWB, 2021, BIOPHYS J, V120, P2400, DOI 10.1016/j.bpj.2021.01.043; Cavaluzzi MJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh015; Chen JS, 2017, NAT REV CHEM, V1, DOI 10.1038/s41570-017-0078; Cofsky JC., 2022, NAT STRUCT MOL BIOL, DOI [10.1101/2021.09.06.459219, DOI 10.1101/2021.09.06.459219]; Cofsky JC, 2020, ELIFE, V9, DOI 10.7554/eLife.55143; Crossley MP, 2019, MOL CELL, V73, P398, DOI 10.1016/j.molcel.2019.01.024; DICKERSON RE, 1994, P NATL ACAD SCI USA, V91, P3579, DOI 10.1073/pnas.91.9.3579; DREW HR, 1981, P NATL ACAD SCI-BIOL, V78, P2179, DOI 10.1073/pnas.78.4.2179; EGLI M, 1992, P NATL ACAD SCI USA, V89, P534, DOI 10.1073/pnas.89.2.534; EGLI M, 1993, BIOCHEMISTRY-US, V32, P3221, DOI 10.1021/bi00064a004; ElHassan MA, 1997, PHILOS T R SOC A, V355, P43, DOI 10.1098/rsta.1997.0002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FEDOROFF OY, 1993, J MOL BIOL, V233, P509, DOI 10.1006/jmbi.1993.1528; Hase F, 2016, NUCLEIC ACIDS RES, V44, P7100, DOI 10.1093/nar/gkw607; Hays FA, 2003, J BIOL CHEM, V278, P49663, DOI 10.1074/jbc.R300033200; Horton NC, 1996, J MOL BIOL, V264, P521, DOI 10.1006/jmbi.1996.0658; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karvelis T, 2021, NATURE, V599, P692, DOI 10.1038/s41586-021-04058-1; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Knott GJ, 2018, SCIENCE, V361, P866, DOI 10.1126/science.aat5011; KOWALCZYKOWSKI SC, 1991, ANNU REV BIOPHYS BIO, V20, P539, DOI 10.1146/annurev.bb.20.060191.002543; Lapinaite A, 2020, SCIENCE, V369, P566, DOI 10.1126/science.abb1390; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Liu C, 2014, J MOL BIOL, V426, P980, DOI 10.1016/j.jmb.2013.11.014; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Lu XJ, 2000, J MOL BIOL, V300, P819, DOI 10.1006/jmbi.2000.3690; M. Pacesa, 2021, bioRxiv, DOI 10.1101/2021.09.16.460614; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McKinney SA, 2003, NAT STRUCT BIOL, V10, P93, DOI 10.1038/nsb883; MELLEMA JR, 1983, NUCLEIC ACIDS RES, V11, P5717, DOI 10.1093/nar/11.16.5717; MILMAN G, 1967, P NATL ACAD SCI USA, V57, P1804, DOI 10.1073/pnas.57.6.1804; Ortiz-Lombardia M, 1999, NAT STRUCT BIOL, V6, P913; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pickar-Oliver A, 2019, NAT REV MOL CELL BIO, V20, P490, DOI 10.1038/s41580-019-0131-5; Roll C, 1998, BIOCHEMISTRY-US, V37, P4059, DOI 10.1021/bi972377w; Saenger W., 1984, PRINCIPLES NUCL ACID; SALAZAR M, 1994, J MOL BIOL, V241, P440, DOI 10.1006/jmbi.1994.1519; Salazar M, 1996, BIOCHEMISTRY-US, V35, P8126, DOI 10.1021/bi9528917; SEEMAN NC, 1994, ANNU REV BIOPH BIOM, V23, P53, DOI 10.1146/annurev.bb.23.060194.000413; SELSING E, 1978, NATURE, V275, P249, DOI 10.1038/275249a0; Simmel FC, 2019, CHEM REV, V119, P6326, DOI 10.1021/acs.chemrev.8b00580; Srinivas N, 2013, NUCLEIC ACIDS RES, V41, P10641, DOI 10.1093/nar/gkt801; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tickle I.J., 2018, STARANISO; Wahl MC, 2000, NUCLEIC ACIDS RES, V28, P4356, DOI 10.1093/nar/28.21.4356; WANG AHJ, 1982, NATURE, V299, P601, DOI 10.1038/299601a0; ZHU LM, 1995, BIOCHEMISTRY-US, V34, P2372, DOI 10.1021/bi00007a033; Zhu X, 2019, NAT STRUCT MOL BIOL, V26, P679, DOI 10.1038/s41594-019-0258-2	54	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0263547	10.1371/journal.pone.0263547	http://dx.doi.org/10.1371/journal.pone.0263547			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7MW	35436289	gold, Green Published, Green Submitted			2022-12-26	WOS:000791258900026
J	Hulcr, J; Gomez, DF; Johnson, AJ				Hulcr, Jiri; Gomez, Demian F.; Johnson, Andrew J.			Collecting and preserving bark and ambrosia beetles (Coleoptera: Curculionidae: Scolytinae & Platypodinae)	PLOS ONE			English	Article							SYMBIOSIS; RECORDS	This protocol describes the different methods to collect and preserve bark and ambrosia beetles, detailing collecting tools, recording relevant data, and optimizing step-by-step methods to extract beetles from twigs, branches, bark, and trunks. It elaborates on trapping techniques, tools, lures, baits, and beetle preservation. The main rule of manual collecting is to not attempt to pry the insect out of the wood or bark, but instead, remove the wood/bark away from the beetle: gently and systematically. The main rule of trapping is that there is no general attractant; instead, attractants and traps should reflect the ecology of the targeted beetle taxa.	[Hulcr, Jiri; Johnson, Andrew J.] Univ Florida, Sch Forest Fisheries & Geomat Sci, Gainesville, FL 32611 USA; [Gomez, Demian F.] Texas A&M Forest Serv, Austin, TX USA	State University System of Florida; University of Florida	Hulcr, J (corresponding author), Univ Florida, Sch Forest Fisheries & Geomat Sci, Gainesville, FL 32611 USA.	hulcr@ufl.edu		Hulcr, Jiri/0000-0002-8706-4618; Gomez, Demian/0000-0001-5437-0160	Animal and Plant Health Inspection Service; U.S. Forest Service; National Science Foundation; National Institute of Food and Agriculture; Texas A&M Forest Service	Animal and Plant Health Inspection Service; U.S. Forest Service(United States Department of Agriculture (USDA)United States Forest Service); National Science Foundation(National Science Foundation (NSF)); National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Texas A&M Forest Service	JH was supported by the following organizations: the Animal and Plant Health Inspection Service, the U.S. Forest Service, the National Science Foundation, and the National Institute of Food and Agriculture. DG was supported by the Texas A&M Forest Service. The funders had and will have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biedermann PHW, 2020, ANNU REV ENTOMOL, V65, P431, DOI 10.1146/annurev-ento-011019-024910; Cognato AI, 2020, FRONT ECOL EVOL, V8, DOI 10.3389/fevo.2020.00027; Eskalen A, 2013, PLANT DIS, V97, P938, DOI 10.1094/PDIS-11-12-1026-RE; Gomez DF, 2019, FLA ENTOMOL, V102, P717, DOI 10.1653/024.102.0408; Gomez DF, 2018, INSECT SYST DIVER, V2, DOI 10.1093/isd/ixy018; Hanks LM, 2013, CHEMOECOLOGY, V23, P21, DOI 10.1007/s00049-012-0116-8; Hartshorn JA, 2021, J ECON ENTOMOL, V114, P776, DOI 10.1093/jee/toaa309; Havill NP, 2019, INSECT SYST DIVER, V3, DOI 10.1093/isd/ixz002; Hoebeke ER, 2018, ZOOTAXA, V4394, P243, DOI 10.11646/zootaxa.4394.2.7; Hughes MA, 2017, BIOL INVASIONS, V19, P2143, DOI 10.1007/s10530-017-1427-z; Hulcr J, 2007, ECOL ENTOMOL, V32, P762, DOI 10.1111/j.1365-2311.2007.00939.x; Hulcr J, 2020, SYMBIOSIS, V81, P101, DOI 10.1007/s13199-020-00686-9; Hulcr J, 2009, ZOOTAXA, P19, DOI 10.11646/zootaxa.2204.1.2; Kolarik M, 2011, MYCOLOGIA, V103, P325, DOI 10.3852/10-124; Kostovcik M, 2015, ISME J, V9, P126, DOI 10.1038/ismej.2014.115; Li YX, 2021, PEER PEER NETW APPL, V14, P2826, DOI 10.1007/s12083-021-01103-8; Mayers CG, 2020, MYCOLOGIA, V112, P1104, DOI 10.1080/00275514.2020.1755209; Oliveira LSS., 2020, ANTON LEEUW INT J G; Paap T, 2018, AUSTRALAS PLANT PATH, V47, P231, DOI 10.1007/s13313-018-0545-0; Rabaglia R, 2008, EARLY DETECTION RAPI; Rabaglia Robert J., 2019, American Entomologist, V65, P29, DOI 10.1093/ae/tmz015; Ramsfield TD, 2016, FORESTRY, V89, P245, DOI 10.1093/forestry/cpw018; Schauff ME, 2001, COLLECTING PRESERVIN, V1443, P68; Schindel DE, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006125; Smith SM, 2019, INSECTS, V10, DOI 10.3390/insects10090261; Wingfield MJ, 2015, SCIENCE, V349, P832, DOI 10.1126/science.aac6674	26	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0265910	10.1371/journal.pone.0265910	http://dx.doi.org/10.1371/journal.pone.0265910			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1E2NP	35427394	Green Published, gold			2022-12-26	WOS:000794332400027
J	Li, YL; Van Houten, CB; Boers, SA; Jansen, R; Cohen, A; Engelhard, D; Kraaij, R; Hiltemann, SD; Ju, J; Fernandez, D; Mankoc, C; Gonzalez, E; De Waal, WJ; Groot, KDM; Wolfs, TFW; Meijers, P; Luijk, B; Oosterheert, JJ; Sankatsing, SUC; Bossink, AWJ; Stein, M; Klein, A; Ashkar, J; Bamberger, E; Srugo, I; Odeh, M; Dotan, Y; Boico, O; Etshtein, L; Paz, M; Navon, R; Friedman, T; Simon, E; Gottlieb, TM; Pri-Or, E; Kronenfeld, G; Oved, K; Eden, E; Stubbs, AP; Bont, LJ; Hays, JP				Li, Yunlei; van Houten, Chantal B.; Boers, Stefan A.; Jansen, Ruud; Cohen, Asi; Engelhard, Dan; Kraaij, Robert; Hiltemann, Saskia D.; Ju, Jie; Fernandez, David; Mankoc, Cristian; Gonzalez, Eva; de Waal, Wouter J.; de Winter-de Groot, Karin M.; Wolfs, Tom F. W.; Meijers, Pieter; Luijk, Bart; Oosterheert, Jan Jelrik; Sankatsing, Sanjay U. C.; Bossink, Aik W. J.; Stein, Michal; Klein, Adi; Ashkar, Jalal; Bamberger, Ellen; Srugo, Isaac; Odeh, Majed; Dotan, Yaniv; Boico, Olga; Etshtein, Liat; Paz, Meital; Navon, Roy; Friedman, Tom; Simon, Einav; Gottlieb, Tanya M.; Pri-Or, Ester; Kronenfeld, Gali; Oved, Kfir; Eden, Eran; Stubbs, Andrew P.; Bont, Louis J.; Hays, John P.			The diagnostic value of nasal microbiota and clinical parameters in a multi-parametric prediction model to differentiate bacterial versus viral infections in lower respiratory tract infections	PLOS ONE			English	Article							CHEST GUIDELINE; SEQUENCE DATA; CHILDREN; NASOPHARYNX; PIPELINE; VIRUS; COUGH; TRIAL; NOSE	BackgroundThe ability to accurately distinguish bacterial from viral infection would help clinicians better target antimicrobial therapy during suspected lower respiratory tract infections (LRTI). Although technological developments make it feasible to rapidly generate patient-specific microbiota profiles, evidence is required to show the clinical value of using microbiota data for infection diagnosis. In this study, we investigated whether adding nasal cavity microbiota profiles to readily available clinical information could improve machine learning classifiers to distinguish bacterial from viral infection in patients with LRTI. ResultsVarious multi-parametric Random Forests classifiers were evaluated on the clinical and microbiota data of 293 LRTI patients for their prediction accuracies to differentiate bacterial from viral infection. The most predictive variable was C-reactive protein (CRP). We observed a marginal prediction improvement when 7 most prevalent nasal microbiota genera were added to the CRP model. In contrast, adding three clinical variables, absolute neutrophil count, consolidation on X-ray, and age group to the CRP model significantly improved the prediction. The best model correctly predicted 85% of the 'bacterial' patients and 82% of the 'viral' patients using 13 clinical and 3 nasal cavity microbiota genera (Staphylococcus, Moraxella, and Streptococcus). ConclusionsWe developed high-accuracy multi-parametric machine learning classifiers to differentiate bacterial from viral infections in LRTI patients of various ages. We demonstrated the predictive value of four easy-to-collect clinical variables which facilitate personalized and accurate clinical decision-making. We observed that nasal cavity microbiota correlate with the clinical variables and thus may not add significant value to diagnostic algorithms that aim to differentiate bacterial from viral infections.	[Li, Yunlei; Hiltemann, Saskia D.; Ju, Jie; Stubbs, Andrew P.] Univ Med Ctr Rotterdam, Erasmus MC Canc Inst, Dept Pathol & Clin Bioinformat, Rotterdam, Netherlands; [van Houten, Chantal B.; Wolfs, Tom F. W.; Bont, Louis J.] Univ Utrecht, Univ Med Ctr Utrecht, Div Paediat Immunol & Infect Dis, Utrecht, Netherlands; [Boers, Stefan A.; Hays, John P.] Univ Med Ctr Rotterdam, Erasmus MC Canc Inst, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Jansen, Ruud] Streeklab Haarlem, Haarlem, Netherlands; [Cohen, Asi; Bamberger, Ellen; Boico, Olga; Etshtein, Liat; Paz, Meital; Navon, Roy; Friedman, Tom; Simon, Einav; Gottlieb, Tanya M.; Pri-Or, Ester; Kronenfeld, Gali; Oved, Kfir; Eden, Eran] MeMed, Tirat Carmel, Israel; [Engelhard, Dan] Hadassah Hebrew Univ Med Ctr, Div Paediat Infect Dis Unit, Jerusalem, Israel; [Kraaij, Robert] Univ Med Ctr Rotterdam, Erasmus MC Canc Inst, Dept Internal Med, Rotterdam, Netherlands; [Fernandez, David; Mankoc, Cristian; Gonzalez, Eva] Noray Bioinformat, Derio, Spain; [de Waal, Wouter J.] Diakonessen Hosp, Dept Paediat, Utrecht, Netherlands; [de Winter-de Groot, Karin M.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Paediat Resp Med, Utrecht, Netherlands; [Meijers, Pieter] Gelderse Vallei Hosp, Dept Paediat, Ede, Netherlands; [Luijk, Bart] Univ Utrecht, Univ Med Ctr Utrecht, Dept Resp Med, Utrecht, Netherlands; [Oosterheert, Jan Jelrik] Univ Utrecht, Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands; [Bossink, Aik W. J.] Diakonessen Hosp, Dept Resp Med, Utrecht, Netherlands; [Stein, Michal; Klein, Adi; Ashkar, Jalal] Hillel Yaffe Med Ctr, Dept Paediat, Hadera, Israel; [Bamberger, Ellen; Srugo, Isaac] Bnai Z Med Ctr, Dept Paediat, Haifa, Israel; [Odeh, Majed] Bnai Z Med Ctr, Dept Internal Med, Haifa, Israel; [Dotan, Yaniv] Rambam Hlth Care Campus, Pulm Div, Haifa, Israel	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Hebrew University of Jerusalem; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Diakonessenhuis; Utrecht University; Utrecht University Medical Center; Gelderse Vallei Hospital; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Diakonessenhuis; Bnai Zion Medical Center; Bnai Zion Medical Center; Rambam Health Care Campus	Hays, JP (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC Canc Inst, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	j.hays@erasmusmc.nl	Hays, J/I-9007-2017	Hays, J/0000-0001-9183-4497	European Union [602860]	European Union(European Commission)	J.P. Hays, D. Engelhard, E. Eden, E. Gonza ' lez and L.J. Bont received funding for The TAILORED Treatment study from the European Union's Seventh Framework Programme (grant number 602860, https://cordis.europa.eu/project/id/602860).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, R PROJECT STAT COMPU; Bassis CM, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-27; Biesbroek G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032942; Bogaert D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017035; Bomar L, 2018, CURR OPIN MICROBIOL, V41, P8, DOI 10.1016/j.mib.2017.10.023; Brealey JC, 2018, RESPIROLOGY, V23, P220, DOI 10.1111/resp.13179; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Breiman L., 2001, MACH LEARN, V45, P5; Brugger SD, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00852-20; Cetinkaya A, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.congress-2019.PA3849; Church DL, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00053-19; Cleary DW, 2017, EMERG TOP LIFE SCI, V1, P297, DOI 10.1042/ETLS20170041; De Boeck I, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02372; Dubourg G, 2019, EXPERT REV ANTI-INFE, V17, P437, DOI 10.1080/14787210.2019.1621168; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edouard S, 2018, EUR J CLIN MICROBIOL, V37, P1725, DOI 10.1007/s10096-018-3305-8; Engelmann I, 2015, PEDIATRICS, V135, pE985, DOI 10.1542/peds.2014-1946; Esposito S, 2018, EUR J CLIN MICROBIOL, V37, P1, DOI 10.1007/s10096-017-3076-7; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Feldman C, 2019, EXPERT REV RESP MED, V13, P63, DOI 10.1080/17476348.2019.1555040; Frank DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010598; Heikema AP, 2020, GENES-BASEL, V11, DOI 10.3390/genes11091105; Hill AT, 2019, CHEST, V155, P155, DOI 10.1016/j.chest.2018.09.016; Hiltemann SD, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giy166; Hossain MZ, 2019, INT J BIOMETEOROL, V63, P209, DOI 10.1007/s00484-018-01654-1; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Kawai Y, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0262912; Keitel K, 2019, CLIN INFECT DIS, V69, P1926, DOI 10.1093/cid/ciz080; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lagkouvardos I, 2017, PEERJ, V5, DOI 10.7717/peerj.2836; Langelier C, 2018, P NATL ACAD SCI USA, V115, pE12353, DOI 10.1073/pnas.1809700115; Lemiengre MB, 2018, SCAND J PRIM HEALTH, V36, P423, DOI 10.1080/02813432.2018.1529900; Lemiengre MB, 2018, BRIT J GEN PRACT, V68, pE204, DOI 10.3399/bjgp18X695033; Lemon KP, 2020, CURR BIOL, V30, pR1118, DOI 10.1016/j.cub.2020.08.010; Luna PN, 2018, MICROBIOME, V6, DOI 10.1186/s40168-017-0385-0; Man WH, 2019, LANCET RESP MED, V7, P417, DOI [10.1016/S2213-2600(18)30449-1, 10.1016/s2213-2600(18)30449-1]; Marshall DC, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0781-4; Matheeussen V, 2018, EUR J CLIN MICROBIOL, V37, P1319, DOI 10.1007/s10096-018-3253-3; Mewes JC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214222; Moore A, 2019, CHEST, V155, P147, DOI 10.1016/j.chest.2018.09.027; Oved K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120012; Perez-Losada M, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0170-5; Petel D, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022133; Mancini DAP, 2008, REV INST MED TROP SP, V50, P41, DOI 10.1590/S0036-46652008000100009; Povoa P., 2019, Clinical Pulmonary Medicine, V26, P118, DOI 10.1097/CPM.0000000000000322; Proctor DM, 2017, CELL HOST MICROBE, V21, P421, DOI 10.1016/j.chom.2017.03.011; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rhedin SA, 2019, JMIR RES PROTOC, V8, DOI 10.2196/12705; Stein M, 2018, DIAGN MICR INFEC DIS, V90, P206, DOI 10.1016/j.diagmicrobio.2017.11.011; Tang JH, 2018, BRAZ J MED BIOL RES, V51, DOI [10.1590/1414-431X20176783, 10.1590/1414-431x20176783]; Thibeault C, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.aba0501; Toivonen L, 2019, THORAX, V74, P592, DOI 10.1136/thoraxjnl-2018-212629; Unger SA, 2017, J INFECTION, V74, pS84, DOI 10.1016/S0163-4453(17)30196-2; van den Munckhof EHA, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01443-8; van Houten CB, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3300-9; van Houten CB, 2019, EUR J CLIN MICROBIOL, V38, P505, DOI 10.1007/s10096-018-03454-2; Venge P, 2019, J APPL LAB MED, V3, P664, DOI 10.1373/jalm.2018.026369; Verbakel JY, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025036	58	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267140	10.1371/journal.pone.0267140	http://dx.doi.org/10.1371/journal.pone.0267140			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7MW	35436301	Green Published, gold			2022-12-26	WOS:000791258900020
J	Mougi, A				Mougi, Akihiko			Adaptive plasticity in activity modes and food web stability	PLOS ONE			English	Article							PREDATOR-SPECIFIC DEFENSE; PHENOTYPIC PLASTICITY; COMPLEXITY; ECOLOGY; BIODIVERSITY; DIVERSITY; DYNAMICS; EVOLUTION; NETWORKS; WEAK	Natural ecosystems are comprised of diverse species and their interspecific interactions, in contrast to an ecological theory that predicts the instability of large ecological communities. This apparent gap has led ecologists to explore the mechanisms that allow complex communities to stabilize, even via environmental changes. A standard approach to tackling this complexity-stability problem is starting with a description of the ecological network of species and their interaction links, exemplified by a food web. This traditional description is based on the view that each species is in an active state; that is, each species constantly forages and reproduces. However, in nature, species' activities can virtually stop when hiding, resting, and diapausing or hibernating, resulting in overlooking another situation where they are inactive. Here I theoretically demonstrate that adaptive phenotypic change in active and inactive modes may be the key to understanding food web dynamics. Accurately switching activity modes can greatly stabilize otherwise unstable communities in which coexistence is impossible, further maintaining strong stabilization, even in a large complex community. I hypothesize that adaptive plastic change in activity modes may play a key role in maintaining ecological communities.	[Mougi, Akihiko] Shimane Univ, Acad Assembly, Inst Agr & Life Sci, Matsue, Shimane, Japan	Shimane University	Mougi, A (corresponding author), Shimane Univ, Acad Assembly, Inst Agr & Life Sci, Matsue, Shimane, Japan.	amougi@gmail.com			Japan Society for the Promotion of Science [20K06826]; Faculty of Life and Environmental Sciences at Shimane University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Faculty of Life and Environmental Sciences at Shimane University	(1) Grant-in-Aid for Scientific Research (C) (#20K06826) from the Japan Society for the Promotion of Science. (2) Faculty of Life and Environmental Sciences at Shimane University for providing financial aid to publish this article. (this statement is required for receiving this financial aid). Please specify this statement anywhere in the article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Berryman AA, 2006, OIKOS, V115, P192, DOI 10.1111/j.0030-1299.2006.15188.x; Brose U, 2006, ECOL LETT, V9, P1228, DOI 10.1111/j.1461-0248.2006.00978.x; Chen X, 2001, P ROY SOC B-BIOL SCI, V268, P869, DOI 10.1098/rspb.2001.1596; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Gellner G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11180; HARVELL CD, 1990, Q REV BIOL, V65, P323, DOI 10.1086/416841; HERBERS JM, 1981, OECOLOGIA, V49, P252, DOI 10.1007/BF00349198; Houston AI, 2014, J ANIM ECOL, V83, P30, DOI 10.1111/1365-2656.12096; HUMPHREYS WF, 1979, J ANIM ECOL, V48, P427, DOI 10.2307/4171; Kishida O, 2010, POPUL ECOL, V52, P37, DOI 10.1007/s10144-009-0182-0; Kondoh M, 2003, SCIENCE, V299, P1388, DOI 10.1126/science.1079154; Kondoh M, 2007, P ROY SOC B-BIOL SCI, V274, P1617, DOI 10.1098/rspb.2007.0335; Kondoh M, 2016, THEOR ECOL-NETH, V9, P15, DOI 10.1007/s12080-015-0266-8; Korstjens AH, 2010, ANIM BEHAV, V79, P361, DOI 10.1016/j.anbehav.2009.11.012; Kovach-Orr C, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0084; Landi P, 2018, POPUL ECOL, V60, P319, DOI 10.1007/s10144-018-0628-3; Matsuda H, 1996, EVOL ECOL, V10, P13, DOI 10.1007/BF01239343; MATSUDA H, 1994, EVOL ECOL, V8, P628, DOI 10.1007/BF01237846; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; McCann K.S., 2011, FOOD WEBS MPB 50; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Mougi A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49143-8; Mougi A, 2012, SCIENCE, V337, P349, DOI 10.1126/science.1220529; Mougi Akihiko, 2021, Biol Lett, V17, P20200673, DOI 10.1098/rsbl.2020.0673; Mougi A, 2009, J ANIM ECOL, V78, P1172, DOI 10.1111/j.1365-2656.2009.01600.x; Namba T, 2015, POPUL ECOL, V57, P3, DOI 10.1007/s10144-015-0482-5; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; Pimm SL, 1991, BALANCE NATURE ECOLO; Pimm SL., 1982, FOOD WEBS, P1, DOI [10.1007/978-94-009-5925-5, DOI 10.1007/978-94-009-5925-5, 10.1007/978-94-009-5925-5_1, DOI 10.1007/978-94-009-5925-5_1]; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Robertson BA, 2013, TRENDS ECOL EVOL, V28, P552, DOI 10.1016/j.tree.2013.04.004; Sih A, 2012, PHILOS T R SOC B, V367, P2762, DOI 10.1098/rstb.2012.0216; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Uchida S, 2007, ECOL MODEL, V206, P263, DOI 10.1016/j.ecolmodel.2007.03.035; Uchida S, 2007, J THEOR BIOL, V247, P713, DOI 10.1016/j.jtbi.2007.04.019; Valdovinos FS, 2010, ECOL LETT, V13, P1546, DOI 10.1111/j.1461-0248.2010.01535.x; Vos M, 2004, OIKOS, V105, P471, DOI 10.1111/j.0030-1299.2004.12930.x	41	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267444	10.1371/journal.pone.0267444	http://dx.doi.org/10.1371/journal.pone.0267444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446908	gold, Green Published			2022-12-26	WOS:000795468200054
J	Naito, N; Hirosawa, T; Tsubomoto, M; Miyagishi, Y; Kikuchi, M				Naito, Nobushige; Hirosawa, Tetsu; Tsubomoto, Makoto; Miyagishi, Yoshiaki; Kikuchi, Mitsuru			Prominent gamma band activity during visual motion perception in early-stage Alzheimer's disease	PLOS ONE			English	Article							COHERENT MOTION; OSCILLATIONS; MAGNETOENCEPHALOGRAPHY; SYNCHRONIZATION; MECHANISMS; DEMENTIA; HUMANS; FIELD; MT	IntroductionAlzheimer's disease (AD) affects multiple neural pathways and regions, resulting in various visual impairments such as motion perception. Generally, gamma-band activities during visual motion perception have been thought to reflect ongoing cognitive processes. Nevertheless, few studies have specifically examined induced gamma band activity during visual motion perception in AD patients. Therefore, after performing magnetoencephalography (MEG) recording during apparent motion (AM) stimulation for the left hemi-visual field in patients diagnosed as having AD in the early stage, we compared the results with findings of cognitive performance. MethodsSeventeen AD patients in the early stage and 17 controls matched for age, sex, and educational attainment participated in this study. For each participant, memory performance was assessed with the Mini-Mental State Examination (MMSE) and the Wechsler Memory Scale-Revised (WMS-R). For MEG analysis, we examined power changes induced in a higher frequency range (20-100 Hz) after AM stimuli. ResultsThe power of induced gamma band activities was significantly higher in AD patients. The power of induced gamma band activities was associated with higher performance on both MMSE and WMS-R tests for attention and concentration in AD patients. ConclusionsGiven that neuronal dysfunction in AD is associated with excitotoxic neurodegeneration, and given that subsequent development of compensatory inhibitory mechanisms also contributes to pathology in AD patients, elevated gamma band oscillations might reflect an imbalance of inhibitory and excitatory activity in AD patients. Moreover, positive correlation between induced gamma activity and cognitive performance might signify a compensating mechanism of inhibitory neurons which preserve the pyramidal neuron from excitotoxicity in a posterior association area.	[Naito, Nobushige; Tsubomoto, Makoto; Miyagishi, Yoshiaki; Kikuchi, Mitsuru] Kanazawa Univ, Dept Psychiat & Behav Sci, Kanazawa, Ishikawa, Japan; [Hirosawa, Tetsu; Kikuchi, Mitsuru] Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University	Kikuchi, M (corresponding author), Kanazawa Univ, Dept Psychiat & Behav Sci, Kanazawa, Ishikawa, Japan.; Kikuchi, M (corresponding author), Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa, Japan.	mitsuruk@med.kanazawa-u.ac.jp						Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; ANSTIS S, 1985, VISION RES, V25, P1051, DOI 10.1016/0042-6989(85)90093-8; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bell KFS, 2007, J NEUROSCI, V27, P10810, DOI 10.1523/JNEUROSCI.3269-07.2007; Bertrand O, 2000, INT J PSYCHOPHYSIOL, V38, P211, DOI 10.1016/S0167-8760(00)00166-5; Brookes MJ, 2005, NEUROIMAGE, V26, P302, DOI 10.1016/j.neuroimage.2005.01.050; Brunet NM, 2019, NEUROIMAGE, V200, P635, DOI 10.1016/j.neuroimage.2019.06.051; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Bundo M, 2000, HUM BRAIN MAPP, V11, P33, DOI 10.1002/1097-0193(200009)11:1<33::AID-HBM30>3.3.CO;2-3; Dejakaisaya H, 2021, EPILEPSIA, V62, P1485, DOI 10.1111/epi.16918; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; GALAMBOS R, 1981, P NATL ACAD SCI-BIOL, V78, P2643, DOI 10.1073/pnas.78.4.2643; Iwakiri M, 2005, ACTA NEUROPATHOL, V109, P467, DOI 10.1007/s00401-005-0985-9; Iwakiri M, 2009, NEUROPATHOLOGY, V29, P263, DOI 10.1111/j.1440-1789.2008.00978.x; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Kaiser J, 2005, NEUROREPORT, V16, P207, DOI 10.1097/00001756-200502280-00001; Kaneoke Y, 2006, PROG NEUROBIOL, V80, P219, DOI 10.1016/j.pneurobio.2006.10.001; Kim EJ, 2007, NEUROLOGY, V69, P1105, DOI 10.1212/01.wnl.0000276956.65528.d4; Koenig T, 2005, NEUROBIOL AGING, V26, P165, DOI 10.1016/j.neurobiolaging.2004.03.008; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Parameshwaran K, 2008, EXP NEUROL, V210, P7, DOI 10.1016/j.expneurol.2007.10.008; Prieto EA, 2007, NEUROIMAGE, V37, P1384, DOI 10.1016/j.neuroimage.2007.03.080; REISBERG B, 1986, GERIATRICS, V41, P30; RIBARY U, 1991, P NATL ACAD SCI USA, V88, P11037, DOI 10.1073/pnas.88.24.11037; SARVAS J, 1987, PHYS MED BIOL, V32, P11, DOI 10.1088/0031-9155/32/1/004; Siegel M, 2007, CEREB CORTEX, V17, P732, DOI 10.1093/cercor/bhk025; Smith AT, 2006, EUR J NEUROSCI, V23, P561, DOI 10.1111/j.1460-9568.2005.04526.x; Sokolov A, 1999, NEUROREPORT, V10, P1997, DOI 10.1097/00001756-199907130-00001; Stam CJ, 2002, J CLIN NEUROPHYSIOL, V19, P562, DOI 10.1097/00004691-200212000-00010; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; van Deursen JA, 2008, J NEURAL TRANSM, V115, P1301, DOI 10.1007/s00702-008-0083-y; Walton HS, 2007, NEUROCHEM INT, V50, P1052, DOI 10.1016/j.neuint.2006.10.007; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wenk GL, 2006, J CLIN PSYCHIAT, V67, P3; Whittington MA, 2003, TRENDS NEUROSCI, V26, P676, DOI 10.1016/j.tins.2003.09.016; ZEKI S, 1991, J NEUROSCI, V11, P641; Zion-Golumbic E, 2007, CEREB CORTEX, V17, P1741, DOI 10.1093/cercor/bhl100	41	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266693	10.1371/journal.pone.0266693	http://dx.doi.org/10.1371/journal.pone.0266693			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0Z7MW	35436287	Green Published, gold			2022-12-26	WOS:000791258900015
J	Pearson, SF; Keren, I; Lance, MM; Raphael, MG				Pearson, Scott F.; Keren, Ilai; Lance, Monique M.; Raphael, Martin G.			Non-breeding changes in at-sea distribution and abundance of the threatened marbled murrelet (Brachyramphus marmoratus) in a portion of its range exhibiting long-term breeding season declines	PLOS ONE			English	Article							BRITISH-COLUMBIA; PUGET-SOUND; HABITAT USE; MOVEMENTS; PATTERNS; SEABIRD; FISHES; TRENDS; PREY	The marbled murrelet (Brachyramphus marmoratus) is classified as a threatened species under the US Endangered Species Act in Washington, Oregon, and California USA due to population declines, loss of breeding habitat, and other factors. To date, population assessments have focused on breeding season at-sea surveys. Consequently, there is little information on this species' distribution, abundance, and population trends during the non-breeding season, when murrelets are found exclusively in the marine environment. To address this information need, we assessed non-breeding (Sep-Mar) at-sea murrelet abundance patterns and population trends over 8 years, in a portion of its range where breeding season surveys indicate a 20-year population decline, Puget Sound, Washington, USA. This allowed us to assess whether non-breeding population trends mirrored those observed during the breeding season suggesting regional year-round conservation concerns and to also identify important over-wintering areas (areas of high abundance). We integrated our non-breeding abundance information with breeding season information to assess year-round patterns of abundance. This allowed us to test the prediction that murrelets move into the relatively protected inner marine waters of Puget Sound from harsher outer coastal habitats during the non-breeding season to molt and over-winter. Similar to trends from the breeding season, we observed strong murrelet density declines across the entire non-breeding period (Sep and Apr) with declines most pronounced in the fall and early winter (lateSep-Dec) survey windows when birds molt and in the spring just prior to breeding (Mar-Apr). Despite these declines, there was essentially no change in murrelet density in mid-winter (January-February) when overall density was lower. Puget Sound murrelet density exhibited a strong north-south gradient with relatively high densities to the north and low densities to the south; murrelets were largely absent from Central Puget Sound. For strata other than Central Puget Sound, density varied seasonally with birds more evenly distributed among strata between September and December but in the late winter/early spring period (Jan-Apr), murrelets were largely absent from all strata except the most northerly Admiralty Inlet Stratum, which appears to be important to murrelets year-round. Depending on the year, non-breeding season densities were nearly the same or higher than breeding season densities indicate that murrelets were not moving into the relatively protected inner marine waters of Puget Sound from more outer coastal environments during the non-breeding season as predicted.	[Pearson, Scott F.; Keren, Ilai; Lance, Monique M.] Washington Dept Fish & Wildlife, Sci Div, Olympia, WA USA; [Raphael, Martin G.] US Forest Serv Pacific Northwest Res Stn, Olympia, WA USA	Washington Department of Fish & Wildlife (WDFW)	Pearson, SF (corresponding author), Washington Dept Fish & Wildlife, Sci Div, Olympia, WA USA.	scott.pearson@dfw.wa.gov		Pearson, Scott/0000-0003-4960-3956	US Navy [N44255-14-2-0007, N44255-12-2-0009, N44255-16-2-0004, N44255-17-2-0002, N62473-17-2-0007, N44255-19-2-0007]; US Fish and Wildlife Service [F12AP00845, F13AF01138, F14AF01107, F16AF01246]	US Navy(United States Department of Defense); US Fish and Wildlife Service(US Fish & Wildlife Service)	SFP and Washington Department of Fish and Wildlife received 6 grants from the US Navy and 4 grants from the US Fish and Wildlife Service to conduct surveys. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The grants from the US Navy and US Fish and Wildlife service were: U.S. Navy, N44255-14-2-0007, Dr. Scott F Pearson U.S. Navy, N44255-12-2-0009, Dr. Scott F Pearson U.S. Navy, N44255-16-2-0004, Dr. Scott F Pearson U.S. Navy, N44255-17-2-0002, Dr. Scott F Pearson U.S. Navy, N62473-17-2-0007, Dr. Scott F Pearson U.S. Navy, N44255-19-2-0007, Dr. Scott F Pearson U.S. Fish and Wildlife Service, F12AP00845, Dr. Scott F Pearson U.S. Fish and Wildlife Service, F13AF01138, Dr. Scott F Pearson U.S. Fish and Wildlife Service, F14AF01107, Dr. Scott F Pearson U.S. Fish and Wildlife Service, F16AF01246, Dr. Scott F Pearson.	Agness AM, 2008, AUK, V125, P346, DOI 10.1525/auk.2008.06203; Beauchamp WD, 1999, CONDOR, V101, P671, DOI 10.2307/1370198; Bertram DF, 2016, MAR ORNITHOL, V44, P3; Bertram DF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134891; Buckland S.T., 2001, pi; Carter Harry R., 1995, U S Forest Service General Technical Report PSW, V152, P99; DeLacy AC, 1972, CHECKLIST PUGET SOUN, P723; Drever MC, 2021, MAR ORNITHOL, V49, P37; EBBESMEYER CC, 1980, ESTUAR COAST MAR SCI, V11, P311, DOI 10.1016/S0302-3524(80)80086-7; Ethier D, 2020, AVIAN CONSERV ECOL, V15, DOI 10.5751/ACE-01711-150220; Gaydos Joseph K., 2011, Northwestern Naturalist, V92, P79; Good TP, 2014, MAR POLLUT BULL, V86, P367, DOI 10.1016/j.marpolbul.2014.06.042; Greene C, 2015, MAR ECOL PROG SER, V525, P153, DOI 10.3354/meps11251; Haynes Trevor B., 2011, Marine Ornithology, V39, P151; Hipfner JM, 2018, ENVIRON POLLUT, V239, P215, DOI 10.1016/j.envpol.2018.04.009; Lorenz TJ, 2018, CONDOR, V120, P201, DOI 10.1650/CONDOR-17-122.1; Lorenz TJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162670; McIver WR., 2021, MARBLED MURRELET EFF; Miller BS, 1980, GEOGRAPHICAL DISTRIB; Miller SL, 2012, CONDOR, V114, P771, DOI 10.1525/cond.2012.110084; Miller SL, NW FOREST PLANTHE 1, P31; Paleczny M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129342; Parker Nadine, 2003, Marine Ornithology, V31, P207; Peery MZ, 2008, AUK, V125, P113, DOI 10.1525/auk.2008.125.1.113; Peery MZ, 2009, CONDOR, V111, P120, DOI 10.1525/cond.2009.080094; Plummer M., 2003, P 3 INT WORKSH DISTR; R Core Team, 2021, R LANGUAGE ENV STAT; Raphael MG, 2015, J MARINE SYST, V146, P17, DOI 10.1016/j.jmarsys.2014.06.010; Raphael MG, 2016, NW FOREST PLANTHE 1, P95; Raphael MG, 2007, GEN TECHNICAL REPORT; Rice CA, 2012, MAR COAST FISH, V4, P117, DOI 10.1080/19425120.2012.680403; Ruckelshaus MH, 2007, SOUND SCIENCESYNTHES; Simenstad C. A., 2011, 201101 US ARM CORPS; USFWS (U.S. Fish and Wildlife Service), 1997, REC PLAN THREAT MARB; Ward EJ, 2015, PEERJ, V3, DOI 10.7717/peerj.704; Wilson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065408	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267165	10.1371/journal.pone.0267165	http://dx.doi.org/10.1371/journal.pone.0267165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446906	Green Published, gold			2022-12-26	WOS:000795468200057
J	Wang, YY; Wu, HX; Shuai, L; Peng, C; Yang, ZW				Wang, YunYan; Wu, Huaxuan; Shuai, Luo; Peng, Chen; Yang, Zhiwei			Detection of plane in remote sensing images using super-resolution	PLOS ONE			English	Article								The object detection of remote sensing image often has low accuracy and high missed or false detection rate due to the large number of small objects, instance level noise and cloud occlusion. In this paper, a new object detection model based on SRGAN and YOLOV3 is proposed, which is called SR-YOLO. It solves the problems of SRGAN network sensitivity to hyper-parameters and modal collapse. Meanwhile, The FPN network in YOLOv3 is replaced by PANet, shortened the distance between the lowest and the highest layers, and the SR-YOLO model has strong robustness and high detection ability by using the enhanced path to enrich the characteristics of each layer. The experimental results on the UCAS-High Resolution Aerial Object Detection Dataset showed SR-YOLO has achieved excellent performance. Compared with YOLOv3, the average precision (AP) of SR-YOLO increased from 92.35% to 96.13%, the log-average miss rate (MR-2) decreased from 22% to 14%, and the Recall rate increased from 91.36% to 95.12%.	[Wang, YunYan; Wu, Huaxuan; Shuai, Luo; Peng, Chen; Yang, Zhiwei] Hubei Univ Technol, Sch Elect & Elect Engn, Wuhan, Peoples R China; [Wang, YunYan] Hubei Univ Technol, Xiangyang Ind Inst, Wuhan, Peoples R China	Hubei University of Technology; Hubei University of Technology	Wu, HX (corresponding author), Hubei Univ Technol, Sch Elect & Elect Engn, Wuhan, Peoples R China.	1436383435@qq.com		Wu, Huaxuan/0000-0003-2638-9029				Arjovsky M., 2017, ARXIV170107875; Bilgazyev E., SPARSE REPRESENTATIO; Bochkovskiy A., 2020, YOLOV4 OPTIMAL SPEED; Bochkovskiy A., 2020, YOLOV4 OPTIMAL SPEED; Chen XG, 2011, PROC CVPR IEEE, P369, DOI 10.1109/CVPR.2011.5995568; Dai X., DYNAMIC HEAD UNIFYIN, P2021; Dollar P, 2012, IEEE T PATTERN ANAL, V34, P743, DOI 10.1109/TPAMI.2011.155; Dong C, 2014, LECT NOTES COMPUT SC, V8692, P184, DOI 10.1007/978-3-319-10593-2_13; Dong YN, 2021, IEEE T CYBERNETICS, V51, P3185, DOI 10.1109/TCYB.2020.3004263; Duan K., 2019, CENTERNET KEYPOINT T; Etten A. V., 2018, YOU ONLY LOOK TWICE; Gao JF, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21041375; Girshick R, 2015, ARXIV E PRINTS; Hamaguchi R., 2018, 2018 IEEECVF C COMPU; Haris M., 2018, PROC INT C NEURAL IN; Haris M., 2018, ARXIV; He K., 2016, CVPR, P770; He KM, 2017, IEEE I CONF COMP VIS, P2980, DOI [10.1109/ICCV.2017.322, 10.1109/TPAMI.2018.2844175]; Hennings-Yeomans PH., SIMULTANEOUS SUPER R; Johnson J, 2016, LECT NOTES COMPUT SC, V9906, P694, DOI 10.1007/978-3-319-46475-6_43; Kim J., 2016, 2016 IEEE C COMPUTER; Kim J, 2016, IEEE CONF COMPUT; Lai W.S., 2017, IEEE C COMPUTER VISI, V2017; Ledig C, 2017, PROC CVPR IEEE, P105, DOI 10.1109/CVPR.2017.19; Li M, 2019, HYDROL PROCESS, V33, P2759, DOI 10.1002/hyp.13526; Li Q., 2019, IEEE T GEOSCIENCE RE; Liang Tingting, 2021, CBNETV2 COMPOSITE BA; Lim B., 2017, 2017 IEEE C COMPUTER; Lin Tsung-Yi, 2017, CVPR, DOI DOI 10.1109/CVPR.2017.106; Long Y, 2017, IEEE T GEOSCI REMOTE, V55, P2486, DOI 10.1109/TGRS.2016.2645610; Milani S., 2012, IMAGE PROCESSING ICI; Nah S, 2017, PROC CVPR IEEE, P257, DOI 10.1109/CVPR.2017.35; Nishiyama M., FACIAL DEBLUR INFERE; Pang JH, 2021, IEEE T CYBERNETICS, V51, P815, DOI 10.1109/TCYB.2019.2940520; Redmon J, 2016, PROC CVPR IEEE, P779, DOI 10.1109/CVPR.2016.91; Ren SQ, 2015, ADV NEUR IN, V28, DOI 10.1109/TPAMI.2016.2577031; Shermeyer J., 2020, 2019 IEEECVF C COMPU; Tong T., 2017, IEEE INT C COMPUTER; Van Etten A, SATELLITE IMAGERY MU; Wei Liu, 2016, Computer Vision - ECCV 2016. 14th European Conference. Proceedings: LNCS 9905, P21, DOI 10.1007/978-3-319-46448-0_2; Xin Y., 2016, EUROPEAN C COMPUTER; Xu Mengde, 2021, END TO END SEMISUPER, P7; Ying T., 2017, IEEE C COMPUTER VISI; Yuan XF, 2020, NEUROCOMPUTING, V396, P375, DOI 10.1016/j.neucom.2018.11.107	45	0	0	15	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0265503	10.1371/journal.pone.0265503	http://dx.doi.org/10.1371/journal.pone.0265503			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446858	gold, Green Published			2022-12-26	WOS:000795468200061
J	Yadav, M; Ali, S; Shrode, RL; Shahi, SK; Jensen, SN; Hoang, J; Cassidy, S; Olalde, H; Guseva, N; Paullus, M; Cherwin, C; Wang, K; Cho, T; Kamholz, J; Mangalam, AK				Yadav, Meeta; Ali, Soham; Shrode, Rachel L.; Shahi, Shailesh K.; Jensen, Samantha N.; Hoang, Jemmie; Cassidy, Samuel; Olalde, Heena; Guseva, Natalya; Paullus, Mishelle; Cherwin, Catherine; Wang, Kai; Cho, Tracey; Kamholz, John; Mangalam, Ashutosh K.			Multiple sclerosis patients have an altered gut mycobiome and increased fungal to bacterial richness	PLOS ONE			English	Article							COMMENSAL FUNGI; MICROBIOME; IMMUNITY; HEALTH; MOUSE; MICE; DIET	Trillions of microbes such as bacteria, fungi, and viruses exist in the healthy human gut microbiome. Although gut bacterial dysbiosis has been extensively studied in multiple sclerosis (MS), the significance of the fungal microbiome (mycobiome) is an understudied and neglected part of the intestinal microbiome in MS. The aim of this study was to characterize the gut mycobiome of patients with relapsing-remitting multiple sclerosis (RRMS), compare it to healthy controls, and examine its association with changes in the bacterial microbiome. We characterized and compared the mycobiome of 20 RRMS patients and 33 healthy controls (HC) using Internal Transcribed Spacer 2 (ITS2) and compared mycobiome interactions with the bacterial microbiome using 16S rRNA sequencing. Our results demonstrate an altered mycobiome in RRMS patients compared with HC. RRMS patients showed an increased abundance of Basidiomycota and decreased Ascomycota at the phylum level with an increased abundance of Candida and Epicoccum genera along with a decreased abundance of Saccharomyces compared to HC. We also observed an increased ITS2/16S ratio, altered fungal and bacterial associations, and altered fungal functional profiles in MS patients compared to HC. This study demonstrates that RRMS patients had a distinct mycobiome with associated changes in the bacterial microbiome compared to HC. There is an increased fungal to bacterial ratio as well as more diverse fungal-bacterial interactions in RRMS patients compared to HC. Our study is the first step towards future studies in delineating the mechanisms through which the fungal microbiome can influence MS disease.	[Yadav, Meeta; Shahi, Shailesh K.; Jensen, Samantha N.; Guseva, Natalya; Mangalam, Ashutosh K.] Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA; [Yadav, Meeta] Univ Iowa, Coll Dent, Iowa City, IA 52242 USA; [Ali, Soham] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Shrode, Rachel L.; Mangalam, Ashutosh K.] Univ Iowa, Informat Grad Program, Iowa City, IA 52242 USA; [Jensen, Samantha N.; Mangalam, Ashutosh K.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA; [Hoang, Jemmie; Cherwin, Catherine] Univ Iowa, Coll Nursing, Iowa City, IA 52242 USA; [Cassidy, Samuel; Olalde, Heena; Paullus, Mishelle; Cho, Tracey; Kamholz, John] Univ Iowa Hosp & Clin, Dept Neurol, Iowa City, IA 52242 USA; [Wang, Kai] Univ Iowa, Coll Publ Hlth, Dept Biostat, Iowa City, IA USA; [Mangalam, Ashutosh K.] Iowa City VA Hlth Syst, Iowa City, IA 52246 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Mangalam, AK (corresponding author), Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA.; Mangalam, AK (corresponding author), Univ Iowa, Informat Grad Program, Iowa City, IA 52242 USA.; Mangalam, AK (corresponding author), Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA.; Mangalam, AK (corresponding author), Iowa City VA Hlth Syst, Iowa City, IA 52246 USA.	Ashutosh-mangalam@uiowa.edu	Mangalam, Ashutosh/I-8565-2017	Mangalam, Ashutosh/0000-0002-9926-2531	Schwab Foundation; NIH R01 [1R01AI137075-01, 1I01CX002212]; NRSA T90 training [5T90DE023520]; University of Iowa's Informatics Fellowship from the Informatics Graduate Program; University of Iowa Department of Pathology	Schwab Foundation; NIH R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA T90 training; University of Iowa's Informatics Fellowship from the Informatics Graduate Program; University of Iowa Department of Pathology	This work was supported by a grant from Schwab Foundation Margaret Heppelmann and Michael Wacek, Departmental Startup fund, NIH R01 grant 1R01AI137075-01, and VA Merit Award 1I01CX002212 to Ashutosh Mangalam. Meeta Yadav is supported by NRSA T90 training grant 5T90DE023520. Rachel Shrode is funded by the University of Iowa's Informatics Fellowship from the Informatics Graduate Program. Soham Ali is supported by the Emory Warner Medical Student Research Fellowship from the University of Iowa Department of Pathology.	Al Bataineh MT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66598-2; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Becker KL, 2015, SEMIN IMMUNOPATHOL, V37, P107, DOI 10.1007/s00281-014-0467-z; Behera B. C., 2017, Journal of Genetic Engineering and Biotechnology, V15, P197, DOI 10.1016/j.jgeb.2016.12.001; Bertolini M, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007717; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Cekanaviciute E, 2017, P NATL ACAD SCI USA, V114, P10713, DOI 10.1073/pnas.1711235114; Chen J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28484; Cosorich I, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700492; De Beeck MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097629; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Dollive S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071806; Dongari-Bagtzoglou A, 2005, J DENT RES, V84, P966, DOI 10.1177/154405910508401101; Erb Downward John R, 2013, Sci Rep, V3, P2191, DOI 10.1038/srep02191; Freedman SN, 2018, NEUROTHERAPEUTICS, V15, P109, DOI 10.1007/s13311-017-0588-x; Gandy KAO, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43356-7; Gao R, 2017, EUR J CLIN MICROBIOL, V36, P757, DOI 10.1007/s10096-016-2881-8; Ggpubr A. K., GGPLOT2 BASED PUBLIC; Grootaert C, 2009, FEMS MICROBIOL ECOL, V69, P231, DOI 10.1111/j.1574-6941.2009.00712.x; Gupta VK, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01162; HADDAD JG, 1972, J NUTR, V102, P269, DOI 10.1093/jn/102.2.269; Hallen-Adams HE, 2017, VIRULENCE, V8, P352, DOI 10.1080/21505594.2016.1247140; Hoggard M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02208; Huseyin CE, 2017, FEMS MICROBIOL REV, V41, P479, DOI 10.1093/femsre/fuw047; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Jangi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12015; Jawhara S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040648; Kruger W, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8020070; Kulshrestha S., 2013, J PHARM RES, V7, P792, DOI [10.1016/j.jopr.2013.07.014, DOI 10.1016/j.jopr.2013.07.014, DOI 10.1016/J.JOPR.2013.07.014]; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Leonardi I, 2018, SCIENCE, V359, P232, DOI 10.1126/science.aao1503; Li JY, 2018, MICROB ECOL, V75, P821, DOI 10.1007/s00248-017-1105-9; Li M, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00176-18; Limon JJ, 2017, CELL HOST MICROBE, V22, P156, DOI 10.1016/j.chom.2017.07.002; Mangalam A, 2017, CELL REP, V20, P1269, DOI 10.1016/j.celrep.2017.07.031; Mangalam AK, 2021, INDIAN J RHEUMATOL, V16, P57, DOI 10.4103/injr.injr_210_20; Manoochehri H, 2020, BIOCATAL AGR BIOTECH, V25, DOI 10.1016/j.bcab.2020.101599; McOrist AL, 2011, J NUTR, V141, P883, DOI 10.3945/jn.110.128504; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miyake S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137429; Nadeem H, 2015, PROCESS BIOCHEM, V50, P1202, DOI 10.1016/j.procbio.2015.04.015; Nilsson RH, 2019, NUCLEIC ACIDS RES, V47, pD259, DOI 10.1093/nar/gky1022; Ochoa-Reparaz J, 2014, FEBS LETT, V588, P4214, DOI 10.1016/j.febslet.2014.09.024; Oksanen J., **DATA OBJECT**; Polme S, 2020, FUNGAL DIVERS, V105, P1, DOI 10.1007/s13225-020-00466-2; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Rehman A, 2016, GUT, V65, P238, DOI 10.1136/gutjnl-2014-308341; SAMONIS G, 1993, ANTIMICROB AGENTS CH, V37, P51, DOI 10.1128/AAC.37.1.51; Shah S, 2021, EBIOMEDICINE, V71, DOI 10.1016/j.ebiom.2021.103557; Shahi S, 2019, JOVE-J VIS EXP, DOI 10.3791/59980; Sokol H, 2017, GUT, V66, P1039, DOI [10.1136/gutjnl-2015-310746, 10.1136/gutjnl-20]; Vallino A, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000688; Wheeler ML, 2017, ANNU REV PATHOL-MECH, V12, P359, DOI 10.1146/annurev-pathol-052016-100342; Wheeler ML, 2016, CELL HOST MICROBE, V19, P865, DOI 10.1016/j.chom.2016.05.003; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yeung F, 2020, CELL HOST MICROBE, V27, P809, DOI 10.1016/j.chom.2020.02.015; Zanne AE, 2020, BIOL REV, V95, P409, DOI 10.1111/brv.12570; Zhang ZD, 2016, IMMUNITY, V44, P330, DOI 10.1016/j.immuni.2016.01.004	59	4	4	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0264556	10.1371/journal.pone.0264556	http://dx.doi.org/10.1371/journal.pone.0264556			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35472144	Green Published, gold			2022-12-26	WOS:000816171900031
J	Yao, XJ; Hu, Y; Zou, XM; Qu, WJ				Yao, Xiaojie; Hu, Yuan; Zou, Xiaomin; Qu, Wenjian			Research disciplinary interactions on scientific collaboration network in photocatalytic hydrogen evolution: Characteristics and dynamics	PLOS ONE			English	Article							INTERDISCIPLINARY RESEARCH; INFORMATION-SCIENCE; PATTERNS; AUTHORSHIP; CENTRALITY; FIELD; COMMUNICATION; THEMES; TRENDS; GROWTH	Interdisciplinary scientific collaboration promotes the innovative development of scientific research. Photocatalytic hydrogen evolution (PHE) is a typical interdisciplinary subject. This study aims to explore the characteristics of discipline interaction and the temporal evolution in the field. Bibliometric analysis could be used to understand the stage of research in a particular subject. In this work, the publications on the topic in Web of Science (WoS) platform from 1999 to 2020 were selected. On the basis of social network theory, the characteristics of interdisciplinary were revealed from three perspectives. First, the disciplinary interaction network is constructed through disciplinary co-occurrence to detect the characteristics of interaction structure among different disciplines. Then the node centrality index is employed to explore the influence of disciplines in the interactive network by using network centrality analysis. Moreover, the dynamic of discipline interaction evolution is studied using blockmodeling analysis. In the field of PHE, the number of disciplines and the intensity of interaction among different subjects gradually increased in the past 20 years. Chemistry and Material Sciences are the core discipline, and they play an important role in the network. The whole network is divided into different discipline groups. The scale of the discipline group is becoming large, and the disciplinary interaction is becoming more complex. The obtained results are helpful for guiding scholars to carry out interdisciplinary interaction. The methods of detecting interdisciplinary interactive relationship could provide paths for interdisciplinary research in other fields.	[Yao, Xiaojie; Hu, Yuan; Zou, Xiaomin; Qu, Wenjian] Nanchang Univ, Sch Publ Policy & Adm, Nanchang, Jiangxi, Peoples R China	Nanchang University	Hu, Y (corresponding author), Nanchang Univ, Sch Publ Policy & Adm, Nanchang, Jiangxi, Peoples R China.	hyuan@ncu.edu.cn		Zou, Xiaomin/0000-0002-7388-8288; Hu, Yuan/0000-0003-0149-4287				Aaldering LJ, 2019, J CLEAN PROD, V212, P362, DOI 10.1016/j.jclepro.2018.12.047; Abramo G, 2018, J INFORMETR, V12, P1182, DOI 10.1016/j.joi.2018.09.001; Ahmad I, 2020, J SUPERCOMPUT, V76, P3555, DOI 10.1007/s11227-018-2714-x; [Anonymous], 2005, RES TECHNOL MANAGE, V48, P63; Araujo T, 2017, J INFORMETR, V11, P88, DOI 10.1016/j.joi.2016.11.002; Arshad A, 2017, ELECTRON LIBR, V35, P167, DOI 10.1108/EL-09-2015-0171; Borgatti SP, 2009, SCIENCE, V323, P892, DOI 10.1126/science.1165821; Bornmann L, 2014, RES EVALUAT, V23, P166, DOI 10.1093/reseval/rvu002; Caputo A, 2019, INT J CONFL MANAGE, V30, P87, DOI 10.1108/IJCMA-06-2018-0078; Chang YW, 2018, LIBR INFORM SCI RES, V40, P125, DOI 10.1016/j.lisr.2018.06.004; Chen PY, 2020, LIBR HI TECH, V38, P293, DOI 10.1108/LHT-01-2019-0026; Choi M, 2021, SCIENTOMETRICS, V126, P683, DOI 10.1007/s11192-020-03765-2; Cugmas M, 2020, SCIENTOMETRICS, V125, P2471, DOI 10.1007/s11192-020-03708-x; Cugmas M, 2016, SCIENTOMETRICS, V106, P163, DOI 10.1007/s11192-015-1790-4; Deng Zhong hua., 2015, J INFORM RESOURCE MA, V5, P89, DOI [10.13365/j.jirm.2015.04.089, DOI 10.13365/J.JIRM.2015.04.089]; Drossel WG, 2018, PROCEDIA MANUF, V21, P197, DOI 10.1016/j.promfg.2018.02.111; Endenich C, 2016, EUR ACCOUNT REV, V25, P613, DOI 10.1080/09638180.2015.1085886; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Gago S, 2012, MATH SLOVACA, V62, P1, DOI 10.2478/s12175-011-0065-7; Genereux M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17228390; Harzing AW, 2016, SCIENTOMETRICS, V106, P787, DOI 10.1007/s11192-015-1798-9; Heffernan T, 2021, HIGH EDUC RES DEV, V40, P981, DOI 10.1080/07294360.2020.1799948; HINZE S, 1994, SCIENTOMETRICS, V29, P353, DOI 10.1007/BF02033445; Jiang F, 2018, SCIENTOMETRICS, V117, P2091, DOI 10.1007/s11192-018-2928-y; Karunan K, 2017, SCIENTOMETRICS, V113, P335, DOI 10.1007/s11192-017-2481-0; Kong XJ, 2019, J NETW COMPUT APPL, V132, P86, DOI 10.1016/j.jnca.2019.01.029; Koseoglu MA, 2018, J HOSP MARKET MANAG, V27, P561, DOI 10.1080/19368623.2018.1399192; Koseoglu MA, 2016, BRQ-BUS RES Q, V19, P153, DOI 10.1016/j.brq.2016.02.001; Kwon S, 2018, MALAYS J LIBR INF SC, V23, P77, DOI 10.22452/mjlis.vol23no2.5; Landherr A, 2010, BUS INFORM SYST ENG+, V2, P371, DOI 10.1007/s12599-010-0127-3; Leydesdorff L, 2008, J AM SOC INF SCI TEC, V59, P1810, DOI 10.1002/asi.20891; Leydesdorff L, 2013, SCIENTOMETRICS, V94, P589, DOI 10.1007/s11192-012-0784-8; Li HJ, 2016, PHYSICA A, V450, P657, DOI 10.1016/j.physa.2016.01.017; Li ZF, 2021, J CLEAN PROD, V289, DOI 10.1016/j.jclepro.2020.125642; Lofrano G, 2018, SCI TOTAL ENVIRON, V624, P461, DOI 10.1016/j.scitotenv.2017.12.145; Ma K, 2019, INT J PROD RES, V57, P2203, DOI 10.1080/00207543.2018.1535204; Matveeva N, 2020, SCIENTOMETRICS, V124, P2383, DOI 10.1007/s11192-020-03602-6; Meishar-Tal H, 2017, INT REV RES OPEN DIS, V18, P1; Nam JM, 2019, ACCOUNTS CHEM RES, V52, P2995, DOI 10.1021/acs.accounts.9b00504; Newcomb TJ, 2021, FISHERIES, V46, P131, DOI 10.1002/fsh.10536; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.026118; Ni CQ, 2017, PUBLIC ADMIN REV, V77, P496, DOI 10.1111/puar.12737; Ostos M, 2017, COLL RES LIBR, V78, P567, DOI 10.5860/crl.78.5.567; Quintella Rogério H, 2012, Journal of Technology Management & Innovation, V7, P85, DOI 10.4067/S0718-27242012000100006; Rau H, 2018, RES POLICY, V47, P266, DOI 10.1016/j.respol.2017.11.005; Reis F, 2018, INFORM SOC-ESTUD, V28, P227; Rhoten D, 2004, SCIENCE, V306, P2046, DOI 10.1126/science.1103628; Ribeiro LC, 2018, SCIENTOMETRICS, V114, P159, DOI 10.1007/s11192-017-2573-x; Rombach P, 2017, SIAM REV, V59, P619, DOI 10.1137/17M1130046; SABIDUSSI G, 1966, PSYCHOMETRIKA, V31, P581, DOI 10.1007/BF02289527; Sarkar S, 2020, SAFETY SCI, V131, DOI 10.1016/j.ssci.2020.104900; Schoolman ED, 2012, SUSTAIN SCI, V7, P67, DOI 10.1007/s11625-011-0139-z; Schummer J, 2004, SCIENTOMETRICS, V59, P425, DOI 10.1023/B:SCIE.0000018542.71314.38; Shen LN, 2019, J MED INTERNET RES, V21, DOI 10.2196/12625; Shen LN, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/mhealth.9581; Shi WT, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12020660; Shiau WL, 2017, INT J INFORM MANAGE, V37, P390, DOI 10.1016/j.ijinfomgt.2017.04.007; Small H, 2010, SCIENTOMETRICS, V83, P835, DOI 10.1007/s11192-009-0121-z; Song CH, 2003, SCIENTOMETRICS, V58, P129, DOI 10.1023/A:1025483625299; Su FL, 2020, J DOC, V76, P1295, DOI 10.1108/JD-08-2019-0159; Tran CY, 2017, COLL RES LIBR, V78, P171, DOI 10.5860/crl.78.2.171; Uehara M., 2018, INFORM COMMUNICATION; Wagner CS, 2011, J INFORMETR, V5, P14, DOI 10.1016/j.joi.2010.06.004; Wang WK, 2021, REV MANAG SCI, V15, P437, DOI 10.1007/s11846-019-00347-2; Wang Y, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249280; WHITE HC, 1976, AM J SOCIOL, V81, P730, DOI 10.1086/226141; Yan WW, 2018, SCIENTOMETRICS, V115, P299, DOI 10.1007/s11192-018-2637-6; Zhong C, 2014, INT J GEOGR INF SCI, V28, P2178, DOI 10.1080/13658816.2014.914521; Zhou X.F., 2013, LIB INFORM SERVICE, V57, P64, DOI [10.7536/j.issn.0252-3116.2013.23.011, DOI 10.7536/J.ISSN.0252-3116.2013.23.011]; Zhou XK, 2021, IEEE T EMERG TOP COM, V9, P246, DOI 10.1109/TETC.2018.2860051; Zhuang YT, 2020, ENGINEERING-PRC, V6, P245, DOI 10.1016/j.eng.2020.01.009; Zupic I, 2015, ORGAN RES METHODS, V18, P429, DOI 10.1177/1094428114562629	74	0	0	8	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266404	10.1371/journal.pone.0266404	http://dx.doi.org/10.1371/journal.pone.0266404			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421145	Green Published, gold			2022-12-26	WOS:000795453600043
J	Zhang, MZ; Sharma, A; Leon, F; Avery, B; Kjelgren, R; McCurdy, CR; Pearson, BJ				Zhang, Mengzi; Sharma, Abhisheak; Leon, Francisco; Avery, Bonnie; Kjelgren, Roger; McCurdy, Christopher R.; Pearson, Brian J.			Plant growth and phytoactive alkaloid synthesis in kratom [Mitragyna speciosa (Korth.)] in response to varying radiance	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; LIGHT; SHADE; PHOTOSYNTHESIS; ABUSE	Leaves harvested from kratom [Mitragyna speciosa (Korth.)] have a history of use as a traditional ethnobotanical medicine to combat fatigue and improve work productivity in Southeast Asia. In recent years, increased interest in the application and use of kratom has emerged globally, including North America, for its potential application as an alternative source of medicine for pain management and opioid withdrawal syndrome mitigation. Although the chemistry and pharmacology of major kratom alkaloids, mitragynine and 7-hydroxymitragynine, are well documented, foundational information on the impact of plant production environment on growth and kratom alkaloids synthesis is unavailable. To directly address this need, kratom plant growth, leaf chlorophyll content, and alkaloid concentration were evaluated under three lighting conditions: field full sun (FLD-Sun), greenhouse unshaded (GH-Unshaded), and greenhouse shaded (GH-Shaded). Nine kratom alkaloids were quantified using an ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method. Greenhouse cultivation generally promoted kratom height and width extension by 93-114% and 53-57%, respectively, compared to FLD-Sun. Similarly, total leaf area and leaf number were increased by 118-160% and 54-80% under such conditions. Average leaf size of plants grown under GH-Shaded was 41 and 69% greater than GH-Unshaded and FLD-Sun, respectively; however, no differences were observed between GH-Unshaded and FLD-Sun treatments. At the termination of the study, total leaf chlorophyll a+b content of FLD-Sun was 17-23% less than those grown in the greenhouse. Total leaf dry mass was maximized when cultivated in the greenhouse and was 89-91% greater than in the field. Leaf content of four alkaloids to include speciociliatine, mitraphylline, corynantheidine, and isocorynantheidine were not significantly impacted by lighting conditions, whereas 7-hydroxymitragynine was below the lower limit of quantification across all treatments. However, mitragynine, paynantheine, and corynoxine concentration per leaf dry mass were increased by 40%, 35%, and 111%, respectively, when cultivated under GH-Shaded compared to FLD-Sun. Additionally, total alkaloid yield per plant was maximized and nearly tripled for several alkaloids when plants were cultivated under such conditions. Furthermore, rapid, non-destructive chlorophyll evaluation correlated well (r(2) = 0.68) with extracted chlorophyll concentrations. Given these findings, production efforts where low-light conditions can be implemented are likely to maximize plant biomass and total leaf alkaloid production.	[Zhang, Mengzi; Kjelgren, Roger; Pearson, Brian J.] Univ Florida, Inst Food & Agr Sci, Midflorida Res & Educ Ctr, Dept Environm Hort, Apopka, FL 32611 USA; [Sharma, Abhisheak; Avery, Bonnie] Univ Florida, Coll Pharm, Dept Pharmaceut, Gainesville, FL USA; [Leon, Francisco; McCurdy, Christopher R.] Univ Florida, Coll Pharm, Dept Med Chem, Gainesville, FL USA; [Avery, Bonnie; McCurdy, Christopher R.] Univ Florida, Clin & Translat Sci Inst, Translat Drug Dev Core, Gainesville, FL USA; [Leon, Francisco] Univ South Carolina, Coll Pharm, Dept Drug Discovery & Biomed Sci, Columbia, SC USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of South Carolina System; University of South Carolina Columbia	Pearson, BJ (corresponding author), Univ Florida, Inst Food & Agr Sci, Midflorida Res & Educ Ctr, Dept Environm Hort, Apopka, FL 32611 USA.	bpearson@ufl.edu	Leon, Juan Francisco/AAB-8829-2022	Leon, Juan Francisco/0000-0002-5064-2381; McCurdy, Christopher Robert/0000-0001-8695-2915; Pearson, Brian/0000-0002-8346-9677; Zhang, Mengzi/0000-0002-5472-8510	University of Florida Clinical and Translational Science Institute; NIH National Center for Advancing Translational Sciences [UL1TR001427]	University of Florida Clinical and Translational Science Institute; NIH National Center for Advancing Translational Sciences	We gratefully acknowledge Kelly and Liz Dunn along with Darren Frankle for plant material and donations to the University of Florida Foundation for supporting the project. In addition, we gratefully acknowledge Scott Acker for his support of our kratom research efforts. We also thank University of Florida Clinical and Translational Science Institute supported in part by the National Institutes of Health National Center for Advancing Translational Sciences [UL1TR001427], and Dr. Heather Enloe for her assistance with the manuscript.	Ahmad K, 2012, J ETHNOPHARMACOL, V141, P446, DOI 10.1016/j.jep.2012.03.009; BOARDMAN NK, 1977, ANNU REV PLANT PHYS, V28, P355, DOI 10.1146/annurev.pp.28.060177.002035; Both AJ., 2002, HORT ENG NEWSLETTER, V17, P5; Brand MH, 1997, HORTSCIENCE, V32, P206, DOI 10.21273/HORTSCI.32.2.206; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; Charoenratana S, 2021, INT J DRUG POLICY, V95, DOI 10.1016/j.drugpo.2021.103197; Chear NJY, 2021, J NAT PROD, V84, P1034, DOI 10.1021/acs.jnatprod.0c01055; Chen YH, 2017, PAK J BOT, V49, P1709; Cinosi E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/968786; Clifford SC, 2004, HORTSCIENCE, V39, P383, DOI 10.21273/HORTSCI.39.2.383; Dai YJ, 2009, ENVIRON EXP BOT, V65, P177, DOI 10.1016/j.envexpbot.2008.12.008; Eggink L L, 2001, BMC Plant Biol, V1, P2, DOI 10.1186/1471-2229-1-2; Evans JR, 2001, PLANT CELL ENVIRON, V24, P755, DOI 10.1046/j.1365-3040.2001.00724.x; Flores-Bocanegra L, 2020, J NAT PROD, V83, P2165, DOI 10.1021/acs.jnatprod.0c00257; Galicia-Jimenez A. B., 2001, Revista Chapingo. Serie Horticultura, V7, P143; Gamage HK, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr013; Gommers CMM, 2013, TRENDS PLANT SCI, V18, P65, DOI 10.1016/j.tplants.2012.09.008; Hassan Z, 2013, NEUROSCI BIOBEHAV R, V37, P138, DOI 10.1016/j.neubiorev.2012.11.012; Hemby SE, 2019, ADDICT BIOL, V24, P874, DOI 10.1111/adb.12639; JANSEN KLR, 1988, J ETHNOPHARMACOL, V23, P115, DOI 10.1016/0378-8741(88)90121-3; Kalaitzoglou P, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00322; Khan SR, 2000, NEW FOREST, V19, P171, DOI 10.1023/A:1006645632023; Kikura-Hanajiri R, 2009, FORENSIC TOXICOL, V27, P67, DOI 10.1007/s11419-009-0070-5; Kruegel AC, 2018, NEUROPHARMACOLOGY, V134, P108, DOI 10.1016/j.neuropharm.2017.08.026; Kruegel AC, 2016, J AM CHEM SOC, V138, P6754, DOI 10.1021/jacs.6b00360; Kurek J., 2019, ALKALOIDS THEIR IMPO, P1, DOI DOI 10.5772/INTECHOPEN.85400; LAM E, 1984, FEBS LETT, V168, P10, DOI 10.1016/0014-5793(84)80197-0; Leon F, 2021, J MED CHEM, V64, P13510, DOI 10.1021/acs.jmedchem.1c00726; Liu Y, 2011, BOT STUD, V52, P191; Liu ZJ, 1997, CAN J BOT, V75, P368, DOI 10.1139/b97-039; Lydecker AG, 2016, J MED TOXICOL, V12, P341, DOI 10.1007/s13181-016-0588-y; Montserrat-de la Paz S, 2015, J ETHNOPHARMACOL, V170, P128, DOI 10.1016/j.jep.2015.05.002; Obeng S, 2020, J MED CHEM, V63, P433, DOI 10.1021/acs.jmedchem.9b01465; Pearson BJ, 2020, ACTA HORTIC, V1274, P89, DOI 10.17660/ActaHortic.2020.1274.10; PONGLUX D, 1994, PLANTA MED, V60, P580, DOI 10.1055/s-2006-959578; Ralphs MH, 1998, J CHEM ECOL, V24, P167, DOI 10.1023/A:1022301331804; Ramani Shilpa, 2008, J Mol Signal, V3, P9, DOI 10.1186/1750-2187-3-9; Runkle E., 2018, GREENHOUSE PRODUCT N, V28, P50; Rusmana Y., 2018, US HUNGER OPIOID ALT, DOI [10.1016/j.msard.2018.08.030, DOI 10.1016/J.MSARD.2018.08.030]; Sharma A, 2021, EXPERT OPIN DRUG MET, V17, P255, DOI 10.1080/17425255.2021.1853706; Sharma A, 2019, DRUG TEST ANAL, V11, P1162, DOI 10.1002/dta.2604; Singh D, 2020, J ETHNOPHARMACOL, V249, DOI 10.1016/j.jep.2019.112462; SUWANLERT S, 1975, B NARCOTICS, V27, P21; Takshak S, 2019, J PHOTOCH PHOTOBIO B, V193, P51, DOI 10.1016/j.jphotobiol.2019.02.002; The Narcotic Drugs Act 2019, 2019, NARC DRUGS ACT 2019; Tran T., 2018, THESIS, DOI 10.15760/honors.583; TSO TC, 1970, PLANT PHYSIOL, V45, P330, DOI 10.1104/pp.45.3.330; WINTERS HF, 1952, PLANT PHYSIOL, V27, P575, DOI 10.1104/pp.27.3.575; Yue K, 2018, PSYCHOPHARMACOLOGY, V235, P2823, DOI 10.1007/s00213-018-4974-9; Zhang MZ, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.597696; Zhang MZ, 2020, SCI HORTIC-AMSTERDAM, V272, DOI 10.1016/j.scienta.2020.109478; Zhang MZ, 2019, HORTSCIENCE, V54, P323, DOI 10.21273/HORTSCI13630-18	52	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0259326	10.1371/journal.pone.0259326	http://dx.doi.org/10.1371/journal.pone.0259326			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35472200	gold, Green Published			2022-12-26	WOS:000816171900043
J	Tang, JH; Deng, HY; Wang, ZX; Zha, HY; Liao, Q; Zhu, CC; Chen, XY; Sun, XY; Jia, SK; Ouyang, G; Liu, X; Xiao, WH				Tang, Jinhua; Deng, Hongyan; Wang, Zixuan; Zha, Huangyuan; Liao, Qian; Zhu, Chunchun; Chen, Xiaoyun; Sun, Xueyi; Jia, Shuke; Ouyang, Gang; Liu, Xing; Xiao, Wuhan			EGLN1 prolyl hydroxylation of hypoxia-induced transcription factor HIF1 alpha is repressed by SET7-catalyzed lysine methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLINE-HYDROXYLATION; GLUCOSE-METABOLISM; HIF-ALPHA; METHYLTRANSFERASE; P53	Egg-laying defective nine 1 (EGLN1) functions as an oxygen sensor to catalyze prolyl hydroxylation of the transcription factor hypoxia-inducible factor-1 alpha under normoxia conditions, leading to its proteasomal degradation. Thus, EGLN1 plays a central role in the hypoxia-inducible factor-mediated hypoxia signaling pathway; however, the posttranslational modifications that control EGLN1 function remain largely unknown. Here, we identified that a lysine monomethylase, SET7, catalyzes EGLN1 methylation on lysine 297, resulting in the repression of EGLN1 activity in catalyzing prolyl hydroxylation of hypoxia-inducible factor-1 alpha. Notably, we demonstrate that the methylation mimic mutant of EGLN1 loses the capability to suppress the hypoxia signaling pathway, leading to the enhancement of cell proliferation and the oxygen consumption rate. Collectively, our data identify a novel modification of EGLN1 that is critical for inhibiting its enzymatic activity and which may benefit cellular adaptation to conditions of hypoxia.	[Tang, Jinhua; Wang, Zixuan; Zha, Huangyuan; Liao, Qian; Zhu, Chunchun; Chen, Xiaoyun; Sun, Xueyi; Jia, Shuke; Ouyang, Gang; Liu, Xing; Xiao, Wuhan] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China; [Tang, Jinhua; Wang, Zixuan; Liao, Qian; Zhu, Chunchun; Chen, Xiaoyun; Sun, Xueyi; Jia, Shuke; Ouyang, Gang; Liu, Xing; Xiao, Wuhan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Deng, Hongyan] Wuhan Univ, Coll Life Sci, Wuhan, Peoples R China; [Liu, Xing; Xiao, Wuhan] Chinese Acad Sci, Innovat Seed Design, Wuhan, Peoples R China; [Xiao, Wuhan] Hubei Hongshan Lab, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Wuhan University; Chinese Academy of Sciences	Liu, X; Xiao, WH (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China.; Liu, X; Xiao, WH (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Liu, X; Xiao, WH (corresponding author), Chinese Acad Sci, Innovat Seed Design, Wuhan, Peoples R China.; Xiao, WH (corresponding author), Hubei Hongshan Lab, Wuhan, Peoples R China.	w-xiao@ihb.ac.cn; liuxing@ihb.ac.cn			NSFC, China [31830101, 31721005]; Strategic Priority Research Program of the Chinese Academy of Sciences, China [XDA24010308]; National Key Research and Development Program of China, China [2018YFD0900602]	NSFC, China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences, China; National Key Research and Development Program of China, China	This work was supported by NSFC, China [31830101 and 31721005 to W. X.]; the Strategic Priority Research Program of the Chinese Academy of Sciences, China (XDA24010308 to W. X.); the National Key Research and Development Program of China, China (2018YFD0900602, to W. X.).	Abu-Remaileh M, 2014, CELL DEATH DIFFER, V21, P1805, DOI 10.1038/cdd.2014.95; Aragones J, 2009, CELL METAB, V9, P11, DOI 10.1016/j.cmet.2008.10.001; Barth S, 2009, J BIOL CHEM, V284, P23046, DOI 10.1074/jbc.M109.032631; Chi H, 2018, NAT BIOTECHNOL, V36, P1059, DOI 10.1038/nbt.4236; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Corrado C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165611; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P140, DOI 10.1038/nsmb1045; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dey A, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz8534; Di Conza G, 2017, CELL REP, V18, P1699, DOI 10.1016/j.celrep.2017.01.051; Ea CK, 2009, P NATL ACAD SCI USA, V106, P18972, DOI 10.1073/pnas.0910439106; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Fong GH, 2008, CELL DEATH DIFFER, V15, P635, DOI 10.1038/cdd.2008.10; Guo JP, 2016, SCIENCE, V353, P929, DOI 10.1126/science.aad5755; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaelin William G Jr, 2017, Trans Am Clin Climatol Assoc, V128, P298; Kim Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10347; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; Kurash JK, 2008, MOL CELL, V29, P392, DOI 10.1016/j.molcel.2007.12.025; Lee G, 2016, SCI REP-UK, V6, DOI 10.1038/srep18928; Lin XH, 2020, GENOM PROTEOM BIOINF, V18, P289, DOI 10.1016/j.gpb.2019.04.005; Liu X, 2015, NUCLEIC ACIDS RES, V43, P5081, DOI 10.1093/nar/gkv379; Ma J, 2019, NUCLEIC ACIDS RES, V47, pD1211, DOI 10.1093/nar/gky869; Nakayama K, 2007, BIOCHEM J, V401, P217, DOI 10.1042/BJ20061135; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Pradhan S, 2009, EPIGENETICS, V4, P282; Semenza GL, 2011, COLD SH Q B, V76, P347, DOI 10.1101/sqb.2011.76.010678; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; Semenza GL, 2014, ANNU REV PHYSIOL, V76, P39, DOI 10.1146/annurev-physiol-021113-170322; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wheaton WW, 2011, AM J PHYSIOL-CELL PH, V300, pC385, DOI 10.1152/ajpcell.00485.2010; Wong BW, 2013, TRENDS BIOCHEM SCI, V38, P3, DOI 10.1016/j.tibs.2012.10.004; Yang M, 2014, HYPOXIA, V2, P127, DOI 10.2147/HP.S47968; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55; Zhang J, 2018, SCIENCE, V361, P290, DOI 10.1126/science.aap8411; Zheng XN, 2014, GENE DEV, V28, P1429, DOI 10.1101/gad.242131.114	43	0	0	6	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101961	10.1016/j.jbc.2022.101961	http://dx.doi.org/10.1016/j.jbc.2022.101961			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3R4NR	35452683	gold, Green Published			2022-12-26	WOS:000838892100012
J	Chae, HD; Hong, SH; Yeoh, HJ; Kang, YR; Lee, SM; Kim, M; Koh, SY; Lee, Y; Park, MS; Choi, JY; Yoo, HJ				Chae, Hee-Dong; Hong, Sung Hwan; Yeoh, Hyun Jung; Kang, Yeo Ryang; Lee, Su Min; Kim, Minyoung; Koh, Seok Young; Lee, Yongeun; Park, Moo Sung; Choi, Ja-Young; Yoo, Hye Jin			Improved diagnostic performance of plain radiography for cervical ossification of the posterior longitudinal ligament using deep learning	PLOS ONE			English	Article							SPINE; CLASSIFICATION; PREVALENCE	Background A high false-negative rate has been reported for the diagnosis of ossification of the posterior longitudinal ligament (OPLL) using plain radiography. We investigated whether deep learning (DL) can improve the diagnostic performance of radiologists for cervical OPLL using plain radiographs. Materials and methods The training set consisted of 915 radiographs from 207 patients diagnosed with OPLL. For the test set, we used 200 lateral cervical radiographs from 100 patients with cervical OPLL and 100 patients without OPLL. An observer performance study was conducted over two reading sessions. In the first session, we compared the diagnostic performance of the DL-model and the six observers. The diagnostic performance was evaluated using the area under the receiver operating characteristic curve (AUC) at the vertebra and patient level. The sensitivity and specificity of the DL model and average observers were calculated in per-patient analysis. Subgroup analysis was performed according to the morphologic classification of OPLL. In the second session, observers evaluated the radiographs by referring to the results of the DL-model. Results In the vertebra-level analysis, the DL-model showed an AUC of 0.854, which was higher than the average AUC of observers (0.826), but the difference was not significant (p = 0.292). In the patient-level analysis, the performance of the DL-model had an AUC of 0.851, and the average AUC of observers was 0.841 (p = 0.739). The patient-level sensitivity and specificity were 91% and 69% in the DL model, and 83% and 68% for the average observers, respectively. Both the DL-model and observers showed decreases in overall performance in the segmental and circumscribed types. With knowledge of the results of the DL-model, the average AUC of observers increased to 0.893 (p = 0.001) at the vertebra level and 0.911 (p < 0.001) at the patient level. In the subgroup analysis, the improvement was largest in segmental-type (AUC difference 0.087; p = 0.002). Conclusions The DL-based OPLL detection model can significantly improve the diagnostic performance of radiologists on cervical radiographs.	[Chae, Hee-Dong; Hong, Sung Hwan; Yeoh, Hyun Jung; Kang, Yeo Ryang; Lee, Su Min; Kim, Minyoung; Koh, Seok Young; Choi, Ja-Young; Yoo, Hye Jin] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Chae, Hee-Dong; Hong, Sung Hwan; Yeoh, Hyun Jung; Kang, Yeo Ryang; Lee, Su Min; Kim, Minyoung; Koh, Seok Young; Choi, Ja-Young; Yoo, Hye Jin] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Hong, Sung Hwan; Choi, Ja-Young] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea; [Lee, Yongeun; Park, Moo Sung] Deepnoid Inc, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Hong, SH (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.; Hong, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea.; Hong, SH (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea.	drhong@snu.ac.kr		Kim, Min Young/0000-0002-9354-2890	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI20C2092, 062018-0260]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI20C2092). Also, this study has received research funding from Deepnoid Inc. (grant number: 062018-0260). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; Abbasi A, 2010, PAIN MED, V11, P709, DOI 10.1111/j.1526-4637.2010.00829.x; Chang H, 2010, CLIN ORTHOP SURG, V2, P8, DOI 10.4055/cios.2010.2.1.8; Derkatch S, 2019, RADIOLOGY, V293, P405, DOI 10.1148/radiol.2019190201; Florian Schroff, 2017, Arxiv, DOI arXiv:1706.05587; Fujimori T, 2016, SPINE, V41, P1668, DOI 10.1097/BRS.0000000000001643; Galbusera F, 2019, JOR SPINE, V2, DOI 10.1002/jsp2.1044; Hillis SL, 2005, STAT MED, V24, P1579, DOI 10.1002/sim.2024; Hwang EJ, 2020, KOREAN J RADIOL, V21, P511, DOI 10.3348/kjr.2019.0821; Jang S, 2019, RADIOLOGY, V291, P359, DOI 10.1148/radiol.2019181648; Jeon TS, 2012, SPINE, V37, pE1498, DOI 10.1097/BRS.0b013e31826efd89; Jian Sun, 2015, Arxiv, DOI arXiv:1512.03385; Kang Moo Sung, 2012, Korean J Spine, V9, P205, DOI 10.14245/kjs.2012.9.3.205; Kudo H, 2013, EUR SPINE J, V22, P205, DOI 10.1007/s00586-012-2573-8; Lampignano J., 2017, BONTRAGERS HDB RADIO; Miura M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92160-9; Olaf Ronneberger, 2015, Arxiv, DOI arXiv:1505.04597; OTAKE S, 1992, AM J NEURORADIOL, V13, P1059; Pan YL, 2020, EUR RADIOL, V30, P4107, DOI 10.1007/s00330-020-06679-y; Park JE, 2020, KOREAN J RADIOL, V21, P1126, DOI 10.3348/kjr.2019.0847; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Sung J, 2021, RADIOLOGY, V299, P450, DOI 10.1148/radiol.2021202818; Tetreault L, 2019, GLOB SPINE J, V9, P85, DOI 10.1177/2192568217720421; TSUYAMA N, 1981, Journal of the Japanese Orthopaedic Association, V55, P425; Watanabe K, 2019, NEUROSPINE, V16, P697, DOI 10.14245/ns.1938426.213; Weng CH, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111826; Wu JC, 2018, NEUROSPINE, V15, P33, DOI 10.14245/ns.1836084.042; Yin MC, 2019, WORLD NEUROSURG, V127, pE299, DOI 10.1016/j.wneu.2019.03.112; Zhao H, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.e18050	30	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267643	10.1371/journal.pone.0267643	http://dx.doi.org/10.1371/journal.pone.0267643			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476649	Green Published, gold			2022-12-26	WOS:000840124300061
J	Ghaznavi, C; Sakamoto, H; Yamasaki, L; Nomura, S; Yoneoka, D; Shibuya, K; Ueda, P				Ghaznavi, Cyrus; Sakamoto, Haruka; Yamasaki, Lisa; Nomura, Shuhei; Yoneoka, Daisuke; Shibuya, Kenji; Ueda, Peter			Salaries, degrees, and babies: Trends in fertility by income and education among Japanese men and women born 1943-1975-Analysis of national surveys	PLOS ONE			English	Article							MARRIAGE	Background While fertility rates have decreased during the second half of the 20th century in Japan, little is known regarding trends in the number of children that men and women have across birth cohorts and whether these differ by education and income. Methods We used data from four rounds of the National Fertility Survey (1992, 2005, 2010 and 2015) and included men and women aged 40-49 years (16728 men and 17628 women). By 5-year birth cohorts, we assessed the distribution of number of children (0, 1, 2 and 3 or more) and total fertility (the mean number of children) at completed fertility (age 45-49 or 40-44 years depending on birth cohort). We assessed trends in these fertility outcomes in men and women separately, and by education (no university education; university education) for men and women and by reported annual income (0 to < 3 000 000 JPY; 3 000 000 to < 6 000 000 JPY; >= 6 000 000 JPY) for men. Results When comparing those born in 1943-1948 with those born in 1971-1975, the proportion with no children had increased from 14.3 to 39.9% for men and from 11.6 to 27.6% for women. This increase coincided with a decrease in the proportions of individuals with 2 or more children. Total fertility had decreased from 1.92 to 1.17 among men and from 1.96 to 1.42 among women. For men, those with a university degree were more likely to have children than those without a university degree in all birth cohorts except 1943-1947. Men with higher income were more likely to have children across birth cohorts. While the proportion who had children had decreased in all income groups, the decrease was steeper among those in the lowest income group. Among women born 1956-1970, those with a university degree were less likely to have children than those without a university degree; this difference was no longer seen among those born 1971-1975. For both men and women, trends in having children and total fertility across birth cohorts did not differ by educational status. Conclusions The decline in the total fertility rate in Japan can be attributed to both an increasing proportion of the population who have no children and a lower number of children among those who have children. Men with lower education and income were less likely to have children and the disparity in the number of children that men have by income had increased in more recent birth cohorts. Among women, higher education was associated with lower fertility, although this pattern was no longer observed among those born in 1971-1975.	[Ghaznavi, Cyrus; Sakamoto, Haruka; Yoneoka, Daisuke] Keio Univ, Sch Med, Dept Hlth Policy & Management, Tokyo, Japan; [Ghaznavi, Cyrus] Washington Univ, Sch Med, Med Educ Program, St Louis, MO USA; [Sakamoto, Haruka; Yamasaki, Lisa; Nomura, Shuhei; Yoneoka, Daisuke; Shibuya, Kenji; Ueda, Peter] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan; [Sakamoto, Haruka; Nomura, Shuhei; Yoneoka, Daisuke; Shibuya, Kenji] Tokyo Fdn Policy Res, Tokyo, Japan; [Yamasaki, Lisa] Nagasaki Univ, Sch Med, Nagasaki, Japan; [Yoneoka, Daisuke] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan; [Ueda, Peter] Karolinska Inst, Dept Med, Div Clin Epidemiol, Stockholm, Sweden	Keio University; Washington University (WUSTL); University of Tokyo; Nagasaki University; National Institute of Infectious Diseases (NIID); Karolinska Institutet	Ueda, P (corresponding author), Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan.; Ueda, P (corresponding author), Karolinska Inst, Dept Med, Div Clin Epidemiol, Stockholm, Sweden.	peter.ueda@gmail.com	Nomura, Shuhei/HCH-5356-2022; Yoneoka, Daisuke/A-9336-2016	Yoneoka, Daisuke/0000-0002-3525-5092; Ueda, Peter/0000-0002-3275-8743; Nomura, Shuhei/0000-0002-2963-7297; Ghaznavi, Cyrus/0000-0002-5942-1948	Ministry of Education, Culture, Sports, Science and Technology of Japan [21H03203]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Grants-in-Aid for Scientific Research (KAKEN) from Ministry of Education, Culture, Sports, Science and Technology of Japan (21H03203) awarded to SN. The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Bar M, 2018, J ECON GROWTH, V23, P427, DOI 10.1007/s10887-018-9160-8; Beaujouan Eva, 2015, VIENNA I DEMOGRAPHY; Brinton MC, 2021, DEMOGR RES, V44, P239, DOI 10.4054/demres.2021.44.10; Cabinet Office; Government of Japan, 2013, 2013 DECL BIRTHR WHI; Cabinet Office; Government of Japan, 2014, SURV MARR FAM FORM; Chudnovskaya M, 2019, EUR J POPUL, V35, P939, DOI 10.1007/s10680-018-9511-3; Fenton KA, 2001, SEX TRANSM INFECT, V77, P84, DOI 10.1136/sti.77.2.84; Ghaznavi C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241571; Ghaznavi C, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6677-5; Gribble JN, 1999, J SEX RES, V36, P16, DOI 10.1080/00224499909551963; Hazan M, 2015, ECON J, V125, P1191, DOI 10.1111/ecoj.12148; Hoem JM, 2006, DEMOGR RES, V14, P331, DOI 10.4054/DemRes.2006.14.15; Hopcroft RL, 2018, FRONT SOCIOL, V3, P1, DOI [10.3389/fsoc.2018.00022, DOI 10.3389/FSOC.2018.00022]; Iijima Sachiko, 2018, Nihon Eiseigaku Zasshi, V73, P305, DOI 10.1265/jjh.73.305; Jalovaara M, 2019, EUR J POPUL, V35, P563, DOI 10.1007/s10680-018-9492-2; Kulu H, 2013, REG STUD, V47, P895, DOI 10.1080/00343404.2011.581276; Lichter DT, 2020, J MARRIAGE FAM, V82, P796, DOI 10.1111/jomf.12603; Miettinen A, 2015, FAM SOC WORK PAP SER; Ministry of Health Labour and Welfare; Japan, 2009, 6 LONG SURV AD 21 CE; Ministry of Health Labour and Welfare; Japan, JINK DOT CHOS; Ministry of Health Labour and Welfare; Japan, NAT FERT SURV; Ministry of Internal Affairs and Communications, 2015, STAT JAP STAT BUR PO; Nakagaki Y., 2018, International Journal of Development Issues, V17, P69, DOI 10.1108/IJDI-06-2017-0106; National Institute of Population and Social Security Research, 2017, POPULATION PROJECTIO; National Institute of Population and Social Security Research, 2017, 15 JAP NAT FERT SURV; National Institute of Population and Social Security Research, 2021, POP STAT BIRTH RAT W; Raymo JM, 2021, DEMOGR RES, V44, P67, DOI 10.4054/demres.2021.44.3; Raymo JM, 2005, AM SOCIOL REV, V70, P801, DOI 10.1177/000312240507000504; Schoppa LJ, 2020, SOC SCI JPN J, V23, P3, DOI 10.1093/ssjj/jyz046; Tanturri Maria., 2015, WORKING PAPER SERIES; Ueda P, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3833; Van Bavel J, 2018, ANNU REV SOCIOL, V44, P341, DOI 10.1146/annurev-soc-073117-041215; Wood J, 2014, DEMOGR RES, V31, DOI 10.4054/DemRes.2014.31.46	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0266835	10.1371/journal.pone.0266835	http://dx.doi.org/10.1371/journal.pone.0266835			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476638	Green Published, gold			2022-12-26	WOS:000840124300020
J	Johnson, MB				Johnson, Mark B.			The prevalence of alcohol-involved crashes across high and low complexity road environments: Does knowing where drinking drivers crash help explain why they crash?	PLOS ONE			English	Article							AGGRESSION	Objective Alcohol use has been linked to impairment of cognitive and psychomotor driving skills, yet the extent to which skill impairment contributes to actual crashes is unknown. A reasonable assumption is that some driving situations have higher skill demands than others. We contend that intersections, the presence of other vehicles or moving objects, and work zones are examples of common situations with higher skill demands. Accordingly, if skill deficits are largely responsible for alcohol-involved crashes, crashes involving a drinking driver (versus only sober drivers) should be overrepresented in these driving situations. Method Publicly available FARS data from 2010 to 2017 were collected. Fatal crashes were coded as alcohol-involved (1+ driver with a blood alcohol concentration [BAC] >= .05 g/dl) or having no impaired driver (BACs = .000). Drug-positive crashes were excluded. Crashes were also coded as involving moving versus stationary objects, occurring at versus away from intersections, being multivehicle versus single vehicle, occurring at or away from work zones. Results Across multiple models, controlling for time of day and type of road, alcohol-involved crashes were significantly underrepresented in crashes at intersections, with moving objects, and other vehicles. Most strikingly, alcohol-involved crashes were 24 percentage points more likely to be with a stationary object than a moving object. Conclusions No evidence supported the idea that skill reductions are a primary contributor to alcohol-involved crashes. Alternative explanations and limitations are discussed.	[Johnson, Mark B.] Pacific Inst Res & Evaluat, Natl Capital Reg Ctr, Beltsville, MD 20705 USA	Pacific Institute for Research & Evaluation (PIRE)	Johnson, MB (corresponding author), Pacific Inst Res & Evaluat, Natl Capital Reg Ctr, Beltsville, MD 20705 USA.	mjohnson@pire.org		Johnson, Mark/0000-0002-4515-4607				Beck A, 2013, DTSCH ARZTEBL INT, V110, P711, DOI 10.3238/arztebl.2013.0711; Berning A., 2014, 812072 DOT HS; Blomberg RD, 2005, CRASH RISK ALCOHOL I; Borkenstein R., 1964, ROLE DRINKING DRIVER; Cerezuela GP, 2004, ACCIDENT ANAL PREV, V36, P1045, DOI 10.1016/j.aap.2004.02.002; CHEREK DR, 1985, J STUD ALCOHOL, V46, P321, DOI 10.15288/jsa.1985.46.321; Ito TA, 1996, PSYCHOL BULL, V120, P60, DOI 10.1037/0033-2909.120.1.60; Johnson M., 2019, CANNABIS, V2, P144, DOI [10.26828/cannabis.2019.02.004, DOI 10.26828/CANNABIS.2019.02.004]; Johnson MB., 2018, BIORXIV, DOI [10.1101/387936, DOI 10.1101/387936]; Johnson MB., 2020, CANNABIS DRIVING IMP; Jongen S, 2016, ACCIDENT ANAL PREV, V89, P31, DOI 10.1016/j.aap.2016.01.001; Kruger HP, 1995, ALCOHOL, DRUGS AND TRAFFIC SAFETY - T'95, VOLS 1 AND 2, P222; Lacey J., 2016, DRUG ALCOHOL CRASH R; Lowrie J, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09095-5; Martin TL, 2013, J FORENSIC SCI, V58, P1238, DOI 10.1111/1556-4029.12227; Michaels J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185909; Moskowitz H., 2000, REV LIT EFFECTS LOW; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Romano E, 2014, J STUD ALCOHOL DRUGS, V75, P56, DOI 10.15288/jsad.2014.75.56; Sewell RA, 2009, AM J ADDICTION, V18, P185, DOI 10.1080/10550490902786934; Sontate KV, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.699726; Stroup W.W., 2013, C APPL STAT AGR, DOI [10.4148/2475-7772.1018, DOI 10.4148/2475-7772.1018]; Stroup WW, 2015, AGRON J, V107, P811, DOI 10.2134/agronj2013.0342; Underwood G, 2007, ERGONOMICS, V50, P1235, DOI 10.1080/00140130701318707; VogelSprott M, 1997, ALCOHOL HEALTH RES W, V21, P161; Yang YQ, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01601; Zador PL, 2000, J STUD ALCOHOL, V61, P387, DOI 10.15288/jsa.2000.61.387	27	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0266459	10.1371/journal.pone.0266459	http://dx.doi.org/10.1371/journal.pone.0266459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35443001	gold, Green Published			2022-12-26	WOS:000822608900023
J	Peng, D; Qian, J; Wei, LY; Luo, CY; Zhang, T; Zhou, LJ; Liu, YY; Ma, Y; Yin, F				Peng, Di; Qian, Jian; Wei, Luyi; Luo, Caiying; Zhang, Tao; Zhou, Lijun; Liu, Yuanyuan; Ma, Yue; Yin, Fei			COVID-19 distributes socially in China: A Bayesian spatial analysis	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; WUHAN; 2019-NCOV	Purpose The ongoing coronavirus disease 2019 (COVID-19) epidemic increasingly threatens the public health security worldwide. We aimed to identify high-risk areas of COVID-19 and understand how socioeconomic factors are associated with the spatial distribution of COVID-19 in China, which may help other countries control the epidemic. Methods We analyzed the data of COVID-19 cases from 30 provinces in mainland China (outside of Hubei) from 16 January 2020 to 31 March 2020, considering the data of demographic, economic, health, and transportation factors. Global autocorrelation analysis and Bayesian spatial models were used to present the spatial pattern of COVID-19 and explore the relationship between COVID-19 risk and various factors. Results Global Moran's I statistics of COVID-19 incidences was 0.31 (P<0.05). The areas with a high risk of COVID-19 were mainly located in the provinces around Hubei and the provinces with a high level of economic development. The relative risk of two socioeconomic factors, the per capita consumption expenditure of households and the proportion of the migrating population from Hubei, were 1.887 [95% confidence interval (CI): 1.469 similar to 2.399] and 1.099 (95% CI: 1.053 similar to 1.148), respectively. The two factors explained up to 78.2% out of 99.7% of structured spatial variations. Conclusion Our results suggested that COVID-19 risk was positively associated with the level of economic development and population movements. Blocking population movement and reducing local exposures are effective in preventing the local transmission of COVID-19.	[Peng, Di] First Peoples Hosp Shuangliu Dist, Chengdu, Sichuan, Peoples R China; [Peng, Di; Qian, Jian; Wei, Luyi; Luo, Caiying; Zhang, Tao; Zhou, Lijun; Liu, Yuanyuan; Ma, Yue; Yin, Fei] Sichuan Univ, West China Sch Publ Hlth, Chengdu, Sichuan, Peoples R China; [Peng, Di; Qian, Jian; Wei, Luyi; Luo, Caiying; Zhang, Tao; Zhou, Lijun; Liu, Yuanyuan; Ma, Yue; Yin, Fei] Sichuan Univ, West China Hosp 4, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Ma, Y; Yin, F (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Chengdu, Sichuan, Peoples R China.; Ma, Y; Yin, F (corresponding author), Sichuan Univ, West China Hosp 4, Chengdu, Sichuan, Peoples R China.	gordonrozen@qq.com; yinfeiscuedu@163.com	Zhou, Li/GSE-4531-2022; liu, yuanyuan/GWZ-5838-2022	Ma, Yue/0000-0002-1980-7520	National Natural Science Foundation of China [81872713, 81803332, 82041033, 81903414]; Sichuan Science & Technology Program [2021YFS0181]; Chengdu Science and Technology Program [2020-YF05-00296-SN]; Chongqing Science and Technology Program [cstc2020jscxcylhX0003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Science & Technology Program; Chengdu Science and Technology Program; Chongqing Science and Technology Program	This work was supported by National Natural Science Foundation of China (grant no. 81872713, 81803332, 82041033, and 81903414), Sichuan Science & Technology Program (grant no. 2021YFS0181), Chengdu Science and Technology Program (No. 2020-YF05-00296-SN), and Chongqing Science and Technology Program (cstc2020jscxcylhX0003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, BAYESIAN DIS MAPPING; [Anonymous], 2020, THERE WERE 12 CLUSTE; [Anonymous], 2020, NO 10 NOTICE ISSUED; [Anonymous], 2020, TOTAL 195 CLUSTERED; [Anonymous], 2020, PREVENTION CONTROL P, Vsecond; Baidu, 2020, BAIDU QIANXI; Blangiardo M, 2015, SPATIAL AND SPATIO-TEMPORAL BAYESIAN MODELS WITH R-INLA, P1, DOI 10.1002/9781118950203; Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003; Gupta A, 2020, MODEL EARTH SYST ENV, V6, P2645, DOI 10.1007/s40808-020-00838-2; Hu R, 2021, J NINGXIA MED U, V43, P1025; Jia JSS, 2020, NATURE, V582, P389, DOI [10.1038/s41586-020-2284-y, 10.1109/LGRS.2020.3028443]; Johnson HC, 2020, EUROSURVEILLANCE, V25, P8, DOI 10.2807/1560-7917.ES.2020.25.9.2000202; Knorr-Held L, 2000, STAT MED, V19, P2555, DOI 10.1002/1097-0258(20000915/30)19:17/18<2555::AID-SIM587>3.0.CO;2-#; Lau H, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa037; Li JY, 2020, MICROBES INFECT, V22, P80, DOI 10.1016/j.micinf.2020.02.002; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Mollalo A, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138884; Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P1, DOI 10.1093/acprof:oso/9780198509882.001.0001; Qi HC, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138778; Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058; Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433; Sarkodie SA, 2020, ENVIRON RES, V191, DOI 10.1016/j.envres.2020.110101; Sjodin H, 2020, INT J EPIDEMIOL, V49, P1443, DOI 10.1093/ije/dyaa121; Sun FN, 2020, ANN EPIDEMIOL, V52, P54, DOI 10.1016/j.annepidem.2020.07.014; Tang B, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020462; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Wang Z, 2020, B WORLD HEALTH ORGAN, P1, DOI [10.2471/BLT.20.255844, DOI 10.2471/BLT.20.255844]; Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020; Wilder-Smith A, 2020, LANCET INFECT DIS, V20, pE102, DOI 10.1016/S1473-3099(20)30129-8; Wu JM, 2022, CRIT REV FOOD SCI, V62, P783, DOI [10.1080/10408398.2020.1828813, 10.1038/s41591-020-0822-7]; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Xie ZX, 2020, SCI TOTAL ENVIRON, V744, DOI 10.1016/j.scitotenv.2020.140929; Zheng CF, 2022, INT J INFECT DIS, V114, P252, DOI 10.1016/j.ijid.2021.11.009	34	1	1	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0267001	10.1371/journal.pone.0267001	http://dx.doi.org/10.1371/journal.pone.0267001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35443008	gold, Green Published			2022-12-26	WOS:000822608900037
J	Broadbent, L; Bamford, CGG; Campos, GL; Manzoor, S; Courtney, D; Ali, A; Touzelet, O; McCaughey, C; Mills, K; Power, UF				Broadbent, Lindsay; Bamford, Connor G. G.; Lopez Campos, Guillermo; Manzoor, Sheerien; Courtney, David; Ali, Ahlam; Touzelet, Olivier; McCaughey, Conall; Mills, Ken; Power, Ultan F.			An endogenously activated antiviral state restricts SARS-CoV-2 infection in differentiated primary airway epithelial cells	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; CORONAVIRUS; INDUCTION; PROTEIN	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the coronavirus disease-19 (COVID-19) pandemic, was identified in late 2019 and caused >5 million deaths by February 2022. To date, targeted antiviral interventions against COVID-19 are limited. The spectrum of SARS-CoV-2 infection ranges from asymptomatic to fatal disease. However, the reasons for varying outcomes to SARS-CoV-2 infection are yet to be elucidated. Here we show that an endogenously activated interferon lambda (IFN lambda 1) pathway leads to resistance against SARS-CoV-2 infection. Using a well-differentiated primary nasal epithelial cell (WD-PNEC) culture model derived from multiple adult donors, we discovered that susceptibility to SARS-CoV-2 infection, but not respiratory syncytial virus (RSV) infection, varied. One of four donors was resistant to SARS-CoV-2 infection. High baseline IFN lambda 1 expression levels and associated interferon stimulated genes correlated with resistance to SARS-CoV-2 infection. Inhibition of the JAK/STAT pathway in WD-PNECs with high endogenous IFN lambda 1 secretion resulted in higher SARS-CoV-2 titres. Conversely, prophylactic IFN lambda treatment of WD-PNECs susceptible to infection resulted in reduced viral titres. An endogenously activated IFN lambda response, possibly due to genetic differences, may be one explanation for the differences in susceptibility to SARS-CoV-2 infection in humans. Importantly, our work supports the continued exploration of IFN lambda as a potential pharmaceutical against SARS-CoV-2 infection.	[Broadbent, Lindsay; Bamford, Connor G. G.; Lopez Campos, Guillermo; Manzoor, Sheerien; Courtney, David; Ali, Ahlam; Touzelet, Olivier; Power, Ultan F.] Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Belfast, North Ireland; [Ali, Ahlam; Mills, Ken] Queens Univ Belfast, Patrick Johnston Ctr Canc Res G, Belfeast, England; [McCaughey, Conall] Belfast Hlth Social Care Trust, Reg Virus Lab, Belfeast, North Ireland	Queens University Belfast; Queens University Belfast	Broadbent, L; Power, UF (corresponding author), Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Belfast, North Ireland.	l.broadbent@qub.ac.uk; u.power@qub.ac.uk	Broadbent, Lindsay/GWQ-4931-2022; Lopez-Campos, Guillermo/O-4349-2017	Broadbent, Lindsay/0000-0002-8755-6946; Lopez-Campos, Guillermo/0000-0003-3011-0940	UKRI/NIHR [MC_PC_19057]; PHA HSCNI RD Division [COM/5613/20]	UKRI/NIHR(UK Research & Innovation (UKRI)); PHA HSCNI RD Division	This study was supported by funding from UKRI/NIHR (MC_PC_19057) to UP and KM (https://www.nihr.ac.uk/) PHA HSCNI R&D Division (COM/5613/20) to UP, KM, LB, CB, and GLC (https://research.hscni.net/); and generous donations from the public and QUB alumni to the Queen's University Belfast Foundation (https://www.qub.ac.uk/alumni/QueensUniversityofBelfastFoundation/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A. Wickenhagen, 2021, medRxiv, DOI 10.1101/2021.05.05.21256681; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bamford CGG., 2021, BIORXIV, DOI [10.1101/2021.07.16.452629, DOI 10.1101/2021.07.16.452629]; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Broadbent L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228229; Broadbent L, 2016, METHODS MOL BIOL, V1442, P119, DOI 10.1007/978-1-4939-3687-8_9; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Del Valle DM, 2020, NAT MED, V26, P1636, DOI [10.1038/s41591-020-1051-9, 10.1101/2020.05.28.20115758]; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Donnelly RP, 2011, TRENDS IMMUNOL, V32, P443, DOI 10.1016/j.it.2011.07.002; Feld JJ, 2021, LANCET RESP MED, V9, P498, DOI 10.1016/S2213-2600(20)30566-X; Felgenhauer U, 2020, J BIOL CHEM, V295, P13958, DOI 10.1074/jbc.AC120.013788; Galani IE, 2021, NAT IMMUNOL, V22, P32, DOI 10.1038/s41590-020-00840-x; Giersch K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03946-9; Gorbea C, 2010, J BIOL CHEM, V285, P23206, DOI 10.1074/jbc.M109.047464; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Huik K, 2013, INFECT GENET EVOL, V20, P78, DOI 10.1016/j.meegid.2013.08.008; Jilg N, 2014, HEPATOLOGY, V59, P1250, DOI 10.1002/hep.26653; Kieran Dee, 2021, J INFECT DIS, pjiab147, DOI [10.1093/infdis/jiab147, DOI 10.1093/INFDIS/JIAB147]; Lazear HM, 2019, IMMUNITY, V50, P907, DOI 10.1016/j.immuni.2019.03.025; Leisman DE, 2020, LANCET RESP MED, V8, P1233, DOI 10.1016/S2213-2600(20)30404-5; Liao Y, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz114; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Madewell ZJ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.31756; Marcos-Villar L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19370-6; Omrani AS, 2014, LANCET INFECT DIS, V14, P1090, DOI 10.1016/S1473-3099(14)70920-X; Pervolaraki K, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007420; Pfaender S, 2020, NAT MICROBIOL, V5, P1330, DOI [10.1038/s41564-020-0769-y, 10.1101/2020.03.05.979260]; Power UF, 1997, VIROLOGY, V230, P155, DOI 10.1006/viro.1997.8465; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Shaw AE, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2004086; Sironi M, 2012, J IMMUNOL, V188, P818, DOI 10.4049/jimmunol.1102179; Skevaki C, 2015, CLIN EXP IMMUNOL, V180, P165, DOI 10.1111/cei.12578; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Stockman LJ, 2006, PLOS MED, V3, P1525, DOI 10.1371/journal.pmed.0030343; Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6; Vanderheiden A, 2020, J VIROL, V94, DOI 10.1128/JVI.00985-20; Villenave R, 2012, P NATL ACAD SCI USA, V109, P5040, DOI 10.1073/pnas.1110203109; Villenave R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-43; Winstone H, 2021, J VIROL, V95, DOI 10.1128/JVI.02422-20; Xu Z, 2020, LANCET, V395, P947, DOI 10.1016/S0140-6736(20)30308-1; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhou SR, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01281-1; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	46	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266412	10.1371/journal.pone.0266412	http://dx.doi.org/10.1371/journal.pone.0266412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7MW	35436306	Green Submitted, Green Published, gold			2022-12-26	WOS:000791258900028
J	de Mangou, A; Combe, A; Coolen-Allou, N; Miltgen, G; Traversier, N; Belmonte, O; Vandroux, D; Bohrer, M; Cousty, J; Caron, M; Vidal, C; Allyn, J; Allou, N				de Mangou, Axel; Combe, Agathe; Coolen-Allou, Nathalie; Miltgen, Guillaume; Traversier, Nicolas; Belmonte, Olivier; Vandroux, David; Bohrer, Michel; Cousty, Julien; Caron, Margot; Vidal, Charles; Allyn, Jerome; Allou, Nicolas			Severe community-acquired pneumonia in Reunion Island: Epidemiological, clinical, and microbiological characteristics, 2016-2018	PLOS ONE			English	Article							MICROBIAL ETIOLOGY; INFLUENZA; DIAGNOSIS; MORTALITY	PurposeNo data are available on severe community-acquired pneumonia (CAP) in the French overseas department of Reunion Island. This is unfortunate as the microorganisms responsible for the disease are likely to differ from those in temperate regions due to a tropical climate and proximity to other islands of the Indian Ocean region. The aim of this study was to assess the epidemiological, clinical, prognosis, and microbiological characteristics of patients with severe CAP in Reunion Island. Materials and methodsThis retrospective study evaluated all patients with CAP aged >18 years and hospitalized in one of the two intensive care units of Reunion Island between 2016 and 2018. Microorganisms were identified by culture from blood and respiratory samples, multiplex polymerase chain reaction from respiratory samples, urinary antigen tests, and serology. ResultsOver the study period, 573 cases of severe CAP were recorded, with a mean incidence of 22 per 100,000 person-years. The most frequently isolated microorganism was influenza (21.9%) followed by Streptococcus pneumoniae (12%). The influenza virus was detected in affected patients all year round. Twenty-four patients with severe CAP came from another island of the Indian Ocean region (4.2%), mainly Madagascar (>50%). Two of these patients presented with melioidosis and 4 were infected with Acinetobacter spp. ConclusionsOur findings have major implications for the management of severe CAP in tropical regions. The most frequently isolated microorganism in patients with severe CAP in Reunion Island is influenza followed by S. pneumoniae. Physicians should be aware that influenza is the main cause of severe CAP in patients living in or returning from Reunion Island, where this virus circulates all year round.	[de Mangou, Axel; Combe, Agathe; Vandroux, David; Caron, Margot; Vidal, Charles; Allyn, Jerome; Allou, Nicolas] Ctr Hosp Univ Felix Guyon, Intens Care Unit, St Denis, France; [Coolen-Allou, Nathalie] Ctr Hosp Univ Felix Guyon, Resp Dis, St Denis, France; [Miltgen, Guillaume; Traversier, Nicolas; Belmonte, Olivier] Ctr Hosp Univ Felix Guyon, Microbiol, St Denis, France; [Miltgen, Guillaume] Univ Reunion, INSERM U1187, UMR Proc Infect Milieu Insulaire Trop, CNRS 9192,IRD 249, St Denis, France; [Bohrer, Michel] St Denis Univ Hosp, Dept Med Informat, St Denis, Reunion Island, France; [Cousty, Julien] Ctr Hosp Univ Sud Reunion, Intens Care Unit, St Pierre, France; [Allyn, Jerome; Allou, Nicolas] St Denis Univ Hosp, Clin Informat Dept, St Denis, Reunion Island, France	CHU Reunion; CHU Reunion; CHU Reunion; Institut National de la Sante et de la Recherche Medicale (Inserm); University of La Reunion; CHU Reunion; CHU Reunion; CHU Reunion	Allou, N (corresponding author), Ctr Hosp Univ Felix Guyon, Intens Care Unit, St Denis, France.; Allou, N (corresponding author), St Denis Univ Hosp, Clin Informat Dept, St Denis, Reunion Island, France.	nicolas.allou@hotmail.fr	Miltgen, Guillaume/AAE-7544-2020	Bohrer, michel/0000-0002-2581-7653; Allyn, Jerome/0000-0001-8057-0393; De Mangou, Axel/0000-0002-4188-0230				Abelleira R, 2019, CAN RESPIR J, V2019, DOI 10.1155/2019/4301039; Adegboye OA, 2020, J EXPO SCI ENV EPID, V30, P448, DOI 10.1038/s41370-019-0176-8; Agence Franaise de Scurit Sanitaire des Produits de SantSocit de Pathologie Infectieuse de langue Franaise-Socit de Pneumologie de Langue Franaise, 2010, ANT VOIE GNRAL INF R; Allou N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006018; Berdyev D, 2011, REANIMATION, V20, pS566, DOI 10.1007/s13546-010-0031-3; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Cavallazzi R, 2020, CHEST, V158, P1008, DOI 10.1016/j.chest.2020.03.051; Chen L, 2020, EUR J CLIN MICROBIOL, V39, P1231, DOI 10.1007/s10096-020-03835-6; Cilloniz C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122120; Davis JS, 2014, CHEST, V146, P1038, DOI 10.1378/chest.13-3065; De Pascale G, 2012, CURR OPIN PULM MED, V18, P213, DOI 10.1097/MCP.0b013e328351f9bd; Dupuis C, 2021, CRIT CARE, V25, DOI 10.1186/s13054-020-03442-z; Ewig S, 1998, AM J RESP CRIT CARE, V158, P1102, DOI 10.1164/ajrccm.158.4.9803114; Fally M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234308; Ferrer M, 2018, PLOS ONE, V13, DOI [10.1371/journal.pone.0191721, 10.1371/journ]; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Hernu R, 2018, INTENS CARE MED, V44, P257, DOI 10.1007/s00134-017-4953-3; Hsu J, 2012, ANN INTERN MED, V156, P512, DOI 10.7326/0003-4819-156-7-201204030-00411; Kramer SC, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006742; Krol P, 2021, TROP MED INT HEALTH, V26, P444, DOI 10.1111/tmi.13542; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lim TK, 2018, RESPIROLOGY, V23, P28, DOI 10.1111/resp.13137; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Lytras T, 2019, CLIN INFECT DIS, V69, P1896, DOI 10.1093/cid/ciz101; Melidou A, 2020, EUROSURVEILLANCE, V25, DOI 10.2807/1560-7917.ES.2020.25.46.2001822; Metlay JP, 2019, AM J RESP CRIT CARE, V200, pE45, DOI 10.1164/rccm.201908-1581ST; Monamele GC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186914; Olson G, 2020, JAMA-J AM MED ASSOC, V323, P885, DOI 10.1001/jama.2019.21118; Paganin F, 2004, EUR RESPIR J, V24, P779, DOI 10.1183/09031936.04.00119503; Rakotoson J L, 2010, Med Trop (Mars), V70, P62; Ratsitorahina M, 2000, TROP MED INT HEALTH, V5, P94, DOI 10.1046/j.1365-3156.2000.00521.x; Razanajatovo Norosoa Harline, 2018, PLoS One, V13, pe0205124, DOI 10.1371/journal.pone.0205124; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Siow WT, 2016, RESPIRATION, V92, P286, DOI 10.1159/000448555; Societe de Pathologie Infectieuse de Langue Francaise, 2016, PROC ACT PRIS CHARG; Soebiyanto RP, 2015, GEOSPATIAL HEALTH, V10, P144, DOI 10.4081/gh.2015.372; Stahl JP, 2006, MED MALADIES INFECT, V36, P235, DOI 10.1016/j.medmal.2006.04.003; Sullivan SG, 2020, EUROSURVEILLANCE, V25, DOI 10.2807/1560-7917.ES.2020.25.47.2001847; Tang JW, 2010, J MED VIROL, V82, P1958, DOI 10.1002/jmv.21892; Uyeki TM, 2019, CLIN INFECT DIS, V68, pE1, DOI [10.1093/cid/ciy866, 10.1093/cid/ciy874]; Vandroux D, 2019, INFECT DIS-NOR, V51, P831, DOI 10.1080/23744235.2019.1668957; Visseaux B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180888; Voiriot G, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1517-9; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Woodhead M, 2006, CRIT CARE, V10, DOI 10.1186/cc4927; Zhang YZ, 2020, SCI TOTAL ENVIRON, V701, DOI 10.1016/j.scitotenv.2019.134607	46	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267184	10.1371/journal.pone.0267184	http://dx.doi.org/10.1371/journal.pone.0267184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1E2NP	35427402	Green Submitted, Green Published, gold			2022-12-26	WOS:000794332400014
J	Gaultier, GN; Nix, EB; Thorgrimson, J; Boreham, D; McCready, W; Ulanova, M				Gaultier, Gabrielle N.; Nix, Eli B.; Thorgrimson, Joelle; Boreham, Douglas; McCready, William; Ulanova, Marina			Naturally acquired antibodies against 7 Streptococcus pneumoniae serotypes in Indigenous and non-Indigenous adults	PLOS ONE			English	Article							INVASIVE PNEUMOCOCCAL DISEASE; CONJUGATE VACCINE; POLYSACCHARIDE VACCINE; CROSS-REACTIONS; CARRIAGE; IMMUNOGENICITY; EPIDEMIOLOGY; ALASKA; COLONIZATION; PROTECTION	Despite the use of pneumococcal conjugate vaccines for pediatric immunization, North American Indigenous populations continue to experience high burden of pneumococcal infections. Naturally acquired antibodies, which can protect unvaccinated adults against pneumococcal infections, have not previously been studied in Canadian Indigenous people. We analysed concentrations of natural serum IgG, IgM and IgA antibodies specific to 7 serotype-specific capsular polysaccharides (3, 6B, 9V, 14, 1 9A, 1 9F and 23F) in 141 healthy individuals (age between 18 and 80 years), including Indigenous adults living in 2 geographical different areas of Ontario, Canada, and non-Indigenous residing in northwestern Ontario. Regardless of the geographical area, concentrations of IgG specific to serotypes 6B, 9V, and 14, IgM specific to 9V, and all serotype-specific IgA were significantly higher in Indigenous study participants as compared to non-Indigenous. The differences are likely attributed to an increased exposure of Indigenous individuals to Streptococcus pneumoniae and/or cross-reactive antigens of other microorganisms or plants present in the environment. Although in non-Indigenous adults concentrations of IgM specific to 9V, 19A, 19F, and 23F significantly decreased with age, this was not observed in Indigenous individuals suggesting that Indigenous people may experience continuous exposure to pneumococci and cross-reactive antigens over the life span. Women had generally higher concentrations of natural IgG and IgM concentrations than men, with more striking differences found in Indigenous adults, potentially associated with larger exposure of women to young children, the major reservoir of pneumococci in communities. Our data suggest that increased rates of pneumococcal infections among Indigenous people are unlikely related to deficiency of naturally acquired antibodies, at least those specific to 7 common serotypes. Determining serological correlates of protection for adults will be essential to identify the groups in need of adult pneumococcal immunizations that may prevent excessive burden of the disease among North American Indigenous people.	[Gaultier, Gabrielle N.; Nix, Eli B.; Thorgrimson, Joelle; Boreham, Douglas; McCready, William; Ulanova, Marina] NOSM Univ, Thunder Bay, ON, Canada		McCready, W (corresponding author), NOSM Univ, Thunder Bay, ON, Canada.	mulanova@nosm.ca		Ulanova, Marina/0000-0002-4794-9999	Northern Ontario Academic Medicine Association (AHSC AFP Innovation Fund) [A-12-06]; Pfizer [53232197]; NOSM Summer Medical Student Research Awards; Mitacs Accelerate; Bruce Power [IT05441]	Northern Ontario Academic Medicine Association (AHSC AFP Innovation Fund); Pfizer(Pfizer); NOSM Summer Medical Student Research Awards; Mitacs Accelerate; Bruce Power	This work received support from: Mitacs Accelerate with contribution by Bruce Power; IT05441; www.mitacs.ca/en/programs/accelerate to MU, DB; Northern Ontario Academic Medicine Association (AHSC AFP Innovation Fund); www.noama.ca; A-12-06 to WM, MU; Pfizer (Investigator Initiated Research Project, Grant 53232197) to M.U. https://www.cybergrants.com/pfizer/Research; and NOSM Summer Medical Student Research Awards to EBN and JT, https://www.nosm.ca/research/student-research-atnosm-2/deans-summer-medical-student-research-awards/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews NJ, 2014, LANCET INFECT DIS, V14, P839, DOI 10.1016/S1473-3099(14)70822-9; [Anonymous], 2019, NATL LAB SURVEILLANC; AUSTRIAN R, 1986, J ANTIMICROB CHEMOTH, V18, P35, DOI 10.1093/jac/18.Supplement_A.35; Bocking N, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofw243; Brown VM, 2009, CLIN INFECT DIS, V49, P1240, DOI 10.1086/605671; Canada TPHAo, 2017, EST NAT VACC COV ROU; Canadian Institutes of Health Research N. S. A. E. R. C. O. C. and Social Sciences and Humanities Research Council of Canada, 2014, TRIC POL STAT ETH CO; Census Profile, 2016, 2016 CENS NW ONT ONT; Cerqueira A, 2019, CAN J MICROBIOL, V65, P805, DOI 10.1139/cjm-2019-0210; Cleophat JE, 2014, CAN J PUBLIC HEALTH, V105, pE268, DOI 10.17269/cjph.105.4315; CORTESE MM, 1992, ARCH INTERN MED, V152, P2277, DOI 10.1001/archinte.152.11.2277; CRUMRINE MH, 1979, INFECT IMMUN, V25, P960, DOI 10.1128/IAI.25.3.960-963.1979; Dalcin D, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3531-9; DAVIDSON M, 1994, J INFECT DIS, V170, P368, DOI 10.1093/infdis/170.2.368; De Wals P, 2020, INT J CIRCUMPOL HEAL, V79, DOI 10.1080/22423982.2020.1799688; Drijkoningen JJC, 2014, CLIN MICROBIOL INFEC, V20, P45, DOI 10.1111/1469-0691.12461; Eton V, 2017, INT J INFECT DIS, V65, P27, DOI 10.1016/j.ijid.2017.09.016; Ferreira DM, 2013, AM J RESP CRIT CARE, V187, P855, DOI 10.1164/rccm.201212-2277OC; Geno KA, 2015, CLIN MICROBIOL REV, V28, P871, DOI 10.1128/CMR.00024-15; Gertz RE, 2021, MBIO, V12, DOI 10.1128/mBio.01037-21; Gimpel AK, 2022, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.761816; Goldblatt D, 2005, J INFECT DIS, V192, P387, DOI 10.1086/431524; Government of Canada PHAoC, 2014, VACC UPT CAN AD RES; Government of Canada PHAoC, 2016, AB PEOPL HIGHL TABL; Government of Canada PHC, 2016, PAG 16 CAN IMM GUI 4; Hammitt LL, 2011, VACCINE, V29, P2287, DOI 10.1016/j.vaccine.2011.01.029; Hammitt LL, 2006, J INFECT DIS, V193, P1487, DOI 10.1086/503805; HEIDELBERGER M, 1982, PROG CH ORG NAT PROD, V42, P287; HEIDELBERGER M, 1984, P NATL ACAD SCI-BIOL, V81, P5247, DOI 10.1073/pnas.81.16.5247; Helferty Melissa, 2013, Int J Circumpolar Health, V72, DOI 10.3402/ijch.v72i0.21606; Henriques-Normark B, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010215; Janoff EN, 1999, J CLIN INVEST, V104, P1139, DOI 10.1172/JCI6310; Jauneikaite E, 2015, J MICROBIOL METH, V113, P41, DOI 10.1016/j.mimet.2015.03.006; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kayhty H, 2006, EXPERT REV VACCINES, V5, P651, DOI 10.1586/14760584.5.5.651; Kelly Len, 2019, CMAJ Open, V7, pE568, DOI 10.9778/cmajo.20190040; King M, 2010, CHRONIC DIS CAN, V31, P2; Laboratories WHOPSR, TRAIN MAN ENZ LINK I; Lacapa R, 2008, CLIN INFECT DIS, V47, P476, DOI 10.1086/590001; LAGERGARD T, 1983, ACTA PATH MICRO IM C, V91, P371; LeBlanc JJ, 2019, VACCINE, V37, P5466, DOI 10.1016/j.vaccine.2019.05.003; LEE CJ, 1985, J INFECT DIS, V151, P658, DOI 10.1093/infdis/151.4.658; Lewnard JA, 2019, LANCET INFECT DIS, V19, pE213, DOI 10.1016/S1473-3099(18)30660-1; Miellet WR, 2021, CLIN INFECT DIS, V73, pE2680, DOI 10.1093/cid/ciaa1551; Miernyk KM, 2009, CLIN INFECT DIS, V49, P241, DOI 10.1086/599824; Millar EV, 2008, CLIN INFECT DIS, V47, P989, DOI 10.1086/591966; Mitrou F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-201; Mosser JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0079578; MUSHER DM, 1990, INFECT IMMUN, V58, P3871, DOI 10.1128/IAI.58.12.3871-3876.1990; Nahm MH, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00074-20; Nix EB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201282; Ontario PH, IMM COV REP SCH PUP; Ortqvist A, 2007, VACCINE, V25, P2445, DOI 10.1016/j.vaccine.2006.09.018; Ownership SchnarchB., 2004, INT J INDIG HEALTH, V1, P80; Park MA, 2021, VACCINE, V39, P2850, DOI 10.1016/j.vaccine.2021.04.015; Paton JC, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.GPP3-0019-2018; Rodriguez ME, 1998, VACCINE, V16, P1941, DOI 10.1016/S0264-410X(98)00129-7; Romero-Steiner S, 1999, CLIN INFECT DIS, V29, P281, DOI 10.1086/520200; Said MA, 2011, VACCINE, V29, P5355, DOI 10.1016/j.vaccine.2011.05.086; Salt P, 2007, CLIN VACCINE IMMUNOL, V14, P593, DOI 10.1128/CVI.00344-06; Scott JAG, 1996, CLIN INFECT DIS, V22, P973, DOI 10.1093/clinids/22.6.973; Scott JR, 2012, J INFECT DIS, V205, P280, DOI 10.1093/infdis/jir730; Simell B, 2008, CLIN VACCINE IMMUNOL, V15, P1391, DOI 10.1128/CVI.00110-08; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Simell B, 2012, CLIN VACCINE IMMUNOL, V19, P1618, DOI 10.1128/CVI.00248-12; Singleton RJ, 2007, JAMA-J AM MED ASSOC, V297, P1784, DOI 10.1001/jama.297.16.1784; Soeters HM, 2021, CLIN INFECT DIS, V73, pE371, DOI 10.1093/cid/ciaa875; Storisteanu DML, 2017, AM J RESP CELL MOL, V56, P423, DOI 10.1165/rcmb.2016-0193PS; Ulanova M, 2021, VACCINE, V39, P699, DOI 10.1016/j.vaccine.2020.12.035; van der Pol WL, 2000, J INFECT DIS, V182, P1139, DOI 10.1086/315825; VANDAM JEG, 1990, ANTON LEEUW INT J G, V58, P1; Vanderkooi OG, 2010, CLIN INFECT DIS, V50, P1247, DOI 10.1086/651681; Voysey M, 2018, CLIN INFECT DIS, V66, P913, DOI 10.1093/cid/cix895; Watt JP, 2007, AM J EPIDEMIOL, V166, P1080, DOI 10.1093/aje/kwm178; Watt JP, 2004, CLIN INFECT DIS, V38, P496, DOI 10.1086/381198; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476; Wenger JD, 2010, PEDIATR INFECT DIS J, V29, P251, DOI 10.1097/INF.0b013e3181bdbed5; Wijayasri S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226353	79	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267051	10.1371/journal.pone.0267051	http://dx.doi.org/10.1371/journal.pone.0267051			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421173	gold, Green Published			2022-12-26	WOS:000795453600102
J	Ishii, M; Itano, O; Morinaga, J; Shirakawa, H; Itano, S				Ishii, Masatsugu; Itano, Osamu; Morinaga, Jun; Shirakawa, Hirofumi; Itano, Satoshi			Potential efficacy of hepatic arterial infusion chemotherapy using gemcitabine, cisplatin, and 5-fluorouracil for intrahepatic cholangiocarcinoma	PLOS ONE			English	Article							BILIARY-TRACT CANCER; PHASE-II; 2ND-LINE TREATMENT; PROGNOSTIC-FACTORS; OXALIPLATIN; COMBINATION; THERAPY; SYSTEM	Intrahepatic cholangiocarcinoma (ICC) has a poor prognosis, as the resectability rate is low due to its diagnosis at a late/advanced stage. Moreover, most patients with resected ICC eventually relapse. Hepatic arterial infusion chemotherapy (HAIC) has been indicated only by a few reports to be effective in patients with advanced ICC; thus, its efficacy for these patients remains unclear. This study aimed to evaluate the efficacy of HAIC using gemcitabine, cisplatin, and 5-fluorouracil in patients with advanced ICC. A total of 18 patients who underwent HAIC were retrospectively investigated. The patients received gemcitabine, cisplatin, and 5-fluorouracil through one artery. In patients who received gemcitabine plus cisplatin (n = 10), the response and disease control rates were 0% and 80.0%, respectively; the median overall survival (OS) and progression-free survival (PFS) after treatment initiation were 6.3 and 3.7 months, respectively. In patients who never received chemotherapy (n = 8), the response and disease control rates were 37.5% and 75%, respectively; the median OS and PFS were 20.6 and 8.1 months, respectively. Moreover, we compared the patients who received HAIC using gemcitabine, cisplatin, and 5-fluorouracil to patients whose tumors were refractory to systemic gemcitabine and cisplatin therapy. The OS of the patients who received HAIC was better than that of the patients who received standard chemotherapy cohort since the gemcitabine plus cisplatin combination therapy-refractory response and disease onset (P = 0.045, 0.006). HAIC using gemcitabine, cisplatin, and 5-fluorouracil may be effective as a therapeutic option for patients with advanced ICC.	[Ishii, Masatsugu; Itano, Satoshi] Kurume Chuo Hosp, Dept Gastroenterol, Fukuoka, Japan; [Ishii, Masatsugu; Shirakawa, Hirofumi] Tochigi Canc Ctr, Dept HepatoBiliary Pancreat Surg, Utsunomiya, Tochigi, Japan; [Itano, Osamu] Int Univ Hlth & Welf, Sch Med, Dept HepatoBiliary Pancreat & Gastrointestinal Su, Chiba, Japan; [Morinaga, Jun] Kumamoto Univ Hosp, Dept Clin Invest, Kumamoto, Japan	Tochigi Prefectural Cancer Center; International University of Health & Welfare; Kumamoto University	Itano, O (corresponding author), Int Univ Hlth & Welf, Sch Med, Dept HepatoBiliary Pancreat & Gastrointestinal Su, Chiba, Japan.	itano@iuhw.ac.jp		Ishii, Masatsugu/0000-0002-7081-7679				Andre T, 2008, BRIT J CANCER, V99, P862, DOI 10.1038/sj.bjc.6604628; Cantore M, 2005, CANCER-AM CANCER SOC, V103, P1402, DOI 10.1002/cncr.20964; de Groen PC, 1999, NEW ENGL J MED, V341, P1368, DOI 10.1056/NEJM199910283411807; Ghiringhelli F, 2013, CHEMOTHERAPY, V59, P354, DOI 10.1159/000362223; He SL, 2014, J CHEMOTHERAPY, V26, P243, DOI 10.1179/1973947813Y.0000000133; Inaba Y, 2011, AM J CLIN ONCOL-CANC, V34, P58, DOI 10.1097/COC.0b013e3181d2709a; Itano O, 2014, JPN J RADIOL, V32, P670, DOI 10.1007/s11604-014-0361-6; Javle M, 2018, J CLIN ONCOL, V36, P276, DOI 10.1200/JCO.2017.75.5009; Kasai K, 2014, ANN SURG ONCOL, V21, P3638, DOI 10.1245/s10434-014-3766-7; Kim BJ, 2017, CANCER CHEMOTH PHARM, V80, P209, DOI 10.1007/s00280-017-3353-2; Konstantinidis IT, 2014, ANN SURG ONCOL, V21, P2675, DOI 10.1245/s10434-014-3649-y; Lee SH, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061769; National Cancer Institute. National Institutes of Health US Department of Health and Human Services, 2017, COMMON TERMINOLOGY C; Obi S, 2015, LIVER CANCER, V4, P188, DOI 10.1159/000367746; Okusaka T, 2010, BRIT J CANCER, V103, P469, DOI 10.1038/sj.bjc.6605779; Park J, 2009, GUT LIVER, V3, P298, DOI 10.5009/gnl.2009.3.4.298; Sawai K, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-203; Tanaka N, 2002, EUR J RADIOL, V41, P42, DOI 10.1016/S0720-048X(01)00414-4; Ueshima K, 2010, ONCOLOGY-BASEL, V78, P148, DOI 10.1159/000315244; Valle Juan, 2010, N Engl J Med, V362, P1273, DOI 10.1056/NEJMoa0908721; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Vogl TJ, 2008, EUR RADIOL, V18, P468, DOI 10.1007/s00330-007-0781-0; West J, 2006, BRIT J CANCER, V94, P1751, DOI 10.1038/sj.bjc.6603127; Yamagami T, 2004, RADIOLOGY, V230, P792, DOI 10.1148/radiol.2303021564	24	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266707	10.1371/journal.pone.0266707	http://dx.doi.org/10.1371/journal.pone.0266707			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C1KV	35452492	gold, Green Published			2022-12-26	WOS:000792887700039
J	Leweri, CM; Bartzke, GS; Msuha, MJ; Treydte, AC				Leweri, Cecilia M.; Bartzke, Gundula S.; Msuha, Maurus J.; Treydte, Anna C.			Spatial and seasonal group size variation of wild mammalian herbivores in multiple use landscapes of the Ngorongoro Conservation Area, Tanzania	PLOS ONE			English	Article							MOVEMENT DECISIONS; NATIONAL-PARK; WATER; DYNAMICS; SAVANNA; DENSITY; HABITAT; HOME; SETTLEMENT; RESPONSES	Group sizes of wild herbivores can be indicators of ecosystem health and proxies for individual and population fitness, particularly in areas where human activities have become increasingly common. We recorded 176 single- and multi-species groups of wild herbivores in human-dominated landscapes of the Ngorongoro Conservation Area (NCA) during dry and wet seasons. We analyzed how wild herbivore group sizes were affected by: (1) season, (2) distance to fully protected area (NCA crater) and to streams, (3) distance to human settlements, and (4) numbers of livestock. Group sizes were generally larger during the wet season than during the dry season and varied seasonally with distance to NCA crater, streams, and human settlements. During the wet season, larger groups were observed further away from the NCA crater whereas the opposite pattern was apparent during the dry season. Average wild herbivore group sizes increased by about three-fold with increasing distance from the streams during the dry season but were invariant to streams during the wet season. Furthermore, during the dry season, group sizes were larger close to settlements but varied little with distance to settlements during the wet season. While livestock presence did not directly affect wild herbivore group size, distance to settlements, streams and distance to the Ngorongoro crater in interaction with rainfall seasonality did. We conclude that the NCA crater functions as a key resource area for wild herbivores such as wildebeest (Connochaetes taurinus) and zebra (Equus quagga burchelli) during the dry season, highlighting the need for its full protection status in this Man and Biosphere reserve.	[Leweri, Cecilia M.; Treydte, Anna C.] Nelson Mandela African Inst Sci & Technol, Sch Life Sci & Bioengn, Dept Sustainable Agr Biodivers & Ecosyst Manageme, Arusha, Tanzania; [Leweri, Cecilia M.] Tanzania Wildlife Res Inst TAWIRI, Wildlife Informat & Educ Unit, Arusha, Tanzania; [Bartzke, Gundula S.] Univ Hohenheim, Inst Crop Sci Biostat, Stuttgart, Germany; [Msuha, Maurus J.] Minist Nat Resources & Tourism, Wildlife Div, Dodoma, Tanzania; [Treydte, Anna C.] Univ Hohenheim, Hans Ruthenberg Inst, Ecol Trop Agr Syst, Stuttgart, Germany; [Treydte, Anna C.] Stockholm Univ, Dept Phys Geog, Stockholm, Sweden	Nelson Mandela African Institution of Science & Technology; University Hohenheim; University Hohenheim; Stockholm University	Leweri, CM (corresponding author), Nelson Mandela African Inst Sci & Technol, Sch Life Sci & Bioengn, Dept Sustainable Agr Biodivers & Ecosyst Manageme, Arusha, Tanzania.; Leweri, CM (corresponding author), Tanzania Wildlife Res Inst TAWIRI, Wildlife Informat & Educ Unit, Arusha, Tanzania.	cecilia.leweri@tawiri.or.tz		Leweri, Cecilia/0000-0002-1051-6022	African Development Bank; Orskov foundation; IdeaWild; African Development Bank (AfDB) [210015503281]	African Development Bank(CGIAR); Orskov foundation; IdeaWild; African Development Bank (AfDB)(CGIAR)	CL received the grants from the African Development Bank and additional funds and research equipment from the Orskov foundation and IdeaWild. African Development Bank (AfDB Grant number 210015503281) Orskov foundation https://www.orskovfoundation.org/IdeaWildhttps://ideawild.org/No - The fundershad no rolein studydesign,data collectionand analysis, decisionto publish,or preparationof themanuscript	Acebes P, 2012, J ARID ENVIRON, V77, P39, DOI 10.1016/j.jaridenv.2011.09.003; Adler PB., LANDSCAPE ECOL, P319; Agresti A, 2013, INTRO LINEAR REGRESS; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Baltazary A., 2019, Environment and Natural Resources Research, V9, P64, DOI 10.5539/enrr.v9n1p64; BARRETTE C, 1991, MAMMALIA, V55, P207, DOI 10.1515/mamm.1991.55.2.207; Benedek AM, 2019, CAN J ZOOL, V97, P312, DOI 10.1139/cjz-2018-0201; Berdahl AM, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0009; Bergstrom R, 1999, AFR J ECOL, V37, P12, DOI 10.1046/j.1365-2028.1999.00165.x; Bhola N, 2012, BIODIVERS CONSERV, V21, P1509, DOI 10.1007/s10531-012-0261-y; BIGALKE R C, 1972, Zoologica Africana, V7, P333; Boles OJC, 2016, AZANIA, V51, P507, DOI 10.1080/0067270X.2016.1249587; Boone RB, 2007, ENVIRON SCI POLICY, V10, P135, DOI 10.1016/j.envsci.2006.09.006; Boone RB, 2006, HUM ECOL, V34, P809, DOI 10.1007/s10745-006-9031-3; Boone RB, 2006, ECOLOGY, V87, P1987, DOI 10.1890/0012-9658(2006)87[1987:SWMPMF]2.0.CO;2; Galvin Kathleen A., 2008, P255, DOI 10.1007/978-1-4020-4906-4_11; Boult VL, 2019, AFR J ECOL, V57, P10, DOI 10.1111/aje.12553; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Butt B, 2012, PASTORALISM, V2, DOI 10.1186/2041-7136-2-9; Center for International Earth Science Information Network (CIESIN)/Columbia University and ITOS (ITOS)/University of G, 2013, GLOB ROADS OP ACC DA; Chamaille-Jammes S, 2007, J APPL ECOL, V44, P625, DOI 10.1111/j.1365-2664.2007.01300.x; Christensen J.H., 2007, CLIMATE CHANGE 2007; Ciuti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050611; Codling EA, 2012, INTERFACE FOCUS, V2, P144, DOI 10.1098/rsfs.2012.0008; Cornelis D, 2011, J MAMMAL, V92, P1287, DOI 10.1644/10-MAMM-A-397.1; Davidson Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055182; de Boer WF, 2010, J MAMMAL, V91, P1280, DOI 10.1644/09-MAMM-A-392.1; Dwyer MJ, 2008, HUM ECOL, V36, P521, DOI 10.1007/s10745-008-9169-2; Estes R.D., 2012, BEHAV GUIDE AFRICAN; Estes RD, 2006, BIOL CONSERV, V131, P106, DOI 10.1016/j.biocon.2006.02.009; Foufopoulos J, 2003, ADV AGROECOL, P219; Fryxell JM, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0013; Georgiadis NJ, 2007, BIOL CONSERV, V137, P461, DOI 10.1016/j.biocon.2007.03.005; Green DS, 2019, GLOB ECOL CONSERV, V20, DOI 10.1016/j.gecco.2019.e00697; HIRST SM, 1969, J WILDLIFE MANAGE, V33, P40, DOI 10.2307/3799648; Homewood K. M., 1991, Maasailand ecology: pastoralist development and wildlife conservation in Ngorongoro, Tanzania.; IUCN IU for C of N, 1979, BIOSPH RES ITS REL O, P19; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Lee MA, 2021, OECOLOGIA, V195, P213, DOI 10.1007/s00442-020-04824-4; Macandza VA, 2012, J ZOOL, V287, P175, DOI 10.1111/j.1469-7998.2012.00900.x; Maliti H, 2008, RIVERS SMALL DRAINAG; Maliti H., 1996, SERENGETI ECOSYSTEM; Marchand P, 2017, J ANIM ECOL, V86, P371, DOI 10.1111/1365-2656.12616; Markham AC, 2015, P NATL ACAD SCI USA, V112, P14882, DOI 10.1073/pnas.1517794112; McSweeney C, 2010, B AM METEOROL SOC, V91, P157, DOI 10.1175/2009BAMS2826.1; Megaze A, 2018, AFR J ECOL, V56, P12, DOI 10.1111/aje.12411; Melita A. W., 2013, Journal of Service Science and Management, V6, P117, DOI 10.4236/jssm.2013.61012; Miller JR, 2007, RESTOR ECOL, V15, P382, DOI 10.1111/j.1526-100X.2007.00234.x; Moehlman PD, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0212530; NASA J., NASA SHUTTL RAD TOP; Niboye E.P., 2010, OPEN GEOGR J, V3, P15, DOI [DOI 10.2174/1874923201003010015, 10.2174/1874923201003010015]; Odadi WO, 2011, SCIENCE, V334, P594; Odadi WO, 2011, EVOL ECOL RES, V13, P237; Ogutu JO, 2011, J ZOOL, V285, P99, DOI 10.1111/j.1469-7998.2011.00818.x; Ogutu JO, 2014, WILDLIFE RES, V41, P323, DOI 10.1071/WR13211; Ogutu JO, 2010, ECOL MONOGR, V80, P241, DOI 10.1890/09-0439.1; Okello, 2015, NATURAL RESOURCES, V6, P91, DOI [10.7717/peerj.5102, DOI 10.7717/PEERJ.5102]; Pachzelt A, 2013, ECOL MODEL, V263, P92, DOI 10.1016/j.ecolmodel.2013.04.025; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; Pays O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034678; Peters MK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13736; Prins HH, 2000, WILDLIFE CONSERVATIO, P5180; R Core Team, 2021, R LANG ENV STAT; Ratner B., 2010, J TARGETING MEASUREM, V18, P65, DOI DOI 10.1057/JT.2009.26; Reid RS, 2012, SAVANNAS OF OUR BIRTH: PEOPLE, WILDLIFE, AND CHANGE IN EAST AFRICA, P1; Riginos C, 2012, PASTORALISM, V2, DOI 10.1186/2041-7136-2-10; Rudolph K, 2019, BEHAV ECOL SOCIOBIOL, V73, DOI 10.1007/s00265-019-2746-0; Schielzeth H, 2013, METHODS ECOL EVOL, V4, P14, DOI 10.1111/j.2041-210x.2012.00251.x; Schweiger AH, 2019, BIOL REV, V94, P1, DOI 10.1111/brv.12432; Setsaas T, 2018, GLOB ECOL CONSERV, V16, DOI 10.1016/j.gecco.2018.e00467; Shen SF, 2014, AM NAT, V183, P301, DOI 10.1086/674378; Sitters J, 2009, BIOL CONSERV, V142, P738, DOI 10.1016/j.biocon.2008.12.001; Stamps JA, 2007, APPL ANIM BEHAV SCI, V102, P392, DOI 10.1016/j.applanim.2006.05.038; Strandburg-Peshkin A, 2017, ELIFE, V6, DOI 10.7554/eLife.19505; Swanson LA, 2007, NGORONGORO CONSERVAT; TAWIRI, 2016, WILDL LIV BOM CENS, P35; Toit D., 2010, WILD RANGELANDS CONS; UNESCO, 1979, NGOR CONS AR; Valeix M., 2017, MANAGING LIVESTOCK W, P395; van der Waal C, 2011, OECOLOGIA, V165, P1095, DOI 10.1007/s00442-010-1899-3; Veldhuis MP, 2019, ECOL LETT, V22, P1536, DOI 10.1111/ele.13350; Veldhuis MP, 2019, SCIENCE, V363, P1424, DOI 10.1126/science.aav0564; Verweij RJT, 2006, OIKOS, V114, P108, DOI 10.1111/j.2006.0030-1299.14209.x; Voeten MM, 1999, OECOLOGIA, V120, P287, DOI 10.1007/s004420050860; Wang MY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146725; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; WESTERN D, 1979, HUM ECOL, V7, P75, DOI 10.1007/BF00889353; Zuur AF., 2009, MIXED EFFECTS MODELS, P199; Zuur Alain F., 2009, P1	89	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267082	10.1371/journal.pone.0267082	http://dx.doi.org/10.1371/journal.pone.0267082			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7VA	35439256	Green Published, gold			2022-12-26	WOS:000791280100034
J	Nolzen, H; Brugger, K; Reichold, A; Brock, J; Lange, M; Thulke, HH				Nolzen, Henning; Brugger, Katharina; Reichold, Adam; Brock, Jonas; Lange, Martin; Thulke, Hans-Hermann			Model-based extrapolation of ecological systems under future climate scenarios: The example of Ixodes ricinus ticks	PLOS ONE			English	Article							BORNE ENCEPHALITIS; DISEASE VECTOR; ACARI; IXODIDAE; DENSITY; HOMOGENIZATION; PATHOGENS; DYNAMICS; IMPACT; RISK	Models can be applied to extrapolate consequences of climate change for complex ecological systems in the future. The acknowledged systems' behaviour at present is projected into the future considering climate projection data. Such an approach can be used to addresses the future activity and density of the castor bean tick Ixodes ricinus, the most widespread tick species in Europe. It is an important vector of pathogens causing Lyme borreliosis and tick-borne encephalitis. The population dynamics depend on several biotic and abiotic factors. Such complexity makes it difficult to predict the future dynamics and density of I. ricinus and associated health risk for humans. The objective of this study is to force ecological models with high-resolution climate projection data to extrapolate I. ricinus tick density and activity patterns into the future. We used climate projection data of temperature, precipitation, and relative humidity for the period 1971-2099 from 15 different climate models. Tick activity was investigated using a climate-driven cohort-based population model. We simulated the seasonal population dynamics using climate data between 1971 and 2099 and observed weather data since 1949 at a specific location in southern Germany. We evaluated derived quantities of local tick ecology, e.g. the maximum questing activity of the nymphal stage. Furthermore, we predicted spatial density changes by extrapolating a German-wide tick density model. We compared the tick density of the reference period (1971-2000) with the counter-factual densities under the near-term scenario (2012-2041), mid-term scenario (2050-2079) and long-term scenario (2070-2099). We found that the nymphal questing peak would shift towards early seasons of the year. Also, we found high spatial heterogeneity across Germany, with predicted hotspots of up to 2,000 nymphs per 100 m(2) and coldspots with constant density. As our results suggest extreme changes in tick behaviour and density, we discuss why caution is needed when extrapolating climate data-driven models into the distant future when data on future climate drive the model projection.	[Nolzen, Henning; Reichold, Adam; Brock, Jonas; Lange, Martin; Thulke, Hans-Hermann] Helmholtz Ctr Environm Res GmbH UFZ, Dept Ecol Modelling, Leipzig, Germany; [Brugger, Katharina] Univ Vet Med Vienna, Unit Vet Publ Hlth & Epidemiol, Vienna, Austria; [Brugger, Katharina] Austrian Publ Hlth Inst Gesundheit Osterreich, Competence Ctr Climate & Hlth, Vienna, Austria	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Veterinary Medicine Vienna	Nolzen, H (corresponding author), Helmholtz Ctr Environm Res GmbH UFZ, Dept Ecol Modelling, Leipzig, Germany.	henning.nolzen@ufz.de	Nolzen, Henning/P-1701-2016; Thulke, Hans-Hermann/I-6923-2013	Nolzen, Henning/0000-0002-8171-8270; Thulke, Hans-Hermann/0000-0002-7670-2231				Alkishe AA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189092; Bateson P, 2017, INTERFACE FOCUS, V7, DOI 10.1098/rsfs.2016.0126; Boehnke D, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/s12942-015-0015-7; Brownstein JS, 2003, ENVIRON HEALTH PERSP, V111, P1152, DOI 10.1289/ehp.6052; Brugger K, 2018, EXP APPL ACAROL, V75, P281, DOI 10.1007/s10493-018-0267-6; Brugger K, 2017, EXP APPL ACAROL, V73, P439, DOI 10.1007/s10493-017-0197-8; Brugger K, 2016, J MED ENTOMOL, V53, P1292, DOI 10.1093/jme/tjw116; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Colyvan M, 2003, OIKOS, V101, P649, DOI 10.1034/j.1600-0706.2003.12349.x; Costa AC, 2009, MATH GEOSCI, V41, P291, DOI 10.1007/s11004-008-9203-3; Daidzic NE, 2019, INT J AVIAT AERONAUT, V6, DOI 10.15394/ijaaa.2019.1374; Daniel M, 2003, EUR J CLIN MICROBIOL, V22, P327, DOI 10.1007/s10096-003-0918-2; Daniel M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1092-y; Dautel H, 1997, J INSECT PHYSIOL, V43, P843, DOI 10.1016/S0022-1910(97)00025-5; Dietze M. C., 2017, ECOLOGICAL FORECASTI; Dobson ADM, 2011, J APPL ECOL, V48, P1029, DOI 10.1111/j.1365-2664.2011.02004.x; DWD. German Weather Service, 2021, CLIM DAT GERM, DOI [10.1371/journal.pone.0244668, DOI 10.1371/JOURNAL.PONE.0244668]; European Environment Agency, 2013, CORINE LAND COVER 20; Gilbert L, 2010, OECOLOGIA, V162, P217, DOI 10.1007/s00442-009-1430-x; Gray J. S., 1991, Review of Medical and Veterinary Entomology, V79, P323; Gray J S, 2009, Interdiscip Perspect Infect Dis, V2009, P593232, DOI 10.1155/2009/593232; Gray J, 2021, TICKS TICK-BORNE DIS, V12, DOI 10.1016/j.ttbdis.2021.101682; Gray JS, 2016, TICKS TICK-BORNE DIS, V7, P992, DOI 10.1016/j.ttbdis.2016.05.006; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2020, JASSS-J ARTIF SOC S, V23, DOI 10.18564/jasss.4259; Guis H, 2012, J R SOC INTERFACE, V9, P339, DOI 10.1098/rsif.2011.0255; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hijmans R.J., 2021, R PACKAGE VERSION 34; Hijmans R.J., 2020, dismo: Species Distribution Modeling; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hvidsten D, 2020, TICKS TICK-BORNE DIS, V11, DOI 10.1016/j.ttbdis.2020.101388; Jacob D, 2014, REG ENVIRON CHANGE, V14, P563, DOI 10.1007/s10113-013-0499-2; Knap N, 2009, VET PARASITOL, V164, P275, DOI 10.1016/j.vetpar.2009.06.001; Maraun D, 2016, CURR CLIM CHANGE REP, V2, P211, DOI 10.1007/s40641-016-0050-x; Martello E, 2014, TICKS TICK-BORNE DIS, V5, P970, DOI 10.1016/j.ttbdis.2014.07.021; Materna J., 2005, Central European Journal of Public Health, V13, P24; Medlock JM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-1; Naik V., 2021, CLIMATE CHANGE 2021, DOI [10.1038/s41597-021-00916-9, DOI 10.1038/S41597-021-00916-9]; OpenStreetMap, 2018, SRTM DIG TERR MOD GE; Ostfeld RS, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0051; Ostfeld RS., 2020, PLANETARY HLTH PROTE, P141; Pereira Henrique M., 2010, CENTURY SCI, V330, P1496, DOI [10.1126/science.1196624, DOI 10.1126/SCIENCE.1196624]; R Core Team, 2021, R LANG ENV STAT; Randolph SE, 1999, J MED ENTOMOL, V36, P741, DOI 10.1093/jmedent/36.6.741; Randolph SE, 2004, PARASITOLOGY, V129, pS37, DOI 10.1017/S0031182004004925; REW R, 1990, IEEE COMPUT GRAPH, V10, P76, DOI 10.1109/38.56302; Ribeiro S, 2016, PHYS CHEM EARTH, V94, P167, DOI 10.1016/j.pce.2015.08.007; Robert Koch-Institut, 2021, SURVSTAT RKI 2 0; Rubel F, 2021, EXP APPL ACAROL, V84, P183, DOI 10.1007/s10493-021-00619-1; Rudin C, 2019, NAT MACH INTELL, V1, P206, DOI 10.1038/s42256-019-0048-x; Ruiz-Fons F, 2012, APPL ENVIRON MICROB, V78, P2669, DOI 10.1128/AEM.06564-11; Rummukainen M, 2016, WIRES CLIM CHANGE, V7, P145, DOI 10.1002/wcc.378; Tapiador FJ, 2020, ATMOS RES, V235, DOI 10.1016/j.atmosres.2019.104785; Teutschbein C, 2012, J HYDROL, V456, P12, DOI 10.1016/j.jhydrol.2012.05.052; Turchin P, 2001, OIKOS, V94, P17, DOI 10.1034/j.1600-0706.2001.11310.x; Zurell D, 2016, GLOBAL CHANGE BIOL, V22, P2651, DOI 10.1111/gcb.13251	56	1	1	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267196	10.1371/journal.pone.0267196	http://dx.doi.org/10.1371/journal.pone.0267196			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C1KV	35452467	Green Published, gold			2022-12-26	WOS:000792887700007
J	Seyoum, E; Demissie, M; Worku, A; Mulu, A; Abdissa, A; Berhane, Y				Seyoum, Eleni; Demissie, Meaza; Worku, Alemayehu; Mulu, Andargachew; Abdissa, Alemseged; Berhane, Yemane			HIV, hepatitis B virus, and hepatitis C virus co-infection among HIV positives in antiretroviral treatment program in selected hospitals in Addis Ababa: A retrospective cross-sectional study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NATURAL-HISTORY; SERO-PREVALENCE; RISK-FACTORS; SEROPREVALENCE; HBV; INFECTIONS; UNIVERSITY; HCV; INDIVIDUALS	IntroductionHIV co-infection with hepatitis B (HIV-HBV) and hepatitis C (HIV-HCV) is known to affect treatment outcomes of antiretroviral therapy (ART); however, its magnitude is not well documented. We aimed to determine the magnitude of HIV-HBV and HIV-HCV co-infections simultaneously in people living with HIV (PLHIV) enrolled in ART care in Addis Ababa. MethodsWe reviewed the medical records of adults >= 15 years who were receiving ART care in three high burden hospitals in Addis Ababa. Baseline clinical and laboratory test results were extracted from medical records. Co-infection was determined based on hepatitis B surface antigen (HBsAg) and hepatitis C virus antibody (anti-HCV) tests obtained from the medical records. A multivariable logistic regression model was used to identify the risk factors for hepatitis B and C co-infections. ResultsA total of 873 HIV-positive participants were included in this study. The median age of the participants was 37.5 years, and 55.7% were women. Overall, HIV-HBV co-infection was 5.96% (95% CI: 4.56-7.74), and HIV-HCV co-infection was 1.72% (95% CI: 1.03-2.83). The multivariable logistic regression showed that the male sex was the most independent predictor for viral hepatitis B co-infection with an odds ratio of 2.42(95% CI:1.27-4.63). However, HIV-HCV co-infection did not show a significant association in any of the sociodemographic data of the participants. ConclusionHIV co-infection with hepatitis B was moderately high in individuals enrolled in ART care in Addis Ababa. Men had significantly higher HIV-HBV co-infection. HIV co-infection with hepatitis C was relatively low. Strengthening integrated viral hepatitis services with HIV care and treatment services should be emphasized to improve patient care in health facilities.	[Seyoum, Eleni] Univ Gondar, Inst Publ Hlth, Gondar, Ethiopia; [Seyoum, Eleni; Berhane, Yemane] Addis Continental Inst Publ Hlth, Epidemiol & Evaluat Dept, Addis Ababa, Ethiopia; [Demissie, Meaza] Addis Continental Inst Publ Hlth, Publ Hlth Dept, Addis Ababa, Ethiopia; [Worku, Alemayehu] Addis Ababa Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Prevent Med, Addis Ababa, Ethiopia; [Mulu, Andargachew; Abdissa, Alemseged] Armauer Hansen Res Inst, Bacterial & Viral Dis Res Directorate, Addis Ababa, Ethiopia	University of Gondar; Addis Continental Institute of Public Health; Addis Continental Institute of Public Health; Addis Ababa University	Seyoum, E (corresponding author), Univ Gondar, Inst Publ Hlth, Gondar, Ethiopia.; Seyoum, E (corresponding author), Addis Continental Inst Publ Hlth, Epidemiol & Evaluat Dept, Addis Ababa, Ethiopia.	Eleniseyoum45@gmail.com	Mulu, Andargachew/GMW-4823-2022	Mulu, Andargachew/0000-0003-2862-0175; Seyoum, Eleni/0000-0003-1202-6577				Abera B, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0696-6; Alemayehu Addisu, 2011, BMC Res Notes, V4, P193, DOI 10.1186/1756-0500-4-193; Ameha Z, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4727-9; [Anonymous], NATL CONSOLIDATED GU; [Anonymous], ETHIOPIA FINAL REPOR; [Anonymous], HIVAIDS; [Anonymous], 2016, CONSOLIDATED GUIDELI, V2nd; [Anonymous], ADDIS ABABA ETHIOPIA; Archampong TNA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1342-4; Atsbaha Ataklti Hailu, 2016, BMC Res Notes, V9, P121, DOI 10.1186/s13104-016-1936-3; Ayana DA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226922; Ayele W, 2002, J MED VIROL, V68, P12, DOI 10.1002/jmv.10164; Central Statistical Agency, 2017, DEM HLTH SURV 2016; Demissie M, 2018, AJAR-AFR J AIDS RES, V17, P259, DOI 10.2989/16085906.2018.1511604; Deressa T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190149; Eluwa GI, 2013, DRUG ALCOHOL DEPEN, V127, P65, DOI 10.1016/j.drugalcdep.2012.06.013; Ethiopia Public Health Institute, 2019, NAT HIV EST PROJ BAS; Goa A, 2019, HEPATIC MED-EVID RES, V11, P137, DOI 10.2147/HMER.S206870; Lewden C, 2005, INT J EPIDEMIOL, V34, P121, DOI 10.1093/ije/dyh307; Liebert U, 2016, BMC INFECT DIS, P16, DOI [10.1186/s12879-016-1338-0, DOI 10.1186/S12879-016-1338-0]; Manyazewal T, 2014, J MED MICROBIOL, V63, P742, DOI 10.1099/jmm.0.063321-0; Melashu Balew, 2014, Asian Pacific Journal of Tropical Disease, V4, P1; Modi AA, 2007, AIDS REV, V9, P25; Mphahlele J, 2008, S AFR J EPIDEMIOL IN, V23; Ranjbar R, 2011, IRAN RED CRESCENT ME, V13, P855; Rao VB, 2015, LANCET INFECT DIS, V15, P819, DOI 10.1016/S1473-3099(15)00006-7; Shimelis T, 2007, SEX TRANSM INFECT, V84, P37, DOI 10.1136/sti.2007.027326; Sun J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175482; Tessema B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-111; WeldemariamAsbeha, 2017, NAT SER HEP B VIR IN; Weldemhret L, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-016-0090-2; Woldegiorgis AE., 2019, COMMUNITY BASED SERO; Wolff FH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010494; Wondimeneh Y, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-171; World Health Organization, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2017, GLOBAL HEPATITIS REP; Yazie TD, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4486-1; Yemanebrhane N., 2017, J AIDS CLIN RES, V8, P1; Zacharakis GH, 2005, J MED VIROL, V77, P173, DOI 10.1002/jmv.20434	39	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267230	10.1371/journal.pone.0267230	http://dx.doi.org/10.1371/journal.pone.0267230			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C1KV	35452472	gold, Green Published			2022-12-26	WOS:000792887700004
J	Sowa, G; Bednarska, A; Ziolkowska, E; Laskowski, R				Sowa, Grzegorz; Bednarska, Agnieszka; Ziolkowska, Elzbieta; Laskowski, Ryszard			Homogeneity of agriculture landscape promotes insecticide resistance in the ground beetle Poecilus cupreus	PLOS ONE			English	Article							CARABID BEETLES; LAMBDA-CYHALOTHRIN; BIOLOGICAL-CONTROL; COLEOPTERA; PESTICIDES; MANAGEMENT; PREDATORS; FITNESS; REPRODUCTION; BIODIVERSITY	The intensification of agriculture leads to increased pesticide use and significant transformation from small fields towards large-scale monocultures. This may significantly affect populations of non-target arthropods (NTA). We aimed to assess whether the multigenerational exposure to plant protection products has resulted in the evolution of resistance to insecticides in the ground beetle Poecilus cupreus originating from different agricultural landscapes. Two contrasting landscapes were selected for the study, one dominated by small and another by large fields. Within each landscape the beetles were collected at nine sites representing range of canola coverage and a variety of habitat types. Part of the collected beetles, after acclimation to laboratory conditions, were tested for sensitivity to Proteus 110 OD-the most commonly used insecticide in the studied landscapes. The rest were bred in the laboratory for two consecutive generations, and part of the beetles from each generation were also tested for sensitivity to selected insecticide. We showed that the beetles inhabiting areas with medium and large share of canola located in the landscape dominated by large fields were less sensitive to the studied insecticide. The persistence of reduced sensitivity to Proteus 110 OD for two consecutive generations indicates that either the beetles have developed resistance to the insecticide or the chronic exposure to pesticides has led to the selection of more resistant individuals naturally present in the studied populations. No increased resistance was found in the beetles from more heterogeneous landscape dominated by small fields, in which spatio-temporal diversity of crops and abundance of small, linear off-crop landscape elements may provide shelter that allows NTAs to survive without developing any, presumably costly, resistance mechanisms.	[Sowa, Grzegorz; Ziolkowska, Elzbieta; Laskowski, Ryszard] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland; [Bednarska, Agnieszka] Polish Acad Sci, Inst Nat Conservat, Krakow, Poland	Jagiellonian University; Polish Academy of Sciences	Sowa, G (corresponding author), Jagiellonian Univ, Inst Environm Sci, Krakow, Poland.	grzegorz.sowa@uj.edu.pl	Laskowski, Ryszard/Q-1505-2019; Bednarska, Agnieszka/C-6856-2015	Laskowski, Ryszard/0000-0002-1968-3230; Sowa, Grzegorz/0000-0001-7855-0545; Bednarska, Agnieszka/0000-0002-1030-3414	National Science Centre, Poland [2016/23/N/NZ8/01679]; Jagiellonian University in Krakow [DS/WBiNoZ/INoS/759/2018]	National Science Centre, Poland(National Science Centre, Poland); Jagiellonian University in Krakow	GS is the author who received each grant. The study was supported by the National Science Centre (https://www.ncn.gov.pl/?language=en), Poland, project Preludium 2016/23/N/NZ8/01679 and Jagiellonian University (https://en.uj.edu.pl/en) in Krako ' w (DS/WBiNoZ/INoS/759/2018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alyokhin A, 2008, AM J POTATO RES, V85, P395, DOI 10.1007/s12230-008-9052-0; Barone M, 2003, OECOLOGIA, V135, P78, DOI 10.1007/s00442-002-1175-2; Bednarska AJ, 2008, ECOTOXICOLOGY, V17, P189, DOI 10.1007/s10646-007-0183-8; BOS M, 1974, GENETICA, V45, P71, DOI 10.1007/BF01508933; Coustau C, 2000, TRENDS ECOL EVOL, V15, P378, DOI 10.1016/S0169-5347(00)01929-7; COX DR, 1972, J R STAT SOC B, V34, P187; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Eurostat, 2019, AGR FOR FISH STAT; Firle S, 1998, ECOLOGY, V79, P2113, DOI 10.1890/0012-9658(1998)079[2113:TIOMAR]2.0.CO;2; Fusser MS, 2016, AGR ECOSYST ENVIRON, V226, P79, DOI 10.1016/j.agee.2016.04.007; Geiger F, 2010, BASIC APPL ECOL, V11, P97, DOI 10.1016/j.baae.2009.12.001; HARRIS CR, 1972, ANNU REV ENTOMOL, V17, P177, DOI 10.1146/annurev.en.17.010172.001141; Hatten TD, 2007, ENVIRON ENTOMOL, V36, P356, DOI 10.1603/0046-225X(2007)36[356:EOTOTA]2.0.CO;2; Hof AR, 2010, AGR ECOSYST ENVIRON, V139, P280, DOI 10.1016/j.agee.2010.08.014; Holland JM, 2016, PEST MANAG SCI, V72, P1638, DOI 10.1002/ps.4318; Jin M, 2017, ENVIRON POLLUT, V222, P109, DOI 10.1016/j.envpol.2016.12.075; Kliot A, 2012, PEST MANAG SCI, V68, P1431, DOI 10.1002/ps.3395; Kulkarni SS, 2015, WEED SCI, V63, P355, DOI 10.1614/WS-D-14-00067.1; Lagisz M, 2008, ECOTOXICOLOGY, V17, P59, DOI 10.1007/s10646-007-0176-7; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Langmaack M, 2001, J APPL ENTOMOL, V125, P313, DOI 10.1046/j.1439-0418.2001.00531.x; Lee JC, 2001, J APPL ECOL, V38, P472, DOI 10.1046/j.1365-2664.2001.00602.x; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Lovei GL, 1996, ANNU REV ENTOMOL, V41, P231, DOI 10.1146/annurev.en.41.010196.001311; MacLeod A, 2004, AGR FOREST ENTOMOL, V6, P147, DOI 10.1111/j.1461-9563.2004.00215.x; Maisonhaute JE, 2010, AGR ECOSYST ENVIRON, V139, P500, DOI 10.1016/j.agee.2010.09.008; Marrec R, 2015, AGR ECOSYST ENVIRON, V199, P282, DOI 10.1016/j.agee.2014.10.005; METCALF RL, 1989, PESTIC SCI, V26, P333, DOI 10.1002/ps.2780260403; MILLER PS, 1993, ZOO BIOL, V12, P333, DOI 10.1002/zoo.1430120404; Mkenda PA, 2019, PEERJ, V7, DOI 10.7717/peerj.8091; Mota-Sanchez D., 2021, ARTHROPOD PESTICIDE; Mullin CA, 2015, PESTIC BIOCHEM PHYS, V120, P27, DOI 10.1016/j.pestbp.2014.12.026; Pathan AK, 2010, J ECON ENTOMOL, V103, P823, DOI 10.1603/EC09260; Purtauf T, 2005, AGR ECOSYST ENVIRON, V108, P165, DOI 10.1016/j.agee.2005.01.005; Richardson D. M., 2008, Bulletin OEPP, V38, P68, DOI 10.1111/j.1365-2338.2008.01183.x; Riddick EW, 2009, BIOCONTROL, V54, P325, DOI 10.1007/s10526-008-9171-z; Riggi LGA, 2016, PEST MANAG SCI, V72, P780, DOI 10.1002/ps.4052; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Rodrigues ARS, 2013, ECOTOX ENVIRON SAFE, V96, P53, DOI 10.1016/j.ecoenv.2013.06.014; ROPER C, 1993, EVOLUTION, V47, P445, DOI 10.1111/j.1558-5646.1993.tb02105.x; SCHOONEES J, 1982, J ENTOMOL SOC S AFR, V45, P261; Seibold S, 2019, NATURE, V574, P671, DOI 10.1038/s41586-019-1684-3; Shahrestani P, 2012, REJUV RES, V15, P49, DOI 10.1089/rej.2011.1201; SIBLY RM, 1989, BIOL J LINN SOC, V37, P101, DOI 10.1111/j.1095-8312.1989.tb02007.x; Simoncini R, 2019, LAND USE POLICY, V88, DOI 10.1016/j.landusepol.2019.104099; Stone D, 2001, ENVIRON POLLUT, V113, P239, DOI 10.1016/S0269-7491(00)00134-2; Symondson WOC, 2002, ANNU REV ENTOMOL, V47, P561, DOI 10.1146/annurev.ento.47.091201.145240; Szyga-Pluta K., 2018, PRZEGLAD GEOGRAFICZN, V90, P495, DOI [10.7163/PrzG.2018.3.5, DOI 10.7163/PRZG.2018.3.5]; Thiele H, 1977, CARABID BEETLES THEI; Thorbek P, 2004, J APPL ECOL, V41, P526, DOI 10.1111/j.0021-8901.2004.00913.x; Torres JB, 2015, J ECON ENTOMOL, V108, P60, DOI 10.1093/jee/tou035; Van Toor R. F., 2006, New Zealand Plant Protection, V59, P208; WALLIN H, 1985, PEDOBIOLOGIA, V28, P19; Willis CE, 2020, CROP PROT, V138, DOI 10.1016/j.cropro.2020.105316; Wo A., 1994, ATLAS REPUBLIC POLAN; Ziolkowska E, 2021, SCI TOTAL ENVIRON, V774, DOI 10.1016/j.scitotenv.2021.145746	57	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266453	10.1371/journal.pone.0266453	http://dx.doi.org/10.1371/journal.pone.0266453			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35472211	gold, Green Published			2022-12-26	WOS:000816171900025
J	Wiggen, TD; Bohn, B; Ulrich, AK; Stovitz, SD; Strickland, AJ; Naumchik, BM; Walsh, S; Smith, S; Baumgartner, B; Kline, S; Yendell, S; Hedberg, C; Beebe, TJ; Demmer, RT				Wiggen, Talia D.; Bohn, Bruno; Ulrich, Angela K.; Stovitz, Steven D.; Strickland, Ali J.; Naumchik, Brianna M.; Walsh, Sara; Smith, Stephen; Baumgartner, Brett; Kline, Susan; Yendell, Stephanie; Hedberg, Craig; Beebe, Timothy J.; Demmer, Ryan T.			SARS-CoV-2 seroprevalence among healthcare workers	PLOS ONE			English	Article							PERSONNEL	BackgroundMonitoring COVID-19 infection risk among health care workers (HCWs) is a public health priority. We examined the seroprevalence of SARS-CoV-2 among HCWs following the fall infection surge in Minnesota, and before and after COVID-19 vaccination. Additionally, we assessed demographic and occupational risk factors for SARS-CoV-2 infection. MethodsWe conducted two rounds of seroprevalence testing among a cohort of HCWs: samples in round 1 were collected from 11/22/20-02/21/21 and in round 2 from 12/18/20-02/15/21. Demographic and occupational exposures assessed with logistic regression were age, sex, healthcare role and setting, and number of children in the household. The primary outcome was SARS-CoV-2 IgG seropositivity. A secondary outcome, SARS-CoV-2 infection, included both seropositivity and self-reported SARS-CoV-2 test positivity. ResultsIn total, 459 HCWs were tested. 43/454 (9.47%) had a seropositive sample 1 and 75/423 (17.7%) had a seropositive sample 2. By time of sample 2 collection, 54% of participants had received at least one vaccine dose and seroprevalence was 13% among unvaccinated individuals. Relative to physicians, the odds of SARS-CoV-2 infection in other roles were increased (Nurse Practitioner: OR[95%CI] 1.93[0.57,6.53], Physician's Assistant: 1.69[0.38,7.52], Nurse: 2.33[0.94,5.78], Paramedic/EMTs: 3.86[0.78,19.0], other: 1.68[0.58,4.85]). The workplace setting was associated with SARS-CoV-2 infection (p = 0.04). SARS-CoV-2 seroprevalence among HCWs reporting duties in the ICU vs. those working in an ambulatory clinic was elevated: OR[95%CI] 2.17[1.01,4.68]. ConclusionsSARS-CoV-2 seroprevalence in HCW increased during our study period which was consistent with community infection rates. HCW role and setting-particularly working in the ICU-is associated with higher risk for SARS-CoV-2 infection.	[Wiggen, Talia D.; Bohn, Bruno; Demmer, Ryan T.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Ulrich, Angela K.] Univ Minnesota, Ctr Infect Dis Res & Policy, Minneapolis, MN USA; [Ulrich, Angela K.; Strickland, Ali J.; Hedberg, Craig] Univ Minnesota, Sch Publ Hlth, Div Environm Hlth Sci, Minneapolis, MN USA; [Stovitz, Steven D.] Univ Minnesota, Med Sch, Dept Family Med & Community Hlth, Minneapolis, MN USA; [Naumchik, Brianna M.] Univ Minnesota, Med Sch, Minneapolis, MN USA; [Walsh, Sara; Smith, Stephen] Univ Chicago, NORC Hlth Sci, Chicago, IL USA; [Baumgartner, Brett] Quansys Biosci, Logan, UT USA; [Kline, Susan] Univ Minnesota, Med Sch, Div Infect Dis & Int Med, Minneapolis, MN USA; [Yendell, Stephanie] Minnesota Dept Hlth, St Paul, MN USA; [Beebe, Timothy J.] Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Minneapolis, MN USA; [Demmer, Ryan T.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Chicago; University of Minnesota System; University of Minnesota Twin Cities; Minnesota Department of Health (MHD); University of Minnesota System; University of Minnesota Twin Cities; Columbia University	Demmer, RT (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA.; Demmer, RT (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA.	demm0009@gmail.com	Stovitz, Steven/K-6329-2019	Bohn, Bruno/0000-0001-8961-6968; Demmer, Ryan/0000-0003-3429-0379; Stovitz, Steven/0000-0002-4168-9823	Minnesota Department of Health [183558]; University of Minnesota Office of the Vice President for Research, the Minnesota Population Center (Eunice Kennedy Shriver National Institute of Child Health and Human Development Population Research Infrastructure Program) [P2C HD041023]; NIH [T32AI05543315]; University of Minnesota's NIH Clinical and Translational Science Award [UL1TR002494]	Minnesota Department of Health; University of Minnesota Office of the Vice President for Research, the Minnesota Population Center (Eunice Kennedy Shriver National Institute of Child Health and Human Development Population Research Infrastructure Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota's NIH Clinical and Translational Science Award	This study was supported by funding from the Minnesota Department of Health Contract Number 183558. Funding to establish the cohort was provided by The University of Minnesota Office of the Vice President for Research, the Minnesota Population Center (funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development Population Research Infrastructure Program P2C HD041023), and by The University of Minnesota's NIH Clinical and Translational Science Award: UL1TR002494. Dr. Ulrich was supported by NIH grant T32AI05543315. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A.Brooks, 2020, medRxiv, DOI 10.1101/2020.04.20.20072470; [Anonymous], 2020, SARS COV 2 HUMAN IGG; [Anonymous], 2021, CDC COVID DATA TRACK; [Anonymous], 2021, SITUATION UPDATE COV; Baker Julia M, 2021, Ann Intern Med, V174, P649, DOI [10.7326/M20-7145, 10.1101/2020.10.30.20222877]; Garcia-Basteiro AL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17318-x; Hughes MM, 2020, MMWR-MORBID MORTAL W, V69, P1364, DOI 10.15585/mmwr.mm6938a3; Jacob JT, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.1283; Korth J, 2020, J CLIN VIROL, V128, DOI 10.1016/j.jcv.2020.104437; Martin CA, 2022, J PUBLIC HEALTH-UK, V44, P234, DOI 10.1093/pubmed/fdaa199; Moscola J, 2020, JAMA-J AM MED ASSOC, V324, P893, DOI 10.1001/jama.2020.14765; Nguyen Long H, 2020, Lancet Public Health, V5, pe475, DOI [10.1101/2020.04.29.20084111, 10.1016/S2468-2667(20)30164-X]; Rosser JI, 2021, INFECT CONT HOSP EP, V42, P1053, DOI 10.1017/ice.2020.1358; Sempos CT, 2021, AM J EPIDEMIOL, V190, P109, DOI 10.1093/aje/kwaa174; Shields A, 2020, THORAX, V75, P1089, DOI 10.1136/thoraxjnl-2020-215414; Sims MD, 2021, CLIN INFECT DIS, V73, pS154, DOI 10.1093/cid/ciaa1684; Steensels D, 2020, JAMA-J AM MED ASSOC, V324, P195, DOI 10.1001/jama.2020.11160; Venugopal U, 2021, INT J INFECT DIS, V102, P63, DOI 10.1016/j.ijid.2020.10.036; Walsh EE, 2020, NEW ENGL J MED, V383, P2439, DOI 10.1056/NEJMoa2027906; Xu X, 2020, NAT MED, V26, P1494, DOI 10.1038/s41591-020-1058-2	20	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266410	10.1371/journal.pone.0266410	http://dx.doi.org/10.1371/journal.pone.0266410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D9PO	35468153	gold, Green Published, Green Submitted			2022-12-26	WOS:000794129600022
J	Butrin, A; Butrin, A; Wawrzak, Z; Moran, GR; Liu, DL				Butrin, Arseniy; Butrin, Anastassiya; Wawrzak, Zdzislaw; Moran, Graham R.; Liu, Dali			Determination of the pH dependence, substrate specificity, and turnovers of alternative substrates for human ornithine aminotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISM-BASED INACTIVATOR; HEPATOCELLULAR-CARCINOMA; IN-VITRO; CRYSTAL-STRUCTURE; GYRATE ATROPHY; LIVER; ACID; RAT; ASSOCIATION; MANAGEMENT	Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver and occurs predominantly in patients with underlying chronic liver diseases. Over the past decade, human ornithine aminotransferase (hOAT), which is an enzyme that catalyzes the metabolic conversion of ornithine into an intermediate for proline or glutamate synthesis, has been found to be overexpressed in HCC cells. hOAT has since emerged as a promising target for novel anticancer therapies, especially for the ongoing rational design effort to discover mechanism-based inactivators (MBIs). Despite the significance of hOAT in human metabolism and its clinical potential as a drug target against HCC, there are significant knowledge deficits with regard to its catalytic mechanism and structural characteristics. Ongoing MBI design efforts require in-depth knowledge of the enzyme active site, in particular, pKa values of potential nucleophiles and residues necessary for the molecular recognition of ligands. Here, we conducted a study detailing the fundamental active-site properties of hOAT using stopped-flow spectrophotometry and X-ray crystallography. Our results quantitatively revealed the pH dependence of the multistep reaction mechanism and illuminated the roles of ornithine alpha-amino and delta-amino groups in substrate recognition and in facilitating catalytic turnover. These findings provided insights of the catalytic mechanism that could benefit the rational design of MBIs against hOAT. In addition, substrate recognition and turnover of several fragment-sized alternative substrates of hOATs, which could serve as structural templates for MBI design, were also elucidated.	[Butrin, Arseniy; Butrin, Anastassiya; Moran, Graham R.; Liu, Dali] Loyola Univ, Dept Chem & Biochem, Chicago, IL 60611 USA; [Wawrzak, Zdzislaw] Northwestern Univ, Synchrotron Res Ctr, Life Sci Collaborat Access Team, Argonne, IL USA	Loyola University Chicago; Northwestern University	Moran, GR; Liu, DL (corresponding author), Loyola Univ, Dept Chem & Biochem, Chicago, IL 60611 USA.	gmoran3@luc.edu; dliu@luc.edu	Liu, Dali/D-2571-2014	Liu, Dali/0000-0002-7587-703X	National Institutes of Health; National Cancer Institute [1R01CA260250-01]; Arthur J. Schmitt Foundation; Loyola University College of Arts and Sciences; National Science Foundation [1904480]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Arthur J. Schmitt Foundation; Loyola University College of Arts and Sciences; National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Institutes of Health, National Cancer Institute grant 1R01CA260250-01 (to D. L.), funding from the Arthur J. Schmitt Foundation (to A. B.), and funds from the Loyola University College of Arts and Sciences and National Science Foundation grant 1904480 (to G. R. M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Butrin A, 2021, ACS CHEM BIOL, V16, P67, DOI 10.1021/acschembio.0c00728; Cadoret A, 2002, ONCOGENE, V21, P8293, DOI 10.1038/sj.onc.1206118; Colnot S, 2004, P NATL ACAD SCI USA, V101, P17216, DOI 10.1073/pnas.0404761101; de Rosamel L, 2017, EXPERT OPIN EMERG DR, V22, P175, DOI 10.1080/14728214.2017.1336538; Dreffs A, 2018, CURR EYE RES, V43, P902, DOI 10.1080/02713683.2018.1458882; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fallingborg J, 1999, DAN MED BULL, V46, P183; Ginguay A, 2017, BIOLOGY-BASEL, V6, DOI 10.3390/biology6010018; Hamm LL, 2015, CLIN J AM SOC NEPHRO, V10, P2232, DOI 10.2215/CJN.07400715; Hao GY, 2018, RSC ADV, V8, P22182, DOI 10.1039/c8ra02095g; Hayashi H, 1997, BIOCHEMISTRY-US, V36, P13558, DOI 10.1021/bi971638z; Hennig M., 1994, ADV LIF SCI-SERIES, V1st, P29; HERZFELD A, 1968, J BIOL CHEM, V243, P3327; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; Kohler ES, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-107; Leathers JS, 2019, J CLIN GASTROENTEROL, V53, P464, DOI 10.1097/MCG.0000000000001085; Lide D.R., 2005, CRC HDB CHEM PHYS IN; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Markova M, 2005, J BIOL CHEM, V280, P36409, DOI 10.1074/jbc.M506977200; Mascarenhas R, 2017, BIOCHEMISTRY-US, V56, P4951, DOI 10.1021/acs.biochem.7b00499; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Milgrom DP, 2016, CURR SURG REP, V4, DOI 10.1007/s40137-016-0143-4; MITCHELL GA, 1989, P NATL ACAD SCI USA, V86, P197, DOI 10.1073/pnas.86.1.197; Montioli R, 2021, BBA-PROTEINS PROTEOM, V1869, DOI 10.1016/j.bbapap.2020.140555; Moschitto MJ, 2019, J AM CHEM SOC, V141, P10711, DOI 10.1021/jacs.9b03254; MUECKLER MM, 1982, J BIOL CHEM, V257, P7178; PARK R, 1979, AM J PHYSIOL, V236, pF240, DOI 10.1152/ajprenal.1979.236.3.F240; PERAINO C, 1963, BIOCHIM BIOPHYS ACTA, V73, P222; PERAINO C, 1972, BIOCHIM BIOPHYS ACTA, V289, P117, DOI 10.1016/0005-2744(72)90114-3; Personeni N, 2017, J ONCOL PRACT, V13, P368, DOI 10.1200/JOP.2017.024604; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RAMESH V, 1991, MOL BIOL MED, V8, P81; de Lope CR, 2012, J HEPATOL, V56, pS75, DOI 10.1016/S0168-8278(12)60009-9; Rothman SC, 2003, J MOL BIOL, V327, P593, DOI 10.1016/S0022-2836(03)00095-0; Sayiner M, 2019, DIGEST DIS SCI, V64, P910, DOI 10.1007/s10620-019-05537-2; Schiroli D, 2015, BBA-PROTEINS PROTEOM, V1854, P1200, DOI 10.1016/j.bbapap.2015.02.023; Shen BW, 1998, J MOL BIOL, V277, P81, DOI 10.1006/jmbi.1997.1583; Shen SD, 2021, J AM CHEM SOC, V143, P8689, DOI 10.1021/jacs.1c02456; Sherman M, 2012, HEPATOLOGY, V56, P793, DOI 10.1002/hep.25869; Shirmanova MV, 2015, BBA-GEN SUBJECTS, V1850, P1905, DOI 10.1016/j.bbagen.2015.05.001; Storici P, 1999, J MOL BIOL, V285, P297, DOI 10.1006/jmbi.1998.2289; Tomlinson C, 2011, PEDIATR RES, V69, P46, DOI 10.1203/PDR.0b013e3181fc6ab7; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; WANG T, 1995, NAT GENET, V11, P185, DOI 10.1038/ng1095-185; WILLIAMS JA, 1982, BIOCHEM J, V201, P221, DOI 10.1042/bj2010221; Wu GY, 2004, J NUTR, V134, p2783S, DOI 10.1093/jn/134.10.2783S; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Zhu W, 2021, J AM CHEM SOC, V143, P8193, DOI 10.1021/jacs.1c03572; Zhu W, 2020, J AM CHEM SOC, V142, P4892, DOI 10.1021/jacs.0c00193; Zigmond E, 2015, ACS MED CHEM LETT, V6, P840, DOI 10.1021/acsmedchemlett.5b00153	52	1	1	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101969	10.1016/j.jbc.2022.101969	http://dx.doi.org/10.1016/j.jbc.2022.101969			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9FR	35460691	gold, Green Published			2022-12-26	WOS:000807755100010
J	Stephan, G; Frenster, JD; Liebscher, I; Placantonakis, DG				Stephan, Gabriele; Frenster, Joshua D.; Liebscher, Ines; Placantonakis, Dimitris G.			Activation of the adhesion G protein-coupled receptor GPR133 by antibodies targeting its N-terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGONIST; GPCRS; EXPOSURE; DOMAIN	We recently demonstrated that GPR133 (ADGRD1), an adhesion G protein-coupled receptor involved in raising cytosolic cAMP levels, is necessary for growth of glioblastoma (GBM) and is de novo expressed in GBM relative to normal brain tissue. Our previous work suggested that dissociation of autoproteolytically generated N-terminal and C-terminal fragments of GPR133 at the plasma membrane correlates with receptor activation and signaling. To promote the goal of developing biologics that modulate GPR133 function, we investigated the effects of antibodies against the N-terminus of GPR133 on receptor signaling. Here, we show that treatment of HEK293T cells overexpressing GPR133 with these antibodies increased cAMP levels in a concentration-dependent manner. Analysis of culture medium following antibody treatment further indicated the presence of complexes of these antibodies with the autoproteolytically cleaved N-terminal fragments of GPR133. In addition, cells expressing a cleavage-deficient mutant of GPR133 (H543R) did not respond to antibody stimulation, suggesting that the effect is cleavage dependent. Finally, we demonstrate the antibody-mediated stimulation of WT GPR133, but not the cleavage-deficient H543R mutant, was reproducible in patient-derived GBM cells. These findings provide a paradigm for modulation of GPR133 function with biologics and support the hypothesis that the intramolecular cleavage in the N-terminus modulates receptor activation and signaling.	[Stephan, Gabriele; Frenster, Joshua D.; Placantonakis, Dimitris G.] NYU Grossman Sch Med, Dept Neurosurg, New York, NY 10016 USA; [Liebscher, Ines] Univ Leipzig, Inst Biochem, Rudolf Schonheimer Mol Biochem, Leipzig, Germany; [Placantonakis, Dimitris G.] NYU Grossman Sch Med, Kimmel Ctr Stem Cell Biol, New York, NY 10016 USA; [Placantonakis, Dimitris G.] NYU Grossman Sch Med, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA; [Placantonakis, Dimitris G.] NYU Grossman Sch Med, Brain & Spine Tumor Ctr, New York, NY 10016 USA; [Placantonakis, Dimitris G.] NYU Grossman Sch Med, Neurosci Inst, New York, NY 10016 USA	Leipzig University	Placantonakis, DG (corresponding author), NYU Grossman Sch Med, Dept Neurosurg, New York, NY 10016 USA.; Placantonakis, DG (corresponding author), NYU Grossman Sch Med, Kimmel Ctr Stem Cell Biol, New York, NY 10016 USA.; Placantonakis, DG (corresponding author), NYU Grossman Sch Med, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA.; Placantonakis, DG (corresponding author), NYU Grossman Sch Med, Brain & Spine Tumor Ctr, New York, NY 10016 USA.; Placantonakis, DG (corresponding author), NYU Grossman Sch Med, Neurosci Inst, New York, NY 10016 USA.	dimitris.placantonakis@nyulangone.org		Frenster, Joshua/0000-0003-2401-1575	NIH/NINDS, United States [R01 NS102665]; NYSTEM, United States (NY State Stem Cell Science) [IIRP C32595GG]; NIH/NIBIB, United States [R01 EB028774]; NIH/NCI, United States [R21CA263402]; NIH/NCATS, United States [2UL1TR001445]; NYU Grossman School of Medicine, United States; DFG (German Research Foundation) , Germany [STE 2843/1-1]; German Research Foundation; European Union, European Union (European Social Fund, European Union);  [209933838];  [421152132 B05];  [246212759]	NIH/NINDS, United States; NYSTEM, United States (NY State Stem Cell Science); NIH/NIBIB, United States; NIH/NCI, United States; NIH/NCATS, United States; NYU Grossman School of Medicine, United States; DFG (German Research Foundation) , Germany(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG)); European Union, European Union (European Social Fund, European Union); ; ; 	This study was supported by NIH/NINDS, United States R01 NS102665 and NYSTEM, United States (NY State Stem Cell Science) IIRP C32595GG to D. G. P. D. G. P was also supported by NIH/NIBIB, United States R01 EB028774, NIH/NCI, United States R21CA263402, NIH/NCATS, United States 2UL1TR001445, NYU Grossman School of Medicine, United States, and DFG (German Research Foundation) , Germany FOR2149. G. S. was supported by a DFG postdoctoral fellowship (STE 2843/1-1) . I. L. was funded by the German Research Foundation (CRC1052 project number 209933838, CRC1423 project number 421152132 B05, FOR2149 project number 246212759, P5) and the European Union, European Union (European Social Fund, European Union) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Bayin NS, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.63; Beliu G, 2021, MOL CELL, V81, P905, DOI 10.1016/j.molcel.2020.12.042; Bhudia N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57989-6; Bianchi E, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21512-w; Bohnekamp J, 2011, J BIOL CHEM, V286, P41912, DOI 10.1074/jbc.C111.265934; de Groot DM, 2009, J IMMUNOL, V183, P4127, DOI 10.4049/jimmunol.0901253; Demberg LM, 2017, J BIOL CHEM, V292, P4383, DOI 10.1074/jbc.M116.763656; Demberg LM, 2015, BIOCHEM BIOPH RES CO, V464, P743, DOI 10.1016/j.bbrc.2015.07.020; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Favara DM, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85408-x; Fischer L, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2937-2; Frenster J. D., 2020, NEUROONCOL ADV, V2; Frenster JD, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100798; Frenster JD, 2018, METHODS MOL BIOL, V1741, P63, DOI 10.1007/978-1-4939-7659-1_4; Frenster JD, 2017, NEUROSURGERY, V64, P177, DOI 10.1093/neuros/nyx227; Gad AA, 2020, ACS PHARMACOL TRANSL, V3, P29, DOI 10.1021/acsptsci.9b00093; Gupte J, 2012, FEBS LETT, V586, P1214, DOI 10.1016/j.febslet.2012.03.014; Hamann J, 2015, PHARMACOL REV, V67, P338, DOI 10.1124/pr.114.009647; Hayflick JS, 2000, J RECEPT SIGNAL TR R, V20, P119, DOI 10.3109/10799890009150640; Kaczmarek I, 2022, BIOL CHEM, V403, P195, DOI 10.1515/hsz-2021-0146; Kishore A, 2016, J BIOL CHEM, V291, P3385, DOI 10.1074/jbc.M115.689349; Krishnan A, 2016, HANDB EXP PHARMACOL, V234, P15, DOI 10.1007/978-3-319-41523-9_2; Langenhan T, 2020, BASIC CLIN PHARMACOL, V126, P5, DOI 10.1111/bcpt.13223; Liebscher I, 2015, CELL REP, V10, P1021, DOI 10.1016/j.celrep.2015.01.065; Monk KR, 2015, MOL PHARMACOL, V88, P617, DOI 10.1124/mol.115.098749; Muller A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005624; Petersen SC, 2015, NEURON, V85, P755, DOI 10.1016/j.neuron.2014.12.057; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Salzman GS, 2017, P NATL ACAD SCI USA, V114, P10095, DOI 10.1073/pnas.1708810114; Scholz N, 2019, ANN NY ACAD SCI, V1456, P80, DOI 10.1111/nyas.14192; Scholz N, 2017, ELIFE, V6, DOI 10.7554/eLife.28360; Stephan G., 2021, NEUROONCOL ADV, V3; Stoveken HM, 2015, P NATL ACAD SCI USA, V112, P6194, DOI 10.1073/pnas.1421785112; Vizurraga A, 2020, J BIOL CHEM, V295, P14065, DOI 10.1074/jbc.REV120.007423; Wilde C, 2016, FASEB J, V30, P666, DOI 10.1096/fj.15-276220	36	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101949	10.1016/j.jbc.2022.101949	http://dx.doi.org/10.1016/j.jbc.2022.101949			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9OQ	35447113	Green Published, gold			2022-12-26	WOS:000807778400001
J	Alqarni, T; Alghamdi, A; Alzahrani, A; Abumelha, K; Alqurashi, Z; Alsaleh, A				Alqarni, Turki; Alghamdi, Abdulrahman; Alzahrani, Alhussain; Abumelha, Khalid; Alqurashi, Zahid; Alsaleh, Ahmad			Prevalence of stress, burnout, and job satisfaction among mental healthcare professionals in Jeddah, Saudi Arabia	PLOS ONE			English	Article							REDUCE BURNOUT; NURSES; PHYSICIANS; WORKING; RESIDENTS	Objective To assess the levels of stress, burnout, and job satisfaction among mental healthcare professionals in Jeddah City, Saudi Arabia. Methods A cross-sectional study was conducted on mental healthcare professionals in Jeddah between January 2017 and October 2018. Sociodemographic characteristics and levels of stress, burnout, and job satisfaction were assessed using the Perceived Stress Scale-14 (PSS-14), Maslach Burnout Inventory (MBI), and Job Satisfaction Scale (JSS). Descriptive statistics were used. Independent sample t-test, one-way ANOVA, Mann-Whitney, and Kruskal-Wallis tests were conducted to assess for effects of demographic variables on the perceived stress score, emotional exhaustion (EE) score, depersonalization (DP) score, professional accomplishment (PA) score, and the job satisfaction score (JSS). Results A total of 107 participants were included (50.5% men; 49.5% women) with response rate of 79.2%. Prevalence of stress was 56.1%. High levels of emotional exhaustion and depersonalization were present among 41 (38.3%) and 26 (24.3%) of the respondents, respectively, while high score of low personal accomplishment were present among 61 (57%) respondents. In terms of job satisfaction, 25 (23.4%) were satisfied and 74 (69.2%) were indecisive. Male participants' emotional exhaustion score (2712) was significantly higher than females (22 +/- 10), (t(105) = 1.99, p-value = 0.049). Also, participants with a monthly income above SR 20,000 had significantly higher total job satisfaction (p-value = 0.041). Conclusions Our findings suggest rates of stress and burnout among mental health professionals that warrant attention, with less than one-quarter of the participants being satisfied with their jobs. Further studies are needed to expand the findings and to explore the contributing factors. Additionally, interventions should be established by authorities to address the increasing rates of stress and burnout.	[Alqarni, Turki; Alghamdi, Abdulrahman; Alzahrani, Alhussain; Alsaleh, Ahmad] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Jeddah, Saudi Arabia; [Alqarni, Turki; Alghamdi, Abdulrahman; Alzahrani, Alhussain; Alsaleh, Ahmad] King Abdullah Int Med Res Ctr, Jeddah, Saudi Arabia; [Alghamdi, Abdulrahman] Minist Natl Guard Hlth Affairs, King Abdulaziz Med City, Dept Med, Psychiat Sect, Jeddah, Saudi Arabia; [Alzahrani, Alhussain] Minist Natl Guard Hlth Affairs, King Abdulaziz Med City, Dept Family Med, Jeddah, Saudi Arabia; [Abumelha, Khalid] King Faisal Specialist Hosp & Res Ctr, Dept Med, Jeddah, Saudi Arabia; [Alqurashi, Zahid] Minist Def, King Fahad Armed Forces Hosp, Dept Psychiat, Jeddah, Saudi Arabia	King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Jeddah; Ministry of National Guard - Health Affairs; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Jeddah; Ministry of National Guard - Health Affairs; King Faisal Specialist Hospital & Research Center; King Fahd Armed Forces Hospital	Alghamdi, A (corresponding author), King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Jeddah, Saudi Arabia.; Alghamdi, A (corresponding author), King Abdullah Int Med Res Ctr, Jeddah, Saudi Arabia.; Alghamdi, A (corresponding author), Minist Natl Guard Hlth Affairs, King Abdulaziz Med City, Dept Med, Psychiat Sect, Jeddah, Saudi Arabia.	Abdurrahman.essa@gmail.com						Aldrees T, 2015, ANN SAUDI MED, V35, P210, DOI 10.5144/0256-4947.2015.210; Alosaimi FD, 2015, SAUDI MED J, V36, P605, DOI 10.15537/smj.2015.5.10814; Alosaimi FD, 2018, ANN SAUDI MED, V38, P214, DOI 10.5144/0256-4947.2018.214; Alsulimani LK, 2021, SAUDI MED J, V42, P306, DOI 10.15537/smj.2021.42.3.20200812; Blau G, 2013, PSYCHIATR REHABIL J, V36, P166, DOI 10.1037/prj0000007; Chan MK, 2019, INT J MED EDUC, V10, P149, DOI 10.5116/ijme.5d21.b621; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Corrigan PW, 1997, PSYCHIATR SERV, V48, P1336; Ewers P, 2002, J ADV NURS, V37, P470, DOI 10.1046/j.1365-2648.2002.02115.x; Fagin L, 1996, INT J SOC PSYCHIATR, V42, P102, DOI 10.1177/002076409604200204; Hamaideh Shaher H, 2011, Issues Ment Health Nurs, V32, P234, DOI 10.3109/01612840.2010.546494; Han S, 2019, ANN INTERN MED, V170, P784, DOI 10.7326/M18-1422; Imai H, 2004, OCCUP ENVIRON MED, V61, P764, DOI 10.1136/oem.2003.009134; Leigh JP, 2002, ARCH INTERN MED, V162, P1577, DOI 10.1001/archinte.162.14.1577; Lluch Cristina, 2022, Healthcare (Basel), V10, DOI 10.3390/healthcare10020364; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Maslach C., 2016, MASLACH BURNOUT INVE, V4th ed.; Melchior MEW, 1997, SOC PSYCH PSYCH EPID, V32, P158, DOI 10.1007/BF00794615; O'Connor K, 2018, EUR PSYCHIAT, V53, P74, DOI 10.1016/j.eurpsy.2018.06.003; Prosser D, 1999, SOC PSYCH PSYCH EPID, V34, P295, DOI 10.1007/s001270050147; Rotenstein LS, 2018, JAMA-J AM MED ASSOC, V320, P1131, DOI 10.1001/jama.2018.12777; Salyers MP, 2011, PSYCHIAT SERV, V62, P214, DOI 10.1176/ps.62.2.pss6202_0214; Shanafelt TD, 2015, MAYO CLIN PROC, V90, P1600, DOI 10.1016/j.mayocp.2015.08.023; Sorgaard KW, 2007, SOC PSYCH PSYCH EPID, V42, P794, DOI 10.1007/s00127-007-0228-6; SPECTOR PE, 1985, AM J COMMUN PSYCHOL, V13, P693, DOI 10.1007/BF00929796; Summers RF, 2020, AM J PSYCHIAT, V177, P955, DOI 10.1176/appi.ajp.2020.19090901; Tsounis Andreas, 2018, BMC Psychol, V6, P27, DOI 10.1186/s40359-018-0241-4; Volpe U, 2014, J PSYCHIATR MENT HLT, V21, P774, DOI 10.1111/jpm.12137; Willard-Grace R, 2019, ANN FAM MED, V17, P36, DOI 10.1370/afm.2338; Woo T, 2020, J PSYCHIATR RES, V123, P9, DOI 10.1016/j.jpsychires.2019.12.015; Yang SY, 2015, ASIAN J PSYCHIATR, V15, P15, DOI 10.1016/j.ajp.2015.04.005	31	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267578	10.1371/journal.pone.0267578	http://dx.doi.org/10.1371/journal.pone.0267578			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476815	Green Published, gold			2022-12-26	WOS:000840124300054
J	Kim, HM; Rhee, TM; Kim, HL				Kim, Hyue Mee; Rhee, Tae-Min; Kim, Hack-Lyoung			Integrated approach of brachial-ankle pulse wave velocity and cardiovascular risk scores for predicting the risk of cardiovascular events	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ARTERIAL STIFFNESS; METABOLIC SYNDROME; AMERICAN-COLLEGE; PROGNOSTIC VALUE; ATHEROSCLEROSIS; MORTALITY; STROKE; IMPACT; INDEX	Background The 2013 American College of Cardiology (ACC)/American Heart Association (AHA) atherosclerotic cardiovascular disease (ASCVD) risk score may be insufficient for accurate prediction of major adverse cardiac events (MACE) in Asians. This study was performed to investigate whether brachial-ankle pulse wave velocity (baPWV) has additional prognostic value to the risk score estimated by the ACC/AHA pooled cohort equations (PCEs). Methods A total of 6,359 patients (3,534 men and 2,825 women) aged 40-79 years without documented cardiovascular disease who underwent baPWV measurement were retrospectively analyzed. Cardiovascular risk scores were calculated using the 2013 ACC/AHA PCEs. Cardiovascular events, including cardiac death, non-fatal myocardial infarction, coronary revascularization and ischemic stroke, were assessed. Results During a median follow-up period of 4.0 years (interquartile range 1.7-6.1 years), cardiovascular events occurred in 129 patients (2.0%). The receiver operating characteristic curve analysis showed that baPWV was stronger in the detection of cardiovascular events than the 2013 ACC/AHA risk score (area under the curve: 0.70 versus 0.62, p<0.001). In the multivariable Cox regression analysis, both baPWV and 2013 ACC/AHA risk score were independently associated with the occurrence of clinical events (p <0.001 for each). The baPWV had incremental prognostic value to the 2013 ACC/AHA risk score in predicting clinical events (global chi-square from 21.23 to 49.51, p<0.001). Conclusion The baPWV appears to be a strong predictor of the risk of cardiovascular events in Koreans. Measuring baPWV in addition to the 2013 ACC/AHA risk score helps identify individuals at risk for MACE aged 40-79 years without previous cardiovascular diseases.	[Kim, Hyue Mee] Chung Ang Univ, Coll Med, Chung Ang Univ Hosp, Div Cardiol,Dept Internal Med, Seoul, South Korea; [Rhee, Tae-Min; Kim, Hack-Lyoung] Seoul Natl Univ, Coll Med, Boramae Med Ctr, Div Cardiol,Dept Internal Med, Seoul, South Korea	Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU); Seoul National University Hospital	Kim, HL (corresponding author), Seoul Natl Univ, Coll Med, Boramae Med Ctr, Div Cardiol,Dept Internal Med, Seoul, South Korea.	khl2876@gmail.com		Kim, Hack-Lyoung/0000-0002-6703-1472; KIM, Hyue Mee/0000-0001-7680-6690				Arnett DK, 2019, CIRCULATION, V140, pE596, DOI [10.1161/CIR.0000000000000678, 10.1016/j.jacc.2019.03.009, 10.1161/CIR.0000000000000677, 10.1016/j.jacc.2019.03.010]; Ato D, 2018, VASC HEALTH RISK MAN, V14, P41, DOI 10.2147/VHRM.S159437; Cavalcante JL, 2011, J AM COLL CARDIOL, V57, P1511, DOI 10.1016/j.jacc.2010.12.017; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; DeFilippis AP, 2017, EUR HEART J, V38, P598, DOI 10.1093/eurheartj/ehw301; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guerin AP, 2001, CIRCULATION, V103, P987; Hutchinson RN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0080973; Jung KJ, 2015, ATHEROSCLEROSIS, V242, P367, DOI 10.1016/j.atherosclerosis.2015.07.033; Kaolawanich Y, 2020, BMC CARDIOVASC DISOR, V20, DOI 10.1186/s12872-020-01550-w; Kavousi M, 2014, JAMA-J AM MED ASSOC, V311, P1416, DOI 10.1001/jama.2014.2632; Kim BY, 2021, J OBES METAB SYNDR, V30, P81, DOI 10.7570/jomes21022; Kim HL, 2021, J CLIN MED, V10, DOI 10.3390/jcm10153291; Kim HL, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00041; Kim HL, 2015, J CARDIOL, V65, P243, DOI 10.1016/j.jjcc.2014.05.009; Kim HL, 2013, CARDIOVASC ULTRASOUN, V11, DOI 10.1186/1476-7120-11-2; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lee CC, 2018, J INVEST MED, V66, P966, DOI 10.1136/jim-2017-000638; Lee HS, 2015, J ATHEROSCLER THROMB, V22, P1040, DOI 10.5551/jat.29918; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; O'Donnell MJ, 2016, LANCET, V388, P761, DOI 10.1016/S0140-6736(16)30506-2; Ohkuma T, 2017, HYPERTENSION, V69, P1045, DOI [10.1161/HYPERTENSIONAHA.117.09097, 10.1161/hypertensionaha.117.09097]; Palombo C, 2016, VASC PHARMACOL, V77, P1, DOI 10.1016/j.vph.2015.11.083; Rhee Eun-Jung, 2019, J Lipid Atheroscler, V8, P78, DOI 10.12997/jla.2019.8.2.78; Sang TT, 2021, HYPERTENS RES, V44, P1175, DOI 10.1038/s41440-021-00678-2; Sheng CS, 2014, HYPERTENSION, V64, P1124, DOI 10.1161/HYPERTENSIONAHA.114.04063; Stehouwer CDA, 2008, DIABETOLOGIA, V51, P527, DOI 10.1007/s00125-007-0918-3; Sugawara J, 2015, PULSE, V3, P106, DOI 10.1159/000430771; Umemura S, 2019, HYPERTENS RES, V42, P1235, DOI 10.1038/s41440-019-0284-9; Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Volgman AS, 2018, CIRCULATION, V138, pE1, DOI 10.1161/CIR.0000000000000580; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wong ND, 2014, NAT REV CARDIOL, V11, P276, DOI 10.1038/nrcardio.2014.26; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Yang XL, 2016, CIRCULATION, V134, P1430, DOI 10.1161/CIRCULATIONAHA.116.022367	39	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267614	10.1371/journal.pone.0267614	http://dx.doi.org/10.1371/journal.pone.0267614			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476644	gold, Green Published			2022-12-26	WOS:000840124300056
J	Pachpande, V; Senapathi, SHV; Williams, K; Chai, S; Mandal, S; Prabhu, S				Pachpande, Vrushali; Senapathi, Sri Harsha Vardhan; Williams, Karen; Chai, Seungwoo; Mandal, Shobha; Prabhu, Sheela			Demographics, comorbidities, and laboratory parameters in hospitalized patients with SARS-CoV2 infection at a community hospital in rural Pennsylvania	PLOS ONE			English	Article							DIABETES-MELLITUS; COVID-19; MORTALITY; SEVERITY	Introduction Inherent differences as well as health disparities among rural and urban populations warrant further studies focused on the characteristics and outcomes in COVID-19 patients in a rural setting. The aim of this study was to describe these elements in patients infected with SARS-CoV2, hospitalized at a single center in rural Pennsylvania. Methods Patients with SARS-CoV2 infections hospitalized between March-December 2020 were studied. Data were obtained from electronic health records generated reports and was retrospectively analyzed. Patients were classified into three groups according to severity. Distribution of variables was studied among these three groups. Using certain variables, we ran logistic regression analysis to study the odds of death and requirement of mechanical ventilation (MV). Results Among 335 hospitalized patients infected with SARS-CoV2, age more than 65 years increased the severity of clinical status and in-hospital mortality. Gender did not affect odds of death nor need for MV. Hypertension was the most common comorbidity, but diabetes mellitus and chronic obstructive pulmonary disease (COPD) increased the risk of death. In terms of laboratory parameters, our data suggests that maximum LDH marginally increased the risk of death and maximum WBC marginally increased the risk of need for MV and death. Conclusion Through our basic analysis of various characteristics of SARS-CoV2 positive patients admitted in a rural hospital, we have identified certain risk factors associated with severe disease and increased in-hospital mortality. These were found to be largely similar to current literature from studies in urban populations, bolstering the reproducibility and generalizability of existing knowledge. This information lays the foundation for future studies to investigate the role of these factors in morbidity and mortality associated with COVID-19 in depth.	[Pachpande, Vrushali; Mandal, Shobha; Prabhu, Sheela] Guthrie Med Grp, Dept Internal Med, Sayre, PA 18840 USA; [Senapathi, Sri Harsha Vardhan; Chai, Seungwoo] Donald Guthrie Fdn, Sayre, PA USA; [Senapathi, Sri Harsha Vardhan] Guthrie Med Grp, Dept Surg, Sayre, PA USA; [Williams, Karen] Guthrie Robert Packer Hosp, Dept Pharm, Sayre, PA USA		Pachpande, V (corresponding author), Guthrie Med Grp, Dept Internal Med, Sayre, PA 18840 USA.	Vrushali.Pachpande@Guthrie.org	Williams, Karen S./AAM-5359-2020	Williams, Karen S./0000-0002-8180-7652; Pachpande, Vrushali/0000-0002-3295-6520				[Anonymous], CLIN SPECTRUM COVID; [Anonymous], WHO DIRECTOR GEN REM; [Anonymous], COVID DATA TRACKER W; [Anonymous], HEALTHCARE ACCESS RU; [Anonymous], LOW COST DEXAMETHASO; Bunn A., 2013, FOUND STAT COMPUT, V2, P1; Chen RZ, 2020, J CLIN HYPERTENS, V22, P1974, DOI 10.1111/jch.14038; CHNA RPH, COMMUNITY HLTH NEEDS; Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191; Huang I, 2020, DIABETES METAB SYND, V14, P395, DOI 10.1016/j.dsx.2020.04.018; Jung CS, 2021, EUR RESPIR J, V58, DOI 10.1183/13993003.00979-2021; Kumar A, 2020, DIABETES METAB SYND, V14, P535, DOI 10.1016/j.dsx.2020.04.044; Lee SC, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83226-9; Li C, 2020, AGING-US, V12, P15670, DOI 10.18632/aging.103770; Liid X., 2021, CLIN DETERMINANTS SE; Medical Association A, 2020, CASE FATALITY RATE C; Mudatsir Mudatsir, 2020, F1000Res, V9, P1107, DOI 10.12688/f1000research.26186.2; National Center for Health Statistics, 2018, HLTH US 2017 SPECIAL; Nguyen NT, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.0417; Oh SM, 2021, AM J EMERG MED, V48, P140, DOI 10.1016/j.ajem.2021.03.083; Rahman A, 2021, AM J TROP MED HYG, V104, P1188, DOI 10.4269/ajtmh.20-1536; Redaelli MB, 2021, SAUDI J MED MED SCI, V9, P59, DOI 10.4103/sjmms.sjmms_542_20; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Shah P, 2020, ANN MED, V52, P354, DOI 10.1080/07853890.2020.1791356; USDA, 2019, ERS RUR AM GLANC; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Williamson E, 2020, MEDRXIV, V7, P1, DOI [10.1101/2020.05.06.20092999v1, 10.1101/2020.05.06.20092999]; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Zaki N, 2021, J INFECT PUBLIC HEAL, V14, P638, DOI 10.1016/j.jiph.2021.01.019	30	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267468	10.1371/journal.pone.0267468	http://dx.doi.org/10.1371/journal.pone.0267468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476841	gold, Green Published			2022-12-26	WOS:000840124300045
J	Tsai, YT; Li, CY; Huang, YH; Chang, TS; Lin, CY; Chuang, CH; Wang, CY; Anuraga, G; Chang, TH; Shih, TC; Lin, ZY; Chen, YL; Chung, I; Lee, KH; Chang, CC; Sung, SY; Yang, KH; Tsui, WL; Yap, CV; Wu, MH				Tsai, Yao-Tsung; Li, Chih-Yi; Huang, Yen-Hua; Chang, Te-Sheng; Lin, Chung-Yen; Chuang, Chia-Hsien; Wang, Chih-Yang; Anuraga, Gangga; Chang, Tzu-Hao; Shih, Tsung-Chieh; Lin, Zu-Yau; Chen, Yuh-Ling; Chung, Ivy; Lee, Kuen-Haur; Chang, Che-Chang; Sung, Shian-Ying; Yang, Kai-Huei; Tsui, Wan-Lin; Yap, Chee-Voon; Wu, Ming-Heng			Galectin-1 orchestrates an inflammatory tumor-stroma crosstalk in hepatoma by enhancing TNFR1 protein stability and signaling in carcinoma-associated fibroblasts	ONCOGENE			English	Article							FACTOR RECEPTOR 1; DISINTEGRIN; SORAFENIB	Most cases of hepatocellular carcinoma (HCC) arise with the fibrotic microenvironment where hepatic stellate cells (HSCs) and carcinoma-associated fibroblasts (CAFs) are critical components in HCC progression. Therefore, CAF normalization could be a feasible therapy for HCC. Galectin-1 (Gal-1), a beta-galactoside-binding lectin, is critical for HSC activation and liver fibrosis. However, few studies has evaluated the pathological role of Gal-1 in HCC stroma and its role in hepatic CAF is unclear. Here we showed that Gal-1 mainly expressed in HCC stroma, but not cancer cells. High expression of Gal-1 is correlated with CAF markers and poor prognoses of HCC patients. In co-culture systems, targeting Gal-1 in CAFs or HSCs, using small hairpin (sh)RNAs or an therapeutic inhibitor (LLS30), downregulated plasminogen activator inhibitor-2 (PAI-2) production which suppressed cancer stem-like cell properties and invasion ability of HCC in a paracrine manner. The Gal-1-targeting effect was mediated by increased a disintegrin and metalloprotease 17 (ADAM17)-dependent TNF-receptor 1 (TNFR1) shedding/cleavage which inhibited the TNF-alpha -> JNK -> c-Jun/ATF2 signaling axis of pro-inflammatory gene transcription. Silencing Gal-1 in CAFs inhibited CAF-augmented HCC progression and reprogrammed the CAF-mediated inflammatory responses in a co-injection xenograft model. Taken together, the findings uncover a crucial role of Gal-1 in CAFs that orchestrates an inflammatory CSC niche supporting HCC progression and demonstrate that targeting Gal-1 could be a potential therapy for fibrosis-related HCC.	[Tsai, Yao-Tsung; Li, Chih-Yi; Chang, Che-Chang; Sung, Shian-Ying; Yang, Kai-Huei; Tsui, Wan-Lin; Yap, Chee-Voon; Wu, Ming-Heng] Taipei Med Univ, Int PhD Program Translat Sci, Taipei, Taiwan; [Tsai, Yao-Tsung; Li, Chih-Yi; Huang, Yen-Hua; Chang, Che-Chang; Sung, Shian-Ying; Yang, Kai-Huei; Tsui, Wan-Lin; Yap, Chee-Voon; Wu, Ming-Heng] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Translat Med, Taipei, Taiwan; [Huang, Yen-Hua] Taipei Med Univ, Dept Biochem & Mol Cell Biol, Taipei, Taiwan; [Huang, Yen-Hua] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Huang, Yen-Hua; Wu, Ming-Heng] Taipei Med Univ, Ctr Cell Therapy & Regenerat Med, Taipei, Taiwan; [Chang, Te-Sheng] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Chang, Te-Sheng] Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Chiayi, Taiwan; [Lin, Chung-Yen; Chuang, Chia-Hsien] Acad Sinica, Inst Informat Sci, Taipei, Taiwan; [Wang, Chih-Yang; Anuraga, Gangga; Lee, Kuen-Haur] Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Chang, Tzu-Hao] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei, Taiwan; [Shih, Tsung-Chieh] Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Lin, Zu-Yau] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan; [Lin, Zu-Yau] Kaohsiung Med Univ, Coll Med, Sch Med, Fac Internal Med, Kaohsiung, Taiwan; [Chen, Yuh-Ling] Natl Cheng Kung Univ, Coll Med, Inst Oral Med, Tainan, Taiwan; [Chung, Ivy] Univ Malaya, Fac Med, Canc Res Inst, Kuala Lumpur 50603, Malaysia; [Chung, Ivy] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia; [Wu, Ming-Heng] TMU Res Ctr Canc Translat Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Chang Gung University; Chang Gung Memorial Hospital; Academia Sinica - Taiwan; Taipei Medical University; Taipei Medical University; University of California System; University of California Davis; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Cheng Kung University; Universiti Malaya; Universiti Malaya	Wu, MH (corresponding author), Taipei Med Univ, Int PhD Program Translat Sci, Taipei, Taiwan.; Wu, MH (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Translat Med, Taipei, Taiwan.; Wu, MH (corresponding author), Taipei Med Univ, Ctr Cell Therapy & Regenerat Med, Taipei, Taiwan.; Wu, MH (corresponding author), TMU Res Ctr Canc Translat Med, Taipei, Taiwan.	mhwu1015@tmu.edu.tw	Chung, Ivy/C-3804-2012; Anuraga, Gangga/AAE-8623-2021	Anuraga, Gangga/0000-0002-0902-3968; Huang, Yen-Hua/0000-0001-6020-9998; Wang, Chih-Yang/0000-0002-4137-5074; Chuang, Chia-Hsien/0000-0002-3639-4684	Chang Gung Memorial Hospital (Chiayi, Taiwan); "TMU Research Center of Cancer Translational Medicine" from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan	Chang Gung Memorial Hospital (Chiayi, Taiwan)(Chang Gung Memorial Hospital); "TMU Research Center of Cancer Translational Medicine" from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan	We thank the National RNAi Core Facility at Academia Sinica, Taiwan for providing shRNA reagents and related services. We thank the Image and Bioinformatics Core Facility of Taipei Medical University for confocal microscopy and the microarray analysis. Human samples were from the Human Tumor Tissue Bank, Chang Gung Memorial Hospital (Chiayi, Taiwan). This work was financially supported by the "TMU Research Center of Cancer Translational Medicine" from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan.	Abolarinwa BA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184624; Bernot D, 2011, J CELL SCI, V124, P1224, DOI 10.1242/jcs.079889; Biffi G, 2021, PHYSIOL REV, V101, P147, DOI 10.1152/physrev.00048.2019; Boulaftali Y, 2013, ARTERIOSCL THROM VAS, V33, P1647, DOI 10.1161/ATVBAHA.113.301494; Castello-Cros R, 2011, CELL CYCLE, V10, P2021, DOI 10.4161/cc.10.12.16002; Chen PC, 2021, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.625943; Chen ZY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01286; Costa A, 2018, CANCER CELL, V33, P463, DOI 10.1016/j.ccell.2018.01.011; Cousin JM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091566; Deng M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005548; Dominguez CX, 2020, CANCER DISCOV, V10, P232, DOI 10.1158/2159-8290.CD-19-0644; Donisi C, 2021, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.601240; Elyada E, 2019, CANCER DISCOV, V9, P1102, DOI 10.1158/2159-8290.CD-19-0094; Feig C, 2013, P NATL ACAD SCI USA, V110, P20212, DOI 10.1073/pnas.1320318110; Finn RS, 2020, NEW ENGL J MED, V382, P1894, DOI 10.1056/NEJMoa1915745; Gao Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0448-6; Izaguirre G, 2019, BIOCHEMISTRY-US, V58, P1679, DOI 10.1021/acs.biochem.8b01295; Lei T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22135-w; Leung Z, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1402-x; Lin ZY, 2012, BIOMED PHARMACOTHER, V66, P525, DOI 10.1016/j.biopha.2012.02.001; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lockett AD, 2013, AM J RESP CELL MOL, V49, P143, DOI 10.1165/rcmb.2012-0515OC; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Martinez-Bosch N, 2020, ADV EXP MED BIOL, V1259, P17, DOI 10.1007/978-3-030-43093-1_2; Monteran L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01835; Ngo MHT, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041931; Nurmik M, 2020, INT J CANCER, V146, P895, DOI 10.1002/ijc.32193; Potikha T, 2019, FASEB J, V33, P7995, DOI 10.1096/fj.201900017R; Sahai E, 2020, NAT REV CANCER, V20, P174, DOI 10.1038/s41568-019-0238-1; Sakimoto T, 2009, INVEST OPHTH VIS SCI, V50, P4618, DOI 10.1167/iovs.08-2669; Sherman MH, 2014, CELL, V159, P80, DOI 10.1016/j.cell.2014.08.007; Shih TC, 2018, CLIN CANCER RES, V24, P4319, DOI 10.1158/1078-0432.CCR-18-0157; Spano D, 2010, MOL MED, V16, P102, DOI 10.2119/molmed.2009.00119; Tarrats N, 2011, HEPATOLOGY, V54, P319, DOI 10.1002/hep.24388; Toegel S, 2016, J IMMUNOL, V196, P1910, DOI 10.4049/jimmunol.1501165; Wu H, 2012, J GASTROEN HEPATOL, V27, P1312, DOI 10.1111/j.1440-1746.2012.07130.x; Wu MH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11212-1; Yeh CC, 2015, MOL CELL PROTEOMICS, V14, P1527, DOI 10.1074/mcp.M114.046417; Zhang PF, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.324	40	2	2	4	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 20	2022	41	21					3011	3023		10.1038/s41388-022-02309-7	http://dx.doi.org/10.1038/s41388-022-02309-7		APR 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	1L8MU	35459781				2022-12-26	WOS:000787474100003
J	Abadi, SAR; Mohammadi, A; Koohi, S				Abadi, Saeedeh Akbari Rokn; Mohammadi, Amirhossein; Koohi, Somayyeh			WalkIm: Compact image-based encoding for high-performance classification of biological sequences using simple tuning-free CNNs	PLOS ONE			English	Article							CONVOLUTIONAL NEURAL-NETWORKS; DV-CURVE; REPRESENTATION; ARCHITECTURE	The classification of biological sequences is an open issue for a variety of data sets, such as viral and metagenomics sequences. Therefore, many studies utilize neural network tools, as the well-known methods in this field, and focus on designing customized network structures. However, a few works focus on more effective factors, such as input encoding method or implementation technology, to address accuracy and efficiency issues in this area. Therefore, in this work, we propose an image-based encoding method, called as WalkIm, whose adoption, even in a simple neural network, provides competitive accuracy and superior efficiency, compared to the existing classification methods (e.g. VGDC, CASTOR, and DLM-CNN) for a variety of biological sequences. Using WalkIm for classifying various data sets (i.e. viruses whole-genome data, metagenomics read data, and metabarcoding data), it achieves the same performance as the existing methods, with no enforcement of parameter initialization or network architecture adjustment for each data set. It is worth noting that even in the case of classifying high-mutant data sets, such as Coronaviruses, it achieves almost 100% accuracy for classifying its various types. In addition, WalkIm achieves high-speed convergence during network training, as well as reduction of network complexity. Therefore WalkIm method enables us to execute the classifying neural networks on a normal desktop system in a short time interval. Moreover, we addressed the compatibility of WalkIm encoding method with free-space optical processing technology. Taking advantages of optical implementation of convolutional layers, we illustrated that the training time can be reduced by up to 500 time. In addition to all aforementioned advantages, this encoding method preserves the structure of generated images in various modes of sequence transformation, such as reverse complement, complement, and reverse modes.	[Abadi, Saeedeh Akbari Rokn; Mohammadi, Amirhossein; Koohi, Somayyeh] Sharif Univ Technol, Dept Comp Engn, Tehran, Iran	Sharif University of Technology	Koohi, S (corresponding author), Sharif Univ Technol, Dept Comp Engn, Tehran, Iran.	koohi@sharfi.edu		Mohammadi, AmirHossein/0000-0002-5040-1940				Abadi SAR, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245095; Al-Ajlan A, 2019, INTERDISCIP SCI, V11, P628, DOI 10.1007/s12539-018-0313-4; Morales JA, 2020, MATH PROBL ENG, V2020, DOI 10.1155/2020/7698590; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; [Anonymous], 2021, HS7 FASTEC IMAGINGS; Ayachi R., 2020, PROC INT C SCI ELECT, V146, P234; Bonidia R.P., 2021, BRIEF BIOINFORM; Buber E, 2018, 2018 6TH INTERNATIONAL CONFERENCE ON CONTROL ENGINEERING & INFORMATION TECHNOLOGY (CEIT); Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chang J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30619-y; Chen Z, 2018, BIOINFORMATICS, V34, P2499, DOI 10.1093/bioinformatics/bty140; Colburn S, 2019, APPL OPTICS, V58, P3179, DOI 10.1364/AO.58.003179; De Marinis L, 2019, IEEE ACCESS, V7, P175827, DOI 10.1109/ACCESS.2019.2957245; Deschavanne PJ, 1999, MOL BIOL EVOL, V16, P1391, DOI 10.1093/oxfordjournals.molbev.a026048; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fabijanska A, 2019, IEEE ACCESS, V7, P81297, DOI 10.1109/ACCESS.2019.2923687; Fiannaca A, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2182-6; Fonseca V, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007231; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hewelt B, 2019, BIOINFORMATICS, V35, P2738, DOI 10.1093/bioinformatics/bty1021; Hoang T, 2020, GENOMICS, V112, P1847, DOI 10.1016/j.ygeno.2019.10.018; Ioffe S., 2015, INT C ONMACHINE LEAR, V37, P448, DOI DOI 10.1007/S13398-014-0173-7.2; Jiao SM, 2019, OPT LETT, V44, P5186, DOI 10.1364/OL.44.005186; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Jurtz VI, 2017, BIOINFORMATICS, V33, P3685, DOI 10.1093/bioinformatics/btx531; Kingma DP., 2014, ADAM METHOD STOCHAST; Kobori Y, 2016, GENOM PROTEOM BIOINF, V14, P103, DOI 10.1016/j.gpb.2015.09.007; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Kwan HK, 2012, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2012-50; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Li YK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12493-2; Liang QX, 2020, NAR GENOM BIOINFORM, V2, DOI 10.1093/nargab/lqaa009; Liao B, 2005, CHEM PHYS LETT, V401, P196, DOI 10.1016/j.cplett.2004.11.059; Lichtblau D, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3330-3; Maleki E, 2018, J OPT SOC AM A, V35, P1929, DOI 10.1364/JOSAA.35.001929; Miladi M., 2020, BIORXIV; NANDY A, 1994, CURR SCI INDIA, V66, P309; Nugent Cameron M., 2020, Metabarcoding and Metagenomics, V4, P81, DOI 10.3897/mbmg.4.55815; Paul T, 2021, GENOMICS, V113, P778, DOI 10.1016/j.ygeno.2020.10.009; Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032; Qi Yanjiao, 2012, Genomics Proteomics & Bioinformatics, V10, P230, DOI 10.1016/j.gpb.2012.07.004; Randhawa GS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232391; Remita MA, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1602-3; Saha S, 2019, BIOINFORMATICS, V35, P2932, DOI 10.1093/bioinformatics/bty1071; Sievers A, 2017, GENES-BASEL, V8, DOI 10.3390/genes8040122; Solis-Reyes S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206409; Spall J, 2020, OPT LETT, V45, P5752, DOI 10.1364/OL.401675; Struck D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku739; Szegedy C, 2015, PROC CVPR IEEE, P1, DOI 10.1109/CVPR.2015.7298594; Xu SF, 2019, OPT EXPRESS, V27, P19778, DOI 10.1364/OE.27.019778; Yan T, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.023901; Yu N., 2018, BIG DATA MIN ANAL, V1, P191, DOI [10.26599/BDMA.2018.9020018, DOI 10.26599/BDMA.2018.9020018]; Zhang ZJ, 2009, BIOINFORMATICS, V25, P1112, DOI 10.1093/bioinformatics/btp130; Zielezinski A, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1319-7	55	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267106	10.1371/journal.pone.0267106	http://dx.doi.org/10.1371/journal.pone.0267106			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1E2NP	35427371	Green Published, gold			2022-12-26	WOS:000794332400017
J	Abuelezam, NN; Greenwood, KL; Galea, S; Al-Naser, R				Abuelezam, Nadia N.; Greenwood, Kristina L.; Galea, Sandro; Al-Naser, Raed			Differential COVID-19 testing, admissions, and mortality for Arab Americans in Southern California	PLOS ONE			English	Article							IMMIGRANT ENCLAVES; MIDDLE-EASTERN; ETHNIC ENCLAVE; NEW-YORK; HEALTH; NATIVITY; PARADOX; ASSOCIATIONS; OUTCOMES; CONTEXT	Background Understanding of COVID-19 acquisition and severity risk in minoritized groups is limited by data collection on race and ethnicity; very little is known about COVID-19 risk among Arab Americans in the United States. Purpose To quantify whether Arab Americans in the El Cajon region of California experienced differential levels of SARS-CoV-2 infection, severity and mortality when compared to other racial/ ethnic groups. Methods A retrospective study was conducted using Sharp Grossmont Hospital's electronic medical records. Patients were included in the study if they were: 18 years of age or older, tested for SARS-CoV-2, admitted for COVID-19 infection, or had COVID-19 listed as a cause of death between March 1, 2020 and January 31, 2021. The primary outcomes of interest were a positive COVID-19 test result, admission to the hospital due to COVID-19, and in hospital COVID-19 related mortality. Comparisons were made across racial/ethnic groups using chisquared statistics and logistic regression models adjusted for sociodemographics, comorbidities, and time from March 2020. Results Arab Americans had greater odds of testing positive for SARS-CoV-2 than non-Hispanic White (adjusted odds ratio, AOR: 3.83, 95% confidence interval, CI: 3.29, 4.46) and non-Hispanic Black (AOR: 2.34, 95% CI: 1.91, 2.88) patients but lower odds of admission (AOR: 0.47, 95% CI: 0.36, 0.63) and in-hospital mortality (AOR: 0.43, 95% CI: 0.28, 0.65) than Hispanic patients. Conclusions There were distinct patterns for COVID-19 infection, severity, and mortality for Arab Americans in Southern California. Without a dedicated ethnic identifier, COVID-19 disparities facing Arab Americans will continue to go undocumented.	[Abuelezam, Nadia N.] Boston Coll, William F Connell Sch Nursing, Chestnut Hill, MA 02167 USA; [Greenwood, Kristina L.] Sharp HealthCare Ctr Res, San Diego, CA USA; [Galea, Sandro] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Al-Naser, Raed] Sharp Grossmont Hosp, La Mesa, CA USA	Boston College; Boston University	Abuelezam, NN (corresponding author), Boston Coll, William F Connell Sch Nursing, Chestnut Hill, MA 02167 USA.	nadia.abuelezam@bc.edu	Galea, Sandro/GLR-6066-2022					Abraido-Lanza AF, 1999, AM J PUBLIC HEALTH, V89, P1543, DOI 10.2105/AJPH.89.10.1543; Abuelezam NN, 2020, AM J PREV MED, V59, P455, DOI 10.1016/j.amepre.2020.06.004; Abuelezam NN, 2019, AM J PUBLIC HEALTH, V109, P1733, DOI 10.2105/AJPH.2019.305308; Abuelezam NN, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00262; Abuelezam NN, 2017, AM J PREV MED, V52, P810, DOI 10.1016/j.amepre.2017.02.021; Abuelezam NN., 2021, J RACIAL ETHN HLTH D, P1, DOI [10.1007/s40615-020-00905-5, DOI 10.1007/S40615-020-00905-5]; [Anonymous], ARAB AM HERITAGE COM; [Anonymous], 2018, USING 2 SEPARATE QUE; Anyane-Yeboa A, 2020, J INTERN MED, V288, P479, DOI 10.1111/joim.13117; Awad GH, 2022, AM J PUBLIC HEALTH, V112, P209, DOI 10.2105/AJPH.2021.306590; Azar KMJ, 2020, HEALTH AFFAIR, V39, P1253, DOI 10.1377/hlthaff.2020.00598; Bassett MT, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003402; Cagney KA, 2007, AM J PUBLIC HEALTH, V97, P919, DOI 10.2105/AJPH.2005.071472; Chiswick B.R., 2005, CITY COMMUNITY, V4, P5, DOI 10.1111/j.1535-6841.2005.00101.x; El-Sayed AM, 2010, J EPIDEMIOL COMMUN H, V64, P155, DOI 10.1136/jech.2008.084491; Galster GC, 1999, HOUS POLICY DEBATE, V10, P395; John DA, 2012, SOC SCI MED, V75, P2085, DOI 10.1016/j.socscimed.2012.01.035; Kane JB, 2018, SOC SCI MED, V209, P67, DOI 10.1016/j.socscimed.2018.05.035; Kindratt T, 2020, HEALTH SERV RES, V55, P21; Lim S, 2017, J IMMIGR MINOR HEALT, V19, P138, DOI 10.1007/s10903-015-0334-6; Logan JR, 2002, AM SOCIOL REV, V67, P299, DOI 10.2307/3088897; Lopez L, 2021, JAMA-J AM MED ASSOC, V325, P719, DOI 10.1001/jama.2020.26443; Marin BG, 2021, REV MED VIROL, V31, DOI 10.1002/rmv.2146; Nasseri K, 2007, CANCER DETECT PREV, V31, P424, DOI 10.1016/j.cdp.2007.10.006; Navar AM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254809; Osypuk TL, 2009, SOC SCI MED, V69, P110, DOI 10.1016/j.socscimed.2009.04.010; PORTES A, 1992, J HEALTH SOC BEHAV, V33, P283, DOI 10.2307/2137309; Poulson M, 2021, J NATL MED ASSOC, V113, P125, DOI 10.1016/j.jnma.2020.07.009; Read JG, 2013, POPUL RES POLICY REV, V32, P611, DOI 10.1007/s11113-013-9286-5; Reitsma MB, 2021, HEALTH AFFAIR, V40, P870, DOI 10.1377/hlthaff.2021.00098; Roy AL, 2013, AM J COMMUN PSYCHOL, V51, P468, DOI 10.1007/s10464-012-9564-0; Semega J., 2020, INCOME POVERTY US 20; Tan SB, 2022, J RACIAL ETHN HEALTH, V9, P236, DOI 10.1007/s40615-020-00948-8; WILSON KL, 1980, AM J SOCIOL, V86, P295, DOI 10.1086/227240; Yaya S, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002913	35	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267116	10.1371/journal.pone.0267116	http://dx.doi.org/10.1371/journal.pone.0267116			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421208	Green Published, gold			2022-12-26	WOS:000795453600109
J	Chang, YH; Chien, LN; Chen, WT; Lin, IC				Chang, Yin-Hsi; Chien, Li-Nien; Chen, Wan-Ting; Lin, I-Chan			Comparison of risks of arterial thromboembolic events and glaucoma with ranibizumab and aflibercept intravitreous injection: A nationwide population-based cohort study	PLOS ONE			English	Article							NERVE-FIBER LAYER; INTRAOCULAR-PRESSURE; VEGF TRAP; MORTALITY; THERAPY; SAFETY; DRUGS; SCORE	BackgroundTo compare intravitreal aflibercept injection with intravitreal ranibizumab injection for the risk of major arterial thromboembolic events (ATEs) and glaucoma. MethodsThis retrospective, nationwide cohort study investigated 15 611 and 3867 patients aged >50 years with at least one pharmacy claim for intravitreal ranibizumab injection and aflibercept injection between 2011 and 2016, respectively. The inverse probability of treatment weighting method was performed to adjust the baseline difference between the two groups and the hazard risk of adverse events was estimated using the Cox proportional regression model. ResultsNo significant difference was noted between intravitreal ranibizumab and aflibercept injection for arterial thromboembolic risk, including ischemic stroke and acute myocardial infarction, during a 2-year follow-up (adjusted hazard ratio (HR): 0.87, 95% confidence interval (CI): 0.53-1.42; P = .583). Subgroup analyses revealed that patients age >65 years (adjusted HR: 0.64, 95% CI: 0.45-0.92) and those without coronary artery disease (adjusted HR: 0.59, 95% CI: 0.37-0.95) had significantly lower arterial thromboembolic risk in the aflibercept group than in the ranibizumab group. Additionally, the risk of glaucoma development after intravitreal injection did not significantly differ between the two groups (adjusted HR: 0.63, 95% CI: 0.37-1.06; P = .084). ConclusionsNo significant differences in the risk of major ATEs and glaucoma were found between ranibizumab and aflibercept, and aflibercept might be safe for use in elderly patients.	[Chang, Yin-Hsi] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Ophthalmol, Taoyuan, Taiwan; [Chang, Yin-Hsi] Taipei Med Univ, Coll Med, Sch Med, Taipei, Taiwan; [Chien, Li-Nien; Chen, Wan-Ting] Taipei Med Univ, Coll Management, Sch HealthCare Adm, Taipei, Taiwan; [Chien, Li-Nien] Taipei Med Univ, Hlth Data Analyt & Stat Ctr, Off Data Sci, Taipei, Taiwan; [Lin, I-Chan] Taipei Med Univ, Dept Ophthalmol, Shuang HoHospital, New Taipei, Taiwan; [Lin, I-Chan] Taipei Med Univ, Coll Med, Sch Med, Dept Ophthalmol, Taipei, Taiwan	Chang Gung Memorial Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University	Lin, IC (corresponding author), Taipei Med Univ, Dept Ophthalmol, Shuang HoHospital, New Taipei, Taiwan.; Lin, IC (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Ophthalmol, Taipei, Taiwan.	ichanlin@gmail.com	chen, want/GRX-0662-2022					Ahn J, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84648-1; Alexander SL, 2007, OPHTHALMOLOGY, V114, P2174, DOI 10.1016/j.ophtha.2007.09.017; Anderson WJ, 2021, INT J RETINA VITR, V7, DOI 10.1186/s40942-021-00307-7; Arnott C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150688; Atchison EA, 2018, OPHTHALMOLOGY, V125, P676, DOI 10.1016/j.ophtha.2017.11.027; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Avery RL, 2014, BRIT J OPHTHALMOL, V98, P1636, DOI 10.1136/bjophthalmol-2014-305252; Bracha P, 2018, SURV OPHTHALMOL, V63, P281, DOI 10.1016/j.survophthal.2017.08.008; Bressler SB, 2015, JAMA OPHTHALMOL, V133, P589, DOI 10.1001/jamaophthalmol.2015.186; Choi HK, 2007, CIRCULATION, V116, P894, DOI 10.1161/CIRCULATIONAHA.107.703389; Dalvin LA, 2019, JAMA OPHTHALMOL, V137, P483, DOI 10.1001/jamaophthalmol.2018.6891; de Vries VA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70269-7; Du J, 2019, J GLAUCOMA, V28, P1035, DOI 10.1097/IJG.0000000000001382; Faraone Stephen V, 2008, P T, V33, P700; Freund KB, 2015, OPHTHALMOLOGY, V122, P1802, DOI 10.1016/j.ophtha.2015.04.018; Good TJ, 2011, BRIT J OPHTHALMOL, V95, P1111, DOI 10.1136/bjo.2010.180729; Hahn P, 2013, OPHTHALMOLOGY, V120, P1100, DOI 10.1016/j.ophtha.2012.11.018; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Hsieh CY, 2019, CLIN EPIDEMIOL, V11, P349, DOI 10.2147/CLEP.S196293; Hykin P, 2019, JAMA OPHTHALMOL, V137, P1256, DOI 10.1001/jamaophthalmol.2019.3305; Karakurt Y, 2018, MED SCI MONITOR, V24, P9019, DOI 10.12659/MSM.910923; Kim SW, 2019, CURR PHARM DESIGN, V25, P184, DOI 10.2174/1381612825666190319165824; Kitchens JW, 2016, OPHTHALMOLOGY, V123, P1511, DOI 10.1016/j.ophtha.2016.02.046; Krishnan E, 2008, ARCH INTERN MED, V168, P1104, DOI 10.1001/archinte.168.10.1104; Lin LY, 2018, EPIDEMIOL HEALTH, V40, DOI 10.4178/epih.e2018062; Lotery A, 2017, EYE, V31, P1697, DOI 10.1038/eye.2017.143; Low A, 2019, BRIT J OPHTHALMOL, V103, P442, DOI 10.1136/bjophthalmol-2018-312691; Maloney MH, 2021, OPHTHALMOLOGY, V128, P417, DOI 10.1016/j.ophtha.2020.07.062; Mansoori T, 2021, J CURR OPHTHALMOL, V33, P6, DOI 10.4103/JOCO.JOCO_5_20; Melgaard L, 2015, JAMA-J AM MED ASSOC, V314, P1030, DOI 10.1001/jama.2015.10725; Ng WY, 2015, AM J OPHTHALMOL, V159, P557, DOI 10.1016/j.ajo.2014.12.005; Nuesi R, 2020, CURR OPHTHALMOL REP, V8, P111, DOI 10.1007/s40135-020-00235-z; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; Parikh R, 2019, OPHTHALMOL RETINA, V3, P16, DOI 10.1016/j.oret.2018.08.002; Pieramici DJ, 2008, EYE, V22, P1330, DOI 10.1038/eye.2008.88; Ramsey DJ, 2022, EYE, V36, P1813, DOI 10.1038/s41433-021-01729-1; Rogers CA, 2018, OPHTHALMOL RETINA, V2, P118, DOI 10.1016/j.oret.2017.05.015; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Touyz RM, 2018, NPJ PRECIS ONCOL, V2, DOI 10.1038/s41698-018-0056-z; Tseng JJ, 2012, J GLAUCOMA, V21, P241, DOI 10.1097/IJG.0b013e31820d7d19; Ueta T, 2014, OPHTHALMOLOGY, V121, P2193, DOI 10.1016/j.ophtha.2014.05.022; van Asten F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197670; Wells JA, 2016, OPHTHALMOLOGY, V123, P1351, DOI 10.1016/j.ophtha.2016.02.022; Xu YP, 2017, INT OPHTHALMOL, V37, P325, DOI 10.1007/s10792-016-0241-4; Ziemssen F, 2020, J OPHTHALMOL, V2020, DOI 10.1155/2020/8652370	47	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267088	10.1371/journal.pone.0267088	http://dx.doi.org/10.1371/journal.pone.0267088			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7MW	35436315	gold, Green Published			2022-12-26	WOS:000791258900018
J	Chen, YS; Clemente, FM; Pagaduan, JC; Crowley-McHattan, Z; Lu, YX; Chien, CH; Bezerra, P; Chiu, YW; Kuo, CD				Chen, Yung-Sheng; Clemente, Filipe Manuel; Pagaduan, Jeffrey Cayaban; Crowley-McHattan, Zachary; Lu, Yu-Xian; Chien, Chia-Hua; Bezerra, Pedro; Chiu, Yi-Wen; Kuo, Cheng-Deng			Relationships between perceived measures of internal load and wellness status during overseas futsal training camps	PLOS ONE			English	Article							PROFESSIONAL SOCCER PLAYERS; PRESEASON; FOOTBALL; FATIGUE; TRANSITION; SEASON	Exercise and sport practitioners frequently utilize rating of perceived exertion (RPE) to evaluate the players' psychophysiological strains during training sessions. The subjective rating of physical exertion level during sports training has been shown to have a reciprocal relationship with wellness status during periodic training or competitive seasons. However, the relationship between subjective physical exertions and wellness status during short-term overseas training camps (OTCs) has not been extensively investigated. This study aimed to examine the perceived responses of physical exertions [session-RPE (sRPE), training monotony, and training strain] and wellness status (fatigue, sleep, delayed onset muscle soreness, stress, and mood) measures in elite young adult futsal players from four separate OTCs with different training tasks. Twenty-seven U-20 male national team futsal players voluntarily participated in this study. The players recruited for OTCs were based on their performance during domestic training camps and the tactical demand of the team. The task of each OTCs was defined as: 1) 1(st) OTC = game-based camp (n = 14); 2) 2(nd) and 3(rd) OTC = training-based camp (n = 20 and n = 17, respectively); and 3) 4(th) OTC = pre-tournament camp (n = 14). The OTCs consisted of 11 training sessions (18.9 hours) and 16 friendly matches (23.8 hours). During daily training sessions and friendly matches, sRPE was used to quantify training load (TL). Additionally, a five-elements general wellness questionnaire was used to evaluate daily wellness status in the morning. The results demonstrated that the mean and sum sRPE in the game-based OTCs were significantly lower compared to the mean sRPE [p < 0.01, effect size (ES) = -4.8; p < 0.01, ES = -2.9] and sum sRPE in the training-based OTCs (p < 0.01, ES = -3.6; p < 0.01, ES = -3.1). The mean (p = 0.01; ES = -2.0) and sum sRPE (p < 0.01; ES = -3.4) in the game-based OTC were also lower than that in the pre-tournament OTC. Conversely, the wellness scores in the game-based OTC were higher compared to the training-based (p = 0.01; ES = 1.8) and the pre-tournament OTCs (p < 0.01; ES = 1.6). There was a negative relationship between mean and sum sRPE and all wellness scores (mean sRPE = r = -0.441 similar to -0.575, p < 0.001; sum sRPE = r = -0.41 similar to -0.559, p < 0.001). Our findings suggested that responses to training sessions, derived from mean and sum sRPE and wellness scores, are dependent upon the task-specific nature of OTCs among elite futsal players. Utilization of mean and sum sRPE and wellness measures to monitor the psychophysiological health during short-term OTCs is recommended.	[Chen, Yung-Sheng; Lu, Yu-Xian] Univ Taipei, Dept Exercise & Hlth Sci, Taipei, Taiwan; [Chen, Yung-Sheng; Chien, Chia-Hua] Exercise & Hlth Promot Assoc, New Taipei City, Taiwan; [Chen, Yung-Sheng; Kuo, Cheng-Deng] Tanyu Res Lab, Taipei, Taiwan; [Clemente, Filipe Manuel; Bezerra, Pedro] Inst Politecn Viana Castelo, Escola Super Desporto & Lazer, Viana Do Castelo, Portugal; [Clemente, Filipe Manuel] Inst Telecomunicacoes, Lisbon, Portugal; [Pagaduan, Jeffrey Cayaban] Palacky Univ, Inst Act Lifestlye, Olomouc, Czech Republic; [Crowley-McHattan, Zachary] Southern Cross Univ, Fac Hlth, Discipline Sport & Exercise Sci, Lismore, Australia; [Lu, Yu-Xian] Natl Taiwan Sport Univ, Grad Inst Athletes & Coaching Sci, Taoyuan, Taiwan; [Bezerra, Pedro] Res Ctr Sports Sci Hlth Sci & Human Dev, Vila Real, Portugal; [Chiu, Yi-Wen] Fu Jen Catholic Univ, Dept Phys Educ, New Taipei City, Taiwan; [Kuo, Cheng-Deng] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan	University of Taipei; Polytechnic Institute of Viana do Castelo; Instituto de Telecomunicacoes; Palacky University Olomouc; Southern Cross University; Fu Jen Catholic University; Taipei Veterans General Hospital	Kuo, CD (corresponding author), Tanyu Res Lab, Taipei, Taiwan.; Kuo, CD (corresponding author), Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan.	cdkuo23@gmail.com	Clemente, Filipe Manuel/AAN-6545-2020; Crowley-McHattan, Zachary J/W-1288-2018; Clemente, Filipe Manuel/G-2625-2012	Crowley-McHattan, Zachary J/0000-0002-5691-3752; Clemente, Filipe Manuel/0000-0001-9813-2842; Kuo, Cheng-Deng/0000-0002-3989-1950	VGHUST Joint Research Program [VGHUST96-P1-06]; Ministry of Science and Technology, Taiwan [MOST-103-2410-H-075-001]	VGHUST Joint Research Program; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The authors would like to thank the head coach Adil Amarante, team members, and U-20 Chinese Taipei futsal team players who volunteered for this study.	Almeida J, 2019, INT J PERF ANAL SPOR, V19, P711, DOI 10.1080/24748668.2019.1648717; Campos-Vazquez MA, 2015, INT J SPORT PHYSIOL, V10, P587, DOI 10.1123/ijspp.2014-0294; Borg G., 1998, BORGS PERCEIVED EXER; Borges L, 2022, RES SPORTS MED, V30, P659, DOI 10.1080/15438627.2021.1929221; Buchheit M, 2013, J SCI MED SPORT, V16, P550, DOI 10.1016/j.jsams.2012.12.003; Chen YS, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.621399; Chen YS, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17030775; Clemente FM, 2020, BIOL SPORT, V37, P389, DOI 10.5114/biolsport.2020.96852; Clemente FM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17061843; Clemente FM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225522; Clemente FM, 2019, PHYSIOL BEHAV, V201, P123, DOI 10.1016/j.physbeh.2019.01.001; Clemente FM, 2017, PHYSIOL BEHAV, V179, P262, DOI 10.1016/j.physbeh.2017.06.021; Duignan C, 2020, J ATHL TRAINING, V55, P944, DOI 10.4085/1062-6050-0528.19; Fessi MS, 2016, RES SPORTS MED, V24, P375, DOI 10.1080/15438627.2016.1222278; Flatt AA, 2019, J SCI MED SPORT, V22, P616, DOI 10.1016/j.jsams.2018.11.022; Flatt AA, 2019, J SCI MED SPORT, V22, P222, DOI 10.1016/j.jsams.2018.07.014; Foster C, 1998, MED SCI SPORT EXER, V30, P1164, DOI 10.1097/00005768-199807000-00023; Foster C, 2001, J STRENGTH COND RES, V15, P109, DOI 10.1519/00124278-200102000-00019; Gabbett TJ, 2017, BRIT J SPORT MED, V51, P1451, DOI 10.1136/bjsports-2016-097298; Haddad M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00612; HOOPER SL, 1995, SPORTS MED, V20, P321, DOI 10.2165/00007256-199520050-00003; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Impellizzeri FM, 2004, MED SCI SPORT EXER, V36, P1042, DOI 10.1249/01.MSS.0000128199.23901.2F; Lu YX., 2019, HUMAN MOVEMENT, V5, P98, DOI [10.5114/hm.2018.83218, DOI 10.5114/HM.2018.83218]; McCall A, 2018, J SCI MED SPORT, V21, P800, DOI 10.1016/j.jsams.2017.12.002; McLean BD, 2010, INT J SPORT PHYSIOL, V5, P367, DOI 10.1123/ijspp.5.3.367; Noor D, 2019, J SCI MED SPORT, V22, P948, DOI 10.1016/j.jsams.2019.02.006; Ouergui I, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17207400; Rago V, 2020, J SPORT MED PHYS FIT, V60, P160, DOI 10.23736/S0022-4707.19.10000-X; Ribeiro JN, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01709; Sarmento H, 2015, INT J PERF ANAL SPOR, V15, P471, DOI 10.1080/24748668.2015.11868807; Sarmento H, 2016, J SPORT SCI, V34, P621, DOI 10.1080/02640414.2015.1066024; Spyrou K, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.569897; de Oliveira RS, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.661262; Teixeira AS, 2019, SPORTS, V7, DOI 10.3390/sports7010007; Wilke CF, 2020, INT J SPORT PHYSIOL, V15, P648, DOI 10.1123/ijspp.2019-0201; Wilke CF, 2021, INT J SPORT PHYSIOL, V16, P557, DOI 10.1123/ijspp.2020-0071	37	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267227	10.1371/journal.pone.0267227	http://dx.doi.org/10.1371/journal.pone.0267227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7VA	35439262	gold, Green Published			2022-12-26	WOS:000791280100027
J	Chiu, CJ; Hua, LC; Chou, CY; Chiang, JH				Chiu, Ching-Ju; Hua, Lin-Chun; Chou, Chieh-Ying; Chiang, Jung-Hsien			Robot-enhanced diabetes care for middle-aged and older adults living with diabetes in the community: A small sample size mixed-method evaluation	PLOS ONE			English	Article							SELF-MANAGEMENT; TECHNOLOGY; ACCEPTANCE; TOMORROW	PurposeThis study assessed robot-enhanced healthcare in practical settings for the purpose of community diabetes care. MethodsA mixed method evaluation collected quantitative and qualitative data on diabetes patients over 45 (N = 30) and community pharmacists (N = 10). It took 15-20 min for the diabetes patients to interact with the robot. Before and after the interaction, questionnaires including a diabetes knowledge test, self-efficacy for diabetes, and feasibility of use of the robot was administered. In-depth interviews with both pharmacists and patients were also conducted. ResultsAfter interacting with the robot, a statistically significant improvement in diabetes knowledge (p < .001) and feasibility of the robot (p = .012) was found, but self-efficacy (p = .171) was not significantly improved. Five themes emerged from interviewing the diabetes patients: Theme 1: meets the needs of self-directed learning for the elderly; Theme 2: reduces alertness and creates comfortable interaction; Theme 3: vividness and richness enhance interaction opportunities; Theme 4: Robots are not without disadvantages, and Theme 5: Every person has unique tastes. Three themes emerged from interviewing pharmacists: Theme 1: Technology must meet the real needs of the patient; Theme 2: creates new services, and Theme 3: The use of robots must conform to real-life situations. ConclusionsBoth the diabetes patients and the pharmacist reported more positive feedback on the robot-enhanced diabetes care than concerns. Self-directed learning, comfortable interaction, and vividness were the most focuses when using robot to enhance self-management for the patients. Pharmacists were most receptive to fit conforming with reality and creating new services.	[Chiu, Ching-Ju; Hua, Lin-Chun; Chou, Chieh-Ying] Natl Cheng Kung Univ, Coll Med, Inst Gerontol, Tainan, Taiwan; [Chou, Chieh-Ying] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Family Med, Tainan, Taiwan; [Chiang, Jung-Hsien] Natl Cheng Kung Univ, Coll Elect Engn & Comp Sci, Dept Comp Sci & Informat Engn, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Hua, LC (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Gerontol, Tainan, Taiwan.	flower921fora@gmail.com			Taiwan Ministry of Science and Technology [MOST 108-2634-F-006 -006]	Taiwan Ministry of Science and Technology	This work was supported by a grant from the Taiwan Ministry of Science and Technology (MOST 108-2634-F-006 -006-). CJC received the award. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alotaibi M.., 2018, INT J ONLINE ENG IJO, V14; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Balali S., 2019, INT C SOC ROB; Broadbent E, 2009, INT J SOC ROBOT, V1, P319, DOI 10.1007/s12369-009-0030-6; Broadbent E, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.8640; Broadbent E, 2012, AUSTRALAS J AGEING, V31, P115, DOI 10.1111/j.1741-6612.2011.00551.x; Cajita MI, 2016, J CARDIOVASC NURS, V31, pE10, DOI 10.1097/JCN.0000000000000305; Dario P., 1999, TECHNOL DISABIL, V10, P77; DAVIS FD, 1989, MANAGE SCI, V35, P982, DOI 10.1287/mnsc.35.8.982; Ezer N., 2009, INT C UNIVERSAL ACCE; Farzandipour M, 2017, APPL CLIN INFORM, V8, P1068, DOI [10.4338/ACI-2017-07-R0116, 10.4338/ACI-2017-07-R-0116]; Fitzgerald JT, 2016, DIABETES EDUCATOR, V42, P178, DOI 10.1177/0145721715624968; Fitzgerald JT, 1998, DIABETES CARE, V21, P706, DOI 10.2337/diacare.21.5.706; Greenwood Deborah A, 2017, J Diabetes Sci Technol, V11, P1015, DOI 10.1177/1932296817713506; Heerink M., 2006, P ROMAN 2006 THE 15, P521, DOI DOI 10.1109/ROMAN.2006.314442; Heitkemper EM, 2017, J AM MED INFORM ASSN, V24, P1024, DOI 10.1093/jamia/ocx025; Henkel Zachary, 2019, Paladyn, Journal of Behavioral Robotics, V10, P140, DOI 10.1515/pjbr-2019-0010; Holtz B, 2012, TELEMED E-HEALTH, V18, P175, DOI 10.1089/tmj.2011.0119; Jayawardena C, 2010, IEEE INT C INT ROBOT; Kleanthous S, 2016, LECT NOTES COMPUT SC, V9755, P35, DOI 10.1007/978-3-319-39949-2_4; Laniel Sebastien, 2017, IEEE Int Conf Rehabil Robot, V2017, P809, DOI 10.1109/ICORR.2017.8009347; Lauridsen SV, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0547-y; Lee JA, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.3196; Li M.F., 2018, HUMAN ASPECTS IT AGE; Mallidi Srivalleesha, 2017, 2017 IEEE International Ultrasonics Symposium (IUS), DOI 10.1109/ULTSYM.2017.8091652; Marcel I.., 1991, J REHABIL RES DEV, V28; Mathison S., 1988, ED RES, V17, P13, DOI DOI 10.3102/0013189X017002013; Namdarian B, 2018, CURR OPIN UROL, V28, P143, DOI 10.1097/MOU.0000000000000474; National Development Council R.o.C.T.., 2017, 2017 IND HOUS DIG OP; National Statistics R.o.C.T.., CLASS DEF URB AR; Or C, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0437-1; Park YH, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1227-7; Petersen S, 2017, J ALZHEIMERS DIS, V55, P569, DOI 10.3233/JAD-160703; POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754; Rachata N.., 2018, INT J APPL CERAM TEC, V11; Rehman H, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0649-y; Salem M., 2015, P 10 ANN ACMIEEE INT; Scheibe Madlen, 2015, Med 2 0, V4, pe1, DOI 10.2196/med20.3912; Smarr Cory-Ann, 2012, Proc Hum Factors Ergon Soc Annu Meet, V56, P153; Sparrow R, 2006, MIND MACH, V16, P141, DOI 10.1007/s11023-006-9030-6; Stafford TE, 2004, DECISION SCI, V35, P259, DOI 10.1111/j.00117315.2004.02524.x; Stanford Patient Education Research Center, 2016, DIAB SELF EFF SCAL; Sung HC, 2015, ASIA-PAC PSYCHIAT, V7, P1, DOI 10.1111/appy.12131; Takahashi Y., 2018, INT C COMP HELP PEOP; Vincent JL, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1664-7; Wan W.-L., 2004, LIVING TECHNOLOGY ED, V37, P17; Whitehead L, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.4883; Wu YH, 2012, ARCH GERONTOL GERIAT, V54, P121, DOI 10.1016/j.archger.2011.02.003; Ye Qing, 2018, J Diabetes Sci Technol, V12, P808, DOI 10.1177/1932296818754907; Yu W.Y.., 2014, EXPLORING FACTORS AF	50	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0265384	10.1371/journal.pone.0265384	http://dx.doi.org/10.1371/journal.pone.0265384			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1E2NP	35427359	Green Published, gold			2022-12-26	WOS:000794332400034
J	Portillo, JR; Soler-Toscano, F; Langa, JA				Portillo, Jose R.; Soler-Toscano, Fernando; Langa, Jose A.			Global structural stability and the role of cooperation in mutualistic systems	PLOS ONE			English	Article							ECOLOGICAL NETWORKS; DYNAMICS; ARCHITECTURE; MODULARITY; REST	Dynamical systems on graphs allow to describe multiple phenomena from different areas of Science. In particular, many complex systems in Ecology are studied by this approach. In this paper we analize the mathematical framework for the study of the structural stability of each stationary point, feasible or not, introducing a generalization for this concept, defined as Global Structural Stability. This approach would fit with the proper mathematical concept of structural stability, in which we find a full description of the complex dynamics on the phase space due to nonlinear dynamics. This fact can be analyzed as an informational field grounded in a global attractor whose structure can be completely characterized. These attractors are stable under perturbation and suppose the minimal structurally stable sets. We also study in detail, mathematically and computationally, the zones characterizing different levels of biodiversity in bipartite graphs describing mutualistic antagonistic systems of population dynamics. In particular, we investigate the dependence of the region of maximal biodiversity of a system on its connectivity matrix. On the other hand, as the network topology does not completely determine the robustness of the dynamics of a complex network, we study the correlation between structural stability and several graph measures. A systematic study on synthetic and biological graphs is presented, including 10 mutualistic networks of plants and seed-dispersal and 1000 random synthetic networks. We compare the role of centrality measures and modularity, concluding the importance of just cooperation strength among nodes when describing areas of maximal biodiversity. Indeed, we show that cooperation parameters are the central role for biodiversity while other measures act as secondary supporting functions.	[Portillo, Jose R.] Univ Seville, Dept Appl Math 1, Seville, Spain; [Soler-Toscano, Fernando] Univ Seville, Dept Philosophy Logic & Philosophy Sci, Seville, Spain; [Langa, Jose A.] Univ Seville, Dept Differential Equat & Numer Anal, Seville, Spain; [Portillo, Jose R.; Langa, Jose A.] Univ Sevilla Antonio Castro Brzezicki, Inst Matemat, Seville, Spain	University of Sevilla; University of Sevilla; University of Sevilla	Portillo, JR (corresponding author), Univ Seville, Dept Appl Math 1, Seville, Spain.; Portillo, JR (corresponding author), Univ Sevilla Antonio Castro Brzezicki, Inst Matemat, Seville, Spain.	josera@us.es	Soler-Toscano, Fernando/L-2478-2014; PORTILLO, JOSE R./M-2117-2013; Langa, Jose A./E-3612-2012	Soler-Toscano, Fernando/0000-0003-1953-4136; PORTILLO, JOSE R./0000-0002-0940-068X; Langa, Jose A./0000-0002-8765-0764	FEDER Ministerio de Economia, Industria y Competitividad [PGC2018-096540-B-I00]; Proyectos Fondo Europeo de Desarrollo Regional (FEDER); Consejeria de Economia, Conocimiento, Empresas y Universidad de la Junta de Andalucia; Programa Operativo FEDER [US-1254251, P20-00592]	FEDER Ministerio de Economia, Industria y Competitividad; Proyectos Fondo Europeo de Desarrollo Regional (FEDER); Consejeria de Economia, Conocimiento, Empresas y Universidad de la Junta de Andalucia(Junta de Andalucia); Programa Operativo FEDER	This work was partially supported by FEDER Ministerio de Economia, Industria y Competitividad grantPGC2018-096540-B-I00, and Proyectos Fondo Europeode Desarrollo Regional(FEDER)and Consejeria de Economia, Conocimiento, Empresas y Universidad de la Juntade Andalucia, by Programa Operativo FEDER2014-2020referencesUS-1254251 and P20-00592. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Afraimovich V, 2018, COMMUN NONLINEAR SCI, V55, P166, DOI 10.1016/j.cnsns.2017.07.005; Andronov A, 1937, CR ACAD SCI URSS, V14, P247; Aragao-Costa ER, 2011, NONLINEARITY, V24, P2099, DOI 10.1088/0951-7715/24/7/010; Aragao-Costa ER, 2012, TOPOL METHOD NONL AN, V39, P57; Babin AV., 1938, MATH PURES APPL, V62, P441; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bascompte J, 2006, SFI S SCI C, P143; Bascompte J, 2020, THEORETICAL ECOLOGY: CONCEPTS AND APPLICATIONS, P93, DOI 10.1093/oso/9780198824282.003.0007; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Bavelas A, 1948, APPL ANTHROPOL, V7, P16, DOI [DOI 10.17730/HUMO.7.3.F4033344851GL053, 10.17730/humo.7.3.f4033344851gl053]; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Bortolan M. C., 2020, MATH SURVEYS MONOGRA, V246; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Carvalho A. N., 2013, APPL MATH SCI, V182, DOI 10.1007/978-1-4614-4581-4; Cenci S, 2018, ECOL EVOL, V8, P6852, DOI 10.1002/ece3.4252; CROSS GW, 1978, LINEAR ALGEBRA APPL, V20, P253, DOI 10.1016/0024-3795(78)90021-6; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Csermely P, 2013, J COMPLEX NETW, V1, P93, DOI 10.1093/comnet/cnt016; Danziger MM, 2019, NAT PHYS, V15, P178, DOI 10.1038/s41567-018-0343-1; Deco G, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00068; Deco G, 2012, J NEUROSCI, V32, P3366, DOI 10.1523/JNEUROSCI.2523-11.2012; Rodriguez AD, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227897; Dellnitz M., 2006, ANAL MODELING SIMULA, P619; Esteban FJ, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006154; Fortuna MA, 2010, J ANIM ECOL, V79, P811, DOI 10.1111/j.1365-2656.2010.01688.x; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Galadi JA, 2021, NEUROIMAGE, V244, DOI 10.1016/j.neuroimage.2021.118551; Greene D, 2010, 2010 INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2010), P176, DOI 10.1109/ASONAM.2010.17; Grilli J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14389; Guerrero G, 2016, LECT NOTES ECON MATH, V683, P309, DOI 10.1007/978-3-319-40803-3_12; Guerrero G, 2017, NONLINEAR ANAL-REAL, V34, P17, DOI 10.1016/j.nonrwa.2016.07.009; Guimaraes PR, 2017, NATURE, V550, P511, DOI 10.1038/nature24273; Hale J. K., 1988, MATH SURVEYS MONOGRA, V25; Henry D., 1981, GEOMETRIC THEORY SEM, DOI [10.1007/BFb0089647, DOI 10.1007/BFB0089647]; Jalili M, 2017, J COMPLEX NETW, V5, P665, DOI 10.1093/comnet/cnx019; Jost J, 2007, NETWORKS: FROM BIOLOGY TO THEORY, P35, DOI 10.1007/978-1-84628-780-0_3; Kalita P, 2019, ENTROPY-SWITZ, V21, DOI 10.3390/e21050493; Ladyzhenskaya O.A., 1991, ATTRACTORS SEMIGROUP; Letellier C, 2018, PHYS REV E, V98, DOI 10.1103/PhysRevE.98.020303; Markovitch O, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192871; Medeiros LP, 2021, AM NAT, V197, pE17, DOI 10.1086/711663; Molkenthin N, 2014, SCI REP-UK, V4, DOI 10.1038/srep04119; Muezzinoglu MK, 2010, INT J BIFURCAT CHAOS, V20, P1653, DOI 10.1142/S0218127410026745; Murty KG, 1988, SIGMA SE RIES APPL M; Naimzada AK, 2009, LECT NOTES EC MATH S; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Norton D. E., 1995, COMMENT MATH U CAROL, V36, P585; Oizumi Masafumi, 2014, PLoS Comput Biol, V10, pe1003588, DOI 10.1371/journal.pcbi.1003588; Ortega R, 2021, WEB LIFE; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Payrato-Borras C, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.031024; Pirani M, 2014, IEEE DECIS CONTR P, P613, DOI 10.1109/CDC.2014.7039449; Rohr RP, 2014, SCIENCE, V345, P416, DOI 10.1126/science.1253497; Saavedra S, 2020, ECOL LETT, V23, P1511, DOI 10.1111/ele.13582; Saavedra S, 2016, ECOL EVOL, V6, P997, DOI 10.1002/ece3.1930; Saavedra S, 2011, NATURE, V478, P233, DOI 10.1038/nature10433; Song CL, 2020, J ECOL, V108, P1677, DOI 10.1111/1365-2745.13349; Song CL, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0767; Song CL, 2018, J THEOR BIOL, V450, P30, DOI 10.1016/j.jtbi.2018.04.030; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Stone L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12857; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Sun JM, 2011, SOCIAL NETWORK DATA ANALYTICS, P177; Suweis S, 2013, NATURE, V500, P449, DOI 10.1038/nature12438; TAKEUCHI Y, 1980, J MATH BIOL, V10, P401, DOI 10.1007/BF00276098; Takeuchi Y., 1996, GLOBAL DYNAMICAL PRO; Temam R., 1997, INFINITE DIMENSIONAL; THOM R, 1975, P348; Xie T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10663-6; Zenil H, 2014, PHYSICA A, V404, P341, DOI 10.1016/j.physa.2014.02.060	74	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267404	10.1371/journal.pone.0267404	http://dx.doi.org/10.1371/journal.pone.0267404			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7VA	35439272	Green Published, gold			2022-12-26	WOS:000791280100028
J	Wang, SW; Liu, XJ; Liu, N				Wang, Shaowen; Liu, Xiaojun; Liu, Na			How to alter path dependency and promote the use of EPC model in public projects of China?	PLOS ONE			English	Article							EVOLUTIONARY GAME; DELIVERY METHODS; SYSTEM DYNAMICS; PERSPECTIVE; SELECTION	The key to promoting the EPC (Engineering, Procurement, Construction) model in China's public construction projects is to alter the path dependence of a project owner's choice of project delivery model (PDM). This study uses evolutionary game theory to discuss the mechanism of government incentives as an external motivation to alter path dependence in the PDM. In addition, a cellular automata simulation to examine the influence of various government incentives on the project owner's choice. The results show that the combination of subsidies and penalties can produce the best incentive. Subsidies are more effective at promoting PDM institutional change, whereas penalties are more effective at preventing PDM institutional change from anti-recession effects. Based on our results, we propose that the Chinese government should take active subsidy measures at the initial stage of EPC promotion, and adopt a dynamic incentive strategy of continuously reducing subsidies and increasing penalties according to the improvement of the development degree of EPC model.	[Wang, Shaowen; Liu, Xiaojun; Liu, Na] Xian Univ Architecture & Technol, Sch Management, Xian, Shaanxi, Peoples R China	Xi'an University of Architecture & Technology	Wang, SW; Liu, XJ (corresponding author), Xian Univ Architecture & Technol, Sch Management, Xian, Shaanxi, Peoples R China.	shaowen_wang@foxmail.com; wisdomwonderful@yeah.net		Wang, Shaowen/0000-0001-9685-485X	National Key R&D Program of China [2018YFD1100202]	National Key R&D Program of China	The authors would like to thank journal referees for valuable observations and suggestions.	Adamtey S, 2021, J ENG DES TECHNOL, V19, P686, DOI 10.1108/JEDT-05-2020-0164; Ahmed S, 2021, BUILDINGS-BASEL, V11, DOI 10.3390/buildings11010011; Aoki M., 2001, COMP I ANAL; Azhar N, 2014, PROCEDIA ENGINEER, V77, P213, DOI 10.1016/j.proeng.2014.07.019; Brunninge O, 2016, MANAG ORGAN HIST, V11, P189, DOI 10.1080/17449359.2016.1150858; Bygballe LE, 2019, PROJ MANAG J, V50, P161, DOI 10.1177/8756972818820213; Cestino J, 2016, J MEDIA RES STUD, V13, P22, DOI 10.1080/16522354.2015.1133785; Choi K, 2020, J MANAGE ENG, V36, DOI 10.1061/(ASCE)ME.1943-5479.0000781; Cremene M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087471; Culp G., 2011, LEADERSH MANAGE ENG, V11, P231, DOI [10.1061/(ASCE)LM.1943-5630.0000133, DOI 10.1061/(ASCE)LM.1943-5630.0000133]; de Leeuw T, 2016, J CLEAN PROD, V135, P435, DOI 10.1016/j.jclepro.2016.06.119; Demetracopoulou V, 2020, J LEG AFF DISPUTE RE, V12, DOI 10.1061/(ASCE)LA.1943-4170.0000340; Du YC, 2019, ADV CIV ENG, V2019, DOI 10.1155/2019/4365358; El Asmar M, 2010, J CONSTR ENG M, V136, P904, DOI 10.1061/(ASCE)CO.1943-7862.0000194; Fan X., 2009, THESIS HARBIN I TECH; Greif A, 2006, POLIT ECON I DECIS, P1, DOI 10.1017/CBO9780511791307; Guo XT, 2021, J URBAN PLAN DEV, V147, DOI 10.1061/(ASCE)UP.1943-5444.0000766; Heinecke S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153260; Kebede SD, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e06462; Kent DC, 2010, J CONSTR ENG M, V136, P815, DOI 10.1061/(ASCE)CO.1943-7862.0000188; Lee RP, 2015, ENERGY RES SOC SCI, V8, P86, DOI 10.1016/j.erss.2015.05.001; Lin QW, 2015, LAND USE POLICY, V45, P8, DOI 10.1016/j.landusepol.2015.01.017; Liu MZ, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11174518; Meshref AN, 2021, OPEN ENG, V11, P269, DOI 10.1515/eng-2021-0028; Minchin RE, 2013, J CONSTR ENG M, V139, DOI 10.1061/(ASCE)CO.1943-7862.0000746; Petursson JG, 2017, ECOL ECON, V131, P166, DOI 10.1016/j.ecolecon.2016.08.028; Pi ZJ, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16132443; Stamatovic B, 2015, PROCEDIA ENGINEER, V117, P655, DOI 10.1016/j.proeng.2015.08.227; Sun HX, 2019, J CLEAN PROD, V235, P1315, DOI 10.1016/j.jclepro.2019.06.329; Wang CS, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16152775; Wang SW, 2022, J ASIAN ARCHIT BUILD, V21, P2095, DOI 10.1080/13467581.2021.1971681; Wang ZZ, 2017, ADV MECH ENG, V9, DOI 10.1177/1687814017715420; Wang ZH, 2013, 2013 FOURTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS DESIGN AND ENGINEERING APPLICATIONS, P277, DOI 10.1109/ISDEA.2013.467; Yuan HP, 2020, J CONSTR ENG M, V146, DOI 10.1061/(ASCE)CO.1943-7862.0001733; Yunus R, 2016, MATEC WEB CONF, V47, DOI 10.1051/matecconf/20164704017; Zhang LP, 2019, J CLEAN PROD, V210, P518, DOI 10.1016/j.jclepro.2018.11.028; Zhang RT, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235516; Zhang SY, 2019, APPL MATH COMPUT, V355, P343, DOI 10.1016/j.amc.2019.02.080; Zhou CH, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11164434; Zhou X, 2019, CLEAN TECHNOL ENVIR, V21, P1039, DOI 10.1007/s10098-019-01691-3; Zou YH, 2017, APPL GEOGR, V88, P38, DOI 10.1016/j.apgeog.2017.08.022	41	0	0	12	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266957	10.1371/journal.pone.0266957	http://dx.doi.org/10.1371/journal.pone.0266957			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7VA	35439263	Green Published, gold			2022-12-26	WOS:000791280100021
J	Chen, EY; Chang, HQ; Gao, R; Qiu, YH; Chen, H; Cheng, X; Gan, L; Ye-Lehmann, S; Zhu, T; Liu, J; Chen, G; Chen, C				Chen, Erya; Chang, Haiqing; Gao, Rui; Qiu, Yanhua; Chen, Hai; Cheng, Xu; Gan, Lu; Ye-Lehmann, Shixin; Zhu, Tao; Liu, Jin; Chen, Guo; Chen, Chan			Poly(I:C) attenuates myocardial ischemia/reperfusion injury by restoring autophagic function	FASEB JOURNAL			English	Article						autophagy; cardio-protection; ischemia; reperfusion injury; Poly(I; C)	ISCHAEMIA/REPERFUSION INJURY; PI3K/AKT/MTOR PATHWAY; REPERFUSION INJURY; HEART; ISCHEMIA; PROTEIN; CARDIOPROTECTION; CONTRIBUTES; PROTECTION; CLEARANCE	Polyinosinic-polycytidylic acid (poly(I:C)) is the agonist of Toll-like receptor 3 (TLR3), which participates in innate immune responses under the condition of myocardial ischemia/reperfusion injury (MIRI). It has been shown that poly(I:C) exhibited cardioprotective activities through the PI3K/Akt pathway, which is the main signal transduction pathway during autophagy. However, the precise mechanism by whether poly(I:C) regulates autophagy remains poorly understood. Thus, this study was designed to investigate the therapeutic effect of poly(I:C) against MIRI and the underlying pathway connection with autophagy. We demonstrated that 1.25 and 5 mg/kg poly(I:C) preconditioning significantly reduced myocardial infarct size and cardiac dysfunction. Moreover, poly(I:C) significantly promoted cell survival by restoring autophagy flux and then regulating it to an adequate level Increased autophagy protein Beclin1 and LC3II together with p62 degradation after additional chloroquine. In addition, mRFP-GFP-LC3 adenoviruses exhibited autophagy activity in neonatal rat cardiac myocytes (NRCMs). Mechanistically, poly(I:C) activated the PI3K/AKT/mTOR pathway to induce autophagy, which was abolished by LY294002 (PI3K antagonist), rapamycin (autophagy activator and mTOR inhibitor), or 3-methyladenine (autophagy inhibitor), suggesting either inhibition of the PI3K/Akt/mTOR pathway or autophagy activity interrupt the beneficial effect of poly(I:C) preconditioning. In conclusion, poly(I:C) promotes cardiomyocyte survival from ischemia/reperfusion injury by regulating autophagy via the PI3K/Akt/mTOR pathway.	[Chen, Erya; Chang, Haiqing; Gao, Rui; Qiu, Yanhua; Cheng, Xu; Zhu, Tao; Liu, Jin; Chen, Guo; Chen, Chan] Sichuan Univ, West China Hosp, Dept Anesthesiol, 37 Guoxue Xiang, Chengdu, Peoples R China; [Chen, Erya; Chang, Haiqing; Gao, Rui; Qiu, Yanhua; Cheng, Xu; Zhu, Tao; Liu, Jin; Chen, Guo; Chen, Chan] Chinese Acad Med Sci, Lab Anesthesia & Crit Care Med, Natl Clin Res Ctr Geriatr, Translat Neurosci Ctr,Res Units West China, Chengdu, Peoples R China; [Chen, Hai] Sichuan Univ, West China Hosp, Dept Resp & Crit Care Med, Targeted Tracer Res & Dev Lab, Chengdu, Peoples R China; [Gan, Lu] Sichuan Univ, West China Hosp, Dept Emergency Med, Chengdu, Peoples R China; [Ye-Lehmann, Shixin] Univ Paris Scalay, Bicetre Hosp, Dis & Hormones Nervous Syst, INSERM Tenured Researcher CR INSERM Res Unit U119, Le Kremlin Bicetre, France	Sichuan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Sichuan University; Sichuan University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP	Chen, G; Chen, C (corresponding author), Sichuan Univ, West China Hosp, Dept Anesthesiol, 37 Guoxue Xiang, Chengdu, Peoples R China.	grace_chenguo@hotmail.com; xychenchan@gmail.com		Chen, Chan/0000-0001-5823-8247	National Natural Science Foundation of China [82171185, 81870858, 81671062]; National Key R&D Program of China [2018YFC2001800]; Science and Technology Plan Project of Sichuan Province [2020YJ0051]; Huimin Technology Research and Development Projects Funding of Chengdu Science and Technology Bureau [2015-HM01-00446-SF]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Science and Technology Plan Project of Sichuan Province; Huimin Technology Research and Development Projects Funding of Chengdu Science and Technology Bureau	This work was supported by the National Natural Science Foundation of China (Grant No. 82171185 and No. 81870858 to Dr. Chan Chen; No. 81671062 to Dr. Tao Zhu); the National Key R&D Program of China (Grant No. 2018YFC2001800 to Dr. Tao Zhu); Science and Technology Plan Project of Sichuan Province (No. 2020YJ0051 to Chen Chan). Huimin Technology Research and Development Projects Funding of Chengdu Science and Technology Bureau (No. 2015--HM01-00446--SF to Dr. Yanhua Qiu)	Ashraf MI, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-6; Chen EY, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00257-w; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Dong JW, 2010, AM J PHYSIOL-HEART C, V298, pH1079, DOI 10.1152/ajpheart.00306.2009; Fan SN, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/161020; Gao T, 2018, J CELL MOL MED, V22, P395, DOI 10.1111/jcmm.13328; Gottlieb RA, 2015, CIRC RES, V116, P504, DOI 10.1161/CIRCRESAHA.116.303787; Gottlieb RA, 2011, AUTOPHAGY, V7, P434, DOI 10.4161/auto.7.4.14442; Ha T, 2008, CARDIOVASC RES, V78, P546, DOI 10.1093/cvr/cvn037; Ha TZ, 2010, CARDIOVASC RES, V87, P694, DOI 10.1093/cvr/cvq116; Heras-Sandoval D, 2014, CELL SIGNAL, V26, P2694, DOI 10.1016/j.cellsig.2014.08.019; Hernandez-Resendiz S, 2018, CURR MED CHEM, V25, P1275, DOI 10.2174/0929867324666170329100619; Heusch G, 2017, EUR HEART J, V38, P774, DOI 10.1093/eurheartj/ehw224; Iwai-Kanai E, 2008, AUTOPHAGY, V4, P322, DOI 10.4161/auto.5603; Jernberg T, 2011, JAMA-J AM MED ASSOC, V305, P1677, DOI 10.1001/jama.2011.522; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li HY, 2021, INNOVATION-AMSTERDAM, V2, DOI 10.1016/j.xinn.2021.100111; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Ma XC, 2012, AUTOPHAGY, V8, P1394, DOI 10.4161/auto.21036; Ma XC, 2012, CIRCULATION, V125, P3170, DOI 10.1161/CIRCULATIONAHA.111.041814; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Oyama J, 2004, CIRCULATION, V109, P784, DOI 10.1161/01.CIR.0000112575.66565.84; Pyo JO, 2012, EXP MOL MED, V44, P73, DOI 10.3858/emm.2012.44.2.029; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Roy B, 2014, CHEM-BIOL INTERACT, V210, P96, DOI 10.1016/j.cbi.2014.01.003; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Shanmugam K, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9173436; Sun H, 2013, ANTI-CANCER AGENT ME, V13, P1048, DOI 10.2174/18715206113139990130; Tao ZW, 2018, ASAIO J, V64, pE105, DOI 10.1097/MAT.0000000000000765; van der Bijl P, 2020, JACC-HEART FAIL, V8, P131, DOI 10.1016/j.jchf.2019.08.014; Wang XH, 2013, CARDIOVASC RES, V97, P432, DOI 10.1093/cvr/cvs356; Xu Xianghua, 2009, J Vis Exp, DOI 10.3791/1308; Zacharowski K, 2000, ARTERIOSCL THROM VAS, V20, P1521, DOI 10.1161/01.ATV.20.6.1521; Zheng YJ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.7; Zhou H, 2018, CELL SIGNAL, V45, P12, DOI 10.1016/j.cellsig.2018.01.020; Zuurbier CJ, 2019, CARDIOVASC RES, V115, P1131, DOI 10.1093/cvr/cvy304	40	1	1	7	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22317	10.1096/fj.202101220RR	http://dx.doi.org/10.1096/fj.202101220RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0O5YU	35438806				2022-12-26	WOS:000783602200001
J	Naser, W; Maymand, S; Rivera, LR; Connor, T; Liongue, C; Smith, CM; Aston-Mourney, K; McCulloch, DR; McGee, SL; Ward, AC				Naser, Wasan; Maymand, Saeed; Rivera, Leni R.; Connor, Timothy; Liongue, Clifford; Smith, Craig M.; Aston-Mourney, Kathryn; McCulloch, Daniel R.; McGee, Sean L.; Ward, Alister C.			Cytokine-inducible SH2 domain containing protein contributes to regulation of adiposity, food intake, and glucose metabolism	FASEB JOURNAL			English	Article						adiposity; appetite; CISH; cytokine; glucose metabolism; leptin; SOCS	ENERGY-EXPENDITURE; INSULIN-RESISTANCE; MICE LACKING; LEPTIN RECEPTOR; GENE-EXPRESSION; NEUROPEPTIDE-Y; SOCS PROTEINS; T-CELLS; SUPPRESSOR; DELETION	The cytokine-inducible SH2 domain containing protein (CISH) is the founding member of the suppressor of cytokine signaling (SOCS) family of negative feedback regulators and has been shown to be a physiological regulator of signaling in immune cells. This study sought to investigate novel functions for CISH outside of the immune system. Mice deficient in CISH were generated and analyzed using a range of metabolic and other parameters, including in response to a high fat diet and leptin administration. CISH knockout mice possessed decreased body fat and showed resistance to diet-induced obesity. This was associated with reduced food intake, but unaltered energy expenditure and microbiota composition. CISH ablation resulted in reduced basal expression of the orexigenic Agrp gene in the arcuate nucleus (ARC) region of the brain. Cish was basally expressed in the ARC, with evidence of co-expression with the leptin receptor (Lepr) gene in Agrp-positive neurons. CISH-deficient mice also showed enhanced leptin responsiveness, although Cish expression was not itself modulated by leptin. CISH-deficient mice additionally exhibited improved insulin sensitivity on a high-fat diet, but not glucose tolerance despite reduced body weight. These data identify CISH as an important regulator of homeostasis through impacts on appetite control, mediated at least in part by negative regulation of the anorexigenic effects of leptin, and impacts on glucose metabolism.	[Naser, Wasan; Maymand, Saeed; Rivera, Leni R.; Connor, Timothy; Liongue, Clifford; Smith, Craig M.; Aston-Mourney, Kathryn; McCulloch, Daniel R.; McGee, Sean L.; Ward, Alister C.] Deakin Univ, Sch Med, Pigdons Rd, Geelong, Vic 3216, Australia; [Naser, Wasan] Univ Baghdad, Coll Sci, Baghdad, Iraq; [Rivera, Leni R.; Liongue, Clifford; Smith, Craig M.; Aston-Mourney, Kathryn; McCulloch, Daniel R.; McGee, Sean L.; Ward, Alister C.] Deakin Univ, IMPACT, Geelong, Vic, Australia	Deakin University; University of Baghdad; Deakin University	Ward, AC (corresponding author), Deakin Univ, Sch Med, Pigdons Rd, Geelong, Vic 3216, Australia.	award@deakin.edu.au			IMPACT at Deakin University; Higher Committee for Education Development (HCED) of Iraq	IMPACT at Deakin University; Higher Committee for Education Development (HCED) of Iraq	The authors recognize the support of funding from IMPACT at Deakin University, while W.N. was supported by the Higher Committee for Education Development (HCED) of Iraq	Aston-Mourney K, 2007, DIABETOLOGIA, V50, P2476, DOI 10.1007/s00125-007-0814-x; Banks AS, 2005, J CLIN INVEST, V115, P2462, DOI 10.1172/JCI23853; Barrios-Correa AA, 2018, J MOL NEUROSCI, V66, P390, DOI 10.1007/s12031-018-1185-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Bond ST, 2017, FASEB J, V31, P2592, DOI 10.1096/fj.201601215R; Burke LK, 2016, MOL METAB, V5, P245, DOI 10.1016/j.molmet.2016.01.005; Campbell JN, 2017, NAT NEUROSCI, V20, P484, DOI 10.1038/nn.4495; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Delconte RB, 2016, NAT IMMUNOL, V17, P816, DOI 10.1038/ni.3470; Denroche HC, 2012, J DIABETES INVEST, V3, P115, DOI 10.1111/j.2040-1124.2012.00203.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Eyckerman S, 2000, FEBS LETT, V486, P33, DOI 10.1016/S0014-5793(00)02205-5; Galic S, 2014, BIOCHEM J, V461, P177, DOI 10.1042/BJ20140143; Gaudy AM, 2010, J BIOL CHEM, V285, P41356, DOI 10.1074/jbc.M110.159111; Gaur V, 2017, DIABETES OBES METAB, V19, P936, DOI 10.1111/dom.12896; Gaur V, 2016, CELL REP, V16, P2802, DOI 10.1016/j.celrep.2016.08.005; Gholizadeh P, 2019, MICROB PATHOGENESIS, V127, P48, DOI 10.1016/j.micpath.2018.11.031; He Z, 2012, MOL CELL BIOL, V32, P1867, DOI 10.1128/MCB.06712-11; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Huh JY, 2014, MOL CELLS, V37, P365, DOI 10.14348/molcells.2014.0074; Jamieson E, 2005, J BIOL CHEM, V280, P31516, DOI 10.1074/jbc.M502163200; Jiao Y, 2013, DIABETOLOGIA, V56, P2435, DOI 10.1007/s00125-013-3014-x; Jorgensen SB, 2013, DIABETES, V62, P56, DOI 10.2337/db12-0443; Kasagi Y, 2004, ENDOCR J, V51, P145, DOI 10.1507/endocrj.51.145; Kawazoe Y, 2001, J EXP MED, V193, P263, DOI 10.1084/jem.193.2.263; Keating N, 2019, CYTOKINE, V118, P64, DOI 10.1016/j.cyto.2018.03.033; Knobelspies H, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-2; Krebs DL, 2004, P NATL ACAD SCI USA, V101, P15446, DOI 10.1073/pnas.0406870101; Krebs DL, 2002, MOL CELL BIOL, V22, P4567, DOI 10.1128/MCB.22.13.4567-4578.2002; Lavens D, 2006, J CELL SCI, V119, P2214, DOI 10.1242/jcs.02947; Lebrun P, 2010, DIABETOLOGIA, V53, P1935, DOI 10.1007/s00125-010-1786-9; Lee SJ, 2013, J NEUROSCI, V33, P15306, DOI 10.1523/JNEUROSCI.0837-13.2013; Li L, 2004, J BIOL CHEM, V279, P34107, DOI 10.1074/jbc.M312672200; Louis C, 2020, J EXP MED, V217, DOI 10.1084/jem.20191421; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Matsumoto A, 1999, MOL CELL BIOL, V19, P6396; McCabe IC, 2019, J CELL BIOCHEM, V120, P4398, DOI 10.1002/jcb.27726; Mercer AJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE904, DOI 10.1152/ajpendo.00540.2013; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Mooney RA, 2001, J BIOL CHEM, V276, P25889, DOI 10.1074/jbc.M010579200; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Nohara K, 2011, ENDOCRINOLOGY, V152, P1661, DOI 10.1210/en.2010-1288; Palmer DC, 2015, J EXP MED, V212, P2095, DOI 10.1084/jem.20150304; Piaggi P, 2018, J ENDOCRINOL INVEST, V41, P83, DOI 10.1007/s40618-017-0732-9; Puff R, 2010, ISLETS, V2, P252, DOI 10.4161/isl.2.4.12556; Reed JA, 2005, J CLIN INVEST, V115, P3035, DOI 10.1172/JCI25681; Rugarn O, 1999, PEPTIDES, V20, P81, DOI 10.1016/S0196-9781(98)00139-9; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sachithanandan N, 2011, DIABETES, V60, P2023, DOI 10.2337/db11-0259; Sachithanandan N, 2010, HEPATOLOGY, V52, P1632, DOI 10.1002/hep.23861; Seyfarth Julia, 2018, Mol Cell Pediatr, V5, P2, DOI 10.1186/s40348-018-0080-7; Sobah ML, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.727987; Speakman JR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00034; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Strebovsky J, 2012, FRONT BIOSCI-LANDMRK, V17, P1627, DOI 10.2741/4008; Torisu T, 2007, GENES CELLS, V12, P143, DOI 10.1111/j.1365-2443.2007.01044.x; Trengove MC, 2013, AM J CLIN EXP IMMUNO, V2, P1; URBAN JH, 1993, ENDOCRINOLOGY, V132, P139, DOI 10.1210/en.132.1.139; Val CH, 2020, J NUTR BIOCHEM, V76, DOI 10.1016/j.jnutbio.2019.108304; Varela L, 2012, EMBO REP, V13, P1079, DOI 10.1038/embor.2012.174; Vink T, 2001, MOL PSYCHIATR, V6, P325, DOI 10.1038/sj.mp.4000854; Vlacich G, 2010, ISLETS, V2, P308, DOI 10.4161/isl.2.5.13058; Wang TT, 2022, AGEING RES REV, V77, DOI 10.1016/j.arr.2022.101611; Wang XL, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-017-0435-2; Wang Z, 2019, AM J PHYSIOL-REG I, V316, pR338, DOI 10.1152/ajpregu.00163.2018; Wauman J, 2018, BBA-MOL CELL RES, V1865, P1312, DOI 10.1016/j.bbamcr.2018.06.009; Yang XXO, 2013, NAT IMMUNOL, V14, P732, DOI 10.1038/ni.2633; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Yoshimura A, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028571; Zadjali F, 2012, FASEB J, V26, P3282, DOI 10.1096/fj.12-205583; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	77	1	1	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22320	10.1096/fj.202101882R	http://dx.doi.org/10.1096/fj.202101882R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0T8JK	35470501				2022-12-26	WOS:000787209100001
J	Ahmed, AA; Strong, MJ; Zhou, XF; Robinson, T; Rocco, S; Siegel, GW; Clines, GA; Moore, BB; Keller, ET; Szerlip, NJ				Ahmed, Aqila A.; Strong, Michael J.; Zhou, Xiaofeng; Robinson, Tyler; Rocco, Sabrina; Siegel, Geoffrey W.; Clines, Gregory A.; Moore, Bethany B.; Keller, Evan T.; Szerlip, Nicholas J.			Differential immune landscapes in appendicular versus axial skeleton	PLOS ONE			English	Article							SUPPRESSOR-CELLS; BONE METASTASIS; MYELOID CELLS; TUMOR MICROENVIRONMENT; SURGICAL-TREATMENT; MARROW; CANCER; PROMOTES; MECHANISMS; DISEASE	Roughly 400,000 people in the U.S. are living with bone metastases, the vast majority occurring in the spine. Metastases to the spine result in fractures, pain, paralysis, and significant health care costs. This predilection for cancer to metastasize to the bone is seen across most cancer histologies, with the greatest incidence seen in prostate, breast, and lung cancer. The molecular process involved in this predilection for axial versus appendicular skeleton is not fully understood, although it is likely that a combination of tumor and local micro-environmental factors plays a role. Immune cells are an important constituent of the bone marrow microenvironment and many of these cells have been shown to play a significant role in tumor growth and progression in soft tissue and bone disease. With this in mind, we sought to examine the differences in immune landscape between axial and appendicular bones in the normal noncancerous setting in order to obtain an understanding of these landscapes. To accomplish this, we utilized mass cytometry by time-of-flight (CyTOF) to examine differences in the immune cell landscapes between the long bone and vertebral body bone marrow from patient clinical samples and C57BL/6J mice. We demonstrate significant differences between immune populations in both murine and human marrow with a predominance of myeloid progenitor cells in the spine. Additionally, cytokine analysis revealed differences in concentrations favoring a more myeloid enriched population of cells in the vertebral body bone marrow. These differences could have clinical implications with respect to the distribution and permissive growth of bone metastases.	[Ahmed, Aqila A.; Zhou, Xiaofeng; Clines, Gregory A.; Moore, Bethany B.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Ahmed, Aqila A.; Keller, Evan T.] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA; [Strong, Michael J.; Rocco, Sabrina; Szerlip, Nicholas J.] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA; [Robinson, Tyler; Keller, Evan T.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; [Siegel, Geoffrey W.] Univ Michigan, Dept Orthopaed Surg, Ann Arbor, MI 48109 USA; [Clines, Gregory A.; Szerlip, Nicholas J.] Vet Affairs Med Ctr, Ann Arbor, MI 48105 USA; [Moore, Bethany B.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Michigan System; University of Michigan	Szerlip, NJ (corresponding author), Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA.; Szerlip, NJ (corresponding author), Vet Affairs Med Ctr, Ann Arbor, MI 48105 USA.	nszerlip@med.umich.edu		Strong, Michael/0000-0001-9930-3578; Robinson, Tyler/0000-0002-6791-6537	National Institutes of Health [P01CA093900, R21NS107879, F32CA254147]; Rogel Cancer Center [G020989]; Department of Defense Prostate Cancer Research Program [PC170089]; VA Merit Review [1I01BX001370]; Society of Neurological Surgeons/RUNN Resident Award	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rogel Cancer Center; Department of Defense Prostate Cancer Research Program(United States Department of Defense); VA Merit Review(US Department of Veterans Affairs); Society of Neurological Surgeons/RUNN Resident Award	This work was supported in part by National Institutes of Health grants P01CA093900 (E.T.K.), R21NS107879 (Alexandra Calinescu), and F32CA254147 (M.J.S.), Rogel Cancer Center grant G020989 (Alexandra Calinescu, N.J.S.), Department of Defense Prostate Cancer Research Program PC170089 Early Investigator Award (N.J. S.), VA Merit Review 1I01BX001370 (G.A.C.), and The Society of Neurological Surgeons/RUNN Resident Award (M.J.S.).	Aarts CEM, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12989; Alyas Faisal, 2007, Magn Reson Imaging Clin N Am, V15, P199, DOI 10.1016/j.mric.2007.03.002; Beatty GL, 2015, CLIN CANCER RES, V21, P687, DOI 10.1158/1078-0432.CCR-14-1860; Bendall SC, 2012, TRENDS IMMUNOL, V33, P323, DOI 10.1016/j.it.2012.02.010; Bidwell BN, 2012, NAT MED, V18, P1224, DOI 10.1038/nm.2830; Bohm P, 2002, J BONE JOINT SURG BR, V84B, P521, DOI 10.1302/0301-620X.84B4.12495; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Capietto Aude-Helene, 2014, Bonekey Rep, V3, P600, DOI 10.1038/bonekey.2014.95; Capietto AH, 2013, J EXP MED, V210, P2257, DOI 10.1084/jem.20130281; Chen H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005112; Chen J, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0757-z; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; D'Amico L, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/143526; Fang H, 2013, CANCER RES, V73, P4965, DOI 10.1158/0008-5472.CAN-13-0661; Fridlender ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031524; Fujisaki J, 2011, NATURE, V474, P216, DOI 10.1038/nature10160; Gabrilovich DI, 2007, CANCER RES, V67, P425, DOI 10.1158/0008-5472.CAN-06-3037; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Ghajar CM, 2015, NAT REV CANCER, V15, P238, DOI 10.1038/nrc3910; Guillerman RP, 2013, PEDIATR RADIOL, V43, pS181, DOI 10.1007/s00247-012-2582-0; HARADA M, 1992, ADV EXP MED BIOL, V324, P83; HARRINGTON KD, 1986, J BONE JOINT SURG AM, V68A, P1110, DOI 10.2106/00004623-198668070-00025; Hatrick NC, 2000, RADIOTHER ONCOL, V56, P335; He DG, 2010, J IMMUNOL, V184, P2281, DOI 10.4049/jimmunol.0902574; Hirata Y, 2018, CELL STEM CELL, V22, P445, DOI 10.1016/j.stem.2018.01.017; Jaffer T, 2016, TRANSL CANCER RES, V5, pS616, DOI 10.21037/tcr.2016.10.06; Jiao SP, 2019, CELL, V179, P1177, DOI 10.1016/j.cell.2019.10.029; Jinnah AH, 2018, CANCERS, V10, DOI 10.3390/cancers10060176; Jones BA, 2010, MOL INTERV, V10, P263, DOI 10.1124/mi.10.5.3; Klein-Goldberg A, 2014, CANCER LETT, V352, P54, DOI 10.1016/j.canlet.2013.08.029; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; KRICUN ME, 1985, SKELETAL RADIOL, V14, P10, DOI 10.1007/BF00361188; Kudo-Saito C, 2013, CANCER RES, V73, P6185, DOI 10.1158/0008-5472.CAN-13-1364; Kumar V, 2016, TRENDS IMMUNOL, V37, P208, DOI 10.1016/j.it.2016.01.004; Kumar V, 2016, IMMUNITY, V44, P303, DOI 10.1016/j.immuni.2016.01.014; Kusmartsev S, 2006, CANCER METAST REV, V25, P323, DOI 10.1007/s10555-006-9002-6; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Lopes EBP, 2017, CURR OSTEOPOROS REP, V15, P593, DOI 10.1007/s11914-017-0411-y; Lyons YA, 2017, NPJ PRECIS ONCOL, V1, DOI 10.1038/s41698-017-0031-0; Ma PW, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01401; Malkiewicz A, 2012, POL J RADIOL, V77, P45, DOI 10.12659/PJR.883628; Marchesi F, 2010, J NEUROIMMUNOL, V224, P39, DOI 10.1016/j.jneuroim.2010.05.007; Marquez EJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14396-9; Meirow Y, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00523; Miller JFAP, 2015, CANCER CELL, V27, P439, DOI 10.1016/j.ccell.2015.03.007; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Murphy DT, 2010, MAGN RESON IMAGING C, V18, P727, DOI 10.1016/j.mric.2010.07.003; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Nouh MR, 2015, WORLD J RADIOL, V7, P448, DOI 10.4329/wjr.v7.i12.448; Paget S., 1889, LANCET, V1, P571, DOI DOI 10.1016/S0140-6736(00)49915-0; Parker KH, 2015, ADV CANCER RES, V128, P95, DOI 10.1016/bs.acr.2015.04.002; Peinado H, 2017, NAT REV CANCER, V17, P302, DOI 10.1038/nrc.2017.6; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Porembka MR, 2012, CANCER IMMUNOL IMMUN, V61, P1373, DOI 10.1007/s00262-011-1178-0; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Ribechini E, 2010, MED MICROBIOL IMMUN, V199, P273, DOI 10.1007/s00430-010-0151-4; Robinson DR, 2017, NATURE, V548, P297, DOI 10.1038/nature23306; Roodman GD, 2009, CANCER METAST BIOL T, V12, P31, DOI 10.1007/978-1-4020-9819-2_2; Rosen CJ, 2009, CRIT REV EUKAR GENE, V19, P109, DOI 10.1615/CritRevEukarGeneExpr.v19.i2.20; Scanzello CR, 2017, CURR OPIN RHEUMATOL, V29, P79, DOI 10.1097/BOR.0000000000000353; Sciubba DM, 2010, J NEUROSURG-SPINE, V13, P94, DOI 10.3171/2010.3.SPINE09202; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; Sinha P, 2008, J IMMUNOL, V181, P4666, DOI 10.4049/jimmunol.181.7.4666; Spitzer MH, 2015, SCIENCE, V349, DOI 10.1126/science.1259425; Strong MJ, 2021, J NEURO-ONCOL, V153, P33, DOI 10.1007/s11060-021-03752-4; Suva LJ, 2011, NAT REV ENDOCRINOL, V7, P208, DOI 10.1038/nrendo.2010.227; Thakur A, 2012, CANCER IMMUNOL IMMUN, V61, P497, DOI 10.1007/s00262-011-1116-1; Tiwana MS, 2016, RADIOTHER ONCOL, V118, P552, DOI 10.1016/j.radonc.2015.10.015; Vande Berg BC, 1998, SKELETAL RADIOL, V27, P471, DOI 10.1007/s002560050423; Volin MV, 2001, AM J PATHOL, V159, P1521, DOI 10.1016/S0002-9440(10)62537-0; Yao Y, 2014, J IMMUNOL METHODS, V415, P1, DOI 10.1016/j.jim.2014.10.010; Zhang H, 2017, ONCOGENE, V36, P2095, DOI 10.1038/onc.2016.367; Zhao ED, 2012, CELL MOL IMMUNOL, V9, P11, DOI 10.1038/cmi.2011.47; Zhou J, 2018, SEMIN IMMUNOL, V35, P19, DOI 10.1016/j.smim.2017.12.004; Zhu YFPP, 2019, JOVE-J VIS EXP, DOI 10.3791/59617	76	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267642	10.1371/journal.pone.0267642	http://dx.doi.org/10.1371/journal.pone.0267642			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476843	gold, Green Published			2022-12-26	WOS:000840124300060
J	Lu, MD; Telwatte, S; Kumar, N; Ferreira, F; Martin, HA; Kadiyala, GN; Wedrychowski, A; Moron-Lopez, S; Chen, TH; Goecker, EA; Coombs, RW; Lu, CM; Wong, JK; Tsibris, A; Yukl, SA				Lu, Michael D.; Telwatte, Sushama; Kumar, Nitasha; Ferreira, Fernanda; Martin, Holly Anne; Kadiyala, Gayatri Nikhila; Wedrychowski, Adam; Moron-Lopez, Sara; Chen, Tsui-Hua; Goecker, Erin A.; Coombs, Robert W.; Lu, Chuanyi M.; Wong, Joseph K.; Tsibris, Athe; Yukl, Steven A.			Novel assays to investigate the mechanisms of latent infection with HIV-2	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; BLOOD MONONUCLEAR-CELLS; LONG TERMINAL REPEAT; PLASMA VIRAL LOAD; TYPE-2 SUBTYPE-A; PERIPHERAL-BLOOD; ANTIRETROVIRAL THERAPY; DRUG-RESISTANCE; GENE-EXPRESSION	Although there have been great advancements in the field of HIV treatment and prevention, there is no cure. There are two types of HIV: HIV-1 and HIV-2. In addition to genetic differences between the two types of HIV, HIV-2 infection causes a slower disease progression, and the rate of new HIV-2 infections has dramatically decreased since 2003. Like HIV-1, HIV-2 is capable of establishing latent infection in CD4(+) T cells, thereby allowing the virus to evade viral cytopathic effects and detection by the immune system. The mechanisms underlying HIV latency are not fully understood, rendering this a significant barrier to development of a cure. Using RT-ddPCR, we previously demonstrated that latent infection with HIV-1 may be due to blocks to HIV transcriptional elongation, distal transcription/polyadenylation, and multiple splicing. In this study, we describe the development of seven highly-specific RT-ddPCR assays for HIV-2 that can be applied to the study of HIV-2 infections and latency. We designed and validated seven assays targeting different HIV-2 RNA regions along the genome that can be used to measure the degree of progression through different blocks to HIV-2 transcription and splicing. Given that HIV-2 is vastly understudied relative to HIV-1 and that it can be considered a model of a less virulent infection, application of these assays to studies of HIV-2 latency may inform new therapies for HIV-2, HIV-1, and other retroviruses.	[Lu, Michael D.; Telwatte, Sushama; Kumar, Nitasha; Martin, Holly Anne; Kadiyala, Gayatri Nikhila; Wedrychowski, Adam; Moron-Lopez, Sara; Lu, Chuanyi M.; Wong, Joseph K.; Yukl, Steven A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Telwatte, Sushama; Kumar, Nitasha; Martin, Holly Anne; Kadiyala, Gayatri Nikhila; Wedrychowski, Adam; Moron-Lopez, Sara; Chen, Tsui-Hua; Lu, Chuanyi M.; Wong, Joseph K.; Yukl, Steven A.] San Francisco VA Hlth Care Syst, Dept Med, San Francisco, CA 94121 USA; [Ferreira, Fernanda] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA; [Goecker, Erin A.; Coombs, Robert W.] Univ Washington, Dept Lab Med & Pathol, Seattle, WA 98195 USA	University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Washington; University of Washington Seattle	Yukl, SA (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Yukl, SA (corresponding author), San Francisco VA Hlth Care Syst, Dept Med, San Francisco, CA 94121 USA.	Steven.Yukl@ucsf.edu		Lu, Michael/0000-0001-7999-1924; Moron-Lopez, Sara/0000-0003-0800-9205	National Institute of Allergy and Infectious Diseases at the National Institutes of Health [1R01AI132128, UW CFAR P30-AI-027757]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health [1R01DK108349, 1R01DK120387]; U.S. Department of Veterans Affairs [IK2 CX000520, I01 BX000192]	National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (1R01AI132128 [SY, JW], UW CFAR P30-AI-027757 [RWC]); the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health (1R01DK108349 [SY], 1R01DK120387 [SY]); and the U.S. Department of Veterans Affairs (IK2 CX000520 [SY], I01 BX000192 [JW]). The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Agbottah E, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-48; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Avettand-Fenoel V, 2014, J CLIN MICROBIOL, V52, P3017, DOI 10.1128/JCM.00724-14; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; BEDNARIK DP, 1987, J VIROL, V61, P1253, DOI 10.1128/JVI.61.4.1253-1257.1987; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Bertine M, 2015, AIDS, V29, P779, DOI 10.1097/QAD.0000000000000607; Bruner KM, 2016, NAT MED, V22, P1043, DOI 10.1038/nm.4156; Bui JK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006283; Chang M, 2017, J CLIN VIROL, V86, P56, DOI 10.1016/j.jcv.2016.11.011; Chang M, 2012, J CLIN VIROL, V55, P128, DOI 10.1016/j.jcv.2012.06.024; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; CLAVEL F, 1987, NEW ENGL J MED, V316, P1180, DOI 10.1056/NEJM198705073161903; CLAVEL F, 1986, SCIENCE, V233, P343, DOI 10.1126/science.2425430; CLAVEL F, 1986, NATURE, V324, P691, DOI 10.1038/324691a0; Cohn LB, 2015, CELL, V160, P420, DOI 10.1016/j.cell.2015.01.020; Colson P, 2005, J MED VIROL, V75, P381, DOI 10.1002/jmv.20296; D'Orso I, 2010, NAT STRUCT MOL BIOL, V17, P815, DOI 10.1038/nsmb.1827; Damond F, 2005, J CLIN MICROBIOL, V43, P4234, DOI 10.1128/JCM.43.8.4234-4236.2005; Damond F, 2002, J CLIN MICROBIOL, V40, P3654, DOI 10.1128/JCM.40.10.3654-3659.2002; Damond F, 2001, J CLIN MICROBIOL, V39, P4264, DOI 10.1128/JCM.39.12.4264-4268.2001; de Mendoza C, 2017, AIDS, V31, P1353, DOI 10.1097/QAD.0000000000001485; DECOCK KM, 1993, JAMA-J AM MED ASSOC, V270, P2083, DOI 10.1001/jama.270.17.2083; Descamps D, 2004, J MED VIROL, V74, P197, DOI 10.1002/jmv.20174; Drylewicz J, 2008, AIDS, V22, P457, DOI 10.1097/QAD.0b013e3282f4ddfc; Duvall MG, 2007, J VIROL, V81, P13486, DOI 10.1128/JVI.00976-07; Duvall MG, 2006, J IMMUNOL, V176, P6973, DOI 10.4049/jimmunol.176.11.6973; Einkauf KB, 2019, J CLIN INVEST, V129, P988, DOI 10.1172/JCI124291; Emiliani S, 1996, P NATL ACAD SCI USA, V93, P6377, DOI 10.1073/pnas.93.13.6377; Emiliani S, 1998, J VIROL, V72, P1666, DOI 10.1128/JVI.72.2.1666-1670.1998; Esbjornsson J, 2019, AIDS RES THER, V16, DOI 10.1186/s12981-019-0239-x; Esbjornsson J, 2019, LANCET HIV, V6, pE25, DOI 10.1016/S2352-3018(18)30254-6; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fischer M, 2002, ANTIVIR THER, V7, P91; Ghose R, 2001, J VIROL, V75, P11336, DOI 10.1128/JVI.75.23.11336-11343.2001; Gueudin M, 2008, AIDS, V22, P211, DOI 10.1097/QAD.0b013e3282f42429; GUTEKUNST KA, 1993, J ACQ IMMUN DEF SYND, V6, P541; Han YF, 2004, J VIROL, V78, P6122, DOI 10.1128/JVI.78.12.6122-6133.2004; Heitzinger K, 2012, INT J STD AIDS, V23, P710, DOI 10.1258/ijsa.2012.011219; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hosmane NN, 2017, J EXP MED, V214, P959, DOI 10.1084/jem.20170193; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Jaffar S, 1997, J ACQ IMMUN DEF SYND, V16, P327, DOI 10.1097/00042560-199712150-00003; Jallow S, 2006, AIDS, V20, P1455, DOI 10.1097/01.aids.0000233582.64467.8e; Jaye A, 2004, J INFECT DIS, V189, P498, DOI 10.1086/381185; Kaiser P, 2006, J INFECT DIS, V194, P1713, DOI 10.1086/508431; Kaiser P, 2017, J VIROL METHODS, V242, P1, DOI 10.1016/j.jviromet.2016.12.017; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; Kim YK, 2006, EMBO J, V25, P3596, DOI 10.1038/sj.emboj.7601248; Kuiken Carla, 2003, AIDS Reviews, V5, P52; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Kyei GB, 2018, MBIO, V9, DOI 10.1128/mBio.01423-18; Lahaye X, 2013, IMMUNITY, V39, P1132, DOI 10.1016/j.immuni.2013.11.002; Landry S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-71; Lassen K, 2004, TRENDS MOL MED, V10, P525, DOI 10.1016/j.molmed.2004.09.006; Lassen KG, 2006, PLOS PATHOG, V2, P650, DOI 10.1371/journal.ppat.0020068; Lassen KG, 2004, J VIROL, V78, P9105, DOI 10.1128/JVI.78.17.9105-9114.2004; Le Hingrat Q, 2020, J VIROL, V94, DOI 10.1128/JVI.01504-19; Lenasi T, 2008, CELL HOST MICROBE, V4, P123, DOI 10.1016/j.chom.2008.05.016; Lin X, 2003, J VIROL, V77, P8227, DOI 10.1128/JVI.77.15.8227-8236.2003; Lorenzi JCC, 2016, P NATL ACAD SCI USA, V113, pE7908, DOI 10.1073/pnas.1617789113; MacNeil A, 2007, J VIROL, V81, P5325, DOI 10.1128/JVI.02625-06; MacNeil A, 2006, J VIROL, V80, P7316, DOI 10.1128/JVI.00604-06; Malatinkova E, 2014, J INT AIDS SOC, V17, P120, DOI 10.7448/IAS.17.4.19674; Maldarelli F, 2014, SCIENCE, V345, P179, DOI 10.1126/science.1254194; MARLINK R, 1994, SCIENCE, V265, P1587, DOI 10.1126/science.7915856; Martinez-Steele E, 2007, AIDS, V21, P317, DOI 10.1097/QAD.0b013e328011d7ab; Menendez-Arias L, 2008, TRENDS PHARMACOL SCI, V29, P42, DOI 10.1016/j.tips.2007.10.013; Moron-Lopez S, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1009060; Nyamweya S, 2013, REV MED VIROL, V23, P221, DOI 10.1002/rmv.1739; Omoto Shinya, 2004, Retrovirology, V1, P44, DOI 10.1186/1742-4690-1-44; Pearson R, 2008, J VIROL, V82, P12291, DOI 10.1128/JVI.01383-08; Peruski AH, 2020, MMWR-MORBID MORTAL W, V69, P63, DOI [10.3886/ICPSR34725.v1, 10.15585/mmwr.mm6903a2]; POMERANTZ RJ, 1992, J VIROL, V66, P1809, DOI 10.1128/JVI.66.3.1809-1813.1992; Popper SJ, 2000, J VIROL, V74, P1554, DOI 10.1128/JVI.74.3.1554-1557.2000; Raugi DN, 2021, CLIN INFECT DIS, V72, P369, DOI 10.1093/cid/ciaa277; Rodriguez SK, 2007, J VIROL, V81, P5331, DOI 10.1128/JVI.02789-06; Sanchez G, 1997, J VIROL, V71, P2233, DOI 10.1128/JVI.71.3.2233-2240.1997; Sarracino A, 2018, MBIO, V9, DOI 10.1128/mBio.02158-18; SCHULZEFORSTER K, 1990, BIOCHEM BIOPH RES CO, V168, P141, DOI 10.1016/0006-291X(90)91685-L; Sheridan PL, 1997, GENE DEV, V11, P3327, DOI 10.1101/gad.11.24.3327; Shi Y, 2005, J GEN VIROL, V86, P3385, DOI 10.1099/vir.0.81259-0; Siliciano JD, 2013, CURR OPIN HIV AIDS, V8, P318, DOI 10.1097/COH.0b013e328361eaca; SIMON F, 1993, AIDS, V7, P1411, DOI 10.1097/00002030-199311000-00002; Smith RA, 2009, J INFECT DIS, V199, P1323, DOI 10.1086/597802; Soares RS, 2011, J VIROL METHODS, V175, P38, DOI 10.1016/j.jviromet.2011.04.012; Soares RS, 2011, J VIROL, V85, P2429, DOI 10.1128/JVI.01921-10; Sonza S, 2002, J VIROL, V76, P12611, DOI 10.1128/JVI.76.24.12611-12621.2002; Soto-Rifo R, 2012, NUCLEIC ACIDS RES, V40, P2653, DOI 10.1093/nar/gkr1093; Sousa AE, 2001, J INFECT DIS, V184, P552, DOI 10.1086/322804; Spach DH, 2020, HIV 2 INFECT; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; Szojka Z, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3404; Telwatte S, 2022, METHODS, V201, P15, DOI 10.1016/j.ymeth.2021.04.011; Telwatte S, 2021, J VIROL METHODS, V292, DOI 10.1016/j.jviromet.2021.114115; Telwatte S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007357; Thiebaut R, 2011, AIDS, V25, P865, DOI 10.1097/QAD.0b013e328344892e; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; Ventura JD, 2020, YALE J BIOL MED, V93, P549; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; Visseaux B, 2016, INFECT GENET EVOL, V46, P233, DOI 10.1016/j.meegid.2016.08.010; Visseaux B, 2015, AIDS, V29, P2209, DOI 10.1097/QAD.0000000000000825; Wagner TA, 2014, SCIENCE, V345, P570, DOI 10.1126/science.1256304; Weinberg MS, 2006, DNA CELL BIOL, V25, P223, DOI 10.1089/dna.2006.25.223; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; WINSLOW BJ, 1993, VIROLOGY, V196, P849, DOI 10.1006/viro.1993.1545; Witvrouw M, 2004, ANTIVIR THER, V9, P57; Yukl S, 2009, VIROLOGY, V387, P98, DOI 10.1016/j.virol.2009.01.013; Yukl SA, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap9927	109	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267402	10.1371/journal.pone.0267402	http://dx.doi.org/10.1371/journal.pone.0267402			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476802	gold, Green Published			2022-12-26	WOS:000840124300038
J	Lim, J; Pavalagantharajah, S; Verschoor, CP; Lentz, E; Loeb, M; Levine, M; Smieja, M; Mbuagbaw, L; Kalina, D; Tarride, JE; O'Shea, T; Cvetkovic, A; van Gaalen, S; Findlater, AR; Lennox, R; Bassim, C; Lokker, C; Alvarez, E				Lim, Jacqueline; Pavalagantharajah, Sureka; Verschoor, Chris P.; Lentz, Eric; Loeb, Mark; Levine, Mitchell; Smieja, Marek; Mbuagbaw, Lawrence; Kalina, Dale; Tarride, Jean-Eric; O'Shea, Tim; Cvetkovic, Anna; van Gaalen, Sarah; Findlater, Aidan Reid; Lennox, Robin; Bassim, Carol; Lokker, Cynthia; Alvarez, Elizabeth			Infectious diseases, comorbidities and outcomes in hospitalized people who inject drugs (PWID) infections in persons who inject drugs	PLOS ONE			English	Article							MEDICAL ADVICE; USERS	Injection drug use poses a public health challenge. Clinical experience indicates that people who inject drugs (PWID) are hospitalized frequently for infectious diseases, but little is known about outcomes when admitted. Charts were identified from local hospitals between 2013-2018 using consultation lists and hospital record searches. Included individuals injected drugs in the past six months and presented with infection. Charts were accessed using the hospital information system, undergoing primary and secondary reviews using Research Electronic Data Capture (REDCap). The Wilcoxon rank-sum test was used for comparisons between outcome categories. Categorical data were summarized as count and frequency, and compared using Fisher's exact test. Of 240 individuals, 33% were admitted to the intensive care unit, 36% underwent surgery, 12% left against medical advice (AMA), and 9% died. Infectious diagnoses included bacteremia (31%), abscess (29%), endocarditis (29%), cellulitis (20%), sepsis (10%), osteomyelitis (9%), septic arthritis (8%), pneumonia (7%), discitis (2%), meningitis/encephalitis (2%), or other (7%). Sixty-six percent had stable housing and 60% had a family physician. Fifty-four percent of patient-initiated discharges were seen in the emergency department within 30 days and 29% were readmitted. PWID are at risk for infections. Understanding their healthcare trajectory is essential to improve their care.	[Lim, Jacqueline] McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada; [Pavalagantharajah, Sureka; Lentz, Eric; Kalina, Dale; O'Shea, Tim; Cvetkovic, Anna; Findlater, Aidan Reid; Bassim, Carol] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Verschoor, Chris P.] Hlth Sci North Res Inst, Sudbury, ON, Canada; [Loeb, Mark; Smieja, Marek] McMaster Univ, Pathol & Mol Med, Hamilton, ON, Canada; [Levine, Mitchell; Mbuagbaw, Lawrence; Tarride, Jean-Eric; Lokker, Cynthia; Alvarez, Elizabeth] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Tarride, Jean-Eric; Alvarez, Elizabeth] McMaster Univ, Ctr Hlth Econ & Policy Anal CHEPA, Hamilton, ON, Canada; [O'Shea, Tim] Populat Hlth Res Inst, Hamilton, ON, Canada; [van Gaalen, Sarah] Queens Univ, Dept Family Med, Kingston, ON, Canada; [Lennox, Robin] McMaster Univ, Dept Family Med, Hamilton, ON, Canada; [Lim, Jacqueline] Univ Toronto, Fac Med, Toronto, ON, Canada	McMaster University; McMaster University; Health Sciences North; Northern Ontario School of Medicine; McMaster University; McMaster University; McMaster University; Population Health Research Institute; Queens University - Canada; McMaster University; University of Toronto	Alvarez, E (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada.; Alvarez, E (corresponding author), McMaster Univ, Ctr Hlth Econ & Policy Anal CHEPA, Hamilton, ON, Canada.	alvare@mcmaster.ca						Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1; Alvarez E, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-035862; Biello KB, 2018, HARM REDUCT J, V15, DOI 10.1186/s12954-018-0263-5; Canadian Network on Hepatitis C Blueprint Writing Committee and Working Groups, 2019, CANHEPC; Challacombe L., 2018, CATIE; Degenhardt L, 2006, SEX TRANSM INFECT, V82, pIII56, DOI 10.1136/sti.2005.019273; Eaton EF, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa074; Gregg E, 2020, J PRIM CARE COMMUNIT, V11, DOI 10.1177/2150132720908370; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Hyshka E, 2012, INT J DRUG POLICY, V23, P261, DOI 10.1016/j.drugpo.2012.03.006; Jacka B, 2020, AM J PUBLIC HEALTH, V110, P45, DOI 10.2105/AJPH.2019.305379; Jaworsky D, 2018, AIDS CARE, V30, P1099, DOI 10.1080/09540121.2018.1434121; Joseph B, 2015, AIDS CARE, V27, P1128, DOI 10.1080/09540121.2015.1032205; Kendall CE, 2017, HARM REDUCT J, V14, DOI 10.1186/s12954-017-0143-4; Lloyd-Smith E, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-405; McNeil R, 2014, SOC SCI MED, V105, P59, DOI 10.1016/j.socscimed.2014.01.010; Millson P, INJECTION DRUG USE H; Palepu A, 2011, J URBAN HEALTH, V88, P545, DOI 10.1007/s11524-011-9562-9; Public Health Agency of Canada, 2014, SUMMARY KEY FINDINGS; R Core Team, R PROJECT STAT COMPU; Reed C, 2013, AM J PUBLIC HEALTH, V103, P105, DOI 10.2105/AJPH.2012.300819; Stanford Center for Population Health Sciences, 2021, OPT SES V4 0 RED DAT, DOI [10.57761/bykd-vz30, DOI 10.57761/BYKD-VZ30]; Ti LP, 2015, AM J PUBLIC HEALTH, V105, pE53, DOI 10.2105/AJPH.2015.302885; Trubnikov M, 2014, Can Commun Dis Rep, V40, P429	24	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0266663	10.1371/journal.pone.0266663	http://dx.doi.org/10.1371/journal.pone.0266663			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35443003	gold, Green Published			2022-12-26	WOS:000822608900030
J	Paul, LA; Li, Y; Leece, P; Gomes, T; Bayoumi, AM; Herring, J; Murray, R; Brown, P				Paul, Lauren A.; Li, Ye; Leece, Pamela; Gomes, Tara; Bayoumi, Ahmed M.; Herring, Jeremy; Murray, Regan; Brown, Patrick			Identifying the changing age distribution of opioid-related mortality with high-frequency data	PLOS ONE			English	Article							INVOLVED OVERDOSE DEATHS; UNITED-STATES; TRENDS; METHADONE; HEROIN; DRUG; RISK	Background Opioid-related mortality continues to rise across North America, and mortality rates have been further exacerbated by the COVID-19 pandemic. This study sought to provide an updated picture of trends of opioid-related mortality for Ontario, Canada between January 2003 and December 2020, in relation to age and sex. Methods Using mortality data from the Office of the Chief Coroner for Ontario, we applied Bayesian Poisson regression to model age/sex mortality per 100,000 person-years, including random walks to flexibly capture age and time effects. Models were also used to explore how trends might continue into 2022, considering both pre- and post-COVID-19 courses. Results From 2003 to 2020, there were 11,633 opioid-related deaths in Ontario. A shift in the age distribution of mortality was observed, with the greatest mortality rates now among younger individuals. In 2003, mortality rates reached maximums at 5.5 deaths per 100,000 person-years (95% credible interval: 4.0-7.6) for males around age 44 and 2.2 deaths per 100,000 person-years (95% CI: 1.5-3.2) for females around age 51. As of 2020, rates have reached maximums at 67.2 deaths per 100,000 person-years (95% CI: 55.3-81.5) for males around age 35 and 16.8 deaths per 100,000 person-years (95% CI: 12.8-22.0) for females around age 37. Our models estimate that opioid-related mortality among the younger population will continue to grow, and that current conditions could lead to male mortality rates that are more than quadruple those of pre-pandemic estimations. Conclusions This analysis may inform a refocusing of public health strategy for reducing rising rates of opioid-related mortality, including effectively reaching both older and younger males, as well as young females, with health and social supports such as treatment and harm reduction measures.	[Paul, Lauren A.] Publ Hlth Ontario, Hlth Protect, Toronto, ON, Canada; [Li, Ye; Leece, Pamela] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Li, Ye; Herring, Jeremy] Publ Hlth Ontario, Knowledge Serv, Toronto, ON, Canada; [Leece, Pamela] Publ Hlth Ontario, Hlth Promot Chron Dis & Injury Prevent, Toronto, ON, Canada; [Leece, Pamela] Womens Coll Hosp, Subst Use Serv, Toronto, ON, Canada; [Leece, Pamela] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Gomes, Tara; Bayoumi, Ahmed M.; Brown, Patrick] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Gomes, Tara; Bayoumi, Ahmed M.] ICES, Toronto, ON, Canada; [Gomes, Tara] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Gomes, Tara; Bayoumi, Ahmed M.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Bayoumi, Ahmed M.] St Michaels Hosp, MAP Ctr Urban Hlth Solut, Toronto, ON, Canada; [Bayoumi, Ahmed M.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Murray, Regan] Off Chief Coroner Ontario, Toronto, ON, Canada; [Murray, Regan] Publ Hlth Agcy Canada, Ottawa, ON, Canada; [Brown, Patrick] Univ Toronto, Dept Stat Sci, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Public Health Agency of Canada; University of Toronto	Li, Y (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.; Li, Y (corresponding author), Publ Hlth Ontario, Knowledge Serv, Toronto, ON, Canada.	ye.li@utoronto.ca		Paul, Lauren/0000-0002-6309-1304	Office of the Chief Coroner for Ontario	Office of the Chief Coroner for Ontario	The authors would like to thank the Office of the Chief Coroner for Ontario for providing the mortality data and Badal Dhar at Public Health Ontario for preparing the population data.	Ahmad FB., 2021, NATL HLTH STAT REPOR; Almeida M, 2020, ARCH WOMEN MENT HLTH, V23, P741, DOI 10.1007/s00737-020-01092-2; Anderson J., 2019, ONLINE J PUBLIC HLTH, V11, P4, DOI [10.5210/ojphi.v11i1.9938, DOI 10.5210/OJPHI.V11I1.9938]; B.C. Ministry of Public Safety and Solicitor General, 2020, FENTANYL DETECTED IL; Barbosa-Leiker Celestina, 2021, Psychiatr Res Clin Pract, V3, P3, DOI 10.1176/appi.prcp.20190051; Canadian Institute for Health Information, 2019, OP PRESCR CAN AR PRA; Carter MW, 2019, INNOV AGING, V3, DOI 10.1093/geroni/igz002; Chen Li Hui, 2014, NCHS Data Brief, P1; Financial Accountability Office of Ontario, 2021, ONT LAB MARK 2020 CO; Fischer B, 2019, LANCET PUBLIC HEALTH, V4, pE81, DOI 10.1016/S2468-2667(18)30232-9; Gao L, 2016, DRUG ALCOHOL DEPEN, V167, P214, DOI 10.1016/j.drugalcdep.2016.08.627; Gladstone EJ, 2016, INJURY PREV, V22, P288, DOI 10.1136/injuryprev-2015-041604; Gomes T, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0217; Gomes T, 2018, J ADDICT MED, V12, P418, DOI 10.1097/ADM.0000000000000412; Gomes Tara, 2014, CMAJ Open, V2, pE256, DOI 10.9778/cmajo.20140027; Gomes T, 2014, CAN FAM PHYSICIAN, V60, P826; Guy GP, 2017, MMWR-MORBID MORTAL W, V66, P697, DOI 10.15585/mmwr.mm6626a4; Haley DF, 2020, JAMA-J AM MED ASSOC, V324, P1615, DOI 10.1001/jama.2020.18543; Hedegaard Holly, 2018, NCHS Data Brief, P1; Huang XW, 2018, AM J PUBLIC HEALTH, V108, P131, DOI 10.2105/AJPH.2017.304142; ISMP Canada, 2021, OP STEW; Linas BP, 2021, J SUBST ABUSE TREAT, V120, DOI 10.1016/j.jsat.2020.108158; McManus S., 2016, MENTAL HLTH WELLBEIN; Mokdad AH, 2018, JAMA-J AM MED ASSOC, V319, P1444, DOI 10.1001/jama.2018.0158; O'Donnell JK, 2017, MMWR-MORBID MORTAL W, V66, P897, DOI 10.15585/mmwr.mm6634a2; Office of the Chief Coroner Ontario Forensic Pathology Service and Ontario Drug Policy Research Network, 2019, OPIOID MORTALITY SUR; Olfson M, 2019, JAMA-J AM MED ASSOC, V322, P2340, DOI 10.1001/jama.2019.16566; Ontario Drug Policy Research Network Office of the Chief Coroner for Ontario/Ontario Ontario Forensic Pathology Service Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2021, CHANGING CIRCUMSTANC; Pierce M, 2018, INT J DRUG POLICY, V55, P121, DOI 10.1016/j.drugpo.2018.02.005; Public Health Agency of Canada, 2021, MOD OP REL DEATHS CO; Public Health Ontario, 2021, PUBL HLTH ONT INT OP; Roxburgh A, 2017, DRUG ALCOHOL DEPEN, V179, P291, DOI 10.1016/j.drugalcdep.2017.07.018; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1; Sharp MJ, 2015, MMWR-MORBID MORTAL W, V64, P377; Shipton EE, 2017, PAIN THER, V6, P203, DOI 10.1007/s40122-017-0080-7; Statistics Canada, 2021, TABL 17 10 0009 01 P, DOI [10.25318/1710000901-eng, DOI 10.25318/1710000901-ENG]; Tuazon E, 2019, DRUG ALCOHOL DEPEN, V205, DOI 10.1016/j.drugalcdep.2019.107614; Wilson N, 2020, MMWR-MORBID MORTAL W, V69, P290, DOI 10.15585/mmwr.mm6911a4	38	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0265509	10.1371/journal.pone.0265509	http://dx.doi.org/10.1371/journal.pone.0265509			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35442953	gold, Green Published			2022-12-26	WOS:000822608900010
J	Perez, CS; Mestriner, C; Ribeiro, LTN; Grillo, FW; Lemos, TW; Carneiro, AA; Guirro, RRD; Guirro, ECO				Perez, Carla S.; Mestriner, Carolina; Ribeiro, Leticia T. N.; Grillo, Felipe W.; Lemos, Tenysson W.; Carneiro, Antonio A.; de Jesus Guirro, Rinaldo Roberto; Guirro, Elaine C. O.			Relationship between lymphedema after breast cancer treatment and biophysical characteristics of the affected tissue	PLOS ONE			English	Article							AXILLARY DISSECTION; CLINICAL MEASURES; UPPER-LIMB; ULTRASOUND; PRESSURE; VOLUME	The treatment of breast cancer is often complicated by lymphedema of the upper limbs. Standard lymphedema evaluation methodologies are not able to measure tissue fibrosis. The ultrasound aspects related to tissue microstructures of lymphedema are neglected in clinical evaluations. The objective of this study was to identify and measure the degree of impairment, topography, and biophysical alterations of subcutaneous lymphedema tissue secondary to the treatment of breast cancer by ultrasonography. Forty-two women at a mean age of 58 (+/- 9.7) years, with unilateral lymphedema due to breast cancer treatment, were evaluated. The upper limbs were divided into affected (affected by lymphedema) and control (contralateral limb). Each limb was subdivided into seven areas, defined by perimetry, evaluated in pairs. The biophysical characteristics thickness, entropy, and echogenicity were evaluated by ultrasonography. The results showed a significant difference in the echogenicity and thickness variables between the affected and unaffected upper limb, in all the extent of the upper limb, while entropy showed no significant difference. The findings indicate that the data presented were consistent both in identifying and measuring the degree of impairment and biophysical changes in the subcutaneous tissue of lymphedema secondary to the treatment of breast cancer.	[Perez, Carla S.; Mestriner, Carolina; de Jesus Guirro, Rinaldo Roberto; Guirro, Elaine C. O.] Univ Sao Paulo, Programa Posgrad Reabilitacao & Desempenho Func, Ribeirao Preto, SP, Brazil; [Perez, Carla S.; Lemos, Tenysson W.; de Jesus Guirro, Rinaldo Roberto; Guirro, Elaine C. O.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Ciencias Saude, Ribeirao Preto, SP, Brazil; [Ribeiro, Leticia T. N.; Grillo, Felipe W.; Carneiro, Antonio A.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Fis, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Perez, CS; Guirro, ECO (corresponding author), Univ Sao Paulo, Programa Posgrad Reabilitacao & Desempenho Func, Ribeirao Preto, SP, Brazil.; Perez, CS; Guirro, ECO (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Ciencias Saude, Ribeirao Preto, SP, Brazil.	carlaperez@alumni.usp.br; ecguirro@fmrp.usp.br		Caldeira de Oliveira Guirro, Elaine/0000-0002-1045-8053; Fernandes Mestriner, Carolina/0000-0002-9042-8961				Adriaenssens N, 2012, RADIOL ONCOL, V46, P284, DOI 10.2478/v10019-012-0033-z; Ashikaga Takamaru, 2005, Lymphatic Research and Biology, V3, P147, DOI 10.1089/lrb.2005.3.147; Bianchi S, 2007, MED RADIOL DIAGN IMA, P1, DOI 10.1007/978-3-540-28163-4; Bok SK, 2018, LYMPHAT RES BIOL, V16, P36, DOI 10.1089/lrb.2016.0048; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen YW, 2008, AM J PHYS MED REHAB, V87, P33, DOI 10.1097/PHM.0b013e31815b6199; De Brucker B, 2016, PLAST RECONSTR SURG, V137, P1673, DOI 10.1097/PRS.0000000000002169; Devoogdt N, 2014, LYMPHAT RES BIOL, V12, P23, DOI 10.1089/lrb.2013.0028; de Oliveira MMF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189176; Harris SR, 2001, CAN MED ASSOC J, V164, P191; Hidding JT, 2016, PHYS THER, V96, P1965, DOI 10.2522/ptj.20150412; Johnson KC, 2016, LYMPHAT RES BIOL, V14, P8, DOI 10.1089/lrb.2015.0001; Kim W, 2008, LYMPHOLOGY, V41, P167; Koo KI, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224457; Lawenda BD, 2009, CA-CANCER J CLIN, V59, P8, DOI 10.3322/caac.20001; Ly CL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010171; Matheus CN, 2011, BREAST CANCER RES TR, V127, P697, DOI 10.1007/s10549-011-1456-8; Munn LL, 2014, MICROVASC RES, V96, P55, DOI 10.1016/j.mvr.2014.06.006; O'Donnell TF, 2017, J VASC SURG-VENOUS L, V5, P261, DOI 10.1016/j.jvsv.2016.10.083; Petrek JA, 2000, CA-CANCER J CLIN, V50, P292, DOI 10.3322/canjclin.50.5.292; Ronka RH, 2004, ACTA ONCOL, V43, P551, DOI 10.1080/02841860410014867; Sander AP, 2002, PHYS THER, V82, P1201, DOI 10.1093/ptj/82.12.1201; Suami H, 2007, PLAST RECONSTR SURG, V120, P982, DOI 10.1097/01.prs.0000277995.25009.3e; Suehiro K, 2014, J MED ULTRASON, V41, P359, DOI 10.1007/s10396-014-0526-z; Szuba A, 2002, CANCER, V95, P2260, DOI 10.1002/cncr.10976; Tassenoy A, 2011, PHYSIOTHERAPY, V97, P234, DOI 10.1016/j.physio.2010.08.003; Warren AG, 2007, ANN PLAS SURG, V59, P464, DOI 10.1097/01.sap.0000257149.42922.7e; Wratten CR, 2007, BREAST J, V13, P266, DOI 10.1111/j.1524-4741.2007.00420.x; Yang EJ, 2018, LYMPHAT RES BIOL, V16, P368, DOI 10.1089/lrb.2017.0047; Yang XF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181250	30	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0264160	10.1371/journal.pone.0264160	http://dx.doi.org/10.1371/journal.pone.0264160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35442985	Green Published, gold			2022-12-26	WOS:000822608900007
J	Baneras, J; Pariggiano, I; Rodenas-Alesina, E; Oristrell, G; Escalona, R; Miranda, B; Rello, P; Soriano, T; Gordon, B; Belahnech, Y; Calabro, P; Garcia-Dorado, D; Ferreira-Gonzalez, I; Radua, J				Baneras, Jordi; Pariggiano, Ivana; Rodenas-Alesina, Eduard; Oristrell, Gerard; Escalona, Roxana; Miranda, Berta; Rello, Pau; Soriano, Toni; Gordon, Blanca; Belahnech, Yassin; Calabro, Paolo; Garcia-Dorado, David; Ferreira-Gonzalez, Ignacio; Radua, Joaquim			Optimal opportunistic screening of atrial fibrillation using pulse palpation in cardiology outpatient clinics: Who and how	PLOS ONE			English	Article							STROKE; RISK; PREVALENCE; EPIDEMIOLOGY; POPULATION; PREDICTORS	BackgroundAtrial fibrillation (AF) remain a prevalent undiagnosed condition frequently encountered in primary care. ObjectiveWe aimed to find the parameters that optimize the diagnostic accuracy of pulse palpation to detect AF. We also aimed to create a simple algorithm for selecting which individuals would benefit from pulse palpation and, if positive, receive an ECG to detect AF. MethodsNurses from four Cardiology outpatient clinics palpated 7,844 pulses according to a randomized list of arterial territories and durations of measure and immediately followed by a 12-lead ECG, which we used as the reference standard. We calculated the sensitivity and specificity of the palpation parameters. We also assessed whether diagnostic accuracy depended on the nurse's experience or on a list of clinical factors of the patients. With this information, we estimated the positive predictive values and false omission rates according to very few clinical factors readily available in primary care (age, sex, and diagnosis of heart failure) and used them to create the algorithm. ResultsThe parameters associated with the highest diagnostic accuracy were palpation of the radial artery and classifying as irregular those palpations in which the nurse was uncertain about pulse regularity or unable to palpate pulse (sensitivity = 79%; specificity = 86%). Specificity decreased with age. Neither the nurse's experience nor any investigated clinical factor influenced diagnostic accuracy. We provide the algorithm to select the >= 40 years old individuals that would benefit from a pulse palpation screening: a) do nothing in <60 years old individuals without heart failure; b) do ECG in >= 70 years old individuals with heart failure; c) do radial pulse palpation in the remaining individuals and do ECG if the pulse is irregular or you are uncertain about its regularity or unable to palpate it. ConclusionsOpportunistic screening for AF using optimal pulse palpation in candidate individuals according to a simple algorithm may have high effectiveness in detecting AF in primary care.	[Baneras, Jordi; Rodenas-Alesina, Eduard; Oristrell, Gerard; Escalona, Roxana; Miranda, Berta; Rello, Pau; Soriano, Toni; Gordon, Blanca; Belahnech, Yassin; Garcia-Dorado, David; Ferreira-Gonzalez, Ignacio] Hosp Univ Vall dHebron, Dept Cardiol, Barcelona, Spain; [Baneras, Jordi; Garcia-Dorado, David; Ferreira-Gonzalez, Ignacio] Autonomous Univ Barcelona, Vall dHebron Hosp, Vall dHebron Res Inst, Barcelona, Spain; [Baneras, Jordi; Garcia-Dorado, David] CIBER CV, ISC III, Madrid, Spain; [Pariggiano, Ivana; Calabro, Paolo] AORN St Anna & San Sebastiano, Div Clin Cardiol, Caserta, Italy; [Pariggiano, Ivana; Calabro, Paolo] Univ Campania Luigi Vanvitelli, Dept Translat Med Sci, Naples, Italy; [Ferreira-Gonzalez, Ignacio] CIBER ESP, ISC III, Madrid, Spain; [Radua, Joaquim] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain; [Radua, Joaquim] CIBERSAM, ISC III, Madrid, Spain; [Radua, Joaquim] Kings Coll London, London, England; [Radua, Joaquim] Karolinska Inst, Stockholm, Sweden	Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Universita della Campania Vanvitelli; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of London; King's College London; Karolinska Institutet	Baneras, J (corresponding author), Hosp Univ Vall dHebron, Dept Cardiol, Barcelona, Spain.; Baneras, J (corresponding author), Autonomous Univ Barcelona, Vall dHebron Hosp, Vall dHebron Res Inst, Barcelona, Spain.; Baneras, J (corresponding author), CIBER CV, ISC III, Madrid, Spain.	jbaneras@vhebron.net	Rodenas-Alesina, Eduard/GRJ-1008-2022; Bañeras, Jordi/AGQ-4877-2022	Bañeras, Jordi/0000-0002-7395-0862; Rodenas-Alesina, Eduard/0000-0003-1638-7820	Instituto de Salud Carlos III [CPII19/00009]; European Union (ERDF/ESF, 'Investing in your future')	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Union (ERDF/ESF, 'Investing in your future')	JR is supported by a Miguel Servet Research Contract (CPII19/00009) from the Instituto de Salud Carlos III and co-funded by European Union (ERDF/ESF, 'Investing in your future'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Camm AJ, 2017, EUROPACE, V19, P169, DOI 10.1093/europace/euw279; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Curry SJ, 2018, JAMA-J AM MED ASSOC, V320, P478, DOI 10.1001/jama.2018.10321; Davis RC, 2012, EUROPACE, V14, P1553, DOI 10.1093/europace/eus087; Diederichsen SZ, 2020, CIRCULATION, V141, P1510, DOI [10.1161/CIRCULATIONAHA.119.044407, 10.1161/circulationaha.119.044407]; Dilaveris PE, 2017, CLIN CARDIOL, V40, P413, DOI 10.1002/clc.22667; Fitzmaurice DA, 2007, BRIT MED J, V335, P383, DOI 10.1136/bmj.39280.660567.55; Freedman B, 2017, CIRCULATION, V135, P1851, DOI 10.1161/CIRCULATIONAHA.116.026693; Freedman B, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004000; Gladstone DJ, 2021, JAMA CARDIOL, V6, P558, DOI 10.1001/jamacardio.2021.0038; Halcox JPJ, 2017, CIRCULATION, V136, P1784, DOI 10.1161/CIRCULATIONAHA.117.030583; Hart RG, 2007, NEUROLOGY, V69, P546; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hindricks G, 2021, EUR HEART J, V42, P373, DOI 10.1093/eurheartj/ehaa612; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Gomez-Doblas JJ, 2014, REV ESP CARDIOL, V67, P259, DOI [10.1016/j.rec.2013.07.014, 10.1016/j.recesp.2013.07.015]; Kahwati L, ATRIAL FIBRILLATION; Lip GYH, 2013, EUR HEART J, V34, P1041, DOI 10.1093/eurheartj/ehs435; Lowres N, 2014, THROMB HAEMOSTASIS, V111, P1167, DOI 10.1160/TH14-03-0231; Lowres N, 2013, THROMB HAEMOSTASIS, V110, P213, DOI 10.1160/TH13-02-0165; Martinez C, 2014, THROMB HAEMOSTASIS, V112, P276, DOI 10.1160/TH4-04-0383; Meschia JF., 2014, AM STROKE ASS, V45, DOI [10.1161/STR.0000000000000046, DOI 10.1161/STR.0000000000000046]; Morgan S, 2002, BRIT J GEN PRACT, V52, P373; Perez MV, 2019, NEW ENGL J MED, V381, P1909, DOI 10.1056/NEJMoa1901183; Stewart S, 2001, HEART, V86, P516, DOI 10.1136/heart.86.5.516; Sudlow M, 1998, BRIT MED J, V317, P327, DOI 10.1136/bmj.317.7154.327; Svennberg E, 2015, CIRCULATION, V131, P2176, DOI 10.1161/CIRCULATIONAHA.114.014343; Taggar JS, 2016, EUR J PREV CARDIOL, V23, P1330, DOI 10.1177/2047487315611347; Welton NJ, 2017, HEALTH TECHNOL ASSES, V21, P1, DOI 10.3310/hta21290; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	31	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266955	10.1371/journal.pone.0266955	http://dx.doi.org/10.1371/journal.pone.0266955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446875	Green Published, gold			2022-12-26	WOS:000795468200067
J	Bizuayehu, T; Menjetta, T; Mohammed, M				Bizuayehu, Temesgen; Menjetta, Tadesse; Mohammed, Metsihet			Obesity among type 2 diabetes mellitus at Sidama Region, Southern Ethiopia	PLOS ONE			English	Article							ADULT-POPULATION; CARE; PREVALENCE; RISK; EPIDEMIOLOGY; HYPERTENSION; ASSOCIATION; DISEASE; IMPACT; DEATH	Background Type 2 diabetes is becoming highly prevalent worldwide and it is one of the leading causes of mortality. The cause of mortality among these patients is mostly related to the dominant presence of modifiable cardiovascular risk factors such as obesity. The aim of the current study is therefore to determine the prevalence of obesity and its associated factors among patients with type 2 diabetes mellitus at Sidama region, Ethiopia. Method Institution-based cross-sectional study design was implemented to determine the prevalence of obesity and its associated factor among patients with type two diabetes at Hawassa University Comprehensive Specialized Hospital and Yirgalem General Hospital from October 16 2018 to December 21, 2018. A simple random sampling technique was implemented to select 314 study participants. After obtaining consent, different patients' related data were collected using a questionnaire. Patients' records were also reviewed. 4m1 of the blood sample was collected from each study participant and analyzed for lipid profile test. Blood glucose level was done using COBAS INTEGRA 6000. A binary logistic regression was used to assess factors that have an association with obesity. A P-value of <0.05 was considered statistically significant. Result The majority of the study participants (67.2%) were male and 61.8% of the study participants were aged >45years. The overall prevalence of overweight and obesity among the study participants was 36.3% and 18.8% respectively. About 41% of the study participants have a normal BMI. Females were more obese (28.2% Vs 14.2%) than males and BMI stratification by sex was statistically significant (P = 0.02). Sex (AOR = 3.0, CI = 1.6-5.7, P-Value = 0.001) and TG (AOR = 3.6, CI = 1.6-8.3, P-Value = 0.003) are factors that were independently associated with obesity among type 2 DM patients. Conclusion Overweight and obesity among type two diabetic patients were prevalent. In addition, obesity and overweight disorder are common among T2DM and gender and triglycerides levels were associated with obesity.	[Bizuayehu, Temesgen; Menjetta, Tadesse] Hawassa Univ, Coll Med & Hlth Sci, Sch Med Lab Sci, Hawassa, Ethiopia; [Mohammed, Metsihet] Hawassa Univ, Dept Lab, Comprehens Specialized Hosp, Hawassa, Ethiopia	Hawassa University; Hawassa University	Menjetta, T (corresponding author), Hawassa Univ, Coll Med & Hlth Sci, Sch Med Lab Sci, Hawassa, Ethiopia.	tademen2000@yahoo.com	tom, tom/GSN-7258-2022	tom, tom/0000-0002-0094-0727				Abdissa D, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e06339; Akalu Y, 2020, DIABET METAB SYND OB, V13, P1621, DOI 10.2147/DMSO.S254537; Al-Sharafi BA, 2014, INT J ENDOCRINOL MET, V12, DOI 10.5812/ijem.13633; [Anonymous], 2004, REPORT CMAMW, V53; Babu GR, 2018, WORLD J DIABETES, V9, P40, DOI 10.4239/wjd.v9.i1.40; Bakhotmah B., 2013, OPEN J ENDOCR METAB, V03, P25, DOI DOI 10.4236/OJEMD.2013.31004; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Bastien M, 2014, PROG CARDIOVASC DIS, V56, P369, DOI 10.1016/j.pcad.2013.10.016; Bhupathiraju SN, 2016, CIRC RES, V118, P1723, DOI 10.1161/CIRCRESAHA.115.306825; Daousi C, 2006, POSTGRAD MED J, V82, P280, DOI 10.1136/pmj.2005.039032; Fox CS, 2008, DIABETES CARE, V31, P1582, DOI 10.2337/dc08-0025; Garcia-Labbe D, 2015, CAN J CARDIOL, V31, DOI 10.1016/j.cjca.2014.12.008; Gezawa ID, 2019, DIABET METAB SYND OB, V12, P2785, DOI 10.2147/DMSO.S226054; Gudina E., 2017, PREVALENCE OVERWEIGH; Hillier TA, 2001, DIABETES CARE, V24, P1522, DOI 10.2337/diacare.24.9.1522; Felix-Redondo FJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-542; Kiros KG, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4791-1; Morrish NJ, 2001, DIABETOLOGIA, V44, pS14, DOI 10.1007/PL00002934; Mugharbel Kholood M, 2003, J Family Community Med, V10, P49; Olebu J., 2014, ADV LIFE SCI TECHNOL, V24, P60; Plourde B, 2014, EXPERT REV CARDIOVAS, V12, P1099, DOI 10.1586/14779072.2014.952283; Radholm K, 2018, DIABETES OBES METAB, V20, P1903, DOI 10.1111/dom.13311; Rossi MCE, 2011, DIABETES CARE, V34, P347, DOI 10.2337/dc10-1709; Said Q, 2010, VALUE HEALTH, V13, P265, DOI 10.1111/j.1524-4733.2009.00649.x; Seifu Y, 2020, DIABET METAB SYND OB, V13, P4571, DOI 10.2147/DMSO.S275230; Sonmez A, 2019, OBESITY FACTS, V12, P167, DOI 10.1159/000496624; Worku A, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0785-1; World Health Organization (WHO), 2010, CHRON DIS HLTH PROM; Zekewos A, 2018, ETHIOP J HEALTH SCI, V28, P451, DOI 10.4314/ejhs.v28i4.11; Zerunian M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86113-5; Zhou XH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144179	31	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266716	10.1371/journal.pone.0266716	http://dx.doi.org/10.1371/journal.pone.0266716			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421153	Green Published, gold			2022-12-26	WOS:000795453600061
J	Donoso, F; Beckman, A; Malinovschi, A; Lilja, HE				Donoso, Felipe; Beckman, Anna; Malinovschi, Andrei; Lilja, Helene Engstrand			Predictors of histopathological esophagitis in infants and adolescents with esophageal atresia within a national follow-up programme	PLOS ONE			English	Article							QUALITY-OF-LIFE; GASTROESOPHAGEAL-REFLUX; CHILDREN; ANESTHESIA; REPAIR; ASSOCIATION; DISORDERS; EXPOSURE; ADULTS; BORN	PurposeEsophageal atresia (EA) is a congenital anomaly of the foregut. Although the survival has improved over the years there is a significant gastrointestinal morbidity affecting physical function and health-related quality of life. The aims of the study were to identify and evaluate predictors of histopathological esophagitis in infants and adolescents with EA. MethodsSingle centre, cross-sectional study including one and 15-year-old patients operated for EA that participated in the national follow-up programme between 2012 and 2020 according to a pre-established protocol including upper endoscopy with oesophageal biopsies and 24h-pH-test. Data was collected from patients' medical records and pH-analysis software. Regression models were used to identify predictors of histopathological oesophagitis. Possible predictors were abnormal reflux index, endoscopic esophagitis, hiatal hernia, symptoms of gastroesophageal reflux (GER) and age. Results65 patients were included, 47 children and 18 adolescents. All children were treated with PPI during their first year of life. Symptoms of GER were reported by 13 (31.7%) of the infant's caregivers, 34 of the children (72.3%) had abnormal reflux index and 32 (68.1%) had histopathological esophagitis. The corresponding numbers for adolescents were 8 (50%), 15 (83.3%) and 10 (55.6%). We found no significant associations between histopathological esophagitis and endoscopic esophagitis, symptoms of GER, hiatus hernia or age group. Abnormal reflux index was an independent predictor of histopathological esophagitis. Seven patients with normal reflux index had histopathological esophagitis, all grade I. ConclusionsWe found a high prevalence of histopathological esophagitis despite PPI treatment in accordance with recommendations. No significant difference between the two age groups was seen. Abnormal reflux index was an independent predictor of histopathological esophagitis. However, we cannot recommend the use of pH-metry as a substitute for esophageal biopsies; future studies are needed to elucidate if esophageal biopsies might be postponed in infants with normal reflux index.	[Donoso, Felipe; Lilja, Helene Engstrand] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Donoso, Felipe; Lilja, Helene Engstrand] Uppsala Univ, Sect Pediat Surg, Childrens Hosp, Uppsala, Sweden; [Beckman, Anna; Malinovschi, Andrei] Uppsala Univ, Dept Med Sci, Clin Physiol, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University	Donoso, F (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.; Donoso, F (corresponding author), Uppsala Univ, Sect Pediat Surg, Childrens Hosp, Uppsala, Sweden.	felipe.donoso@kbh.uu.se		Donoso, Felipe/0000-0002-6428-0123	HRH Crownprincess Lovisa's Association for Child Medical Care [2020-00586]; Gillbergska foundation	HRH Crownprincess Lovisa's Association for Child Medical Care; Gillbergska foundation	Funding was provided to FD from HRH Crownprincess Lovisa's Association for Child Medical Care, Grant number 2020-00586, http://www.kronprinsessanlovisa.se/.and the Gillbergska foundation, Grant number N/A, http://www.gillbergska.se/.The funders had no role in the study design, data collection and analysis, decision topublish, or preparation of the manuscript.	BOIXOCHOA J, 1980, J PEDIATR SURG, V15, P74, DOI 10.1016/S0022-3468(80)80407-6; Boleken M., 2007, REDUCED NEURONAL INN, P1512, DOI [10.1007/s00268-007-9070-y, DOI 10.1007/S00268-007-9070-Y]; Castilloux J, 2010, CAN J GASTROENTEROL, V24, P312, DOI 10.1155/2010/902847; Catalano P, 2011, J PEDIATR GASTR NUTR, V52, P686, DOI 10.1097/MPG.0b013e318202a3e5; Cestari R, 2007, AM J SURG PATHOL, V31, P706, DOI 10.1097/PAS.0b013e31802c9dd5; Cheng W, 1999, PEDIATR SURG INT, V15, P8, DOI 10.1007/s003830050500; Cheng W, 1997, PEDIATR SURG INT, V12, P552; CPEG, CALC WHO ANTHR Z SCO; Davies MRQ, 1996, BRIT J SURG, V83, P1268, DOI 10.1046/j.1365-2168.1996.02337.x; de Bortoli N, 2015, DIGEST LIVER DIS, V47, P1027, DOI 10.1016/j.dld.2015.08.010; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2006, ACTA PAEDIATR, V95, P5, DOI 10.1080/08035320500495373; Dimaggio C., 2020, LONG TERM DIFFERENCE; DiMaggio C, 2011, ANESTH ANALG, V113, P1143, DOI 10.1213/ANE.0b013e3182147f42; DiMaggio C, 2009, J NEUROSURG ANESTH, V21, P286, DOI 10.1097/ANA.0b013e3181a71f11; Dingemann C, 2020, EUR J PEDIATR SURG, V30, P475, DOI 10.1055/s-0039-3400284; Donoso F, 2017, EUR J PEDIATR SURG, V27, P50, DOI 10.1055/s-0036-1593607; Donoso F, 2016, J PEDIATR SURG, V51, P1421, DOI 10.1016/j.jpedsurg.2016.03.010; Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59; Flick ARP, 2020, COGNITIVE BEHAV OUTC, P128, DOI [10.1542/peds.2011-0351, DOI 10.1542/PEDS.2011-0351]; Gatzinsky V, 2011, EUR J PEDIATR SURG, V21, P94, DOI 10.1055/s-0030-1270454; Grunder FR, 2019, J PEDIATR GASTR NUTR, V69, P45, DOI 10.1097/MPG.0000000000002328; ISMAIL-BEIGI F, 1970, Gastroenterology, V58, P163; KIRKPATRICK JA, 1961, AMER J ROENTGENOL RA, V86, P884; Koivusalo A, 2005, J PEDIATR SURG, V40, P307, DOI 10.1016/j.jpedsurg.2004.10.014; Koivusalo AI, 2016, J PEDIATR GASTR NUTR, V62, P562, DOI 10.1097/MPG.0000000000000972; Krishnan U, 2016, J PEDIATR GASTR NUTR, V63, P550, DOI 10.1097/MPG.0000000000001401; Legrand C, 2012, ARCH DIS CHILD, V97, P808, DOI 10.1136/archdischild-2012-301730; Li K., 2007, STRUCTURAL CHARACTER, P1433, DOI [10.1016/j.jpedsurg.2007.03.050, DOI 10.1016/J.JPEDSURG.2007.03.050]; Lilja HE, 2008, PEDIATR SURG INT, V24, P531, DOI 10.1007/s00383-008-2122-z; Montgomery M, 1998, J PEDIATR SURG, V33, P476, DOI 10.1016/S0022-3468(98)90091-4; Oddsberg J, 2012, PEDIATR SURG INT, V28, P249, DOI 10.1007/s00383-011-3014-1; Paramalingam S, 2013, EUR J PEDIATR SURG, V23, P273, DOI 10.1055/s-0032-1330845; Pedersen RN, 2013, J PEDIATR SURG, V48, P2487, DOI 10.1016/j.jpedsurg.2013.07.019; Peetsold MG, 2010, ACTA PAEDIATR, V99, P411, DOI 10.1111/j.1651-2227.2009.01579.x; Petit LM, 2019, EUR J PEDIATR SURG, V29, P510, DOI 10.1055/s-0038-1676505; Qi BQ, 1997, J PEDIATR SURG, V32, P1580, DOI 10.1016/S0022-3468(97)90457-7; Rodd C, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-32; Schalamon BJ., 2003, IS IT NECESSARY, V38, P702; Sistonen SJ, 2011, PEDIATR SURG INT, V27, P1141, DOI 10.1007/s00383-011-2980-7; Sistonen SJ, 2010, ANN SURG, V251, P1167, DOI 10.1097/SLA.0b013e3181c9b613; Stenstrom P, 2017, EUR J PEDIATR SURG, V27, P192, DOI 10.1055/s-0036-1584179; van Wijk M, 2013, J PEDIATR SURG, V48, P2496, DOI 10.1016/j.jpedsurg.2013.07.024; Vergouwe FWT, 2019, J PEDIATR GASTR NUTR, V69, P515, DOI 10.1097/MPG.0000000000002468; Vergouwe FWT., 2018, 4 CANC CASES ESOPHAG, V24, P1056, DOI [10.3748/wjg.v24.i9.1056, DOI 10.3748/WJG.V24.I9.1056]; Wilder RT, 2009, ANESTHESIOLOGY, V110, P796, DOI 10.1097/01.anes.0000344728.34332.5d; Yasuda JL, 2019, J PEDIATR GASTR NUTR, V69, P163, DOI 10.1097/MPG.0000000000002336	47	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266995	10.1371/journal.pone.0266995	http://dx.doi.org/10.1371/journal.pone.0266995			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1E2NP	35427378	gold, Green Published			2022-12-26	WOS:000794332400048
J	Fekete, A; Maidhof, RM; Specker, E; Nater, UM; Leder, H				Fekete, Anna; Maidhof, Rosa M.; Specker, Eva; Nater, Urs M.; Leder, Helmut			Does art reduce pain and stress? A registered report protocol of investigating autonomic and endocrine markers of music, visual art, and multimodal aesthetic experience	PLOS ONE			English	Article							EMOTIONAL RESPONSES; SALIVARY CORTISOL; ALPHA-AMYLASE; PERCEPTION; MODEL; MODULATION; ABSORPTION; HEALTH; BRAIN; QUESTIONNAIRE	The pain- and stress-reducing effects of music are well-known, but the effects of visual art, and the combination of these two, are much less investigated. We aim to (1) investigate the pain- and (2) stress-reducing effects of multimodal (music + visual art) aesthetic experience as we expect this to have stronger effects than a single modal aesthetic experience (music/visual art), and in an exploratory manner, (3) investigate the underlying mechanisms of aesthetic experience, and the (4) individual differences. In a repeated-measures design (music, visual art, multimodal aesthetic experience, control) participants bring self-selected "movingly beautiful" visual artworks and pieces of music to the lab, where pain and stress are induced by the cold pressor test. Activity of the pain and stress responsive systems are measured by subjective reports, autonomic (electrocardiography, electrodermal activity, salivary alpha-amylase) and endocrine markers (salivary cortisol).	[Fekete, Anna; Specker, Eva; Leder, Helmut] Univ Vienna, Fac Psychol, Dept Cognit Emot & Methods Psychol, Vienna, Austria; [Maidhof, Rosa M.; Nater, Urs M.] Univ Vienna, Fac Psychol, Dept Clin & Hlth Psychol, Vienna, Austria; [Leder, Helmut] Univ Vienna, Vienna Cognit Sci Hub, Vienna, Austria	University of Vienna; University of Vienna; University of Vienna	Fekete, A (corresponding author), Univ Vienna, Fac Psychol, Dept Cognit Emot & Methods Psychol, Vienna, Austria.; Maidhof, RM (corresponding author), Univ Vienna, Fac Psychol, Dept Clin & Hlth Psychol, Vienna, Austria.	anna.fekete@univie.ac.at; rosa.maidhof@univie.ac.at		Maidhof, Rosa M./0000-0001-6355-9141; Fekete, Anna/0000-0002-7858-9826; Nater, Urs/0000-0002-2430-5090	Forderungstipendium of the University of Vienna	Forderungstipendium of the University of Vienna	The study will be funded by internal resources and by the Forderungstipendium of the University of Vienna. The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actis-Grosso R, 2017, PSIHOLOGIJA, V50, P285, DOI 10.2298/PSI1703285A; Adam EK, 2009, PSYCHONEUROENDOCRINO, V34, P1423, DOI 10.1016/j.psyneuen.2009.06.011; Aigen K, 2007, NORD J MUSIC THER, V16, P112, DOI 10.1080/08098130709478181; al'Absi M, 2002, PAIN, V96, P197, DOI 10.1016/S0304-3959(01)00447-X; Arnett JJ, 2014, LANCET PSYCHIAT, V1, P569, DOI 10.1016/S2215-0366(14)00080-7; Augustin MD, 2012, I-PERCEPTION, V3, P319, DOI 10.1068/i0511aap; Aviram J, 2015, PAIN MED, V16, P1137, DOI 10.1111/pme.12665; Bernatzky G, 2011, NEUROSCI BIOBEHAV R, V35, P1989, DOI 10.1016/j.neubiorev.2011.06.005; Boucsein W, 2012, ELECTRODERMAL ACTIVITY, SECOND EDITION, P1, DOI 10.1007/978-1-4614-1126-0; Brieber D, 2015, ACTA PSYCHOL, V154, P36, DOI 10.1016/j.actpsy.2014.11.004; Brielmann AA, 2017, J VISION, V17, DOI 10.1167/17.14.9; Brielmann AA, 2017, CURR BIOL, V27, P1506, DOI 10.1016/j.cub.2017.04.018; Brinck I, 2018, COGN PROCESS, V19, P201, DOI 10.1007/s10339-017-0805-x; Brown S, 2011, NEUROIMAGE, V58, P250, DOI 10.1016/j.neuroimage.2011.06.012; Buchanan TW, 2006, LEARN MEMORY, V13, P382, DOI 10.1101/lm.206306; Carr DB, 1999, LANCET, V353, P2051, DOI 10.1016/S0140-6736(99)03313-9; Cepeda MS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004843.pub2; Chanda ML, 2013, TRENDS COGN SCI, V17, P179, DOI 10.1016/j.tics.2013.02.007; Chapman CR, 2008, J PAIN, V9, P122, DOI 10.1016/j.jpain.2007.09.006; Chatterjee A, 2014, TRENDS COGN SCI, V18, P370, DOI 10.1016/j.tics.2014.03.003; Clow A., 2006, J HOLIST HEALTHC, V3, P29; Coffee K, 2007, MUS MANAGE CURATOR, V22, P377, DOI 10.1080/09647770701757732; de Tommaso M, 2008, CONSCIOUS COGN, V17, P1152, DOI 10.1016/j.concog.2008.07.002; de Wied M, 2001, PAIN, V90, P163, DOI 10.1016/S0304-3959(00)00400-0; de Witte M, 2020, HEALTH PSYCHOL REV, V14, P294, DOI 10.1080/17437199.2019.1627897; Dobek CE, 2014, J PAIN, V15, P1057, DOI 10.1016/j.jpain.2014.07.006; EDENS JL, 1995, BEHAV THER, V26, P197, DOI 10.1016/S0005-7894(05)80102-9; Fancourt D., 2019, WHAT IS EVIDENCE ROL; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fayaz A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010364; Feneberg AC., 2020, FRONT PSYCHIATRY, V11, P1, DOI [10.3389/fpsyt.2020.00001, DOI 10.3389/FPSYT.2020.00001]; Fillingim RB, 2000, NEUROSCI BIOBEHAV R, V24, P485, DOI 10.1016/S0149-7634(00)00017-8; Fingerhut J, 2020, MONIST, V103, P223, DOI 10.1093/monist/onz037; Fink G., 2017, REFERENCE MODULE NEU, P1, DOI [10.1016/b978-0-12-809324-5.02208-2, DOI 10.1016/B978-0-12-809324-5.02208-2]; Garcia RL, 2016, PSYCHOL MUSIC, V44, P967, DOI 10.1177/0305735615602144; Gold A, 2013, PSYCHOL MUSIC, V41, P545, DOI 10.1177/0305735612440613; Grossi E, 2019, CULT MED PSYCHIAT, V43, P4, DOI 10.1007/s11013-018-9593-8; Hekmat H. M., 1993, PSYCHOL MUSIC, V21, P163, DOI DOI 10.1177/030573569302100205; Herbert M, 2019, CAVE; Howlin C, 2021, EUR J PAIN, V25, P1712, DOI 10.1002/ejp.1780; Howlin C, 2020, J MUSIC THER, V57, P127, DOI 10.1093/jmt/thaa003; Hsieh C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107390; Ishizu T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021852; Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293; Kenntner-Mabiala R, 2007, BIOL PSYCHOL, V75, P19, DOI 10.1016/j.biopsycho.2006.10.005; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; Klasen M, 2012, REV NEUROSCIENCE, V23, P381, DOI 10.1515/revneuro-2012-0040; Klossika I, 2006, PAIN, V124, P264, DOI 10.1016/j.pain.2006.08.007; Kucyi A, 2015, TRENDS NEUROSCI, V38, P86, DOI 10.1016/j.tins.2014.11.006; Lane MR., 2005, HOLIST NURS PRACT, V19, P122, DOI [10.1097/00004650-200505000-00008, DOI 10.1097/00004650-200505000-00008]; Law M, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-043549; Law M, 2020, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.03092; Leder H, 2004, BRIT J PSYCHOL, V95, P489, DOI 10.1348/0007126042369811; Leder H, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00155; Leder H, 2015, PHYS LIFE REV, V13, P67, DOI 10.1016/j.plrev.2015.04.037; Leder H, 2014, BRIT J PSYCHOL, V105, P443, DOI 10.1111/bjop.12084; Lee JH, 2016, J MUSIC THER, V53, P430, DOI 10.1093/jmt/thw012; Lesage FX, 2012, OCCUP MED-OXFORD, V62, P600, DOI 10.1093/occmed/kqs140; Limbert W.M., 1998, EMPIR STUD ARTS, V16, P33, DOI [https://doi.org/10.2190/V8BL-GBJK-TLFP-R321, DOI 10.2190/V8BL-GBJK-TLFP-R321, 10.2190/V8BL-GBJK-TLFP-R321]; Linnemann A, 2017, JOVE-J VIS EXP, DOI 10.3791/54920; Linnemann A, 2016, PSYCHONEUROENDOCRINO, V72, P97, DOI 10.1016/j.psyneuen.2016.06.003; Linnemann A, 2015, PSYCHONEUROENDOCRINO, V60, P82, DOI 10.1016/j.psyneuen.2015.06.008; Martinez-Marti ML, 2018, PSYCHOL AESTHET CREA, V12, P272, DOI 10.1037/aca0000164; Macdonald JSP, 2011, ATTEN PERCEPT PSYCHO, V73, P1780, DOI 10.3758/s13414-011-0144-4; Madsen SMK, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514558271; Marin MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183531; Marin MM, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3519/fnhum.2015.00536; Marin MM, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00443; Marin MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072412; Marin MM, 2012, EMOTION, V12, P618, DOI 10.1037/a0025020; Markovic S, 2012, I-PERCEPTION, V3, P1, DOI 10.1068/i0450aap; Mastandrea S, 2019, ARTS HEALTH, V11, P123, DOI 10.1080/17533015.2018.1443953; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 2010, METABOLISM, V59, pS9, DOI 10.1016/j.metabol.2010.07.012; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; McIntyre MH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231697; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Menninghaus W, 2019, PSYCHOL REV, V126, P171, DOI 10.1037/rev0000135; Merskey H, 1994, CLASSIFICATION CHRON, DOI DOI 10.1016/0304-3959(86)90113-2; Minarini G., 2020, AUTONOMIC NERVOUS SY; Mitchell LA, 2006, EUR J PAIN, V10, P343, DOI 10.1016/j.ejpain.2005.03.005; Mitchell LA., 2008, PSYCHOL AESTHET CREA, V2, P162, DOI [10.1037/1931-3896.2.3.162, DOI 10.1037/1931-3896.2.3.162, DOI 10.1177/0305735608097245]; Mitchell LA, 2006, J MUSIC THER, V43, P295, DOI 10.1093/jmt/43.4.295; Miu AC, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01951; Miu AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030618; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Nieminen S, 2011, CORTEX, V47, P1138, DOI 10.1016/j.cortex.2011.05.008; Oesch P., 2017, HOGREFE VERLAG; Pelletier CL, 2004, J MUSIC THER, V41, P192, DOI 10.1093/jmt/41.3.192; Pelowski M., 2014, INT J EDUC ARTS, P15; Pelowski M, 2017, PHYS LIFE REV, V21, P80, DOI 10.1016/j.plrev.2017.02.003; Pelowski M, 2011, NEW IDEAS PSYCHOL, V29, P80, DOI 10.1016/j.newideapsych.2010.04.001; RAINVILLE P, 1992, SOMATOSENS MOT RES, V9, P265, DOI 10.3109/08990229209144776; Reniers RLEP, 2011, J PERS ASSESS, V93, P84, DOI 10.1080/00223891.2010.528484; RITZ T, 1995, DIAGNOSTICA, V41, P53; Roy M, 2008, PAIN, V134, P140, DOI 10.1016/j.pain.2007.04.003; Salas J., 1990, MUSIC THER, V9, P1, DOI [10.1093/mt/9.1.1, DOI 10.1093/MT/9.1.1]; Sandstrom G.M., 2010, MUSIC MED, V2, P137, DOI [10.1177/1943862110371486, DOI 10.1177/1943862110371486]; Sandstrom GM, 2013, PSYCHOL MUSIC, V41, P216, DOI 10.1177/0305735611422508; Schneiderman N, 2005, ANNU REV CLIN PSYCHO, V1, P607, DOI 10.1146/annurev.clinpsy.1.102803.144141; Schoeller F, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01093; SCOTT J, 1976, PAIN, V2, P175, DOI 10.1016/0304-3959(76)90113-5; Skoluda N, 2015, PSYCHONEUROENDOCRINO, V51, P227, DOI 10.1016/j.psyneuen.2014.10.002; Skov M, 2020, PERSPECT PSYCHOL SCI, V15, P630, DOI 10.1177/1745691619897963; Storm H, 2008, CURR OPIN ANESTHESIO, V21, P796, DOI 10.1097/ACO.0b013e3283183fe4; Strahler J, 2017, NEUROSCI BIOBEHAV R, V83, P657, DOI 10.1016/j.neubiorev.2017.08.015; Stuckey HL, 2010, AM J PUBLIC HEALTH, V100, P254, DOI 10.2105/AJPH.2008.156497; Talbot K, 2019, BRIT J ANAESTH, V123, pE263, DOI 10.1016/j.bja.2019.03.033; TELLEGEN A, 1974, J ABNORM PSYCHOL, V83, P268, DOI 10.1037/h0036681; Thoma MV., 2011, HORIZONS NEUROSCIENC, V6, P1; Thoma MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070156; Tiihonen M, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01218; van Elk M., 2016, COLLABRA, V2, DOI [10.1525/collabra.36, DOI 10.1525/COLLABRA.36]; Vessel EA, 2012, FRONT HUM NEUROSCI, V6, P1, DOI 10.3389/fnhum.2012.00066; Villemure C, 2002, PAIN, V95, P195, DOI 10.1016/S0304-3959(02)00007-6; Wang TT, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01018; Yehuda N, 2011, J ADULT DEV, V18, P85, DOI 10.1007/s10804-010-9117-4; Zagari MJ, 1996, PHARMACOECONOMICS, V10, P356, DOI 10.2165/00019053-199610040-00005	119	2	2	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266545	10.1371/journal.pone.0266545	http://dx.doi.org/10.1371/journal.pone.0266545			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421152	Green Published, gold			2022-12-26	WOS:000795453600051
J	Hoff, U; Markmann, D; Thurn-Valassina, D; Nieminen-Kelhae, M; Erlangga, Z; Schmitz, J; Braesen, JH; Budde, K; Melk, A; Hegner, B				Hoff, Uwe; Markmann, Denise; Thurn-Valassina, Daniela; Nieminen-Kelhae, Melina; Erlangga, Zulrahman; Schmitz, Jessica; Braesen, Jan Hinrich; Budde, Klemens; Melk, Anette; Hegner, Bjoern			The mTOR inhibitor Rapamycin protects from premature cellular senescence early after experimental kidney transplantation	PLOS ONE			English	Article							RENAL-TRANSPLANTATION; REPERFUSION INJURY; AGE; CYCLOSPORINE; P16(INK4A); EXPRESSION; REGULATOR; SIROLIMUS; HISTOLOGY; FAILURE	Interstitial fibrosis and tubular atrophy, a major cause of kidney allograft dysfunction, has been linked to premature cellular senescence. The mTOR inhibitor Rapamycin protects from senescence in experimental models, but its antiproliferative properties have raised concern early after transplantation particularly at higher doses. Its effect on senescence has not been studied in kidney transplantation, yet. Rapamycin was applied to a rat kidney transplantation model (3 mg/kg bodyweight loading dose, 1.5 mg/kg bodyweight daily dose) for 7 days. Low Rapamycin trough levels (2.1-6.8 ng/mL) prevented the accumulation of p16(INK4a) positive cells in tubules, interstitium, and glomerula. Expression of the cytokines MCP-1, IL-1 beta, and TNF-alpha, defining the proinflammatory senescence-associated secretory phenotype, was abrogated. Infiltration with monocytes/macrophages and CD8(+) T-lymphocytes was reduced and tubular function was preserved by Rapamycin. Inhibition of mTOR was not associated with impaired structural recovery, higher glucose levels, or weight loss. mTOR inhibition with low-dose Rapamycin in the immediate posttransplant period protected from premature cellular senescence without negative effects on structural and functional recovery from preservation/reperfusion damage, glucose homeostasis, and growth in a rat kidney transplantation model. Reduced senescence might maintain the renal regenerative capacity rendering resilience to future injuries resulting in protection from interstitial fibrosis and tubular atrophy.	[Hoff, Uwe; Budde, Klemens; Hegner, Bjoern] Free Univ Berlin, Humboldt Univ Berlin, Berlin Inst Hlth, Dept Nephrol & Crit Care Med, Berlin, Germany; [Markmann, Denise] Nieren und Dialysezentrum Schoneberg Tempelhof, Berlin, Germany; [Thurn-Valassina, Daniela; Erlangga, Zulrahman; Melk, Anette] Childrens Hospital, Hannover Med Sch, Hannover, Germany; [Nieminen-Kelhae, Melina] Free Univ Berlin, Humboldt Univ Berlin, Berlin Inst Hlth, Dept Neurosurg, Berlin, Germany; [Schmitz, Jessica; Braesen, Jan Hinrich] Inst Pathol, Hannover Med Sch, Nephropathol Unit, Hannover, Germany; [Hegner, Bjoern] Vitanas Hosp Geriatr Med, Berlin, Germany	Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Hannover Medical School; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Hannover Medical School	Hegner, B (corresponding author), Free Univ Berlin, Humboldt Univ Berlin, Berlin Inst Hlth, Dept Nephrol & Crit Care Med, Berlin, Germany.; Hegner, B (corresponding author), Vitanas Hosp Geriatr Med, Berlin, Germany.	bjoern.hegner@gmx.de	Budde, Klemens/AAD-2170-2020	Budde, Klemens/0000-0002-7929-5942; Hegner, Bjorn/0000-0003-3524-1165; Erlangga, Zulrahman/0000-0002-5019-3387; Nieminen-Kelha, Melina/0000-0002-7577-8058				Abbadie C, 2020, TRENDS BIOCHEM SCI, V45, P371, DOI 10.1016/j.tibs.2020.02.005; Alimonti A, 2010, J CLIN INVEST, V120, P681, DOI 10.1172/JCI40535; Andrade Luis Gustavo Modelli de, 2017, Braz. J. Nephrol., V39, P70, DOI 10.5935/0101-2800.20170012; Baar MP, 2017, ONCOTARGET, V8, P86985, DOI 10.18632/oncotarget.18046; Bemelman FJ, 2017, AM J TRANSPLANT, V17, P1020, DOI 10.1111/ajt.14048; Brasen JH, 2005, KIDNEY INT, V67, P1583, DOI 10.1111/j.1523-1755.2005.00240.x; Braun H, 2012, J AM SOC NEPHROL, V23, P1467, DOI 10.1681/ASN.2011100967; Calcinotto A, 2019, PHYSIOL REV, V99, P1047, DOI 10.1152/physrev.00020.2018; Cao Q, 2015, PHYSIOLOGY, V30, P183, DOI 10.1152/physiol.00046.2014; Dong D, 2017, ONCOTARGET, V8, P16109, DOI 10.18632/oncotarget.14884; Dragun D, 2004, KIDNEY INT, V65, P1076, DOI 10.1111/j.1523-1755.2004.00478.x; Dragun D, 2000, KIDNEY INT, V58, P2166, DOI 10.1046/j.1523-1755.2000.00390.x; Ekberg H, 2007, NEW ENGL J MED, V357, P2562, DOI 10.1056/NEJMoa067411; Fuller TF, 2006, KIDNEY INT, V70, P570, DOI 10.1038/sj.ki.5001591; Fuller TF, 2010, TRANSPLANTATION, V89, P402, DOI 10.1097/TP.0b013e3181caa499; Fuller TF, 2012, TRANSPLANTATION, V94, P679, DOI 10.1097/TP.0b013e318265c4d8; Gingell-Littlejohn M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068133; Gurgen D, 2011, HYPERTENSION, V57, P648, DOI 10.1161/HYPERTENSIONAHA.110.166157; Hegner B, 2009, ARTERIOSCL THROM VAS, V29, P232, DOI 10.1161/ATVBAHA.108.179457; Herranz N, 2015, NAT CELL BIOL, V17, P1205, DOI 10.1038/ncb3225; Jennings P, 2007, AM J PHYSIOL-RENAL, V293, pF831, DOI 10.1152/ajprenal.00005.2007; Kirkland JL, 2020, J INTERN MED, V288, P518, DOI 10.1111/joim.13141; Koppelstaetter C, 2008, AGING CELL, V7, P491, DOI 10.1111/j.1474-9726.2008.00398.x; Koppelstaetter C, 2018, TOXICOL IN VITRO, V48, P86, DOI 10.1016/j.tiv.2018.01.004; Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; McGlynn LM, 2009, AGING CELL, V8, P45, DOI 10.1111/j.1474-9726.2008.00447.x; Mehrabi A, 2006, CLIN TRANSPLANT, V20, P30, DOI 10.1111/j.1399-0012.2006.00598.x; Melk A, 2003, KIDNEY INT, V63, P2134, DOI 10.1046/j.1523-1755.2003.00032.x; Melk A, 2005, AM J TRANSPLANT, V5, P1375, DOI 10.1111/j.1600-6143.2005.00846.x; Melk A, 2004, KIDNEY INT, V65, P510, DOI 10.1111/j.1523-1755.2004.00438.x; Melk A, 2009, AM J TRANSPLANT, V9, P114, DOI 10.1111/j.1600-6143.2008.02500.x; Montero N, 2019, TRANSPLANTATION, V103, P2031, DOI 10.1097/TP.0000000000002769; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Naesens M, 2014, TRANSPLANTATION, V98, P427, DOI 10.1097/TP.0000000000000183; Naesens M, 2011, DISCOV MED, V11, P65; Nie DB, 2021, STEM CELLS INT, V2021, DOI 10.1155/2021/6638249; Pena MDS, 2018, AM J PHYSIOL-RENAL, V315, pF880, DOI 10.1152/ajprenal.00195.2016; Sagiv A, 2013, BIOGERONTOLOGY, V14, P617, DOI 10.1007/s10522-013-9473-0; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schaub T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56237-w; Timsit MO, 2010, KIDNEY INT, V78, pS54, DOI 10.1038/ki.2010.424; Van Loon E, 2020, TRANSPLANTATION, V104, pE46, DOI 10.1097/TP.0000000000003012; van Willigenburg H, 2018, PHARMACOL RES, V130, P322, DOI 10.1016/j.phrs.2018.02.015; Verzola D, 2008, AM J PHYSIOL-RENAL, V295, pF1563, DOI 10.1152/ajprenal.90302.2008; Viana SD, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/3693625; Waldner M, 2016, BRIT J CLIN PHARMACO, V82, P1158, DOI 10.1111/bcp.12893; Weichhart T, 2018, GERONTOLOGY, V64, P127, DOI 10.1159/000484629; Westhoff JH, 2008, HYPERTENSION, V52, P123, DOI 10.1161/HYPERTENSIONAHA.107.099432; WHITE E, 1969, TRANSPLANTATION, V8, P602, DOI 10.1097/00007890-196911000-00007	50	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266319	10.1371/journal.pone.0266319	http://dx.doi.org/10.1371/journal.pone.0266319			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446876	Green Published, gold			2022-12-26	WOS:000795468200066
J	Jiao, Z; Zhou, Y; Miao, ZJ; Wen, XY; Yun, YP				Jiao, Zhen; Zhou, Yu; Miao, Zhijia; Wen, Xueyou; Yun, Yupan			Research on catalytic denitrification by zero-valent iron (Fe-0) and Pd-Ag catalyst	PLOS ONE			English	Article							NITRATE REDUCTION; REMOVAL; WATER; CU; OPTIMIZATION	This study primarily focused on how to effectively remove nitrate by catalytic denitrification through zero-valent iron (Fe-0) and Pd-Ag catalyst. Response surface methodology (RSM), instead of the single factor experiments and orthogonal tests, was firstly applied to optimize the condition parameters of the catalytic process. Results indicated that RSM is accurate and feasible for the condition optimization of catalytic denitrification. Better catalytic performance (71.6% N-2 Selectivity) was obtained under the following conditions: 5.1 pH, 127 min reaction time, 3.2 mass ration (Pd: Ag), and 4.2 g/L Fe-0, which was higher than the previous study designed by single factor experiments and orthogonal tests, 68.1% and 68.7% of N-2 Selectivity, respectively. However, under this optimal conditions, N-2 selectivity showed a mild decrease (69.3%), when the real wastewater was used as influent. Further study revealed that cations (K+, Na+, Ca2+, Mg2+, and Al3+) and anions (Cl-, HCO3-, and SO42-) exist in wastewater could have distinctive influence on N-2 selectivity. Finally, the reaction mechanism and kinetic model of catalytic denitrification were further studied.	[Jiao, Zhen] Univ Sci & Technol Beijing, Sch Energy & Environm Engn, Beijing, Peoples R China; [Jiao, Zhen; Zhou, Yu; Miao, Zhijia; Wen, Xueyou; Yun, Yupan] Hebei GEO Univ, Hebei Prov Collaborat Innovat Ctr Sustainable Uti, Sch Water Resources & Environm, Inst Intelligence & Environm Ind Technol,Hebei Pr, Shijiazhuang, Hebei, Peoples R China	University of Science & Technology Beijing; Hebei GEO University	Yun, YP (corresponding author), Hebei GEO Univ, Hebei Prov Collaborat Innovat Ctr Sustainable Uti, Sch Water Resources & Environm, Inst Intelligence & Environm Ind Technol,Hebei Pr, Shijiazhuang, Hebei, Peoples R China.	yundzdx@126.com			Natural Science Foundation of Hebei Province [B2019403127, C2021403002]; PhD Research Startup Foundation of Hebei GEO University [BQ2019038]; Fundamental Research Funds for the Universities in Hebei province [QN202108]	Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); PhD Research Startup Foundation of Hebei GEO University; Fundamental Research Funds for the Universities in Hebei province	This work was supported by the Natural Science Foundation of Hebei Province (B2019403127, C2021403002), the PhD Research Startup Foundation of Hebei GEO University (BQ2019038), and the Fundamental Research Funds for the Universities in Hebei province (QN202108).	Chengbing Yu., 2018, ADV TEXTILE TECHNOLO, P1; Choi EK, 2013, J ENVIRON SCI-CHINA, V25, P1696, DOI 10.1016/S1001-0742(12)60226-5; [崔宝臣 CUI Baochen], 2008, [应用化工, Applied Chemical Industry], V37, P1081; Dadras FS, 2014, COLOR TECHNOL, V130, P86, DOI 10.1111/cote.12073; Deganello F, 2000, APPL CATAL B-ENVIRON, V24, P265, DOI 10.1016/S0926-3373(99)00109-5; Gao WL, 2003, APPL CATAL B-ENVIRON, V46, P341, DOI 10.1016/S0926-3373(03)00226-1; Haddar W, 2014, IND CROP PROD, V52, P588, DOI 10.1016/j.indcrop.2013.11.019; Hao SZ, 2017, J CLEAN PROD, V167, P192, DOI 10.1016/j.jclepro.2017.07.255; Hong He., 2008, ENV CATALYSIS MECH A; Imran MA, 2016, COLOR TECHNOL, V132, P414, DOI 10.1111/cote.12230; Jasper JT, 2014, ENVIRON SCI TECHNOL, V48, P11512, DOI 10.1021/es502785t; Julkapli NM, 2015, INT J HYDROGEN ENERG, V40, P948, DOI 10.1016/j.ijhydene.2014.10.129; Jung S, 2014, ENVIRON SCI TECHNOL, V48, P9651, DOI 10.1021/es502263p; Khalil AME, 2016, CHEM ENG J, V287, P367, DOI 10.1016/j.cej.2015.11.038; Li PJ, 2017, J CLEAN PROD, V151, P21, DOI 10.1016/j.jclepro.2017.03.042; Liou YH, 2009, ENVIRON SCI TECHNOL, V43, P2482, DOI 10.1021/es802498k; Lubphoo Y, 2016, J TAIWAN INST CHEM E, V59, P285, DOI 10.1016/j.jtice.2015.08.005; McAdam EJ, 2006, DESALINATION, V196, P135, DOI 10.1016/j.desal.2006.03.008; Min SK., 2013, APPL CATAL B-ENVIRON, V143, P354; Nathany A, 2014, J TEXT I, V105, P1146, DOI 10.1080/00405000.2013.876150; Ryu A, 2011, APPL CATAL B-ENVIRON, V105, P128, DOI 10.1016/j.apcatb.2011.04.002; Schlicker O, 2000, GROUND WATER, V38, P403, DOI 10.1111/j.1745-6584.2000.tb00226.x; Shen J., 2016, J ZHEJIANG SHUREN U, V16, P31; Soares MIM, 2000, WATER AIR SOIL POLL, V123, P183, DOI 10.1023/A:1005242600186; Soares OSGP, 2011, DESALINATION, V279, P367, DOI 10.1016/j.desal.2011.06.037; Tunay O, 2015, GLOBAL NEST J, V17, P248; VORLOP KD, 1989, CHEM-ING-TECH, V61, P836, DOI 10.1002/cite.330611023; Ye ZP, 2016, CARBOHYD POLYM, V147, P354, DOI 10.1016/j.carbpol.2016.03.092; Yun YP, 2018, J WATER REUSE DESAL, V8, P29, DOI 10.2166/wrd.2016.122; Yun YP, 2016, WATER SCI TECHNOL, V73, P2697, DOI 10.2166/wst.2016.129; Yun YP, 2016, WATER AIR SOIL POLL, V227, DOI 10.1007/s11270-016-2792-4; Zhang Y., 2003, CATALYTIC REDUCTION; Zhao WR, 2014, CHEM ENG J, V254, P410, DOI 10.1016/j.cej.2014.05.144	33	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266057	10.1371/journal.pone.0266057	http://dx.doi.org/10.1371/journal.pone.0266057			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1E2NP	35427386	Green Published, Green Submitted, gold			2022-12-26	WOS:000794332400011
J	Maruyama, Y; Nakayama, M; Abe, M; Yokoo, T; Minakuchi, J; Nitta, K				Maruyama, Yukio; Nakayama, Masaaki; Abe, Masanori; Yokoo, Takashi; Minakuchi, Jun; Nitta, Kosaku			Association between serum beta 2-microglobulin and mortality in Japanese peritoneal dialysis patients: A cohort study	PLOS ONE			English	Article							RESIDUAL RENAL-FUNCTION; BETA-TRACE PROTEIN; CARDIOVASCULAR-DISEASE; KIDNEY-FUNCTION; RISK-FACTORS; CYSTATIN-C; PREDICTORS; BETA(2)-MICROGLOBULIN; CREATININE; MARKERS	Background Higher serum beta 2-microglobulin (B2M) concentrations are associated with higher mortality in the general population, non-dialyzed chronic kidney disease patients and patients receiving hemodialysis (HD). However, this relationship among patients on peritoneal dialysis (PD) has not been validated. Methods We collected baseline data for 3,011 prevalent PD patients from a nationwide dialysis registry in Japan at the end of 2010. Clinical outcomes for 9 years were then evaluated using the registry at the end of 2011 to 2019. All-cause and cardiovascular (CV) mortality was assessed using Cox regression analysis and competing-risks regression analysis, respectively. We used multiple imputation to deal with missing covariate data. Results During a median follow-up of 87 months, 2,054 patients transferred to combined therapy with PD and HD or HD directly. A total of 3,011 patients, 1,235 (41.0%) died, including 437 patients (14.5%) from CV causes. Among them, 612 patients died after transfer to other dialysis modalities. Univariate analyses revealed no significant association between serum B2M and mortality, whereas higher serum B2M was independently associated with both all-cause and CV mortalities in adjusted models. However, the significant association between serum B2M and CV mortality disappeared in analysis treating serum B2M as a categorical variable. The effect of serum B2M on all-cause mortality was significantly higher among patients with higher urinary volume and a significant interaction was evident. Conclusions Using a large-scale registry, we found that serum B2M contributes tenuously but significantly to worse outcome and residual kidney function significantly affects this relationship. On the contrary, serum B2M per se had no predictive value for patient outcome in prevalent PD patients.	[Maruyama, Yukio; Yokoo, Takashi] Jikei Univ, Dept Internal Med, Div Nephrol & Hypertens, Sch Med, Tokyo, Japan; [Maruyama, Yukio; Abe, Masanori; Nitta, Kosaku] Japanese Soc Dialysis Therapy, Comm Renal Data Registry, Tokyo, Japan; [Nakayama, Masaaki] St Lukes Int Hosp, Dept Nephrol, Tokyo, Japan; [Abe, Masanori] Nihon Univ, Dept Internal Med, Div Nephrol Hypertens & Endocrinol, Sch Med, Tokyo, Japan; [Minakuchi, Jun] Kawashima Hosp, Dept Kidney Dis, Tokushima, Japan; [Nitta, Kosaku] Tokyo Womens Med Univ, Dept Internal Med 4, Tokyo, Japan	Jikei University; St. Luke's International Hospital; Nihon University; Tokyo Women's Medical University	Maruyama, Y (corresponding author), Jikei Univ, Dept Internal Med, Div Nephrol & Hypertens, Sch Med, Tokyo, Japan.; Maruyama, Y (corresponding author), Japanese Soc Dialysis Therapy, Comm Renal Data Registry, Tokyo, Japan.	maruyama@td5.so-net.ne.jp		Maruyama, Yukio/0000-0002-5602-8104				ACCHIARDO S, 1989, AM J KIDNEY DIS, V13, P70, DOI 10.1016/S0272-6386(89)80119-2; Aloisio KM, 2014, STATA J, V14, P863, DOI 10.1177/1536867X1401400410; AMICI G, 1993, NEPHRON, V65, P469, DOI 10.1159/000187533; [Anonymous], 2002, NEPHROL DIAL TRANSPL, V17, P16; Astor BC, 2012, AM J KIDNEY DIS, V59, P653, DOI 10.1053/j.ajkd.2011.11.042; Bargman JM, 2001, J AM SOC NEPHROL, V12, P2158, DOI 10.1681/ASN.V12102158; Bianchi C, 2001, RENAL FAILURE, V23, P419, DOI 10.1081/JDI-100104725; Brown EA, 2020, PERITON DIALYSIS INT, V40, P244, DOI 10.1177/0896860819895364; Brown P H, 1988, Nephrol Dial Transplant, V3, P169; Brunati CCM, 2019, BLOOD PURIFICAT, V48, P86, DOI 10.1159/000499830; Chang TI, 2019, NEPHROL DIAL TRANSPL, V34, P138, DOI 10.1093/ndt/gfy193; Cheung AK, 2006, J AM SOC NEPHROL, V17, P546, DOI 10.1681/ASN.2005020132; Conway T P, 1976, Adv Exp Med Biol, V73 Pt B, P87; Coviello V, 2004, STATA J, V4, P103, DOI 10.1177/1536867X0400400201; Donadio C, 2001, J PHARMACEUT BIOMED, V24, P835, DOI 10.1016/S0731-7085(00)00550-1; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fink JC, 1999, AM J KIDNEY DIS, V34, P694, DOI 10.1016/S0272-6386(99)70395-1; Foster MC, 2016, AM J KIDNEY DIS, V68, P68, DOI 10.1053/j.ajkd.2016.01.015; Foster MC, 2013, AM J KIDNEY DIS, V62, P42, DOI 10.1053/j.ajkd.2013.01.016; Ignacio de Ulíbarri J., 2005, Nutr. Hosp., V20, P38; Jadoul M, 2016, NEPHROL DIAL TRANSPL, V31, P507, DOI 10.1093/ndt/gfv318; Jaques DA, 2021, J NEPHROL, V34, P473, DOI 10.1007/s40620-020-00906-x; Juraschek SP, 2013, CLIN J AM SOC NEPHRO, V8, P584, DOI 10.2215/CJN.08700812; Kalantar-Zadeh K, 2003, KIDNEY INT, V63, P793, DOI 10.1046/j.1523-1755.2003.00803.x; KIN K, 1979, IMMUNOLOGY, V36, P47; Koh ES, 2015, AM J NEPHROL, V42, P91, DOI 10.1159/000439060; Lo WK, 2006, PERITON DIALYSIS INT, V26, P520; Moist LM, 2000, J AM SOC NEPHROL, V11, P556, DOI 10.1681/ASN.V113556; Nakai S, 2012, THER APHER DIAL, V16, P483, DOI 10.1111/j.1744-9987.2012.01143.x; Nakao M, 2017, NEPHROLOGY, V22, P907, DOI 10.1111/nep.12911; Nakayama M, 2010, THER APHER DIAL, V14, P489, DOI 10.1111/j.1744-9987.2010.00901.x; Paniagua R, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1351307; Shafi T, 2016, KIDNEY INT, V89, P1099, DOI 10.1016/j.kint.2015.10.011; Wu HC, 2017, J CLIN LAB ANAL, V31, DOI 10.1002/jcla.22056; Xue JL, 2002, KIDNEY INT, V61, P741, DOI 10.1046/j.1523-1755.2002.00176.x; Yokoyama K, 2008, CLIN NEPHROL, V69, P121; Zhang JL, 2022, THER APHER DIAL, V26, P267, DOI 10.1111/1744-9987.13729	37	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266882	10.1371/journal.pone.0266882	http://dx.doi.org/10.1371/journal.pone.0266882			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421178	gold, Green Published			2022-12-26	WOS:000795453600075
J	Moss, SJ; Lee, CH; Doig, CJ; Whalen-Browne, L; Stelfox, HT; Fiest, KM				Moss, Stephana J.; Hee Lee, Chel; Doig, Christopher J.; Whalen-Browne, Liam; Stelfox, Henry T.; Fiest, Kirsten M.			Delirium diagnosis without a gold standard: Evaluating diagnostic accuracy of combined delirium assessment tools	PLOS ONE			English	Article							CONFUSION ASSESSMENT METHOD; DISEASE PREVALENCE; ERROR RATES; ABSENCE; CAREGIVERS; TESTS	BackgroundFluctuating course of delirium and complexities of ICU care mean delirium symptoms are hard to identify or commonly confused with other disorders. Delirium is difficult to diagnose, and clinicians and researchers may combine assessments from multiple tools. We evaluated diagnostic accuracy of different combinations of delirium assessments performed in each enrolled patient. MethodsData were obtained from a previously conducted cross-sectional study. Eligible adult patients who remained admitted to ICU for >24 hours with at least one family member present were consecutively enrolled as patient-family dyads. Clinical delirium assessments (Intensive Care Delirium Screening Checklist [ICSDC] and Confusion Assessment Method-ICU [CAM-ICU]) were completed twice daily by bedside nurse or trained research assistant, respectively. Family delirium assessments (Family Confusion Assessment Method and Sour Seven) were completed once daily by family members. We pooled all delirium assessment tools in a single two-class latent model and pairwise (i.e., combined, clinical or family assessments) Bayesian analyses. ResultsSeventy-three patient-family dyads were included. Among clinical delirium assessments, the ICDSC had lower sensitivity (0.72; 95% Bayesian Credible [BC] interval 0.54-0.92) and higher specificity (0.90; 95%BC, 0.82-0.97) using Bayesian analyses compared to pooled latent class analysis and CAM-ICU had higher sensitivity (0.90; 95%BC, 0.70-1.00) and higher specificity (0.94; 95%BC, 0.80-1.00). Among family delirium assessments, the Family Confusion Assessment Method had higher sensitivity (0.83; 95%BC, 0.71-0.92) and higher specificity (0.93; 95%BC, 0.84-0.98) using Bayesian analyses compared to pooled latent class analysis and the Sour Seven had higher specificity (0.85; 95%BC, 0.67-0.99) but lower sensitivity (0.64; 95%BC 0.47-0.82). ConclusionsResults from delirium assessment tools are often combined owing to imperfect reference standards for delirium measurement. Pairwise Bayesian analyses that explicitly accounted for each tool's (performed within same patient) prior sensitivity and specificity indicate that two combined clinical or two combined family delirium assessment tools have fair diagnostic accuracy.	[Moss, Stephana J.; Doig, Christopher J.; Stelfox, Henry T.; Fiest, Kirsten M.] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada; [Moss, Stephana J.; Hee Lee, Chel; Doig, Christopher J.; Whalen-Browne, Liam; Stelfox, Henry T.; Fiest, Kirsten M.] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; [Moss, Stephana J.; Hee Lee, Chel; Doig, Christopher J.; Whalen-Browne, Liam; Stelfox, Henry T.; Fiest, Kirsten M.] Alberta Hlth Serv, Calgary, AB, Canada; [Moss, Stephana J.; Doig, Christopher J.; Stelfox, Henry T.; Fiest, Kirsten M.] Univ Calgary, OBrien Inst Publ Hlth, Calgary, AB, Canada; [Moss, Stephana J.; Fiest, Kirsten M.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Fiest, Kirsten M.] Univ Calgary, Cumming Sch Med, Dept Psychiat, Calgary, AB, Canada	University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary; University of Calgary; University of Calgary; University of Calgary	Fiest, KM (corresponding author), Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada.; Fiest, KM (corresponding author), Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada.; Fiest, KM (corresponding author), Alberta Hlth Serv, Calgary, AB, Canada.; Fiest, KM (corresponding author), Univ Calgary, OBrien Inst Publ Hlth, Calgary, AB, Canada.; Fiest, KM (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.; Fiest, KM (corresponding author), Univ Calgary, Cumming Sch Med, Dept Psychiat, Calgary, AB, Canada.	kmfiest@ucalgary.ca		Whalen-Browne, Liam/0000-0002-1335-9413	Medical Services Incorporated Foundation; Canadian Institutes of Health Research; Alberta Health Services; Canadian Frailty Network (Technology Evaluation in the Elderly Network); Government of Canada through the Networks of Centres of Excellence program; CIHR Doctoral Research Award	Medical Services Incorporated Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Health Services; Canadian Frailty Network (Technology Evaluation in the Elderly Network); Government of Canada through the Networks of Centres of Excellence program; CIHR Doctoral Research Award(Canadian Institutes of Health Research (CIHR))	Supported, in part, by grants from the Medical Services Incorporated Foundation, Canadian Institutes of Health Research, and Alberta Health Services (to Dr. Fiest). This research is funded by Canadian Frailty Network (Technology Evaluation in the Elderly Network), which is supported by the Government of Canada through the Networks of Centres of Excellence program (to Dr. Fiest). Dr. Moss was supported by a CIHR Doctoral Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asafu-Adjei JK, 2015, INT J PATTERN RECOGN, V29, DOI 10.1142/S0218001415500238; Bergeron N, 2001, INTENS CARE MED, V27, P859, DOI 10.1007/s001340100909; Bigatello LM, 2013, J TRAUMA ACUTE CARE, V74, P876, DOI 10.1097/TA.0b013e31827e1b69; Brundin-Mather R, 2018, J CRIT CARE, V47, P295, DOI 10.1016/j.jcrc.2018.07.021; Carvalho João Pedro Lins Mendes, 2013, Rev. bras. ter. intensiva, V25, P148, DOI 10.5935/0103-507X.20130026; Chang C., 2000, RESPONSE FEATURE ANA; Collins J, 2014, STAT MED, V33, P4141, DOI 10.1002/sim.6218; Crainiceanu C, 2010, J STAT SOFTW, V32, P1; Dendukuri N, 2004, BIOMETRICS, V60, P388, DOI 10.1111/j.0006-341X.2004.00183.x; Dendukuri N, 2001, BIOMETRICS, V57, P158, DOI 10.1111/j.0006-341X.2001.00158.x; Devlin JW, 2013, INTENS CARE MED, V39, P2196, DOI 10.1007/s00134-013-3105-7; Diwell RA, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0719-1; FARAONE SV, 1994, AM J PSYCHIAT, V151, P650; Fiest KM, 2020, CRIT CARE MED, V48, P954, DOI 10.1097/CCM.0000000000004367; Gelinas C, 2018, CRIT CARE NURSE, V38, P38, DOI 10.4037/ccn2018633; HUI SL, 1980, BIOMETRICS, V36, P167, DOI 10.2307/2530508; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; JOSEPH L, 1995, AM J EPIDEMIOL, V141, P263, DOI 10.1093/oxfordjournals.aje.a117428; Krewulak KD, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242378; Krewulak Karla D, 2019, CMAJ Open, V7, pE294, DOI 10.9778/cmajo.20180123; Lawlor PG, 2014, CURR OPIN SUPPORT PA, V8, P286, DOI 10.1097/SPC.0000000000000062; Leonard MM, 2014, J PAIN SYMPTOM MANAG, V48, P176, DOI 10.1016/j.jpainsymman.2013.10.024; Leslie DL, 2011, J AM GERIATR SOC, V59, pS241, DOI 10.1111/j.1532-5415.2011.03671.x; Linzer DAaJ L, 2013, POLCA POLYTOMOUS VAR; Morandi A, 2009, INT REV PSYCHIATR, V21, P43, DOI 10.1080/09540260802675296; Patel MB, 2018, CRIT CARE MED, V46, P1832, DOI 10.1097/CCM.0000000000003349; Pun BT, 2007, CHEST, V132, P624, DOI 10.1378/chest.06-1795; Pun BT, 2013, SEMIN RESP CRIT CARE, V34, P179, DOI 10.1055/s-0033-1342972; RINDSKOPF D, 1986, STAT MED, V5, P21, DOI 10.1002/sim.4780050105; Rizzo JA, 2001, MED CARE, V39, P740, DOI 10.1097/00005650-200107000-00010; Shenkin SD, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1367-9; Shulman RW, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0217-2; Steis MR, 2012, J AM GERIATR SOC, V60, P2121, DOI 10.1111/j.1532-5415.2012.04200.x; Thomas C, 2012, J AM GERIATR SOC, V60, P1471, DOI 10.1111/j.1532-5415.2012.04066.x; Tommasi M, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01240; Ulbricht CM, 2018, PSYCHIAT RES, V266, P228, DOI 10.1016/j.psychres.2018.03.003; Vats D, 2018, REVISITING GELMAN RU; WALTER SD, 1988, J CLIN EPIDEMIOL, V41, P923, DOI 10.1016/0895-4356(88)90110-2	38	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267110	10.1371/journal.pone.0267110	http://dx.doi.org/10.1371/journal.pone.0267110			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0Z7MW	35436316	Green Published, gold			2022-12-26	WOS:000791258900005
J	Righolt, CM; Willows, K; Kliewer, E; Mahmud, S				Righolt, Christiaan M.; Willows, Karla; Kliewer, Erich; Mahmud, Salaheddin			Incidence of anogenital warts after the introduction of the quadrivalent HPV vaccine program in Manitoba, Canada	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; GENITAL WARTS; ADMINISTRATIVE DATA; UNITED-STATES; IMPACT; DIAGNOSES; WOMEN; AGE; PREVALENCE; TRENDS	BackgroundThe incidence of anogenital warts (AGW) decreased after the introduction of the quadrivalent human papillomavirus (qHPV) vaccine in multiple jurisdictions. We studied how comparing AGW incidence rates with different outcomes affects the interpretation of the qHPV vaccination program. To do this, we replicated multiple study designs within a single jurisdiction (Manitoba). MethodsWe measured the incidence rates of AGW, AGW-related prescriptions, chlamydia, and gonorrhea (the latter two as sham outcomes) between 2001 and 2017 using several clinical and administrative health databases from Manitoba. We then used incidence rate ratios (IRRs) to compare, for each outcome, the rate for the 1997-1998 birth cohort (the first cohorts eligible for the publicly funded qHPV vaccination program) and the older 1995-1996 birth cohort. ResultsAGW incidence in Manitoba dropped 72% (95% confidence interval 54-83%) among 16-18 year-old girls and 51% (14-72%) among boys after the introduction of the female-only qHPV vaccination program. Trends in AGW-related prescriptions were different from trends in AGW diagnoses as these prescriptions peaked shortly after the introduction of the publicly funded qHPV vaccine program. Chlamydia and gonorrhea incidence rates also decreased 12% (5-18%) and 16% (-1-30%), respectively, for 16-18 year-old girls. ConclusionsThe publicly funded school-based qHPV vaccine program reduced AGW incidence in Manitoba by three-quarters in young females. AGW-related prescriptions are a poor proxy for medically attended AGW after the introduction of the publicly funded qHPV vaccination program. Different sexual habits in adolescents are, at most, responsible for a small portion of the reduction in AGW incidence.	[Righolt, Christiaan M.; Willows, Karla; Kliewer, Erich; Mahmud, Salaheddin] Univ Manitoba, Vaccine & Drug Evaluat Ctr, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Righolt, Christiaan M.] Childrens Hosp Res Inst Manitoba, Winnipeg, MB, Canada; [Kliewer, Erich] British Columbia Canc Agcy, Canc Control Res, Vancouver, BC, Canada	University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; British Columbia Cancer Agency	Mahmud, S (corresponding author), Univ Manitoba, Vaccine & Drug Evaluat Ctr, Dept Community Hlth Sci, Winnipeg, MB, Canada.	Salah.Mahmud@gmail.com			Merck Investigator Studies Program (IIS) [51109]; Canada Research Chair Program [231458]	Merck Investigator Studies Program (IIS); Canada Research Chair Program(Canada Research Chairs)	This work was supported by the Merck Investigator Studies Program (IIS #51109) with a grant to the International Centre for Infectious Diseases (ICID). The sponsor had no role in the design or conduct of the study, including but not limited to, data identification, collection, management, analysis and interpretation, or preparation, review, or approval of the results. The opinions presented in the report do not necessarily reflect those of the sponsor. SMM's work is supported, in part, by funding from the Canada Research Chair Program (#231458). There was no additional external funding received for this study.	[Anonymous], 2012, 2012 CANC SYST PERF; [Anonymous], 2014, 2014 CANC SYST PERF; [Anonymous], 2015, EP CHLAM GON WINN HL; Baandrup L, 2013, SEX TRANSM DIS, V40, P130, DOI 10.1097/OLQ.0b013e31827bd66b; Bauer HM, 2012, AM J PUBLIC HEALTH, V102, P833, DOI 10.2105/AJPH.2011.300465; Bollerup S, 2016, SEX TRANSM DIS, V43, P238, DOI 10.1097/OLQ.0000000000000418; Chow EPF, 2015, SEX TRANSM INFECT, V91, P214, DOI 10.1136/sextrans-2014-051813; Deeks S L, 2017, Can Commun Dis Rep, V43, P138; Dominiak-Felden G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132404; Donovan B, 2011, LANCET INFECT DIS, V11, P39, DOI 10.1016/S1473-3099(10)70225-5; Drolet M, 2019, LANCET, V394, P497, DOI 10.1016/S0140-6736(19)30298-3; Drolet M, 2015, LANCET INFECT DIS, V15, P565, DOI 10.1016/S1473-3099(14)71073-4; Fairley CK, 2009, SEX TRANSM INFECT, V85, P499, DOI 10.1136/sti.2009.037788; Falcaro M, 2021, LANCET, V398, P2084, DOI 10.1016/S0140-6736(21)02178-4; Flagg EW, 2018, AM J PUBLIC HEALTH, V108, P112, DOI 10.2105/AJPH.2017.304119; Flagg EW, 2013, AM J PUBLIC HEALTH, V103, P1428, DOI 10.2105/AJPH.2012.301182; Garland SM, 2016, CLIN INFECT DIS, V63, P519, DOI 10.1093/cid/ciw354; Garland SM, 2009, J INFECT DIS, V199, P805, DOI 10.1086/597071; Guerra FM, 2016, VACCINE, V34, P4678, DOI 10.1016/j.vaccine.2016.08.020; Herweijer E, 2018, VACCINE, V36, P1917, DOI 10.1016/j.vaccine.2018.02.097; Kann L, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6708a1; Kliewer E., 2010, UPTAKE HUMAN PAPILLO; Kliewer EV, 2009, SEX TRANSM DIS, V36, P380, DOI 10.1097/OLQ.0b013e318198de8c; Kozyrskyj AL, 1998, ANN PHARMACOTHER, V32, P1152, DOI 10.1345/aph.18117; Leval A, 2012, J INFECT DIS, V206, P860, DOI 10.1093/infdis/jis405; Liu B, 2014, SEX TRANSM INFECT, V90, P532, DOI 10.1136/sextrans-2013-051307; Mahmud S, 2011, VACCINE, V29, P7975, DOI 10.1016/j.vaccine.2011.08.068; Mahmud SM, 2012, EMERG INFECT DIS, V18, P801, DOI 10.3201/eid1805.111596; Martens P., 2015, COST SMOKING MANITOB; Mikolajczyk RT, 2013, SEX TRANSM DIS, V40, P28, DOI 10.1097/OLQ.0b013e3182756efd; Naleway AL, 2020, SEX TRANSM DIS, V47, P179, DOI 10.1097/OLQ.0000000000001103; Oliphant J, 2017, NEW ZEAL MED J, V130, P9; Oliphant J, 2011, NEW ZEAL MED J, V124, P51; Read TRH, 2011, SEX TRANSM INFECT, V87, P544, DOI 10.1136/sextrans-2011-050234; Robinson JR, 1997, MED CARE, V35, P932, DOI 10.1097/00005650-199709000-00006; ROOS LL, 1993, MED CARE, V31, P201, DOI 10.1097/00005650-199303000-00002; Singh H, 2009, AM J GASTROENTEROL, V104, P3015, DOI 10.1038/ajg.2009.574; Smith LM, 2017, INT J EPIDEMIOL, V46, P939, DOI 10.1093/ije/dyw195; Smith LM, 2015, PEDIATRICS, V135, pE1131, DOI 10.1542/peds.2014-2961; Taur Y, 2007, CLIN INFECT DIS, V44, P769, DOI 10.1086/511866; Twenge, 2017, ARCH SEX BEHAV; Twenge JM, 2017, ARCH SEX BEHAV, V46, P433, DOI 10.1007/s10508-016-0798-z; Willows K, 2018, SEX TRANSM DIS, V45, P254, DOI 10.1097/OLQ.0000000000000742; Wright TC, 2008, GYNECOL ONCOL, V109, pS40, DOI 10.1016/j.ygyno.2008.02.002; Wylie JL, 2016, SEX TRANSM INFECT, V92, P55, DOI 10.1136/sextrans-2014-051702	45	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267646	10.1371/journal.pone.0267646	http://dx.doi.org/10.1371/journal.pone.0267646			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35472093	gold, Green Published			2022-12-26	WOS:000816171900034
J	Tagawa, K; Hosoya, T; Hyakumura, K; Suzuki, D; Yoshizawa, S; Praxaysombath, B				Tagawa, Kazuki; Hosoya, Tadatsugu; Hyakumura, Kimihiko; Suzuki, Dai; Yoshizawa, Satoshi; Praxaysombath, Bounthob			The effects of season, geography, and urbanization on the diversity of edible insects at food markets in Laos	PLOS ONE			English	Article								Laos, a mountainous and landlocked country located in Southeast Asia, has the highest percentage of people using insects as food in the world. Lao people obtain edible insects through harvesting in the natural environment and purchasing at food markets. There has been no comprehensive survey about sales of insects at food markets in the wider areas, and our understanding of sales of insects in Laos is limited. Our study aims to identify environmental factors affecting the sales and the diversity of edible insects sold at food markets in Laos. We visited 37 and 55 markets, during the dry and rainy seasons respectively, in northern Laos to record species of sold insects. We then analyzed the correlations between insect sales and three potential factors (seasons, provinces, and urbanization indices around the markets). There was no significant difference in the percentage of markets selling insects between in the dry and rainy seasons; 40-50% of the markets sold insects in both seasons. The composition of sold insects differed between in the dry and rainy seasons, which reflects the seasonality and life history of each insect species. There tended to be more groups of insects for sale in the Vientiane capital than in the other provinces in both seasons. This trend may reflect that it is more difficult to obtain edible insects through wild harvesting in highly urbanized Vientiane capital than in the other provinces, and the commercial demand for insects is increasing. This possibility is directly supported by the positive correlation between the urbanization index and the insect sales in the rainy season. Laos has recently undergone rapid urbanization, particularly in the Vientiane capital, and we predict that commercial demand for edible insects will be much higher in the Vientiane capital and the urbanized cities in the future.	[Tagawa, Kazuki; Hosoya, Tadatsugu; Suzuki, Dai; Yoshizawa, Satoshi] Kyushu Univ, Inst Decis Sci Sustainable Soc, Fukuoka, Japan; [Tagawa, Kazuki] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka, Japan; [Hyakumura, Kimihiko] Kyushu Univ, Inst Trop Agr, Fukuoka, Japan; [Yoshizawa, Satoshi] Kyushu Univ, Grad Sch Social, Cultural Studies, Fukuoka, Japan; [Praxaysombath, Bounthob] Natl Univ Laos, Fac Sci, Viangchan, Laos; [Tagawa, Kazuki] Miyazaki Int Coll, Sch Educ, Dept Childhood Educ, Miyazaki, Japan; [Hosoya, Tadatsugu] Nihon Univ, Coll Bioresource Sci, Fujisawa, Japan; [Suzuki, Dai] Tokai Univ, Sch Biol Sci, Dept Biol, Sapporo, Japan	Kyushu University; Kyushu University; Kyushu University; Kyushu University; Nihon University; Tokai University	Tagawa, K (corresponding author), Kyushu Univ, Inst Decis Sci Sustainable Soc, Fukuoka, Japan.; Tagawa, K (corresponding author), Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka, Japan.; Tagawa, K (corresponding author), Miyazaki Int Coll, Sch Educ, Dept Childhood Educ, Miyazaki, Japan.	hin@kyudai.jp		Hyakumura, Kimihiko/0000-0001-9187-6435	JSPS program for Leading Graduate Schools (Graduate Education and Research Training Program in Decision Science for a Sustainable Society); JSPS KAKENHI [19KK0024]	JSPS program for Leading Graduate Schools (Graduate Education and Research Training Program in Decision Science for a Sustainable Society); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	KT, TH, KH, DS, and SY: JSPS program for Leading Graduate Schools (Graduate Education and Research Training Program in Decision Science for a Sustainable Society). KT,TH, and KH: JSPSKAKENHI Grant Number 19KK0024.https://www.jsps.go.jp/english/e-grants/Thesefundershad no role in studydesign data collectionand analysis, decisionto publish,orpreparationof the manuscrip	Alexandratos N., 2012, 1203 ESA FAO UN AGR, DOI [10.22004/ag.econ.288998, DOI 10.22004/AG.ECON.288998]; [Anonymous], 2021, FORESTRY M NATL REDD; Barennes H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136458; Bin KS, 2016, FOR SCI TECHNOL, V12, P98, DOI 10.1080/21580103.2015.1075437; Boulidam S., 2010, Forest insects as food: humans bite back. Proceedings of a workshop on Asia-Pacific resources and their potential for development, Chiang Mai, Thailand, 19-21 February, 2008, P131; Choulamany X., 2004, P WORKSH HELD LUANG, P341; Depatment of Forestry, LAOS NAT FOR MON SYS; Forister ML, 2019, CONSERV SCI PRACT, V1, DOI 10.1111/csp2.80; Fox J., 2019, R COMPANION APPL REG, V.; Goulson D, 2019, CURR BIOL, V29, pR967, DOI 10.1016/j.cub.2019.06.069; Hanboonsong Y, 2014, EDIBLE INSECTS LAO P; Johnson A, 2003, WILDLIFE HUNTING USE; Kehoe R, 2021, ECOL ENTOMOL, V46, P743, DOI 10.1111/een.12985; Koh LP, 2004, BIOTROPICA, V36, P272, DOI 10.1111/j.1744-7429.2004.tb00319.x; Luczaj L, 2021, J ETHNOBIOL ETHNOMED, V17, DOI 10.1186/s13002-020-00423-y; Mbata KJ, 2002, J INSECT CONSERV, V6, P115, DOI 10.1023/A:1020953030648; Mitsuhashi J., 2016, Edible insects of the world; Morales-Ramos JA, 2015, J ECON ENTOMOL, V108, P2259, DOI 10.1093/jee/tov208; Mottet, 2013, TACKLING CLIMATE CHA; Nonaka K, 2008, TROPICS, V17, P325, DOI 10.3759/tropics.17.325; Okamoto K, 2014, ADV ASIAN HUM-ENV RE, P29, DOI 10.1007/978-4-431-54956-7_2; Oonincx DGAB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051145; R Core Team, 2021, R LANG ENV STAT; Rafiqui PS, 2009, CITIES, V26, P38, DOI 10.1016/j.cities.2008.10.002; Ramos-Elorduy Julieta, 2009, Entomological Research, V39, P271, DOI 10.1111/j.1748-5967.2009.00238.x; Sharifi A, 2014, LANDSCAPE URBAN PLAN, V131, P1, DOI 10.1016/j.landurbplan.2014.07.014; Sjorslev JG., 2000, 0001 LARREC; Suzuki D, 2015, CURR HERPETOL, V34, P112, DOI 10.5358/hsj.34.112; Tang CF, 2019, FOOD PROD PROCESS NU, V1, DOI 10.1186/s43014-019-0008-1; Van Huis A, 2013, EDIBLE INSECTS FUTUR; Van Itterbeeck J, 2014, ETHNOBIOL LETT, V5, P4, DOI 10.14237/ebl.5.2014.125; Vongpraseuth T., 2020, AM ACAD SCI RES J EN, V70, P1; Whitaker DP., 1971, LOAS COUNTRY STUDY; WOLDA H, 1988, ANNU REV ECOL SYST, V19, P1, DOI 10.1146/annurev.es.19.110188.000245; Xayyasith S, 2020, FORKTAIL, P47; Yen AL, 2015, J INSECTS FOOD FEED, V1, P33, DOI 10.3920/JIFF2014.0017; Yen AL, 2015, CURR OPIN INSECT SCI, V12, P102, DOI 10.1016/j.cois.2015.11.003	37	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267307	10.1371/journal.pone.0267307	http://dx.doi.org/10.1371/journal.pone.0267307			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7MW	35436314	Green Published, gold			2022-12-26	WOS:000791258900024
J	Wank, I; Kutsche, L; Kreitz, S; Reeh, P; Hess, A				Wank, Isabel; Kutsche, Lisa; Kreitz, Silke; Reeh, Peter; Hess, Andreas			Imaging the influence of peripheral TRPV1-signaling on cerebral nociceptive processing applying fMRI-based graph theory in a resiniferatoxin rat model	PLOS ONE			English	Article							RECEPTOR POTENTIAL CHANNELS; PRIMARY AFFERENT NEURONS; TRP CHANNELS; IN-VIVO; PAIN; CAPSAICIN; STIMULATION; MODULATION; EXPRESSION; ISOFLURANE	Resiniferatoxin (RTX), an extract from the spurge plant Euphorbia resinifera, is a potent agonist of the transient receptor potential cation channel subfamily V member 1 (TRPV1), mainly expressed on peripheral nociceptors-a prerequisite for nociceptive heat perception. Systemic overdosing of RTX can be used to desensitize specifically TRPV1-expressing neurons, and was therefore utilized here to selectively characterize the influence of TRPV1-signaling on central nervous system (CNS) temperature processing. Resting state and CNS temperature processing of male rats were assessed via functional magnetic resonance imaging before and after RTX injection. General linear model-based and graph-theoretical network analyses disentangled the underlying distinct CNS circuitries. At baseline, rats displayed an increase of nociception-related response amplitude and activated brain volume that correlated highly with increasing stimulation temperatures. In contrast, RTX-treated rats showed a clear disruption of thermal nociception, reflected in a missing increase of CNS responses to temperatures above 48 degrees C. Graph-theoretical analyses revealed two distinct brain subnetworks affected by RTX: one subcortical (brainstem, lateral and medial thalamus, hippocampus, basal ganglia and amygdala), and one cortical (primary sensory, motor and association cortices). Resting state analysis revealed first, that peripheral desensitization of TRPV1-expressing neurons did not disrupt the basic resting-state-network of the brain. Second, only at baseline, but not after RTX, noxious stimulation modulated the RS-network in regions associated with memory formation (e.g. hippocampus). Altogether, the combination of whole-brain functional magnetic resonance imaging and RTX-mediated desensitization of TRPV1-signaling provided further detailed insight into cerebral processing of noxious temperatures.	[Wank, Isabel; Kutsche, Lisa; Kreitz, Silke; Hess, Andreas] Friedrich Alexander Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, Erlangen, Germany; [Reeh, Peter] Friedrich Alexander Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Hess, A (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, Erlangen, Germany.	andreas.hess@fau.de	Reeh, Peter W./J-8981-2012	Reeh, Peter W./0000-0002-4367-094X; Wank, Isabel/0000-0002-0702-7754	Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg	We would like to thank Sandra Strobelt and Johannes Kaesser for their excellent technical assistance regarding the work presented in this manuscript. We acknowledge financial support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg within the funding programme "Open Access Publication Funding".	ALBEFESSARD D, 1985, BRAIN RES REV, V9, P217, DOI 10.1016/0165-0173(85)90013-X; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Anand P, 2011, BRIT J ANAESTH, V107, P490, DOI 10.1093/bja/aer260; Bai XF, 2018, J MOL NEUROSCI, V64, P93, DOI 10.1007/s12031-017-1009-7; Binzen U, 2006, NEUROSCIENCE, V142, P527, DOI 10.1016/j.neuroscience.2006.06.020; Bishnoi M, 2011, J PAIN, V12, P991, DOI 10.1016/j.jpain.2011.03.005; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brederson JD, 2013, EUR J PHARMACOL, V716, P61, DOI 10.1016/j.ejphar.2013.03.003; CASEY KL, 1994, J NEUROPHYSIOL, V71, P802, DOI 10.1152/jn.1994.71.2.802; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Derry Sheena, 2017, Cochrane Database Syst Rev, V1, pCD007393, DOI 10.1002/14651858.CD007393.pub4; Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; HARDY JD, 1957, AM J PHYSIOL, V189, P1; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Hess A, 2007, EUR J PAIN, V11, P109, DOI 10.1016/j.ejpain.2006.01.005; Hess A, 2011, P NATL ACAD SCI USA, V108, P3731, DOI 10.1073/pnas.1011774108; Humphries MD, 2002, NETWORK-COMP NEURAL, V13, P131, DOI 10.1088/0954-898X/13/1/305; Iadarola MJ, 2018, PAIN, V159, P2105, DOI 10.1097/j.pain.0000000000001314; Ingvar M, 1999, PHILOS T R SOC B, V354, P1347, DOI 10.1098/rstb.1999.0483; Kanai Y, 2005, NEUROPHARMACOLOGY, V49, P977, DOI 10.1016/j.neuropharm.2005.05.003; Karai L, 2004, J CLIN INVEST, V113, P1344, DOI 10.1172/JCI200420449; Karmouty-Quintana H, 2007, BRIT J PHARMACOL, V150, P1022, DOI 10.1038/sj.bjp.0707168; Kim HS, 2004, PAIN, V109, P488, DOI 10.1016/j.pain.2004.02.027; Kim YS, 2014, NEURON, V81, P873, DOI 10.1016/j.neuron.2013.12.011; Knabl J, 2008, NATURE, V451, P330, DOI 10.1038/nature06493; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Kreitz S., 2012, P INT SOC MAG RESON; Kreitz S, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00334; Larauche M, 2004, AUTON NEUROSCI-BASIC, V110, P89, DOI 10.1016/j.autneu.2003.11.003; Lawson JJ, 2008, J PAIN, V9, P298, DOI 10.1016/j.jpain.2007.12.001; Leiman D, 2020, OSTEOARTHR CARTILAGE, V28, pS138; Lenz C, 1998, ANESTHESIOLOGY, V89, P1480, DOI 10.1097/00000542-199812000-00026; Levine JD, 2007, BBA-MOL BASIS DIS, V1772, P989, DOI 10.1016/j.bbadis.2007.01.008; Liang ZF, 2013, NEUROIMAGE, V83, P237, DOI 10.1016/j.neuroimage.2013.06.029; Marrone MC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15292; MARSH SJ, 1987, NEUROSCIENCE, V23, P275, DOI 10.1016/0306-4522(87)90289-2; Martins D, 2014, NEUROPHARMACOLOGY, V85, P151, DOI 10.1016/j.neuropharm.2014.05.034; Masamoto K, 2009, EUR J NEUROSCI, V30, P242, DOI 10.1111/j.1460-9568.2009.06812.x; Melzack R, 1999, PAIN, pS121, DOI 10.1016/S0304-3959(99)00145-1; Menon Vinod, 2010, Brain Struct Funct, V214, P655, DOI 10.1007/s00429-010-0262-0; Merskey H.E., 1986, PAIN S, V3, P1; Mitchell K, 2014, PAIN, V155, P733, DOI 10.1016/j.pain.2014.01.007; Mitchell K, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-94; Moriyama T, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-3; Mou J, 2013, PAIN, V154, P1632, DOI 10.1016/j.pain.2013.04.044; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nauerth A, 2002, Google Patents, assignee. Method of correcting higher order field inhomogeneities in a magnetic resonance apparatus, Patent No. [US2002, 2002 2002]; Neely GG, 2010, CELL, V143, P628, DOI 10.1016/j.cell.2010.09.047; Neubert JK, 2003, PAIN, V104, P219, DOI 10.1016/S0304-3959(03)00009-5; Nilius B, 2014, PHARMACOL REV, V66, P676, DOI 10.1124/pr.113.008268; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pogorzala LA, 2013, J NEUROSCI, V33, P5533, DOI 10.1523/JNEUROSCI.5788-12.2013; Premkumar LS, 2013, LIFE SCI, V92, P415, DOI 10.1016/j.lfs.2012.08.010; Price JL, 2003, ANN NY ACAD SCI, V985, P50; Ramos-Cabrer P, 2005, NMR BIOMED, V18, P440, DOI 10.1002/nbm.978; Reeh P W, 2000, Prog Brain Res, V129, P39; Roberts JC, 2004, BRAIN RES, V995, P176, DOI 10.1016/j.brainres.2003.10.001; Sergeeva M, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0783-2; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Starr CJ, 2009, J NEUROSCI, V29, P2684, DOI 10.1523/JNEUROSCI.5173-08.2009; SZALLASI A, 1989, NEUROSCIENCE, V30, P515, DOI 10.1016/0306-4522(89)90269-8; Szallasi A, 1999, PHARMACOL REV, V51, P159; SZALLASI A, 1989, BRAIN RES, V503, P68, DOI 10.1016/0006-8993(89)91705-8; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Szallasi A, 2006, TRENDS MOL MED, V12, P545, DOI 10.1016/j.molmed.2006.09.001; SZOLCSANYI J, 1990, J PHARMACOL EXP THER, V255, P923; Team N., 2006, NETWORK WORKBENCH TO; Toth A, 2005, MOL BRAIN RES, V135, P162, DOI 10.1016/j.molbrainres.2004.12.003; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Tremoleda JL, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-44; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; van Oort J, 2017, NEUROSCI BIOBEHAV R, V83, P281, DOI 10.1016/j.neubiorev.2017.10.015; Vandewauw I, 2018, NATURE, V555, P662, DOI 10.1038/nature26137; Vazey EM, 2014, P NATL ACAD SCI USA, V111, P3859, DOI 10.1073/pnas.1310025111; Villemure C, 2002, PAIN, V95, P195, DOI 10.1016/S0304-3959(02)00007-6; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; WESTFALL PH, 1993, BIOMETRICS, V49, P941, DOI 10.2307/2532216; WINTER J, 1990, BRAIN RES, V520, P131, DOI 10.1016/0006-8993(90)91698-G; Wong GY, 2009, BRAIN RES REV, V60, P267, DOI 10.1016/j.brainresrev.2008.12.006; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zerbi V, 2019, NEURON, V103, P702, DOI 10.1016/j.neuron.2019.05.034	85	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266669	10.1371/journal.pone.0266669	http://dx.doi.org/10.1371/journal.pone.0266669			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D8GY	35482725	gold, Green Published			2022-12-26	WOS:000794035700007
J	Wilson, BJ; Arnott, ER; Early, JB; Wade, CM; McGreevy, PD				Wilson, Bethany J.; Arnott, Elizabeth R.; Early, Jonathan B.; Wade, Claire M.; McGreevy, Paul D.			Valued personality traits in livestock herding Kelpies-Development and application of a livestock herding dog assessment form	PLOS ONE			English	Article							CANINE PERSONALITY; BEHAVIOR; TEMPERAMENT; QUESTIONNAIRE; IMPULSIVITY; VALIDATION; DIMENSIONS; BOLDNESS; PUPPIES; SEARCH	Livestock herding dogs contribute greatly to the rural economy of Australia. However, their selection currently lacks a cohesive or methodical approach. For example, there is no accessible tool for assessing Australian livestock herding dogs' suitability for work. The purpose of the current study was to devise a herding dog assessment form, the Herding Dog Assessment Form-Personality (HDAF-P), to facilitate collection of data on relevant behavioural phenotypes of large numbers of working Kelpies and to apply the HDAF-P to identify personality traits needed for herding dog performance. The focus was on creating a succinct form that was salient and accessible to livestock herding dog owners. Wherever practical, terms and methods from published personality questionnaires were integrated. Seventeen terms were included as behavioural descriptors in the HDAF-P which was then used by 95 owners to assess a sample of 228 of their working Kelpies. Owners were also asked to rate the overall ability of their dog(s). Of these dogs, 210 (all twelve months or older) were fully described and their data were used in the analysis. Thus, the study was designed to reveal which personality traits are most critical to the overall ability of the herding dogs and to undertake an exploratory analysis of the patterns of dog behaviour revealed by the HDAF-P in non-juvenile dogs. The traits that showed the strongest correlations (using Kendall's Tau correlation analysis) with overall ability were initiative (T = 0.41, p < 0.001), persistence (T = 0.36, p < 0.001), intelligence (T = 0.32, p < 0.001), confidence (T = 0.36, p < 0.001) and nervousness (T = -0.30, p < 0.001). An exploratory principal component analysis of trait scores revealed that 64.5% of the variance could be explained by four components that share several similarities with those reported by previous dog personality studies. These findings confirm that the HDAF-P has potential for the practical assessment of livestock herding dog personality and can elucidate traits that should be considered for prioritisation in training and breeding to optimise herding dog ability.	[Wilson, Bethany J.; Arnott, Elizabeth R.; Early, Jonathan B.] Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Sydney, NSW, Australia; [Wade, Claire M.] Univ Sydney, Fac Sci, Sch Life & Environm Sci, Sydney, NSW, Australia; [McGreevy, Paul D.] Univ New England, Fac Sci, Sch Environm & Rural Sci, Armidale, NSW, Australia	University of Sydney; University of Sydney; University of New England	Arnott, ER (corresponding author), Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Sydney, NSW, Australia.	pmcgree2@une.edu.au		Wade, Claire/0000-0003-3413-4771	Rural Industries Research and Development Corporation [PRJ 007 806]; Meat and Livestock Australia	Rural Industries Research and Development Corporation; Meat and Livestock Australia(Meat and Livestock Australia)	We thank the Working Kelpie Council of Australia, Meat and Livestock Australia, Rural Industries Research and Development Corporation and all stock herding dog owners who participated in the study.	Alan A., 2010, ANAL ORDINAL CATEGOR; Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Arata S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100767; Arnott ER, 2014, ANIM WELFARE, V23, P189, DOI 10.7120/09627286.23.2.189; Arnott ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104457; Arvelius P, 2013, J VET BEHAV, V8, P9, DOI 10.1016/j.jveb.2012.04.007; Batt LS, 2008, J VET BEHAV, V3, P143, DOI 10.1016/j.jveb.2008.04.003; Brady K, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00103; Branson N., 2009, AUSTR WORKING DOG SU; Bray EE, 2021, FRONT VET SCI, V8, DOI 10.3389/fvets.2021.644431; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; Carter AJ, 2012, BEHAV ECOL SOCIOBIOL, V66, P153, DOI 10.1007/s00265-011-1263-6; Diederich C, 2006, APPL ANIM BEHAV SCI, V97, P51, DOI 10.1016/j.applanim.2005.11.018; Dv Rooy., 2014, CANINE GENETICS EPID, V1; Early JB, 2014, J VET BEHAV, V9, P370, DOI 10.1016/j.jveb.2014.07.003; Evans KM, 2015, J VET BEHAV, V10, P459, DOI 10.1016/j.jveb.2015.08.004; Fratkin JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054907; Gedye J., 2000, TRAINING NOTES FARME; Harvey ND, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174261; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; Jones AC, 2005, APPL ANIM BEHAV SCI, V95, P1, DOI 10.1016/j.applanim.2005.04.008; Kassambara Alboukadel, 2020, CRAN; Ley J, 2008, APPL ANIM BEHAV SCI, V110, P305, DOI 10.1016/j.applanim.2007.04.016; Ley JM, 2009, APPL ANIM BEHAV SCI, V119, P85, DOI 10.1016/j.applanim.2009.02.027; Ley JM, 2009, APPL ANIM BEHAV SCI, V116, P220, DOI 10.1016/j.applanim.2008.09.009; Mirko E, 2013, APPL ANIM BEHAV SCI, V149, P45, DOI 10.1016/j.applanim.2013.10.003; Muller CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147753; Overall KL, 2011, TOP COMPANION ANIM M, V26, P2, DOI 10.1053/j.tcam.2011.01.001; Parsons AD., 2010, KELPIE; Passalacqua C, 2013, APPL ANIM BEHAV SCI, V147, P139, DOI 10.1016/j.applanim.2013.05.003; Patronek GJ, 2016, J VET BEHAV, V15, P66, DOI 10.1016/j.jveb.2016.08.001; Payne EM, 2015, J VET BEHAV, V10, P471, DOI 10.1016/j.jveb.2015.08.005; Perkins R., 2011, EDUCAUSE Q; R Core Team, 2021, R LANG ENV STAT; Rayment DJ, 2016, APPL ANIM BEHAV SCI, V180, P100, DOI 10.1016/j.applanim.2016.04.002; Rayment DJ, 2015, APPL ANIM BEHAV SCI, V163, P1, DOI 10.1016/j.applanim.2014.11.020; Revelle William, 2020, CRAN; Riemer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101237; Riemer S, 2014, ANIM COGN, V17, P815, DOI 10.1007/s10071-013-0701-4; Rooney NJ, 2007, APPL ANIM BEHAV SCI, V103, P90, DOI 10.1016/j.applanim.2006.03.016; Starling MJ, 2013, VET J, V197, P868, DOI 10.1016/j.tvjl.2013.05.019; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P133, DOI 10.1016/S0168-1591(02)00121-1; Taylor KD, 2006, J VET BEHAV, V1, P94, DOI 10.1016/j.jveb.2006.09.002; TEIGEN KH, 1994, THEOR PSYCHOL, V4, P525, DOI 10.1177/0959354394044004; Wilson BJ, 2011, J ANIM BREED GENET, V128, P230, DOI 10.1111/j.1439-0388.2010.00903.x; Wilson BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039620; Wilsson E, 1998, APPL ANIM BEHAV SCI, V58, P151, DOI 10.1016/S0168-1591(97)00093-2; Wright H.F., 2011, INT J COMP PSYCHOL, V24; Wright HF, 2012, PHYSIOL BEHAV, V105, P676, DOI 10.1016/j.physbeh.2011.09.019	49	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267266	10.1371/journal.pone.0267266	http://dx.doi.org/10.1371/journal.pone.0267266			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35472124	Green Published, gold			2022-12-26	WOS:000816171900027
J	Yang, MK; Sa, HS; Kim, N; Jeon, HS; Hyon, JY; Choung, H; Khwarg, SI				Yang, Min Kyu; Sa, Ho-Seok; Kim, Namju; Jeon, Hyun Sun; Hyon, Joon Young; Choung, Hokyung; Khwarg, Sang In			Quantitative analysis of morphological and functional alterations of the meibomian glands in eyes with marginal entropion	PLOS ONE			English	Article							LIPID LAYER THICKNESS; TEAR FILM; MEIBOGRAPHY; DYSFUNCTION; AGE	Purpose To quantitatively analyze morphological and functional alterations of the meibomian glands in eyes with marginal entropion and their changes after surgery. Methods Sixty eyes of 52 patients with marginal entropion and underwent meibography and interferometer were included. One-hundred and seventeen age- and sex-matched eyes with minimal to mild meibomian gland dysfunction (MGD) were recruited as control eyes. Meibomian gland loss (MGL) and lipid layer thickness (LLT) were compared between eyes with marginal entropion and control eyes. Subgroup analysis was performed according to the extent of entropion. MGL and average LLT at 1 and 5 months after surgery were compared with those of 20 eyes with marginal entropion followed without surgery. Results In eyes with marginal entropion, MGL was higher (27.7% vs. 12.8%, P = 0.014), and average LLT was thinner (64 nm vs. 86 nm, P = 0.005) than those in control eyes. MGL was higher in eyes with more extensive entropion (> 2/3 eyelid width) than in eyes with less extensive entropion (<= 1/3 eyelid width) (40.5% vs. 13.2%, P = 0.001). Average LLT increased after surgery (97 nm at 1 month, P = 0.003; 75 nm at 5 months, P = 0.319), and thicker than that of eyes followed without surgery (97 nm vs. 66 nm, P = 0.046). MGLs after surgery remained unchanged from the preoperative MGL (all P > 0.7). Conclusion Marginal entropion is associated with morphological and functional alterations of the meibomian glands. Functional improvement after entropion repair suggests that marginal entropion could cause or exacerbate MGD. Further studies are required to establish the role of entropion repair in managing MGD.	[Yang, Min Kyu; Sa, Ho-Seok] Univ Ulsan, Asan Med Ctr, Dept Ophthalmol, Coll Med, Seoul, South Korea; [Kim, Namju; Jeon, Hyun Sun; Hyon, Joon Young] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Bundang Hosp, Seongnam, South Korea; [Choung, Hokyung] Seoul Metropolitan Govt Seoul Natl Univ, Dept Ophthalmol, Boramae Med Ctr, Seoul, South Korea; [Khwarg, Sang In] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul Natl Univ Hosp, Seoul, South Korea	University of Ulsan; Asan Medical Center; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Kim, N (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Bundang Hosp, Seongnam, South Korea.	resourceful@hanmail.net		Hyon, Joon Young/0000-0003-3620-1536				Abdelaziz FM, 2020, CLIN OPHTHALMOL, V14, P2043, DOI 10.2147/OPTH.S261783; ALRAJHI AA, 1993, OPHTHALMOLOGY, V100, P1293; Arita R, 2008, OPHTHALMOLOGY, V115, P911, DOI 10.1016/j.ophtha.2007.06.031; Arita R, 2015, OPHTHALMOLOGY, V122, P925, DOI 10.1016/j.ophtha.2014.12.018; Arita R, 2012, GRAEF ARCH CLIN EXP, V250, P1181, DOI 10.1007/s00417-012-1943-6; Arita R, 2009, OPHTHALMOLOGY, V116, P379, DOI 10.1016/j.ophtha.2008.10.012; Blackie CA, 2009, CORNEA, V28, P789, DOI 10.1097/ICO.0b013e318191b870; Choi YJ, 2014, OPHTHAL PLAST RECONS, V30, P51, DOI 10.1097/IOP.0000000000000008; Eom Y, 2013, AM J OPHTHALMOL, V155, P1104, DOI 10.1016/j.ajo.2013.01.008; Erdogan M, 2015, TURK OFTALMOL DERG, V45, P203, DOI 10.4274/tjo.20591; Finis D, 2013, CORNEA, V32, P1549, DOI 10.1097/ICO.0b013e3182a7f3e1; Foulks GN, 2012, OPHTHALMOLOGY, V119, pS1, DOI 10.1016/j.ophtha.2012.06.064; Isreb MA, 2003, EYE, V17, P79, DOI 10.1038/sj.eye.6700224; Jung JW, 2016, INVEST OPHTH VIS SCI, V57, P4076, DOI 10.1167/iovs.16-19251; Kim JS, 2018, SEMIN OPHTHALMOL, V33, P231, DOI 10.1080/08820538.2016.1208764; Kubo M, 2001, JPN J OPHTHALMOL, V45, P653, DOI 10.1016/S0021-5155(01)00417-8; Kuckelkorn R, 1997, OPHTHALMIC SURG LAS, V28, P156; Lee Sang Min, 2018, Korean J Ophthalmol, V32, P445, DOI 10.3341/kjo.2018.0012; Maissa C, 2010, CONTACT LENS ANTERIO, V33, P176, DOI 10.1016/j.clae.2010.02.003; Mitra M, 2005, EYE, V19, P657, DOI 10.1038/sj.eye.6701611; Nelson JD, 2011, INVEST OPHTH VIS SCI, V52, P1930, DOI 10.1167/iovs.10-6997b; Nerad JA., 2010, TECHNIQUES OPHTHALMI, P99; Park J, 2018, CAN J OPHTHALMOL, V53, P373, DOI 10.1016/j.jcjo.2017.11.006; [Потемкин Виталий Витальевич Potemkin Vitaly V.], 2016, [Офтальмологические ведомости, Oftal'mologicheskie vedomosti], V9, P5, DOI 10.17816/OV915-12; Pult H, 2012, CONTACT LENS ANTERIO, V35, P77, DOI 10.1016/j.clae.2011.08.003; Siah WF, 2019, ACTA OPHTHALMOL, V97, pE1116, DOI 10.1111/aos.14155; Tse DT, 2014, OPHTHAL PLAST RECONS, V30, P450, DOI 10.1097/IOP.0000000000000281; Yamaguchi M, 2006, AM J OPHTHALMOL, V141, P669, DOI 10.1016/j.ajo.2005.11.004; Yeotikar NS, 2016, INVEST OPHTH VIS SCI, V57, P3996, DOI 10.1167/iovs.15-18467	29	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267118	10.1371/journal.pone.0267118	http://dx.doi.org/10.1371/journal.pone.0267118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421204	Green Published, gold			2022-12-26	WOS:000795453600110
J	Zhao, H; Chen, Z; Li, H; Zhao, YH; Wang, Q; Li, WW				Zhao, Hui; Chen, Zhe; Li, Hao; Zhao, Yue-Hong; Wang, Qun; Li, Wei-Wei			Suppressed COP9 signalosome 5 promotes hemocyte proliferation through Cyclin E in the early G1 phase to defend against bacterial infection in crab	FASEB JOURNAL			English	Article						antibacterial immunity; CSN5; Cyclin E; Eriocheir sinensis; hemocytes proliferation	CELL-CYCLE; DEGRADATION; JAB1/CSN5; IDENTIFICATION; PROGRESSION; SEPARATION; RECEPTOR	Hemocytes are invertebrate immune cells that are similar to blood cells in vertebrates and play a crucial role in innate immunity. Previous work has found that mature circulating hemocytes lack the ability to proliferate. However, recent single-cell RNA sequencing and functional studies in invertebrate have challenged this view. Here, we report that bacteria induced hemocytes proliferation in the Chinese mitten crab, Eriocheir sinensis. Flow cytometry was used to collect non-proliferating and proliferating hemocytes populations, while the expression of EsCyclin E was highly expressed in proliferating hemocytes, but the expression of EsCsn5 was significantly suppressed in proliferating hemocytes. Subsequent studies have found EsCsn5 distributed in two fractions include holo-complex and monomeric form, whereas knockdown of EsCsn5 has little impact on the amount of the holo-complex. EsCsn5 was widely expressed in different crab tissues, while its expression was significantly reduced upon bacterial infection. Crab hemocytes showed significantly enhanced proliferation when EsCsn5 was genetically knocked down, suggesting a critical role for CSN5 in the negative regulation of crab hemocyte proliferation. Moreover, EsCSN5 but not the EsCSN8 was demonstrated to negatively regulate the early G1 phase of the cell cycle by controlling the degradation of EsCyclin E through ubiquitination steps, rather than affecting its transcription. Furthermore, in the EsCyclin E-suppressed crab there was a significantly reduced survival rate and an up-regulated hemolymph bacterial concentration. Taken together, this study provides evidence demonstrating that invertebrate hemocytes down-regulate the expression of EsCsn5 upon bacterial challenge, thus promoting proliferation in an EsCyclin E-dependent manner in order to protect the crab from infection.	[Zhao, Hui; Chen, Zhe; Li, Hao; Zhao, Yue-Hong; Wang, Qun; Li, Wei-Wei] East China Normal Univ, Sch Life Sci, Lab Invertebrate Immunol Def, 500 Dongchuan Rd, Shanghai 200241, Peoples R China	East China Normal University	Li, WW (corresponding author), East China Normal Univ, Sch Life Sci, Lab Invertebrate Immunol Def, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.	wwli@bio.ecnu.edu.cn	Wang, Qun/I-7778-2013	Wang, Qun/0000-0001-7929-7692	Shanghai Rising--Star Program [20QA1403000]; National Natural Science Foundation of China [31972820, 31970490]	Shanghai Rising--Star Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Shanghai Rising--Star Program (Grant 20QA1403000 to WWL) and National Natural Science Foundation of China (Grants 31972820 to WWL and 31970490 to QW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; Cerenius L, 2010, ADV EXP MED BIOL, V708, P239; Chamovitz DA, 2001, EMBO REP, V2, P96, DOI 10.1093/embo-reports/kve028; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Dantas-Lima JJ, 2013, AQUACULTURE, V408, P128, DOI 10.1016/j.aquaculture.2013.04.031; Denti S, 2006, J BIOL CHEM, V281, P32188, DOI 10.1074/jbc.M604746200; Doronkin S, 2003, DEV CELL, V4, P699, DOI 10.1016/S1534-5807(03)00121-7; Eibel H, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0434-8; Junkunlo K, 2019, J BIOL CHEM, V294, P708, DOI 10.1074/jbc.RA118.005489; Koiwai K, 2021, ELIFE, V10, DOI 10.7554/eLife.66954; Kondo MTS., 2012, AQUACULTURE SCI, V60, P151; Kruisbeek Ada M, 2004, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0312s60; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Li H, 2021, J IMMUNOL, V207, P2265, DOI 10.4049/jimmunol.2100575; LUO H, 1995, EMBO J, V14, P1412, DOI 10.1002/j.1460-2075.1995.tb07127.x; Menon S, 2007, NAT IMMUNOL, V8, P1236, DOI 10.1038/ni1514; Munier AI, 2002, EMBO REP, V3, P1195, DOI 10.1093/embo-reports/kvf242; Nandi D, 2006, J BIOSCIENCES, V31, P137, DOI 10.1007/BF02705243; Panattoni M, 2008, J EXP MED, V205, P465, DOI 10.1084/jem.20070725; Patel S, 2017, GENE, V626, P209, DOI 10.1016/j.gene.2017.05.043; Raddi G, 2020, SCIENCE, V369, P1128, DOI 10.1126/science.abc0322; Richardson KS, 2005, MOL CANCER RES, V3, P645, DOI 10.1158/1541-7786.MCR-05-0233; Soderhall I, 2016, DEV COMP IMMUNOL, V58, P129, DOI 10.1016/j.dci.2015.12.009; SODERHALL K, 1983, DEV COMP IMMUNOL, V7, P229, DOI 10.1016/0145-305X(83)90004-6; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Tattikota SG, 2020, ELIFE, V9, DOI 10.7554/eLife.54818; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; van de Braak CBT, 2002, FISH SHELLFISH IMMUN, V12, P253, DOI 10.1006/fsim.2001.0369; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Yang L, 2019, J BIOL CHEM, V294, P14704, DOI 10.1074/jbc.RA119.009559; Yang XM, 2002, CURR BIOL, V12, P667, DOI 10.1016/S0960-9822(02)00791-1; Yoneda-Kato N, 2005, EMBO J, V24, P1739, DOI 10.1038/sj.emboj.7600656; Zhao YH, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100943; Zhu JJ, 2019, NAT REV MOL CELL BIO, V20, P436, DOI 10.1038/s41580-019-0123-5	38	0	0	11	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22321	10.1096/fj.202101710RRRR	http://dx.doi.org/10.1096/fj.202101710RRRR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0N3DF	35429011				2022-12-26	WOS:000782721900001
J	Tedeschi, T; Lee, K; Zhu, W; Fawzi, AA				Tedeschi, Thomas; Lee, Kendal; Zhu, Wei; Fawzi, Amani A.			Limited hyperoxia-induced proliferative retinopathy: A model of persistent retinal vascular dysfunction, preretinal fibrosis and hyaloidal vascular reprogramming for retinal rescue	PLOS ONE			English	Article							ANGIOGENESIS; PREMATURITY; REGRESSION	Background Retinopathy of prematurity (ROP) remains the leading cause for blindness in children. Limited hyperoxia induced proliferative retinopathy (L-HIPR) was recently introduced as a potential animal model for ROP and persistent fetal vasculature; however, the detailed pathological changes remain unclear. Methods To model L-HIPR, we placed C57BL/6J mice in 65% oxygen from birth to post-natal day 7 (P7). We examined eyes at intervals between P12 and P30. Retinal morphometry, thickness, and preretinal fibrosis were quantified at different time points on histological sections stained with hematoxylin and eosin (H&E) and Masson Trichrome, respectively. Vascular development, angiogenesis, inflammation, and pericyte coverage were analyzed using immunohistochemistry staining in retinal flat mounts and cross sections. Results In L-HIPR, the hyaloidal vessels persisted until the latest time point in this study, P30 and began to invaginate the peripheral then central retina starting at P12. Central retinal distortion was noted beginning at P17, while the peripheral retina demonstrated a trend of thinning from P12 to P30. We found that L-HIPR was associated with delayed and abnormal retinal vascular development with subsequent retinal inflammation, pericyte loss and preretinal fibrosis. Conclusion Our study presents a detailed analysis of the L-HIPR animal model demonstrating vitreoretinal pathologic changes, preretinal fibrosis and persistent hyaloidal vessels into adulthood. Based on our findings, we suggest that the persistence and peculiar stepwise migration of the hyaloidal vessels into the retina may provide a potential rescue mechanism for inner retinal development that deserves further study.	[Tedeschi, Thomas; Lee, Kendal; Zhu, Wei; Fawzi, Amani A.] Northwestern Univ, Feinberg Sch Med, Dept Ophthalmol, Chicago, IL 60611 USA; [Zhu, Wei] Changshu 2 Peoples Hosp, Dept Ophthalmol, Changshu, Jiangsu, Peoples R China	Northwestern University; Feinberg School of Medicine	Fawzi, AA (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Ophthalmol, Chicago, IL 60611 USA.	afawzimd@gmail.com		fawzi, amani/0000-0002-9568-3558; Tedeschi, Thomas/0000-0001-6454-0952	National Institutes of Health [1R01EY030121]; Illinois Society for the Prevention of Blindness	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Illinois Society for the Prevention of Blindness	This work was supported by a grant from the National Institutes of Health (1R01EY030121, A.A.F.), and the Illinois Society for the Prevention of Blindness (KL). NO-The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brumbaugh JE, 2021, PEDIATR RES, DOI 10.1038/s41390-021-01778-y; Campbell JP, 2016, OPHTHALMOLOGY, V123, P2338, DOI 10.1016/j.ophtha.2016.07.026; Chou JC, 2014, INVEST OPHTH VIS SCI, V55, P2516, DOI 10.1167/iovs.13-13676; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Hartnett ME, 2012, NEW ENGL J MED, V367, P2515, DOI 10.1056/NEJMra1208129; Ito M, 1999, ANAT EMBRYOL, V200, P403, DOI 10.1007/s004290050289; Kurihara T, 2010, DEVELOPMENT, V137, P1563, DOI 10.1242/dev.049015; Lajko M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180384; Lajko M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166886; Liu CH, 2017, FASEB J, V31, P4665, DOI 10.1096/fj.201700336R; McMenamin PG, 2016, INVEST OPHTH VIS SCI, V57, P6513, DOI 10.1167/iovs.16-19928; Nguyen MTT, 2019, NAT CELL BIOL, V21, P420, DOI 10.1038/s41556-019-0301-x; Nakamura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032167; Selvam S, 2018, PROG RETIN EYE RES, V63, P1, DOI 10.1016/j.preteyeres.2017.11.001; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Yoshikawa Y, 2016, J EXP MED, V213, P1175, DOI 10.1084/jem.20151966; Zhang C, 2011, EUR J CELL BIOL, V90, P440, DOI 10.1016/j.ejcb.2011.01.003	18	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267576	10.1371/journal.pone.0267576	http://dx.doi.org/10.1371/journal.pone.0267576			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476813	gold, Green Published			2022-12-26	WOS:000840124300052
J	Jiao, DY; Chen, YJ; Wang, YL; Sun, HR; Shi, Q; Zhang, L; Zhao, XY; Liu, YJ; He, HY; Lv, ZH; Liu, C; Zhang, PZ; Gao, K; Huang, Y; Li, Y; Li, L; Wang, CJ				Jiao, Dongyue; Chen, Yingji; Wang, Yalan; Sun, Huiru; Shi, Qing; Zhang, Liang; Zhao, Xiaying; Liu, Yajuan; He, Huiying; Lv, Zeheng; Liu, Chuan; Zhang, Pingzhao; Gao, Kun; Huang, Yan; Li, Yao; Li, Liang; Wang, Chenji			DCAF12 promotes apoptosis and inhibits NF-kappa B activation by acting as an endogenous antagonist of IAPs	ONCOGENE			English	Article							STRUCTURAL BASIS; CASPASE INHIBITORS; SERINE-PROTEASE; CELL-DEATH; XIAP; IDENTIFICATION; FAMILY; REAPER; GROWTH; GENE	Members of the Inhibitor of Apoptosis Protein (IAP) family are essential for cell survival and appear to neutralize the cell death machinery by binding pro-apoptotic caspases. dcaf12 was recently identified as an apoptosis regulator in Drosophila. However, the underlying molecular mechanisms are unknown. Here we revealed that human DCAF12 homolog binds multiple IAPs, including XIAP, cIAP1, cIAP2, and BRUCE, through recognition of BIR domains in IAPs. The pro-apoptotic function of DCAF12 is dependent on its capacity to bind IAPs. In response to apoptotic stimuli, DCAF12 translocates from the nucleus to the cytoplasm, where it blocks the interaction between XIAP and pro-apoptotic caspases to facilitate caspase activation and apoptosis execution. Similarly, DCAF12 suppresses NF-kappa B activation in an IAP binding-dependent manner. Moreover, DCAF12 acts as a tumor suppressor to restrict the malignant phenotypes of cancer cells. Together, our results suggest that DCAF12 is an evolutionarily conserved IAP antagonist.	[Jiao, Dongyue; Chen, Yingji; Wang, Yalan; Sun, Huiru; Shi, Qing; Zhang, Liang; Zhao, Xiaying; Liu, Yajuan; He, Huiying; Huang, Yan; Li, Yao; Wang, Chenji] Fudan Univ, Shanghai Stomatol Hosp, Shanghai 200438, Peoples R China; [Jiao, Dongyue; Chen, Yingji; Wang, Yalan; Sun, Huiru; Shi, Qing; Zhang, Liang; Zhao, Xiaying; Liu, Yajuan; He, Huiying; Huang, Yan; Li, Yao; Wang, Chenji] Fudan Univ, MOE Engn Res Ctr Gene Technol, Shanghai Engn Res Ctr Ind Microorg, Sch Stomatol,Sch Life Sci,State Key Lab Genet Eng, Shanghai 200438, Peoples R China; [Lv, Zeheng; Gao, Kun] Tongji Univ, Shanghai Matern & Infant Hosp 1, Sch Med, Dept Clin Lab, Shanghai 200092, Peoples R China; [Liu, Chuan; Li, Liang] Zibo Cent Hosp, Dept Thyroid & Breast Surg, Zibo 255036, Peoples R China; [Zhang, Pingzhao] Fudan Univ, Shanghai Canc Ctr, Shanghai 200032, Peoples R China; [Zhang, Pingzhao] Fudan Univ, Dept Pathol, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Tongji University; Fudan University; Fudan University	Wang, CJ (corresponding author), Fudan Univ, Shanghai Stomatol Hosp, Shanghai 200438, Peoples R China.; Wang, CJ (corresponding author), Fudan Univ, MOE Engn Res Ctr Gene Technol, Shanghai Engn Res Ctr Ind Microorg, Sch Stomatol,Sch Life Sci,State Key Lab Genet Eng, Shanghai 200438, Peoples R China.; Li, L (corresponding author), Zibo Cent Hosp, Dept Thyroid & Breast Surg, Zibo 255036, Peoples R China.	liliangzb@sina.com; chenjiwang@fudan.edu.cn			National Natural Science Foundation of China [91957125, 81972396, 81672558, 91954106, 81872109, 81872260, 81572768]; Natural Science Foundation of Shanghai [22ZR1449200, 22ZR1406600]; Natural Science Foundation of Shandong Province [ZR2021MH212]; Open Research Fund of State Key Laboratory of Genetic Engineering, Fudan University [SKLGE-2111]; Science and Technology Research Program of Shanghai [9DZ2282100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Open Research Fund of State Key Laboratory of Genetic Engineering, Fudan University; Science and Technology Research Program of Shanghai	We thank Dr. Mikihiko Naito for providing BRUCE cDNAs. This work was in part supported by the National Natural Science Foundation of China (No. 91957125, 81972396, 81672558 to CW; No. 91954106, 81872109 to KG.; No. 81872260, 81572768 to PZ) the Natural Science Foundation of Shanghai (No. 22ZR1449200 to KG; 22ZR1406600 to CW), the Natural Science Foundation of Shandong Province (No. ZR2021MH212 to LL), the Open Research Fund of State Key Laboratory of Genetic Engineering, Fudan University (No. SKLGE-2111 to KG), the Science and Technology Research Program of Shanghai (No. 9DZ2282100).	BIRNBAUM MJ, 1994, J VIROL, V68, P2521, DOI 10.1128/JVI.68.4.2521-2528.1994; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Cho YS, 2020, GENE DEV, V34, P53, DOI 10.1101/gad.333146.119; Damgaard RB, 2013, EMBO MOL MED, V5, P1278, DOI 10.1002/emmm.201303090; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Dubrez-Daloz L, 2008, CELL CYCLE, V7, P1036, DOI 10.4161/cc.7.8.5783; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Galban S, 2010, CELL DEATH DIFFER, V17, P54, DOI 10.1038/cdd.2009.81; Gao K, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0561-6; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Hao YY, 2004, NAT CELL BIOL, V6, P849, DOI 10.1038/ncb1159; Hu XY, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1200-y; Huang YH, 2003, J BIOL CHEM, V278, P49517, DOI 10.1074/jbc.M310061200; Huang YH, 2001, CELL, V104, P781, DOI 10.1016/S0092-8674(01)00273-2; Hwangbo DS, 2016, DEV BIOL, V413, P50, DOI 10.1016/j.ydbio.2016.03.003; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Kalkavan H, 2018, CELL DEATH DIFFER, V25, P46, DOI 10.1038/cdd.2017.179; Kim K, 2013, MOL CELL, V52, P459, DOI 10.1016/j.molcel.2013.09.017; Koren I, 2018, CELL, V173, P1622, DOI 10.1016/j.cell.2018.04.028; Kumar S, 2020, PHARMACOL THERAPEUT, V214, DOI 10.1016/j.pharmthera.2020.107610; Larisch S, 2000, NAT CELL BIOL, V2, P915, DOI 10.1038/35046566; Liston P, 2001, NAT CELL BIOL, V3, P128, DOI 10.1038/35055027; Lu M, 2007, MOL CELL, V26, P689, DOI 10.1016/j.molcel.2007.05.006; Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004; Okada H, 2002, MOL CELL BIOL, V22, P3509, DOI 10.1128/MCB.22.10.3509-3517.2002; Patron LA, 2019, J CELL BIOL, V218, P993, DOI 10.1083/jcb.201805099; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Ravichandran R, 2019, EMBO REP, V20, DOI 10.15252/embr.201847352; Richter B W, 2000, Sci STKE, V2000, ppe1, DOI 10.1126/stke.2000.44.pe1; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Shi Y, 2002, CELL DEATH DIFFER, V9, P93, DOI 10.1038/sj/cdd/4400957; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Tenev T, 2002, EMBO J, V21, P5118, DOI 10.1093/emboj/cdf530; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Varfolomeev E, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001878; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Verhagen AM, 2001, GENOME BIOL, V2; Wajant H, 2011, FEBS J, V278, P862, DOI 10.1111/j.1742-4658.2011.08015.x; Wang XX, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00609-16; Yang YL, 2000, CELL RES, V10, P169, DOI 10.1038/sj.cr.7290046; Zheng C, 2010, MOL CELL, V38, P101, DOI 10.1016/j.molcel.2010.03.009	45	0	0	1	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 20	2022	41	21					3000	3010		10.1038/s41388-022-02319-5	http://dx.doi.org/10.1038/s41388-022-02319-5		APR 2022	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	1L8MU	35459779				2022-12-26	WOS:000787474100002
J	Chen, PC; Lee, YC; Su, YC; Lee, CH; Chen, JH; Chen, CY				Chen, Pin-Chun; Lee, Yuan-Chi; Su, Yu-Chieh; Lee, Cheng-Hung; Chen, Jian-Han; Chen, Chung-Yen			Does hepatectomy improve outcomes of breast cancer with liver metastasis? A nationwide analysis of real-world data in Taiwan	PLOS ONE			English	Article							HEPATIC RESECTION; SURGICAL-TREATMENT; PROGNOSTIC-FACTORS; COLORECTAL-CANCER; BRAIN METASTASES; SURGERY; NEUROENDOCRINE; CHEMOTHERAPY; SURVIVAL; ABLATION	BackgroundLiver metastases from breast cancer are associated with poor prognosis, and treatment options are usually restricted to palliative systemic therapy. The impact of liver resection on metastasis remains controversial. The aim of this study is to investigate whether liver resection can offer better survival outcomes in cases of isolated liver metastases from breast cancer. MethodsWe conducted a nationwide cohort study using a claims dataset from Taiwan's National Health Insurance Research Database (NHIRD). We identified all patients with breast cancer (diagnostic code ICD-9: 174.x) from the Registry for Catastrophic Illness Patient Database (RCIPD) of the NHIRD who underwent mastectomy between January 1, 2000, and December 31, 2008. Patients with other malignancies (history, initially, or during follow-up), those with a history of metastasis prior to or at initial admission for mastectomy, and those without liver metastases were excluded. Patients with other metastases between mastectomy and liver metastasis and those who died at first admission for liver resection were also excluded. All patients were followed up until December 31, 2013, or withdraw from the database because of death. ResultsData were analyzed for 1,116 patients who fulfilled the inclusion criteria (resection group: 89; non-resection group: 1,027). There were no differences in age, Charlson Comorbidity Index, or major coexisting diseases except renal disease between two groups. Kaplan-Meier analysis demonstrated that the liver resection group had significantly better overall survival (OS) than the non-resection group. (1-year: 96.6% vs. 52.3%, 2-year: 86.8% vs. 35.4%, 3-year: 72.3% vs. 25.2%, 5-year: 51.6% vs. 16.9%, respectively, p<0.001). Cox analysis revealed that the liver resection group exhibited a significant improvement in patient survival (hazard ratio [HR] = 0.321, 95% confidence interval [CI]: 0.234-0.440, p<0.001). ConclusionThese findings indicate that liver resection may offer better survival benefit in patients with breast cancer who develop new liver metastases post mastectomy.	[Chen, Pin-Chun] Eda Hosp, Div Colon & Rectal Surg, Dept Surg, Kaohsiung, Taiwan; [Chen, Pin-Chun; Lee, Yuan-Chi] Edada Chang Hosp, Div Gen Surg, Kaohsiung, Taiwan; [Lee, Yuan-Chi; Chen, Jian-Han; Chen, Chung-Yen] Eda Hosp, Div Gen Surg, Kaohsiung, Taiwan; [Lee, Yuan-Chi; Su, Yu-Chieh; Chen, Jian-Han; Chen, Chung-Yen] I Shou Univ, Coll Med, Sch Med, Kaohsiung, Taiwan; [Su, Yu-Chieh] Eda Hosp, Div Hematol Oncol, Kaohsiung, Taiwan; [Lee, Cheng-Hung] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Gen Surg, Chiayi, Taiwan; [Lee, Cheng-Hung] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Chen, Jian-Han; Chen, Chung-Yen] Eda Hosp, Bariatr & Metab Int Surg Ctr, Kaohsiung, Taiwan	E-Da Hospital; E-Da Hospital; I Shou University; E-Da Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; E-Da Hospital	Chen, JH (corresponding author), Eda Hosp, Div Gen Surg, Kaohsiung, Taiwan.; Chen, JH (corresponding author), I Shou Univ, Coll Med, Sch Med, Kaohsiung, Taiwan.; Chen, JH (corresponding author), Eda Hosp, Bariatr & Metab Int Surg Ctr, Kaohsiung, Taiwan.	jamihan1981@gmail.com		Chen, Jian-Han/0000-0001-7360-2238	E-Da Hospital, Taiwan; IRB [EDAHI-109-001, EDAHI-110-003, EDAHP-106-060, EDAHP-111-007]	E-Da Hospital, Taiwan; IRB	Funding: We are grateful to the grant support of E -Da Hospital, Taiwan, and IRB (EDAHI-109-001, EDAHI-110-003, EDAHP-106-060, EDAHP-111-007).	Abbott DE, 2012, SURGERY, V151, P710, DOI 10.1016/j.surg.2011.12.017; Adam R, 2006, ANN SURG, V244, P897, DOI 10.1097/01.sla.0000246847.02058.1b; Adam R, 2012, ONCOLOGIST, V17, P1225, DOI 10.1634/theoncologist.2012-0121; Ali SM, 2018, ANN SURG ONCOL, V25, P32, DOI 10.1245/s10434-016-5745-7; Bacalbasa N, 2014, ANTICANCER RES, V34, P5563; Bale R, 2019, CANCERS, V11, DOI 10.3390/cancers11091341; Cardoso F, 2020, ANN ONCOL, V31, P1623, DOI 10.1016/j.annonc.2020.09.010; Chan WSH, 2010, EPMA J, V1, P563, DOI 10.1007/s13167-010-0056-8; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Chinese Hospital Association, 2000, ICD 9 CM ENGL CHIN D; Chun YS, 2020, EJSO-EUR J SURG ONC, V46, P1588, DOI 10.1016/j.ejso.2020.03.214; Dent R, 2009, BREAST CANCER RES TR, V115, P423, DOI 10.1007/s10549-008-0086-2; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Durr HR, 2002, CLIN ORTHOP RELAT R, P191; Elias D, 2003, AM J SURG, V185, P158, DOI 10.1016/S0002-9610(02)01204-7; Ellis OV, 2021, J SURG RES, V268, P650, DOI 10.1016/j.jss.2021.07.032; Ercolani G, 2018, DIGEST SURG, V35, P372, DOI 10.1159/000486523; Fairhurst K, 2016, BREAST, V30, P175, DOI 10.1016/j.breast.2016.09.011; Feng Y, 2020, AM J SURG, V220, P945, DOI 10.1016/j.amjsurg.2020.02.047; Golse N, 2017, CLIN BREAST CANCER, V17, P256, DOI 10.1016/j.clbc.2016.12.012; Gradishar WJ, 2021, J NATL COMPR CANC NE, V19, P485, DOI 10.6004/jnccn.2021.0023; Gradishar WJ, 2020, J NATL COMPR CANC NE, V18, P452, DOI 10.6004/jnccn.2020.0016; He X, 2020, CLIN TRANSL ONCOL, V22, P512, DOI 10.1007/s12094-019-02155-2; He ZY, 2017, TRANSL ONCOL, V10, P1, DOI 10.1016/j.tranon.2016.10.004; Hoffmann K, 2010, ANN SURG ONCOL, V17, P1546, DOI 10.1245/s10434-010-0931-5; JARDINES L, 1993, SEMIN ONCOL, V20, P538; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kostov DV, 2013, J BREAST CANCER, V16, P184, DOI 10.4048/jbc.2013.16.2.184; Labgaa I, 2018, AM J SURG, V215, P125, DOI 10.1016/j.amjsurg.2017.09.030; Margonis GA, 2016, HPB, V18, P700, DOI 10.1016/j.hpb.2016.05.014; Mariani P, 2013, EJSO-EUR J SURG ONC, V39, P1377, DOI 10.1016/j.ejso.2013.09.021; Orlandi A., 2021, J PERS MED, P11, DOI [10.3390/jpm12010011, DOI 10.3390/JPM12010011]; Orlandi A, 2021, J PERS MED, V11, DOI 10.3390/jpm11030187; Patkar S, 2021, J SURG ONCOL, V123, P957, DOI 10.1002/jso.26373; Pentheroudakis G, 2006, BREAST CANCER RES TR, V97, P237, DOI 10.1007/s10549-005-9117-4; Pieper DR, 1997, ANN SURG ONCOL, V4, P481, DOI 10.1007/BF02303672; Pocard M, 2000, EUR J SURG ONCOL, V26, P155, DOI 10.1053/ejso.1999.0761; Prochazkova K, 2021, IN VIVO, V35, P417, DOI 10.21873/invivo.12273; Rahnemai-Azar AA, 2021, SURG ONCOL CLIN N AM, V30, P27, DOI 10.1016/j.soc.2020.09.003; Rivera K, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.643383; Ruiz A, 2018, EUR J CANCER, V95, P1, DOI 10.1016/j.ejca.2018.02.024; Ruiz A, 2018, BREAST CANCER RES TR, V170, P89, DOI 10.1007/s10549-018-4714-1; Ruiz A, 2017, ANN SURG ONCOL, V24, P535, DOI 10.1245/s10434-016-5522-7; Sadot E, 2016, ANN SURG, V264, P147, DOI 10.1097/SLA.0000000000001371; Seidman AD, 1996, SEMIN ONCOL, V23, P55; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Spolverato G, 2017, ANN SURG, V265, P792, DOI 10.1097/SLA.0000000000001715; Spolverato G, 2015, J SURG RES, V198, P155, DOI 10.1016/j.jss.2015.05.048; Sunden M, 2020, EJSO-EUR J SURG ONC, V46, P1006, DOI 10.1016/j.ejso.2020.02.008; Treska V, 2015, ARCH MED SCI, V11, P683, DOI 10.5114/aoms.2015.52376; Wronski M, 1997, CANCER, V80, P1746, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1746::AID-CNCR8>3.0.CO;2-C; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Xiao YB, 2018, J ZHEJIANG UNIV-SC B, V19, P829, DOI 10.1631/jzus.B1700516	53	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266960	10.1371/journal.pone.0266960	http://dx.doi.org/10.1371/journal.pone.0266960			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446891	gold, Green Published			2022-12-26	WOS:000795468200039
J	Feo, A; Celico, F				Feo, Alessandra; Celico, Fulvio			Investigating the migration of immiscible contaminant fluid flow in homogeneous and heterogeneous aquifers with high-precision numerical simulations	PLOS ONE			English	Article							SATURATED-UNSATURATED FLOW; FINITE-ELEMENT METHODS; POROUS-MEDIA; 2-PHASE FLOW; TRANSVERSAL METHOD; RICHARDS EQUATION; MULTIPHASE FLOW; LARGE-SCALE; TRANSPORT; SCHEMES	Numerical modeling of the migration of three-phase immiscible fluid flow in variably saturated zones is challenging due to the different behavior of the system between unsaturated and saturated zones. This behavior results in the use of different numerical methods for the numerical simulation of the fluid flow depending on whether it is in the unsaturated or saturated zones. This paper shows that using a high-resolution shock-capturing conservative method to resolve the nonlinear governing coupled partial differential equations of a three-phase immiscible fluid flow allows the numerical simulation of the system through both zones providing a unitary vision (and resolution) of the migration of an immiscible contaminant problem within a porous medium. In particular, using different initial scenarios (including impermeable "lenses" in heterogeneous aquifers), three-dimensional numerical simulation results are presented on the temporal evolution of the contaminant migration following the saturation profiles of the three-phases fluids flow in variably saturated zones. It is considered either light nonaqueous phase liquid with a density less than the water, or dense nonaqueous phase liquid, which has densities greater than the water initially released in unsaturated dry soil. Our study shows that the fate of the migration of immiscible contaminants in variably saturated zones can be accurately described, using a unique mathematical conservative model, with different evolution depending on the value of the system's physical parameters, including the contaminant density, and accurately tracking the evolution of the sharp (shock) contaminant front.	[Feo, Alessandra; Celico, Fulvio] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parma, Italy; [Feo, Alessandra] Ist Nazl Fis Nucl, Grp Collegato Parma, Parma, Italy	University of Parma; Istituto Nazionale di Fisica Nucleare (INFN)	Feo, A (corresponding author), Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parma, Italy.; Feo, A (corresponding author), Ist Nazl Fis Nucl, Grp Collegato Parma, Parma, Italy.	alessandra.feo@unipr.it		Feo, Alessandra/0000-0002-3332-2490				Ahmed M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126273; Akai K., 1997, P JAPAN SOC CIVIL EN, V1264, P87; Allen G, 2011, CACTUS USERS GUIDE; [Anonymous], 2003, LECT NOTES COMPUTER; Ansari MR, 2013, INT J HEAT FLUID FL, V42, P209, DOI 10.1016/j.ijheatfluidflow.2013.02.003; Berardi M, 2019, APPL NUMER MATH, V135, P264, DOI 10.1016/j.apnum.2018.08.013; Bergamaschi L, 1999, INT J NUMER METH ENG, V45, P1025, DOI 10.1002/(SICI)1097-0207(19990720)45:8<1025::AID-NME615>3.3.CO;2-7; Cactus developers, CACT COMP TOOLK; CELIA MA, 1992, WATER RESOUR RES, V28, P2819, DOI 10.1029/92WR01488; Chen HX, 2019, COMPUT METHOD APPL M, V350, P641, DOI 10.1016/j.cma.2019.03.023; Chen LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124095; Christlieb A, 2016, J COMPUT PHYS, V327, P337, DOI 10.1016/j.jcp.2016.09.048; Coralic V, 2014, J COMPUT PHYS, V274, P95, DOI 10.1016/j.jcp.2014.06.003; de Frahan MTH, 2015, J COMPUT PHYS, V280, P489, DOI 10.1016/j.jcp.2014.09.030; Essaid HI, 2015, WATER RESOUR RES, V51, P4861, DOI 10.1002/2015WR017121; Farthing MW, 2017, SOIL SCI SOC AM J, V81, P1257, DOI 10.2136/sssaj2017.02.0058; Farthing MW, 2003, ADV WATER RESOUR, V26, P373, DOI 10.1016/S0309-1708(02)00187-2; FAUST CR, 1985, WATER RESOUR RES, V21, P587, DOI 10.1029/WR021i004p00587; FAUST CR, 1989, WATER RESOUR RES, V25, P2449, DOI 10.1029/WR025i012p02449; Feo A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83956-w; FORSYTH PA, 1995, ADV WATER RESOUR, V18, P25, DOI 10.1016/0309-1708(95)00020-J; FREEZE RA, 1971, WATER RESOUR RES, V7, P347, DOI 10.1029/WR007i002p00347; Gao YL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51405-4; Hammond GE, 2014, WATER RESOUR RES, V50, P208, DOI 10.1002/2012WR013483; HOU TY, 1994, MATH COMPUT, V62, P497, DOI 10.1090/S0025-5718-1994-1201068-0; Jones JE, 2001, ADV WATER RESOUR, V24, P763, DOI 10.1016/S0309-1708(00)00075-0; Kees CE, 2008, COMPUT METHOD APPL M, V197, P4610, DOI 10.1016/j.cma.2008.06.005; Kou J., 2004, INT J NUMER ANAL MOD, V1, P20; Kucharik M, 2006, APPL NUMER MATH, V56, P589, DOI 10.1016/j.apnum.2005.04.004; Kurganov A, 2000, J COMPUT PHYS, V160, P241, DOI 10.1006/jcph.2000.6459; LAX P, 1960, COMMUN PUR APPL MATH, V13, P217, DOI 10.1002/cpa.3160130205; Liang RH, 2021, ENERGIES, V14, DOI 10.3390/en14102757; Lichtner PC, 2019, PFLOTRAN WEB PAGE; Luo H, 2013, J COMPUT PHYS, V236, P477, DOI 10.1016/j.jcp.2012.11.026; Maltsev V, 2022, PHYS FLUIDS, V34, DOI 10.1063/5.0077314; Maxwell RM, 2013, ADV WATER RESOUR, V53, P109, DOI 10.1016/j.advwatres.2012.10.001; Miller CT, 1998, ADV WATER RESOUR, V21, P77, DOI 10.1016/S0309-1708(96)00036-X; Niu GY, 2014, ECOHYDROLOGY, V7, P427, DOI 10.1002/eco.1362; Orgogozo L, 2014, COMPUT PHYS COMMUN, V185, P3358, DOI 10.1016/j.cpc.2014.08.004; Orgogozo L, 2022, COMPUT PHYS COMMUN, V270, DOI 10.1016/j.cpc.2021.108182; Pandare AK, 2020, INT J NUMER METH FL, V92, P874, DOI 10.1002/fld.4810; Paniconi C, 2015, WATER RESOUR RES, V51, P7090, DOI 10.1002/2015WR017780; PARKER JC, 1987, WATER RESOUR RES, V23, P618, DOI 10.1029/WR023i004p00618; Peng XL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177187; Praseeja AV, 2019, J POROUS MEDIA, V22, P889, DOI 10.1615/JPorMedia.2019024580; Rabbani O, 2021, ADV MECH ENG, V13, DOI 10.1177/16878140211045240; Rabbani O, 2019, COMPUT MATH APPL, V77, P3195, DOI 10.1016/j.camwa.2019.02.010; Rezzolla Zanotti O, 2013, RELATIVISTIC HYDRODY; Rousseau M, 2021, WATER RESOUR RES, V57, DOI 10.1029/2021WR029978; Salazar AJ, 2000, NUMER METH PART D E, V16, P30; Schnetter E, 2004, CLASSICAL QUANT GRAV, V21, P1465, DOI 10.1088/0264-9381/21/6/014; Schnetter E, 2006, CLASSICAL QUANT GRAV, V23, pS553, DOI 10.1088/0264-9381/23/16/S14; Shyue KM, 1998, J COMPUT PHYS, V142, P208, DOI 10.1006/jcph.1998.5930; Soga K, 2004, J HAZARD MATER, V110, P13, DOI 10.1016/j.jhazmat.2004.02.034; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Yang C, 2021, COMPUT GEOSCI-UK, V151, DOI 10.1016/j.cageo.2021.104760; Zha YY, 2019, WIRES WATER, V6, DOI 10.1002/wat2.1364; Zia S, 2022, INT J NONLIN SCI NUM, V23, P433, DOI 10.1515/ijnsns-2019-0169	58	0	0	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266486	10.1371/journal.pone.0266486	http://dx.doi.org/10.1371/journal.pone.0266486			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D9PO	35468165	Green Submitted, Green Published, gold			2022-12-26	WOS:000794129600006
J	Gairing, SJ; Galle, PR; Schattenberg, JM; Kostev, K; Labenz, C				Gairing, Simon Johannes; Galle, Peter Robert; Schattenberg, Joern Markus; Kostev, Karel; Labenz, Christian			Portal vein thrombosis is associated with an increased risk of bone fractures	PLOS ONE			English	Article							MORBIDITY	BackgroundPortal vein thrombosis (PVT) is a rare but severe disease that often leads to portal hypertension-related complications. It is well-known that patients with portal hypertension associated with liver cirrhosis are at increased risk for bone fractures, however data on the impact of PVT on fracture risk are lacking. AimsThis study aimed to explore the impact of PVT on the incidence of bone fractures in a large German primary care cohort. MethodsPatients with PVT were extensively matched to non-PVT individuals in a 1:5 ratio. The primary outcome of the study was the incidence of any bone fracture. ResultsThis study included 596 patients with PVT and 2,980 non-PVT individuals. During five years of follow-up, the cumulative incidence of bone fractures was significantly higher in PVT patients (n = 87, 13.6%) than in those without PVT (n = 186, 6.7%) (p<0.001). In Cox-regression analyses, PVT was positively associated with bone fractures (HR: 2.16; 95% CI: 1.59-2.93). This association was stronger in women (HR: 2.55; 95% CI: 1.65-3.95) than in men (HR: 1.87; 95% CI: 1.22-2.87). The strongest association was observed in the age group 51-60 years (HR: 2.50, 95% CI: 1.40-4.47). The association between PVT and bone fractures was maintained in subgroup analyses of patients with (HR: 2.03, 95% CI: 1.13-3.63) and without liver cirrhosis (HR: 1.82, 95% CI: 1.28-2.58). ConclusionsPVT is independently associated with a higher incidence of bone fractures. Patients with PVT should be critically evaluated for fracture risk and preventive measures should be considered.	[Gairing, Simon Johannes; Galle, Peter Robert; Schattenberg, Joern Markus; Labenz, Christian] Johannes Gutenberg Univ Mainz, Dept Internal Med 1, Univ Med Ctr, Mainz, Germany; [Gairing, Simon Johannes; Galle, Peter Robert; Schattenberg, Joern Markus; Labenz, Christian] Johannes Gutenberg Univ Mainz, Cirrhosis Ctr Mainz CCM, Univ Med Ctr, Mainz, Germany; [Kostev, Karel] IQVIA, Epidemiol, Frankfurt, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; IQVIA	Labenz, C (corresponding author), Johannes Gutenberg Univ Mainz, Dept Internal Med 1, Univ Med Ctr, Mainz, Germany.	Christian.labenz@unimedizin-mainz.de	Galle, Peter R/T-5292-2018	Galle, Peter R/0000-0001-8294-0992; Kostev, Karel/0000-0002-2124-7227; Labenz, Christian/0000-0001-8390-9663				Chen TL, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017342; Cool J, 2019, J GASTROEN HEPATOL, V34, P1088, DOI 10.1111/jgh.14501; Gairing SJ, 2021, Z GASTROENTEROL, V59, P43, DOI 10.1055/a-1330-9827; Garcia-Pagan JC, 2016, J HEPATOL, V64, P179, DOI 10.1016/j.jhep.2015.07.040; Gioia Stefania, 2020, Curr Gastroenterol Rep, V22, P56, DOI 10.1007/s11894-020-00792-0; Ioannidis G, 2009, CAN MED ASSOC J, V181, P265, DOI 10.1503/cmaj.081720; Lattanzi B, 2019, LIVER INT, V39, P1937, DOI 10.1111/liv.14160; Liang J, 2018, CLIN ENDOCRINOL, V89, P408, DOI 10.1111/cen.13762; Mariconda M, 2015, BONE JOINT J, V97B, P383, DOI 10.1302/0301-620X.97B3.34504; Minguez B, 2006, HEPATOLOGY, V43, P707, DOI 10.1002/hep.21126; Nazrun AS, 2014, THER CLIN RISK MANAG, V10, P937, DOI 10.2147/TCRM.S72456; Northup PG, 2021, HEPATOLOGY, V73, P366, DOI 10.1002/hep.31646; Otete H, 2018, J HEPATOL, V69, P697, DOI 10.1016/j.jhep.2018.04.002; Rathmann W, 2018, INT J CLIN PHARM TH, V56, P459, DOI 10.5414/CP203320; Roman E, 2011, AM J GASTROENTEROL, V106, P476, DOI 10.1038/ajg.2010.413; Seijo Susana, 2014, Clin Liver Dis (Hoboken), V3, P118, DOI 10.1002/cld.336; Tapper EB, 2021, J HEPATOL, V75, P582, DOI 10.1016/j.jhep.2021.04.012; Tsai CF, 2013, J HEPATOL, V58, P706, DOI 10.1016/j.jhep.2012.12.001	18	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267535	10.1371/journal.pone.0267535	http://dx.doi.org/10.1371/journal.pone.0267535			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C1KV	35452487	gold, Green Published			2022-12-26	WOS:000792887700010
J	Jiang, D; Ma, T; Hao, MM; Ding, FY; Sun, K; Wang, Q; Kang, TT; Wang, D; Zhao, S; Li, M; Xie, XL; Fan, PW; Meng, Z; Zhang, SZ; Qian, YS; Edwards, J; Chen, S; Li, Y				Jiang, Dong; Ma, Tian; Hao, Mengmeng; Ding, Fangyu; Sun, Kai; Wang, Qian; Kang, Tingting; Wang, Di; Zhao, Shen; Li, Meng; Xie, Xiaolan; Fan, Peiwei; Meng, Ze; Zhang, Shize; Qian, Yushu; Edwards, John; Chen, Shuai; Li, Yin			Quantifying risk factors and potential geographic extent of African swine fever across the world	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; VISCERAL LEISHMANIASIS; GLOBAL DISTRIBUTION; RUSSIAN-FEDERATION; AVIAN INFLUENZA; SOFT TICKS; VIRUS; INFECTION; CHINA; PIGS	African swine fever (ASF) has spread to many countries in Africa, Europe and Asia in the past decades. However, the potential geographic extent of ASF infection is unknown. Here we combined a modeling framework with the assembled contemporary records of ASF cases and multiple covariates to predict the risk distribution of ASF at a global scale. Local spatial variations in ASF risk derived from domestic pigs is influenced strongly by livestock factors, while the risk of having ASF in wild boars is mainly associated with natural habitat covariates. The risk maps show that ASF is to be ubiquitous in many areas, with a higher risk in areas in the northern hemisphere. Nearly half of the world's domestic pigs (1.388 billion) are in the high-risk zones. Our results provide a better understanding of the potential distribution beyond the current geographical scope of the disease.	[Jiang, Dong; Ma, Tian; Hao, Mengmeng; Ding, Fangyu; Sun, Kai; Wang, Di; Zhao, Shen; Xie, Xiaolan; Fan, Peiwei; Meng, Ze; Qian, Yushu; Chen, Shuai] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Jiang, Dong; Ma, Tian; Hao, Mengmeng; Ding, Fangyu; Sun, Kai; Wang, Di; Xie, Xiaolan; Chen, Shuai] Univ Chinese Acad Sci, Coll Resources & Environm, Beijing, Peoples R China; [Wang, Qian] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England; [Kang, Tingting] Peking Univ, Sch Urban Planning & Design, Shenzhen Grad Sch, Shenzhen, Guangdong, Peoples R China; [Li, Meng] Nantong Univ, Sch Geog Sci, Nantong, Peoples R China; [Zhang, Shize] Chinese Acad Sci, Comp Network Informat Ctr, Beijing, Peoples R China; [Edwards, John; Li, Yin] Murdoch Univ, Ctr Biosecur & One Hlth, Sch Vet Med, Perth, WA, Australia; [Li, Yin] CSIRO, Brisbane, Qld, Australia	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Oxford; Peking University; University Town of Shenzhen; Nantong University; Chinese Academy of Sciences; Computer Network Information Center, CAS; Murdoch University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Ding, FY; Chen, S (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.; Ding, FY; Chen, S (corresponding author), Univ Chinese Acad Sci, Coll Resources & Environm, Beijing, Peoples R China.; Li, Y (corresponding author), Murdoch Univ, Ctr Biosecur & One Hlth, Sch Vet Med, Perth, WA, Australia.; Li, Y (corresponding author), CSIRO, Brisbane, Qld, Australia.	dingfy@igsnrr.ac.cn; chens.20b@igsnrr.ac.cn; yin.li@csiro.au	Ding, Fangyu/GLR-0429-2022; Li, Yin/X-5635-2018	Kang, Tingting/0000-0001-9059-2094; Li, Yin/0000-0001-5720-5267	Strategic Priority Research Program of the Chinese Academy of Sciences [XDA19040305]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank Qiaoling Zhu for providing valuable suggestions and myriad research staff who participated in compiling the most comprehensive occurrence dataset of African swine fever.	Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Blome S, 2013, VIRUS RES, V173, P122, DOI 10.1016/j.virusres.2012.10.026; Cappai S, 2020, J VET SCI, V21, DOI 10.4142/jvs.2020.21.e14; Cappai S, 2018, PREV VET MED, V152, P1, DOI 10.1016/j.prevetmed.2018.01.004; Carlson J, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9110977; Chenais E, 2019, PORCINE HEALTH MANAG, V5, DOI 10.1186/s40813-018-0109-2; Cho KH, 2021, TRANSBOUND EMERG DIS, V68, P385, DOI 10.1111/tbed.13689; Costard S, 2013, VIRUS RES, V173, P191, DOI 10.1016/j.virusres.2012.10.030; Dee SA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194509; Denstedt E, 2021, TRANSBOUND EMERG DIS, V68, P2669, DOI 10.1111/tbed.13964; Ding FY, 2021, PREV VET MED, V190, DOI 10.1016/j.prevetmed.2021.105317; Ding FY, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3778-z; Dixon LK, 2019, ANTIVIR RES, V165, P34, DOI 10.1016/j.antiviral.2019.02.018; Fasina FO, 2012, PREV VET MED, V107, P65, DOI 10.1016/j.prevetmed.2012.05.011; Ge SQ, 2018, EMERG INFECT DIS, V24, P2131, DOI 10.3201/eid2411.181274; Gilbert M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5116; Gulenkin VM, 2011, PREV VET MED, V102, P167, DOI 10.1016/j.prevetmed.2011.07.004; Jiang D, 2021, SCI TOTAL ENVIRON, V764, DOI 10.1016/j.scitotenv.2020.144275; Jiang D, 2019, RENEW SUST ENERG REV, V104, P167, DOI 10.1016/j.rser.2019.01.024; Kim HJ, 2019, EMERG INFECT DIS, V25, P1231, DOI 10.3201/eid2506.181684; Laddomada A, 2019, TRANSBOUND EMERG DIS, V66, P1114, DOI 10.1111/tbed.13138; Lewis JS, 2017, SCI REP-UK, V7, DOI 10.1038/srep44152; Liang RR, 2020, TRANSBOUND EMERG DIS, V67, P935, DOI 10.1111/tbed.13424; Lu Y, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-1903-z; Ma J, 2020, PREV VET MED, V175, DOI 10.1016/j.prevetmed.2019.104861; Malogolovkin A, 2012, VET MICROBIOL, V158, P415, DOI 10.1016/j.vetmic.2012.03.002; Monteagudo PL, 2017, J VIROL, V91, DOI [10.1128/JVI.01058-17, 10.1128/jvi.01058-17]; MONTGOMERY R. Eustace, 1921, Journal of Comparative Pathology and Therapeutics, V34, P159; Mur L, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-145; Normile D, 2018, SCIENCE, V361, P741, DOI 10.1126/science.361.6404.741; Nyamwaya D, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2019-8; Olsevskis E, 2016, RES VET SCI, V105, P28, DOI 10.1016/j.rvsc.2016.01.006; Pautienius A, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1090-8; Rolesu S, 2021, FRONT VET SCI, V8, DOI 10.3389/fvets.2021.692448; Rowlands RJ, 2008, EMERG INFECT DIS, V14, P1870, DOI 10.3201/eid1412.080591; Sanchez-Cordon PJ, 2018, VET J, V233, P41, DOI 10.1016/j.tvjl.2017.12.025; Sanchez-Vizcaino JM, 2021, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.632292; Stokstad E, 2017, SCIENCE, V358, P1516, DOI 10.1126/science.358.6370.1516; Urner N, 2021, PREV VET MED, V186, DOI 10.1016/j.prevetmed.2020.105229; Uspensky I, 2014, TICKS TICK-BORNE DIS, V5, P41, DOI 10.1016/j.ttbdis.2013.07.011; Le VP, 2019, EMERG INFECT DIS, V25, P1433, DOI 10.3201/eid2507.190303; Vial L, 2018, VET PARASITOL, V249, P2, DOI 10.1016/j.vetpar.2017.10.022; Vial L, 2009, PARASITE, V16, P191, DOI 10.1051/parasite/2009163191; Wang N, 2019, SCIENCE, V366, P640, DOI 10.1126/science.aaz1439; Wang T, 2021, INFECT DIS POVERTY, V10, DOI 10.1186/s40249-021-00920-6; Yoon H, 2020, TRANSBOUND EMERG DIS, V67, P2245, DOI 10.1111/tbed.13552; Zheng CJ, 2019, CLIN INFECT DIS, V69, P1205, DOI 10.1093/cid/ciy1050	47	2	2	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267128	10.1371/journal.pone.0267128	http://dx.doi.org/10.1371/journal.pone.0267128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446903	Green Published, gold			2022-12-26	WOS:000795468200068
J	Kotake, K; Kumazawa, T; Adachi, T				Kotake, Kunihiko; Kumazawa, Toshihiko; Adachi, Takahiro			Long-term administration of Tetragenococcus halophilus No. 1 over generations affects the immune system of mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; HYPERTENSION; RISK; DIET; SOY	Japanese people have been consuming miso soup over generations; it is beneficial for health and longevity. In this study, Tetragenococcus halophilus No. 1 in miso was found to possess salient immunomodulatory functions. Recently, we also demonstrated its effect on boosting immunological robustness. Although the consumption of miso is suggested to affect health over generations, such a long-term experiment has not been conducted until now. Thus, we evaluated the effects of miso-derived T. halophilus No. 1 over generations on the immune system of mice. As the generations increase, the proportion of germinal center B cells tends to increase. Furthermore, we found that CD4(+) T cells expressing CD69, an activation marker, were increased in the third generation of mice. In addition, the proportion of follicular helper T cells and regulatory T cells tended to increase. Among the subsets of CD4(+) T cells in the fourth generation, effector T cells and effector memory T cells tended to increase. In contrast, central memory T cells and naive T cells decreased. Moreover, autoimmunity was suppressed by long-term administration of T. halophilus No. 1. Based on these findings, we believe that the long-term administration of T. halophilus No. 1 over generations promotes immune activation and tolerance and enhances immunological robustness.	[Kotake, Kunihiko; Kumazawa, Toshihiko] Ichibiki Co Ltd, Nagoya, Japan; [Kotake, Kunihiko; Kumazawa, Toshihiko; Adachi, Takahiro] Tokyo Med & Dent Univ, Med Res Inst, Dept Precis Hlth, Bunkyo, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Adachi, T (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Precis Hlth, Bunkyo, Tokyo, Japan.	tadachi.imm@mri.tmd.ac.jp		Adachi, Takahiro/0000-0002-3711-8577	Japan Society for the Promotion of Science [17H06170, 19H04036]; Nipponham Foundation for the Future of Food; Tojuro Iijima Foundation for Food Science and Technology; Ichibiki Co Ltd; Naoki Tsuchida Memorial Research Grant	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nipponham Foundation for the Future of Food; Tojuro Iijima Foundation for Food Science and Technology; Ichibiki Co Ltd; Naoki Tsuchida Memorial Research Grant	This research was partly funded by Ichibiki Co Ltd (https://www.ichibiki.co.jp/).The funder provided support in the form of salaries for authors K.K. and T.K. and provided resorce. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section. This work was supported in part by grants from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/; No. 17H06170 and 19H04036), Nipponham Foundation for the Future of Food (https://www.miraizaidan.or.jp/), Tojuro Iijima Foundation for Food Science and Technology(http://www.iijimakinenzaidan.or.jp/), and Naoki Tsuchida Memorial Research Grant (https://www.tmd.ac.jp/tmdresearch/studysupport/grant/tsuchidagrant/) (to T.A.). There was no additional external funding received for this study.	Abe S, 2020, CLIN NUTR, V39, P298, DOI 10.1016/j.clnu.2019.02.010; Adachi T, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00601; Baggia S, 1996, J SOC GYNECOL INVEST, V3, P121, DOI 10.1016/1071-5576(96)00002-0; Burris RL, 2020, ATHEROSCLEROSIS, V313, P26, DOI 10.1016/j.atherosclerosis.2020.09.018; CASEY ML, 1989, J CLIN INVEST, V83, P430, DOI 10.1172/JCI113901; Cuomo M, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11020142; Ehrenstein MR, 2000, J EXP MED, V191, P1253, DOI 10.1084/jem.191.7.1253; EHRENSTEIN MR, 1995, KIDNEY INT, V48, P705, DOI 10.1038/ki.1995.341; Forsberg A, 2020, PEDIAT ALLERG IMM-UK, V31, P544, DOI 10.1111/pai.13240; HIRAYAMA T, 1982, Nutrition and Cancer, V3, P223, DOI 10.1080/01635588109513726; Ito M, 2019, ENVIRON HEALTH PREV, V24, DOI 10.1186/s12199-019-0782-z; Jasarevic E, 2014, NEUROBIOL LEARN MEM, V116, P59, DOI 10.1016/j.nlm.2014.08.009; Karabegovic I, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22752-6; Kotake K, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0261680; Kumazawa T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208821; Lampi KM, 2012, J PEDIATR-US, V161, P830, DOI 10.1016/j.jpeds.2012.04.058; Markopoulou P, 2019, J PEDIATR-US, V210, P69, DOI 10.1016/j.jpeds.2019.02.041; Minami Y, 2020, CANCER SCI, V111, P2558, DOI 10.1111/cas.14459; Okouchi R, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030560; Surzenko N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0223395; Watanabe H, 2006, HYPERTENS RES, V29, P731, DOI 10.1291/hypres.29.731; Watanabe H, 2018, AM J HYPERTENS, V31, P43, DOI 10.1093/ajh/hpx129; Yamamoto S, 2003, J NATL CANCER I, V95, P906, DOI 10.1093/jnci/95.12.906; Yoshikawa S, 2016, SCI REP-UK, V6, DOI 10.1038/srep18738; Yoshinaga M, 2012, NUTRITION, V28, P924, DOI 10.1016/j.nut.2011.09.010	25	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267473	10.1371/journal.pone.0267473	http://dx.doi.org/10.1371/journal.pone.0267473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35472068	gold, Green Published			2022-12-26	WOS:000816171900005
J	Magid, HSA; Milliren, CE; Rice, K; Molanphy, N; Ruiz, K; Gooding, HC; Richmond, TK; Odden, MC; Nagata, JM				Magid, Hoda S. Abdel; Milliren, Carly E.; Rice, Kathryn; Molanphy, Nina; Ruiz, Kennedy; Gooding, Holly C.; Richmond, Tracy K.; Odden, Michelle C.; Nagata, Jason M.			Adolescent individual, school, and neighborhood influences on young adult hypertension risk	PLOS ONE			English	Article							BLOOD-PRESSURE; GENDER-DIFFERENCES; MULTILEVEL MODELS; DISCRIMINATION; PREVALENCE; AWARENESS; OBESITY	BackgroundGeographic and contextual socioeconomic risk factors in adolescence may be more strongly associated with young adult hypertension than individual-level risk factors. This study examines the association between individual, neighborhood, and school-level influences during adolescence on young adult blood pressure. MethodsData were analyzed from the National Longitudinal Study of Adolescent to Adult Health (1994-1995 aged 11-18 and 2007-2008 aged 24-32). We categorized hypertension as systolic blood pressure >= 140 mm Hg and/or diastolic blood pressure >= 90 mm Hg. Secondary outcomes included continuous systolic and diastolic blood pressure. We fit a series of cross-classified multilevel models to estimate the associations between young adulthood hypertension with individual-level, school-level, and neighborhood-level factors during adolescence (i.e., fixed effects) and variance attributable to each level (i.e., random effects). Models were fit using Bayesian estimation procedures. For linear models, intra-class correlations (ICC) are reported for random effects. ResultsThe final sample included 13,911 participants in 128 schools and 1,917 neighborhoods. Approximately 51% (7,111) young adults were hypertensive. Individual-level characteristics-particularly older ages, Non-Hispanic Black race, Asian race, male sex, BMI, and current smoking-were associated with increased hypertension. Non-Hispanic Black (OR = 1.21; 95% CI: 1.03-1.42) and Asian (OR = 1.28; 95% CI: 1.02-1.62) students had higher odds of hypertension compared to non-Hispanic White students. At the school level, hypertension was associated with the percentage of non-Hispanic White students (OR for 10% higher = 1.06; 95% CI: 1.01-1.09). Adjusting for individual, school, and neighborhood predictors attenuated the ICC for both the school (from 1.4 null to 0.9 fully-adjusted) and neighborhood (from 0.4 to 0.3). ConclusionWe find that adolescents' schools and individual-level factors influence young adult hypertension, more than neighborhoods. Unequal conditions in school environments for adolescents may increase the risk of hypertension later in life. Our findings merit further research to better understand the mechanisms through which adolescents' school environments contribute to adult hypertension and disparities in hypertension outcomes later in life.	[Magid, Hoda S. Abdel; Odden, Michelle C.] Stanford Univ, Dept Epidemiol & Populat Hlth, Stanford, CA 94305 USA; [Magid, Hoda S. Abdel; Rice, Kathryn; Molanphy, Nina; Ruiz, Kennedy] Santa Clara Univ, Publ Hlth Sci Program, Santa Clara, CA 95053 USA; [Milliren, Carly E.] Boston Childrens Hosp, Inst Ctr Clin & Translat Res, Boston, MA USA; [Gooding, Holly C.] Emory Univ, Sch Med, Dept Pediat, Div Gen Pediat & Adolescent Med, Atlanta, GA USA; [Gooding, Holly C.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Richmond, Tracy K.] Boston Childrens Hosp, Div Adolescent & Young Adult Med, Boston, MA USA; [Richmond, Tracy K.] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Nagata, Jason M.] Univ Calif San Francisco, Div Adolescent & Young Adult Med, San Francisco, CA 94143 USA	Stanford University; Santa Clara University; Harvard University; Boston Children's Hospital; Emory University; Children's Healthcare of Atlanta (CHOA); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Francisco	Nagata, JM (corresponding author), Univ Calif San Francisco, Div Adolescent & Young Adult Med, San Francisco, CA 94143 USA.	jason.nagata@ucsf.edu		Nagata, Jason/0000-0002-6541-0604	National Heart, Lung, and Blood Institute [K08HL159350]; American Heart Association [CDA34760281]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association)	J.M.N. is supported by the National Heart, Lung, and Blood Institute (K08HL159350) and the American Heart Association (CDA34760281).	Anyaegbu EI, 2014, PEDIATR CLIN N AM, V61, P131, DOI 10.1016/j.pcl.2013.09.011; Barker KM, 2020, SSM-POPUL HLTH, V12, DOI 10.1016/j.ssmph.2020.100661; Browne W. J., 2017, MCMC ESTIMATION MLWI; Carolina Population Center, 2020, ADD HLTH LONG DES NA; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Churchwell Keith, 2020, Circulation, V142, pe454, DOI 10.1161/CIR.0000000000000936; Dolezsar CM, 2014, HEALTH PSYCHOL, V33, P20, DOI 10.1037/a0033718; Dunn EC, 2015, HEALTH PLACE, V31, P224, DOI 10.1016/j.healthplace.2014.12.001; Evans CR, 2016, SOC SCI MED, V162, P21, DOI 10.1016/j.socscimed.2016.06.002; Everett B, 2015, BIODEMOGR SOC BIOL, V61, P1, DOI 10.1080/19485565.2014.929488; Falkner B, 2010, PEDIATR NEPHROL, V25, P1219, DOI 10.1007/s00467-009-1200-3; Flynn JT, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-3035; Goldstein H., 2002, Understanding Statistics, V1, P223, DOI 10.1207/S15328031US0104_02; Goncalves VSS, 2019, PUBLIC HEALTH NUTR, V22, P2625, DOI 10.1017/S1368980019001010; Gooding HC, 2014, J GEN INTERN MED, V29, P1098, DOI 10.1007/s11606-014-2809-x; Goosby BJ, 2012, HEALTH PLACE, V18, P296, DOI 10.1016/j.healthplace.2011.10.002; Harris K.M., 2013, ADD HLTH STUDY DESIG, DOI [DOI 10.17615/C6TW87, 10.1002/grl.50460]; Hicken MT, 2014, AM J PUBLIC HEALTH, V104, P117, DOI 10.2105/AJPH.2013.301395; Hsieh HF, 2022, J INTERPERS VIOLENCE, V37, pNP7202, DOI 10.1177/0886260520969390; Khoury M, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00148; Lewis TT, 2015, ANNU REV CLIN PSYCHO, V11, P407, DOI 10.1146/annurev-clinpsy-032814-112728; Marliana R., 2018, J HYPERTENS, V36, pe2; McNiece KL, 2007, J PEDIATR-US, V150, P640, DOI 10.1016/j.jpeds.2007.01.052; Mello D, 2020, SOC SCI MED, V255, DOI 10.1016/j.socscimed.2020.113010; Milliren CE, 2018, HEALTH PLACE, V52, P121, DOI 10.1016/j.healthplace.2018.05.009; Min JW, 2020, HEALTH PLACE, V65, DOI 10.1016/j.healthplace.2020.102383; Nguyen QC, 2011, EPIDEMIOLOGY, V22, P532, DOI 10.1097/EDE.0b013e31821c79d2; Niu L, 2019, J ADOLESCENT HEALTH, V64, P405, DOI 10.1016/j.jadohealth.2018.09.024; O'Malley PM, 2007, AM J PREV MED, V33, pS187, DOI 10.1016/j.amepre.2007.07.001; Ostchegaa Y, 2020, HYPERTENSION PREVALE; Rabash J., 2001, MODELING NONHIERARCH; Rasbash J., 2017, USERS GUIDE MLWIN, V12, P13; Richmond TK, 2006, PEDIATRICS, V117, P2158, DOI 10.1542/peds.2005-1920; Richmond TK, 2016, OBESITY, V24, P2570, DOI 10.1002/oby.21672; Riley M, 2018, AM FAM PHYSICIAN, V98, P486; RODRIGUEZ G, 1995, J ROY STAT SOC A STA, V158, P73, DOI 10.2307/2983404; Wang XL, 2006, CIRCULATION, V114, P2780, DOI 10.1161/CIRCULATIONAHA.106.643940	38	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266729	10.1371/journal.pone.0266729	http://dx.doi.org/10.1371/journal.pone.0266729			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1D8GY	35482649	gold, Green Published			2022-12-26	WOS:000794035700094
J	Ngai, HL; Yang, X; Chu, AJ; Harper, R; Jacobsen, ABJE; Lau, DTW; Yu, HY; Lee, HK; Shaw, PC				Ngai, Hiu-Lam; Yang, Xiao; Chu, Adrian Jun; Harper, Rachel; Jacobsen, Alice B. J. E.; Lau, David Tai-Wai; Yu, Ho-Yin; Lee, Hung-Kay; Shaw, Pang-Chui			Multi-methodological approach for the Quality assessment of Senecionis scandentis Herba (Qianliguang) in the herbal market	PLOS ONE			English	Article								We set forth to assess the quality of an herbal medicine sold in Hong Kong called Qianliguang by employing a multi-methodological approach. The quality is set by its identity, chemical composition, and bioactivities, among others. Qianliguang (Senecionis scandentis Herba, Senecio scandens Buch.-Ham. ex D.Don) has known antibacterial properties. However, it is poisonous and overconsumption can result in liver damage. Eighteen Qianliguang samples were purchased from herbal shops at various districts in Hong Kong. Samples were first authenticated organoleptically. DNA barcoding at the psbA-trnH, ITS2, and rbcL loci was then conducted to confirm the species. HPLC-UV was performed to screen for the presence of the chemical compounds and to quantify the flavonoid hyperoside. UPLC-MS was used to quantify the amount of the toxic pyrrolizidine alkaloid (PA) adonifoline. Microdilution assay was performed to show the antibacterial effect on Streptococcus aureus and S. pneumoniae. Results showed that five samples were found to be substituted by species belonging to the genus Lespedeza; four samples were mixtures containing not only Qianliguang but also Achyranthes aspera L., Lonicera confusa DC., or Solanum nigrum L. HPLC-UV showed that only ten contained enough hyperoside to meet the standard requirement. In addition, nine samples had adonifoline that exceeded the toxicity standard requirement. In the microdilution assay, samples containing Qianliguang showed inhibition on S. aureus and S. pneumoniae, while among the five Lespedeza sp. samples the antibacterial effects on S. aureus were not detectable; only one sample showed inhibition to S. pneumoniae. Our study illustrated the necessity of using a multi-methodological approach for herbal medicine quality assessment. We also showed that Qianliguang samples in the Hong Kong market were either toxic or adulterated. It is therefore essential to improve the quality control of Qianliguang and probably other herbs in the herbal market.	[Ngai, Hiu-Lam; Shaw, Pang-Chui] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Peoples R China; [Yang, Xiao; Chu, Adrian Jun; Harper, Rachel; Jacobsen, Alice B. J. E.] Chinese Univ Hong Kong Kong, Dept Microbiol, Hong Kong, Peoples R China; [Lau, David Tai-Wai] Chinese Univ Hong Kong, Sch Life Sci, Siu Ying Hu Herbarium, Hong Kong, Peoples R China; [Yu, Ho-Yin; Lee, Hung-Kay] Chinese Univ Hong Kong, Dept Chem, Hong Kong, Peoples R China; [Shaw, Pang-Chui] Chinese Univ Hong Kong, LDS YYC R&D Ctr Chinese Med, Hong Kong, Peoples R China; [Shaw, Pang-Chui] Chinese Univ Hong Kong, Inst Chinese Med, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Shaw, PC (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Peoples R China.; Lee, HK (corresponding author), Chinese Univ Hong Kong, Dept Chem, Hong Kong, Peoples R China.; Shaw, PC (corresponding author), Chinese Univ Hong Kong, LDS YYC R&D Ctr Chinese Med, Hong Kong, Peoples R China.; Shaw, PC (corresponding author), Chinese Univ Hong Kong, Inst Chinese Med, Hong Kong, Peoples R China.	hklee@cuhk.edu.hk; pcshaw@cuhk.edu.hk	Jacobsen, Alice/HGD-5740-2022	Ngai, Hiu-lam/0000-0002-8436-8501; Chu, Adrian/0000-0001-9206-9395; Lau, Tai Wai David/0000-0002-3443-1808; Yu, Ho Yin/0000-0001-6258-2761; Shaw, Pang-Chui/0000-0001-6848-5073				Academia Sinica Center for Digital Cultures Forestry Bureau, 2022, TAIWAN ENCY LIFE; Bao BJ., 2021, FLORA CHINA, V5, p1a; Calkins H, 2017, J ARRYTHM, V33, P369, DOI 10.1016/j.joa.2017.08.001; Chang FR, 2021, MICROSC RES TECHNIQ, V84, P1089, DOI 10.1002/jemt.23651; Chen LX., 2006, STRAIT PHARM J, V18, P13; Chen YL., 2021, FLORA CHINA, V20, P510; Chen YL., 2021, FLORA CHINA, V20, P533; Devey DS, 2009, TAXON, V58, P7, DOI 10.1002/tax.581003; DOEBLEY J, 1990, EVOLUTION, V44, P1097, DOI [10.2307/2409569, 10.1111/j.1558-5646.1990.tb03828.x]; Gao T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-324; Gesto-Borroto R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217313; Han JP, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/741476; Hong Kong Baptist UniversitySchool of Chinese Medicine, 2022, SEN SCAND BUCH HAM E; Hospital Authority Toxicology Reference Laboratory, 2018, ATL POIS PLANTS HONG; Ichim MC, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01227; International Barcode of Life Consortium (iBOL), 2022, DNA BARC INT BARC LI; Kumar JUS, 2018, 3 BIOTECH, V8, DOI 10.1007/s13205-018-1169-3; Lo YT, 2018, CHIN MED-UK, V13, DOI 10.1186/s13020-018-0188-7; Naidu P. V. L., 2006, Biosciences, Biotechnology Research Asia, V3, P171; The Committee of Pharmacopeia of the People's Republic of China, 2020, PHARM PEOPL REP CHIN, V11th; Van Schalkwyk FJ, 2021, FORENSIC SCI INT, V320, DOI 10.1016/j.forsciint.2020.110680; [万勇 Wan Yong], 2021, [药物分析杂志, Chinese Journal of Pharmaceutical Analysis], V41, P1724; Wang DM, 2013, J ETHNOPHARMACOL, V149, P1, DOI 10.1016/j.jep.2013.05.048; Wang Y, 2020, J MASS SPECTROM, V55, DOI 10.1002/jms.4532; Whitlock BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011533; Word Health Organisation (WHO), 2011, QUAL CONTR METH HERB; Wu Bin, 2003, Zhongguo Zhongyao Zazhi, V28, P97; Xiong AZ, 2014, ANAL BIOANAL CHEM, V406, P7715, DOI 10.1007/s00216-014-8175-z; Xiong AZ, 2012, METABOLOMICS, V8, P614, DOI 10.1007/s11306-011-0354-8; [熊爱珍 Xiong Aizhen], 2010, [药物分析杂志, Chinese Journal of Pharmaceutical Analysis], V30, P936; Yanaso S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0257243; Yang M., 2021, QIANBAI BIYAN TABLET, V5209618, P1, DOI [10.1155/2021/5209618, DOI 10.1155/2021/5209618]; Yang XJ, 2011, J PHARMACEUT BIOMED, V56, P165, DOI 10.1016/j.jpba.2011.05.004; Yik MHY, 2021, J TRADIT COMPL MED, V11, P598, DOI 10.1016/j.jtcme.2021.07.005; Yik MHY, 2021, PLANTS-BASEL, V10, DOI 10.3390/plants10010161; Yu N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195240; Zhang SY., 2022, J ANHUI AGR SCI, V50, P202, DOI [10.3969/j.issn.0517-6611.2022.02.055, DOI 10.3969/J.ISSN.0517-6611.2022.02.055]; Zhu L., 2015, WORLD J TRADIT CHIN, V1, P1	38	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267143	10.1371/journal.pone.0267143	http://dx.doi.org/10.1371/journal.pone.0267143			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421189	gold, Green Published			2022-12-26	WOS:000795453600113
J	Rabil, MJ; Tunc, S; Bish, DR; Bish, EK				Rabil, Marie Jeanne; Tunc, Sait; Bish, Douglas R.; Bish, Ebru K.			Benefits of integrated screening and vaccination for infection control	PLOS ONE			English	Article							COVID-19; INFLUENZA	ImportanceScreening and vaccination are essential in the fight against infectious diseases, but need to be integrated and customized based on community and disease characteristics. ObjectiveTo develop effective screening and vaccination strategies, customized for a college campus, to reduce COVID-19 infections, hospitalizations, deaths, and peak hospitalizations. Design, setting, and participantsWe construct a compartmental model of disease spread under vaccination and routine screening, and study the efficacy of four mitigation strategies (routine screening only, vaccination only, vaccination with partial or full routine screening), and a no-intervention strategy. The study setting is a hypothetical college campus of 5,000 students and 455 faculty members during the Fall 2021 academic semester, when the Delta variant was the predominant strain. For sensitivity analysis, we vary the screening frequency, daily vaccination rate, initial vaccine coverage, and screening and vaccination compliance; and consider scenarios that represent low/medium/high transmission and test efficacy. Model parameters come from publicly available or published sources. ResultsWith low initial vaccine coverage (30% in our study), even aggressive vaccination and screening result in a high number of infections: 1,020 to 2,040 (1,530 to 2,480) with routine daily (every other day) screening of the unvaccinated; 280 to 900 with daily screening extended to the newly vaccinated in base- and worst-case scenarios, which respectively consider reproduction numbers of 4.75 and 6.75 for the Delta variant. ConclusionIntegrated vaccination and routine screening can allow for a safe opening of a college when both the vaccine effectiveness and the initial vaccine coverage are sufficiently high. The interventions need to be customized considering the initial vaccine coverage, estimated compliance, screening and vaccination capacity, disease transmission and adverse outcome rates, and the number of infections/peak hospitalizations the college is willing to tolerate.	[Rabil, Marie Jeanne; Tunc, Sait] Virginia Polytech Inst & State Univ, Grad Dept Ind & Syst Engn, Blacksburg, VA 24061 USA; [Bish, Douglas R.; Bish, Ebru K.] Univ Alabama, Culverhouse Coll Business, Dept Informat Syst Stat & Management Sci, Tuscaloosa, AL USA	Virginia Polytechnic Institute & State University; University of Alabama System; University of Alabama Tuscaloosa	Rabil, MJ (corresponding author), Virginia Polytech Inst & State Univ, Grad Dept Ind & Syst Engn, Blacksburg, VA 24061 USA.	mariejeanne@vt.edu		Rabil, Marie Jeanne/0000-0003-0267-7026				Allassan Fadel, ALL US AD NOW EL COV; Anderson RM., 2016, IMPACT VACCINATION E; Andrews N., 2021, MEDRXIV; Barrett ADT, 2016, NEW ENGL J MED, V375, P301, DOI 10.1056/NEJMp1606997; Best Colleges, THES AR COLL REQ VAC; CDC, DEM TRENDS COVID 19; Centers for Disease Control, KEY THINGS KNOW COVI; Centers for Disease Control, VAR PROP; Centers for Disease Control, 1 CONF CAS OM VAR DE; Chou WYS, 2020, HEALTH COMMUN, V35, P1718, DOI 10.1080/10410236.2020.1838096; Cleveland Clinic, COVID 19 PCR TEST; CNN, CORN U REP MOR 900 C; COVID-Net, LAB CONF COVID 19 AS; Deckert A, 2020, B WORLD HEALTH ORGAN, V98, P590, DOI 10.2471/BLT.20.257188; Ehreth J, 2003, VACCINE, V21, P596, DOI 10.1016/S0264-410X(02)00623-0; Emory University, COVID 19 VACC; FDA, FDA TAK KEY ACT FIGH; Fitzgerald JC, 2020, PEDIATR CRIT CARE ME, V21, P595, DOI 10.1097/PCC.0000000000002304; Fujimoto AB, 2021, VACCINE, V39, P5055, DOI 10.1016/j.vaccine.2021.06.067; Goldberg Y, 2021, NEW ENGL J MED, V385, pE85, DOI 10.1056/NEJMoa2114228; Holcombe Madeline, MORE 91 MILLION LIVE; Kahn B., 2020, FRAMEWORK EQUITABLE; Kattela K, OMICRON DELTA ALPHA; Kortela E, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251661; Liu Y., J TRAVEL MED, V2021; Mayo Clinic, HERD IMM COVID 19 CO; Medical Device Network, DIFF PATHS SAM DEST; Menni C, 2022, LANCET, V399, P1618, DOI 10.1016/S0140-6736(22)00327-0; Mervosh Sarah, JUST GOT MY VACCINE; Meyer JC, 2020, SA PHARM J, V87, P26; Motta FC., 2021, JAMA HLTH FORUM, V2; Orenstein WA, 2017, P NATL ACAD SCI USA, V114, P4031, DOI 10.1073/pnas.1704507114; Our world in data, COVID 19 VACC BOOST; Our World in Data, 2022, SHAR SARS COV 2 SEQ; Paltiel AD, 2021, ANN INTERN MED, V174, P1563, DOI 10.7326/M21-2965; Paltiel AD, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16818; Philipson T, 2000, HANDB ECON, V17, P1761; Poletti P, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.1085; QUARTS, HER AR COR TEST MAT; Rabi R, 2021, PUBLIC HEALTH NURS, V38, P781, DOI 10.1111/phn.12907; Rahmandad H, 2008, MANAGE SCI, V54, P998, DOI 10.1287/mnsc.1070.0787; Rappuoli R, 2014, P NATL ACAD SCI USA, V111, P12288, DOI 10.1073/pnas.1402981111; Ribas A, 2021, CANCER DISCOV, V11, P233, DOI 10.1158/2159-8290.CD-20-1817; Roy B., 2020, NEJM CATALYST INNOVA, V1; Shahangian S, 2006, LABMEDICINE, V37, P210, DOI 10.1309/KHAG13KEDDVQMRKX; Shim E, 2021, J CLIN MED, V10, DOI 10.3390/jcm10040591; Statista, NUMB COVID 19 VACC D; Statista, NUMB COR DIS 2019 CO; Statista, TOT NUMB CAS COVID 1; Stites EC, 2020, MED-CAMBRIDGE, V1, P78, DOI 10.1016/j.medj.2020.08.001; Syracuse University, COVID 19 UPD CAMP AC; U S A Facts, US COR VACC TRACK; UK Health Security Agency, SARS COV 2 VAR CONC; University of Michigan Health, HUM IMM VIR HIV TEST; University of Toronto, COVID 19 PLANN UPD; Urgent Care, ADV ONS LAB INV SCRE; Verger P., 2020, RESTORING CONFIDENCE; Wacharapluesadee S, 2020, J MED VIROL, V92, P2193, DOI 10.1002/jmv.26005; Wendelboe AM, 2011, INFECT CONT HOSP EP, V32, P990, DOI 10.1086/661916; Woloshin S, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2015897; Yohe S, 2020, GOOD ARE COVID 19 SA; Zha WT, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268819002188; Zhao S, 2021, EPIDEMICS-NETH, V36, DOI 10.1016/j.epidem.2021.100482; Zhao XM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0255864	64	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267388	10.1371/journal.pone.0267388	http://dx.doi.org/10.1371/journal.pone.0267388			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446872	Green Published, Green Submitted, gold			2022-12-26	WOS:000795468200018
J	Suntivich, R; Songjang, W; Jiraviriyakul, A; Ruchirawat, S; Chatwichien, J				Suntivich, Rinrada; Songjang, Worawat; Jiraviriyakul, Arunya; Ruchirawat, Somsak; Chatwichien, Jaruwan			LC-MS/MS metabolomics-facilitated identification of the active compounds responsible for anti-allergic activity of the ethanol extract of Xenostegia tridentata	PLOS ONE			English	Article							L. HALLIER F; MASS-SPECTROMETRY; UNTARGETED METABOLOMICS; MOUSE MODEL; LUTEOLIN; ANTIOXIDANT; FLAVONOIDS; CELLS; DEGRANULATION; PROTECT	In vivo and in vitro anti-allergic activities of ethanol extract of Xenostegia tridentata (L.) D.F. Austin & Staples were investigated using passive cutaneous anaphylaxis reaction assay and RBL-2H3 cell degranulation assay, respectively. The crude ethanol extract exhibited promising activities when compared with the known anti-allergic agents, namely dexamethasone and ketotifen fumarate. The ethyl acetate subfraction showed the highest anti-allergic activity among various sub-partitions and showed better activity than the crude extract, consistent with the high abundance of total phenolic and flavonoid contents in this subfraction. LC-MS/MS metabolomics analysis and bioassay-guided isolation were then used to identify chemical constituents responsible for the anti-allergic activity. The results showed that major components of the ethyl acetate subfraction consist of 3,5-dicaffeoylquinic acid, quercetin-3-O-rhamnoside, kaempferol-3-O-rhamnoside and luteolin-7-O-glucoside. The inhibitory activity of the isolated compounds against mast cell degranulation was validated, ensuring their important roles in the anti-allergic activity of the plant. Notably, besides showing the anti-allergic activity of X. tridentata, this work highlights the role of metabolomic analysis in identifying and selectively isolating active metabolites from plants.	[Suntivich, Rinrada] Natl Sci & Technol Dev Agcy NSTDA, Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani, Thailand; [Songjang, Worawat; Jiraviriyakul, Arunya] Naresuan Univ, Fac Allied Hlth Sci, Dept Med Technol, Phitsanulok, Thailand; [Songjang, Worawat; Jiraviriyakul, Arunya] Naresuan Univ, Fac Allied Hlth Sci, Integrat Biomed Res Unit IBRU, Phitsanulok, Thailand; [Ruchirawat, Somsak; Chatwichien, Jaruwan] Chulabhorn Royal Acad, Chulabhorn Grad Inst, Program Chem Sci, Bangkok, Thailand; [Ruchirawat, Somsak] Chulabhorn Res Inst, Lab Med Chem, Bangkok, Thailand; [Ruchirawat, Somsak; Chatwichien, Jaruwan] Minist Higher Educ Sci Res & Innovat, Ctr Excellence Environm Hlth & Toxicol EHT, OPS, Bangkok, Thailand	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Naresuan University; Naresuan University; Chulabhorn Graduate Institute; Chulabhorn Royal Academy; Chulabhorn Research Institute	Chatwichien, J (corresponding author), Chulabhorn Royal Acad, Chulabhorn Grad Inst, Program Chem Sci, Bangkok, Thailand.; Chatwichien, J (corresponding author), Minist Higher Educ Sci Res & Innovat, Ctr Excellence Environm Hlth & Toxicol EHT, OPS, Bangkok, Thailand.	jaruwanc@cgi.ac.th			Agricultural Research Development Agency (Public Organization) [CRP6305030720]; National Science and Technology Development Agency [FDA-CO2563-12800-TH]	Agricultural Research Development Agency (Public Organization); National Science and Technology Development Agency	This work was supported by the Agricultural Research Development Agency (Public Organization) [grant numbers CRP6305030720] and the National Science and Technology Development Agency [grant number FDA-CO2563-12800-TH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.:JC.	Abdelaziz MM, 2000, ALLERGY, V55, P425, DOI 10.1034/j.1398-9995.2000.00114.x; Alonso A, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00023; Ambika AP, 2019, ADV WOUND CARE, V8, P28, DOI 10.1089/wound.2017.0781; Antonelli J, 2017, ARXIV, V125; Appleton J., 2010, NAT MED J, V2, P1; Aron S, 2013, INDIAN J TRADIT KNOW, V12, P693; Arunachalam K., 2011, INT J PHARM PHARM SC, V3, P75; Arunachalam K, 2012, ASIAN PAC J TROP MED, V5, P175, DOI 10.1016/S1995-7645(12)60020-0; Austin D. F., 2014, Ethnobotany Research and Applications, V12, P433; Baba A, 2016, CELL PHYSIOL BIOCHEM, V38, P15, DOI 10.1159/000438605; Bertrand S, 2016, MOLECULES, V21, DOI 10.3390/molecules21030259; Bidkar A. A., 2009, Journal of Natural Remedies, V9, P79; Chang CC, 2002, J FOOD DRUG ANAL, V10, P178; Chung MJ, 2015, INT IMMUNOPHARMACOL, V25, P302, DOI 10.1016/j.intimp.2015.01.031; Demarque DP, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58046-y; Dierick BJH, 2020, EXPERT REV PHARM OUT, V20, P437, DOI 10.1080/14737167.2020.1819793; Espindola LS, 2018, MOLECULES, V23, DOI 10.3390/molecules23061494; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Giner E, 2011, J NAT PROD, V74, P1079, DOI 10.1021/np100934u; Hosseinzade A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00051; Inoue T, 2002, BIOL PHARM BULL, V25, P256, DOI 10.1248/bpb.25.256; Itoh T, 2009, BIOORGAN MED CHEM, V17, P5374, DOI 10.1016/j.bmc.2009.06.050; Jegal J, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/4307161; Jenett-Siems K, 2005, PHYTOCHEMISTRY, V66, P1448, DOI 10.1016/j.phytochem.2005.04.027; Jeon IH, 2014, MOLECULES, V19, P6941, DOI 10.3390/molecules19066941; Jo BG, 2020, NAT PROD COMMUN, V15, P1, DOI 10.1177/1934578X20942352; Jorge TF, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0370; Jorge TF, 2016, MASS SPECTROM REV, V35, P620, DOI 10.1002/mas.21449; Kamble S., 2017, J PHARMACOGN PHYTOCH, V6, P470; Kawai Mari, 2007, Allergol Int, V56, P113; Kellogg JJ, 2016, J NAT PROD, V79, P376, DOI 10.1021/acs.jnatprod.5b01014; KRISHNAPPAN A L, 1992, Fitoterapia, V63, P190; Kuehn HS, 2008, J IMMUNOL, V181, P7706, DOI 10.4049/jimmunol.181.11.7706; Kure A, 2016, J AGR FOOD CHEM, V64, P4246, DOI 10.1021/acs.jafc.6b00964; Kurita KL, 2015, P NATL ACAD SCI USA, V112, P11999, DOI 10.1073/pnas.1507743112; Van LV, 2022, BIOMED PHARMACOTHER, V146, DOI 10.1016/j.biopha.2021.112611; Mak TW, 2006, IMMUNE RESPONSE: BASIC AND CLINICAL PRINCIPLES, P1; Mastuda H, 2002, BIOORGAN MED CHEM, V10, P3123, DOI 10.1016/S0968-0896(02)00227-4; Metzger Henry, 1999, Allergology International, V48, P161, DOI 10.1046/j.1440-1592.1999.00132.x; Nair K V, 1983, Anc Sci Life, V3, P60; Neyanila SK., 2013, INT J PHARM RES ANAL, V3, P99; Park CM, 2019, NUTR RES PRACT, V13, P473, DOI 10.4162/nrp.2019.13.6.473; Pavithra P. S., 2010, International Journal of Green Pharmacy, V4, P22; Rajashekhara N., 2009, AYU, V30, P503; Shukla AK, 2000, J MASS SPECTROM, V35, P1069, DOI 10.1002/1096-9888(200009)35:9<1069::AID-JMS54>3.0.CO;2-C; Siriwoharn T, 2004, J AGR FOOD CHEM, V52, P8021, DOI 10.1021/jf048619y; Son A, 2006, CELL RES, V16, P230, DOI 10.1038/sj.cr.7310031; Sowndhararajan K, 2014, AGRIC AGRIC SCI PROC, V2, P406, DOI 10.1016/j.aaspro.2014.11.057; Sowndhararajan K, 2010, FOOD SCI BIOTECHNOL, V19, P663, DOI 10.1007/s10068-010-0093-z; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Ueda H, 2002, BIOL PHARM BULL, V25, P1197, DOI 10.1248/bpb.25.1197; Waller DG., 2018, MED PHARM THERAPEUTI, P451; Weckwerth W, 2003, ANNU REV PLANT BIOL, V54, P669, DOI 10.1146/annurev.arplant.54.031902.135014	54	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0265505	10.1371/journal.pone.0265505	http://dx.doi.org/10.1371/journal.pone.0265505			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1E2NP	35427369	Green Published, gold			2022-12-26	WOS:000794332400042
J	Xu, DS; Chen, LP; Wu, XF; Ji, L				Xu, Deshun; Chen, Liping; Wu, Xiaofang; Ji, Lei			Molecular typing and epidemiology profiles of human adenovirus infection among hospitalized patients with severe acute respiratory infection in Huzhou, China	PLOS ONE			English	Article							FEATURES; OUTBREAK; CHILDREN	BackgroundSevere acute respiratory infections (SARI) threaten human health and cause a large number of hospitalizations every year. However, as one of the most common pathogen that cause acute respiratory tract infection, the molecular epidemiological information relating to human adenoviruses (HAdVs) among patients with SARI is limited. Here, we evaluate the epidemiological and molecular characteristics of HAdV infections among hospitalized patients with SARI from January 2017 to December 2019 in Huzhou, China. MethodsFrom January 2017 to December 2019, a total of 657 nasopharyngeal swabs collected from inpatients with SARI were screened for HAdV and other common respiratory viruses by multiplex real-time PCR. All samples that tested positive for HAdV were further typed by sequencing partial sequences of hexon gene. Genotypes of HAdV were confirmed by phylogenetic analysis. Epidemiological data were analyzed using Microsoft Excel 2010 and service solutions (SPSS) 21.0 software. Results251 (38.20%) samples were positive for at least one respiratory virus. HAdV was the second common viral pathogen detected, with a detection rate of 7.08%. Infection with HAdV was found in all age groups tested (0<2, 2<5, 5<15, 15<50, 50<65, >= 65). Children under 15 years old accounted for 84.62% (44/52) of the infections. Higher activity of HAdV infection could be seen in spring-early autumn season. Seven different types of HAdV belonging to 4 species (HAdV-A, B, C, E) were identified in hospitalized SARI cases, with HAdV-B3 as the most prevalent HAdV types, followed by HAdV-B7 and HAdV-E4. HAdV-B3 was the most frequently detected genotype in 2017 and 2019, accounting for 75.00% (9/12) and 63.64% (7/11) of typed HAdV infections in 2017 and 2019, respectively. No predominant strain was responsible for HAdV infections in 2018, although HAdV-B7 (28.57%, 2/7) and HAdV-C1 (28.57%, 2/7) were the major causative genotypes. ConclusionsThis study revealed the prevalence and the molecular epidemiological characteristics of HAdV infections among hospitalized patients with SARI in Huzhou from January 2017 to December 2019. The HAdV prevalence is related to age and season. As the most prevalent HAdV types, HAdV-B3 was co-circulating with other types and presented an alternate prevalence pattern.	[Xu, Deshun; Chen, Liping; Wu, Xiaofang; Ji, Lei] Huzhou Ctr Dis Control & Prevent, Huzhou, Peoples R China		Ji, L (corresponding author), Huzhou Ctr Dis Control & Prevent, Huzhou, Peoples R China.	jileichn@163.com		ji, lei/0000-0001-6753-6465	Natural Science Foundation of Huzhou Science and Technology Bureau [2021YZ23]	Natural Science Foundation of Huzhou Science and Technology Bureau	This work was supported by grants from Natural Science Foundation of Huzhou Science and Technology Bureau (grant number: 2021YZ23), the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alroy KA, 2018, INFLUENZA OTHER RESP, V12, P632, DOI 10.1111/irv.12571; Chakhunashvili G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201497; Chen Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153468; Chittaganpitch M, 2018, INFLUENZA OTHER RESP, V12, P482, DOI 10.1111/irv.12554; Ghebremedhin B, 2014, EUR J MICROBIOL IMMU, V4, P26, DOI 10.1556/EuJMI.4.2014.1.2; Hague E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194516; Hoeben RC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013003; Lee J, 2010, J MED VIROL, V82, P624, DOI 10.1002/jmv.21701; Li YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123234; Lin MR, 2017, CLIN MICROBIOL INFEC, V23, P110, DOI 10.1016/j.cmi.2016.11.004; Liu C., 2015, BMC INFECT DIS, V15, P015; Lu X, 2006, ARCH VIROL, V151, P1587, DOI 10.1007/s00705-005-0722-7; Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073; Lynch JP, 2016, SEMIN RESP CRIT CARE, V37, P586, DOI 10.1055/s-0036-1584923; Price RHM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37481-y; Pscheidt VM, 2021, REV MED VIROL, V31, DOI 10.1002/rmv.2189; Sandkovsky U, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0416-y; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Wo Y, 2015, ARCH VIROL, V160, P633, DOI 10.1007/s00705-014-2308-8; Xie LY, 2019, J MED VIROL, V91, P392, DOI 10.1002/jmv.25333; Xu WT, 2018, JPN J INFECT DIS, V71, P134, DOI [10.7883/yoken.jjid.2017.412, 10.7883/yoken.JJID.2017.412]; Zhao MC, 2020, J CLIN VIROL, V123, DOI 10.1016/j.jcv.2019.104254; Zhao YJ, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4385-5; Zheng Y X, 2019, Zhonghua Liu Xing Bing Xue Za Zhi, V40, P911, DOI 10.3760/cma.j.issn.0254-6450.2019.08.008; Zhu Z, 2009, J CLIN MICROBIOL, V47, P697, DOI 10.1128/JCM.01769-08	25	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0265987	10.1371/journal.pone.0265987	http://dx.doi.org/10.1371/journal.pone.0265987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446868	Green Published, gold			2022-12-26	WOS:000795468200062
J	Smith, LB; Duge, E; Valenzuela-Leon, PC; Brooks, S; Martin-Martin, I; Ackerman, H; Calvo, E				Smith, Leticia Barion; Duge, Emma; Valenzuela-Leon, Paola Carolina; Brooks, Steven; Martin-Martin, Ines; Ackerman, Hans; Calvo, Eric			Novel salivary antihemostatic activities of long-form D7 proteins from the malaria vector Anopheles gambiae facilitate hematophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XA-DIRECTED ANTICOAGULANT; YELLOW-FEVER MOSQUITO; AMINE-BINDING PROTEIN; FEMALE MOSQUITO; FACTOR-XII; ACTIVATION; THROMBIN; GLANDS; INHIBITION; EXPRESSION	To successfully feed on blood, hematophagous arthropods must combat the host's natural hemostatic and inflammatory responses. Salivary proteins of blood-feeding insects such as mosquitoes contain compounds that inhibit these common host defenses against blood loss, including vasoconstriction, platelet aggregation, blood clotting, pain, and itching. The D7 proteins are some of the most abundantly expressed proteins in female mosquito salivary glands and have been implicated in inhibiting host hemostatic and inflammatory responses. Anopheles gambiae, the primary vector of malaria, expresses three D7 long-form and five D7 short-form proteins. Previous studies have characterized the AngaD7 short-forms, but the D7 long-form proteins have not yet been characterized in detail. Here, we characterized the A. gambiae D7 long-forms by first determining their binding kinetics to hemostatic agonists such as leukotrienes and serotonin, which are potent activators of vasoconstriction, edema formation, and postcapillary venule leakage, followed by ex vivo functional assays. We found that AngaD7L1 binds leukotriene C4 and thromboxane A2 analog U-46619; AngaD7L2 weakly binds leukotrienes B4 and D4; and AngaD7L3 binds serotonin. Subsequent functional assays confirmed AngaD7L1 inhibits U-46619-induced platelet agserotonin-induced platelet aggregation and vasoconstriction. It is therefore possible that AngaD7L proteins counteract host hemostasis by scavenging these mediators. Finally, we demonstrate that AngaD7L2 had a dose-dependent anticoagulant effect via the intrinsic coagulation pathway by interacting with factors XII, XIIa, and XI. The uncovering of these interactions in the present study will be essential for compreinterface.	[Smith, Leticia Barion; Duge, Emma; Valenzuela-Leon, Paola Carolina; Brooks, Steven; Martin-Martin, Ines; Ackerman, Hans; Calvo, Eric] NIAID, NIH, Lab Malaria & Vector Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Calvo, E (corresponding author), NIAID, NIH, Lab Malaria & Vector Res, Bethesda, MD 20892 USA.	calvo@niaid.nih.gov	Martin Martin, Ines/I-9358-2012	Martin Martin, Ines/0000-0002-0956-7324; Duge, Emma/0000-0001-9098-7053; Valenzuela Leon, Paola/0000-0002-5740-5178; Smith, Leticia/0000-0002-8798-326X; Brooks, Steven/0000-0001-7357-1419; Calvo, Eric/0000-0001-7880-2730	Division of Intramural Research Program of the NIH/NIAID [AI001246]	Division of Intramural Research Program of the NIH/NIAID	We thank Andre Laughing house, Kevin Lee,and Yonas Gebremicale for excellent mosquito rearing. This research was supported by the Division of Intramural Research Program of the NIH/NIAID (AI001246).The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health	Alvarenga PH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000547; Andersen JF, 2003, J BIOL CHEM, V278, P4611, DOI 10.1074/jbc.M211438200; Andrews RK, 2004, THROMB RES, V114, P447, DOI 10.1016/j.thromres.2004.07.020; Arca B, 2002, INSECT MOL BIOL, V11, P47, DOI 10.1046/j.0962-1075.2001.00309.x; Arca B, 2005, J EXP BIOL, V208, P3971, DOI 10.1242/jeb.01849; Arca B, 1999, P NATL ACAD SCI USA, V96, P1516, DOI 10.1073/pnas.96.4.1516; Bolla M, 2004, HYPERTENSION, V43, P1264, DOI 10.1161/01.HYP.0000127438.39744.07; Boyce JA, 2007, IMMUNOL REV, V217, P168, DOI 10.1111/j.1600-065X.2007.00512.x; Brass L, 2010, HEMATOL-AM SOC HEMAT, P387, DOI 10.1182/asheducation-2010.1.387; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Calvo E, 2004, INSECT MOL BIOL, V13, P73, DOI 10.1111/j.1365-2583.2004.00463.x; Calvo E, 2011, J BIOL CHEM, V286, P27998, DOI 10.1074/jbc.M111.247924; Calvo E, 2009, P NATL ACAD SCI USA, V106, P3728, DOI 10.1073/pnas.0813190106; Calvo E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-57; Francischetti IMB, 1999, BIOCHEMISTRY-US, V38, P16678, DOI 10.1021/bi991231p; Isawa H, 2002, J BIOL CHEM, V277, P27651, DOI 10.1074/jbc.M203505200; JAMES AA, 1991, MOL BIOCHEM PARASIT, V44, P245, DOI 10.1016/0166-6851(91)90010-4; Kenneth KR, 1998, J BIOL CHEM, V273, P20802, DOI 10.1074/jbc.273.33.20802; Koh CY, 2009, THROMB HAEMOSTASIS, V102, P437, DOI 10.1160/TH09-04-0221; Lanfrancotti A, 2002, FEBS LETT, V517, P67, DOI 10.1016/S0014-5793(02)02578-4; Malafronte RD, 2003, INSECT BIOCHEM MOLEC, V33, P63, DOI 10.1016/S0965-1748(02)00168-6; Mans BJ, 2008, J BIOL CHEM, V283, P18721, DOI 10.1074/jbc.M800188200; Mans BJ, 2007, J BIOL CHEM, V282, P36626, DOI 10.1074/jbc.M706410200; Martin-Martin I, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10101372; Martin-Martin I, 2021, FEBS J, V288, P2014, DOI 10.1111/febs.15524; Martin-Martin I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16665-z; Monroe D, 2002, ARTERIOSCL THROM VAS, V22, P1381, DOI 10.1161/01.ATV.0000031340.68494.34; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; Ribeiro JMC, 2009, ADV INSECT PHYSIOL, V37, P59, DOI 10.1016/S0065-2806(09)37002-2; Rojkjaer R, 1997, EUR J BIOCHEM, V247, P491, DOI 10.1111/j.1432-1033.1997.00491.x; Scarpassa VM, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5545-0; Shahid M., 2009, OPEN IMMUNOL J, V2, P9, DOI [10.2174/1874226200902010009, DOI 10.2174/1874226200902010009]; Shi T, 2004, P NATL ACAD SCI USA, V101, P3939, DOI 10.1073/pnas.0400281101; SOTER NA, 1983, J INVEST DERMATOL, V80, P115, DOI 10.1111/1523-1747.ep12531738; Stark KR, 1995, EXP PARASITOL, V81, P321, DOI 10.1006/expr.1995.1123; Suwan N, 2002, INSECT MOL BIOL, V11, P223, DOI 10.1046/j.1365-2583.2002.00329.x; Valenzuela JG, 2000, J BIOL CHEM, V275, P18717, DOI 10.1074/jbc.M001486200; Valenzuela JG, 2002, INSECT MOL BIOL, V11, P149, DOI 10.1046/j.1365-2583.2002.00319.x; Vanhoutte P. M., 1986, NATO ASI SERIES ED, P135; Wolf K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147664; World Health Organization, 2019, REP EP	43	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101971	10.1016/j.jbc.2022.101971	http://dx.doi.org/10.1016/j.jbc.2022.101971			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T5WI	35460690	Green Published, gold			2022-12-26	WOS:000804798000002
J	DeOre, BJ; Partyka, PP; Fan, F; Galie, PA				DeOre, Brandon J.; Partyka, Paul P.; Fan, Fan; Galie, Peter A.			CD44 mediates shear stress mechanotransduction in an in vitro blood-brain barrier model through small GTPases RhoA and Rac1	FASEB JOURNAL			English	Article						biophysics; blood-brain barrier; hyaluronic acid	ENDOTHELIAL-CELLS; HYALURONAN; JUNCTIONS; OLIGOSACCHARIDES; ACTIVATION; COMPLEX; MATRIX	Fluid shear stress is an important mediator of vascular permeability, yet the molecular mechanisms underlying the effect of shear on the blood-brain barrier (BBB) have yet to be clarified in cerebral vasculature despite its importance for brain homeostasis. The goal of this study is to probe components of shear mechanotransduction within the BBB to gain a better understanding of pathologies associated with changes in cerebral perfusion including ischemic stroke. Interrogating the effects of shear stress in vivo is complicated by the complexity of factors in the brain parenchyma and the difficulty associated with modulating blood flow regimes. The in vitro model used in this study is compatible with real-time measurement of barrier function using a transendothelial electrical resistance as well as immunocytochemistry and dextran permeability assays. These experiments reveal that there is a threshold level of shear stress required for barrier formation and that the composition of the extracellular matrix, specifically the presence of high molecular weight hyaluronan, dictates the flow response. Gene editing to modulate the expression of CD44, a mechanosensitive receptor for hyaluronan, demonstrates that the receptor is required for the endothelial response to shear stress. Manipulation of small GTPase activity reveals CD44 activates Rac1 while inhibiting RhoA activation. Additionally, adducin-gamma localizes to tight junctions in response to shear stress and RhoA inhibition and is required to maintain the barrier. This study identifies specific components of the mechanosensing complex associated with the BBB response to fluid shear stress and, therefore, illuminates potential targets for barrier manipulation in vivo.	[DeOre, Brandon J.; Partyka, Paul P.; Galie, Peter A.] Rowan Univ, Dept Biomed Engn, 201 Mullica Hill Rd, Glassboro, NJ 08028 USA; [Fan, Fan] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA	Rowan University; University of Mississippi; University of Mississippi Medical Center	Galie, PA (corresponding author), Rowan Univ, Dept Biomed Engn, 201 Mullica Hill Rd, Glassboro, NJ 08028 USA.	galie@rowan.edu		Galie, Peter/0000-0001-5161-4924; DeOre, Brandon/0000-0001-8586-3646	American Heart Association Scientist Development Grant [17SDG33460432]; National Institute of Health [RO1AG057842]; National Science Foundation Graduate Research Fellowship [2019287762]	American Heart Association Scientist Development Grant(American Heart Association); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	We express gratitude to Kiet Tran for his invaluable assistance in helping to fabricate 3D vessels used in our experiments. We would also like to thank Dr. Robert Nagele of Rowan's School of Osteopathic Medicine for providing the hCMEC/D3 cell line used for these experiments. This work was supported by an American Heart Association Scientist Development Grant awarded to P.A.G. (17SDG33460432), National Institute of Health grant awarded to F.F. (RO1AG057842), and National Science Foundation Graduate Research Fellowship (2019287762) awarded to B.J.D.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Adamson R. H., 1994, Microcirculation (New York), V1, P251, DOI 10.3109/10739689409146752; Al-Ahmad AJ, 2019, J CEREBR BLOOD F MET, V39, P1759, DOI 10.1177/0271678X18767748; Baines AJ, 2014, BBA-BIOMEMBRANES, V1838, P605, DOI 10.1016/j.bbamem.2013.05.030; Baumer Y, 2008, HISTOCHEM CELL BIOL, V129, P179, DOI 10.1007/s00418-007-0358-7; Benson K, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-5; Bouhrira N, 2020, BIOFABRICATION, V12, DOI 10.1088/1758-5090/ab5898; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Bourguignon LYW, 2014, AM J PATHOL, V184, P1912, DOI 10.1016/j.ajpath.2014.03.010; Bowers HC, 2019, EXP CELL RES, V376, P49, DOI 10.1016/j.yexcr.2019.01.012; Cucullo L, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-40; Cyphert Jaime M, 2015, Int J Cell Biol, V2015, P563818, DOI 10.1155/2015/563818; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Deed R, 1997, INT J CANCER, V71, P251, DOI 10.1002/(SICI)1097-0215(19970410)71:2<251::AID-IJC21>3.0.CO;2-J; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dorland YL, 2017, CELL MOL LIFE SCI, V74, P279, DOI 10.1007/s00018-016-2325-8; Fan F, 2017, AM J PHYSIOL-RENAL, V312, pF971, DOI 10.1152/ajprenal.00529.2016; Galie PA, 2015, LAB CHIP, V15, P1205, DOI 10.1039/c4lc01236d; Gao WJ, 2021, AM J PHYSIOL-RENAL, V320, pF97, DOI 10.1152/ajprenal.00423.2020; Givens C, 2016, ANTIOXID REDOX SIGN, V25, P373, DOI 10.1089/ars.2015.6493; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; HUDETZ AG, 1994, ADV EXP MED BIOL, V345, P633; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Knowland D, 2014, NEURON, V82, P603, DOI 10.1016/j.neuron.2014.03.003; Kugelmann D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31408-3; Kugelmann D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126213; Lai AY, 2018, J NEUROCHEM, V144, P659, DOI 10.1111/jnc.14130; Li YSJ, 2005, J BIOMECH, V38, P1949, DOI 10.1016/j.jbiomech.2004.09.030; Mairey E, 2006, J EXP MED, V203, P1939, DOI 10.1084/jem.20060482; Matou-Nasri S, 2009, INT J ONCOL, V35, P761, DOI 10.3892/ijo_00000389; Matsuoka Y, 2000, CELL MOL LIFE SCI, V57, P884, DOI 10.1007/PL00000731; Mikelis CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7725; Naydenov NG, 2010, MOL BIOL CELL, V21, P3506, DOI 10.1091/mbc.E10-03-0259; Pahakis MY, 2007, BIOCHEM BIOPH RES CO, V355, P228, DOI 10.1016/j.bbrc.2007.01.137; Partyka PP, 2017, BIOMATERIALS, V115, P30, DOI 10.1016/j.biomaterials.2016.11.012; Placone AL, 2015, BIOMATERIALS, V42, P134, DOI 10.1016/j.biomaterials.2014.11.046; Polacheck WJ, 2017, NATURE, V552, P258, DOI 10.1038/nature24998; Ponce AG., 2019, FASEB J, V33, DOI [10.1096/fasebj.2019.33.1_supplement.686.3, DOI 10.1096/FASEBJ.2019.33.1_SUPPLEMENT.686.3]; Radeva MY, 2018, ACTA PHYSIOL, V222, DOI 10.1111/apha.12860; Ramirez SH, 2008, J IMMUNOL, V180, P1854, DOI 10.4049/jimmunol.180.3.1854; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Razinia Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16486-z; Reed MJ, 2019, TISSUE BARRIERS, V7, DOI 10.1080/21688370.2019.1651157; Shekhar Shashank, 2017, J Pharm Sci Exp Pharmacol, V2017, P21; Sherman LS, 2002, GLIA, V38, P93, DOI 10.1002/glia.10053; Singleton PA, 2006, J BIOL CHEM, V281, P34381, DOI 10.1074/jbc.M603680200; Sladojevic N, 2017, EXPERT REV NEUROTHER, V17, P1167, DOI 10.1080/14737175.2017.1395700; Stamatovic SM, 2006, J BIOL CHEM, V281, P8379, DOI 10.1074/jbc.M513122200; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; VILLRINGER A, 1994, CIRC RES, V75, P55, DOI 10.1161/01.RES.75.1.55; Wang ZG, 2016, MOL NEUROBIOL, V53, P7298, DOI 10.1007/s12035-015-9583-6; Waschke J, 2004, AM J PHYSIOL-HEART C, V286, pH394, DOI 10.1152/ajpheart.00221.2003; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wimmer I, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00711; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Yan XX, 2012, CURR GERIATR REP, V1, P85, DOI 10.1007/s13670-012-0009-2	56	9	9	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22278	10.1096/fj.202100822RR	http://dx.doi.org/10.1096/fj.202100822RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0O0ZF	35436025	Green Submitted			2022-12-26	WOS:000783258200001
J	Jebena, DD; Tenagashaw, MW				Jebena, Debela Daba; Tenagashaw, Mesfin Wogayehu			Breastfeeding practice and factors associated with exclusive breastfeeding among mothers in Horro District, Ethiopia: A community-based cross-sectional study	PLOS ONE			English	Article							AREA	Background Breastfeeding is the process of feeding a newborn with the mother's milk, and it is very important for enhancing child and maternal health. The proportion and duration of breastfeeding may vary by location, and is poorly practiced for cultural, economic, and societal reasons. Thus, this study was conducted to determine breastfeeding practices and determinants of exclusive breastfeeding among mothers of six month aged infants in the Horro district, Ethiopia. Methods We used a community-based cross-sectional study among 649 mothers of index infants. A multi-stage sampling procedure was used to select the women. Data were collected from March 15 to April 5, 2020. Face-to-face interviews were used to collect data using a semi-structured questionnaire. Bivariable and multivariable logistic regression were performed to examine the factors associated with exclusive breastfeeding. Results All women who participated in the study have ever breastfed their children at some point. Exclusive breastfeeding and breastfeeding initiation were found to be good (70.4% and 61.8%, respectively) within 24 hours prior to the survey time. Having had information about breastfeeding during antenatal care (AOR = 4.15, 95% CI = 2.36, 7.30), postnatal care follow-up (AOR = 4.74, 95% CI = 2.92, 7.70), having infant aged 0-1month (AOR = 12.14, 95% CI = 3.83, 38.46) and 2-3 month (AOR = 8.62, 95% CI = 5.00, 14.85), being a single birth (AOR = 12.91, 95% CI = 3.86, 43.21), having monthly income of <= 100 Ethiopian Birrs (AOR = 1.96, 95% CI = 1.16, 3.32), and breastfeeding initiation within one hour of birth (AOR = 1.94, 95% CI = 1.13, 3.35) were found to be a significantly associated factors of exclusive breastfeeding. Conclusion Despite meeting the global nutrition target of 2025, the practice of exclusive breastfeeding was lower than the WHO recommendations. Providing education about breastfeeding during antenatal care follow-up and increasing access to postnatal care follow-up is recommended to enhance exclusive breastfeeding practices in the study area.	[Jebena, Debela Daba; Tenagashaw, Mesfin Wogayehu] Bahir Dar Inst Technol, Dept Appl Human Nutr, Bahir Dar, Ethiopia		Jebena, DD (corresponding author), Bahir Dar Inst Technol, Dept Appl Human Nutr, Bahir Dar, Ethiopia.	Dabala.daba@gmail.com		Jebena, Debela Daba/0000-0002-9411-2841	School of Research and Graduate Studies, Bahir Dar Institute of Technology	School of Research and Graduate Studies, Bahir Dar Institute of Technology	This research was funded by School of Research and Graduate Studies, Bahir Dar Institute of Technology through its program of funding researches conducted by its staff. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agho KE, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-2; Agho KE, 2019, NUTRIENTS, V11, DOI 10.3390/nu11123007; Ahmad Muhammad Owais, 2012, J Ayub Med Coll Abbottabad, V24, P116; Al Ghwass MME, 2011, BREASTFEED MED, V6, P191, DOI 10.1089/bfm.2011.0035; Alzaheb RA, 2017, CLIN MED INSIGHTS-PE, V11, DOI 10.1177/1179556517748912; [Anonymous], WOMENS EXCEPTIONAL C; [Anonymous], 2016, WHOCDR935; [Anonymous], 2020, GLOBAL NUTR REPORT 2; Arage G., 2016, ADV PUBLIC HLTH, V2016, P1, DOI DOI 10.1155/2016/3426249; Asemahagn MA, 2016, INT BREASTFEED J, V11, DOI 10.1186/s13006-016-0081-x; Ayisi RK., 2014, GJBAHS, V3, P180; Backstrom K., 1989, INT J EARLY CHILD, V21, P35, DOI [10.1007/BF03174582, DOI 10.1007/BF03174582]; Center for Disease Control and Prevention (CDC), 2018, BREASTF REP CARD US; Central Statistics Agency (CSA), 2016, ETH DEM HLTH SURV; Clark A., 2014, MINDWARE INTRO PHILO, DOI [10.32398/cjhp.v1i3.527, DOI 10.32398/CJHP.V1I3.527]; Dalcastagne SV, 2018, SAO PAULO MED J, V136, P533, DOI 10.1590/1516-3180.2018.0262161118; Department of Health and Human Service Office on Women's Health, 2003, Nutr Clin Care, V6, P125; Himani BK, 2011, NURS MIDWIFERY RES J, V7, P99, DOI [10.33698/nrf0125, DOI 10.33698/NRF0125]; Jama A, 2020, INT BREASTFEED J, V15, DOI 10.1186/s13006-020-0252-7; Khasawneh W, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0140-y; Kontic-Vucinic O, 2006, INT J FERTIL WOMEN M, V51, P116; Liebling R., 2010, MODEL CARE MATERN SE, P171, DOI [10.1017/CBO9781107478336.019, DOI 10.1017/CBO9781107478336.019]; Mekuria G, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-014-0027-0; Michaelsen Kim Fleischer, 2003, FEEDING NUTR INFANT; Mundagowa PT, 2019, INT BREASTFEED J, V14, DOI 10.1186/s13006-019-0225-x; Murray EK, 2007, BIRTH-ISS PERINAT C, V34, P202, DOI 10.1111/j.1523-536X.2007.00172.x; Odei JA., 2013, FACTORS ASS EXCLUSIV; Osibogun OO, 2018, INT BREASTFEED J, V13, DOI 10.1186/s13006-018-0182-9; Panigrahi A, 2019, CLIN EPIDEMIOL GLOB, V7, P424, DOI 10.1016/j.cegh.2018.11.004; Popkin BM, 2020, LANCET, V395, P65, DOI 10.1016/S0140-6736(19)32497-3; Runsewe-Abiodun TamramatI., 2016, SIERRA LEONE J BIOME, V8, P4; Seifu W., 2014, J PEDIAT NEONATAL CA, V1, P1, DOI [10.15406/jpnc.2014.01.00017, DOI 10.15406/JPNC.2014.01.00017]; Senarath U, 2010, J HUM LACT, V26, P248, DOI 10.1177/0890334409357562; Setegn T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-217; Shankar Radhakrishnan, 2012, International Journal of Health and Allied Sciences, V1, P64; Shifraw T, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-015-0047-4; Steve I. O., 2006, International Journal of Tropical Medicine, V1, P123; Tadesse T, 2016, INT BREASTFEED J, V11, DOI 10.1186/s13006-016-0085-6; Taha Z, 2018, INT BREASTFEED J, V13, DOI 10.1186/s13006-018-0192-7; Tamiru D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-363; Teka B, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-014-0028-z; Tewabe T, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0103-3; WHO, 2018, 71 WORLD HLTH ASS IN; WHO and UNICEF, 2018, PROT PROM SUPP BREAS, V48; WHO/UNICEF, 2012, GLOB NUTR TARG 2025; Wolde T., 2014, RESEARCHER, V6, P91; World Health Organization, 2018, GUID COUNS WOM IMPR; World Health Organization (WHO), INF YOUNG CHILD FEED; Yalew W., 2014, INT J MED SCI PUBLIC, V3, P532, DOI [10.5455/ijmsph.2014.250220141, DOI 10.5455/IJMSPH.2014.250220141]; Yeneabat T, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-262; Zenebu Begna Bayissa, 2015, International Journal of Research and Development in Pharmacy and Life Sciences, V4, P1590	51	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267269	10.1371/journal.pone.0267269	http://dx.doi.org/10.1371/journal.pone.0267269			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476799	Green Published, gold			2022-12-26	WOS:000840124300031
J	Allen, JL; Doidge, NP; Cheng, C; Lynch, M; Crabb, HK; Scheerlinck, JP; Bushell, R; Browning, GF; Marenda, MS				Allen, Joanne L.; Doidge, Nicholas P.; Cheng, Christina; Lynch, Michael; Crabb, Helen K.; Scheerlinck, Jean-Pierre; Bushell, Rhys; Browning, Glenn F.; Marenda, Marc S.			Genomic characterisation of an entomopathogenic strain of Serratia ureilytica in the critically endangered phasmid Dryococelus australis	PLOS ONE			English	Article							HELIOTHIS-VIRESCENS LEPIDOPTERA; FIELD GEL-ELECTROPHORESIS; MARCESCENS; OUTBREAK; TRANSMISSION; VIRULENCE; VERSION; TOOL	Between 2014 and 2019, unexpected mortalities were observed in a colony of Dryococelus australis, an endangered stick-insect kept at the Melbourne Zoo for a breeding and conservation program. Pure cultures of Serratia spp. were obtained from the haemolymph of moribund and recently deceased individuals. The combined bacteriological and histopathological observations suggested an infectious cause of these mortalities. Genotyping of Serratia sp. isolated from the insects and their environment revealed a predominant strain profile. A representative isolate, AM923, was entirely sequenced and compared to 616 publicly available Serratia spp. genomes, including 37 associated with insects. The genomes were distributed into 3 distinct groups, with 63% of the insect-associated isolates within a single clade (clade A) containing AM923, separated from most environmental/plant-associated strains (clade B) and human isolates (clade C). Average nucleotide identity and phylogenetic analyses identified AM923 as S. ureilytica and revealed similarities with putatively entomopathogenic strains. An experimental infection model in honey bees (Apis mellifera) confirmed the pathogenic potential of AM923. A urease operon was found in most insect isolates and a PCR assay, based on the ureB gene sequence, was used to confirm the presence of AM923 in experimentally infected bees. This species-specific PCR could be applied to detect entomopathogenic Serratia spp. in infected insects or their environment.	[Allen, Joanne L.; Doidge, Nicholas P.; Cheng, Christina; Crabb, Helen K.; Browning, Glenn F.; Marenda, Marc S.] Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Melbourne Vet Sch, Parkville, Vic, Australia; [Doidge, Nicholas P.; Cheng, Christina; Lynch, Michael] Melbourne Zoo, Parkville, Vic, Australia; [Scheerlinck, Jean-Pierre] Univ Melbourne, Fac Vet & Agr Sci, Ctr Anim Biotechnol, Melbourne Vet Sch, Parkville, Vic, Australia; [Bushell, Rhys; Marenda, Marc S.] Univ Melbourne, Fac Vet & Agr Sci, Melbourne Vet Sch, Werribee, Vic, Australia	University of Melbourne; University of Melbourne; University of Melbourne	Allen, JL (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Melbourne Vet Sch, Parkville, Vic, Australia.	jlallen@unimelb.edu.au	Browning, Glenn/P-4459-2014; Allen, Joanne/L-2354-2015	Browning, Glenn/0000-0002-0903-2469; MARENDA, MARC/0000-0001-6778-1110; Allen, Joanne/0000-0003-4740-9404				Abebe-Akele F, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1697-8; Abreo E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37118-0; Allen JL, 2011, J VET DIAGN INVEST, V23, P1236, DOI 10.1177/1040638711425589; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Aryal SK, 2017, J INVERTEBR PATHOL, V150, P54, DOI 10.1016/j.jip.2017.09.008; Bayley C, 2018, VET PATHOL, V55, P719, DOI 10.1177/0300985818766210; BELL JV, 1969, J INVERTEBR PATHOL, V13, P151, DOI 10.1016/0022-2011(69)90251-1; Bertelli C, 2017, NUCLEIC ACIDS RES, V45, pW30, DOI 10.1093/nar/gkx343; Bertels F, 2014, MOL BIOL EVOL, V31, P1077, DOI 10.1093/molbev/msu088; Bhadra B, 2005, INT J SYST EVOL MICR, V55, P2155, DOI 10.1099/ijs.0.63674-0; Bourdin T, 2021, APPL ENVIRON MICROB, V87, DOI 10.1128/AEM.01399-21; BUCHER G. E., 1960, JOUR OF INSECT PATHOL, V2, P172; Burritt NL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167752; Carlile Nicholas, 2009, Ecological Management & Restoration, V10, pS124, DOI 10.1111/j.1442-8903.2009.00450.x; CARLINI CR, 1981, TOXICON, V19, P667, DOI 10.1016/0041-0101(81)90104-5; Chen SC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01483; Chouikha I, 2014, P NATL ACAD SCI USA, V111, P18709, DOI 10.1073/pnas.1413209111; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Filippidou S, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00102; FLYG C, 1980, J GEN MICROBIOL, V120, P173; Gasper J., 2017, Scientific Papers: Animal Science and Biotechnologies, V50, P192; Grimont F, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P219, DOI 10.1007/0-387-30746-x_11; GRIMONT PAD, 1978, ANNU REV MICROBIOL, V32, P221, DOI 10.1146/annurev.mi.32.100178.001253; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hejazi A, 1997, J MED MICROBIOL, V46, P903, DOI 10.1099/00222615-46-11-903; Henry B, 2001, AM J INFECT CONTROL, V29, P312, DOI 10.1067/mic.2001.117043; Heras J, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0703-0; Iguchi A, 2014, GENOME BIOL EVOL, V6, P2096, DOI 10.1093/gbe/evu160; Inglis GD, 2001, J ECON ENTOMOL, V94, P362, DOI 10.1603/0022-0493-94.2.362; Jain C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07641-9; Krueger F, TRIM GALORE V0 4 4; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Ligozzi M, 2010, J CLIN MICROBIOL, V48, P1690, DOI 10.1128/JCM.01528-09; Liu M, 2019, NUCLEIC ACIDS RES, V47, pD660, DOI 10.1093/nar/gky1123; Miranda G, 1996, J CLIN MICROBIOL, V34, P3138, DOI 10.1128/JCM.34.12.3138-3141.1996; Mohapatra BR, 2007, FEMS MICROBIOL LETT, V277, P98, DOI 10.1111/j.1574-6968.2007.00948.x; Moradigaravand D, 2016, GENOME RES, V26, P1101, DOI 10.1101/gr.205245.116; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Parte AC, 2020, INT J SYST EVOL MICR, V70, P5607, DOI 10.1099/ijsem.0.004332; Petersen LM, 2013, CAN J MICROBIOL, V59, P627, DOI 10.1139/cjm-2013-0343; Raymann K, 2018, MBIO, V9, DOI 10.1128/mBio.01649-18; Seemann T., 2017, ABRICATE MASS SCREEN; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shelomi Matan, 2015, Journal of Orthoptera Research, V24, P29; Shi ZY, 1997, J CLIN MICROBIOL, V35, P325, DOI 10.1128/JCM.35.1.325-327.1997; Sikorowski PP, 1998, BIOL CONTROL, V12, P50, DOI 10.1006/bcon.1997.0609; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Versalovic James, 1994, Methods in Molecular and Cellular Biology, V5, P25; Vigeant P, 1998, INFECT CONT HOSP EP, V19, P791; Wick RR, FAST5 FASTQ TOOL; Wick RR, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005595	52	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0265967	10.1371/journal.pone.0265967	http://dx.doi.org/10.1371/journal.pone.0265967			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35442959	Green Published, gold			2022-12-26	WOS:000822608900015
J	Homma, C; Inokuchi, D; Nakamura, Y; Uy, WH; Ohnishi, K; Yamaguchi, H; Adachi, M				Homma, Chiho; Inokuchi, Daiki; Nakamura, Yohei; Uy, Wilfredo H.; Ohnishi, Kouhei; Yamaguchi, Haruo; Adachi, Masao			Effectiveness of blocking primers and a peptide nucleic acid (PNA) clamp for 18S metabarcoding dietary analysis of herbivorous fish	PLOS ONE			English	Article							CORAL-REEF; FRESH-WATER; IDENTIFICATION; RESILIENCE	The structure of food webs and carbon flow in aquatic ecosystems can be better understood by studying contributing factors such as the diets of herbivorous fish. Metabarcoding using a high-throughput sequencer has recently been used to clarify prey organisms of various fish except herbivorous fish. Since sequences of predator fish have dominated in sequences obtained by metabarcoding, we investigated a method for suppressing the amplification of fish DNA by using a blocking primer or peptide nucleic acid (PNA) clamp to determine the prey organisms of herbivorous fish. We designed three blocking primers and one PNA clamp that anneal to fish-specific sequences and examined how efficient they were in suppressing DNA amplification in various herbivorous fish. The results showed that the PNA clamp completely suppressed fish DNA amplification, and one of the blocking primers suppressed fish DNA amplification but less efficiently than the PNA clamp. Finally, we conducted metabarcoding using mock community samples as templates to determine whether the blocking primer or the PNA clamp was effective in suppressing fish DNA amplification. The results showed that the PNA clamp suppressed 99.3%-99.9% of fish DNA amplification, whereas the blocking primer suppressed 3.3%-32.9%. Therefore, we propose the application of the PNA clamp for clarifying the prey organisms and food preferences of various herbivorous fish.	[Homma, Chiho; Ohnishi, Kouhei; Yamaguchi, Haruo; Adachi, Masao] Ehime Univ, United Grad Sch Agr Sci, Matsuyama, Ehime, Japan; [Inokuchi, Daiki; Nakamura, Yohei; Ohnishi, Kouhei; Yamaguchi, Haruo; Adachi, Masao] Kochi Univ, Fac Agr & Marine Sci, Nankoku, Kochi, Japan; [Uy, Wilfredo H.] Mindanao State Univ Naawan, Inst Fisheries Res & Dev, Naawan, Misamis Orienta, Philippines	Ehime University; Kochi University; Mindanao State University System; Mindanao State University-Naawan	Adachi, M (corresponding author), Ehime Univ, United Grad Sch Agr Sci, Matsuyama, Ehime, Japan.; Adachi, M (corresponding author), Kochi Univ, Fac Agr & Marine Sci, Nankoku, Kochi, Japan.	madachi@kochi-u.ac.jp						Albaina A, 2016, ECOL EVOL, V6, P1809, DOI 10.1002/ece3.1986; Amundsen PA, 2019, J FISH BIOL, V95, P1364, DOI 10.1111/jfb.14151; Bakker ES, 2016, AQUAT BOT, V135, P18, DOI 10.1016/j.aquabot.2016.04.008; Bennett S, 2015, ECOL LETT, V18, P714, DOI 10.1111/ele.12450; Bradley IM, 2016, APPL ENVIRON MICROB, V82, P5878, DOI 10.1128/AEM.01630-16; Budarf AC, 2011, J FISH BIOL, V79, P112, DOI 10.1111/j.1095-8649.2011.02999.x; Choat JH, 2002, MAR BIOL, V140, P613, DOI 10.1007/s00227-001-0715-3; Chow S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225610; Chow S, 2011, MAR BIOTECHNOL, V13, P305, DOI 10.1007/s10126-010-9301-3; Clements KD, 2017, BIOL J LINN SOC, V120, P729, DOI 10.1111/bij.12914; Clements KD, 2009, FUNCT ECOL, V23, P79, DOI 10.1111/j.1365-2435.2008.01524.x; Corse E, 2017, MOL ECOL RESOUR, V17, pe146, DOI 10.1111/1755-0998.12703; De Sousa L.L., 2019, ENV DNA, V1, P199, DOI 10.1002/edn3.27; Dorenbosch M, 2011, FRESHWATER BIOL, V56, P1783, DOI 10.1111/j.1365-2427.2011.02618.x; Duarte CM, 1996, LIMNOL OCEANOGR, V41, P1758, DOI 10.4319/lo.1996.41.8.1758; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Froese R., 2021, FISHBASE WORLD WIDE; Gomi K, 2021, J FISH BIOL, V99, P131, DOI 10.1111/jfb.14704; Green M. R., 2012, MOLECULAR CLONING A; Hanmer J, 2017, OECOLOGIA, V184, P127, DOI 10.1007/s00442-017-3855-y; Harms-Tuohy CA, 2016, MAR ECOL PROG SER, V558, P181, DOI 10.3354/meps11738; Hartley JL., 1996, FOCUS, V18, P27; Hata Hiroki, 2016, P122; Hayashi K., 2013, FISH JAPAN PICTORIAL, P577; Helfman GS, 2009, DIVERSITY FISHES BIO; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Igloi GL, 1998, P NATL ACAD SCI USA, V95, P8562, DOI 10.1073/pnas.95.15.8562; Jakubaviciute E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186929; Leray M, 2015, PEERJ, V3, DOI 10.7717/peerj.1047; Leray M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058076; LEWIS SM, 1986, ECOL MONOGR, V56, P183, DOI 10.2307/2937073; Mantyka CS, 2007, CORAL REEFS, V26, P435, DOI 10.1007/s00338-007-0214-1; Mendes TC, 2018, MAR BIOL, V165, DOI 10.1007/s00227-018-3438-4; Nakamura Y, 2003, ICHTHYOL RES, V50, P15, DOI 10.1007/s102280300002; Nishitani G, 2020, HARMFUL ALGAE, V99, DOI 10.1016/j.hal.2020.101928; Orum H, 2000, Curr Issues Mol Biol, V2, P27; Pinol J, 2015, MOL ECOL RESOUR, V15, P819, DOI 10.1111/1755-0998.12355; Plass-Johnson JG, 2013, CORAL REEFS, V32, P429, DOI 10.1007/s00338-012-0988-7; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; PREJS A, 1984, ENVIRON BIOL FISH, V10, P281, DOI 10.1007/BF00001481; Sakaguchi SO, 2017, FISHERIES SCI, V83, P47, DOI 10.1007/s12562-016-1040-6; Sano M., 1984, U MUSEUM, V25, P1; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shehzad W, 2012, MOL ECOL, V21, P1951, DOI 10.1111/j.1365-294X.2011.05424.x; Sousa LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep28762; Su ML, 2018, ESTUAR COAST, V41, P560, DOI 10.1007/s12237-017-0279-1; Takahashi M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60779-9; Terahara T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025715; Verges A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0846; Vestheim H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-12	51	1	1	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0266268	10.1371/journal.pone.0266268	http://dx.doi.org/10.1371/journal.pone.0266268			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35442965	Green Published, gold			2022-12-26	WOS:000822608900020
J	Moats, C; Cook, K; Armantrout, K; Crank, H; Uttke, S; Maher, K; Bochart, RM; Lawrence, G; Axthelm, MK; Smedley, JV				Moats, Cassandra; Cook, Kimberly; Armantrout, Kimberly; Crank, Hugh; Uttke, Samantha; Maher, Kelly; Bochart, Rachele M.; Lawrence, George; Axthelm, Michael K.; Smedley, Jeremy, V			Antimicrobial prophylaxis does not improve post-surgical outcomes in SIV/SHIV-uninfected or SIV/SHIV-infected macaques (Macaca mulatta and Macaca fascicularis) based on a retrospective analysis	PLOS ONE			English	Article							COMPLICATIONS; PREVENTION; RISK	Surgical antimicrobial prophylaxis is indicated when performing contaminated surgeries, when specific surgical implants are placed, and for prolonged surgical procedures. Unnecessary prophylactic antibiotics are often utilized for macaque surgeries, despite medical and veterinary guidelines. In this study we compared complication rates in macaques receiving peripheral lymph node (PLN) and laparoscopic biopsies, with and without antimicrobial prophylaxis. A majority of animals were SIV or SHIV infected at the time of surgery, so we also compared post-operative complication rates based on infection status. We found no significant difference in PLN biopsy complication rates for animals that received antimicrobial prophylaxis versus those that did not. Animals who underwent laparoscopic procedures and received prophylactic antibiotics had a higher complication rate than those who did not receive them. Complication rates did not differ significantly for SIV/SHIV infected versus uninfected animals for both laparoscopic biopsy procedures and PLN biopsy procedures. SIV/SHIV infected animals that underwent PLN biopsies had no significant difference in complication rates with and without antimicrobial prophylaxis, and SIV/SHIV infected animals receiving prophylactic antibiotics for laparoscopic biopsies had a higher complication rate than those that did not. This study suggests that perioperative prophylactic antibiotics have no role in the management of SIV/SHIV-infected and uninfected macaques undergoing clean, minimally invasive surgeries. Additionally, we recommend eliminating unnecessary antibiotic use in study animals due to their potential confounding impacts on research models and their potential to promote antimicrobial resistance.	[Moats, Cassandra; Cook, Kimberly; Armantrout, Kimberly; Crank, Hugh; Uttke, Samantha; Maher, Kelly; Bochart, Rachele M.; Axthelm, Michael K.; Smedley, Jeremy, V] Oregon Natl Primate Res Ctr, Infect Dis Resource, Beaverton, OR 97006 USA; [Moats, Cassandra] Johns Hopkins Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; [Lawrence, George] Oregon Natl Primate Res Ctr, Directors Off, Beaverton, OR USA	Oregon Health & Science University; Oregon National Primate Research Center; Johns Hopkins University; Johns Hopkins Medicine; Oregon Health & Science University; Oregon National Primate Research Center	Moats, C (corresponding author), Oregon Natl Primate Res Ctr, Infect Dis Resource, Beaverton, OR 97006 USA.; Moats, C (corresponding author), Johns Hopkins Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA.	cmoats1@jhmi.edu		Uttke, Samantha/0000-0001-8773-2930	Office of the Director, National Institutes of Health [3U42 OD023038]; Oregon National Primate Research Center NIH Core Grant [P51OD011092]	Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon National Primate Research Center NIH Core Grant	This work was supported by the Office of the Director, National Institutes of Health (3U42 OD023038), and the Oregon National Primate Research Center NIH Core Grant (P51OD011092) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Animal Hospital Association/American Association of Feline Practitioners, 2014, BAS GUID JUD THER US; Berrios SI, 2017, JAMA SURG, V152, P784, DOI 10.1001/jamasurg.2017.0904; Bochart RM, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009565; Charani E, 2017, INT J INFECT DIS, V60, P29, DOI 10.1016/j.ijid.2017.04.020; Cheng H, 2017, SURG INFECT, V18, P722, DOI 10.1089/sur.2017.089; Chintanaphol M, 2018, JAIDS-J ACQ IMM DEF, V79, P244, DOI [10.1097/QAI.0000000000001780, 10.1097/qai.0000000000001780]; Cline AN, 2005, J MED PRIMATOL, V34, P303; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; Gaston RG, 2010, HAND CLIN, V26, P265, DOI 10.1016/j.hcl.2010.01.002; Gordon SN, 2016, J IMMUNOL, V197, P2726, DOI 10.4049/jimmunol.1600674; Gould N, 2001, GYNECOL ONCOL, V82, P329, DOI 10.1006/gyno.2001.6266; Greenstein AW, 2019, COMPARATIVE MED, V69, P311, DOI 10.30802/AALAS-CM-18-000089; Grubert TA, 2002, CLIN INFECT DIS, V34, P822, DOI 10.1086/339043; Hao XP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9020; Harper A, 2021, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.596166; Hatziioannou T, 2012, NAT REV MICROBIOL, V10, P852, DOI 10.1038/nrmicro2911; Hensley-McBain T, 2018, MUCOSAL IMMUNOL, V11, P1429, DOI 10.1038/s41385-018-0032-5; Iizumi T, 2017, ARCH MED RES, V48, P727, DOI 10.1016/j.arcmed.2017.11.004; Manuzak JA, 2020, MUCOSAL IMMUNOL, V13, P471, DOI 10.1038/s41385-019-0238-1; Perret-Gentil MI, 2000, J INVEST SURG, V13, P181; R Core Team, 2020, R LANG ENV STAT COMP; Roberts MC, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02199; Rothenberger MK, 2015, SURG INFECT, V16, P68, DOI 10.1089/sur.2013.179; Salkind AR, 2011, AM FAM PHYSICIAN, V83, P585; Shapiro MB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13972-y; Simpson G. L., 2016, PERMUTE FUNCTIONS GE; Zevin AS, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnx228; Zevin AS, 2017, JOVE-J VIS EXP, DOI 10.3791/55617; Zhang L, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-115	29	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0266616	10.1371/journal.pone.0266616	http://dx.doi.org/10.1371/journal.pone.0266616			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35442982	gold, Green Published			2022-12-26	WOS:000822608900028
J	Abdel-Tawab, MS; Fouad, H; Othman, AM; Eid, RA; Mohammed, MA; Hassan, A; Reyad, HR				Abdel-Tawab, Marwa Sayed; Fouad, Hanan; Othman, Asmaa M.; Eid, Ragaey A.; Mohammed, Marwa Abdeltawab; Hassan, Ahmed; Reyad, Hoda Ramadan			Evaluation of gene expression of PLEKHS1, AADAC, and CDKN3 as novel genomic markers in gastric carcinoma	PLOS ONE			English	Article								Gastric cancer (GC) is considered lethal aggressive cancer. In Egypt, GC has a low incidence but unfortunately, it is mostly diagnosed at an advanced stage with a poor prognosis. Assessment of novel markers that can be used in the early detection of GC is an urgent need. The present study was performed to assess the association of the Pleckstrin homology domain-containing S1 (PLEKHS1) arylacetamide deacetylase (AADAC, and Cyclin-dependent kinase inhibitor 3 (CDKN3) genes with GC and to correlate their gene expression levels with tumor stage, grade, and other clinicopathological features. The current work was performed on forty gastric tissue samples; twenty in Group 1 with GC tissues at different stages, and grades and twenty in Group 2 (control group) with non-tumorous tissue. PLEKHS1, AADAC, and CDKN3 gene expression were assessed by RT-qPCR. AADAC, CDKN3 genes were significantly (p<0.001) upregulated, while PLEKHS1 gene was significantly (p<0.001) downregulated in the GC group than the control group. AADAC gene expression exhibited a high significant (p<0.001) positive correlation with the tumor grades and the tumor stages. A high significant negative correlation between AADAC, and CDKN3 gene expression (r = -.760, p<0.001) was found. The three studied parameters showed high significant sensitivity and specificity in the prediction of the presence of GC. PLEKHS1, AADAC, and CDKN3 gene expressions were suggested to be used as diagnostic and predictive biomarkers of GC, additionally, AADAC may be used as a prognostic marker in these patients for further future confirming studies.	[Abdel-Tawab, Marwa Sayed; Reyad, Hoda Ramadan] Beni Suef Univ, Fac Med, Med Biochem Dept, Bani Suwayf, Egypt; [Fouad, Hanan] Cairo Univ, Fac Med, Dept Med Biochem, Giza, Egypt; [Fouad, Hanan] Galala Univ, Fac Med, Suez, Suez Governorat, Egypt; [Othman, Asmaa M.] Beni Suef Univ, Fac Med, Dept Internal Med, Bani Suwayf, Egypt; [Eid, Ragaey A.] Beni Suef Univ, Fac Med, Dept Trop Med, Dept Gastroenterol Hepatol & Endem Med, Bani Suwayf, Egypt; [Mohammed, Marwa Abdeltawab] Beni Suef Univ, Fac Med, Med Physiol Dept, Bani Suwayf, Egypt; [Hassan, Ahmed] Beni Suef Univ, Fac Med, Clin Oncol Dept, Bani Suwayf, Egypt	Egyptian Knowledge Bank (EKB); Beni Suef University; Egyptian Knowledge Bank (EKB); Cairo University; Galala University; Egyptian Knowledge Bank (EKB); Beni Suef University; Egyptian Knowledge Bank (EKB); Beni Suef University; Egyptian Knowledge Bank (EKB); Beni Suef University; Egyptian Knowledge Bank (EKB); Beni Suef University	Abdel-Tawab, MS (corresponding author), Beni Suef Univ, Fac Med, Med Biochem Dept, Bani Suwayf, Egypt.	drmarwasayed2016@gmail.com	Fouad, Hanan/C-9385-2019; Eid, Ragaey Ahmad/AAX-1859-2021; Eid, Ragaey A/GLN-3307-2022	Fouad, Hanan/0000-0002-9939-1034; Eid, Ragaey Ahmad/0000-0002-3077-8265; Eid, Ragaey A/0000-0002-3077-8265; Abdel-Tawab, Marwa/0000-0001-5776-4923				Bray F., 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, V68, p394 424; Chen J., 2021, An innovative prognostic model based on four genes in Asian patient with gastric Cancer, V53, P148, DOI 10.4143/crt.2020.424; Deng Z., 2019, Mining TCGA database for tumor microenvironment-related genes of prognostic value in hepatocellular carcinoma, V2019, DOI 10.1155/2019/2408348; Ferlay J, 2010, BREAST CANCER EPIDEMIOLOGY, P1, DOI 10.1007/978-1-4419-0685-4_1; Fredriksson NJ., 2014, Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types, V46, P63, DOI 10.1038/ng.3141; Gunderson LL., 1982, Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy, V8, p1 11; Hannon GJ., 1994, KAP: a dual specificity phosphatase that interacts with cyclin-dependent kinases, V91, P5, DOI 10.1073/pnas.91.5.1731; Hashem TAA., 2016, HER 2 NEU STATUS GAS, V29, P449; Johnson LN., 2002, Structural studies with inhibitors of the cell cycle regulatory kinase cyclin-dependent protein kinase 2, V93, P24, DOI 10.1016/s0163-7258(02)00181-x; Kobayashi Y., 2012, rat, and mouse, V40, P9, DOI 10.1124/dmd.111.043067; Lai MW, 2012, UROL ONCOL-SEMIN ORI, V30, P871, DOI 10.1016/j.urolonc.2010.09.010; Li Y., 2017, Knockdown of cyclin-dependent kinase inhibitor 3 inhibits proliferation and invasion in human gastric cancer cells, V25, P721, DOI 10.3727/096504016X14772375848616; Liu L-M., 2016, CRITICAL ROLE CDKN3, V9, P172; Liu X., 2018, Identification of potential key genes associated with the pathogenesis and prognosis of gastric cancer based on integrated bioinformatics analysis, V9, P265, DOI 10.3389/fgene.2018.00265; Liu Y., 2020, Identification and verification of three key genes associated with survival and prognosis of COAD patients via integrated bioinformatics analysis, V40, DOI 10.1042/BSR20200141; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nalepa G., 2013, The tumor suppressor CDKN3 controls mitosis, V201, p997 1012, DOI 10.1083/jcb.201205125; Niculescu MD., 2004, Choline availability modulates human neuroblastoma cell proliferation and alters the methylation of the promoter region of the cyclindependent kinase inhibitor 3 gene, V89, P1252, DOI 10.1111/j.1471-4159.2004.02414.x; Ooi CH., 2009, Oncogenic pathway combinations predict clinical prognosis in gastric cancer, V5, DOI 10.1371/journal.pgen.1000676; Pignot G., 2019, PLEKHS1: A new molecular marker predicting risk of progression of nonmuscleinvasive bladder cancer, V18, P3471; Probst MR., 1994, Human liver arylacetamide deacetylase. Molecular cloning of a novel esterase involved in the metabolic activation of arylamine carcinogens with high sequence similarity to hormone-sensitive lipase, V269; Shrestha B, 2019, DECLARATION HELSINKI, V17, P52, DOI [10.11124/JBISRIR-2017-003901, DOI 10.11124/JBISRIR-2017-003901]; Wang JS, 2019, CANCER MANAG RES, V11, P3253, DOI 10.2147/CMAR.S193793; Weinhold N., 2014, Genome-wide analysis of noncoding regulatory mutations in cancer, V46, P5, DOI 10.1038/ng.3101; Wu C, 2020, BMC SURG, V20, DOI 10.1186/s12893-020-00856-y; Wu K-Z., 2020, J-LJWJoGO. Identification of a nine-gene prognostic signature for gastric carcinoma using integrated bioinformatics analyses, V12, P975, DOI 10.4251/wjgo.v12.i9.975; Xiong W., 2015, MICROARRAY ANAL LONG, V16, P3395, DOI [10.7314/apjcp.2015.16.8.3395, DOI 10.7314/APJCP.2015.16.8.3395]; Yamazaki K, 1997, GENOMICS, V44, P248, DOI 10.1006/geno.1997.4879; Yang C, 2015, MECHANISTIC STUDIES, V16, DOI [10.7314/apjcp.2015.16.3.965, DOI 10.7314/APJCP.2015.16.3.965]; Ye J., 2012, Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction, V13, P11, DOI 10.1186/1471-2105-13-134; Zhang YJ, 2020, J PATHOL, V251, P135, DOI 10.1002/path.5434; Zhao L, 2019, J CELL PHYSIOL, V234, P6350, DOI 10.1002/jcp.27365; Zhou J.-G., 2020, FRONT ONCOL, V10, P1147, DOI [10.3389/fonc.2020.01147, DOI 10.3389/FONC.2020.01147]	33	0	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0265184	10.1371/journal.pone.0265184	http://dx.doi.org/10.1371/journal.pone.0265184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446856	gold, Green Published			2022-12-26	WOS:000795468200058
J	Dikshit, R; Gupta, N; Dey, A; Viswanathan, K; Kumar, A				Dikshit, Rashmi; Gupta, Nitin; Dey, Arjun; Viswanathan, Koushik; Kumar, Aloke			Microbial induced calcite precipitation can consolidate martian and lunar regolith simulants	PLOS ONE			English	Article							SPOROSARCINA-PASTEURII; SOIL; UREASE; CONSTRUCTION; BIOPOLYMER; IRON	We demonstrate that Microbial Induced Calcite Precipitation (MICP) can be utilized for creation of consolidates of Martian Simulant Soil (MSS) and Lunar Simulant Soil (LSS) in the form of a 'brick'. A urease producer bacterium, Sporosarcina pasteurii, was used to induce the MICP process for the both simulant soils. An admixture of guar gum as an organic polymer and NiCl2, as bio- catalyst to enhance urease activity, was introduced to increase the compressive strength of the biologically grown bricks. A casting method was utilized for a slurry consisting of the appropriate simulant soil and microbe; the slurry over a few days consolidated in the form of a 'brick' of the desired shape. In case of MSS, maximum strength of 3.3 MPa was obtained with 10mM NiCl2 and 1% guar gum supplementation whereas in case of LSS maximum strength of 5.65 Mpa was obtained with 1% guar gum supplementation and 10mM NiCl2. MICP mediated consolidation of the simulant soil was confirmed with field emission scanning electron microscopy (FESEM), X-ray diffraction (XRD) and thermogravimetry (TG). Our work demonstrates a biological approach with an explicit casting method towards manufacturing of consolidated structures using extra-terrestrial regolith simulant; this is a promising route for in situ development of structural elements on the extra-terrestrial habitats.	[Dikshit, Rashmi; Gupta, Nitin; Viswanathan, Koushik; Kumar, Aloke] Indian Inst Sci, Dept Mech Engn, Bangalore, Karnataka, India; [Dey, Arjun] UR Rao Satellite Ctr, Thermal Syst Grp, Bangalore, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Space (DoS), Government of India; Indian Space Research Organisation (ISRO); U R Rao Satellite Centre (URSC)	Kumar, A (corresponding author), Indian Inst Sci, Dept Mech Engn, Bangalore, Karnataka, India.	alokekumar@iisc.ac.in		Kumar, Aloke/0000-0002-7797-8336	Department of Biotechnology, Ministry of Science and Technology, GOI [BT/PR31844/BIC/101/1206/2019]; Indian Space Research Organisation [ISTC0415]	Department of Biotechnology, Ministry of Science and Technology, GOI; Indian Space Research Organisation(Department of Space (DoS), Government of India)	RD BT/PR31844/BIC/101/1206/2019 Department of Biotechnology, Ministry of Science and Technology, GOI https://dbtindia.gov.in/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AK ISTC0415 Indian Space Research Organisation https://www.isro.gov.in/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achal V, 2009, J IND MICROBIOL BIOT, V36, P981, DOI 10.1007/s10295-009-0578-z; ALLEN CC, 1992, ENGINEERING, CONSTRUCTION, AND OPERATIONS IN SPACE III, VOLS 1 AND 2, P1209; Allen DD., 1992, STRENGTH FRACTURE GL; Altun AA., 2021, OPEN CERAMICS, V5; Anand M, 2012, PLANET SPACE SCI, V74, P42, DOI 10.1016/j.pss.2012.08.012; Anbu P, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1869-2; Benini S, 1999, STRUCTURE, V7, P205, DOI 10.1016/S0969-2126(99)80026-4; Benini S, 2014, J BIOL INORG CHEM, V19, P1243, DOI 10.1007/s00775-014-1182-x; Bhaduri S, 2016, JOVE-J VIS EXP, DOI 10.3791/53253; Binder AB., 1990, LUNAR DERIVED CONSTR, P117; Bogdahn C., 2019, IN SITU HABITAT DESI; Brittain HG, 2020, PROFILES DRUG SUBSTA, V45 th; Cannon KM, 2019, ICARUS, V317, P470, DOI 10.1016/j.icarus.2018.08.019; Carrier WD, 2003, J GEOTECH GEOENVIRON, V129, P956, DOI 10.1061/(ASCE)1090-0241(2003)129:10(956); Castanier S, 2000, OF MICROBES AND ART: THE ROLE OF MICROBIAL COMMUNITIES IN THE DEGRADATION AND PROTECTION OF CULTURAL HERITAGE, P203; Cesaretti G, 2014, ACTA ASTRONAUT, V93, P430, DOI 10.1016/j.actaastro.2013.07.034; Chang I, 2015, CONSTR BUILD MATER, V74, P65, DOI 10.1016/j.conbuildmat.2014.10.026; Cliffton EW., 1990, FUSED REGOLITH STRUC, P541; CORAZZARI I, HIST FUTURE PERSPECT; Cuzman OA, 2015, WORLD J MICROB BIOT, V31, P897, DOI 10.1007/s11274-015-1844-z; Dhami NK, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00314; Dikshit R, 2021, CERAM INT, V47, P14892, DOI 10.1016/j.ceramint.2020.07.309; Dikshit R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236745; Faierson EJ., 2012, POTENTIAL ISRU LUNAR, P201; Fujita Y, 2000, GEOMICROBIOL J, V17, P305, DOI 10.1080/782198884; German RM., 2003, UNPUBL MANUSCRIPT RE, P2003; Ghosh T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210339; Greene KA, 2004, ENGINEERING, CONSTRUCTION AND OPERATIONS IN CHALLENGING ENVIRONMENTS: EARTH AND SPACE 2004, P45; Gualtieri T, 2015, MATER LETT, V143, P276, DOI 10.1016/j.matlet.2014.11.153; Happel J.A., 1993, APPL MECH REV, V46, P313; Happel JA., 1991, DESIGN CONCEPTS PRES; Indyk SJ, 2017, ACTA ASTRONAUT, V140, P517, DOI 10.1016/j.actaastro.2017.09.018; JABRI E, 1995, SCIENCE, V268, P998, DOI 10.1126/science.7754395; Kallapur S., 2021, ASTRONAUT; Kaminskaia NV, 1997, INORG CHEM, V36, P5917, DOI 10.1021/ic961500p; Khoshnevis B., 2012, 13th ASCE Aerospace Division Conference on Engineering, Science, Construction, and Operations in Challenging Environments. 5th NASA/ASCE Workshop on Granular Materials in Space Exploration. Earth and Space 2012. Proceedings., P1458, DOI 10.1061/9780784412190.155; Kim YJ, 2021, CERAM INT, V47, P26891, DOI 10.1016/j.ceramint.2021.06.098; Krajewska B, 2009, J MOL CATAL B-ENZYM, V59, P9, DOI 10.1016/j.molcatb.2009.01.003; Lambert SE, 2019, WATER RES, V160, P158, DOI 10.1016/j.watres.2019.05.069; Leach N, 2012, INT J ARCHIT COMPUT, V10, P423, DOI 10.1260/1478-0771.10.3.423; Leonard R.S., 1988, SULFUR BASED CONSTRU, P1295; Liu M, 2022, CONSTR BUILD MATER, V314, DOI 10.1016/j.conbuildmat.2021.125661; Mann S., 2001, BIOMINERALIZATION PR; Maroney MJ, 2014, CHEM REV, V114, P4206, DOI 10.1021/cr4004488; Mudgil D, 2014, J FOOD SCI TECH MYS, V51, P409, DOI 10.1007/s13197-011-0522-x; Muguda S, 2017, GEOTECH LETT, V7, P309, DOI 10.1680/jgele.17.00081; NASA, SITES DEFAULT FILES; Naser MZ, 2019, PROG MATER SCI, V105, DOI 10.1016/j.pmatsci.2019.100577; Nawarathna THK, 2018, ACS SUSTAIN CHEM ENG, V6, P10315, DOI 10.1021/acssuschemeng.8b01658; Polowczyk I, 2016, MATERIALS, V9, DOI 10.3390/ma9110944; Randall DG, 2018, J ENVIRON CHEM ENG, V6, P2627, DOI 10.1016/j.jece.2018.04.012; Roberts AD, 2021, MATER TODAY BIO, V12, DOI 10.1016/j.mtbio.2021.100136; Seedhouse E., 2016, RED DRAGONS ICE DRAG, P145; Sorokina EV, 2013, MICROBIOLOGY+, V82, P439, DOI 10.1134/S0026261713040115; Sritharan M, 2000, WORLD J MICROB BIOT, V16, P769, DOI 10.1023/A:1008995313232; Stern A, 2012, NATURE, V484, P417, DOI 10.1038/484417a; Stocks-Fischer S, 1999, SOIL BIOL BIOCHEM, V31, P1563, DOI 10.1016/S0038-0717(99)00082-6; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Sujatha ER, 2019, SOILS FOUND, V59, P2155, DOI 10.1016/j.sandf.2019.11.012; Taylor LA, 2005, J AEROSPACE ENG, V18, P188, DOI 10.1061/(ASCE)0893-1321(2005)18:3(188); Tiano P, 1999, J MICROBIOL METH, V36, P139, DOI 10.1016/S0167-7012(99)00019-6; Venugopal I, 2020, ADV SPACE RES, V66, P2711, DOI 10.1016/j.asr.2020.08.021; Wang D, 2019, CONSTR BUILD MATER, V224, P336, DOI 10.1016/j.conbuildmat.2019.07.056; Wilhelm S, 2014, STRUCT CONCRETE, V15, P419, DOI 10.1002/suco.201300088; Yoon JH, 2001, INT J SYST EVOL MICR, V51, P1079, DOI 10.1099/00207713-51-3-1079	65	0	0	10	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266415	10.1371/journal.pone.0266415	http://dx.doi.org/10.1371/journal.pone.0266415			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421143	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000795453600046
J	Kuang, LF; Mo, PQ; Wang, KJ; Chen, B				Kuang, Lianfei; Mo, Pin-Qiang; Wang, Kuan-Jun; Chen, Bin			An elastic-plastic solution for the optimal thickness of a frozen soil wall considering an interaction with the surrounding rock	PLOS ONE			English	Article							CAVITIES; MODEL	The technology of artificial ground freezing has been widely applied in geotechnical engineering to support underground spaces, whereas the effects of excavation-induced large deformation and frictional and dilatant behavior of geomaterials are neglected in the current design. In this paper, a rigorous elastic-plastic solution of cavity contraction is proposed using a non-associated Mohr-Coulomb failure criterion to provide the optimal thickness of the frozen soil wall for excavation using artificial ground freezing technology, considering an interaction between the frozen soil wall and the surrounding soil/rock. After validation of a case study on a deep mine shaft against a numerical simulation, a thorough parametric study investigates the variation in the optimal thickness with the soil properties and initial stress conditions, as well as the effects of interaction and the critical condition. Compared to the existing solution, the proposed optimal thickness of the frozen soil wall is shown to contribute to both the design and cost-effectiveness in practical engineering, including tunneling and mine shaft construction.	[Kuang, Lianfei; Mo, Pin-Qiang] China Univ Min & Technol, Sch Mech & Civil Engn, State Key Lab Geomech & Deep Underground Engn, Xuzhou, Jiangsu, Peoples R China; [Mo, Pin-Qiang] Shenzhen Urban Publ Safety & Technol Inst, R&D Ctr, Shenzhen, Guangdong, Peoples R China; [Wang, Kuan-Jun] POWER CHINA Huadong Engn Corp Ltd, Zhejiang Huadong Construction Engn, Hangzhou, Zhejinag, Peoples R China; [Chen, Bin] Wuhan Surveying Geotech Res Inst Co LTD MCC, MCC Underground Space Technol Res Inst, Wuhan, Hubei, Peoples R China	China University of Mining & Technology	Mo, PQ (corresponding author), China Univ Min & Technol, Sch Mech & Civil Engn, State Key Lab Geomech & Deep Underground Engn, Xuzhou, Jiangsu, Peoples R China.; Mo, PQ (corresponding author), Shenzhen Urban Publ Safety & Technol Inst, R&D Ctr, Shenzhen, Guangdong, Peoples R China.	pinqiang.mo@cumt.edu.cn	Mo, Pin-Qiang/AAT-7462-2020	Mo, Pin-Qiang/0000-0002-1469-4838	Fundamental Research Funds for the Central Universities [2020ZDPYMS18]; National Natural Science Foundation of China [51908546, 52178374, 52108356]; China Postdoctoral Science Foundation [2020T130699]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	KUANG: the Fundamental Research Funds for the Central Universities (Grant No. 2020ZDPYMS18) MO: National Natural Science Foundation of China (Grant No. 51908546, Grant No. 52178374), China Postdoctoral Science Foundation (Grant No. 2020T130699) WANG: the National Natural Science Foundation of China (Grant No. 52108356) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTM, 2017, STAND PRACT CLASS SO; Brown E., 1980, UNDERGROUND EXCAVATI, DOI 10.1201/9781482288926; Chen HH, 2022, J ROCK MECH GEOTECH, V14, P922, DOI 10.1016/j.jrmge.2021.10.016; Domke O., 1915, GLUCKAUF, V51, P1129; Harris J.S., 1995, INT J ROCK MECH MIN, V11, p173A; Hong RB, 2022, ARAB J SCI ENG, V47, P4657, DOI 10.1007/s13369-021-06216-z; Lai YM, 2013, COLD REG SCI TECHNOL, V87, P6, DOI 10.1016/j.coldregions.2012.12.001; Leng Y. G., 2014, THESIS CHINA U MININ; Li M, 2021, COLD REG SCI TECHNOL, V182, DOI 10.1016/j.coldregions.2020.103197; Lijith KP, 2022, INT J GEOMECH, V22, DOI 10.1061/(ASCE)GM.1943-5622.0002228; Liu FW, 2021, J INTELL FUZZY SYST, V41, P1887, DOI 10.3233/JIFS-210608; Liu Y, 2022, ACTA GEOTECH, V17, P257, DOI 10.1007/s11440-021-01221-w; MAIR RJ, 1993, PREDICTIVE SOIL MECHANICS, P449; Mo PQ, 2022, ACTA GEOTECH, V17, P2325, DOI 10.1007/s11440-021-01412-5; Mo PQ, 2018, CAN GEOTECH J, V55, P1029, DOI 10.1139/cgj-2016-0695; Mo PQ, 2017, INT J GEOMECH, V17, DOI 10.1061/(ASCE)GM.1943-5622.0000816; Mo PQ, 2014, INT J NUMER ANAL MET, V38, P961, DOI 10.1002/nag.2288; Niggemann K, 2020, LECT NOTES CIVIL ENG, V50, P273, DOI 10.1007/978-981-15-0454-9_29; Quamruzzaman C., 2012, IOSR J MECH CIVIL EN, V2, P07, DOI [10.9790/1684-0240713, DOI 10.9790/1684-0240713]; Roman LT, 2010, SOIL MECH FOUND ENG+, V47, P96, DOI 10.1007/s11204-010-9095-3; Semin MA, 2020, J MIN SCI+, V56, P149, DOI 10.1134/S106273912001659X; Soo S., 1992, J COLD REG ENG, V6, P73, DOI [10.1061/(ASCE)0887-381X(1992)6:2(73)., DOI 10.1061/(ASCE)0887-381X(1992)6:2(73)]; Wang Q, 2013, APPL MECH MATER, V353-356, P1577, DOI 10.4028/www.scientific.net/AMM.353-356.1577; [杨维好 Yang Weihao], 2013, [岩土工程学报, Chinese Journal of Geotechnical Engineering], V35, P175; [杨维好 Yang Weihao], 2012, [岩土工程学报, Chinese Journal of Geotechnical Engineering], V34, P516; Yang Zhongnian, 2022, Arabian Journal of Geosciences, V15, DOI 10.1007/s12517-022-09432-5; Yu H-S., 2000, CAVITY EXPANSION MET; YU HS, 1991, GEOTECHNIQUE, V41, P173, DOI 10.1680/geot.1991.41.2.173; YU HS, 1995, INT J NUMER ANAL MET, V19, P793, DOI 10.1002/nag.1610191104; Yu HS, 1999, INT J NUMER ANAL MET, V23, P1245, DOI 10.1002/(SICI)1096-9853(199910)23:12<1245::AID-NAG30>3.0.CO;2-W; Zhang D, 2016, SHOCK VIB, V2016, DOI 10.1155/2016/3049097; Zhao Y, 2022, SENSORS-BASEL, V22, DOI 10.3390/s22030885; Zhuang PZ, 2021, ACTA GEOTECH, V16, P237, DOI 10.1007/s11440-020-00994-w; Zueter AF, 2022, J THERM SCI ENG APPL, V14, DOI 10.1115/1.4052595	34	0	0	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267014	10.1371/journal.pone.0267014	http://dx.doi.org/10.1371/journal.pone.0267014			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35472066	gold, Green Published			2022-12-26	WOS:000816171900001
J	Maresh, K; Papageorgiou, A; Ridout, D; Harrison, N; Mandy, W; Skuse, DE; Muntoni, FE				Maresh, Kate; Papageorgiou, Andriani; Ridout, Deborah; Harrison, Neil; Mandy, William; Skuse, David E.; Muntoni, Francesco E.			Development of a novel startle response task in Duchenne muscular dystrophy	PLOS ONE			English	Article							ANXIETY DISORDERS; HUMAN FEAR; HEART-RATE; EXTINCTION; BRAIN; ACQUISITION; CHILDREN; DEFICIT; BOYS; DYSFUNCTION	Duchenne muscular dystrophy (DMD), an X-linked childhood-onset muscular dystrophy caused by loss of the protein dystrophin, can be associated with neurodevelopmental, emotional and behavioural problems. A DMD mouse model also displays a neuropsychiatric phenotype, including increased startle responses to threat which normalise when dystrophin is restored in the brain. We hypothesised that startle responses may also be increased in humans with DMD, which would have potential translational therapeutic implications. To investigate this, we first designed a novel discrimination fear-conditioning task and tested it in six healthy volunteers, followed by male DMD (n = 11) and Control (n = 9) participants aged 7-12 years. The aims of this methodological task development study were to: i) confirm the task efficacy; ii) optimise data processing procedures; iii) determine the most appropriate outcome measures. In the task, two neutral visual stimuli were presented: one 'safe' cue presented alone; one 'threat' cue paired with a threat stimulus (aversive noise) to enable conditioning of physiological startle responses (skin conductance response, SCR, and heart rate). Outcomes were the unconditioned physiological startle responses to the initial threat, and retention of conditioned responses in the absence of the threat stimulus. We present the protocol development and optimisation of data processing methods based on empirical data. We found that the task was effective in producing significantly higher physiological startle SCR in reinforced 'threat' trials compared to 'safe' trials (P < .001). Different data extraction methods were compared and optimised, and the optimal sampling window was derived empirically. SCR amplitude was the most effective physiological outcome measure when compared to SCR area and change in heart rate, with the best profile on data processing, the least variance, successful conditioned response retention (P = .01) and reliability assessment in test-retest analysis (rho = .86). The definition of this novel outcome will allow us to study this response in a DMD population.	[Maresh, Kate; Papageorgiou, Andriani; Muntoni, Francesco E.] UCL Great Ormond St Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England; [Maresh, Kate; Muntoni, Francesco E.] UCL, MRC Ctr Neuromuscular Dis, London, England; [Ridout, Deborah] UCL Great Ormond St Inst Child Hlth, Dept Populat Policy & Practice, London, England; [Ridout, Deborah; Muntoni, Francesco E.] UCL, NIHR Great Ormond St Hosp, Great Ormond St Inst Child Hlth, Biomed Res Ctr, London, England; [Ridout, Deborah; Muntoni, Francesco E.] Great Ormond St Hosp Trust, London, England; [Harrison, Neil] Cardiff Univ, Div Psychol Med & Clin Neurosci, Cardiff, Wales; [Mandy, William] UCL, Dept Clin Educ & Hlth Psychol, London, England; [Skuse, David E.] UCL Great Ormond St Inst Child Hlth, Dept Behav & Brain Sci, London, England; [Ridout, Deborah; Muntoni, Francesco E.] Great Ormond St Hosp Trust, London, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Cardiff University; University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Muntoni, FE (corresponding author), UCL Great Ormond St Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England.; Muntoni, FE (corresponding author), UCL, MRC Ctr Neuromuscular Dis, London, England.; Muntoni, FE (corresponding author), UCL, NIHR Great Ormond St Hosp, Great Ormond St Inst Child Hlth, Biomed Res Ctr, London, England.; Muntoni, FE (corresponding author), Great Ormond St Hosp Trust, London, England.; Muntoni, FE (corresponding author), Great Ormond St Hosp Trust, London, England.	f.muntoni@ucl.ac.uk		Harrison, Neil/0000-0002-9584-3769; Skuse, David/0000-0002-7891-5732; Ridout, Deborah/0000-0003-1336-6450; Maresh, Kate/0000-0002-7046-122X; Mandy, William/0000-0002-3564-5808; Papageorgiou, Andriani/0000-0002-1186-4651; Muntoni, Francesco/0000-0002-9102-5232	Great Ormond Street Hospital Children's Charity [V0119]; Medical Research Council (MRC) via the MRC Centre for Neuromuscular Diseases Grant [MR/K000608/1]; EU Horizon 2020 Grant [83245]	Great Ormond Street Hospital Children's Charity; Medical Research Council (MRC) via the MRC Centre for Neuromuscular Diseases Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU Horizon 2020 Grant	The study 'A Study of Emotional Function in Duchenne Muscular Dystrophy (EmoDe Study)' was funded by Great Ormond Street Hospital Children's Charity (Award no. V0119), and supported KM and AP (https://www.gosh.org/).KM was also supported by the Medical Research Council (MRC) via the MRC Centre for Neuromuscular Diseases Grant no. MR/K000608/1 (Institute of Neurology, University College London; https://www.ucl.ac.uk/centre-for-neuromusculardiseases/).The partial support of EU Horizon 2020 Grant no. 83245 Brain Involvement iN Dystrophinopathies to FM (UCL) is also acknowledged (https://ec.europa.eu/programmes/horizon2020/en/h2020-sections-projects).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audiology AAo, 2010, NOIS CHART AM AC AUD; Bach DR, 2010, INT J PSYCHOPHYSIOL, V76, P52, DOI 10.1016/j.ijpsycho.2010.01.011; Backhouse M, 2012, BRIT J OCCUP THER, V75, P271, DOI 10.4276/030802212X13383757345148; Banihani R, 2015, J CHILD NEUROL, V30, P1472, DOI 10.1177/0883073815570154; BiopacSystemsInc, SKIN COND RESP AN 20; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Braithwaite J.J., 2015, GUIDE ANAL ELECTRODE; Camm AJ, 1996, CIRCULATION, V93, P1043; Castegnetti G, 2016, PSYCHOPHYSIOLOGY, V53, P930, DOI 10.1111/psyp.12637; Colombo P, 2017, EUR J PAEDIATR NEURO, V21, P639, DOI 10.1016/j.ejpn.2017.02.007; Cotton S, 2001, DEV MED CHILD NEUROL, V43, P497, DOI 10.1017/S0012162201000913; Curzon P, 2009, FRONT NEUROSCI, P19; da Silva TD, 2018, PEDIATR CARDIOL, V39, P869, DOI 10.1007/s00246-018-1881-0; DAVIS M, 1992, P255; Dawson ME, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P159, DOI 10.1017/cbo9780511546396.007; Doorenweerd N, 2021, BRAIN IMAGING BEHAV, V15, P2297, DOI 10.1007/s11682-020-00422-3; Doorenweerd N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12981-5; DUBOWITZ V, 1965, ARCH DIS CHILD, V40, P296, DOI 10.1136/adc.40.211.296; Dunsmoor JE, 2007, BEHAV NEUROSCI, V121, P635, DOI 10.1037/0735-7044.121.4.635; Dvir M, 2019, BEHAV RES THER, V120, DOI 10.1016/j.brat.2019.103431; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; Fowles DC, 2000, PSYCHOPHYSIOLOGY, V37, P777, DOI 10.1111/1469-8986.3760777; FOWLES DC, 1981, PSYCHOPHYSIOLOGY, V18, P232, DOI 10.1111/j.1469-8986.1981.tb03024.x; Gao Y, 2010, DEVELOPMENTAL SCI, V13, P201, DOI 10.1111/j.1467-7687.2009.00874.x; Glenn CR, 2012, DEV PSYCHOBIOL, V54, P675, DOI 10.1002/dev.20616; Golding J., 1999, GROWING CHANGING PAR; Goyenvalle A, 2015, NAT MED, V21, P270, DOI 10.1038/nm.3765; Gross CT, 2012, NAT REV NEUROSCI, V13, P651, DOI 10.1038/nrn3301; Hendriksen JGM, 2006, PEDIATR NEUROL, V34, P296, DOI 10.1016/j.pediatrneurol.2005.08.029; Hinton VJ, 2007, J AUTISM DEV DISORD, V37, P1925, DOI 10.1007/s10803-006-0325-5; Hinton VJ, 2009, PEDIATR NEUROL, V41, P339, DOI 10.1016/j.pediatrneurol.2009.05.011; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Inc BS, 2018, ECG AN 2018; Jovanovic T, 2014, NEUROBIOL LEARN MEM, V113, P135, DOI 10.1016/j.nlm.2013.10.016; Kleiner M, 2007, PERCEPTION, V36, P14; KLORMAN R, 1980, PSYCHOPHYSIOLOGY, V17, P513, DOI 10.1111/j.1469-8986.1980.tb02290.x; Lau JYF, 2008, J AM ACAD CHILD PSY, V47, P94, DOI 10.1097/chi.0b01e31815a5f01; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Leuchs L, 2019, PSYCHOPHYSIOLOGY, V56, DOI 10.1111/psyp.13283; Lissek S, 2005, BEHAV RES THER, V43, P1391, DOI 10.1016/j.brat.2004.10.007; Lonsdorf TB, 2019, ELIFE, V8, DOI 10.7554/eLife.52465; Lonsdorf TB, 2017, NEUROSCI BIOBEHAV R, V77, P247, DOI 10.1016/j.neubiorev.2017.02.026; Lovie P., 2005, ENCY STAT BEHAV SCI; Maren S, 2014, NEUROBIOL LEARN MEM, V113, P19, DOI 10.1016/j.nlm.2013.10.012; MILLER G, 1989, BRAIN DEV-JPN, V11, P247, DOI 10.1016/S0387-7604(89)80044-0; Mineka S, 2002, BIOL PSYCHIAT, V52, P927, DOI 10.1016/S0006-3223(02)01669-4; Miskovic V, 2012, PSYCHOPHYSIOLOGY, V49, P1230, DOI 10.1111/j.1469-8986.2012.01398.x; Pane M, 2012, J PEDIATR-US, V161, P705, DOI 10.1016/j.jpeds.2012.03.020; Pangalila RF, 2015, ARCH PHYS MED REHAB, V96, P1242, DOI 10.1016/j.apmr.2015.02.012; Pattwell SS, 2012, P NATL ACAD SCI USA, V109, P16318, DOI 10.1073/pnas.1206834109; Ricotti V, 2016, DEV MED CHILD NEUROL, V58, P77, DOI 10.1111/dmcn.12922; Robertson CE, 2017, NAT REV NEUROSCI, V18, P671, DOI 10.1038/nrn.2017.112; Roelofs K, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0206; Schiele MA, 2016, DEV PSYCHOBIOL, V58, P471, DOI 10.1002/dev.21393; Sehlmeyer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005865; Sekiguchi M, 2009, BRAIN, V132, P124, DOI 10.1093/brain/awn253; Shechner T, 2015, DEPRESS ANXIETY, V32, P277, DOI 10.1002/da.22318; Shechner T, 2014, BIOL PSYCHOL, V100, P1, DOI 10.1016/j.biopsycho.2014.04.001; Snow WM, 2013, NEUROSCI BIOBEHAV R, V37, P743, DOI 10.1016/j.neubiorev.2013.03.016; Suzuki Y, 2017, MUSCLE NERVE, V55, P591, DOI 10.1002/mus.25383; Thomas TO, 2015, PEDIATR CARDIOL, V36, P561, DOI 10.1007/s00246-014-1050-z; Vaillend C, 2002, HIPPOCAMPUS, V12, P713, DOI 10.1002/hipo.10068; Waters AM, 2009, J ABNORM PSYCHOL, V118, P311, DOI 10.1037/a0015635; Wood ET, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-020-01154-0	65	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0264091	10.1371/journal.pone.0264091	http://dx.doi.org/10.1371/journal.pone.0264091			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7VA	35439255	Green Submitted, Green Published, gold			2022-12-26	WOS:000791280100033
J	Seki, Y; Ichihara, A				Seki, Yasufumi; Ichihara, Atsuhiro			Association between overweight and growth hormone secretion in patients with non-functioning pituitary tumors	PLOS ONE			English	Article							INSULIN TOLERANCE-TEST; ADULT GH DEFICIENCY; ENDOCRINE-SOCIETY; DIAGNOSIS; MANAGEMENT; HYPOTHYROIDISM; REPLACEMENT; GUIDELINES; DISEASE; TESTS	IntroductionGrowth hormone (GH) deficiency (GHD) is often complicated by non-functioning pituitary tumors (NFPTs); however, its prevalence remains unclear because preoperative screening for GHD with provocative tests is not recommended. Accordingly, we attempted to clarify the characteristics of GHD in unoperated patients with NFPT. Materials and methodsWe retrospectively reviewed adult patients with non-functioning pituitary adenoma (NFPA) and Rathke's cyst who underwent preoperative GH-releasing peptide-2 (GHRP-2) tests from January 2013 to December 2016. We investigated the association between peak GH response to GHRP-2 and background characteristics. ResultsAmong 104 patients (85 NFPA and 19 Rathke's cysts), 45 (43%) presented severe GHD, as diagnosed using GHRP-2 tests. Body mass index (beta = -0.210, P = 0.007), free thyroxine (beta = 0.440, P < 0.001), and tumor height (beta = -0.254, P < 0.001) were significant variables for determining the peak GH response to GHRP-2 in multiple regression analyses. Overweight (odds ratio, 3.86; 95% confidence interval, 1.02-14.66) was significantly associated with severe GHD after adjustment for age, sex, creatinine, free thyroxine, tumor height and clinical diagnosis. The regression slopes between tumor height and peak GH response to GHRP-2 significantly differed between overweight patients and non-overweight individuals, as determined by analysis of covariance (P = 0.040). In the 48 patients who underwent postoperative GHRP-2 tests, severe postoperative GHD was significantly more common in overweight patients than non-overweight individuals (100% vs. 48%, P < 0.001). ConclusionWe observed a negative synergistic effect between overweight and tumor size on GH secretion in patients with NFPTs, indicating that GH provocation tests for diagnosing underestimated GHD could be considered in overweight unoperated patients with large NFPTs.	[Seki, Yasufumi; Ichihara, Atsuhiro] Tokyo Womens Med Univ, Dept Endocrinol & Hypertens, Tokyo, Japan	Tokyo Women's Medical University	Seki, Y (corresponding author), Tokyo Womens Med Univ, Dept Endocrinol & Hypertens, Tokyo, Japan.	seki.yasufumi@twmu.ac.jp	Seki, Yasufumi/GXN-0888-2022	Seki, Yasufumi/0000-0002-1950-7704	Japan Society for the Promotion of Science (JSPS) KAKENHI [18K16212]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Editage (http://www.editage.jp/) for English language editing.	Chanson P, 2015, ANN ENDOCRINOL-PARIS, V76, P239, DOI 10.1016/j.ando.2015.04.002; Chihara K, 2007, EUR J ENDOCRINOL, V157, P19, DOI 10.1530/EJE-07-0066; Cordido F, 2003, EUR J ENDOCRINOL, V149, P117, DOI 10.1530/eje.0.1490117; Cordido F, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/434562; Esposito D, 2019, PITUITARY, V22, P422, DOI 10.1007/s11102-019-00960-0; Feldt-Rasmussen U, 2016, ENDOCRINE, V54, P15, DOI 10.1007/s12020-016-1047-x; Fleseriu M, 2016, J CLIN ENDOCR METAB, V101, P3888, DOI 10.1210/jc.2016-2118; Fukuda I, 2014, NEUROL MED-CHIR, V54, P599, DOI 10.2176/nmc.ra.2014-0088; Galland F, 2015, ANN ENDOCRINOL-PARIS, V76, P191, DOI 10.1016/j.ando.2015.04.004; Gasco V, 2021, NEUROENDOCRINOLOGY, V111, P442, DOI 10.1159/000508103; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Isojima T, 2012, ENDOCR J, V59, P771, DOI 10.1507/endocrj.EJ12-0110; Kinoshita Y, 2013, ENDOCR J, V60, P97, DOI 10.1507/endocrj.EJ12-0230; Kobayashi N, 2018, ENDOCR J, V65, P827, DOI 10.1507/endocrj.EJ17-0536; Levin A, 2014, KIDNEY INT, V85, P49, DOI 10.1038/ki.2013.444; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Molitch ME, 2008, ENDOCRIN METAB CLIN, V37, P151, DOI 10.1016/j.ecl.2007.10.011; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Scacchi M, 1999, INT J OBESITY, V23, P260, DOI 10.1038/sj.ijo.0800807; Soga A, 2020, ENDOCR J, V67, P167, DOI 10.1507/endocrj.EJ19-0288; Stochholm K, 2006, EUR J ENDOCRINOL, V155, P61, DOI 10.1530/eje.1.02191; Svensson J, 2004, J CLIN ENDOCR METAB, V89, P3306, DOI 10.1210/jc.2003-031601; Tzanela M, 2010, EUR J ENDOCRINOL, V162, P29, DOI 10.1530/EJE-09-0390; VALCAVI R, 1993, J CLIN ENDOCR METAB, V77, P616, DOI 10.1210/jc.77.3.616; Yang A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52644-1; Yuen KCJ, 2008, CLIN ENDOCRINOL, V69, P292, DOI 10.1111/j.1365-2265.2008.03201.x; Yuen KCJ, 2019, ENDOCR PRACT, V25, P1191, DOI 10.4158/GL-2019-0405	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267324	10.1371/journal.pone.0267324	http://dx.doi.org/10.1371/journal.pone.0267324			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C1KV	35452483	Green Published, gold			2022-12-26	WOS:000792887700035
J	Shi, ZG; Lopez, J; Kalliney, W; Sutton, B; Simpson, J; Maggert, K; Liu, S; Wan, J; Stack, MS				Shi, Zonggao; Lopez, Jacqueline; Kalliney, William; Sutton, Bobbie; Simpson, Joyce; Maggert, Kevin; Liu, Sheng; Wan, Jun; Stack, M. Sharon			Development and evaluation of ActSeq: A targeted next-generation sequencing panel for clinical oncology use	PLOS ONE			English	Article							CANCER	PurposeThe demand for high-throughput genetic profiling of somatic mutations in cancer tissues is growing. We sought to establish a targeted next generation sequencing (NGS) panel test for clinical oncology practice. MethodsCustomized probes were designed to capture exonic regions of 141 genes selected for the panel, which was aimed for the detection of clinically actionable genetic variations in cancer, including KRAS, NRAS, BRAF, ALK, ROS1, KIT and EGFR. The size of entire targeted regions is 0.8 Mb. Library preparation used NEBNext Ultra II FS kit coupled with target enrichment. Paired-end sequencing was run on Illumina NextSeq 500 at a read length of 150 nt. A bioinformatics workflow focusing on single nucleotide variant and short insertions and deletions (SNV/indel) discovery was established using open source, in-house and commercial software tools. Standard reference DNA samples were used in testing the sensitivity and precision and limit of detection in variant calling. ResultsThe general performance of the panel was observed in pilot runs. Average total reads per sample ranged from 30 million to 48 million, 73% ~82% unique reads. All runs had more than 99% average mapping rate. Mean target coverage ranged from 727x to 879x. Depth of coverage at 50x or more reached 87% of targeted region and 60% of targeted region received 500x or more coverage depth. Using OncoSpan HD827 DNA, which bears 144 variants (SNV/indel) from 80 genes that are within the targeted region on the panel, our somatic variant calling pipeline reached 97% sensitivity and 100% precision respectively, with near 48 million reads. High concordance with orthogonal approaches in variant detection was further verified with 7 cancer cell lines and 45 clinical specimens. ConclusionWe developed a NGS panel with a focus on clinically actionable gene mutations and validated the performance in library construction, sequencing and variant calling. High concordance with reference materials and orthogonal mutation detection was observed.	[Shi, Zonggao; Kalliney, William; Stack, M. Sharon] Univ Notre Dame, Harper Canc Res Inst, Notre Dame, IN USA; [Lopez, Jacqueline] Univ Notre Dame, Genom & Bioinformat Core Facil, Notre Dame, IN USA; [Kalliney, William; Sutton, Bobbie; Simpson, Joyce; Maggert, Kevin] South Bend Med Fdn, South Bend, IN USA; [Liu, Sheng; Wan, Jun] Indiana Univ Sch Med, Collaborat Core Canc Bioinformat, Indianapolis, IN USA; [Shi, Zonggao; Kalliney, William; Stack, M. Sharon] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN USA; [Liu, Sheng; Wan, Jun] Indiana Univ Sch Med, Dept Med & Mol Genet, United 0States Amer, Indianapolis, IN USA	University of Notre Dame; University of Notre Dame; Indiana University System; Indiana University Bloomington; University of Notre Dame; Indiana University System; Indiana University Bloomington	Shi, ZG; Stack, MS (corresponding author), Univ Notre Dame, Harper Canc Res Inst, Notre Dame, IN USA.; Shi, ZG; Stack, MS (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN USA.	zshi2@nd.edu; sstack@nd.edu		Lopez, Jacqueline/0000-0001-9608-7611; Shi, Zonggao/0000-0001-7503-2953	Walther Cancer Foundation;  [0183.01]	Walther Cancer Foundation; 	MSS received funding (WCF#:0183.01) from Walther Cancer Foundation (https://www. walther.org) for this study. The funder had no role in study design, data collection and analysis,<ITALIC><BOLD> </BOLD></ITALIC>decision to publish, or preparation of the manuscript.	Benson AB, 2018, J NATL COMPR CANC NE, V16, P359, DOI 10.6004/jnccn.2018.0021; Berger MF, 2018, NAT REV CLIN ONCOL, V15, P353, DOI 10.1038/s41571-018-0002-6; Chakravarty Debyani, 2017, JCO Precis Oncol, V2017, DOI 10.1200/PO.17.00011; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Flaherty KT, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.19.03010; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Hyman DM, 2017, CELL, V168, P584, DOI 10.1016/j.cell.2016.12.015; Kerick M, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-68; Koboldt DC, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00791-w; Kozarewa Iwanka, 2015, Curr Protoc Mol Biol, V112, DOI 10.1002/0471142727.mb0721s112; Lee YT, 2018, EUR J PHARMACOL, V834, P188, DOI 10.1016/j.ejphar.2018.07.034; Lindeman NI, 2018, J THORAC ONCOL, V13, P323, DOI 10.1016/j.jtho.2017.12.001; Liu YY, 2021, CANCER LETT, V503, P163, DOI 10.1016/j.canlet.2021.01.024; Nogrady B, 2020, NATURE, V579, pS10, DOI 10.1038/d41586-020-00845-4; Rusch M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06485-7; Sabatini LM, 2016, J MOL DIAGN, V18, P319, DOI 10.1016/j.jmoldx.2015.11.010; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; Shin HY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15464; Sorich MJ, 2015, ANN ONCOL, V26, P13, DOI 10.1093/annonc/mdu378; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Sutton BC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183715; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; Zook JM, 2014, NAT BIOTECHNOL, V32, P246, DOI 10.1038/nbt.2835	23	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266914	10.1371/journal.pone.0266914	http://dx.doi.org/10.1371/journal.pone.0266914			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446881	gold, Green Published			2022-12-26	WOS:000795468200053
J	Gonzalez-Gil, A; Porell, RN; Fernandes, SM; Maenpaa, E; Li, TA; Li, T; Wong, PC; Aoki, K; Tiemeyer, M; Yu, ZJ; Orsburn, BC; Bumpus, NN; Matthews, RT; Schnaar, RL				Gonzalez-Gil, Anabel; Porell, Ryan N.; Fernandes, Steve M.; Maenpaa, Eila; Li, T. August; Li, Tong; Wong, Philip C.; Aoki, Kazuhiro; Tiemeyer, Michael; Yu, Zaikuan J.; Orsburn, Benjamin C.; Bumpus, Namandje N.; Matthews, Russell T.; Schnaar, Ronald L.			Human brain sialoglycan ligand for CD33, a microglial inhibitory Siglec implicated in Alzheimer's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE-BETA; KERATAN SULFATE; COMMON VARIANTS; MICE DEFICIENT; MAST-CELLS; REVEALS; RECOGNITION; CD2AP; EPHA1; SELF	Alzheimer's disease (AD) is characterized by accumulation of misfolded proteins. Genetic studies implicate microglia, brain-resident phagocytic immune cells, in AD pathogenesis. As positive effectors, microglia clear toxic proteins, whereas as negative effectors, they release proinflammatory mediators. An imbalance of these functions contributes to AD progression. Polymorphisms of human CD33, an inhibitory microglial receptor, are linked to AD susceptibility; higher CD33 expression correlates with increased AD risk. CD33, also called Siglec-3, is a member of the sialic acid-binding immunoglobulin-type lectin (Siglec) family of immune regulatory receptors. Siglec-mediated inhibition is initiated by binding to complementary sialoglycan ligands in the tissue environment. Here, we identify a single sialoglycoprotein in human cerebral cortex that binds CD33 as well as Siglec-8, the most abundant Siglec on human microglia. The ligand, which we term receptor protein tyrosine phosphatase zeta (RPTP zeta)(S3L), is composed of sialylated keratan sulfate chains carried on a minor isoform/glycoform of RPTP zeta (phosphacan) and is found in the extracellular milieu of the human brain parenchyma. Brains from human AD donors had twofold higher levels of RPTP zeta(S3L) than age-matched control donors, raising the possibility that RPTP zeta(S3L) overexpression limits misfolded protein clearance contributing to AD pathology. Mice express the same structure, a sialylated keratan sulfate RPTP zeta isoform, that binds mouse Siglec-F and crossreacts with human CD33 and Siglec-8. Brains from mice engineered to lack RPTP zeta, the sialyltransferase St3gal4, or the keratan sulfate sulfotransferase Chst1 lacked Siglec binding, establishing the ligand structure. The unique CD33 and Siglec-8 ligand, RPTP zeta(S3L), may contribute to AD progression.	[Gonzalez-Gil, Anabel; Porell, Ryan N.; Fernandes, Steve M.; Maenpaa, Eila; Li, T. August; Yu, Zaikuan J.; Orsburn, Benjamin C.; Bumpus, Namandje N.; Schnaar, Ronald L.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Li, Tong; Wong, Philip C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Wong, Philip C.; Schnaar, Ronald L.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Aoki, Kazuhiro; Tiemeyer, Michael] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Matthews, Russell T.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University System of Georgia; University of Georgia; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Schnaar, RL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.; Schnaar, RL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	schnaar@jhu.edu		Porell, Ryan/0000-0003-3332-6819; Alvarenga, Anabel/0000-0002-1618-8920	National Institute on Aging, National Institutes of Health (NIH) [AG062342, AG068089]; NIH [K12HL141952, T32-GM008763, T32GM080189]	National Institute on Aging, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institute on Aging, National Institutes of Health (NIH) grants AG062342 and AG068089 and NIH training grants K12HL141952 (to A. G.-G.), T32-GM008763 (T. A. L.), and T32GM080189 (to R. N. P. and E. M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Aires V, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.684430; Alsema AM, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.00134; Butler CA, 2021, J NEUROCHEM, V158, P297, DOI 10.1111/jnc.15349; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Betancourt LH, 2018, J PROTEOME RES, V17, P2556, DOI 10.1021/acs.jproteome.8b00228; Bhattacherjee A, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0698-6; Bochner BS, 2005, J BIOL CHEM, V280, P4307, DOI 10.1074/jbc.M412378200; Bull C, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2026102118; Cao HA, 2011, IMMUNOLOGY, V132, P18, DOI 10.1111/j.1365-2567.2010.03368.x; Caterson B, 2018, GLYCOBIOLOGY, V28, P182, DOI 10.1093/glycob/cwy003; Chatila ZK, 2021, NEUROSCIENTIST, DOI 10.1177/10738584211024531; Chouhan J.K., 2017, DRUG DISCOV TODAY DI, V25-26, P45, DOI [10.1016/j.ddmod.2018.10.004, DOI 10.1016/J.DDMOD.2018.10.004]; Duan ST, 2021, J IMMUNOL, V206, P2290, DOI 10.4049/jimmunol.1901212; Duan ST, 2020, ANNU REV IMMUNOL, V38, P365, DOI 10.1146/annurev-immunol-102419-035900; Duan ST, 2019, J CLIN INVEST, V129, P1387, DOI 10.1172/JCI125456; Eill GJ, 2020, J BIOL CHEM, V295, P955, DOI 10.1074/jbc.RA119.010830; Ellies LG, 2002, BLOOD, V100, P3618, DOI 10.1182/blood-2002-04-1007; Ellies LG, 2002, P NATL ACAD SCI USA, V99, P10042, DOI 10.1073/pnas.142005099; ERONEN I, 1985, BIOCHIM BIOPHYS ACTA, V843, P155, DOI 10.1016/0304-4165(85)90063-7; Funderburgh JL, 2002, IUBMB LIFE, V54, P187, DOI 10.1080/15216540214932; Galatro TF, 2017, NAT NEUROSCI, V20, P1162, DOI 10.1038/nn.4597; Garwood J, 2003, J BIOL CHEM, V278, P24164, DOI 10.1074/jbc.M211721200; Gonzalez-Gil A, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10051260; Gonzalez-Gil A, 2021, J ALLERGY CLIN IMMUN, V147, P1442, DOI 10.1016/j.jaci.2020.08.001; Gonzalez-Gil A, 2018, GLYCOBIOLOGY, V28, P786, DOI 10.1093/glycob/cwy057; Griciuc A, 2021, CURR OPIN NEUROL, V34, P228, DOI 10.1097/WCO.0000000000000911; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Harroch S, 2000, MOL CELL BIOL, V20, P7706, DOI 10.1128/MCB.20.20.7706-7715.2000; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Johansson MEV, 2012, METHODS MOL BIOL, V842, P109, DOI 10.1007/978-1-61779-513-8_6; Keenan TDL, 2012, INVEST OPHTH VIS SCI, V53, P7528, DOI 10.1167/iovs.12-10797; Kikly KK, 2000, J ALLERGY CLIN IMMUN, V105, P1093, DOI 10.1067/mai.2000.107127; Kiwamoto T, 2014, J ALLERGY CLIN IMMUN, V133, P240, DOI 10.1016/j.jaci.2013.05.018; Klaas M, 2012, SEMIN IMMUNOPATHOL, V34, P353, DOI 10.1007/s00281-012-0310-3; Lewcock JW, 2020, NEURON, V108, P801, DOI 10.1016/j.neuron.2020.09.029; Li T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12082; Lindahl B, 1996, J BIOL CHEM, V271, P16991, DOI 10.1074/jbc.271.29.16991; Lunnon K, 2011, J IMMUNOL, V186, P7215, DOI 10.4049/jimmunol.0903833; Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Mathys H, 2019, NATURE, V570, P332, DOI 10.1038/s41586-019-1195-2; Morshed N, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20209819; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Patnode ML, 2013, J BIOL CHEM, V288, P26533, DOI 10.1074/jbc.M113.485409; Peles E, 1998, TRENDS BIOCHEM SCI, V23, P121, DOI 10.1016/S0968-0004(98)01195-5; Pluvinage JV, 2019, NATURE, V568, P187, DOI 10.1038/s41586-019-1088-4; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Propster JM, 2016, P NATL ACAD SCI USA, V113, pE4170, DOI 10.1073/pnas.1602214113; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Scheltens P, 2021, LANCET, V397, P1577, DOI 10.1016/S0140-6736(20)32205-4; Schwabe T, 2020, NEUROBIOL DIS, V143, DOI 10.1016/j.nbd.2020.104962; Shen HH, 2018, P NATL ACAD SCI USA, V115, P9813, DOI 10.1073/pnas.1815273115; Stanley P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005199; Sturgill ER, 2012, GLYCOBIOLOGY, V22, P1289, DOI 10.1093/glycob/cws103; Varki A., 2017, ESSENTIALS GLYCOBIOL, VThird, P453; Yu HF, 2017, GLYCOBIOLOGY, V27, P657, DOI 10.1093/glycob/cwx026; Zhang M, 2007, BLOOD, V109, P4280, DOI 10.1182/blood-2006-08-039255; Zhang Z, 2017, P NATL ACAD SCI USA, V114, pE2947, DOI 10.1073/pnas.1615036114	58	1	1	6	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101960	10.1016/j.jbc.2022.101960	http://dx.doi.org/10.1016/j.jbc.2022.101960			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9FR	35452678	Green Published, gold			2022-12-26	WOS:000807755100007
J	Shibuya, K; Ebihara, K; Ebihara, C; Sawayama, N; Isoda, M; Yamamuro, D; Takahashi, M; Nagashima, S; Ishibashi, S				Shibuya, Koji; Ebihara, Ken; Ebihara, Chihiro; Sawayama, Nagisa; Isoda, Masayo; Yamamuro, Daisuke; Takahashi, Manabu; Nagashima, Shuichi; Ishibashi, Shun			AAA-ATPase valosin-containing protein binds the transcription factor SREBP1 and promotes its proteolytic activation by rhomboid protease RHBDL4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE; IDENTIFICATION; DYSFUNCTION; CLEAVAGE; MODELS; CDC48; MICE; RBD2; SCAP	Valosin-containing protein (VCP) is a member of AAAATPase superfamily involved in various cellular functions. To investigate the pathophysiological role of VCP in metabolic disorders, we generated knock-in mice bearing an A232E mutation in VCP, a known human VCP pathogenic variant. When heterozygous mutant mice (A232E/+) were fed a high-fat diet, we observed that fatty liver was ameliorated and the proteolytic processing of the transcription factor sterol regulatory element-binding protein 1 (SREBP1) was impaired. Further coimmunoprecipitation analysis in wildtype mice revealed interactions of VCP with SREBP1 and a rhomboid protease, RHBDL4, in the liver, and these interactions were attenuated in A232E/+ mice. Consistent with these results, we show that knockdown or chemical inhibition of VCP or RHBDL4 in human hepatocytes impaired the proteolytic processing of SREBP1. Finally, we found that knockdown of E3 ligases such as glycoprotein 78 and HMG-CoA reductase degradation protein 1 disrupted the interaction of VCP with SREBP1 and impaired the proteolytic processing of SREBP1. These results suggest that VCP recognizes ubiquitinylated SREBP1 and recruits it to RHBDL4 to promote its proteolytic processing. The present study reveals a novel proteolytic processing pathway of SREBP1 and may lead to development of new therapeutic strategies to treat fatty liver diseases.	[Shibuya, Koji; Ebihara, Ken; Ebihara, Chihiro; Sawayama, Nagisa; Isoda, Masayo; Yamamuro, Daisuke; Takahashi, Manabu; Nagashima, Shuichi; Ishibashi, Shun] Jichi Med Univ, Dept Internal Med, Div Endocrinol & Metab, Sch Med, Shimotsuke, Tochigi, Japan	Jichi Medical University	Ebihara, K (corresponding author), Jichi Med Univ, Dept Internal Med, Div Endocrinol & Metab, Sch Med, Shimotsuke, Tochigi, Japan.	kebihara@jichi.ac.jp		Nagashima, Shuichi/0000-0003-2509-8588				Burr R, 2017, J BIOL CHEM, V292, P16333, DOI 10.1074/jbc.M117.802025; Fleig L, 2012, MOL CELL, V47, P558, DOI 10.1016/j.molcel.2012.06.008; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Higuchi N, 2008, HEPATOL RES, V38, P1122, DOI 10.1111/j.1872-034X.2008.00382.x; Hodson L, 2019, P NUTR SOC, V78, P126, DOI 10.1017/S0029665118002653; Hosoi T, 2008, MOL PHARMACOL, V74, P1610, DOI 10.1124/mol.108.050070; Hwang J, 2016, EMBO J, V35, P2332, DOI 10.15252/embj.201693923; Ide Y, 2019, JACC-BASIC TRANSL SC, V4, P701, DOI 10.1016/j.jacbts.2019.06.001; Ikeda HO, 2014, SCI REP-UK, V4, DOI 10.1038/srep05970; Kim J, 2015, BIOCHEM BIOPH RES CO, V468, P606, DOI 10.1016/j.bbrc.2015.10.165; Kuriyama H, 2005, CELL METAB, V1, P41, DOI 10.1016/j.cmet.2004.11.004; Lee JJ, 2013, J BIOL CHEM, V288, P6998, DOI 10.1074/jbc.M112.417576; Liu TF, 2012, CELL METAB, V16, P213, DOI 10.1016/j.cmet.2012.06.014; Manno A, 2010, GENES CELLS, V15, P911, DOI 10.1111/j.1365-2443.2010.01428.x; Marjot T, 2020, ENDOCR REV, V41, P66, DOI 10.1210/endrev/bnz009; Matthews KA, 2010, GENETICS, V185, P189, DOI 10.1534/genetics.110.114975; Monnerie H, 2017, J NEUROCHEM, V140, P53, DOI 10.1111/jnc.13721; Nakakuki S., 2021, BIORXIV, DOI [10.1101/457590, DOI 10.1101/457590]; Nakano M, 2017, EBIOMEDICINE, V22, P225, DOI 10.1016/j.ebiom.2017.07.024; Nakano N, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00096; Niwa H, 2012, J BIOL CHEM, V287, P8561, DOI 10.1074/jbc.M111.302778; Noguchi M, 2005, J BIOL CHEM, V280, P41332, DOI 10.1074/jbc.M509700200; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Peng J, 2018, CELL PHYSIOL BIOCHEM, V47, P784, DOI 10.1159/000490030; Pennisi G, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16224334; Takeuchi Y, 2010, J BIOL CHEM, V285, P11681, DOI 10.1074/jbc.M109.096107; Tang WK, 2016, SCI REP-UK, V6, DOI 10.1038/srep20037; Tang WK, 2010, EMBO J, V29, P2217, DOI 10.1038/emboj.2010.104; Tong ZT, 2014, MOL CELL PROTEOMICS, V13, P2871, DOI 10.1074/mcp.M114.040774; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Wei JC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06091-7; Xu X, 2013, SEMIN LIVER DIS, V33, P301, DOI 10.1055/s-0033-1358523; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Ye YH, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00039; Yoshino S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70689-5; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Zhang XY, 2015, P NATL ACAD SCI USA, V112, pE1705, DOI 10.1073/pnas.1418820112	37	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101936	10.1016/j.jbc.2022.101936	http://dx.doi.org/10.1016/j.jbc.2022.101936			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9DZ	35430252	gold, Green Published			2022-12-26	WOS:000807750700013
J	Annerino, A; Faltas, M; Srinivasan, M; Gouma, PI				Annerino, Anthony; Faltas, Michael; Srinivasan, Manoj; Gouma, Pelagia-Irene			Towards skin-acetone monitors with selective sensitivity: Dynamics of PANI-CA films	PLOS ONE			English	Article							SWEAT COMPOSITION; EXHALED BREATH; GAS SENSOR; EXERCISE; BLOOD	Most research aimed at measuring biomarkers on the skin is only concerned with sensing chemicals in sweat using electrical signals, but these methods are not truly non-invasive nor non-intrusive because they require substantial amounts of sweat to get a reading. This project aims to create a truly non-invasive wearable sensor that continuously detects the gaseous acetone (a biomarker related to metabolic disorders) that ambiently comes out of the skin. Composite films of polyaniline and cellulose acetate, exhibiting chemo-mechanical actuation upon exposure to gaseous acetone, were tested in the headspaces above multiple solutions containing acetone, ethanol, and water to gauge response sensitivity, selectivity, and repeatability. The bending of the films in response to exposures to these environments was tracked by an automatic video processing code, which was found to out-perform an off-the-shelf deep neural network-based tracker. Using principal component analysis, we showed that the film bending is low dimensional with over 90% of the shape changes being captured with just two parameters. We constructed forward models to predict shape changes from the known exposure history and found that a linear model can explain 40% of the observed variance in film tip angle changes. We constructed inverse models, going from third order fits of shape changes to acetone concentrations where about 45% of the acetone variation and about 30% of ethanol variation are captured by linear models, and non-linear models did not perform substantially better. This suggests there is sufficient sensitivity and inherent selectivity of the films. These models, however, provide evidence for substantial hysteretic or long-time-scale responses of the PANI films, seemingly due to the presence of water. Further experiments will allow more accurate discrimination of unknown exposure environments. Nevertheless, the sensor will operate with high selectivity in low sweat body locations, like behind the ear or on the nails.	[Annerino, Anthony; Faltas, Michael; Gouma, Pelagia-Irene] Ohio State Univ, Mat Sci & Engn, Columbus, OH 43210 USA; [Srinivasan, Manoj; Gouma, Pelagia-Irene] Ohio State Univ, Mech & Aerosp Engn, Columbus, OH 43210 USA; [Srinivasan, Manoj] Ohio State Univ, Program Biophys, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Annerino, A (corresponding author), Ohio State Univ, Mat Sci & Engn, Columbus, OH 43210 USA.	Annerino.2@osu.edu	; Srinivasan, Manoj/E-8751-2011	Faltas, Michael/0000-0002-2700-9211; Srinivasan, Manoj/0000-0002-7811-3617	National Science Foundation SCH-INT grant [IIS 2014506]	National Science Foundation SCH-INT grant	This study was supported by the National Science Foundation SCH-INT grant number IIS 2014506 awarded to PG and MS. https://www.nsf.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi SM, 2017, DRUG ALCOHOL DEPEN, V178, P417, DOI 10.1016/j.drugalcdep.2017.05.031; Anderson JC, 2015, OBESITY, V23, P2327, DOI 10.1002/oby.21242; Aparicio-Martinez E, 2018, J NANOMATER, V2018, DOI 10.1155/2018/6519694; Bag A, 2021, ADV MATER TECHNOL-US, V6, DOI 10.1002/admt.202000883; Bandodkar AJ, 2020, MATTER-US, V2, P795, DOI 10.1016/j.matt.2020.03.004; Bandodkar AJ, 2014, TRENDS BIOTECHNOL, V32, P363, DOI 10.1016/j.tibtech.2014.04.005; Biscay J, 2021, TALANTA, V224, DOI 10.1016/j.talanta.2020.121815; Funada TOT, 2012, ADV GAS CHROMATOGRAP; Ganguly A, 2020, SLAS TECHNOL, V25, P25, DOI 10.1177/2472630319882003; Gouma P, 2011, PROCEDIA ENGINEER, V25, DOI 10.1016/j.proeng.2011.12.385; Gouma P, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/3/037110; He X, 2019, FRONT MATER SCI, V13, P305, DOI 10.1007/s11706-019-0472-1; Huang HH, 2004, SENSOR ACTUAT B-CHEM, V101, P316, DOI 10.1016/j.snb.2004.04.001; Kang N, 2016, ACS SENSORS, V1, P1060, DOI 10.1021/acssensors.6b00414; Kao KW, 2012, SENSORS-BASEL, V12, P7157, DOI 10.3390/s120607157; Klous L, 2020, J THERM BIOL, V93, DOI 10.1016/j.jtherbio.2020.102697; Luo XJ, 2020, IEEE SENS J, V20, P3757, DOI 10.1109/JSEN.2019.2959029; MANOLIS A, 1983, CLIN CHEM, V29, P5; Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; Miekisch W, 2004, CLIN CHIM ACTA, V347, P25, DOI 10.1016/j.cccn.2004.04.023; Mojtabavi M., 2016, ADV DEVICE MAT, V2, P1, DOI DOI 10.1080/20550308.2016.1198559; Morgan RM, 2004, ACTA PHYSIOL SCAND, V182, P37, DOI 10.1111/j.1365-201X.2004.01305.x; Mori K, 2008, REDOX REP, V13, P139, DOI 10.1179/135100008X259240; Mork AK, 2006, TOXICOL LETT, V164, P6, DOI 10.1016/j.toxlet.2005.11.005; Patterson MJ, 2002, ACTA PHYSIOL SCAND, V174, P41, DOI 10.1046/j.1365-201x.2002.00927.x; Raghu AV, 2019, ACS APPL NANO MATER, V2, P1152, DOI 10.1021/acsanm.8b01975; Singh E, 2017, ACS APPL MATER INTER, V9, P34544, DOI 10.1021/acsami.7b07063; Solga SF, 2006, BIOMARKERS, V11, P174, DOI 10.1080/13547500500421070; Thirumalaikumar S., 2021, 2021 IEEE INT S CIRC, P1; Torrey L., 2009, CHAPTER 11 TRANSFER; Toyooka T, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/3/036005; Turner C, 2008, RAPID COMMUN MASS SP, V22, P526, DOI 10.1002/rcm.3402; Turner C, 2011, EXPERT REV MOL DIAGN, V11, P497, DOI 10.1586/ERM.11.31; Vasilescu A, 2021, BIOSENS BIOELECTRON, V182, DOI 10.1016/j.bios.2021.113193; Yamada Y, 2015, ANAL CHEM, V87, P7588, DOI 10.1021/acs.analchem.5b00296; Yamai K, 2009, REDOX REP, V14, P285, DOI 10.1179/135100009X12525712409850; Ye M, 2015, BIOSENS BIOELECTRON, V73, P208, DOI 10.1016/j.bios.2015.04.023	37	0	0	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267311	10.1371/journal.pone.0267311	http://dx.doi.org/10.1371/journal.pone.0267311			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476814	Green Submitted, Green Published, gold			2022-12-26	WOS:000840124300033
J	Quandelacy, TM; Adams, LE; Munoz, J; Santiago, GA; Kada, S; Johansson, MA; Alvarado, LI; Rivera-Amill, V; Paz-Bailey, G				Quandelacy, Talia M.; Adams, Laura E.; Munoz, Jorge; Santiago, Gilberto A.; Kada, Sarah; Johansson, Michael A.; Alvarado, Luisa I.; Rivera-Amill, Vanessa; Paz-Bailey, Gabriela			Reduced spread of influenza and other respiratory viral infections during the COVID-19 pandemic in southern Puerto Rico	PLOS ONE			English	Article							TIME RT-PCR; UNITED-STATES; NONPHARMACEUTICAL INTERVENTIONS; IMPACT; COUNTRIES; VIRUSES	Introduction Impacts of COVID-19 mitigation measures on seasonal respiratory viruses is unknown in sub-tropical climates. Methods We compared weekly testing and test-positivity of respiratory infections in the 2019-2020 respiratory season to the 2012-2018 seasons in southern Puerto Rico using Wilcoxon signed rank tests. Results Compared to the average for the 2012-2018 seasons, test-positivity was significantly lower for Influenza A (p<0.001) & B (p<0.001), respiratory syncytial virus (RSV) (p<0.01), respiratory adenovirus (AdV) (p<0.05), and other respiratory viruses (p<0.001) following March 2020 COVID-19 stay at home orders. Conclusions Mitigation measures and behavioral social distancing choices may have reduced respiratory viral spread in southern Puerto Rico.	[Quandelacy, Talia M.; Adams, Laura E.; Munoz, Jorge; Santiago, Gilberto A.; Kada, Sarah; Johansson, Michael A.; Paz-Bailey, Gabriela] Ctr Dis Control & Prevent, Dengue Branch, San Juan, PR 00920 USA; [Quandelacy, Talia M.] Univ Colorado, Dept Epidemiol, Anschutz Med Campus, Aurora, CO 80045 USA; [Alvarado, Luisa I.; Rivera-Amill, Vanessa] Ponce Hlth Sci Univ, Ponce, PR USA	Centers for Disease Control & Prevention - USA; University of Colorado System; University of Colorado Anschutz Medical Campus; Ponce Health Sciences University	Quandelacy, TM (corresponding author), Ctr Dis Control & Prevent, Dengue Branch, San Juan, PR 00920 USA.; Quandelacy, TM (corresponding author), Univ Colorado, Dept Epidemiol, Anschutz Med Campus, Aurora, CO 80045 USA.	tquandelacy@cdc.gov		Quandelacy, Talia/0000-0002-4059-577X; Kada, Sarah/0000-0002-0021-0492				Adams Laura E, 2019, Disaster Med Public Health Prep, P1, DOI 10.1017/dmp.2019.79; Agca H, 2021, J INFECT PUBLIC HEAL, V14, P1186, DOI 10.1016/j.jiph.2021.08.004; Andrus JK, 2020, AM J TROP MED HYG, V103, P593, DOI 10.4269/ajtmh.20-0571; [Anonymous], 2020, PUERTO RICO ANNOUNCE; Arriola CS, 2015, VACCINE, V33, P3829, DOI 10.1016/j.vaccine.2015.06.093; Baker RE, 2020, P NATL ACAD SCI USA, V117, P30547, DOI 10.1073/pnas.2013182117; Britton PN, 2020, LANCET CHILD ADOLESC, V4, pE42, DOI 10.1016/S2352-4642(20)30307-2; CDC, 2020, COR DIS 2019 COVID 1; CDC, 2022, COVID 19 TRAV; CDC, 2020, WEEKLY INFLUENZA SUR; CDC, 2020, PREV SEAS INFL; Centers for Disease Control and Prevention, 2020, FLU VACCINATION COVE; Cowling BJ, 2020, LANCET PUBLIC HEALTH, V5, pE279, DOI 10.1016/S2468-2667(20)30090-6; Dare R, 2016, J MED VIROL, V88, P1891, DOI 10.1002/jmv.24549; Davis WW, 2022, INFLUENZA OTHER RESP, V16, P568, DOI 10.1111/irv.12953; Dawood FS, 2020, MMWR-MORBID MORTAL W, V69, P177, DOI 10.15585/mmwr.mm6907a1; Government of Canada, 2020, FLUWATCH ANN REP 201; Health PRDo, 2020, SIST VIG INFL PUERT; Hodjat P, 2021, MICROBIOL SPECTR, V9, DOI 10.1128/Spectrum.00430-21; Itaya T, 2020, INT J INFECT DIS, V97, P78, DOI 10.1016/j.ijid.2020.05.088; Jackson ML., 2020, MEDRXIV; Kuo SC, 2020, EMERG INFECT DIS, V26, P1928, DOI 10.3201/eid2608.201192; Marzan-Rodriguez M, 2020, AM J PUBLIC HEALTH, V110, P1348, DOI 10.2105/AJPH.2020.305805; Olsen SJ, 2021, MMWR-MORBID MORTAL W, V70, P1013, DOI 10.15585/mmwr.mm7029a1; Olsen SJ, 2020, MMWR-MORBID MORTAL W, V69, P1305, DOI 10.15585/mmwr.mm6937a6; Organization WH, 2016, USE PCR SURVEILLANCE, V2011; Parry MF, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa511; Parums Dinah V, 2021, Med Sci Monit, V27, pe934949, DOI 10.12659/MSM.934949; Paulino RD, 2013, REV INST MED TROP SP, V55, P432, DOI 10.1590/S0036-46652013000600012; Paz-Bailey G, 2020, INFLUENZA OTHER RESP, V14, P515, DOI 10.1111/irv.12744; Sanchez-Gonzalez L, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247481; Sheller M, 2021, J SUSTAIN TOUR, V29, P1436, DOI 10.1080/09669582.2020.1791141; Singer BD, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd0086; Soo RJJ, 2020, EMERG INFECT DIS, V26, P1933, DOI 10.3201/eid2608.201229; Takahashi M, 2021, J MED VIROL, V93, P698, DOI 10.1002/jmv.26500; Tomashek KM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005859; Vicari AS, 2021, AM J TROP MED HYG, V105, P93, DOI 10.4269/ajtmh.21-0339; Wan WY, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.15973; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	39	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0266095	10.1371/journal.pone.0266095	http://dx.doi.org/10.1371/journal.pone.0266095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476785	Green Published, gold			2022-12-26	WOS:000840124300008
J	Stewart, TM; Fry, D; McAra, L; Hamilton, S; King, A; Laurie, M; McCluskey, G				Stewart, Tracy M.; Fry, Debi; McAra, Lesley; Hamilton, Sarah; King, Albert; Laurie, Margaret; McCluskey, Gillean			Rates, perceptions and predictors of depression, anxiety and Post Traumatic Stress Disorder (PTSD)-like symptoms about Covid-19 in adolescents	PLOS ONE			English	Article							MENTAL-HEALTH	Increasing evidence has shown that the Covid-19 outbreak, and subsequent school closures and exam cancellations that followed, has impacted adolescent mental health. The current cross-sectional study examined rates of depression, anxiety and Post Traumatic Stress Disorder (PTSD)-like symptoms about Covid-19 in adolescents and whether current or past mental health support, additional support in school, keyworker status, poorer household relationships since the outbreak of Covid-19 or reduced physical activity were associated with elevated levels of depression, anxiety or PTSD-like symptoms. Lastly, it examined perceived changes in mental health due to the Covid-19 pandemic, school closures and the cancellation of exams. A total of 899 adolescents (14-18 years) took part in the 'in isolation instead of in school' (INISS) project. Findings indicated that older adolescents, females, those who currently or previously received mental health support or additional support in school and adolescents who reported poorer relationships at home since Covid-19 were more likely to meet clinical threshold levels for their mental health. Adolescents highlighted worsening of their mental health due to Covid-19 and school closures with mixed positive and negative impact of exam cancellations. Adolescents experiencing clinical threshold levels of depression and anxiety uniquely reported worsening of their mental health since the Covid-19 pandemic, school closures and exam cancellations. Understanding the rates, perceptions and factors associated with increases in depression, anxiety and PTSD-like symptoms in adolescents during the Covid-19 pandemic will inform national policy in supporting adolescent mental health and recovery from the Covid-19 pandemic.	[Stewart, Tracy M.; Fry, Debi; Laurie, Margaret; McCluskey, Gillean] Univ Edinburgh, Moray House Sch Educ & Sport, Edinburgh, Midlothian, Scotland; [McAra, Lesley] Univ Edinburgh, Edinburgh Law Sch, Edinburgh, Midlothian, Scotland; [Hamilton, Sarah] UNICEF, London, England; [King, Albert] Scottish Govt, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Stewart, TM (corresponding author), Univ Edinburgh, Moray House Sch Educ & Sport, Edinburgh, Midlothian, Scotland.	Tracy.Stewart@ed.ac.uk	Laurie, Margaret/AAC-2169-2019	Laurie, Margaret/0000-0002-6774-6830; Stewart, Tracy/0000-0002-8807-1174	Chief Scientist Office [COV/EDI/20/16]; Knowledge Exchange and Impact Innovation Fund award from the University of Edinburgh	Chief Scientist Office; Knowledge Exchange and Impact Innovation Fund award from the University of Edinburgh	Funding for the study was provided from the Chief Scientist Office (grant reference: COV/EDI/20/16; PI: GM), and a Research, Knowledge Exchange and Impact Innovation Fund award from the University of Edinburgh (PI: TMS). The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altemus M, 2014, FRONT NEUROENDOCRIN, V35, P320, DOI 10.1016/j.yfrne.2014.05.004; Andrews JL, 2020, TRENDS COGN SCI, V24, P585, DOI 10.1016/j.tics.2020.05.001; Asbury K, 2021, J AUTISM DEV DISORD, V51, P1772, DOI 10.1007/s10803-020-04577-2; Barendse M., 2021, PSYARXIV PREPRINT, DOI [10.31234/osf.io/hn7us, DOI 10.31234/OSF.IO/HN7US]; Bhopal K., 2020, PREPRINT; Biddle SJH, 2019, PSYCHOL SPORT EXERC, V42, P146, DOI 10.1016/j.psychsport.2018.08.011; Biddle SJH, 2011, BRIT J SPORT MED, V45, P886, DOI 10.1136/bjsports-2011-090185; Bignardi G, 2021, ARCH DIS CHILD, V106, P791, DOI 10.1136/archdischild-2020-320372; Bronfenbrenner U., 2007, HDB CHILD DEV, V6th ed., P793, DOI DOI 10.1002/9780470147658.CHPSY0114; Brown B. B., 2009, HDB ADOLESCENT PSYCH, DOI DOI 10.1002/9780470479193.ADLPSY002004; Browne DT, 2015, WIRES COGN SCI, V6, P397, DOI 10.1002/wcs.1349; Chorpita BF., 2020, RESOURCES CHILD 1 FO; Collins WA., 1990, PARENT CHILD RELATIO, P85; Danese A, 2020, BRIT J PSYCHIAT, V216, P159, DOI 10.1192/bjp.2019.244; Davico C, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.572997; de Miranda DM, 2020, INT J DISAST RISK RE, V51, DOI 10.1016/j.ijdrr.2020.101845; Ebesutani C, 2012, PSYCHOL ASSESSMENT, V24, P833, DOI 10.1037/a0027283; Haag K, 2020, PSYCHOL MED, V50, P1755, DOI 10.1017/S0033291719001971; Hafstad GS, 2021, LANCET REG HEALTH-EU, V5, DOI 10.1016/j.lanepe.2021.100093; Levita L., 2020, PREPRINT, DOI [10.31234/osf.io/uq4rn, DOI 10.31234/OSF.IO/UQ4RN]; Lewis SJ, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n521; Lewis SJ, 2019, LANCET PSYCHIAT, V6, P247, DOI 10.1016/S2215-0366(19)30031-8; Liu HY, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102087; Magson NR, 2021, J YOUTH ADOLESCENCE, V50, P44, DOI 10.1007/s10964-020-01332-9; Mansfield Karen L, 2021, JCPP Adv, V1, pe12021, DOI 10.1002/jcv2.12021; Mansfield KL., SCH MENT HEALTH; McCluskey G, 2021, EMOT BEHAV DIFFIC, V26, P46, DOI 10.1080/13632752.2021.1903182; Neppl TK, 2016, J FAM PSYCHOL, V30, P12, DOI 10.1037/fam0000168; Newlove-Delgado T, 2021, LANCET PSYCHIAT, V8, P353, DOI 10.1016/S2215-0366(20)30570-8; Ng K, 2020, BMJ OPEN SPORT EXERC, V6, DOI 10.1136/bmjsem-2020-000919; O'Sullivan K, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18031062; Organisation for Economic Co-operation and Development OECD, 2021, SUPP YOUNG PEOPL MEN; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Perrin S, 2005, BEHAV COGN PSYCHOTH, V33, P487, DOI 10.1017/S1352465805002419; Pierce M, 2020, LANCET PSYCHIAT, V7, P883, DOI 10.1016/S2215-0366(20)30308-4; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Viner R, 2021, medRxiv, DOI 10.1101/2021.02.10.21251526; Racine N, 2022, EUR CHILD ADOLES PSY, V31, P1479, DOI 10.1007/s00787-020-01672-8; Repetti RL, 2002, PSYCHOL BULL, V128, P330, DOI 10.1037/0033-2909.128.2.330; Rosen ML, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0255294; Sadler K., 2018, MENTAL HLTH CHILDREN; Stewart-Brown S, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-15; Thapar A, 2012, LANCET, V379, P1056, DOI 10.1016/S0140-6736(11)60871-4; The Scottish Youth Parliament YouthLink Scotland and Young Scot, LOCKDOWNLOWDOWN WHAT; Thorisdottir IE, 2021, LANCET PSYCHIAT, V8, P663, DOI 10.1016/S2215-0366(21)00156-5; UN, POL BRIEF IMP COVID; Westrupp EM, 2021, EUR CHILD ADOLES PSY, DOI 10.1007/s00787-021-01861-z; Widnall E., 2020, YOUNG PEOPLES MENTAL; Woolf K, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-044753; Wright Nicola, 2021, JCPP Adv, V1, pe12008, DOI 10.1111/jcv2.12008; Xie XY, 2020, JAMA PEDIATR, V174, P898, DOI 10.1001/jamapediatrics.2020.1619; Xu DD, 2020, J AFFECT DISORDERS, V268, P20, DOI 10.1016/j.jad.2020.02.034; Zainudeen ZT, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-050523; Zhou SJ, 2020, EUR CHILD ADOLES PSY, V29, P749, DOI 10.1007/s00787-020-01541-4; Zijlmans J, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.692853	55	3	3	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0266818	10.1371/journal.pone.0266818	http://dx.doi.org/10.1371/journal.pone.0266818			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476795	Green Published, gold			2022-12-26	WOS:000840124300019
J	Dulacha, D; Were, V; Oyugi, E; Kiptui, R; Owiny, M; Boru, W; Gura, Z; Perry, RT				Dulacha, Diba; Were, Vincent; Oyugi, Elvis; Kiptui, Rebecca; Owiny, Maurice; Boru, Waqo; Gura, Zeinab; Perry, Robert T.			Reduction in malaria burden following the introduction of indoor residual spraying in areas protected by long-lasting insecticidal nets in Western Kenya, 2016-2018	PLOS ONE			English	Article							MORTALITY; EFFICACY	Background Long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS) are the main malaria vector control measures deployed in Kenya. Widespread pyrethroid resistance among the primary vectors in Western Kenya has necessitated the re-introduction of IRS using an organophosphate insecticide, pirimiphos-methyl (Actellic (R) 300CS), as a pyrethroid resistance management strategy. Evaluation of the effectiveness of the combined use of non-pyrethroid IRS and LLINs has yielded varied results. We aimed to evaluate the effect of non-pyrethroid IRS and LLINs on malaria indicators in a high malaria transmission area. Methods We reviewed records and tallied monthly aggregate of outpatient department (OPD) attendance, suspected malaria cases, those tested for malaria and those testing positive for malaria at two health facilities, one from Nyatike, an intervention sub-county, and one from Suba, a comparison sub-county, both located in Western Kenya, from February 1, 2016, through March 31, 2018. The first round of IRS was conducted in February-March 2017 in Nyatike sub-county and the second round one year later in both Nyatike and Suba sub-counties. The mass distribution of LLINs has been conducted in both locations. We performed descriptive analysis and estimated the effect of the interventions and temporal changes of malaria indicators using Poisson regression for a period before and after the first round of IRS. Results A higher reduction in the intervention area in total OPD, the proportion of OPD visits due to suspected malaria, testing positivity rate and annual malaria incidences were observed except for the total OPD visits among the under 5 children (59% decrease observed in the comparison area vs 33% decrease in the intervention area, net change -27%, P <0.001). The percentage decline in annual malaria incidence observed in the intervention area was more than twice the observed percentage decline in the comparison area across all the age groups. A marked decline in the monthly testing positivity rate (TPR) was noticed in the intervention area, while no major changes were observed in the comparison area. The monthly TPR reduced from 46% in February 2016 to 11% in February 2018, representing a 76% absolute decrease in TPR among all ages (RR = 0.24, 95% CI 0.12-0.46). In the comparison area, TPR was 16% in both February 2016 and February 2018 (RR = 1.0, 95% CI 0.52-2.09). A month-by-month comparison revealed lower TPR in Year 2 compared to Year 1 in the intervention area for most of the one year after the introduction of the IRS. Conclusions Our findings demonstrated a reduced malaria burden among populations protected by both non-pyrethroid IRS and LLINs implying a possible additional benefit afforded by the combined intervention in the malaria-endemic zone.	[Dulacha, Diba; Oyugi, Elvis; Owiny, Maurice; Boru, Waqo; Gura, Zeinab] Minist Hlth, Field Epidemiol & Lab Training Program, Nairobi, Kenya; [Were, Vincent] US Ctr Dis Control & Prevent, Nairobi, Kenya; [Kiptui, Rebecca] Minist Hlth, Natl Malaria Control Program, Nairobi, Kenya; [Perry, Robert T.] US Ctr Dis Control & Prevent, US Presidents Malaria Initiat Kenya, Malaria Branch, Div Parasit Dis & Malaria,Ctr Global Hlth, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Dulacha, D (corresponding author), Minist Hlth, Field Epidemiol & Lab Training Program, Nairobi, Kenya.	diba8088@gmail.com						Chen H, 2008, J MED ENTOMOL, V45, P242, DOI 10.1603/0022-2585(2008)45[242:MLAKRK]2.0.CO;2; Eisele TP, 2010, INT J EPIDEMIOL, V39, P88, DOI 10.1093/ije/dyq026; Gertler P. J., 2016, IMPACT EVALUATION PR; Gimnig JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145282; Hamel MJ, 2011, AM J TROP MED HYG, V85, P1080, DOI 10.4269/ajtmh.2011.10-0684; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; Kawada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022574; Kleinschmidt I, 2018, LANCET INFECT DIS, V18, P640, DOI 10.1016/S1473-3099(18)30172-5; Kleinschmidt I, 2009, AM J TROP MED HYG, V81, P519, DOI 10.4269/ajtmh.2009.81.519; MOH, 2015, INSECTICIDE RESISTAN; MOH, 2014, KEN MAL STRAT 2009 2; MoH, 2015, KENYA MALARIA INDICA; Noor A., 2016, EPIDEMIOLOGY CONTROL; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; Oguttu DW, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1871-3; Okia M, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2293-6; Pinder M, 2015, LANCET, V385, P1436, DOI 10.1016/S0140-6736(14)61007-2; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; PMI, 2017, PMI AFR IRS AIRS PRO; Protopopoff N, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-158; Pryce J, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000363.pub3; Raouf S, 2017, CLIN INFECT DIS, V65, P453, DOI 10.1093/cid/cix251; Saeed S, 2019, INT J PUBLIC HEALTH, V64, P637, DOI 10.1007/s00038-018-1195-2; Steinhardt LC, 2013, AM J TROP MED HYG, V88, P855, DOI 10.4269/ajtmh.12-0747; WHO, 2011, WORLD MALARIA REPORT 2011, P1; World Health Organization, 2015, IND RES SPRAYING OP	26	2	2	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0266736	10.1371/journal.pone.0266736	http://dx.doi.org/10.1371/journal.pone.0266736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35442999	Green Published, Green Submitted, gold			2022-12-26	WOS:000822608900033
J	Asante-Asamani, E; Grange, D; Rawal, D; Santiago, Z; Loustau, J; Brazill, D				Asante-Asamani, Emmanuel; Grange, Daniel; Rawal, Devarshi; Santiago, Zully; Loustau, John; Brazill, Derrick			A role for myosin II clusters and membrane energy in cortex rupture for Dictyostelium discoideum	PLOS ONE			English	Article							TUMOR-CELL INVASION; ACTIN; MIGRATION; DYNAMICS; SHAPE; CONTRACTION; PRESSURE; TENSION; BLEBS	Blebs, pressure driven protrusions of the cell membrane, facilitate the movement of eukaryotic cells such as the soil amoeba Dictyostelium discoideum, white blood cells and cancer cells. Blebs initiate when the cell membrane separates from the underlying cortex. A local rupture of the cortex, has been suggested as a mechanism by which blebs are initiated. However, much clarity is still needed about how cells inherently regulate rupture of the cortex in locations where blebs are expected to form. In this work, we examine the role of membrane energy and the motor protein myosin II (myosin) in facilitating the cell driven rupture of the cortex. We perform under-agarose chemotaxis experiments, using Dictyostelium discoideum cells, to visualize the dynamics of myosin and calculate changes in membrane energy in the blebbing region. To facilitate a rapid detection of blebs and analysis of the energy and myosin distribution at the cell front, we introduce an autonomous bleb detection algorithm that takes in discrete cell boundaries and returns the coordinate location of blebs with its shape characteristics. We are able to identify by microscopy naturally occurring gaps in the cortex prior to membrane detachment at sites of bleb nucleation. These gaps form at positions calculated to have high membrane energy, and are associated with areas of myosin enrichment. Myosin is also shown to accumulate in the cortex prior to bleb initiation and just before the complete disassembly of the cortex. Together our findings provide direct spatial and temporal evidence to support cortex rupture as an intrinsic bleb initiation mechanism and suggests that myosin clusters are associated with regions of high membrane energy where its contractile activity leads to a rupture of the cortex at points of maximal energy.	[Asante-Asamani, Emmanuel] Clarkson Univ, Dept Math, Potsdam, NY USA; [Grange, Daniel] SUNY Stony Brook, Dept Appl Math, New York, NY USA; [Rawal, Devarshi; Loustau, John] Hunter Coll, Math & Stat Dept, New York, NY USA; [Santiago, Zully] Baruch Coll, Dept Nat Sci, New York, NY USA; [Brazill, Derrick] Hunter Coll, Biol Sci Dept, New York, NY 10065 USA	Clarkson University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Baruch College (CUNY); City University of New York (CUNY) System; Hunter College (CUNY)	Brazill, D (corresponding author), Hunter Coll, Biol Sci Dept, New York, NY 10065 USA.	brazill@genectr.hunter.cuny.edu		Grange, Daniel/0000-0002-7643-496X; Asante-Asamani, Emmanuel/0000-0002-4710-8006	National Science Foundation [MCB-1244162]; PSC-CUNY grant [692710047]; Research Centers in Minority Institutions Program grant from the National Institute on Minority Health and Health Disparities-National Institutes of Health (NIH) [8G12 MD007599]; Research Initiative for Scientific Enhancement (RISE) program at Hunter College - NIH [GM060665]	National Science Foundation(National Science Foundation (NSF)); PSC-CUNY grant; Research Centers in Minority Institutions Program grant from the National Institute on Minority Health and Health Disparities-National Institutes of Health (NIH); Research Initiative for Scientific Enhancement (RISE) program at Hunter College - NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants to DB from the National Science Foundation (MCB-1244162, https://www.nsf.gov), a PSC-CUNY grant (692710047, https://www.cuny.edu/), as well as a Research Centers in Minority Institutions Program grant from the National Institute on Minority Health and Health Disparities-National Institutes of Health (NIH) (8G12 MD007599, https://www.nih.gov).ZS was supported by the Research Initiative for Scientific Enhancement (RISE) program at Hunter College which is funded by the NIH (GM060665, https://www.nih.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alert R, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.068101; Alert R, 2015, BIOPHYS J, V108, P1878, DOI 10.1016/j.bpj.2015.02.027; Bernard Q, 2018, P NATL ACAD SCI USA, V115, pE3788, DOI [10.1073/pnas.1718285115, 10.1073/pnas.1718595115]; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Broedersz CP, 2010, SOFT MATTER, V6, P4120, DOI 10.1039/c0sm00285b; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Chikina AS, 2019, J CELL BIOL, V218, P445, DOI 10.1083/jcb.201806075; Collier S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06875-9; Crevenna AH, 2015, ELIFE, V4, DOI 10.7554/eLife.04599; CUNNINGHAM CC, 1995, J CELL BIOL, V129, P1589, DOI 10.1083/jcb.129.6.1589; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; Evans L.C, 2010, PARTIAL DIFFERENTIAL; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gardel ML, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.158302; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Ibo M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163866; Kass M., 1987, Proceedings of the First International Conference on Computer Vision (Cat. No.87CH2465-3), P259, DOI 10.1007/BF00133570; Keller H, 1998, CELL MOTIL CYTOSKEL, V41, P181, DOI 10.1002/(SICI)1097-0169(1998)41:2<181::AID-CM8>3.3.CO;2-M; Kessin RH., 2001, DICTYOSTELIUM EVOLUT, V38; Landau L.D., 1987, PHYS TODAY; Langridye PD, 2006, EXP CELL RES, V312, P2009, DOI 10.1016/j.yexcr.2006.03.007; Lim FY, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/28004; Loustau J., 2017, ELEMENTS NUMERICAL A; Manakova K, 2016, BIOPHYS J, V110, P1636, DOI 10.1016/j.bpj.2016.03.008; Maugis B., 2004, J CELL SCI, V16, P3884; Paluch E, 2005, BIOPHYS J, V89, P724, DOI 10.1529/biophysj.105.060590; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Santiago Z, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211975; Sitarska E, 2020, CURR OPIN CELL BIOL, V66, P11, DOI 10.1016/j.ceb.2020.04.001; Strychalski W, 2016, BIOPHYS J, V110, P1168, DOI 10.1016/j.bpj.2016.01.012; Strychalski W, 2015, J COMPUT PHYS, V282, P77, DOI 10.1016/j.jcp.2014.10.004; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Tsujioka M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214736; Tyson RA, 2014, P NATL ACAD SCI USA, V111, P11703, DOI 10.1073/pnas.1322291111; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Woolley TE, 2017, PHYS REV E, V96, DOI 10.1103/PhysRevE.96.012409; Woolley TE, 2015, J THEOR BIOL, V380, P83, DOI 10.1016/j.jtbi.2015.04.023; Yoshida K, 2006, J CELL SCI, V119, P3833, DOI 10.1242/jcs.03152; Zatulovskiy E, 2014, J CELL BIOL, V204, P1027, DOI 10.1083/jcb.201306147	47	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0265380	10.1371/journal.pone.0265380	http://dx.doi.org/10.1371/journal.pone.0265380			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D9PO	35468148	gold, Green Published			2022-12-26	WOS:000794129600025
J	Bock, S; Schnabel, L				Bock, Sean; Schnabel, Landon			Distressed Democrats and relaxed Republicans? Partisanship and mental health during the COVID-19 pandemic	PLOS ONE			English	Article							CONSERVATIVES; HAPPIER	The COVID-19 pandemic was a potent stressor, yielding unprecedented levels of mental distress. However, public health responses and personal reactions to the pandemic were politically polarized, with Democrats highlighting and Republicans downplaying its severity. Did Republicans subsequently experience as much mental distress as Democrats during the COVID-19 pandemic? This study examines partisan patterns in mental health outcomes at three time points throughout the pandemic. Results demonstrate a clear partisan distress gap, with Democrats consistently reporting worse mental health than Republicans. Trend data suggest that the 2020 pandemic patterns are a continuation and exacerbation of an existing partisan distress gap. Consideration of race, however, demonstrates a widening partisan distress gap, specific to white Americans. Among white Americans, therefore, Democrats experienced a substantially greater increase in distress in response to the pandemic than Republicans.	[Bock, Sean] Harvard Univ, Dept Sociol, Cambridge, MA 02138 USA; [Schnabel, Landon] Cornell Univ, Dept Sociol, Uris Hall, Ithaca, NY 14853 USA	Harvard University; Cornell University	Schnabel, L (corresponding author), Cornell Univ, Dept Sociol, Uris Hall, Ithaca, NY 14853 USA.	schnabel@cornell.edu						Allcott H., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts); APA, 2020, NEW POLL COVID 19 IM; Betsch C., 2021, P NATL ACAD SCI US N, V118; Bierman A, 2020, J HEALTH SOC BEHAV, V61, P398, DOI 10.1177/0022146520970190; Bock S., 2021, SOCIUS, V7, P1; Brooks AC, 2017, OPINION DEPRESSED PO; Gadarian SK, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249596; Golberstein E., 2020, CORONAVIRUS DIS 2019, P819; Gravlee CC, 2009, AM J PHYS ANTHROPOL, V139, P47, DOI 10.1002/ajpa.20983; Green J, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc2717; Grossman G, 2020, P NATL ACAD SCI USA, V117, P24144, DOI 10.1073/pnas.2007835117; Hagerty Sarah L, 2020, Brain Behav Immun Health, V5, P100078, DOI 10.1016/j.bbih.2020.100078; Hu Y, 2021, FRONT SOCIOL, V6, DOI 10.3389/fsoc.2021.714626; Hu Y, 2021, J ADOLESCENT HEALTH, V69, P26, DOI 10.1016/j.jadohealth.2021.04.005; Kim HHS, 2021, GERONTOLOGIST, V61, P103, DOI 10.1093/geront/gnaa168; Krieger N, 2013, AM J PUBLIC HEALTH, V103, P2234, DOI 10.2105/AJPH.2013.301350; Lara-Millan A, 2014, AM SOCIOL REV, V79, P866, DOI 10.1177/0003122414549552; Lee J, 2020, LANCET CHILD ADOLESC, V4, P421, DOI 10.1016/S2352-4642(20)30109-7; Lench HC, 2019, EMOTION, V19, P1, DOI 10.1037/emo0000411; Link BG., 1995, SOCIAL CONDITIONS FU, P80; Liu JJ., 2020, MENTAL HLTH CONSIDER, P347; Makridis C., 2020, REAL COST POLITICAL; Napier JL, 2008, PSYCHOL SCI, V19, P565, DOI 10.1111/j.1467-9280.2008.02124.x; Newman DB, 2019, SOC PSYCHOL PERS SCI, V10, P494, DOI 10.1177/1948550618768241; NORC, 2020, COVID RESP TRACK STU; Rothwell JT, 2021, EFFECTS INFORM POLIC; Schlenker BR, 2012, J RES PERS, V46, P127, DOI 10.1016/j.jrp.2011.12.009; Schnabel L, 2022, J SCI STUD RELIG, V61, P530, DOI 10.1111/jssr.12720; Sharkey P, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2100846118; Simchon A, 2020, J EXP PSYCHOL GEN, V149, P2154, DOI 10.1037/xge0000767; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Van Hiel A, 2009, EUR J PERSONALITY, V23, P33, DOI 10.1002/per.702; van Stekelenburg A, 2021, J MED INTERNET RES, V23, DOI 10.2196/24069; Vargas-Salfate S, 2018, BRIT J SOC PSYCHOL, V57, P567, DOI 10.1111/bjso.12254; Wang Ke, PSYARXIV PREPRINTS, V2021; Weisel O, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2026745118; Yam KC, 2020, P NATL ACAD SCI USA, V117, P25429, DOI 10.1073/pnas.2009252117	37	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266562	10.1371/journal.pone.0266562	http://dx.doi.org/10.1371/journal.pone.0266562			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1F9GM	35446860	gold, Green Published			2022-12-26	WOS:000795468200037
J	Ecoffet, P; Fontbonne, N; Andre, JB; Bredeche, N				Ecoffet, Paul; Fontbonne, Nicolas; Andre, Jean-Baptiste; Bredeche, Nicolas			Policy search with rare significant events: Choosing the right partner to cooperate with	PLOS ONE			English	Article							CHOICE	This paper focuses on a class of reinforcement learning problems where significant events are rare and limited to a single positive reward per episode. A typical example is that of an agent who has to choose a partner to cooperate with, while a large number of partners are simply not interested in cooperating, regardless of what the agent has to offer. We address this problem in a continuous state and action space with two different kinds of search methods: a gradient policy search method and a direct policy search method using an evolution strategy. We show that when significant events are rare, gradient information is also scarce, making it difficult for policy gradient search methods to find an optimal policy, with or without a deep neural architecture. On the other hand, we show that direct policy search methods are invariant to the rarity of significant events, which is yet another confirmation of the unique role evolutionary algorithms has to play as a reinforcement learning method.	[Ecoffet, Paul; Fontbonne, Nicolas; Bredeche, Nicolas] Sorbonne Univ, ISIR, CNRS, Paris, France; [Andre, Jean-Baptiste] Ecole Normale Super, Inst Jean Nicod, Dept Etud Cognit, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Bredeche, N (corresponding author), Sorbonne Univ, ISIR, CNRS, Paris, France.	nicolas.bredeche@sorbonne-universite.fr			Agence Nationale pour la Recherche [ANR-17-EURE-0017]	Agence Nationale pour la Recherche(French National Research Agency (ANR))	We would like to thank Yann Chevaleyre, Olivier Sigaud and Mathieu Seurin for feedbacks and comments.	Allen-Zhu Z, 2019, PR MACH LEARN RES, V97; [Anonymous], 2017, 5 INT C LEARN REPR I; [Anonymous], RAY GEN PURPOSE UNIV; Arefin MR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72971-y; Auger A, 2005, IEEE C EVOL COMPUTAT, P1769; Bhatnagar S, 2006, J MACH LEARN RES, V7, P1937; Bshary R, 2003, DAHL WS ENV, P167; Campenni M, 2014, J THEOR BIOL, V344, P49, DOI 10.1016/j.jtbi.2013.11.019; Ciosek K, 2017, AAAI CONF ARTIF INTE, P1819; CMA-ES, COV MATR AD EV STRAT; Conti E., 2017, ARXIV171206560; Debove S, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0392; Du SS, 2018, PR MACH LEARN RES, V80; Ecoffet P., 2020, ARTIFICIAL LIFE C P, P251; Ecoffet P, 2021, J THEOR BIOL, V527, DOI 10.1016/j.jtbi.2021.110805; Frank J., 2008, P 25 INT C MACHINE L, P336; Fudenberg D., 1998, THEORY LEARNING GAME, V36; Greif A., 2010, PRIMER GAME THEORY, V4; Hansen N, 2001, EVOL COMPUT, V9, P159, DOI 10.1162/106365601750190398; HANSEN N, 2006, NEW EVOLUTIONARY COM, P75, DOI DOI 10.1007/3-540-32494-1_4; Hansen N., 2020, CMA PYCMA R3 0 3; Igel C, 2003, IEEE C EVOL COMPUTAT, P2588; Konidaris G., 2006, P 23 INT C MACH LEAR, P489, DOI DOI 10.1145/1143844.1143906; McNamara JM, 2008, NATURE, V451, P189, DOI 10.1038/nature06455; Morse G, 2016, GECCO'16: PROCEEDINGS OF THE 2016 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P477, DOI 10.1145/2908812.2908916; Neyshabur B., 2018, ARXIV180512076; Papadimitriou C. H., 2001, PROC 33 S THEORY COM, P749, DOI DOI 10.1145/380752.380883; Pytorch, US; Riedmiller M, 2018, PR MACH LEARN RES, V80; RLlib, IND GRAD REINF LEARN; Salimans T., 2017, EVOLUTION STRATEGIES; Schulman J., 2015, ARXIV PREPRINT ARXIV; Schulman J., 2017, PROXIMAL POLICY OPTI, DOI 10.48550/arXiv.1707.06347; Schulman J, 2015, PR MACH LEARN RES, V37, P1889; Sigaud O, 2019, NEURAL NETWORKS, V113, P28, DOI 10.1016/j.neunet.2019.01.011; Simms EL, 2002, INTEGR COMP BIOL, V42, P369, DOI 10.1093/icb/42.2.369; Such FP, 2017, ARXIV171206567; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; TANIMOTO J., 2021, SOCIOPHYSICS APPROAC; Weibull J W, 1997, EVOLUTIONARY GAME TH; Wilkinson GS, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0095	42	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266841	10.1371/journal.pone.0266841	http://dx.doi.org/10.1371/journal.pone.0266841			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35472212	Green Submitted, Green Published, gold			2022-12-26	WOS:000816171900009
J	Jain, K; Stanage, TH; Wood, EA; Cox, MM				Jain, Kanika; Stanage, Tyler H.; Wood, Elizabeth A.; Cox, Michael M.			The Escherichia coli serS gene promoter region overlaps with the rarA gene	PLOS ONE			English	Article							ARRESTED REPLICATION FORKS; RECOMBINATION PROTEINS; POSTREPLICATION REPAIR; DNA-REPLICATION; RECA PROTEIN; BINDING; RESCUE; TRANSCRIPTION; CHROMOSOME; PATHWAYS	Deletion of the entire gene encoding the RarA protein of Escherichia coli results in a growth defect and additional deficiencies that were initially ascribed to a lack of RarA function. Further work revealed that most of the effects reflected the presence of sequences in the rarA gene that affect expression of the downstream gene, serS. The serS gene encodes the seryl aminoacyl-tRNA synthetase. Decreases in the expression of serS can trigger the stringent response. The sequences that affect serS expression are located in the last 15 nucleotides of the rarA gene.	[Jain, Kanika; Stanage, Tyler H.; Wood, Elizabeth A.; Cox, Michael M.] Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Jain, K (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.	kjain5@wisc.edu			National Institutes of Health [RM1 GM130450]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work has been funded by the National Institutes of Health grant RM1 GM130450 awarded to MMC. (https://reporter.nih.gov/search/96Y00MTMIE2nWHo0t_XG6w/project-details/10152643) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2013, ANNU REV GENET, V47, P1, DOI 10.1146/annurev-genet-111212-133232; BARON C, 1991, J BIOL CHEM, V266, P20375; Barre FX, 2001, P NATL ACAD SCI USA, V98, P8189, DOI 10.1073/pnas.111008998; Bichara M, 2011, MUTAT RES-REV MUTAT, V727, P104, DOI 10.1016/j.mrrev.2011.04.003; BLANAR MA, 1984, P NATL ACAD SCI-BIOL, V81, P4622, DOI 10.1073/pnas.81.15.4622; Bork JM, 2001, EMBO J, V20, P7313, DOI 10.1093/emboj/20.24.7313; Branzei D, 2017, CRIT REV BIOCHEM MOL, V52, P381, DOI 10.1080/10409238.2017.1304355; Bremer Hans, 2008, EcoSal Plus, V3, DOI 10.1128/ecosal.5.2.3; Byrne RT, 2014, J BACTERIOL, V196, P3534, DOI 10.1128/JB.01589-14; Courcelle J, 2001, P NATL ACAD SCI USA, V98, P8196, DOI 10.1073/pnas.121008898; Courcelle J, 2015, DNA REPAIR, V32, P86, DOI 10.1016/j.dnarep.2015.04.018; Cox MM, 2001, ANNU REV GENET, V35, P53, DOI 10.1146/annurev.genet.35.102401.090016; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Cox MM, 2000, PROG NUCLEIC ACID RE, V63, P311, DOI 10.1016/S0079-6603(08)60726-6; Cox MM, 2002, MUTAT RES-FUND MOL M, V510, P107, DOI 10.1016/S0027-5107(02)00256-7; Dai XF, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.231; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dutra BE, 2007, P NATL ACAD SCI USA, V104, P216, DOI 10.1073/pnas.0608293104; Fleur TL., 2021, BIORXIV; Fuchs RP, 2016, DNA REPAIR, V44, P51, DOI 10.1016/j.dnarep.2016.05.006; Goodman MF, 2014, J BIOL CHEM, V289, P26772, DOI 10.1074/jbc.X114.607374; Gourse RL, 2018, ANNU REV MICROBIOL, V72, P163, DOI 10.1146/annurev-micro-090817-062444; Grompone G, 2004, MOL MICROBIOL, V52, P551, DOI 10.1111/j.1365-2958.2004.03997.x; Hauryliuk V, 2015, NAT REV MICROBIOL, V13, P298, DOI 10.1038/nrmicro3448; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Henrikus SS, 2018, CURR GENET, V64, P1189, DOI 10.1007/s00294-018-0840-x; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Huang LC, 1997, J BACTERIOL, V179, P6076, DOI 10.1128/jb.179.19.6076-6083.1997; Jain K, 2021, PLOS GENET, V17, DOI 10.1371/journal.pgen.1009972; Jain K, 2021, MOL MICROBIOL, V115, P1122, DOI 10.1111/mmi.14655; Keller KL, 2001, MUTAT RES-DNA REPAIR, V486, P21, DOI 10.1016/S0921-8777(01)00077-5; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; Kim T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005278; Klein HL, 2002, MOL CELL, V9, P471, DOI 10.1016/S1097-2765(02)00493-8; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8241, DOI 10.1073/pnas.131009198; KUZMINOV A, 1995, MOL MICROBIOL, V16, P373, DOI 10.1111/j.1365-2958.1995.tb02403.x; Kuzminov A, 1999, GENE DEV, V13, P345, DOI 10.1101/gad.13.3.345; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8461, DOI 10.1073/pnas.151260698; KUZMINOV A, 1993, BIOESSAYS, V15, P355, DOI 10.1002/bies.950150511; LEINFELDER W, 1988, NATURE, V331, P723, DOI 10.1038/331723a0; Lenski R E, 1991, Biotechnology, V15, P173; Lestini R, 2007, EMBO J, V26, P3804, DOI 10.1038/sj.emboj.7601804; Liu KQ, 2015, CURR OPIN MICROBIOL, V24, P72, DOI 10.1016/j.mib.2015.01.012; LLOYD RG, 1988, MOL GEN GENET, V212, P317, DOI 10.1007/BF00334702; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lovett ST, 2002, GENETICS, V160, P851; Lovett ST, 2017, DNA REPAIR, V56, P118, DOI 10.1016/j.dnarep.2017.06.014; Mangiameli SM, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006582; McCool JD, 2004, MOL MICROBIOL, V53, P1343, DOI 10.1111/j.1365-2958.2004.04225.x; Mendoza-Vargas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007526; Merrikh H, 2012, NAT REV MICROBIOL, V10, P449, DOI 10.1038/nrmicro2800; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Michel B, 2000, MOL MICROBIOL, V37, P180, DOI 10.1046/j.1365-2958.2000.01989.x; Michel B, 2000, TRENDS BIOCHEM SCI, V25, P173, DOI 10.1016/S0968-0004(00)01560-7; Michel B, 2001, P NATL ACAD SCI USA, V98, P8181, DOI 10.1073/pnas.111008798; Michel B, 2007, DNA REPAIR, V6, P967, DOI 10.1016/j.dnarep.2007.02.016; Michel B, 2017, MOL MICROBIOL, V104, P1008, DOI 10.1111/mmi.13677; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; ROTHMAN RH, 1977, MOL GEN GENET, V155, P267, DOI 10.1007/BF00272805; Sherratt DJ, 2004, PHILOS T R SOC B, V359, P61, DOI 10.1098/rstb.2003.1365; Shibata T, 2005, GENES CELLS, V10, P181, DOI 10.1111/j.1365-2443.2005.00831.x; Srivatsan A, 2008, CURR OPIN MICROBIOL, V11, P100, DOI 10.1016/j.mib.2008.02.001; Syeda AH, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016550; TOSA T, 1971, J BACTERIOL, V106, P966, DOI 10.1128/JB.106.3.966-971.1971; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; UMEZU K, 1994, J BIOL CHEM, V269, P30005	70	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0260282	10.1371/journal.pone.0260282	http://dx.doi.org/10.1371/journal.pone.0260282			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1E2NP	35427362	Green Published, Green Submitted, gold			2022-12-26	WOS:000794332400003
J	Kaneko, N; Sasaki, A; Yokoyama, H; Masugi, Y; Nakazawa, K				Kaneko, Naotsugu; Sasaki, Atsushi; Yokoyama, Hikaru; Masugi, Yohei; Nakazawa, Kimitaka			Effects of action observation and motor imagery of walking on the corticospinal and spinal motoneuron excitability and motor imagery ability in healthy participants	PLOS ONE			English	Article							PARKINSONS-DISEASE; GAIT; MODULATION; PLASTICITY; REHABILITATION; TASK	Action observation (AO) and motor imagery (MI) are used for the rehabilitation of patients who face difficulty walking. Rehabilitation involving AO, MI, and AO combined with MI (AO+MI) facilitates gait recovery after neurological disorders. However, the mechanism by which it positively affects gait function is unclear. We previously examined the neural mechanisms underlying AO and MI of walking, focusing on AO+MI and corticospinal and spinal motor neuron excitability, which play important roles in gait function. Herein, we investigated the effects of a short intervention using AO+MI of walking on the corticospinal and spinal motor neuron excitability and MI ability of participants. Twelve healthy individuals participated in this study, which consisted of a 20 min intervention. Before the experiment, we measured MI ability using the Vividness of Movement Imagery Questionnaire-2 (VMIQ-2). We used motor evoked potential and F-wave measurements to evaluate the corticospinal and spinal motor neuron excitability at rest, pre-intervention, 0 min, and 15 min post-intervention. We also measured corticospinal excitability during MI of walking and the participant's ability to perform MI using a visual analog scale (VAS). There were no significant changes in corticospinal and spinal motor neuron excitability during and after the intervention using AO+MI (p>0.05). The intervention temporarily increased VAS scores, thus indicating clearer MI (p<0.05); however, it did not influence corticospinal excitability during MI of walking (p>0.05). Furthermore, there was no significant correlation between the VMIQ-2 and VAS scores and changes in corticospinal and spinal motor neuron excitability. Therefore, one short intervention using AO+MI increased MI ability in healthy individuals; however, it was insufficient to induce plastic changes at the cortical and spinal levels. Moreover, the effects of intervention using AO+MI were not associated with MI ability. Our findings provide information about intervention using AO+MI in healthy individuals and might be helpful in planning neurorehabilitation strategies.	[Kaneko, Naotsugu; Sasaki, Atsushi; Yokoyama, Hikaru; Masugi, Yohei; Nakazawa, Kimitaka] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan; [Kaneko, Naotsugu; Sasaki, Atsushi] Japan Soc Promot Sci, Tokyo, Japan; [Masugi, Yohei] Tokyo Int Univ, Sch Hlth Sci, Saitama, Japan	University of Tokyo; Japan Society for the Promotion of Science	Nakazawa, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan.	nakazawa@idaten.c.u-tokyo.ac.jp	Yokoyama, Hikaru/GLT-6054-2022	Kaneko, Naotsugu/0000-0002-1587-9287	Meiji Yasuda Life Foundation of Health and Welfare [19J21897]; Meiji Yasuda Life Foundation of Health and Welfare; JSPS [18H04082]; Iwadare Scholarship Foundation; TOBE MAKI Scholarship Foundation; Tomiyama Cultural Foundation; University of Tokyo Edge Capital Partners Co., Ltd.	Meiji Yasuda Life Foundation of Health and Welfare(Meiji Yasuda Life Foundation of Health and Welfare); Meiji Yasuda Life Foundation of Health and Welfare(Meiji Yasuda Life Foundation of Health and Welfare); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Iwadare Scholarship Foundation; TOBE MAKI Scholarship Foundation; Tomiyama Cultural Foundation; University of Tokyo Edge Capital Partners Co., Ltd.	This work was supported by a Grant-in -Aid for Japan Society for the Promotion of Science (JSPS) Fellows to N.K. [#19J21897], Meiji Yasuda Life Foundation of Health and Welfare to N. K., and Grant-in-Aid for Scientific Research (A) from JSPS to K.N. [#18H04082]. N.K. acknowledges the scholarship from the Iwadare Scholarship Foundation, TOBE MAKI Scholarship Foundation, Tomiyama Cultural Foundation, and The University of Tokyo Edge Capital Partners Co., Ltd.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avanzino L, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00105; Bakker M, 2008, CLIN NEUROPHYSIOL, V119, P2519, DOI 10.1016/j.clinph.2008.07.282; Bang DH, 2013, CLIN REHABIL, V27, P1118, DOI 10.1177/0269215513501528; Bassolino M, 2014, CEREB CORTEX, V24, P3268, DOI 10.1093/cercor/bht190; Berends HI, 2013, EXP BRAIN RES, V229, P337, DOI 10.1007/s00221-013-3571-8; Bisio A, 2019, J PHYSIOL-LONDON, V597, P3233, DOI 10.1113/JP277799; Bisio A, 2015, CLIN NEUROPHYSIOL, V126, P1212, DOI 10.1016/j.clinph.2014.08.024; Bonassi G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09597-0; Bovonsunthonchai S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63914-8; Burianova H, 2016, CEREB CORTEX, V26, P1072, DOI 10.1093/cercor/bhu287; Caligiore D, 2019, FRONT SYST NEUROSCI, V13, DOI 10.3389/fnsys.2019.00007; Caligiore D, 2017, NEUROSCI BIOBEHAV R, V72, P210, DOI 10.1016/j.neubiorev.2016.11.005; Cheng YW, 2005, NEUROREPORT, V16, P1711, DOI 10.1097/01.wnr.0000183325.13618.5f; Cohen J.E., 1988, STAT POWER ANAL BEHA; Debarnot U, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88142-6; Decety J, 1996, BEHAV BRAIN RES, V77, P45, DOI 10.1016/0166-4328(95)00225-1; Deutsch JE, 2012, PHYS THER, V92, P1065, DOI 10.2522/ptj.20110277; Dickstein R, 2004, PHYS THER, V84, P1167, DOI 10.1093/ptj/84.12.1167; Eaves DL, 2016, BRAIN COGNITION, V106, P90, DOI 10.1016/j.bandc.2016.04.013; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Fadiga L, 1999, NEUROPSYCHOLOGIA, V37, P147; Holmes PS, 2017, CURR OPIN PSYCHOL, V16, P43, DOI 10.1016/j.copsyc.2017.03.009; Iseki K, 2008, NEUROIMAGE, V41, P1021, DOI 10.1016/j.neuroimage.2008.03.010; Kaneko N, 2021, NEUROIMAGE, V225, DOI 10.1016/j.neuroimage.2020.117486; Kaneko N, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9120333; Kaneko N, 2018, NEUROSCI LETT, V684, P218, DOI 10.1016/j.neulet.2018.07.041; Kaneko N, 2018, NEUROREPORT, V29, P169, DOI 10.1097/WNR.0000000000000941; Knikou M, 2014, J NEUROPHYSIOL, V111, P2264, DOI 10.1152/jn.00871.2013; Lapole T, 2012, APPL PHYSIOL NUTR ME, V37, P657, DOI [10.1139/H2012-032, 10.1139/h2012-032]; Loporto M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064911; Marusic U, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/5651391; Meers R, 2020, CORTEX, V126, P322, DOI 10.1016/j.cortex.2020.01.012; Miyai I, 2001, NEUROIMAGE, V14, P1186, DOI 10.1006/nimg.2001.0905; Moriuchi T, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.581652; Morse DT, 1999, EDUC PSYCHOL MEAS, V59, P518, DOI 10.1177/00131649921969901; Mouthon A, 2015, NEUROSCIENCE, V303, P535, DOI 10.1016/j.neuroscience.2015.07.031; Nedelko V, 2012, J NEUROL PHYS THER, V36, P182, DOI 10.1097/NPT.0b013e318272cad1; Perez MA, 2004, EXP BRAIN RES, V159, P197, DOI 10.1007/s00221-004-1947-5; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Roberts R, 2008, J SPORT EXERCISE PSY, V30, P200, DOI 10.1123/jsep.30.2.200; Rosenthal Robert, 1994, HDB RES SYNTHESIS, V621, P231; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; Sakamoto M, 2009, NEUROSCI RES, V65, P23, DOI 10.1016/j.neures.2009.05.003; Sarasso E, 2021, MOVEMENT DISORD, V36, P2569, DOI 10.1002/mds.28717; Takahashi M, 2008, NEUROREPORT, V19, P727, DOI 10.1097/WNR.0b013e3282fd0dc3; Takahashi Y, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00149; Villiger M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072403; Vogt S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00807; Williams J, 2012, BEHAV BRAIN RES, V226, P369, DOI 10.1016/j.bbr.2011.09.014; Wright DJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00951; Yamazaki Y, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01361; Yasui T, 2019, EXP BRAIN RES, V237, P637, DOI 10.1007/s00221-018-5454-5; ZAPPIA M, 1993, ELECTROEN CLIN NEURO, V89, P67, DOI 10.1016/0168-5597(93)90087-6	53	2	2	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266000	10.1371/journal.pone.0266000	http://dx.doi.org/10.1371/journal.pone.0266000			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7MW	35436303	gold, Green Published			2022-12-26	WOS:000791258900001
J	Liu, C; Kobayashi, T; Shiba, T; Hayashi, N				Liu, Chihyun; Kobayashi, Tatsuhiko; Shiba, Tomoaki; Hayashi, Naoyuki			Effects of aging and exercise habits on blood flow profile of the ocular circulation	PLOS ONE			English	Article							LASER SPECKLE FLOWGRAPHY; OPTIC-NERVE HEAD; INTRAOCULAR-PRESSURE; AEROBIC EXERCISE; MODEL; RISK; STIFFNESS; WOMEN	Purpose We examined the effects of aging and exercise habits on the ocular blood flow (OBF) and its profiles throughout the optic nerve head region and choroidal area. We hypothesized that exercise habits reduce the stiffness of vessels in the ocular circulation, which generally increases with aging. Methods Participants in a medical checkup program (698 males and 192 females aged 28 to 80 years) were categorized into 2 groups (with and without exercise habits) based on participant self-reporting and the definition of the Ministry of Health, Labor and Welfare of Japan (MHLW). OBF in the right eye was measured and analyzed using laser speckle blow-graphy. The blowout time (BOT), which is the time during which the blood flow is higher than half of the mean of the minimum and maximum signals during one heartbeat, was calculated as an index of the blood flow profile. BOT has been used as an indicator of the flexibility of blood vessels. Results BOT significantly decreased with aging. Neither the self-reported nor MHLW-based exercise habits significantly affected the ocular circulation. Conclusion These results indicate that the stiffness of the ocular vessels increases with aging, and this cannot be prevented by exercise habits.	[Liu, Chihyun; Hayashi, Naoyuki] Tokyo Inst Technol, Sch Environm & Soc, Dept Social & Human Sci, Tokyo, Japan; [Kobayashi, Tatsuhiko] Toho Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan; [Shiba, Tomoaki] Int Univ Hlth & Welf, Narita Hosp, Dept Ophthalmol, Chiba, Japan; [Hayashi, Naoyuki] Waseda Univ, Fac Sport Sci, Saitama, Japan	Tokyo Institute of Technology; Toho University; International University of Health & Welfare; Waseda University	Hayashi, N (corresponding author), Tokyo Inst Technol, Sch Environm & Soc, Dept Social & Human Sci, Tokyo, Japan.; Hayashi, N (corresponding author), Waseda Univ, Fac Sport Sci, Saitama, Japan.	naohayashi@waseda.jp	Hayashi, Naoyuki/C-1457-2015	Hayashi, Naoyuki/0000-0002-9814-3530	JSPS KAKENHI [21K11643]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 21K11643 to NH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa N, 2014, INVEST OPHTH VIS SCI, V55, P7991, DOI 10.1167/iovs.14-15373; Aizawa N, 2011, CLIN OPHTHALMOL, V5, P1171, DOI 10.2147/OPTH.S22093; Anderson AJ, 2019, OPHTHALMOLOGY, V126, P965, DOI 10.1016/j.ophtha.2018.12.035; Anderson FA, 2003, CIRCULATION, V107, pI9, DOI 10.1161/01.CIR.0000078469.07362.E6; [Anonymous], 2005, Nihon Naika Gakkai Zasshi, V94, P794; Aoyagi Y, 2010, EUR J APPL PHYSIOL, V109, P455, DOI 10.1007/s00421-010-1357-2; Armstrong MEG, 2015, CIRCULATION, V131, P721, DOI 10.1161/CIRCULATIONAHA.114.010296; Ashor AW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110034; Dinenno FA, 2001, J PHYSIOL-LONDON, V531, P573, DOI 10.1111/j.1469-7793.2001.0573i.x; Ferrier KE, 2001, HYPERTENSION, V38, P222, DOI 10.1161/01.HYP.38.2.222; Fukuoka S, 2008, ACTA OPHTHALMOL, V86, P434, DOI 10.1111/j.1600-0420.2007.01068.x; Green DJ, 2009, EXERC SPORT SCI REV, V37, P196, DOI 10.1097/JES.0b013e3181b7b6e3; Haraguchi N, 2019, HYPERTENS RES, V42, P1599, DOI 10.1038/s41440-019-0264-0; Hayashi K, 2005, JPN J PHYSIOL, V55, P235, DOI 10.2170/jjphysiol.S2116; Kiyota N, 2018, INVEST OPHTH VIS SCI, V59, P3488, DOI 10.1167/iovs.18-23872; KLEIN BEK, 1992, INVEST OPHTH VIS SCI, V33, P2224; Kobayashi T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52145-1; Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Krasnicki Pawel, 2006, Klin Oczna, V108, P294; Lee MJ, 2019, OPHTHALMOLOGY, V126, P958, DOI 10.1016/j.ophtha.2018.10.012; Luft N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168190; Miyaji A., 2016, J AGING SCI, V4, P148, DOI [10.4172/2329-8847.1000148, DOI 10.4172/2329-8847.1000148]; Quigley C, 2019, J AAPOS, V23, P159, DOI 10.1016/j.jaapos.2018.12.011; Rand R., 2005, SHIELDS TXB GLAUCOMA, VFifth; Reitsamer HA, 2002, INVEST OPHTH VIS SCI, V43, P3728; ROBINSON F, 1986, INVEST OPHTH VIS SCI, V27, P722; Ryskulova A, 2008, AM J PUBLIC HEALTH, V98, P454, DOI 10.2105/AJPH.2006.098202; Santos-Parker JR, 2014, ADV PHYSIOL EDUC, V38, P296, DOI 10.1152/advan.00088.2014; Seals DR, 2001, J AM COLL CARDIOL, V38, P506, DOI 10.1016/S0735-1097(01)01348-1; Shiba T, 2017, GRAEF ARCH CLIN EXP, V255, P99, DOI 10.1007/s00417-016-3521-9; Shibata S, 2018, J PHYSIOL-LONDON, V596, P2783, DOI 10.1113/JP275301; Shiga Y, 2013, INVEST OPHTH VIS SCI, V54, P7699, DOI 10.1167/iovs.13-12930; Sugiyama T, 2014, PHOTONICS, V1, P220, DOI 10.3390/photonics1030220; Takahashi H, 2013, EXP EYE RES, V108, P10, DOI 10.1016/j.exer.2012.12.003; Takeshima S, 2019, INVEST OPHTH VIS SCI, V60, P677, DOI 10.1167/iovs.18-25694; Tanaka S, 2019, ANN HUM BIOL, V46, P305, DOI 10.1080/03014460.2019.1635644; Teramoto T, 2008, J ATHEROSCLER THROMB, V15, P1, DOI 10.5551/jat.E580; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; Wang L, 2012, INVEST OPHTH VIS SCI, V53, P8303, DOI 10.1167/iovs.12-10911; Wang YX, 2019, INT J OPHTHALMOL-CHI, V12, P510, DOI 10.18240/ijo.2019.03.24; Wen SW, 2019, MICROCIRCULATION, V26, DOI 10.1111/micc.12463; World Health Organization, 2019, UN EYE HLTH GLOB ACT, P119; Wu SY, 1997, ARCH OPHTHALMOL-CHIC, V115, P1572, DOI 10.1001/archopht.1997.01100160742012; Yanagida K, 2015, INVEST OPHTH VIS SCI, V56, P4880, DOI 10.1167/iovs.15-16567	44	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266684	10.1371/journal.pone.0266684	http://dx.doi.org/10.1371/journal.pone.0266684			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421147	Green Published, gold			2022-12-26	WOS:000795453600058
J	Nasar, S; Ostevik, K; Murtaza, G; Rausher, MD				Nasar, Sidra; Ostevik, Kate; Murtaza, Ghulam; Rausher, Mark D.			Morphological and molecular characterization of variation in common bean (Phaseolus vulgaris L.) germplasm from Azad Jammu and Kashmir, Pakistan	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENETIC DIVERSITY; DOMESTICATION; LANDRACES; REGION; ACCESSIONS; GROWTH	Phaseolus vulgaris, an essential food and source of protein, is cultivated across the world. This study was carried out to investigate the diversity and population structure of 34 P. vulgaris landrace accessions collected from the Azad Jammu and Kashmir (AJ&K) regions of Pakistan. The samples were analyzed both morphologically and using genetic variation identified through RNA sequencing. Our results indicated that most genetic variation occurs among local accessions, with little genetic variation occurring between geographical regions. In addition, the accessions fell into two major genetic groups. Morphological analysis revealed that these two genetic groups differ in a number of quantitative traits, including seed length, seed width, and seed weight. One accession, DUD-11, appears to be a mixture of the two major groups genetically as well as morphologically. Among the other accessions, DUD-8, RWK-2, and NGD-1 depicted particularly high seed weight along with higher seed length, seed width, and seed yield per plant. We suggest focusing on these accessions in future breeding programs. More generally, our results provide baseline data that will be useful for crop improvement and effective cultivation practices in Pakistan.	[Nasar, Sidra; Murtaza, Ghulam] Univ Azad Jammu & Kashmir, Dept Bot, Muzaffarabad, Pakistan; [Ostevik, Kate; Rausher, Mark D.] Duke Univ, Dept Biol, Durham, NC USA; [Ostevik, Kate] Univ Calif Riverside, Dept Evolut Ecol & Organismal Biol, Riverside, CA USA	University of Azad Jammu & Kashmir; Duke University; University of California System; University of California Riverside	Rausher, MD (corresponding author), Duke Univ, Dept Biol, Durham, NC USA.	mrausher@duke.edu	Ostevik, Kate/AAL-6594-2020; Murtaza, Ghulam/S-4561-2017	Ostevik, Kate/0000-0002-2197-9284; Murtaza, Ghulam/0000-0001-8495-2217	National Science Foundation (USA) [DEB 1542387]	National Science Foundation (USA)(National Science Foundation (NSF))	Incidental materials for genetic analyses funded in part by National Science Foundation (USA) grant DEB 1542387 to MDR.	Abbasi MA., 2018, J APP AGR BIOTEC, V2, P21; Ali A., 2020, PURE APPL BIOL, V9, P528, DOI [10.19045/bspab.2020.90058, DOI 10.19045/BSPAB.2020.90058]; ASIM M, 2011, PAK J BOT, V43, P213; Banoo A, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.571618; Bitocchi E, 2013, NEW PHYTOL, V197, P300, DOI 10.1111/j.1469-8137.2012.04377.x; Bitocchi E, 2012, P NATL ACAD SCI USA, V109, pE788, DOI 10.1073/pnas.1108973109; Bode D., 2013, Agriculture and Forestry, V59, P175; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buah S, 2017, GENET RESOUR CROP EV, V64, P1985, DOI 10.1007/s10722-017-0490-8; BURTON GW, 1953, AGRON J, V45, P478, DOI 10.2134/agronj1953.00021962004500100005x; Cabral PDS, 2018, GENET MOL RES, V17, DOI 10.4238/gmr18106; Celmeli T, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8090166; Chhatre VE, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1593-0; Lobaton JD, 2018, PLANT GENOME-US, V11, DOI 10.3835/plantgenome2017.08.0068; De Luca D, 2018, GENETICA, V146, P29, DOI 10.1007/s10709-017-9994-6; Delfini J, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82437-4; DUNCAN WG, 1968, CROP SCI, V8, P670, DOI 10.2135/cropsci1968.0011183X000800060009x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans A. M., 1973, Potentials of field beans and other food legumes in Latin America.: Adams, M. W. : Plant architecture and physiological efficiency in the field bean., P279; Evans A. M., 1980, Advances in legume science (Summerfield, R.J.; Bunting, A.H. [Editors])., P337; Freyre R, 1996, ECON BOT, V50, P195, DOI 10.1007/BF02861451; Ge Y, 2019, GENES-BASEL, V10, DOI 10.3390/genes10030215; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guerra-Garcia A, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01891; Gyang P.J., 2017, J ADV BIOL BIOTECHNO, V13, P1, DOI [10.9734/JABB/2017/33519, DOI 10.9734/JABB/2017/33519]; Harvey D, 2008, ANAL CHEM 2 0; IBPGR, 1982, DESCR PHAS VULG; Jannat S, 2019, J ANIM PLANT SCI-PAK, V29, P205; Kenicer G, 2005, ENDINB J BOT, V62, P195; Khaliq A, 2019, CUST AGRONEGOCIO, V15, P243; Khan Sher, 2019, Sarhad Journal of Agriculture, V35, P579, DOI 10.17582/journal.sja/2019/35.2.579.586; KOENIG R, 1989, THEOR APPL GENET, V78, P809, DOI 10.1007/BF00266663; Kuhn DN, 2016, ACTA HORTIC, V1111, P315, DOI 10.17660/ActaHortic.2016.1111.45; Kwak M, 2009, THEOR APPL GENET, V118, P979, DOI 10.1007/s00122-008-0955-4; Leebens-Mack JH, 2019, NATURE, V574, P679, DOI 10.1038/s41586-019-1693-2; Leggett Richard M., 2013, Frontiers in Genetics, V4, P288, DOI 10.3389/fgene.2013.00288; Lei L, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00698; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lioi L, 2012, GENET RESOUR CROP EV, V59, P455, DOI 10.1007/s10722-011-9696-3; Liu K, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-019-0132-8; Loko L. E. Y., 2018, Journal of Plant Breeding and Crop Science, V10, P304; LUSH J. L., 1940, Record of Proceedings. American Society of Animal Production, P293; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Mamidi S, 2011, FUNCT PLANT BIOL, V38, P953, DOI 10.1071/FP11124; Marotti I, 2007, GENET RESOUR CROP EV, V54, P175, DOI 10.1007/s10722-005-3133-4; Meza N, 2013, GENET RESOUR CROP EV, V60, P1329, DOI 10.1007/s10722-012-9922-7; Nadeem MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205363; Nasar S, 2022, PAK J BOT, V54, P497, DOI 10.30848/PJB2022-2(3); Nawaz I., 2020, SARHAD J AGR, V36, P33, DOI [10.17582/journal.sja/2020/36.1.33.41, DOI 10.17582/JOURNAL.SJA/2020/36.1.33.41]; Nemli S, 2017, TURK J AGRIC FOR, V41, P389, DOI 10.3906/tar-1707-89; Nkhata W, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243238; Nogueira AF, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249858; Ophir R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088998; PARC (Pakistan Agriculture Research Council), 2020, NAT COORD PULS PROGR; Pritchard JK, 2000, GENETICS, V155, P945; Rana JC, 2015, EUPHYTICA, V205, P441, DOI 10.1007/s10681-015-1406-3; Rendon-Anaya M, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1190-6; Romiguier J, 2014, NATURE, V515, P261, DOI 10.1038/nature13685; Rong J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-895; Rosales-Serna R, 2005, CROP SCI, V45, P1951, DOI 10.2135/cropsci2004.0582; Sexton PJ, 1997, FIELD CROP RES, V52, P69, DOI 10.1016/S0378-4290(96)03452-1; Shah Asad Hussain, 2020, Indian Journal of Agricultural Research, V54, P629, DOI 10.18805/IJARe.A-421; Trendov N., 2019, FAO YB FISHERY AQUAC, DOI DOI 10.30875/E36CFD60-EN; Valentini G, 2018, PLANT MOL BIOL REP, V36, P897, DOI 10.1007/s11105-018-1129-4; Venkataravanappa V, 2021, J GEN PLANT PATHOL, V87, P94, DOI 10.1007/s10327-020-00979-3; Wang K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01835-9; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wu J, 2020, NAT GENET, V52, P118, DOI [10.1038/s41588-019-0546-0, 10.5281/zenodo.3236786]; Zhang XY, 2008, THEOR APPL GENET, V117, P629, DOI 10.1007/s00122-008-0807-2; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606; Zizumbo-Villarreal D, 2005, CROP SCI, V45, P1073, DOI 10.2135/cropsci2004.0340	72	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0265817	10.1371/journal.pone.0265817	http://dx.doi.org/10.1371/journal.pone.0265817			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35472209	gold, Green Published			2022-12-26	WOS:000816171900041
J	Shash, H; Alabdulqader, R; Alshehri, L; Alkathery, N; Al-Abdulrahman, R; Alahmed, S; Bubshait, D; AlKhater, S; Al-Nafie, A				Shash, Hwazen; Alabdulqader, Rana; Alshehri, Lama; Alkathery, Norah; Al-Abdulrahman, Rozanna; Alahmed, Shatha; Bubshait, Dalal; AlKhater, Suzan; Al-Nafie, Awatif			Blood utilization and quality indicators at a university hospital in the Eastern Province of Saudi Arabia	PLOS ONE			English	Article							ORDER SCHEDULE; SCREEN	BackgroundBlood transfusion is a common, essential procedure when treating many different medical and surgical conditions. Efficient utilization of blood bank facilities by frequent auditing is crucial; however, few studies have examined blood utilization in Saudi Arabia. We aimed to review the blood ordering patterns and transfusion practices, and blood bank audit effectiveness at a single center in Saudi Arabia and compare our results with those of a similar study performed in the same center 20 years ago. Materials and methodsThis study was a retrospective descriptive chart review of all healthy blood donors and recipients from January 1, 2016, to December 31, 2020. We evaluated the crossmatching-to-transfusion ratio (C/T) as an indicator of blood bank utilization and compared the findings with those of the previous study. We also evaluated changes in blood bank utilization during the coronavirus disease 2019 pandemic. ResultsFindings from 27,414 donors (men, 94.9%; mean age, 32.2 + 9.6 years) showed a 71% increase in blood donations compared to that of 2000. The donations gradually increased over the years, peaking just before COVID-19 pandemic started in March 2020. For 3,836 patients, 13,324 units of blood were crossmatched (average, 3.47 crossmatch/patient), with 23% of the crossmatch requests from surgical departments. The average C/T ratio, transfusion index, and transfusion probability (T%) were 1.37, 2.55, and 73.2%, respectively. The C/T ratio decreased by 54% between 2000 and 2020. During the pandemic, crossmatching decreased by 26% between 2019 and 2020, but with comparable C/T ratio in 2019 (1.45) and 2020 (1.39). ConclusionOur hospital blood bank utilization improved over the past 20 years, showing increased donations, reduced C/T ratio, and increased T%. This improvement emphasizes the importance of blood donation campaigns, blood bank auditing, restrictive transfusion guidelines, and physician education.	[Shash, Hwazen; Alabdulqader, Rana; Alshehri, Lama; Alkathery, Norah; Al-Abdulrahman, Rozanna; Alahmed, Shatha; Bubshait, Dalal; AlKhater, Suzan] Imam Abdulrahman Bin Faisal Univ, Coll Med, Dammam, Saudi Arabia; [Shash, Hwazen; Bubshait, Dalal; AlKhater, Suzan] King Fahad Hosp Univ, Dept Pediat, Al Khobar, Saudi Arabia; [Al-Nafie, Awatif] King Fahad Hosp Univ, Dept Pathol, Al Khobar, Saudi Arabia	Imam Abdulrahman Bin Faisal University; Imam Abdulrahman Bin Faisal University; Imam Abdulrahman Bin Faisal University	Shash, H (corresponding author), Imam Abdulrahman Bin Faisal Univ, Coll Med, Dammam, Saudi Arabia.; Shash, H (corresponding author), King Fahad Hosp Univ, Dept Pediat, Al Khobar, Saudi Arabia.	hashash@iau.edu.sa		Shash, Hwazen/0000-0002-4128-9504				Abdelgader AM, 2020, TRANSFUSION, V60, pS28, DOI 10.1111/trf.15683; Al-Awamy BH, 2000, SAUDI MED J, V21, P8; Al-Johar AW, 2016, CLIN LAB, V62, P771, DOI 10.7754/Clin.Lab.2015.150718; Al-Jubran KM, 2016, SAUDI MED J, V37, P864, DOI 10.15537/smj.2016.8.14494; Al-Raddadi RM, 2018, J MED VIROL, V90, P526, DOI 10.1002/jmv.24973; Alanzi T, 2019, J BLOOD MED, V10, P417, DOI 10.2147/JBM.S217950; Alkhaldy H, 2021, J APPL HEMATOLOGY, V12, P6, DOI [10.4103/joah.joah_112_20, DOI 10.4103/JOAH.JOAH_112_20]; AlOtaibi N, 2021, J BLOOD MED, V12, P863, DOI 10.2147/JBM.S328981; [Anonymous], GEN AUTHORITY STAT K; Ayob Y, 2014, ISBT SCI SER, V9, P72, DOI 10.1111/voxs.12089; Bani M, 2010, BLOOD TRANSFUS-ITALY, V8, P278, DOI [10.2450/2010.0156-09, 10.2450/2010.0156.09]; Barriteau CM, 2020, TRANSFUSION, V60, P1919, DOI 10.1111/trf.15947; Bashawri LA, 2002, SAUDI MED J, V23, P555; Bawazir WM, 2020, SAUDI MED J, V41, P628, DOI 10.15537/smj.2020.6.25084; Becker J, 2011, GUIDELINES PATIENT B; BORAL LI, 1977, TRANSFUSION, V17, P163, DOI 10.1046/j.1537-2995.1977.17277151923.x; Carson JL, 2016, JAMA-J AM MED ASSOC, V316, P2025, DOI 10.1001/jama.2016.9185; DeSimone RA, 2021, TRANSFUSION, V61, P692, DOI 10.1111/trf.16202; Elsafi SH, 2020, J BLOOD MED, V11, P243, DOI 10.2147/JBM.S254168; Frank SM, 2014, ANESTHESIOLOGY, V121, P501, DOI 10.1097/ALN.0000000000000338; FRIEDMAN BA, 1976, TRANSFUSION, V16, P380; Gehrie EA., 2020, BALANCING SUPPLY DEM; Hall TC, 2013, TRANSFUS MED HEMOTH, V40, P27, DOI 10.1159/000345660; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Karaca BNS, 2020, J HEMATOLOGY TRANSFU, V7, P1085; Kaur D, 2016, HTIJ, V2, P53, DOI [10.15406/htij.2016.02.00037, DOI 10.15406/HTIJ.2016.02.00037]; Malik S, 2018, SAUDI J LAPAROSCOPY, V3, P21; MOH, MOH LAUNCH WAT BLOOD; Organization WH, 2012, BLOOD DON SEL GUID A; Organization WH, 2010, 100 VOL BLOOD DON GL; Reesink HW, 2013, VOX SANG, V104, P350, DOI 10.1111/vox.12003; Rehan M., 2016, J RAWALPINDI MED COL, V30, P222; Safwenberg J, 1997, VOX SANG, V72, P162, DOI 10.1046/j.1423-0410.1997.7230162.x; Stanworth SJ, 2020, LANCET HAEMATOL, V7, pE756, DOI 10.1016/S2352-3026(20)30186-1; Tayara Bader Kamal, 2015, Int J Appl Basic Med Res, V5, P111, DOI 10.4103/2229-516X.157156; Wallis JP, 2000, J CLIN PATHOL, V53, P673, DOI 10.1136/jcp.53.9.673; Wang YJ, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016703; Yahia AIO, 2020, TRANSFUS APHER SCI, V59, DOI 10.1016/j.transci.2020.102836	38	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267449	10.1371/journal.pone.0267449	http://dx.doi.org/10.1371/journal.pone.0267449			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C1KV	35452477	Green Published, gold			2022-12-26	WOS:000792887700032
J	Shishir, TA; Jannat, T; Bin Naser, I				Shishir, Tushar Ahmed; Jannat, Taslimun; Bin Naser, Iftekhar			An in-silico study of the mutation-associated effects on the spike protein of SARS-CoV-2, Omicron variant	PLOS ONE			English	Article							WEB SERVER; STABILITY; TOOL	The emergence of Omicron (B.1.1.529), a new Variant of Concern in the COVID-19 pandemic, while accompanied by the ongoing Delta variant infection, has once again fueled fears of a new infection wave and global health concern. In the Omicron variant, the receptor-binding domain (RBD) of its spike glycoprotein is heavily mutated, a feature critical for the transmission rate of the virus by interacting with hACE2. In this study, we used a combination of conventional and advanced neural network-based in silico approaches to predict how these mutations would affect the spike protein. The results demonstrated a decrease in the electrostatic potentials of residues corresponding to receptor recognition sites, an increase in the alkalinity of the protein, a change in hydrophobicity, variations in functional residues, and an increase in the percentage of alpha-helix structure. Moreover, several mutations were found to modulate the immunologic properties of the potential epitopes predicted from the spike protein. Our next step was to predict the structural changes of the spike and their effect on its interaction with the hACE2. The results revealed that the RBD of the Omicron variant had a higher affinity than the reference. Moreover, all-atom molecular dynamics simulations concluded that the RBD of the Omicron variant exhibits a more dispersed interaction network since mutations resulted in an increased number of hydrophobic interactions and hydrogen bonds with hACE2.	[Shishir, Tushar Ahmed; Jannat, Taslimun; Bin Naser, Iftekhar] BRAC Univ, Dept Math & Nat Sci, Dhaka, Bangladesh; [Shishir, Tushar Ahmed] Rangamati Gen Hosp, Chattogram, Bangladesh	Bangladesh Rural Advancement Committee BRAC; BRAC University	Bin Naser, I (corresponding author), BRAC Univ, Dept Math & Nat Sci, Dhaka, Bangladesh.	iftekhar.naser@bracu.ac.bd	Shishir, Tushar Ahmed/HHS-2252-2022	Shishir, Tushar Ahmed/0000-0002-1347-1739				[Anonymous], 1969, IMMUNOL TOLER, P1, DOI [10.1016/b978-1-4832-2727-6.50008-7, DOI 10.1016/B978-1-4832-2727-6.50008]; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Artimo Panu, 2012, Nucleic Acids Res, V40, pW597, DOI 10.1093/nar/gks400; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bartonek L, 2019, NUCLEIC ACIDS RES, V47, pW632, DOI 10.1093/nar/gkz407; Bernhofer M, 2021, NUCLEIC ACIDS RES, V49, pW535, DOI 10.1093/nar/gkab354; Bonnal RJP, 2012, BIOINFORMATICS, V28, P1035, DOI 10.1093/bioinformatics/bts080; Brouwer PJM, 2020, SCIENCE, V369, P643, DOI 10.1126/science.abc5902; Burley SK, 2019, NUCLEIC ACIDS RES, V47, pD464, DOI 10.1093/nar/gky1004; Callaway E, 2021, NATURE, V600, P21, DOI 10.1038/d41586-021-03552-w; Cantuti-Castelvetri L, 2020, SCIENCE, V370, P856, DOI 10.1126/science.abd2985; Cao HL, 2019, J CHEM INF MODEL, V59, P1508, DOI 10.1021/acs.jcim.8b00697; Choi JY, 2021, YONSEI MED J, V62, P961, DOI 10.3349/ymj.2021.62.11.961; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Clausen TM, 2020, CELL, V183, P1043, DOI [10.1016/j.cell.2020.09.033, 10.1101/2020.07.14.201616]; de Brevern AG, 2012, NUCLEIC ACIDS RES, V40, pW317, DOI 10.1093/nar/gks482; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dhanda SK, 2019, NUCLEIC ACIDS RES, V47, pW502, DOI 10.1093/nar/gkz452; Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4; Drozd O.V., 2018, PROC NATL ACAD SCI B, V63, P472, DOI [10.29235/1029-8940-2018-63-4-391-400, DOI 10.29235/1029-8940-2018-63-4-391-400, 10.29235/1029-8940-2018-63-4-472-485, DOI 10.29235/1029-8940-2018-63-4-472-485]; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Dyer O, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n3013; Farinholt T, 2021, BMC MED, V19, DOI [10.1186/s12916-021-02103-4, 10.1101/2021.06.28.21258780]; FERSHT AR, 1993, CURR OPIN STRUC BIOL, V3, P75, DOI 10.1016/0959-440X(93)90205-Y; Garcia-Beltran WF, 2021, CELL, V184, P2372, DOI [10.1016/j.cell.2021.03.013, 10.1016/j.cell.2021.04.006, 10.1101/2021.02.14.21251704]; GISAID, 2020, ADV VIRUS RES, V2008, P1; Harvey WT, 2021, NAT REV MICROBIOL, V19, P409, DOI 10.1038/s41579-021-00573-0; Hu G, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24773-7; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Karim SSA, 2021, LANCET, V398, P2126, DOI 10.1016/S0140-6736(21)02758-6; Klausen MS, 2019, PROTEINS, V87, P520, DOI 10.1002/prot.25674; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kumar V, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22179131; Laskowski RA, 2020, PROTEIN SCI, V29, P111, DOI 10.1002/pro.3746; Laurini E, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-99827-3; Li SQ, 2021, REV MED VIROL, V31, DOI 10.1002/rmv.2168; Lindstrom JC, 2022, INFECT DIS-NOR, V54, P72, DOI 10.1080/23744235.2021.1977382; Lista MJ., 2021, BIORXIV, DOI [10.1101/2021.11.09.467693v1%0Ahttps://www.biorxiv.org/content/10.1101/2021.11.09.467693v1.abstract, DOI 10.1101/2021.11.09.467693V1%0AHTTPS://WWW.BIORXIV.ORG/CONTENT/10.1101/2021.11.09.467693V1.ABSTRACT]; Liu BX, 2020, J MED INTERNET RES, V22, DOI 10.2196/22299; Lupala CS, 2022, BIOCHEM BIOPH RES CO, V590, P34, DOI 10.1016/j.bbrc.2021.12.079; Mallapaty S, 2022, NATURE, V601, P174, DOI 10.1038/d41586-021-03830-7; Manavalan B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01783; Manavalan B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01695; Manavalan B, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00276; Martonak R, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.075503; Mascellino MT, 2021, INFECT DRUG RESIST, V14, P3459, DOI 10.2147/IDR.S315727; Mathieu E, 2021, NAT HUM BEHAV, V5, P947, DOI 10.1038/s41562-021-01122-8; MATTHEWS BW, 1993, ANNU REV BIOCHEM, V62, P139, DOI 10.1146/annurev.bi.62.070193.001035; McCallum M, 2022, SCIENCE, V375, P864, DOI 10.1126/science.abn8652; Mckay MJ, 2018, BBA-BIOMEMBRANES, V1860, P2108, DOI 10.1016/j.bbamem.2018.02.010; Motozono C, 2021, CELL HOST MICROBE, V29, P1124, DOI 10.1016/j.chom.2021.06.006; Ng KT, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020178; Ozili P.K., 2020, SPILLOVER COVID 19 I; Prevost J, 2021, CELL HOST MICROBE, V29, P322, DOI 10.1016/j.chom.2021.02.010; Rath SL, 2022, BIOCHEM BIOPH RES CO, V592, P18, DOI 10.1016/j.bbrc.2022.01.006; Reynisson B, 2020, NUCLEIC ACIDS RES, V48, pW449, DOI 10.1093/nar/gkaa379; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rodrigues CHM, 2021, PROTEIN SCI, V30, P60, DOI 10.1002/pro.3942; Rodriguez-Coira J, 2021, ALLERGY, V76, P1922, DOI 10.1111/all.14714; Romer RA, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82849-2; Scialo F, 2020, LUNG, V198, P867, DOI 10.1007/s00408-020-00408-4; Shah P, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.637651; Sievers F, 2018, PROTEIN SCI, V27, P135, DOI 10.1002/pro.3290; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Slater K, 2003, ENV IMPACT TEXT, P1, DOI [10.1533/9781855738645.1, DOI 10.1533/9781855738645.1]; Tatsi EB, 2021, EPIDEMIOL INFECT, V149, DOI 10.1017/S0950268821002430; Tekewe A, 2016, PROTEIN SCI, V25, P1507, DOI 10.1002/pro.2953; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tregoning JS, 2021, NAT REV IMMUNOL, V21, P626, DOI 10.1038/s41577-021-00592-1; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vehlow C, 2011, BIOINFORMATICS, V27, P1573, DOI 10.1093/bioinformatics/btr163; Wang K, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00426-x; Wang LS, 2021, SCIENCE, V373, P759, DOI 10.1126/science.abh1766; World Health Organization, CLASS OM B 1 1 529 S; Wu YC, 2020, J CHIN MED ASSOC, V83, P217, DOI 10.1097/JCMA.0000000000000270; Xue LC, 2016, BIOINFORMATICS, V32, P3676, DOI 10.1093/bioinformatics/btw514; Yan YM, 2020, NAT PROTOC, V15, P1829, DOI 10.1038/s41596-020-0312-x; Yu YL, 2020, J PHYS CHEM B, V124, P6797, DOI 10.1021/acs.jpcb.0c04795; Zhang LZ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19808-4; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhou B, 2021, NATURE, V592, P122, DOI 10.1038/s41586-021-03361-1	82	4	4	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266844	10.1371/journal.pone.0266844	http://dx.doi.org/10.1371/journal.pone.0266844			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446879	Green Submitted, gold, Green Published			2022-12-26	WOS:000795468200047
J	Sun, N; Li, XB; Luo, F; Xiao, L				Sun, Nan; Li, Xiabo; Luo, Fan; Xiao, Liang			Mechanical properties of charcoal and its representativeness of vegetation in northern China	PLOS ONE			English	Article							CAL YR BP; QUANTITATIVE RECONSTRUCTION; LOESS PLATEAU; WOOD; IMPACT; BASIN; FRAGMENTATION; TEMPERATURE; RECORDS; SITES	The objective of this paper is to examine the representativeness of charcoal taxa at archeological sites in northern China. We carried out standardized laboratory compression tests on 168 samples representing 21 taxa charred at four different temperatures to characterize the mechanical properties of common taxa in temperate China. The results indicate that significant fragmentation differences occur between taxa. Ring-porous/semi-ring-porous taxa with a moderate density (>0.55 g/cm(3)) are overrepresented, while those with a very low to low density (<0.55 g/cm(3)) are moderately represented. Diffuse-porous taxa with slightly dense uniseriate rays, rare multiseriate rays and distinct helical thickenings are underrepresented, and those with slightly dense multiseriate rays are overrepresented, while those with rare to moderate multiseriate rays and helical thickening absence are moderately represented. Gymnosperm trees are generally well represented. Among the ubiquitous taxa at the archeological sites across northern China, Quercus and Ulmus may be overrepresented, and Pinus, Salix, Populus, and Acer may be underrepresented, while Betula may be moderately represented.	[Sun, Nan; Li, Xiabo; Luo, Fan; Xiao, Liang] Changan Univ, Sch Earth Sci & Resources, Xian, Peoples R China; [Sun, Nan; Xiao, Liang] Northwest Univ, Shaanxi Key Lab Early Life & Environm, Xian, Shaanxi, Peoples R China	Chang'an University; Northwest University Xi'an	Sun, N (corresponding author), Changan Univ, Sch Earth Sci & Resources, Xian, Peoples R China.; Sun, N (corresponding author), Northwest Univ, Shaanxi Key Lab Early Life & Environm, Xian, Shaanxi, Peoples R China.	sunnan@chd.edu.cn			National Natural Science Foundation of China [41672156, 41872017]; Natural Science Basic Research Plan in Shaanxi Province of China [2022JM-170]; Special Fund for Basic Scientific Research of Central Colleges, Chang'an University, China [310827171001, 300102271402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Basic Research Plan in Shaanxi Province of China; Special Fund for Basic Scientific Research of Central Colleges, Chang'an University, China	This work was supported by the National Natural Science Foundation of China (No. 41672156, 41872017); Natural Science Basic Research Plan in Shaanxi Province of China (No. 2022JM-170); and the Special Fund for Basic Scientific Research of Central Colleges, Chang'an University, China (No. 310827171001, 300102271402). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allue E, 2017, QUATERN INT, V457, P172, DOI 10.1016/j.quaint.2016.10.024; An JH., 1992, CHIN ARCHAEOL; Antal MJ, 2003, IND ENG CHEM RES, V42, P1619, DOI 10.1021/ie0207919; Assis MR, 2016, WOOD SCI TECHNOL, V50, P519, DOI 10.1007/s00226-016-0812-6; Bartkowiak M, 2004, J THERM ANAL CALORIM, V77, P295, DOI 10.1023/B:JTAN.0000033214.95457.fe; Bishop RR, 2015, QUATERNARY SCI REV, V108, P51, DOI 10.1016/j.quascirev.2014.11.004; Blanchette RA, 2000, INT BIODETER BIODEGR, V46, P189, DOI 10.1016/S0964-8305(00)00077-9; BLANKENHORN PR, 1973, CARBON, V11, P603, DOI 10.1016/0008-6223(73)90326-6; Braadbaart F, 2008, J ARCHAEOL SCI, V35, P2434, DOI 10.1016/j.jas.2008.03.016; Chabal L, 1987, WOOD ARCHAEOLOGY ACT; Chabal L., 1997, LANTHRACOLOGIE MTHOD; Cheng JQ., 1992, CHINESE TIMBER ANN, V1st; Cheng YM, 2011, SCI CHINA EARTH SCI, V54, P509, DOI 10.1007/s11430-011-4168-3; Chrzazvez J, 2014, J ARCHAEOL SCI, V44, P30, DOI 10.1016/j.jas.2014.01.006; Costa LJ, 2018, SCI FOR, V46, P606, DOI 10.18671/scifor.v46n120.09; Delhon C, 2021, ENVIRON ARCHAEOL, V26, P159, DOI 10.1080/14614103.2018.1522783; Institute of timber Chinese Academy of Forestry Sciences, 1982, WOOD PHYS MECH PROP, V1st; Kabukcu C, 2017, QUATERNARY SCI REV, V176, P85, DOI 10.1016/j.quascirev.2017.10.001; Lancelotti C, 2010, ARCHAEOL ANTHROP SCI, V2, P307, DOI 10.1007/s12520-010-0046-8; [李虎 Li Hu], 2014, [第四纪研究, Quaternary Sciences], V34, P35; Li XQ, 2012, J ARCHAEOL SCI, V39, P3141, DOI 10.1016/j.jas.2012.04.052; Liu FW, 2019, QUATERN INT, V516, P141, DOI 10.1016/j.quaint.2018.05.033; Marston JM, 2009, J ARCHAEOL SCI, V36, P2192, DOI 10.1016/j.jas.2009.06.002; Ruiz-Alonso M, 2017, QUATERN INT, V431, P61, DOI 10.1016/j.quaint.2015.11.076; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Schmidt MWI, 2000, GLOBAL BIOGEOCHEM CY, V14, P777, DOI 10.1029/1999GB001208; Scott AC, 2007, INT J COAL GEOL, V70, P53, DOI 10.1016/j.coal.2006.02.009; Scott AC, 2010, PALAEOGEOGR PALAEOCL, V291, P11, DOI 10.1016/j.palaeo.2009.12.012; SHACKLETON CM, 1992, J ARCHAEOL SCI, V19, P631, DOI 10.1016/0305-4403(92)90033-Y; Shen H, 2019, VEG HIST ARCHAEOBOT, V28, P187, DOI 10.1007/s00334-018-0691-x; Shen H, 2017, REV PALAEOBOT PALYNO, V238, P7, DOI 10.1016/j.revpalbo.2016.12.003; Shen H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134847; Sun N, 2012, CLIM PAST, V8, P625, DOI 10.5194/cp-8-625-2012; Sun N, 2016, HOLOCENE, V26, P1200, DOI 10.1177/0959683616638417; Sun N, 2013, QUATERN INT, V308, P27, DOI 10.1016/j.quaint.2013.05.014; [孙楠 Sun Nan], 2010, [第四纪研究, Quaternary Sciences], V30, P319; SWIFT LW, 1993, CAN J FOREST RES, V23, P2242, DOI 10.1139/x93-278; [谭志海 Tan Zhihai], 2008, [第四纪研究, Quaternary Sciences], V28, P733; Thery-Parisot I, 2010, PALAEOGEOGR PALAEOCL, V291, P142, DOI 10.1016/j.palaeo.2009.09.016; Thry-Parisot I, 2010, TAPHONOMY BURNED ORG, V2, P8193; Wang SZ., 2014, DISIJI YANJIU, V34, P43, DOI DOI 10.3969/j.issn.1001.7410.2014.01.06; Wang SZ., 2012, DISIJI YANJIU, V32, P226, DOI DOI 10.3969/j.issn.1001-7410.2012.02.07; Wang SZ., 2011, ARCHAEOLOGY, V3, P91; Wang SZ., 2014, RELICS S, P117; Wang SZ., 2016, RELICS S, V2, P148; Yang HP, 2007, FUEL, V86, P1781, DOI 10.1016/j.fuel.2006.12.013; Zhao HL, 2015, SCI CHINA EARTH SCI, V58, P1404, DOI 10.1007/s11430-015-5068-8; Zhao ZJ., 2004, ARCHAEOLOGY, V3, P80; Zhu XH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177287	49	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267044	10.1371/journal.pone.0267044	http://dx.doi.org/10.1371/journal.pone.0267044			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1F9AX	35421172	gold, Green Published			2022-12-26	WOS:000795453600099
J	Xu, J; Ding, JC				Xu, Jian; Ding, Jicheng			GNSS multipath suppression technology based on postcorrelation and independent component analysis	PLOS ONE			English	Article							MITIGATION; ALGORITHMS	In urban and other complex environments, satellite navigation signals are vulnerable to multipath interference, especially medium- and short-delay multipath interference, which seriously affects the positioning accuracy. Aiming at the problem that the effect of traditional methods on medium and short multipath suppression is not obvious and it is difficult to accurately estimate the direction of arrival (DOA) when beamforming is used, a multipath suppression scheme based on a postcorrelation and independent component analysis (ICA) algorithm is proposed in this paper. First, the satellite navigation signal on each array element is despread and demodulated by postcorrelation technology to improve the signal-to-noise ratio (SNR), and then the direct signal component is directly extracted by the ICA algorithm to filter the noise while suppressing the multipath interference. Simulation results show that this method can effectively suppress medium and short multipath interference when the SNR of satellite navigation signals is as low as -30 dB, significantly improve the SNR of navigation messages and reduce the bit error rate, which provides a new solution for global navigation satellite system (GNSS) multipath suppression.	[Xu, Jian] Harbin Univ Commerce, Sch Comp & Informat Engn, Harbin, Heilongjiang, Peoples R China; [Ding, Jicheng] Harbin Engn Univ, Coll Automat, Harbin, Heilongjiang, Peoples R China	Harbin University of Commerce; Harbin Engineering University	Xu, J (corresponding author), Harbin Univ Commerce, Sch Comp & Informat Engn, Harbin, Heilongjiang, Peoples R China.	ufoxj@163.com			Harbin University of Commerce's school-level scientific research project [18XN023]	Harbin University of Commerce's school-level scientific research project	Thank Jicheng Ding for providing some ideas and some program codes for this subject.	Bingham E, 2000, Int J Neural Syst, V10, P1, DOI 10.1142/S0129065700000028; Blunt SD, 2011, IEEE T AERO ELEC SYS, V47, P332, DOI 10.1109/TAES.2011.5705679; Broumandan A, 2016, P IEEE, V104, P1246, DOI 10.1109/JPROC.2016.2529600; Budiarto H, 2004, IEICE T COMMUN, VE87B, P958; Cebrian J M, 2010, 2010 5 ESA WORKSHOP, P18; Closas P, 2009, IEEE J-STSP, V3, P695, DOI 10.1109/JSTSP.2009.2023831; Dai WJ, 2014, GPS SOLUT, V18, P417, DOI 10.1007/s10291-013-0341-9; Dong D, 2016, J GEODESY, V90, P255, DOI 10.1007/s00190-015-0870-9; Guo Y, 2012, 2012 5TH INTERNATIONAL CONGRESS ON IMAGE AND SIGNAL PROCESSING (CISP), P1537; Huovinen T, 2007, INT CONF ACOUST SPEE, P685; Hyvarinen A, 1997, INT CONF ACOUST SPEE, P3917, DOI 10.1109/ICASSP.1997.604766; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Izadpanah A, 2009, THESIS; Kim Y, 2012, MOB INF SYST, V8, P315, DOI 10.1155/2012/109129; Liu C, 2021, REMOTE SENS-BASEL, V13, DOI 10.3390/rs13020304; Liu SJ, 2017, IEEE ANTENN WIREL PR, V16, P2465, DOI 10.1109/LAWP.2017.2724302; McGraw G., 1999, P 1999 NAT TECHN M I, P333; Misra P, 2006, GLOBAL POSITIONING S; Sahmoudi M, 2008, IEEE T WIREL COMMUN, V7, P4362, DOI 10.1109/T-WC.2008.070700; Shafiee E, 2018, J NAVIGATION, V71, P169, DOI 10.1017/S0373463317000558; Suzuki T, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21072503; Tao Y, 2021, GPS SOLUT, V25, DOI 10.1007/s10291-020-01074-y; Townsend B. R., 1995, Navigation. Journal of the Institute of Navigation, V42, P503; Van Dierendonck A. J., 1992, Navigation. Journal of the Institute of Navigation, V39, P265; Wang MH, 2018, ISPRS INT GEO-INF, V7, DOI 10.3390/ijgi7060228; Wang ZR, 2019, GPS SOLUT, V23, DOI 10.1007/s10291-019-0897-0; Xu HS, 2020, SATELLITE NAVIG, V1, DOI 10.1186/s43020-020-00016-w; Yu L, 2010, IET MICROW ANTENNA P, V4, P1310, DOI 10.1049/iet-map.2009.0433; Yu L, 2010, DIGIT SIGNAL PROCESS, V20, P379, DOI 10.1016/j.dsp.2009.08.010; Zhao L., 2009, ICA ALGORITHM ITS AP; Zhao Yongbo, 2009, 2009 3rd IEEE International Symposium on Microwave, Antenna, Propagation and EMC Technologies for Wireless Communications (MAPE 2009), P444, DOI 10.1109/MAPE.2009.5355951; Zhong P, 2010, J GEODESY, V84, P145, DOI 10.1007/s00190-009-0352-z	32	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267216	10.1371/journal.pone.0267216	http://dx.doi.org/10.1371/journal.pone.0267216			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446904	gold, Green Published			2022-12-26	WOS:000795468200049
J	Rider, SD; Gadgil, RY; Hitch, DC; Damewood, FJ; Zavada, N; Shanahan, M; Alhawach, V; Shrestha, R; Shin-ya, K; Leffak, M				Rider, S. Dean, Jr.; Gadgil, Rujuta Yashodhan; Hitch, David C.; Damewood, French J.; Zavada, Nathen; Shanahan, Matilyn; Alhawach, Venicia; Shrestha, Resha; Shin-ya, Kazuo; Leffak, Michael			Stable G-quadruplex DNA structures promote replication-dependent genome instability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAK-INDUCED REPLICATION; C-MYC GENE; MYOTONIC-DYSTROPHY; INTERACTIVE AGENT; REPEAT; ORIGIN; TELOMESTATIN; REPAIR; ACTIVATION; MECHANISMS	G-quadruplex (G4)-prone structures are abundant in mammalian genomes, where they have been shown to influence DNA replication, transcription, and genome stability. In this article, we constructed cells with a single ectopic homopurine/homopyrimidine repeat tract derived from the polycystic kidney disease type 1 (PKD1) locus, which is capable of forming triplex (H3) and G4 DNA structures. We show that ligand stabilization of these G4 structures results in deletions of the G4 consensus sequence, as well as kilobase deletions spanning the G4 and ectopic sites. Furthermore, we show that DNA double-strand breaks at the ectopic site are dependent on the nuclease Mus81. Hypermutagenesis during sister chromatid repair extends several kilobases from the G4 site and breaks at the G4 site resulting in microhomology-mediated translocations. To determine whether H3 or G4 structures are responsible for homopurine/homopyrimidine tract instability, we derived constructs and cell lines from the PKD1 repeat, which can only form H3 or G4 structures. Under normal growth conditions, we found that G4 cell lines lost the G4 consensus sequence early during clonal outgrowth, whereas H3 cells showed DNA instability early during outgrowth but only lost reporter gene expression after prolonged growth. Thus, both the H3 and G4 non-B conformation DNAs exhibit genomic instability, but they respond differently to endogenous replication stress. Our results show that the outcomes of replication-dependent double-strand breaks at non-B-DNAs model the instability observed in microhomology-mediated break-induced replication (BIR). Marked variability in the frequency of mutagenesis during BIR suggests possible dynamic heterogeneity in the BIR replisome.	[Rider, S. Dean, Jr.; Gadgil, Rujuta Yashodhan; Hitch, David C.; Damewood, French J.; Zavada, Nathen; Shanahan, Matilyn; Alhawach, Venicia; Shrestha, Resha; Leffak, Michael] Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; [Shin-ya, Kazuo] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Tokyo, Japan	University System of Ohio; Wright State University Dayton; National Institute of Advanced Industrial Science & Technology (AIST)	Leffak, M (corresponding author), Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA.	Michael.leffak@wright.edu		Zavada, Nathen/0000-0002-5595-5491; Leffak, Michael/0000-0002-6328-785X	Wright State University Biomedical Sciences PhD program	Wright State University Biomedical Sciences PhD program	V. A. and R. S. were supported by the Wright State University Biomedical Sciences PhD program. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bacolla A, 2009, MOL CARCINOGEN, V48, P273, DOI 10.1002/mc.20507; Bahrambeigi V, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0676-0; Balakumaran BS, 2000, HUM MOL GENET, V9, P93, DOI 10.1093/hmg/9.1.93; Barthelemy J, 2017, NUCLEIC ACIDS RES, V45, P509, DOI 10.1093/nar/gkw1091; Barthelemy J, 2016, NUCLEIC ACIDS RES, V44, P6803, DOI 10.1093/nar/gkw433; Belotserkovskii BP, 2007, J BIOL CHEM, V282, P32433, DOI 10.1074/jbc.M704618200; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Brosh RM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00372; Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295; Chen XM, 2013, NUCLEIC ACIDS RES, V41, P6460, DOI 10.1093/nar/gkt368; Cho DH, 2007, BBA-MOL BASIS DIS, V1772, P195, DOI 10.1016/j.bbadis.2006.05.013; Costantino L, 2014, SCIENCE, V343, P88, DOI 10.1126/science.1243211; De Magis A, 2019, P NATL ACAD SCI USA, V116, P816, DOI 10.1073/pnas.1810409116; Donnianni RA, 2019, MOL CELL, V76, P371, DOI 10.1016/j.molcel.2019.07.033; Donnianni RA, 2013, P NATL ACAD SCI USA, V110, P13475, DOI 10.1073/pnas.1309800110; Gadgil RY, 2020, J BIOL CHEM, V295, P15378, DOI 10.1074/jbc.RA120.013495; Gazy I, 2019, DNA REPAIR, V74, P63, DOI 10.1016/j.dnarep.2018.12.004; Guedin A, 2010, NUCLEIC ACIDS RES, V38, P7858, DOI 10.1093/nar/gkq639; Guo JZ, 2016, CELL RES, V26, P775, DOI 10.1038/cr.2016.66; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; Hansel-Hertsch R, 2017, NAT REV MOL CELL BIO, V18, P279, DOI 10.1038/nrm.2017.3; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Hiatt SM, 2021, HUM GENET GENOM ADV, V2, DOI 10.1016/j.xhgg.2021.100023; Khristich AN, 2020, J BIOL CHEM, V295, P4134, DOI 10.1074/jbc.REV119.007678; Kim MY, 2002, J AM CHEM SOC, V124, P2098, DOI 10.1021/ja017308q; KIT S, 1961, J MOL BIOL, V3, P711, DOI 10.1016/S0022-2836(61)80075-2; Kononenko AV, 2018, NAT STRUCT MOL BIOL, V25, P669, DOI 10.1038/s41594-018-0094-9; Kramara J, 2018, TRENDS GENET, V34, P518, DOI 10.1016/j.tig.2018.04.002; Kramara J, 2017, NAT STRUCT MOL BIOL, V24, P11, DOI 10.1038/nsmb.3361; Krasilnikova MM, 2004, MOL CELL BIOL, V24, P2286, DOI 10.1128/MCB.24.6.2286-2295.2004; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; Lambert S, 2005, CELL, V121, P689, DOI 10.1016/j.cell.2005.03.022; Lee WTC, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22830-9; Lewis TW, 2019, NUCLEIC ACIDS RES, V47, P3503, DOI 10.1093/nar/gkz026; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liu GQ, 2003, MOL CELL BIOL, V23, P1832, DOI 10.1128/MCB.23.5.1832-1842.2003; Liu GQ, 2007, MOL CELL BIOL, V27, P7828, DOI 10.1128/MCB.01276-07; Liu GQ, 2013, MOL CELL BIOL, V33, P571, DOI 10.1128/MCB.01265-12; Liu GQ, 2012, J BIOL CHEM, V287, P33412, DOI 10.1074/jbc.M112.402503; Liu GQ, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-7; Liu GQ, 2010, NAT CHEM BIOL, V6, P652, DOI [10.1038/nchembio.416, 10.1038/NCHEMBIO.416]; Lokanga RA, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.708860; Lyu J, 2022, NUCLEIC ACIDS RES, V50, DOI 10.1093/nar/gkab1073; Malkova A, 2012, ANNU REV GENET, V46, P455, DOI 10.1146/annurev-genet-110711-155547; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MCWHINNEY C, 1995, DNA CELL BIOL, V14, P565, DOI 10.1089/dna.1995.14.565; MCWHINNEY C, 1990, NUCLEIC ACIDS RES, V18, P1233, DOI 10.1093/nar/18.5.1233; McWhinney C., 1988, CANC CELLS, P467; Miyazaki T, 2012, CLIN CANCER RES, V18, P1268, DOI 10.1158/1078-0432.CCR-11-1795; Naiman K, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21198-0; Nakamura T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03785-8; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; Patel HP, 2004, NUCLEIC ACIDS RES, V32, P1460, DOI 10.1093/nar/gkh312; Prorok P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11104-0; Sakofsky CJ, 2017, CRIT REV BIOCHEM MOL, V52, P395, DOI 10.1080/10409238.2017.1314444; Sakofsky CJ, 2014, CELL REP, V7, P1640, DOI 10.1016/j.celrep.2014.04.053; Shalaby T, 2010, MOL CANCER THER, V9, P167, DOI 10.1158/1535-7163.MCT-09-0586; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Spivakovsky-Gonzalez E, 2021, GENETICS, V219, DOI 10.1093/genetics/iyab125; Sundararajan R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001339; Sundararajan R, 2010, GENETICS, V184, P65, DOI 10.1534/genetics.109.111039; Tahara H, 2006, ONCOGENE, V25, P1955, DOI 10.1038/sj.onc.1209217; Tao L, 2000, J CELL BIOCHEM, V78, P442, DOI 10.1002/1097-4644(20000901)78:3<442::AID-JCB9>3.0.CO;2-1; Tauchi T, 2006, ONCOGENE, V25, P5719, DOI 10.1038/sj.onc.1209577; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Trivedi A, 1998, DNA CELL BIOL, V17, P885, DOI 10.1089/dna.1998.17.885; Usdin K, 2015, CRIT REV BIOCHEM MOL, V50, P142, DOI 10.3109/10409238.2014.999192; Valton AL, 2014, EMBO J, V33, P732, DOI 10.1002/embj.201387506; Verdin H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003358; Waltz SE, 1996, NUCLEIC ACIDS RES, V24, P1887, DOI 10.1093/nar/24.10.1887; Wang WT, 2021, MOL CELL, V81, P2975, DOI 10.1016/j.molcel.2021.05.024; Yang DZ, 2006, NUCLEOS NUCLEOT NUCL, V25, P951, DOI 10.1080/15257770600809913; Yang JH, 2007, GENE, V393, P110, DOI 10.1016/j.gene.2007.01.025; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399	75	1	1	6	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101947	10.1016/j.jbc.2022.101947	http://dx.doi.org/10.1016/j.jbc.2022.101947			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9FR	35447109	gold, Green Published			2022-12-26	WOS:000807755100001
J	Gentile, A; Magnacca, N; Matteis, R; Moreno, M; Cioffi, F; Giacco, A; Lanni, A; Lange, P; Senese, R; Goglia, F; Silvestri, E; Lombardi, A				Gentile, Alessandra; Magnacca, Nunzia; Matteis, Rita; Moreno, Maria; Cioffi, Federica; Giacco, Antonia; Lanni, Antonia; Lange, Pieter; Senese, Rosalba; Goglia, Fernando; Silvestri, Elena; Lombardi, Assunta			Ablation of uncoupling protein 3 affects interrelated factors leading to lipolysis and insulin resistance in visceral white adipose tissue	FASEB JOURNAL			English	Article						endoplasmic reticulum; insulin resistance; lipolysis; mitochondria; uncoupling protein; white adipose tissue	ENDOPLASMIC-RETICULUM STRESS; MITOCHONDRIAL DYSFUNCTION; ER STRESS; ADIPONECTIN; OBESITY; EXPRESSION; SECRETION; ACTIVATION; HORMONE; GENE	The physiological role played by uncoupling protein 3 (UCP3) in white adipose tissue (WAT) has not been elucidated so far. In the present study, we evaluated the impact of the absence of the whole body UCP3 on WAT physiology in terms of ability to store triglycerides, oxidative capacity, response to insulin, inflammation, and adipokine production. Wild type (WT) and UCP3 Knockout (KO) mice housed at thermoneutrality (30 degrees C) have been used as the animal model. Visceral gonadic WAT (gWAT) from KO mice showed an impaired capacity to store triglycerides (TG) as indicated by its lowered weight, reduced adipocyte diameter, and higher glycerol release (index of lipolysis). The absence of UCP3 reduces the maximal oxidative capacity of gWAT, increases mitochondrial free radicals, and activates ER stress. These processes are associated with increased levels of monocyte chemoattractant protein-1 and TNF-alpha. The response of gWAT to in vivo insulin administration, revealed by (ser473)-AKT phosphorylation, was blunted in KO mice, with a putative role played by eif2a, JNK, and inflammation. Variations in adipokine levels in the absence of UCP3 were observed, including reduced adiponectin levels both in gWAT and serum. As a whole, these data indicate an important role of UCP3 in regulating the metabolic functionality of gWAT, with its absence leading to metabolic derangement. The obtained results help to clarify some aspects of the association between metabolic disorders and low UCP3 levels.	[Gentile, Alessandra; Magnacca, Nunzia; Lombardi, Assunta] Univ Naples Federico II, Dept Biol, Via Cinthia, I-80126 Naples, Italy; [Matteis, Rita] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy; [Moreno, Maria; Cioffi, Federica; Giacco, Antonia; Goglia, Fernando; Silvestri, Elena] Univ Sannio, Dept Sci & Technol, Benevento, Italy; [Lanni, Antonia; Lange, Pieter; Senese, Rosalba] Univ Campania Luigi Vanvitelli, Dept Environm Biol & Pharmaceut Sci & Technol, Caserta, Italy; [Gentile, Alessandra] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy	University of Naples Federico II; University of Urbino; University of Sannio; Universita della Campania Vanvitelli; University of Milan	Lombardi, A (corresponding author), Univ Naples Federico II, Dept Biol, Via Cinthia, I-80126 Naples, Italy.; Silvestri, E (corresponding author), Univ Sannio, Dept Sci & Technol, Benevento, Italy.	silvestri@unisannio.it; assunta.lombardi@unina.it		Silvestri, Elena/0000-0002-0592-9033	Universita degli Studi di Napoli Federico II (UNINA); Universita degli Studi di Urbino Carlo Bo (University of Urbino); University of Sannio	Universita degli Studi di Napoli Federico II (UNINA); Universita degli Studi di Urbino Carlo Bo (University of Urbino); University of Sannio	Universita degli Studi di Napoli Federico II (UNINA); Universita degli Studi di Urbino Carlo Bo (University of Urbino); University of Sannio	Agarwal S, 2017, BBA-MOL BASIS DIS, V1863, P174, DOI 10.1016/j.bbadis.2016.10.002; Antoniades C, 2009, OBES REV, V10, P269, DOI 10.1111/j.1467-789X.2009.00571.x; Bjorndal B, 2011, J OBES, V2011, DOI 10.1155/2011/490650; Cadenas S, 2018, BBA-BIOENERGETICS, V1859, P940, DOI 10.1016/j.bbabio.2018.05.019; Chan CB, 2006, CURR DIABETES REV, V2, P271, DOI 10.2174/157339906777950660; Choi CS, 2007, J CLIN INVEST, V117, P1995, DOI 10.1172/JCI13579; Cioffi F, 2009, BIOFACTORS, V35, P417, DOI 10.1002/biof.54; Clark AM, 2009, ANAL CHEM, V81, P2350, DOI 10.1021/ac8026965; Costford SR, 2008, AM J PHYSIOL-ENDOC M, V295, pE1018, DOI 10.1152/ajpendo.00779.2007; Dasgupta S, 2010, BIOCHEM J, V429, P451, DOI 10.1042/BJ20100330; Roman DAD, 2010, METABOLISM, V59, P608, DOI 10.1016/j.metabol.2009.09.004; de Vries MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047134; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Driver AS, 2000, NEUROTOXICOL TERATOL, V22, P175, DOI 10.1016/S0892-0362(99)00069-0; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Fasshauer M, 2002, BIOCHEM BIOPH RES CO, V290, P1084, DOI 10.1006/bbrc.2001.6307; Flamment M, 2012, TRENDS ENDOCRIN MET, V23, P381, DOI 10.1016/j.tem.2012.06.003; Foley KP, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100440; FREDHOLM BB, 1981, INT J OBESITY, V5, P643; Fruhbeck G, 2014, NUTR RES REV, V27, P63, DOI 10.1017/S095442241400002X; Girousse A, 2012, INT J OBESITY, V36, P581, DOI 10.1038/ijo.2011.113; Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Hilse KE, 2016, BBA-BIOENERGETICS, V1857, P72, DOI 10.1016/j.bbabio.2015.10.011; Hotamisligil GS, 2000, INT J OBESITY, V24, pS23, DOI 10.1038/sj.ijo.0801497; Kos K, 2009, DIABETES OBES METAB, V11, P285, DOI 10.1111/j.1463-1326.2008.00909.x; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; Lim JH, 2009, CELL SIGNAL, V21, P169, DOI 10.1016/j.cellsig.2008.10.004; Lionetti L, 2009, NUTR METAB CARDIOVAS, V19, P146, DOI 10.1016/j.numecd.2008.10.010; Lombardi A, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080916; Lombardi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116498; Lombardi A, 2010, J BIOL CHEM, V285, P16599, DOI 10.1074/jbc.M110.102699; Mensink M, 2007, DIABETES OBES METAB, V9, P594, DOI 10.1111/j.1463-1326.2006.00628.x; Mondal AK, 2012, METAB SYNDR RELAT D, V10, P297, DOI 10.1089/met.2012.0002; Ozcan L, 2013, CELL METAB, V18, P803, DOI 10.1016/j.cmet.2013.10.011; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Ramezani-Moghadam M, 2015, J BIOL CHEM, V290, P5533, DOI 10.1074/jbc.M114.598011; Ryden M, 2004, BIOCHEM BIOPH RES CO, V318, P168, DOI 10.1016/j.bbrc.2004.04.010; Schrauwen P, 2004, DIABETES, V53, P1412, DOI 10.2337/diabetes.53.6.1412; Senese R, 2011, PFLUG ARCH EUR J PHY, V461, P153, DOI 10.1007/s00424-010-0892-3; Siddals KW, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740289; Silvestri E, 2020, FASEB J, V34, P15146, DOI 10.1096/fj.202000995R; Sobel BE, 1999, CIRCULATION, V99, P2496, DOI 10.1161/01.CIR.99.19.2496; Sohn JH, 2018, J BIOL CHEM, V293, P13974, DOI 10.1074/jbc.RA118.003541; Torre-Villalvazo I, 2018, J CELL BIOCHEM, V119, P5970, DOI 10.1002/jcb.26794; Villalobos-Labra R, 2019, MOL ASPECTS MED, V66, P49, DOI 10.1016/j.mam.2018.11.001; Wang CH, 2013, FEBS J, V280, P1039, DOI 10.1111/febs.12096; Xu L, 2010, HORM METAB RES, V42, P643, DOI 10.1055/s-0030-1255034; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yamauchi Toshimasa, 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P243, DOI 10.2174/1568008033340090	51	0	0	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22325	10.1096/fj.202101816RR	http://dx.doi.org/10.1096/fj.202101816RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0Q2SG	35452152	hybrid			2022-12-26	WOS:000784773400001
J	Kotyan, S; Matsuki, M; Vargas, DV				Kotyan, Shashank; Matsuki, Moe; Vargas, Danilo Vasconcellos			Transferability of features for neural networks links to adversarial attacks and defences	PLOS ONE			English	Article								The reason for the existence of adversarial samples is still barely understood. Here, we explore the transferability of learned features to Out-of-Distribution (OoD) classes. We do this by assessing neural networks' capability to encode the existing features, revealing an intriguing connection with adversarial attacks and defences. The principal idea is that, "if an algorithm learns rich features, such features should represent Out-of-Distribution classes as a combination of previously learned In-Distribution (ID) classes". This is because OoD classes usually share several regular features with ID classes, given that the features learned are general enough. We further introduce two metrics to assess the transferred features representing OoD classes. One is based on inter-cluster validation techniques, while the other captures the influence of a class over learned features. Experiments suggest that several adversarial defences decrease the attack accuracy of some attacks and improve the transferability-of-features as measured by our metrics. Experiments also reveal a relationship between the proposed metrics and adversarial attacks (a high Pearson correlation coefficient and low p-value). Further, statistical tests suggest that several adversarial defences, in general, significantly improve transferability. Our tests suggests that models having a higher transferability-of-features have generally higher robustness against adversarial attacks. Thus, the experiments suggest that the objectives of adversarial machine learning might be much closer to domain transfer learning, as previously thought.	[Kotyan, Shashank; Vargas, Danilo Vasconcellos] Kyushu Univ, Dept Informat Sci & Engn, Fukuoka, Japan; [Matsuki, Moe] SoftBank Grp Corp, Tokyo, Japan; [Vargas, Danilo Vasconcellos] Univ Tokyo, Sch Engn, Dept Elect Engn & Informat Syst, Tokyo, Japan	Kyushu University; University of Tokyo	Kotyan, S (corresponding author), Kyushu Univ, Dept Informat Sci & Engn, Fukuoka, Japan.	kotyan.shashank.651@s.kyushu-u.ac.jp			JST [JP-50243]; JSPS KAKENHI [JP20241216]	JST(Japan Science & Technology Agency (JST)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	DV, JST, ACT-I Grant Number JP-50243, https://www.jst.go.jp/kisoken/act-i/index.html DV, JSPS KAKENHI Grant Number JP20241216, https://www.jsps.go.jp/english/e-grants/.	Agarwal C, 2019, IEEE IMAGE PROC, P3801, DOI 10.1109/ICIP.2019.8803601; Akata Z, 2015, PROC CVPR IEEE, P2927, DOI 10.1109/CVPR.2015.7298911; Alexey Dosovitskiy, 2015, Arxiv, DOI arXiv:1412.6806; Alexey Kurakin, 2017, Arxiv, DOI arXiv:1607.02533; Anders C. Hansen, 2019, Arxiv, DOI arXiv:1906.01478; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Nguyen A, 2015, PROC CVPR IEEE, P427, DOI 10.1109/CVPR.2015.7298640; Athalye A., 2018, OBFUSCATED GRADIENTS; Athalye A, 2018, PR MACH LEARN RES, V80; Bing Xu, 2016, Arxiv, DOI arXiv:1511.03034; Bo Li, 2018, Arxiv, DOI arXiv:1801.02613; Bucher M, 2016, LECT NOTES COMPUT SC, V9909, P730, DOI 10.1007/978-3-319-46454-1_44; Buckman J., 2018, INT C LEARN REPR; Carlini N, 2017, P IEEE S SECUR PRIV, P39, DOI 10.1109/SP.2017.49; Casasanto D, 2008, MEM COGNITION, V36, P1047, DOI 10.3758/MC.36.6.1047; Chen JB, 2020, P IEEE S SECUR PRIV, P1277, DOI 10.1109/SP40000.2020.00045; Christian Szegedy, 2015, Arxiv, DOI arXiv:1412.6572; Danilo Vasconcellos Vargas, 2020, Arxiv, DOI arXiv:1906.06026; Das N., 2017, ARXIV; David Evans, 2017, Arxiv, DOI arXiv:1704.01155; David HA, 1997, AM STAT, V51, P9, DOI 10.2307/2684684; David J. Fleet, 2016, Arxiv, DOI arXiv:1511.05122; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Dziugaite G. K., 2016, ARXIV; Fawzi A, 2018, ADV NEUR IN, V31; Fawzi A, 2018, PROC CVPR IEEE, P3762, DOI 10.1109/CVPR.2018.00396; Fu Y, 2015, ARXIV; Guo C., 2018, INT C LEARNING REPRE; Guo YW, 2018, ADV NEUR IN, V31; Hazan T., 2016, PERTURBATIONS OPTIMI; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; Ilyas A, 2019, ADV NEUR IN, V32; Jang U, 2017, ANN COMPUT SECURITY, P262, DOI 10.1145/3134600.3134635; Kotyan S, ARXIV; Krizhevsky Alex, 2009, LEARNING MULTIPLE LA; Lampert CH, 2009, PROC CVPR IEEE, P951, DOI 10.1109/CVPRW.2009.5206594; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Madry A., 2017, ARXIV170606083; Min Lin, 2014, Arxiv, DOI arXiv:1312.4400; Moosavi-Dezfooli SM, 2017, PROC CVPR IEEE, P86, DOI 10.1109/CVPR.2017.17; Moosavi-Dezfooli SM, 2016, PROC CVPR IEEE, P2574, DOI 10.1109/CVPR.2016.282; Moosavi-Dezfooli SM, 2018, INT C LEARN REPR; Muller R, 2019, ADV NEUR IN, V32; Nikos Komodakis, 2017, Arxiv, DOI arXiv:1605.07146; Papernot N, 2016, P IEEE S SECUR PRIV, P582, DOI 10.1109/SP.2016.41; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Sabour S, 2017, ADV NEUR IN, V30; Sharif M, 2016, CCS'16: PROCEEDINGS OF THE 2016 ACM SIGSAC CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY, P1528, DOI 10.1145/2976749.2978392; Shigeto Y, 2015, LECT NOTES ARTIF INT, V9284, P135, DOI 10.1007/978-3-319-23528-8_9; Song Y., 2018, INT C LEARNING REPRE; Szegedy C, 2016, P IEEE C COMP VIS PA, P2818; Szegedy C, 2014, INTRIGUING PROPERTIE, P6; Tao GH, 2018, ADV NEUR IN, V31; Tramer F., 2020, ARXIV; Tramer Florian, 2018, INT C LEARNING REPRE; Uesato J, 2018, PR MACH LEARN RES, V80; Vargas D. V., 2019, ARXIV; Walker CM, 2016, COGNITION, V156, P30, DOI 10.1016/j.cognition.2016.07.008; Walker CM, 2014, PSYCHOL SCI, V25, P161, DOI 10.1177/0956797613502983; Xiao H., 2017, ARXIV170807747; Yan CX, 2022, IEEE T PATTERN ANAL, V44, P9733, DOI 10.1109/TPAMI.2021.3127346; Zhang ZM, 2016, LECT NOTES COMPUT SC, V9911, P533, DOI 10.1007/978-3-319-46478-7_33; Zhang ZM, 2015, IEEE I CONF COMP VIS, P4166, DOI 10.1109/ICCV.2015.474	69	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0266060	10.1371/journal.pone.0266060	http://dx.doi.org/10.1371/journal.pone.0266060			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476838	Green Published, gold			2022-12-26	WOS:000840124300007
J	Lerdsamran, H; Mungaomklang, A; Iamsirithaworn, S; Prasertsopon, J; Wiriyarat, W; Saritsiri, S; Anusorntanawat, R; Siriyakorn, N; Intalapaporn, P; Sirikhetkon, S; Sangsiriwut, K; Dangsakul, W; Sawadpongpan, S; Thinpan, N; Kitidee, K; Okada, P; Techasuwanna, R; Mongkalangoon, N; Prasert, K; Puthavathana, P				Lerdsamran, Hatairat; Mungaomklang, Anek; Iamsirithaworn, Sopon; Prasertsopon, Jarunee; Wiriyarat, Witthawat; Saritsiri, Suthee; Anusorntanawat, Ratikorn; Siriyakorn, Nirada; Intalapaporn, Poj; Sirikhetkon, Somrak; Sangsiriwut, Kantima; Dangsakul, Worawat; Sawadpongpan, Suteema; Thinpan, Nattakan; Kitidee, Kuntida; Okada, Pilailuk; Techasuwanna, Ranida; Mongkalangoon, Noparat; Prasert, Kriengkrai; Puthavathana, Pilaipan			Seroprevalence of anti-SARS-CoV-2 antibodies in Thai adults during the first three epidemic waves	PLOS ONE			English	Article							SARS-COV-2	This study determined the presence of anti-SARS-CoV-2 antibodies in 4964 individuals, comprising 300 coronavirus disease-19 (COVID-19) prepandemic serum samples, 142 COVID-19 patients, 2113 individuals at risk due to their occupations, 1856 individuals at risk due to sharing workplaces or communities with COVID-19 patients, and 553 Thai citizens returning after spending extended periods of time in countries with a high disease prevalence. We recruited participants between May 2020 and May 2021, which spanned the first two epidemic waves and part of the third wave of the COVID-19 outbreaks in Thailand. Their sera were tested in a microneutralization and a chemiluminescence immunoassay for IgG against the N protein. Furthermore, we performed an immunofluorescence assay to resolve discordant results between the two assays. None of the prepandemic sera contained anti-SARS-CoV-2 antibodies, while antibodies developed in 88% (15 of 17) of the COVID-19 patients at 8-14 days and in 94-100% of the patients between 15 and 60 days after disease onset. Neutralizing antibodies persisted for at least 8 months, longer than IgG antibodies. Of the 2113 individuals at risk due to their occupation, none of the health providers, airport officers, or public transport drivers were seropositive, while antibodies were present in 0.44% of entertainment workers. Among the 1856 individuals at risk due to sharing workplaces or communities with COVID-19 patients, seropositivity was present in 1.9, 1.5, and 7.5% of the Bangkok residents during the three epidemic waves, respectively, and in 1.3% of the Chiang Mai people during the first epidemic wave. The antibody prevalence varied between 6.5 and 47.0% in 553 Thai people returning from high-risk countries. This serosurveillance study found a low infection rate of SARS-CoV-2 in Thailand before the emergence of the Delta variant in late May 2021. The findings support the Ministry of Public Health's data, which are based on numbers of patients and contact tracing.	[Lerdsamran, Hatairat; Prasertsopon, Jarunee; Sawadpongpan, Suteema; Thinpan, Nattakan; Kitidee, Kuntida; Puthavathana, Pilaipan] Mahidol Univ, Fac Med Technol, Ctr Res & Innovat, Nakhon Pathom, Thailand; [Mungaomklang, Anek; Sirikhetkon, Somrak] Minist Publ Hlth, Dept Dis Control, Inst Urban Dis Control & Prevent, Bangkok, Thailand; [Iamsirithaworn, Sopon; Techasuwanna, Ranida; Mongkalangoon, Noparat] Minist Publ Hlth, Dept Dis Control, Nonthaburi, Thailand; [Wiriyarat, Witthawat] Mahidol Univ, Fac Vet Sci, Nakhon Pathom, Thailand; [Saritsiri, Suthee] Bangkok Metropolitan Adm, Dept Hlth, Publ Hlth Ctr Thaweewatthana 67, Bangkok, Thailand; [Anusorntanawat, Ratikorn] Minist Publ Hlth, Off Permanent Secretary, Chaophraya Yommarat Hosp, Suphanburi, Thailand; [Siriyakorn, Nirada; Intalapaporn, Poj] Minist Publ Hlth, Rajavithi Hosp, Dept Med Serv, Bangkok, Thailand; [Sangsiriwut, Kantima] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Prevent & Social Med, Bangkok, Thailand; [Dangsakul, Worawat; Okada, Pilailuk] Minist Publ Hlth, Dept Med Sci, Nonthaburi, Thailand; [Prasert, Kriengkrai] Minist Publ Hlth, Dept Med Serv, Nakhon Phanom Prov Hosp, Nakhon Phanom, Thailand	Mahidol University; Ministry of Public Health - Thailand; Ministry of Public Health - Thailand; Mahidol University; Ministry of Public Health - Thailand; Rajavithi Hospital; Mahidol University; Ministry of Public Health - Thailand; Ministry of Public Health - Thailand	Puthavathana, P (corresponding author), Mahidol Univ, Fac Med Technol, Ctr Res & Innovat, Nakhon Pathom, Thailand.	pilaipan.put@mahidol.edu		Dangsagul, Worawat/0000-0002-6066-5245	National Research Council of Thailand (NRCT); NRCT [11/2563]; Department of Disease Control Ministry of Public Health, Thailand; National Science and Technology Development Agency (NSTDA), Thailand [P-17-50551]	National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT)); NRCT; Department of Disease Control Ministry of Public Health, Thailand; National Science and Technology Development Agency (NSTDA), Thailand	This study was financially supported by the National Research Council of Thailand (NRCT), Grant No. NRCT 11/2563; the Department of Disease Control Ministry of Public Health, Thailand; and the National Science and Technology Development Agency (NSTDA), Thailand, Grant No. P-17-50551. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2022, REUTER COVID 19 TRAC; Brouwer PJM, 2020, SCIENCE, V369, P643, DOI 10.1126/science.abc5902; Cheepsattayakorn A., 2021, AM J INTERNAL MED, V9, P114; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Dutta NK, 2020, J VIROL, V94, DOI 10.1128/JVI.00647-20; Gallais F, 2021, EBIOMEDICINE, V71, DOI 10.1016/j.ebiom.2021.103561; Gudbjartsson DF, 2020, NEW ENGL J MED, V383, P1724, DOI 10.1056/NEJMoa2026116; Haveri A, 2021, EUR J IMMUNOL, V51, P3202, DOI 10.1002/eji.202149535; Keng CT, 2005, J VIROL, V79, P3289, DOI 10.1128/JVI.79.6.3289-3296.2005; Khemanitthathai S., 2021, SITUATION MIGRANT WO; Kittikraisak W, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254563; Laohong K, 2021, BANGKOK POST; Legros V, 2021, CELL MOL IMMUNOL, V18, P318, DOI 10.1038/s41423-020-00588-2; Lerdsamran H, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06921-y; Lerdsamran H, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1074-8; Morikane K, 2021, WEST PAC SURVEILL RE, V12, DOI 10.5365/wpsar.2020.11.3.012; Murhekar MV, 2020, INDIAN J MED RES, V152, P48, DOI 10.4103/ijmr.IJMR_3290_20; Negara MRM, 2021, MED J INDONES, V30, P89, DOI 10.13181/mji.oa.215304; Our World in Data, 2021, THAIL COR PAND COUNT; Perez-Saez J, 2021, CLIN MICROBIOL INFEC, V27, DOI 10.1016/j.cmi.2021.06.040; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Premkumar L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc8413; Reicher S, 2021, EUR J EPIDEMIOL, V36, P727, DOI 10.1007/s10654-021-00749-1; Sah P, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2109229118; Sansanayudh N., 2020, J SE ASIAN MED RES, V4, P67; Sirilak S., 2020, THAILANDS EXPERIENCE; Stadlbauer D, 2020, NATURE, DOI 10.1038/s41586-020-2912-6; Tanaka A, 2021, J INFECTION, V82, pE1, DOI 10.1016/j.jinf.2021.01.010; Thai PBS World, 2021, PROB SOUGHT POL OFF; Tribune B., 2021, BANGKOK TRIBUNE ONLI; West EA, 2020, INT J PUBLIC HEALTH, V65, P1529, DOI 10.1007/s00038-020-01494-0; WHO Cambodia, CAMB COR DIS 2019 CO; Win A, 2020, QJM-INT J MED, V113, P856, DOI 10.1093/qjmed/hcaa290; Yang HT, 2021, NAT REV MICROBIOL, V19, P685, DOI 10.1038/s41579-021-00630-8	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0263316	10.1371/journal.pone.0263316	http://dx.doi.org/10.1371/journal.pone.0263316			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476709	Green Published, gold			2022-12-26	WOS:000840124300001
J	Odeniyide, P; Yohe, ME; Pollard, K; Vaseva, AV; Calizo, A; Zhang, L; Rodriguez, FJ; Gross, JM; Allen, AN; Wan, XL; Somwar, R; Schreck, KC; Kessler, L; Wang, JW; Pratilas, CA				Odeniyide, Patience; Yohe, Marielle E.; Pollard, Kai; Vaseva, Angelina V.; Calizo, Ana; Zhang, Lindy; Rodriguez, Fausto J.; Gross, John M.; Allen, Amy N.; Wan, Xiaolin; Somwar, Romel; Schreck, Karisa C.; Kessler, Linda; Wang, Jiawan; Pratilas, Christine A.			Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma	ONCOGENE			English	Article							PHASE-II TRIAL; FARNESYLTRANSFERASE INHIBITOR TIPIFARNIB; ACUTE MYELOGENOUS LEUKEMIA; METASTATIC BREAST-CANCER; TRANSFERASE INHIBITOR; MEMBRANE ASSOCIATION; ONCOLOGY-GROUP; SOLID TUMORS; RAS; CHILDREN	Activating RAS mutations are found in a subset of fusion-negative rhabdomyosarcoma (RMS), and therapeutic strategies to directly target RAS in these tumors have been investigated, without clinical success to date. A potential strategy to inhibit oncogenic RAS activity is the disruption of RAS prenylation, an obligate step for RAS membrane localization and effector pathway signaling, through inhibition of farnesyltransferase (FTase). Of the major RAS family members, HRAS is uniquely dependent on FTase for prenylation, whereas NRAS and KRAS can utilize geranylgeranyl transferase as a bypass prenylation mechanism. Tumors driven by oncogenic HRAS may therefore be uniquely sensitive to FTase inhibition. To investigate the mutation-specific effects of FTase inhibition in RMS we utilized tipifarnib, a potent and selective FTase inhibitor, in in vitro and in vivo models of RMS genomically characterized for RAS mutation status. Tipifarnib reduced HRAS processing, and plasma membrane localization leading to decreased GTP-bound HRAS and decreased signaling through RAS effector pathways. In HRAS-mutant cell lines, tipifarnib reduced two-dimensional and three-dimensional cell growth, and in vivo treatment with tipifarnib resulted in tumor growth inhibition exclusively in HRAS-mutant RMS xenografts. Our data suggest that small molecule inhibition of FTase is active in HRAS-driven RMS and may represent an effective therapeutic strategy for a genomically-defined subset of RMS patients.	[Odeniyide, Patience; Pollard, Kai; Calizo, Ana; Zhang, Lindy; Allen, Amy N.; Wang, Jiawan; Pratilas, Christine A.] Johns Hopkins Univ, Sch Med, Dept Pediat Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA; [Yohe, Marielle E.; Wan, Xiaolin] NCI, Pediat Oncol Branch, NIH, Bethesda, MD 20892 USA; [Vaseva, Angelina V.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Rodriguez, Fausto J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Lab Med & Pathol, Los Angeles, CA 90095 USA; [Rodriguez, Fausto J.; Gross, John M.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Somwar, Romel] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Schreck, Karisa C.; Pratilas, Christine A.] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Schreck, Karisa C.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Kessler, Linda] Kura Oncol, San Diego, CA USA	Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; University of Texas Health San Antonio; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Johns Hopkins University; Memorial Sloan Kettering Cancer Center; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Pratilas, CA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA.; Pratilas, CA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA.	cpratil1@jhmi.edu		Wang, Jiawan/0000-0002-2137-1826; Calizo, Ana/0000-0002-2581-6378; Odeniyide, Patience/0000-0002-9783-1657; Rodriguez, Fausto/0000-0001-8662-1219	Kura Oncology [NIH T32CA060441]; SKCCC Cancer Center Core Support [NIH P30 CA006973]; Memorial Sloan Kettering Cancer Center Support Grant [P30 CA008748]; Childhood Solid Tumor Network	Kura Oncology; SKCCC Cancer Center Core Support; Memorial Sloan Kettering Cancer Center Support Grant; Childhood Solid Tumor Network	This work has been funded by a grant from Kura Oncology (to CAP), the NIH T32CA060441 Pediatric Oncology Fellowship Training grant (to PO), the SKCCC Cancer Center Core Support (NIH P30 CA006973) and the Memorial Sloan Kettering Cancer Center Support Grant (P30 CA008748, RS). Cell line SJRHB000026_X1 was graciously provided by the Childhood Solid Tumor Network. Immunostaining was performed at the Oncology Tissue Services Core of Johns Hopkins University.	Alonso-Alonso R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63434-5; [Anonymous], 2021, CANCER DISCOV, V11; Arndt CAS, 2009, J CLIN ONCOL, V27, P5182, DOI 10.1200/JCO.2009.22.3768; Baba TT, 2008, J MUSCLE RES CELL M, V29, P127, DOI 10.1007/s10974-008-9146-9; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Berzat AC, 2006, METHOD ENZYMOL, V407, P575, DOI 10.1016/S0076-6879(05)07046-1; BOS JL, 1989, CANCER RES, V49, P4682; Burnett AK, 2012, BRIT J HAEMATOL, V158, P519, DOI 10.1111/j.1365-2141.2012.09165.x; Case M, 2008, CANCER RES, V68, P6803, DOI 10.1158/0008-5472.CAN-08-0101; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; Chen X, 2013, CANCER CELL, V24, P710, DOI 10.1016/j.ccr.2013.11.002; Cloughesy TF, 2006, J CLIN ONCOL, V24, P3651, DOI 10.1200/JCO.2006.06.2323; Contente Sara, 2011, Genes Cancer, V2, P166, DOI 10.1177/1947601911405042; Cox AD, 2002, CANCER BIOL THER, V1, P599, DOI 10.4161/cbt.306; Cox AD, 2015, CLIN CANCER RES, V21, P1819, DOI 10.1158/1078-0432.CCR-14-3214; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Dalin MG, 2016, CLIN CANCER RES, V22, P4623, DOI 10.1158/1078-0432.CCR-16-0637; DER CJ, 1991, CANCER CELL-MON REV, V3, P331; Ding HS, 2014, HAEMATOLOGICA, V99, P60, DOI 10.3324/haematol.2013.087734; Ding HS, 2011, BLOOD, V118, DOI 10.1182/blood-2011-02-334870; End DW, 2001, CANCER RES, V61, P131; Fedele C, 2018, CANCER DISCOV, V8, P1237, DOI 10.1158/2159-8290.CD-18-0444; Gervais R, 2005, ANN ONCOL, V16, P90, DOI 10.1093/annonc/mdi018; Gilardi M, 2020, MOL CANCER THER, V19, P1784, DOI 10.1158/1535-7163.MCT-19-0958; Haas-Kogan DA, 2011, NEURO-ONCOLOGY, V13, P298, DOI 10.1093/neuonc/noq202; Hanna GJ, 2020, CANCER-AM CANCER SOC, V126, P3972, DOI 10.1002/cncr.33036; Harousseau JL, 2009, BLOOD, V114, P1166, DOI 10.1182/blood-2009-01-198093; Hillig RC, 2019, P NATL ACAD SCI USA, V116, P2551, DOI 10.1073/pnas.1812963116; Ho A, 2018, MOL CANCER THER, V17, DOI 10.1158/1535-7163.TARG-17-LB-A10; Ho A, 2019, MOL CANCER THER, V18, DOI 10.1158/1535-7163.TARG-19-PR08; Hong DS, 2020, NEW ENGL J MED, V383, P1207, DOI 10.1056/NEJMoa1917239; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Karp JE, 2008, CLIN CANCER RES, V14, P3077, DOI 10.1158/1078-0432.CCR-07-4743; Kazi A, 2019, CLIN CANCER RES, V25, P5984, DOI 10.1158/1078-0432.CCR-18-3399; Kurzrock R, 2003, BLOOD, V102, P4527, DOI 10.1182/blood-2002-11-3359; Lebowitz PF, 1998, ONCOGENE, V17, P1439, DOI 10.1038/sj.onc.1202175; Lee HW, 2020, CLIN CANCER RES, V26, P5113, DOI 10.1158/1078-0432.CCR-20-1246; Lee HW, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00741-6; LERNER EC, 1995, J BIOL CHEM, V270, P26802, DOI 10.1074/jbc.270.45.26802; Li T, 2009, ANN ONCOL, V20, P642, DOI 10.1093/annonc/mdn689; Li TH, 2012, BREAST CANCER RES TR, V134, P345, DOI 10.1007/s10549-012-2071-z; Liu ZH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16135-6; Pratilas CA, 2008, CANCER RES, V68, P9375, DOI 10.1158/0008-5472.CAN-08-2223; Rao S, 2004, J CLIN ONCOL, V22, P3950, DOI 10.1200/JCO.2004.10.037; Raponi M, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-56; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; Rowinsky EK, 1999, J CLIN ONCOL, V17, P3631, DOI 10.1200/JCO.1999.17.11.3631; Sasaki AT, 2009, METHODS MOL BIOL, V571, P333, DOI 10.1007/978-1-60761-198-1_23; Sebti SM, 2000, EXPERT OPIN INV DRUG, V9, P2767, DOI 10.1517/13543784.9.12.2767; SEPPLORENZINO L, 1995, CANCER RES, V55, P5302; Shern JF, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.10515; Shukla N, 2012, CLIN CANCER RES, V18, P748, DOI 10.1158/1078-0432.CCR-11-2056; Sparano JA, 2009, CLIN CANCER RES, V15, P2942, DOI 10.1158/1078-0432.CCR-08-2658; Stalnecker CA, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aay6013; Stewart E, 2017, NATURE, V549, P96, DOI 10.1038/nature23647; Stieglitz E, 2015, PEDIATR BLOOD CANCER, V62, P629, DOI 10.1002/pbc.25342; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; Tanaka T, 2017, J CELL PHYSIOL, V232, P192, DOI 10.1002/jcp.25411; Untch BR, 2018, CANCER RES, V78, P4642, DOI 10.1158/0008-5472.CAN-17-1925; Van Cutsem E, 2004, J CLIN ONCOL, V22, P1430, DOI 10.1200/JCO.2004.10.112; Wang JY, 2017, MEDCHEMCOMM, V8, P841, DOI 10.1039/c7md00030h; Weigel BJ, 2016, J CLIN ONCOL, V34, P117, DOI 10.1200/JCO.2015.63.4048; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Widemann BC, 2006, J CLIN ONCOL, V24, P507, DOI 10.1200/JCO.2005.03.8638; Widemann BC, 2014, NEURO-ONCOLOGY, V16, P707, DOI 10.1093/neuonc/nou004; Widemann BC, 2011, PEDIATR BLOOD CANCER, V56, P226, DOI 10.1002/pbc.22775; Wong GS, 2018, NAT MED, V24, P968, DOI 10.1038/s41591-018-0022-x; Wurzer G, 2001, J CELL BIOCHEM, P1; Zujewski J, 2000, J CLIN ONCOL, V18, P927, DOI 10.1200/JCO.2000.18.4.927	69	2	2	1	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 20	2022	41	21					2973	2983		10.1038/s41388-022-02305-x	http://dx.doi.org/10.1038/s41388-022-02305-x		APR 2022	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	1L8MU	35459782	hybrid, Green Published			2022-12-26	WOS:000787474100004
J	Ashebir, G; Nigussie, H; Glagn, M; Beyene, K; Getie, A				Ashebir, Gedife; Nigussie, Haymanot; Glagn, Mustefa; Beyene, Kassaw; Getie, Asmare			Determinants of hyperemesis gravidarum among pregnant women attending health care service in public hospitals of Southern Ethiopia	PLOS ONE			English	Article							NAUSEA; DEPRESSION; RISK; QUESTIONNAIRE; DIET	BackgroundHyperemesis gravidarum is severe nausea and excessive vomiting, starting between 4 and 6 gestational weeks, peak at between 8 and 12 weeks and usually improve and subside by 20 weeks of pregnancy. Identifying the determinants of hyperemesis gravidarum has a particular importance for early detection and intervention to reduce the health, psychosocial and economic impact. In Ethiopia there is low information on determinants of hyperemesis gravidarum. MethodsInstitution based unmatched case-control study design was conducted from April 12- June 12, 2021. A structured face-to-face interviewer administered questionnaire and checklist for document review were used to collect the data from 360 study participants (120 cases and 240 controls). The data were collected by KoBocollect 1.3, and then exported to statistical package for social science version 25 for further analysis. Both bi-variable and multivariable logistic regression analysis were done to identify the determinants and a p-value < 0.05 with a 95% confidence level was used to declare statistical significance. ResultBeing an urban dweller (AOR = 2.1, 95% CI: 1.01, 4.34), having polygamous husband (AOR = 2.92, 95% CI: 1.27, 6.68), having history asthma/ other respiratory tract infections (AOR = 3.56, 95% CI: 1.43, 8.82), saturated fat intake (AOR = 4.06 95% CI: 1.98, 8.3), no intake of ginger (AOR = 3.04 95% CI: 1.14, 8.09), and inadequate intake of vitamin B rich foods (2.2, 95% CI: 1.14-4.2) were the determinants of hyperemesis gravidarum. ConclusionThis study revealed that, urban residence, having polygamous husband, history of asthma/other respiratory tract infections, intake of saturated fat, no intake of ginger, inadequate intake of vitamin B reach foods were found to be independent determinants of hyperemesis gravidarum. It is better if healthcare providers and government authorities exert continual effort to give health education and counselling service concerning to dietary practice and asthma attacks. It is advisable if pregnant women adhere to healthy diets and limit intake of saturated fats and also husband and nearby relatives give care and support for pregnant women.	[Ashebir, Gedife; Nigussie, Haymanot; Glagn, Mustefa] Arba Minch Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Arba Minch, Ethiopia; [Beyene, Kassaw] Arba Minch Univ, Coll Med & Hlth Sci, Dept Midwifery, Arba Minch, Ethiopia; [Getie, Asmare] Arba Minch Univ, Coll Med & Hlth Sci, Sch Nursing, Arba Minch, Ethiopia	Arba Minch University; Arba Minch University; Arba Minch University	Beyene, K (corresponding author), Arba Minch Univ, Coll Med & Hlth Sci, Dept Midwifery, Arba Minch, Ethiopia.	kassaw.kb3@gmail.com						American Scientific., 2012, AM SCI 0613; Amogne FK., 2018, CLIN MOTHER CHILD HL, V15, P2; Botswana S., 2016, BOTSWANA MATERNAL MO; Cohen S, 1994, PERCEIVED STRESS SCA; Elmstahl S, 1996, EUR J CLIN NUTR, V50, P143; Erick M, 2018, OBSTET GYNECOL, V131, P935, DOI 10.1097/AOG.0000000000002604; Fiaschi L, 2016, HUM REPROD, V31, P1675, DOI 10.1093/humrep/dew128; Gabra A, 2018, HLTH SCI J, V12, P1; GOLDIN BR, 1986, AM J CLIN NUTR, V44, P945, DOI 10.1093/ajcn/44.6.945; Grooten IJ, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.01.042; Hailemariam S DA., 2016, PREVALENCE HYPEREMES, V5, P376; Haugen M, 2011, BRIT J NUTR, V106, P596, DOI 10.1017/S0007114511000675; healthline, WHY IS VIT B COMPL I; Heitmann K, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1249-0; Hizli D, 2012, J PSYCHOSOM OBST GYN, V33, P171, DOI 10.3109/0167482X.2012.717129; infobloom, WHAT IS CONN VOM AST; Kallen B, 2003, ACTA OBSTET GYN SCAN, V82, P916, DOI 10.1034/j.1600-0412.2003.00307.x; Kejela G., 2018, CLIN MOTHER CHILD HL, V15; Kender EE, 2015, DUNSEN ADAM, V28, P119, DOI 10.5350/DAJPN2015280204; Kuma T, 2013, ETHIOP J HEALTH DEV, V27, P200; Kuo Shih-Hsien, 2007, J Midwifery Womens Health, V52, pe1, DOI 10.1016/j.jmwh.2006.10.002; Lee NM, 2011, GASTROENTEROL CLIN N, V40, P309, DOI 10.1016/j.gtc.2011.03.009; Lete I, 2016, INTEGR MED INSIGHTS, V11, DOI 10.4137/IMI.S36273; London V, 2017, PHARMACOLOGY, V100, P161, DOI 10.1159/000477853; Lowe B, 2004, J AFFECT DISORDERS, V81, P61, DOI 10.1016/S0165-0327(03)00198-8; Lu Q Bin, 2015, SCI REP-UK, V5, P1; Mahmoud G., 2012, MED J CAIRO U, V80; McCarthy FP, 2014, INT J WOMENS HEALTH, V6, P719, DOI 10.2147/IJWH.S37685; McCarthy FP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027678; Meighan M, 2005, JOGNN-J OBST GYN NEO, V34, P172, DOI 10.1177/0884217504273673; Mitchell-Jones N, 2017, BJOG-INT J OBSTET GY, V124, P20, DOI 10.1111/1471-0528.14180; Mutlugunes E., 2013, CUMHURIYET NURS J, V2, P8; naturalremedyideas, NAUS VOM DIARRH 14 C; ndtv, US; Paoin W, 2018, HEALTH INF MANAG J, V47, P77, DOI 10.1177/1833358317701277; Pertz HH, 2011, PLANTA MED, V77, P973, DOI 10.1055/s-0030-1270747; Senturk M., 2015, MED SCI DISCOVERY, V2, P323; Signorello LB, 1998, EPIDEMIOLOGY, V9, P636, DOI 10.1097/00001648-199811000-00013; Thomson M, 2014, J AM BOARD FAM MED, V27, P115, DOI 10.3122/jabfm.2014.01.130167; Turkmen H, 2020, J PSYCHOSOM OBST GYN, V41, P282, DOI 10.1080/0167482X.2019.1678020; Veenendaal MVE, 2011, BJOG-INT J OBSTET GY, V118, P1302, DOI 10.1111/j.1471-0528.2011.03023.x; Walstab J, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12107; Yeh CC, 2018, J CHIN MED ASSOC, V81, P755, DOI 10.1016/j.jcma.2017.09.001	43	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266054	10.1371/journal.pone.0266054	http://dx.doi.org/10.1371/journal.pone.0266054			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35472152	Green Published, gold			2022-12-26	WOS:000816171900028
J	Flory, A; Kruglyak, KM; Tynan, JA; McLennan, LM; Rafalko, JM; Fiaux, PC; Hernandez, GE; Marass, F; Nakashe, P; Ruiz-Perez, CA; Fath, DM; Jennings, T; Motalli-Pepio, R; Wotrang, K; McCleary-Wheeler, AL; Lana, S; Phillips, B; Flesner, BK; Leibman, NF; LaDue, T; Tripp, CD; Coomber, BL; Woods, JP; Miller, M; Aiken, SW; Wolf-Ringwall, A; Borgatti, A; Kraska, K; Thomson, CB; Cahalane, AK; Murray, RL; Kisseberth, WC; Camps-Palau, MA; Floch, F; Beaudu-Lange, C; Klajer-Peres, A; Keravel, O; Fribourg-Blanc, LA; Mazetier, PC; Marco, A; McLeod, MB; Portillo, E; Clark, TS; Judd, S; Feinberg, CK; Benitez, M; Runyan, C; Hackett, L; Lafey, S; Richardson, D; Vineyard, S; Campbell, MT; Dharajiya, N; Jensen, TJ; van den Boom, D; Diaz, LA; Grosu, DS; Polk, A; Marsal, K; Hicks, SC; Lytle, KM; Holtvoigt, L; Chibuk, J; Chorny, I; Tsui, DWY				Flory, Andi; Kruglyak, Kristina M.; Tynan, John A.; McLennan, Lisa M.; Rafalko, Jill M.; Fiaux, Patrick Christian; Hernandez, Gilberto E.; Marass, Francesco; Nakashe, Prachi; Ruiz-Perez, Carlos A.; Fath, Donna M.; Jennings, Thuy; Motalli-Pepio, Rita; Wotrang, Kate; McCleary-Wheeler, Angela L.; Lana, Susan; Phillips, Brenda; Flesner, Brian K.; Leibman, Nicole F.; LaDue, Tracy; Tripp, Chelsea D.; Coomber, Brenda L.; Woods, J. Paul; Miller, Mairin; Aiken, Sean W.; Wolf-Ringwall, Amber; Borgatti, Antonella; Kraska, Kathleen; Thomson, Christopher B.; Kosanovich Cahalane, Alane; Murray, Rebecca L.; Kisseberth, William C.; Camps-Palau, Maria A.; Floch, Franck; Beaudu-Lange, Claire; Klajer-Peres, Aurelia; Keravel, Olivier; Fribourg-Blanc, Luc-Andre; Mazetier, Pascale Chicha; Marco, Angelo; McLeod, Molly B.; Portillo, Erin; Clark, Terry S.; Judd, Scott; Feinberg, C. Kirk; Benitez, Marie; Runyan, Candace; Hackett, Lindsey; Lafey, Scott; Richardson, Danielle; Vineyard, Sarah; Tefend Campbell, Mary; Dharajiya, Nilesh; Jensen, Taylor J.; van den Boom, Dirk; Diaz, Luis A.; Grosu, Daniel S.; Polk, Arthur; Marsal, Kalle; Hicks, Susan Cho; Lytle, Katherine M.; Holtvoigt, Lauren; Chibuk, Jason; Chorny, Ilya; Tsui, Dana W. Y.			Clinical validation of a next-generation sequencing-based multi-cancer early detection "liquid biopsy" blood test in over 1,000 dogs using an independent testing set: The CANcer Detection in Dogs (CANDiD) study	PLOS ONE			English	Article							BENIGN BREAST DISEASE; CELL-FREE DNA; INTEROBSERVER VARIABILITY; ENDOMETRIAL HYPERPLASIA; INCIDENTAL DETECTION; CANINE; NEOPLASIA; DIAGNOSIS; RISK; PERFORMANCE	Cancer is the leading cause of death in dogs, yet there are no established screening paradigms for early detection. Liquid biopsy methods that interrogate cancer-derived genomic alterations in cell-free DNA in blood are being adopted for multi-cancer early detection in human medicine and are now available for veterinary use. The CANcer Detection in Dogs (CANDiD) study is an international, multi-center clinical study designed to validate the performance of a novel multi-cancer early detection "liquid biopsy" test developed for noninvasive detection and characterization of cancer in dogs using next-generation sequencing (NGS) of blood-derived DNA; study results are reported here. In total, 1,358 cancer-diagnosed and presumably cancer-free dogs were enrolled in the study, representing the range of breeds, weights, ages, and cancer types seen in routine clinical practice; 1,100 subjects met inclusion criteria for analysis and were used in the validation of the test. Overall, the liquid biopsy test demonstrated a 54.7% (95% CI: 49.3-60.0%) sensitivity and a 98.5% (95% CI: 97.0-99.3%) specificity. For three of the most aggressive canine cancers (lymphoma, hemangiosarcoma, osteosarcoma), the detection rate was 85.4% (95% CI: 78.4-90.9%); and for eight of the most common canine cancers (lymphoma, hemangiosarcoma, osteosarcoma, soft tissue sarcoma, mast cell tumor, mammary gland carcinoma, anal sac adenocarcinoma, malignant melanoma), the detection rate was 61.9% (95% CI: 55.3-68.1%). The test detected cancer signal in patients representing 30 distinct cancer types and provided a Cancer Signal Origin prediction for a subset of patients with hematological malignancies. Furthermore, the test accurately detected cancer signal in four presumably cancer-free subjects before the onset of clinical signs, further supporting the utility of liquid biopsy as an early detection test. Taken together, these findings demonstrate that NGS-based liquid biopsy can offer a novel option for noninvasive multi-cancer detection in dogs.	[Flory, Andi; Kruglyak, Kristina M.; Tynan, John A.; McLennan, Lisa M.; Rafalko, Jill M.; Fiaux, Patrick Christian; Hernandez, Gilberto E.; Marass, Francesco; Nakashe, Prachi; Ruiz-Perez, Carlos A.; Fath, Donna M.; Jennings, Thuy; Motalli-Pepio, Rita; Wotrang, Kate; McCleary-Wheeler, Angela L.; Dharajiya, Nilesh; Jensen, Taylor J.; van den Boom, Dirk; Diaz, Luis A.; Grosu, Daniel S.; Polk, Arthur; Marsal, Kalle; Hicks, Susan Cho; Lytle, Katherine M.; Holtvoigt, Lauren; Chibuk, Jason; Chorny, Ilya; Tsui, Dana W. Y.] PetDx, La Jolla, CA 92037 USA; [Flory, Andi; Phillips, Brenda; Aiken, Sean W.; Kraska, Kathleen] Vet Specialty Hosp San Diego, San Diego, CA USA; [Flory, Andi; Miller, Mairin; Thomson, Christopher B.] Vet Specialty Hosp North Cty, San Marcos, CA USA; [McCleary-Wheeler, Angela L.; Flesner, Brian K.] Univ Missouri, Dept Vet Med & Surg, Columbia, MO USA; [Lana, Susan] Colorado State Univ, Dept Clin Sci, Ft Collins, CO 80523 USA; [Flesner, Brian K.] Univ Penn, Dept Clin Sci & Adv Med, Philadelphia, PA 19104 USA; [Leibman, Nicole F.; Camps-Palau, Maria A.] Anim Med Ctr, New York, NY USA; [LaDue, Tracy] Southeast Vet Oncol & Internal Med, Orange Pk, FL USA; [Tripp, Chelsea D.; Murray, Rebecca L.] Bridge Anim Referral Ctr, Edmonds, WA USA; [Coomber, Brenda L.] Univ Guelph, Dept Biomed Sci, Ontario Vet Coll, Guelph, ON, Canada; [Woods, J. Paul; Richardson, Danielle] Univ Guelph, Ontario Vet Coll, Mona Campbell Ctr Anim Canc, Inst Comparat Canc Invest, Guelph, ON, Canada; [Wolf-Ringwall, Amber; Borgatti, Antonella] Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA; [Kosanovich Cahalane, Alane] Vet Specialty Hosp Hong Kong, Wan Chai, Hong Kong, Peoples R China; [Kisseberth, William C.] Ohio State Univ, Coll Vet Med, Dept Vet Clin Sci, Columbus, OH 43210 USA; [Floch, Franck] Oncovet, Villeneuve Dascq, France; [Floch, Franck] AniCura TRIOVet, Rennes, France; [Beaudu-Lange, Claire] Clin Vet Pierre Bleue, Pipriac, France; [Klajer-Peres, Aurelia; Keravel, Olivier] Eiffelvet, Paris, France; [Fribourg-Blanc, Luc-Andre] Clin Vet SeineVet, Rouen, France; [Mazetier, Pascale Chicha] Clin Vet Mazetier, Argenteuil, France; [Marco, Angelo; Feinberg, C. Kirk; Benitez, Marie] Governor Anim Clin Inc, San Diego, CA USA; [McLeod, Molly B.] City Paws Home Hlth, Columbus, OH USA; [Portillo, Erin] VCA Valley Oak Vet Ctr, Chico, CA USA; [Clark, Terry S.] VCA Metroplex Anim Hosp, Irving, TX USA; [Judd, Scott] Prices Creek Vet Serv, Lewisburg, OH USA; [Runyan, Candace] Carlsbad Anim Hosp, Carlsbad, CA USA; [Hackett, Lindsey] Oceanside Vet Hosp, Oceanside, CA USA; [Lafey, Scott] Amici Pet Hosp Little Italy, San Diego, CA USA; [Vineyard, Sarah] Colony Vet Hosp, San Diego, CA USA; [Tefend Campbell, Mary] Carriage Hills Anim Hosp, Montgomery, AL USA; [Dharajiya, Nilesh] Healthbit Inc, San Diego, CA USA; [Jensen, Taylor J.] Lab Corp Amer, Durham, NC USA; [Diaz, Luis A.] Mem Sloan Kettering Canc Ctr, Div Solid Tumor Oncol, 1275 York Ave, New York, NY 10021 USA	University of Missouri System; University of Missouri Columbia; Colorado State University; University of Pennsylvania; University of Guelph; University of Guelph; University of Minnesota System; University of Minnesota Twin Cities; University System of Ohio; Ohio State University; Memorial Sloan Kettering Cancer Center	Rafalko, JM (corresponding author), PetDx, La Jolla, CA 92037 USA.	jrafalko@petdx.com	Flesner, Brian/GXZ-6439-2022; Beaudu-Lange, claire/GZG-5401-2022	Rafalko, Jill/0000-0003-3241-9781; Marass, Francesco/0000-0002-8993-7320; Fiaux, Patrick/0000-0001-9614-7370; Lytle, Katherine/0000-0002-7826-0107				Adalsteinsson VA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00965-y; American Animal Hospital Association, IS MY DOG RISK CANC; American Cancer Society, AM CANC SOC GUID EAR; American Veterinary Medical Association, US PET OWN STAT; American Veterinary Medical Association, CANC PETS; [Anonymous], 2019, BUSINESSWIRE 0513; Avanzini S, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc4308; Aziz H., 2022, J GASTROINTEST SURG, P1, DOI [10.1007/s11605-021-05032-y, DOI 10.1007/S11605-021-05032-Y]; Baioni E, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1126-0; Batschinski K, 2018, CAN VET J, V59, P967; Baumgartner JM, 2020, ANN SURG ONCOL, V27, P3259, DOI 10.1245/s10434-020-08331-x; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Bianchi DW, 2015, JAMA-J AM MED ASSOC, V314, P162, DOI 10.1001/jama.2015.7120; Biller B, 2016, J AM ANIM HOSP ASSOC, V52, P181, DOI 10.5326/JAAHA-MS-6570; Carbonnel M, 2021, J CLIN MED, V10, DOI 10.3390/jcm10184233; Cawley J., 2020, ARCH CANC BIOL THER, V1, P37, DOI DOI 10.33696/CANCERBIOLOGY.1.008; Chakravarty D, 2017, JCO PRECIS ONCOL, V1; Chibuk J, 2021, FRONT VET SCI, V8, DOI 10.3389/fvets.2021.664718; Christopher MM, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00246; Clarke CA, 2021, CANCER CELL, V39, P447, DOI 10.1016/j.ccell.2021.02.004; Cohen JD, 2018, SCIENCE, V359, P926, DOI 10.1126/science.aar3247; Conteduca V, 2013, INT J ONCOL, V43, P973, DOI 10.3892/ijo.2013.2041; Corbetta M, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.654140; Desjonqueres E, 2022, LIVER INT, V42, P492, DOI 10.1111/liv.15152; Dharajiya NG, 2018, CLIN CHEM, V64, P329, DOI 10.1373/clinchem.2017.277517; Donlin, 2020, OPEN LETT EXECUTIVE; Etzioni R, 2022, JNCI-J NATL CANCER I, V114, P349, DOI 10.1093/jnci/djab168; Fleming JM, 2011, J VET INTERN MED, V25, P187, DOI 10.1111/j.1939-1676.2011.0695.x; Food and Drug Administration (FDA), 2020, FDA APPR 1 LIQ BIOPS; Friedman E, 2015, BRIT J CANCER, V112, P765, DOI 10.1038/bjc.2015.14; Gajecka M, 2016, MOL GENET GENOMICS, V291, P513, DOI 10.1007/s00438-015-1130-7; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; GRAIL Inc, 2021, GRAIL PRES INT PATHF; Hackshaw A, 2021, BRIT J CANCER, V125, P1432, DOI 10.1038/s41416-021-01498-4; Hartmann LC, 2005, NEW ENGL J MED, V353, P229, DOI 10.1056/NEJMoa044383; Haug U, 2020, EUR J GASTROEN HEPAT, V32, P575, DOI 10.1097/MEG.0000000000001669; Hennigan S Thomas, 2019, JCO Precis Oncol, V3, DOI 10.1200/PO.19.00176; Henriksen TV, 2020, MOL ONCOL, V14, P1670, DOI 10.1002/1878-0261.12729; Hortobagyi GN., 2017, AJCC CANC STAGING MA, P587, DOI DOI 10.1007/978-3-319-40618-3_48; Howe KL, 2021, NUCLEIC ACIDS RES, V49, pD884, DOI 10.1093/nar/gkaa942; Hubbell E, 2021, CANCER EPIDEM BIOMAR, V30, P460, DOI 10.1158/1055-9965.EPI-20-1134; Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI 10.1056/NEJMoa1311194; Ip PPC, 2018, VIRCHOWS ARCH, V472, P907, DOI 10.1007/s00428-018-2314-4; Kim JJ, 2018, JAMA-J AM MED ASSOC, V320, P706, DOI 10.1001/jama.2017.19872; Klein EA, 2021, ANN ONCOL, V32, P1167, DOI 10.1016/j.annonc.2021.05.806; Knight SR, 2019, TRANSPLANTATION, V103, P273, DOI 10.1097/TP.0000000000002482; Koehler JW, 2018, J NEUROPATH EXP NEUR, V77, P2018, DOI 10.1093/jnen/nly085; Kooyker AI, 2020, INT J CANCER, V147, P1098, DOI 10.1002/ijc.32839; Kruglyak KM, 2021, FRONT VET SCI, V8, DOI 10.3389/fvets.2021.704835; Ku CK, 2017, VET COMP ONCOL, V15, P1206, DOI 10.1111/vco.12256; Kustanovich A, 2019, CANCER BIOL THER, V20, P1057, DOI 10.1080/15384047.2019.1598759; Lacey JV, 2009, MATURITAS, V63, P39, DOI 10.1016/j.maturitas.2009.02.005; Lanman RB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140712; Lee BM, 2020, VET COMP ONCOL, V18, P590, DOI 10.1111/vco.12582; Lehman CD, 2017, RADIOLOGY, V283, P49, DOI 10.1148/radiol.2016161174; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lindquist KE, 2022, J CLIN PATHOL, V75, P302, DOI 10.1136/jclinpath-2020-207257; Lo YMD, 2020, NAT REV CLIN ONCOL, V17, P525, DOI 10.1038/s41571-020-0404-0; LONDON SJ, 1992, JAMA-J AM MED ASSOC, V267, P941, DOI 10.1001/jama.267.7.941; Lurkin A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-150; Miller AM, 2019, NATURE, V565, P654, DOI 10.1038/s41586-019-0882-3; Mochizuki H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144170; Mutter GL, 2007, INT J GYNECOL PATHOL, V26, P103, DOI 10.1097/PGP.0b013e31802e4696; Nadauld LD, 2021, CANCERS, V13, DOI 10.3390/cancers13143501; Nadler DL., 2014, ADV EPIDEMIOL, V2014, P1, DOI [10.1155/2014/746769, DOI 10.1155/2014/746769]; National Cancer Institute, CANC SCREEN OV; National Cancer Institute, WHAT IS COMP ONC; National Cancer Institute, SCREEN TESTS; Nees LK, 2022, ARCH GYNECOL OBSTET, V306, P407, DOI 10.1007/s00404-021-06380-5; Nguyen F, 2018, BREAST CANCER RES TR, V167, P635, DOI 10.1007/s10549-017-4548-2; Odegaard JI, 2018, CLIN CANCER RES, V24, P3539, DOI 10.1158/1078-0432.CCR-17-3831; Pantanowitz L, 2020, LANCET DIGIT HEALTH, V2, pE407, DOI 10.1016/S2589-7500(20)30159-X; Papadopoulos N, 2006, NAT BIOTECHNOL, V24, P985, DOI 10.1038/nbt1234; Patel A, 2020, JAMA ONCOL, V6, P1488, DOI 10.1001/jamaoncol.2020.2592; Peretz-Machluf R, 2021, METHODS MOL BIOL, V2243, P249, DOI 10.1007/978-1-0716-1103-6_12; Pinsky PF, 2015, ANN INTERN MED, V162, P485, DOI 10.7326/M14-2086; Prouteau A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80332-y; Ransohoff DF, 2004, NAT REV CANCER, V4, P309, DOI 10.1038/nrc1322; Ravicini S, 2018, VET COMP ONCOL, V16, P450, DOI 10.1111/vco.12400; Razavi P, 2019, NAT MED, V25, P1928, DOI 10.1038/s41591-019-0652-7; Reese DJ, 2011, JAVMA-J AM VET MED A, V238, P998, DOI 10.2460/javma.238.8.998; Richards KL, 2015, IMMUNOL REV, V263, P173, DOI 10.1111/imr.12238; Rosa M, 2019, ANN DIAGN PATHOL, V43, DOI 10.1016/j.anndiagpath.2019.151407; Schaefer DMW, 2007, VET COMP ONCOL, V5, P145, DOI 10.1111/j.1476-5829.2007.00122.x; Schiffman JD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0231; Shapley M, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X515412; Sharon E, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005629; Shen H, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.694441; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Silva N. L. T., 2019, Comparative Clinical Pathology, V28, P253, DOI 10.1007/s00580-018-2824-0; Smith RA, 2019, CA-CANCER J CLIN, V69, P184, DOI 10.3322/caac.21557; Stark AC, 2020, AM J VET RES, V81, P416, DOI 10.2460/ajvr.81.5.416; Strasberg SM, 2021, J GASTROINTEST SURG, V25, P2700, DOI 10.1007/s11605-021-05106-x; Sultan F, 2018, OPEN VET J, V8, P25, DOI 10.4314/ovj.v8i1.5; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Tecilla M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224945; Thomas R, 2003, BRIT J CANCER, V89, P1530, DOI 10.1038/sj.bjc.6601275; Vail D., 2019, WITHROW MACEWEN SMAL; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Walz JZ, 2020, VET COMP ONCOL, V18, P381, DOI 10.1111/vco.12561; Wang YX, 2015, TRANSL CANCER RES, V4, P270, DOI 10.3978/j.issn.2218-676X.2015.06.02; Weber B, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-294; Williams JM, 2014, J AM ANIM HOSP ASSOC, V50, P83, DOI 10.5326/JAAHA-MS-5988; Wilson IJ, 2018, J VET INTERN MED, V32, P157, DOI 10.1111/jvim.14901; Zamora K., 2021, J AM OSTEOPATH COLL, V1, P6	106	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266623	10.1371/journal.pone.0266623	http://dx.doi.org/10.1371/journal.pone.0266623			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35471999	gold, Green Published			2022-12-26	WOS:000816171900014
J	Lee, TW; Bae, W; Kim, S; Choi, J; Bae, E; Jang, H; Chang, SH; Park, DJ				Lee, Tae Won; Bae, Wooram; Kim, Seongmin; Choi, Jungyoon; Bae, Eunjin; Jang, Ha Nee; Chang, Se-Ho; Park, Dong Jun			Incidence, risk factors, and prognosis of acute kidney injury in hospitalized patients with acute cholangitis	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; INFLAMMATORY RESPONSE SYNDROME; INTENSIVE-CARE-UNIT; TOKYO GUIDELINES; ORGAN FAILURE; SEPTIC SHOCK; SEPSIS; DEFINITIONS; MORTALITY; DISEASE	Background The association between acute cholangitis (AC) and acute kidney injury (AKI) remains unclear. We investigated the incidence, and clinical course of AKI in patients with AC, and the long-term prognosis. Methods We performed a single-center retrospective study of patients hospitalized with AC in a tertiary care center from January 2011 to December 2017. The risk factors for AKI were evaluated, and AKI severity was analyzed using the Systemic Inflammatory Response System (SIRS), quick sequential organ failure assessment (qSOFA) score, and 2018 Tokyo Guidelines (TG) grade. To calculate the relative risk of death based on AKI, hazard ratios (HRs) and 95% confidence intervals (Cis) were obtained using Cox's proportional hazard models. Results A total of 1,438 patients with AC were included, of whom 18.2% (n = 261) developed AKI. AKI patients were older, and had a lower systolic blood pressure and more comorbidities including hypertension (HT), chronic kidney disease, and cardiovascular accidents. Disease severity (as assessed by SIRS, qSOFA, and the Tokyo Guidelines grade) was higher in the AKI group, as was the in-hospital mortality rate. Multivariate analysis revealed that age, HT, SIRS and qSOFA scores >= 2, and TG grade of III were significant risk factors for AKI. Kaplan-Meier analysis revealed significantly higher mortality in the AKI than non-AKI group. AKI (HR = 1.853; 95% CI: 1.115-3.079) and TG grade III (HR = 2.139; 95% CI: 1.190-3,846) were independent predictors of all-cause AC mortality, even after adjusting for all covariates. The annual rate of decline in the estimated glomerular filtration rate was faster in the AKI than non-AKI group (2.9 +/- 6.7 vs. 0.5 +/- 5.3 mL/min/1.73 m(2)/year, p < 0.001). Conclusions AKI development increased AC severity and mortality. Our results suggest that clinicians should monitor AKI status and perform appropriate management as soon as possible.	[Lee, Tae Won; Bae, Wooram; Kim, Seongmin; Choi, Jungyoon; Bae, Eunjin; Park, Dong Jun] Gyeongsang Natl Univ, Dept Internal Med, Changwon Hosp, Chang Won, South Korea; [Bae, Eunjin; Chang, Se-Ho; Park, Dong Jun] Gyeongsang Natl Univ, Dept Internal Med, Coll Med, Jinju, South Korea; [Bae, Eunjin; Chang, Se-Ho; Park, Dong Jun] Gyeongsang Natl Univ, Inst Hlth Sci, Jinju, South Korea; [Jang, Ha Nee; Chang, Se-Ho] Gyeongsang Natl Univ Hosp, Dept Internal Med, Jinju, South Korea	Gyeongsang National University; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University Hospital	Park, DJ (corresponding author), Gyeongsang Natl Univ, Dept Internal Med, Changwon Hosp, Chang Won, South Korea.; Park, DJ (corresponding author), Gyeongsang Natl Univ, Dept Internal Med, Coll Med, Jinju, South Korea.; Park, DJ (corresponding author), Gyeongsang Natl Univ, Inst Hlth Sci, Jinju, South Korea.	drpdj@naver.com		Park, Dong/0000-0001-5233-537X				Akram AR, 2010, CHEST, V138, P825, DOI 10.1378/chest.09-3071; Annane D, 2003, AM J RESP CRIT CARE, V168, P165, DOI 10.1164/rccm.2201087; Baykara N, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2013-1; Beger H G, 1995, HPB Surg, V8, P215, DOI 10.1155/1995/74384; BISMUTH H, 1975, ANN SURG, V181, P881, DOI 10.1097/00000658-197506000-00022; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bornman Philippus C, 2003, J Hepatobiliary Pancreat Surg, V10, P406, DOI 10.1007/s00534-002-0710-1; Bydash JR, 2011, CLIN J AM SOC NEPHRO, V6, P2555, DOI 10.2215/CJN.09560911; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Churpek MM, 2017, AM J RESP CRIT CARE, V195, P906, DOI 10.1164/rccm.201604-0854OC; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; DAWSON JL, 1975, POSTGRAD MED J, V51, P510, DOI 10.1136/pgmj.51.598.510; Doyle JF, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1353-y; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Faust JS, 2016, ANN EMERG MED, V67, p15A, DOI 10.1016/j.annemergmed.2016.03.018; FRIEDMAN GD, 1993, AM J SURG, V165, P399, DOI 10.1016/S0002-9610(05)80930-4; Guerin C, 2000, AM J RESP CRIT CARE, V161, P872, DOI 10.1164/ajrccm.161.3.9809066; Hoste EAJ, 2003, J AM SOC NEPHROL, V14, P1022, DOI 10.1097/01.ASN.0000059863.48590.E9; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Jeon DH, 2019, RENAL FAILURE, V41, P204, DOI 10.1080/0886022X.2019.1591995; Kimura Y, 2007, J HEPATO-BILIARY-PAN, V14, P15, DOI 10.1007/s00534-006-1152-y; Kimura Y, 2013, J HEPATO-BIL-PAN SCI, V20, P8, DOI 10.1007/s00534-012-0564-0; Kiriyama S, 2018, J HEPATO-BIL-PAN SCI, V25, P17, DOI 10.1002/jhbp.512; Kiriyama S, 2017, J HEPATO-BIL-PAN SCI, V24, P329, DOI 10.1002/jhbp.458; Leligdowicz A, 2014, AM J RESP CRIT CARE, V189, P1204, DOI 10.1164/rccm.201310-1875OC; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Miura F, 2018, J HEPATO-BIL-PAN SCI, V25, P31, DOI 10.1002/jhbp.509; Ostermann M, 2007, CRIT CARE MED, V35, P1837, DOI 10.1097/01.CCM.0000277041.13090.0A; Sakhuja A, 2015, AM J RESP CRIT CARE, V192, P951, DOI 10.1164/rccm.201502-0329OC; Sawhney S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006497; Sekimoto M, 2007, J HEPATO-BILIARY-PAN, V14, P11, DOI 10.1007/s00534-006-1151-z; SepNet Critical Care Trials Grp, 2016, INTENS CARE MED, V42, P1980, DOI 10.1007/s00134-016-4504-3; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sun G, 2014, J HEPATO-BIL-PAN SCI, V21, P113, DOI 10.1002/jhbp.9; Touzani S, 2021, GASTROENT RES PRACT, V2021, DOI 10.1155/2021/4583493; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Yegenaga I, 2004, AM J KIDNEY DIS, V43, P817, DOI 10.1053/j.ajkd.2003.12.045	40	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267023	10.1371/journal.pone.0267023	http://dx.doi.org/10.1371/journal.pone.0267023			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421169	Green Published, gold			2022-12-26	WOS:000795453600095
J	McFadden, WA; Yanowitz, JA				McFadden, William A.; Yanowitz, Judith A.			idpr: A package for profiling and analyzing Intrinsically Disordered Proteins in R	PLOS ONE			English	Article							TUMOR-SUPPRESSOR P53; ALPHA-SYNUCLEIN; HUMAN-DISEASES; DNA-BINDING; SEQUENCE; PREDICTION; MUTATIONS; REGIONS	Intrinsically disordered proteins (IDPs) and intrinsically disordered regions (IDRs) are proteins or protein-domains that do not have a single native structure, rather, they are a class of flexible peptides that can rapidly adopt multiple conformations. IDPs are quite abundant, and their dynamic characteristics provide unique advantages for various biological processes. The field of "unstructured biology " has emerged, in part, because of numerous computational studies that had identified the unique characteristics of IDPs and IDRs. The package 'idpr', short for Intrinsically Disordered Proteins in R, implements several R functions that match the established characteristics of IDPs to protein sequences of interest. This includes calculations of residue composition, charge-hydropathy relationships, and predictions of intrinsic disorder. Additionally, idpr integrates several amino acid substitution matrices and calculators to supplement IDP-based workflows. Overall, idpr aims to integrate tools for the computational analysis of IDPs within R, facilitating the analysis of these important, yet under-characterized, proteins. The idpr package can be downloaded from Bioconductor(https://bioconductor.org/packages/idpr/).	[McFadden, William A.; Yanowitz, Judith A.] Womens Res Inst, Pittsburgh, PA 15213 USA; [Yanowitz, Judith A.] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA; [McFadden, William A.] Emory Univ, Sch Med, Lab Biochem Pharmacol, Atlanta, GA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Emory University	Yanowitz, JA (corresponding author), Womens Res Inst, Pittsburgh, PA 15213 USA.; Yanowitz, JA (corresponding author), Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA.	yanowitzjl@mwri.magee.edu	McFadden, William/GXN-3378-2022; Yanowitz, Judith L/AGJ-8504-2022	McFadden, William/0000-0001-6911-2172; Yanowitz, Judith L/0000-0001-6886-8787	National Institutes of Health [R01GM127569]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Institutes of Health, grant #R01GM127569 to Judith Yanowitz. https://public.era.nih.gov/commonsplus/. The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basile W, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007186; Bhargava V, 2020, DEV CELL, V52, P38, DOI 10.1016/j.devcel.2019.11.007; Borgermann N, 2019, EMBO J, V38, DOI 10.15252/embj.2019101496; Brown CJ, 2010, MOL BIOL EVOL, V27, P609, DOI 10.1093/molbev/msp277; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; Buzek J, 2002, NUCLEIC ACIDS RES, V30, P2340, DOI 10.1093/nar/30.11.2340; Carmell MA, 2016, ELIFE, V5, DOI 10.7554/eLife.19993; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2018, PROTEIN SCI, V27, P331, DOI 10.1002/pro.3334; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Erdos Gabor, 2020, Curr Protoc Bioinformatics, V70, pe99, DOI 10.1002/cpbi.99; Eriksson SE, 2019, J MOL CELL BIOL, V11, P330, DOI 10.1093/jmcb/mjz005; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Flagmeier P, 2016, P NATL ACAD SCI USA, V113, P10328, DOI 10.1073/pnas.1604645113; Forcelloni S, 2020, J MOL EVOL, V88, P164, DOI 10.1007/s00239-019-09921-4; Franzosa EA, 2009, MOL BIOL EVOL, V26, P2387, DOI 10.1093/molbev/msp146; Fujioka S, 2014, PARKINSONISM RELAT D, V20, P1129, DOI [10.1016/S1353-8020(13)70010-5, 10.1016/j.parkreldis.2014.07.014]; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; HAINAUT P, 1993, CANCER RES, V53, P4469; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kannan S, 2016, SCI REP-UK, V6, DOI 10.1038/srep23750; Kasten M, 2013, MOVEMENT DISORD, V28, P697, DOI 10.1002/mds.25499; Kim DH, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10030428; Kozlowski LP, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0159-9; Kulkarni P, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201800061; Kurgan L, 2020, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2020, P149; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li JZ, 2015, INT J MOL SCI, V16, P23446, DOI 10.3390/ijms161023446; Liu YM, 2019, BRIEF BIOINFORM, V20, P330, DOI 10.1093/bib/bbx126; Lucking CB, 2000, CELL MOL LIFE SCI, V57, P1894, DOI 10.1007/PL00000671; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Maillet A, 2012, ANTIOXID REDOX SIGN, V16, P1285, DOI 10.1089/ars.2011.4434; McCarty J, 2019, J PHYS CHEM LETT, V10, P1644, DOI 10.1021/acs.jpclett.9b00099; Meng Fanchi, 2017, Curr Protoc Protein Sci, V88, DOI 10.1002/cpps.28; Meszaros B, 2018, NUCLEIC ACIDS RES, V46, pW329, DOI 10.1093/nar/gky384; Morgan M., 2021, R PACKAGE; Niklas KJ, 2018, J EXP BOT, V69, P1437, DOI 10.1093/jxb/erx493; Ooms J., 2014, PREPRINT; Pages H., 2021, R PACKAGE; Pancsa R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034687; Po HN, 2001, J CHEM EDUC, V78, P1499, DOI 10.1021/ed078p1499; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Quaglia F, 2022, NUCLEIC ACIDS RES, V50, pD480, DOI 10.1093/nar/gkab1082; R Core Team, 2021, R LANG ENV STAT; Radivojac P., 2001, BIOCOMPUTING 2002 WO, P589; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; RAINWATER R, 1995, MOL CELL BIOL, V15, P3892; Sullivan KD, 2018, CELL DEATH DIFFER, V25, P133, DOI 10.1038/cdd.2017.174; Sun Y, 1996, FREE RADICAL BIO MED, V21, P335, DOI 10.1016/0891-5849(96)00109-8; Surget S, 2014, ONCOTARGETS THER, V7, P57, DOI 10.2147/OTT.S53876; Theillet FX, 2016, NATURE, V530, P45, DOI 10.1038/nature16531; Theillet Francois-Xavier, 2013, Intrinsically Disord Proteins, V1, pe24360, DOI 10.4161/idp.24360; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Trivedi R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52532-8; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2019, FRONT PHYS-LAUSANNE, V7, DOI 10.3389/fphy.2019.00010; Uversky Vladimir N, 2016, Intrinsically Disord Proteins, V4, pe1135015, DOI 10.1080/21690707.2015.1135015; Uversky VN, 2013, BBA-PROTEINS PROTEOM, V1834, P932, DOI 10.1016/j.bbapap.2012.12.008; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; Uversky VN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S7; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Vise PD, 2005, NUCLEIC ACIDS RES, V33, P2061, DOI 10.1093/nar/gki336; Warren C, 2017, J MOL BIOL, V429, P2401, DOI 10.1016/j.jmb.2017.06.005; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105; Wickham H., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [10.21105/joss.01686, DOI 10.21105/JOSS.01686]; Wickham H., 2020, DPLYR GRAMMAR DATA M; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xu LJ, 2016, PARKINSONS DIS-US, V2016, DOI 10.1155/2016/1720621; Xue B, 2012, J BIOMOL STRUCT DYN, V30, P137, DOI 10.1080/07391102.2012.675145	76	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266929	10.1371/journal.pone.0266929	http://dx.doi.org/10.1371/journal.pone.0266929			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7MW	35436286	Green Published, gold			2022-12-26	WOS:000791258900035
J	Morais, EM; Silva, AAR; de Sousa, FWA; de Azevedo, IMB; Silva, HF; Santos, AMG; Beserra, JEA; de Carvalho, CP; Eberlin, MN; Porcari, AM; Araujo, FDD				Morais, Estefenson Marques; Rosini Silva, Alex Ap; Araujo de Sousa, Francisco Wderson; Barboza de Azevedo, Izabelle Maria; Silva, Helane Franca; Goncalves Santos, Alice Maria; Aguiar Beserra Junior, Jose Evando; de Carvalho, Caroline Pais; Eberlin, Marcos Nogueira; Porcari, Andreia M.; da Silva Araujo, Francisca Diana			Endophytic Trichoderma strains isolated from forest species of the Cerrado-Caatinga ecotone are potential biocontrol agents against crop pathogenic fungi	PLOS ONE			English	Article							SECONDARY METABOLITES; LIQUID-CHROMATOGRAPHY; QUADRUPOLE-TIME; ABSCISIC-ACID; PLANT-GROWTH; MECHANISMS; IDENTIFICATION; DERIVATIVES; MANAGEMENT; PROFILES	The indiscriminate use of chemical pesticides increasingly harms the health of living beings and the environment. Thus, biological control carried out by microorganisms has gained prominence, since it consists of an environmentally friendly alternative to the use of pesticides for controlling plant diseases. Herein, we evaluated the potential role of endophytic Trichoderma strains isolated from forest species of the Cerrado-Caatinga ecotone as biological control agents of crop pathogenic fungi. Nineteen Trichoderma strains were used to assess the antagonistic activity by in vitro bioassays against the plant pathogens Colletotrichum truncatum, Lasiodiplodia theobromae, Macrophomina phaseolina, and Sclerotium delphinii isolated from soybean, cacao, fava bean, and black pepper crops, respectively. All Trichoderma strains demonstrated inhibitory activity on pathogen mycelial growth, with maximum percent inhibition of 70% against C. truncatum, 78% against L. theobromae, 78% against M. phaseolina, and 69% against S. delphinii. Crude methanol extracts (0.5 to 2.0 mg mL(-1)) of Trichoderma strains were able to inhibit the growth of C. truncatum, except Trichoderma sp. T3 (UFPIT06) and T. orientale (UFPIT09 and UFPIT17) at 0.5 mg mL(-1), indicating that the endophytes employ a biocontrol mechanism related to antibiosis, together with multiple mechanisms. Discriminant metabolites of Trichoderma extracts were unveiled by liquid chromatography-tandem mass spectrometry-based metabolomics combined with principal component analysis (PCA), which included antifungal metabolites and molecules with other bioactivities. These results highlight the biocontrol potential of Trichoderma strains isolated from the Cerrado-Caatinga ecotone against crop pathogenic fungi, providing support for ongoing research on disease control in agriculture.	[Morais, Estefenson Marques; Araujo de Sousa, Francisco Wderson; Barboza de Azevedo, Izabelle Maria; Silva, Helane Franca; Goncalves Santos, Alice Maria; da Silva Araujo, Francisca Diana] Univ Fed Piaui, Campus Prof Cinobelina Elves, Bom Jesus, PI, Brazil; [Rosini Silva, Alex Ap; Porcari, Andreia M.] Sao Francisco Univ, MS4Life Lab Mass Spectrometry, Hlth Sci Postgrad Program, Sao Paulo, SP, Brazil; [Aguiar Beserra Junior, Jose Evando] Univ Fed Piaui, Dept Plant Sci, Campus Ministro Petronio Portela, Teresina, PI, Brazil; [de Carvalho, Caroline Pais; Eberlin, Marcos Nogueira] Univ Prebiteriana Mackenzie, Sch Mat Engn Nanotechnol, MackMass Lab, Sao Paulo, SP, Brazil	Universidade Federal do Piaui; Universidade Federal do Piaui; Universidade Presbiteriana Mackenzie	Araujo, FDD (corresponding author), Univ Fed Piaui, Campus Prof Cinobelina Elves, Bom Jesus, PI, Brazil.	diana.araujo@ufpi.edu.br	Araújo, Francisca D. S./D-7286-2012; Beserra, Jose Evando/M-9560-2017	Araújo, Francisca D. S./0000-0002-1777-813X; Beserra, Jose Evando/0000-0002-0490-9612; Rosini, Alex/0000-0002-6400-5201	National Council for Scientific and Technological Development (CNPq/PIBIC); MackPesquisa; Coordination for the Improvement of Higher Education Personnel (CAPES) [001]; Sao Paulo Research Foundation (FAPESP) [2019/04314-6]	National Council for Scientific and Technological Development (CNPq/PIBIC)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MackPesquisa; Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	F.W.A.S. is supported by the National Council for Scientific and Technological Development (CNPq/PIBIC). C.P.C. and M.N.E. are supported by the MackPesquisa. A.A.R.S is supported by the Coordination for the Improvement of Higher Education Personnel (CAPES, Finance Code 001). A.M.P. is supported by Sao Paulo Research Foundation (FAPESP, grant number 2019/04314-6). Funding for open access charge: MackPesquisa.	Ahmed E. A., 2014, Annals of Agricultural Science (Cairo), V59, P273; Anadu NO, 2006, J MED CHEM, V49, P3897, DOI 10.1021/jm0602817; [Anonymous], WORLD WIDE FUND NATU; Begum M. M., 2008, Pertanika Journal of Tropical Agricultural Science, V31, P45; Benitez T, 2004, INT MICROBIOL, V7, P249; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; Beserra J.E.A., 2017, BRAZILIAM J BIOSYSTE, V11, P79, DOI DOI 10.18011/BIOENG2017V11N1P79-87; Biodiversidade do cerrado, CBC ICMBIO; Caatinga, MINISTRIO MEIO AMBIE; Camporota P, 1985, AGRONOMIE, V5, P613; Cheng MJ, 2013, CHEM NAT COMPD+, V49, P523, DOI 10.1007/s10600-013-0658-1; Choi HK, 2017, ARCH DERMATOL RES, V309, P795, DOI 10.1007/s00403-017-1782-8; Dapic I, 2019, CROAT CHEM ACTA, V92, P411, DOI 10.5562/cca3506; Das S., 2020, INT J CURRENT MICROB, V9, P993, DOI [https://doi.org/10.20546/ijcmas.2020.905.109, DOI 10.20546/IJCMAS.2020.905.109, 10.20546/ijcmas.2020.905.109]; de Souza SM, 2005, Z NATURFORSCH C, V60, P693; Dieu A, 2020, NAT PROD RES, V34, P3358, DOI 10.1080/14786419.2018.1561678; Druzhinina IS, 2011, NAT REV MICROBIOL, V9, P749, DOI 10.1038/nrmicro2637; Fang M., 2006, FRONTIERS CHEM CHINA, V1, P15; Farid MM., 2020, SCI REP-UK, V10, P1, DOI [10.1038/s41598-019-56847-4, DOI 10.1038/S41598-019-56847-4]; Fernandes EG, 2015, MICROBIOL RES, V181, P84, DOI 10.1016/j.micres.2015.05.010; Ghorbanpour M, 2018, BIOL CONTROL, V117, P147, DOI 10.1016/j.biocontrol.2017.11.006; Grosskinsky DK, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24798; Guzman-Guzman P, 2019, PHYTOPATHOLOGY, V109, P6, DOI 10.1094/PHYTO-07-18-0218-RVW; Harrison JG, 2020, ENVIRON MICROBIOL, V22, P2107, DOI 10.1111/1462-2920.14968; Mendoza JLH, 2015, BRAZ J MICROBIOL, V46, P1093, DOI 10.1590/S1517-838246420120177; Huang X, 2017, PESTIC BIOCHEM PHYS, V143, P272, DOI 10.1016/j.pestbp.2016.11.010; Illescas M, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10080991; Inglis PW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228485; Jagtap GP, 2014, LEGUME RES, V37, P329, DOI 10.5958/j.0976-0571.37.3.050; Kark S., 2017, REFERENCE MODULE LIF, V2016, P1, DOI [10.1016/b978-0-12-809633-8.02290-1, DOI 10.1016/B978-0-12-809633-8.02290-1]; Kaur J., 2020, NEW FUT DEV MICROBIO, P209, DOI [10.1016/B978-0-12-821006-2.00016-9, DOI 10.1016/B978-0-12-821006-2.00016]; Khaledi Nima, 2016, Journal of Plant Protection Research, V56, P21, DOI 10.1515/jppr-2016-0004; Khan RAA, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8060817; Kondo N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6338; Kottb M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00995; Kredics L, 2014, BIOTECHNOLOGY AND BIOLOGY OF TRICHODERMA, P3, DOI 10.1016/B978-0-444-59576-8.00001-1; Kyekyeku JO, 2017, FITOTERAPIA, V119, P108, DOI 10.1016/j.fitote.2017.04.007; Lapola DM, 2014, NAT CLIM CHANGE, V4, P27, DOI 10.1038/NCLIMATE2056; Legrand F, 2017, BIOL CONTROL, V113, P26, DOI 10.1016/j.biocontrol.2017.06.011; Leiter E, 2017, BIOCONTROL, V62, P125, DOI 10.1007/s10526-016-9781-9; Li TT, 2020, BIOL CONTROL, V140, DOI 10.1016/j.biocontrol.2019.104122; Liu MH, 2013, J PHARMACEUT BIOMED, V74, P141, DOI 10.1016/j.jpba.2012.10.024; Lu XM, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-95946-z; Macias-Rubalcava M, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-016-2174-5; Ma J, 2020, 3 BIOTECH, V10, DOI 10.1007/s13205-020-02301-6; Mariano RLR., 1993, REV ANUAL PATOLOGIA, V1, P369; Meng-Reiterer J, 2015, ANAL BIOANAL CHEM, V407, P8019, DOI 10.1007/s00216-015-8975-9; Mousumi Bhadra, 2014, Bangladesh Journal of Scientific and Industrial Research, V49, P125; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nagy K, 2019, SCI TOTAL ENVIRON, V647, P1052, DOI 10.1016/j.scitotenv.2018.08.067; Ni M, 2019, J ENVIRON SCI HEAL B, V54, P20, DOI 10.1080/03601234.2018.1507227; Nicoletti R, 2015, AGRICULTURE-BASEL, V5, P918, DOI 10.3390/agriculture5040918; Noriler SA, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01526; Obaiah N, 2020, CHEMISTRYSELECT, V5, P178, DOI 10.1002/slct.201903472; Oh JH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21113981; Oliveira JA., 1991, THESIS FEDERAL U LAV; Phukhamsakda C, 2018, MOLECULES, V23, DOI 10.3390/molecules23092190; Reino Jose Luis, 2008, Phytochemistry Reviews, V7, P89, DOI 10.1007/s11101-006-9032-2; Salim HA., 2017, J SCI AGR, V1, P244, DOI [10.25081/jsa.2017.v1.820, DOI 10.25081/JSA.2017.V1.820]; Saravanakumar K, 2020, PHYSIOL MOL PLANT P, V109, DOI 10.1016/j.pmpp.2020.101458; Severo R, 2021, AUSTRALAS PLANT PATH, V50, P661, DOI 10.1007/s13313-021-00815-y; Silva HF, 2021, NOVA HEDWIGIA, V112, P485, DOI 10.1127/nova_hedwigia/2021/0622; Silva HF, 2020, REV ARVORE, V44, DOI 10.1590/1806-908820200000009; Silva HF, 2020, REV BRAS CIENC AGRAR, V15, DOI 10.5039/agraria.v15i1a7680; Sridharan AP, 2021, MICROB PATHOGENESIS, V150, DOI 10.1016/j.micpath.2020.104714; Swain H, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.633881; Tam EWT, 2014, J CLIN MICROBIOL, V52, P1153, DOI 10.1128/JCM.03258-13; Thangavelu R, 2007, AUSTRALAS PLANT PATH, V36, P595, DOI 10.1071/AP07072; Thiruvengadam M, 2016, PLANT GROWTH REGUL, V80, P377, DOI 10.1007/s10725-016-0178-7; Tian Y, 2020, ENVIRON POLLUT, V267, DOI [10.1016/j.envpol.2020.115559, 10.1016/J.envpol.2020.115559]; Villa F, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00654; Vinci G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209664; Wanjiku E. K., 2021, Advances in Agriculture, V2021, DOI 10.1155/2021/8867858; Wood KV, 2002, PHYTOCHEMISTRY, V59, P759, DOI 10.1016/S0031-9422(02)00049-3; Xie YD, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.645484; Yadav M, 2021, J FUNGI, V7, DOI 10.3390/jof7040307; Yang ML, 2011, J NAT PROD, V74, P1996, DOI 10.1021/np100902f; Yao YQ, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.437; Zhang L, 2018, J PHARMACEUT BIOMED, V153, P221, DOI 10.1016/j.jpba.2018.02.055; Zhong TH, 2022, NAT PROD RES, V36, P414, DOI 10.1080/14786419.2020.1771706; Zhu JJ, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201701073	81	1	1	6	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0265824	10.1371/journal.pone.0265824	http://dx.doi.org/10.1371/journal.pone.0265824			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1E2NP	35427356	gold, Green Published			2022-12-26	WOS:000794332400040
J	Nunez-Ruiz, A; Sanchez-Brena, F; Lopez-Pacheco, C; Acevedo-Dominguez, NA; Soldevila, G				Nunez-Ruiz, Aleida; Sanchez-Brena, Flor; Lopez-Pacheco, Cynthia; Acevedo-Dominguez, Naray A.; Soldevila, Gloria			Obesity modulates the immune macroenvironment associated with breast cancer development	PLOS ONE			English	Article							REGULATORY T-CELLS; ADIPOSE-TISSUE INFLAMMATION; DIET-INDUCED OBESITY; TUMOR PROGRESSION; MACROPHAGES; LEPTIN; FAT; ADIPOCYTES; PROMOTES; CD4(+)	Growing evidence demonstrates a strong correlation between obesity and an increased risk of breast cancer, although the mechanisms involved have not been completely elucidated. Some reports have described a crosstalk between adipocytes, cancer cells, and immune cells within the tumor microenvironment, however, it is currently unknown whether obesity can promote tumor growth by inducing systemic alterations of the immune cell homeostasis in peripheral lymphoid organs and adipose tissue. Here, we used the E0771 breast cancer cell line in a mouse model of diet-induced obesity to analyze the immune subpopulations present in the tumors, visceral adipose tissue (VAT), and spleen of lean and obese mice. Our results showed a significant reduction in the frequency of infiltrating CD8(+) T cells and a decreased M1/M2 macrophage ratio, indicative of the compromised anti-tumoral immune response reported in obesity. Despite not finding differences in the percentage or numbers of intratumoral Tregs, phenotypic analysis showed that they were enriched in CD39(+), PD-1(+) and CCR8(+) cells, compared to the draining lymph nodes, confirming the highly immunosuppressive profile of infiltrating Tregs reported in established tumors. Analysis of peripheral T lymphocytes showed that tumor development in obese mice was associated to a significant increase in the percentage of peripheral Tregs, which supports the systemic immunosuppressive effect caused by the tumor. Interestingly, evaluation of immune subpopulations in the VAT showed that the characteristic increase in the M1/M2 macrophage ratio reported in obesity, was completely reversed in tumor-bearing mice, resembling the M2-polarized profile found in the microenvironment of the growing tumor. Importantly, VAT Tregs, which are commonly decreased in obese mice, were significantly increased in the presence of breast tumors and displayed significantly higher levels of Foxp3, indicating a regulatory feedback mechanism triggered by tumor growth. Altogether, our results identify a complex reciprocal relationship between adipocytes, immune cells, and the tumor, which may modulate the immune macroenvironment that promotes breast cancer development in obesity.	[Nunez-Ruiz, Aleida; Sanchez-Brena, Flor; Lopez-Pacheco, Cynthia; Acevedo-Dominguez, Naray A.; Soldevila, Gloria] Univ Nacl Autonoma Mexico, Dept Inmunol, Inst Invest Biomed, Mexico City, Mexico; [Lopez-Pacheco, Cynthia] Univ Nacl Autonoma Mexico, Lab Nacl Citometria Flujo, Inst Invest Biomed, Mexico City, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Soldevila, G (corresponding author), Univ Nacl Autonoma Mexico, Dept Inmunol, Inst Invest Biomed, Mexico City, Mexico.	soldevi@unam.mx		Soldevila, Gloria/0000-0003-1539-2548	CONACYT Mexico [187]; Conacyt [276303, 284198, 931451]	CONACYT Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Work was supported by grant #187 from CONACYT Mexico. ANR (#276303), FSB (#284198) were recipients of pre-doctoral and NAD (#931451) from master ' s degree fellowships from Conacyt. CLP was recipient of a postdoctoral fellowship from Conacyt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agurs-Collins T, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00765; Allen BM, 2020, NAT MED, V26, P1125, DOI 10.1038/s41591-020-0892-6; Andarawewa KL, 2005, CANCER RES, V65, P10862, DOI 10.1158/0008-5472.CAN-05-1231; Andersen CJ, 2016, ADV NUTR, V7, P66, DOI 10.3945/an.115.010207; Ando S, 2019, CANCERS, V11, DOI 10.3390/cancers11010062; Arendt LM, 2013, CANCER RES, V73, P6080, DOI 10.1158/0008-5472.CAN-13-0926; Avgerinos KI, 2019, METABOLISM, V92, P121, DOI 10.1016/j.metabol.2018.11.001; Battle M, 2014, INT J CANCER, V134, P1605, DOI 10.1002/ijc.28496; Berger S, 2017, INT J OBESITY, V41, P1676, DOI 10.1038/ijo.2017.163; Blucher C, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00293; Boutilier AJ, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22136995; Brandon EL, 2009, CANCER BIOL THER, V8, P1871, DOI 10.4161/cbt.8.19.9650; Budimir N, 2022, CANCER IMMUNOL RES, V10, P146, DOI 10.1158/2326-6066.CIR-21-0515; Cai JJ, 2019, ONCOTARGETS THER, V12, P8437, DOI 10.2147/OTT.S221340; Castoldi A, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00637; Cildir G, 2013, TRENDS MOL MED, V19, P487, DOI 10.1016/j.molmed.2013.05.001; Collins S, 2004, PHYSIOL BEHAV, V81, P243, DOI 10.1016/j.physbeh.2004.02.006; D'Esposito V, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01554; De Rosa V, 2007, IMMUNITY, V26, P241, DOI 10.1016/j.immuni.2007.01.011; Deiuliis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016376; Deng GP, 2018, AM J CLIN EXP IMMUNO, V7, P81; Deng T, 2016, ANNU REV PATHOL-MECH, V11, P421, DOI 10.1146/annurev-pathol-012615-044359; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; Elisia I, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228633; Engin A, 2017, ADV EXP MED BIOL, V960, P571, DOI 10.1007/978-3-319-48382-5_25; Facciabene A, 2012, CANCER RES, V72, P2162, DOI 10.1158/0008-5472.CAN-11-3687; Faria SS, 2020, J BREAST CANCER, V23, P233, DOI 10.4048/jbc.2020.23.e35; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fink LN, 2014, OBESITY, V22, P747, DOI 10.1002/oby.20615; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Gershuni VM, 2016, CURR SURG REP, V4, DOI 10.1007/s40137-016-0134-5; Gibson JT, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.590794; Gonzalez H, 2018, GENE DEV, V32, P1267, DOI 10.1101/gad.314617.118; Gu JW, 2011, CANCER BIOL THER, V11, P910, DOI 10.4161/cbt.11.10.15473; Han S, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00279; He JY, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0309-z; He QF, 2019, BRIEF FUNCT GENOMICS, V18, P99, DOI 10.1093/bfgp/ely006; Heymsfield SB, 2017, NEW ENGL J MED, V376, P254, DOI 10.1056/NEJMra1514009; Huang Y, 2015, ONCOTARGET, V6, P17462, DOI 10.18632/oncotarget.3958; Iyengar NM, 2015, ANNU REV MED, V66, P297, DOI 10.1146/annurev-med-050913-022228; Jayasingam SD, 2020, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01512; Jie HB, 2013, BRIT J CANCER, V109, P2629, DOI 10.1038/bjc.2013.645; Jung JI, 2015, INT J CANCER, V136, P258, DOI 10.1002/ijc.28983; Kado T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48678-0; Kammoun HL, 2014, REV ENDOCR METAB DIS, V15, P31, DOI 10.1007/s11154-013-9274-4; Kawai O, 2008, CANCER-AM CANCER SOC, V113, P1387, DOI 10.1002/cncr.23712; Kim HJ, 2015, SCIENCE, V350, P334, DOI 10.1126/science.aad0616; Kiran S, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.680944; Kolb R, 2020, CANCERS, V12, DOI 10.3390/cancers12061686; Labani-Motlagh A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00940; Lee S, 2011, J EPIDEMIOL, V21, P161, DOI 10.2188/jea.JE20100128; Lengyel E, 2018, TRENDS CANCER, V4, P374, DOI 10.1016/j.trecan.2018.03.004; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Li SJ, 2020, CANCERS, V12, DOI 10.3390/cancers12123864; Li YJ, 2020, LIPIDS HEALTH DIS, V19, DOI 10.1186/s12944-020-01342-3; Liu YY, 2015, CANCER RES, V75, P5046, DOI 10.1158/0008-5472.CAN-15-0706; Lu JL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01173; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Luo W, 2020, LIFE SCI, V243, DOI 10.1016/j.lfs.2019.117246; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Maimela NR, 2019, COMPUT STRUCT BIOTEC, V17, P1, DOI 10.1016/j.csbj.2018.11.004; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Margiotta D, 2016, EUR REV MED PHARMACO, V20, P636; Margolis M, 2015, BIOCHIMIE, V108, P133, DOI 10.1016/j.biochi.2014.11.009; Martinez VG, 2017, CLIN CANCER RES, V23, P7388, DOI 10.1158/1078-0432.CCR-17-1004; Maurizi G, 2018, J CELL PHYSIOL, V233, P88, DOI 10.1002/jcp.25855; Mayi TH, 2012, J BIOL CHEM, V287, P21904, DOI 10.1074/jbc.M111.315200; McFarlin BK, 2012, COMPARATIVE MED, V62, P462; McLaughlin T, 2017, J CLIN INVEST, V127, P5, DOI 10.1172/JCI88876; Evangelista GCM, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00685; Mittal D, 2014, CURR OPIN IMMUNOL, V27, P16, DOI 10.1016/j.coi.2014.01.004; Mittal S, 2018, EXPERT REV MOL DIAGN, V18, P227, DOI 10.1080/14737159.2018.1439382; Nishimoto S, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501332; Nunez NG, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17046-2; Olson OC, 2017, SCIENCE, V358, P1130, DOI 10.1126/science.aao5801; Overacre-Delgoffe AE, 2017, CELL, V169, P1130, DOI 10.1016/j.cell.2017.05.005; Park YJ, 2019, P NATL ACAD SCI USA, V116, P3106, DOI 10.1073/pnas.1810254116; Pinto ML, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01875; Plitas G, 2016, IMMUNITY, V45, P1122, DOI 10.1016/j.immuni.2016.10.032; Procaccini C, 2012, J IMMUNOL, V189, P2941, DOI 10.4049/jimmunol.1200935; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Raskov H, 2021, BRIT J CANCER, V124, P359, DOI 10.1038/s41416-020-01048-4; Semeraro M, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1218106; Serbulea V, 2018, P NATL ACAD SCI USA, V115, pE6254, DOI 10.1073/pnas.1800544115; Shi LS, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/4093214; Solis-Castillo LA, 2020, BREAST CANCER-TOKYO, V27, P837, DOI 10.1007/s12282-020-01079-y; Sousa S, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0621-0; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Teraoka N, 2011, INT J CANCER, V129, P528, DOI 10.1002/ijc.25711; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tiainen S, 2020, BREAST CANCER RES TR, V179, P565, DOI 10.1007/s10549-019-05491-7; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Vitale I, 2019, CELL METAB, V30, P36, DOI 10.1016/j.cmet.2019.06.001; Wagner NM, 2013, OBESITY, V21, P461, DOI 10.1002/oby.20087; Wang FL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109742; Wang J, 2016, CANCER EPIDEMIOL, V42, P1, DOI 10.1016/j.canep.2016.02.010; Wang ZM, 2019, NAT MED, V25, P141, DOI 10.1038/s41591-018-0221-5; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wong MD, 2013, J IMMUNOL, V190, P5402, DOI 10.4049/jimmunol.1202382; Wu Q, 2021, BIOMARK RES, V9, DOI 10.1186/s40364-020-00257-6; Yano H, 2019, IMMUNOLOGY, V157, P232, DOI 10.1111/imm.13067; Zyromski NJ, 2009, SURGERY, V146, P258, DOI 10.1016/j.surg.2009.02.024	102	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266827	10.1371/journal.pone.0266827	http://dx.doi.org/10.1371/journal.pone.0266827			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35472214	gold, Green Published			2022-12-26	WOS:000816171900037
J	Takahara, T; Yamaguchi, H; Seki, K; Onodera, S				Takahara, Terumasa; Yamaguchi, Hidetaka; Seki, Kazutoshi; Onodera, Sho			Modulation of subjective peripheral sensation, F-waves, and somatosensory evoked potentials in response to unilateral pinch task measured on the contractile and non-contractile sides	PLOS ONE			English	Article							SHORT-LATENCY; MEDIAN NERVE; MOVEMENT; CORTEX; AREAS; STIMULATION; ELBOW	Depression of the sensory input during voluntary muscle contractions has been demonstrated using electrophysiological methods in both animals and humans. However, the association between electrophysiological responses of the sensory system and subjective peripheral sensation (SPS) during a voluntary muscle contraction remains unclear. This study aimed to describe the changes in SPS, spinal alpha-motoneuron excitability (F-wave to M-wave amplitude), and somatosensory evoked potentials (SEPs) during a unilateral pinch-grip task. Outcome variables were measured on the side ipsilateral and contralateral to the muscle contraction and at rest (control). Participants were 8 healthy men aged 20.9 +/- 0.8 years. The isometric pinch-grip task was performed at 30% of the maximum voluntary isometric force measured for the right and left hands separately. The appearance rate of the F-wave during the task was significantly higher for the ipsilateral (right) hand than for the contralateral (left) hand and control condition. Although there was no difference in the F-wave latency between hands and the control condition, the amplitude of the F-wave was significantly higher for the ipsilateral (right) hand than for the contralateral (left) hand and the control condition. There was no difference in the amplitude of the SEP at N20. However, the amplitude at P25 was significantly lower for the ipsilateral (right) hand than for the contralateral (left) hand and the control condition. The accuracy rate of detecting tactile stimulation, evaluated for 20 repetitions using a Semmes-Weinstein monofilament at the sensory threshold for each participant, was significantly lower during the pinch-grip task for both the ipsilateral (right) and contralateral (left) hands than in the control condition. Overall, our findings show that SPS and neurophysiological parameters were not modulated in parallel during the task, with changes in the subjective sensation preceding changes in electrophysiological indices during the motor task. Our findings provide basic information on sensory-motor coordination.	[Takahara, Terumasa; Yamaguchi, Hidetaka] KIBI Int Univ, Dept Sport Social Management, Takahashi, Okayama, Japan; [Seki, Kazutoshi] Univ Mkt & Distribut Sci, Dept Human Hlth & Wellbeing, Kobe, Hyogo, Japan; [Onodera, Sho] Kawasaki Univ Med Welf, Dept Hlth & Sports Sci, Kurashiki, Okayama, Japan		Takahara, T (corresponding author), KIBI Int Univ, Dept Sport Social Management, Takahashi, Okayama, Japan.	takahara@kiui.ac.jp		Takahara, Terumasa/0000-0001-6007-3752				ALLISON T, 1989, J NEUROPHYSIOL, V62, P711, DOI 10.1152/jn.1989.62.3.711; ALLISON T, 1989, J NEUROPHYSIOL, V62, P694, DOI 10.1152/jn.1989.62.3.694; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; BelhajSaif A, 1996, EXP BRAIN RES, V111, P405; BOCKER KBE, 1993, ELECTROEN CLIN NEURO, V88, P105, DOI 10.1016/0168-5597(93)90061-S; BURKE D, 1989, BRAIN, V112, P417, DOI 10.1093/brain/112.2.417; CHENEY PD, 1980, J NEUROPHYSIOL, V44, P773, DOI 10.1152/jn.1980.44.4.773; CHERON G, 1991, ELECTROEN CLIN NEURO, V80, P522, DOI 10.1016/0168-5597(91)90134-J; Gerrett N, 2015, PHYSIOL BEHAV, V152, P11, DOI 10.1016/j.physbeh.2015.08.032; KAKIGI R, 1995, J NEUROL SCI, V128, P195, DOI 10.1016/0022-510X(94)00230-L; Kirimoto H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108058; Maeda K, 1999, NEUROREPORT, V10, P301, DOI 10.1097/00001756-199902050-00018; MAIER MA, 1993, J NEUROPHYSIOL, V69, P772, DOI 10.1152/jn.1993.69.3.772; MUIR RB, 1983, BRAIN RES, V261, P312, DOI 10.1016/0006-8993(83)90635-2; Nakata H, 2003, BRAIN TOPOGR, V15, P211, DOI 10.1023/A:1023908707851; NISHIHIRA Y, 1990, J SPORT MED PHYS FIT, V30, P291; Rivner MH, 2008, CLIN NEUROPHYSIOL, V119, P1215, DOI 10.1016/j.clinph.2008.01.103; RUSHTON DN, 1981, BRAIN, V104, P465, DOI 10.1093/brain/104.3.465; Staines WR, 1997, EXP BRAIN RES, V115, P147, DOI 10.1007/PL00005674; Takahara T, 2020, BMC NEUROSCI, V21, DOI 10.1186/s12868-020-00592-2; Takahara T, 2018, EUR J APPL PHYSIOL, V118, P1773, DOI 10.1007/s00421-018-3907-y; TAYLOR JL, 1992, J PHYSIOL-LONDON, V457, P503, DOI 10.1113/jphysiol.1992.sp019390; Tinazzi M, 1997, EVOKED POTENTIAL, V104, P312, DOI 10.1016/S0168-5597(97)00023-3; Wasaka T, 2012, NEUROIMAGE, V59, P1501, DOI 10.1016/j.neuroimage.2011.08.024; Zehr EP, 1999, EXP BRAIN RES, V124, P474, DOI 10.1007/s002210050643	25	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0261393	10.1371/journal.pone.0261393	http://dx.doi.org/10.1371/journal.pone.0261393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C1KV	35452456	gold, Green Published			2022-12-26	WOS:000792887700005
J	Vrontaras, N; Myrvali, K; Kyrou, D; Metallidis, S; Tsachouridou, O; Chini, M; Meliou, M; Psichogiou, M; Basoulis, D; Antoniadou, A; Protopapas, K; Panagopoulos, P; Petrakis, V; Gogos, C; Leonidou, L; Karamanidou, C				Vrontaras, Nikolaos; Myrvali, Katerina; Kyrou, Dimitrios; Metallidis, Simeon; Tsachouridou, Olga; Chini, Maria; Meliou, Maria; Psichogiou, Mina; Basoulis, Dimitrios; Antoniadou, Anastasia; Protopapas, Konstantinos; Panagopoulos, Periklis; Petrakis, Vasilis; Gogos, Charalambos; Leonidou, Lydia; Karamanidou, Christina			An exploration of the quality of life of people living with HIV in Greece: Challenges and opportunities	PLOS ONE			English	Article							EXPERIENCES	Objective Improving the quality of life (QoL) of people living with HIV (PLWH) has been proposed as a new priority in HIV care. The objective of this cross-sectional, qualitative study was to explore the perspectives of PLWH in Greece regarding their QoL. Design Twenty-four semi-structured interviews were conducted with PLWH receiving care across six HIV clinics in Greece. The thematic analysis of the transcribed interviews resulted in four themes and eleven subthemes. Results First, fear of repercussions (e.g., stigmatization) makes PLWH reluctant to disclose their diagnosis in public settings or disclose accounting for factors like the confidant's discretion. Second, participants are challenged by HIV's unique biopsychosocial facets (e.g., uncertainty about symptoms) and fear for the future (e.g., a confidant revealing their HIV status without consent). Third, support received by specialist services is satisfactory in contrast to non-HIV specialist services, where significant improvements are needed to reduce stigmatization. Finally, the experiences of PLWH include contrasting elements of post-traumatic growth and an inability to accept their seropositivity (e.g., avoiding social interactions). Conclusions Empowering PLWH in these QoL areas is greatly needed. Increasing the life expectancy of PLWH is only the initial step; their QoL needs to be secured as the next priority in HIV care.	[Vrontaras, Nikolaos; Myrvali, Katerina; Kyrou, Dimitrios; Karamanidou, Christina] Ctr Res & Technol Hellas, Inst Appl Biosci, Thessaloniki, Greece; [Metallidis, Simeon; Tsachouridou, Olga] Aristotle Univ Thessaloniki, ACHEPA Univ Hosp, Med Sch, Dept Internal Med 1, Thessaloniki, Greece; [Chini, Maria; Meliou, Maria] Korgialeneio Benakeio Red Cross Gen Hosp, Infect Dis Unit, Dept Internal Med 3, Athens, Greece; [Psichogiou, Mina] Natl & Kapodistrian Univ Athens, Internal Med & Infect Dis, Athens, Greece; [Basoulis, Dimitrios] Laikon Gen Hosp, Med Sch, Athens, Greece; [Basoulis, Dimitrios; Antoniadou, Anastasia; Protopapas, Konstantinos] Natl & Kapodistrian Univ Athens, Athens, Greece; [Antoniadou, Anastasia; Protopapas, Konstantinos] Attikon Gen Hosp, Med Sch, Athens, Greece; [Panagopoulos, Periklis; Petrakis, Vasilis] Democritus Univ Thrace, Univ Gen Hosp, Dept Internal Med, Alexandroupolis, Greece; [Gogos, Charalambos; Leonidou, Lydia] Univ Hosp Patras, Dept Internal Med & Infect Dis, Rion, Greece	Centre for Research & Technology Hellas; Aristotle University of Thessaloniki; National & Kapodistrian University of Athens; Laiko General Hospital; National & Kapodistrian University of Athens; National & Kapodistrian University of Athens; National & Kapodistrian University of Athens; University Hospital Attikon; Democritus University of Thrace; University of Patras	Vrontaras, N (corresponding author), Ctr Res & Technol Hellas, Inst Appl Biosci, Thessaloniki, Greece.	nikosvro@certh.gr		Kyrou, Dimitrios/0000-0002-2015-7617; Vrontaras, Nikolaos/0000-0003-1171-9304; Meliou, Maria/0000-0003-0357-538X	Gilead Sciences Hellas	Gilead Sciences Hellas	This work was funded by Gilead Sciences Hellas (https://www.gilead.com/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexias G., 2015, INT J RECENT SCI RES, V6, P6807; Amos IA., 2015, COUNS PSYCHOL REV, V30, P47; Arias-Colmenero T, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17020639; Basavaraj K H, 2010, Indian J Sex Transm Dis AIDS, V31, P75, DOI 10.4103/0253-7184.74971; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Chambers LA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2197-0; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Farnsworth V, 2016, BRIT J EDUC STUD, V64, P139, DOI 10.1080/00071005.2015.1133799; Furlotte C, 2017, CAN J AGING, V36, P125, DOI 10.1017/S0714980817000022; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Harris TG, 2018, AIDS, V32, P1563, DOI 10.1097/QAD.0000000000001870; Kyrou D, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-07380-6; Lazarus JV, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0640-4; Miners A, 2014, LANCET HIV, V1, pE32, DOI 10.1016/S2352-3018(14)70018-9; Noble Helen, 2015, Evid Based Nurs, V18, P34, DOI 10.1136/eb-2015-102054; Stroumpouki T, 2020, APPL NURS RES, V53, DOI 10.1016/j.apnr.2020.151249; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Voigt P., 2017, EU GEN DATA PROTECTI, V10, P3152676; Wallach I., 2019, NURSCARE OPEN ACCESS, V6, P28, DOI DOI 10.15406/NCOAJ.2019.06.00179; World Health Organization, 2016, WHOHIV201605	20	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266962	10.1371/journal.pone.0266962	http://dx.doi.org/10.1371/journal.pone.0266962			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421179	Green Published, gold			2022-12-26	WOS:000795453600087
J	Zhao, Q; Feng, LG; Liu, H; Yu, M; Shang, S; Zhu, YQ; Xie, YP; Li, J; Meng, YZ				Zhao, Qing; Feng, Langang; Liu, Hai; Yu, Mei; Shang, Shu; Zhu, Yuqi; Xie, YanPing; Li, Jing; Meng, Yuzhu			Impact of agile intuition on innovation behavior: Chinese evidence and a new proposal	PLOS ONE			English	Article							INFORMATION-TECHNOLOGY; KNOWLEDGE MANAGEMENT; PERFORMANCE; CAPABILITY; SYSTEMS; FIRM	With the tendency toward economic and strategy decoupling between China and the United States and amidst the anti-globalization trend, enterprises are facing unprecedented challenges and opportunities. In this study, we reveal how the agile intuition (AI) of top managers with respect to the external environment affects enterprise innovation behavior (IB) based on the cognition-behavior framework. Strategic learning (SL) is considered a moderator, and knowledge sharing (KS) is considered a mediator. The survey sample consists of 305 managers from 47 enterprises in China during the COVID-19 period. The empirical results show that top management agile intuition significantly promotes enterprise IB; knowledge sharing (KS) partially mediates the relationship between top manager AI and enterprise IB; and SL suppresses the promotion effect of top manager AI on enterprise IB to a certain extent, hindering blind innovation. In a surprising result, we find that strategic guidance by an external consultant does not significantly affect the enterprise IB in China.	[Zhao, Qing; Liu, Hai; Yu, Mei; Shang, Shu; Zhu, Yuqi; Xie, YanPing; Li, Jing; Meng, Yuzhu] Guizhou Univ Finance & Econ, Coll Business Adm, Guiyang, Peoples R China; [Feng, Langang] Guizhou Univ Finance & Econ, High End Think Tank Guizhou Green Dev Strategy, Guiyang, Peoples R China; [Feng, Langang] Guizhou Univ Finance & Econ, Guizhou Key Lab Big Data Stat Anal, Guiyang, Peoples R China	Guizhou University of Finance & Economics; Guizhou University of Finance & Economics; Guizhou University of Finance & Economics	Yu, M (corresponding author), Guizhou Univ Finance & Econ, Coll Business Adm, Guiyang, Peoples R China.	YuMeiYuMeiwork@126.com			National Social Science Foundation of China [17BJY076]; Guizhou Province Philosophy and Social Science Planning Project, China [21GZYB61]	National Social Science Foundation of China; Guizhou Province Philosophy and Social Science Planning Project, China	Langang Feng received the project. This research was funded by the National Social Science Foundation of China (grant number: 17BJY076) and Guizhou Province Philosophy and Social Science Planning Project, China (grant number: 21GZYB61). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2010, STRATEG ENTREP J, V4, P271, DOI 10.1002/sej.96; Aguirre-Urreta MI, 2019, DATA BASE ADV INF SY, V50, P45; Aiken LS., 1991, EVAL PRACT, V14, P167; Alavi M, 2001, MIS QUART, V25, P107, DOI 10.2307/3250961; Anderson BS, 2009, STRATEG ENTREP J, V3, P218, DOI 10.1002/sej.72; Aric KH, 2018, PANOECONOMICUS, V65, P65, DOI 10.2298/PAN150410026A; Chakravarty A, 2013, INFORM SYST RES, V24, P976, DOI 10.1287/isre.2013.0500; Chen Y., 2013, EUR J INFORM SYST, V11, P33; Child J, 2009, MANAGE ORGAN REV, V5, P57, DOI 10.1111/j.1740-8784.2008.00136.x; CORDERO R, 1990, RES POLICY, V19, P185, DOI 10.1016/0048-7333(90)90048-B; Dijksterhuis A, 2006, SCIENCE, V311, P1005, DOI 10.1126/science.1121629; Eriksson IV., 2000, AMCI, V3, P22; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Gee Woo Bock, 2002, Information Resources Management Journal, V15, P14, DOI 10.4018/irmj.2002040102; Harraf A., 2015, J APPL BUS RES, V31, P675, DOI [DOI 10.19030/JABR.V31I2.9160, 10.19030/jabr.v31i2.9160]; Harvey M, 2002, J WORLD BUS, V37, P127, DOI 10.1016/S1090-9516(02)00072-X; Helfat CE, 2003, STRATEGIC MANAGE J, V24, P997, DOI 10.1002/smj.332; Hunt RA, 2019, STRATEG ENTREP J, V13, P478, DOI 10.1002/sej.1317; Inman RA, 2011, J OPER MANAG, V29, P343, DOI 10.1016/j.jom.2010.06.001; Jin SV, 2019, MARK INTELL PLAN, V37, P567, DOI 10.1108/MIP-09-2018-0375; Khatri N, 2000, HUM RELAT, V53, P57, DOI 10.1177/0018726700531004; Kim S, 2008, LIBR INFORM SCI RES, V30, P282, DOI 10.1016/j.lisr.2008.04.003; Kuwada K, 1998, ORGAN SCI, V9, P719, DOI 10.1287/orsc.9.6.719; Lian YH., 2013, ADV SOCIAL SCI, V13, P95; Lin HF., 2004, Journal of Management Decision, V42, P108, DOI DOI 10.1108/00251740410510181; [卢启程 LU Qi-cheng], 2009, [研究与发展管理, R & D management], V21, P70; Nee V., 2020, EC SOCIOLOGY CAPITAL; Ojha D, 2014, INT J PROD ECON, V147, P385, DOI 10.1016/j.ijpe.2013.02.029; Papadakis VM., 1999, BUS STRATEGY REV, V10, P29; PETTY RE, 1984, J PERS SOC PSYCHOL, V46, P69, DOI 10.1037/0022-3514.46.1.69; PETTY RE, 1983, J CONSUM RES, V10, P135, DOI 10.1086/208954; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Provis C, 2017, J BUS ETHICS, V140, P5, DOI 10.1007/s10551-015-2688-z; Roberts N, 2012, J MANAGE INFORM SYST, V28, P231, DOI 10.2753/MIS0742-1222280409; Sambamurthy V, 2003, MIS QUART, V27, P237; Shrader R, 2007, ENTREP THEORY PRACT, V31, P893, DOI 10.1111/j.1540-6520.2007.00206.x; Siemsen E, 2009, M&SOM-MANUF SERV OP, V11, P429, DOI 10.1287/msom.1080.0233; Singh S, 2021, J CO-OP ORGAN MANAG, V9, DOI 10.1016/j.jcom.2021.100150; Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037/0033-2909.119.1.3; Swafford PM, 2006, J OPER MANAG, V24, P170, DOI 10.1016/j.jom.2005.05.002; Tallon PP, 2011, MIS QUART, V35, P463; Tan ABC, 2021, CREAT INNOV MANAG, V30, P697, DOI 10.1111/caim.12462; Thomas JB, 2001, ORGAN SCI, V12, P331, DOI 10.1287/orsc.12.3.331.10105; Tsai WP, 2011, ACAD MANAGE J, V54, P761, DOI 10.5465/AMJ.2011.64870138; van den Hooff B., 2004, Journal of Knowledge Management, V8, P117, DOI 10.1108/13673270410567675; Wang YC., 1992, LEADERSHIP SCI, V2, P16; Weech-Maldonado R, 2019, INQUIRY-J HEALTH CAR, V56, DOI 10.1177/0046958018825061; Yan F., 2002, J MANAGEMENT ENG, V2, P39	48	0	0	10	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0262426	10.1371/journal.pone.0262426	http://dx.doi.org/10.1371/journal.pone.0262426			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1D8GY	35482704	gold, Green Published			2022-12-26	WOS:000794035700060
J	Wiesehofer, C; Wiesehofer, M; Dankert, JT; Chung, JJ; von Ostau, NE; Singer, BB; Wennemuth, G				Wiesehoefer, Caroline; Wiesehoefer, Marc; Dankert, Jaroslaw Thomas; Chung, Jean-Ju; von Ostau, Nicola Edith; Singer, Bernhard Bonaventura; Wennemuth, Gunther			CatSper and its CaM-like Ca2+ sensor EFCAB9 are necessary for the path chirality of sperm	FASEB JOURNAL			English	Article						4D sperm movement; capacitation; CatSper; EFCAB9; path chirality	MOUSE SPERM; TYROSINE PHOSPHORYLATION; HOLOGRAPHIC MICROSCOPY; CHANNEL; SPERMATOZOA; CALCIUM; MOTILITY; ACTIVATION; ENTRY; HYPERACTIVATION	Successful fertilization depends on sperm motility adaptation. Ejaculated and activated sperm beat symmetrically in high frequency, move linearly, and swim with clockwise chirality. After capacitation, sperm beat asymmetrically with lower amplitude and a high lateral head excursion. This motility change called hyperactivation requires CatSper activation and an increase in intracellular Ca2+. However, whether CatSper-mediated Ca2+ influx participates in controlling the swim path chirality is unknown. In this study, we show that the clockwise path chirality is preserved in mouse sperm regardless of capacitation state but is lost in the sperm either lacking the entire CatSper channel or its Ca2+ sensor EFCAB9. Pharmacological inhibition of CatSper with either mibefradil or NNC 55-0396 leads to the same loss in swim path chirality. Exposure of sperm to the recombinant N-terminal part of the zona pellucida protein 2 randomizes chirality in capacitated cells, but not in non-capacitated ones. We conclude that Ca2+ sensitive regulation of CatSper activity orchestrates clockwise swim path chirality of sperm and any substantial change, such as the physiological stimulus of zona pellucida glycoproteins, results in a loss of chirality.	[Wiesehoefer, Caroline; Wiesehoefer, Marc; Dankert, Jaroslaw Thomas; von Ostau, Nicola Edith; Singer, Bernhard Bonaventura; Wennemuth, Gunther] Univ Duisburg Essen, Dept Anat, D-45147 Essen, Germany; [Chung, Jean-Ju] Yale Sch Med, Dept Cellular & Mol Physiol, New Haven, CT USA; [von Ostau, Nicola Edith] Univ Hosp Essen, Dept Urol, Essen, Germany	University of Duisburg Essen; Yale University; University of Duisburg Essen	Wennemuth, G (corresponding author), Univ Duisburg Essen, Dept Anat, D-45147 Essen, Germany.	gunther.wennemuth@uk-essen.de	Dankert, Jaroslaw Thomas/GWV-8070-2022; Dankert, Jaroslaw Thomas/A-2400-2017	Dankert, Jaroslaw Thomas/0000-0002-5950-0742; Dankert, Jaroslaw Thomas/0000-0002-5950-0742; Chung, Jean-Ju/0000-0001-8018-1355	Deutsche Forschungsgemeinschaft (DFG) [WE 2344/9-3]; HHS \ NIH \ National Institute of Child Health and Human Development (NICHD) [R01HD096745]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); HHS \ NIH \ National Institute of Child Health and Human Development (NICHD)	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: WE 2344/9-3; HHS vertical bar NIH vertical bar National Institute of Child Health and Human Development (NICHD), Grant/Award Number: R01HD096745	Alvarez L, 2012, J CELL BIOL, V196, P653, DOI 10.1083/jcb.201106096; Arnoult C, 1999, P NATL ACAD SCI USA, V96, P6757, DOI 10.1073/pnas.96.12.6757; Arnoult C, 1996, P NATL ACAD SCI USA, V93, P13004, DOI 10.1073/pnas.93.23.13004; Asquith KL, 2004, J CELL SCI, V117, P3645, DOI 10.1242/jcs.01214; AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581; Avella MA, 2014, J CELL BIOL, V205, P801, DOI 10.1083/jcb.201404025; Avella MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9946; Babcock DF, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0067-3; Baibakov B, 2012, J CELL BIOL, V197, P897, DOI 10.1083/jcb.201203062; Balbach M, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.572735; BALTZ JM, 1988, BIOPHYS J, V54, P643, DOI 10.1016/S0006-3495(88)83000-5; Ben-Yehuda K, 2022, ADV INTELL SYST-GER, V4, DOI 10.1002/aisy.202100200; BLEIL JD, 1983, DEV BIOL, V95, P317, DOI 10.1016/0012-1606(83)90032-5; BROKAW CJ, 1979, J CELL BIOL, V82, P401, DOI 10.1083/jcb.82.2.401; Caballero-Campo P, 2006, BIOL REPROD, V74, P760, DOI 10.1095/biolreprod.105.047522; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; Carlson AE, 2007, DEV BIOL, V312, P183, DOI 10.1016/j.ydbio.2007.09.017; Carlson AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006844; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Chung JJ, 2017, ELIFE, V6, DOI [10.7554/eLife.23082, 10.7547/elife.23082.001]; Chung JJ, 2014, CELL, V157, P808, DOI 10.1016/j.cell.2014.02.056; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; Dai C, 2019, GENET MED, V21, P431, DOI 10.1038/s41436-018-0064-y; Daloglu MU, 2018, LIGHT-SCI APPL, V7, DOI 10.1038/lsa.2017.121; Dardikman-Yoffe G, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay7619; De Toni L, 2018, PROTEIN PEPTIDE LETT, V25, P446, DOI 10.2174/0929866525666180418122203; Ded L, 2020, ELIFE, V9, DOI 10.7554/eLife.62043; Di Caprio G, 2015, J BIOPHOTONICS, V8, P779, DOI 10.1002/jbio.201400093; Di Caprio G, 2014, BIOMED OPT EXPRESS, V5, P690, DOI 10.1364/BOE.5.000690; Di Caprio G, 2010, IEEE J SEL TOP QUANT, V16, P833, DOI 10.1109/JSTQE.2009.2036741; Dubey V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39523-5; Dudiki T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141961; Florman HM, 2008, INT J DEV BIOL, V52, P503, DOI 10.1387/ijdb.082696hf; Gong A, 2021, EUR PHYS J E, V44, DOI 10.1140/epje/s10189-021-00076-z; Ho K, 2009, REPROD FERT DEVELOP, V21, P345, DOI 10.1071/RD08183; Hwang JY, 2019, CELL, V177, P1480, DOI 10.1016/j.cell.2019.03.047; Ishijima S, 2002, MOL REPROD DEV, V61, P376, DOI 10.1002/mrd.10017; Ishikawa Y, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.135418; Jansen V, 2015, ELIFE, V4, DOI 10.7554/eLife.05161; Jikeli JF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8985; Karako L., 2021, FRONT PHYS-LAUSANNE, V9, P1; KATZ DF, 1981, BIOL REPROD, V25, P785, DOI 10.1095/biolreprod25.4.785; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; KNOX C, 1966, SCIENCE, V153, P989, DOI 10.1126/science.153.3739.989; Lin SY, 2021, NATURE, V595, P746, DOI 10.1038/s41586-021-03742-6; LINDEMANN CB, 1988, CELL MOTIL CYTOSKEL, V10, P420, DOI 10.1002/cm.970100309; Lishko PV, 2011, NATURE, V471, P387, DOI 10.1038/nature09767; Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; Marquet P, 2005, OPT LETT, V30, P468, DOI 10.1364/OL.30.000468; Marquez B, 2007, DEV BIOL, V303, P214, DOI 10.1016/j.ydbio.2006.11.007; Miki K, 2013, CURR BIOL, V23, P443, DOI 10.1016/j.cub.2013.02.007; Miller MR, 2016, SCIENCE, V352, P555, DOI 10.1126/science.aad6887; Muschol M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199678; Nandagiri A, 2021, ELIFE, V10, DOI 10.7554/eLife.62524; Navarrete FA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33589; Navarrete FA, 2015, J CELL PHYSIOL, V230, P1758, DOI 10.1002/jcp.24873; Navarro B, 2007, P NATL ACAD SCI USA, V104, P7688, DOI 10.1073/pnas.0702018104; Nolan MA, 2004, P NATL ACAD SCI USA, V101, P13483, DOI 10.1073/pnas.0405580101; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Quill TA, 2003, P NATL ACAD SCI USA, V100, P14869, DOI 10.1073/pnas.2136654100; Quill TA, 2001, P NATL ACAD SCI USA, V98, P12527, DOI 10.1073/pnas.221454998; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Rennhack A, 2018, BRIT J PHARMACOL, V175, P3144, DOI 10.1111/bph.14355; Sanchez-Cardenas C, 2018, BIOL REPROD, V99, P1010, DOI 10.1093/biolre/ioy132; Santi CM, 2010, FEBS LETT, V584, P1041, DOI 10.1016/j.febslet.2010.02.005; Seifert R, 2015, EMBO J, V34, P379, DOI 10.15252/embj.201489376; STAUSS CR, 1995, BIOL REPROD, V53, P1280, DOI 10.1095/biolreprod53.6.1280; Strunker T, 2011, NATURE, V471, P382, DOI 10.1038/nature09769; Su TW, 2016, ANIM REPROD SCI, V169, P45, DOI 10.1016/j.anireprosci.2015.12.012; Su TW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01664; Su TW, 2012, P NATL ACAD SCI USA, V109, P16018, DOI 10.1073/pnas.1212506109; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; SUAREZ SS, 1992, BIOL REPROD, V46, P686, DOI 10.1095/biolreprod46.4.686; Suarez SS, 2008, HUM REPROD UPDATE, V14, P647, DOI 10.1093/humupd/dmn029; Tateno H, 2013, P NATL ACAD SCI USA, V110, P18543, DOI 10.1073/pnas.1317113110; Ramirez-Gomez HV, 2019, METHOD CELL BIOL, V151, P473, DOI 10.1016/bs.mcb.2018.12.002; Visconti PE, 2009, P NATL ACAD SCI USA, V106, P667, DOI 10.1073/pnas.0811895106; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Wandernoth PM, 2015, J BIOL CHEM, V290, P29202, DOI 10.1074/jbc.M115.698597; Wang HF, 2021, NAT REV UROL, V18, P46, DOI 10.1038/s41585-020-00390-9; Wennemuth G, 2000, J BIOL CHEM, V275, P21210, DOI 10.1074/jbc.M002068200; Wennemuth G, 2003, J GEN PHYSIOL, V122, P115, DOI 10.1085/jgp.200308839; Xia JS, 2007, BIOL REPROD, V77, P551, DOI 10.1095/biolreprod.107.061358; Xia JS, 2009, BIOL REPROD, V80, P1092, DOI 10.1095/biolreprod.108.074039; Xie F, 2006, DEV BIOL, V296, P353, DOI 10.1016/j.ydbio.2006.05.038; YANAGIMA.R, 1970, J REPROD FERTIL, V23, P193, DOI 10.1530/jrf.0.0230193; Yanagimachi R., 1994, P189; Zhao Y., 2021, 448910 BIORXIV	88	2	2	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22288	10.1096/fj.202101656RR	http://dx.doi.org/10.1096/fj.202101656RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0O5SD	35438819	hybrid			2022-12-26	WOS:000783584900001
J	Awoke, T; Teka, B; Aseffa, A; Sebre, S; Seman, A; Yeshitela, B; Abebe, T; Mihret, A				Awoke, Tewachew; Teka, Brhanu; Aseffa, Abraham; Sebre, Shemse; Seman, Aminu; Yeshitela, Biruk; Abebe, Tamrat; Mihret, Adane			Detection of bla(KPC) and bla(NDM) carbapenemase genes among Klebsiella pneumoniae isolates in Addis Ababa, Ethiopia: Dominance of bla(NDM)	PLOS ONE			English	Article							MULTIDRUG-RESISTANT; BETA-LACTAMASE; ENTEROBACTERIACEAE	Background Infections caused by Klebsiella pneumoniae have been difficult to control because of the worldwide emergence of carbapenem-resistant isolates mainly due to carbapenemase production. Information regarding carbapenemase-producing K. pneumoniae is still scarce in Ethiopia. Therefore, the current study aimed to determine the prevalence of carbapenemase-producing K. pneumoniae and to assess the occurrence of bla(NDM) and bla(KPC) carbapenemase genes(.) Methods A cross-sectional study was conducted from September 2018 to February 2019 at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. A total of 132 non-duplicate K. pneumoniae isolates were studied. Phenotypic confirmation of carbapenemase production was done by modified Carbapenem Inactivation Method (mCIM). Multiplex PCR was performed for the detection of carbapenemase-encoding genes bla(KPC), and bla(NDM). Results Out of the total 132 K. pneumoniae isolates, 39 (29.6%) were non-susceptible to one or more carbapenems. The prevalence of carbapenemase-producing isolates from the total was 28 (21.2%) with mCIM of which the most dominant gene was bla(NDM) 26 (92.9%) and one isolate carried bla(KPC) concomitantly. Carbapenemase-producing K. pneumoniae isolates were 100% non-susceptible to half of the antimicrobials used in the study, including meropenem and ertapenem. Previous use of carbapenems was associated with carbapenemase production (P = 0.004). Conclusions The prevalence of carbapenemase-producing K. pneumoniae isolates was worrying in the study area. To our knowledge, the study described the emergence of bla(NDM) and bla(KPC) gene carrying K. pneumoniae in Ethiopia for the first time. Further large-scale molecular-based studies, including other carbapenemase genes and sequencing of K. pneumoniae, are warranted to have a clear awareness about the presence of antimicrobial resistance high-risk clones in Ethiopia.	[Awoke, Tewachew] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Bahir Dar, Ethiopia; [Teka, Brhanu; Sebre, Shemse; Seman, Aminu; Abebe, Tamrat; Mihret, Adane] Addis Ababa Univ, Coll Hlth Sci, Sch Med, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia; [Aseffa, Abraham; Yeshitela, Biruk; Mihret, Adane] Armauer Hansen Res Inst, Addis Ababa, Ethiopia	Bahir Dar University; Addis Ababa University	Awoke, T (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Bahir Dar, Ethiopia.	tewachew.awoke@bdu.edu.et	; Aseffa, Abraham/J-3248-2016	Awoke, Tewachew/0000-0002-2493-8461; Aseffa, Abraham/0000-0002-8028-1150	Armauer Hansen Research Institute	Armauer Hansen Research Institute	This work was supported by Armauer Hansen Research Institute. It had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam B., 2020, PATHOGENIC BACTERIA, DOI DOI 10.5772/INTECHOPEN.90100; Cheesbrough M, 2006, DISTRICT LAB PRACTIC, V2nd, DOI [10.1017/CBO9780511543470, DOI 10.1017/CBO9780511543470]; Chiu SK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26691-z; CLSI, 2018, M100S28 CLSI S, V28th; Desta K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161685; Dirar M, 2020, CUREUS, V12, DOI 10.7759/cureus.7260; El-Budawy MF, 2017, INT J MICROBIOL, V2017, DOI 10.1155/2017/8050432; El-Feky M., 2017, EGYPT J MED MICROBIO, V26, P1, DOI [10.12816/0046244, DOI 10.12816/0046244]; Elbadawi HS, 2021, BMC MICROBIOL, V21, DOI 10.1186/s12866-021-02133-1; Eshetie S, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0054-7; Fenta T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227736; Gebretekle GB, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00109; Harada S, 2008, KOREAN J LAB MED, V28, P401, DOI 10.3343/kjlm.2008.28.6.401; Hashemizadeh Z, 2020, INFECT DRUG RESIST, V13, P921, DOI 10.2147/IDR.S227955; Karaiskos I, 2014, EXPERT OPIN PHARMACO, V15, P1351, DOI 10.1517/14656566.2014.914172; Kazemian H, 2019, MED PRIN PRACT, V28, P547, DOI 10.1159/000500311; Legese MH, 2017, INFECT DRUG RESIST, V10, P27, DOI 10.2147/IDR.S127177; Logan LK, 2017, J INFECT DIS, V215, pS28, DOI 10.1093/infdis/jiw282; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mathlouthi N, 2016, J INFECT DEV COUNTR, V10, P718, DOI 10.3855/jidc.7426; Meletis G, 2016, THER ADV INFECT DIS, V3, P15, DOI 10.1177/2049936115621709; Moges F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215177; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Pitout JDD, 2015, ANTIMICROB AGENTS CH, V59, P5873, DOI 10.1128/AAC.01019-15; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P934, DOI 10.1128/AAC.01247-10; Pritsch M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2289-9; Ranjbar R, 2019, INFECT DRUG RESIST, V12, P603, DOI 10.2147/IDR.S199639; Ranjbar R, 2016, MICROB PATHOGENESIS, V100, P244, DOI 10.1016/j.micpath.2016.10.002; Ranjbar R, 2016, J INFECT PUBLIC HEAL, V9, P499, DOI 10.1016/j.jiph.2015.12.012; Shakib P, 2012, BIOL-TARGETS THER, V6, P1, DOI 10.2147/BTT.S27582; Walsh TR, 2010, INT J ANTIMICROB AG, V36, pS8, DOI 10.1016/S0924-8579(10)70004-2; Wu WJ, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00115-18	33	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267657	10.1371/journal.pone.0267657	http://dx.doi.org/10.1371/journal.pone.0267657			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476721	gold, Green Published			2022-12-26	WOS:000840124300062
J	Kiyomi, A; Yoshida, K; Arai, C; Usuki, R; Yamazaki, K; Hoshino, N; Kurokawa, A; Imai, S; Suzuki, N; Toyama, A; Sugiura, M				Kiyomi, Anna; Yoshida, Kensuke; Arai, Chie; Usuki, Risa; Yamazaki, Kyosuke; Hoshino, Naoto; Kurokawa, Akira; Imai, Shinobu; Suzuki, Naoto; Toyama, Akira; Sugiura, Munetoshi			Salivary inflammatory mediators as biomarkers for oral mucositis and oral mucosal dryness in cancer patients: A pilot study	PLOS ONE			English	Article							HEALTH CARE; CHEMOTHERAPY; RISK; HEAD; XEROSTOMIA; CYTOKINES; THERAPY	Oral mucositis (OM) is a common side effect in patients with cancer receiving chemotherapy and radiotherapy; however, no salivary mediator is known to be associated with OM. We aimed to determine candidate salivary inflammatory mediators potentially associated with OM in patients with cancer. To this end, we compared the relationships between OM grade, oral mucosal dryness, and inflammatory mediators (Interleukin (IL)-1 beta, IL-6, IL-10, IL-12p70, tumor necrosis factor (TNF), prostaglandin E2, and vascular endothelial growth factor) in patients with cancer and in healthy volunteers (HV). We collected saliva samples from 18 patients with cancer according to the following schedule: 1) within 14 days of treatment initiation, 2) within 3 days of OM occurrence, 3) when OM was improved or got worsened, and 4) within 7 days after chemotherapy completion. The oral care support team determined the OM grade at each sample collection point based on CTCAE version 5.0. Salivary inflammatory mediator concentrations were detected using cytometric bead array or enzyme-linked immunoassay. We compared oral mucosal dryness in pre- and post-index patients with cancer to that in HV (n = 33) using an oral moisture-checking device. Fourteen of eighteen patients experienced OM (four, grade 3 OM; four, grade 2 OM; six, grade 1 OM). IL-6, IL-10, and TNF salivary concentrations were significantly increased in the post-index group compared to those in the pre-index group (p = 0.0002, p = 0.0364, and p = 0.0160, respectively). Additionally, salivary IL-6, IL-10, and TNF levels were significantly higher in the post-index group than in the HV group (p < 0.0001, p < 0.05, and p < 0.05, respectively). Significant positive correlations were observed between OM grade and salivary IL-6, IL-10, and TNF levels (p = 0.0004, r = 0.4939; p = 0.0171, r = 0.3394; and p = 0007, r = 0.4662, respectively). Oral mucosal dryness was significantly higher in the HV than in the pre- and post-index groups (p < 0.001). Our findings suggest that salivary IL-6, IL-10, and TNF levels may be used as biomarkers for OM occurrence and grade in patients with cancer. Furthermore, monitoring oral mucosal dryness and managing oral hygiene before cancer treatment is essential.	[Kiyomi, Anna; Arai, Chie; Usuki, Risa; Yamazaki, Kyosuke; Imai, Shinobu; Sugiura, Munetoshi] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Drug Safety & Risk Management, Tokyo, Japan; [Yoshida, Kensuke; Kurokawa, Akira] Niigata Univ, Fac Dent, Div Oral & Maxillofacial Surg, Niigata, Japan; [Yoshida, Kensuke; Kurokawa, Akira] Niigata Univ, Grad Sch Med & Dent Sci, Niigata, Japan; [Yoshida, Kensuke; Hoshino, Naoto; Suzuki, Naoto; Toyama, Akira] Niigata Univ, Div Hosp Pharm, Med & Dent Hosp, Niigata, Japan	Tokyo University of Pharmacy & Life Sciences; Niigata University; Niigata University; Niigata University	Kiyomi, A (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Drug Safety & Risk Management, Tokyo, Japan.	akiyomi@toyaku.ac.jp		Kiyomi, Anna/0000-0003-3802-0210	Tokyo University of Pharmacy and Life Sciences	Tokyo University of Pharmacy and Life Sciences	Funding was provided by the Tokyo University of Pharmacy and Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rudayni AHM, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18147418; Baima G, 2021, METABOLOMICS, V17, DOI 10.1007/s11306-020-01754-3; Biagini D, 2020, TALANTA, V216, DOI 10.1016/j.talanta.2020.120979; Bossi P, 2016, INT J RADIAT ONCOL, V96, P959, DOI 10.1016/j.ijrobp.2016.08.047; Cinausero M, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00354; Davies AN, 2001, J PAIN SYMPTOM MANAG, V22, P820, DOI 10.1016/S0885-3924(01)00318-9; Diesch T, 2021, CYTOKINE, V143, DOI 10.1016/j.cyto.2021.155506; Elting LS, 2007, INT J RADIAT ONCOL, V68, P1110, DOI 10.1016/j.ijrobp.2007.01.053; Epstein Joel B, 2003, Oncology (Williston Park), V17, P1767; Figueira J, 2017, J PHARMACEUT BIOMED, V140, P295, DOI 10.1016/j.jpba.2017.03.037; Fleming M, 2020, SUPPORT CARE CANCER, V28, P1121, DOI 10.1007/s00520-019-04908-9; Fukushima Y, 2017, ORAL SCI INT, V14, P33, DOI 10.1016/S1348-8643(17)30017-4; Hanchanale S, 2015, SUPPORT CARE CANCER, V23, P881, DOI 10.1007/s00520-014-2477-8; Huang YJ, 2014, FREE RADICAL BIO MED, V70, P223, DOI 10.1016/j.freeradbiomed.2014.02.024; Hyvarinen E, 2021, METABOLITES, V11, DOI 10.3390/metabo11090587; Kashiwazaki H, 2012, SUPPORT CARE CANCER, V20, P367, DOI 10.1007/s00520-011-1116-x; Katakura Akira, 2007, Bull Tokyo Dent Coll, V48, P199, DOI 10.2209/tdcpublication.48.199; Khan A, 2012, J PROTEOMICS, V75, P4802, DOI 10.1016/j.jprot.2012.05.018; Krzaczek PM, 2019, WSPOLCZESNA ONKOL, V23, P81, DOI 10.5114/wo.2019.85878; Kubota K, 2015, SUPPORT CARE CANCER, V23, P3323, DOI 10.1007/s00520-015-2774-x; Lalla RV, 2014, CANCER-AM CANCER SOC, V120, P1453, DOI 10.1002/cncr.28592; Miyano Kanako, 2015, Folia Pharmacologica Japonica, V146, P76, DOI 10.1254/fpj.146.76; Salvador DRN, 2017, LASER MED SCI, V32, P1801, DOI 10.1007/s10103-017-2263-1; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; Patil DJ, 2021, J ORAL MAX SURG MED, V33, P546, DOI 10.1016/j.ajoms.2021.02.003; Pena-Bautista C, 2019, J PHARMACEUT BIOMED, V164, P742, DOI 10.1016/j.jpba.2018.11.043; Saito H, 2014, SUPPORT CARE CANCER, V22, P2935, DOI 10.1007/s00520-014-2282-4; Sakellari I, 2015, ANN HEMATOL, V94, P1733, DOI 10.1007/s00277-015-2437-5; Shumaker Nicholas D, 2009, Compend Contin Educ Dent, V30, P388; Sonis ST., 2013, AM SOC CLIN ONCOL ED, DOI [10.1200/EdBook_AM.2013.33.e236, DOI 10.1200/EDBOOK_AM.2013.33.E236]; Sonis ST, 2009, ORAL ONCOL, V45, P1015, DOI 10.1016/j.oraloncology.2009.08.006; Vera-Llonch M, 2006, CANCER-AM CANCER SOC, V106, P329, DOI 10.1002/cncr.21622; Wardley AM, 2000, BRIT J HAEMATOL, V110, P292, DOI 10.1046/j.1365-2141.2000.02202.x; Wolfram RM, 2006, BIOFACTORS, V28, P21, DOI 10.1002/biof.5520280103; WOO SB, 1993, CANCER, V72, P1612, DOI 10.1002/1097-0142(19930901)72:5<1612::AID-CNCR2820720520>3.0.CO;2-Q; Wysocka-Slowik A, 2021, ANN HEMATOL, V100, P2079, DOI 10.1007/s00277-021-04568-y; Yatsuoka W, 2021, J CLIN MED, V10, DOI 10.3390/jcm10122631	37	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267092	10.1371/journal.pone.0267092	http://dx.doi.org/10.1371/journal.pone.0267092			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476641	Green Published, gold			2022-12-26	WOS:000840124300025
J	Koppenhafer, SL; Goss, KL; Voigt, E; Croushore, E; Terry, WW; Ostergaard, J; Gordon, PM; Gordon, DJ				Koppenhafer, Stacia L.; Goss, Kelli L.; Voigt, Ellen; Croushore, Emma; Terry, William W.; Ostergaard, Jason; Gordon, Peter M.; Gordon, David J.			Inhibitor of DNA binding 2 (ID2) regulates the expression of developmental genes and tumorigenesis in ewing sarcoma	ONCOGENE			English	Article							LOOP-HELIX PROTEIN; MYELOID-LEUKEMIA; FUSION PROTEINS; UP-REGULATION; STEM-CELLS; DIFFERENTIATION; TARGET; INITIATION; FAMILY; OVEREXPRESSION	Sarcomas are difficult to treat and the therapy, even when effective, is associated with long-term and life-threatening side effects. In addition, the treatment regimens for many sarcomas, including Ewing sarcoma, rhabdomyosarcoma, and osteosarcoma, are relatively unchanged over the past two decades, indicating a critical lack of progress. Although differentiation-based therapies are used for the treatment of some cancers, the application of this approach to sarcomas has proven challenging. Here, using a CRISPR-mediated gene knockout approach, we show that Inhibitor of DNA Binding 2 (ID2) is a critical regulator of developmental-related genes and tumor growth in vitro and in vivo in Ewing sarcoma tumors. We also identified that homoharringtonine, which is an inhibitor of protein translation and FDA-approved for the treatment of leukemia, decreases the level of the ID2 protein and significantly reduces tumor growth and prolongs mouse survival in an Ewing sarcoma xenograft model. Furthermore, in addition to targeting ID2, homoharringtonine also reduces the protein levels of ID1 and ID3, which are additional members of the ID family of proteins with well-described roles in tumorigenesis, in multiple types of cancer. Overall, these results provide insight into developmental regulation in Ewing sarcoma tumors and identify a novel, therapeutic approach to target the ID family of proteins using an FDA-approved drug.	[Koppenhafer, Stacia L.; Goss, Kelli L.; Croushore, Emma; Terry, William W.; Gordon, David J.] Univ Iowa, Div Pediat Hematol Oncol, Dept Pediat, Iowa City, IA 52242 USA; [Voigt, Ellen] Univ Iowa, Carver Coll Med, Iowa City, IA 52242 USA; [Ostergaard, Jason; Gordon, Peter M.] Univ Minnesota, Div Pediat Hematol Oncol, Dept Pediat, Minneapolis, MN 55455 USA	University of Iowa; University of Iowa; University of Minnesota System; University of Minnesota Twin Cities	Gordon, DJ (corresponding author), Univ Iowa, Div Pediat Hematol Oncol, Dept Pediat, Iowa City, IA 52242 USA.	david-j-gordon@uiowa.edu		Gordon, David/0000-0003-1830-4371; Croushore, Emma/0000-0002-8029-9289	University of Iowa Dance Marathon Award; Holden Comprehensive Cancer Center Sarcoma Multidisciplinary Oncology Group Seed Grant; Matt Morrell and Natalie Sanchez Pediatric Cancer Research Foundation; Aiming for a Cure; NIH [R37-CA217910]; NCI [P30CA086862]; University of Iowa Carver College of Medicine; Holden Comprehensive Cancer Center (NCI) [P30CA086862]	University of Iowa Dance Marathon Award; Holden Comprehensive Cancer Center Sarcoma Multidisciplinary Oncology Group Seed Grant; Matt Morrell and Natalie Sanchez Pediatric Cancer Research Foundation; Aiming for a Cure; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Iowa Carver College of Medicine; Holden Comprehensive Cancer Center (NCI)	We would like to acknowledge Henry Keen for assistance with the analysis of the RNAseq data. DJG is supported by a University of Iowa Dance Marathon Award, a Holden Comprehensive Cancer Center Sarcoma Multidisciplinary Oncology Group Seed Grant, Sammy's Superheroes, The Matt Morrell and Natalie Sanchez Pediatric Cancer Research Foundation, Aiming for a Cure, and NIH Grant R37-CA217910. This work was also supported by a grant (P30CA086862) from the NCI, administered through the Holden Comprehensive Cancer Center at The University of Iowa. The authors would like to acknowledge use of the University of Iowa Flow Cytometry Facility and the DNA sequencing facility (Genomics Division of the Iowa Institute of Human Genetics) which are supported, in part, by the University of Iowa Carver College of Medicine and the Holden Comprehensive Cancer Center (NCI P30CA086862).	Bae WJ, 2017, BRIT J CANCER, V117, P1810, DOI 10.1038/bjc.2017.373; Bajikar SS, 2017, DEV CELL, V43, P418, DOI 10.1016/j.devcel.2017.10.027; Balamuth NJ, 2010, LANCET ONCOL, V11, P184, DOI 10.1016/S1470-2045(09)70286-4; Behjati S, 2021, CANCER DISCOV, V11, P542, DOI 10.1158/2159-8290.CD-20-0926; Bell BA, 2001, MED PEDIATR ONCOL, V37, P103, DOI 10.1002/mpo.1177; BENEZRA R, 1990, ANN NY ACAD SCI, V599, P1, DOI 10.1111/j.1749-6632.1990.tb42359.x; Benezra R, 2001, BBA-REV CANCER, V1551, pF39, DOI 10.1016/S0304-419X(01)00028-2; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bounpheng MA, 1999, FASEB J, V13, P2257, DOI 10.1096/fasebj.13.15.2257; Chen XX, 2019, FRONT MED-PRC, V13, P378, DOI 10.1007/s11684-018-0658-4; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Ehrlich M, 2017, P NATL ACAD SCI USA, V114, pE2243, DOI 10.1073/pnas.1614412114; Eliazer S, 2003, MOL CELL BIOL, V23, P482, DOI 10.1128/MCB.23.2.482-492.2003; Fukuma M, 2003, ONCOGENE, V22, P1, DOI 10.1038/sj.onc.1206055; Gordon DJ, 2016, ONCOGENE, V35, P3092, DOI 10.1038/onc.2015.368; Goss KL, 2021, ONCOGENE, V40, P564, DOI 10.1038/s41388-020-01552-0; Goss KL, 2017, ONCOTARGET, V8, P87016, DOI 10.18632/oncotarget.18776; Goss KL, 2016, ONCOTARGET, V7, P63003, DOI 10.18632/oncotarget.11416; GREIG RG, 1985, P NATL ACAD SCI USA, V82, P3698, DOI 10.1073/pnas.82.11.3698; Hancock JD, 2008, CELL CYCLE, V7, P250, DOI 10.4161/cc.7.2.5229; Hao L, 2016, BIOCHEM BIOPH RES CO, V470, P643, DOI 10.1016/j.bbrc.2016.01.090; Howard TP, 2020, CLIN CANCER RES, V26, P4995, DOI 10.1158/1078-0432.CCR-19-2717; Huang YH, 2020, CANCER DISCOV, V10, P142, DOI 10.1158/2159-8290.CD-19-0529; Hwang DH, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-117; IAVARONE A, 1994, GENE DEV, V8, P1270, DOI 10.1101/gad.8.11.1270; Islam MS, 2009, NEUROCHEM INT, V54, P192, DOI 10.1016/j.neuint.2008.10.011; Jen Y, 1996, DEV DYNAM, V207, P235; JEN Y, 1992, GENE DEV, V6, P1466, DOI 10.1101/gad.6.8.1466; Jin J, 2013, LANCET ONCOL, V14, P599, DOI 10.1016/S1470-2045(13)70152-9; Keenan AB, 2019, NUCLEIC ACIDS RES, V47, pW212, DOI 10.1093/nar/gkz446; Khoury JD, 2005, ADV ANAT PATHOL, V12, P212, DOI 10.1097/01.pap.0000175114.55541.52; Koppenhafer SL, 2018, MOL CANCER THER, V17, P2676, DOI 10.1158/1535-7163.MCT-18-0260; KREIDER BL, 1992, SCIENCE, V255, P1700, DOI 10.1126/science.1372755; Lachmann A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03751-6; Lam SSY, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf3735; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lasorella A, 2005, MOL CELL BIOL, V25, P3563, DOI 10.1128/MCB.25.9.3563-3574.2005; Lasorella A, 2002, CANCER RES, V62, P301; Lasorella A, 1996, MOL CELL BIOL, V16, P2570; Lasorella A, 2014, NAT REV CANCER, V14, P77, DOI 10.1038/nrc3638; Leacock SW, 2012, DIS MODEL MECH, V5, P95, DOI 10.1242/dmm.007401; Lee J, 2006, BLOOD, V107, P2686, DOI 10.1182/blood-2005-07-2798; Lessnick SL, 2012, ANNU REV PATHOL-MECH, V7, P145, DOI 10.1146/annurev-pathol-011110-130237; Ligon KL, 2006, GLIA, V54, P1, DOI 10.1002/glia.20273; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maire CL, 2010, STEM CELLS, V28, P1611, DOI 10.1002/stem.480; Maire CL, 2009, J NEUROSCI RES, V87, P3438, DOI 10.1002/jnr.22194; Meng J, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2327-1; Merritt N, 2021, ELIFE, V10, DOI 10.7554/eLife.62857; Mistry H, 2013, MOL CANCER THER, V12, P2651, DOI 10.1158/1535-7163.MCT-13-0103-T; Nair R, 2014, MOL THER, V22, P1407, DOI 10.1038/mt.2014.83; Nishimori H, 2002, ONCOGENE, V21, P8302, DOI 10.1038/sj.onc.1206025; OGATA T, 1993, P NATL ACAD SCI USA, V90, P9219, DOI 10.1073/pnas.90.19.9219; Ohmura S, 2021, MOL CANCER, V20, DOI 10.1186/s12943-021-01393-9; Park HR, 2006, TUMORI, V92, P236, DOI 10.1177/030089160609200309; Patel AV, 2016, EBIOMEDICINE, V9, P110, DOI 10.1016/j.ebiom.2016.06.007; Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Potikyan G, 2008, LAB INVEST, V88, P1291, DOI 10.1038/labinvest.2008.99; RIECHMANN V, 1994, NUCLEIC ACIDS RES, V22, P749, DOI 10.1093/nar/22.5.749; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761; Riggi N, 2014, CANCER CELL, V26, P668, DOI 10.1016/j.ccell.2014.10.004; Riggi N, 2009, EXPERT REV ANTICANC, V9, P1025, DOI 10.1586/ERA.09.81; Roschger C, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-016-0161-y; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Sachdeva R, 2019, CANCER RES, V79, P4057, DOI 10.1158/0008-5472.CAN-18-1357; Samanta J, 2004, DEVELOPMENT, V131, P4131, DOI 10.1242/dev.01273; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schwentner R, 2017, ONCOTARGET, V8, P10980, DOI 10.18632/oncotarget.14091; Sole A, 2021, CANCER RES, V81, P4994, DOI 10.1158/0008-5472.CAN-20-3837; Svoboda LK, 2014, EPIGENETICS-US, V9, P1613, DOI 10.4161/15592294.2014.988048; Szu J, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.659601; Tam WF, 2008, BLOOD, V112, P1981, DOI 10.1182/blood-2007-07-103010; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Torchia EC, 2003, CANCER RES, V63, P3464; Toretsky JA, 2006, CANCER RES, V66, P5574, DOI 10.1158/0008-5472.CAN-05-3293; Trausch-Azar JS, 2004, J BIOL CHEM, V279, P32614, DOI 10.1074/jbc.M403794200; Veerasamy M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051842; Venneti S, 2011, AM J SURG PATHOL, V35, P1463, DOI 10.1097/PAS.0b013e318224d2cd; von Levetzow C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019305; Wang L, 2015, BLOOD, V126, P640, DOI 10.1182/blood-2015-03-635532; Waters T, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-07668-6; Williams SA, 2011, CELL, V146, P917, DOI 10.1016/j.cell.2011.07.040; Winer ES, 2018, ONCOL THER, V6, P9, DOI 10.1007/s40487-018-0058-6; Wojnarowicz PM, 2021, NPJ BREAST CANCER, V7, DOI 10.1038/s41523-021-00266-0; Wojnarowicz PM, 2019, CELL REP, V29, P62, DOI 10.1016/j.celrep.2019.08.073; Zhang CX, 2020, CANCER-AM CANCER SOC, V126, P344, DOI 10.1002/cncr.32534; Zhao GS, 2019, AM J TRANSL RES, V11, P2117; Zhao ZX, 2020, INT J MED SCI, V17, P995, DOI 10.7150/ijms.42805; Zhao ZY, 2015, TUMOR BIOL, V36, P4189, DOI 10.1007/s13277-015-3055-5; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	93	0	0	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 13	2022	41	20					2873	2884		10.1038/s41388-022-02310-0	http://dx.doi.org/10.1038/s41388-022-02310-0		APR 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	1F4TJ	35422476	Green Accepted			2022-12-26	WOS:000782543300002
J	de Castro, CT; Pereira, M; dos Santos, DB				de Castro, Caroline Tianeze; Pereira, Marcos; dos Santos, Djanilson Barbosa			Association between paracetamol use during pregnancy and perinatal outcomes: Prospective NISAMI cohort	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; DATA-COLLECTION; CASE-DEFINITION; ACETAMINOPHEN; RISK; MEDICATIONS; GUIDELINES; EXPOSURE; SAFETY	BackgroundParacetamol is widely used to manage fever and pain during pregnancy worldwide. However, paracetamol may affect the pregnant woman and fetus, once this drug crosses the placental barrier after therapeutic doses and may impair fetal liver function, affecting fetus growth and development. Thus, this study aimed to investigate the association between paracetamol use during pregnancy and perinatal outcomes as preterm birth, low birth weight, and small for gestational age. Methods and findingsData from 760 pregnant women within the NISAMI Cohort between June 2012 and February 2014 were analyzed. Logistic regression was used to estimate the association among paracetamol use during pregnancy and preterm birth, low birth weight, and small for gestational age. Multivariate analyses were adjusted for socioeconomic, maternal, pregnancy, and newborn covariates. Around 14% of women were exposed to paracetamol during pregnancy. A decrease in paracetamol use throughout pregnancy was observed. Lower risk of low birth weight in infants born to women exposed to the drug (OR 0.21; IC 95% 0.01-0.99) was found. Paracetamol use during pregnancy was not statistically associated with preterm birth or small for gestational age. ConclusionsThe findings of this study do not suggest an increased risk of perinatal outcomes. However, it should not be assumed that paracetamol is a risk-free medication and its use must be rational.	[de Castro, Caroline Tianeze; dos Santos, Djanilson Barbosa] Univ Fed Bahia, Multidisciplinary Hlth Inst, Vitoria Da Conquista, BA, Brazil; [Pereira, Marcos] Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil; [dos Santos, Djanilson Barbosa] Univ Fed Reconcavo Bahia, Hlth Sci Ctr, Santo Antonio De Jesus, BA, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal do Reconcavo da Bahia	de Castro, CT (corresponding author), Univ Fed Bahia, Multidisciplinary Hlth Inst, Vitoria Da Conquista, BA, Brazil.	carolinetianeze@gmail.com	Castro, Caroline Tianeze/AAD-5559-2021	Castro, Caroline Tianeze/0000-0002-9445-8842; Barbosa dos Santos, Djanilson/0000-0002-6128-1155; Pereira, Marcos/0000-0003-3766-2502	Research Foundation of the State of Bahia [7190/2011, APP0038/2011, BOL0401/2019]; National Council for Scientific and Technological Development [481509/2012-7]	Research Foundation of the State of Bahia; National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by the Research Foundation of the State of Bahia, grant number 7190/2011, APP0038/2011, and BOL0401/2019 and the National Council for Scientific and Technological Development, grant number 481509/2012-7. The funders had no role in study design, study selection and data extraction, data analysis, decision to publish, or preparation of the manuscript.	Adam MP, 2011, AM J MED GENET C, V157C, P175, DOI 10.1002/ajmg.c.30313; Alijahan Rahele, 2014, Iran J Reprod Med, V12, P47; Allegaert K, 2017, SEMIN FETAL NEONAT M, V22, P308, DOI 10.1016/j.siny.2017.07.006; Arneja J, 2020, PEDIATR RES, V87, P1263, DOI 10.1038/s41390-019-0726-8; Bandoli G, 2020, PAEDIATR PERINAT EP, V34, P237, DOI 10.1111/ppe.12595; Barrio BC, 2020, AN PEDIATR, V93, P196, DOI 10.1016/j.anpedi.2019.12.016; Benevent J, 2019, DRUG SAFETY, V42, P45, DOI 10.1007/s40264-018-0712-9; Guerra GCB, 2008, REV BRAS GINECOL OBS, V30, P12, DOI 10.1590/S0100-72032008000100003; Chang YK, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-02903-1; Costa Dário Alves da Silva, 2017, Cad. Saúde Pública, V33, pe00026316, DOI 10.1590/0102-311x00026316; Czeizel AE, 2005, PAEDIATR PERINAT EP, V19, P106, DOI 10.1111/j.1365-3016.2005.00631.x; DATASUS. Departamento de Informtica do SUS DATASUS, 2017, INF SAD EST VIT BANC; Dathe K, 2017, PHARMACOEPIDEM DR S, V26, P1197, DOI 10.1002/pds.4277; Daw JR, 2011, PHARMACOEPIDEM DR S, V20, P895, DOI 10.1002/pds.2184; Fagundes AA., 2004, VIGILANCIA ALIMENTAR; Feldkamp ML, 2010, OBSTET GYNECOL, V115, P109, DOI 10.1097/AOG.0b013e3181c52616; Gómez-Duarte Oscar Gilberto, 2019, Rev. colomb. anestesiol., V47, P81, DOI 10.1097/cj9.0000000000000111; Grzeskowiak LE, 2012, EUR J CLIN PHARMACOL, V68, P459, DOI 10.1007/s00228-011-1154-9; Gunn JKL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009986; Instituto Brasileiro de Geografia e Estatstica, 2011, CENS DEMOGRFICO2010; Jeena PM, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-03328-6; Ko TJ, 2014, PEDIATR NEONATOL, V55, P20, DOI 10.1016/j.pedneo.2013.05.005; Li DK, 2003, BRIT MED J, V327, P368, DOI 10.1136/bmj.327.7411.368; Lutz BH, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17030989; Maskova J, 2011, CENT EUR J MED, V6, P435, DOI 10.2478/s11536-011-0039-8; Migliore E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135775; Nitsche JF, 2017, AM J PERINAT, V34, P541, DOI 10.1055/s-0036-1593845; OBRIEN WF, 1993, AM J OBSTET GYNECOL, V168, P1164, DOI 10.1016/0002-9378(93)90362-M; Quinn JA, 2016, VACCINE, V34, P6047, DOI 10.1016/j.vaccine.2016.03.045; Rebordosa C, 2010, J MATERN-FETAL NEO M, V23, P371, DOI 10.3109/14767050903334877; Rebordosa C, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.040; Rebordosa C, 2009, INT J EPIDEMIOL, V38, P706, DOI 10.1093/ije/dyp151; Schlaudecker EP, 2017, VACCINE, V35, P6518, DOI 10.1016/j.vaccine.2017.01.040; Sinclair SM, 2016, J MIDWIFERY WOM HEAL, V61, P52, DOI 10.1111/jmwh.12358; Temu T.B., 2016, ASIAN PAC J REPROD, V5, P365, DOI [DOI 10.1016/j.apjr.2016.07.009, 10.1016/j.apjr.2016.07.009]; Thulstrup AM, 1999, AM J PERINAT, V16, P321, DOI 10.1055/s-2007-993879; Tovo-Rodrigues L, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1942-1; Volqvartz T, 2020, BASIC CLIN PHARMACOL, V127, P205, DOI 10.1111/bcpt.13396; Werler MM, 2005, AM J OBSTET GYNECOL, V193, P771, DOI 10.1016/j.ajog.2005.02.100; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Ystrom E, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-3840	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267270	10.1371/journal.pone.0267270	http://dx.doi.org/10.1371/journal.pone.0267270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7MW	35436308	gold, Green Published			2022-12-26	WOS:000791258900014
J	Gomes, ID; Santana, CA; Marcolino, LS; de Lima, LHF; de Melo-Minardi, RC; Dias, RS; de Paula, SO; Silveira, SD				Gomes, Isabela de Souza; Santana, Charles Abreu; Marcolino, Leandro Soriano; Franca de Lima, Leonardo Henrique; de Melo-Minardi, Raquel Cardoso; Dias, Roberto Sousa; de Paula, Sergio Oliveira; Silveira, Sabrina de Azevedo			Computational prediction of potential inhibitors for SARS-COV-2 main protease based on machine learning, docking, MM-PBSA calculations, and metadynamics	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; DRUG DISCOVERY; FORCE-FIELD; GROMACS; SOFTWARE; DESIGN; TOOL	The development of new drugs is a very complex and time-consuming process, and for this reason, researchers have been resorting heavily to drug repurposing techniques as an alternative for the treatment of various diseases. This approach is especially interesting when it comes to emerging diseases with high rates of infection, because the lack of a quickly cure brings many human losses until the mitigation of the epidemic, as is the case of COVID-19. In this work, we combine an in-house developed machine learning strategy with docking, MM-PBSA calculations, and metadynamics to detect potential inhibitors for SARS-COV-2 main protease among FDA approved compounds. To assess the ability of our machine learning strategy to retrieve potential compounds we calculated the Enrichment Factor of compound datasets for three well known protein targets: HIV-1 reverse transcriptase (PDB 4B3P), 5-HT2A serotonin receptor (PDB 6A94), and H1 histamine receptor (PDB 3RZE). The Enrichment Factor for each target was, respectively, 102.5, 12.4, 10.6, which are considered significant values. Regarding the identification of molecules that can potentially inhibit the main protease of SARS-COV-2, compounds output by the machine learning step went through a docking experiment against SARS-COV-2 M-pro. The best scored poses were the input for MM-PBSA calculations and metadynamics using CHARMM and AMBER force fields to predict the binding energy for each complex. Our work points out six molecules, highlighting the strong interaction obtained for M-pro-mirabegron complex. Among these six, to the best of our knowledge, ambenonium has not yet been described in the literature as a candidate inhibitor for the SARS-COV-2 main protease in its active pocket.	[Gomes, Isabela de Souza; Silveira, Sabrina de Azevedo] Univ Fed Vicosa, Dept Comp Sci, Vicosa, MG, Brazil; [Santana, Charles Abreu; de Melo-Minardi, Raquel Cardoso] Univ Fed Minas Gerais, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil; [Santana, Charles Abreu; de Melo-Minardi, Raquel Cardoso] Univ Fed Minas Gerais, Dept Comp Sci, Belo Horizonte, MG, Brazil; [Marcolino, Leandro Soriano] Univ Lancaster, Sch Comp & Commun, Lancaster, England; [Franca de Lima, Leonardo Henrique] Univ Fed Sao Joao Rei, Dept Exact & Biol Sci, Sete Lagoas Campus, Sete Lagoas, MG, Brazil; [Dias, Roberto Sousa] Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil; [de Paula, Sergio Oliveira] Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Lancaster University; Universidade Federal de Sao Joao del-Rei; Universidade Federal de Vicosa; Universidade Federal de Vicosa	Silveira, SD (corresponding author), Univ Fed Vicosa, Dept Comp Sci, Vicosa, MG, Brazil.	sabrina@ufv.br	Silveira, Sabrina/AID-6483-2022	Silveira, Sabrina/0000-0002-4723-2349; de Souza Gomes, Isabela/0000-0001-9311-707X; Lima, Leonardo/0000-0003-4346-9880	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [23038.004007/2014-82, 051/2013]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 23038.004007/2014-82 -Grant 051/2013; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). The funding agencies had no role in study design, data collection, analysis and interpretation, decision to publish, or preparation of the manuscript.	Acharya C, 2011, CURR COMPUT-AID DRUG, V7, P10, DOI 10.2174/157340911793743547; Ahmed SF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12030254; Anderson AC, 2003, CHEM BIOL, V10, P787, DOI 10.1016/j.chembiol.2003.09.002; [Anonymous], RDKIT OPEN SOURCE CH; Banegas-Luna AJ, 2018, FUTURE MED CHEM, V10, P2641, DOI 10.4155/fmc-2018-0076; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biovia D.S., 2017, DISCOVERY STUDIO MOD; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Brandt AML, 2016, PROTEINS, V84, P473, DOI 10.1002/prot.24994; Burley SK, 2021, NUCLEIC ACIDS RES, V49, pD437, DOI 10.1093/nar/gkaa1038; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cereto-Massague A, 2015, METHODS, V71, P58, DOI 10.1016/j.ymeth.2014.08.005; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Davies M, 2015, NUCLEIC ACIDS RES, V43, pW612, DOI 10.1093/nar/gkv352; Dzamba M., 2015, ARXIV151002855; Ekins S, 2019, NAT MATER, V18, P435, DOI 10.1038/s41563-019-0338-z; Galindez G, 2021, NAT COMPUT SCI, V1, P33, DOI 10.1038/s43588-020-00007-6; Garcia-Hernandez C, 2019, J CHEM INF MODEL, V59, P1410, DOI 10.1021/acs.jcim.8b00820; Gilson MK, 2016, NUCLEIC ACIDS RES, V44, pD1045, DOI 10.1093/nar/gkv1072; Gimeno A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061375; Gonczarek A, 2018, COMPUT BIOL MED, V100, P253, DOI 10.1016/j.compbiomed.2017.09.007; Guo HX, 2017, EXPERT SYST APPL, V73, P220, DOI 10.1016/j.eswa.2016.12.035; HESTENES MR, 1952, J RES NAT BUR STAND, V49, P409, DOI 10.6028/jres.049.044; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jin ZM, 2020, NATURE, V582, P289, DOI 10.1038/s41586-020-2223-y; Kuhne R, 2009, J CHEM INF MODEL, V49, P2660, DOI 10.1021/ci900313u; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Le TT, 2020, BIOINFORMATICS, V36, P250, DOI 10.1093/bioinformatics/btz470; Legnik S, 2015, J CHEM INF MODEL, V55, P1521, DOI 10.1021/acs.jcim.5b00136; Li HJ, 2021, WIRES COMPUT MOL SCI, V11, DOI 10.1002/wcms.1478; Lo YC, 2018, DRUG DISCOV TODAY, V23, P1538, DOI 10.1016/j.drudis.2018.05.010; Luo HM, 2021, BRIEF BIOINFORM, V22, P1604, DOI 10.1093/bib/bbz176; Martins PM, 2021, BMC BIOINFORMATICS, V22, DOI 10.1186/s12859-020-03881-z; Mendolia I, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-03645-9; Mirza MU, 2020, J PHARM ANAL, V10, P320, DOI 10.1016/j.jpha.2020.04.008; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morse P.M., 1953, METHODS THEORETICAL; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rifaioglu AS, 2019, BRIEF BIOINFORM, V20, P1878, DOI 10.1093/bib/bby061; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Santana CA, 2020, BIOINFORMATICS, V36, pI726, DOI 10.1093/bioinformatics/btaa805; Shang JL, 2017, BIOINFORMATICS, V33, P3480, DOI 10.1093/bioinformatics/btx418; Sledz P, 2018, CURR OPIN STRUC BIOL, V48, P93, DOI 10.1016/j.sbi.2017.10.010; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Spinner CD, 2020, JAMA-J AM MED ASSOC, V324, P1048, DOI 10.1001/jama.2020.16349; Tropsha A, 2010, MOL INFORM, V29, P476, DOI 10.1002/minf.201000061; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; U.S. Food & Drug Administration, US; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VANGUNSTEREN WF, 1990, ANGEW CHEM INT EDIT, V29, P992, DOI 10.1002/anie.199009921; VEKLURY, US; Wall ME, 2003, PRACTICAL APPROACH M, P91, DOI DOI 10.1007/0-306-47815-3_5; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037; Wu CR, 2020, ACTA PHARM SIN B, V10, P766, DOI 10.1016/j.apsb.2020.02.008; Yasuo N, 2019, J CHEM INF MODEL, V59, P1050, DOI 10.1021/acs.jcim.8b00673; Zaki M.J., 2014, DATA MINING ANAL FUN; Zhang LL, 2020, SCIENCE, V368, P409, DOI 10.1126/science.abb3405; Zheng MH, 2014, MOL DIVERS, V18, P829, DOI 10.1007/s11030-014-9545-3; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	65	2	2	9	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267471	10.1371/journal.pone.0267471	http://dx.doi.org/10.1371/journal.pone.0267471			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C1KV	35452494	gold, Green Published			2022-12-26	WOS:000792887700006
J	Huruba, R; Nemera, S; Ngute, F; Sahomba, M; Mundy, PJ; Sebata, A; MacFadyen, DN				Huruba, Rangarirai; Nemera, Servious; Ngute, Faith; Sahomba, Meshack; Mundy, Peter J.; Sebata, Allan; MacFadyen, Duncan N.			Short duration overnight cattle kraaling in natural rangelands: Does time after kraal use affect their utilization by wildlife and above ground grass parameters?	PLOS ONE			English	Article							BODY-SIZE; LARGE HERBIVORES; RESOURCE; NUTRIENT; NITROGEN; GROWTH; HETEROGENEITY; PRODUCTIVITY; FREQUENCY; DYNAMICS	In east and southern Africa some private ranch owners are corralling (hereafter kraaling) cattle overnight for short periods (for example, seven days) in natural rangelands to create nutrient enriched hotspots which are attractive to large herbivores. However, the effect of season and time after kraal use (alt. age of nutrient enriched hotspots) on large herbivore use of these sites has not been examined. We collated the number of large herbivore sightings per day from camera traps during wet, early and late dry season in nutrient enriched hotspots of varying ages (1, 2, 3 and 4 years) and surrounding vegetation. In addition, above ground grass biomass and height in nutrient enriched hotspots was compared to that of the surrounding vegetation. Furthermore, we tested if repeated grazing in nutrient enriched hotspots stimulated grass compensatory growth. Large herbivore use of nutrient enriched hotspots was similar during wet, early and late dry season. Time after kraal use had a significant effect on mixed feeders (impala and African savanna elephant) utilization of nutrient enriched hotspots but not grazers (zebra and warthog) and browsers (giraffe and greater kudu). Both impala and African savanna elephants mostly used nutrient enriched hotspots one year after kraal use. Aboveground grass biomass and height were higher in surrounding vegetation than in nutrient enriched hotspots. Repeated clipping (proxy for grazing) resulted in compensatory aboveground grass biomass in nutrient enriched hotspots, which declined with time after kraal use. We concluded that nutrient enriched hotspots created through short duration overnight kraaling were important foraging sites for large herbivores.	[Huruba, Rangarirai; Nemera, Servious; Ngute, Faith; Mundy, Peter J.; Sebata, Allan] Natl Univ Sci & Technol, Dept Forest Resources & Wildlife Management, Ascot, Zimbabwe; [Huruba, Rangarirai; MacFadyen, Duncan N.] E Oppenheimer & Son Pty Ltd, Parktown, South Africa	National University of Science & Technology - Zimbabwe	Huruba, R (corresponding author), Natl Univ Sci & Technol, Dept Forest Resources & Wildlife Management, Ascot, Zimbabwe.; Huruba, R (corresponding author), E Oppenheimer & Son Pty Ltd, Parktown, South Africa.	rhuruba@gmail.com	Huruba, Ranga/CAH-2962-2022	Huruba, Ranga/0000-0001-6572-6740				Anderson TM, 2010, ECOLOGY, V91, P1519, DOI 10.1890/09-0739.1; Arsenault R, 2008, OIKOS, V117, P1711, DOI 10.1111/j.1600-0706.2008.16575.x; Augustine David J., 2011, Smithsonian Contributions to Zoology, P55; Augustine DJ, 2003, ECOL APPL, V13, P1325, DOI 10.1890/02-5283; Augustine DJ, 2003, J APPL ECOL, V40, P137, DOI 10.1046/j.1365-2664.2003.00778.x; Augustine DJ, 2001, ECOLOGY, V82, P3149, DOI 10.1890/0012-9658(2001)082[3149:EOMGOS]2.0.CO;2; BELSKY AJ, 1986, AM NAT, V127, P870, DOI 10.1086/284531; Burkepile DE, 2017, J ECOL, V105, P674, DOI 10.1111/1365-2745.12714; Carbone C, 2001, ANIM CONSERV, V4, P75, DOI 10.1017/S1367943001001081; Clauss M, 2003, OECOLOGIA, V136, P14, DOI 10.1007/s00442-003-1254-z; Codron D, 2009, MAMM BIOL, V74, P36, DOI 10.1016/j.mambio.2007.12.005; Codron J, 2011, OECOLOGIA, V165, P89, DOI 10.1007/s00442-010-1835-6; DEMMENT MW, 1985, AM NAT, V125, P641, DOI 10.1086/284369; Donihue CM, 2013, ECOLOGY, V94, P827, DOI 10.1890/12-0856.1; Dunham KM, 2003, BIOL CONSERV, V113, P111, DOI 10.1016/S0006-3207(02)00354-3; Fierer N, 2002, SOIL BIOL BIOCHEM, V34, P777, DOI 10.1016/S0038-0717(02)00007-X; Fleurance G, 2010, ANIMAL, V4, P480, DOI 10.1017/S1751731109991133; Ford AT, 2014, SCIENCE, V346, P346, DOI 10.1126/science.1252753; FULS ER, 1992, J ARID ENVIRON, V22, P191, DOI 10.1016/S0140-1963(18)30591-3; Hawkes CV, 2001, ECOLOGY, V82, P2045, DOI 10.1890/0012-9658(2001)082[2045:TIOHOP]2.0.CO;2; HILBERT DW, 1981, OECOLOGIA, V51, P14, DOI 10.1007/BF00344645; Hobbs NT, 1996, J WILDLIFE MANAGE, V60, P695, DOI 10.2307/3802368; Huruba R, 2018, AGR ECOSYST ENVIRON, V257, P144, DOI 10.1016/j.agee.2018.02.004; Huruba R, 2017, RANGELAND J, V39, P113, DOI 10.1071/RJ16016; Kirkman K. P., 2002, African Journal of Range & Forage Science, V19, P93, DOI 10.2989/10220110209485780; Kolowski JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186679; LACA EA, 1992, GRASS FORAGE SCI, V47, P91, DOI 10.1111/j.1365-2494.1992.tb02251.x; Mayengo G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230192; McNaughton SJ, 1996, ECOLOGY, V77, P974, DOI 10.2307/2265518; MCNAUGHTON SJ, 1979, AM NAT, V113, P691, DOI 10.1086/283426; MCNAUGHTON SJ, 1983, OIKOS, V40, P329, DOI 10.2307/3544305; Meek DP., 2016, REMOTE SENS ECOL CON, DOI [10.1002/rse2.32, DOI 10.1002/RSE2.32]; Muchiru AN, 2008, J ARID ENVIRON, V72, P940, DOI 10.1016/j.jaridenv.2007.11.012; Mudongo EI, 2016, RANGELAND ECOL MANAG, V69, P327, DOI 10.1016/j.rama.2016.04.003; OWENSMITH N, 1982, AM NAT, V119, P151, DOI 10.1086/283902; Porensky LM, 2015, RANGELAND ECOL MANAG, V68, P131, DOI 10.1016/j.rama.2015.01.002; Porensky LM, 2012, OECOLOGIA, V168, P749, DOI 10.1007/s00442-011-2123-9; RUESS RW, 1987, OIKOS, V49, P101, DOI 10.2307/3565559; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Shannon G, 2013, ACTA OECOL, V46, P48, DOI 10.1016/j.actao.2012.10.013; Sibanda P, 2016, AFR J RANGE FOR SCI, V33, P217, DOI 10.2989/10220119.2016.1243580; Tomlinson KW, 2004, FUNCT ECOL, V18, P489, DOI 10.1111/j.0269-8463.2004.00873.x; Treydte AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082831; TURNER CL, 1993, ECOL APPL, V3, P175, DOI 10.2307/1941800; van der Waal C, 2011, OECOLOGIA, V165, P1095, DOI 10.1007/s00442-010-1899-3; Veblen KE, 2012, J ARID ENVIRON, V78, P119, DOI 10.1016/j.jaridenv.2011.10.016; Veblen KE, 2019, ECOL APPL, V29, DOI 10.1002/eap.1982; Venter ZS, 2021, AFR J RANGE FOR SCI, V38, P141, DOI 10.2989/10220119.2020.1766565; Werner PA, 2013, ECOL MONOGR, V83, P67, DOI 10.1890/12-1153.1; Wolf A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071352; Young CA, 2020, AMYOTROPH LAT SCL FR, V21, P364, DOI 10.1080/21678421.2020.1752244	51	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0248795	10.1371/journal.pone.0248795	http://dx.doi.org/10.1371/journal.pone.0248795			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D8GY	35482714	Green Published, gold, Green Submitted			2022-12-26	WOS:000794035700008
J	Ombelet, S; Natale, A; Ronat, JB; Vandenberg, O; Jacobs, J; Hardy, L				Ombelet, Sien; Natale, Alessandra; Ronat, Jean-Baptiste; Vandenberg, Olivier; Jacobs, Jan; Hardy, Liselotte			Considerations in evaluating equipment-free blood culture bottles: A short protocol for use in low-resource settings	PLOS ONE			English	Article								Use of equipment-free, "manual" blood cultures is still widespread in low-resource settings, as requirements for implementation of automated systems are often not met. Quality of manual blood culture bottles currently on the market, however, is usually unknown. An acceptable quality in terms of yield and speed of growth can be ensured by evaluating the bottles using simulated blood cultures. In these experiments, bottles from different systems are inoculated in parallel with blood and a known quantity of bacteria. Based on literature review and personal experiences, we propose a short and practical protocol for an efficient evaluation of manual blood culture bottles, aimed at research or reference laboratories in low-resource settings. Recommendations include: (1) practical equivalence of horse blood and human blood; (2) a diverse selection of 10 to 20 micro-organisms to be tested (both slow- and fast-growing reference organisms); (3) evaluation of both adult and pediatric bottle formulations and blood volumes; (4) a minimum sample size of 120 bottles per bottle type; (5) a formal assessment of usability. Different testing scenarios for increasing levels of reliability are provided, along with practical tools such as worksheets and surveys that can be used by laboratories wishing to evaluate manual blood culture bottles.	[Ombelet, Sien; Jacobs, Jan; Hardy, Liselotte] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Ombelet, Sien; Jacobs, Jan] Katholieke Univ Leuven, Immunol & Microbiol Dept, Leuven, Belgium; [Natale, Alessandra; Ronat, Jean-Baptiste] Med Sans Frontieres, Paris, France; [Ronat, Jean-Baptiste] Univ Paris Saclay, INSERM U1184, Team ReSIST, Sch Med, Paris, France; [Ronat, Jean-Baptiste] Bicetre Hosp, AP HP, Bacteriol Hyg Unit, Le Kremlin Bicetre, France; [Vandenberg, Olivier] Univ Libre Bruxelles ULB, Ctr Environm Hlth & Occupat Hlth, Sch Publ Hlth, Brussels, Belgium; [Vandenberg, Olivier] ULB, Innovat & Business Dev Unit, Univ Lab Brussel LHUB ULB, Lab Hosp Univ Bruxelles, Brussels, Belgium; [Vandenberg, Olivier] UCL, Fac Med Sci, Div Infect & Immun, London, England	Institute of Tropical Medicine (ITM); KU Leuven; Doctors Without Borders; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universite de Franche-Comte; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of London; University College London	Hardy, L (corresponding author), Inst Trop Med, Dept Clin Sci, Antwerp, Belgium.	lhardy@itg.be	Jacobs, Jan/GRX-7316-2022	Ombelet, Sien/0000-0002-4943-0736	Medecins Sans Frontieres (Operational Centre Paris)	Medecins Sans Frontieres (Operational Centre Paris)	This work was partly funded by Medecins Sans Frontieres (Operational Centre Paris). The funder participated in study design and preparation of the manuscript.	ALFA M, 1995, J CLIN MICROBIOL, V33, P1185, DOI 10.1128/JCM.33.5.1185-1191.1995; Almuhayawi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142398; Altun O, 2016, J CLIN MICROBIOL, V54, P1148, DOI 10.1128/JCM.03362-15; AUCKENTHALER R, 1982, J CLIN MICROBIOL, V15, P860, DOI 10.1128/JCM.15.5.860-864.1982; Bard JD, 2016, J CLIN MICROBIOL, V54, P1418, DOI 10.1128/JCM.02919-15; Baskurt Oguz K., 1997, American Journal of Physiology, V273, pH2604; Beckwith T.G., 1993, MECH MEASUREMENTS, VFifth., P591; Ben-David A, 2014, J MICROBIOL METH, V107, P214, DOI 10.1016/j.mimet.2014.08.023; Biondi EA, 2014, JAMA PEDIATR, V168, P844, DOI 10.1001/jamapediatrics.2014.895; Chan CHH, 2017, ARTIF ORGANS, V41, P934, DOI 10.1111/aor.12932; Chandrasekaran S, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/jcm.01678-17, 10.1128/JCM.01678-17]; Cockerill FR, 2004, CLIN INFECT DIS, V38, P1724, DOI 10.1086/421087; Dailey PJ, 2019, DIAGNOSTICS, V9, DOI 10.3390/diagnostics9010010; Durkalski VL, 2003, STAT MED, V22, P2417, DOI 10.1002/sim.1438; Elliott TSJ, 1998, EUR J CLIN MICROBIOL, V17, P566; FrancescoVigano E, 2002, DIAGN MICR INFEC DIS, V44, P235, DOI 10.1016/S0732-8893(02)00451-0; Galbraith S, 2010, J NEUROSCI, V30, P10601, DOI 10.1523/JNEUROSCI.0362-10.2010; Grand View Research, 2018, BLOOD CULT TESTS MAR; IMDRF, 2018, ESSENTIAL PRINCIPLES; Jacobs J, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00205; Jennison MW, 1940, J BACTERIOL, V39, P389, DOI 10.1128/JB.39.4.389-397.1940; Kellogg JA, 2000, J CLIN MICROBIOL, V38, P2181; Kikuchi K, 2017, CAN J INFECT DIS MED, V2017, DOI 10.1155/2017/4896791; Kuijpers L.M.F., 2016, MALARIA J, P1, DOI [10.1186/s12936-015-1044-1, DOI 10.1186/S12936-015-1044-1]; Lambregts MMC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208819; Lambregts MMC, 2018, EUR J HAEMATOL, V100, P206, DOI 10.1111/ejh.13001; Ruiz-Giardin JM, 2015, INT J INFECT DIS, V41, P6, DOI 10.1016/j.ijid.2015.10.008; Marlowe EM, 2003, J CLIN MICROBIOL, V41, P1266, DOI 10.1128/JCM.41.3.1266-1269.2003; Martinez JA, 2007, CLIN MICROBIOL INFEC, V13, P709, DOI 10.1111/j.1469-0691.2007.01736.x; Menchinelli G, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00221; Miller NS, 2011, J CLIN MICROBIOL, V49, P1624, DOI 10.1128/JCM.01958-10; Miller N, 2018, ACTA CLIN BELG, V73, P16, DOI 10.1080/17843286.2017.1331618; Natale A, 2020, LANCET MICROBE, V1, pE56, DOI 10.1016/S2666-5247(20)30012-4; Nawrot U, 2015, EUR J CLIN MICROBIOL, V34, P161, DOI 10.1007/s10096-014-2218-4; Ombelet S, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00131; Park J, 2017, CLIN LAB, V63, P39, DOI 10.7754/Clin.Lab.2016.160502; RIMMER K, 1988, J CLIN PATHOL, V41, P676, DOI 10.1136/jcp.41.6.676; Rodriguez-Tudela JL, 2008, CLIN MICROBIOL INFEC, V14, P398, DOI 10.1111/j.1469-0691.2007.01935.x; Rogers MS, 1998, J CLIN PATHOL, V51, P635, DOI 10.1136/jcp.51.8.635; ROZDZINSKI E, 1991, ZBL BAKT-INT J MED M, V275, P320, DOI 10.1016/S0934-8840(11)80295-1; Russell FM, 2006, J CLIN MICROBIOL, V44, P3346, DOI 10.1128/JCM.02631-05; Samuel LP, 2011, DIAGN MICR INFEC DIS, V71, P101, DOI 10.1016/j.diagmicrobio.2011.06.001; Somily AM, 2018, ANN SAUDI MED, V38, P194, DOI 10.5144/0256-4947.2018.194; STEVENS CM, 1994, J CLIN MICROBIOL, V32, P1750, DOI 10.1128/JCM.32.7.1750-1756.1994; Sutton S., 2011, J VALID TECHNOL, Vvol. 17, P42; TOMASIEWICZ DM, 1980, J FOOD PROTECT, V43, P282, DOI 10.4315/0362-028X-43.4.282; Totty H, 2017, EUR J CLIN MICROBIOL, V36, P1795, DOI 10.1007/s10096-017-2994-8; Vigano EF, 2004, MICROBIOLOGICA, V27, P235; Wain J, 2001, J CLIN MICROBIOL, V39, P1571, DOI 10.1128/JCM.39.4.1571-1576.2001; Wang SK, 2010, BRAZ J MICROBIOL, V41, P283, DOI 10.1590/S1517-83822010000200003; WEENK GH, 1992, INT J FOOD MICROBIOL, V17, P159, DOI 10.1016/0168-1605(92)90113-H; Weinbren MJ, 2005, J ANTIMICROB CHEMOTH, V55, P131, DOI 10.1093/jac/dkh502; Weng X, 1996, BIORHEOLOGY, V33, P365, DOI 10.1016/0006-355X(96)00028-5; WILSON ML, 1994, CLIN LAB MED, V14, P119, DOI 10.1016/S0272-2712(18)30399-8; World Health Organization,, 2020, TECHNICAL SPECIFICAT; YAGUPSKY P, 1990, CLIN MICROBIOL REV, V3, P269, DOI 10.1128/CMR.3.3.269-279.1990; Zhou LQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150576	57	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267491	10.1371/journal.pone.0267491	http://dx.doi.org/10.1371/journal.pone.0267491			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D9PO	35468169	Green Published, gold			2022-12-26	WOS:000794129600019
J	Yao, YP; Liu, WL; Gao, ZP				Yao, Yanping; Liu, Weili; Gao, Zhipeng			Impact damage to the middle trough of a scraper conveyor based on the engineering discrete element method and orthogonal matrix analysis	PLOS ONE			English	Article							WEAR; PARAMETERS; SURFACE; LOAD	The middle trough serves as a key part of a scraper conveyor. During the working process, falling raw coal lands on the middle plate of the trough, causing impact damage. This study aims to find the optimal working condition combination to minimize impact damage to the middle trough based on the engineering discrete element method (EDEM) and orthogonal matrix analysis (OMA). In EDEM software, simulation data of the impact damage depth and normal cumulative contact energy of the middle trough corresponding to the four influencing factors of the transverse laying roll angle, front lean angle, raw coal particle size, and chain layout and spacing under different horizontal conditions are obtained. Matrices of the impact damage depth and normal cumulative contact energy are separately established. Based on the respective factor layer, level and evaluation index weight matrices, a global weight matrix is finally obtained. The optimal combination of working conditions is obtained, and the weight of each factor on impact damage to the middle trough is determined by the weight coefficient. The accuracy of the simulation results is then verified in experiments. Among the considered factors, the raw coal particle size achieves the highest impact damage coefficient. When the raw coal particle size is the smallest (0.5 times the basic particle size), the transverse roll angle and front lean angle of the middle trough are positive (5 degrees and 10 degrees, respectively), the chain adopts the double-center chain arrangement, and minimal impact damage to the middle trough occurs. OMA reduces the test times to determine the optimal working conditions of a scraper conveyor.	[Yao, Yanping] Taiyuan Univ Sci & Technol, Taiyuan, Shanxi, Peoples R China; [Liu, Weili] Taiyuan Inst China Coal Technol & Engn Corp, Taiyuan, Shanxi, Peoples R China; [Gao, Zhipeng] XCMG Construct Machinery Co Ltd, Xuzhou, Jiangsu, Peoples R China	Taiyuan University of Science & Technology; XCMG Group	Yao, YP (corresponding author), Taiyuan Univ Sci & Technol, Taiyuan, Shanxi, Peoples R China.	yanpingyaocn@163.com			Key Research and Development Plan Project of Shanxi Province [201903D121079]; Scientific and Technological Achievement Transformation and Cultivation Project of the Colleges and University in Shanxi Province [2020CG043]; Research Project of Postgraduate Education Reform in Shanxi Province [2020YJJG253]; Shanxi Province Higher Education Reform and Innovation Project [J2020205]; University Doctoral Foundation [20202030]	Key Research and Development Plan Project of Shanxi Province; Scientific and Technological Achievement Transformation and Cultivation Project of the Colleges and University in Shanxi Province; Research Project of Postgraduate Education Reform in Shanxi Province; Shanxi Province Higher Education Reform and Innovation Project; University Doctoral Foundation	This project was subsidized by the Key Research and Development Plan Project of Shanxi Province (201903D121079), Scientific and Technological Achievement Transformation and Cultivation Project of the Colleges and University in Shanxi Province (2020CG043), Research Project of Postgraduate Education Reform in Shanxi Province (2020YJJG253), Shanxi Province Higher Education Reform and Innovation Project (J2020205), and University Doctoral Foundation (20202030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwaly EA, 2021, J PHARMACEUT BIOMED, V203, DOI 10.1016/j.jpba.2021.114175; Chen ZK, 2015, OPT LASER TECHNOL, V66, P166, DOI 10.1016/j.optlastec.2014.08.016; China University of Mining and Technology, 2017, A wear detection device and method for middle groove of scraper conveyor, Patent No. [CN201710224906.5[P], 2017102249065 2017102249065]; Curry DR., 2016, INT C DISCR EL METH, P1219; Gao ZP., 2021, THESIS TAIYUAN U SCI, DOI [10.3390/polym12030648, DOI 10.3390/POLYM12030648]; Ge SR, 2017, WEAR, V376, P1097, DOI 10.1016/j.wear.2017.01.015; Ghodki BM, 2019, COMPUT PART MECH, V6, P3, DOI 10.1007/s40571-018-0194-7; Grincova A, 2019, MEASUREMENT, V131, P362, DOI 10.1016/j.measurement.2018.09.003; Groger T, 2007, BULK SOLIDS HANDLING, V27, P17; Hu DG., 2015, THESIS CHINA U MININ; Jafari A, 2016, POWDER TECHNOL, V297, P126, DOI 10.1016/j.powtec.2016.04.008; Mangwandi C, 2007, CHEM ENG SCI, V62, P437, DOI 10.1016/j.ces.2006.08.063; [毛君 Mao Jun], 2018, [机械设计, Journal of Machine Design], V35, P47; Oldal I, 2015, J MECH SCI TECHNOL, V29, P3789, DOI 10.1007/s12206-015-0825-3; Osa JL, 2016, INT J MACH TOOL MANU, V110, P43, DOI 10.1016/j.ijmachtools.2016.07.004; Reid AW, 2014, J DYN SYST-T ASME, V136, DOI 10.1115/1.4026326; Sardar S, 2018, MEASUREMENT, V127, P42, DOI 10.1016/j.measurement.2018.05.090; Shi ZY, 2017, WEAR, V380-381, P36, DOI 10.1016/j.wear.2017.03.005; Sinha R, 2018, ARCH METALL MATER, V63, P359, DOI 10.24425/118948; Sun YL, 2016, MATER DESIGN, V89, P215, DOI 10.1016/j.matdes.2015.09.109; Walker P, 2019, ADV INTELL SYST, V835, P633, DOI 10.1007/978-3-319-97490-3_60; Wang HC., 2012, CHINESE J GEOPHYS, V55, P733; Wang Yuan, 2019, Industry and Mine Automation, V45, P19, DOI 10.13272/j.issn.1671-251x.2018120073; Xia R, 2019, MATH PROBL ENG, V2019, P1; Xia R., 2019, THESIS TAIYUAN U TEC; Yang HT, 2016, J INNER MONGOLIA U N, V31, P465; Yang XB, 2018, IOP C SERIES MAT SCI, V397, P012; Yao YP, 2021, COAL MINE MACHINERY, V42, P35; Zhang J, 2017, J MATER SCI TECHNOL, V33, P645, DOI 10.1016/j.jmst.2016.11.014; Zhang YJ, 2016, ENERG POLICY, V96, P534, DOI 10.1016/j.enpol.2016.06.033	30	0	0	6	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266831	10.1371/journal.pone.0266831	http://dx.doi.org/10.1371/journal.pone.0266831			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7MW	35436300	gold, Green Published			2022-12-26	WOS:000791258900032
J	Marsango, S; Ward, RJ; Jenkins, L; Butcher, AJ; Al Mahmud, Z; Dwomoh, L; Nagel, F; Schulz, S; Tikhonova, IG; Tobin, AB; Milligan, G				Marsango, Sara; Ward, Richard J.; Jenkins, Laura; Butcher, Adrian J.; Al Mahmud, Zobaer; Dwomoh, Louis; Nagel, Falko; Schulz, Stefan; Tikhonova, Irina G.; Tobin, Andrew B.; Milligan, Graeme			Selective phosphorylation of threonine residues defines GPR84-arrestin interactions of biased ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR; GPR84; AGONISTS	GPR84 is an immune cell-expressed, proinflammatory receptor currently being assessed as a therapeutic target in conditions including fibrosis and inflammatory bowel disease. Although it was previously shown that the orthosteric GPR84 activators 2-HTP and 6-OAU promoted its interactions with arrestin-3, a G protein-biased agonist DL 175 did not. Here, we show that replacement of all 21 serine and threonine residues within i-loop 3 of GPR84, but not the two serines in the C-terminal tail, eliminated the incorporation of [P-32] and greatly reduced receptor- arrestin-3 interactions promoted by 2-HTP. GPR84 was phosphorylated constitutively on residues Ser(221) and Ser(224), while various other amino acids are phosphorylated in response to 2-HTP. Consistent with this, an antiserum able to identify pSer(221)/pSer(224 )recognized GPR84 from cells treated with and without activators, whereas an antiserum able to identify pThr(263)/pThr(264) only recognized GPR84 after exposure to 2-HTP and not DL-175. Two distinct GPR84 antagonists as well as inhibition of G protein- coupled receptor kinase 2/3 prevented phosphorylation of pThr(263)/pThr(264), but neither strategy affected constitutive phosphorylation of Ser(221)/Ser(224). Furthermore, mutation of residues Thr263 and Thr264 to alanine generated a variant of GPR84 also limited in 2-HTP-induced interactions with arrestin-2 and-3. By contrast, this mutant was unaffected in its capacity to reduce cAMP levels. Taken together, these results define a key pair of threonine residues, regulated only by subsets of GPR84 small molecule activators and by GRK2/3 that define effective interactions with arrestins and provide novel tools to monitor the phosphorylation and functional status of GPR84.	[Marsango, Sara; Ward, Richard J.; Jenkins, Laura; Al Mahmud, Zobaer; Dwomoh, Louis; Tobin, Andrew B.; Milligan, Graeme] Univ Glasgow, Inst Mol, Coll Med, Ctr Translat Pharmacol, Glasgow City, Scotland; [Butcher, Adrian J.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Nagel, Falko; Schulz, Stefan] 7TM Antibodies GmbH, Jena, Germany; [Schulz, Stefan] Univ Hosp Jena, Inst Pharmacol & Toxicol, Jena, Germany; [Tikhonova, Irina G.] Queens Univ Belfast, Med Biol Ctr, Sch Pharm, Belfast, North Ireland	University of Glasgow; University of Cambridge; Friedrich Schiller University of Jena; Queens University Belfast	Milligan, G (corresponding author), Univ Glasgow, Inst Mol, Coll Med, Ctr Translat Pharmacol, Glasgow City, Scotland.	Graeme.Milligan@glasgow.ac.uk		Dwomoh, Louis/0000-0001-7024-6450	Biotechnology and Biosciences Research Council [BB/T000562/1, BB/R007101/1]; Medical Research Council [MC_PC_17160, EP/T022175/1]; ORBIT (Opportunities in Receptor Biology for Industrial Translation) grant from Sosei-Heptares; European COST Action [CA18133]	Biotechnology and Biosciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ORBIT (Opportunities in Receptor Biology for Industrial Translation) grant from Sosei-Heptares; European COST Action	This work was funded by each of the Biotechnology and Biosciences Research Council (grant reference BB/T000562/1) to G. M. and A. B. T., and grant reference BB/R007101/1 to I. G. T., an ORBIT (Opportunities in Receptor Biology for Industrial Translation) grant from Sosei-Heptares to G. M. and A. B. T., and the Medical Research Council (Confidence in Concept, grant number MC_PC_17160 [to G. M.] ) . This project made use of computational time on Kelvin-2 (grant no. EP/T022175/1) G. M., A. B. T., and I. G. T. participate in the European COST Action CA18133 (ERNEST) .	Al Mahmud Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18159-3; Butcher AJ, 2016, J BIOL CHEM, V291, P8862, DOI 10.1074/jbc.M115.681726; Butcher AJ, 2014, J BIOL CHEM, V289, P18451, DOI 10.1074/jbc.M114.568816; Cao YB, 2019, METHODS MOL BIOL, V1957, P59, DOI 10.1007/978-1-4939-9158-7_3; Chen LH, 2020, J MED CHEM, V63, P15399, DOI 10.1021/acs.jmedchem.0c01378; Divorty N, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2022.101655; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gaidarov I, 2018, PHARMACOL RES, V131, P185, DOI 10.1016/j.phrs.2018.02.021; Glide, 2020, MACROMODEL SCHROD RE, DOI DOI 10.1021/jm0306430; Gurevich VV, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00125; Jenkins L, 2021, ACS PHARMACOL TRANSL, V4, P1598, DOI 10.1021/acsptsci.1c00151; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kliewer A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08162-1; Kliewer A, 2017, TRENDS PHARMACOL SCI, V38, P621, DOI 10.1016/j.tips.2017.04.002; Kose M, 2020, J MED CHEM, V63, P2391, DOI 10.1021/acs.jmedchem.9b01339; Kryshtafovych A, 2021, PROTEINS, V89, P1607, DOI 10.1002/prot.26237; Liu J, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0156-0; Liu Y, 2016, ACS MED CHEM LETT, V7, P579, DOI 10.1021/acsmedchemlett.6b00025; Lowe JD, 2015, MOL PHARMACOL, V88, P347, DOI 10.1124/mol.115.098293; Lucy D, 2019, ACS CHEM BIOL, V14, P2055, DOI 10.1021/acschembio.9b00533; Mancini SJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38539-1; Mann A, 2015, BRIT J PHARMACOL, V172, P311, DOI 10.1111/bph.12627; Marsango S, 2022, BRIT J PHARMACOL, V179, P3529, DOI 10.1111/bph.15248; Matthees ESF, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.687489; Milligan G, 2017, CHEM REV, V117, P67, DOI 10.1021/acs.chemrev.6b00056; Namkung Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12178; Nikaido Y, 2015, J BIOCHEM, V157, P311, DOI 10.1093/jb/mvu075; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pillaiyar T, 2018, ACS OMEGA, V3, P3365, DOI 10.1021/acsomega.7b02092; Pillaiyar T, 2017, J MED CHEM, V60, P3636, DOI 10.1021/acs.jmedchem.6b01593; Recio C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01419; Seyedabadi M, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11020218; Sulon Sarah M, 2021, Curr Opin Endocr Metab Res, V16, P56, DOI 10.1016/j.coemr.2020.09.002; Suzuki M, 2013, J BIOL CHEM, V288, P10684, DOI 10.1074/jbc.M112.420042; Takeda S, 2003, LIFE SCI, V74, P367, DOI 10.1016/j.lfs.2003.09.030; Thal DM, 2011, MOL PHARMACOL, V80, P294, DOI 10.1124/mol.111.071522; Tikhonova IG, 2017, HANDB EXP PHARMACOL, V236, P57, DOI 10.1007/164_2016_52; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Wanka L, 2022, BIOL CHEM, V403, P133, DOI 10.1515/hsz-2021-0128; Ward RJ, 2011, METHODS MOL BIOL, V746, P21, DOI 10.1007/978-1-61779-126-0_2; Wojciechowicz ML, 2020, NAT REV DRUG DISCOV, V19, P374, DOI 10.1038/d41573-020-00029-9; Zurkovsky L, 2017, NEUROPHARMACOLOGY, V121, P20, DOI 10.1016/j.neuropharm.2017.04.021	43	5	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101932	10.1016/j.jbc.2022.101932	http://dx.doi.org/10.1016/j.jbc.2022.101932			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T7QP	35427647	Green Published, Green Accepted, gold			2022-12-26	WOS:000804923000001
J	Qian, FH; Arner, BE; Kelly, KM; Annageldiyev, C; Sharma, A; Claxton, DF; Paulson, RF; Prabhu, KS				Qian, Fenghua; Arner, Brooke E.; Kelly, Kathleen M.; Annageldiyev, Charyguly; Sharma, Arati; Claxton, David F.; Paulson, Robert F.; Prabhu, K. Sandeep			Interleukin-4 treatment reduces leukemia burden in acute myeloid leukemia	FASEB JOURNAL			English	Article						AML; H-PGDS; IL-4; PPAR gamma; prostaglandin	CHRONIC LYMPHOCYTIC-LEUKEMIA; ENDOTHELIAL GROWTH-FACTOR; CANCER-CELLS; HODGKIN-LYMPHOMA; BREAST-CANCER; PPAR-GAMMA; APOPTOSIS; LIGAND; EXPRESSION; ACTIVATION	Interleukin-4 (IL-4) is a signature cytokine pivotal in Type 2 helper T cell (Th2) immune response, particularly in allergy and hypersensitivity. Interestingly, IL-4 increases endogenous levels of prostaglandin D-2 (PGD(2)) and its metabolites, Delta(12)-prostaglandin J(2) (Delta(12)-PGJ(2)) and 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)), collectively called cyclopentenone PGs (CyPGs). However, the therapeutic role of IL-4 in hematologic malignancies remains unclear. Here, we employed a murine model of acute myeloid leukemia (AML), where human MLL-AF9 fusion oncoprotein was expressed in hematopoietic progenitor cells, to test the effect of IL-4 treatment in vivo. Daily intraperitoneal treatment with IL-4 at 60 mu g/kg/d significantly alleviated the severity of AML, as seen by decreased leukemia-initiating cells (LICs). The effect of IL-4 was mediated, in part, by the enhanced expression of hematopoietic- PGD(2) synthase (H-PGDS) to effect endogenous production of CyPGs, through autocrine and paracrine signaling mechanisms. Similar results were seen with patient-derived AML cells cultured ex vivo with IL-4. Use of GW9662, a peroxisome proliferator-activated receptor gamma (PPAR gamma) antagonist, suggested endogenous CyPGs-PPAR gamma axis mediated p53-dependent apoptosis of LICs by IL-4. Taken together, our results reveal a beneficial role of IL-4 treatment in AML suggesting a potential therapeutic regimen worthy of clinical trials in patients with AML.	[Qian, Fenghua; Arner, Brooke E.; Kelly, Kathleen M.; Paulson, Robert F.; Prabhu, K. Sandeep] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Qian, Fenghua; Arner, Brooke E.; Kelly, Kathleen M.; Paulson, Robert F.; Prabhu, K. Sandeep] Penn State Univ, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA; [Qian, Fenghua; Arner, Brooke E.; Kelly, Kathleen M.; Paulson, Robert F.; Prabhu, K. Sandeep] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA; [Kelly, Kathleen M.] Penn State Univ, Dept Vet & Biomed Sci, Mammalian Pathol Sect, Anim Diagnost Lab, University Pk, PA 16802 USA; [Annageldiyev, Charyguly; Sharma, Arati; Claxton, David F.] Penn State Univ, Penn State Canc Inst, Div Hematol & Oncol, Coll Med, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Paulson, RF; Prabhu, KS (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA.	rfp5@psu.edu; ksprabhu@psu.edu			USDA \ National Institute of Food and Agriculture (NIFA) [4771]	USDA \ National Institute of Food and Agriculture (NIFA)	HHS vertical bar| National Institutes of Health (NIH), Grant/Award Number: DK077152; USDA vertical bar National Institute of Food and Agriculture (NIFA), Grant/Award Number: 4771	Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; AKASHI K, 1991, J CLIN INVEST, V88, P223, DOI 10.1172/JCI115281; AKASHI K, 1993, LEUKEMIA LYMPHOMA, V9, P205, DOI 10.3109/10428199309147371; Bankaitis KV, 2015, CLIN EXP METASTAS, V32, P847, DOI 10.1007/s10585-015-9747-9; Barrett AJ, 2020, BRIT J HAEMATOL, V188, P147, DOI 10.1111/bjh.16310; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; CHRISTHAZELHOF E, 1979, BIOCHIM BIOPHYS ACTA, V572, P43, DOI 10.1016/0005-2760(79)90198-X; DEFRANCE T, 1992, BLOOD, V79, P990; Finch ER, 2017, BLOOD, V129, P1802, DOI 10.1182/blood-2016-08-736405; Finch ER, 2015, CANCER PREV RES, V8, P989, DOI 10.1158/1940-6207.CAPR-15-0050; Food and Drug Administration, 2005, CTR DRUG EVAL RES CD, V7; Gandhi UH, 2011, J BIOL CHEM, V286, P27471, DOI 10.1074/jbc.M111.260547; GIVON T, 1992, BLOOD, V79, P2392; Grimwade D, 2001, BLOOD, V98, P1312, DOI 10.1182/blood.V98.5.1312; Han H, 2007, APOPTOSIS, V12, P2101, DOI 10.1007/s10495-007-0124-2; Hasegawa H, 2007, BLOOD, V110, P1664, DOI 10.1182/blood-2007-01-068981; Hegde S, 2011, BLOOD, V118, P6909, DOI 10.1182/blood-2010-11-317750; HERRMANN F, 1991, BLOOD, V78, P2070; Huaux F, 2005, AM J PATHOL, V167, P1485, DOI 10.1016/S0002-9440(10)61235-7; JANSEN JH, 1993, LEUKEMIA, V7, P643; Jordan CT, 2007, BEST PRACT RES CL HA, V20, P13, DOI 10.1016/j.beha.2006.10.005; Joukov V, 1996, EMBO J, V15, P290; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; Kawakami M, 2005, BLOOD, V105, P3707, DOI 10.1182/blood-2004-08-3216; Kim EH, 2008, CARCINOGENESIS, V29, P688, DOI 10.1093/carcin/bgm299; Kim S, 2021, J EXP CLIN CANC RES, V40, DOI 10.1186/s13046-021-01839-4; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kudva AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080622; Liang KW, 2017, CELL, V168, P59, DOI 10.1016/j.cell.2016.12.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundin J, 2001, BRIT J HAEMATOL, V112, P155, DOI 10.1046/j.1365-2141.2001.02525.x; LUO HY, 1991, J IMMUNOTHER, V10, P418, DOI 10.1097/00002371-199112000-00005; MANABE A, 1994, BLOOD, V83, P1731, DOI 10.1182/blood.V83.7.1731.bloodjournal8371731; Martinez PEP., 2014, BLOOD, V124, P2146; McKenna HJ, 1996, EXP HEMATOL, V24, P378; Mitchell K, 2018, J EXP MED, V215, P1709, DOI 10.1084/jem.20180147; Narayan N, 2017, LEUKEMIA, V31, P808, DOI 10.1038/leu.2016.279; Narayan N, 2018, EXP HEMATOL, V62, P1, DOI 10.1016/j.exphem.2018.03.007; Norris D., 2008, WHO CLASSIFICATION T, V2; Pena-Martinez P, 2018, LEUKEMIA, V32, P588, DOI 10.1038/leu.2017.261; PURI RK, 1994, INT J CANCER, V58, P574, DOI 10.1002/ijc.2910580421; Qian FH, 2019, CRIT REV BIOCHEM MOL, V54, P484, DOI 10.1080/10409238.2020.1717430; Scavelli C, 2004, LEUKEMIA, V18, P1054, DOI 10.1038/sj.leu.2403355; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; Shay AE, 2017, J BIOL CHEM, V292, P14544, DOI 10.1074/jbc.M117.785014; Shin SW, 2009, CLIN CANCER RES, V15, P5414, DOI 10.1158/1078-0432.CCR-08-3101; Slovak ML, 2000, BLOOD, V96, P4075, DOI 10.1182/blood.V96.13.4075; Stoddart A, 2014, BLOOD, V123, P1069, DOI 10.1182/blood-2013-07-517953; Tao M, 2001, LEUKEMIA LYMPHOMA, V41, P161, DOI 10.3109/10428190109057966; URADE Y, 1987, J BIOL CHEM, V262, P3820; Venmar KT, 2014, CANCER RES, V74, P4329, DOI 10.1158/0008-5472.CAN-14-0093; Volkert S, 2014, GENE CHROMOSOME CANC, V53, P402, DOI 10.1002/gcc.22151; Wang R, 2020, CANCER LETT, V469, P151, DOI 10.1016/j.canlet.2019.10.032; Wiernik PH, 2010, J IMMUNOTHER, V33, P1006, DOI 10.1097/CJI.0b013e3181f5dfc5; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0	56	2	2	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22328	10.1096/fj.202200251R	http://dx.doi.org/10.1096/fj.202200251R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0U0KS	35471732				2022-12-26	WOS:000787349100001
J	Schregel, J; Holthausen, JS; Sciascia, QL; Li, ZY; Gors, S; Eggert, A; Tuchscherer, A; Zentek, J; Metges, CC				Schregel, Johannes; Holthausen, Johannes Schulze; Sciascia, Quentin L.; Li, Zeyang; Goers, Solvig; Eggert, Anja; Tuchscherer, Armin; Zentek, Juergen; Metges, Cornelia C.			Effects of oral glutamine supplementation on jejunal morphology, development, and amino acid profiles in male low birth weight suckling piglets	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; SMALL-INTESTINE; PROTEIN-SYNTHESIS; NEONATAL PIGLETS; LEUKOCYTE SUBSETS; GUT; PERFORMANCE; METABOLISM; PIG; COLOSTRUM	Background It has been shown that small intestine development in low birth weight (LBW) piglets is impaired. Glutamine (Gln) has been reported to improve piglet health and intestinal function in weaned piglets, but data is scarce in suckling piglets. This study was conducted to investigate the effects of oral Gln supplementation compared to Alanine (Ala) on jejunal development and function in 5 and 12 d old male LBW and normal birth weight (NBW) suckling piglets. Results Gln had no effect on the jejunal morphology, development, tissue and digesta amino acid profiles and mRNA abundance of genes involved in amino acid transport, metabolism, glutathione synthesis in LBW piglets when compared to Ala supplementation and birth weight controls at 5 and 12 d. Only the concentration of Gln in jejunal tissue was higher in NBW piglets supplemented with Gln compared to Ala at 5 d (P < 0.05). A comparison of the birth weight groups showed no differences between LBW and NBW piglets at 5 and 12 d in any parameter. Jejunal crypt depth, villus height / width, tunica muscularis thickness, number of goblet and IgA positive cells, the ratio of jejunal RNA to DNA and the concentration of DNA, protein and RNA changed (P < 0.05) from 5 compared to 12 d. The concentrations of several free, and protein bound amino acids as well as amino metabolites differed between age groups in jejunal tissue but the digesta concentrations were affected to a lesser extent. Conclusions Oral Gln supplementation to suckling male piglets over the first 12 d of life was not associated with changes in jejunal parameters measured in this study. The absence of effects may indicate that Gln is absorbed as well as metabolized in the upper intestinal tract and thus could benefit intestinal development at a more proximal location.	[Schregel, Johannes; Sciascia, Quentin L.; Li, Zeyang; Goers, Solvig; Metges, Cornelia C.] Inst Nutr Physiol, Res Inst Farm Anim Biol FBN, Dummerstorf, Germany; [Holthausen, Johannes Schulze; Zentek, Juergen] Free Univ Berlin, Dept Vet Med, Inst Anim Nutr, Berlin, Germany; [Eggert, Anja; Tuchscherer, Armin] Inst Genet & Biometry, Res Inst Farm Anim Biol FBN, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Free University of Berlin; Forschungsinstitut fur Nutztierbiologie (FBN)	Metges, CC (corresponding author), Inst Nutr Physiol, Res Inst Farm Anim Biol FBN, Dummerstorf, Germany.	metges@fbn-dummerstorf.de		Schulze Holthausen, Johannes/0000-0002-8675-9258	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [ME 1420/10-1, 396713213, ZE 322/4-1]; FBN (Forschungsinstitut fur Nutztierbiologie)	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); FBN (Forschungsinstitut fur Nutztierbiologie)	Supported by a grant from the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG), grant number: ME 1420/10-1, project number 396713213; grant number: ZE 322/4-1, project number 396713213, and matched funding from the FBN (Forschungsinstitut fur Nutztierbiologie). https://www.dfg.de/https://www.fbn-dummerstorf.de/The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. There was no additional external funding received for this study.	Adeola O, 2006, J ANIM SCI, V84, P112, DOI 10.2527/2006.841112x; Al Masri S, 2015, J SWINE HEALTH PROD, V23, P186; ALLEN WD, 1973, IMMUNOLOGY, V24, P493; Arnaud AP, 2020, FASEB J, V34, P1430, DOI 10.1096/fj.201902514R; Barszcz M, 2011, J ANIM FEED SCI, V20, P3, DOI 10.22358/jafs/66152/2011; Baxter EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030318; Beaulieu AD, 2010, J ANIM SCI, V88, P2767, DOI 10.2527/jas.2009-2222; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertolo RFP, 1999, JPEN-PARENTER ENTER, V23, P47, DOI 10.1177/014860719902300247; Bevilacqua M, 2020, METABOLITES, V10, DOI 10.3390/metabo10070278; Buddington RK, 2001, AM J PHYSIOL-REG I, V280, pR241, DOI 10.1152/ajpregu.2001.280.1.R241; Burkey TE, 2009, J ANIM SCI, V87, P1493, DOI 10.2527/jas.2008-1330; BURRIN DG, 1995, PEDIATR RES, V37, P593, DOI 10.1203/00006450-199505000-00006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; BUTLER JE, 1981, VET IMMUNOL IMMUNOP, V2, P53, DOI 10.1016/0165-2427(81)90038-6; Cabrera RA, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-29; Che LQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157314; Chen JJ, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11092561; Collinder E, 2002, J VET MED A, V49, P203, DOI 10.1046/j.1439-0442.2002.00407.x; Cruzat V, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111564; D'Inca R, 2010, LIVEST SCI, V133, P20, DOI 10.1016/j.livsci.2010.06.015; Danicke S, 2006, TOXICOL LETT, V165, P297, DOI 10.1016/j.toxlet.2006.05.006; DARCYVRILLON B, 1994, PEDIATR RES, V36, P175, DOI 10.1203/00006450-199408000-00007; De Vos M, 2014, LIVEST SCI, V159, P165, DOI 10.1016/j.livsci.2013.11.012; DECHELOTTE P, 1991, AM J PHYSIOL, V260, pG677, DOI 10.1152/ajpgi.1991.260.5.G677; Duttlinger AW, 2019, J ANIM SCI, V97, P2035, DOI 10.1093/jas/skz098; Everaert N, 2017, ANIM FEED SCI TECH, V233, P89, DOI 10.1016/j.anifeedsci.2017.06.011; Ferenc K, 2018, J PHYSIOL PHARMACOL, V69, DOI 10.26402/jpp.2018.2.06; Ferenc K, 2017, DIS MARKERS, V2017, DOI 10.1155/2017/5238134; Ferrara F, 2017, J ANIM PHYSIOL AN N, V101, P531, DOI 10.1111/jpn.12490; Forder REA, 2007, POULTRY SCI, V86, P2396, DOI 10.3382/ps.2007-00222; German AJ, 1999, J COMP PATHOL, V120, P129, DOI 10.1053/jcpa.1998.0262; Getty CM, 2015, J ANIM SCI, V93, P5754, DOI 10.2527/jas.2015-9293; Godlewski M M, 2005, J Physiol Pharmacol, V56 Suppl 3, P7; Hales J, 2013, J ANIM SCI, V91, P4991, DOI 10.2527/jas.2012-5740; HAMPSON DJ, 1986, RES VET SCI, V40, P32, DOI 10.1016/S0034-5288(18)30482-X; Haynes TE, 2009, AMINO ACIDS, V37, P131, DOI 10.1007/s00726-009-0243-x; He WL, 2019, J ANIM SCI, V97, P68; He Y, 2019, J NUTR, V149, P1904, DOI 10.1093/jn/nxz155; Hedemann MS, 2006, J ANIM SCI, V84, P1375, DOI 10.2527/2006.8461375x; HIGASHIGUCHI T, 1993, JPEN-PARENTER ENTER, V17, P307, DOI 10.1177/0148607193017004307; Hornickel IN, 2011, ACTA HISTOCHEM, V113, P163, DOI 10.1016/j.acthis.2009.09.009; Hsu CB, 2012, ASIAN AUSTRAL J ANIM, V25, P674, DOI 10.5713/ajas.2011.11359; Huting AMS, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11020402; Huygelen V, 2015, LIVEST SCI, V182, P129, DOI 10.1016/j.livsci.2015.11.003; Ji FJ, 2019, ANIMAL, V13, P2727, DOI 10.1017/S1751731119001800; Jiang Q, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122617; Kuhla B, 2010, PROTEOMICS, V10, P2573, DOI 10.1002/pmic.200900789; Levine UY, 2013, APPL ENVIRON MICROB, V79, P3879, DOI 10.1128/AEM.00589-13; Li TT, 2021, J ANIM SCI BIOTECHNO, V12, DOI 10.1186/s40104-020-00538-y; Li ZY, 2022, BRIT J NUTR, V128, P2330, DOI 10.1017/S0007114522000459; Liu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091091; Luise D, 2019, J ANIM SCI BIOTECHNO, V10, DOI 10.1186/s40104-019-0380-3; Manso HECCC, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-2; Marchant JN, 2000, VET REC, V147, P209, DOI 10.1136/vr.147.8.209; MCELROY MC, 1992, BIOCHIM BIOPHYS ACTA, V1117, P153, DOI 10.1016/0304-4165(92)90073-4; Morise A, 2008, ANIMAL, V2, P73, DOI 10.1017/S175173110700095X; Mulisch M, 2010, ROMEIS MIKROSKOPISCH; Nebendahl C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076705; Pieper R, 2016, J ANIM SCI, V94, P989, DOI 10.2527/jas.2015-9942; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rasch I, 2019, J NUTR, V149, P432, DOI 10.1093/jn/nxy296; Rehfeldt C, 2011, J ANIM SCI, V89, P329, DOI 10.2527/jas.2010-2970; Rohart F, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005752; ROTHKOTTER HJ, 1991, PEDIATR RES, V29, P237, DOI 10.1203/00006450-199103000-00004; Sciascia Q, 2016, J ANIM SCI, V94, P441, DOI 10.2527/jas.2015-9788; Sciascia Q, 2013, J DAIRY SCI, V96, P2327, DOI 10.3168/jds.2012-6267; Sharma D, 2016, CLIN MED INSIGHTS-PE, V10, P67, DOI 10.4137/CMPed.S40070; Stoll B, 1998, J NUTR, V128, P606, DOI 10.1093/jn/128.3.606; Storey JD BA., 2021, QVALUE Q VALUE ESTIM; Stoy ACF, 2014, CLIN NUTR, V33, P322, DOI 10.1016/j.clnu.2013.05.013; Thongsong B, 2019, VET J, V247, P1, DOI 10.1016/j.tvjl.2019.02.006; Torchiano M., 2020, PACKAGE EFFSIZE; Tsao M, 1999, ANAL BIOCHEM, V269, P143, DOI 10.1006/abio.1998.3091; Van Ginneken C, 2002, DIGEST DIS SCI, V47, P868, DOI 10.1023/A:1014768806773; Waly N, 2001, J COMP PATHOL, V124, P172, DOI 10.1053/jcpa.2000.0450; Wang J, 2022, ANIM NUTR, V8, P216, DOI 10.1016/j.aninu.2021.07.009; Wang J, 2016, J ANIM SCI BIOTECHNO, V7, DOI 10.1186/s40104-016-0063-2; Wang JJ, 2008, J NUTR, V138, P1025, DOI 10.1093/jn/138.6.1025; Wang QY, 2018, CELL PHYSIOL BIOCHEM, V48, P2103, DOI 10.1159/000492552; Wang W, 2016, FASEB J, V30, P863, DOI 10.1096/fj.15-274779; Wang XQ, 2018, BRIT J NUTR, V119, P734, DOI [10.1017/S0007114518000375, 10.1017/s0007114518000375]; Windmueller HG., 1984, GLUTAMINE METABOLISM; Wiyaporn M, 2013, LIVEST SCI, V158, P215, DOI 10.1016/j.livsci.2013.10.016; Wu G, 2011, J ANIM SCI, V89, P2017, DOI 10.2527/jas.2010-3614; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; WU GY, 1994, J NUTR, V124, P415, DOI 10.1093/jn/124.3.415; Wu GY, 1996, J NUTR, V126, P2578, DOI 10.1093/jn/126.10.2578; WU GY, 1995, AM J PHYSIOL-REG I, V268, pR334; Xi PB, 2012, J NUTR BIOCHEM, V23, P1012, DOI 10.1016/j.jnutbio.2011.05.009; XU RJ, 1994, J PEDIATR GASTR NUTR, V18, P231, DOI 10.1097/00005176-199402000-00018; Yi D, 2015, AMINO ACIDS, V47, P65, DOI 10.1007/s00726-014-1842-8; Yi GF, 2005, J ANIM SCI, V83, P634; Yin J, 2013, FREE RADICAL RES, V47, P1027, DOI 10.3109/10715762.2013.848277; Yoo SS, 1997, J NUTR, V127, P2253, DOI 10.1093/jn/127.11.2253; Zhang J, 2017, ACTA AGR SCAND A-AN, V67, P15, DOI 10.1080/09064702.2017.1333133; Zhao YL, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10111976; Zhou H, 2021, J ANIM SCI BIOTECHNO, V12, DOI 10.1186/s40104-021-00581-3; Zhu YH, 2017, AM J PHYSIOL-GASTR L, V312, pG434, DOI 10.1152/ajpgi.00020.2017	99	1	1	10	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267357	10.1371/journal.pone.0267357	http://dx.doi.org/10.1371/journal.pone.0267357			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476806	gold, Green Published			2022-12-26	WOS:000840124300035
J	Wu, JQ; Shen, S; Liu, TQ; Ren, XF; Zhu, C; Liang, QY; Cui, X; Chen, L; Cheng, P; Cheng, W; Wu, AH				Wu, Jianqi; Shen, Shuai; Liu, Tianqi; Ren, Xiufang; Zhu, Chen; Liang, Qingyu; Cui, Xiao; Chen, Ling; Cheng, Peng; Cheng, Wen; Wu, Anhua			Chemerin enhances mesenchymal features of glioblastoma by establishing autocrine and paracrine networks in a CMKLR1-dependent manner	ONCOGENE			English	Article							KAPPA-B; MICROARRAY DATA; RECEPTOR CCRL2; RNA-SEQ; CANCER; CELLS; EXPRESSION; GPR1; MACROPHAGES; PROGRESSION	Glioblastoma multiforme (GBM) with mesenchymal features exhibits enhanced chemotherapeutic resistance and results in reduced overall survival. Recent studies have suggested that there is a positive correlation between the GBM mesenchymal status and immune cell infiltration. However, the mechanisms by which GBM acquires its mesenchymal features in a tumor immune microenvironment-dependent manner remains unknown. Here, we uncovered a chemerin-mediated autocrine and paracrine network by which the mesenchymal phenotype of GBM cells is strengthened. We identified chemerin as a prognostic secretory protein mediating the mesenchymal phenotype-promoting network between tumor-associated macrophages (TAMs) and tumor cells in GBM. Mechanistically, chemerin promoted the mesenchymal features of GBM by suppressing the ubiquitin-proteasomal degradation of CMKLR1, a chemerin receptor predominantly expressed on TAMs and partially expressed on GBM cells, thereby enhancing NF-kappa B pathway activation. Moreover, chemerin was found to be involved in the recruitment of TAMs in the GBM tumor microenvironment. We revealed that chemerin also enhances the mesenchymal phenotype-promoting ability of TAMs and promotes their M2 polarization via a CMKLR1/NF-kappa B axis, which further exacerbates the mesenchymal features of GBM. Blocking the chemerin/CMKLR1 axis with 2-(alpha-naphthoyl) ethyltrimethylammonium iodide disrupted the mesenchymal network and suppressed tumor growth in GBM. These results suggest the therapeutic potential of targeting the chemerin/CMKLR1 axis to block the mesenchymal network in GBM.	[Wu, Jianqi; Shen, Shuai; Liu, Tianqi; Zhu, Chen; Liang, Qingyu; Cui, Xiao; Cheng, Peng; Cheng, Wen; Wu, Anhua] China Med Univ, Hosp 1, Dept Neurosurg, Shenyang, Peoples R China; [Ren, Xiufang] China Med Univ, Hosp 1, Dept Pathol, Shenyang, Peoples R China; [Chen, Ling] Chinese Peoples Liberat Army China PLA, Gen Hosp, Inst Neurosurg Chinese PLA, Med Sch Chinese PLA,Dept Neurosurg, Beijing, Peoples R China	China Medical University; China Medical University	Cheng, W; Wu, AH (corresponding author), China Med Univ, Hosp 1, Dept Neurosurg, Shenyang, Peoples R China.	cmu071207@163.com; ahwu@cmu.edu.cn						Achyut BR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14079-4; Al Delbany D, 2021, CANCERS, V13, DOI 10.3390/cancers13195000; Baj T, 2018, RECENT PATENTS INFLA, V12, P69, DOI [10.2174/1872213X12666180703163824, 10.2174/1872213x12666180703163824]; Bao ZS, 2014, GENOME RES, V24, P1765, DOI 10.1101/gr.165126.113; Barberi T, 2018, CANCER IMMUNOL IMMUN, V67, P1491, DOI 10.1007/s00262-018-2184-2; Baumert BG, 2016, LANCET ONCOL, V17, P1521, DOI 10.1016/S1470-2045(16)30313-8; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Cahill KE, 2016, NEURO-ONCOLOGY, V18, P329, DOI 10.1093/neuonc/nov265; Chen ZH, 2017, CANCER RES, V77, P2266, DOI 10.1158/0008-5472.CAN-16-2310; Cheng W, 2017, J NEUROSURG, V126, P249, DOI 10.3171/2015.11.JNS15432; Cheng W, 2016, NEUROLOGY, V86, P2226, DOI 10.1212/WNL.0000000000002770; Darmanis S, 2017, CELL REP, V21, P1399, DOI 10.1016/j.celrep.2017.10.030; Del Prete A, 2017, BLOOD, V130, P1223, DOI 10.1182/blood-2017-04-777680; DeNardo DG, 2019, NAT REV IMMUNOL, V19, P369, DOI 10.1038/s41577-019-0127-6; Dimitriadis Georgios K, 2018, Oncotarget, V9, P16678, DOI 10.18632/oncotarget.24659; Dongre A, 2019, NAT REV MOL CELL BIO, V20, P69, DOI 10.1038/s41580-018-0080-4; Dubois-Vedrenne Ingrid, 2021, Oncotarget, V12, P1903, DOI 10.18632/oncotarget.28056; El-Sagheer G, 2018, BREAST CANCER-TARGET, V10, P169, DOI 10.2147/BCTT.S178181; Engler JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043339; Fedele M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112746; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Goralski KB, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194778; Graham KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112925; Guo Deliang, 2013, CNS Oncol, V2, P289; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Hoffmann M, 2018, TOXICOL LETT, V291, P61, DOI 10.1016/j.toxlet.2018.04.004; Huang C, 2020, MOL THER-ONCOLYTICS, V18, P602, DOI 10.1016/j.omto.2020.08.013; Huang JF, 2010, BMB REP, V43, P491, DOI 10.5483/BMBRep.2010.43.7.491; Jacenik D, 2020, CLIN CHIM ACTA, V504, P146, DOI 10.1016/j.cca.2020.02.008; Ji ZS, 2022, CELL BIOL TOXICOL, V38, P611, DOI 10.1007/s10565-021-09636-7; Jia QZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07767-w; Kiczmer P, 2020, EXP MOL PATHOL, V113, DOI 10.1016/j.yexmp.2020.104377; Kumar JD, 2016, BRIT J CANCER, V114, P1152, DOI 10.1038/bjc.2016.93; Kumar JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104877; Kumar V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43428-8; Kusne Y, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005196; Li JJ, 2018, BRIT J CANCER, V118, P1337, DOI 10.1038/s41416-018-0077-y; Li M, 2021, ARCH PHARM RES, V44, P194, DOI 10.1007/s12272-021-01311-z; Liang QY, 2021, THERANOSTICS, V11, P9884, DOI 10.7150/thno.63202; Lin Y, 2017, ONCOGENE, V36, P3599, DOI 10.1038/onc.2016.516; Long PM, 2015, J CELL PHYSIOL, V230, P1929, DOI 10.1002/jcp.24927; Lu YB, 2020, TECHNOL CANCER RES T, V19, DOI 10.1177/1533033820948053; Man JH, 2018, CELL STEM CELL, V22, P104, DOI 10.1016/j.stem.2017.10.005; Muller S, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1362-4; Neftel C, 2019, CELL, V178, P835, DOI 10.1016/j.cell.2019.06.024; Pachynski RK, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00983; Pachynski RK, 2012, J EXP MED, V209, P1427, DOI 10.1084/jem.20112124; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Pozniak PD, 2014, J NEUROIMMUNE PHARM, V9, P133, DOI 10.1007/s11481-013-9517-x; Quail DF, 2017, CANCER CELL, V31, P326, DOI 10.1016/j.ccell.2017.02.009; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Regan-Komito D, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01621; Rennier K, 2020, CLIN CANCER RES, V26, P5019, DOI 10.1158/1078-0432.CCR-19-4245; Rourke JL, 2015, MOL CELL ENDOCRINOL, V417, P36, DOI 10.1016/j.mce.2015.09.002; Rourke JL, 2014, J ENDOCRINOL, V222, P201, DOI 10.1530/JOE-14-0069; Schioppa T, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.615031; Schmitt MJ, 2021, CANCER DISCOV, V11, P754, DOI 10.1158/2159-8290.CD-20-0219; Segerman A, 2016, CELL REP, V17, P2994, DOI 10.1016/j.celrep.2016.11.056; Sielska M, 2013, J PATHOL, V230, P310, DOI 10.1002/path.4192; Su X, 2021, CLIN CHIM ACTA, V517, P41, DOI 10.1016/j.cca.2021.02.010; Tong N, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.706286; Treeck O, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153750; Tummler C, 2017, ONCOTARGET, V8, P95135, DOI 10.18632/oncotarget.19619; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang CH, 2014, PEPTIDES, V51, P131, DOI 10.1016/j.peptides.2013.10.009; Wang GY, 2022, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.798837; Wang QH, 2018, CANCER CELL, V33, P152, DOI 10.1016/j.ccell.2017.12.012; Wang QH, 2017, CANCER CELL, V32, P42, DOI 10.1016/j.ccell.2017.06.003; Wang SC, 2012, LAB INVEST, V92, P151, DOI 10.1038/labinvest.2011.128; Wang Y, 2019, J CELL BIOCHEM, V120, P6459, DOI 10.1002/jcb.27936; Wei J, 2020, NEURO-ONCOLOGY, V22, P180, DOI 10.1093/neuonc/noz212; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Woroniecka KI, 2018, CLIN CANCER RES, V24, P3792, DOI 10.1158/1078-0432.CCR-18-0047; Xu CH, 2017, ONCOTARGET, V8, P22483, DOI 10.18632/oncotarget.14956; Xue GD, 2012, CANCER DISCOV, V2, P248, DOI 10.1158/2159-8290.CD-11-0270; Yamini B, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7090125; Yang YL, 2018, REPROD BIOL ENDOCRIN, V16, P1, DOI 10.1186/s12958-018-0363-9; Ye XZ, 2012, J IMMUNOL, V189, P444, DOI 10.4049/jimmunol.1103248; Ye YS, 2021, J PERIODONTOL, V92, P1470, DOI 10.1002/JPER.20-0675; Zabel BA, 2008, J EXP MED, V205, P2207, DOI 10.1084/jem.20080300; Zhang CB, 2017, CLIN CANCER RES, V23, P6279, DOI 10.1158/1078-0432.CCR-16-2598; Zhang RL, 2020, INT J MED MICROBIOL, V310, DOI 10.1016/j.ijmm.2020.151416; Zhang ZP, 2020, CANCER IMMUNOL RES, V8, P966, DOI 10.1158/2326-6066.CIR-19-0759; Zhu L, 2021, LIFE SCI, V278, DOI 10.1016/j.lfs.2021.119530	87	0	0	2	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 20	2022	41	21					3024	3036		10.1038/s41388-022-02295-w	http://dx.doi.org/10.1038/s41388-022-02295-w		APR 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	1L8MU	35459783	hybrid, Green Published			2022-12-26	WOS:000787474100001
J	Bihan, DG; Rydzak, T; Wyss, M; Pittman, K; McCoy, KD; Lewis, IA				Bihan, Dominique G.; Rydzak, Thomas; Wyss, Madeleine; Pittman, Keir; McCoy, Kathy D.; Lewis, Ian A.			Method for absolute quantification of short chain fatty acids via reverse phase chromatography mass spectrometry	PLOS ONE			English	Article							LC-MS; GUT MICROBIOTA; METABOLITES; HEALTH; FECES; MICE; DIET	Short chain fatty acids (SCFAs; including acetate, propionate, and butyrate) are an important class of biological molecules that play a major role in modulating host-microbiome interactions. Despite significant research into SCFA-mediated biological mechanisms, absolute quantification of these molecules in their native form by liquid chromatography mass spectrometry is challenging due to their relatively poor chromatographic properties. Herein, we introduce SQUAD, an isotope-based strategy for absolute quantification of SCFAs in complex biological samples. SQUAD uses aniline derivatization in conjunction with isotope dilution and analysis by reverse-phase liquid chromatography mass spectrometry. We show that SQUAD enables absolute quantification of biologically relevant SCFAs in complex biological samples with a lower limit of detection of 40 nM and a lower limit of quantification ranging from 160 nM to 310 nM. We observed an intra- and inter-day precision under 3% (relative standard deviation) and errors in intra- and inter-day accuracy under 10%. To demonstrate this quantification strategy, we analyzed SCFAs in the caecal contents of germ free versus conventionally raised specific pathogen free (SPF) mice. We showed that acetate was the most abundant SCFA in both types of mice and was present at 200-fold higher concentration in the SPF mice. We also illustrated the use of our quantification strategy in in vitro microbial cultures from five different species of bacteria grown in Mueller Hinton media. This study illustrates the diverse SCFA production rates across microbial taxa with acetate production serving as one of the key differentiating factors across the species. In summary, we introduce an isotope dilution strategy for absolute quantification of aniline-dativized SCFAs and illustrate the utility of this approach for microbiome research.	[Bihan, Dominique G.; Rydzak, Thomas; Pittman, Keir; Lewis, Ian A.] Univ Calgary, Dept Biol Sci, Calgary, AB, Canada; [Wyss, Madeleine; McCoy, Kathy D.] Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Dept Physiol & Pharmacol, Calgary, AB, Canada	University of Calgary; University of Calgary	Lewis, IA (corresponding author), Univ Calgary, Dept Biol Sci, Calgary, AB, Canada.	ian.lewis2@ucalgary.ca			Natural Sciences and Engineering Research Council [DG 04547]; Canadian Institute for Health Research [10024122]; International Microbiome Centre; IMPACTT Microbiome Research Core (CIHR) [IMC-161484]; Eyes-High Postdoctoral Fellowship from the University of Calgary; Canada Foundation for Innovation John R. Evans Leadership Fund [34986]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); International Microbiome Centre; IMPACTT Microbiome Research Core (CIHR)(Canadian Institutes of Health Research (CIHR)); Eyes-High Postdoctoral Fellowship from the University of Calgary; Canada Foundation for Innovation John R. Evans Leadership Fund	I.A.L. is supported by the Natural Sciences and Engineering Research Council (DG 04547; www.nserc-crsng.gc.ca), the Canadian Institute for Health Research (10024122, www.cihr-irsc.gc.ca), and holds an Alberta Innovates Translational Health Chair (www.albertainnovates.ca).I.A.L.and K.D.M. are both supported by the International Microbiome Centre (https://imc. ucalgary.ca/), and the IMPACTT Microbiome Research Core (CIHR IMC-161484; www.impacttmicrobiome.ca).T.R.is supported by an Eyes-High Postdoctoral Fellowship from the University of Calgary (www.ucalgary.ca).Metabolomics data were acquired at the Calgary Metabolomics Research Facility, which is supported by the International Microbiome Centre and the Canada Foundation for Innovation John R. Evans Leadership Fund (34986; www.innovation.ca).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazanella M, 2017, AM J CLIN NUTR, V106, P1274, DOI 10.3945/ajcn.117.157529; Bruheim P, 2013, J CHROMATOGR A, V1296, P196, DOI 10.1016/j.chroma.2013.03.072; Chan JCY, 2017, J PHARMACEUT BIOMED, V138, P43, DOI 10.1016/j.jpba.2017.01.044; Ciccimaro E, 2010, BIOANALYSIS, V2, P311, DOI 10.4155/BIO.09.185; Clasquin Michelle F, 2012, Curr Protoc Bioinformatics, VChapter 14, DOI 10.1002/0471250953.bi1411s37; Cook SI, 1998, ALIMENT PHARM THER, V12, P499, DOI 10.1046/j.1365-2036.1998.00337.x; Cornejo-Pareja I, 2019, EUR J CLIN NUTR, V72, P26, DOI 10.1038/s41430-018-0306-8; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Fleissner CK, 2010, BRIT J NUTR, V104, P919, DOI 10.1017/S0007114510001303; Han J, 2015, ANAL CHIM ACTA, V854, P86, DOI 10.1016/j.aca.2014.11.015; HOVERSTAD T, 1986, J NUTR, V116, P1772, DOI 10.1093/jn/116.9.1772; Lewis IA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004085; MCGRATH LT, 1992, ANAL BIOCHEM, V207, P227, DOI 10.1016/0003-2697(92)90004-Q; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; Probert CSJ, 2004, GUT, V53, P58, DOI 10.1136/gut.53.1.58; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Saha S, 2021, MOLECULES, V26, DOI 10.3390/molecules26216444; Wichmann A, 2013, CELL HOST MICROBE, V14, P582, DOI 10.1016/j.chom.2013.09.012; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Xu W, 2015, ANAL CHEM, V87, P829, DOI 10.1021/ac503619q; Yang WC, 2008, ANAL CHEM, V80, P9508, DOI 10.1021/ac801693c; Zeng MF, 2018, J CHROMATOGR B, V1083, P137, DOI 10.1016/j.jchromb.2018.02.040; Zhao GH, 2006, BIOMED CHROMATOGR, V20, P674, DOI 10.1002/bmc.580; Zheng XJ, 2013, METABOLOMICS, V9, P818, DOI 10.1007/s11306-013-0500-6; Zhou B, 2012, MOL BIOSYST, V8, P470, DOI 10.1039/c1mb05350g	26	4	4	7	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0267093	10.1371/journal.pone.0267093	http://dx.doi.org/10.1371/journal.pone.0267093			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35443015	gold, Green Published			2022-12-26	WOS:000822608900040
J	Abebe, D; Tsegaw, A				Abebe, Dagmawi; Tsegaw, Asamere			Pattern of vitreo-retinal diseases at University of Gondar tertiary eye care and training center, North-West Ethiopia	PLOS ONE			English	Article							RETINAL DISEASES; PREVALENCE; SPECTRUM	ObjectiveVitreoretinal diseases are common causes of ocular morbidities and blindness. Data on the spectrum of vitreoretinal diseases needs to be studied and known in order to establish appropriate vitreoretinal care setups. The aim of this study was to determine the patterns of vitreoretinal diseases among patients who visited the vitreoretina clinic of University of Gondar Tertiary Eye Care and Training Center, NW Ethiopia (UoG-TECTC). MethodologyA hospital based cross sectional study was conducted from October/2017-September/2018. All patients who visited the vitreoretinal clinic for the first time during the study period were studied. Data were collected with standardized data extraction format entered into SPSS statistical package Version 20 and analyzed. ResultA total of 739 new patients who visited the vitreoretinal clinic were included in the study. The mean age was 50.26 +/- 19 years. The age group between 21-60 years accounted for 59.7% of study patients. Male's accounted for 63.1% and 58.7% of the participants were from urban areas. Bilateral disease was diagnosed in 504 (68.2%) of patients and 220 (29.7%) were bilaterally blind at presentation. Three hundred eighty nine (52.6%) of them had duration of illness six months and above.Diabetic Retinopathy (DR), Age Related Macular Degeneration (AMD) and Rhegmatoginous Retinal Detachment (RRD) were the top three retinal diseases accounting for 21.3%(196), 17.3% (128) and 12.4% (92) of diagnoses respectively. Systemic comorbidities were found in 44% (325) of the patients with diabetes mellitus, hypertension and hyperlipidemia being the commonest, occurring in 27.8%, 6.3% and 2.8% of study patients respectively. Cataract was the commonest ocular comorbidity seen in 33.5% of study participants. ConclusionVitreoretinal diseases affected a significant number of patients presented to our center and most of the study patients presented late with significant vision loss and blindness. Males were affected more than females and the age group between 21-60 years accounted nearly two-third of study patients. This is the working age group suffering from vision loss from vitreoretinal diseases. DR, AMD and RRD were the commonest retinal pathologies accounting for nearly half of the vitreoretinal diseases and these conditions are treatable either surgically or medically. However, available facilities for the management of these diseases are not adequate at the center. Strengthening the vitreoretinal services of UoG-TECTC with relevant equipment is recommended.	[Abebe, Dagmawi; Tsegaw, Asamere] Univ Gondar, Coll Med & Hlth Sci, Dept Ophthalmol, Gondar, Ethiopia	University of Gondar	Tsegaw, A (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Dept Ophthalmol, Gondar, Ethiopia.	asameret@yahoo.com						[Anonymous], 2003, Community Eye Health, V16, P19; Brilliant GEP R. P., 1981, EPIDEMIOLOGY BLINDNE; Chauhan A., 2016, J MED SCI CLIN RES, V4; Eze BI, 2010, MIDDLE EAST AFR J OP, V17, P246, DOI 10.4103/0974-9233.65491; Fijalkowski N, 2013, OSLI RETINA, V44, P133, DOI 10.3928/23258160-20130313-06; Furtado JM, 2012, SURV OPHTHALMOL, V57, P149, DOI 10.1016/j.survophthal.2011.07.002; Hatef E, 2008, RETINA-J RET VIT DIS, V28, P755, DOI 10.1097/IAE.0b013e3181613463; Khan A., 2011, PAK J OPHTHALMOL, V27, P155; Li JQ., 2017, RETINAL DISEASESIN E; Nwosu S N, 2000, Ophthalmic Epidemiol, V7, P41, DOI 10.1076/0928-6586(200003)7:1;1-2;FT041; Onakpoya OH, 2008, J NATL MED ASSOC, V100, P1286, DOI 10.1016/S0027-9684(15)31506-6; Teshome T, 2004, ETHIOPIAN MED J, V42, P185; Thapa SS, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-9; Thapa SS, 2011, BMC OPHTHALMOL, V11, DOI 10.1186/1471-2415-11-2; Uhumwangho O M, 2015, J West Afr Coll Surg, V5, P1	15	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267425	10.1371/journal.pone.0267425	http://dx.doi.org/10.1371/journal.pone.0267425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446916	gold, Green Published			2022-12-26	WOS:000795468200028
J	Almeida, VM; Loria, JP; Marana, SR				Almeida, Vitor M.; Loria, J. Patrick; Marana, Sandro R.			A simple method to determine changes in the affinity between HisF and HisH in the Imidazole Glycerol Phosphate Synthase heterodimer	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MILLISECOND MOTIONS; PATHWAY	The bi-enzyme HisF-HisH heterodimer is part of the pathway that produces histidine and purines in bacteria and lower eukaryotes, but it is absent in mammals. This heterodimer has been largely studied probing the basis of the allosteric effects and the structural stability in proteins. It is also a potential target for antibacterial drugs. In this work, we developed a simple method to evaluate changes in the affinity between HisF and HisH in the heterodimer of the bacteria Thermotoga maritima. HisH contains a single tryptophan residue, which is exposed in the free protein, but buried in the heterodimer interface. Hence, the intrinsic fluorescence maximum of this residue changes to shorter wavelengths upon dimerization. Thus, we used the fluorescence intensity at this shorter wavelength to monitor heterodimer accumulation when HisH was combined with sub-stoichiometric HisF. Under conditions where the HisF-HisH heterodimer is in equilibrium with the free states of these enzymes, when [HisH] > [HisF], we deduced a linear function connecting [HisF-HisH] to [HisF], in which the slope depends on the heterodimer dissociation constant (K-d). Based on this equation, taking fluorescence intensities as proxies of the heterodimer and HisF concentrations, we experimentally determined the K-d at four different temperatures. These K-d values were compared to those evaluated using ITC. Both methods revealed an increase in the HisF and HisH binding affinity as the temperature increases. In spite of differences in their absolute values, the K-d determined using these methods presented an evident linear correlation. To demonstrate the effectiveness of the fluorescence method we determined the effect on the K-d caused by 12 single mutations in HisF. Coherently, this test singled out the only mutation in the binding interface. In brief, the method described here effectively probes qualitative effects on the K-d, can be carried out using common laboratory equipment and is scalable.	[Almeida, Vitor M.; Marana, Sandro R.] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, SP, Brazil; [Loria, J. Patrick] Yale Univ, Dept Chem, New Haven, CT USA; [Loria, J. Patrick] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA	Universidade de Sao Paulo; Yale University; Yale University	Marana, SR (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, SP, Brazil.	srmarana@iq.usp.br	Marana, Sandro/D-3867-2012	Marana, Sandro/0000-0002-5117-1921	FAPESP [2016/12899-6, 2017/25543-8, 2018/25952-8, 2019/24112-9]; CAPES [01, 8887.309511/2018-00, 88882.332955/2010-01]; CNPq (Conselho Nacional de Desenvolvimento Cientifico); NIH (National Institute of Health); NIH	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientifico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NIH (National Institute of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	SRM is a staff member of the Departamento de Bioquimica Instituto de Quimica USP. We thank CSF and RKS for helpful discussion.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Beismann-Driemeyer S, 2001, J BIOL CHEM, V276, P20387, DOI 10.1074/jbc.M102012200; Chaudhuri BN, 2001, STRUCTURE, V9, P987, DOI 10.1016/S0969-2126(01)00661-X; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Douangamath A, 2002, STRUCTURE, V10, P185, DOI 10.1016/S0969-2126(02)00702-5; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Holinski A, 2017, PROTEINS, V85, P312, DOI 10.1002/prot.25225; HUBER R, 1986, ARCH MICROBIOL, V144, P324, DOI 10.1007/BF00409880; Klem H, 2022, TOP CATAL, V65, P165, DOI 10.1007/s11244-021-01521-1; Kulis-Horn RK, 2014, MICROB BIOTECHNOL, V7, P5, DOI 10.1111/1751-7915.12055; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lipchock JM, 2010, STRUCTURE, V18, P1596, DOI 10.1016/j.str.2010.09.020; Lisi GP, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00004; Lisi GP, 2017, P NATL ACAD SCI USA, V114, pE3414, DOI 10.1073/pnas.1700448114; Lisi GP, 2016, STRUCTURE, V24, P1155, DOI 10.1016/j.str.2016.04.010; Lunardi J, 2013, CURR TOP MED CHEM, V13, P2866, DOI 10.2174/15680266113136660203; Omi R, 2002, J BIOCHEM, V132, P759, DOI 10.1093/oxfordjournals.jbchem.a003284; Rivalta I, 2016, BIOCHEMISTRY-US, V55, P6484, DOI 10.1021/acs.biochem.6b00859; Rivalta I, 2012, P NATL ACAD SCI USA, V109, pE1428, DOI 10.1073/pnas.1120536109; Smulski DR, 2001, J BACTERIOL, V183, P3353, DOI 10.1128/JB.183.11.3353-3364.2001; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Winkler Malcolm E, 2009, EcoSal Plus, V3, DOI 10.1128/ecosalplus.3.6.1.9; Wurm JP, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22968-6; Yao XQ, 2022, J CHEM THEORY COMPUT, V18, P1173, DOI 10.1021/acs.jctc.1c00669	25	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267536	10.1371/journal.pone.0267536	http://dx.doi.org/10.1371/journal.pone.0267536			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C1KV	35452497	gold, Green Published			2022-12-26	WOS:000792887700014
J	Kim, YJ; Yoon, SJ; Suh, SY; Hiratsuka, Y; Kang, B; Lee, SW; Ahn, HY; Suh, KJ; Kim, JW; Kim, SH; Kim, JW; Lee, KW; Kim, JH; Lee, JS				Kim, Yu Jung; Yoon, Seok Joon; Suh, Sang-Yeon; Hiratsuka, Yusuke; Kang, Beodeul; Lee, Si Won; Ahn, Hong-Yup; Suh, Koung Jin; Kim, Ji-Won; Kim, Se Hyun; Kim, Jin Won; Lee, Keun-Wook; Kim, Jee Hyun; Lee, Jong Seok			Performance of clinician prediction of survival in oncology outpatients with advanced cancer	PLOS ONE			English	Article							TERMINAL CANCER; ACCURACY	BackgroundWe aimed to investigate the performance of clinician prediction of survival (CPS) and the association between CPS and the prognostic confidence of clinicians in ambulatory medical oncology outpatients. MethodsEight medical oncologists estimated the expected survival of their patients in a prospective cohort study. They were asked to provide a temporal type of CPS in weeks, together with their level of confidence for each prediction (0-100%). We analyzed the accuracy of CPS, the association between CPS and the prognostic confidence, and the characteristics of patients showing inaccurate CPS. ResultsA total of 200 advanced cancer patients were enrolled and the median overall survival was 7.6 months. CPS was accurate in 67 (33.5%) patients, underestimated in 87 (43.5%), and overestimated in 46 (23.0%). The overall accuracy of CPS for 12-week, 24-week, 36-week, and 48-week survival was 83.0%, 72.0%, 75.5%, and 74.0%, respectively. The specificity was highest for 12-week survival (90.2%) and the sensitivity was highest for 48-week survival (96.1%). The sensitivity of 12-week CPS was 51.4% and the area under the receiver operating characteristic (AUROC) curve was 0.79 (95% confidence interval [CI] 0.71-0.87). The prognostic confidence of clinicians was not significantly associated with the accuracy of prediction (P = 0.359). Patients with overestimated survival had significantly poorer global health status and physical/role/emotional functioning in the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). Additionally, they showed significantly higher levels of fatigue, nausea/vomiting, pain, dyspnea, and loss of appetite. ConclusionThe overall accuracy of CPS in predicting 12-week to 48-week survival was high in medical oncology outpatients. However the sensitivity of 12-week CPS was low and prognostic confidence was not associated with the accuracy of CPS. Patients with overestimated CPS showed poorer quality of life and higher symptom burden.	[Kim, Yu Jung; Suh, Koung Jin; Kim, Ji-Won; Kim, Se Hyun; Kim, Jin Won; Lee, Keun-Wook; Kim, Jee Hyun; Lee, Jong Seok] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Div Hematol & Med Oncol,Coll Med, Seongnam, South Korea; [Yoon, Seok Joon] Chungnam Natl Univ Hosp, Dept Family Med, Daejeon, South Korea; [Suh, Sang-Yeon] Dongguk Univ, Dept Family Med, Ilsan Hosp, Goyang, South Korea; [Suh, Sang-Yeon] Dongguk Univ, Dept Med, Med Sch, Seoul, South Korea; [Hiratsuka, Yusuke] Takeda Gen Hosp, Dept Palliat Med, Aizu Wakamatsu, Fukushima, Japan; [Hiratsuka, Yusuke] Tohoku Univ, Dept Palliat Med, Sch Med, Sendai, Miyagi, Japan; [Kang, Beodeul] CHA Univ, Bundang Med Ctr, Div Med Oncol, Seongnam, South Korea; [Lee, Si Won] Yonsei Univ, Yonsei Canc Ctr, Dept Internal Med, Div Med Oncol,Coll Med, Seoul, South Korea; [Ahn, Hong-Yup] Dongguk Univ, Dept Stat, Med Sch, Seoul, South Korea	Seoul National University (SNU); Chungnam National University; Chungnam National University Hospital; Dongguk University; NHIS Ilsan Hospital; Dongguk University; Tohoku University; Pochon Cha University; Yonsei University; Yonsei University Health System; Dongguk University	Suh, SY (corresponding author), Dongguk Univ, Dept Family Med, Ilsan Hosp, Goyang, South Korea.; Suh, SY (corresponding author), Dongguk Univ, Dept Med, Med Sch, Seoul, South Korea.	lisasuhmd@hotmail.com	; Ahn, Hongyup/M-5043-2017	Kim, Yu Jung/0000-0002-5037-0523; Suh, Koung Jin/0000-0002-1881-8738; Hiratsuka, Yusuke/0000-0003-2334-3893; Ahn, Hongyup/0000-0001-8149-6981; Kim, Se Hyun/0000-0002-2292-906X	National Research Foundation of Korea (NRF) - Korean Government (Ministry of Science, Informatics, Communication and Technology) [2015R1C1A2A01053357]	National Research Foundation of Korea (NRF) - Korean Government (Ministry of Science, Informatics, Communication and Technology)	We thank the participating patients and clinical research nurses (Jin Suk Kim and Esther Jeon) for supporting this study.	Amano K, 2015, J PAIN SYMPTOM MANAG, V50, P139, DOI 10.1016/j.jpainsymman.2015.03.004; Butow PN, 2020, J CLIN ONCOL, V38, P877, DOI 10.1200/JCO.18.02112; Cheon S, 2016, ANN PALLIAT MED, V5, P22, DOI 10.3978/j.issn.2224-5820.2015.08.04; Chow E., 2010, J PAIN MANAG, V3, P73; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Glare P, 2003, BRIT MED J, V327, P195, DOI 10.1136/bmj.327.7408.195; Glare PA, 2008, J PALLIAT MED, V11, P84, DOI 10.1089/jpm.2008.9992; Hui D, 2019, SUPPORT CARE CANCER, V27, P1973, DOI 10.1007/s00520-019-04727-y; Hui D, 2011, ONCOLOGIST, V16, P1642, DOI 10.1634/theoncologist.2011-0173; Kiely BE, 2013, J CLIN ONCOL, V31, P3565, DOI 10.1200/JCO.2012.44.7821; Kim YJ, 2022, CANCER RES TREAT, V54, P621, DOI 10.4143/crt.2021.483; Kondziolka D, 2014, J NEUROSURG, V120, P24, DOI 10.3171/2013.9.JNS13788; Llobera J, 2000, EUR J CANCER, V36, P2036, DOI 10.1016/S0959-8049(00)00291-4; Maltoni M, 2005, J CLIN ONCOL, V23, P6240, DOI 10.1200/JCO.2005.06.866; Stone PC, 2007, ANN ONCOL, V18, P971, DOI 10.1093/annonc/mdl343; Tavares T, 2018, PALLIATIVE MED, V32, P413, DOI 10.1177/0269216317705788; Vigano A, 2004, CANCER, V101, P1090, DOI 10.1002/cncr.20472; White N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161407; Yun YH, 2004, QUAL LIFE RES, V13, P863, DOI 10.1023/B:QURE.0000021692.81214.70	19	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267467	10.1371/journal.pone.0267467	http://dx.doi.org/10.1371/journal.pone.0267467			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446910	gold, Green Published			2022-12-26	WOS:000795468200030
J	Ogasawara, Y				Ogasawara, Yu			New seasonal measurement with stability and clustering seasonal patterns: A case study in Japan from 2011 to 2019	PLOS ONE			English	Article							TOURISM DEMAND; INTERVAL; OCCUPANCY	Seasonality of tourism demand witnesses fluctuations over multiple years. The fluctuations and seasonality often cause seasonal pattern changes. This study presents a new seasonal measurement that considers the stability of seasonal patterns. The measurement is based on a seasonal index and expressed interval-valued data, which are a kind of symbolic data. As a case study, the new measurements are calculated from Japanese overnight data from 2011 to 2019 and the results classify the seasonal patterns of 47 prefectures using a hierarchical clustering method for interval-valued data based on Ward's method. The analysis results indicate that there are differences in not only seasonal patterns but also their stability between domestic overnight demand and inbound overnight demand. The analysis procedure suggested in this study could be helpful in organizing numerous other unstable seasonal patterns.	[Ogasawara, Yu] Tokyo Metropolitan Univ, Dept Tourism Sci, Hachioji, Tokyo, Japan	Tokyo Metropolitan University	Ogasawara, Y (corresponding author), Tokyo Metropolitan Univ, Dept Tourism Sci, Hachioji, Tokyo, Japan.	ogayu@tmu.ac.jp		Ogasawara, Yu/0000-0002-9738-712X	JSPS KAKENHI [JP20K20080]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	I appreciate the helpful comments from reviewers. They greatly improved this manuscript.	Bar-On R. R., 1999, Tourism Economics, V5, P437; BarOn R., 1975, SEASONALITY TOURISM; Baum T., 1999, International Journal of Tourism Research, V1, P299, DOI 10.1002/(SICI)1522-1970(199909/10)1:5<299::AID-JTR198>3.3.CO;2-C; Baum T., 1999, TOURISM ECON, V5, P5, DOI DOI 10.1177/135481669900500101; Billard L, 2006, SYMBOLIC DATA ANAL C, V1st; Bock H.-H., 2012, ANAL SYMBOLIC DATA E; Boffa F, 2012, ANN TOURISM RES, V39, P1176, DOI 10.1016/j.annals.2012.01.006; Cabanes G, 2013, PATTERN RECOGN, V46, P3030, DOI 10.1016/j.patcog.2013.03.023; Chen CC, 2012, INT J TOUR RES, V14, P339, DOI 10.1002/jtr.864; Cuccia T, 2011, TOURISM MANAGE, V32, P589, DOI 10.1016/j.tourman.2010.05.008; D'Urso P, 2016, PATTERN RECOGN, V58, P49, DOI 10.1016/j.patcog.2016.04.005; D'Urso P, 2011, APPL SOFT COMPUT, V11, P3877, DOI 10.1016/j.asoc.2011.01.006; De Cantis S, 2011, TOURISM ECON, V17, P655, DOI 10.5367/te.2011.0055; de Carvalho FDAT, 2006, COMPUTATION STAT, V21, P231, DOI 10.1007/s00180-006-0261-z; De Carvalho FDT, 2009, PATTERN RECOGN, V42, P1223, DOI 10.1016/j.patcog.2008.11.016; Fukui M, 2020, TOURISM ECON, V26, P776, DOI 10.1177/1354816618825014; Guizzardi A, 2010, TOURISM MANAGE, V31, P367, DOI 10.1016/j.tourman.2009.03.017; Guzman-Parra VF, 2015, TOUR MANAG PERSPECT, V16, P123, DOI 10.1016/j.tmp.2015.07.014; Hylleberg S., 1992, MODELLING SEASONALIT; Japan Tourism Agency, 2016, PRESS REL JAP 1 WORL; Japan Tourism Agency, 2020, PRESS REL EAS CONG D; Jeffrey D., 1999, Tourism Economics, V5, P69; Karamustafa K, 2010, EUROMED J BUS, V5, P191, DOI 10.1108/14502191011065509; Kiers HA., 2012, DATA ANAL CLASSIFICA; Koenig N., 2003, Tourism Economics, V9, P229; Koenig N, 2004, ANN TOURISM RES, V31, P374, DOI 10.1016/j.annals.2003.12.006; Koenig-Lewis N., 2005, International Journal of Tourism Research, V7, P201, DOI 10.1002/jtr.531; Kureha M, 2008, GLOBAL ENV RES, V12, P137; Lim C, 2001, ANN TOURISM RES, V28, P68, DOI 10.1016/S0160-7383(00)00002-5; Lin LC, 2021, STAT METHOD APPL-GER, V30, P295, DOI 10.1007/s10260-020-00525-7; Liu Q, 2008, M&SOM-MANUF SERV OP, V10, P288, DOI 10.1287/msom.1070.0169; Lundtorp S., 2001, MEASURING TOURISM SE, P23; Masaaki K., 2014, ASIA PACIFIC WORLD, V5, P32, DOI [10.3167/apw.2014.050204, DOI 10.3167/APW.2014.050204]; Ministry of Land Infrastructure Transport and Tourism, 2017, VIS JAP LOC COLL PRO; Ministry of Land Infrastructure Transport and Tourism, 2016, VIS JAP N LOC COLL P; Nakahira K., 2019, J ECON BUS, V2, P531, DOI [10.31014/aior.1992.02.02.106, DOI 10.31014/AIOR.1992.02.02.106]; Ogasawara Y, 2021, INT J APPROX REASON, V129, P103, DOI 10.1016/j.ijar.2020.11.001; Pegg S, 2012, INT J HOSP MANAG, V31, P659, DOI 10.1016/j.ijhm.2011.09.001; Saito H, 2018, TOURISM MANAGE, V69, P180, DOI 10.1016/j.tourman.2018.06.005; Shapoval V, 2018, J TRAVEL RES, V57, P310, DOI 10.1177/0047287517696960; Song HY, 2019, ANN TOURISM RES, V75, P338, DOI 10.1016/j.annals.2018.12.001; Sorensen N. K., 1999, Tourism Economics, V5, P9; Talluri KT, 2004, INT SER OPER RES MAN, P1; UNWTO, 2020, INT TOUR HIGHL, DOI [10.18111/9789284422456, DOI 10.18111/9789284422456]; Wu L., 2013, J SOCIAL SAFETY SCI, V21, P109	45	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267453	10.1371/journal.pone.0267453	http://dx.doi.org/10.1371/journal.pone.0267453			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C1KV	35452473	gold, Green Published			2022-12-26	WOS:000792887700003
J	Pettifor, A; DiPrete, BL; Shook-Sa, BE; Premkumar, L; Kuczynski, K; Dittmer, D; Aiello, A; Wallet, S; Maile, R; Tan, JY; Jadi, R; Pluta, L; de Silva, AM; Weber, DJ; Kim, M; Sena, AC; Jones, CD				Pettifor, Audrey; DiPrete, Bethany L.; Shook-Sa, Bonnie E.; Premkumar, Lakshmanane; Kuczynski, Kriste; Dittmer, Dirk; Aiello, Allison; Wallet, Shannon; Maile, Robert; Tan, Joyce; Jadi, Ramesh; Pluta, Linda; de Silva, Aravinda M.; Weber, David J.; Kim, Min; Sena, Arlene C.; Jones, Corbin D.			A prospective study of asymptomatic SARS-CoV-2 infection among individuals involved in academic research under limited operations during the COVID-19 pandemic	PLOS ONE			English	Article								BackgroundEarly in the pandemic, transmission risk from asymptomatic infection was unclear, making it imperative to monitor infection in workplace settings. Further, data on SARS-CoV-2 seroprevalence within university populations has been limited. MethodsWe performed a longitudinal study of University research employees on campus July-December 2020. We conducted questionnaires on COVID-19 risk factors, RT-PCR testing, and SARS-CoV-2 serology using an in-house spike RBD assay, laboratory-based Spike NTD assay, and standard nucleocapsid platform assay. We estimated prevalence and cumulative incidence of seroconversion with 95% confidence intervals using the inverse of the Kaplan-Meier estimator. Results910 individuals were included in this analysis. At baseline, 6.2% (95% CI 4.29-8.19) were seropositive using the spike RBD assay; four (0.4%) were seropositive using the nucleocapsid assay, and 44 (4.8%) using the Spike NTD assay. Cumulative incidence was 3.61% (95% CI: 2.04-5.16). Six asymptomatic individuals had positive RT-PCR results. ConclusionsPrevalence and incidence of SARS-CoV-2 infections were low; however, differences in target antigens of serological tests provided different estimates. Future research on appropriate methods of serological testing in unvaccinated and vaccinated populations is needed. Frequent RT-PCR testing of asymptomatic individuals is required to detect acute infections, and repeated serosurveys are beneficial for monitoring subclinical infection.	[Pettifor, Audrey; DiPrete, Bethany L.; Aiello, Allison; Weber, David J.] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [DiPrete, Bethany L.] Univ North Carolina Chapel Hill, Injury Prevent Res Ctr, Chapel Hill, NC USA; [Shook-Sa, Bonnie E.] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC USA; [Premkumar, Lakshmanane; Dittmer, Dirk; Wallet, Shannon; Maile, Robert; Jadi, Ramesh; Pluta, Linda; de Silva, Aravinda M.] Univ North Carolina Chapel Hill, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Kuczynski, Kriste] Univ North Carolina Chapel Hill, Sch Med, Dept Social Med, Chapel Hill, NC USA; [Wallet, Shannon] Univ North Carolina Chapel Hill, Adams Sch Dent, Div Oral & Craniofacial Hlth Sci, Chapel Hill, NC USA; [Maile, Robert] Univ North Carolinaat Chapel Hill, Sch Med, Dept Surg, Chapel Hill, NC USA; [Tan, Joyce] Univ North Carolina Chapel Hill, Sch Med, Dept Genet, Chapel Hill, NC USA; [Weber, David J.; Kim, Min; Sena, Arlene C.] Univ North Carolina Chapel Hill, Sch Med, Div Infect Dis, Chapel Hill, NC USA; [Jones, Corbin D.] Univ North Carolina Chapel Hill, Dept Biol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Pettifor, A (corresponding author), Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA.	apettif@email.unc.edu		Maile, Robert/0000-0002-9126-4188; Pettifor, Audrey/0000-0002-3387-0817; DiPrete, Bethany Linnea/0000-0003-1298-4433	North Carolina Policy Collaboratory through North Carolina General Assembly (NCGA)	North Carolina Policy Collaboratory through North Carolina General Assembly (NCGA)	This work was supported by the North Carolina Policy Collaboratory through appropriation from the North Carolina General Assembly (NCGA) in support of research on treatment, community testing and prevention of COVID-19 (as mandated by the NCGA in subdivision (23) of Section 3.3 of Session Law 2020-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A. F.Cunningham, 2020, medRxiv, DOI 10.1101/2020.06.16.20133025; Bajema KL, 2021, JAMA INTERN MED, V181, P450, DOI 10.1001/jamainternmed.2020.7976; Barzin A, 2020, MBIO, V11, DOI 10.1128/mBio.02426-20; Burgess S, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3364; C.Kalinich, 2020, medRxiv, DOI 10.1101/2020.10.21.20217042; Cevik M, 2021, LANCET MICROBE, V2, pE13, DOI 10.1016/S2666-5247(20)30172-5; JOHANSSON MA, 2021, JAMA NETW OPEN, V4, DOI [10.1001/jamanetworkopen.2020.35057, DOI 10.1001/JAMANETWORKOPEN.2020.35057]; Kim SE, 2020, INT J INFECT DIS, V95, P441, DOI 10.1016/j.ijid.2020.04.083; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Lemieux JE., PHYLOGENETIC ANAL SA, V2021, DOI [10.1126/science.abe3261, DOI 10.1126/SCIENCE.ABE3261]; Lewis D, 2021, NATURE, V590, P544, DOI 10.1038/d41586-021-00460-x; Lumley SF, 2021, CLIN INFECT DIS, V73, pE699, DOI 10.1093/cid/ciab004; Lumley T, SURVEY ANAL COMPLEX; Narowski TM., 2021, SARS COV 2 MRNA VACC, DOI [10.1101/2021.06.19.449100, DOI 10.1101/2021.06.19.449100]; Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012; Premkumar L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc8413; R Core Team, 2021, R LANG ENV STAT; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Yan DY, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.652842	19	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267353	10.1371/journal.pone.0267353	http://dx.doi.org/10.1371/journal.pone.0267353			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D9PO	35468150	gold, Green Published, Green Submitted			2022-12-26	WOS:000794129600003
J	Wang, GY; Shen, YZ; Li, CL; Zhu, QP; ZhanBota, A				Wang, Gangyi; Shen, Yuzhuo; Li, Chunlei; Zhu, Qiuping; ZhanBota, Aidyn			The regulatory effect of herd structure on pig production under the environmental regulation	PLOS ONE			English	Article								Integrating pig production stability and pollution control is a matter of social livelihood and green development. This paper estimates the policy effectiveness of environmental regulation based on the big data of Chinese government websites and combines the pig production data of various provinces in China from 2008 to 2018 to construct a mediating effect model, empirically analyzing the relationship between environmental regulations, herd structure, and pig production. Research shows: (1) Improving environmental regulations in the short term will increase the slaughter of pigs, but in the long run it will decrease first and then increase; (2) At this stage, environmental regulations can increase the slaughter of pigs by changing the herd structure; (3) Reasonable adjustment of the herd structure can effectively increase the slaughter of pigs; (4) The herd structure can be used as a supplementary monitoring indicator to stabilize the supply of pigs. Combine it with the change rate of sow stock to provide early warning of fluctuations in pig production, and the early warning herd structure values are 0.0980 and 0.1135. There are two key initiatives to achieve supply and price stability in the pig industry that taking into account environmental protection: first, an industrial regulation instrument based on the herd structure needs to be established; second, an early warning system for pig production fluctuations should be established with reference to the early warning system for pork price fluctuations.	[Wang, Gangyi; Shen, Yuzhuo; Li, Chunlei; Zhu, Qiuping; ZhanBota, Aidyn] Northeast Agr Univ, Sch Econ & Management, Harbin, Peoples R China	Northeast Agricultural University - China	Shen, YZ (corresponding author), Northeast Agr Univ, Sch Econ & Management, Harbin, Peoples R China.	shenyuzhuo@neau.edu.cn			Humanities and Social Science Foundation of Ministry of education of China, Research on Protection and Utilization of Pig Genetic Resources in China: Organization, Efficiency and Innovation [21YJA790053]; Natural Science Foundation of Heilongjiang; Research on Capital Stress and Counseling of Pig Industry in Heilongjiang Province under Environmental Regulation [LH2019G002]; Chongqing Yingcai Program Social Science Planning Project Research on Identification of Safety Boundary, Driving Factors and Upgrading Path of Pig Industry; Northeast Agricultural University Talent Program	Humanities and Social Science Foundation of Ministry of education of China, Research on Protection and Utilization of Pig Genetic Resources in China: Organization, Efficiency and Innovation; Natural Science Foundation of Heilongjiang(Natural Science Foundation of Heilongjiang Province); Research on Capital Stress and Counseling of Pig Industry in Heilongjiang Province under Environmental Regulation; Chongqing Yingcai Program Social Science Planning Project Research on Identification of Safety Boundary, Driving Factors and Upgrading Path of Pig Industry; Northeast Agricultural University Talent Program	This study was funded by the Humanities and Social Science Foundation of Ministry of education of China, Research on Protection and Utilization of Pig Genetic Resources in China: Organization, Efficiency and Innovation [21YJA790053], the Natural Science Foundation of Heilongjiang (CN), Research on Capital Stress and Counseling of Pig Industry in Heilongjiang Province under Environmental Regulation [LH2019G002], the Chongqing Yingcai Program Social Science Planning Project Research on Identification of Safety Boundary, Driving Factors and Upgrading Path of Pig Industry, and the Northeast Agricultural University Talent Program in the form of grants and funds to GW.	[Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; Azzam A, 2015, CAN J AGR ECON, V63, P333, DOI 10.1111/cjag.12053; Bowen, 2019, ENV RES LETT, V14; Chen S, 2022, J AGR ECON, V73, P541, DOI 10.1111/1477-9552.12464; Ding YF., 2020, J BIOSAFETY BIOSECUR, V2, P44, DOI 10.1016/j.jobb.2020.04.001; Gao YJ., 2015, CHINESE J ANIMAL SCI, V16, P65; [谷安平 Gu Anping], 2010, [数理统计与管理, Application of Statistics and Management], V29, P812; Han ZQ., 2018, HEILONGJIANG ANIMAL, V06, P69, DOI [10.13881/j.cnki.hljxmsy.2017.07.0256, DOI 10.13881/J.CNKI.HLJXMSY.2017.07.0256]; [李秉龙 LI Binglong], 2007, [农业经济问题, Issues in Agricultural Economy], V28, P18; Li GS., 2015, CHIN RURAL EC, V8, P44; Li PC., 2020, ISSUES AGR EC, V6, P109, DOI [10.13246/j.cnki.iae.2020.06.010, DOI 10.13246/J.CNKI.IAE.2020.06.010]; Liu Q., 2014, CHINA POPULATION RES, V12, P32; Ma SG., 2009, DESIGN IMPLEMENTATIO; Pan D., 2019, CHINA RURAL EC, V7, P89; Peng JS., 2008, MANAGE WORLD, V09, P25, DOI [10.19744/j.cnki.11-1235/f.2008.09.003, DOI 10.19744/J.CNKI.11-1235/F.2008.09.003]; Pla LM, 2004, COMPUT ELECTRON AGR, V45, P51, DOI 10.1016/j.compag.2004.06.005; [秦天 Qin Tian], 2021, [中国人口·资源与环境, China Population Resources and Environment], V31, P61; Rao D., 2019, CHINESE J RABBIT FAR, V3, P13; Rocadembosch J, 2016, PORCINE HEALTH MANAG, V2, DOI 10.1186/s40813-016-0027-0; Tong J., 2016, EC RES J, V07, P43; Wang, 2015, J AGR SCI TECH-IRAN, V4, P150, DOI [10.13304/j.nykjdb.2015.179, DOI 10.13304/J.NYKJDB.2015.179]; Wang GY., 2018, CHINESE RURAL EC, V06, P55; Wang HM., 2019, DONGYUE TRIBUNE, V5, P120, DOI [10.15981/j.cnki.dongyueluncong.2019.05.015, DOI 10.15981/J.CNKI.DONGYUELUNCONG.2019.05.015]; [温忠麟 Wen Zhonglin], 2004, [心理学报, Acta Psychologica Sinica], V36, P614; Xu LF., 2021, J ARID LAND RESOURCE, V4, P46, DOI [10.13448/j.cnki.jalre.2021.097, DOI 10.13448/J.CNKI.JALRE.2021.097]; Yang HT., 2020, CHINESE J AGR RESOUR, V3, P94; You JH., 2016, EC REV, V03, P26, DOI [10.19361/j.er.2016.03.03, DOI 10.19361/J.ER.2016.03.03]; Zhang, 2020, ISSUES AGR EC, V12, P50, DOI [10.13246/j.cnki.iae.2020.12.006, DOI 10.13246/J.CNKI.IAE.2020.12.006]; Zhang GX., 2014, CHINA POPULATION, V12, P62; Zhao N., 2019, CHINESE J ANIMAL SCI, V10, P177; [周建军 Zhou Jianjun], 2018, [农业现代化研究, Research of Agricultural Modernization], V39, P440; [周晶 Zhou Jing], 2014, [农业现代化研究, Research of Agricultural Modernization], V35, P750; Zhu N., 2017, J CHINA AGR U, V5, P174	33	0	0	14	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266687	10.1371/journal.pone.0266687	http://dx.doi.org/10.1371/journal.pone.0266687			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35472219	Green Published, gold			2022-12-26	WOS:000816171900010
J	Wassihun, B; Alemayehu, Y; Gultie, T; Tekabe, B; Gebeyehu, B				Wassihun, Biresaw; Alemayehu, Yosef; Gultie, Teklemariam; Tekabe, Beemnet; Gebeyehu, Birhaneselasie			Non-pharmacological labor pain management practice and associated factors among skilled attendants working in public health facilities in Gamo and Gofa zone, Southern Ethiopia: A cross-sectional study	PLOS ONE			English	Article							EPIDURAL ANALGESIA; CHILDBIRTH; RELIEF; BIRTH	BackgroundLabor pain management is crucial to ensure the quality of obstetric care but it is one of the neglected areas in obstetrics. This study aimed to assess the practice of labor pain management and associated factors among skilled attendants working in public health facilities in Southern, Ethiopia from November 1-January 26, 2019. MethodsAn Institution-based cross-sectional study design was conducted from November 1-January 26, 2019. A simple random sampling technique was used to select a total of 272 obstetric care providers. Data were collected using pretested, and structured questionnaires. Data were entered to Epi data version 3.1 statistical software and exported to SPSS 22 for analysis. Bivariate and multivariate logistic regression analyses were performed to identify associated factors. P-value ResultOverall, 37.5% (95%CI: 32%, 43%) of health care providers had a good practice on non-pharmacological labor pain management. Clinical experience of 5 years and above (AOR = 2.91, 95%CI: 1.60, 5.42), favorable attitude (AOR = 2.82, 95%CI: 1.56, 5.07), midwife profession (AOR = 1.45, 95%CI: 1.98, 4.27), and working in satisfactory delivery rooms (AOR = 3.45, 95%CI: 2.09, 7.43), were significantly associated with a health professional good practice of labor pain management. ConclusionThis study showed that the practice of non-pharmacological labor pain management was poor in public health facilities in Gamo and Gofa zone. It was observed that having a favorable attitude, having >= 5 years of work experience, being a midwife by professional, and having a satisfactory delivery room were found to be significant predictors of the practice of non -pharmacological labor pain management. Therefore, all health facilities and concerned bodies need efforts to focus on providing training to midwives on non-pharmacological labor pain management practice.	[Wassihun, Biresaw; Alemayehu, Yosef; Gultie, Teklemariam] Arba Minch Univ, Coll Med & Hlth Sci, Dept Midwifery, Arba Minch, Ethiopia; [Tekabe, Beemnet] Arba Minch Univ, Coll Med & Hlth Sci, Dept Hlth Informat, Arba Minch, Ethiopia; [Gebeyehu, Birhaneselasie] Univ Gondar, Coll Med & Hlth Sci, Sch Nursing, Dept Med Nursing, Gondar, Ethiopia	Arba Minch University; Arba Minch University; University of Gondar	Wassihun, B (corresponding author), Arba Minch Univ, Coll Med & Hlth Sci, Dept Midwifery, Arba Minch, Ethiopia.	bireswas@gmail.com	Gultie, Teklemariam/H-5819-2019	Gultie, Teklemariam/0000-0001-7266-8569; Alemayehu Gebrehiwot, Yosef/0000-0002-7233-3029				Arba MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151082; Aziato L, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0398-y; Bishaw KA, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-2844-z; Cyna AM, 2004, BRIT J ANAESTH, V93, P505, DOI 10.1093/bja/aeh225; Geltore TE, 2018, J PAIN RES, V11, P3089, DOI 10.2147/JPR.S165417; FMOH, 2013, FMOH STAND MIDW CAR, P64; Gido R., 2021, OBSTET GYNECOL INT, V2021, P9973001; Howell CJ, 2001, BRIT J OBSTET GYNAEC, V108, P27, DOI 10.1016/S0306-5456(00)00012-7; Iliadou M., 2009, HLTH SCI J, V3, P197; Klein MC, 2001, BIRTH-ISS PERINAT C, V28, P243, DOI 10.1046/j.1523-536X.2001.00243.x; Mugambe JM, 2007, S AFR FAM PRACT, V49, P16, DOI 10.1080/20786204.2007.10873535; Mung'ayi V, 2008, East Afr Med J, V85, P438; Nystedt A, 2004, J CLIN NURS, V13, P455, DOI 10.1046/j.1365-2702.2003.00849.x; Ogboli-Nwasor E, 2011, J Pain Res, V4, P227, DOI 10.2147/JPR.S21085; Ohaeri Beatrice, 2019, Eur J Midwifery, V3, P3, DOI 10.18332/ejm/99544; Roets L, 2005, Curationis, V28, P73; Sahile E, 2017, HLTH SCI J, V11; Sauls DJ, 2002, JOGNN, V31, P733, DOI 10.1177/088421702129005380; Soet JE, 2003, BIRTH-ISS PERINAT C, V30, P36, DOI 10.1046/j.1523-536X.2003.00215.x; Tasnim S, 2010, MED TODAY, V22, P20, DOI [10.3329/medtoday, DOI 10.3329/MEDTODAY]; Thomson G, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0735-4; Vehvilainen-Julkunen K, 2014, ANN MED HEALTH SCI R, V4, P511, DOI 10.4103/2141-9248.139290; WHO, 2016, ETH DEM HLTH SURV; WHO, 2019, TRENDS MAT MORT 2000	24	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266322	10.1371/journal.pone.0266322	http://dx.doi.org/10.1371/journal.pone.0266322			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1F9GM	35446867	gold, Green Published			2022-12-26	WOS:000795468200041
J	Wollney, EN; Bylund, CL; Bedenfield, N; Rosselli, M; Curiel-Cid, RE; Kitaigorodsky, M; Levy, X; Armstrong, MJ				Wollney, Easton N.; Bylund, Carma L.; Bedenfield, Noheli; Rosselli, Monica; Curiel-Cid, Rosie E.; Kitaigorodsky, Marcela; Levy, Ximena; Armstrong, Melissa J.			Clinician approaches to communicating a dementia diagnosis: An interview study	PLOS ONE			English	Article							OLDER-ADULTS; DISCLOSURE; CARE; EXPERIENCES; PREFERENCES; LIFE	Background Individuals with cognitive impairment and their families place a high value on receiving a dementia diagnosis, but clinician approaches vary. There is a need for research investigating experiences of giving and receiving dementia diagnoses. The current study aimed to investigate clinician approaches to giving dementia diagnoses as part of a larger study investigating patient, caregiver, and clinician experiences during the diagnosis encounter. Method Investigators conducted telephone interviews with Florida-based clinicians who give dementia diagnoses either rarely or commonly. Interviews employed a semi-structured interview guide querying communication practices used by clinicians when giving dementia diagnoses and how clinicians learned to give dementia diagnoses. Investigators used a descriptive qualitative design to conduct a thematic analysis of data. Results Fifteen Florida-based clinicians participated, representing diverse backgrounds related to gender, race/ethnicity, specialty, and practice setting. Participants reported using patient and family-centered communication practices including checking patient understanding, communicating empathically, and involving family members. Some clinicians explicitly asked patients and/or family members about their preferences regarding diagnosis disclosure; many clinicians tailored their disclosure based on patient and family characteristics or reactions. Some clinicians reported using specific diagnoses, while others used general terms such as "memory disorder." Clinicians reported positively framing information, including instilling hope, focusing on healthy behaviors, and discussing symptom management. Finally, clinicians provided patient/family education and arranged follow up. Clinicians reported learning approaches to dementia diagnosis disclosure through formal training and self-education. Conclusions Diverse Florida-based clinicians described dementia disclosure practices largely consistent with published guidance, but clinicians varied on approaches relating to soliciting patient disclosure preferences and terminology used. Clinicians caring for diverse populations described that cultural background affects the disclosure process, but more research is needed regarding this finding and best practices for individuals from different backgrounds.	[Wollney, Easton N.; Bylund, Carma L.] Univ Florida, Coll Med, Dept Hlth Outcomes & Biomed Informat, Gainesville, FL USA; [Bylund, Carma L.] Univ Florida, Coll Med, Dept Med, Gainesville, FL USA; [Bedenfield, Noheli; Armstrong, Melissa J.] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA; [Rosselli, Monica] Florida Atlantic Univ, Dept Psychol, Davie, FL USA; [Curiel-Cid, Rosie E.; Kitaigorodsky, Marcela] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [Levy, Ximena] Florida Atlantic Univ, Div Res, Clin Res Unit, Boca Raton, FL 33431 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; Florida Atlantic University; University of Miami; State University System of Florida; Florida Atlantic University	Armstrong, MJ (corresponding author), Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA.	melissa.armstrong@neurology.ufl.edu		Wollney, Easton/0000-0003-2981-8060	Florida Department of Health, Public Health Research, Biomedical Research Program [20A08]; NIH National Center for Advancing Translational Sciences [UL1TR001427]	Florida Department of Health, Public Health Research, Biomedical Research Program; NIH National Center for Advancing Translational Sciences	Work on this manuscript was supported by the Florida Department of Health, Public Health Research, Biomedical Research Program (grant 20A08, Co-PI's Melissa Armstrong & Carma Bylund) and used resources provided by University of Florida Clinical and Translational Science Institute, which is supported in part by the NIH National Center for Advancing Translational Sciences under award number UL1TR001427. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Florida Department of Health or National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funder URLs: http://www.floridahealth.gov/provider-and-partner-resources/research/funding-opportunity-announcements/alzheimersfoa.html https://ncats.nih.gov/.	Abe M, 2019, BMC FAM PRACT, V20, DOI 10.1186/s12875-019-0964-1; Adams T., 2005, DEMENTIA, V4, P185, DOI [DOI 10.1177/1471301205051092, 10.1177/1471301205051092]; Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; Aminzadeh F, 2012, CAN GERIATR J, V15, P85, DOI 10.5770/cgj.15.42; As Association, 2017, POL BRIEF EARL DET D; Baile W F, 2000, Oncologist, V5, P302, DOI 10.1634/theoncologist.5-4-302; Bamford C, 2004, INT J GERIATR PSYCH, V19, P151, DOI 10.1002/gps.1050; Bracher M, 2020, PATIENT EDUC COUNS, V103, P245, DOI 10.1016/j.pec.2019.08.031; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Braun V, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.26152; Brodaty Henry, 2009, Dialogues Clin Neurosci, V11, P217; Canada ASo, 2007, COMM DIAGN; Carpenter BD, 2007, PSYCHOL AGING, V22, P650, DOI 10.1037/0882-7974.22.3.650; Clarke V., 2014, ENCY QUALITY LIFE WE, P6626; Colorafi KJ, 2016, HERD-HEALTH ENV RES, V9, P16, DOI 10.1177/1937586715614171; Connell CM, 2004, GERONTOLOGIST, V44, P500, DOI 10.1093/geront/44.4.500; Dang BN, 2017, BMC MED EDUC, V17, DOI 10.1186/s12909-017-0868-5; Dhedhi SA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004439; Faison WE, 2003, J GERIATR PSYCH NEUR, V16, P225, DOI 10.1177/0891988703258668; Fortinsky RH, 2001, AGING MENT HEALTH, V5, pS35; Given L., 2008, SAGE ENCY QUALITATIV, DOI [10.4135/9781412963909, DOI 10.4135/9781412963909]; Griffin JM, 2020, J APPL GERONTOL, V39, P1184, DOI 10.1177/0733464819880449; Grossberg George T, 2010, Prim Care Companion J Clin Psychiatry, V12, DOI 10.4088/PCC.09cs00833oli; Juckett G, 2005, AM FAM PHYSICIAN, V72, P2267; Kaduszkiewicz H, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-54; Karnieli-Miller O, 2012, INT PSYCHOGERIATR, V24, P1756, DOI 10.1017/S1041610212000841; Karnieli-Miller O, 2012, PATIENT EDUC COUNS, V88, P381, DOI 10.1016/j.pec.2012.06.014; King Ann, 2013, J Grad Med Educ, V5, P385, DOI 10.4300/JGME-D-13-00072.1; Lecouturier J, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-95; Lewis S, 2015, HEALTH PROMOT PRACT, V16, P473, DOI 10.1177/1524839915580941; Lin PJ, 2021, MED CARE, V59, P679, DOI 10.1097/MLR.0000000000001577; Lin PJ, 2020, J AM GERIATR SOC, V68, P1763, DOI 10.1111/jgs.16442; Low LF, 2019, DEMENTIA-LONDON, V18, P2856, DOI 10.1177/1471301218761911; Mate KE, 2012, INT PSYCHOGERIATR, V24, P1962, DOI 10.1017/S1041610212001111; Morse J. M., 2002, INT J QUAL METHODS, P13, DOI 10.1177/160940690200100202; Organization) WWH, 2012, DEM PUBL HLTH PRIOR; Pehrson C, 2016, PATIENT EDUC COUNS, V99, P610, DOI 10.1016/j.pec.2015.11.021; Peixoto Vanessa Giffoni de Medeiros Nunes Pinheiro, 2020, Dement. neuropsychol., V14, P333, DOI 10.1590/1980-57642020dn14-040001; Phillips J, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X653598; Riva M, 2014, AGING CLIN EXP RES, V26, P427, DOI 10.1007/s40520-014-0195-1; Sagbakken M, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3720-7; Samsi K, 2014, INT J GERIATR PSYCH, V29, P58, DOI 10.1002/gps.3969; Sandelowski M, 2003, QUAL HEALTH RES, V13, P905, DOI 10.1177/1049732303253488; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Strauss, 2015, BASICS QUALITATIVE R; Strauss A., 1998, BASICS QUALITATIVE R; Strauss AL., 1987, QUALITATIVE ANAL SOC, Vxv, P319; STRUTZEL E, 1968, NURS RES, V17, P364; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; van den Dungen P, 2014, INT PSYCHOGERIATR, V26, P1603, DOI 10.1017/S1041610214000969; Vick JB, 2018, INT J GERIATR PSYCH, V33, pE103, DOI 10.1002/gps.4732; Wangler J, 2020, WIEN MED WOCHENSCHR, V170, P230, DOI 10.1007/s10354-019-00722-4; Werner Perla, 2013, Alzheimers Dement, V9, pe74, DOI 10.1016/j.jalz.2012.02.006; WESTERMEYER J, 1987, HOSP COMMUNITY PSYCH, V38, P160; Yates J, 2021, INT PSYCHOGERIATR, V33, P1161, DOI 10.1017/S1041610221000119	55	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267161	10.1371/journal.pone.0267161	http://dx.doi.org/10.1371/journal.pone.0267161			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1F9AX	35421205	gold, Green Published			2022-12-26	WOS:000795453600114
J	Schor, S; Pu, SY; Nicolaescu, V; Azari, S; Koivomagi, M; Karim, M; Cassonnet, P; Saul, S; Neveu, G; Yueh, AD; Demeret, C; Skotheim, JM; Jacob, Y; Randall, G; Einav, S				Schor, Stanford; Pu, Szuyuan; Nicolaescu, Vlad; Azari, Siavash; Koivomagi, Mardo; Karim, Marwah; Cassonnet, Patricia; Saul, Sirle; Neveu, Gregory; Yueh, Andrew; Demeret, Caroline; Skotheim, Jan M.; Jacob, Yves; Randall, Glenn; Einav, Shirit			The cargo adapter protein CLINT1 is phosphorylated by the Numb-associated kinase BIKE and mediates dengue virus infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; CLATHRIN; GENOME; EPSINR; IDENTIFICATION; REPLICATION; TRAFFICKING; REGULATOR; SECRETION; COMPLEXES	The signaling pathways and cellular functions regulated by the four Numb-associated kinases are largely unknown. We reported that AAK1 and GAK control intracellular trafficking of RNA viruses and revealed a requirement for BIKE in early and late stages of dengue virus (DENV) infection. However, the downstream targets phosphorylated by BIKE have not yet been identified. Here, to identify BIKE substrates, we conducted a barcode fusion genetics-yeast two-hybrid screen and retrieved publicly available data generated via affinity-purification mass spectrometry. We subsequently validated 19 of 47 putative BIKE interactors using mammalian cell-based protein-protein interaction assays. We found that CLINT1, a cargo-specific adapter implicated in bidirectional Golgi-to-endosome trafficking, emerged as a predominant hit in both screens. Our experiments indicated that BIKE catalyzes phosphorylation of a threonine 294 CLINT1 residue both in vitro and in cell culture. Our findings revealed that CLINT1 phosphorylation mediates its binding to the DENV nonstructural 3 protein and subsequently promotes DENV assembly and egress. Additionally, using live-cell imaging we revealed that CLINT1 cotraffics with DENV particles and is involved in mediating BIKE's role in DENV infection. Finally, our data suggest that additional cellular BIKE interactors implicated in the host immune and stress responses and the ubiquitin proteasome system might also be candidate phosphorylation substrates of BIKE. In conclusion, these findings reveal cellular substrates and pathways regulated by the understudied Numb-associated kinase enzyme BIKE, a mechanism for CLINT1 regulation, and control of DENV infection via BIKE signaling, with potential implications for cell biology, virology, and host-targeted antiviral design.	[Schor, Stanford; Pu, Szuyuan; Azari, Siavash; Karim, Marwah; Saul, Sirle; Neveu, Gregory; Einav, Shirit] Stanford Univ, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; [Nicolaescu, Vlad; Randall, Glenn] Univ Chicago, Dept Microbiol, Chicago, IL USA; [Koivomagi, Mardo; Skotheim, Jan M.] Stanford Univ, Dept Biol, Stanford, CA USA; [Cassonnet, Patricia; Demeret, Caroline; Jacob, Yves] Pasteur Inst, Natl Ctr Sci Res, Dept Virol, Mol Genet RNA Virus Genet GMVR, Paris, France; [Yueh, Andrew] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan, Taiwan; [Einav, Shirit] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Schor, Stanford; Pu, Szuyuan; Azari, Siavash; Karim, Marwah; Saul, Sirle; Neveu, Gregory; Einav, Shirit] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Cassonnet, Patricia; Demeret, Caroline; Jacob, Yves] Paris Diderot Univ, Paris, France	Stanford University; University of Chicago; Stanford University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Health Research Institutes - Taiwan; Stanford University; UDICE-French Research Universities; Universite Paris Cite	Einav, S (corresponding author), Stanford Univ, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA.; Einav, S (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.; Einav, S (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	seinav@stanford.edu	Azari, Siavash/AHE-4003-2022; Skotheim, Jan/C-3238-2015	Azari, Siavash/0000-0002-6787-279X; Neveu, Gregory/0000-0002-2363-6031; Karim, Marwah/0000-0003-0990-3962; Koivomagi, Mardo/0000-0003-4691-6930; Skotheim, Jan/0000-0001-8420-6820	Department of Defense (DoD), United States, Congressionally Directed Medical Research Programs (CDMRP), United States [W81XWH2110456]; National Institute of Allergy and Infectious Diseases (NIAID), United States [R01AI137514]; Stanford SPARK program; Child Health Research Institute, United States; Lucile Packard Foundation for Children's Health; Stanford CTSA, United States [UL1 TR000093]; PhRMA Foundation Postdoctoral Fellowship in Translational Medicine; NIH, United States [P30 CA124435]	Department of Defense (DoD), United States, Congressionally Directed Medical Research Programs (CDMRP), United States; National Institute of Allergy and Infectious Diseases (NIAID), United States; Stanford SPARK program; Child Health Research Institute, United States; Lucile Packard Foundation for Children's Health; Stanford CTSA, United States; PhRMA Foundation Postdoctoral Fellowship in Translational Medicine; NIH, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by award number W81XWH2110456 and W81XWH2110456 from the Department of Defense (DoD), United States, Congressionally Directed Medical Research Programs (CDMRP), United States, award number R01AI137514 from the National Institute of Allergy and Infectious Diseases (NIAID), United States, and grants from the Stanford SPARK program to S. E. or G. R. S. P. was supported by the Child Health Research Institute, United States, Lucile Packard Foundation for Children's Health, as well as the Stanford CTSA, United States (grant number UL1 TR000093). M.K was supported by a PhRMA Foundation Postdoctoral Fellowship in Translational Medicine. This work was also supported in part by NIH, United States P30 CA124435 utilizing the Stanford Cancer Institute, United States Proteomics/Mass Spectrometry Shared Resource. The opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the U.S. Army, National Institutes of Health, or the other funders. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934; Ayala-Nunez NV, 2011, METHODS, V55, P137, DOI 10.1016/j.ymeth.2011.07.009; Barouch-Bentov R, 2016, MBIO, V7, DOI 10.1128/mBio.01456-16; Bekerman E, 2017, J CLIN INVEST, V127, P1338, DOI 10.1172/JCI89857; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; BOUT A, 1989, CYTOGENET CELL GENET, V52, P147, DOI 10.1159/000132865; Buraschi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045559; Cassonnet P, 2011, NAT METHODS, V8, P990, DOI 10.1038/nmeth.1773; Chidambaram S, 2008, J CELL SCI, V121, P329, DOI 10.1242/jcs.012708; Choudhury R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4078; Clague MJ, 2017, FEBS J, V284, P1753, DOI 10.1111/febs.14007; COHEN PTW, 1989, BIOCHEM J, V260, P931, DOI 10.1042/bj2600931; Coller KE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002466; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; Davies CW, 2013, BIOCHEMISTRY-US, V52, P7818, DOI 10.1021/bi401106b; Dergai O, 2010, BIOCHEM BIOPH RES CO, V402, P408, DOI 10.1016/j.bbrc.2010.10.045; Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005; Duncan MC, 2003, NAT CELL BIOL, V5, P77, DOI 10.1038/ncb901; Eden ER, 2010, NAT CELL BIOL, V12, P267, DOI 10.1038/ncb2026; Escamilla M, 2008, SCHIZOPHR RES, V106, P253, DOI 10.1016/j.schres.2008.09.005; Eyre NS, 2017, J VIROL, V91, DOI 10.1128/JVI.01455-17; FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991; Fognani C, 2002, NUCLEIC ACIDS RES, V30, P2043, DOI 10.1093/nar/30.9.2043; Gebhard LG, 2016, J VIROL, V90, P5451, DOI 10.1128/JVI.00206-16; Gupta G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134823; Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107; Hirst J, 2004, MOL BIOL CELL, V15, P5593, DOI 10.1091/mbc.E04-06-0468; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; Huang CYH, 2010, VIROLOGY, V396, P305, DOI 10.1016/j.virol.2009.10.027; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; In JG, 2014, BIOCHEM J, V463, P201, DOI 10.1042/BJ20140468; Janoueix-Lerosey I, 1998, EUR J BIOCHEM, V252, P290, DOI 10.1046/j.1432-1327.1998.2520290.x; Joshi B, 2004, EUR J BIOCHEM, V271, P2189, DOI 10.1111/j.1432-1033.2004.04149.x; Kalthoff C, 2002, MOL BIOL CELL, V13, P4060, DOI 10.1091/mbc.E02-03-0171; Kearns AE, 2001, J BIOL CHEM, V276, P42213, DOI 10.1074/jbc.M106163200; Koivomagi M, 2011, NATURE, V480, P128, DOI 10.1038/nature10560; Krieger JR, 2013, MOL CELL PROTEOMICS, V12, P499, DOI 10.1074/mcp.M112.020768; Kudelko M, 2012, J BIOL CHEM, V287, P767, DOI 10.1074/jbc.M111.270579; Lee MH, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.4; Lin Z, 2014, J VIROL, V88, P11872, DOI 10.1128/JVI.01867-14; Liu HP, 2009, J CLIN LAB ANAL, V23, P362, DOI 10.1002/jcla.20344; Lopez-Coral A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31426-1; Luck K, 2017, TRENDS BIOCHEM SCI, V42, P342, DOI 10.1016/j.tibs.2017.02.006; Markmiller S, 2018, CELL, V172, P590, DOI 10.1016/j.cell.2017.12.032; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Mercado-Matos J, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00590-17; Cuartas-Lopez AM, 2018, VIRUS RES, V256, P153, DOI 10.1016/j.virusres.2018.08.013; Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Molli PR, 2008, ONCOGENE, V27, P1971, DOI 10.1038/sj.onc.1210839; Nagy Zoltan, 2018, Curr Protoc Protein Sci, V93, pe64, DOI 10.1002/cpps.64; Nakatsu F, 2003, CELL STRUCT FUNCT, V28, P419, DOI 10.1247/csf.28.419; Neveu G, 2015, J VIROL, V89, P4387, DOI 10.1128/JVI.02705-14; Neveu G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002845; Patkar CG, 2008, J VIROL, V82, P3342, DOI 10.1128/JVI.02447-07; Progida C, 2016, J CELL SCI, V129, P3971, DOI 10.1242/jcs.185702; Pu SY, 2018, J MED CHEM, V61, P6178, DOI 10.1021/acs.jmedchem.8b00613; Pu SY, 2011, J VIROL, V85, P2927, DOI 10.1128/JVI.01986-10; Pu SY, 2020, ANTIVIR RES, V184, DOI 10.1016/j.antiviral.2020.104966; Ramamurthy Narayan, 2016, Wellcome Open Res, V1, P17, DOI 10.12688/wellcomeopenres.9917.1; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Robinson M, 2018, CELL MOL LIFE SCI, V75, P3693, DOI 10.1007/s00018-018-2882-0; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; Saint-Pol A, 2004, DEV CELL, V6, P525, DOI 10.1016/S1534-5807(04)00100-5; Sato J, 2009, GENES CELLS, V14, P627, DOI 10.1111/j.1365-2443.2009.01296.x; Silva-Ayala D, 2013, P NATL ACAD SCI USA, V110, P10270, DOI 10.1073/pnas.1304932110; Sordillo JE, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-158; Sorensen EB, 2008, TRAFFIC, V9, P1791, DOI 10.1111/j.1600-0854.2008.00790.x; Sorrell FJ, 2016, STRUCTURE, V24, P401, DOI 10.1016/j.str.2015.12.015; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tai AW, 2001, J CELL BIOL, V153, P1499, DOI 10.1083/jcb.153.7.1499; Tanaka M, 2009, MOL CELL BIOL, V29, P402, DOI 10.1128/MCB.01035-08; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; Verdonck S, 2019, J MED CHEM, V62, P5810, DOI 10.1021/acs.jmedchem.9b00136; Vincentelli R, 2015, NAT METHODS, V12, P787, DOI [10.1038/nmeth.3438, 10.1038/NMETH.3438]; Wasiak S, 2002, J CELL BIOL, V158, P855, DOI 10.1083/jcb.200205078; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Wiemann S, 2016, NAT METHODS, V13, P191, DOI 10.1038/nmeth.3776; Xiao F, 2018, MBIO, V9, DOI 10.1128/mBio.02233-17; Yachie N, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156660; Yang CC, 2013, ANTIVIR RES, V98, P228, DOI 10.1016/j.antiviral.2013.03.001; Yang CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060873; Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001	84	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101956	10.1016/j.jbc.2022.101956	http://dx.doi.org/10.1016/j.jbc.2022.101956			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9DZ	35452674	Green Published, gold			2022-12-26	WOS:000807750700008
J	Qiao, P; Zhi, DL; Yu, C; Zhang, C; Wu, KY; Fang, H; Shao, S; Yin, W; Dang, EL; Li, K; Wang, G				Qiao, Pei; Zhi, Dalong; Yu, Chen; Zhang, Chen; Wu, Kunyi; Fang, Hui; Shao, Shuai; Yin, Wen; Dang, Erle; Li, Ke; Wang, Gang			Activation of the C3a anaphylatoxin receptor inhibits keratinocyte proliferation by regulating keratin 6, keratin 16, and keratin 17 in psoriasis	FASEB JOURNAL			English	Article						C3a anaphylatoxin receptor; complement; downregulation; keratin; proliferation; psoriasis	COMPLEMENT; SKIN; C5A; HYPERPROLIFERATION; PATHOGENESIS; NEUTROPHIL; EXPRESSION; SYSTEM; K16	Emerging evidence suggests that signaling through the C3a anaphylatoxin receptor (C3aR) protects against various inflammation-related diseases. However, the role of C3aR in psoriasis remains unknown. The purpose of this study was to investigate the possible protective role of C3aR in psoriasis and to explore the underlying molecular mechanisms. We initially found that the psoriatic epidermis exhibited significantly decreased C3aR expression. C3aR showed protective roles in mouse models of imiquimod (IMQ)- and interleukin-23-induced psoriasis. Furthermore, increased epidermal thickness and keratin 6 (K6), K16, and K17 expression occurred in the ears and backs of C3aR(-/-) mice. Pharmacological treatment with a C3aR agonist ameliorated IMQ-induced psoriasiform lesions in mice and decreased the expression of K6, K16, and K17. Additionally, the signal transducer and activator of transcription 3 (STAT3) pathway participated in the protective function of C3aR. More importantly, the expression levels of K6, K16, and K17 in keratinocytes were all restored in HaCaT cells transfected with a C3aR-overexpression plasmid after treating them with colivelin (a STAT3 activator). Our findings demonstrate that C3aR protects against the development of psoriasis and suggest that C3aR confers protection by negatively regulating K6, K16, and K17 expression in a STAT3-dependent manner, thus inhibiting keratinocyte proliferation and helping reverse the pathogenesis of psoriasis.	[Qiao, Pei; Zhi, Dalong; Yu, Chen; Zhang, Chen; Fang, Hui; Shao, Shuai; Dang, Erle; Wang, Gang] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, 127 Changle Western Rd, Xian 710032, Peoples R China; [Qiao, Pei; Yin, Wen] Fourth Mil Med Univ, Xijing Hosp, Dept Transfus Med, Xian, Peoples R China; [Wu, Kunyi; Li, Ke] Xi An Jiao Tong Univ, Affiliated Hosp 2, Sch Med, Core Res Lab, Xian 710004, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Xi'an Jiaotong University	Wang, G (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, 127 Changle Western Rd, Xian 710032, Peoples R China.; Li, K (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Sch Med, Core Res Lab, Xian 710004, Peoples R China.	ke.li@mail.xjtu.edu.cn; xjwgang@fmmu.edu.cn	Wang, Gang/H-6710-2019	Yu, Chen/0000-0001-7387-1198	National Natural Science Foundation of China [82173411, 82030096, 81972929, 81903206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (nos. 82173411, 82030096, 81972929, and 81903206).	Ahmad S, 2019, NEUROMOL MED, V21, P467, DOI 10.1007/s12017-019-08545-7; Banda NK, 2012, J IMMUNOL, V188, P1469, DOI 10.4049/jimmunol.1102310; Boehncke WH, 2015, LANCET, V386, P983, DOI 10.1016/S0140-6736(14)61909-7; Cai YH, 2012, CELL MOL IMMUNOL, V9, P302, DOI 10.1038/cmi.2012.15; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; EMBER JA, 1991, BIOCHEMISTRY-US, V30, P3603, DOI 10.1021/bi00229a003; Giacomassi C, 2017, J INVEST DERMATOL, V137, P760, DOI 10.1016/j.jid.2016.11.011; Giang J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00639; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Jiang S, 2015, GENOM PROTEOM BIOINF, V13, P224, DOI 10.1016/j.gpb.2015.04.002; Jin L, 2014, MED RES REV, V34, P438, DOI 10.1002/med.21291; KORGE B, 1990, J INVEST DERMATOL, V95, P450, DOI 10.1111/1523-1747.ep12555613; LEIGH IM, 1995, BRIT J DERMATOL, V133, P501, DOI 10.1111/j.1365-2133.1995.tb02696.x; Litvinchuk A, 2018, NEURON, V100, P1337, DOI 10.1016/j.neuron.2018.10.031; Ma Q, 2014, BONE MARROW TRANSPL, V49, P972, DOI 10.1038/bmt.2014.75; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262; Mommers JM, 2000, DERMATOLOGY, V201, P15, DOI 10.1159/000018422; Muenstermann M, 2019, VIRULENCE, V10, P677, DOI 10.1080/21505594.2019.1640035; Nabizadeh JA, 2016, J IMMUNOL, V196, P4783, DOI 10.4049/jimmunol.1600210; OHKOHCHI K, 1986, Journal of Dermatology (Tokyo), V13, P266; Panelius J, 2015, FRONT MED-LAUSANNE, V2, DOI 10.3389/fmed.2015.00003; Pozo-Rodrigalvarez A, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.604812; Qiao P, 2019, J INVEST DERMATOL, V139, P1470, DOI 10.1016/j.jid.2018.12.019; Qiao P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00235-3; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rosenberg EW, 1999, CLIN EXP DERMATOL, V24, P339; Schonthaler HB, 2013, IMMUNITY, V39, P1171, DOI 10.1016/j.immuni.2013.11.011; Shi XW, 2011, J INVEST DERMATOL, V131, P2401, DOI 10.1038/jid.2011.222; TAKEMATSU H, 1986, BRIT J DERMATOL, V114, P1, DOI 10.1111/j.1365-2133.1986.tb02773.x; Timar KK, 2006, MOL IMMUNOL, V43, P317, DOI 10.1016/j.molimm.2005.02.009; Ward PA, 2010, J INNATE IMMUN, V2, P439, DOI 10.1159/000317194; Wei LL, 2020, ARTERIOSCL THROM VAS, V40, P2070, DOI 10.1161/ATVBAHA.120.314150; Wende E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062257; Wu KY, 2019, KIDNEY INT, V96, P612, DOI 10.1016/j.kint.2019.03.005; Wu MCL, 2013, P NATL ACAD SCI USA, V110, P9439, DOI 10.1073/pnas.1218815110; Zhang XW, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080807; Zheng QY, 2020, INT IMMUNOPHARMACOL, V85, DOI 10.1016/j.intimp.2020.106692; Zheng QY, 2016, SCI REP-UK, V6, DOI 10.1038/srep33489	38	1	1	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22322	10.1096/fj.202101458R	http://dx.doi.org/10.1096/fj.202101458R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0N3GL	35429062				2022-12-26	WOS:000782730300001
J	She, M; Li, T; Shi, WQ; Li, B; Zhou, XD				She, Man; Li, Tao; Shi, Wenqing; Li, Bing; Zhou, Xiaodong			AREG is involved in scleral remodeling in form-deprivation myopia via the ERK1/2-MMP-2 pathway	FASEB JOURNAL			English	Article						AREG; ERK1; 2; MMP-2; myopia; scleral remodeling	GROWTH-FACTOR RECEPTOR; OCULAR GROWTH; AMPHIREGULIN; KINASE	Previous studies have found that amphiregulin (AREG) may participate in eye elongation during the development of myopia, but the mechanism remains unclear. Here, we tested tear concentrations of AREG in adults and detected the role of AREG in scleral remodeling in form-deprivation myopia (FDM) in guinea pigs. We found the tear concentrations of AREG in myopes were significantly higher than those in emmetropes using enzyme-linked immunosorbent assay (ELISA). Tear concentrations of AREG were negatively correlated with spherical equivalent refraction and positively correlated with axial length (AL) and AL/corneal radii. We then used RNAi, DNA transfection and PD98059 treatments to determine the effects of AREG on extracellular signal-regulated kinase 1/2 (ERK1/2) and matrix metalloprotease-2 (MMP-2) in primary scleral fibroblasts (SFs). The hypothesis was further verified via loss- and gain-of-function experiments by intravitreal application of anti-AREG antibody (anti-AR) or AREG in form-deprivation eyes in guinea pigs. Immunofluorescence assay was used for cell type identification. Western-blot and q-PCR were used for the detection of relative expressions. Transmission electron microscopy was performed for posterior scleral observation. In vitro, we found AREG overexpression increased phospho-ERK1/2 and MMP-2 expression, while depletion of AREG inhibited their expressions. PD98059 (an effective ERK1/2 inhibitor) inhibited AREG-induced MMP-2 upregulation. In vivo, we found anti-AR treatments suppressed FDM by inhibiting scleral remodeling, while AREG treatments promoted FDM. Our results suggest that AREG in tear fluids can serve as a potential biomarker in myopes. AREG is involved in scleral remodeling through the ERK1/2-MMP-2 pathway. AREG is a potential target for myopia control.	[She, Man; Li, Tao; Shi, Wenqing; Zhou, Xiaodong] Fudan Univ, Dept Ophthalmol, Jinshan Hosp, 1508 Longhang Rd, Shanghai 201508, Peoples R China; [Li, Bing] Fudan Univ, Cent Lab, Jinshan Hosp, 1508 Longhang Rd, Shanghai 201508, Peoples R China	Fudan University; Fudan University	Zhou, XD (corresponding author), Fudan Univ, Dept Ophthalmol, Jinshan Hosp, 1508 Longhang Rd, Shanghai 201508, Peoples R China.; Li, B (corresponding author), Fudan Univ, Cent Lab, Jinshan Hosp, 1508 Longhang Rd, Shanghai 201508, Peoples R China.	libingbm@163.com			Project of Shanghai Shenkang Hospital Development Center [SHDC2020CR1043B--004]; Project of Shanghai Jinshan District's Family Planning Commission [JSZK2019H01]	Project of Shanghai Shenkang Hospital Development Center; Project of Shanghai Jinshan District's Family Planning Commission	This work was supported by Project of Shanghai Shenkang Hospital Development Center (grant No. SHDC2020CR1043B--004) and Project of Shanghai Jinshan District's Family Planning Commission (grant No. JSZK2019H01)	Aluru SV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051979; Atta G, 2021, HISTOCHEM CELL BIOL, V156, P123, DOI 10.1007/s00418-021-01985-y; Baird PN, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-020-00231-4; Berasain C, 2014, SEMIN CELL DEV BIOL, V28, P31, DOI 10.1016/j.semcdb.2014.01.005; Boote C, 2020, PROG RETIN EYE RES, V74, DOI 10.1016/j.preteyeres.2019.100773; Dong L, 2019, ACTA OPHTHALMOL, V97, pE460, DOI 10.1111/aos.14080; Fan Q, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11008; Hagan S, 2016, EPMA J, V7, DOI 10.1186/s13167-016-0065-3; Harper AR, 2015, EXP EYE RES, V133, P100, DOI 10.1016/j.exer.2014.07.015; Huang LM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11541-1; Iomdina Elena, 2015, Pomeranian J Life Sci, V61, P146; Jiang WJ, 2017, EBIOMEDICINE, V17, P134, DOI 10.1016/j.ebiom.2017.02.021; Jonas JB, 2021, GRAEF ARCH CLIN EXP, V259, P3229, DOI 10.1007/s00417-021-05200-5; Kastelan S, 2020, BIOCHEM MEDICA, V30, DOI 10.11613/BM.2020.030502; Li M, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/5126560; Lin YY, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00276; Mahmoodzadeh S, 2010, CARDIOVASC RES, V85, P719, DOI 10.1093/cvr/cvp350; Metlapally R, 2015, PROG MOL BIOL TRANSL, V134, P241, DOI 10.1016/bs.pmbts.2015.05.005; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Peterson JL, 2014, INVEST OPHTH VIS SCI, V55, P2870, DOI 10.1167/iovs.13-12943; Platen C, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/4310419; Qiu C, 2018, INVEST OPHTH VIS SCI, V59, P2401, DOI 10.1167/iovs.18-23855; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; Reddy KB, 1999, INT J CANCER, V82, P268, DOI 10.1002/(SICI)1097-0215(19990719)82:2<268::AID-IJC18>3.3.CO;2-W; Resnikoff S, 2019, INVEST OPHTH VIS SCI, V60, pMI, DOI 10.1167/iovs.18-25983; Sahay P, 2017, INVEST OPHTH VIS SCI, V58, pBIO106, DOI 10.1167/iovs.17-21723; Sharma NS, 2019, INDIAN J OPHTHALMOL, V67, P38, DOI 10.4103/ijo.IJO_568_18; She M, 2022, CURR EYE RES, V47, P477, DOI 10.1080/02713683.2021.1998543; She M, 2021, EXP THER MED, V21, DOI 10.3892/etm.2021.9802; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Tao YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071441; Tung SL, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.25; Van Doren SR, 2015, MATRIX BIOL, V44-46, P224, DOI 10.1016/j.matbio.2015.01.005; Wang SF, 2021, CANCER LETT, V523, P82, DOI 10.1016/j.canlet.2021.09.043; Watson PG, 2004, EXP EYE RES, V78, P609, DOI 10.1016/S0014-4835(03)00212-4; Wong CW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52156-y; Wu H, 2018, P NATL ACAD SCI USA, V115, pE7091, DOI 10.1073/pnas.1721443115; Yao BY, 2017, EXP CELL RES, V359, P10, DOI 10.1016/j.yexcr.2017.06.024; Yotsumoto F, 2010, CANCER SCI, V101, P2351, DOI 10.1111/j.1349-7006.2010.01671.x; You JJ, 2013, MOL VIS, V19, P509; Zhao F, 2018, AM J PATHOL, V188, P1754, DOI 10.1016/j.ajpath.2018.04.011	42	0	0	4	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22289	10.1096/fj.202200132R	http://dx.doi.org/10.1096/fj.202200132R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0O0ZW	35436023				2022-12-26	WOS:000783259900001
J	Yan, YX; Dong, J; Li, YL; Lu, YK; Yang, K; Wang, T; Zhang, X; Xiao, HB				Yan, Yu-Xiang; Dong, Jing; Li, Yan-Ling; Lu, Ya-Ke; Yang, Kun; Wang, Tao; Zhang, Xiao; Xiao, Huan-Bo			CircRNA hsa_circ_0071336 is associated with type 2 diabetes through targeting the miR-93-5p/GLUT4 axis	FASEB JOURNAL			English	Article						biomarker; GLUT4; hsa_circ_0071336; type 2 diabetes	INSULIN-RESISTANCE; POTENTIAL BIOMARKERS; THERAPEUTIC TARGETS; CIRCULAR RNAS; GLUT4; MUSCLE; BLOOD; MESSENGERS; MICRORNAS; REVEALS	Glucose transporter 4 (GLUT4) is a dominant regulator of whole-body glucose homeostasis. Accumulating evidence has shown that circular RNAs (circRNAs) play significant roles in the pathogenesis of disease. The aim of the present study was to identify the circRNA that can be used as a novel biomarker for type 2 diabetes (T2D) through regulating GLUT4. Based on previous microarray analysis comparing T2D cases and healthy controls, hsa_circ_0071336, which was predicted to be a regulator of GLUT4 by acting as a competitive endogenous RNAs (ceRNA) to sponge miR-93-5p, was selected for further validation. The clinical significance of circulating hsa_circ_0071336 was investigated in a large independent cohort. The results showed that circulating hsa_circ_0071336 was significantly downregulated in blood in T2D and had a high diagnostic accuracy for discriminating T2D and impaired fasting glucose (IFG) from healthy controls. Low expression of circ_0071336 was an independent predictor of T2D, IFG and insulin resistance. A luciferase reporter assay and western-blot analysis indicated that miR-93-5p was a direct target of hsa_circ_0071336, and miR-93-5p may negatively regulate the expression of GLUT4. The expression levels of hsa_circ_007136 were negatively related to miR-93-5p expression and positively correlated with the mRNA expression of GLUT4 in adipose tissues. In conclusion, hsa_circRNA_0071336 can be considered as a potential novel and stable biomarker for T2D and its early detection. hsa_circ_0071336 regulates the GLUT4 expression by sponging miR-93-5p and maybe involved in the pathogenesis of T2D. These findings may unveil new targets for the prevention, diagnosis and treatment of T2D.	[Yan, Yu-Xiang; Li, Yan-Ling; Lu, Ya-Ke; Yang, Kun] Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, 10 Xitoutiao, Beijing 100069, Peoples R China; [Yan, Yu-Xiang; Li, Yan-Ling; Lu, Ya-Ke; Yang, Kun] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China; [Dong, Jing] Capital Med Univ, Xuanwu Hosp, Hlth Management Ctr, Beijing, Peoples R China; [Wang, Tao; Zhang, Xiao] Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing, Peoples R China; [Wang, Tao; Zhang, Xiao] China Int Neurosci Inst China INI, Beijing, Peoples R China; [Xiao, Huan-Bo] Capital Med Univ, Dept Prevent Med, Yanjing Med Coll, 4 Dadong Rd, Beijing 101300, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University	Yan, YX (corresponding author), Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, 10 Xitoutiao, Beijing 100069, Peoples R China.; Xiao, HB (corresponding author), Capital Med Univ, Dept Prevent Med, Yanjing Med Coll, 4 Dadong Rd, Beijing 101300, Peoples R China.	yanyxepi@ccmu.edu.cn; smallmoon1973@163.com	li, yan/GTI-4638-2022		National Natural Science Foundation of China [81773511, 81573214]; Beijing Municipal Natural Science Foundation [7162020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	This study was supported by the National Natural Science Foundation of China (81773511, 81573214) and the Beijing Municipal Natural Science Foundation (7162020).	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Amiral J, 2021, TRANSFUS APHER SCI, V60, DOI 10.1016/j.transci.2021.103209; Bayoumi AS, 2018, ACTA PHARMACOL SIN, V39, P1100, DOI 10.1038/aps.2017.196; Buysschaert M, 2016, CURR DIABETES REV, V12, P8, DOI 10.2174/1573399811666150122150233; Chen LL, 2015, RNA BIOL, V12, P381, DOI 10.1080/15476286.2015.1020271; Chen XF, 2020, J CLIN LAB ANAL, V34, DOI 10.1002/jcla.23439; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; Gaster M, 2001, DIABETES, V50, P1324, DOI 10.2337/diabetes.50.6.1324; Gratchev A, 2012, IMMUNOBIOLOGY, V217, P476, DOI 10.1016/j.imbio.2012.01.008; Guay C, 2013, NAT REV ENDOCRINOL, V9, P513, DOI 10.1038/nrendo.2013.86; Guo HF, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11051207; Hayashi Y, 2010, BIOL PHARM BULL, V33, P1033, DOI 10.1248/bpb.33.1033; Herman MA, 2006, J CLIN INVEST, V116, P1767, DOI 10.1172/JCI29027; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Karolina DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022839; Kipmen-Korgun D, 2009, SCAND J CLIN LAB INV, V69, P350, DOI 10.1080/00365510802632163; Lu YK, 2021, J CLIN ENDOCR METAB, V106, pE2688, DOI 10.1210/clinem/dgab101; Mirra P, 2015, EPIGENOMICS-UK, V7, P653, DOI [10.2217/EPI.15.18, 10.2217/epi.15.18]; Qu SB, 2015, CANCER LETT, V365, P141, DOI 10.1016/j.canlet.2015.06.003; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Stoll L, 2018, MOL METAB, V9, P69, DOI 10.1016/j.molmet.2018.01.010; TOZZO E, 1995, AM J PHYSIOL-ENDOC M, V268, pE956, DOI 10.1152/ajpendo.1995.268.5.E956; Tsao TS, 2001, FASEB J, V15, P958, DOI 10.1096/fj.00-0381; Xu HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep12453; Yan YX, 2016, J EPIDEMIOL, V26, P355, DOI 10.2188/jea.JE20150183; Yan YX., IDENTIFICATION CIRCU; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zaiou M, 2019, ADV EXP MED BIOL, V1134, P177, DOI 10.1007/978-3-030-12668-1_10; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhang WZ, 2021, ADIPOCYTE, V10, P189, DOI 10.1080/21623945.2021.1908655; Zhao ZZ, 2017, ACTA DIABETOL, V54, P237, DOI 10.1007/s00592-016-0943-0; Zhao ZD, 2021, GENOMICS, V113, P3967, DOI 10.1016/j.ygeno.2021.09.020; Zhou M, 2021, MOL MED REP, V23, DOI 10.3892/mmr.2021.11968; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693; Zou HL, 2017, GRAEF ARCH CLIN EXP, V255, P1159, DOI 10.1007/s00417-017-3638-5	37	0	0	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22324	10.1096/fj.202200149RR	http://dx.doi.org/10.1096/fj.202200149RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0O6CY	35439323				2022-12-26	WOS:000783613100001
J	Cui, LY; Shao, XY; Sun, WY; Zheng, FL; Dong, JS; Li, J; Wang, H; Li, JJ				Cui, Luying; Shao, Xinyu; Sun, Wenye; Zheng, Fangling; Dong, Junsheng; Li, Jun; Wang, Heng; Li, Jianji			Anti-inflammatory effects of progesterone through NF-kappa B and MAPK pathway in lipopolysaccharide- or Escherichia coli-stimulated bovine endometrial stromal cells	PLOS ONE			English	Article							OVARIAN ACTIVITY; MESSENGER-RNA; EXPRESSION; POSTPARTUM; INTERLEUKIN-1-BETA; ACTIVATION; CYTOKINE; SYNTHASE; GENES; ALPHA	Postpartum uterine infection in dairy cows is commonly caused by pathogenic bacteria such as Escherichia coli (E. coli). Progesterone elicits immunosuppressive function within bovine endometrium, and has been suggested to be related to postpartum uterine infection. Endometrial stroma is exposed to bacteria due to the disruption of epithelium during parturition, but the effect and mechanism of progesterone on innate immune response of stromal cells has not been reported. This study evaluated the impact of progesterone on inflammatory response of primary endometrial stromal cells stimulated by lipopolysaccharide or heat-killed E. coli. Quantitative PCR analysis revealed that progesterone repressed mRNA induction of IL1B, IL6, TNF, CXCL8, NOS2, and PTGS2 in stromal cells in response to lipopolysaccharide or E. coli challenge. Consistently, Western blot and immunofluorescence staining results showed that progesterone suppressed lipopolysaccharide- or E. coli-induced MAPK and NF-kappa B activations characterized with decreased phosphorylations of ERK1/2, JNK, P38, I kappa B alpha, and P65, and inhibition of P65 nuclear translocation. In unstimulated stromal cells, progesterone alone did not affect the mRNA transcription for IL6, TNF, CXCL8, NOS2, and PTGS2, and the signaling cascade of MAPK and NF-kappa B, but decreased IL1B mRNA expression. These results revealed that the anti-inflammatory effect of progesterone in lipopolysaccharide- or E. coli-challenged endometrial stromal cells was probably mediated through MAPK and NF-kappa B pathways.	[Cui, Luying; Shao, Xinyu; Sun, Wenye; Zheng, Fangling; Dong, Junsheng; Li, Jun; Wang, Heng; Li, Jianji] Yangzhou Univ, Coll Vet Med, Yangzhou, Jiangsu, Peoples R China; [Cui, Luying; Shao, Xinyu; Sun, Wenye; Zheng, Fangling; Dong, Junsheng; Li, Jun; Wang, Heng; Li, Jianji] Yangzhou Univ, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China; [Cui, Luying; Shao, Xinyu; Sun, Wenye; Zheng, Fangling; Dong, Junsheng; Li, Jun; Wang, Heng; Li, Jianji] Minist Educ, Joint Int Res Lab Agr & Agriprod Safety, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University	Wang, H; Li, JJ (corresponding author), Yangzhou Univ, Coll Vet Med, Yangzhou, Jiangsu, Peoples R China.; Wang, H; Li, JJ (corresponding author), Yangzhou Univ, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China.; Wang, H; Li, JJ (corresponding author), Minist Educ, Joint Int Res Lab Agr & Agriprod Safety, Yangzhou, Jiangsu, Peoples R China.	sdaulellow@163.com; yzjjli@163.com			National Natural Science Foundation of China [32072937, 32102735, 31802253]; China Postdoctoral Science Foundation [2018M632398]; Natural Science Foundation of Jiangsu Province [BK20210808]; earmarked fund for Jiangsu Agricultural Industry Technology System [JATS[2021]499]; College of Veterinary Medicine, Yangzhou University; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Topnotch Academic Programs Project of Jiangsu Higher Education Institutions (TAPP)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); earmarked fund for Jiangsu Agricultural Industry Technology System; College of Veterinary Medicine, Yangzhou University; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Topnotch Academic Programs Project of Jiangsu Higher Education Institutions (TAPP)	L. C.: The National Natural Science Foundation of China (NO: 31802253); the China Postdoctoral Science Foundation (NO: 2018M632398); J. D.: The National Natural Science Foundation of China (NO: 32102735); the Natural Science Foundation of Jiangsu Province (NO: BK20210808); H. W.: The earmarked fund for Jiangsu Agricultural Industry Technology System (JATS[2021]499); J. L. (Jianji Li): The National Natural Science Foundation of China (NO: 32072937); College of Veterinary Medicine, Yangzhou University (Institution funding): The Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); the Topnotch Academic Programs Project of Jiangsu Higher Education Institutions (TAPP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arosh JA, 2002, BIOL REPROD, V67, P161, DOI 10.1095/biolreprod67.1.161; Bhatt D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00071; Butts CL, 2007, INT IMMUNOL, V19, P287, DOI 10.1093/intimm/dxl145; Chew CL, 2018, TRENDS MOL MED, V24, P66, DOI 10.1016/j.molmed.2017.11.003; Cronin JG, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092718; Cui LY, 2021, FRONT VET SCI, V8, DOI 10.3389/fvets.2021.637707; Cui LY, 2021, DEV COMP IMMUNOL, V121, DOI 10.1016/j.dci.2021.104074; Cui LY, 2020, BMC VET RES, V16, DOI 10.1186/s12917-020-2231-z; Cui LY, 2020, DEV COMP IMMUNOL, V105, DOI 10.1016/j.dci.2019.103568; Dhaliwal GS, 2001, ANIM REPROD SCI, V67, P135, DOI 10.1016/S0378-4320(01)00124-5; Ding XF, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.575865; Foley C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-489; Goddard LM, 2013, VASC PHARMACOL, V59, P36, DOI 10.1016/j.vph.2013.06.001; Hansen PJ, 1998, J REPROD IMMUNOL, V40, P63, DOI 10.1016/S0165-0378(98)00035-7; Hashimoto K, 2013, J BIOL CHEM, V288, P10061, DOI 10.1074/jbc.M112.421156; Hellberg S, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.672168; HENRICKS DM, 1972, ENDOCRINOLOGY, V90, P1336, DOI 10.1210/endo-90-5-1336; Herath S, 2006, J REPROD IMMUNOL, V69, P13, DOI 10.1016/j.jri.2005.09.007; Herath S, 2006, ENDOCRINOLOGY, V147, P562, DOI 10.1210/en.2005-1113; Herath S, 2009, ENDOCRINOLOGY, V150, P1912, DOI 10.1210/en.2008-1379; Horie S, 2005, FERTIL STERIL, V83, P1530, DOI 10.1016/j.fertnstert.2004.11.042; Koh YQ, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13676; Laird SM, 1996, HUM REPROD, V11, P1318; Lei K, 2015, MOL ENDOCRINOL, V29, P1454, DOI 10.1210/me.2015-1122; Lewis Gregory S, 2003, Reprod Biol Endocrinol, V1, P117; Lewis GS, 2004, ANIM REPROD SCI, V82-3, P281, DOI 10.1016/j.anireprosci.2004.04.026; Menzies FM, 2011, IMMUNOLOGY, V134, P281, DOI 10.1111/j.1365-2567.2011.03488.x; Mita S, 2011, FERTIL STERIL, V96, P1485, DOI 10.1016/j.fertnstert.2011.09.040; Okabe H, 2014, J REPROD IMMUNOL, V104, P80, DOI 10.1016/j.jri.2014.03.008; Opsomer G, 2000, THERIOGENOLOGY, V53, P841, DOI 10.1016/S0093-691X(00)00234-X; Piersanti RL, 2019, J DAIRY SCI, V102, P2686, DOI 10.3168/jds.2018-15595; Pulugulla SH, 2018, CYTOKINE, V111, P373, DOI 10.1016/j.cyto.2018.10.001; Rekawiecki R, 2015, THERIOGENOLOGY, V84, P348, DOI 10.1016/j.theriogenology.2015.03.024; Salzman AL, 2000, INT J MOL MED, V6, P209; Saut JPE, 2014, REPRODUCTION, V148, P593, DOI 10.1530/REP-14-0230; Shah NM, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00198; Sheldon IM, 2004, ANIM REPROD SCI, V82-3, P295, DOI 10.1016/j.anireprosci.2004.04.006; Sordillo LM, 2016, J DAIRY SCI, V99, P4967, DOI 10.3168/jds.2015-10354; STEVENSON JS, 1979, J ANIM SCI, V48, P570, DOI 10.2527/jas1979.483570x; Su L, 2009, IMMUNOL LETT, V125, P151, DOI 10.1016/j.imlet.2009.07.003; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; WEBB R, 1980, J REPROD FERTIL, V59, P133, DOI 10.1530/jrf.0.0590133; Yan CB, 2021, THERIOGENOLOGY, V167, P85, DOI 10.1016/j.theriogenology.2021.03.012; Yoshino O, 2003, J CLIN ENDOCR METAB, V88, P2236, DOI 10.1210/jc.2002-021788	44	1	1	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0266144	10.1371/journal.pone.0266144	http://dx.doi.org/10.1371/journal.pone.0266144			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476705	gold, Green Published			2022-12-26	WOS:000840124300009
J	Korolainen, H; Lolicato, F; Enkavi, G; Perez-Gil, J; Kulig, W; Vattulainen, I				Korolainen, Hanna; Lolicato, Fabio; Enkavi, Giray; Perez-Gil, Jesus; Kulig, Waldemar; Vattulainen, Ilpo			Dimerization of the pulmonary surfactant protein C in a membrane environment	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; FORCE-FIELD; SP-B; MODEL; STABILITY; MUTATION; DOMAIN	Surfactant protein C (SP-C) has several functions in pulmonary surfactant. These include the transfer of lipids between different membrane structures, a role in surfactant recycling and homeostasis, and involvement in modulation of the innate defense system. Despite these important functions, the structures of functional SP-C complexes have remained unclear. SP-C is known to exist as a primarily alpha-helical structure with an apparently unstructured N-terminal region, yet there is recent evidence that the functions of SP-C could be associated with the formation of SP-C dimers and higher oligomers. In this work, we used molecular dynamics simulations, two-dimensional umbrella sampling, and well-tempered metadynamics to study the details of SP-C dimerization. The results suggest that SP-C dimerizes in pulmonary surfactant membranes, forming dimers of different topologies. The simulations identified a dimerization motif region V(21)xxxVxxxGxxxM(33) that is much larger than the putative A(30)xxxG(34) motif that is commonly assumed to control the dimerization of some alpha-helical transmembrane domains. The results provide a stronger basis for elucidating how SP-C functions in concert with other surfactant proteins.	[Korolainen, Hanna; Lolicato, Fabio; Enkavi, Giray; Kulig, Waldemar; Vattulainen, Ilpo] Univ Helsinki, Dept Phys, Helsinki, Finland; [Lolicato, Fabio] Heidelberg Univ, Biochem Ctr, Heidelberg, Germany; [Perez-Gil, Jesus] Univ Complutense Madrid, Hosp 12 Octubre Imas12, Dept Biochem & Mol Biol, Fac Biol,Res Inst, Madrid, Spain	University of Helsinki; Ruprecht Karls University Heidelberg; Complutense University of Madrid; Hospital Universitario 12 de Octubre	Kulig, W; Vattulainen, I (corresponding author), Univ Helsinki, Dept Phys, Helsinki, Finland.	waldemar.kulig@helsinki.fi; ilpo.vattulainen@helsinki.fi	; Lolicato, Fabio/B-1515-2016	Korolainen, Hanna/0000-0002-8166-9202; Lolicato, Fabio/0000-0001-7537-0549; Kulig, Waldemar/0000-0001-7568-0029; Vattulainen, Ilpo/0000-0001-7408-3214	Academy of Finland [307415]; Doctoral Programme in Materials Research and Nanosciences (MATRENA); Spanish Ministry of Science and Innovation [RTI2018-094564-B-100]; regional Government of Madrid [P2018/NMT-4389]; CSC-IT Centre for Science Ltd. (Espoo, Finland); Finnish Grid and Cloud Infrastructure [urn:nbn:fi:research-infras-2016072533]	Academy of Finland(Academy of Finland); Doctoral Programme in Materials Research and Nanosciences (MATRENA); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); regional Government of Madrid; CSC-IT Centre for Science Ltd. (Espoo, Finland); Finnish Grid and Cloud Infrastructure(Finnish IT center for science)	We thank the Academy of Finland (grant no. 307415) (W.K., G.E., I.V.) and the Doctoral Programme in Materials Research and Nanosciences (MATRENA) (H.K.) for financial support. J.P.-G. acknowledges funding from the Spanish Ministry of Science and Innovation RTI2018-094564-B-100) and the regional Government of Madrid (P2018/NMT-4389). CSC-IT Centre for Science Ltd. (Espoo, Finland) and the Finnish Grid and Cloud Infrastructure (persistent identifier urn:nbn:fi:research-infras-2016072533) are acknowledged for excellent computational resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin RS, 2001, J PEDIATR-US, V139, P85, DOI 10.1067/mpd.2001.114545; Barriga A, 2021, BBA-BIOMEMBRANES, V1863, DOI 10.1016/j.bbamem.2021.183572; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Brasch F, 2004, EUR RESPIR J, V24, P30, DOI 10.1183/09031936.04.00000104; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cabre EJ, 2018, J BIOL CHEM, V293, P9399, DOI 10.1074/jbc.RA117.000222; Carvalheda CA, 2015, J CHEM INF MODEL, V55, P2206, DOI 10.1021/acs.jcim.5b00076; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; Enkavi G, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005831; Glasser SW, 2001, P NATL ACAD SCI USA, V98, P6366, DOI 10.1073/pnas.101500298; Goerke J, 1998, BBA-MOL BASIS DIS, V1408, P79, DOI 10.1016/S0925-4439(98)00060-X; Gunther A, 2012, EUR RESPIR REV, V21, P152, DOI 10.1183/09059180.00001012; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Javanainen M, 2014, J CHEM THEORY COMPUT, V10, P2577, DOI 10.1021/ct500046e; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Johansson J, 1997, EUR J BIOCHEM, V244, P675, DOI 10.1111/j.1432-1033.1997.00675.x; Johansson J, 2003, SWISS MED WKLY, V133, P275; JOHANSSON J, 1994, BIOCHEMISTRY-US, V33, P6015, DOI 10.1021/bi00185a042; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kairys V, 2004, EUR J BIOCHEM, V271, P2086, DOI 10.1111/j.1432-1033.2004.04107.x; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Korfei M, 2008, AM J RESP CRIT CARE, V178, P838, DOI 10.1164/rccm.200802-313OC; Lopez-Rodriguez E, 2014, BBA-BIOMEMBRANES, V1838, P1568, DOI 10.1016/j.bbamem.2014.01.028; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Martinez L, 2009, J COMPUT CHEM, V30, P2157, DOI 10.1002/jcc.21224; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Nag K, 1997, BIOPHYS J, V72, P2638, DOI 10.1016/S0006-3495(97)78907-0; Nag K, 1996, BIOPHYS J, V71, P246, DOI 10.1016/S0006-3495(96)79221-4; Nogee LM, 2002, CHEST, V121, p20S, DOI 10.1378/chest.121.3_suppl.20S; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Olmeda B, 2017, ANN ANAT, V209, P78, DOI 10.1016/j.aanat.2016.09.008; Orzaez M, 2005, FEBS LETT, V579, P1633, DOI 10.1016/j.febslet.2005.01.078; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Perez-Gil J, 2008, BBA-BIOMEMBRANES, V1778, P1676, DOI 10.1016/j.bbamem.2008.05.003; Perez-Gil J, 2008, BIOPHYS J, V94, P1542, DOI 10.1529/biophysj.107.113829; PEREZGIL J, 1995, BIOCHEMISTRY-US, V34, P3964, DOI 10.1021/bi00012a014; Ramirez E, 2006, BIOPHYS J, V90, P2698, DOI 10.1529/biophysj.105.073270; Roldan N, 2016, BIOPHYS J, V111, P1703, DOI 10.1016/j.bpj.2016.09.016; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Sarabipour S, 2013, BBA-BIOMEMBRANES, V1828, P1829, DOI 10.1016/j.bbamem.2013.03.022; Serrano AG, 2006, CHEM PHYS LIPIDS, V141, P105, DOI 10.1016/j.chemphyslip.2006.02.017; Singh SK., 2014, HUMAN RESP VIRAL INF; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291	47	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267155	10.1371/journal.pone.0267155	http://dx.doi.org/10.1371/journal.pone.0267155			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476695	gold, Green Published, Green Accepted			2022-12-26	WOS:000840124300026
J	Plunkett, G; Swindles, GT				Plunkett, Gill; Swindles, Graeme T.			Bucking the trend: Population resilience in a marginal environment	PLOS ONE			English	Article							AMEBAS PROTOZOA RHIZOPODA; CLIMATE-CHANGE; ICE-AGE; RACOMITRIUM-LANUGINOSUM; SOCIAL VULNERABILITY; HOLOCENE; IRELAND; COLLAPSE; VARIABILITY; HISTORY	Evaluating the impact of environmental changes on past societies is frequently confounded by the difficulty of establishing cause-and-effect at relevant scales of analysis. Commonly, paleoenvironmental records lack the temporal and spatial resolution to link them with historic events, yet there remains a tendency to correlate climate change and cultural transformations on the basis of their seeming synchronicity. Here, we challenge perceptions of societal vulnerability to past environmental change using an integrated paleoenvironmental and land-use history of a remote upland site in the north of Ireland. We present a high-resolution, multi-proxy record that illustrates extended occupation of this marginal locality throughout the climate oscillations of the last millennium. Importantly, historically-dated volcanic ash markers enable us to pinpoint precisely in our record the timing of major national demographic crises such as the Black Death and the European, Irish and Great (Potato) Famines. We find no evidence that climate downturns or demographic collapses had an enduring impact on the use of the uplands: either the community escaped the effects of these events, or population levels recovered rapidly enough (within a generation) to leave no appreciable mark on the palaeoenvironmental record. Our findings serve to illustrate the spatial complexity of human activity that can enable communities to withstand or quickly bounce back from largescale calamities. In neglecting to consider such local-scale variability in social and economic organization, generalized models of societal collapse risk overplaying the vulnerability of populations to long- and short-term ecological stressors to the detriment of identifying the social constraints that influence a population's response to change.	[Plunkett, Gill] Queens Univ Belfast, Sch Nat & Built Environm, Archaeol & Palaeoecol, Belfast, Antrim, North Ireland; [Swindles, Graeme T.] Queens Univ Belfast, Geog Sch Nat & Built Environm, Belfast, Antrim, North Ireland; [Swindles, Graeme T.] Carleton Univ, Ottawa Carleton Geosci Ctr, Ottawa, ON, Canada; [Swindles, Graeme T.] Carleton Univ, Dept Earth Sci, Ottawa, ON, Canada	Queens University Belfast; Queens University Belfast; Carleton University; University of Ottawa; Carleton University	Plunkett, G (corresponding author), Queens Univ Belfast, Sch Nat & Built Environm, Archaeol & Palaeoecol, Belfast, Antrim, North Ireland.	g.plunkett@qub.ac.uk		Plunkett, Gill/0000-0003-1014-3454; Swindles, Graeme/0000-0001-8039-1790				Ahmed M, 2013, NAT GEOSCI, V6, P339, DOI [10.1038/ngeo1797, 10.1038/NGEO1797]; Amesbury MJ, 2016, QUATERNARY SCI REV, V152, P132, DOI 10.1016/j.quascirev.2016.09.024; [Anonymous], 2016, MET OFFICE NO IRELAN; [Anonymous], NATL ARCH IRELAND; Armit I, 2014, P NATL ACAD SCI USA, V111, P17045, DOI 10.1073/pnas.1408028111; Arnold TE, 2021, QUATERNARY SCI REV, V251, DOI 10.1016/j.quascirev.2020.106693; Bailey AJ, 2011, PROG HUM GEOG, V35, P686, DOI 10.1177/0309132510383358; Baillie M., 2006, NEW LIGHT BLACK DEAT; Baillie M. G. L., 1995, SLICE TIME DENDROCHR; Barber K.E., 1994, HOLOCENE, V4, P198, DOI [10.1177/095968369400400209, DOI 10.1177/095968369400400209]; Berglund B., 2009, CURR SWED ARCHAEOL, V17, P55; Bevan A, 2017, P NATL ACAD SCI USA, V114, pE10524, DOI 10.1073/pnas.1709190114; Blackford J., 1993, INT PEAT J, V5, P7; Blom Phillipp., 2019, NATURES MUTINY LITTL; Bragg OM, 2001, CATENA, V42, P345, DOI 10.1016/S0341-8162(00)00146-6; Brooks N, 2012, GEOGR TIDSSKR-DEN, V112, P93, DOI 10.1080/00167223.2012.741881; Buntgen U, 2020, DENDROCHRONOLOGIA, V64, DOI 10.1016/j.dendro.2020.125757; Buntgen U, 2016, NAT GEOSCI, V9, P231, DOI 10.1038/NGEO2652; Burgess C., 1985, UPLAND SETTLEMENT BR, P195; Butzer KW, 2012, P NATL ACAD SCI USA, V109, P3632, DOI 10.1073/pnas.1114845109; Campbell BMS., 2016, GREAT TRANSITION CLI; Campbell BMS, 2020, P ROY IRISH ACAD C, V120, P159, DOI 10.3318/PRIAC.2020.120.13; Charman DJ, 2007, HOLOCENE, V17, P217, DOI 10.1177/0959683607075836; Charman DJ, 2009, QUATERNARY SCI REV, V28, P1811, DOI 10.1016/j.quascirev.2009.05.013; Charman DJ, 2000, IDENTIFICATION PEATL; Comenetz J., 2002, Environmental Hazards, V4, P113, DOI 10.1016/j.hazards.2003.08.001; Costello E, 2021, MEDIEV ARCHAEOL, V65, P151, DOI 10.1080/00766097.2020.1826123; Costello K, 2020, TOP STRINGS TWIST SK; CRAWFORD EM, 1989, FAMINE : THE IRISH EXPERIENCE 900-1900, P1; Cutter SL, 2003, SOC SCI QUART, V84, P242, DOI 10.1111/1540-6237.8402002; D'Arcy G, 2021, NEW HIBERNIA REV, V25, P89; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; Degroot D, 2021, NATURE, V591, P539, DOI 10.1038/s41586-021-03190-2; Dickson D., 2013, ATLAS GREAT IRISH FA, P23; Donders TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104774; Donnelly C., 2018, COLERAINE HEART GLEN; Drake BL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01289-z; Duan WL, 2016, NAT HAZARDS, V82, P401, DOI 10.1007/s11069-016-2207-2; DUGMORE AJ, 1992, J QUATERNARY SCI, V7, P173, DOI 10.1002/jqs.3390070208; Ellis CJ, 2003, J BRYOL, V25, P7, DOI 10.1179/037366803125002617; Engler S, 2013, CLIM PAST, V9, P1161, DOI 10.5194/cp-9-1161-2013; Ersgard L., 2016, ENVIRONMENT, P69; Faegri K., 1975, Textbook of pollen analysis.; Fagan B. M., 2001, LITTLE ICE AGE CLIMA; Feehan J., 2013, ATLAS GREAT IRISH FA, P28; Flaherty E, 2014, ECOL COMPLEX, V19, P35, DOI 10.1016/j.ecocom.2014.04.002; Fraser EDG, 2006, ECOL COMPLEX, V3, P328, DOI 10.1016/j.ecocom.2007.02.006; Fredh ED, 2019, VEG HIST ARCHAEOBOT, V28, P529, DOI 10.1007/s00334-019-00712-x; Fyfe RM, 2003, VEG HIST ARCHAEOBOT, V12, P215, DOI 10.1007/s00334-003-0018-3; Goddard A., 1971, THESIS QUEENS U BELF; Grimm E.C., 2004, TGVIEW; Grimm E.C, 1992, TILIA TILIA GRAPH VE; Haldon J, 2018, P NATL ACAD SCI USA, V115, P3210, DOI 10.1073/pnas.1716912115; HALL V A, 1989, Irish Naturalists' Journal, V23, P82; HALL VA, 1990, NEW PHYTOL, V115, P377, DOI 10.1111/j.1469-8137.1990.tb00464.x; Hall VA, 1998, REV PALAEOBOT PALYNO, V103, P59, DOI 10.1016/S0034-6667(98)00026-8; HALL VA, 1994, REV PALAEOBOT PALYNO, V82, P75, DOI 10.1016/0034-6667(94)90020-5; Hendon D, 1997, HOLOCENE, V7, P199, DOI 10.1177/095968369700700207; Huhtamaa H, 2021, CLIMATE DISCUSS, V124, DOI [10.5194/cp-2021-147, DOI 10.5194/CP-2021-147]; Huhtamaa H, 2017, HOLOCENE, V27, P3, DOI 10.1177/0959683616646188; Huntley MJW, 2013, HOLOCENE, V23, P1572, DOI 10.1177/0959683613499051; JOWSEY PC, 1966, NEW PHYTOL, V65, P245, DOI 10.1111/j.1469-8137.1966.tb06356.x; Kaniewski D, 2015, WIRES CLIM CHANGE, V6, P369, DOI 10.1002/wcc.345; Kennedy L., 2013, ULSTER 1600 POLITICS, P28, DOI [10.1093/acprof:oso/9780199583119.003.0011, DOI 10.1093/ACPROF:OSO/9780199583119.003.0011]; Kennedy L., 2013, ULSTER 1600 POLITICS, P58; Lageras P., 2014, ARCHAEOLOGIA BALTICA, V20, P77, DOI [10.15181/ab.v20i0.809, DOI 10.15181/AB.V20I0.809]; Lageras P., 2016, ENV SOC BLACK DEATH, P6; Levitt MS., 2019, CLIODYNAMICS, V10, P31, DOI [10.21237/C7clio10142572, DOI 10.21237/C7CLIO10142572]; Luterbacher J, 2020, EURO-MEDITERR J ENVI, V5, DOI 10.1007/s41207-020-00197-5; Lyons MC., 1989, FAMINE IRISH EXPERIE, P39; Mackay H., 2021, CLIM DISCUSS, DOI [10.5194/cp-2021-170, DOI 10.5194/CP-2021-170]; Maher LA, 2011, CAMB ARCHAEOL J, V21, P1, DOI 10.1017/S0959774311000011; Mann ME., 2002, ENCY GLOBAL ENV CHAN, P504; Mann ME, 2009, SCIENCE, V326, P1256, DOI 10.1126/science.1177303; Manning K, 2014, QUATERNARY SCI REV, V101, P28, DOI 10.1016/j.quascirev.2014.07.003; Mauquoy D, 1999, HOLOCENE, V9, P423, DOI 10.1191/095968399673322360; McAnany PA, 2010, QUESTIONING COLLAPSE; McCafferty P., 2005, CELTIC GODS COMETS I; McConnell JR, 2020, P NATL ACAD SCI USA, V117, P15443, DOI 10.1073/pnas.2002722117; McCracken E., 1971, The Irish woods since Tudor times. Distribution and exploitation.; McCracken E, 1947, ULSTER J ARCHAEOLOGY, V10, P15; McNeill TE., 1980, ANGLONORMAN ULSTER H; Middleton G, 2012, J ARCHAEOL RES, V20, P257, DOI 10.1007/s10814-011-9054-1; Moore P.D., 1991, BLACKWELL SCI PUBLI; O Grada C, 2009, FAMINE SHORT HIST; Oppenheimer C, 2003, PROG PHYS GEOG, V27, P230, DOI 10.1191/0309133303pp379ra; Oppenheimer C, 2018, CLIMATIC CHANGE, V147, P369, DOI 10.1007/s10584-018-2171-9; Parry M.L., 1981, CLIMATE HIST STUDIES, P319; Pfister C, 2006, CLIM PAST, V2, P115, DOI 10.5194/cp-2-115-2006; Plunkett G., 2007, ENV ARCHAEOLOGY IREL, P221; Plunkett G, 2018, EARTH-SCI REV, V179, P20, DOI 10.1016/j.earscirev.2018.02.006; Ramsey CB, 2008, QUATERNARY SCI REV, V27, P42, DOI 10.1016/j.quascirev.2007.01.019; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Redman CL, 2005, AM ANTHROPOL, V107, P70, DOI 10.1525/aa.2005.107.1.070; Reimer PJ, 2020, RADIOCARBON, V62, P725, DOI 10.1017/RDC.2020.41; Riede F, 2009, HUM BIOL, V81, P309, DOI 10.3378/027.081.0311; Robine JM, 2008, CR BIOL, V331, P171, DOI 10.1016/j.crvi.2007.12.001; Roos-Barraclough F, 2004, HOLOCENE, V14, P7, DOI 10.1191/0959683604hl685rp; Rose NL, 2005, J PALEOLIMNOL, V34, P349, DOI 10.1007/s10933-005-4925-4; ROSE NL, 1995, HOLOCENE, V5, P328, DOI 10.1177/095968369500500308; Schmid BV, 2015, P NATL ACAD SCI USA, V112, P3020, DOI 10.1073/pnas.1412887112; Shamsuddoha M., 2007, CLIMATE CHANGE IMPAC; Sigl M, 2015, NATURE, V523, P543, DOI 10.1038/nature14565; Singh S.R., 2014, INT J INTERDISCIP MU, V1, P71; Skold E, 2010, VEG HIST ARCHAEOBOT, V19, P121, DOI 10.1007/s00334-009-0234-6; Smyth WJ., 2013, ATLAS GREAT IRISH FA, P13; STOCKMARR J, 1971, Pollen et Spores, V13, P615; Streeter R, 2012, P NATL ACAD SCI USA, V109, P3664, DOI 10.1073/pnas.1113937109; Svensson E., 2019, RURALIA, P171; Svensson E., 2013, LUND ARCHAEOLOGICAL, V18, P89; Swindles GT, 2010, QUATERNARY SCI REV, V29, P1577, DOI 10.1016/j.quascirev.2009.01.003; Swindles GT, 2009, J PALEOLIMNOL, V42, P123, DOI 10.1007/s10933-008-9266-7; Swindles GT, 2007, HOLOCENE, V17, P177, DOI 10.1177/0959683607075830; Swindles GT, 2015, QUATERNARY SCI REV, V120, P107, DOI 10.1016/j.quascirev.2015.04.019; Swindles GT, 2013, EARTH-SCI REV, V126, P300, DOI 10.1016/j.earscirev.2013.08.012; Swindles GT., 2006, THESIS QUEENS U BEL; Tallavaara M, 2012, HOLOCENE, V22, P215, DOI 10.1177/0959683611414937; Tallis JH, 1995, J ECOL, V83, P1021, DOI 10.2307/2261183; Tipping R., 2002, LANDSCAPES, V3, P10, DOI [10.1179/lan.2002.3.2.10, DOI 10.1179/LAN.2002.3.2.10]; Turney CSM, 2016, ANTHROPOCENE, V13, P69, DOI 10.1016/j.ancene.2016.02.002; van Hoof TB, 2006, PALAEOGEOGR PALAEOCL, V237, P396, DOI 10.1016/j.palaeo.2005.12.013; Weiss H, 2001, SCIENCE, V291, P609, DOI 10.1126/science.1058775; Welinder S, 2019, FORNVANNEN, V114, P36; Yeloff D, 2007, J BIOGEOGR, V34, P575, DOI 10.1111/j.1365-2699.2006.01674.x; Zhang DD, 2011, P NATL ACAD SCI USA, V108, P17296, DOI 10.1073/pnas.1104268108	125	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0266680	10.1371/journal.pone.0266680	http://dx.doi.org/10.1371/journal.pone.0266680			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476782	gold, Green Published			2022-12-26	WOS:000840124300014
J	Chansaenroj, J; Yorsaeng, R; Puenpa, J; Wanlapakorn, N; Chirathaworn, C; Sudhinaraset, N; Sripramote, M; Chalongviriyalert, P; Jirajariyavej, S; Kiatpanabhikul, P; Saiyarin, J; Soudon, C; Thienfaidee, O; Ayuthaya, TPN; Brukesawan, C; Intharasongkroh, D; Chaiwanichsiri, D; Issarasongkhram, M; Kitphati, R; Mungaomklang, A; Thitithanyanont, A; Nagavajara, P; Poovorawan, Y				Chansaenroj, Jira; Yorsaeng, Ritthideach; Puenpa, Jiratchaya; Wanlapakorn, Nasamon; Chirathaworn, Chintana; Sudhinaraset, Natthinee; Sripramote, Manit; Chalongviriyalert, Piti; Jirajariyavej, Supunee; Kiatpanabhikul, Phatharaporn; Saiyarin, Jatuporn; Soudon, Chulikorn; Thienfaidee, Orawan; Ayuthaya, Thitisan Palakawong Na; Brukesawan, Chantapat; Intharasongkroh, Duangnapa; Chaiwanichsiri, Dootchai; Issarasongkhram, Mila; Kitphati, Rungrueng; Mungaomklang, Anek; Thitithanyanont, Arunee; Nagavajara, Pijaya; Poovorawan, Yong			Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients	PLOS ONE			English	Article							IGA; INFECTION; RESPONSES; EVOLUTION; PLASMA	Understanding antibody responses after natural severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can guide the coronavirus disease 2019 (COVID-19) vaccine schedule, especially in resource-limited settings. This study aimed to assess the dynamics of SARS-CoV-2 antibodies, including anti-spike protein 1 (S1) immunoglobulin (Ig)G, anti-receptor-binding domain (RBD) total Ig, anti-S1 IgA, and neutralizing antibody against wild-type SARS-CoV-2 over time in a cohort of patients who were previously infected with the wild-type SARS-CoV-2. Between March and May 2020, 531 individuals with virologically confirmed cases of wild-type SARS-CoV-2 infection were enrolled in our immunological study. Blood samples were collected at 3-, 6-, 9-, and 12-months post symptom onset or detection of SARS-CoV-2 by RT-PCR (in asymptomatic individuals). The neutralizing titers against SARS-CoV-2 were detected in 95.2%, 86.7%, 85.0%, and 85.4% of recovered COVID-19 patients at 3, 6, 9, and 12 months after symptom onset, respectively. The seropositivity rate of anti-S1 IgG, anti-RBD total Ig, anti-S1 IgA, and neutralizing titers remained at 68.6%, 89.6%, 77.1%, and 85.4%, respectively, at 12 months after symptom onset. We observed a high level of correlation between neutralizing and SARS-CoV-2 spike protein-specific antibody titers. The half-life of neutralizing titers was estimated at 100.7 days (95% confidence interval = 44.5-327.4 days, R-2 = 0.106). These results support that the decline in serum antibody levels over time in both participants with severe disease and mild disease were depended on the symptom severity, and the individuals with high IgG antibody titers experienced a significantly longer persistence of SARS-CoV-2-specific antibody responses than those with lower titers.	[Chansaenroj, Jira; Yorsaeng, Ritthideach; Puenpa, Jiratchaya; Wanlapakorn, Nasamon; Chirathaworn, Chintana; Sudhinaraset, Natthinee; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Dept Pediat, Bangkok, Thailand; [Sripramote, Manit; Chalongviriyalert, Piti] Bangkok Metropolitan Adm, Med Serv Dept, Bangkok, Thailand; [Jirajariyavej, Supunee] Taksin Hosp, Bangkok Metropolitan Adm, Med Serv Dept, Bangkok, Thailand; [Kiatpanabhikul, Phatharaporn] Charoenkrung Pracharak Hosp, Bangkok Metropolitan Adm, Med Serv Dept, Bangkok, Thailand; [Saiyarin, Jatuporn] Klang Gen Hosp, Bangkok Metropolitan Adm, Med Serv Dept, Bangkok, Thailand; [Soudon, Chulikorn] Sirindhorn Hosp, Bangkok Metropolitan Adm, Med Serv Dept, Bangkok, Thailand; [Thienfaidee, Orawan] Ratchaphiphat Hosp, Med Serv Dept, Bangkok Metropolitan Adm, Bangkok, Thailand; [Ayuthaya, Thitisan Palakawong Na] Bangkok Metropolitan Adm, Hlth Dept, Publ Hlth Ctr 28, Bangkok, Thailand; [Brukesawan, Chantapat] Bangkok Metropolitan Adm, Hlth Dept, Publ Hlth Ctr 26, Bangkok, Thailand; [Intharasongkroh, Duangnapa; Chaiwanichsiri, Dootchai] Thai Red Cross Soc, Natl Blood Ctr, Bangkok, Thailand; [Issarasongkhram, Mila; Kitphati, Rungrueng; Mungaomklang, Anek] Minist Publ Hlth, Dept Dis Control, Inst Urban Dis Control & Prevent, Bangkok, Thailand; [Thitithanyanont, Arunee] Mahidol Univ, Fac Sci, Dept Microbiol, Bangkok, Thailand; [Nagavajara, Pijaya] Bangkok Metropolitan Adm, Off Permanent Secretary, Bangkok, Thailand	Chulalongkorn University; Thai Red Cross Society; Ministry of Public Health - Thailand; Mahidol University	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Dept Pediat, Bangkok, Thailand.	Yong.P@chula.ac.th	Yorsaeng, Ritthideach/AAD-3153-2019; ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	Yorsaeng, Ritthideach/0000-0001-9391-663X; 	Health Systems Research Institute, National Research Council of Thailand; Center of Excellence in Clinical Virology of Chulalongkorn University/King Chulalongkorn Memorial Hospital [GCE 59 009-30-005]; MK Restaurant Group Public Company; Chulalongkorn University	Health Systems Research Institute, National Research Council of Thailand; Center of Excellence in Clinical Virology of Chulalongkorn University/King Chulalongkorn Memorial Hospital; MK Restaurant Group Public Company; Chulalongkorn University(Chulalongkorn University)	This study was supported by a Health Systems Research Institute, National Research Council of Thailand, the Center of Excellence in Clinical Virology of Chulalongkorn University/King Chulalongkorn Memorial Hospital (GCE 59 009-30-005), MK Restaurant Group Public Company to & nbsp; <ITALIC><BOLD> </BOLD></ITALIC>Yong Poovorawan, and the Second Century Fund (C2F), Chulalongkorn University to Jira Chansaenroj. Jira Chansaenroj received a salary from the Second Century Fund (C2F), Chulalongkorn University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anka AU, 2021, SCAND J IMMUNOL, V93, DOI 10.1111/sji.12998; Bene MC, 2020, CLIN INFECT DIS, V71, P897, DOI 10.1093/cid/ciaa426; Bloch EM, 2020, BLOOD, V136, P654, DOI 10.1182/blood.2020007714; Bloch EM, 2020, J CLIN INVEST, V130, P2757, DOI 10.1172/JCI138745; Brouwer PJM, 2020, SCIENCE, V369, P643, DOI 10.1126/science.abc5902; Chansaenroj J, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-02659-4; Chirathaworn C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236905; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Flieder T, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247665; Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Grandjean L, 2022, CLIN INFECT DIS, V74, P1220, DOI 10.1093/cid/ciab607; Gudbjartsson DF, 2020, NEW ENGL J MED, V383, P1724, DOI 10.1056/NEJMoa2026116; Guo L, 2020, CLIN INFECT DIS, V71, P778, DOI 10.1093/cid/ciaa310; Hsueh PR, 2004, CLIN MICROBIOL INFEC, V10, P1062, DOI 10.1111/j.1469-0691.2004.01009.x; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huang M, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-00209-2; Huang Z, 2020, CLIN EXP IMMUNOL, V202, P210, DOI 10.1111/cei.13500; Iwasaki A, 2020, NAT REV IMMUNOL, V20, P339, DOI 10.1038/s41577-020-0321-6; Iyer AS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe0367; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Leong KW, 2014, DNA CELL BIOL, V33, P823, DOI 10.1089/dna.2014.2639; Levring MB, 2022, J MED VIROL, V94, P1711, DOI 10.1002/jmv.27486; Lippi G, 2020, CLIN CHEM LAB MED, V58, P1156, DOI 10.1515/cclm-2020-0473; Liu L, 2020, EMERG MICROBES INFEC, V9, P1664, DOI 10.1080/22221751.2020.1791738; Muecksch F, 2021, J INFECT DIS, V223, P389, DOI 10.1093/infdis/jiaa659; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; Olas K, 2005, CLIN EXP IMMUNOL, V140, P478, DOI 10.1111/j.1365-2249.2005.02779.x; Oortwijn BD, 2007, MOL IMMUNOL, V44, P966, DOI 10.1016/j.molimm.2006.03.014; Ota Miyo, 2020, Nat Rev Immunol, V20, P351, DOI 10.1038/s41577-020-0316-3; Peterhoff D, 2021, INFECTION, V49, P75, DOI 10.1007/s15010-020-01503-7; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Schaffner A, 2020, J CLIN MED, V9, DOI 10.3390/jcm9123989; Siracusano G, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.772239; Siriwattananon K, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9070744; Sterlin D, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abd2223; Tang JJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21463-2; Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8; Theel ES, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00797-20; To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1; Vacharathit V, 2021, INT J INFECT DIS, V112, P227, DOI 10.1016/j.ijid.2021.09.021; Wajnberg A, 2020, SCIENCE, V370, P1227, DOI 10.1126/science.abd7728; Wang H, 2020, CELL, V182, P713, DOI 10.1016/j.cell.2020.06.008; Ward S, 2020, J ALLERGY CLIN IMMUN, V146, P23, DOI 10.1016/j.jaci.2020.05.012; Wheatley AK, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21444-5; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; World Health Organization, COVID 19 CLIN MAN LI; Yang JY, 2021, NATURE, DOI 10.1038/s41586-020-03108-4; Yu HQ, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01526-2020; Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344; Zhu FC, 2020, LANCET, V396, P479, DOI 10.1016/S0140-6736(20)31605-6	51	4	4	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267102	10.1371/journal.pone.0267102	http://dx.doi.org/10.1371/journal.pone.0267102			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446889	Green Published, gold, Green Submitted			2022-12-26	WOS:000795468200019
J	De Pascale, G; Cutuli, SL; Carelli, S; Xhemalaj, R; Rosa, T; Bello, G; Vargas, J; Cesarano, M; Montini, L; Tanzarella, ES; Pintaudi, G; Di Muro, M; Grieco, DL; Antonelli, M				De Pascale, Gennaro; Cutuli, Salvatore Lucio; Carelli, Simone; Xhemalaj, Rikardo; Rosa, Tommaso; Bello, Giuseppe; Vargas, Joel; Cesarano, Melania; Montini, Luca; Tanzarella, Eloisa Sofia; Pintaudi, Gabriele; Di Muro, Mariangela; Grieco, Domenico Luca; Antonelli, Massimo			Remdesivir plus Dexamethasone in COVID-19: A cohort study of severe patients requiring high flow oxygen therapy or non-invasive ventilation	PLOS ONE			English	Article							SEPSIS; SCORE	IntroductionRemdesivir and Dexamethasone represent the cornerstone of therapy for critically ill patients with acute hypoxemic respiratory failure caused by Coronavirus Disease 2019 (COVID-19). However, clinical efficacy and safety of concomitant administration of Remdesivir and Dexamethasone (Rem-Dexa) in severe COVID-19 patients on high flow oxygen therapy (HFOT) or non-invasive ventilation (NIV) remains unknown. Materials and methodsProspective cohort study that was performed in two medical Intensive Care Units (ICUs) of a tertiary university hospital. The clinical impact of Rem-Dexa administration in hypoxemic patients with COVID-19, who required NIV or HFOT and selected on the simplified acute physiology score II, the sequential organ failure assessment score and the Charlson Comorbidity Index score, was investigated. The primary outcome was 28-day intubation rate; secondary outcomes were end-of-treatment clinical improvement and PaO2/FiO2 ratio, laboratory abnormalities and clinical complications, ICU and hospital length of stay, 28-day and 90-day mortality. ResultsWe included 132 patients and found that 28-day intubation rate was significantly lower among Rem-Dexa group (19.7% vs 48.5%, p<0.01). Although the end-of-treatment clinical improvement was larger among Rem-Dexa group (69.7% vs 51.5%, p = 0.05), the 28-day and 90-day mortalities were similar (4.5% and 10.6% vs. 15.2% and 16.7%; p = 0.08 and p = 0.45, respectively). The logistic regression and Cox-regression models showed that concomitant Rem-Dexa therapy was associated with a reduction of 28-day intubation rate (OR 0.22, CI95% 0.05-0.94, p = 0.04), in absence of laboratory abnormalities and clinical complications (p = ns). ConclusionsIn COVID-19 critically ill patients receiving HFO or NIV, 28-day intubation rate was lower in patients who received Rem-Dexa and this finding corresponded to lower end-of-treatment clinical improvement. The individual contribution of either Remdesevir or Dexamethasone to the observed clinical effect should be further investigated.	[De Pascale, Gennaro; Cutuli, Salvatore Lucio; Carelli, Simone; Xhemalaj, Rikardo; Rosa, Tommaso; Bello, Giuseppe; Vargas, Joel; Cesarano, Melania; Montini, Luca; Tanzarella, Eloisa Sofia; Pintaudi, Gabriele; Di Muro, Mariangela; Grieco, Domenico Luca; Antonelli, Massimo] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Emergenza Anestesiol & Rianimaz, Rome, Italy; [De Pascale, Gennaro; Cutuli, Salvatore Lucio; Carelli, Simone; Xhemalaj, Rikardo; Rosa, Tommaso; Bello, Giuseppe; Vargas, Joel; Cesarano, Melania; Montini, Luca; Tanzarella, Eloisa Sofia; Pintaudi, Gabriele; Di Muro, Mariangela; Grieco, Domenico Luca; Antonelli, Massimo] Univ Cattolica Sacro Cuore, Ist Anestesiol & Rianimaz, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	De Pascale, G (corresponding author), Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Emergenza Anestesiol & Rianimaz, Rome, Italy.; De Pascale, G (corresponding author), Univ Cattolica Sacro Cuore, Ist Anestesiol & Rianimaz, Rome, Italy.	gennaro.depascalemd@gmail.com	Grieco, Domenico Luca/D-9706-2018	Grieco, Domenico Luca/0000-0002-4557-6308; Cutuli, Salvatore Lucio/0000-0001-8135-6284; Di Muro, Mariangela/0000-0002-1070-4955; Vargas, Joel/0000-0002-9765-4945				Arabi YM, 2020, INTENS CARE MED, V46, P2067, DOI 10.1007/s00134-020-06223-y; Arabi YM, 2018, AM J RESP CRIT CARE, V197, P757, DOI 10.1164/rccm.201706-1172OC; Beigel JH, 2021, CURR OPIN CRIT CARE, V27, P487, DOI 10.1097/MCC.0000000000000866; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Benfield T, 2021, CLIN INFECT DIS, V73, P2031, DOI 10.1093/cid/ciab536; Borba MGS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.8857; Borbone N, 2021, MOLECULES, V26, DOI 10.3390/molecules26040986; Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282; Chang D, 2020, JAMA-J AM MED ASSOC, V323, P1092, DOI 10.1001/jama.2020.1623; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; COVID-19 Treatment Guidelines Panel, 2021, COR DIS 2019 COVID 1; Cutuli SL, 2021, MEDICINA-LITHUANIA, V57, DOI 10.3390/medicina57060552; De la Calle C, 2016, EUR J CLIN MICROBIOL, V35, P497, DOI 10.1007/s10096-015-2566-8; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Goldman JD, 2020, NEW ENGL J MED, V383, P1827, DOI 10.1056/NEJMoa2015301; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Grieco DL, 2021, INTENS CARE MED, V47, P851, DOI 10.1007/s00134-021-06459-2; Grieco DL, 2021, JAMA-J AM MED ASSOC, V325, P1731, DOI 10.1001/jama.2021.4682; Hanson K., CLIN INFECT DIS, V2021; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Lapadula G, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa481; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Nili A, 2020, REV MED VIROL, V30, DOI 10.1002/rmv.2133; Olender Susan A, 2021, Clin Infect Dis, V73, pe4166, DOI 10.1093/cid/ciaa1041; Pasquini Z, 2020, J ANTIMICROB CHEMOTH, V75, P3359, DOI 10.1093/jac/dkaa321; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Rochwerg B, 2020, INTENS CARE MED, V46, P2226, DOI 10.1007/s00134-020-06312-y; Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653; Steinberg KP, 2006, NEW ENGL J MED, V354, P1671; Villar J, 2020, LANCET RESP MED, V8, P267, DOI 10.1016/S2213-2600(19)30417-5; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839; Williamson BN, 2020, NATURE, V585, P273, DOI 10.1038/s41586-020-2423-5	35	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267038	10.1371/journal.pone.0267038	http://dx.doi.org/10.1371/journal.pone.0267038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D8GY	35482703	gold, Green Published			2022-12-26	WOS:000794035700074
J	Li, JD; Cen, WD; Tong, CH; Wang, LA; Zhang, WG; Deng, SQV.; Yu, JHV.; Lu, BCV.				Li, Jiandong; Cen, Wenda; Tong, Chenhao; Wang, Luna; Zhang, Weiguang; Deng, Shiqing V.; Yu, Jianhua V.; Lu, Baochun V.			Fangchinoline induces gallbladder cancer cell apoptosis by suppressing PI3K/Akt/XIAP axis	PLOS ONE			English	Article							FOCAL ADHESION KINASE; SIGNALING PATHWAY; PROLIFERATION; INHIBITOR; AUTOPHAGY; THERAPY; FAK; AKT	Gallbladder cancer (GBC) is the most common biliary tract malignancy with a dismal prognosis. The development of new drugs may help to improve prognosis. This study found that fangchinoline, a bisbenzylisoquinoline alkaloids, inhibited the proliferation and clone formation of GBC cells in a dose-dependent manner. Moreover, Hoechst staining, TUNEL assays, and flow cytometry demonstrated that fangchinoline effectively induced apoptosis in GBC cells. Further studies found that an anti-apoptotic pathway, the PI3K/Akt/XIAP axis, was significantly inhibited in GBC cells after treating with fangchinoline. Finally, we confirmed that fangchinoline restrained xenograft tumor growth in vivo. Our findings indicate that fangchinoline can be considered a potential drug for GBC treatment.	[Li, Jiandong; Tong, Chenhao; Wang, Luna] Zhejiang Univ Sch Med, Hangzhou, Zhejiang, Peoples R China; [Li, Jiandong; Cen, Wenda; Tong, Chenhao; Wang, Luna; Deng, Shiqing V.; Yu, Jianhua V.; Lu, Baochun V.] Zhejiang Univ Sch Med, Shaoxing Peoples Hosp, Shaoxing Hosp, Dept Hepatobiliary Surg, Shaoxing, Zhejiang, Peoples R China; [Li, Jiandong; Cen, Wenda; Tong, Chenhao; Wang, Luna; Deng, Shiqing V.; Yu, Jianhua V.; Lu, Baochun V.] Shaoxing Key Lab Minimally Invas Abdominal Surg &, Shaoxing, Zhejiang, Peoples R China; [Cen, Wenda; Deng, Shiqing V.; Yu, Jianhua V.; Lu, Baochun V.] Shaoxing Univ, Affiliated Hosp 1, Shaoxing, Zhejiang, Peoples R China; [Zhang, Weiguang] Shaoxing Second Hosp, Dept Mol Med Clin Lab, Shaoxing, Zhejiang, Peoples R China	Shaoxing University	Yu, JHV.; Lu, BCV. (corresponding author), Zhejiang Univ Sch Med, Shaoxing Peoples Hosp, Shaoxing Hosp, Dept Hepatobiliary Surg, Shaoxing, Zhejiang, Peoples R China.; Yu, JHV.; Lu, BCV. (corresponding author), Shaoxing Key Lab Minimally Invas Abdominal Surg &, Shaoxing, Zhejiang, Peoples R China.; Yu, JHV.; Lu, BCV. (corresponding author), Shaoxing Univ, Affiliated Hosp 1, Shaoxing, Zhejiang, Peoples R China.	yujianhua@zju.edu.cn; sygd_lbc@126.com			Zhejiang Provincial Natural Science Foundation of China [81602044, 2022RC080]; National Natural Science Foundation of China (NSFC) [2020RC127]; Zhejiang Provincial Medical and Health Science and Technology Project [2019ZD057];  [LY22H160008];  [LY19H160016];  [LBY22H030001]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Medical and Health Science and Technology Project; ; ; 	This work was supported by Zhejiang Provincial Natural Science Foundation of China under grant no. LY22H160008, LY19H160016, National Natural Science Foundation of China (NSFC) no. 81602044, Zhejiang Provincial Medical and Health Science and Technology Project under grant no. 2022RC080 and 2020RC127. Dr. Jianhua Yu received these funding and was responsible for the decision to publish this manuscript. This work was also supported by Zhejiang Provincial Natural Science Foundation of China under grant no. LBY22H030001 and Zhejiang Provincial Medical and Health Science and Technology Project under grant no. 2019ZD057. Dr. Baochun Lu received the funding and was responsible for data collection of this manuscript.	Baiu Ioana, 2018, JAMA, V320, P1294, DOI 10.1001/jama.2018.11815; Bredesen DE, 1995, ANN NEUROL, V38, P839, DOI 10.1002/ana.410380604; Choi HS, 2000, J ETHNOPHARMACOL, V69, P173, DOI 10.1016/S0378-8741(99)00141-5; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Demircioglu F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15104-3; Fan B, 2017, CELL PHYSIOL BIOCHEM, V43, P1003, DOI 10.1159/000481698; Feng FB, 2018, BIOMED PHARMACOTHER, V102, P1209, DOI 10.1016/j.biopha.2018.03.142; Goldar Samira, 2015, Asian Pac J Cancer Prev, V16, P2129; Guo BY, 2016, TUMOR BIOL, V37, P2709, DOI 10.1007/s13277-015-3990-1; Guo BY, 2015, J DRUG TARGET, V23, P266, DOI 10.3109/1061186X.2014.992898; Hao HF, 2009, ONCOL REP, V22, P973, DOI 10.3892/or_00000524; Harmon BV, 1997, ADV GENET, V35, P35, DOI 10.1016/S0065-2660(08)60447-2; Hellmann MD, 2019, NEW ENGL J MED, V381, P2020, DOI 10.1056/NEJMoa1910231; HOCKENBERY D, 1995, AM J PATHOL, V146, P16; Kim C, 2018, NUTRIENTS, V10, DOI 10.3390/nu10081021; Kim HS, 1997, J ETHNOPHARMACOL, V58, P117, DOI 10.1016/S0378-8741(97)00092-5; Krell RW, 2019, CHIN CLIN ONCOL, V8, DOI 10.21037/cco.2019.06.06; Lamarca A, 2014, ANN ONCOL, V25, P2328, DOI 10.1093/annonc/mdu162; Lee HS, 2017, TOXICOL APPL PHARM, V332, P32, DOI 10.1016/j.taap.2017.07.017; Li D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141681; Li T, 2020, BIOCHEM PHARMACOL, V175, DOI 10.1016/j.bcp.2020.113921; Li XC, 2017, INT J MOL MED, V40, P311, DOI 10.3892/ijmm.2017.3013; Ma YH, 2016, ONCOL REP, V36, P49, DOI 10.3892/or.2016.4820; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Morizane C, 2018, JPN J CLIN ONCOL, V48, P703, DOI 10.1093/jjco/hyy082; Pawson T, 2000, GENE DEV, V14, P1027; Pistritto G, 2016, AGING-US, V8, P603, DOI 10.18632/aging.100934; Reyes-Farias M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133177; Schmidt MA, 2019, CHIN CLIN ONCOL, V8, DOI 10.21037/cco.2019.08.13; Shi J, 2017, ONCOL REP, V38, P63, DOI 10.3892/or.2017.5678; Su DM, 2017, BIOMED PHARMACOTHER, V93, P1197, DOI 10.1016/j.biopha.2017.07.063; Tang SM, 2020, BIOMED PHARMACOTHER, V121, DOI 10.1016/j.biopha.2019.109604; Tsutsumi T, 2003, BIOL PHARM BULL, V26, P313, DOI 10.1248/bpb.26.313; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wang CD, 2014, ASIAN PAC J CANCER P, V15, P769, DOI 10.7314/APJCP.2014.15.2.769; Xing ZB, 2011, CHEM PHARM BULL, V59, P1476, DOI 10.1248/cpb.59.1476; Xing ZB, 2013, PHYTOTHER RES, V27, P1790, DOI 10.1002/ptr.4936; Yang J, 2020, EUR J MED CHEM, V186, DOI 10.1016/j.ejmech.2019.111898; Zhang FJ, 2012, J PHARM PHARMACOL, V64, P120, DOI 10.1111/j.2042-7158.2011.01382.x; Zhou J, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1265-1	40	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266738	10.1371/journal.pone.0266738	http://dx.doi.org/10.1371/journal.pone.0266738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446864	Green Published, gold			2022-12-26	WOS:000795468200016
J	Marquioni, V; Rossi, FPN; Mendonca, DC; Martins, LF; Behlau, F; Setubal, JC; da Silva, AM; Novo-Mansur, MTM				Marquioni, Vinicius; Nobre Rossi, Fernando Pacheco; Mendonca, Deborah Cezar; Martins, Layla Farage; Behlau, Franklin; Setubal, Joao Carlos; da Silva, Aline Maria; Marques Novo-Mansur, Maria Teresa			Isolation and characterization of vB_XciM_LucasX, a new jumbo phage that infects Xanthomonas citri and Xanthomonas fuscans	PLOS ONE			English	Article							FILAMENTOUS PHAGE; BACTERIOPHAGES; TREES; BACTERIA; SEQUENCE; GENOME; AGENTS	Citrus canker is one of the main bacterial diseases that affect citrus crops and is caused by Xanthomonas citri which affects all citrus species worldwide. New strategies to control citrus canker are necessary and the use of bacteriophages as biocontrol agent could be an alternative. Phages that infect Xanthomonas species have been studied, such as XacN1, a myovirus that infects X. citri. Here we report the isolation and characterization of a new jumbo phage, vb_XciM_LucasX, which infects X. citri and X. fuscans. Transmission electron microscopy allowed classification of LucasX in the Myoviridae family, which was corroborated by its genomic sequencing, annotation, and proteome clustering. LucasX has a 305,651 bp-long dsDNA genome. ORF prediction and annotation revealed 157 genes encoding putative structural proteins such as capsid and tail related proteins and phage assembly associated proteins, however, for most of the structural proteins it was not possible assign specific functions. Its genome encodes several proteins related to DNA replication and nucleotide metabolism, five putative RNA polymerases, at least one homing endonuclease mobile element, a terminase large subunit (TerL), an endolysin and many proteins classified as beneficial to the host. Proteome clustering and phylogeny analyses showed that LucasX is a new jumbo phage having as its closest neighbor the Xanthomonas jumbo phage Xoo-sp14. LucasX presented a burst size of 40 PFU/infected cell of X. citri 306, was completely inactivated at temperatures above 50 degrees C, presented survival lower than 25% after 80 s of exposition to artificial UV light and had practically no tolerance to concentrations above 2.5 g/L NaCl or 40% ethanol. LucasX presented optimum pH at 7 and a broad range of Xanthomonas hosts, infecting twenty-one of the twenty-three strains tested. Finally, the LucasX yield was dependent on the host strain utilized, resulting one order of magnitude higher in X. fuscans C 752 than in X. citri 306, which points out to the possibility of phage yield improvement, an usual challenge for biocontrol purposes.	[Marquioni, Vinicius; Marques Novo-Mansur, Maria Teresa] Univ Fed Sao Carlos UFSCar, Dept Genet & Evolucao DGE, Lab Bioquim & Biol Mol Aplicada LBBMA, Sao Carlos, SP, Brazil; [Nobre Rossi, Fernando Pacheco; Martins, Layla Farage; Setubal, Joao Carlos; da Silva, Aline Maria] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, SP, Brazil; [Mendonca, Deborah Cezar] Univ Sao Paulo, Inst Fis Sao Carlos, Grp Biofis & Biol Estrutural Sergio Mascarenhas, Sao Carlos, SP, Brazil; [Behlau, Franklin] Fundo Def Citricultura Fundecitrus, Dept Pesquisa & Desenvolvimento, Araraquara, SP, Brazil	Universidade Federal de Sao Carlos; Universidade de Sao Paulo; Universidade de Sao Paulo; Fundo de Defesa da Citricultura	Novo-Mansur, MTM (corresponding author), Univ Fed Sao Carlos UFSCar, Dept Genet & Evolucao DGE, Lab Bioquim & Biol Mol Aplicada LBBMA, Sao Carlos, SP, Brazil.	marinovo@ufscar.br	da Silva, Aline Maria/C-3649-2012; Mansur, Maria Teresa Marques Novo/G-4779-2012; Setubal, Joao Carlos/C-7305-2012; Behlau, Franklin/K-7012-2012	da Silva, Aline Maria/0000-0001-9249-4922; Mansur, Maria Teresa Marques Novo/0000-0003-0308-6287; Setubal, Joao Carlos/0000-0001-9174-2816; Behlau, Franklin/0000-0001-5964-9494; Pacheco Nobre Rossi, Fernando/0000-0003-4196-9208	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brazil (CAPES) [001]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [2007/50910-2]; CAPES; Conselho Nacional de Desenvolvimento Cienti'fico e Tecnologico (CNPq); FAPESP [2009/54216-9]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cienti'fico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brazil (CAPES) -Finance Code 001 (VM) and by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo -FAPESP (Programa Jovem Pesquisador -Proc. 2007/50910-2). FPNR was supported by a fellowship from CAPES. AMDS and JCS received a Research Fellowship Award from the Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnologico (CNPq). EM facility utilized at LME/IQSC was supported by FAPESP (grant 2009/54216-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid D., 2018, BIORXIV, P477885, DOI [10.1101/477885, DOI 10.1101/477885]; Ahmad AA, 2017, FEBS OPEN BIO, V7, P1715, DOI 10.1002/2211-5463.12312; Ahmad AA, 2014, APPL ENVIRON MICROB, V80, P77, DOI 10.1128/AEM.02310-13; Ajuebor J, 2018, ANTIBIOTICS-BASEL, V7, DOI 10.3390/antibiotics7020037; Vojnov AA, 2010, APPL MICROBIOL BIOT, V87, P467, DOI 10.1007/s00253-010-2631-2; [Anonymous], BABRAHAM BIOINFORMAT; Balogh B, 2003, PLANT DIS, V87, P949, DOI 10.1094/PDIS.2003.87.8.949; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BBToolsDOE Joint Genome Institute, BBTOOLSDOE JOINT GEN; Behlau F, 2020, TROP PLANT PATHOL, V45, P200, DOI 10.1007/s40858-020-00340-1; Bhunchoth A, 2015, J APPL MICROBIOL, V118, P1023, DOI 10.1111/jam.12763; Bock CH, 2010, PLANT DIS, V94, P725, DOI 10.1094/PDIS-94-6-0725; Bolduc B, 2017, PEERJ, V5, DOI 10.7717/peerj.3243; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boyacioglu Olcay, 2013, Bacteriophage, V3, pe24620; Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365; Buttimer Colin, 2017, Front Microbiol, V8, P34, DOI 10.3389/fmicb.2017.00034; Carroll-Portillo A, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13020328; Clavijo-Coppens F, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13050725; Czajkowski R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119812; D'Accolti M, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9020261; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Das M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128902; Di Lallo G, 2014, J BASIC MICROB, V54, P1210, DOI 10.1002/jobm.201300951; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Ference CM, 2018, MOL PLANT PATHOL, V19, P1302, DOI 10.1111/mpp.12638; Ferguson Sean, 2013, Bacteriophage, V3, pe24323; Garcia R, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01187; Gasic K, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02021; Gottwald T. R., 2002, Plant Health Progress, P1; Graham JH, 2004, MOL PLANT PATHOL, V5, P1, DOI 10.1046/j.1364-3703.2004.00197.x; Iriarte FB, 2007, APPL ENVIRON MICROB, V73, P1704, DOI 10.1128/AEM.02118-06; Jones Jeffrey B, 2012, Bacteriophage, V2, P208, DOI 10.4161/bact.23857; Jurac K, 2019, APPL MICROBIOL BIOT, V103, P685, DOI 10.1007/s00253-018-9527-y; Kim SG, 2021, MICROB CELL FACT, V20, DOI 10.1186/s12934-021-01549-8; Kizheva Y, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e07084; Korf IHE, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12121470; Kropinski AM, 2009, ENVIRON MICROBIOL, V11, P2775, DOI 10.1111/j.1462-2920.2009.01970.x; Kwon J, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13010027; Lamichhane JR, 2018, AGRON SUSTAIN DEV, V38, DOI 10.1007/s13593-018-0503-9; Lang AS, 2012, NAT REV MICROBIOL, V10, P472, DOI 10.1038/nrmicro2802; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lanza FE., 2018, CHARACTERISTICS CITR, V109, P44, DOI 101094/PHYTO-04-18-0114-R; Mancuso F, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100537; Manohar P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206278; McNair K, 2019, BIOINFORMATICS, V35, P4537, DOI 10.1093/bioinformatics/btz265; Moreira LM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-238; Narr A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01975; Nazir A, 2020, MICROBIOL RESOUR ANN, V9, DOI 10.1128/MRA.01072-20; Neumann E, 2020, J GEN VIROL, V101, P1219, DOI 10.1099/jgv.0.001487; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Hippler FWR, 2018, ENVIRON SCI POLLUT R, V25, P13134, DOI 10.1007/s11356-018-1529-x; Rombouts S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00279; Sauvageau D, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-81; SOLIOZ M, 1977, ARCH BIOCHEM BIOPHYS, V181, P300, DOI 10.1016/0003-9861(77)90508-2; Timilsina S, 2020, NAT REV MICROBIOL, V18, P415, DOI 10.1038/s41579-020-0361-8; Wei CH, 2017, VIROL SIN, V32, P476, DOI 10.1007/s12250-017-3987-6; Yang MY, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00259; Yeh TY, 2017, ARCH VIROL, V162, P567, DOI 10.1007/s00705-016-3105-3; Yeh TY, 2020, VIROLOGY, V548, P160, DOI 10.1016/j.virol.2020.06.010; Yoshikawa G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22239-3; Yuan YH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00403; Zurabov F, 2021, VIROL J, V18, DOI 10.1186/s12985-020-01485-w	63	1	1	7	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266891	10.1371/journal.pone.0266891	http://dx.doi.org/10.1371/journal.pone.0266891			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421196	gold, Green Published			2022-12-26	WOS:000795453600077
J	Molina, A; Vyas, P; Khlystov, N; Kumar, S; Kothari, A; Deriso, D; Liu, ZR; Banavar, S; Flaum, E; Prakash, M				Molina, Anton; Vyas, Pranav; Khlystov, Nikita; Kumar, Shailabh; Kothari, Anesta; Deriso, Dave; Liu, Zhiru; Banavar, Samhita; Flaum, Eliott; Prakash, Manu			Low cost centrifugal melt spinning for distributed manufacturing of non-woven media	PLOS ONE			English	Article							WILDFIRE; FABRICATION; CLIMATE	Centralized manufacturing and global supply chains have emerged as an efficient strategy for large-scale production of goods throughout the 20th century. However, while this system of production is highly efficient, it is not resilient. The COVID-19 pandemic has seen numerous supply chains fail to adapt to sudden changes in supply and demand, including those for goods critical to the pandemic response such as personal protective equipment. Here, we consider the production of the non-woven polypropylene filtration media used in face filtering respirators (FFRs). The FFR supply chain's reliance on non-woven media sourced from large, centralized manufacturing facilities led to a supply chain failure. In this study, we present an alternative manufacturing strategy that allows us to move towards a more distributed manufacturing practice that is both scalable and robust. Specifically, we demonstrate that a fiber production technique known as centrifugal melt spinning can be implemented with modified, commercially-available cotton candy machines to produce nano- and microscale non-woven fibers. We evaluate several post processing strategies to transform the produced material into viable filtration media and then characterize these materials by measuring filtration efficiency and breathability, comparing them against equivalent materials used in commercially-available FFRs. Additionally, we demonstrate that waste plastic can be processed with this technique, enabling the development of distributed recycling strategies to address the growing plastic waste crisis. Since this method can be employed at small scales, it allows for the development of an adaptable and rapidly deployable distributed manufacturing network for non-woven materials that is financially accessible to more people than is currently possible.	[Molina, Anton] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA USA; [Molina, Anton; Vyas, Pranav; Kumar, Shailabh; Kothari, Anesta; Banavar, Samhita; Prakash, Manu] Stanford Univ, Dept Bioengn, Stanford, CA USA; [Khlystov, Nikita] Stanford Univ, Dept Chem Engn, Stanford, CA USA; [Deriso, Dave] Stanford Univ, Dept Elect Engn, Stanford, CA USA; [Liu, Zhiru] Stanford Univ, Dept Appl Phys, Stanford, CA USA; [Flaum, Eliott] Stanford Univ, Program Biophys, Stanford, CA USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Prakash, M (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA USA.	manup@stanford.edu		Flaum, Eliott/0000-0001-8737-7967; Prakash, Manu/0000-0002-8046-8388; Liu, Zhiru/0000-0002-2604-631X	UCSF COVID-19 Response Fund; Schmidt Futures; NSF CCC grant [DBI1548297]; HHMI-Gates Faculty Award; NSF Graduate Research Fellowship Program; Moore Foundation	UCSF COVID-19 Response Fund; Schmidt Futures; NSF CCC grant; HHMI-Gates Faculty Award; NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); Moore Foundation(Gordon and Betty Moore Foundation)	MP thanks UCSFCOVID-19 Response Fund, Schmidt Futures, Moore Foundation, NSFCCC grant(DBI1548297), CZ BioHub, and HHMI Gates Faculty Award for financial support of the project.AM is supported by NSF Graduate Research Fellowship Program. The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.	Abatzoglou JT, 2016, P NATL ACAD SCI USA, V113, P11770, DOI 10.1073/pnas.1607171113; Abraham JP, 2020, REV MED VIROL, V30, DOI 10.1002/rmv.2115; Adams S, 2019, ANN ONCOL, V30, P397, DOI 10.1093/annonc/mdy517; Amaya L., 2020, FSG; [Anonymous], 2021, PLASTIC BANK; Badrossamay MR, 2010, NANO LETT, V10, P2257, DOI 10.1021/nl101355x; Bai Y, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201706680; Bandi MM, 2020, P ROY SOC A-MATH PHY, V476, DOI 10.1098/rspa.2020.0469; BBC, 2020, CHINA MAKES THEM HAS; Bitker J., 2020, FACEBOOK FLEXPORT BA; Bonilla R, 2012, J MICROSC-OXFORD, V248, P266, DOI 10.1111/j.1365-2818.2012.03671.x; Brooks AL, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat0131; Buckminster Fuller Institute, 2017, MAT; Chagas AM, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000730; Chen HH, 2017, TEXT RES J, V87, P2349, DOI 10.1177/0040517516671121; Corsini L, 2019, TECHNOL SOC, V58, DOI 10.1016/j.techsoc.2019.02.003; Fan X, 2018, ACS SUSTAIN CHEM ENG, V6, P11606, DOI 10.1021/acssuschemeng.8b01827; Farrell H., 2020, WILL GOVT RESTRICT F; Glampedaki P., 2015, SUPERABSORBENT FINIS; GUTMANN F, 1948, REV MOD PHYS, V20, P457, DOI 10.1103/RevModPhys.20.457; Han XL, 2006, ENVIRON INT, V32, P106, DOI 10.1016/j.envint.2005.05.020; Hossain E, 2020, PHYS FLUIDS, V32, DOI 10.1063/5.0023940; Hutten IM., 2007, HDB NONWOVEN FILTER; Ilyas S, 2020, SCI TOTAL ENVIRON, V749, DOI 10.1016/j.scitotenv.2020.141652; Jafari M, 2021, SEP PURIF TECHNOL, V260, DOI 10.1016/j.seppur.2020.118185; James L, 2017, ZSPOOLS; Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022; Kao K.-C., 2004, DIELECTRIC PHENOMENA; Knorr W, 2016, BIOGEOSCIENCES, V13, P267, DOI 10.5194/bg-13-267-2016; Konda A, 2020, ACS NANO, V14, P6339, DOI 10.1021/acsnano.0c03252; Kowalski W., 1999, ASHRAE T, V105; Kreiger M, 2013, ACS SUSTAIN CHEM ENG, V1, P1511, DOI 10.1021/sc400093k; Laplume AO, 2016, J INT BUS STUD, V47, P595, DOI 10.1057/jibs.2015.47; Lee J, 2020, POLYMERS-BASEL, V12, DOI 10.3390/polym12030721; Leite Karina F S, 2021, Public Health Pract (Oxf), V2, P100094, DOI 10.1016/j.puhip.2021.100094; Liao L, 2020, ACS NANO, V14, P6348, DOI 10.1021/acsnano.0c03597; Linton T., 2020, HARVARD BUS REV; Liu C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7205; Liu YJ, 2020, J APPL POLYM SCI, V137, DOI 10.1002/app.48299; Mellado P, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3662015; Mohammed MI, 2019, ACS SUSTAIN CHEM ENG, V7, P13955, DOI 10.1021/acssuschemeng.9b02368; Nel A, 2005, SCIENCE, V308, P804, DOI 10.1126/science.1108752; Padron S, 2013, J APPL PHYS, V113, DOI 10.1063/1.4769886; Patel A, 2017, HEALTH SECUR, V15, P244, DOI 10.1089/hs.2016.0129; Pearce JM, 2020, J MANUF MATER PROC, V4, DOI 10.3390/jmmp4020049; Peters A, 2021, ANTIMICROB RESIST IN, V10, DOI 10.1186/s13756-021-00921-y; Prakash Lab, 2020, PROJECT 1000 BY 1000; Prata JC, 2020, ENVIRON SCI TECHNOL, V54, P7760, DOI 10.1021/acs.est.0c02178; Raghavan B, 2013, J ENG FIBER FABR, V8, P52; Ramsden P, 2015, MAKING GOOD OUR FUTU; Rauch E, 2016, J CLEAN PROD, V135, P127, DOI 10.1016/j.jclepro.2016.06.106; Reifenhauser GmbH, 2020, REIF REIC SHORT DEL; Rogalski JJ, 2017, NANOCOMPOSITES, V3, P97, DOI 10.1080/20550324.2017.1393919; Saberian M, 2021, SCI TOTAL ENVIRON, V769, DOI 10.1016/j.scitotenv.2021.145527; Sanchez FAC, 2020, J CLEAN PROD, V264, DOI 10.1016/j.jclepro.2020.121602; Santander P, 2020, RESOUR CONSERV RECY, V154, DOI 10.1016/j.resconrec.2019.104531; Sarkar K, 2010, MATER TODAY, V13, P12, DOI 10.1016/S1369-7021(10)70199-1; Srai JS, 2016, INT J PROD RES, V54, P6917, DOI 10.1080/00207543.2016.1192302; Sterr CM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248099; Sugihara K, 2021, SOFT MATTER, V17, P10, DOI 10.1039/d0sm02004d; Textile World, 2020, SINOPEC PUTS ITS 1 M; Trump Donald, 2020, PROCLAMATION SUSPENS; Ullah S, 2020, ACS APPL NANO MATER, V3, P7231, DOI 10.1021/acsanm.0c01562; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; Veit D., 2015, TEXTILE TECHNOLOGY I; Weiss RR, 1989, US Patent, Patent No. [4,872,821, 4872821 4872821]; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Xu Jiaquan, 2020, NCHS Data Brief, P1; Yu CJ, 2016, MATER DESIGN, V107, P171, DOI 10.1016/j.matdes.2016.06.044; Zander NE, 2017, MATERIALS, V10, DOI 10.3390/ma10091044; Zangmeister CD, 2020, ACS NANO, V14, P9188, DOI 10.1021/acsnano.0c05025; Zhang R, 2013, ATMOS CHEM PHYS, V13, P7053, DOI 10.5194/acp-13-7053-2013; Zhang RY, 2020, P NATL ACAD SCI USA, V117, P14857, DOI 10.1073/pnas.2009637117; Zhao M, 2020, NANO LETT, V20, P5544, DOI 10.1021/acs.nanolett.0c02211; Zhong S, 2018, RESOUR CONSERV RECY, V128, P48, DOI 10.1016/j.resconrec.2017.09.023	76	0	0	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0264933	10.1371/journal.pone.0264933	http://dx.doi.org/10.1371/journal.pone.0264933			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7VA	35439249	Green Published, gold			2022-12-26	WOS:000791280100023
J	Ruonala, V; Pekkonen, E; Airaksinen, O; Kankaanpaa, M; Karjalainen, PA; Rissanen, SM				Ruonala, Verneri; Pekkonen, Eero; Airaksinen, Olavi; Kankaanpaa, Markku; Karjalainen, Pasi A.; Rissanen, Saara M.			Changes in elbow flexion EMG morphology during adjustment of deep brain stimulator in advanced Parkinson's disease	PLOS ONE			English	Article							SUBTHALAMIC NUCLEUS; SIGNAL MORPHOLOGY; SURFACE EMG; MEDICATION; TREMOR; NEUROSTIMULATION; PARAMETERS; PATTERNS; FEATURES	Objective Deep brain stimulation (DBS) is an effective treatment for motor symptoms of advanced Parkinson's disease (PD). Currently, DBS programming outcome is based on a clinical assessment. In an optimal situation, an objectively measurable feature would assist the operator to select the appropriate settings for DBS. Surface electromyographic (EMG) measurements have been used to characterise the motor symptoms of PD with good results; with proper methodology, these measurements could be used as an aid to program DBS. Methods Muscle activation measurements were performed for 13 patients who had advanced PD and were treated with DBS. The DBS pulse voltage, frequency, and width were changed during the measurements. The measured EMG signals were analysed with parameters that characterise the EMG signal morphology, and the results were compared to the clinical outcome of the adjustment. Results The EMG signal correlation dimension, recurrence rate, and kurtosis changed significantly when the DBS settings were changed. DBS adjustment affected the signal recurrence rate the most. Relative to the optimal settings, increased recurrence rates (median +/- IQR) 1.1 +/- 0.5 (-0.3 V), 1.3 +/- 1.1 (+0.3 V), 1.7 +/- 0.4 (-30 Hz), 1.7 +/- 0.8 (+30 Hz), 2.0 +/- 1.7 (+30 mu s), and 1.5 +/- 1.1 (DBS off) were observed. With optimal stimulation settings, the patients' Unified Parkinson's Disease Rating Scale motor part (UPDRS-III) score decreased by 35% on average compared to turning the device off. However, the changes in UPRDS-III arm tremor and rigidity scores did not differ significantly in any settings compared to the optimal stimulation settings. Conclusion Adjustment of DBS treatment alters the muscle activation patterns in PD patients. The changes in the muscle activation patterns can be observed with EMG, and the parameters calculated from the signals differ between optimal and non-optimal settings of DBS. This provides a possibility for using the EMG-based measurement to aid the clinicians to adjust the DBS.	[Ruonala, Verneri; Karjalainen, Pasi A.; Rissanen, Saara M.] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Pekkonen, Eero] Helsinki Univ Hosp, Dept Neurol, Helsinki, Finland; [Pekkonen, Eero] Univ Helsinki, Dept Clin Neurosci Neurol, Helsinki, Finland; [Airaksinen, Olavi] Kuopio Univ Hosp, Dept Physiol & Rehabil Med, Kuopio, Finland; [Kankaanpaa, Markku] Tampere Univ Hosp, Dept Physiol & Rehabil Med, Tampere, Finland	University of Eastern Finland; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Kuopio University Hospital; University of Eastern Finland; Tampere University; Tampere University Hospital	Ruonala, V (corresponding author), Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland.	verneri.ruonala@uef.fi	Rissanen, Saara/F-7500-2011; Karjalainen, Pasi/G-4043-2016	Rissanen, Saara/0000-0003-0669-347X; Karjalainen, Pasi/0000-0002-1267-493X; Pekkonen, Eero/0000-0003-1621-8752	Academy of Finland [252748]	Academy of Finland(Academy of Finland)	This study was supported by the Academy of Finland under project 252748. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blahak C, 2009, MOVEMENT DISORD, V24, P1221, DOI 10.1002/mds.22536; Brocker DT, 2013, EXP NEUROL, V239, P60, DOI 10.1016/j.expneurol.2012.09.008; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Flament D, 2003, CLIN NEUROPHYSIOL, V114, P2385, DOI 10.1016/S1388-2457(03)00254-2; Heida T, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-70; Heldman DA, 2014, PARKINSONISM RELAT D, V20, P590, DOI 10.1016/j.parkreldis.2014.02.022; Hellwig B, 2009, CLIN NEUROPHYSIOL, V120, P431, DOI 10.1016/j.clinph.2008.11.002; Koeglsperger T, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00410; Levin J, 2009, MOVEMENT DISORD, V24, P57, DOI 10.1002/mds.22291; LeWitt PA, 2008, NEW ENGL J MED, V359, P2468, DOI 10.1056/NEJMct0800326; Meigal AI, 2009, J ELECTROMYOGR KINES, V19, pE206, DOI 10.1016/j.jelekin.2008.02.008; Mewett DT, 2004, MED BIOL ENG COMPUT, V42, P524, DOI 10.1007/BF02350994; Montgomery J., 2016, DEEP BRAIN STIMULATI, P4979; Muthuraman M, 2011, MOVEMENT DISORD, V26, P1548, DOI 10.1002/mds.23672; Nieminen H, 1996, Electromyogr Clin Neurophysiol, V36, P49; Pfann KD, 2001, MOVEMENT DISORD, V16, P1048, DOI 10.1002/mds.1220; Rissanen S, 2007, PHYSIOL MEAS, V28, P1507, DOI 10.1088/0967-3334/28/12/005; Rissanen SM, 2015, CLIN NEUROPHYSIOL, V126, P2290, DOI 10.1016/j.clinph.2015.01.021; Rissanen SM, 2011, IEEE T BIO-MED ENG, V58, P2545, DOI 10.1109/TBME.2011.2159380; Rissanen SM, 2009, IEEE T BIO-MED ENG, V56, P2280, DOI 10.1109/TBME.2009.2023795; Robichaud JA, 2002, MOVEMENT DISORD, V17, P950, DOI 10.1002/mds.10218; Ruonala V, 2014, J ELECTROMYOGR KINES, V24, P300, DOI 10.1016/j.jelekin.2013.12.007; Ruonala V, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00035; Schapira AHV, 2017, NAT REV NEUROSCI, V18, P435, DOI 10.1038/nrn.2017.62; Schuepbach WMM, 2013, NEW ENGL J MED, V368, P610, DOI 10.1056/NEJMoa1205158; Steigerwald F, 2016, MOVEMENT DISORD, V31, P1240, DOI 10.1002/mds.26669; Sturman MM, 2004, BRAIN, V127, P2131, DOI 10.1093/brain/awh237; Tarvainen MP, 2002, IEEE T BIO-MED ENG, V49, P172, DOI 10.1109/10.979357; Vaillancourt DE, 2006, MOVEMENT DISORD, V21, P50, DOI 10.1002/mds.20672; Volkmann J, 2002, MOVEMENT DISORD, V17, pS181, DOI 10.1002/mds.10162; WEBBER CL, 1994, J APPL PHYSIOL, V76, P965, DOI 10.1152/jappl.1994.76.2.965	31	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266936	10.1371/journal.pone.0266936	http://dx.doi.org/10.1371/journal.pone.0266936			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421176	Green Published, gold			2022-12-26	WOS:000795453600085
J	Shutters, ST; Applegate, JM				Shutters, Shade T.; Applegate, J. M.			The urban wage premium is disappearing in US micropolitan areas	PLOS ONE			English	Article							CITIES; GLOBALIZATION; GROWTH	A key driver of urbanization is the pursuit of economic opportunities in cities. One such opportunity is the promise of higher wages in larger cities, a phenomenon known as the urban wage premium. While an urban wage premium has been well-documented among U. S. metropolitan areas, little is known about its existence in micropolitan areas, which represent an important link between rural and dense urban areas. Here we measure the power law scaling coefficient of annual wages versus employment for both U.S. metropolitan and micropolitan areas over a 37-year period. We take this coefficient to be a quantification of the urban wage premium for each type of urban area and find the relationship is superlinear in all years for both area types. Though both area types once had wage premiums of similar magnitude, the wage premium in micropolitan areas has steadily declined since the late 1980s while in metropolitan areas it has generally increased. This growing gap between micropolitan and metropolitan wage premiums is ongoing in parallel to other diverging characteristics, such as inequality and voting behavior, suggesting that our result is part of a broader social, cultural, and political divergence between small and large cities. Finally, we speculate that if urban residents respond to the COVID-19 crisis by migrating, the trends we describe may change significantly.	[Shutters, Shade T.; Applegate, J. M.] Arizona State Univ, Sch Complex Adapt Syst, Tempe, AZ 85281 USA; [Shutters, Shade T.; Applegate, J. M.] Global Climate Forum, Berlin, Germany	Arizona State University; Arizona State University-Tempe	Shutters, ST (corresponding author), Arizona State Univ, Sch Complex Adapt Syst, Tempe, AZ 85281 USA.; Shutters, ST (corresponding author), Global Climate Forum, Berlin, Germany.	shade.shutters@asu.edu						Alessia M, 2020, J REGIONAL SCI, V60, P823, DOI 10.1111/jors.12486; Atkinson AB, 2011, J ECON LIT, V49, P3, DOI 10.1257/jel.49.1.3; Balland PA, 2020, NAT HUM BEHAV, V4, P248, DOI 10.1038/s41562-019-0803-3; Bendix A, COR PAND SPELLS END; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2014, SCI REP-UK, V4, DOI 10.1038/srep05393; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Blien U, 2009, ANN REGIONAL SCI, V43, P71, DOI 10.1007/s00168-007-0205-8; Carlsen F, 2016, REG SCI URBAN ECON, V60, P39, DOI 10.1016/j.regsciurbeco.2016.06.006; Combes PP, 2008, J URBAN ECON, V63, P723, DOI 10.1016/j.jue.2007.04.004; Cordes SM., 2015, MICROPOLITAN AM NEW; CQ Press, 2020, PRES GEN EL RET COUN; Cunningham C, 2016, J ECON BEHAV ORGAN, V126, P120, DOI 10.1016/j.jebo.2016.01.001; D'Costa S, 2014, REG SCI URBAN ECON, V48, P168, DOI 10.1016/j.regsciurbeco.2014.06.006; DIELEMAN FM, 1994, URBAN STUD, V31, P357, DOI 10.1080/00420989420080371; Echeverri-Carroll EL, 2011, URBAN STUD, V48, P253, DOI 10.1177/0042098010369393; Evans AW., 1973, EC RESIDENTIAL LOCAT, P188; Fernandes TF, 2019, IND INNOV, V26, P988, DOI 10.1080/13662716.2019.1591940; Fish LJ, 2021, CONTEMP ECON POLICY, V39, P220, DOI 10.1111/coep.12496; Florida R, 2012, J ECON GEOGR, V12, P355, DOI 10.1093/jeg/lbr017; Gould ED, 2007, REV ECON STUD, V74, P477, DOI 10.1111/j.1467-937X.2007.00428.x; Hartt M, 2018, URBAN STUD, V55, P2946, DOI 10.1177/0042098017730013; Heuermann D, 2010, URBAN STUD, V47, P749, DOI 10.1177/0042098009352363; Hidalgo C., 2015, WHY INFORM GROWS EVO; Hidalgo CA, 2009, P NATL ACAD SCI USA, V106, P10570, DOI 10.1073/pnas.0900943106; International Organization for Migration, 2015, WORLD MIGRATION REPO; Jacobs J., 1969, EC CITIES; Kemeny T., 2020, 41 INT IN I LON SCH; Kerns-D'Amore K., 2022, PANDEMIC DID NOT DIS; Keuschnigg M, 2019, P NATL ACAD SCI USA, V116, P13759, DOI 10.1073/pnas.1906258116; Korpi M, 2011, J ECON GEOGR, V11, P1051, DOI 10.1093/jeg/lbq043; Kurre JA, 2003, INT REGIONAL SCI REV, V26, P86, DOI 10.1177/0160017602238987; Lobo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058407; Marshall A., 1890, PRINCIPLES EC; Martinez-Fernandez C, 2012, INT J URBAN REGIONAL, V36, P213, DOI 10.1111/j.1468-2427.2011.01092.x; Matano A, 2016, J REGIONAL SCI, V56, P191, DOI 10.1111/jors.12235; Mayer H, 2010, EUR PLAN STUD, V18, P1545, DOI 10.1080/09654313.2010.504336; MAZUMDAR D, 1976, OXFORD ECON PAP, V28, P406, DOI 10.1093/oxfordjournals.oep.a041351; McGovern T., 2021, US GEN ELECTION PRES; Menton J., 2020, USA TODAY, V2020; MIT Election Data and Science Lab, 2018, COUNTY PRESIDENTIAL, DOI [10.7910/DVN/VOQCHQ, DOI 10.7910/DVN/VOQCHQ]; Moretti E., 2012, NEW GEOGRAPHY JOBS; Mulligan GF, 2006, ANN REGIONAL SCI, V40, P203, DOI 10.1007/s00168-005-0034-6; O'Connor K., 2002, AUSTRALASIAN J REGIO, V8, P247; Office of Management and Budget, 2020, OMB B, V2001; Piketty T, 2003, Q J ECON, V118, P1, DOI 10.1162/00335530360535135; Sassen Saskia., 2005, BROWN J WORLD AFFAIR, VXI, P27; Sassen Saskia, 2000, AM STUD, V41, P79; Scott A., 2007, URBAN RURAL DIVIDE M; Shoichet CE, CORONAVIRUS IS MAKIN; Shutters ST, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196915; Simensen J, 1999, J WORLD HIST, V10, P391, DOI 10.1353/jwh.1999.0027; Tavernise S., 2020, NEW YORK TIMES 0419; U.S. Bureau of Economic Analysis, 2019, REG PRIC PAR STAT ME; U.S. Bureau of Labor Statistics, 2019, Q CENS EMPL WAG; U.S. Bureau of Labor Statistics, 2020, CONS PRIC IND; U.S. Census Bureau, 2020, DEL FIL COR BAS STAT; U.S. Census Bureau, 2019, METR MICR STAT AR US; Vanham P., WORLD EC FOR ANN M; Vias AC, 2012, CITIES, V29, pS24, DOI 10.1016/j.cities.2011.12.005; World Bank, 2002, GLOBALIZATION GROWTH, DOI 10.1596/0-8213-5048-X; Youn H, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2015.0937; Zhao SXB, 2003, CITIES, V20, P265, DOI 10.1016/S0264-2751(03)00031-3	63	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267210	10.1371/journal.pone.0267210	http://dx.doi.org/10.1371/journal.pone.0267210			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421197	Green Published, gold			2022-12-26	WOS:000795453600116
J	Wang, XY; Chen, Y; Zhang, S; Deng, JN				Wang, Xiaoyu; Chen, Yu; Zhang, Steven; Deng, Jinxia Nancy			Molecular dynamics simulations reveal the selectivity mechanism of structurally similar agonists to TLR7 and TLR8	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; BLOOD MONONUCLEAR-CELLS; RNA-EDITING LIGASE; CYTOKINE PRODUCTION; INHIBITORS; PROTEIN; RECOGNITION; EXPRESSION; DISCOVERY; BINDING	TLR7 and TLR8 are key members of the Toll-like receptor family, playing crucial roles in the signaling pathways of innate immunity, and thus become attractive therapeutic targets of many diseases including infections and cancer. Although TLR7 and TLR8 show a high degree of sequence homology, their biological response to small molecule binding is very different. Aiming to understand the mechanism of selective profiles of small molecule modulators against TLR7 and TLR8, we carried out molecular dynamic simulations on three imidazoquinoline derivatives bound to the receptors separately. They are Resiquimod (R), Hybrid-2 (H), and Gardiquimod (G), selective agonists of TLR7 and TLR8. Our MD trajectories indicated that in the complex of TLR7-R and TLR7-G, the two chains forming the TLR7 dimer tended to remain "open" conformation, while the rest systems maintained in the closed format. The agonists R, H, and G developed conformational deviation mainly on the aliphatic tail. Furthermore, we attempted to quantify the selectivity between TLR7 and TLR8 by binding free energies via MM-GBSA method. It showed that the three selected modulators were more favorable for TLR7 than TLR8, and the ranking from the strongest to the weakest was H, R and G, aligning well with experimental data. In the TLR7, the flexible and hydrophobic aliphatic side chain of H has stronger van der Waals interactions with V381 and F351 but only pick up interaction with one amino acid residue i.e. Y353 of TLR8. Unsurprisingly, the positively charged side chain of G has less favorable interaction with I585 of TLR7 and V573 of TLR8 explaining G is weak agonist of both TLR7 and TLR8. All three imidazoquinoline derivatives can form stable hydrogen bonds with D555 of TLR7 and the corresponding D543 of TLR8. In brief, the set of total 400ns MD studies sheds light on the potential selectivity mechanisms of agonists towards TLR7 and TLR8, indicating the van der Waals interaction as the driving force for the agonists binding, thus provides us insights for designing more potent and selective modulators to cooperate with the hydrophobic nature of the binding pocket.	[Wang, Xiaoyu; Chen, Yu] Shanghai ChemPartner Co Ltd, Computat Chem Dept, Shanghai, Peoples R China; [Zhang, Steven] Shanghai ChemPartner Co Ltd, Chem Dept, Shanghai, Peoples R China; [Deng, Jinxia Nancy] ChemPartner, Computat Chem Dept, San Francisco, CA 94080 USA		Deng, JN (corresponding author), ChemPartner, Computat Chem Dept, San Francisco, CA 94080 USA.	ndeng@chempartner.us		Deng, Jinxia/0000-0002-3362-4595				Agrawal S, 2007, BIOCHEM SOC T, V35, P1461, DOI 10.1042/BST0351461; Amaro RE, 2008, P NATL ACAD SCI USA, V105, P17278, DOI 10.1073/pnas.0805820105; [Anonymous], 2019, SCHRDINGER RELEASE 2; Barr TA, 2007, EUR J IMMUNOL, V37, P3040, DOI 10.1002/eji.200636483; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Berhanu WM, 2013, PROTEINS, V81, P1542, DOI 10.1002/prot.24302; Brentano Fabia, 2009, V517, P329, DOI 10.1007/978-1-59745-541-1_20; Brown JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003664; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cervantes-Barragan L, 2007, BLOOD, V109, P1131, DOI 10.1182/blood-2006-05-023770; Crozat K, 2009, IMMUNOL REV, V227, P129, DOI 10.1111/j.1600-065X.2008.00736.x; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Distinto S, 2012, EUR J MED CHEM, V48, P284, DOI 10.1016/j.ejmech.2011.12.027; Durrant JD, 2011, CHEM BIOL DRUG DES, V78, P323, DOI 10.1111/j.1747-0285.2011.01164.x; Durrant JD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000803; Durrant JD, 2010, J MED CHEM, V53, P5025, DOI 10.1021/jm100456a; Durrant JD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000676; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Etheve L, 2016, NUCLEIC ACIDS RES, V44, P9990, DOI 10.1093/nar/gkw841; Freddolino PL, 2008, BIOPHYS J, V94, pL75, DOI 10.1529/biophysj.108.131565; Freddolino PL, 2009, BIOPHYS J, V97, P2338, DOI 10.1016/j.bpj.2009.08.012; Freddolino PL, 2006, STRUCTURE, V14, P437, DOI 10.1016/j.str.2005.11.014; Ganapathi L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134640; Gay NJ, 2014, NAT REV IMMUNOL, V14, P546, DOI 10.1038/nri3713; Gentile F, 2015, MOLECULES, V20, P8316, DOI 10.3390/molecules20058316; Gibbard RJ, 2006, J BIOL CHEM, V281, P27503, DOI 10.1074/jbc.M605003200; Grant BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025711; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hipp MM, 2013, IMMUNITY, V39, P711, DOI 10.1016/j.immuni.2013.09.004; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Huang SH, 2020, J BIOMOL STRUCT DYN, V38, P5537, DOI 10.1080/07391102.2019.1699448; Hucke O, 2014, J MED CHEM, V57, P1932, DOI 10.1021/jm4004522; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ivetac A, 2010, CHEM BIOL DRUG DES, V76, P201, DOI 10.1111/j.1747-0285.2010.01012.x; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kaur R, 2020, EXPERT REV VACCINES, V19, P105, DOI 10.1080/14760584.2019.1711057; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; Komatsuda A, 2008, CLIN EXP IMMUNOL, V152, P482, DOI 10.1111/j.1365-2249.2008.03646.x; Kubarenko A, 2007, BIOCHEM SOC T, V35, P1515, DOI 10.1042/BST0351515; Lin JH, 2002, J AM CHEM SOC, V124, P5632, DOI 10.1021/ja0260162; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Ma F, 2010, CELL MOL IMMUNOL, V7, P381, DOI 10.1038/cmi.2010.30; Mackman RL, 2020, J MED CHEM, V63, P10188, DOI 10.1021/acs.jmedchem.0c00100; Mahita J, 2018, PROTEINS, V86, P475, DOI 10.1002/prot.25467; McGowan DC, 2019, CURR TOP MED CHEM, V19, P2228, DOI 10.2174/1568026619666191009165418; Ojha R, 2020, INT J BIOL MACROMOL, V156, P548, DOI 10.1016/j.ijbiomac.2020.04.097; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Patel MC, 2014, FUTURE VIROL, V9, P811, DOI 10.2217/fvl.14.70; Patinote C, 2020, EUR J MED CHEM, V193, DOI 10.1016/j.ejmech.2020.112238; Patra MC, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082857; Rastelli G, 2002, BIOORGAN MED CHEM, V10, P1437, DOI 10.1016/S0968-0896(01)00410-2; Roelofs MF, 2005, ARTHRITIS RHEUM, V52, P2313, DOI 10.1002/art.21278; Sacre S, 2016, EUR J IMMUNOL, V46, P772, DOI 10.1002/eji.201546123; Sanbonmatsu KY, 2007, J STRUCT BIOL, V157, P470, DOI 10.1016/j.jsb.2006.10.023; Schames JR, 2004, J MED CHEM, V47, P1879, DOI 10.1021/jm0341913; Sheyhidin I, 2011, WORLD J GASTROENTERO, V17, P3745, DOI 10.3748/wjg.v17.i32.3745; Shi C, 2012, ACS MED CHEM LETT, V3, P501, DOI 10.1021/ml300079e; Shukla NM, 2010, J MED CHEM, V53, P4450, DOI 10.1021/jm100358c; Sousa SF, 2011, J PHYS CHEM B, V115, P7045, DOI 10.1021/jp200075s; Tanji H, 2015, NAT STRUCT MOL BIOL, V22, P109, DOI 10.1038/nsmb.2943; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159; Tojo S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19025-z; Tseng CY, 2014, CHEM BIOL DRUG DES, V83, P656, DOI 10.1111/cbdd.12278; Viricel C, 2015, J MOL GRAPH MODEL, V57, P131, DOI 10.1016/j.jmgm.2015.01.015; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang Y, 2011, BIOORG MED CHEM LETT, V21, P7064, DOI 10.1016/j.bmcl.2011.09.094; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Zhang T, 2013, J PHYS CHEM B, V117, P3993, DOI 10.1021/jp312573y; Zhang ZK, 2016, IMMUNITY, V45, P737, DOI 10.1016/j.immuni.2016.09.011; Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162; Zhu JZ, 2008, MOL IMMUNOL, V45, P3238, DOI 10.1016/j.molimm.2008.02.028; Zink M, 2009, BIOPHYS J, V96, P1350, DOI 10.1016/j.bpj.2008.11.028	80	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0260565	10.1371/journal.pone.0260565	http://dx.doi.org/10.1371/journal.pone.0260565			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C1KV	35452465	Green Published, Green Submitted, gold			2022-12-26	WOS:000792887700011
J	Wen, CX; Yu, YF; Gao, CF; Qi, X; Cardona, CJ; Xing, Z				Wen, Chunxia; Yu, Yufeng; Gao, Chengfeng; Qi, Xian; Cardona, Carol J.; Xing, Zheng			Concomitant pyroptotic and apoptotic cell death triggered in macrophages infected by Zika virus	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; HUMAN MONOCYTES; COXSACKIEVIRUS B4; OXIDATIVE STRESS; DENGUE; MECHANISM; REPLICATION; RESPONSES	Zika virus (ZIKV) is a positive-sense RNA flavivirus and can cause serious neurological disorders including microcephaly in infected fetuses. As a mosquito-borne arbovirus, it enters the bloodstream and replicates in various organs. During pregnancy, it can be transmitted from the blood of the viremic mother to the fetus by crossing the placental barrier. Monocytes and macrophages are considered the earliest blood cell types to be infected by ZIKV. As a first line defense, these cells are crucial components in innate immunity and host responses and may impact viral pathogenesis in humans. Previous studies have shown that ZIKV infection can activate inflammasomes and induce proinflammatory cytokines in monocytes. In this report, we showed that ZIKV could infect and induce cell death in human and murine macrophages. In addition to the presence of cleaved caspase-3, indicating that apoptosis was involved, we identified the cleaved caspase-1 and gasdermin D (GSDMD) as well as increased secretion of IL-1 beta and IL-18. This suggests that the inflammasome was activated and that may lead to pyroptosis in infected macrophages. The pyroptosis was NLRP3-dependent and could be suppressed in the macrophages treated with shRNA to target and knockdown caspase-1. It was also be inhibited by an inhibitor for caspase-1, indicating that the pyroptosis was triggered via a canonical approach. Our findings in this study demonstrate a concomitant occurrence of apoptosis and pyroptosis in ZIKV-infected macrophages, with two mechanisms involved in the cell death, which may have potentially significant impacts on viral pathogenesis in humans.	[Wen, Chunxia; Gao, Chengfeng] Nanjing Univ, Med Sch, Jiangsu Prov Key Lab Med, Nanjing, Peoples R China; [Yu, Yufeng] Shanxi Med Univ, Sch Basic Med Sci, Shanxi Prov Key Lab Funct Prot, Taiyuan, Peoples R China; [Qi, Xian] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Peoples R China; [Cardona, Carol J.; Xing, Zheng] Univ Minnesota Twin Cities, Coll Vet Med, Dept Vet Biomed Sci, St Paul, MN USA	Nanjing University; Shanxi Medical University; Jiangsu Provincial Center for Disease Control & Prevention; University of Minnesota System; University of Minnesota Twin Cities	Qi, X (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Peoples R China.	qixiansyc@hotmail.com	白, 芷/HCH-4603-2022; Xing, Zheng/G-8366-2011	Xing, Zheng/0000-0002-7288-0268	Natural Science Foundation of China (NSFC) [81971923]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported partially by a fund from the Natural Science Foundation of China (NSFC; www.nsfc.gov.cn) to ZX (81971923). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alidjinou EK, 2015, VIRUSES-BASEL, V7, P6067, DOI 10.3390/v7112924; Autissier P, 2010, CYTOM PART A, V77A, P410, DOI 10.1002/cyto.a.20859; Ayala-Nunez NV, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12408-x; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Brubaker SW, 2014, CELL, V156, P800, DOI 10.1016/j.cell.2014.01.021; Campbell JH, 2014, AIDS, V28, P2175, DOI 10.1097/QAD.0000000000000408; Christgen S, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00237; de Carvalho GC, 2019, IMMUNOBIOLOGY, V224, P792, DOI 10.1016/j.imbio.2019.08.007; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491; Espina LM, 2003, AM J TROP MED HYG, V68, P48, DOI 10.4269/ajtmh.2003.68.48; FESQ H, 1994, IMMUNOBIOLOGY, V190, P175, DOI 10.1016/S0171-2985(11)80292-5; Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3; Freistadt MS, 1996, J VIROL, V70, P6486, DOI 10.1128/JVI.70.9.6486-6492.1996; Green DR, 2019, CELL, V177, P1094, DOI 10.1016/j.cell.2019.04.024; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; Hanon E, 1998, ARCH VIROL, V143, P441, DOI 10.1007/s007050050301; Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442; Hober D, 2001, J INFECT DIS, V184, P1098, DOI 10.1086/323801; Ito M, 1996, FEMS IMMUNOL MED MIC, V15, P115, DOI 10.1111/j.1574-695X.1996.tb00061.x; Jurado KA, 2017, NAT MICROBIOL, V2, P1460, DOI 10.1038/s41564-017-0049-7; Khaiboullina SF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16072-3; Kim YJ, 2019, INT J NANOMED, V14, P8195, DOI 10.2147/IJN.S221328; Klomporn P, 2011, VIROLOGY, V409, P189, DOI 10.1016/j.virol.2010.10.010; Kopitar-Jerala N, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00873; Krejbich-Trotot P, 2011, FASEB J, V25, P314, DOI 10.1096/fj.10-164178; Nguyen LN, 2022, J MOL BIOL, V434, DOI 10.1016/j.jmb.2021.167249; Lambot M, 1998, J GEN VIROL, V79, P1745, DOI 10.1099/0022-1317-79-7-1745; Luo HL, 2018, ANTIVIR RES, V151, P55, DOI 10.1016/j.antiviral.2018.01.003; Messias CV, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4622-y; Michlmayr D, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107569; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Nikitina E, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092821; Orzalli MH, 2017, TRENDS CELL BIOL, V27, P810, DOI 10.1016/j.tcb.2017.05.007; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015; Tan TY, 2013, J GEN VIROL, V94, P2215, DOI 10.1099/vir.0.055277-0; Turpin J, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23031287; Turpin J, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073750; Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; Zhang H, 2020, FOOD FUNCT, V11, P4202, DOI [10.1039/d0fo00732c, 10.1039/D0FO00732C]; Zhang L, 2014, HEPATOB PANCREAT DIS, V13, P138, DOI 10.1016/S1499-3872(14)60024-2; Zhang XL, 2021, FOOD CHEM TOXICOL, V149, DOI 10.1016/j.fct.2021.112027; Zheng YY, 2018, EMBO J, V37, DOI 10.15252/embj.201899347	46	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0257408	10.1371/journal.pone.0257408	http://dx.doi.org/10.1371/journal.pone.0257408			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446851	gold, Green Published			2022-12-26	WOS:000795468200074
J	Yang, J; Kim, HY; Park, S; Sentissi, I; Green, N; Oh, BK; Kim, Y; Oh, KH; Paek, E; Park, YJ; Oh, IH; Lee, SH				Yang, Jangmi; Kim, Hae-Young; Park, Seup; Sentissi, Ilham; Green, Nathan; Oh, Byung Kwon; Kim, Yujin; Oh, Kyung Hyun; Paek, Eunseong; Park, Young Joon; Oh, In-Hwan; Lee, Seung Heon			Cost-effectiveness of a medication event monitoring system for tuberculosis management in Morocco	PLOS ONE			English	Article							RESISTANT TUBERCULOSIS; TREATMENT OUTCOMES; RETREATMENT; DEFAULT; RELAPSE	BackgroundDigital health technologies have been used to enhance adherence to TB medication, but the cost-effectiveness remains unclear. MethodsWe used the real data from the study conducted from April 2014 to December 2020 in Morocco using a smart pillbox with a web-based medication monitoring system, called Medication Event Monitoring Systems (MEMS). Cost-effectiveness was evaluated using a decision analysis model including Markov model for Multi-drug resistant (MDR) TB from the health system perspective. The primary outcome was the incremental cost-effectiveness ratio (ICER) per disability adjusted life-year (DALY) averted. Two-way sensitive analysis was done for the treatment success rate between MEMS and standard of care. ResultsThe average total per-patient health system costs for treating a new TB patient under MEMS versus standard of care were $398.70 and $155.70, respectively. The MEMS strategy would reduce the number of drug-susceptible TB cases by 0.17 and MDR-TB cases by 0.01 per patient over five years. The ICER of MEMS was $434/DALY averted relative to standard of care, and was most susceptible to the TB treatment success rate of both strategies followed by the managing cost of MEMS. ConclusionMEMS is considered cost-effective for managing infectious active TB in Morocco.	[Yang, Jangmi; Kim, Yujin] Natl Evidence Based Hlth Care Collaborating Agcy, Seoul, South Korea; [Kim, Hae-Young] New York Univ Grossman, Dept Populat Hlth, Sch Med, New York, NY USA; [Park, Seup; Oh, Byung Kwon; Paek, Eunseong; Park, Young Joon; Lee, Seung Heon] Global Care Int, Seoul, South Korea; [Sentissi, Ilham] Moroccan League TB Ligue Marocaine Lute TB LMCT, Chief Publ Hlth Serv & Epidemiol Surveillance, Rabat, Morocco; [Green, Nathan] UCL, Dept Stat Sci, London, England; [Oh, Kyung Hyun] Korean Natl TB Assoc, Korean Inst TB, Cheongju, South Korea; [Oh, Kyung Hyun] World Hlth Org Reg Off Western Pacific, End TB & Leprosy Unit, Manila, Philippines; [Oh, In-Hwan] Kyung Hee Univ, Sch Med, Dept Prevent Med, Seoul, South Korea; [Lee, Seung Heon] Korea Univ, Dept Internal Med, Div Pulm Sleep & Crit Care Med, Ansan Hosp, Ansan, South Korea	University of London; University College London; World Health Organization; Kyung Hee University; Korea University; Korea University Medicine (KU Medicine)	Lee, SH (corresponding author), Global Care Int, Seoul, South Korea.; Lee, SH (corresponding author), Korea Univ, Dept Internal Med, Div Pulm Sleep & Crit Care Med, Ansan Hosp, Ansan, South Korea.	lee-sh@korea.ac.kr		Green, Nathan/0000-0003-2745-1736	Korea International Cooperation Agency (KOICA) fund [2014-0027/2018-031]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health and Welfare, Republic of Korea [HI20C1068]	Korea International Cooperation Agency (KOICA) fund; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health and Welfare, Republic of Korea	S. Park, E. Paek, and Y. J. Park received support from the Korea International Cooperation Agency (KOICA) fund (2014-0027/2018-031). S. H. Lee received a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (Grant number: HI20C1068). The roles of funders were monitoring the outcomes.	Alipanah N, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002595; Alliance for Affordable Internet, 2015, AFF REP 2014; [Anonymous], 2008, 4 WHO; Broomhead S, 2012, TELEMED E-HEALTH, V18, P24, DOI 10.1089/tmj.2011.0143; Chuck C, 2016, INT J TUBERC LUNG D, V20, P588, DOI 10.5588/ijtld.15.0738; Dooley KE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-140; El Hamdouni M, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3931-5; Global Burden of Disease Collaborative Network, 2020, GLOBAL BURDEN DIS ST; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Korea Center for Disease Control and Prevention, 2007, NAT GUID MAN TUB 200; Law S, 2014, EUR RESPIR J, V43, P566, DOI 10.1183/09031936.00005613; Lipsitch M, 1998, INT J TUBERC LUNG D, V2, P187; Liu XQ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001876; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; Ministere de la Sante, 2016, MAN REF SYST INF SAN; Nahid P, 2016, CLIN INFECT DIS, V63, P853, DOI 10.1093/cid/ciw566; Nsengiyumva NP, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.01363-2018; Nunn AJ, 2010, INT J TUBERC LUNG D, V14, P241; Ottmani SE, 2006, INT J TUBERC LUNG D, V10, P1367; Park S, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16030412; Royaume du Maroc Ministre de la Sant Direction Rgionale de la Sant Rabat Sal Knitra, 2018, MONOGRAPHIE REGIONAL; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Snidal SJ, 2015, AM J TROP MED HYG, V92, P1271, DOI 10.4269/ajtmh.14-0413; Tachfouti N, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.121.2335; Tuck C, 2019, TROP MED INT HEALTH, V24, P260, DOI 10.1111/tmi.13191; WHO, 2020, WHO REPORT; WHO, 2017, HDB US DIG TECHN SUP; WHO, 2017, GUIDELINES TREATMENT; [WHO] World Health Organization, 2018, TUB COUNTR PROF; World Health Organization, GLOBAL TUBERCULOSIS; World Health Organization, 2016, IMPL END TB STRAT ES; World Health Organization, 2013, DEFINITIONS REPORTIN; World Health Organization, 2019, TUB DOWNL DAT MOR; World Health Organization, 2022, GLOB HLTH OBS	34	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267292	10.1371/journal.pone.0267292	http://dx.doi.org/10.1371/journal.pone.0267292			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7VA	35439273	Green Submitted, Green Published, gold			2022-12-26	WOS:000791280100012
J	Zhang, QQ; Fan, QX; Gao, HB; Wu, YL; Xu, FJ				Zhang, Qianqian; Fan, Qiuxia; Gao, Hongbin; Wu, Yulong; Xu, Fujing			A study on pick cutting properties with full-scale rotary cutting experiments and numerical simulations	PLOS ONE			English	Article							HARD-ROCK TBM; FORCE; PERFORMANCE; PREDICTION; MODEL	To investigate the cutting forces on road-header picks, a series of full-scale single-pick rotary cutting tests on sandstone samples were conducted at the National Engineering Laboratory of Coal Mining Machinery and Equipment, China. The primary objective of this study is to optimize the cut spacing and to verify the numerical simulation results. Cutting forces are investigated under different cutting depths and cut spacings. Cut spacing is optimized by analyzing the specific energy, coarseness index, and cutting force. The rock cutting process is simulated on a pick model using the PFC3D software. Rock samples are used as models, and particle assemblies and micro-properties are calibrated by uniaxial compressive strength tests and Brazilian disc tensile strength tests. The optimum ratio of cut spacing to cutting depth for the analyzed sandstone is determined to be in the range of 3 to 4. The experimental results show that a higher coarseness index corresponds to an increased block ratio, and specific energy decreases under optimum cutting conditions. Forces acting on the pick model are determined by simulation. A reasonable agreement exists between the experimental and numerical simulation results regarding the pick forces. The influence of the cut spacing on the rock-breaking effect observed in the experiments is confirmed by numerical simulations. Therefore, numerical simulations using the PFC3D software represent a reliable method for predicting the pick forces.	[Zhang, Qianqian; Fan, Qiuxia; Gao, Hongbin; Wu, Yulong; Xu, Fujing] Shanxi Univ, Sch Automat & Software Engn, Taiyuan, Peoples R China	Shanxi University	Zhang, QQ (corresponding author), Shanxi Univ, Sch Automat & Software Engn, Taiyuan, Peoples R China.	zhangqianqian@sxu.edu.cn			Shanxi Provincial Natural Science Foundation of China [201901D211120]; Scientific Research Project of Returnees Studying Abroad in Shanxi Province [2020-007]; National Natural Science Foundation of China [61903240]	Shanxi Provincial Natural Science Foundation of China; Scientific Research Project of Returnees Studying Abroad in Shanxi Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the Shanxi Provincial Natural Science Foundation of China (No. 201901D211120), the funder is Qiuxia Fan, whose role in this study is data collection and analysis; In part by the Scientific Research Project of Returnees Studying Abroad in Shanxi Province (No. 2020-007), the funder is Qiuxia Fan, whose role in this study is data collection and analysis; In part by the National Natural Science Foundation of China (61903240), the funder is Fujing Xu, whose role in this study is preparation of the manuscript.	Abu Bakar MZ, 2014, ROCK MECH ROCK ENG, V47, P1891, DOI 10.1007/s00603-013-0482-8; Abu Bakar MZ, 2013, TUNN UNDERGR SP TECH, V34, P124, DOI 10.1016/j.tust.2012.11.009; Bilgin N, 2006, INT J ROCK MECH MIN, V43, P139, DOI 10.1016/j.ijrmms.2005.04.009; Comakli R, 2021, TUNN UNDERGR SP TECH, V108, DOI 10.1016/j.tust.2020.103702; Cundall P.A., 1992, ENG COMPUT, V9, P101, DOI DOI 10.1108/EB023851; Dai XW, 2021, INT J ROCK MECH MIN, V146, DOI 10.1016/j.ijrmms.2021.104834; EVANS I, 1984, INT J MINING ENG, V2, P63, DOI 10.1007/BF00880858; Gao KD, 2014, FRAT INTEGRITA STRUT, P43, DOI 10.3221/IGF-ESIS.27.06; Gokan R M., 1997, P 4 S MINE MECHANIZA, P5761; Goktan RM, 2005, J S AFR I MIN METALL, V105, P257; Itasca Consulting Group, 2006, PART FLOW COD 3 DIM; Jeong HY, 2016, ROCK MECH ROCK ENG, V49, P1517, DOI 10.1007/s00603-015-0834-7; Jeong H, 2018, GEOMECH ENG, V15, P811, DOI 10.12989/gae.2018.15.3.811; Kang H, 2016, INT J ROCK MECH MIN, V88, P129, DOI 10.1016/j.ijrmms.2016.07.021; Li X, 2018, EXP MECH, V58, P709, DOI 10.1007/s11340-017-0372-1; Mc Feat-Smith I, 1977, P C ROCK ENG; Moon T, 2012, ROCK MECH ROCK ENG, V45, P837, DOI 10.1007/s00603-011-0180-3; Potyondy DO, 2004, INT J ROCK MECH MIN, V41, P1329, DOI 10.1016/j.ijrmms.2004.09.011; Rostami J, 1996, P C MECH EXCAVATIONS; Roxborough Ff L Z., 1995, P 6 UNDERGROUND OPER; Shao W, 2018, INT J ROCK MECH MIN, V107, P39, DOI 10.1016/j.ijrmms.2018.04.044; Su O, 2011, INT J ROCK MECH MIN, V48, P434, DOI 10.1016/j.ijrmms.2010.08.012; Tuncdemir H, 2008, INT J ROCK MECH MIN, V45, P278, DOI 10.1016/j.ijrmms.2007.04.010; van Wyk G, 2014, INT J ROCK MECH MIN, V65, P8, DOI 10.1016/j.ijrmms.2013.10.003; Wang X, 2017, ARAB J GEOSCI, V10, DOI 10.1007/s12517-017-3307-3; Wang ZJ, 2021, PROCESS SAF ENVIRON, V149, P591, DOI 10.1016/j.psep.2021.03.016; Wang ZJ, 2022, MECH SYST SIGNAL PR, V162, DOI 10.1016/j.ymssp.2021.108018; Wang ZJ, 2021, STRUCT HEALTH MONIT, V20, P3354, DOI 10.1177/1475921720986945; Yilmaz NG, 2007, INT J ROCK MECH MIN, V44, P962, DOI 10.1016/j.ijrmms.2007.02.005	29	0	0	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266872	10.1371/journal.pone.0266872	http://dx.doi.org/10.1371/journal.pone.0266872			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421177	Green Published, gold			2022-12-26	WOS:000795453600073
J	Cardenas, VM; Kennedy, JL; Williams, M; Nembhard, WN; Zohoori, N; Du, RF; Jin, J; Boothe, D; Fischbach, LA; Kirkpatrick, C; Modi, Z; Caid, K; Owens, S; Forrest, JC; James, L; Boehme, KW; Olgaard, E; Gardner, SF; Amick, BC				Cardenas, Victor M.; Kennedy, Joshua L.; Williams, Mark; Nembhard, Wendy N.; Zohoori, Namvar; Du, Ruofei; Jin, Jing; Boothe, Danielle; Fischbach, Lori A.; Kirkpatrick, Catherine; Modi, Zeel; Caid, Katherine; Owens, Shana; Forrest, J. Craig; James, Laura; Boehme, Karl W.; Olgaard, Ericka; Gardner, Stephanie F.; Amick, Benjamin C., III			State-wide random seroprevalence survey of SARS-CoV-2 past infection in a southern US State, 2020	PLOS ONE			English	Article							ANTIBODIES; RESPONSES	The purpose of this cross-sectional study was to estimate the proportion of Arkansas residents who were infected with the SARS-CoV-2 virus between May and December 2020 and to assess the determinants of infection. To estimate seroprevalence, a state-wide population-based random-digit dial sample of non-institutionalized adults in Arkansas was surveyed. Exposures were age, sex, race/ethnicity, education, occupation, contact with infected persons, comorbidities, height, and weight. The outcome was past COVID-19 infection measured by serum antibody test. We found a prevalence of 15.1% (95% CI: 11.1%, 20.2%) by December 2020. Seropositivity was significantly elevated among participants who were non-Hispanic Black, Hispanic (prevalence ratio [PRs]:1.4 [95% CI: 0.8, 2.4] and 2.3 [95% CI: 1.3, 4.0], respectively), worked in high-demand essential services (PR: 2.5 [95% CI: 1.5, 4.1]), did not have a college degree (PR: 1.6 [95% CI: 1.0, 2.4]), had an infected household or extra-household contact (PRs: 4.7 [95% CI: 2.1, 10.1] and 2.6 [95% CI: 1.2, 5.7], respectively), and were contacted in November or December (PR: 3.6 [95% CI: 1.9, 6.9]). Our results indicate that by December 2020, one out six persons in Arkansas had a past SARS-CoV-2 infection.	[Cardenas, Victor M.; Nembhard, Wendy N.; Zohoori, Namvar; Jin, Jing; Boothe, Danielle; James, Laura; Amick, Benjamin C., III] Univ Arkansas Med Sci, Fay W Boozman Coll Publ Hlth, Dept Epidemiol, Little Rock, AR 72205 USA; [Kennedy, Joshua L.] Univ Arkansas Med Sci, Coll Med, Dept Pediat, Little Rock, AR 72205 USA; [Kennedy, Joshua L.; Kirkpatrick, Catherine; Modi, Zeel; Caid, Katherine; Owens, Shana] Univ Arkansas Med Sci, Coll Med, Dept Internal Med, Little Rock, AR 72205 USA; [Kennedy, Joshua L.] Arkansas Childrens Res Inst, Little Rock, AR USA; [Williams, Mark] Univ Arkansas Med Sci, Fay W Boozman Coll Publ Hlth, Dept Hlth Behav & Hlth Educ, Little Rock, AR 72205 USA; [Zohoori, Namvar; Fischbach, Lori A.] Arkansas Dept Hlth, Little Rock, AR 72205 USA; [Du, Ruofei; Jin, Jing] Univ Arkansas Med Sci, Coll Publ Hlth, Dept Biostat, Little Rock, AR 72205 USA; [Fischbach, Lori A.] Los Angeles Cty Dept Publ Hlth, Outbreak Management Branch, Los Angeles, CA USA; [Forrest, J. Craig; Boehme, Karl W.] Univ Arkansas Med Sci, Coll Med, Dept Microbiol & Immunol, Little Rock, AR 72205 USA; [Boehme, Karl W.] Univ Arkansas Med Sci, Ctr Microbial Pathogenesis & Host Inflammatory Re, Little Rock, AR 72205 USA; [Olgaard, Ericka] Univ Arkansas Med Sci, Coll Med, Dept Pathol, Little Rock, AR 72205 USA; [Gardner, Stephanie F.] Univ Arkansas Med Sci, Coll Pharm, Little Rock, AR 72205 USA; [Amick, Benjamin C., III] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; Los Angeles County Department of Public Health; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Cardenas, VM (corresponding author), Univ Arkansas Med Sci, Fay W Boozman Coll Publ Hlth, Dept Epidemiol, Little Rock, AR 72205 USA.	vmcardenas@uams.edu		Cardenas, Victor/0000-0002-7951-0980; Jin, Jing/0000-0003-1771-9938; Zohoori, Namvar/0000-0003-3990-8799	2020 Coronavirus Relief Fund-CARES Act; National Center for Advancing Translational Sciences (NCATS) [UL1 TR003107]	2020 Coronavirus Relief Fund-CARES Act; National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The work was supported through a research contract agreement with the Arkansas Department of Health with funding from the 2020 Coronavirus Relief Fund -CARES Act (VMC, LAF and LJ -PIs of record) and by grant UL1 TR003107 from the National Center for Advancing Translational Sciences (NCATS) (LJ -PI)."In addition, we state that "(T)he funders had no role in study design, data collection and analysis, the decision to publish, or preparation of the manuscript.	Allen H, 2022, LANCET REG HEALTH-EU, V12, DOI 10.1016/j.lanepe.2021.100252; Anesrake Pasek J., 2018, ANESRAKE ANES RAKING; Angulo FJ, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.33706; Angulo FJ, 2020, JAMA-J AM MED ASSOC, V323, P2247, DOI 10.1001/jama.2020.7872; Appa A., 2020, OPEN FORUM INFECT DI, V8, DOI [10.1093/ofid/ofaa531, DOI 10.1093/OFID/OFAA531]; Bendavid E, 2021, INT J EPIDEMIOL, V50, P410, DOI 10.1093/ije/dyab010; Bieler GS, 2010, AM J EPIDEMIOL, V171, P618, DOI 10.1093/aje/kwp440; Biggs HM, 2020, MMWR-MORBID MORTAL W, V69, P965, DOI 10.15585/mmwr.mm6929e2; Brogan DJ., 2005, ENCY BIOSTATISTICS, V2, DOI [10.1002/0470011815.b2a16072, DOI 10.1002/0470011815.B2A16072]; Bruckner TA, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82662-x; Bryan A, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00941-20; Chan PA, 2021, AM J PUBLIC HEALTH, V111, P700, DOI 10.2105/AJPH.2020.306115; Demonbreun AR, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.146148; Feehan AK, 2021, EMERG INFECT DIS, V27, P314, DOI 10.3201/eid2701.203808; Feehan AK, 2020, EMERG INFECT DIS, V26, P2765, DOI 10.3201/eid2611.203029; Greenland S., 2008, MODERN EPIDEMIOLOGY; He ZY, 2021, LANCET, V397, P1075, DOI 10.1016/S0140-6736(21)00238-5; Jing QL, 2020, LANCET INFECT DIS, V20, P1141, DOI 10.1016/S1473-3099(20)30471-0; KLEINBAUM J, 1982, J CLIN ENDOCR METAB, V55, P787, DOI 10.1210/jcem-55-4-787; Levy P.S., 2013, SAMPLING POPULATIONS; Lin YC, 2021, J MICROBIOL IMMUNOL, V54, P816, DOI 10.1016/j.jmii.2021.02.003; MANTEL N, 1959, J NATL CANCER I, V22, P719; McLaughlin CC., 2020, MEDRXIV, DOI [10.1101/2020.07.19.20157198, DOI 10.1101/2020.07.19.20157198]; Menachemi N, 2020, MMWR-MORBID MORTAL W, V69, P960, DOI 10.15585/mmwr.mm6929e1; Nash D, MEDRXIV PREPRINT 202, V12, DOI [10.1101/2021.02.12.21251659v2, DOI 10.1101/2021.02.12.21251659V2]; Pathela P, 2021, J INFECT DIS, V224, P196, DOI 10.1093/infdis/jiab200; Rosenberg ES, 2020, ANN EPIDEMIOL, V48, P23, DOI 10.1016/j.annepidem.2020.06.004; Santarelli A, 2021, J OSTEOPATH MED, V121, P199, DOI 10.1515/jom-2020-0287; SCHUIRMANN DJ, 1987, J PHARMACOKINET BIOP, V15, P657, DOI 10.1007/BF01068419; Sempos CT, 2021, AM J EPIDEMIOL, V190, P109, DOI 10.1093/aje/kwaa174; Shah BV, 2003, P JOINT STAT M SECT; Sood N, 2020, JAMA-J AM MED ASSOC, V323, P2425, DOI 10.1001/jama.2020.8279; Stout RL, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.1552; U.S. Census Bureau Population Division, AG SEX RAC HISP OR 6; U. S. Centers for Disease Control and Prevention, COVID 19 DAT TRACK T; U.S. Centers for Disease Control and Prevention, NAT COMM LAB SER SUR; U.S. Centers for Disease Control and Prevention's National Institute of Safety and Health, NIOSH IND OCC COMP C; U.S. Office of Management and Budget, B MICR STAT AR COMB; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598	40	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267322	10.1371/journal.pone.0267322	http://dx.doi.org/10.1371/journal.pone.0267322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476717	Green Published, gold			2022-12-26	WOS:000840124300034
J	Nicholson, C; Beattie, L; Beattie, M; Razzaghi, T; Chen, SX				Nicholson, Charles; Beattie, Lex; Beattie, Matthew; Razzaghi, Talayeh; Chen, Sixia			A machine learning and clustering-based approach for county-level COVID-19 analysis	PLOS ONE			English	Article							MATHEMATICAL-THEORY; K-MEANS; ALGORITHM; REGULARIZATION; SIMULATION; SELECTION; NUMBER	COVID-19 is a global pandemic threatening the lives and livelihood of millions of people across the world. Due to its novelty and quick spread, scientists have had difficulty in creating accurate forecasts for this disease. In part, this is due to variation in human behavior and environmental factors that impact disease propagation. This is especially true for regionally specific predictive models due to either limited case histories or other unique factors characterizing the region. This paper employs both supervised and unsupervised methods to identify the critical county-level demographic, mobility, weather, medical capacity, and health related county-level factors for studying COVID-19 propagation prior to the widespread availability of a vaccine. We use this feature subspace to aggregate counties into meaningful clusters to support more refined disease analysis efforts.	[Nicholson, Charles; Razzaghi, Talayeh] Univ Oklahoma, Sch Ind & Syst Engn, Norman, OK 73019 USA; [Nicholson, Charles; Beattie, Lex; Beattie, Matthew] Univ Oklahoma, Data Sci & Analyt Inst, Norman, OK 73019 USA; [Chen, Sixia] Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma Health Sciences Center	Nicholson, C (corresponding author), Univ Oklahoma, Sch Ind & Syst Engn, Norman, OK 73019 USA.; Nicholson, C (corresponding author), Univ Oklahoma, Data Sci & Analyt Inst, Norman, OK 73019 USA.	cnicholson@ou.edu	Beattie, Matthew/AHA-0774-2022	Beattie, Matthew/0000-0001-7623-6894; Razzaghi, Talayeh/0000-0001-8052-9876	Office of the Vice President for Research and Partnerships, University of Oklahoma	Office of the Vice President for Research and Partnerships, University of Oklahoma	C.N., L.B., T.R., M.B., and S.C. received funding from the Office of the Vice President for Research and Partnerships, University of Oklahoma. Funder website: https://www.ou.edu/research-norman The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A. J.Gu, 2020, medRxiv, DOI 10.1101/2020.03.26.20044842; Agin W. E, 2017, PRACTICAL GUIDE CLUS, P1; Altieri N., 2021, HARVARD DATA SCI REV, DOI [10.1162/99608f92.1d4e0dae, DOI 10.1162/99608F92.1D4E0DAE]; Arora H., 2012, ACM TRANS MANAG INF, V2, P1, DOI [10.1145/2070710.2070714, DOI 10.1145/2070710.2070714]; Arora P, 2016, PROCEDIA COMPUT SCI, V78, P507, DOI 10.1016/j.procs.2016.02.095; Arrazola J, 2020, MMWR-MORBID MORTAL W, V69, P1853, DOI 10.15585/mmwr.mm6949a3; Beale E. M. L., 1969, CLUSTER ANAL; Beattie M., 2018, COMBINING CLASSIFICA; Bhattacharya A, 2014, INT J ECON SCI, V3, P1; Brady KD, 1999, BIOORGAN MED CHEM, V7, P621, DOI 10.1016/S0968-0896(99)00009-7; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; CDC, 2022, SMOK TOB PROD US US; Chen GX, 2002, STAT SINICA, V12, P241; Chen XY, 2020, INT J ENV RES PUB HE, V17, DOI [10.3390/ijerph17124437, 10.3390/ijerph17082893]; Cooper I, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110057; Cooray A, 2016, ROY SOC OPEN SCI, Patent No. 00988; Coretto P, 2010, ADV DATA ANAL CLASSI, V4, P111, DOI 10.1007/s11634-010-0065-4; Cuevas E, 2020, COMPUT BIOL MED, V121, DOI 10.1016/j.compbiomed.2020.103827; Curiskis A, 2020, MIDWEST OUTBREAKS PA; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Delamater PL, 2019, EMERG INFECT DIS, V25, P1, DOI 10.3201/eid2501.171901; Di Lorenzo P., 2021, **DATA OBJECT**; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Google, 2020, PUBL DAT WEATH CLIM; Google llc, 2020, GOOGLE; Greenwell B., 2020, Gbm: Generalized Boosted Regression Models. R Package Version, 2.1.8; Gupta Rajan, 2020, ACM Digital Government: Research and Practice, V1, DOI 10.1145/3411761; Ho TK, 1998, IEEE T PATTERN ANAL, V20, P832, DOI 10.1109/34.709601; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Hothorn T, 2015, J MACH LEARN RES, V16, P3905; Hou C, 2020, J MED VIROL, V92, P841, DOI 10.1002/jmv.25827; J. A.Syage, 2020, medRxiv, DOI 10.1101/2020.06.21.20136937; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; Kanungo T, 2002, IEEE T PATTERN ANAL, V24, P881, DOI 10.1109/TPAMI.2002.1017616; Kaufman L., 1987, Statistical Data Analysis Based on the L1-Norm and Related Methods. First International Conference, P405; Keating D, 2020, RURAL AREAS MAY BE M; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Kermack WO, 1933, P R SOC LOND A-CONTA, V141, P94, DOI 10.1098/rspa.1933.0106; Kermack WO, 1932, P R SOC LOND A-CONTA, V138, P55, DOI 10.1098/rspa.1932.0171; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Killeen B. D, 2020, PREPRINT; Killeen BD, 2020, ARXIV; Kisi O, 2019, HYDROLOG SCI J, V64, P1240, DOI 10.1080/02626667.2019.1632460; Kuhn M., 2021, CARET CLASSIFICATION; Lakhani HV, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124279; Leung NHL, 2021, NAT REV MICROBIOL, V19, P528, DOI 10.1038/s41579-021-00535-6; Likas A, 2003, PATTERN RECOGN, V36, P451, DOI 10.1016/S0031-3203(02)00060-2; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; MARRIOTT FH, 1971, BIOMETRICS, V27, P501, DOI 10.2307/2528592; Milborrow S., 2021, **DATA OBJECT**; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; MURTAGH F, 1983, COMPUT J, V26, P354, DOI 10.1093/comjnl/26.4.354; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; Nikolopoulos K, 2021, EUR J OPER RES, V290, P99, DOI 10.1016/j.ejor.2020.08.001; Park HS, 2009, EXPERT SYST APPL, V36, P3336, DOI 10.1016/j.eswa.2008.01.039; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; R Core Team, 2020, R LANG ENV STAT COMP; Rockett RJ, 2020, NAT MED, V26, DOI [10.1038/s41591-020-1000-7., 10.1038/s41591-020-1000-7]; Roda WC, 2020, INFECT DIS MODEL, V5, P271, DOI 10.1016/j.idm.2020.03.001; Rodriguez MZ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210236; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Saeys Y, 2008, LECT NOTES ARTIF INT, V5212, P313, DOI 10.1007/978-3-540-87481-2_21; Siebers P, 2010, J SIMUL, V4, P204, DOI 10.1057/jos.2010.14; Silva PCL, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110088; Simon N, 2011, J STAT SOFTW, V39, P1; Sun H., 2020, J DATA SCI, V18, P455, DOI [DOI 10.6339/JDS.202007_18(3).0010, 10.6339/jds.202007_18(3).0010]; Tang L, 2020, INT STAT REV, V88, P462, DOI 10.1111/insr.12402; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; USA Facts, 2020, US COR CAS DEATHS; Wang L., ARXIV; Wendelboe AM, OSDH RELEASES COVID; Yang ZF, 2020, J THORAC DIS, V12, P165, DOI 10.21037/jtd.2020.02.64; Zhang CH, 2020, J RURAL HEALTH, V36, P433, DOI 10.1111/jrh.12476; Zhou Y., 2020, SPATIOTEMPORAL EPIDE, DOI [DOI 10.1162/99608F92.79-1F45E, 10.1162/99608f92.79e1f45e, DOI 10.1162/99608F92.79E1F45E, 10.1162/99608f92.79-1f45e]; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	77	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267558	10.1371/journal.pone.0267558	http://dx.doi.org/10.1371/journal.pone.0267558			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476849	Green Published, gold			2022-12-26	WOS:000840124300050
J	Xiao, BX; Mercer, GD; Jin, L; Lee, HL; Chen, TT; Wang, YF; Liu, YP; Denniston, AK; Egan, CA; Li, J; Lu, Q; Xu, P; Congdon, N				Xiao, Baixiang; Mercer, Gareth D.; Jin, Ling; Lee, Han Lin; Chen, Tingting; Wang, Yanfang; Liu, Yuanping; Denniston, Alastair K.; Egan, Catherine A.; Li, Jia; Lu, Qing; Xu, Ping; Congdon, Nathan			Outreach screening to address demographic and economic barriers to diabetic retinopathy care in rural China	PLOS ONE			English	Article							RISK-FACTORS; PREVALENCE; URBAN	Importance Poor access to existing care for diabetic retinopathy (DR) limits effectiveness of proven treatments. Objectives We examined whether outreach screening in rural China improves equity of access. Design, setting and participants We compared prevalence of female sex, age > = 65 years, primary education or below, and requiring referral care for DR between three cohorts with diabetes examined for DR in neighboring areas of Guangdong, China: passive case detection at secondary-level hospitals (n = 193); persons screened during primary-level DR outreach (n = 182); and individuals with newly- or previously-diagnosed diabetes in a population survey (n = 579). The latter reflected the "ideal" reach of a screening program. Results Compared to the population cohort, passive case detection reached fewer women (50.8% vs. 62.3%, p = 0.006), older adults (37.8% vs. 51.3%, p < 0.001), and less-educated persons (39.9% vs. 89.6%, p < 0.001). Outreach screening, compared to passive case detection, improved representation of the elderly (49.5% vs. 37.8%, p = 0.03) and less-educated (70.3% vs. 39.9%, p<0.001). The proportion of women (59.8% vs 62.3%, P>0.300) and persons aged > = 65 years (49.5% vs 51.3%, p = 0.723) in the outreach screening and population cohorts did not differ significantly. Prevalence of requiring referral care for DR was significantly higher in the outreach screening cohort (28.0%) than the population (14.0%) and passive case detection cohorts (7.3%, p<0.001 for both). Conclusions and relevance Primary-level outreach screening improves access for the poorly-educated and elderly, and removes gender inequity in access to DR care in this setting, while also identifying more severely-affected patients than case finding in hospital.	[Xiao, Baixiang] Nanchang Univ, Affiliated Eye Hosp, Nanchang, Jiangxi, Peoples R China; [Mercer, Gareth D.] McGill Univ, Dept Ophthalmol & Visual Sci, Montreal, PQ, Canada; [Jin, Ling; Wang, Yanfang; Liu, Yuanping; Congdon, Nathan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Peoples R China; [Lee, Han Lin; Congdon, Nathan] Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Chen, Tingting] Sun Yat Sen Univ, Affiliated Hosp 1, Ophthalmol Dept, Guangzhou, Peoples R China; [Denniston, Alastair K.] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Egan, Catherine A.] NHS Fdn Trust, Moorfields Eye Hosp, London, England; [Li, Jia; Lu, Qing; Xu, Ping; Congdon, Nathan] Orbis Int, New York, NY 10018 USA	Nanchang University; McGill University; Sun Yat Sen University; Queens University Belfast; Sun Yat Sen University; University of Birmingham; Oxford University Hospitals NHS Foundation Trust; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Congdon, N (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Peoples R China.; Congdon, N (corresponding author), Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland.; Congdon, N (corresponding author), Orbis Int, New York, NY 10018 USA.	ncongdon1@gmail.com		Denniston, Alastair/0000-0001-7849-0087; Mercer, Gareth/0000-0002-9904-6361	Orbis International; Sun Yat-sen University; Ulverscroft Foundation (UK); Bayer; Zhongshan Ophthalmic Center	Orbis International; Sun Yat-sen University; Ulverscroft Foundation (UK); Bayer(Bayer AG); Zhongshan Ophthalmic Center	NC received funding from: Orbis International, Zhongshan Ophthalmic Center, Sun Yat-sen University, Bayer, Ulverscroft Foundation (UK).	Bragg F, 2017, JAMA-J AM MED ASSOC, V317, P280, DOI 10.1001/jama.2016.19720; Chen TT, 2018, AM J OPHTHALMOL, V194, P54, DOI 10.1016/j.ajo.2018.07.006; FERRIS FL, 1994, PREV MED, V23, P740, DOI 10.1006/pmed.1994.1127; FERRIS FL, 1982, AM J OPHTHALMOL, V94, P91, DOI 10.1016/0002-9394(82)90197-0; Flaxman SR, 2017, LANCET GLOB HEALTH, V5, pE1221, DOI 10.1016/S2214-109X(17)30393-5; Jin GM, 2018, INVEST OPHTH VIS SCI, V59, P5067, DOI 10.1167/iovs.18-24280; Kashim RM, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010157; Lane M, 2018, SURV OPHTHALMOL, V63, P406, DOI 10.1016/j.survophthal.2017.10.009; Lash TL, 2009, APPL QUANTITATIVE BI; Leasher JL, 2016, DIABETES CARE, V39, P1643, DOI 10.2337/dc15-2171; Levesque JF, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-18; Lian JX, 2013, OPHTHALMOLOGY, V120, P1247, DOI 10.1016/j.ophtha.2012.11.024; Liu GG, 2017, ANNU REV PUBL HEALTH, V38, P431, DOI 10.1146/annurev-publhealth-031816-044247; McKenna M, 2018, BRIT J OPHTHALMOL, V102, P1471, DOI 10.1136/bjophthalmol-2018-312440; Quigley HA, 2002, AM J OPHTHALMOL, V133, P386, DOI 10.1016/S0002-9394(01)01380-0; Scanlon PH, 2003, BRIT J OPHTHALMOL, V87, P1258, DOI 10.1136/bjo.87.10.1258; Shi WX, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-7; Tian MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125262; Walker EA, 2008, AM J PREV MED, V34, P185, DOI 10.1016/j.amepre.2007.11.020; Wang DD, 2010, OPHTHALMOLOGY, V117, P1755, DOI 10.1016/j.ophtha.2010.01.019; Wang FH, 2009, OPHTHALMOLOGY, V116, P461, DOI 10.1016/j.ophtha.2008.10.003; Wang JW, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7591-6; Wang LM, 2017, JAMA-J AM MED ASSOC, V317, P2515, DOI 10.1001/jama.2017.7596; Wong TY, 2018, OPHTHALMOLOGY, V125, P1608, DOI 10.1016/j.ophtha.2018.04.007; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang SH, 2010, NEW ENGL J MED, V362, P2425; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Zhang SD, 2019, CLIN EXP OPHTHALMOL, V47, P1000, DOI 10.1111/ceo.13564; ZHONG XL, 1982, CHINESE MED J-PEKING, V95, P423	29	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0266380	10.1371/journal.pone.0266380	http://dx.doi.org/10.1371/journal.pone.0266380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35442967	gold, Green Published			2022-12-26	WOS:000822608900022
J	Aung, YN; Tun, STT; Vanisaveth, V; Chindavongsa, K; Kanya, L				Aung, Yu Nandar; Tun, Sai Thein Than; Vanisaveth, Viengxay; Chindavongsa, Keobouphaphone; Kanya, Lucy			Cost-effectiveness analysis of G6PD diagnostic test for Plasmodium vivax radical cure in Lao PDR: An economic modelling study	PLOS ONE			English	Article							DIRECTLY-OBSERVED THERAPY; PRIMAQUINE; MALARIA; DEFICIENCY; ELIMINATION; PROVINCE	BackgroundPlasmodium vivax (Pv) infections were 68% of the total malaria burden in Laos in 2019. The parasite causes frequent relapses, which can be prevented by primaquine (PMQ). Testing for glucose-6-phosphate-dehydrogenase (G6PD) deficiency is recommended before giving PMQ to avoid haemolysis. Because of the risk of haemolysis in G6PD intermediate deficiencies among females, Laos uses the PMQ 14-days regimen only in G6PD normal females. Among G6PD point-of-care tests, qualitative tests cannot differentiate between G6PD normal and intermediate females. Quantitative tests are required to differentiate between G6PD normal and intermediate deficiencies. However, the quantitative test lacks the cost-effectiveness evidence necessary for decision-making for large-scale adoption. This study examined the cost-effectiveness of quantitative G6PD test, with either supervised PMQ treatment or unsupervised PMQ treatment, against the usual unsupervised PMQ 8-weeks strategy. Supervised PMQ 8-weeks strategy without G6PD testing was also compared against the unsupervised PMQ 8-weeks strategy since the former had recently been adopted in malaria high burden villages that had village malaria volunteers. A budget impact analysis was conducted to understand the incremental cost and effect needed for a nationwide scale-up of the chosen strategy. MethodsA decision tree model compared the cost-effectiveness of implementing four strategies at one health facility with an average of 14 Pv cases in one year. The strategies were unsupervised PMQ strategy, supervised PMQ strategy, G6PD test with unsupervised PMQ strategy, and G6PD test with supervised PMQ strategy. Disability Adjusted Life Years (DALYs) was the effect measure. Costs were calculated from a payer perspective, and sensitivity analyses were conducted. One Gross Domestic Product (GDP) per capita of Laos was set as the cost-effectiveness threshold. Budget impact analysis was conducted using the health facility wise Pv data in Laos in 2020. FindingsSupervised PMQ strategy was extendedly dominated by G6PD test strategies. When compared against the unsupervised PMQ strategy, both G6PD test strategies were more costly but more effective. Their Incremental Cost-Effectiveness Ratios (ICER) were 96.72US$ for the G6PD test with unsupervised PMQ strategy and 184.86US$ for the G6PD test with supervised PMQ strategy. Both ICERs were lower than one GDP per capita in Laos. Following the sensitivity analysis, low adherence for PMQ 14 days made both G6PD test strategies less cost-effective. The lower the Pv case number reported in a health facility, the higher the ICER was. In the budget impact analysis, the expected budget need was only half a million US$ when the G6PD test rollout was discriminately done depending on the Pv case number reported at the health facilities. Indiscriminate roll out of G6PD test to all health facilities was most expensive with least effect impact.	[Aung, Yu Nandar; Kanya, Lucy] London Sch Econ & Polit Sci, Dept Hlth Policy, London, England; [Tun, Sai Thein Than] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Tun, Sai Thein Than] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England; [Vanisaveth, Viengxay; Chindavongsa, Keobouphaphone] Minist Hlth, Ctr Malaria Parasitol & Entomol, Viangchan, Laos	University of London; London School Economics & Political Science; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford	Aung, YN (corresponding author), London Sch Econ & Polit Sci, Dept Hlth Policy, London, England.	dr.yu.ndaung@gmail.com		Aung, Yu Nandar/0000-0002-4449-1361				Abbott, BINAXNOW G6PD; Abreha T, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002299; AccessBio, OTH PROD; Adhikari B, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4070-9; Alam MS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206331; Ashley EA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-418; Bancone G, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2652-y; Bill & Melinda Gates foundation, MALARIA; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; Chu CS, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz023; Chu CS, 2018, CLIN INFECT DIS, V67, P1543, DOI 10.1093/cid/ciy319; Chu CS, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2248-y; Chu CS, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002224; Devine A, 2020, AM J TROP MED HYG, V103, P394, DOI 10.4269/ajtmh.19-0943; Devine A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005602; Douglas NM, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002379; Drummond MF, 2015, METHODS EC EVALUATIO; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; Hatswell AJ, 2017, VALUE HEALTH, V20, pA746, DOI 10.1016/j.jval.2017.08.2074; Henriques G, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2390-6; Howes RE, 2013, ADV PARASIT, V81, P133, DOI 10.1016/B978-0-12-407826-0.00004-7; IHME, 2018, GLOBAL BURDEN DIS ST; John GK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-280; Johnson P, 2020, BETA DISTRIBUTION201; Khantikul N, 2009, J HEALTH POPUL NUTR, V27, P4; Lao PDR, 2020, NAT MAL TREATM GUID; Lao PDR, 2020, ROLL OUT PRIM P VIV; Lao PDR, PUBL SERV OP LAO PDR; Lao PDR, 20182020 RAI2E NAT M; Lao PDR, 2019, MAL PROGR DAT YEAR 2; Lao PDR, MAL PROGR DAT YEAR 2; Leslie T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002861; Ley B, 2019, PLOS MED, V16, DOI [10.1371/journal.pmed.1002992, 10.1371/journal.pmed.1002992.r001, 10.1371/journal.pmed.1002992.r002, 10.1371/journal.pmed.1002992.r003, 10.1371/journal.pmed.1002992.r004]; Ley B, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0896-8; Lubell Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017439; Maneeboonyang W, 2011, SE ASIAN J TROP MED, V42, P9; Ministry of Health LP, 2020, REG ART RES IN 3 EL; Mulligan J, 2003, DIS CONTROL PRIORITI, P9; National Malaria Control Program MoH Lao PDR, 2020, MAL NAT STRAT PLAN 2; National Malaria Program M Lao PDR, 20212023 RAI3E NAT M; Ong KIC, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2715-0; PATH, EXP REV PAN DIAGN AP; Peixoto HM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1140-x; SD Biosensor, G6PD TM SD BIOS; Shretta R, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1890-0; Simmalavong N, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2104-5; Takeuchi R, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-308; The Global Fund, LIST MAL RDTS REM 20; The World Bank, GDP CAP PER CURR US; U.S. Presidents Malaria Initiative, RDMA THAIL LAOS REG; UNOPS, 2021, RAI3E TOW EL MAL; USAID, US PROV 700000 SUPP; von Seidlein L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-112; White MT, 2016, AM J TROP MED HYG, V95, P52, DOI 10.4269/ajtmh.16-0182; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2016, GLOB HLTH OBS DAT RE; WHO, WHO CHOICE UN COST E; WHO, 2018, GUID G6PD DEF RAP DI; WHO G, 2020, WHO METHODS DATA SOU; World Bank Group, 2017, MANAGING TRANSITION; World Health O, MACR HLTH INV HLTH E; World Health Organization, LAO PEOPL DEM REPUBL; Zobrist S, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009649	63	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267193	10.1371/journal.pone.0267193	http://dx.doi.org/10.1371/journal.pone.0267193			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D9PO	35468145	gold, Green Accepted, Green Published			2022-12-26	WOS:000794129600018
J	Badri, P; Baracos, V; Ganatra, S; Lai, HL; Samim, F; Amin, M				Badri, Parvaneh; Baracos, Vickie; Ganatra, Seema; Lai, Hollis; Samim, Firoozeh; Amin, Maryam			Retrospective study of factors associated with late detection of oral cancer in alberta: A qualitative study	PLOS ONE			English	Article							PATIENT DELAY; STAGE DIAGNOSIS; HEAD; DISPARITIES; REASONS; LESIONS	Oral cancer continues to be diagnosed in advanced stages, giving patients lower chances of survival. The objective of this study was to explore reasons for delayed diagnosis of oral cancer in Alberta. A retrospective qualitative design was implemented through seven steps suggested for conducting a narrative clinical document. Data was retrieved from the Alberta Cancer Registry database between 2005 and 2017. A sample of initial consultation notes (ICN) of oral and oropharyngeal cancer patients were identified through a purposeful sampling method and added to the study until saturation was achieved. A deductive analysis approach inspired by the model pathways to treatment health care provider (HCP) was employed. From the 34 ICN included in our analysis, five main categories were identified: appraisal interval, help-seeking interval, diagnosis interval, pre-treatment interval, and other contributing factors such as health-related behaviours, system delay, and tumor characteristics. These factors negatively contributed to early detection of oral and oropharyngeal cancers and affect treatment wait time with patients, providers, and the healthcare system. Patient's lack of awareness, provider's oversight and prolonged access to care were the main reasons of delay in cancer diagnosis and management in our study. A sustainable plan for public awareness interventions and implementation of a solid curriculum for medical and dental students is needed to enhance their related knowledge, competence in clinical judgement, and treatment managements.	[Badri, Parvaneh; Lai, Hollis; Amin, Maryam] Univ Alberta, Fac Med & Dent, Sch Dent, Edmonton, AB, Canada; [Baracos, Vickie] Univ Alberta, Cross Canc Inst, Fac Med & Dent, Dept Oncol, Edmonton, AB, Canada; [Ganatra, Seema] Univ Alberta, Sch Dent, Div Oral Med Pathol & Radiol, Edmonton, AB, Canada; [Samim, Firoozeh] McGill Univ, Fac Dent, Oral pathologist Div Oral Med, Montreal, PQ, Canada	University of Alberta; University of Alberta; University of Alberta; McGill University	Amin, M (corresponding author), Univ Alberta, Fac Med & Dent, Sch Dent, Edmonton, AB, Canada.	maryam.amin@ualberta.ca		Badri, Parvaneh/0000-0001-8626-8275; Amin, Maryam/0000-0003-2249-5465				Adrien J, 2014, ORAL ONCOL, V50, P90, DOI 10.1016/j.oraloncology.2013.10.016; Badri P, 2021, J CAN DENT ASSOC, V87; Baumann E, 2016, HEALTH EDUC RES, V31, P136, DOI 10.1093/her/cyv099; Baykul T, 2010, J INT MED RES, V38, P737, DOI 10.1177/147323001003800302; Benoot C, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0114-6; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Brouha XDR, 2005, HEAD NECK-J SCI SPEC, V27, P939, DOI 10.1002/hed.20270; Canadian Cancer Statistics Advisory Committee in Collaboration with the Canadian Cancer Society Statistics Canada and the Public Health Agency of Canada, 2021, CAN CANC STAT 2021; Cavanagh, 1997, NURSE RES, V4, P5, DOI [DOI 10.7748/NR1997.04.4.3.5.C5869, DOI 10.7748/NR.4.3.5.S2]; Felippu AWD, 2016, BRAZ J OTORHINOLAR, V82, P140, DOI 10.1016/j.bjorl.2015.10.009; Dios PD, 2005, ORAL ONCOL, V41, P142, DOI 10.1016/j.oraloncology.2004.07.008; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ford PJ, 2013, J Cancer Policy, V1, pE2, DOI 10.1016/j.jcpo.2013.04.002; Garbuglia AR, 2014, CANCERS, V6, P1705, DOI 10.3390/cancers6031705; Gearing RE, 2006, J CAN ACAD CHILD ADO, V15, P126; Gupta N, 2016, NEPAL J EPIDEMIOL, V6, P613, DOI 10.3126/nje.v6i4.17255; Hammerlid E, 2001, LARYNGOSCOPE, V111, P669, DOI 10.1097/00005537-200104000-00021; Harris JR, 2014, CURR ONCOL, V21, pE704, DOI 10.3747/co.21.1980; Holmes JD, 2003, J ORAL MAXIL SURG, V61, P285, DOI 10.1053/joms.2003.50056; Hong CJ, 2015, PLAST SURG-CHIR PLAS, V23, P48, DOI 10.1177/229255031502300101; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Kyngas H., 2019, APPL CONTENT ANAL NU, DOI DOI 10.1007/978-3-030-30199-6; Kyngas H, 2020, APPLICATION OF CONTENT ANALYSIS IN NURSING SCIENCE RESEARCH, P13, DOI 10.1007/978-3-030-30199-6_2; Lee JJ, 2016, J CANCER EDUC, V31, P8, DOI 10.1007/s13187-014-0777-9; LeHew C, 2010, J PUBLIC HEALTH DENT, V70, P93, DOI 10.1111/j.1752-7325.2009.00148.x; Lim K, 2003, BRIT DENT J, V194, P497, DOI 10.1038/sj.bdj.4810069; Llewellyn CD, 2004, J ORAL PATHOL MED, V33, P525, DOI 10.1111/j.1600-0714.2004.00222.x; Mayan MJ., 2016, ESSENTIALS QUALITATI, DOI [10.4324/9781315429250, DOI 10.4324/9781315429250]; Morse J. M., 1995, QUALITATIVE RES METH; Noonan B, 2014, EUR J ONCOL NURS, V18, P118, DOI 10.1016/j.ejon.2013.07.005; O'Connor T E, 2010, Ir Med J, V103, P105; Patel UA, 2012, LARYNGOSCOPE, V122, P1756, DOI 10.1002/lary.23357; Patton MQ., 2002, QUALITATIVE RES EVAL, V3rd; Rogers SN, 2007, ORAL ONCOL, V43, P648, DOI 10.1016/j.oraloncology.2006.08.001; Rogers SN, 2011, BRIT J ORAL MAX SURG, V49, P349, DOI 10.1016/j.bjoms.2010.06.018; Salkind AR, 2010, SOUTH MED J, V103, P896, DOI 10.1097/SMJ.0b013e3181eab419; Sarkar S, 2014, J CLIN DIAGN RES, V8, pJG01, DOI 10.7860/JCDR/2014/8301.4806; Scott SE, 2006, PSYCHO-ONCOL, V15, P474, DOI 10.1002/pon.976; Seoane-Romero JM, 2012, MED ORAL PATOL ORAL, V17, pE35, DOI 10.4317/medoral.17399; Smith C. P., 2000, CONTENT ANAL NARRATI; Steele TO, 2011, OTOLARYNG CLIN N AM, V44, P221, DOI 10.1016/j.otc.2010.10.002; Stefanuto P, 2014, OR SURG OR MED OR PA, V117, P424, DOI 10.1016/j.oooo.2013.12.407; Walter F, 2012, J HEALTH SERV RES PO, V17, P110, DOI 10.1258/jhsrp.2011.010113; Watson JM, 2009, COMMUNITY DENT ORAL, V37, P333, DOI 10.1111/j.1600-0528.2009.00470.x; Webster JD, 2019, J ORAL PATHOL MED, V48, P595, DOI 10.1111/jop.12915; Yardimci G, 2014, WORLD J CLIN CASES, V2, P866, DOI 10.12998/wjcc.v2.i12.866; Yu T., 2007, DELAY DIAGNOSIS HEAD	48	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266558	10.1371/journal.pone.0266558	http://dx.doi.org/10.1371/journal.pone.0266558			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35472099	Green Published, gold			2022-12-26	WOS:000816171900030
J	Besi, EE; Hooi, WK; Pungga, RS; Yong, CSY; Mustafa, M; Go, R				Besi, Edward Entalai; Hooi, Wai Keong; Pungga, Runi Sylvester; Yong, Christina Seok Yien; Mustafa, Muskhazli; Go, Rusea			Rare orchid species in Malaysia: New records, recollections and amended descriptions	PLOS ONE			English	Article							LIMESTONE; DIVERSITY	Paphiopedilum exul, Calanthe chrysoglossoides, and Luisia brachystachys are reported here as new records for Malaysia, whereas Bryobium cordiferum subsp. borneense, Habenaria rostellifera, and Taeniophyllum rugulosum are three rare orchid species recollected from Sarawak, Perlis, and Perak, respectively. This paper highlights brief descriptions and photographic illustrations of each species for easy identification. Besides, notes on morphological comparisons with the closely related species and artificial taxonomic keys are included as well.	[Besi, Edward Entalai; Pungga, Runi Sylvester; Yong, Christina Seok Yien; Mustafa, Muskhazli; Go, Rusea] Univ Putra Malaysia, Fac Sci, Dept Biol, Serdang, Selangor, Malaysia; [Hooi, Wai Keong] 2063 Bukit Blossom,Jalan Tok Ungku, Seremban, Negeri Sembilan, Malaysia; [Pungga, Runi Sylvester] Int Affairs Div, Kuching, Sarawak, Malaysia	Universiti Putra Malaysia	Go, R (corresponding author), Univ Putra Malaysia, Fac Sci, Dept Biol, Serdang, Selangor, Malaysia.	rusea@upm.edu.my		Go, Rusea/0000-0003-3922-5082	UPM-KRIBB (Korea Research Institute of Bioscience and Biotechnology) [6384300]; University Putra Malaysia (UPM); Ministry of Higher Education Malaysia (MOHE)	UPM-KRIBB (Korea Research Institute of Bioscience and Biotechnology); University Putra Malaysia (UPM); Ministry of Higher Education Malaysia (MOHE)(Ministry of Education, Malaysia)	This study was sponsored by the UPM-KRIBB (Korea Research Institute of Bioscience and Biotechnology) grant (Vot. 6384300), Young Academic Scheme (TAM) issued by University Putra Malaysia (UPM) and IPTA Academic Training <ITALIC><BOLD> </BOLD></ITALIC>Scheme (SLAI) issued by Ministry of Higher Education Malaysia (MOHE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auyob NA., 2016, MALAY NAT J, V68, P49; Besi EE, 2020, NAT CONSERV RES, V5, P125, DOI 10.24189/ncr.2020.048; Besi EE, 2020, PHYTOTAXA, V454, P31, DOI 10.11646/phytotaxa.454.1.3; Besi EE, 2020, PAK J BOT, V52, P1019, DOI 10.30848/PJB2020-3(21); BESI EE, 2019, LANKESTERIANA, V19, P107, DOI [DOI 10.15517/LANK.V19I2.38775, 10.15517/LANK.V19I2.38775]; Besi EE., 2018, MALAY NAT J, V70, P251; Bridson D, 2000, HERBARIUM HDB, V3rd; Carr CE., 1932, GARD B SING, V7, P61; Clayton D., 2013, THE GENUS CALANTHE, P409; Comber JB., 2001, ORCHIDS OF SUMATRA, P1026; Cribb P., 1998, GENUS PAPHIOPEDILUM, P427; Cribb Phillip, 1993, Kew Magazine, V10, P5; Cribb PJ., 1987, COLLINGRIDE ASS, P222; Go R., 2018, SARAWAK LIMESTONE FO; Go R., 2010, ORCHIDS PERLIS JEWEL; Go R., 2017, FOLIA MALAYSIANA, V18, P21; Go R., 2008, ORCHIDS PEAT SWAMP F, P136; Go R., 2014, ORCHIDEA SELANGOREAN; Go R., 2020, ORCHID REV, V1331, P162; Go R, 2011, BIODIVERS CONSERV, V20, P2263, DOI 10.1007/s10531-011-0087-z; Govaerts R., 2021, WORLD CHECKLIST ORCH; Harris J.G., 1994, PLANT IDENTIFICATION; Holttum RE., 1957, REVISED FLORA MALAYA, V1, P759; Isa SFM, 2018, PERTANIKA J TROP AGR, V41, P1245; Jin NY, 2012, SAINS MALAYS, V41, P505; Jin XH, 2018, PHYTOKEYS, P1, DOI 10.3897/phytokeys.94.23887; Kiew R, 1993, 27293 WORLD WILDL FU; Kiew R., 2010, FLORA PENINSULAR M 2, V1, P3; Kiew R, 2021, NAT CONSERV-BULGARIA, P21, DOI 10.3897/natureconservation.44.60175; Koopowitz H., 2008, TROPICAL SLIPPER ORC, P412; Kurzweil H., 2009, Thai Forest Bulletin (Botany), P7; Latiff A., 2001, KEPELBAGAIAN BIOL PE, P19; Leong PKF., 2014, MALES ORCHID J, V13, P113; Liew TS, 2016, TROP CONSERV SCI, V9, P903, DOI 10.1177/194008291600900219; Mathew D, 1992, 27792 MYS WORLD WILD; Md Isa SF., 2015, SETIU WETLANDS SPECI, P51; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nordin FA., 2015, ORCHIDS MONTANE FORE, P216; Ong PT., 2017, CHECKLIST ORCHIDS PE; Ong PT., 2015, ORCHID REV, V123, P28; Pfitzer EHH., 1903, PFLANZENR, V4, P4; Pridgeon AM., 2001, ORCHIDOIDEAE PART 1, V2; Rahimatsah A., 2002, BIODIVERSITY MANAGEM, P23; Reichenbach HG., 1878, OTIA BOT HAMBURG, V1, P34; Rice R., 2018, PHOTO INTRO VANDOID; Ridley HN., 1891, GARD CHRON, V3, P94; Ridley HN., 1986, BOT J LINN SOC, V31, P261, DOI [10.1111/j.1095-8339.1896.tb00808.x, DOI 10.1111/J.1095-8339.1896.TB00808.X]; Ridley HN., 1908, J STRAITS BRANCH ROY, V49, P42; Rolfe RA., 1896, ORCHID REV, V4, P162; Rolfe RA., 1896, B MISC INFORM KEW, V534, P202; Rusea G, 2009, BLUMEA, V54, P109, DOI 10.3767/000651909X474168; Schlechter R., 1914, REPERT SPEC NOV REGN, V1, P664; Schultes RE., 1963, GENERIC NAMES ORCHID, P331; SEIDENFADEN G, 1977, DAN BOT ARK, V31, P5; Seidenfaden G., 1992, The orchids of peninsular Malaysia and Singapore.; Sharma D., 1992, SURVEY MATA AYER FOR; Smith JJ., 1930, MEDEDEELINGEN VANS R, V2, P1; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Sulistiarini D., 2014, REINWARDTIA, V10, P383, DOI [10.14203/reinwardtia.v10i4.276, DOI 10.14203/REINWARDTIA.V10I4.276]; Turner IM., 1995, GARDENS B SINGAPORE, V47, P559; Vermeulen J., 1991, BULBOPHYLLUM, V2; WOOD J J, 1984, Kew Bulletin, V39, P73, DOI 10.2307/4107856; Wood JJ., 1994, CHECKLIST ORCHIDS BO, P409; Yong WSY., 2005, PERTANIKA J TROP AGR, V28, P135	64	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267485	10.1371/journal.pone.0267485	http://dx.doi.org/10.1371/journal.pone.0267485			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35472161	gold, Green Published			2022-12-26	WOS:000816171900022
J	Matheson, CD; Vickruck, CR; McEvoy, CJ; Vernon, KK; Mason, R				Matheson, Carney D.; Vickruck, Cory R.; McEvoy, Chris J.; Vernon, Kim K.; Mason, Robert			Composition of trace residues from the contents of 11(th)-12(th) century sphero-conical vessels from Jerusalem	PLOS ONE			English	Article							FATTY-ACID RATIOS; GAS-CHROMATOGRAPHY; CHEMICAL INSIGHTS; GREEK FIRE; MEDIEVAL; SPECTROMETRY	The residues from the internal surface of four archaeological ceramic sherds, excavated from the Armenian Gardens, Jerusalem were analysed to characterise the contents of the original vessel. The sherds derive from four small, thick-walled, sphero-conical vessels recovered from a destruction layer, dating between the 11th and 12th century, Jerusalem. The residue has been analysed using light microscopy, biochemical characterisation, gas chromatography mass spectroscopy, inductively coupled plasma atomic emission spectroscopy and cold vapour atomic fluorescence spectrometry. This analysis established the presence of various compounds including fatty acids and notable levels of mercury, sulphur, aluminium, potassium, magnesium, nitrates and phosphorous. The contents and probable functions of the four vessels were characterised from the residues on these sherds as different from each other, reflecting their different decoration, manufacture and ceramic typologies. One of these vessels contains residue that indicate the vessel held oils. The residue of the second vessel is consistent with either scented materials or medicinal contents, while a third probably contained medicinal material. The unique fourth sherd is from a stoneware sphero-conical vessel with very thick walls, no decoration and the residue supports the possibility it was used for the storage of chemicals or may have held the chemical ingredients for an explosive device, consistent with a medieval grenade. This residue analysis of Mamluk sphero-conical vessels provides insight into luxury items, medicines, technology and trade in medieval Jerusalem.	[Matheson, Carney D.; Vickruck, Cory R.; McEvoy, Chris J.] Lakehead Univ, Dept Anthropol, Thunder Bay, ON, Canada; [Matheson, Carney D.] Lakehead Univ, Dept Biol, Thunder Bay, ON, Canada; [Matheson, Carney D.; Vernon, Kim K.] Lakehead Univ, Lakehead Univ Mol Archaeochem & Residue Serv LUMA, Thunder Bay, ON, Canada; [Matheson, Carney D.; Vernon, Kim K.] Griffith Univ, Sch Environm & Sci, Nathan, Qld, Australia; [Mason, Robert] Royal Ontario Museum, Toronto, ON, Canada	Lakehead University; Lakehead University; Lakehead University; Griffith University; Royal Ontario Museum	Matheson, CD (corresponding author), Lakehead Univ, Dept Anthropol, Thunder Bay, ON, Canada.; Matheson, CD (corresponding author), Lakehead Univ, Dept Biol, Thunder Bay, ON, Canada.; Matheson, CD (corresponding author), Lakehead Univ, Lakehead Univ Mol Archaeochem & Residue Serv LUMA, Thunder Bay, ON, Canada.; Matheson, CD (corresponding author), Griffith Univ, Sch Environm & Sci, Nathan, Qld, Australia.	c.matheson@griffith.edu.au	Vernon, Kim/GXW-0252-2022	Vernon, Kim/0000-0002-4875-5053; Matheson, Carney/0000-0002-3890-1838	Royal Ontario Museum; Lakehead University Molecular, Archaeochemistry and Residue Services (LUMARS); Lakehead University Department of Anthropology	Royal Ontario Museum; Lakehead University Molecular, Archaeochemistry and Residue Services (LUMARS); Lakehead University Department of Anthropology	We would like to thank the support of the Royal Ontario Museum, Lakehead University Molecular, Archaeochemistry and Residue Services (LUMARS), the Lakehead University Department of Anthropology, Johane Jonkas of the Lakehead University Environmental Laboratory (LUEL), Greg Kepka and Jiali Wen of the Lakehead University Instrumentation Laboratory (LUIL) and Brian Vernon for valuable editing of the manuscript.	Adahl K., 1997, MEDELHAVSMUSEET B, V30, P58; Barnard H, 2016, MUQARNAS, V33, P409, DOI 10.1163/22118993_03301P012; BLANCOU J, 1995, REV SCI TECH OIE, V14, P31; Boas AJ, 1998, NEAR EAST ARCHAEOL, V61, P138, DOI 10.2307/3210688; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brosh N., 1980, ATIQOT, V14, P114; Cheronis ND., 1937, J CHEM EDUC, V14, P360, DOI [10.1021/ed014p360, DOI 10.1021/ED014P360]; Chester GJ., 1871, RECOVERY JERUSALEM N, P480; Colombini MP, 2005, MICROCHEM J, V79, P83, DOI 10.1016/j.microc.2004.05.004; Crowther A, 2015, J ARCHAEOL SCI, V53, P374, DOI 10.1016/j.jas.2014.10.008; Croxton RS, 2010, FORENSIC SCI INT, V199, P93, DOI 10.1016/j.forsciint.2010.03.019; Davidson HR., 1973, BYZANTINISCHE Z, V66, P61, DOI [10.1515/bz-1973-0105, DOI 10.1515/BZ-1973-0105]; Davis T. L., 1943, CHEM POWDER EXPLOSIV; de Saulcy MF, 1874, MEMOIRES SOC NATL AN, V35, P25; Eerkens JW, 2005, ARCHAEOMETRY, V47, P83, DOI 10.1111/j.1475-4754.2005.00189.x; Elnaggar A, 2017, ARCHAEOMETRY, V59, P133, DOI 10.1111/arcm.12239; Ettinghausen R., 1965, J NEAR EASTERN STUD, V24, P218, DOI [10.1086/371816, DOI 10.1086/371816]; Evershed RP, 2002, ACCOUNTS CHEM RES, V35, P660, DOI 10.1021/ar000200f; FALHOLT K, 1973, CLIN CHIM ACTA, V46, P105, DOI 10.1016/0009-8981(73)90016-8; Fullagar R, 2015, ARCHAEOL OCEAN, V50, P3, DOI 10.1002/arco.5053; Ghouchani A., 1992, MUQARNAS, V9, P72, DOI [10.2307/1523137, DOI 10.2307/1523137]; Hauser W., 1942, METROPOL MUS ART B, V3, P89; Healy JF., 2000, PLINY ELDER SCI TECH; Hildburgh WalterLeo., 1951, ARCHAEOLOGIA, V94, P27, DOI [10.1017/S0261340900007207, DOI 10.1017/S0261340900007207]; Hime HWL., 1904, GUNPOWDER AMMUNITION; Keall EJ., 1992, P SEMIN ARAB STUD, V22, P29; Keall EJ., 1993, MUQARNAS, V10, P275; Lane Arthur, 1957, EARLY ISLAMIC POTTER; Malainey ME, 1999, J ARCHAEOL SCI, V26, P83, DOI 10.1006/jasc.1998.0305; Mare WH., 1987, ARCHAEOLOGY JERUSALE; Mason R. B., 2004, SHINE SUN LUSTRE PAI; Matheson CD, 2014, J ARCHAEOL SCI, V52, P116, DOI 10.1016/j.jas.2014.08.016; Mercier M., 1952, FEU GREGEOIS FEUX GU; Mercier M., 1937, EC STAT, V4, P87; Michalski S, 2013, J FORENSIC SCI, V58, pS215, DOI 10.1111/1556-4029.12010; Muhammad TM, 2009, INT J MARIT HIST, V21, P55, DOI 10.1177/084387140902100104; NISSENBAUM A, 1986, J CHEM EDUC, V63, P297, DOI 10.1021/ed063p297; Partington JR., 1960, HIST GREEK FIRE GUNP; Peris-Vicente J, 2009, ANAL LETT, V42, P2637, DOI 10.1080/00032710903243604; Post P, 1929, HANDBRANDGESCHOSS OD, V3, P42; Pozhidaev V, 2017, ARCHAEOMETRY, V59, P1095, DOI 10.1111/arcm.12292; Pozhidaev VM, 2016, J ANAL CHEM+, V71, P1151, DOI 10.1134/S1061934816110113; Rapp G, 2009, ARCHAEOMINERALOGY; Rogers M., 1969, FORSCHUNGEN KUNST AS, P147; Roland A., 1992, TECHNOL CULT, V33, P655; Sandler A, 2013, CATENA, V110, P119, DOI 10.1016/j.catena.2013.05.016; Sarah P, 2006, CATENA, V67, P50, DOI 10.1016/j.catena.2006.02.007; Savage-Smith E., 1997, SCI TOOLS MAGIC 2, P324; SCHEIN S, 1984, TRADITIO, V40, P175, DOI 10.1017/S0362152900003913; Seyrig H, 1959, FLOCONS GRENADES EOL, V36, P81; Sharvit J., 2008, ISRAEL ANTIQUITIES A, P101, DOI [10.1249/MSS.0b013e3181893f30, DOI 10.1249/MSS.0B013E3181893F30]; Shimron AE., 2020, ARCHAEOLOGICAL DISCO, V8, P92, DOI [10.4236/ad.2020.81006, DOI 10.4236/AD.2020.81006]; Singleton VL., 1996, ORIGINS ANCIENT HIST, P67; Sommer H., 1940, IND ENG CHEM ANAL ED, V12, P368, DOI [10.1021/ac50146a027, DOI 10.1021/AC50146A027]; Stanica A-D., 2016, SPRAW, V68, P327, DOI [10.23858/SA68.2016.015, DOI 10.23858/SA68.2016.015]; Stevenson J., 1875, EXPUGATIONE TERRAE S; THOMANN J, 2015, ASIATISCHE STUDIEN E, V69, P971; Tushingham AD, 1985, BRIT ACAD MONOGRAPHS; Valiulina S, 2016, PAMATKY ARCHEOL, V107, P237; Vezzoli V, 2016, J ISLAM ARCHAEOL, V3, P209, DOI 10.1558/jia.v3i2.32828; Warner Rex, 1954, THUCYDIDES PELOPONNE; Whelan M, 1930, J BIOL CHEM, V86, P189; Whitcomb D, 2016, J ISLAM ARCHAEOL, V3, P179, DOI 10.1558/jia.v3i2.32825; Yeleuov M., 2014, LIFE SCI J, V11, P384; Yuan CK, 2006, APPL ERGON, V37, P113, DOI 10.1016/j.apergo.2005.06.008	65	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267350	10.1371/journal.pone.0267350	http://dx.doi.org/10.1371/journal.pone.0267350			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D9PO	35468154	Green Published, gold			2022-12-26	WOS:000794129600011
J	Matsumura, G; Isayama, N; Sato, H				Matsumura, Goki; Isayama, Noriko; Sato, Hideki			Evaluation method for cell-free in situ tissue-engineered vasculature monitoring: Proof of growth and development in a canine IVC model	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; AUTOGRAFTS	We previously developed a non-cell-dependent biodegradable scaffold to create in situ tissue-engineered vasculature (iTEV) and tested it in a canine inferior vena cava (IVC) model. As iTEV features change dramatically during tissue generation, practical, simple, and accurate methods to evaluate iTEV are needed. The present study examined the usefulness of a novel method to evaluate iTEV growth and remodeling according to a simple formula using angiography: hepatic vein (HV) index = (IVC-HV junction angle) divided by (pi x [minimal internal iTEV diameter divided by 2](2)). HV index strongly correlated with the pressure gradient across iTEV, which tended to improve during the tissue generation period up to 12 months post-implantation. Time-course changes in HV index reflected iTEV tissue development and in-vivo characteristics, such as hemodynamic congestion. In conclusion, HV index is useful to assess iTEV graft function because it represents both the morphometrics and hemodynamics of iTEV with only diagnostic imaging data.	[Matsumura, Goki] Tokyo Womens Med Univ, Med Safety Management Dept, Shinjuku Ku, Tokyo, Japan; [Matsumura, Goki; Isayama, Noriko] Tokyo Womens Med Univ, Heart Inst Japan, Dept Cardiovasc Surg, Shinjuku Ku, Tokyo, Japan; [Isayama, Noriko] Ueno No Mori Anim Clin, Tokyo, Japan; [Sato, Hideki] Gunze Ltd, QOL Res Ctr, Kyoto, Japan	Tokyo Women's Medical University; Tokyo Women's Medical University	Matsumura, G (corresponding author), Tokyo Womens Med Univ, Med Safety Management Dept, Shinjuku Ku, Tokyo, Japan.; Matsumura, G (corresponding author), Tokyo Womens Med Univ, Heart Inst Japan, Dept Cardiovasc Surg, Shinjuku Ku, Tokyo, Japan.	matsumura.goki@twmu.ac.jp		MATSUMURA, GOKI/0000-0002-1134-3346; Isayama, Noriko/0000-0002-4240-2134	KAKENHI Japan Society for the Promotion of Science (JSPS) [17K10739, 23591878]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Research Promotion Society for Cardiovascular Diseases	KAKENHI Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Research Promotion Society for Cardiovascular Diseases	This work was supported in part by KAKENHI (Grant-in-aid for Scientific Research) of the Japan Society for the Promotion of Science (JSPS) (C: number 17K10739, C: number 23591878) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and in part by an Open Research Grant from the Japan Research Promotion Society for Cardiovascular Diseases (2018 and 2019). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Drews JD, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax6919; Hibino N, 2011, FASEB J, V25, P4253, DOI 10.1096/fj.11-186585; Hibino N, 2010, J THORAC CARDIOV SUR, V139, P431, DOI 10.1016/j.jtcvs.2009.09.057; Isayama N, 2014, BIOMATERIALS, V35, P3589, DOI 10.1016/j.biomaterials.2014.01.006; Isayama N, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-54; Matsumura G, 2003, CIRCULATION, V108, P1729, DOI 10.1161/01.CIR.0000092165.32213.61; Matsumura G, 2003, BIOMATERIALS, V24, P2303, DOI 10.1016/S0142-9612(03)00043-7; Matsumura G, 2006, TISSUE ENG, V12, P3075, DOI 10.1089/ten.2006.12.3075; Matsumura G, 2013, BIOMATERIALS, V34, P6422, DOI 10.1016/j.biomaterials.2013.05.037; Matsumura G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035760; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047; Sugiura T, 2018, SEMIN THORAC CARDIOV, V30, P175, DOI 10.1053/j.semtcvs.2018.02.002	13	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267274	10.1371/journal.pone.0267274	http://dx.doi.org/10.1371/journal.pone.0267274			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7MW	35436313	Green Published, gold			2022-12-26	WOS:000791258900004
J	Nejadghaderi, SA; Roshani, S; Mohammadi, E; Yoosefi, M; Rezaei, N; Esfahani, Z; Azadnajafabad, S; Ahmadi, N; Shahin, S; Kazemi, A; Shabestari, AN; Khosravi, A; Mokdad, AH; Larijani, B; Farzadfar, F				Nejadghaderi, Seyed Aria; Roshani, Shahin; Mohammadi, Esmaeil; Yoosefi, Moein; Rezaei, Negar; Esfahani, Zahra; Azadnajafabad, Sina; Ahmadi, Naser; Shahin, Sarvenaz; Kazemi, Ameneh; Shabestari, Alireza Namazi; Khosravi, Ardeshir; Mokdad, Ali H.; Larijani, Bagher; Farzadfar, Farshad			The global, regional, and national burden and quality of care index (QCI) of colorectal cancer; a global burden of disease systematic analysis 1990-2019	PLOS ONE			English	Article							DISPARITIES	BackgroundColorectal cancer (CRC) is among the five most incident and lethal cancers in world and its burden varies between countries and sexes. We aimed to present a comprehensive measure called the quality of care index (QCI) to evaluate the inequity and healthcare quality of care regarding CRC by sex and location. MethodsData on the burden of CRC were extracted from the Global Burden of Disease study 2019. It was transformed to four ratios, including mortality-to-incidence, disability-adjusted life years (DALYs)-to-prevalence, prevalence-to-incidence, and years of life lost (YLLs)-to-years lived with disability (YLDs). Principal component analysis was implemented on the four ratios and the most influential component was considered as QCI with a score ranging from zero to 100, for which higher scores represented better quality of care. Gender Disparity Ratio (GDR) was calculated by dividing QCI for females by males. ResultsThe global incidence and death numbers of CRC were 2,166,168 (95% uncertainty interval: 1,996,298-2,342,842) and 1,085,797 (1,002,795-1,149,679) in 2019, respectively. Globally, QCI and GDR values were 77.6 and 1.0 respectively in 2019. There was a positive association between the level of quality of care and socio-demographic index (SDI) quintiles. Region of the Americas and African Region had the highest and lowest QCI values, respectively (84.4 vs. 23.6). The QCI values started decreasing beyond the age of 75 in 2019 worldwide. ConclusionThere is heterogeneity in QCI between SDI quintiles. More attention should be paid to people aged more than 75 years old because of the lower quality of care in this group.	[Nejadghaderi, Seyed Aria; Roshani, Shahin; Mohammadi, Esmaeil; Yoosefi, Moein; Rezaei, Negar; Esfahani, Zahra; Azadnajafabad, Sina; Ahmadi, Naser; Shahin, Sarvenaz; Kazemi, Ameneh; Farzadfar, Farshad] Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Endocrinol & Metab Populat Sci Inst, Tehran, Iran; [Mohammadi, Esmaeil] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran; [Rezaei, Negar; Kazemi, Ameneh; Larijani, Bagher; Farzadfar, Farshad] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran; [Esfahani, Zahra] Univ Social Welf & Rehabil Sci, Dept Biostat, Tehran, Iran; [Shabestari, Alireza Namazi] Univ Tehran Med Sci, Sch Med, Dept Geriatr Med, Tehran, Iran; [Khosravi, Ardeshir] Iranian Minist Hlth & Med Educ, Tehran, Iran; [Mokdad, Ali H.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Ministry of Health & Medical Education (MOHME); Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Farzadfar, F (corresponding author), Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Endocrinol & Metab Populat Sci Inst, Tehran, Iran.; Farzadfar, F (corresponding author), Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran.	f-farzadfar@tums.ac.ir	Roshani, Shahin/GLT-0683-2022; Azadnajafabad, Sina/ABC-5770-2020; Shahin, Sarvenaz/HHC-4847-2022; Nejadghaderi, Seyed Aria/AAU-1280-2021	Azadnajafabad, Sina/0000-0003-0105-3801; Nejadghaderi, Seyed Aria/0000-0002-8692-9720; Larijani, Bagher/0000-0001-5386-7597				Aminorroaya A, 2022, EUR J PREV CARDIOL, V29, P371, DOI 10.1093/eurjpc/zwab066; [Anonymous], 2018, DELIVERING QUALITY H; [Anonymous], GLOBAL HLTH OBSERVAT; Araghi M, 2019, INT J CANCER, V144, P2992, DOI 10.1002/ijc.32055; Azadnajafabad S, 2021, CANCER MED-US, V10, P2496, DOI 10.1002/cam4.3823; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V315, P2564, DOI 10.1001/jama.2016.5989; Carethers JM, 2020, GASTROENTEROLOGY, V158, P354, DOI 10.1053/j.gastro.2019.10.029; Daniel CL, 2017, FRONT BIOSCI-LANDMRK, V22, P465, DOI 10.2741/4495; DataBank, SERV DEL IND; Diseases and Injuries Collaborators, 2020, LANCET, V396, P1204, DOI [10.1016/S0140-6736(20)30925-9, DOI 10.1016/S0140-6736(20)30925-9]; Doshmangir L, 2021, INT J EQUITY HEALTH, V20, DOI 10.1186/s12939-020-01372-4; Ebell MH, 2018, PUBLIC HEALTH REV, V39, DOI 10.1186/s40985-018-0080-0; Esteva M, 2014, CANCER EPIDEMIOL, V38, P346, DOI 10.1016/j.canep.2014.05.002; Fitzmaurice C, 2019, JAMA ONCOL, V5, P1749, DOI 10.1001/jamaoncol.2019.2996; Fleming M, 2012, J GASTROINTEST ONCOL, V3, P153, DOI 10.3978/j.issn.2078-6891.2012.030; Fullman N, 2018, LANCET, V391, P2236, DOI [10.1016/S0140-6736(18)30994-2, 10.1016/s0140-6736(18)30994-2]; Gancayco J, 2013, J CLIN GASTROENTEROL, V47, P630, DOI 10.1097/MCG.0b013e31828345c8; *GBD 2019 RISK FAC, 2019, LANCET, V0396; Gonzalez JR, 2005, J EPIDEMIOL COMMUN H, V59, P506, DOI 10.1136/jech.2004.028902; Hamashima C, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4244-6; Holme O, 2018, ANN INTERN MED, V168, P775, DOI 10.7326/M17-1441; Institute for Health Metrics and Evaluation (IHME), 2015, GBD COMPARE; Institute for Health Metrics and Evaluation (IHME), 2020, GBD COMPARE; Institute for Health Metrics and Evaluation (IHME), GBD COMP 2019; Johnson CM, 2013, CANCER CAUSE CONTROL, V24, P1207, DOI 10.1007/s10552-013-0201-5; Kagawa-Singer M, 2010, CA-CANCER J CLIN, V60, P12, DOI 10.3322/caac.20051; Keykhaei M, 2021, EXP HEMATOL ONCOL, V10, DOI 10.1186/s40164-021-00198-2; Kim SE, 2015, WORLD J GASTROENTERO, V21, P5167, DOI 10.3748/wjg.v21.i17.5167; Kingsley J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167452; Koolman X, 2004, HEALTH ECON, V13, P649, DOI 10.1002/hec.884; Larsen S, 2020, GUT, V69, P197, DOI 10.1136/gutjnl-2019-319108; Lozano R, 2020, LANCET, V396, P1250, DOI 10.1016/S0140-6736(20)30750-9; Melnitchouk N, 2018, COST EFFECT RESOUR A, V16, DOI 10.1186/s12962-018-0104-0; Mohammadi E, 2020, QUALITY CARE INDEX Q, DOI [10.17504/protocols.io.bprjmm4n, DOI 10.17504/PROTOCOLS.IO.BPRJMM4N]; Mohammadi E, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247120; Murray CJL, 2018, LANCET, V392, P1995, DOI [10.1016/S0140-6736(18)32278-5, 10.1016/s0140-6736(18)32278-5]; Safiri S, 2019, LANCET GASTROENTEROL, V4, P913, DOI 10.1016/S2468-1253(19)30345-0; Sano Y, 2016, DIGEST ENDOSC, V28, P243, DOI 10.1111/den.12579; Serra-Rexach JA, 2012, ONCOLOGIST, V17, P1277, DOI 10.1634/theoncologist.2012-0060; Stanaway JD, 2018, LANCET, V392, P1923, DOI 10.1016/s0140-6736(18)32225-6; Stevens GA, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002116, 10.1371/journal.pmed.1002056]; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Tabary M., 2021, PANCREATOLOGY; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; WAGSTAFF A, 1991, J HEALTH ECON, V10, P169, DOI 10.1016/0167-6296(91)90003-6; Wang HD, 2020, LANCET, V396, P1160, DOI 10.1016/S0140-6736(20)30977-6; Wee LE, 2012, PREV MED, V55, P61, DOI 10.1016/j.ypmed.2012.04.011; West R, 2017, PSYCHOL HEALTH, V32, P1018, DOI 10.1080/08870446.2017.1325890; World Health Organization, 2019, ICD 10 VERS 2019; World Health Organization, WHAT IS QUALITY CARE; Yager SS, 2014, AM J CLIN ONCOL-CANC, V37, P555, DOI 10.1097/COC.0b013e318282a830	51	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0263403	10.1371/journal.pone.0263403	http://dx.doi.org/10.1371/journal.pone.0263403			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1F9GM	35446852	Green Published, gold			2022-12-26	WOS:000795468200063
J	Sakamoto, K; Mukai, Y; Kawai, S; Nagaoka, K; Inoue, S; Takase, S; Yakabe, D; Ikeda, S; Mannoji, H; Nagayama, T; Chishaki, A; Tsutsui, H				Sakamoto, Kazuo; Mukai, Yasushi; Kawai, Shunsuke; Nagaoka, Kazuhiro; Inoue, Shujiro; Takase, Susumu; Yakabe, Daisuke; Ikeda, Shota; Mannoji, Hiroshi; Nagayama, Tomomi; Chishaki, Akiko; Tsutsui, Hiroyuki			Intra-atrial activation pattern is useful to localize the areas of non-pulmonary vein triggers of atrial fibrillation	PLOS ONE			English	Article							LOW-VOLTAGE AREAS; CATHETER ABLATION; PERSISTENT; IMPACT	BackgroundPulmonary vein isolation (PVI) is an established ablation procedure for atrial fibrillation (AF), however, PVI alone is insufficient to suppress AF recurrence. Non-pulmonary vein (non-PV) trigger ablation is one of the promising strategies beyond PVI and has been shown to be effective in refractory/persistent AF cases. To make non-PV trigger ablation more standardized, it is essential to develop a simple method to localize the origin of non-PV triggers. MethodsWe retrospectively analyzed 37 non-PV triggers in 751 ablation sessions for symptomatic AF from January 2017 to December 2020. Regarding non-PV triggers, intra-atrial activation interval from the earliest in right atrium (RA) to proximal coronary sinus (CS) (RA-CSp) and that from the earliest in RA to distal CS (RA-CSd) obtained by a basically-positioned duodecapolar RA-CS catheter were compared among 3 originating non-PV areas [RA, atrial septum (SEP) and left atrium (LA)]. ResultsRA-CSp of RA non-PV trigger (56.4 +/- 23.4 ms) was significantly longer than that of SEP non-PV (14.8 +/- 25.6 ms, p = 0.019) and LA non-PV (-24.9 +/- 27.9 ms, p = 0.0004). RA-CSd of RA non-PV (75.9 +/- 32.1 ms) was significantly longer than that of SEP non-PV (34.2 +/- 32.6 ms, p = 0.040) and LA non-PV (-13.3 +/- 41.2 ms, p = 0.0008). RA-CSp and RA-CSd of SEP non-PV were significantly longer than those of LA non-PV (p = 0.022 and p = 0.016, respectively). Sensitivity and specificity of an algorithm to differentiate the area of non-PV trigger using RA-CSp (cut-off value: 50 ms) and RA-CSd (cut-off value: 0 ms) were 88% and 97% for RA non-PV, 81% and 73% for SEP non-PV, 65% and 95% for LA non-PV, respectively. ConclusionsThe analysis of intra-atrial activation sequences was useful to differentiate non-PV trigger areas. A simple algorithm to localize the area of non-PV trigger would be helpful to identify non-PV trigger sites in AF ablation.	[Sakamoto, Kazuo; Mukai, Yasushi; Kawai, Shunsuke; Takase, Susumu; Yakabe, Daisuke; Ikeda, Shota; Nagayama, Tomomi; Tsutsui, Hiroyuki] Kyushu Univ, Dept Cardiovasc Med, Grad Sch Med Sci, Higashi Ku, Fukuoka, Japan; [Mukai, Yasushi; Kawai, Shunsuke] Japanese Red Cross Fukuoka Hosp, Dept Cardiovasc Med, Minami Ku, Fukuoka, Japan; [Nagaoka, Kazuhiro] St Marys Hosp, Dept Cardiol, Kurume, Fukuoka, Japan; [Inoue, Shujiro] Aso Iizuka Hosp, Dept Cardiol, Fukuoka, Japan; [Yakabe, Daisuke] Kyushu Med Ctr, Dept Cardiol, Chuo Ku, Fukuoka, Japan; [Mannoji, Hiroshi] Hamanomachi Hosp, Dept Cardiol, Chuo Ku, Fukuoka, Japan; [Chishaki, Akiko] Fukuoka Dent Coll Hosp, Div Cardiol, Sawara Ku, Fukuoka, Japan	Kyushu University; Fukuoka Dental College (FDC)	Mukai, Y (corresponding author), Kyushu Univ, Dept Cardiovasc Med, Grad Sch Med Sci, Higashi Ku, Fukuoka, Japan.; Mukai, Y (corresponding author), Japanese Red Cross Fukuoka Hosp, Dept Cardiovasc Med, Minami Ku, Fukuoka, Japan.	y_mukai@junnai.org		Ikeda, Shota/0000-0002-3737-3578; Takase, Susumu/0000-0002-3929-0071				Calkins H, 2018, EUROPACE, V20, P157, DOI [10.1093/europace/eux275, 10.1016/j.hrthm.2017.05.012, 10.1093/europace/eux274]; Della Rocca DG, 2020, J CARDIOVASC ELECTR, V31, P2154, DOI 10.1111/jce.14638; Della Rocca DG, 2018, ARRHYTH ELECTROPHYSI, V7, P256, DOI 10.15420/aer.2018.56.2; Dixit S, 2012, CIRC-ARRHYTHMIA ELEC, V5, P287, DOI 10.1161/CIRCEP.111.966226; Driessen AHG, 2016, J AM COLL CARDIOL, V68, P1155, DOI 10.1016/j.jacc.2016.06.036; Gianni C, 2018, EUROPACE, V20, P1566, DOI 10.1093/europace/euy034; Hayashi K, 2015, HEART RHYTHM, V12, P1918, DOI 10.1016/j.hrthm.2015.05.003; Hindricks G, 2021, EUR HEART J, V42, P373, DOI [10.1093/eurheartj/ehaa612, 10.15829/1560-4071-2021-4701]; Inoue K, 2021, CIRC J, V85, P1897, DOI 10.1253/circj.CJ-21-0126; Jilek C, 2019, EUROPACE, V21, P12, DOI 10.1093/europace/euy289; Kato N, 2020, J CARDIOVASC ELECTR, V31, P174, DOI 10.1111/jce.14314; Kawai S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48669-1; Kubala M, 2019, J CARDIOVASC ELECTR, V30, P865, DOI 10.1111/jce.13899; Kuroi Akio, 2015, JACC Clin Electrophysiol, V1, P127, DOI 10.1016/j.jacep.2015.02.020; Matsunaga-Lee Y, 2020, INT J CARDIOL, V321, P81, DOI 10.1016/j.ijcard.2020.08.015; Nakamaru R, 2019, JACC-CLIN ELECTROPHY, V5, P1319, DOI 10.1016/j.jacep.2019.08.002; Narui R, 2017, J INTERV CARD ELECTR, V49, P51, DOI 10.1007/s10840-017-0238-6; Nogami A, 2021, J ARRYTHM, V37, P709, DOI 10.1002/joa3.12491; Rillo M, 2021, J ARRYTHM, V37, P338, DOI 10.1002/joa3.12521; Rolf S, 2014, CIRC-ARRHYTHMIA ELEC, V7, P825, DOI 10.1161/CIRCEP.113.001251; Sakamoto Y, 2020, BMC CARDIOVASC DISOR, V20, DOI 10.1186/s12872-020-01685-w; Sanders P, 2007, EUR HEART J, V28, P1862, DOI 10.1093/eurheartj/ehl548; Santangeli P, 2017, HEART RHYTHM, V14, P1087, DOI 10.1016/j.hrthm.2017.02.030; Santangeli P, 2016, HEART RHYTHM, V13, P374, DOI 10.1016/j.hrthm.2015.10.023; Sciarra L, 2010, EUROPACE, V12, P1707, DOI 10.1093/europace/euq327; Takamiya T, 2021, J CARDIOVASC ELECTR, V32, P1251, DOI 10.1111/jce.15002; Takamiya T, 2021, J INTERV CARD ELECTR, V62, P381, DOI 10.1007/s10840-020-00913-9; Tohoku S, 2021, J CARDIOVASC ELECTR, V32, P224, DOI 10.1111/jce.14830; Verma A, 2015, NEW ENGL J MED, V372, P1812, DOI 10.1056/NEJMoa1408288; Vogler J, 2015, J AM COLL CARDIOL, V66, P2743, DOI 10.1016/j.jacc.2015.09.088	30	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0264894	10.1371/journal.pone.0264894	http://dx.doi.org/10.1371/journal.pone.0264894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D9PO	35468171	gold, Green Published			2022-12-26	WOS:000794129600030
J	Schlegel, P; Berry, DA; Chhetri, DK				Schlegel, Patrick; Berry, David A.; Chhetri, Dinesh K.			Analysis of vibratory mode changes in symmetric and asymmetric activation of the canine larynx	PLOS ONE			English	Article							FUNDAMENTAL-FREQUENCY; SUBGLOTTAL PRESSURE; PHONATION; VOICE; ACOUSTICS; REGISTER; PITCH	Investigations of neuromuscular control of voice production have primarily focused on the roles of muscle activation levels, posture, and stiffness at phonation onset. However, little work has been done investigating the stability of the phonation process in regards to spontaneous changes in vibratory mode of vocal fold oscillation as a function of neuromuscular activation. We evaluated 320 phonatory conditions representing combinations of superior and recurrent laryngeal nerve (SLN and RLN) activations in an in vivo canine model of phonation. At each combination of neuromuscular input, airflow was increased linearly to reach phonation onset and beyond from 300 to 1400 mL/s. High-speed video and acoustic data were recorded during phonation, and spectrograms and glottal-area-based parameters were calculated. Vibratory mode changes were detected based on sudden increases or drops of local fundamental frequency. Mode changes occurred only when SLNs were concurrently stimulated and were more frequent for higher, less asymmetric RLN stimulation. A slight increase in amplitude and cycle length perturbation usually preceded the changes in the vibratory mode. However, no inherent differences between signals with mode changes and signals without were found.	[Schlegel, Patrick; Berry, David A.; Chhetri, Dinesh K.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Head & Neck Surg, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Schlegel, P (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Head & Neck Surg, Los Angeles, CA 90095 USA.	pschlegel@ucla.edu			National Institutes of Health (NIH)/National Institute on Deafness and Other Communication (NIDCD) [R01 DC11300]; NIH/NIDCD [R01 DC013323]	National Institutes of Health (NIH)/National Institute on Deafness and Other Communication (NIDCD); NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	D.K.C. received funding from the National Institutes of Health (NIH)/National Institute on Deafness and Other Communication (NIDCD) under grant No R01 DC11300. D.A.B. received funding from the NIH/NIDCD under grant R01 DC013323 (Funder website: https://www.nidcd.nih.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipour F, 2011, CURR BIOINFORM, V6, P323, DOI 10.2174/157489311796904655; Berry DA, 1996, J VOICE, V10, P129, DOI 10.1016/S0892-1997(96)80039-7; Bonilha HS, 2008, AM J SPEECH-LANG PAT, V17, P367, DOI 10.1044/1058-0360(2008/07-0059); Chhetri DK, 2016, LARYNGOSCOPE, V126, P1123, DOI 10.1002/lary.25550; Chhetri DK, 2014, LARYNGOSCOPE, V124, P2544, DOI 10.1002/lary.24774; Chhetri DK, 2013, LARYNGOSCOPE, V123, P3110, DOI 10.1002/lary.24209; Chhetri DK, 2012, J ACOUST SOC AM, V131, P1401, DOI 10.1121/1.3672686; Chhetri DK, 2009, LARYNGOSCOPE, V119, P222, DOI 10.1002/lary.20031; Chhetri DK., 2010, J ACOUST SOC AM, V127, P2021; de Jesus Goncalves MH, 2015, THESIS FRIEDRICH ALE; Haben CM, 2003, J VOICE, V17, P3, DOI 10.1016/S0892-1997(03)00032-8; Hirano M., 1982, STRUCTURE MECH PROPE, P271; Kist AM, 2021, J SPEECH LANG HEAR R, V64, P1889, DOI 10.1044/2021_JSLHR-20-00498; KITZING P, 1982, FOLIA PHONIATR, V34, P234, DOI 10.1159/000265659; Kniesburges S, 2011, CURR BIOINFORM, V6, P305, DOI 10.2174/157489311796904637; Lohscheller J, 2008, LARYNGOSCOPE, V118, P753, DOI 10.1097/MLG.0b013e318161f9e1; Lungova V, 2020, CELL MOL LIFE SCI, V77, P3781, DOI 10.1007/s00018-020-03506-x; Mittal R, 2013, ANNU REV FLUID MECH, V45, P437, DOI 10.1146/annurev-fluid-011212-140636; Qiu QJ, 2003, FOLIA PHONIATR LOGO, V55, P128, DOI 10.1159/000070724; Roubeau B, 2009, J VOICE, V23, P425, DOI 10.1016/j.jvoice.2007.10.014; Rubin JS., 2014, DIAGNOSIS TREATMENT; Schlegel P, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66405-y; Sonninen A, 1999, J VOICE, V13, P319, DOI 10.1016/S0892-1997(99)80039-3; Soriano RM., 2021, ANATOMY HEAD NECK LA; SORON HI, 1963, J ACOUST SOC AM, V35, P1876, DOI 10.1121/1.2142605; SUNDBERG J, 1993, J VOICE, V7, P15, DOI 10.1016/S0892-1997(05)80108-0; Svec JG, 1999, J ACOUST SOC AM, V106, P1523, DOI 10.1121/1.427149; Titze I. R., 2000, PRINCIPLES VOICE PRO; Titze IR, 2008, J ACOUST SOC AM, V123, P2733, DOI 10.1121/1.2832337; TITZE IR, 1994, J ACOUST SOC AM, V95, P1133, DOI 10.1121/1.408461; Unteregger F, 2017, LARYNGOSCOPE, V127, P1639, DOI 10.1002/lary.26430; Zhang ZY, 2018, J ACOUST SOC AM, V144, P1216, DOI 10.1121/1.5053116; Zhang ZY, 2016, J ACOUST SOC AM, V140, P2614, DOI 10.1121/1.4964509	33	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266910	10.1371/journal.pone.0266910	http://dx.doi.org/10.1371/journal.pone.0266910			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421159	gold, Green Published			2022-12-26	WOS:000795453600081
J	Wong, KH; Kong, BLH; Siu, TY; Wu, HY; But, GWC; Shaw, PC; Lau, DTW				Wong, Kwan-Ho; Kong, Bobby Lim-Ho; Siu, Tin-Yan; Wu, Hoi-Yan; But, Grace Wing-Chiu; Shaw, Pang-Chui; Lau, David Tai-Wai			Complete chloroplast genomes of Asparagus aethiopicus L., A. densiflorus (Kunth) Jessop 'Myers', and A. cochinchinensis (Lour.) Merr.: Comparative and phylogenetic analysis with congenerics	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEATS; MOLECULAR PHYLOGENY; OFFICINALIS L.; RESISTANCE; CULTIVARS; AFRICA; INTRON; PLANTS; DNA	Asparagus species are widely used for medicinal, horticultural, and culinary purposes. Complete chloroplast DNA (cpDNA) genomes of three Asparagus specimens collected in Hong Kong-A. aethiopicus, A. densiflorus 'Myers', and A. cochinchinensis-were de novo assembled using Illumina sequencing. Their sizes ranged from 157,069 to 157,319 bp, with a total guanine-cytosine content of 37.5%. Structurally, a large single copy (84,598-85,350 bp) and a small single copy (18,677-18,685 bp) were separated by a pair of inverted repeats (26,518-26,573 bp). In total, 136 genes were annotated for A. aethiopicus and A. densiflorus 'Myers'; these included 90 mRNA, 38 tRNA, and 8 rRNA genes. Further, 132 genes, including 87 mRNA, 37 tRNA, and 8 rRNA genes, were annotated for A. cochinchinensis. For comparative and phylogenetic analysis, we included NCBI data for four congenerics, A. setaceus, A. racemosus, A. schoberioides, and A. officinalis. The gene content, order, and genome structure were relatively conserved among the genomes studied. There were similarities in simple sequence repeats in terms of repeat type, sequence complementarity, and cpDNA partition distribution. A. densiflorus 'Myers' had distinctive long sequence repeats in terms of their quantity, type, and length-interval frequency. Divergence hotspots, with nucleotide diversity (Pi) >= 0.015, were identified in five genomic regions: accD-psaI, ccsA, trnS-trnG, ycf1, and ndhC-trnV. Here, we summarise the historical changes in the generic subdivision of Asparagus. Our phylogenetic analysis, which also elucidates the nomenclatural complexity of A. aethiopicus and A. densiflorus 'Myers', further supports their close phylogenetic relationship. The findings are consistent with prior generic subdivisions, except for the placement of A. racemosus, which requires further study. These de novo assembled cpDNA genomes contribute valuable genomic resources and help to elucidate Asparagus taxonomy.	[Wong, Kwan-Ho; Siu, Tin-Yan; Lau, David Tai-Wai] Chinese Univ Hong Kong, Sch Life Sci, Shiu Ying Hu Herbarium, Hong Kong, Peoples R China; [Wong, Kwan-Ho; Kong, Bobby Lim-Ho; But, Grace Wing-Chiu; Shaw, Pang-Chui] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Peoples R China; [Kong, Bobby Lim-Ho; Wu, Hoi-Yan; Shaw, Pang-Chui; Lau, David Tai-Wai] Chinese Univ Hong Kong, Li Dak Sum Yip Yio Chin R&D Ctr Chinese Med, Hong Kong, Peoples R China; [Shaw, Pang-Chui] Chinese Univ Hong Kong, State Key Lab Res Bioact & Clin Applicat Med Plan, Hong Kong, Peoples R China; [Shaw, Pang-Chui] Chinese Univ Hong Kong, Inst Chinese Med, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Lau, DTW (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shiu Ying Hu Herbarium, Hong Kong, Peoples R China.; Lau, DTW (corresponding author), Chinese Univ Hong Kong, Li Dak Sum Yip Yio Chin R&D Ctr Chinese Med, Hong Kong, Peoples R China.	lautaiwai@cuhk.edu.hk		Siu, Tin Yan/0000-0001-5725-3314; WONG, Kwan Ho/0000-0001-8251-6331; Lau, Tai Wai David/0000-0002-3443-1808	Wu Jieh Yee Charitable Foundation Limited	Wu Jieh Yee Charitable Foundation Limited	The research work was supported by a donation fund from Wu Jieh Yee Charitable Foundation Limited. The fund has no formal grant number. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altunel T. A., 2021, Turkish Journal of Agriculture - Food Science and Technology, V9, P1092, DOI 10.24925/turjaf.v9i6.1092-1099.4269; Amiryousefi A, 2018, BIOINFORMATICS, V34, P3030, DOI 10.1093/bioinformatics/bty220; [Anonymous], 2016, SCRIPTA HORTICULTURA, V18, P1; [Anonymous], 2018, ASTM C33C33M 18, DOI DOI 10.1520/C0033_C0033M-18; Arber A, 1924, ANN BOT-LONDON, V38, P635, DOI 10.1093/oxfordjournals.aob.a089921; Arber A, 1925, MONOCOTYLEDONS MORPH, DOI [10.1017/CBO9780511708626, DOI 10.1017/CBO9780511708626]; ASTM International, 2016, STANDARD TEST METHOD, DOI DOI 10.1520/D5298-16; Bailey LH, 1976, CONCISE DICT PLANTS; Baker JG, 1875, BOT J LINN SOC, P594; Baker JG, 1896, FLORA CAPENSIS BEING, V6, P256, DOI [10.5962/bhl.title.821, DOI 10.5962/BHL.TITLE.821]; BANSAL RK, 1986, NEW ZEAL J AGR RES, V29, P539, DOI 10.1080/00288233.1986.10423507; Batchelor Kathryn L., 2006, Plant Protection Quarterly, V21, P128; Beier S, 2017, BIOINFORMATICS, V33, P2583, DOI 10.1093/bioinformatics/btx198; Bopana N, 2008, IN VITRO CELL DEV-PL, V44, P525, DOI 10.1007/s11627-008-9137-y; Bowden D., 1995, PAC CONSERV BIOL, V2, P293, DOI [10.1071/PC960293, DOI 10.1071/PC960293]; Breyer-Brandwijk M.G., 1962, MED POISONOUS PLANTS, V2nd; Brudno M, 2003, BIOINFORMATICS, V19, pi54, DOI 10.1093/bioinformatics/btg1005; But PPH, 2012, ADV BOT RES, V62, P1, DOI 10.1016/B978-0-12-394591-4.00001-5; Castanon MLG, 2008, ACTA HORTIC, P319, DOI 10.1145/1346281.1346322; Chen XQ, 2000, FLORA CHINA, V24; Clifford HT., 1987, FLORA AUSTR, V45, P148; Conran J, 2005, HORTICULTURAL FLORA, P284; Conran JG., 1986, AUSTROBAILEYA, V2, P300; Council of Heads of Australasian Herbaria (CHAH), 2006, ASP DENS MEYERS; Dahlgren RMT., 1985, FAMILIES MONOCOTYLED; Development Bureau The Government of Hong Kong Special Administrative Region, 2016, SKYR GREEN PICT GUID; Duke JA, 1985, MED PLANTS CHINA, V2; Falavigna A, 2008, ACTA HORTIC, P291, DOI 10.17660/ActaHortic.2008.776.37; Fan LL, 2009, BIOL PHARM BULL, V32, P1439, DOI 10.1248/bpb.32.1439; FELLINGHAM AC, 1995, BOTHALIA, V25, P205, DOI 10.4102/abc.v25i2.728; Florida Exotic Pest Plant Council (FLEPPC), 2019, FLOR EX PEST PLANT C; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; [付欢 Fu Huan], 2020, [化学研究与应用, Chemical Research and Application], V32, P637; Fukuda T, 2005, PLANT SPEC BIOL, V20, P121, DOI 10.1111/j.1442-1984.2005.00131.x; GEOFFRIAU E, 1992, EUPHYTICA, V61, P169, DOI 10.1007/BF00039655; Green P. S., 1986, Plantsman, V7, P249; Greiner S, 2019, NUCLEIC ACIDS RES, V47, pW59, DOI 10.1093/nar/gkz238; Greiner T, 1919, STANDARD CYCLOPEDIA, P406, DOI [10.5962/bhl.title.23351, DOI 10.5962/BHL.TITLE.23351]; Hernandez-Leon S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070501; [胡嘉蕴 HU Jia-yun], 2010, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V21, P307; Hu QM., 2011, FLORA HONG KONG, V4, P266; Hu Shi-qiang, 2005, Control and Decision, V20, P361; Huber H., 1969, MITTEILUNGEN BOT STA, V8, P219; Huttleston DG., 1970, BAILEYA, V17, P58; Ito T, 2007, GENET RESOUR CROP EV, V54, P1063, DOI 10.1007/s10722-006-9186-1; Jahan R, 2020, HERBAL MEDICINE IN INDIA: INDIGENOUS KNOWLEDGE, PRACTICE, INNOVATION AND ITS VALUE, P363, DOI 10.1007/978-981-13-7248-3_23; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jessop JP., 1966, BOTHALIA, V9, P31, DOI [10.4102/abc.v9i1.1576, DOI 10.4102/ABC.V9I1.1576]; Jiangsu New Medical College, 1977, ENC CHIN MAT MED, V1, P858; Judd W, 2001, HARV PAP BOT, V6, P223; Kanh RP., 1952, B U ILLINOIS AGR EXP, P1; Kanno A, 1997, THEOR APPL GENET, V95, P1196, DOI 10.1007/s001220050681; Kanno A., 2011, WILD CROP RELATIVES, P23, DOI [10.1007/978-3-642-20450-0, DOI 10.1007/978-3-642-20450-0]; Kapoor LD, 1990, CRC HDB AYURVEDIC ME; Katoh K., 2017, BRIEF BIOINFORM, DOI [10.1093/bib/bbx108, doi.org/10.1093/bib/bbx108, DOI 10.1093/BIB/BBX108]; Kubota S, 2012, THEOR APPL GENET, V124, P345, DOI 10.1007/s00122-011-1709-2; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kunth CS, 1850, TOMUS QUINTUS; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lee YO, 1997, BREEDING SCI, V47, P375; Lee YO, 1996, THEOR APPL GENET, V92, P10, DOI 10.1007/BF00222945; Leon C, 2017, CHINESE MED PLANTS; Lewis WH, 1977, MED BOT PLANTS AFFEC; Li JR, 2019, MITOCHONDRIAL DNA B, V4, P2639, DOI 10.1080/23802359.2019.1643798; Li W, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216645; Li XW, 2015, BIOL REV, V90, P157, DOI 10.1111/brv.12104; Li Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194613; Linnaei C, 1753, TOMUS, DOI [10.5962/bhl.title.669, DOI 10.5962/BHL.TITLE.669]; Malcomber S. T., 1993, Kew Bulletin, V48, P63, DOI 10.2307/4115749; Marcellan ON, 1996, CAN J BOT, V74, P1621, DOI 10.1139/b96-196; Marcellan ON., 1999, SCI HORTIC-ENGLAND, V81, P1, DOI [10.1016/S0304-4238(98)00255-6, DOI 10.1016/S0304-4238(98)00255-6]; Mathew B, 1989, KEW BULL, V44, P181, DOI [10.2307/4114662, DOI 10.2307/4114662]; McCollum G. D., 1988, Asparagus Research Newsletter, V6, P1; Mercati F, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0217-5; MOISAN-THIERY M, 2005, POTATO RES, V48, P191, DOI DOI 10.1007/BF02742376; Moreno R., 2006, GENET RESOUR CROP EV, V53, P729, DOI [10.1007/s10722-004-4717-0, DOI 10.1007/S10722-004-4717-0]; Norton JB, 1913, B USDA SCI, P9; Norup MF, 2015, MOL PHYLOGENET EVOL, V92, P25, DOI 10.1016/j.ympev.2015.06.002; OBERMEYER A A, 1984, Bothalia, V15, P77; OBERMEYER AA, 1983, S AFR J BOT, V2, P243; Obermeyer AA., 1992, FLORA SO AFRICA 3, P11; Ochiai T, 2002, ACTA HORTIC, P225, DOI 10.17660/ActaHortic.2002.589.31; Pereira-Lorenzo S, 2008, SCI HORTIC-AMSTERDAM, V117, P160, DOI 10.1016/j.scienta.2008.03.033; Perry LM., 1980, MED PLANTS E SE ASIA; Peters CR., 1992, EDIBLE WILD PLANTS S; Quisumbing E., 1951, MED PLANTS PHILIPPIN; Regel E, 1890, GARTENFLORA, P490; Regel E, 1890, ACTA HORTI PETROPOLI, V11, P302; RHS, 2021, AW GARD MER LISTSORN; Rozas J., 2019, DNA SEQUENCE POLYM D; Saha PS, 2015, PROTOPLASMA, V252, P1121, DOI 10.1007/s00709-014-0746-5; Schneider K, 1997, AM POTATO J, V74, P149, DOI 10.1007/BF02851594; Sheng WenTao, 2017, Journal of Plant Breeding and Genetics, V5, P121; Sonoda T, 2001, J JPN SOC HORTIC SCI, V70, P244, DOI 10.2503/jjshs.70.244; South Florida Water Management District, 2003, WATERWISE S FLOR LAN; Staples G, 2005, TROPICAL GARDEN FLOR; STEPHENS CT, 1988, PLANT DIS, V72, P334, DOI 10.1094/PD-72-0334; STEPHENS CT, 1989, HORTSCIENCE, V24, P365; Straley GB., 2003, FLORA N AM N MEXICO, V26, P213; Tardio J, 2006, BOT J LINN SOC, V152, P27, DOI 10.1111/j.1095-8339.2006.00549.x; The Royal Horticultural Society (RHS), 1999, NEW ENC PLANTS FLOW, V3rd ed; The Royal Horticultural Society (RHS), 2008, NEW ENC HERBS THEIR, V3rd ed; The Royal Horticultural Society (RHS), 1992, NEW ROYAL HORTICULTU; The State Pharmacopoeia Commission of the People's Republic of China, 2010, PHARMACOPOEIA PEOPLE; The State Pharmacopoeia Commission of the People's Republic of China, 2020, PHARMACOPOEIA PEOPLE; Tillich M, 2017, NUCLEIC ACIDS RES, V45, pW6, DOI 10.1093/nar/gkx391; Willdenow CL, 1808, GESELLSCHAFT NATURFO, V1808, P14; Williams AV, 2016, MOL PHYLOGENET EVOL, V96, P1, DOI 10.1016/j.ympev.2015.11.021; Wong M, 2008, ORNAMENTALS FLOWERS, P1; Yu JK, 2002, GENOME, V45, P652, DOI [10.1139/g02-025, 10.1139/G02-025]	113	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266376	10.1371/journal.pone.0266376	http://dx.doi.org/10.1371/journal.pone.0266376			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D9PO	35468142	Green Published, gold			2022-12-26	WOS:000794129600023
J	Kroning, A; van den Boom, J; Kracht, M; Kueck, AF; Meyer, H				Kroning, Alexander; van den Boom, Johannes; Kracht, Matthias; Kueck, Anja F.; Meyer, Hemmo			Ubiquitin-directed AAA+ ATPase p97/VCP unfolds stable proteins crosslinked to DNA for proteolysis by SPRTN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DVC1 C1ORF124; P97 ADAPTER; MECHANISM; REPAIR	The protease SPRTN degrades DNA-protein crosslinks (DPCs) that threaten genome stability. SPRTN has been connected to the ubiquitin-directed protein unfoldase p97 (also called VCP or Cdc48), but a functional cooperation has not been demonstrated directly. Here, we biochemically reconstituted p97-assisted proteolysis with purified proteins and showed that p97 targets ubiquitin-modified DPCs and unfolds them to prepare them for proteolysis by SPRTN. We demonstrate that purified SPRTN alone was unable to degrade a tightly-folded Eos fluorescent reporter protein even when Eos was crosslinked to DNA (Eos-DPC). However, when present, p97 unfolded poly-ubiquitinated Eos-DPC in a manner requiring its ubiquitin adapter, Ufd1-Npl4. Notably, we show that, in cooperation with p97 and Ufd1-Npl4, SPRTN proteolyzed unfolded Eos-DPC, which relied on recognition of the DNA-crosslink by SPRTN. In a simplified unfolding assay, we further demonstrate that p97, while unfolding a protein substrate, can surmount the obstacle of a DNA crosslink site in the substrate. Thus, our data demonstrate that p97, in conjunction with Ufd1-Npl4, assists SPRTN-mediated proteolysis of tightly-folded proteins crosslinked to DNA, even threading bulky protein-DNA adducts. These findings will be relevant for understanding how cells handle DPCs to ensure genome stability and for designing strategies that target p97 in combination cancer therapy.	[Kroning, Alexander; van den Boom, Johannes; Kracht, Matthias; Kueck, Anja F.; Meyer, Hemmo] Univ Duisburg Essen, Fac Biol, Ctr Med Biotechnol, Essen, Germany	University of Duisburg Essen	Meyer, H (corresponding author), Univ Duisburg Essen, Fac Biol, Ctr Med Biotechnol, Essen, Germany.	hemmo.meyer@uni-due.de	Meyer, Hemmo/GNH-5784-2022	Meyer, Hemmo/0000-0003-1883-1796; Kueck, Anja F./0000-0003-2746-2793	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Collaborative Research Center [424228829, SFB 1430]; Collaborative Research Center [SFB 1093]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Collaborative Research Center(German Research Foundation (DFG)); Collaborative Research Center	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Collaborative Research Center SFB 1430 (Project-ID 424228829) and Collaborative Research Center SFB 1093 (project B2) to H. M.	Balakirev MY, 2015, ELIFE, V4, DOI [10.7554/eLife.06763.001, 10.7554/eLife.06763]; Blythe EE, 2017, P NATL ACAD SCI USA, V114, pE4380, DOI 10.1073/pnas.1706205114; Bodnar NO, 2017, CELL, V169, P722, DOI 10.1016/j.cell.2017.04.020; Carvalho AF, 2012, MOL BIOTECHNOL, V51, P254, DOI 10.1007/s12033-011-9463-x; Davis EJ, 2012, NAT STRUCT MOL BIOL, V19, P1093, DOI 10.1038/nsmb.2394; Fielden J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15000-w; Huang JZ, 2020, MOL CELL, V79, P824, DOI 10.1016/j.molcel.2020.06.027; Ji ZJ, 2022, MOL CELL, V82, P570, DOI 10.1016/j.molcel.2021.11.033; Kracht M, 2020, J MOL BIOL, V432, P6061, DOI 10.1016/j.jmb.2020.10.001; Larsen NB, 2019, MOL CELL, V73, P574, DOI 10.1016/j.molcel.2018.11.024; Lessel D, 2014, NAT GENET, V46, P1239, DOI 10.1038/ng.3103; Li FX, 2019, CELL REP, V26, P3336, DOI 10.1016/j.celrep.2019.02.082; Lopez-Mosqueda J, 2016, ELIFE, V5, DOI 10.7554/eLife.21491; Maskey RS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6744; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Mosbech A, 2012, NAT STRUCT MOL BIOL, V19, P1084, DOI 10.1038/nsmb.2395; Olszewski MM, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0283-z; Reinking HK, 2020, MOL CELL, V80, P102, DOI 10.1016/j.molcel.2020.08.003; Reinking HK, 2020, DNA REPAIR, V88, DOI 10.1016/j.dnarep.2020.102822; Ruggiano A, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-020-01539-3; Stingele J, 2016, MOL CELL, V64, P688, DOI 10.1016/j.molcel.2016.09.031; Stingele J, 2014, CELL, V158, P327, DOI 10.1016/j.cell.2014.04.053; Twomey EC, 2019, SCIENCE, V365, P462, DOI 10.1126/science.aax1033; van den Boom J, 2021, NAT STRUCT MOL BIOL, V28, P964, DOI 10.1038/s41594-021-00684-5; van den Boom J, 2018, MOL CELL, V69, P182, DOI 10.1016/j.molcel.2017.10.028; Vaz B, 2016, MOL CELL, V64, P704, DOI 10.1016/j.molcel.2016.09.032; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Weith M, 2018, MOL CELL, V72, P766, DOI 10.1016/j.molcel.2018.09.020; Ye YH, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00039; Zhang MS, 2012, NAT METHODS, V9, P727, DOI [10.1038/NMETH.2021, 10.1038/nmeth.2021]; Zhao SB, 2021, NUCLEIC ACIDS RES, V49, DOI 10.1093/nar/gkaa1224	31	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101976	10.1016/j.jbc.2022.101976	http://dx.doi.org/10.1016/j.jbc.2022.101976			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9DZ	35469923	Green Published, gold			2022-12-26	WOS:000807750700003
J	Zhang, Q; Haak, AJ; Sjogren, B				Zhang, Qian; Haak, Andrew J.; Sjogren, Benita			Regulator of G protein signaling 2 inhibits Gaq-dependent uveal melanoma cell growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RGS PROTEINS; ACTIVATION; MUTATIONS; YAP/TAZ; YAP	Activating mutations in G alpha(q/11) are a major driver of uveal melanoma (UM), the most common intraocular cancer in adults. While progress has recently been made in targeting G alpha(q/11) for UM therapy, the crucial role for these proteins in normal physiology and their high structural similarity with many other important GTPase proteins renders this approach challenging. The aim of the current study was to validate whether a key regulator of Gq signaling, regulator of G protein signaling 2 (RGS2), can inhibit G alpha(q)-mediated UM cell growth. We used two UM cell lines, 92.1 and Mel-202, which both contain the most common activating mutation G alpha(Q209L)(q) and developed stable cell lines with doxycycline-inducible RGS2 protein expression. Using cell viability assays, we showed that RGS2 could inhibit cell growth in both of these UM cell lines. We also found that this effect was independent of the canonical GTPase-activating protein activity of RGS2 but was dependent on the association between RGS2 and G alpha(q). Furthermore, RGS2 induction resulted in only partial reduction in cell growth as compared to siRNA-mediated Gaq knockdown, perhaps because RGS2 was only able to reduce mitogen-activated protein kinase signaling downstream of phospholipase C beta, while leaving activation of the Hippo signaling mediators yes-associated protein 1/TAZ, the other major pathway downstream of Gaq, unaffected. Taken together, our data indicate that RGS2 can inhibit UM cancer cell growth by associating with G alpha(Q209L)(q) as a partial effector antagonist.	[Zhang, Qian; Sjogren, Benita] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Haak, Andrew J.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Mayo Clinic	Sjogren, B (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.	jsjogren@purdue.edu						Anger T, 2004, J BIOL CHEM, V279, P3906, DOI 10.1074/jbc.M309496200; Annala S, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aau5948; Aravamudhan A, 2020, AM J PHYSIOL-LUNG C, V318, pL852, DOI 10.1152/ajplung.00324.2019; Bodmann EL, 2014, BIOCHEM J, V458, P131, DOI 10.1042/BJ20130782; Carvajal RD, 2017, BRIT J OPHTHALMOL, V101, P38, DOI 10.1136/bjophthalmol-2016-309034; Chen X, 2017, CANCER CELL, V31, P685, DOI 10.1016/j.ccell.2017.04.002; Choi KM, 2021, J CELL PHYSIOL, V236, P7759, DOI 10.1002/jcp.30459; Cunningham ML, 2001, J BIOL CHEM, V276, P5438, DOI 10.1074/jbc.M007699200; Daniels AB, 2012, INVEST OPHTH VIS SCI, V53, P6991, DOI 10.1167/iovs.12-10427; Feng XD, 2019, CANCER CELL, V35, P457, DOI 10.1016/j.ccell.2019.01.009; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Griewank KG, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2012.00971.x; Haak AJ, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau6296; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Kaliki S, 2017, EYE, V31, P241, DOI 10.1038/eye.2016.275; Ladds G, 2007, CELL SIGNAL, V19, P103, DOI 10.1016/j.cellsig.2006.05.027; Li HP, 2019, CELL REP, V29, P3200, DOI 10.1016/j.celrep.2019.03.021; Liu HL, 2015, ONCOL REP, V34, P295, DOI 10.3892/or.2015.3949; Ma JF, 2021, ONCOGENE, V40, P806, DOI 10.1038/s41388-020-01569-5; Maziarz M, 2018, J BIOL CHEM, V293, P19586, DOI 10.1074/jbc.RA118.005291; Mizuno N, 2009, NEUROSIGNALS, V17, P42, DOI 10.1159/000186689; Nance MR, 2013, STRUCTURE, V21, P438, DOI 10.1016/j.str.2012.12.016; Nguyen CH, 2009, J CELL BIOL, V186, P755, DOI 10.1083/jcb.200811058; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Onken MD, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100403; Pavel M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05388-x; Phan HTN, 2017, MOL PHARMACOL, V92, P451, DOI 10.1124/mol.117.109215; Salim S, 2003, J BIOL CHEM, V278, P15842, DOI 10.1074/jbc.M210663200; Shankaranarayanan A, 2008, J BIOL CHEM, V283, P34923, DOI 10.1074/jbc.M805860200; Sjogren B, 2012, MOL PHARMACOL, V82, P500, DOI 10.1124/mol.112.079293; Sjogren B, 2010, PROG MOL BIOL TRANSL, V91, P81, DOI 10.1016/S1877-1173(10)91004-1; Sjogren B, 2017, BRIT J PHARMACOL, V174, P427, DOI 10.1111/bph.13716; Sjogren B, 2016, J PHARMACOL EXP THER, V357, P311, DOI 10.1124/jpet.115.231571; Sprang SR, 2007, ADV PROTEIN CHEM, V74, P1, DOI 10.1016/S0065-3233(07)74001-9; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Yoo JH, 2016, CANCER CELL, V29, P889, DOI 10.1016/j.ccell.2016.04.015; Yu FX, 2014, CANCER CELL, V25, P822, DOI 10.1016/j.ccr.2014.04.017; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	41	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101955	10.1016/j.jbc.2022.101955	http://dx.doi.org/10.1016/j.jbc.2022.101955			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3R4NR	35452684	Green Published, gold			2022-12-26	WOS:000838892100010
J	Jung, SW; Kim, SM; Kim, A; Park, SH; Moon, JY; Lee, SH				Jung, Su Woong; Kim, Su-Mi; Kim, Arum; Park, Seon Hwa; Moon, Ju-Young; Lee, Sang-Ho			Midbody plays an active role in fibroblast-myofibroblast transition by mediating TGF-beta signaling	FASEB JOURNAL			English	Article						fibroblast-myofibroblast transition; midbody; renal fibroblasts; TGF-beta; Smad signaling	PRIMARY CILIA; CYTOKINESIS; CELLS; CILIOGENESIS; COLCHICINE; POLARITY; SEPTINS	The transition of fibroblasts into myofibroblasts is a crucial step in kidney fibrosis. However, the biological processes involved in this transdifferentiation are incompletely understood. In this study, we discovered that the midbody plays a role in the fibroblast-myofibroblast transition by mediating TGF-beta/Smad signaling. Combining bulk RNA-seq, histology, and the western blot of unilateral ureteral obstruction kidneys, we demonstrated that the pathway related to microtubules is implicated in kidney fibrosis, and the blocking of microtubule dynamics by colchicine improved kidney fibrosis. Subsequently, to explore microtubule-based organelles in detail, we cultured NRK-49F (rat kidney fibroblast cell line) and HKC-8 (human proximal tubule cell line) under transforming growth factor-beta 1 (TGF-beta 1) stimulation, which caused deciliation in both cell lines during epithelial-mesenchymal and fibroblast-myofibroblast transition. We identified another microtubule-based organelle, the midbody, whose formation is promoted by TGF-beta 1 in fibroblasts as a result of proliferation in contrast to tubular cells. Notably, TGF-beta receptors were present in the midbody of both cell lines. In TGF-beta 1-treated fibroblasts, colchicine or Hedgehog pathway inhibitor 4 impaired the midbody formation, and attenuated the upregulation of canonical TGF-beta/Smad signaling and alpha-SMA expression. These findings offer novel insight into the midbody as an active organelle involved in fibroblast-myofibroblast transition by mediating TGF-beta/Smad signaling, which could be a potential therapeutic target.	[Jung, Su Woong; Kim, Su-Mi; Kim, Arum; Park, Seon Hwa; Moon, Ju-Young; Lee, Sang-Ho] Kyung Hee Univ Hosp Gangdong, Dept Internal Med, Div Nephrol, 892 Dongnam Ro, Seoul 05278, South Korea	Kyung Hee University; Kyung Hee University Hospital	Lee, SH (corresponding author), Kyung Hee Univ Hosp Gangdong, Dept Internal Med, Div Nephrol, 892 Dongnam Ro, Seoul 05278, South Korea.	lshkidney@khu.ac.kr		Jung, Su Woong/0000-0002-9053-924X	National Research Foundation of Korea Grant - Korean government, Ministry of Science and ICT [2020R1A2B5B03001928]	National Research Foundation of Korea Grant - Korean government, Ministry of Science and ICT	This work was supported by the National Research Foundation of Korea Grant funded by the Korean government, Ministry of Science and ICT (2020R1A2B5B03001928).	Bernabe-Rubio M, 2016, J CELL BIOL, V214, P259, DOI 10.1083/jcb.201601020; Capalbo L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12507-9; Chikina M, 2015, BIOINFORMATICS, V31, P1584, DOI 10.1093/bioinformatics/btv015; Clement CA, 2013, CELL REP, V3, P1806, DOI 10.1016/j.celrep.2013.05.020; Crowell EF, 2014, J CELL SCI, V127, P3840, DOI 10.1242/jcs.154732; D'Avino PP, 2016, SEMIN CELL DEV BIOL, V53, P57, DOI 10.1016/j.semcdb.2016.01.018; Dionne LK, 2015, CURR OPIN CELL BIOL, V35, P51, DOI 10.1016/j.ceb.2015.04.010; Duffield JS, 2014, J CLIN INVEST, V124, P2299, DOI 10.1172/JCI72267; Estey MP, 2010, J CELL BIOL, V191, P741, DOI 10.1083/jcb.201006031; Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Fumoto K, 2012, J CELL SCI, V125, P4822, DOI 10.1242/jcs.108142; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Han SJ, 2018, BIOCHEM BIOPH RES CO, V496, P450, DOI 10.1016/j.bbrc.2018.01.079; Han SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep27775; Horgan CP, 2011, CELL BIOL INT, V35, P171, DOI 10.1042/CBI20100284; Hu B, 2003, AM J RESP CELL MOL, V29, P397, DOI 10.1165/rcmb.2003-0063OC; Hu CK, 2012, MOL BIOL CELL, V23, P1024, DOI 10.1091/mbc.E11-08-0721; Huang ZN, 2015, NUCLEIC ACIDS RES, V43, pD328, DOI 10.1093/nar/gku1125; Itano S, 2017, MOL MED REP, V15, P4169, DOI 10.3892/mmr.2017.6539; Johnson CA, 2017, FEBS LETT, V591, P4009, DOI 10.1002/1873-3468.12676; Jung SW, 2021, J GERONTOL A-BIOL, V76, P385, DOI 10.1093/gerona/glaa318; Kim JI, 2013, AM J PHYSIOL-RENAL, V304, pF1283, DOI 10.1152/ajprenal.00427.2012; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kim S, 2018, KOREAN J INTERN MED, V33, P568, DOI 10.3904/kjim.2016.131; Kuo TC, 2011, NAT CELL BIOL, V13, P1214, DOI 10.1038/ncb2332; Leaf IA, 2017, NEPHROL DIAL TRANSPL, V32, P89, DOI 10.1093/ndt/gfw388; Madhivanan K, 2014, TRAFFIC, V15, P1031, DOI 10.1111/tra.12195; Peterman E, 2019, J CELL BIOL, V218, P3903, DOI 10.1083/jcb.201906148; Peterman E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10871-0; Rozycki M, 2014, MOL BIOL CELL, V25, P643, DOI 10.1091/mbc.E13-07-0429; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Silverman-Gavrila R, 2008, THESCIENTIFICWORLDJO, V8, P611, DOI 10.1100/tsw.2008.87; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Sobh M, 1998, NEPHRON, V79, P452, DOI 10.1159/000045092; Takahashi K, 2018, J CELL SCI, V131, DOI 10.1242/jcs.208769; TUCKER RW, 1979, CELL, V18, P1065, DOI 10.1016/0092-8674(79)90219-8; Vestergaard ML, 2016, METHODS MOL BIOL, V1307, P123, DOI 10.1007/7651_2014_127; Villalobos E, 2019, CIRCULATION, V139, P2342, DOI 10.1161/CIRCULATIONAHA.117.028752; Willard FS, 2001, CELL SIGNAL, V13, P653, DOI 10.1016/S0898-6568(01)00185-1	40	0	0	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22272	10.1096/fj.202101613R	http://dx.doi.org/10.1096/fj.202101613R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0O0ZG	35436011				2022-12-26	WOS:000783258300001
J	Akiyama, N; Uozumi, R; Akiyama, T; Koeda, K; Shiroiwa, T; Ogasawara, K				Akiyama, Naomi; Uozumi, Ryuji; Akiyama, Tomoya; Koeda, Keisuke; Shiroiwa, Takeru; Ogasawara, Kuniaki			Choking injuries: Associated factors and error-producing conditions among acute hospital patients in Japan	PLOS ONE			English	Article							QUALITATIVE CONTENT-ANALYSIS; DEATHS; RISK; SUFFOCATION; EVENTS; FALLS	Choking can lead to mortality and residual impairments. This study aimed to determine the factors associated with choking among acute hospital patients and examine error-producing conditions to suggest choking-prevention policies. Among 36,364 cases reported by hospital staff at an acute university hospital from 2012 to 2018 were examined using a retrospective study, 35,440 were analysis as the number of cases analysed for the study. We used descriptive statistics to present patient characteristics and conducted univariable and multivariable logistic regression analyses to identify factors associated with choking. Additionally, we conducted content analysis (root cause analysis) to examine error-producing conditions and prevention policies. Sixty-eight cases were related to choking injuries; of these, 43 patients (63.2%) were male, and 38 (55.9%) were aged 65 years and older. Choking cases had a high percent of adverse outcomes involving residual impairment or death (n = 23, 33.8%). Mental illness (adjusted odds ratio [95% confidence interval]: 3.14 [1.39- 7.08]), and hospitalisation in the general wards (adjusted odds ratio [95% confidence interval]: 3.13 [1.70-5.76]) were associated with an increased probability of choking. Error production was caused by food (n = 25, 36.8%) and medical devices or supplies (n = 13, 19.1%). Almost all contributory factors were associated with inadequate checking (n = 66, 97.1%) and misperception of risk (n = 65, 95.6%). Choking poses a highly significant burden on patients, and hospital administrators should minimise the risk of choking to prevent related injuries. Hospital administrators should provide training and education to their staff and develop adequate protocols and procedures to prevent choking.	[Akiyama, Naomi; Koeda, Keisuke; Ogasawara, Kuniaki] Iwate Med Univ, Sch Med, Yahaba, Iwate, Japan; [Uozumi, Ryuji] Kyoto Univ, Grad Sch Med, Dept Biomed Stat & Bioinformat, Kyoto, Japan; [Akiyama, Tomoya] Iwate Med Univ, Sch Nursing, Yahaba, Iwate, Japan; [Shiroiwa, Takeru] Natl Inst Publ Hlth NIPH, Ctr Outcomes Res, Econ Evaluat Hlth C2H, Wako, Saitama, Japan; [Akiyama, Naomi] Gifu Univ Hlth Sci, Sch Nursing, Gifu, Gifu, Japan; [Akiyama, Tomoya] Nagoya Univ Hosp, Dept Nursing, Career Support Off, Nagoya, Aichi, Japan	Iwate Medical University; Kyoto University; Iwate Medical University; Nagoya University	Akiyama, N (corresponding author), Iwate Med Univ, Sch Med, Yahaba, Iwate, Japan.; Akiyama, N (corresponding author), Gifu Univ Hlth Sci, Sch Nursing, Gifu, Gifu, Japan.	nakiyama@kuhp.kyoto-u.ac.jp	Akiyama, naomi/ABF-1776-2020	Akiyama, naomi/0000-0001-6365-9310	 [JP 20H01598];  [JP 20K18889];  [JP 20H04147];  [JP 20K10697]	; ; ; 	Akiyama's research was partially supported by a Grant-in-Aid for Scientific Research (B) (Number JP 20H01598) and Grant-in-Aid for Young Scientists (Number JP 20K18889). Ryuji Uozumi's research was partially supported by a Grant-in-Aid for Scientific Research (B) (Number JP 20H04147). Tomoya Akiyama's research was supported by a Grant-in-Aid for Scientific Research (C) (Number JP 20K10697). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboumrad M, 2018, PSYCHO-ONCOLOGY, V27, P2237, DOI 10.1002/pon.4815; Akiyama N., 2020, J JPN ACAD NURS EVAL, V10, P1; [Anonymous], 2017, Sentinel Event Alert, P1; Bouldin ELD, 2013, J PATIENT SAF, V9, P13, DOI 10.1097/PTS.0b013e3182699b64; Brkic Fuad, 2018, Med Arch, V72, P220, DOI 10.5455/medarh.2018.72.220-223; CARTER G, 1984, PSYCHOL MED, V14, P691, DOI 10.1017/S0033291700015300; Chen CF, 2015, J NURS RES, V23, P94, DOI [10.1097/jnr.0000000000000060, 10.1097/JNR.0000000000000060]; Cichero JAY, 2018, GERIATRICS-BASEL, V3, DOI 10.3390/geriatrics3040069; Creswell J.W., 2003, HDB MIXED METHODS SO, V209, P209, DOI DOI 10.4135/9781506335193; Dolkas L, 2007, J FORENSIC SCI, V52, P176, DOI 10.1111/j.1556-4029.2006.00297.x; Duckett SA., 2020, STATPEARLS; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; ENDSLEY MR, 1995, HUM FACTORS, V37, P32, DOI 10.1518/001872095779049543; Flin R, 2009, HUMAN FACTORS PATIEN; Foltran F, 2012, INT J PEDIATR OTORHI, V76, pS12, DOI 10.1016/j.ijporl.2012.02.004; Food Safety Commission of Japan, 2020, RISK ASS REP CHOK AC; Fujita S, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008128; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Gross JB, 2002, ANESTHESIOLOGY, V96, P1004; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Hill AM, 2010, J AM GERIATR SOC, V58, P1347, DOI 10.1111/j.1532-5415.2010.02856.x; James JT, 2013, J PATIENT SAF, V9, P122, DOI 10.1097/PTS.0b013e3182948a69; Japan Council for Quality Health Care Division of Adverse Event Prevention, 2011, PROJ COLL MED NEARM; Kellogg KM, 2017, BMJ QUAL SAF, V26, P381, DOI 10.1136/bmjqs-2016-005991; Knickman JR, 2002, HEALTH SERV RES, V37, P849, DOI 10.1034/j.1600-0560.2002.56.x; Komiya K, 2013, GERIATR GERONTOL INT, V13, P388, DOI 10.1111/j.1447-0594.2012.00912.x; Kramarow Ellen, 2015, NCHS Data Brief, P199; Kramarow E, 2014, INJURY PREV, V20, P200, DOI 10.1136/injuryprev-2013-040795; Ministry of Health Labour and Welfare, 2019, CURR STAT CLINICAL I; OECD, 2005, LONG TERM CARE OLDER, DOI 10.1787/47be1c78-en; Patient Safety network, 2019, ADV EV NEAR MISS ERR; Reason J, 1995, Qual Health Care, V4, P80, DOI 10.1136/qshc.4.2.80; Rodziewicz TL., 2020, STATPEARLS INTERNET; Ruschena D, 2003, BRIT J PSYCHIAT, V183, P446, DOI 10.1192/bjp.183.5.446; Samuels R, 2006, J INTELL DISABIL RES, V50, P362, DOI 10.1111/j.1365-2788.2005.00784.x; Sasso R, 2018, WEST J EMERG MED, V19, P707, DOI 10.5811/westjem.2018.4.37198; Schwendimann R, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3335-z; Shorr RI, 2008, J AM GERIATR SOC, V56, P701, DOI 10.1111/j.1532-5415.2007.01605.x; Southern Health NHS Foundation, 2019, CHOK MAN RISK CHOK G; The Joint Commission Center for Transforming Healthcare, 2014, IMPR TRANS CAR HAND; Uyemura MC, 2005, AM FAM PHYSICIAN, V72, P287; Warda Lynne, 2004, Paediatr Child Health, V9, P331; Warner J, 2004, LANCET, V363, P674, DOI 10.1016/S0140-6736(04)15664-X; Williams J. C., 1988, Conference Record for 1988 IEEE Fourth Conference on Human Factors and Power Plants (IEEE Cat. No.88CH2576-7), P436, DOI 10.1109/HFPP.1988.27540	44	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267430	10.1371/journal.pone.0267430	http://dx.doi.org/10.1371/journal.pone.0267430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476697	gold, Green Published			2022-12-26	WOS:000840124300041
J	Zhu, S; Zhang, CL; Cao, DY; Bai, J; Yu, SN; Chen, J; Wang, J; Ren, T; Yang, JX; Yu, M; Xiao, X; Gong, YH; Guan, YF; Li, PL; Yue, Y; Yin, RT; Wang, YJ; An, RF; Lou, G; Yuan, JL; Zhang, GN; Xia, XF; Yang, L; Xiang, Y				Zhu, Shan; Zhang, Chunliu; Cao, Dongyan; Bai, Jing; Yu, Shuangni; Chen, Jie; Wang, Jing; Ren, Tong; Yang, Jiaxin; Yu, Mei; Xiao, Xiao; Gong, Yuhua; Guan, Yanfang; Li, Peiling; Yue, Ying; Yin, Rutie; Wang, Yongjun; An, Ruifang; Lou, Ge; Yuan, Jianlin; Zhang, Guonan; Xia, Xuefeng; Yang, Ling; Xiang, Yang			Genomic and TCR profiling data reveal the distinct molecular traits in epithelial ovarian cancer histotypes	ONCOGENE			English	Article							MICROSATELLITE INSTABILITY; ANTITUMOR-ACTIVITY; DNA-REPAIR; CHEMOTHERAPY; MUTATIONS; RESISTANT; BLOCKADE; SAFETY; CELLS	Epithelial ovarian cancer (EOC) is classified into five major histotypes: high-grade serous (HGSOC), low-grade serous (LGSOC), clear cell (CCOC), endometrioid (ENOC), and mucinous (MOC). However, the landscape of molecular and immunological alterations in these histotypes, especially LGSOC, CCOC, ENOC, and MOC, is largely uncharacterized. We collected 101 treatment-naive EOC patients. The resected tumor tissues and paired preoperative peripheral blood samples were collected and subjected to target sequencing of 1021 cancer-associated genes and T cell repertoire sequencing. Distinct characteristics of mutations were identified among the five histotypes. Furthermore, tumor mutation burden (TMB) was found to be higher in CCOC and ENOC, but lower in LGSOC and HGSOC. Alterations associated with DNA damage repair (DDR) pathways and homologous recombination deficiencies (HRD) were prevalent in five histotypes. CCOC demonstrated increased level of T cell clonality compared with HSGOC. Interestingly, the proportion of the 100 most common T cell clones was associated with TMB and tumor neoantigen burden in CCOC, highlighting more sensitive anti-tumor responses in this histotype, which was also evidenced by the enhanced convergent recombination of T cell clones. These findings shed light on the molecular traits of genomic alteration and T cell repertoire in the five major EOC histotypes and may help optimize clinical management of EOC with different histotypes.	[Zhu, Shan; Cao, Dongyan; Ren, Tong; Yang, Jiaxin; Yu, Mei; Xiang, Yang] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Natl Clin Res Ctr Obstetr & Gynecol Dis, Dept Obstet & Gynecol,State Key Lab Complex Sever, Beijing, Peoples R China; [Zhang, Chunliu; Bai, Jing; Gong, Yuhua; Guan, Yanfang; Xia, Xuefeng; Yang, Ling] Geneplus Inst, Beijing, Peoples R China; [Yu, Shuangni; Chen, Jie] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Pathol, Beijing, Peoples R China; [Wang, Jing] Cent South Univ, Hunan Canc Hosp, Dept Gynecol Oncol, Changsha, Peoples R China; [Wang, Jing] Cent South Univ, Affiliated Canc Hosp, Xiangya Sch Med, Changsha, Peoples R China; [Xiao, Xiao] Geneplus Shenzhen, Shenzhen, Peoples R China; [Li, Peiling] Harbin Med Univ, Dept Obstet & Gynecolgoy, Affiliated Hosp 2, Harbin, Peoples R China; [Yue, Ying] First Hosp Jilin Univ, Dept Gynecol Oncol, Changchun, Peoples R China; [Yin, Rutie] Sichuan Univ, Dept Obstet & Gynecol, West China Hosp 2, Chengdu, Peoples R China; [Wang, Yongjun] Peking Univ Int Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China; [An, Ruifang] Xi An Jiao Tong Univ, Dept Obstet & Gynecol, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China; [Lou, Ge] Harbin Med Univ Canc Hosp, Dept Gynecol Oncol, Harbin, Peoples R China; [Yuan, Jianlin] Xinjiang Med Univ, Dept Gynecol, Affiliated Tumor Hosp, Urumqi, Peoples R China; [Zhang, Guonan] Sichuan Canc Hosp, Dept Gynecol Oncol, Chengdu, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Central South University; Central South University; Harbin Medical University; Jilin University; Sichuan University; Peking University; Xi'an Jiaotong University; Xinjiang Medical University	Xiang, Y (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Natl Clin Res Ctr Obstetr & Gynecol Dis, Dept Obstet & Gynecol,State Key Lab Complex Sever, Beijing, Peoples R China.; Yang, L (corresponding author), Geneplus Inst, Beijing, Peoples R China.	yangl@geneplus.org.cn; xiangy@pumch.cn			National Natural Science Foundation of China [81772783, 81971475]; Chinese Academy of Medical Sciences Initiative for Innovative Medicine [CAMS-2017-I2M-1-002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Medical Sciences Initiative for Innovative Medicine	This work was supported by grants from the National Natural Science Foundation of China (Nos. 81772783 and 81971475) and the Chinese Academy of Medical Sciences Initiative for Innovative Medicine (Nos. CAMS-2017-I2M-1-002).	Abbosh C, 2018, NAT REV CLIN ONCOL, V15, P577, DOI 10.1038/s41571-018-0058-3; Abbosh C, 2017, NATURE, V545, P446, DOI 10.1038/nature22364; Alexandros Karatzoglou AS, 2004, J STAT SOFTW, V011, pI09; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Assasi N, 2016, DNA MISMATCH REPAIR; Balachandran VP, 2017, NATURE, V551, P512, DOI 10.1038/nature24462; Banerjee S, 2021, LANCET ONCOL, V22, P1721, DOI 10.1016/S1470-2045(21)00531-3; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brown JS, 2017, CANCER DISCOV, V7, P20, DOI 10.1158/2159-8290.CD-16-0860; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Cheasley D, 2021, J PATHOL, V253, P41, DOI 10.1002/path.5545; Chui MH, 2019, CANCER RES, V79, P5536, DOI 10.1158/0008-5472.CAN-18-3029; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dash P, 2017, NATURE, V547, P89, DOI 10.1038/nature22383; Dejima H, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22890-x; Disis ML, 2019, JAMA ONCOL, V5, P393, DOI 10.1001/jamaoncol.2018.6258; Elsherif SB, 2021, ABDOM RADIOL, V46, P2264, DOI 10.1007/s00261-021-03081-0; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Glanville J, 2017, NATURE, V547, P94, DOI 10.1038/nature22976; Gorringe KL, 2020, GYNECOL ONCOL, V156, P552, DOI 10.1016/j.ygyno.2019.12.015; GRIFFITHS CT, 1978, SURG CLIN N AM, V58, P131, DOI 10.1016/s0039-6109(16)41440-4; Gulhan DC, 2019, NAT GENET, V51, P912, DOI 10.1038/s41588-019-0390-2; Hamanishi J, 2015, J CLIN ONCOL, V33, P4015, DOI 10.1200/JCO.2015.62.3397; Han C, 2018, GYNECOL ONCOL REP, V25, P41, DOI 10.1016/j.gore.2018.05.011; Han JF, 2020, CANCER IMMUNOL RES, V8, P146, DOI 10.1158/2326-6066.CIR-19-0398; Hess V, 2004, J CLIN ONCOL, V22, P1040, DOI 10.1200/JCO.2004.08.078; Hoffmann K, 2020, EMBO J, V39, DOI 10.15252/embj.2019104013; Hogan SA, 2019, CANCER IMMUNOL RES, V7, P77, DOI 10.1158/2326-6066.CIR-18-0136; Hollis RL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18819-5; Jessen E, 2021, BMC MED GENOMICS, V14, DOI 10.1186/s12920-021-00898-y; Jia QZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07767-w; Joshi K, 2019, NAT MED, V25, P1549, DOI 10.1038/s41591-019-0592-2; Kuo KT, 2009, AM J PATHOL, V174, P1597, DOI 10.2353/ajpath.2009.081000; Lan AH, 2019, FUTURE ONCOL, V15, P2029, DOI 10.2217/fon-2018-0886; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Lheureux S, 2019, CA-CANCER J CLIN, V69, P280, DOI 10.3322/caac.21559; Lheureux S, 2019, LANCET, V393, P1240, DOI 10.1016/S0140-6736(18)32552-2; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li J, 2012, BIOINFORMATICS, V28, P1307, DOI 10.1093/bioinformatics/bts146; Mabuchi S, 2016, J GYNECOL ONCOL, V27, DOI 10.3802/jgo.2016.27.e31; Macintyre G, 2018, NAT GENET, V50, P1262, DOI 10.1038/s41588-018-0179-8; Matulonis UA, 2019, ANN ONCOL, V30, P1080, DOI 10.1093/annonc/mdz135; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mendivil AA, 2018, GYNECOL ONCOL REP, V26, P41, DOI 10.1016/j.gore.2018.09.002; Moioli M, 2019, EXPERT OPIN INV DRUG, V28, P1025, DOI 10.1080/13543784.2019.1693999; Niu BF, 2014, BIOINFORMATICS, V30, P1015, DOI 10.1093/bioinformatics/btt755; O'Donnell T, 2018, BMC CANCER, V18, DOI 10.1186/s12885-017-3825-0; Oliveira DVNP, 2021, CANCERS, V13, DOI 10.3390/cancers13205242; Pisano C, 2005, ANTICANCER RES, V25, P3501; Prat J, 2012, VIRCHOWS ARCH, V460, P237, DOI 10.1007/s00428-012-1203-5; Previs RA, 2016, EXPERT REV MOL DIAGN, V16, P1337, DOI 10.1080/14737159.2016.1259069; Pujade-Lauraine E, 2017, ANN ONCOL, V28, P57, DOI 10.1093/annonc/mdx442; Radovich M, 2020, JAMA ONCOL, V6, P1410, DOI 10.1001/jamaoncol.2020.2295; Reuben A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14273-0; Reuben A, 2017, CANCER DISCOV, V7, P1088, DOI 10.1158/2159-8290.CD-17-0256; Robert C, 2019, LANCET ONCOL, V20, P1239, DOI 10.1016/S1470-2045(19)30388-2; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Rosenthal R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0893-4; Sato N, 2012, ONCOL REP, V27, P1336, DOI 10.3892/or.2012.1626; Simoni Y, 2018, NATURE, V557, P575, DOI 10.1038/s41586-018-0130-2; Sun YX, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00430; Takekuma Munetaka, 2016, Gynecol Oncol Res Pract, V3, P5, DOI 10.1186/s40661-016-0026-5; Tarazona N, 2019, ANN ONCOL, V30, P1804, DOI 10.1093/annonc/mdz390; Tholander B, 2020, UPSALA J MED SCI, V125, P325, DOI 10.1080/03009734.2020.1826612; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Torre LA, 2018, CA-CANCER J CLIN, V68, P284, DOI 10.3322/caac.21456; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Wang ZJ, 2018, CANCER RES, V78, P6486, DOI 10.1158/0008-5472.CAN-18-1814; Xu W, 2016, CRIT REV ONCOL HEMAT, V102, P26, DOI 10.1016/j.critrevonc.2016.03.015; Yamamoto H, 2015, ARCH TOXICOL, V89, P899, DOI 10.1007/s00204-015-1474-0; Zamarin D, 2020, J CLIN ONCOL, V38, P1814, DOI 10.1200/JCO.19.02059; Zhang AW, 2018, CELL, V173, P1755, DOI 10.1016/j.cell.2018.03.073; Zhang L, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1544-9	76	0	0	5	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 27	2022	41	22					3093	3103		10.1038/s41388-022-02277-y	http://dx.doi.org/10.1038/s41388-022-02277-y		APR 2022	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	1U7PG	35468938				2022-12-26	WOS:000787133900001
J	Pang, Z; Dong, XR; Deng, HY; Wang, CZ; Liao, XD; Liao, CH; Liao, YH; Tian, WD; Cheng, JK; Chen, GQ; Yi, HY; Huang, L				Pang, Zhi; Dong, Xinran; Deng, Huayun; Wang, Chengzhi; Liao, Xiaodong; Liao, Chunhua; Liao, Yahui; Tian, Weidong; Cheng, Jinke; Chen, Guoqiang; Yi, Haiying; Huang, Lei			MUC1 triggers lineage plasticity of Her2 positive mammary tumors	ONCOGENE			English	Article							SIGNALING PATHWAYS; BREAST; ONCOPROTEIN; ACTIVATION; OVEREXPRESSION; AMPLIFICATION; TUMORIGENESIS; EXPRESSION; RESISTANCE; MUTATIONS	Aberrant overexpression of mucin 1 (MUC1) and human epidermal growth factor receptor 2 (HER2) are often observed in breast cancer. However, the role of concomitant MUC1/HER2 in the development of breast cancer has not been fully illustrated. Following analysis of public microarray datasets that revealed a correlation between double MUC1 and HER2 positivity and a worse clinical outcome, we generated a mouse model overexpressing both Her2 and MUC1 cytoplasmic domain (MUC1-CD) to investigate their interaction in mammary carcinogenesis. Coexpression of Her2 and MUC1-CD conferred a growth advantage and promoted the development of spontaneous mammary tumors. Genomic analysis revealed that enforced expression of MUC1-CD and Her2 induces mammary tumor lineage plasticity, which is supported by gene reprogramming and mammary stem cell enrichment. Through gain- and loss-of-function strategies, we show that coexpression of Her2 and MUC1-CD is associated with downregulation of tricarboxylic acid (TCA) cycle genes in tumors. Importantly, the reduction in TCA cycle genes induced by MUC1-CD was found to be significantly connected to poor prognosis in HER2(+) breast cancer patients. In addition, MUC1 augments the Her2 signaling pathway by inducing Her2/Egfr dimerization. These findings collectively demonstrate the vital role of MUC1-CD/Her2 collaboration in shaping the mammary tumor landscape and highlight the prognostic and therapeutic implications of MUC1 in patients with HER2(+) breast cancer.	[Pang, Zhi; Deng, Huayun; Wang, Chengzhi; Liao, Xiaodong; Liao, Chunhua; Cheng, Jinke; Chen, Guoqiang; Huang, Lei] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Reprod Med,Dept Histoembryol Gen, Chinese Minist Educ,Key Lab Cell Differentiat & A, Shanghai, Peoples R China; [Pang, Zhi] Fudan Univ, Minist Educ, Key Lab Carcinogenesis & Canc Invas, Liver Canc Inst,Zhongshan Hosp, Shanghai, Peoples R China; [Dong, Xinran; Tian, Weidong] Fudan Univ, Ctr Mol Med, Childrens Hosp, Shanghai, Peoples R China; [Liao, Yahui] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Pharm,Huangpu Branch, Shanghai, Peoples R China; [Tian, Weidong] Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Sch Life Sci, Dept Computat Biol,State Key Lab Genet Engn, Shanghai, Peoples R China; [Yi, Haiying] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Breast Surg,Huangpu Branch, Shanghai, Peoples R China	Shanghai Jiao Tong University; Fudan University; Fudan University; Shanghai Jiao Tong University; Fudan University; Shanghai Jiao Tong University	Huang, L (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Reprod Med,Dept Histoembryol Gen, Chinese Minist Educ,Key Lab Cell Differentiat & A, Shanghai, Peoples R China.; Yi, HY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Breast Surg,Huangpu Branch, Shanghai, Peoples R China.	yihaiying@163.com; leihuang@shsmu.edu.cn		Cheng, Jinke/0000-0002-4344-5363; Liao, Xiaodong/0000-0001-9230-5220; chen, guo qiang/0000-0003-4936-2363; Pang, Zhi/0000-0001-8677-9008	National Natural Science Foundation of China [81874197, 82073111]; Science and Technology Commission of Shanghai Municipality [21S11901600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Natural Science Foundation of China (grant numbers 81874197 and 82073111), Science and Technology Commission of Shanghai Municipality (grant number 21S11901600) to Huang L. The authors appreciate Dr. Shuhai Lin for constructive suggestions.	Alam M, 2014, ONCOTARGET, V5, P2622, DOI 10.18632/oncotarget.1848; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Arkhipov A, 2013, ELIFE, V2, DOI 10.7554/eLife.00708; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Barberan S, 2019, SEMIN CELL DEV BIOL, V87, P45, DOI 10.1016/j.semcdb.2018.05.011; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; [程布凯 Cheng Bukai], 2014, [中国科学. 生命科学, Scientia Sinica Vitae], V44, P143; Cho HJ, 2018, ONCOGENE, V37, P861, DOI 10.1038/onc.2017.386; Chung SS, 2014, INT J ONCOL, V44, P403, DOI 10.3892/ijo.2013.2195; D'Amato V, 2015, CANCER TREAT REV, V41, P877, DOI 10.1016/j.ctrv.2015.08.001; El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017; Fishbein L, 2017, CANCER CELL, V31, P181, DOI 10.1016/j.ccell.2017.01.001; Garcia-Heredia JM, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9071693; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; Gimm O, 2000, CANCER RES, V60, P6822; Guo JX, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.644857; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; Gyorffy B, 2021, COMPUT STRUCT BIOTEC, V19, P4101, DOI 10.1016/j.csbj.2021.07.014; Hanker AB, 2013, P NATL ACAD SCI USA, V110, P14372, DOI 10.1073/pnas.1303204110; Harrell JC, 2012, BREAST CANCER RES TR, V132, P523, DOI 10.1007/s10549-011-1619-7; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Hynes NE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003186; Janiszewska M, 2015, NAT GENET, V47, P1212, DOI 10.1038/ng.3391; Johnson S., 2013, BIOPROTOC, V3, pe326; Khodarev NN, 2009, CANCER RES, V69, P2833, DOI 10.1158/0008-5472.CAN-08-4513; Kufe DW, 2013, ONCOGENE, V32, P1073, DOI 10.1038/onc.2012.158; Kufe DW, 2020, CARCINOGENESIS, V41, P1173, DOI 10.1093/carcin/bgaa082; Lacunza E, 2010, CANCER GENET CYTOGEN, V201, P102, DOI 10.1016/j.cancergencyto.2010.05.015; Li Y, 2018, ONCOTARGET, V9, P3446, DOI 10.18632/oncotarget.23316; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019102; Marquez J, 2019, J CLIN MED, V8, DOI 10.3390/jcm8122161; Mehla K, 2014, BBA-REV CANCER, V1845, P126, DOI 10.1016/j.bbcan.2014.01.001; Meier-Abt F, 2014, TRENDS MOL MED, V20, P143, DOI 10.1016/j.molmed.2013.11.002; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Nassar A, 2014, INT J CLIN EXP PATHO, V7, P6254; Nath S, 2014, TRENDS MOL MED, V20, P332, DOI 10.1016/j.molmed.2014.02.007; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Raimundo N, 2011, TRENDS MOL MED, V17, P641, DOI 10.1016/j.molmed.2011.06.001; Raina D, 2014, ONCOGENE, V33, P3422, DOI 10.1038/onc.2013.308; Rajabi H, 2018, ONCOGENE, V37, P2079, DOI 10.1038/s41388-017-0096-9; Sawai Y, 2003, J HEPATOL, V39, P991, DOI 10.1016/S0168-8278(03)00498-7; Schneider MR, 2016, ONCOGENE, V35, P2949, DOI 10.1038/onc.2015.372; Schroeder JA, 2004, ONCOGENE, V23, P5739, DOI 10.1038/sj.onc.1207713; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Tanaka H, 2013, J NEURO-ONCOL, V111, P273, DOI 10.1007/s11060-012-1027-9; Vermeer PD, 2013, CANCER RES, V73, P5787, DOI 10.1158/0008-5472.CAN-13-0760; Visvader JE, 2014, GENE DEV, V28, P1143, DOI 10.1101/gad.242511.114; Wang DS, 2019, CELL RES, V29, P832, DOI 10.1038/s41422-019-0225-9; Weerts MJA, 2016, ONCOTARGET, V7, P29166, DOI 10.18632/oncotarget.8688; Wei T, 2017, J ROY STAT SOC D-STA, V56, P24; Wu BW, 2020, CELL METAB, V32, DOI 10.1016/j.cmet.2020.10.025; Yasumizu Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14219-6; Zhou ZQ, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7010016	58	1	1	3	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 27	2022	41	22					3064	3078		10.1038/s41388-022-02320-y	http://dx.doi.org/10.1038/s41388-022-02320-y		APR 2022	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	1U7PG	35461328				2022-12-26	WOS:000785962300002
J	Kiragu, ZW; Rockers, PC; Onyango, MA; Mungai, J; Mboya, J; Laing, R; Wirtz, VJ				Kiragu, Zana Wangari; Rockers, Peter C.; Onyango, Monica A.; Mungai, John; Mboya, John; Laing, Richard; Wirtz, Veronika J.			Household access to non-communicable disease medicines during universal health care roll-out in Kenya: A time series analysis	PLOS ONE			English	Article								Objectives This study aims to describe trends and estimate impact of county-level universal health coverage expansion in Kenya on household availability of non-communicable disease medicines, medicine obtainment at public hospitals and proportion of medicines obtained free of charge. Methods Data from phone surveillance of households in eight Kenyan counties between December 2016 and September 2019 were used. Three primary outcomes related to access were assessed based on patient report: availability of non-communicable disease medicines at the household; non-communicable disease medicine obtainment at a public hospital versus a different outlet; and non-communicable disease medicine obtainment free of cost versus at a non-zero price. Mixed models adjusting for fixed and random effects were used to estimate associations between outcomes of interest and UHC exposure. Results The 197 respondents with universal health coverage were similar on all demographic factors to the 415 respondents with no universal health coverage. Private chemists were the most popular place of purchase throughout the study. Adjusting for demographic factors, county and time fixed effects, there was a significant increase in free medicines (aOR 2.55, 95% CI 1.73, 3.76), significant decrease in medicine obtainment at public hospitals (aOR 0.68, 95% CI 0.47, 0.97), and no impact on the availability of non-communicable disease medicines in households (a beta -0.004, 95% CI -0.058, 0.050) with universal health coverage. Conclusions Access to universal health coverage caused a significant increase in free non-communicable disease medicines, indicating financial risk protection. Interestingly, this is not accompanied with increases in public hospitals purchases or household availability of non-communicable disease medicines, with public health centers playing a greater role in supply of free medicines. This raises the question as to the status of supply-side investments at the public hospitals, to facilitate availability of quality-assured medicines.	[Kiragu, Zana Wangari; Rockers, Peter C.; Onyango, Monica A.; Laing, Richard; Wirtz, Veronika J.] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02215 USA; [Mungai, John; Mboya, John] Innovat Poverty Act, Nairobi, Kenya; [Laing, Richard] Univ Western Cape, Sch Publ Hlth, Bellville, South Africa	Boston University; Innovations for Poverty Action (IPA); University of the Western Cape	Kiragu, ZW (corresponding author), Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02215 USA.	zkiragu@bu.edu		Kiragu, Zana/0000-0003-1289-5983; Wirtz, Veronika J./0000-0002-0863-8768	Sandoz International GmBH	Sandoz International GmBH	The authors have read the journal's policy and have the following competing interests: This work was supported by commercial funder Sandoz International GmBH, a subsidiary of Novartis International AG. Peter C. Rockers received grants from Access Accelerated, Gilead Sciences, F. Hoffmann-La Roche, and Amgen outside the submitted work. Richard O. Laing received nonfinancial support from Novartis International AG, Gilead Sciences, and F. Hoffmann-La Roche outside the submitted work. Veronika J. Wirtz received grants from Access Accelerated, Gilead Sciences, F. Hoffmann-La Roche, and Amgen outside the submitted work. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Ashigbie PG, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-035132; Barasa E, 2018, HEALTH SYST REFORM, V4, P346, DOI 10.1080/23288604.2018.1513267; Cameron A, 2011, B WORLD HEALTH ORGAN, V89, P412, DOI 10.2471/BLT.10.084327; Centre for Sport and Human Rights, 2019, MAPP ACC REM MECH SP; Dutta A., 2018, KENYA HLTH FINANCING; Gathara P, 2018, MAKUENI HEALTHCARE R; Government of Makueni County, 2018, MAK UNV 200 BED ULTR; Indonesia T., 2021, TELKOM CSS 2021 2025; Kenya National Bureau of Statistics, 2019, 2019 KEN POP HOUS CE, V4; Laing R., 2016, EVALUATION NOVARTIS; Makeuni County Government, 2020, MAK UN HLTH CAR REC; Ministry of Health, 2015, KEN NAT STRAT PREV C; Ministry of Health, 2015, KEN STEPWISE SURV NO; Mulaki A., 2019, KENYA HLTH SYSTEM AS; Nzwili F, 2018, KENYAN PRESIDENT LAU; Onyango MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201917; Pariyo GW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214450; Pariyo GW, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7302; PRB, 2019, FAM PLANN DAT 2019; Rockers PC, 2019, LANCET GLOB HEALTH, V7, pE492, DOI 10.1016/S2214-109X(18)30563-1; Rockers PC, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000828; Rockers PC, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013386; Subramanian S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190113; ThinkWell Gobal, 2019, KEN KNOWL LEARN BRIE; Turpin K., 2018, E AFR MED J, V95, P1286; UN, 2015, UN; Vialle-Valentin CE, 2015, HEALTH POLICY PLANN, V30, P1044, DOI 10.1093/heapol/czu107; Wamai RG, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6051-z; Wangia E, 2018, POLICY BRIEF REFOCUS; Wirtz VJ, 2018, TROP MED INT HEALTH, V23, P879, DOI 10.1111/tmi.13081; World Health Organization, 2013, GLOB ACT PLAN PREV C; World Health Organization, 2012, WORLD HLTH DAY 2012	32	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0266715	10.1371/journal.pone.0266715	http://dx.doi.org/10.1371/journal.pone.0266715			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35443014	Green Published, gold			2022-12-26	WOS:000822608900032
J	Stevens, DR; Rohn, MCH; Hinkle, SN; Williams, AD; Kumar, R; Lipsky, LM; Grobman, W; Sherman, S; Kanner, J; Chen, Z; Mendola, P				Stevens, Danielle R.; Rohn, Matthew C. H.; Hinkle, Stefanie N.; Williams, Andrew D.; Kumar, Rajesh; Lipsky, Leah M.; Grobman, William; Sherman, Seth; Kanner, Jenna; Chen, Zhen; Mendola, Pauline			Maternal body composition and gestational weight gain in relation to asthma control during pregnancy	PLOS ONE			English	Article							EXACERBATIONS; OBESITY; MANAGEMENT; PULMONARY; OUTCOMES; HEALTH	Background Poor asthma control is common during pregnancy and contributes to adverse pregnancy outcomes. Identification of risk factors for poor gestational asthma control is crucial. Objective Examine associations of body composition and gestational weight gain with asthma control in a prospective pregnancy cohort (n = 299). Methods Exposures included pre-pregnancy body mass index (BMI), first trimester skinfolds, and trimester-specific gestational weight gain. Outcomes included percent predicted forced expiratory volumes (FEV1, FEV6), forced vital capacity (FVC), peak expiratory flow (PEF), FEV1/FVC, symptoms (activity limitation, nighttime symptoms, inhaler use, and respiratory symptoms), and exacerbations (asthma attacks, medical encounters). Linear and Poisson models examined associations with lung function (beta (95% confidence interval (CI)), asthma symptom burden (relative rate ratio (RR (95%CI)), and exacerbations (RR (95%CI)). Results Women with a BMI >= 30 had lower percent predicted FVC across pregnancy (beta(ThirdTrimester): -5.20 (-8.61, -1.78)) and more frequent night symptoms in the first trimester (RR: 1.66 (1.08, 2.56)). Higher first trimester skinfolds were associated with lower FEV1, FEV6, and FVC, and more frequent night symptoms and inhaler use across pregnancy. Excessive first trimester gestational weight gain was associated with more frequent activity limitation in the first trimester (RR: 3.36 (1.15, 9.80)) and inhaler use across pregnancy (RRThirdTrimester: 3.49 (1.21, 10.02)). Conclusions Higher adiposity and first trimester excessive gestational weight gain were associated with restrictive changes in lung function and symptomology during pregnancy.	[Stevens, Danielle R.; Rohn, Matthew C. H.; Hinkle, Stefanie N.; Lipsky, Leah M.; Kanner, Jenna; Chen, Zhen; Mendola, Pauline] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Intramural Populat Hlth Res, Bethesda, MD 20892 USA; [Williams, Andrew D.] Univ North Dakota, UND Sch Med & Hlth Sci, Grand Forks, ND USA; [Kumar, Rajesh; Grobman, William] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Sherman, Seth] Emmes Co, Rockville, MD USA; [Mendola, Pauline] Univ Buffalo, Sch Publ Hlth & Hlth Profess, Buffalo, NY 14215 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of North Dakota Grand Forks; Northwestern University; Feinberg School of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Mendola, P (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Intramural Populat Hlth Res, Bethesda, MD 20892 USA.; Mendola, P (corresponding author), Univ Buffalo, Sch Publ Hlth & Hlth Profess, Buffalo, NY 14215 USA.	pmendola@buffalo.edu			National Institutes of Health's Intramural Research Program at the Eunice Kennedy Shriver National Institute of Child Health and Human Development [HHSN275201300013C, HHSN275201300014C, HHSN275201300026I, HHSN27500001, HHSN275000017]	National Institutes of Health's Intramural Research Program at the Eunice Kennedy Shriver National Institute of Child Health and Human Development	This work was supported by the National Institutes of Health's Intramural Research Program at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (clinical site contracts HHSN275201300013C to Northwestern University, HHSN275201300014C to the University of Alabama at Birmingham; and the Emmes Company for the Data Coordinating Center HHSN275201300026I, HHSN27500001, HHSN275000017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232621; Ali Z, 2018, J ALLERGY CLIN IMMUN, V141, P761, DOI 10.1016/j.jaci.2017.03.040; Bime C, 2012, CURR OPIN PULM MED, V18, P48, DOI 10.1097/MCP.0b013e32834db0f2; Bonham CA, 2018, CHEST, V153, P515, DOI 10.1016/j.chest.2017.08.029; Byberg KK, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-017-0567-3; Chen YC, 2019, INT J OBESITY, V43, P73, DOI 10.1038/s41366-018-0160-8; Chen ZH, 2017, AM J RESP CRIT CARE, V195, P1181, DOI 10.1164/rccm.201608-1691OC; Cole SR, 2010, INT J EPIDEMIOL, V39, P417, DOI 10.1093/ije/dyp334; Cornelius T, 2020, AM J EPIDEMIOL, V189, P1173, DOI 10.1093/aje/kwaa059; Dombrowski Mitchell P, 2008, Obstet Gynecol, V111, P457, DOI 10.1097/AOG.0b013e3181665ff4; Forno E, 2017, CURR OPIN ALLERGY CL, V17, P123, DOI 10.1097/ACI.0000000000000339; Global Initiative for Asthma, 2022, GLOB STRAT ASTHM MAN; Granell R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001669; Grindheim G, 2012, BJOG-INT J OBSTET GY, V119, P94, DOI 10.1111/j.1471-0528.2011.03158.x; Grzeskowiak Luke E, 2016, ERJ Open Res, V2; Hendler I, 2006, OBSTET GYNECOL, V108, P77, DOI 10.1097/01.AOG.0000223180.53113.0f; Hossain Md Jobayer, 2015, J Biom Biostat, V6, P248; Jensen ME, 2021, J ALLER CL IMM-PRACT, V9, P1578, DOI 10.1016/j.jaip.2020.10.061; Kemppainen M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197593; Ketel IJG, 2007, EUR J ENDOCRINOL, V156, P655, DOI 10.1530/EJE-06-0730; Kominiarek MA, 2017, AM J OBSTET GYNECOL, V217, P642, DOI 10.1016/j.ajog.2017.05.040; Mendola P, 2014, J ALLERGY CLIN IMMUN, V133, P85, DOI 10.1016/j.jaci.2013.06.012; Mendola P, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.007; Miethe S, 2020, J ALLERGY CLIN IMMUN, V146, P685, DOI 10.1016/j.jaci.2020.08.011; Most J, 2018, EUR J CLIN NUTR, V72, P645, DOI 10.1038/s41430-018-0152-8; Murphy VE, 2020, J ALLER CL IMM-PRACT, V8, P219, DOI 10.1016/j.jaip.2019.06.033; Murphy VE, 2017, J ALLER CL IMM-PRACT, V5, P981, DOI 10.1016/j.jaip.2017.03.040; Murphy VE, 2017, SEMIN RESP CRIT CARE, V38, P160, DOI 10.1055/s-0037-1600906; Murphy VE, 2005, OBSTET GYNECOL, V106, P1046, DOI 10.1097/01.AOG.0000185281.21716.02; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; National Asthma Educatio and Prevention Program, 2007, EXPERT PANEL REPORT; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Okupa AY, 2013, CHEST, V143, P993, DOI 10.1378/chest.12-1055; Perkins NJ, 2018, AM J EPIDEMIOL, V187, P568, DOI 10.1093/aje/kwx348; Prevention CfDCa, NAT HEATH NUTR EX SU; Pugh SJ, 2019, PUBLIC HEALTH NUTR, V22, P797, DOI [10.1017/s1368980018003749, 10.1017/S1368980018003749]; Robijn AL, 2019, CLIN EXP ALLERGY, V49, P1403, DOI 10.1111/cea.13474; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; SCHATZ M, 1988, Journal of Allergy and Clinical Immunology, V81, P509, DOI 10.1016/0091-6749(88)90187-X; Shin D, 2014, MATERN CHILD HLTH J, V18, P1667, DOI 10.1007/s10995-013-1407-6; Sideleva O, 2012, AM J RESP CRIT CARE, V186, P598, DOI 10.1164/rccm.201203-0573OC; Tashiro H, 2019, ALLERGOL INT, V68, P135, DOI 10.1016/j.alit.2018.10.004; Textor J, 2016, INT J EPIDEMIOL, V45, P1887, DOI 10.1093/ije/dyw341; Widen EM, 2014, EUR J CLIN NUTR, V68, P643, DOI 10.1038/ejcn.2014.40; Zhang Y, 2020, AM J EPIDEMIOL, V189, P583, DOI 10.1093/aje/kwz257	45	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0267122	10.1371/journal.pone.0267122	http://dx.doi.org/10.1371/journal.pone.0267122			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35442986	gold, Green Published			2022-12-26	WOS:000822608900041
J	Chen, KQ; Anderson, A; Kawakami, H; Kim, J; Barrett, J; Kawakami, Y				Chen, Katherine Q.; Anderson, Aaron; Kawakami, Hiroko; Kim, Jennifer; Barrett, Janaya; Kawakami, Yasuhiko			Normal embryonic development and neonatal digit regeneration in mice overexpressing a stem cell factor, Sall4	PLOS ONE			English	Article							OKIHIRO-SYNDROME; MURINE HOMOLOG; EXPRESSION; GENE; LIMB; PROTEINS; POU5F3; ROLES; FETAL; FATE	Sall4 encodes a transcription factor and is known to participate in the pluripotency network of embryonic stem cells. Sall4 expression is known to be high in early stage post-implantation mouse embryos. During early post-gastrulation stages, Sall4 is highly expressed in the tail bud and distal limb buds, where progenitor cells are maintained in an undifferentiated status. The expression of Sall4 is rapidly downregulated during embryonic development. We previously demonstrated that Sall4 is required for limb and posterior axial skeleton development by conditional deletion of Sall4 in the T (Brachyury) lineage. To gain insight into Sall4 functions in embryonic development and postnatal digit regeneration, we genetically overexpressed Sall4 in the mesodermal lineage by the TCre transgene and a novel knockin allele of Rosa26-loxP-stop-loxP-Sall4. In significant contrast to severe defects by Sall4 loss of function reported in previous studies, overexpression of Sall4 resulted in normal morphology and pattern in embryos and neonates. The length of limb long bones showed subtle reduction in Sall4-overexpression mice. It is known that the digit tip of neonatal mice has level-specific regenerative ability after experimental amputation. We observed Sall4 expression in the digit tip by using a sensitive Sall4-LacZ knock-in reporter expression. Sall4 overexpression did not alter the regenerative ability of the terminal phalange that normally regenerates after amputation. Moreover, Sall4 overexpression did not confer regenerative ability to the second phalange that normally does not regenerate after amputation. These genetic experiments show that overexpression of Sall4 does not alter the development of the appendicular and axial skeleton, or neonatal digit regeneration. The results suggest that Sall4 acts as a permissive factor rather than playing an instructive role.	[Chen, Katherine Q.; Anderson, Aaron; Kawakami, Hiroko; Kim, Jennifer; Barrett, Janaya; Kawakami, Yasuhiko] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Kawakami, Hiroko; Kawakami, Yasuhiko] Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA; [Kawakami, Hiroko; Kawakami, Yasuhiko] Univ Minnesota, Dev Biol Ctr, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Kawakami, Y (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.; Kawakami, Y (corresponding author), Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA.; Kawakami, Y (corresponding author), Univ Minnesota, Dev Biol Ctr, Minneapolis, MN 55455 USA.	kawak005@umn.edu		Chen, Katherine/0000-0002-0982-9179; Anderson, Aaron/0000-0003-1797-5229; Kawakami, Yasuhiko/0000-0002-0043-9705	National Institutes of Health [R01AR064195]; University of Minnesota's Undergraduate Research Opportunity Program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota's Undergraduate Research Opportunity Program	This study was supported by a grant from the National Institutes of Health (https://www.nih.gov) to YK (R01AR064195). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Sandy Zhang for her excellent technical assistance. We are also grateful to Dr. David Zarkower for sharing materials to generate the R26-Sall4 mouse line, to the University of Minnesota Cytogenomics Laboratory and the Mouse Genetics Laboratory for their excellent service in karyotyping and chimera production, respectively. KQC, AA and JK were partially supported by the University of Minnesota's Undergraduate Research Opportunity Program.	Akiyama R, 2015, P NATL ACAD SCI USA, V112, P5075, DOI 10.1073/pnas.1421949112; Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Asakawa K, 2018, CELL REP, V24, P1562, DOI 10.1016/j.celrep.2018.07.024; Barembaum M, 2007, DEVELOPMENT, V134, P3805, DOI 10.1242/dev.02885; Bohm J, 2008, AM J PATHOL, V173, P1455, DOI 10.2353/ajpath.2008.071039; BORGENS RB, 1982, SCIENCE, V217, P747, DOI 10.1126/science.7100922; Borozdin W, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.019901; Chan AL, 2017, STEM CELL REP, V9, P956, DOI 10.1016/j.stemcr.2017.08.001; Chen KQ, 2020, GENETICS, V215, P129, DOI 10.1534/genetics.120.303069; de Celis JF, 2009, INT J DEV BIOL, V53, P1385, DOI 10.1387/ijdb.072408jd; Dong XH, 2017, J BIOL CHEM, V292, P13045, DOI 10.1074/jbc.M117.777094; Eildermann K, 2012, CELLS TISSUES ORGANS, V196, P206, DOI 10.1159/000335031; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; Erickson JR, 2016, NPJ REGEN MED, V1, DOI 10.1038/npjregenmed.2016.16; Gassei K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053976; Han MJ, 2003, DEVELOPMENT, V130, P5123, DOI 10.1242/dev.00710; Harvey SA, 2006, DEVELOPMENT, V133, P1165, DOI 10.1242/dev.02259; Hobbs RM, 2012, CELL STEM CELL, V10, P284, DOI 10.1016/j.stem.2012.02.004; Hohenstein Peter, 2008, Pathogenetics, V1, P3, DOI 10.1186/1755-8417-1-3; Kohlhase J, 2002, HUM MOL GENET, V11, P2979, DOI 10.1093/hmg/11.23.2979; Kohlhase J, 2002, CYTOGENET GENOME RES, V98, P274, DOI 10.1159/000071048; Koshiba-Takeuchi K, 2006, NAT GENET, V38, P175, DOI 10.1038/ng1707; Lindeman RE, 2015, CURR BIOL, V25, P764, DOI 10.1016/j.cub.2015.01.034; Lovelace DL, 2016, DEVELOPMENT, V143, P1893, DOI 10.1242/dev.132761; Miller A, 2016, DEVELOPMENT, V143, P3074, DOI 10.1242/dev.139113; Muneoka Ken, 2008, Birth Defects Research, V84, P265, DOI 10.1002/bdrc.20137; NAGY A, 2003, MANIPULATING MOUSE E, P289; Neff AW, 2011, DEV DYNAM, V240, P979, DOI 10.1002/dvdy.22554; Neff AW, 2005, DEV DYNAM, V233, P356, DOI 10.1002/dvdy.20363; Nicole L, 2017, ONCOTARGET, V8, P22968, DOI 10.18632/oncotarget.14952; Paik EJ, 2013, STEM CELL REP, V1, P425, DOI 10.1016/j.stemcr.2013.10.001; Pantier R, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.11.046; Perantoni AO, 2005, DEVELOPMENT, V132, P3859, DOI 10.1242/dev.01945; Rao S, 2010, MOL CELL BIOL, V30, P5364, DOI 10.1128/MCB.00419-10; REGINELLI AD, 1995, DEVELOPMENT, V121, P1065; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Simkin J, 2013, METHODS MOL BIOL, V1037, P419, DOI 10.1007/978-1-62703-505-7_24; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stewart R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002936; Sweetman D, 2006, DEV BIOL, V293, P285, DOI 10.1016/j.ydbio.2006.02.009; Tahara N, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.177659; Tahara N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34745-5; Tatetsu H, 2016, GENE, V584, P111, DOI 10.1016/j.gene.2016.02.019; Tsubooka N, 2009, GENES CELLS, V14, P683, DOI 10.1111/j.1365-2443.2009.01301.x; Warren M, 2007, GENESIS, V45, P51, DOI 10.1002/dvg.20264; Xu K, 2017, J BIOL CHEM, V292, P1798, DOI 10.1074/jbc.M116.767061; Yamaguchi YL, 2015, STEM CELLS, V33, P289, DOI 10.1002/stem.1853; Young JJ, 2014, DEVELOPMENT, V141, P1683, DOI 10.1242/dev.099374; Zhang X, 2015, CANCER LETT, V357, P55, DOI 10.1016/j.canlet.2014.11.037	49	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267273	10.1371/journal.pone.0267273	http://dx.doi.org/10.1371/journal.pone.0267273			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D8GY	35482646	Green Published, gold			2022-12-26	WOS:000794035700069
J	Hampton, JS; Dunstan, H; Toop, SJ; Flesch, J; Andreotti, A; Pain, D				Hampton, Jordan S.; Dunstan, Heath; Toop, Simon J.; Flesch, Jason; Andreotti, Alessandro; Pain, Deborah			Lead ammunition residues in a hunted Australian grassland bird, the stubble quail (Coturnix pectoralis): Implications for human and wildlife health	PLOS ONE			English	Article							GAME MEAT; BULLET FRAGMENTS; EXPOSURE; SHOT; CONTAMINATION; RISKS	Scavenging and predatory wildlife can ingest lead (Pb) from lead-based ammunition and become poisoned when feeding on shot game animals. Humans can similarly be exposed to ammunition-derived lead when consuming wild-shot game animals. Studies have assessed the degree of lead contamination in the carcasses of game animals but this scrutiny has not so far extended to Australia. Stubble quail (Coturnix pectoralis) are one of the only native non-waterfowl bird species that can be legally hunted in Australia, where it is commonly hunted with lead shot. The aim of this study was to characterize lead contamination in quail harvested with lead-based ammunition. The frequency, dimensions, and number of lead fragments embedded in carcasses were assessed through use of radiography (X-ray). From these data, the average quantity of lead available to scavenging wildlife was estimated along with potential risks to human consumers. We radiographed 37 stubble quail harvested by hunters using 12-gauge (2.75") shotguns to fire shells containing 28 g (1 oz) of #9 (2 mm or 0.08" diameter) lead shot in western Victoria, Australia, in Autumn 2021. Radiographs revealed that 81% of carcasses contained embedded pellets and/or fragments with an average of 1.62 embedded pellets detected per bird. By excising and weighing a sample of 30 shotgun pellets (all had a mass of 0.75 grain or 48.6 mg), we calculated an average lead load of 78 mg/100 g of body mass. This was a conservative estimate, because fragments were not considered. This level of lead contamination was comparable to hunted bird species examined using similar methods in Europe. The quantity and characteristics of lead ammunition residues found suggest that predatory and scavenging wildlife and some groups of human consumers will be at risk of negative health impacts.	[Hampton, Jordan S.] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic, Australia; [Hampton, Jordan S.] Murdoch Univ, Harry Butler Inst, Murdoch, WA, Australia; [Dunstan, Heath; Toop, Simon J.; Flesch, Jason] Game Management Author, Melbourne, Vic, Australia; [Andreotti, Alessandro] Ist Super Protez & Ric Ambientale, Area Avifauna Migratrice, Ozzano Dell Emilia, Italy; [Pain, Deborah] Univ Cambridge, Dept Zool, Cambridge, England	University of Melbourne; Murdoch University; Italian Institute for Environmental Protection & Research (ISPRA); University of Cambridge	Hampton, JS (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic, Australia.; Hampton, JS (corresponding author), Murdoch Univ, Harry Butler Inst, Murdoch, WA, Australia.	Jordan.hampton@unimelb.edu.au		Hampton, Jordan/0000-0003-0472-3241	McKenzie Fellowship program of the University of Melbourne; Victorian Game Management Authority	McKenzie Fellowship program of the University of Melbourne; Victorian Game Management Authority	The McKenzie Fellowship program of the University of Melbourne and the Victorian Game Management Authority funded this study. The funders did play a role in the preparation of the manuscript (three employees of the Game Management Authority are authors (HD, SDT and JSF)). The funders did not play a role in the analysis or decision to publish.	Andreotti A, 2016, ITAL J ANIM SCI, V15, P22, DOI 10.1080/1828051X.2016.1142360; Andreotti A, 2013, EUR J WILDLIFE RES, V59, P705, DOI 10.1007/s10344-013-0725-8; Calvert HS, 1876, FIELD, V47, P189; Centers for Disease Control and Prevention (CDC), 2012, LOW LEV LEAD EXP HAR; Cramp S., 1980, HDB BIRDS EUROPE MID; Cramp S., 1977, BIRDS EUROPE MIDDLE; Cramp S., 1989, HDB BIRDS EUROPE MID; Ecke F, 2017, ENVIRON SCI TECHNOL, V51, P5729, DOI 10.1021/acs.est.6b06024; Fernandez V, 2021, ENVIRON SCI POLLUT R, V28, P45486, DOI 10.1007/s11356-021-13880-z; FRITH HJ, 1977, AUST WILDLIFE RES, V4, P85; Fuchs B, 2021, ENVIRON POLLUT, V287, DOI 10.1016/j.envpol.2021.117595; Game Management Authority, 2020, GMA HUNT METH SURV 2; Gerofke A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200792; Gil-Sanchez JM, 2018, SCI TOTAL ENVIRON, V613, P483, DOI 10.1016/j.scitotenv.2017.09.069; Golden NH, 2016, REV ENVIRON CONTAM T, V237, P123, DOI 10.1007/978-3-319-23573-8_6; Green RE, 2022, SCI TOTAL ENVIRON, V823, DOI 10.1016/j.scitotenv.2022.154017; Green RE, 2012, FOOD CHEM TOXICOL, V50, P4180, DOI 10.1016/j.fct.2012.08.032; Green RE., 2021, CONSERVATION EVIDENC, V18, P1; Green RE, 2019, AMBIO, V48, P954, DOI 10.1007/s13280-019-01194-x; Hampton JO, 2021, SCI TOTAL ENVIRON, V789, DOI 10.1016/j.scitotenv.2021.147998; Hampton JO, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247785; Hampton JO, 2018, WILDLIFE RES, V45, P287, DOI 10.1071/WR17180; Hanley BJ., 2022, J WILDLIFE MANAGE, V86, pe22177; Herring G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167926; Hunt WG, 2006, WILDLIFE SOC B, V34, P167, DOI 10.2193/0091-7648(2006)34[167:BFIDRI]2.0.CO;2; Hunt WG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005330; Ishii C, 2020, J VET MED SCI, V82, P1118, DOI 10.1292/jvms.20-0104; Johansen P, 2004, ENVIRON POLLUT, V127, P125, DOI 10.1016/S0269-7491(03)00255-0; Johansen P, 2001, ENVIRON POLLUT, V112, P501, DOI 10.1016/S0269-7491(00)00130-5; Jordan J. S., 1951, Biological Notes Urbana, VNo. 26, P1; Kanstrup N, 2019, AMBIO, V48, P1009, DOI 10.1007/s13280-019-01152-7; Kelly J, 2021, J WILDLIFE DIS, V57, P917, DOI 10.7589/JWD-D-20-00185; Kendall RJ, 1996, ENVIRON TOXICOL CHEM, V15, P4, DOI 10.1002/etc.5620150103; Khazindar AR, 2021, CUREUS, V13, DOI 10.7759/cureus.16638; KINGHORN J. R., 1926, EMU, V26, P112; Knott J, 2010, SCI TOTAL ENVIRON, V409, P95, DOI 10.1016/j.scitotenv.2010.08.053; Kollander B, 2017, ANAL BIOANAL CHEM, V409, P1877, DOI 10.1007/s00216-016-0132-6; Lohr MT, 2020, SCI TOTAL ENVIRON, V715, DOI 10.1016/j.scitotenv.2019.135913; Mateo R, 2007, SCI TOTAL ENVIRON, V372, P480, DOI 10.1016/j.scitotenv.2006.10.022; Mateo R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015892; Moloney P., 2020, ESTIMATES DUCK STUBB; Moloney PD., WILDLIFE RES; Monclus L, 2020, SCI TOTAL ENVIRON, V748, DOI 10.1016/j.scitotenv.2020.141437; Olsen P.D., 2005, WEDGE TAILED EAGLE; ORDOG GJ, 1988, J TRAUMA, V28, P624, DOI 10.1097/00005373-198805000-00011; Ozkan OV, 2015, CASE REP SURG, V2015, DOI 10.1155/2015/496372; Pain DJ, 2019, AMBIO, V48, P935, DOI 10.1007/s13280-019-01159-0; Pain DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010315; Pauli JN, 2007, J WILDLIFE MANAGE, V71, P103, DOI 10.2193/2005-620; Pay JM, 2021, ENVIRON TOXICOL CHEM, V40, P219, DOI 10.1002/etc.4914; Rosenberg AG, 2019, J PEDIATR GASTR NUTR, V69, pE159, DOI 10.1097/MPG.0000000000002438; Schulz JH, 2021, J ENVIRON MANAGE, V277, DOI 10.1016/j.jenvman.2020.111438; Schulz K, 2021, J NUTR SCI, V10, DOI 10.1017/jns.2021.15; Singh NJ, 2021, DIVERS DISTRIB, V27, P1848, DOI 10.1111/ddi.13373; Slabe VA, 2022, SCIENCE, V375, P779, DOI 10.1126/science.abj3068; Spina F., 2003, BIOL CONS FAUNA, V13, P1; Thomas VG, 2020, AMBIO, V49, P2026, DOI 10.1007/s13280-020-01336-6; Thomas VG., 2021, ENVIRON POLICY LAW, V51, P239; Wetmore A., 1919, LEAD POISONING WATER	59	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267401	10.1371/journal.pone.0267401	http://dx.doi.org/10.1371/journal.pone.0267401			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446880	Green Submitted, Green Published, gold			2022-12-26	WOS:000795468200072
J	Sganga, DE; Dahlke, FT; Sorensen, SR; Butts, IAE; Tomkiewicz, J; Mazurais, D; Servili, A; Bertolini, F; Politis, SN				Sganga, Daniela E.; Dahlke, Flemming T.; Sorensen, Sune R.; Butts, Ian A. E.; Tomkiewicz, Jonna; Mazurais, David; Servili, Arianna; Bertolini, Francesca; Politis, Sebastian N.			CO2 induced seawater acidification impacts survival and development of European eel embryos	PLOS ONE			English	Article							EARLY-LIFE STAGES; TIME QUANTITATIVE PCR; ACID-BASE PHYSIOLOGY; HEAT-SHOCK PROTEINS; OCEAN ACIDIFICATION; ANGUILLA-ANGUILLA; FACTOR RECEPTORS; GENE-EXPRESSION; CARBON-DIOXIDE; ION REGULATION	Fish embryos may be vulnerable to seawater acidification resulting from anthropogenic carbon dioxide (CO2) emissions or from excessive biological CO2 production in aquaculture systems. This study investigated CO2 effects on embryos of the European eel (Anguilla anguilla), a catadromous fish that is considered at risk from climate change and that is targeted for hatchery production to sustain aquaculture of the species. Eel embryos were reared in three independent recirculation systems with different pH/CO2 levels representing "control" (pH 8.1, 300 mu atm CO2), end-of-century climate change ("intermediate", pH 7.6, 900 mu atm CO2) and "extreme" aquaculture conditions (pH 7.1, 3000 mu atm CO2). Sensitivity analyses were conducted at 4, 24, and 48 hours post-fertilization (hpf) by focusing on development, survival, and expression of genes related to acute stress response (crhr1, crfr2), stress/repair response (hsp70, hsp90), water and solute transport (aqp1, aqp3), acid-base regulation (nkcc1a, ncc, car15), and inhibitory neurotransmission (GABAA alpha 6b, Gabra1). Results revealed that embryos developing at intermediate pH showed similar survival rates to the control, but egg swelling was impaired, resulting in a reduction in egg size with decreasing pH. Embryos exposed to extreme pH had 0.6-fold decrease in survival at 24 hpf and a 0.3-fold change at 48 compared to the control. These observed effects of acidification were not reflected by changes in expression of any of the here studied genes. On the contrary, differential expression was observed along embryonic development independent of treatment, indicating that the underlying regulating systems are under development and that embryos are limited in their ability to regulate molecular responses to acidification. In conclusion, exposure to predicted end-of-century ocean pCO(2) conditions may affect normal development of this species in nature during sensitive early life history stages with limited physiological response capacities, while extreme acidification will negatively influence embryonic survival and development under hatchery conditions.	[Sganga, Daniela E.; Sorensen, Sune R.; Tomkiewicz, Jonna; Bertolini, Francesca; Politis, Sebastian N.] Tech Univ Denmark, Natl Inst Aquat Resources, Lyngby, Denmark; [Dahlke, Flemming T.] Thunen Inst Fisheries Ecol, Bremerhaven, Germany; [Sorensen, Sune R.] Billund Aquaculture, Billund, Denmark; [Butts, Ian A. E.] Auburn Univ, Sch Fisheries Aquaculture & Aquat Sci, Auburn, AL USA; [Mazurais, David; Servili, Arianna] Univ Brest, CNRS, IRD, LEMAR,Ifremer, Plouzane, France	Technical University of Denmark; Johann Heinrich von Thunen Institute; Auburn University System; Auburn University; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale	Sganga, DE (corresponding author), Tech Univ Denmark, Natl Inst Aquat Resources, Lyngby, Denmark.	delsg@aqua.dtu.dk	Sganga, Daniela Eliana/GPP-1095-2022	Sganga, Daniela Eliana/0000-0001-8545-3508; Servili, Arianna/0000-0002-6813-7500; Bertolini, Francesca/0000-0003-4181-3895; Mazurais, David/0000-0002-5686-2510; Sorensen, Sune Riis/0000-0001-5981-1383				Alderman SL, 2009, GEN COMP ENDOCR, V164, P61, DOI 10.1016/j.ygcen.2009.04.007; Alsop D, 2008, AM J PHYSIOL-REG I, V294, pR711, DOI 10.1152/ajpregu.00671.2007; Bates NR, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003759; Bates NR, 2001, DEEP-SEA RES PT II, V48, P1507, DOI 10.1016/S0967-0645(00)00151-X; Baumann H, 2019, CAN J ZOOL, V97, P399, DOI 10.1139/cjz-2018-0198; Bonhommeau S, 2008, FISH OCEANOGR, V17, P32, DOI 10.1111/j.1365-2419.2007.00453.x; Borges FO, 2019, BIOL LETTERS, V15, DOI 10.1098/rsbl.2018.0627; Brauner CJ, 2019, FISH PHYSIOL, V37, P69, DOI 10.1016/bs.fp.2019.08.003; Broach JS, 2017, AQUAC RES, V48, P3589, DOI 10.1111/are.13185; Butts IAE, 2014, AQUACULTURE, V426, P9, DOI 10.1016/j.aquaculture.2014.01.020; Butts IAE, 2016, AQUACULTURE, V464, P451, DOI 10.1016/j.aquaculture.2016.07.028; Gutierrez-Estrada JC, 2015, PROG OCEANOGR, V130, P112, DOI 10.1016/j.pocean.2014.10.007; Cattano C, 2018, ECOL MONOGR, V88, P320, DOI 10.1002/ecm.1297; Cerda J, 2010, J EXP ZOOL PART A, V313A, P623, DOI 10.1002/jez.634; Chauvigne F, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00066; Chen LM, 2010, AM J PHYSIOL-REG I, V299, pR1163, DOI 10.1152/ajpregu.00319.2010; Cross EL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53930-8; Dahlke F, 2020, J EXP BIOL, V223, DOI 10.1242/jeb.212589; Dahlke FT, 2017, GLOBAL CHANGE BIOL, V23, P1499, DOI 10.1111/gcb.13527; Dalsgaard J, 2013, AQUACULT ENG, V53, P2, DOI 10.1016/j.aquaeng.2012.11.008; DeSouza EB, 1995, PSYCHONEUROENDOCRINO, V20, P789, DOI 10.1016/0306-4530(95)00011-9; Dickson A., 2010, GUIDE BEST PRACTICES, P17, DOI DOI 10.2777/58454; Dickson AG, 2003, MAR CHEM, V80, P185, DOI 10.1016/S0304-4203(02)00133-0; dos Santos JA, 2020, AQUAT TOXICOL, V219, DOI 10.1016/j.aquatox.2019.105382; Duis K., 2000, SENSITIVITY EARLY LI, V214, P224, DOI [10.1002/1522-7278(2000)15:33.0.CO;2-M, DOI 10.1002/1522-7278(2000)15:33.0.CO;2-M]; EDDY FB, 1983, COMP BIOCHEM PHYS C, V75, P1, DOI 10.1016/0742-8413(83)90002-6; Esbaugh AJ, 2012, J COMP PHYSIOL B, V182, P921, DOI 10.1007/s00360-012-0668-5; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Finn RN, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00044; Flynn EE, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cov033; Forsgren E, 2013, ECOL EVOL, V3, P3637, DOI 10.1002/ece3.709; Franke A, 2011, BIOGEOSCIENCES, V8, P3697, DOI 10.5194/bg-8-3697-2011; Friedland KD, 2007, ICES J MAR SCI, V64, P519, DOI 10.1093/icesjms/fsm022; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Gattuso J.-P., SEACARB SEAWATER CAR; Gilmour KM, 2009, J EXP BIOL, V212, P1647, DOI 10.1242/jeb.029181; Goodkin NF, 2015, GEOPHYS RES LETT, V42, P4931, DOI 10.1002/2015GL064431; Gorissen M, 2016, FISH PHYSIOL, V35, P75, DOI 10.1016/B978-0-12-802728-8.00003-5; Hamilton SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169670; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Heuer RM, 2019, FISH PHYSIOL, V37, P161, DOI 10.1016/bs.fp.2019.08.002; Heuer RM, 2014, AM J PHYSIOL-REG I, V307, pR1061, DOI 10.1152/ajpregu.00064.2014; Hiroi J, 2008, J EXP BIOL, V211, P2584, DOI 10.1242/jeb.018663; Hofmann AF, 2010, AQUAT GEOCHEM, V16, P507, DOI 10.1007/s10498-009-9084-1; Huising M, 2004, J MOL ENDOCRINOL, V32, P627, DOI 10.1677/jme.0.0320627; Hwang PP, 2007, COMP BIOCHEM PHYS A, V148, P479, DOI 10.1016/j.cbpa.2007.06.416; Hwang PP, 2011, AM J PHYSIOL-REG I, V301, pR28, DOI 10.1152/ajpregu.00047.2011; JOHANSSON N, 1981, WATER RESOUR BULL, V17, P994; Kaneko T, 2002, FISHERIES SCI, V68, P1, DOI 10.1046/j.1444-2906.2002.00382.x; Keinanen M, 2003, ECOTOX ENVIRON SAFE, V55, P314, DOI 10.1016/S0147-6513(02)00128-8; KNEPPER MA, 1994, P NATL ACAD SCI USA, V91, P6255, DOI 10.1073/pnas.91.14.6255; Knights B, 2003, SCI TOTAL ENVIRON, V310, P237, DOI 10.1016/S0048-9697(02)00644-7; Koenigstein S, 2018, GLOBAL CHANGE BIOL, V24, P526, DOI 10.1111/gcb.13848; Kottmann JS, 2021, GEN COMP ENDOCR, V311, DOI 10.1016/j.ygcen.2021.113854; Kottmann JS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235617; Koumpiadis P, 2021, REPROD DOMEST ANIM, V56, P1497, DOI 10.1111/rda.14011; Krone PH, 1997, BIOCHEM CELL BIOL, V75, P487, DOI 10.1139/bcb-75-5-487; Kwiatkowski L, 2020, BIOGEOSCIENCES, V17, P3439, DOI 10.5194/bg-17-3439-2020; Lai F, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cow068; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopes AF, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-3026-4; Lopes AR, 2021, SCI TOTAL ENVIRON, V774, DOI 10.1016/j.scitotenv.2021.145499; Maclver B, 2009, J EXP BIOL, V212, P2856, DOI 10.1242/jeb.025882; McKenzie DJ, 2003, J EXP BIOL, V206, P1717, DOI 10.1242/jeb.00352; McKenzie DJ, 2002, J COMP PHYSIOL B, V172, P339, DOI 10.1007/s00360-002-0260-5; Miest JJ, 2019, FISH SHELLFISH IMMUN, V87, P105, DOI 10.1016/j.fsi.2018.12.048; Mordenti O., 2019, EELS BIOL MONITORING; Morrell BK, 2020, DIVERSITY-BASEL, V12, DOI 10.3390/d12010025; Mu J, 2015, BIOGEOSCIENCES, V12, P3861, DOI 10.5194/bg-12-3861-2015; Munday PL, 2008, FISH FISH, V9, P261, DOI 10.1111/j.1467-2979.2008.00281.x; Murray CS, 2019, CONSERV PHYSIOL, V7, DOI 10.1093/conphys/coz084; Nilsson GE, 2012, NAT CLIM CHANGE, V2, P201, DOI [10.1038/nclimate1352, 10.1038/NCLIMATE1352]; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Ou M, 2015, NAT CLIM CHANGE, V5, P950, DOI 10.1038/NCLIMATE2694; Perrin MH, 1999, ANN NY ACAD SCI, V885, P312, DOI 10.1111/j.1749-6632.1999.tb08687.x; Pike C., 2020, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-2.RLTS.T60344A152845178.EN; Pimentel MS, 2016, CLIMATIC CHANGE, V137, P495, DOI 10.1007/s10584-016-1682-5; Politis SN, 2021, AQUACULTURE, V539, DOI 10.1016/j.aquaculture.2021.736651; Politis SN, 2018, GEN COMP ENDOCR, V259, P54, DOI 10.1016/j.ygcen.2017.11.003; Politis SN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198294; Politis SN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182726; Politis SN, 2014, J EXP MAR BIOL ECOL, V461, P407, DOI 10.1016/j.jembe.2014.09.014; Portner H., 2019, IPCC SPECIAL REPORT, P142; R Core Team, 2020, R LANG ENV STAT COMP; Raftery TD, 2015, NEUROTOXICOL TERATOL, V49, P10, DOI 10.1016/j.ntt.2015.02.006; Raftery TD, 2014, ENVIRON SCI TECHNOL, V48, P804, DOI 10.1021/es404322p; Randall DJ., 1988, EGGS LARVAE PHYSL DE; Reynalte-Tataje DA, 2015, NEOTROP ICHTHYOL, V13, P179, DOI 10.1590/1982-0224-20130127; Roberts RJ, 2010, J FISH DIS, V33, P789, DOI 10.1111/j.1365-2761.2010.01183.x; Sampaio E, 2018, SCI TOTAL ENVIRON, V618, P388, DOI 10.1016/j.scitotenv.2017.11.059; Schmidt J., 1922, Philosophical Transactions of the Royal Society London B, V211, P179; Schunter C, 2018, NAT ECOL EVOL, V2, P334, DOI 10.1038/s41559-017-0428-8; Shrivastava J, 2019, AQUAT TOXICOL, V212, P54, DOI 10.1016/j.aquatox.2019.04.024; Skov PV, 2019, FISH PHYSIOL, V37, P287, DOI 10.1016/bs.fp.2019.07.004; Sorensen SR, 2016, AQUACULTURE, V456, P50, DOI 10.1016/j.aquaculture.2016.01.015; Sorensen SR, 2016, ZYGOTE, V24, P121, DOI 10.1017/S0967199414000811; Sorensen SR, 2014, AQUACULTURE, V426, P1, DOI 10.1016/j.aquaculture.2014.01.011; Sun LB, 2019, ENVIRON GEOCHEM HLTH, V41, P1847, DOI 10.1007/s10653-018-0159-z; Talbot K, 2015, J EXP BIOL, V218, P3931, DOI 10.1242/jeb.129759; Tiedke J, 2013, BIOCHEM BIOPH RES CO, V441, P624, DOI 10.1016/j.bbrc.2013.10.104; Tingaud-Sequeira A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-38; Tingaud-Sequeira A, 2009, AM J PHYSIOL-REG I, V296, pR1041, DOI 10.1152/ajpregu.91002.2008; Tomkiewicz J., 2019, EELS BIOL MONITORING, P340; Tresguerres M, 2017, J EXP BIOL, V220, P2136, DOI 10.1242/jeb.144113; Tseng YC, 2013, COMP BIOCHEM PHYS A, V165, P119, DOI 10.1016/j.cbpa.2013.02.005; van Ginneken VJT, 2005, REV FISH BIOL FISHER, V15, P367, DOI 10.1007/s11160-006-0005-8; VANDENTHILLART G, 2009, SPAWNING MIGRATION E; Wang YF, 2009, AM J PHYSIOL-REG I, V296, pR1650, DOI 10.1152/ajpregu.00119.2009; Watson SA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185469; Wittmann AC, 2013, NAT CLIM CHANGE, V3, P995, DOI 10.1038/NCLIMATE1982; Zimmer AM, 2017, J EXP BIOL, V220, P3843, DOI 10.1242/jeb.140210	112	0	0	8	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267228	10.1371/journal.pone.0267228	http://dx.doi.org/10.1371/journal.pone.0267228			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7MW	35436318	Green Published, gold			2022-12-26	WOS:000791258900030
J	Zhou, X; Sobczak, GS; McKay, CM; Litovsky, RY				Zhou, Xin; Sobczak, Gabriel S.; McKay, Colette M.; Litovsky, Ruth Y.			Effects of degraded speech processing and binaural unmasking investigated using functional near-infrared spectroscopy (fNIRS)	PLOS ONE			English	Article							MASKING LEVEL DIFFERENCE; ENERGETIC MASKING; AUDITORY-CORTEX; SPATIAL RELEASE; HEMODYNAMIC-RESPONSES; LISTENING EFFORT; COCKTAIL PARTY; BRAIN-STEM; INTELLIGIBILITY; ACTIVATION	The present study aimed to investigate the effects of degraded speech perception and binaural unmasking using functional near-infrared spectroscopy (fNIRS). Normal hearing listeners were tested when attending to unprocessed or vocoded speech, presented to the left ear at two speech-to-noise ratios (SNRs). Additionally, by comparing monaural versus diotic masker noise, we measured binaural unmasking. Our primary research question was whether the prefrontal cortex and temporal cortex responded differently to varying listening configurations. Our a priori regions of interest (ROIs) were located at the left dorsolateral prefrontal cortex (DLPFC) and auditory cortex (AC). The left DLPFC has been reported to be involved in attentional processes when listening to degraded speech and in spatial hearing processing, while the AC has been reported to be sensitive to speech intelligibility. Comparisons of cortical activity between these two ROIs revealed significantly different fNIRS response patterns. Further, we showed a significant and positive correlation between self-reported task difficulty levels and fNIRS responses in the DLPFC, with a negative but non-significant correlation for the left AC, suggesting that the two ROIs played different roles in effortful speech perception. Our secondary question was whether activity within three sub-regions of the lateral PFC (LPFC) including the DLPFC was differentially affected by varying speech-noise configurations. We found significant effects of spectral degradation and SNR, and significant differences in fNIRS response amplitudes between the three regions, but no significant interaction between ROI and speech type, or between ROI and SNR. When attending to speech with monaural and diotic noises, participants reported the latter conditions being easier; however, no significant main effect of masker condition on cortical activity was observed. For cortical responses in the LPFC, a significant interaction between SNR and masker condition was observed. These findings suggest that binaural unmasking affects cortical activity through improving speech reception threshold in noise, rather than by reducing effort exerted.	[Zhou, Xin; Litovsky, Ruth Y.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Sobczak, Gabriel S.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [McKay, Colette M.] Bion Inst Australia, Melbourne, Vic, Australia; [McKay, Colette M.] Univ Melbourne, Dept Med Bion, Melbourne, Vic, Australia; [Litovsky, Ruth Y.] Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI USA; [Litovsky, Ruth Y.] Univ Wisconsin, Dept Surg, Div Otolaryngol, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Bionics Institute; University of Melbourne; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zhou, X (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.	xzhou353@wisc.edu	Zhou, Xin/AAU-7702-2020	Zhou, Xin/0000-0002-5285-947X; McKay, Colette/0000-0002-1659-9789	National Institute on Deafness and Other Communication Disorders (NIH-NIDCD) [R01DC003083]; UW-Madison's Office of the Vice Chancellor for Research; Core grant from NIH-NICHD [U54HD090256]	National Institute on Deafness and Other Communication Disorders (NIH-NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); UW-Madison's Office of the Vice Chancellor for Research; Core grant from NIH-NICHD	This study was supported by National Institute on Deafness and Other Communication Disorders (NIH-NIDCD, R01DC003083 to RL), UW-Madison's Office of the Vice Chancellor for Research, and a Core grant from NIH-NICHD (U54HD090256 to Waisman Center).	Aasted CM, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.2.020801; [Anonymous], 1969, IEEE T ACOUST SPEECH, VAU17, P225; Arbogast TL, 2002, J ACOUST SOC AM, V112, P2086, DOI 10.1121/1.1510141; Bakdash JZ, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00456; Barbey AK, 2013, CORTEX, V49, P1195, DOI 10.1016/j.cortex.2012.05.022; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Binder JR, 2004, NAT NEUROSCI, V7, P295, DOI 10.1038/nn1198; Boushel R, 2001, SCAND J MED SCI SPOR, V11, P213, DOI 10.1034/j.1600-0838.2001.110404.x; Brigadoi S, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.2.025005; Brungart DS, 2002, J ACOUST SOC AM, V112, P664, DOI 10.1121/1.1490592; Cameron S, 2011, J AM ACAD AUDIOL, V22, P697, DOI 10.3766/jaaa.22.10.7; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Clinard CG, 2017, JARO-J ASSOC RES OTO, V18, P355, DOI 10.1007/s10162-016-0603-7; Cui X, 2011, NEUROIMAGE, V54, P2808, DOI 10.1016/j.neuroimage.2010.10.069; Culling J.F., 2021, BINAURAL HEARING EDI, P209, DOI DOI 10.1007/978-3-030-57100-9; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Defenderfer J, 2017, NEUROPSYCHOLOGIA, V106, P31, DOI 10.1016/j.neuropsychologia.2017.09.004; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Eisner F, 2010, J NEUROSCI, V30, P7179, DOI 10.1523/JNEUROSCI.4040-09.2010; Foundas AL, 1998, BRAIN LANG, V64, P282, DOI 10.1006/brln.1998.1974; FOUNDAS AL, 1994, NEUROPSYCHOLOGIA, V32, P1225, DOI 10.1016/0028-3932(94)90104-X; Fowler CG, 2017, J SPEECH LANG HEAR R, V60, P2364, DOI 10.1044/2017_JSLHR-H-16-0251; Funane T, 2014, NEUROIMAGE, V85, P150, DOI 10.1016/j.neuroimage.2013.02.026; Gagnon L, 2012, NEUROIMAGE, V59, P2518, DOI 10.1016/j.neuroimage.2011.08.095; Gilbert HJ, 2015, J NEUROSCI, V35, P209, DOI 10.1523/JNEUROSCI.1131-14.2015; Goodwin JR, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.1.015002; Goupell MJ, 2016, J ACOUST SOC AM, V140, P1652, DOI 10.1121/1.4962378; Hawley ML, 2004, J ACOUST SOC AM, V115, P833, DOI 10.1121/1.1639908; Hervais-Adelman AG, 2012, LANG COGNITIVE PROC, V27, P1145, DOI 10.1080/01690965.2012.662280; Hughes LE, 2014, J NEUROPHYSIOL, V112, P3086, DOI 10.1152/jn.00062.2014; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Huppert TJ, 2006, NEUROIMAGE, V29, P368, DOI 10.1016/j.neuroimage.2005.08.065; Ishida IM, 2009, EAR HEARING, V30, P713, DOI 10.1097/AUD.0b013e3181b61cc8; Jancke L, 2002, HEARING RES, V170, P166, DOI 10.1016/S0378-5955(02)00488-4; Jones GL, 2011, J ACOUST SOC AM, V130, P1463, DOI 10.1121/1.3613928; Kidd G, 2008, J ACOUST SOC AM, V124, P3793, DOI 10.1121/1.2998980; Kurzban R, 2013, BEHAV BRAIN SCI, V36, P661, DOI 10.1017/S0140525X12003196; Lawrence RJ, 2018, HEARING RES, V370, P53, DOI 10.1016/j.heares.2018.09.005; Leon-Carrion J., 2012, NEUROIMAGING METHODS, DOI [10.5772/23146, DOI 10.5772/23146]; Liang L-Y., 2016, BRAIN ACTIVATION PRE; Litovsky RY, 2005, J ACOUST SOC AM, V117, P3091, DOI 10.1121/1.1873913; McAlpine D, 1996, J ACOUST SOC AM, V100, P490, DOI 10.1121/1.415862; McGarrigle R, 2014, INT J AUDIOL, V53, P433, DOI 10.3109/14992027.2014.890296; Molavi B, 2010, IEEE ENG MED BIO, P5, DOI 10.1109/IEMBS.2010.5626589; Nazeer H, 2020, J NEURAL ENG, V17, DOI 10.1088/1741-2552/abb417; Noah JA, 2015, JOVE-J VIS EXP, DOI 10.3791/52116; Olds C, 2016, EAR HEARING, V37, pE160, DOI 10.1097/AUD.0000000000000258; Palmer AR, 2002, ACTA ACUST UNITED AC, V88, P312; Pichora-Fuller MK, 2016, EAR HEARING, V37, p5S, DOI 10.1097/AUD.0000000000000312; Pinti P., 2019, FRONT HUM NEUROSCI, P12, DOI [10.3389/fnhum.2019.00012, DOI 10.3389/FNHUM.2019.00012]; Pollonini L, 2014, HEARING RES, V309, P84, DOI 10.1016/j.heares.2013.11.007; Quaresima V, 2019, ORGAN RES METHODS, V22, P46, DOI 10.1177/1094428116658959; Rennies J, 2018, J ACOUST SOC AM, V144, P2147, DOI 10.1121/1.5057114; Rennies J, 2014, J ACOUST SOC AM, V136, P2642, DOI 10.1121/1.4897398; Rovetti J, 2019, TRENDS HEAR, V23, DOI 10.1177/2331216519886722; Rowland SC, 2018, TRENDS HEAR, V22, DOI 10.1177/2331216518804116; Santiago JM, 2020, INT ARCH OTORHINOLAR, V24, pE399, DOI 10.1055/s-0040-1701266; Santosa H, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00418; Sato T, 2016, NEUROIMAGE, V141, P120, DOI 10.1016/j.neuroimage.2016.06.054; SAYERS BM, 1957, J ACOUST SOC AM, V29, P973, DOI 10.1121/1.1914990; Scholkmann F, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.10.105004; Scott SK, 2004, J ACOUST SOC AM, V115, P813, DOI 10.1121/1.1639336; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Spierer L, 2009, BRAIN, V132, P1953, DOI 10.1093/brain/awp127; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; STUDEBAKER GA, 1985, J SPEECH HEAR RES, V28, P455, DOI 10.1044/jshr.2803.455; Tachtsidis I, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.039801; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Wack DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041263; Weder S, 2020, EAR HEARING, V41, P1187, DOI 10.1097/AUD.0000000000000836; Weder S, 2018, JARO-J ASSOC RES OTO, V19, P273, DOI 10.1007/s10162-018-0661-0; Wijayasiri P, 2017, HEARING RES, V351, P55, DOI 10.1016/j.heares.2017.05.010; Wild CJ, 2012, J NEUROSCI, V32, P14010, DOI 10.1523/JNEUROSCI.1528-12.2012; Winn MB, 2015, EAR HEARING, V36, pe153, DOI 10.1097/AUD.0000000000000145; Woldorff MG, 1999, HUM BRAIN MAPP, V7, P49, DOI 10.1002/(SICI)1097-0193(1999)7:1<49::AID-HBM5>3.3.CO;2-A; Wolf M, 2002, NEUROIMAGE, V16, P704, DOI 10.1006/nimg.2002.1128; Wong WYS, 2004, EAR HEARING, V25, P57, DOI 10.1097/01.AUD.0000111257.11898.64; Zekveld AA, 2014, NEUROIMAGE, V101, P76, DOI 10.1016/j.neuroimage.2014.06.069; Zekveld AA, 2014, PSYCHOPHYSIOLOGY, V51, P277, DOI 10.1111/psyp.12151; Zekveld AA, 2010, EAR HEARING, V31, P480, DOI 10.1097/AUD.0b013e3181d4f251; Zhang M, 2018, TRENDS HEAR, V22, DOI 10.1177/2331216518817464; Zhou X, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244186; Zhou X, 2018, TRENDS HEAR, V22, DOI 10.1177/2331216518786850	86	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267588	10.1371/journal.pone.0267588	http://dx.doi.org/10.1371/journal.pone.0267588			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1D9PO	35468160	gold, Green Published			2022-12-26	WOS:000794129600032
J	Chen, HH; Lin, CJ; Anand, A; Lin, HJ; Lin, HY; Mao, JY; Wang, PH; Tseng, YJ; Tzou, WS; Huang, CC; Wang, RYL				Chen, Han-Hsiang; Lin, Chin-Jung; Anand, Anisha; Lin, Han-Jia; Lin, Hung-Yun; Mao, Ju-Yi; Wang, Pei-Hua; Tseng, Yufeng Jane; Tzou, Wen-Shyong; Huang, Chih-Ching; Wang, Robert Y. L.			Development of antiviral carbon quantum dots that target the Japanese encephalitis virus envelope protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENGUE VIRUS; GRAPHENE OXIDE; FULLERENE DERIVATIVES; CRYSTAL-STRUCTURE; CURCUMIN; INHIBITION; ENTRY; NS3; NANOMATERIALS; MUTATION	Japanese encephalitis is a mosquito-borne disease caused by the Japanese encephalitis virus (JEV) that is prevalent in Asia and the Western Pacific. Currently, there is no effective treatment for Japanese encephalitis. Curcumin (Cur) is a compound extracted from the roots of Curcuma longa, and many studies have reported its antiviral and anti-inflammatory activities. However, the high cytotoxicity and very low solubility of Cur limit its biomedical applications. In this study, Cur carbon quantum dots (Cur-CQDs) were synthesized by mild pyrolysis-induced polymerization and carbonization, leading to higher water solubility and lower cytotoxicity, as well as superior antiviral activity against JEV infection. We found that CurCQDs effectively bound to the E protein of JEV, preventing viral entry into the host cells. In addition, after continued treatment of JEV with Cur-CQDs, a mutant strain of JEV was evolved that did not support binding of Cur-CQDs to the JEV envelope. Using transmission electron microscopy, biolayer interferometry, and molecular docking analysis, we revealed that the S123R and K312R mutations in the E protein play a key role in binding Cur-CQDs. The S123 and K312 residues are located in structural domains II and III of the E protein, respectively, and are responsible for binding to receptors on and fusing with the cell membrane. Taken together, our results suggest that the E protein of flaviviruses represents a potential target for the development of CQD-based inhibitors to prevent or treat viral infections.	[Chen, Han-Hsiang; Wang, Robert Y. L.] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Div Microbiol & Immunol, Taoyuan, Taiwan; [Lin, Chin-Jung; Anand, Anisha; Lin, Han-Jia; Lin, Hung-Yun; Mao, Ju-Yi; Tzou, Wen-Shyong; Huang, Chih-Ching] Natl Taiwan Ocean Univ, Dept Biosci & Biotechnol, Keelung, Taiwan; [Lin, Han-Jia; Huang, Chih-Ching] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan; [Wang, Pei-Hua; Tseng, Yufeng Jane] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei, Taiwan; [Tseng, Yufeng Jane] Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Taipei, Taiwan; [Huang, Chih-Ching] Kaohsiung Med Univ, Coll Pharm, Sch Pharm, Kaohsiung, Taiwan; [Wang, Robert Y. L.] Chang Gung Univ, Coll Med, Dept Biomed Sci, Taoyuan, Taiwan; [Wang, Robert Y. L.] Chang Gung Mem & Childrens Hosp, Dept Pediat, Div Pediat Infect Dis, Linkou, Taiwan; [Wang, Robert Y. L.] Chang Gung Mem Hosp, Kidney Res Ctr, Linkou, Taiwan; [Wang, Robert Y. L.] Chang Gung Mem Hosp, Dept Nephrol, Linkou, Taiwan	Chang Gung University; National Taiwan Ocean University; National Taiwan Ocean University; National Taiwan University; National Taiwan University; Kaohsiung Medical University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Wang, RYL (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Div Microbiol & Immunol, Taoyuan, Taiwan.; Huang, CC (corresponding author), Natl Taiwan Ocean Univ, Dept Biosci & Biotechnol, Keelung, Taiwan.; Huang, CC (corresponding author), Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan.; Huang, CC (corresponding author), Kaohsiung Med Univ, Coll Pharm, Sch Pharm, Kaohsiung, Taiwan.; Wang, RYL (corresponding author), Chang Gung Univ, Coll Med, Dept Biomed Sci, Taoyuan, Taiwan.; Wang, RYL (corresponding author), Chang Gung Mem & Childrens Hosp, Dept Pediat, Div Pediat Infect Dis, Linkou, Taiwan.; Wang, RYL (corresponding author), Chang Gung Mem Hosp, Kidney Res Ctr, Linkou, Taiwan.; Wang, RYL (corresponding author), Chang Gung Mem Hosp, Dept Nephrol, Linkou, Taiwan.	huanging@ntou.edu.tw; yuwang@mail.cgu.edu.tw	Huang, Chih-Ching/D-3103-2012; Tzou, Wen-Shyong/H-4517-2014	Huang, Chih-Ching/0000-0002-0363-1129; Tzou, Wen-Shyong/0000-0002-6726-1390	Ministry of Science and Technology of Taiwan [110 to 2221-E-019 to 001, 110 to 2320-B-182 to 029, 110 to 2811-M-019 to 501]; Chang Gung memorial hospital research fund [CMRPD1H0321-3, CMRPD1K0251-2, CMRPD1L0061]; Center of Excellence for the Oceans, National Taiwan Ocean University from The Featured Areas Research Center Program within Ministry of Education (MOE) in Taiwan	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung memorial hospital research fund(Chang Gung Memorial Hospital); Center of Excellence for the Oceans, National Taiwan Ocean University from The Featured Areas Research Center Program within Ministry of Education (MOE) in Taiwan	This study was supported by the Ministry of Science and Technology of Taiwan under Contract Nos. 110 to 2221-E-019 to 001, 110 to 2320-B-182 to 029 and 110 to 2811-M-019 to 501, by Chang Gung memorial hospital research fund (CMRPD1H0321-3, CMRPD1K0251-2 and CMRPD1L0061) and by the Center of Excellence for the Oceans, National Taiwan Ocean University from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan.	Ahsan H, 1999, CHEM-BIOL INTERACT, V121, P161, DOI 10.1016/S0009-2797(99)00096-4; ALLISON SL, 1995, J VIROL, V69, P695, DOI 10.1128/JVI.69.2.695-700.1995; Baikerikar S, 2017, PHARMACOGN RES, V9, pS15, DOI 10.4103/pr.pr_30_17; Balasubramanian A, 2019, ANTIVIR RES, V162, P71, DOI 10.1016/j.antiviral.2018.12.002; Barras A, 2016, ACS APPL MATER INTER, V8, P9004, DOI 10.1021/acsami.6b01681; Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200; Carro SD, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13010013; Chakravarty M, 2021, DRUG DELIV TRANSL RE, V11, P748, DOI 10.1007/s13346-020-00818-0; Clark MJ, 2016, CELL CHEM BIOL, V23, P443, DOI 10.1016/j.chembiol.2016.03.010; Aparicio JAC, 2020, MRS ADV, V5, P3345, DOI 10.1557/adv.2020.410; Das C, 2020, INT J NANOMED, V15, P9301, DOI 10.2147/IJN.S280976; Mendes LAD, 2020, CHEM-BIOL INTERACT, V331, DOI 10.1016/j.cbi.2020.109218; de Wispelaere M, 2018, CELL CHEM BIOL, V25, P1006, DOI 10.1016/j.chembiol.2018.05.011; Du T, 2018, ACS APPL BIO MATER, V1, P1286, DOI 10.1021/acsabm.8b00154; Du T, 2016, CARBON, V110, P278, DOI 10.1016/j.carbon.2016.09.032; Dutta K, 2009, J NEUROIMMUNE PHARM, V4, P328, DOI 10.1007/s11481-009-9158-2; EDWARD Z, 1993, MICROBIOL IMMUNOL, V37, P239, DOI 10.1111/j.1348-0421.1993.tb03206.x; Fahmi MZ, 2016, RSC ADV, V6, P92996, DOI 10.1039/c6ra21062g; Falynskova IN, 2014, PHARM CHEM J+, V48, P85, DOI 10.1007/s11094-014-1053-3; Fan WC, 2016, VIRUS RES, V220, P112, DOI 10.1016/j.virusres.2016.04.021; Frabasile S, 2017, SCI REP-UK, V7, DOI 10.1038/srep41864; Fritz R, 2008, J CELL BIOL, V183, P353, DOI 10.1083/jcb.200806081; Fujisawa S, 2004, ANTICANCER RES, V24, P563; Garg P, 2020, NANO TODAY, V35, DOI 10.1016/j.nantod.2020.101001; Hansen V, 2016, JAMA-J AM MED ASSOC, V316, P2149, DOI 10.1001/jama.2016.12423; Heinz FX, 2000, ADV VIRUS RES, V55, P231, DOI 10.1016/S0065-3527(00)55005-2; Hiraga K, 2021, ACS SYNTH BIOL, V10, P357, DOI 10.1021/acssynbio.0c00542; Hu T, 2021, VIROL J, V18, DOI 10.1186/s12985-021-01611-2; Iannazzo D, 2018, BIOCONJUGATE CHEM, V29, P3084, DOI 10.1021/acs.bioconjchem.8b00448; Innocenzi P, 2020, CHEM SCI, V11, P6606, DOI 10.1039/d0sc02658a; Iro MA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011367.pub2; Jackman JA, 2021, ADV FUNCT MATER, V31, DOI 10.1002/adfm.202008352; Jelinek T, 2008, EXPERT REV VACCINES, V7, P689, DOI 10.1586/14760584.7.5.689; Johari J, 2012, INT J MOL SCI, V13, P16785, DOI 10.3390/ijms131216785; Kataoka H, 2016, BIOORG MED CHEM LETT, V26, P4565, DOI 10.1016/j.bmcl.2016.08.086; Kim M, 2021, EUR J PHARMACOL, V904, DOI 10.1016/j.ejphar.2021.174144; Klimova R, 2020, FULLER NANOTUB CAR N, V28, P487, DOI 10.1080/1536383X.2019.1706495; Kurane I, 2000, VACCINE, V18, P33, DOI 10.1016/S0264-410X(00)00041-4; Li Kuohan, 2014, Virologica Sinica, V29, P74, DOI 10.1007/s12250-014-3438-6; Li PC, 2019, ACS INFECT DIS, V5, P460, DOI 10.1021/acsinfecdis.8b00322; Lian WL, 2018, ACS INFECT DIS, V4, P1395, DOI 10.1021/acsinfecdis.8b00127; Lin CJ, 2019, SMALL, V15, DOI 10.1002/smll.201902641; Liu HB, 2015, J VIROL, V89, P5668, DOI 10.1128/JVI.00293-15; Liu JJ, 2020, ACS CENTRAL SCI, V6, P2179, DOI 10.1021/acscentsci.0c01306; Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11; Mansfield KL, 2017, VET MICROBIOL, V201, P85, DOI 10.1016/j.vetmic.2017.01.014; Martinez ZS, 2016, ANTIMICROB AGENTS CH, V60, P5731, DOI 10.1128/AAC.00341-16; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Monath TP, 2002, J VIROL, V76, P1932, DOI 10.1128/JVI.76.4.1932-1943.2002; Mostafavi ST, 2009, DESALINATION, V238, P271, DOI 10.1016/j.desal.2008.02.018; Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014; Pacho MN, 2021, J PHARM PHARMACOL, V73, P357, DOI 10.1093/jpp/rgaa045; Nayak V, 2009, J VIROL, V83, P4338, DOI 10.1128/JVI.02574-08; Nelson KM, 2017, ACS MED CHEM LETT, V8, P467, DOI 10.1021/acsmedchemlett.7b00139; Nelson KM, 2017, J MED CHEM, V60, P1620, DOI 10.1021/acs.jmedchem.6b00975; Nour AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003585; Osminkina LA, 2022, BIOACT MATER, V7, P39, DOI 10.1016/j.bioactmat.2021.06.001; Padilla L, 2014, ARCH VIROL, V159, P573, DOI 10.1007/s00705-013-1849-6; Peng MH, 2017, ANTIVIR RES, V143, P176, DOI 10.1016/j.antiviral.2017.03.026; Pilaquinga F, 2021, WIRES NANOMED NANOBI, V13, DOI 10.1002/wnan.1707; Ramos-Soriano J, 2019, J AM CHEM SOC, V141, P15403, DOI 10.1021/jacs.9b08003; Schmidt AG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002627; Serrano-Aroca A, 2021, ACS NANO, V15, P8069, DOI 10.1021/acsnano.1c00629; Skalny AV, 2020, INT J MOL MED, V46, P17, DOI 10.3892/ijmm.2020.4575; Solomon T, 2000, J NEUROL NEUROSUR PS, V68, P405, DOI 10.1136/jnnp.68.4.405; Stiasny K, 2002, J VIROL, V76, P3784, DOI 10.1128/JVI.76.8.3784-3790.2002; TAKEGAMI T, 1995, VIRUS GENES, V9, P105, DOI 10.1007/BF01702653; Tollas S, 2014, BIOORG MED CHEM LETT, V24, P2420, DOI 10.1016/j.bmcl.2014.04.032; Tong T, 2020, SMALL, V16, DOI 10.1002/smll.201906206; Tortella G, 2021, ANTIBIOTICS-BASEL, V10, DOI 10.3390/antibiotics10070783; Turtle L, 2018, NAT REV NEUROL, V14, P298, DOI 10.1038/nrneurol.2018.30; Unal MA, 2021, SMALL, V17, DOI 10.1002/smll.202101483; Wang RYL, 2013, VIROLOGY, V443, P236, DOI 10.1016/j.virol.2013.05.001; Wang XX, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00024-6; Woo JH, 2003, CARCINOGENESIS, V24, P1199, DOI 10.1093/carcin/bgg082; Wu YP, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-128; Yamaguchi Y, 2013, J GEN VIROL, V94, P90, DOI 10.1099/vir.0.044925-0; Yang J, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010020; Yang XX, 2017, NANOSCALE, V9, P16086, DOI 10.1039/c7nr06520e; Yang XX, 2016, NANOSCALE, V8, P3040, DOI 10.1039/c5nr07918g; Ye SY, 2015, ACS APPL MATER INTER, V7, P21571, DOI 10.1021/acsami.5b06876; Yoon BK, 2021, ACS NANO, V15, P125, DOI 10.1021/acsnano.0c07489; Yun SI, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7030068; Zandi K, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-91; Zeng QS, 2021, LIGHT-SCI APPL, V10, DOI 10.1038/s41377-021-00579-6; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019; Zhou JR, 2021, NANO TODAY, V36, DOI 10.1016/j.nantod.2020.101031; Zhou YY, 2018, ARCH VIROL, V163, P1351, DOI 10.1007/s00705-018-3765-2; Ziem B, 2017, NANOSCALE, V9, P3774, DOI 10.1039/c7nr00611j	89	3	3	6	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101957	10.1016/j.jbc.2022.101957	http://dx.doi.org/10.1016/j.jbc.2022.101957			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3R4NR	35452675	Green Published, gold			2022-12-26	WOS:000838892100011
J	Kondo, K; Harada, Y; Nakano, M; Suzuki, T; Fukushige, T; Hanzawa, K; Yagi, H; Takagi, K; Mizuno, K; Miyamoto, Y; Taniguchi, N; Kato, K; Kanekura, T; Dohmae, N; Machida, K; Maruyama, I; Inoue, H				Kondo, Kiyotaka; Harada, Yoichiro; Nakano, Miyako; Suzuki, Takehiro; Fukushige, Tomoko; Hanzawa, Ken; Yagi, Hirokazu; Takagi, Koichi; Mizuno, Keiko; Miyamoto, Yasuhide; Taniguchi, Naoyuki; Kato, Koichi; Kanekura, Takuro; Dohmae, Naoshi; Machida, Kentaro; Maruyama, Ikuro; Inoue, Hiromasa			Identification of distinct N-glycosylation patterns on extracellular vesicles from small-cell and non-small-cell lung cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; FUCOSYL-TRANSFERASE 8; LINKED OLIGOSACCHARIDES; CORE FUCOSYLATION; EXPRESSION; INTEGRIN; EXOSOMES; PURIFICATION; GLYCANS; ALPHA	Asparagine-linked glycosylation (N-glycosylation) of proteins in the cancer secretome has been gaining increasing attention as a potential biomarker for cancer detection and diagnosis. Small extracellular vesicles (sEVs) constitute a large part of the cancer secretome, yet little is known about whether their N-glycosylation status reflects known cancer characteristics. Here, we investigated the N-glycosylation of sEVs released from small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC) cells. We found that the N-glycans of SCLC-sEVs were characterized by the presence of structural units also found in the brain N-glycome, while NSCLC-sEVs were dominated by typical lung-type N-glycans with NSCLC-associated core fucosylation. In addition, lectin-assisted N-glycoproteomics of SCLC-sEVs and NSCLC-sEVs revealed that integrin alpha V was commonly expressed in sEVs of both cancer cell types, while the epithelium-specific integrin alpha 6 beta 4 heterodimer was selectively expressed in NSCLC-sEVs. Importantly, N-glycomics of the immunopurified integrin alpha 6 from NSCLC-sEVs identified NSCLC-type N-glycans on this integrin subunit. Thus, we conclude that protein N-glycosylation in lung cancer sEVs may potentially reflect the histology of lung cancers.	[Kondo, Kiyotaka; Takagi, Koichi; Mizuno, Keiko; Machida, Kentaro; Inoue, Hiromasa] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pulm Med, Kagoshima, Japan; [Harada, Yoichiro; Taniguchi, Naoyuki] Osaka Int Canc Inst, Dept Glycooncol & Med Biochem, Chuo Ku, Osaka, Japan; [Nakano, Miyako] Hiroshima Univ, Grad Sch Integrated Sci Life, Higashihiroshima, Japan; [Suzuki, Takehiro; Dohmae, Naoshi] RIKEN Ctr Sustainable Resource Sci, Biomol Characterizat Unit, Wako, Saitama, Japan; [Fukushige, Tomoko; Kanekura, Takuro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Dermatol, Kagoshima, Japan; [Hanzawa, Ken; Miyamoto, Yasuhide] Osaka Int Canc Inst, Dept Mol Biol, Chuo Ku, Osaka, Japan; [Yagi, Hirokazu; Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi, Japan; [Kato, Koichi] Natl Inst Nat Sci, Exploratory Res Ctr Life & Living Syst ExCELLS, Okazaki, Aichi, Japan; [Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci IMS, Okazaki, Aichi, Japan; [Maruyama, Ikuro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Syst Biol Thromboregulat, Kagoshima, Japan	Kagoshima University; Hiroshima University; RIKEN; Kagoshima University; Nagoya City University; National Institutes of Natural Sciences (NINS) - Japan; The Exploratory Research Center on Life & Living Systems (ExCELLS); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Kagoshima University	Inoue, H (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pulm Med, Kagoshima, Japan.; Harada, Y (corresponding author), Osaka Int Canc Inst, Dept Glycooncol & Med Biochem, Chuo Ku, Osaka, Japan.	yoharada3@mc.pref.osaka.jp; inoue@m2.kufm.kagoshima-u.ac.jp	; Taniguchi, Naoyuki/I-4182-2014	Mizuno, Keiko/0000-0001-6738-7906; Kato, Koichi/0000-0001-7187-9612; Taniguchi, Naoyuki/0000-0001-5889-5968	SENSHIN Medical Research Foundation; Kodama Memorial Fund for Medical Research; JSPS KAKENHI [JP19K06546, JP17K09661, JP21K08160]; Japan Agency of Medical Research and Development (AMED) [JP20ek0410052]; Takeda Science Foundation	SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Kodama Memorial Fund for Medical Research; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency of Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was partly supported by grants from the SENSHIN Medical Research Foundation (Y. H.), the Kodama Memorial Fund for Medical Research (Y. H.), JSPS KAKENHI (Grant Number JP19K06546 to Y. H. and JP17K09661 and JP21K08160 to H. I.), the Japan Agency of Medical Research and Development (AMED) (JP20ek0410052 to H. I.), and the Takeda Science Foundation (Y. H.).	AOYAGI Y, 1991, CANCER-AM CANCER SOC, V67, P2390, DOI 10.1002/1097-0142(19910501)67:9<2390::AID-CNCR2820670928>3.0.CO;2-V; Asano N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09143-8; Becker A, 2016, CANCER CELL, V30, P836, DOI 10.1016/j.ccell.2016.10.009; Borromeo MD, 2016, CELL REP, V16, P1259, DOI 10.1016/j.celrep.2016.06.081; Brabender J, 2001, CLIN CANCER RES, V7, P1850; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; CARNEY DN, 1985, CANCER RES, V45, P2913; Chen CY, 2013, P NATL ACAD SCI USA, V110, P630, DOI 10.1073/pnas.1220425110; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; Davis TL, 2001, J BIOL CHEM, V276, P26099, DOI 10.1074/jbc.M102811200; Granovsky M, 2000, NAT MED, V6, P306; GREEN ED, 1988, J BIOL CHEM, V263, P18253; GU JG, 1993, J BIOCHEM, V113, P614, DOI 10.1093/oxfordjournals.jbchem.a124091; Gu JG, 2004, GLYCOCONJUGATE J, V21, P9, DOI 10.1023/B:GLYC.0000043741.47559.30; Haga Y, 2019, ANAL CHEM, V91, P2247, DOI 10.1021/acs.analchem.8b04829; Hang QL, 2016, SCI REP-UK, V6, DOI 10.1038/srep33507; Harada Y, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108261; Harada Y, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236074; Harada Y, 2019, FEBS LETT, V593, P942, DOI 10.1002/1873-3468.13377; Honma R, 2015, ONCOLOGY-BASEL, V88, P298, DOI 10.1159/000369495; Hoshino A, 2020, CELL, V182, P1044, DOI 10.1016/j.cell.2020.07.009; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Itakura Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061160; Jia LY, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00565; Jia N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62074-z; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kosaka N, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0219-1; Kosaka N, 2016, J CLIN INVEST, V126, P1163, DOI 10.1172/JCI81130; Kuo CS, 2015, CELL, V163, P394, DOI 10.1016/j.cell.2015.09.021; Lee J, 2020, P NATL ACAD SCI USA, V117, P28743, DOI 10.1073/pnas.2014207117; Liu HO, 2015, JPN J CLIN ONCOL, V45, P844, DOI 10.1093/jjco/hyv080; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Mercurio AM, 2001, CURR OPIN CELL BIOL, V13, P541, DOI 10.1016/S0955-0674(00)00249-0; METZELAAR MJ, 1991, J BIOL CHEM, V266, P3239; MIYAMOTO H, 1986, ACTA MED OKAYAMA, V40, P65; Nakano M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009001; Osumi D, 2009, CANCER SCI, V100, P888, DOI 10.1111/j.1349-7006.2009.01125.x; Pabst M, 2007, ANAL CHEM, V79, P5051, DOI 10.1021/ac070363i; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Pozo K, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102953; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Robinson JL, 2019, CELL REP, V26, P2622, DOI 10.1016/j.celrep.2019.02.025; Rusch V, 1997, CLIN CANCER RES, V3, P515; SATO Y, 1993, NEW ENGL J MED, V328, P1802, DOI 10.1056/NEJM199306243282502; SHIBUYA N, 1989, J BIOCHEM-TOKYO, V106, P1098, DOI 10.1093/oxfordjournals.jbchem.a122972; SHOREIBAH MG, 1992, J BIOL CHEM, V267, P2920; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stewart RL, 2015, LAB INVEST, V95, P976, DOI 10.1038/labinvest.2015.82; Swanton C, 2016, NEW ENGL J MED, V374, P1864, DOI 10.1056/NEJMra1504688; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takahashi N, 2003, TRENDS GLYCOSCI GLYC, V15, P235, DOI 10.4052/tigg.15.235; TOMIYA N, 1988, ANAL BIOCHEM, V171, P73, DOI 10.1016/0003-2697(88)90126-1; TOWNSEND RR, 1989, ANAL BIOCHEM, V182, P1; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; Uozumi N, 1996, J BIOL CHEM, V271, P27810, DOI 10.1074/jbc.271.44.27810; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wilson NL, 2002, J PROTEOME RES, V1, P521, DOI 10.1021/pr025538d; Wuhrer M, 2006, RAPID COMMUN MASS SP, V20, P1747, DOI 10.1002/rcm.2509; Xue H, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-52; Yamamoto M, 2019, ANAL BIOCHEM, V580, P21, DOI 10.1016/j.ab.2019.06.001; Yanagisawa M, 2007, GLYCOBIOLOGY, V17, p57R, DOI 10.1093/glycob/cwm018; Zhao YY, 2008, FEBS J, V275, P1939, DOI 10.1111/j.1742-4658.2008.06346.x; Zhao YY, 2006, J BIOL CHEM, V281, P38343, DOI 10.1074/jbc.M608764200	68	0	0	11	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101950	10.1016/j.jbc.2022.101950	http://dx.doi.org/10.1016/j.jbc.2022.101950			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3R4NR	35447118	gold, Green Published			2022-12-26	WOS:000838892100008
J	Mojumdar, A; Adam, N; Cobb, JA				Mojumdar, Aditya; Adam, Nancy; Cobb, Jennifer A.			Nej1 interacts with Sae2 at DNA double-stranded breaks to inhibit DNA resection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							END RESECTION; ENDONUCLEASE ACTIVITY; FUNCTIONAL MRX; RAD50 HOOK; COMPLEX; REPAIR; MRE11; REPLICATION; HELICASE; PROTEIN	The two major pathways of DNA double-strand break repair, nonhomologous end-joining and homologous recombination, are highly conserved from yeast to mammals. The regulation of 5'-DNA resection controls repair pathway choice and influences repair outcomes. Nej1 was first identified as a canonical NHEJ factor involved in stimulating the ligation of broken DNA ends, and more recently, it was shown to participate in DNA end-bridging and in the inhibition of 5'-resection mediated by the nuclease/helicase complex Dna2-Sgs1. Here, we show that Nej1 interacts with Sae2 to impact DSB repair in three ways. First, we show that Nej1 inhibits interaction of Sae2 with the Mre11-Rad50-Xrs2 complex and Sae2 localization to DSBs. Second, we found that Nej1 inhibits Sae2-dependent recruitment of Dna2 independently of Sgs1. Third, we determined that NEJ1 and SAE2 showed an epistatic relationship for end-bridging, an event that restrains broken DNA ends and reduces the frequency of genomic deletions from developing at the break site. Finally, we demonstrate that deletion of NEJ1 suppressed the synthetic lethality of sae2 Delta sgs1 Delta mutants, and that triple mutant viability was dependent on Dna2 nuclease activity. Taken together, these findings provide mechanistic insight to how Nej1 functionality inhibits the initiation of DNA resection, a role that is distinct from its involvement in endjoining repair at DSBs.	[Cobb, Jennifer A.] Univ Calgary, Dept Biochem & Mol Biol, Robson DNA Sci Ctr, Arnie Charbonneau Canc Inst,Cumming Sch Med, Calgary, AB, Canada; Univ Calgary, Dept Oncol, Robson DNA Sci Ctr, Arnie Charbonneau Canc Inst,Cumming Sch Med, Calgary, AB, Canada	University of Calgary; University of Calgary	Cobb, JA (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Robson DNA Sci Ctr, Arnie Charbonneau Canc Inst,Cumming Sch Med, Calgary, AB, Canada.	jcobb@ucalgary.ca		Mojumdar, Aditya/0000-0003-0254-6958	CIHR [MOP-82736, MOP-137062]; NSERC [418122]	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Our work was supported by operating grants from CIHR MOP-82736; MOP-137062 and NSERC 418122 awarded to J. A. C.	Andres SN, 2019, J BIOL CHEM, V294, P3312, DOI 10.1074/jbc.RA118.006759; Arora S, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00156-17; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bonetti D, 2015, EMBO REP, V16, P351, DOI 10.15252/embr.201439764; Bressan DA, 1998, GENETICS, V150, P591; Budd ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004267; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; Budd ME, 2000, MUTAT RES-DNA REPAIR, V459, P173, DOI 10.1016/S0921-8777(99)00072-5; Bustard DE, 2012, J BIOL CHEM, V287, P11374, DOI 10.1074/jbc.M111.336263; Cannavo E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06417-5; Cannavo E, 2014, NATURE, V514, P122, DOI 10.1038/nature13771; Carter SD, 2009, P NATL ACAD SCI USA, V106, P12037, DOI 10.1073/pnas.0903869106; Cejka P, 2015, J BIOL CHEM, V290, P22931, DOI 10.1074/jbc.R115.675942; Ceppi I, 2020, P NATL ACAD SCI USA, V117, P8859, DOI 10.1073/pnas.2001165117; Chen X, 2011, J BIOL CHEM, V286, P4931, DOI 10.1074/jbc.M110.195024; Daley JM, 2017, CELL REP, V21, P324, DOI 10.1016/j.celrep.2017.09.048; Deshpande RA, 2007, DNA REPAIR, V6, P1507, DOI 10.1016/j.dnarep.2007.04.014; Ferrari M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004928; Frank-Vaillant M, 2001, GENE DEV, V15, P3005, DOI 10.1101/gad.206801; Fu Q, 2014, MOL CELL BIOL, V34, P778, DOI 10.1128/MCB.00963-13; Gilles JF, 2017, METHODS, V115, P55, DOI 10.1016/j.ymeth.2016.11.016; Gobbini E, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005685; Hoa NN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124495; Hohl M, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008422; Hohl M, 2015, MOL CELL, V57, P479, DOI 10.1016/j.molcel.2014.12.018; Hohl M, 2011, NAT STRUCT MOL BIOL, V18, P1124, DOI 10.1038/nsmb.2116; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Jia PP, 2017, DNA REPAIR, V59, P9, DOI 10.1016/j.dnarep.2017.09.001; Kim HS, 2008, GENETICS, V178, P711, DOI 10.1534/genetics.107.081331; Kumar S, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.15; Kumar S, 2013, GENE DEV, V27, P313, DOI 10.1101/gad.204750.112; Lobachev K, 2004, CURR BIOL, V14, P2107, DOI 10.1016/j.cub.2004.11.051; Mahaney BL, 2014, DNA REPAIR, V14, P9, DOI 10.1016/j.dnarep.2013.12.002; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Mojumdar A, 2019, CELL REP, V28, P1564, DOI 10.1016/j.celrep.2019.07.018; Oz R, 2020, P NATL ACAD SCI USA, V117, P21403, DOI 10.1073/pnas.2008645117; Palmbos PL, 2008, GENETICS, V180, P1809, DOI 10.1534/genetics.108.095539; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Sorenson KS, 2017, J BIOL CHEM, V292, P14576, DOI 10.1074/jbc.M117.796011; Symington LS, 2016, CRIT REV BIOCHEM MOL, V51, P195, DOI 10.3109/10409238.2016.1172552; Valencia M, 2001, NATURE, V414, P666, DOI 10.1038/414666a; Wiltzius JJW, 2005, NAT STRUCT MOL BIOL, V12, P403, DOI 10.1038/nsmb928; Wu DL, 2008, GENETICS, V178, P1237, DOI 10.1534/genetics.107.083535; Yu TY, 2018, P NATL ACAD SCI USA, V115, pE11961, DOI 10.1073/pnas.1816539115; Zhang Y, 2007, NAT STRUCT MOL BIOL, V14, P639, DOI 10.1038/nsmb1261; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	50	3	3	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101937	10.1016/j.jbc.2022.101937	http://dx.doi.org/10.1016/j.jbc.2022.101937			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3R4NR	35429499	gold, Green Published			2022-12-26	WOS:000838892100001
J	Yokoo, T; Tanabe, A; Yoshida, Y; Caaveiro, JMM; Nakakido, M; Ikeda, Y; Fujimura, Y; Matsumoto, M; Entzminger, K; Maruyama, T; Okumura, CJ; Nangaku, M; Tsumoto, K				Yokoo, Takanori; Tanabe, Aki; Yoshida, Yoko; Caaveiro, Jose M. M.; Nakakido, Makoto; Ikeda, Yoichiro; Fujimura, Yoshihiro; Matsumoto, Masaneori; Entzminger, Kevin; Maruyama, Toshiaki; Okumura, C. J.; Nangaku, Masaomi; Tsumoto, Kouhei			Antibody recognition of complement factor H reveals a flexible loop involved in atypical hemolytic uremic syndrome pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; FACTOR-I; AUTOANTIBODIES; PROTEIN; C3B; DISCRIMINATION; MUTATIONS; CFHR1; SITE	Atypical hemolytic uremic syndrome (aHUS) is a disease associated with dysregulation of the immune complement system, especially of the alternative pathway (AP). Complement factor H (CFH), consisting of 20 domains called complement control protein (CCP1-20), downregulates the AP as a cofactor for mediating C3 inactivation by complement factor I. However, anomalies related to CFH are known to cause excessive complement activation and cytotoxicity. In aHUS, mutations and the presence of anti-CFH autoantibodies (AAbs) have been reported as plausible causes of CFH dysfunction, and it is known that CFH-related aHUS carries a high probability of end-stage renal disease. Elucidating the detailed functions of CFH at the molecular level will help to understand aHUS pathogenesis. Herein, we used biophysical data to reveal that a heavy-chain antibody fragment, termed VHH4, recognized CFH with high affinity. Hemolytic assays also indicated that VHH4 disrupted the protective function of CFH on sheep erythrocytes. Furthermore, Xray crystallography revealed that VHH4 recognized the Leu1181-Leu1189(CCP20) loop, a known anti-CFH AAbs epitope. We next analyzed the dynamics of the C-terminal region of CFH and showed that the epitopes recognized by anti-CFH AAbs and VHH4 were the most flexible regions in CCP18-20. Finally, we conducted mutation analyses to elucidate the mechanism of VHH4 recognition of CFH and revealed that VHH4 inserts the Trp1183(CCP20) residue of CFH into the pocket formed by the complementary determining region 3 loop. These results suggested that anti-CFH AAbs may adopt a similar molecular mechanism to recognize the flexible loop of Leu1181Leu1189(CCP20), leading to aHUS pathogenesis.	[Yokoo, Takanori; Nakakido, Makoto; Tsumoto, Kouhei] Sch Engn Univ Tokyo, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo, Japan; [Tanabe, Aki; Nakakido, Makoto; Tsumoto, Kouhei] Sch Engn Univ Tokyo, Dept Bioengn, Bunkyo Ku, Tokyo, Japan; [Yoshida, Yoko; Ikeda, Yoichiro; Nangaku, Masaomi] Univ Tokyo, Div Nephrol & Endocrinol, Bunkyo Ku, Tokyo, Japan; [Caaveiro, Jose M. M.] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Global Healthcare, Higashi Ku, Fukuoka, Japan; [Fujimura, Yoshihiro; Matsumoto, Masaneori] Nara Med Univ, Dept Blood Transfus Med, Kashihara, Nara, Japan; [Entzminger, Kevin; Maruyama, Toshiaki; Okumura, C. J.] Abwiz Bio Inc, San Diego, CA USA; [Tsumoto, Kouhei] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo, Japan	University of Tokyo; Kyushu University; Nara Medical University; University of Tokyo	Nakakido, M; Tsumoto, K (corresponding author), Sch Engn Univ Tokyo, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo, Japan.; Nakakido, M; Tsumoto, K (corresponding author), Sch Engn Univ Tokyo, Dept Bioengn, Bunkyo Ku, Tokyo, Japan.; Tsumoto, K (corresponding author), Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo, Japan.	nakakido@g.ecc.u-tokyo.ac.jp; tsumoto@bioeng.t.u-tokyo.ac.jp		Matsumoto, Masanori/0000-0002-7243-3126; Tanabe, Aki/0000-0002-1018-9586; Fujimura, Yoshihiro/0000-0002-4887-5741	Japan Society for the Promotion of Science [20K16377, 16H02420, 20H02531]; Japan Agency for Medical Research and Development [JP20 AM0101094j]; University of Tokyo, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); University of Tokyo, Japan	This work was funded in part by Japan Society for the Promotion of Science (grant no. 20K16377 to A. T. 16H02420 and 20H02531 to K. T.) and by Japan Agency for Medical Research and Development (grant no. JP20 AM0101094j to K. T.) . The super-computing resources used in this study were provided by the Human Genome Center at the Institute of Medical Science, the University of Tokyo, Japan.	Abarrategui-Garrido C, 2009, BLOOD, V114, P4261, DOI 10.1182/blood-2009-05-223834; Akiba H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50722-y; Al Qaraghuli MM, 2017, J MOL RECOGNIT, V30, DOI 10.1002/jmr.2592; Barbas C. F., 2001, PHAGE DISPLAY LAB MA; Bhattacharjee A, 2015, J BIOL CHEM, V290, P9500, DOI 10.1074/jbc.M114.630871; Blanc C, 2012, J IMMUNOL, V189, P3528, DOI 10.4049/jimmunol.1200679; Blaum BS, 2015, NAT CHEM BIOL, V11, P77, DOI [10.1038/NCHEMBIO.1696, 10.1038/nchembio.1696]; Bushey RT, 2016, CELL REP, V15, P1505, DOI 10.1016/j.celrep.2016.04.038; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dhillon B, 2010, INVEST OPHTH VIS SCI, V51, P5858, DOI 10.1167/iovs.09-5124; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dragon-Durey MA, 2009, J MED GENET, V46, P447, DOI 10.1136/jmg.2008.064766; Dragon-Durey MA, 2005, J AM SOC NEPHROL, V16, P555, DOI 10.1681/ASN.2004050380; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; Goh GKM, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9050178; Henry KA, 2018, MABS-AUSTIN, V10, P815, DOI 10.1080/19420862.2018.1489633; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hofer J, 2014, SEMIN THROMB HEMOST, V40, P431, DOI 10.1055/s-0034-1375297; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Ishii M, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.015996; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jozsi M, 2008, BLOOD, V111, P1512, DOI 10.1182/blood-2007-09-109876; Jozsi M, 2007, BLOOD, V110, P1516, DOI 10.1182/blood-2007-02-071472; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kerr H, 2017, J BIOL CHEM, V292, P13345, DOI 10.1074/jbc.M117.795088; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kromann-Hansen T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03457-7; Kumar R, 2019, EUR J MED CHEM, V182, DOI 10.1016/j.ejmech.2019.111602; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Makabe K, 2005, BIOCHEM BIOPH RES CO, V328, P98, DOI 10.1016/j.bbrc.2004.12.141; Makou E, 2015, BIOCHEM SOC T, V43, P812, DOI 10.1042/BST20150074; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; Meri S, 2016, FEBS LETT, V590, P2418, DOI 10.1002/1873-3468.12284; Meri T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003308; Moore I, 2010, BLOOD, V115, P379, DOI 10.1182/blood-2009-05-221549; Morgan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032187; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noris M, 2009, NEW ENGL J MED, V361, P1676, DOI 10.1056/NEJMra0902814; Pechtl IC, 2011, J BIOL CHEM, V286, P11082, DOI 10.1074/jbc.M110.211839; Prosser BE, 2007, J EXP MED, V204, P2277, DOI 10.1084/jem.20071069; Raina R, 2019, THER APHER DIAL, V23, P4, DOI 10.1111/1744-9987.12763; de Cordoba SR, 2014, SEMIN THROMB HEMOST, V40, P422, DOI 10.1055/s-0034-1375296; Rodriguez E, 2014, BIOSCIENCE REP, V34, P635, DOI 10.1042/BSR20140117; Schmidt CQ, 2008, CLIN EXP IMMUNOL, V151, P14, DOI 10.1111/j.1365-2249.2007.03553.x; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; Strobel S, 2011, KIDNEY INT, V80, P397, DOI 10.1038/ki.2011.152; Strobel S, 2010, NEPHROL DIAL TRANSPL, V25, P136, DOI 10.1093/ndt/gfp388; Swindells MB, 2017, J MOL BIOL, V429, P356, DOI 10.1016/j.jmb.2016.08.019; Trojnar E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00302; Uversky VN, 2021, CRIT REV BIOCHEM MOL, V56, P149, DOI 10.1080/10409238.2020.1869683; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755; Xue XG, 2017, NAT STRUCT MOL BIOL, V24, P643, DOI 10.1038/nsmb.3427; Yang B, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102568; Yoshida Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124655; Zadura AF, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4016; Zavrtanik U, 2018, J MOL BIOL, V430, P4369, DOI 10.1016/j.jmb.2018.09.002	63	2	2	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101962	10.1016/j.jbc.2022.101962	http://dx.doi.org/10.1016/j.jbc.2022.101962			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9DZ	35452676	gold, Green Published			2022-12-26	WOS:000807750700015
J	Zhou, Q; Hu, HQ; Li, ZY				Zhou, Qing; Hu, Huiqing; Li, Ziyin			KLIF-associated cytoskeletal proteins in Trypanosoma brucei regulate cytokinesis by promoting cleavage furrow positioning and ingression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL MORPHOGENESIS; BLOOD-STREAM; INITIATION; FLAGELLUM; KINASE; DUPLICATION; EXPRESSION; ROLES	Cytokinesis in the early divergent protozoan Trypanosoma brucei occurs from the anterior cell tip of the new-flagellum daughter toward the nascent posterior end of the oldflagellum daughter of a dividing biflagellated cell. The cleavage furrow ingresses unidirectionally along the preformed cell division fold and is regulated by an orphan kinesin named kinesin localized to the ingressing furrow (KLIF) that localizes to the leading edge of the ingressing furrow. Little is known about how furrow ingression is controlled by KLIF and whether KLIF interacts with and cooperates with other cytokinesis regulatory proteins to promote furrow ingression. Here, we investigated the roles of KLIF in cleavage furrow ingression and identified a cohort of KLIF-associated cytoskeletal proteins as essential cytokinesis regulators. By genetic complementation, we demonstrated the requirement of the kinesin motor activity, but not the putative tropomyosin domain, of KLIF in promoting furrow ingression. We further showed that depletion of KLIF impaired the resolution of the nascent posterior of the old-flagellar daughter cell, thereby stalking cleavage furrow ingression at late stages of cytokinesis. Through proximity biotinylation, we identified a subset of cytoskeleton-associated proteins (CAPs) as KLIF-proximal proteins, and functional characterization of these cytoskeletal proteins revealed the essential roles of CAP46 and CAP52 in positioning the cleavage furrow and the crucial roles of CAP42 and CAP50 in promoting cleavage furrow ingression. Together, these results identified multiple cytoskeletal proteins as cytokinesis regulators and uncovered their essential and distinct roles in cytokinesis.	[Zhou, Qing; Hu, Huiqing; Li, Ziyin] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Li, ZY (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	Ziyin.Li@uth.tmc.edu	Zhou, Qing/A-8296-2019	Zhou, Qing/0000-0003-2096-1960	National Institutes of Health, United States [AI101437, AI118736]; Clinical and Translational Proteomics Service Center at University of Texas Health Science Center at Houston, United States	National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Proteomics Service Center at University of Texas Health Science Center at Houston, United States	This work was supported by the National Institutes of Health, United States R01 grants AI101437 and AI118736 to Z. L. and in part by the Clinical and Translational Proteomics Service Center at University of Texas Health Science Center at Houston, United States. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BALASUBRAMANIAN MK, 1992, NATURE, V360, P84, DOI 10.1038/360084a0; Brasseur A, 2013, EUKARYOT CELL, V12, P168, DOI 10.1128/EC.00077-12; Dean S, 2017, TRENDS PARASITOL, V33, P80, DOI 10.1016/j.pt.2016.10.009; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; Hammarton TC, 2007, MOL MICROBIOL, V65, P1229, DOI 10.1111/j.1365-2958.2007.05866.x; Hilton NA, 2018, MOL MICROBIOL, V109, P306, DOI 10.1111/mmi.13986; Hu HQ, 2019, J BIOL CHEM, V294, P16672, DOI 10.1074/jbc.RA119.010538; Hu HQ, 2012, J CELL SCI, V125, P4126, DOI 10.1242/jcs.106534; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Kumar P, 2006, EUKARYOT CELL, V5, P92, DOI 10.1128/EC.5.1.92-102.2006; Kurasawa Y, 2018, J BIOL CHEM, V293, P10275, DOI 10.1074/jbc.RA118.003113; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Li ZY, 2006, EUKARYOT CELL, V5, P1026, DOI 10.1128/EC.00129-06; Li ZY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000575; May SF, 2012, MOL MICROBIOL, V84, P77, DOI 10.1111/j.1365-2958.2012.08008.x; McAllaster MR, 2015, MOL BIOL CELL, V26, P3013, DOI 10.1091/mbc.E15-04-0219; Olego-Fernandez S, 2009, PROTIST, V160, P576, DOI 10.1016/j.protis.2009.05.003; Oliferenko S, 2009, GENE DEV, V23, P660, DOI 10.1101/gad.1772009; Pham KTM, 2019, J CELL SCI, V132, DOI 10.1242/jcs.230581; Poon SK, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.110037; Schock M, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9112234; Shen SY, 2001, MOL BIOCHEM PARASIT, V113, P171, DOI 10.1016/S0166-6851(00)00383-2; SHERWIN T, 1989, CELL, V57, P211, DOI 10.1016/0092-8674(89)90959-8; Sinclair AN, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009588; Sunter JD, 2015, J CELL SCI, V128, P1580, DOI 10.1242/jcs.166447; Tu XM, 2006, J BIOL CHEM, V281, P9677, DOI 10.1074/jbc.M511504200; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wei Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5060; Wheeler RJ, 2013, MOL MICROBIOL, V90, P1339, DOI 10.1111/mmi.12436; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zhang X, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00199-19; Zhou Q, 2018, J BIOL CHEM, V293, P16177, DOI 10.1074/jbc.RA118.004888; Zhou Q, 2016, J BIOL CHEM, V291, P14395, DOI 10.1074/jbc.M116.726133; Zhou Q, 2016, P NATL ACAD SCI USA, V113, P3287, DOI 10.1073/pnas.1601596113; Zhou Q, 2015, J CELL SCI, V128, P2361, DOI 10.1242/jcs.168377; Zhou Q, 2011, J CELL SCI, V124, P3848, DOI 10.1242/jcs.087676	36	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101943	10.1016/j.jbc.2022.101943	http://dx.doi.org/10.1016/j.jbc.2022.101943			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3R4NR	35447115	gold, Green Published			2022-12-26	WOS:000838892100004
J	Pagenaud, A; Ravache, A; Bourgeois, K; Mathivet, M; Bourguet, E; Vidal, E; Thibault, M				Pagenaud, Angelique; Ravache, Andreas; Bourgeois, Karen; Mathivet, Mathieu; Bourguet, Edouard; Vidal, Eric; Thibault, Martin			Nest-site selection and its influence on breeding success in a poorly-known and declining seabird: The Tahiti petrel Pseudobulweria rostrata	PLOS ONE			English	Article							STORM-PETREL; HABITAT SELECTION; CAVITY SELECTION; MODEL SELECTION; NEW-CALEDONIA; PTERODROMA; SHEARWATER; ISLAND; CONSERVATION; BIOLOGY	The Tahiti petrel (Pseudobulweria rostrata) is a rare and declining seabird whose breeding biology and nest-site selection are poorly known. Nest-site selection is critical to seabird population fitness, and understanding the factors driving it is essential for designing effective conservation measures. Here, we measured several variables (topographical, physical and environmental) to characterize Tahiti petrel nesting habitats and burrows (i.e., width, height, depth and type: rocky cavity, dug into the soil or under a root) on Nemou Island in New Caledonia. The data were clustered using the HCPC (Hierarchical Clustering on Principal Component) method to identify principal habitat groups. This method was combined with logistic regressions to examine the influence of the variables on nest-site selection and breeding success. Our results showed that nest-site selection is linked to habitat groups (a combination of substrate and vegetation data), slope, orientation and soil depth, while breeding success is only influenced by nest characteristics (i.e., burrow type and width). Tahiti petrels prefer to nest on steep slopes in mature forests with rocky substrate and deep soil. Burrows were scatterred in small sub-colonies or isolated pairs, suggesting that nest-site selection depends on habitat quality rather than conspecific density. The study also revealed that breeding success is lower in rocky cavities and increases in burrows with wide entrances. Our nest-site selection survey is the first for the genus Pseudobulweria, and provides critical information for designing effective conservation programs in New Caledonia and the Pacific.	[Pagenaud, Angelique; Ravache, Andreas; Mathivet, Mathieu; Vidal, Eric; Thibault, Martin] Univ New Caledonia, Univ Reunion, CNRS, UMR ENTROPIE,IRD,IFREMER, Noumea, New Caledonia; [Pagenaud, Angelique; Ravache, Andreas; Bourgeois, Karen; Vidal, Eric] Univ Avignon, Univ Aix Marseille, CNRS, IRD,IMBE,Ctr IRD, Noumea, New Caledonia; [Bourguet, Edouard] EB Expertise, Noumea, New Caledonia	Ifremer; Institut de Recherche pour le Developpement (IRD); Universite Nouvelle Caledonie; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Pagenaud, A (corresponding author), Univ New Caledonia, Univ Reunion, CNRS, UMR ENTROPIE,IRD,IFREMER, Noumea, New Caledonia.; Pagenaud, A (corresponding author), Univ Avignon, Univ Aix Marseille, CNRS, IRD,IMBE,Ctr IRD, Noumea, New Caledonia.	angelique.pagenaud@ird.fr	ravache, andreas/AAN-1196-2020; THIBAULT, Martin/J-5856-2019	ravache, andreas/0000-0001-5413-3149; THIBAULT, Martin/0000-0002-2386-4501; PAGENAUD, Angelique/0000-0003-4254-8894	Province Sud; CNRT "Nickel et son environnement"; DAFE-NC	Province Sud; CNRT "Nickel et son environnement"; DAFE-NC	Funds and support for this study were mainly provided by the Province Sud (PhD scholarship to A.P.), the CNRT "Nickel et son environnement" and the DAFE-NC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Al-Daffaie K, 2017, AIP CONF PROC, V1842, DOI 10.1063/1.4982860; Aubry LM, 2009, ECOLOGY, V90, P2491, DOI 10.1890/08-1475.1; Barros A, 2016, BIOL INVASIONS, V18, P3149, DOI 10.1007/s10530-016-1205-3; Baudal-Franceschi J, 2011, ETUDE FAISABILITE DU; Benoit MP, 2002, WATERBIRDS, V25, P202, DOI 10.1675/1524-4695(2002)025[0202:SOTSLO]2.0.CO;2; Bester Adam J., 2007, Marine Ornithology, V35, P21; BirdLife International, SPEC FACTSH PSEUD RO; Boieiro M, 2018, J NAT CONSERV, V43, P35, DOI 10.1016/j.jnc.2018.02.013; Bolton M, 2004, BIOL CONSERV, V116, P73, DOI 10.1016/S0006-3207(03)00178-2; Bourgeois K, 2008, J WILDLIFE MANAGE, V72, P1188, DOI 10.2193/2007-052; Bourgeois K, 2007, CR BIOL, V330, P205, DOI 10.1016/j.crvi.2006.12.007; Bourgeois K, 2014, ACTA ORNITHOL, V49, P9, DOI 10.3161/000164514X682850; Brandt CA, 1995, AUK, V112, P571; Bretagnolle V, 2021, EMU, V121, P303, DOI 10.1080/01584197.2021.1938611; Bried Joel, 2002, P263; Brooke M, 2004, ALBATROSSES PETRELS; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Buxton RT, 2015, BIOL INVASIONS, V17, P1453, DOI 10.1007/s10530-014-0807-x; Buxton RT, 2012, CONDOR, V114, P733, DOI 10.1525/cond.2012.110091; Camprasse ECM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172278; Charleton Kristin, 2009, Notornis, V56, P1; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; Cruz-Delgado F, 2010, BIRD CONSERV INT, V20, P306, DOI 10.1017/S095927091000002X; Cuthbert R, 2002, IBIS, V144, P423, DOI 10.1046/j.1474-919X.2002.00071.x; Cuthbert RJ, 2013, BIRD CONSERV INT, V23, P113, DOI 10.1017/S0959270912000494; d'Entremont KJN, 2020, AVIAN CONSERV ECOL, V15, DOI 10.5751/ACE-01526-150111; Daunt F, 2007, FUNCT ECOL, V21, P561, DOI 10.1111/j.1365-2435.2007.01260.x; Dias MP, 2019, BIOL CONSERV, V237, P525, DOI 10.1016/j.biocon.2019.06.033; Fagundes AI, 2016, ZOOLOGY, V119, P421, DOI 10.1016/j.zool.2016.05.014; Garcia-Borboroglu P, 2004, J AVIAN BIOL, V35, P162, DOI 10.1111/j.0908-8857.2004.03149.x; Gonzalez-Solis J, 2004, OIKOS, V105, P247, DOI 10.1111/j.0030-1299.2004.12997.x; Hamer Keith C., 2002, P217; Harris MP, 1997, IBIS, V139, P468, DOI 10.1111/j.1474-919X.1997.tb04660.x; Heenan CB, 2013, AVIAN BIOL RES, V6, P104, DOI 10.3184/003685013X13614670646299; Holmes GI, 2020, CAN J ZOOL, V98, P573, DOI 10.1139/cjz-2019-0264; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Jones H.P., 2011, P317; Jones HP, 2012, J WILDLIFE MANAGE, V76, P2, DOI 10.1002/jwmg.240; Jones J, 2001, AUK, V118, P557, DOI 10.1642/0004-8038(2001)118[0557:HSSIAE]2.0.CO;2; Jones MJ., 1986, B MUS MUN FUNCHAL, V38, P110; Kassambara A., 2017, PACKAGE FACTOEXTRA E, V76; Kulaszewicz I, 2018, POLAR RES, V37, DOI 10.1080/17518369.2018.1547044; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lund, 2017, REPOS CRAN; Marine Marie, 2019, Seabird, V32, P46; Mazerolle MJ, 2015, AICCMODAVG MODEL SEL; Mejias MA, 2017, WILSON J ORNITHOL, V129, P586; Michielsen RJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217708; Militao T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174803; Miskelly CM, 2009, BIOL CONSERV, V142, P1965, DOI 10.1016/j.biocon.2009.03.027; MuMIn Barton K., 2015, **DATA OBJECT**; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Olivier F, 2006, ECOL MODEL, V195, P187, DOI 10.1016/j.ecolmodel.2005.10.036; Pagenaud A, 2022, BIRD CONSERV INT, V32, P246, DOI 10.1017/S0959270921000113; Paleczny M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129342; Palmas P, 2017, BIOL CONSERV, V214, P250, DOI 10.1016/j.biocon.2017.08.003; Parsons M, 2008, ICES J MAR SCI, V65, P1520, DOI 10.1093/icesjms/fsn155; Powell CDL, 2007, EMU, V107, P275, DOI 10.1071/MU07005; Price CA, 2021, J EXP MAR BIOL ECOL, V537, DOI 10.1016/j.jembe.2020.151498; Probst JM, 2000, BIOL CONSERV, V93, P135, DOI 10.1016/S0006-3207(99)00114-7; R Core Team, 2021, R LANGUAGE ENV STAT; Ramos JA, 1997, CONDOR, V99, P634, DOI 10.2307/1370475; Rauzon Mark J., 2014, Marine Ornithology, V42, P143; Ravache A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72206-0; Rayner MJ, 2007, EMU, V107, P59, DOI 10.1071/MU06038; Rodriguez A, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00094; Rodriguez A, 2017, CONSERV BIOL, V31, P986, DOI 10.1111/cobi.12900; Rodriguez B, 2022, ARDEOLA, V69, P115, DOI 10.13157/arla.69.1.2022.sc1; Satge YG., 2020, BIRD CONSERV INT, P1, DOI [10.1017/S0959270920000490, DOI 10.1017/S0959270920000490]; Schreiber E.A., 2002, P179; Schulz M, 2005, EMU, V105, P323, DOI 10.1071/MU04058; Schumann N, 2013, EMU, V113, P135, DOI 10.1071/MU12088; Scott D, 2009, NEW ZEAL J ZOOL, V36, P291, DOI 10.1080/03014220909510156; Smith J.L., 2011, P27; Stenhouse IJ, 2000, CAN J ZOOL, V78, P1267, DOI 10.1139/cjz-78-7-1267; Stienen EWM, 2017, MAR POLLUT BULL, V115, P194, DOI 10.1016/j.marpolbul.2016.12.019; STOKES DL, 1991, AUK, V108, P923; Sullivan W, 2001, NEW ZEAL J ECOL, V25, P65; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Titmus AJ, 2017, THESIS U HAWAII; Troy JR, 2014, J FISH WILDL MANAG, V5, P315, DOI 10.3996/112013-JFWM-074; VanderWerf EA, 2019, GLOB ECOL CONSERV, V19, DOI 10.1016/j.gecco.2019.e00667; Venables WN., 2002, MODERN APPL STAT S, V4, DOI 10.1007/978-0-387-21706-2; Villard P, 2006, IBIS, V148, P285, DOI 10.1111/j.1474-919X.2006.00528.x; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; WARHAM J, 1990, PETRELS THEIR ECOLOG; Warham J., 1996, BEHAV POPULATION BIO; Whitehead AL, 2014, BIOL CONSERV, V169, P109, DOI 10.1016/j.biocon.2013.11.002; Zuur AF, 2016, METHODS ECOL EVOL, V7, P636, DOI 10.1111/2041-210X.12577; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	92	1	1	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267408	10.1371/journal.pone.0267408	http://dx.doi.org/10.1371/journal.pone.0267408			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476680	gold, Green Published, Green Submitted			2022-12-26	WOS:000840124300039
J	Ai, H				Ai, Hu			GSEA-SDBE: A gene selection method for breast cancer classification based on GSEA and analyzing differences in performance metrics	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; EXPRESSION; TUMOR; ALGORITHM; RECEPTOR; PKMYT1; TSLP; GROWTH; CELLS	MotivationSelecting the most relevant genes for sample classification is a common process in gene expression studies. Moreover, determining the smallest set of relevant genes that can achieve the required classification performance is particularly important in diagnosing cancer and improving treatment. ResultsIn this study, I propose a novel method to eliminate irrelevant and redundant genes, and thus determine the smallest set of relevant genes for breast cancer diagnosis. The method is based on random forest models, gene set enrichment analysis (GSEA), and my developed Sort Difference Backward Elimination (SDBE) algorithm; hence, the method is named GSEA-SDBE. Using this method, genes are filtered according to their importance following random forest training and GSEA is used to select genes by core enrichment of Kyoto Encyclopedia of Genes and Genomes pathways that are strongly related to breast cancer. Subsequently, the SDBE algorithm is applied to eliminate redundant genes and identify the most relevant genes for breast cancer diagnosis. In the SDBE algorithm, the differences in the Matthews correlation coefficients (MCCs) of performing random forest models are computed before and after the deletion of each gene to indicate the degree of redundancy of the corresponding deleted gene on the remaining genes during backward elimination. Next, the obtained MCC difference list is divided into two parts from a set position and each part is respectively sorted. By continuously iterating and changing the set position, the most relevant genes are stably assembled on the left side of the gene list, facilitating their identification, and the redundant genes are gathered on the right side of the gene list for easy elimination. A cross-comparison of the SDBE algorithm was performed by respectively computing differences between MCCs and ROC_AUC_score and then respectively using 10-fold classification models, e.g., random forest (RF), support vector machine (SVM), k-nearest neighbor (KNN), extreme gradient boosting (XGBoost), and extremely randomized trees (ExtraTrees). Finally, the classification performance of the proposed method was compared with that of three advanced algorithms for five cancer datasets.Results showed that analyzing MCC differences and using random forest models was the optimal solution for the SDBE algorithm. Accordingly, three consistently relevant genes (i.e., VEGFD, TSLP, and PKMYT1) were selected for the diagnosis of breast cancer. The performance metrics (MCC and ROC_AUC_score, respectively) of the random forest models based on 10-fold verification reached 95.28% and 98.75%. In addition, survival analysis showed that VEGFD and TSLP could be used to predict the prognosis of patients with breast cancer.Moreover, the proposed method significantly outperformed the other methods tested as it allowed selecting a smaller number of genes while maintaining the required classification accuracy.	[Ai, Hu] Guizhou Police Coll, Dept Criminal Technol, Guiyang, Guizhou, Peoples R China		Ai, H (corresponding author), Guizhou Police Coll, Dept Criminal Technol, Guiyang, Guizhou, Peoples R China.	HuAi10657@outlook.com		Lisen Ai, HuAi/0000-0002-4740-9378	Guizhou Province Science and Technology Planning Project [2847]	Guizhou Province Science and Technology Planning Project	F YES, Guizhou Province Science and Technology Planning Project (Qianke He [2016] Support 2847).	Alickovic E, 2017, NEURAL COMPUT APPL, V28, P753, DOI 10.1007/s00521-015-2103-9; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Angerer P, 2020, BIOINFORMATICS, V36, P4291, DOI 10.1093/bioinformatics/btaa198; Borowski A, 2013, CYTOKINE, V61, P546, DOI 10.1016/j.cyto.2012.10.025; Boughorbel S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177678; Chawla N, 2005, J ARTIF INTELL RES, V23, P331, DOI 10.1613/jair.1509; Chen T., 2016, KDD16 P 22 ACM, DOI DOI 10.1145/2939672.2939785; Corren J, 2019, NAT IMMUNOL, V20, P1603, DOI 10.1038/s41590-019-0524-9; Deng HT, 2013, PATTERN RECOGN, V46, P3483, DOI 10.1016/j.patcog.2013.05.018; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Elyasigomari V, 2017, J BIOMED INFORM, V67, P11, DOI 10.1016/j.jbi.2017.01.016; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Foldvary N, 2000, NEUROLOGY, V54, P630, DOI 10.1212/WNL.54.3.630; Geurts P, 2006, MACH LEARN, V63, P3, DOI 10.1007/s10994-006-6226-1; Giovannantonio MD, 2021, J MED GENET, V58, P392, DOI 10.1136/jmedgenet-2019-106799; Harris NC, 2013, J BIOL CHEM, V288, P8176, DOI 10.1074/jbc.M112.439299; Hartmaier RJ, 2017, CANCER RES, V77, P2464, DOI 10.1158/0008-5472.CAN-16-2479; Honkanen HK, 2016, NEOPLASIA, V18, P436, DOI 10.1016/j.neo.2016.05.002; Jethon A, 2012, PATHOL ONCOL RES, V18, P867, DOI 10.1007/s12253-012-9516-x; Khoury P., 2015, P 2015 INT JOINT C N, P1, DOI [10.1109/IJCNN.2015.7280777, DOI 10.1109/IJCNN.2015.7280777]; Kohavi J., 1994, P 11 INT C MACH LEAR, P121, DOI [DOI 10.1016/B978-1-55860-335-6.50023-4, 10.1016/B978-1-55860-335-6.50023-4]; Koyama Yu, 2003, Clin Breast Cancer, V4, P354, DOI 10.3816/CBC.2003.n.041; Kuang SZ, 2021, BIOINFORMATICS, V37, P396, DOI 10.1093/bioinformatics/btaa717; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu L, 2017, EXP CELL RES, V358, P209, DOI 10.1016/j.yexcr.2017.06.014; Novak EM, 2016, MED HYPOTHESES, V97, P22, DOI 10.1016/j.mehy.2016.10.008; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Olkhanud PB, 2011, J IMMUNOL, V186, P5656, DOI 10.4049/jimmunol.1100463; Ono H, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2247-0; Pashaei E, 2017, APPL SOFT COMPUT, V56, P94, DOI 10.1016/j.asoc.2017.03.002; Pesaranghader A, 2016, BIOINFORMATICS, V32, P1380, DOI 10.1093/bioinformatics/btv755; Piao Y, 2012, BIOINFORMATICS, V28, P3306, DOI 10.1093/bioinformatics/bts602; Pok G, 2010, BIOINFORMATION, V4, P385, DOI 10.6026/97320630004385; Ray RJ, 1996, EUR J IMMUNOL, V26, P10, DOI 10.1002/eji.1830260103; Reimand J, 2019, NAT PROTOC, V14, P482, DOI 10.1038/s41596-018-0103-9; Robinson D, 2006, J ROY STAT SOC A STA, V169, P656, DOI 10.1111/j.1467-985X.2006.00430_9.x; Rohe A, 2012, BIOORG MED CHEM LETT, V22, P1219, DOI 10.1016/j.bmcl.2011.11.064; Sampathkumar A, 2020, J AMB INTEL HUM COMP, V11, P4743, DOI 10.1007/s12652-020-01731-7; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Tian SY, 2018, ONCOL LETT, V15, P8545, DOI 10.3892/ol.2018.8418; Xiao YF, 2014, BIOINFORMATICS, V30, P801, DOI 10.1093/bioinformatics/btr671; Xie JY, 2011, EXPERT SYST APPL, V38, P5809, DOI 10.1016/j.eswa.2010.10.050; Zeng XQ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S6-S8	45	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0263171	10.1371/journal.pone.0263171	http://dx.doi.org/10.1371/journal.pone.0263171			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35472078	Green Published, gold			2022-12-26	WOS:000816171900006
J	Andriano, TM; Arnsten, J; Patel, VV				Andriano, Tyler M.; Arnsten, Julia; Patel, Viraj V.			Social determinants of health and HIV Pre-Exposure Prophylaxis (PrEP) interest and use among young Black and Latinx sexual minority men	PLOS ONE			English	Article							UNITED-STATES; SOCIOECONOMIC DISPARITIES; CARE; PREVENTION; FACILITATORS; PERCEPTIONS; BARRIERS; INCOME	Young Black and Latinx sexual minority men (YBLSMM) have low use of HIV pre-exposure prophylaxis (PrEP), despite high rates of new HIV diagnosis. While unmet social determinants of health (SDOH) have been associated with low uptake of preventive health services, this association is unknown for PrEP. To understand the relationship between SDOH and PrEP adoption in this population, we analyzed data from an online survey of HIV-negative YBLSMM aged 18-29 in New York City (n = 143). Participants completed a 17-item SDOH needs scale measuring basic, health/social-services, and economic needs. We used regression models to examine associations of unmet SDOH with outcomes of intention to use PrEP and current PrEP use. Of those not on PrEP (n = 114), 69 (61%) intended to use PrEP. More unmet SDOH needs overall were associated with intention to use PrEP (OR 1.4; 95% CI 1.1, 2.0), as were more unmet basic needs (OR 1.7; 95% CI 1.1, 2.5) and more unmet economic needs (OR 1.3; 95% CI 1.0, 1.7). Unmet SDOH needs were not associated with current PrEP use. Findings suggest that intention to use PrEP among YBLSMM is a likely marker of unmet SDOH needs, as YBLSMM with unmet needs may have limited resources to support moving from intention to actual use. Future research should evaluate programs engaging YBLSMM intending to use PrEP with interventions to screen for and address SDOH.	[Andriano, Tyler M.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Arnsten, Julia; Patel, Viraj V.] Montefiore Med Ctr, Albert Einstein Coll Med, Div Gen Internal Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Patel, VV (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Div Gen Internal Med, Bronx, NY 10467 USA.	vpatel@montefiore.org		Andriano, Tyler/0000-0003-2104-7337	NIH [K23MH102118]; Einstein-Rockefeller-CUNY Center for AIDS Research [NIH P30AI051519]; Einstein Office of Medical Student Research	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Einstein-Rockefeller-CUNY Center for AIDS Research; Einstein Office of Medical Student Research	This study was supported in part by NIH K23MH102118, the Einstein-Rockefeller-CUNY Center for AIDS Research (NIH P30AI051519), and the Einstein Office of Medical Student Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172354; Bauermeister JA, 2014, CURR HIV RES, V11, P520, DOI 10.2174/1570162X12666140129100411; Brinkley-Rubinstein L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205593; Brooks RA, 2015, INT J STD AIDS, V26, P1040, DOI 10.1177/0956462415570159; Cahill S, 2018, J HOMOSEXUAL, V65, P600, DOI 10.1080/00918369.2017.1328221; Centers for Disease Control and Prevention, 2019, HIV SURV REP, V31; Chan PA, 2019, AIDS PATIENT CARE ST, V33, P434, DOI 10.1089/apc.2019.0064; Chan PA, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20903; De Jesus M, 2018, PUBLIC HEALTH REP, V133, p28S, DOI 10.1177/0033354918801353; Furukawa NW, 2020, HEALTH SERV RES, V55, P524, DOI 10.1111/1475-6773.13285; Hannaford A, 2018, AIDS BEHAV, V22, P1080, DOI 10.1007/s10461-017-2011-3; Hare C., 2019, P C RETROVIRUSES OPP; Harling G, 2013, SEX TRANSM DIS, V40, P575, DOI 10.1097/OLQ.0b013e31829529cf; Huang Ya-Lin A, 2020, Clin Infect Dis, DOI 10.1093/cid/ciaa037; Huang YLA, 2018, MMWR-MORBID MORTAL W, V67, P1147, DOI 10.15585/mmwr.mm6741a3; Kreuter MW, 2016, PREV MED, V91, P70, DOI 10.1016/j.ypmed.2016.08.006; Kubicek K, 2015, ARCH SEX BEHAV, V44, P487, DOI 10.1007/s10508-014-0398-8; Lankowski AJ, 2019, AIDS BEHAV, V23, P1797, DOI 10.1007/s10461-018-2296-x; Linnemayr S, 2015, JAIDS-J ACQ IMM DEF, V68, pE61, DOI 10.1097/QAI.0000000000000499; Ompad DC, 2018, AM J MENS HEALTH, V12, P1384, DOI 10.1177/1557988316651206; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Patel VV, 2018, JMIR RES PROTOC, V7, DOI 10.2196/11375; Pinto RM, 2018, AIDS BEHAV, V22, P3681, DOI 10.1007/s10461-018-2184-4; Remien RH, 2015, JAIDS-J ACQ IMM DEF, V69, pS16, DOI 10.1097/QAI.0000000000000577; Rolle CP, 2019, AIDS BEHAV, V23, P296, DOI 10.1007/s10461-019-02654-x; Sales JM, 2014, J ADOLESCENT HEALTH, V55, P698, DOI 10.1016/j.jadohealth.2014.05.005; Serota DP., 2018, CLIN INFECT DIS; Spinelli MA, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25472; Wheeler DP, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25223; Wheeler DP, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25180	30	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267031	10.1371/journal.pone.0267031	http://dx.doi.org/10.1371/journal.pone.0267031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1E2NP	35427397	gold, Green Published			2022-12-26	WOS:000794332400006
J	Forster, J; Kohlmorgen, B; Haas, J; Weis, P; Breunig, L; Turnwald, D; Mizaikoff, B; Schoen, C				Forster, Johannes; Kohlmorgen, Britta; Haas, Julian; Weis, Philipp; Breunig, Lukas; Turnwald, Doris; Mizaikoff, Boris; Schoen, Christoph			A streamlined method for the fast and cost-effective detection of bacterial pathogens from positive blood cultures for the BacT/ALERT blood culture system using the Vitek MS mass spectrometer	PLOS ONE			English	Article							DESORPTION-IONIZATION-TIME; MALDI-TOF MS; POLYMERASE-CHAIN-REACTION; DIRECT IDENTIFICATION; MICROBIAL IDENTIFICATION; RAPID IDENTIFICATION; SAMPLE PREPARATION; CLINICAL IMPACT; MICROORGANISMS; SEPSIS	Background and objective Prompt pathogen identification of blood stream infections is essential to provide appropriate antibiotic treatment. Therefore, the objective of this prospective single centre study was to establish an inexpensive, fast and accurate protocol for bacterial species identification with SDS protein-extraction directly from BacT/Alert(R) blood culture (BC) bottles by VitekMS(R). Results Correct species identification was obtained for 198/266 (74.4%, 95%-CI = [68.8%, 79.6%]) of pathogens. The protocol was more successful in identifying 87/96 (91.4%, 95%-CI = [83.8%, 93.2%]) gram-negative bacteria than 110/167 (65.9%, 95%-CI = [58.1%, 73.0%]) gram-positive bacteria. The hands-on time for sample preparation and measurement was about 15 min for up to five samples. This is shorter than for most other protocols using a similar lysis-centrifugation approach for the combination of BacT/Alert(R) BC bottles and the Vitek(R) MS mass spectrometer. The estimated costs per sample were approx. 1.80(sic) which is much cheaper than for commercial kits. Conclusion This optimized protocol allows for accurate identification of bacteria directly from blood culture bottles for laboratories equipped with BacT/Alert(R) blood culture bottles and VitekMS(R) mass spectrometer.	[Forster, Johannes; Kohlmorgen, Britta; Turnwald, Doris; Schoen, Christoph] Univ Wurzburg, Inst Hyg & Microbiol, Wurzburg, Germany; [Kohlmorgen, Britta] Charite Univ Med Berlin, Inst Hyg & Environm Med, Berlin, Germany; [Haas, Julian; Mizaikoff, Boris] Hahn Schickard Soc Appl Res, Ulm, Germany; [Weis, Philipp] Caritas Krankenhaus Bad Mergentheim, Dept Internal Med 1, Bad Mergentheim, Germany; [Breunig, Lukas] DRK Klinikum Berlin Westend, Dept Internal Med Cardiol, Berlin, Germany; [Mizaikoff, Boris] Ulm Univ, Inst Analyt & Bioanalyt Chem, Ulm, Germany	University of Wurzburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Caritas Hospital Bad Mergentheim; Ulm University	Forster, J (corresponding author), Univ Wurzburg, Inst Hyg & Microbiol, Wurzburg, Germany.	forster_j1@ukw.de		Kohlmorgen, Britta/0000-0001-5609-6142; /0000-0002-8138-5891				Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Barberino MG, 2017, BRAZ J INFECT DIS, V21, P339, DOI 10.1016/j.bjid.2017.03.007; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Brown J, 2010, PHARMACOECONOMICS, V28, P567, DOI 10.2165/11533020-000000000-00000; Broyer P, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00911; Brozanski BS, 2006, J PERINATOL, V26, P688, DOI 10.1038/sj.jp.7211597; Buehler SS, 2016, CLIN MICROBIOL REV, V29, P59, DOI 10.1128/CMR.00053-14; Clark AE, 2013, CLIN MICROBIOL REV, V26, P547, DOI 10.1128/CMR.00072-12; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Farina C, 2015, NEW MICROBIOL, V38, P245; Ferroni A, 2010, J CLIN MICROBIOL, V48, P1542, DOI 10.1128/JCM.02485-09; Foster AGW, 2013, J CLIN MICROBIOL, V51, P3717, DOI 10.1128/JCM.01679-13; Fothergill A, 2013, J CLIN MICROBIOL, V51, P805, DOI 10.1128/JCM.02326-12; Liese JG, 2019, CLIN MICROBIOL INFEC, V25, P857, DOI 10.1016/j.cmi.2018.10.020; Loonen AJM, 2012, EUR J CLIN MICROBIOL, V31, P1575, DOI 10.1007/s10096-011-1480-y; Machen A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087870; Meex C, 2012, J MED MICROBIOL, V61, P1511, DOI 10.1099/jmm.0.044750-0; Mizrahi A, 2018, INFECT DIS-NOR, V50, P668, DOI 10.1080/23744235.2018.1458147; Peters RPH, 2006, J CLIN MICROBIOL, V44, P119, DOI 10.1128/JCM.44.1.119-123.2006; Prod'hom G, 2010, J CLIN MICROBIOL, V48, P1481, DOI 10.1128/JCM.01780-09; R Core Team, 2021, R LANGUAGE ENV STAT; Randazzo A, 2016, J MICROBIOL METH, V130, P1, DOI 10.1016/j.mimet.2016.08.019; Romero-Gomez MP, 2011, J INFECTION, V62, P251, DOI 10.1016/j.jinf.2010.12.008; Ruiz-Aragon J, 2018, ENFERM INFEC MICR CL, V36, P484, DOI 10.1016/j.eimc.2017.08.012; Samaranayake WAMP, 2020, BMC RES NOTES, V13, DOI 10.1186/s13104-019-4861-4; Simon L., 2018, J CLIN MICROBIOL; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Smole SC, 2002, J MICROBIOL METH, V48, P107, DOI 10.1016/S0167-7012(01)00315-3; TeKippe EM, 2013, J CLIN MICROBIOL, V51, P1421, DOI 10.1128/JCM.02680-12; Vlek ALM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032589; Wattal C, 2016, EUR J CLIN MICROBIOL, V35, P75, DOI 10.1007/s10096-015-2510-y; Wellinghausen N, 2004, DIAGN MICR INFEC DIS, V48, P229, DOI 10.1016/j.diagmicrobio.2003.11.005	32	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267669	10.1371/journal.pone.0267669	http://dx.doi.org/10.1371/journal.pone.0267669			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D8GY	35482712	gold, Green Published			2022-12-26	WOS:000794035700085
J	Kumar, S; Sohil, A; Kichloo, MA; Sharma, N				Kumar, Sudesh; Sohil, Asha; Kichloo, Muzaffar A.; Sharma, Neeraj			Landscape heterogeneity affects diurnal raptor communities in a sub-tropical region of northwestern Himalayas, India	PLOS ONE			English	Article							JAMMU-AND-KASHMIR; LAND-USE; BREEDING PERFORMANCE; POPULATION DECLINES; SPECIES COMPOSITION; CONSERVATION STATUS; FALCO-PEREGRINUS; EXTINCTION RISK; BETA-DIVERSITY; TOP PREDATORS	Raptors are highly sensitive to environmental and human-induced changes. In addition, several species of raptors exist in considerably small numbers. It is thus critical to conserve raptors and their habitats across relatively larger landscapes. We examined the diurnal raptor assemblages and seasonality in a subtropical habitat in India's northwestern Himalayas. Quantitative data on diurnal birds of prey and their habitat features across six distinct habitat types were collected from 33 sample sites. We observed 3,434 individuals of 28 diurnal raptors belonging to two orders and three families during a two-year survey from December 2016 to November 2018. A significant variation in bird species richness and abundance was found across habitats and seasons, with farmlands and winters being the most diverse and speciose. The generalized linear model, used to determine raptor community responses, indicated that elevation and proximity to dumping sites significantly affected the raptor abundance. The non-metric multidimensional scaling (NMDS) revealed significant differences in raptor assemblages across the habitat types. The study concluded that raptors' persistence is largely determined by their preference for favourable feeding, roosting, and nesting opportunities. The presence of protected and habitat-exclusive species validates the high conservation importance of these ecosystems, particularly the forest patches and farmlands, necessitating robust conservation and management measures in this part of northwestern Himalaya.	[Kumar, Sudesh] Govt MAM Coll, Dept Environm Sci, Jammu, Jammu & Kashmir, India; [Sohil, Asha] Univ Jammu, PG Dept Environm Sci, Jammu, Jammu & Kashmir, India; [Kichloo, Muzaffar A.] Govt Degree Coll, Dept Environm Sci, Banihal, Jammu & Kashmir, India; [Sharma, Neeraj] Univ Jammu, Inst Mt Environm, Jammu, Jammu & Kashmir, India	University of Jammu; University of Jammu	Sharma, N (corresponding author), Univ Jammu, Inst Mt Environm, Jammu, Jammu & Kashmir, India.	nirazsharma@gmail.com		Sharma, Neeraj/0000-0002-6196-9160				Altwegg R, 2014, IBIS, V156, P107, DOI 10.1111/ibi.12125; Andersen David E., 2007, P89; Anderson DL, 2001, BIOTROPICA, V33, P511, DOI 10.1111/j.1744-7429.2001.tb00205.x; Angelov I, 2013, BIRD CONSERV INT, V23, P1, DOI 10.1017/S0959270912000123; [Anonymous], 2004, BIRDS EUR UN STAT AS; Asha Sohil, 2020, Acta Ecologica Sinica - International Journal, V40, P323, DOI 10.1016/j.chnaes.2020.02.005; Austin JE, 2000, WETLANDS, V20, P660, DOI 10.1672/0277-5212(2000)020[0660:EORTWO]2.0.CO;2; Aynalem Shimelis, 2008, Tropical Ecology, V49, P199; Basnet TB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150498; Bellocq MI, 2008, ANN ZOOL FENN, V45, P128, DOI 10.5735/086.045.0204; Bennett PM, 1997, P ROY SOC B-BIOL SCI, V264, P401, DOI 10.1098/rspb.1997.0057; Berry ME, 1998, CONDOR, V100, P601, DOI 10.2307/1369742; Bibby CJ, 1992, BIRD CENSUS TECHNIQU; Bierregaard RO, 1998, J RAPTOR RES, V32, P19; Bildstein K. L., 2006, MIGRATING RAPTORS WO; BirdLife International, 2017, IUCN RED LIST BIRDS; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Bogliani G, 1999, ANIM BEHAV, V57, P125, DOI 10.1006/anbe.1998.0959; Both C, 2010, P ROY SOC B-BIOL SCI, V277, P1259, DOI 10.1098/rspb.2009.1525; Botha A, 2015, AFRICAN GEOGRAPHIC; Brochet AL, 2019, BIRD CONSERV INT, V29, P10, DOI 10.1017/S0959270917000533; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Buij R, 2013, BIOL CONSERV, V166, P231, DOI 10.1016/j.biocon.2013.06.028; Cardador L, 2011, ANIM CONSERV, V14, P382, DOI 10.1111/j.1469-1795.2011.00449.x; Carnicer J, 2012, BIOL REV, V87, P457, DOI 10.1111/j.1469-185X.2011.00210.x; Carrete M, 2010, BIOL LETTERS, V6, P167, DOI 10.1098/rsbl.2009.0739; Ceballos G, 2017, P NATL ACAD SCI USA, V114, pE6089, DOI 10.1073/pnas.1704949114; Chambers S.A., 2008, PARKS VICTORIA TECHN, V55; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chernet T, 2001, WATER RES, V35, P2819, DOI 10.1016/S0043-1354(01)00002-1; Clarke KR, 2001, MAR ECOL P SER, V84, P21; Clergeau P, 1998, CONDOR, V100, P413, DOI 10.2307/1369707; Cooke R., 2018, URBANIZATION RAPTORS; Craighead JJ., 1956, HAWKS OWLS WILDLIFE, DOI [10.1016/0002-9610(56)90132-5, DOI 10.1016/0002-9610(56)90132-5]; Cramp S, 1998, COMPLETE BIRDS W PAL; Cusa M, 2015, URBAN ECOSYST, V18, P1427, DOI 10.1007/s11252-015-0459-3; DEGRAAF RM, 1985, ENVIRON MANAGE, V9, P493, DOI 10.1007/BF01867324; Del Hoyo J, 1994, HDB BIRDS WORLD, V2; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Donazar JA, 2016, ARDEOLA, V63, P181, DOI 10.13157/arla.63.1.2016.rp8; eBird, EL DAT BAS; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Ferguson-Lees J., 2001, RAPTORS WORLD, P320; Fisher IJ, 2006, BIOL CONSERV, V131, P421, DOI 10.1016/j.biocon.2006.02.018; Franck AR, 2017, PHYTOKEYS, P11, DOI 10.3897/phytokeys.85.14935; Fuller MR., 1987, RAPTOR MANAGEMENT TE, P37; Galligan TH, 2014, BIRD CONSERV INT, V24, P272, DOI 10.1017/S0959270913000580; Gamauf A, 1998, AUK, V115, P713; Garbett R, 2018, SCI TOTAL ENVIRON, V630, P1654, DOI 10.1016/j.scitotenv.2018.02.220; Garcia JT, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-333; Garcia-Heras MS, 2016, NAT CONSERV-BULGARIA, P23, DOI 10.3897/natureconservation.15.9800; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; Gavashelishvili A, 2006, ANIM CONSERV, V9, P159, DOI 10.1111/j.1469-1795.2005.00017.x; Girma Z, 2017, ECOL EVOL, V7, P3397, DOI 10.1002/ece3.2926; Goriup P., 2007, ASSESSMENT MERITS CM; Greene HW., 1988, SPECIES RICHNESS TRO, P259; Grewal B., 2016, PICTORIAL FIELD GUID; Grimmett R., 2013, BIRDS INDIAN SUBCONT, P528; Guisan A., 2017, APPL R; Hager SB, 2009, J RAPTOR RES, V43, P210, DOI 10.3356/JRR-08-63.1; Hall JC., 2015, INDIAN FOR, V141, P1; Hamada A., 2015, J JAP SOC REVEGET TE, V41, P145; Hansson A., 2014, ANIMAL MOVEMENT SCAL, V1st; Herremans M, 2000, BIOL CONSERV, V94, P31, DOI 10.1016/S0006-3207(99)00166-4; Iknayan KJ, 2018, P NATL ACAD SCI USA, V115, P8597, DOI 10.1073/pnas.1805123115; IUCN, IUCN RED LIST THREAT; Janes S.W., 1985, P159; Jankowiak L, 2015, ORNIS FENNICA, V92, P76; Jemenez B, 2007, ENVIRON SCI POLLUT R, V14, P61, DOI 10.1065/espr2006.01.015; Jones MP, 2007, J EXOT PET MED, V16, P69, DOI 10.1053/j.jepm.2007.03.012; Kagan RA, 2016, VET PATHOL, V53, P1030, DOI 10.1177/0300985816646431; Kasambe R., 2014, MISTNET, V15, P24; Katayama N, 2015, AGR ECOSYST ENVIRON, V214, P21, DOI 10.1016/j.agee.2015.08.014; Kichloo Muzaffar A., 2020, Journal of Threatened Taxa, V12, P16166, DOI 10.11609/jott.5537.12.9.16166-16169; Klaassen RHG, 2014, J ANIM ECOL, V83, P176, DOI 10.1111/1365-2656.12135; Klippel AH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134877; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Legendre P, 2013, ECOL LETT, V16, P951, DOI 10.1111/ele.12141; Lehman RN, 2001, WILDLIFE SOC B, V29, P804; Maceda Juan Jose, 2003, Ornitologia Neotropical, V14, P419; Maeda Tau, 2009, Japanese Journal of Ornithology, V58, P55, DOI 10.3838/jjo.58.55; Manly B.F.J., 2002, RESOURCE SELECTION A; Manu SA, 2000, THESIS U OXFORD; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Markandya A, 2008, ECOL ECON, V67, P194, DOI 10.1016/j.ecolecon.2008.04.020; Martin RO, 2014, OIKOS, V123, P1457, DOI 10.1111/oik.01058; Martos-Martins R, 2020, NEOTROP BIOL CONSERV, V15, P245, DOI 10.3897/neotropical.15.e52251; McClure CJW, 2018, BIOL CONSERV, V227, P390, DOI 10.1016/j.biocon.2018.08.012; McClure CJW, 2018, BIOL CONSERV, V224, P26, DOI 10.1016/j.biocon.2018.04.041; Mebs T., 2006, GREIFVOGEL EUROPAS N, V495; Mengesha G, 2008, INT J ENV SCI, V34, P15; Meunier FD, 2000, BIOL CONSERV, V92, P291, DOI 10.1016/S0006-3207(99)00094-4; Miller JN, 1997, LANDSCAPE ECOL, V12, P137, DOI 10.1023/A:1007970716227; MILLSAP B A, 1988, Journal of Raptor Research, V22, P8; Mojica EK, 2018, J WILDLIFE MANAGE, V82, P495, DOI 10.1002/jwmg.21412; Molina B., 2008, AGUILUCHO LAGUNERO E; Monadjem A, 2013, BIRD CONSERV INT, V23, P247, DOI 10.1017/S0959270912000330; Morrison ML., 2006, WILDLIFE HABITAT REL; Mortberg UM, 2001, LANDSCAPE ECOL, V16, P193, DOI 10.1023/A:1011190902041; Motta-Junior José Carlos, 2010, Biota Neotrop., V10, P255, DOI 10.1590/S1676-06032010000400042; Mougeot Francois, 2011, P190; Murn Campbell, 2008, Vulture News, V58, P35; Naoroji R., 2011, BIRDS PREY INDIAN SU, P692, DOI [10.1136/medethics-2011-100187, DOI 10.1136/MEDETHICS-2011-100187]; Newton I, 1979, S DAKOTA BUTEO BOOKS; Norfolk O, 2017, AFR J ECOL, V55, P530, DOI 10.1111/aje.12383; Oaks JL, 2004, NATURE, V427, P630, DOI 10.1038/nature02317; Ogada D, 2016, CONSERV LETT, V9, P89, DOI 10.1111/conl.12182; Okudela K, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087193, 10.1371/journal.pone.0093359]; Ortega-Alvarez R, 2009, LANDSCAPE URBAN PLAN, V90, P189, DOI 10.1016/j.landurbplan.2008.11.003; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Panasci TA, 2002, WILSON BULL, V114, P114, DOI 10.1676/0043-5643(2002)114[0114:RHBEIF]2.0.CO;2; Pandey N, 2020, AVIAN RES, V11, DOI 10.1186/s40657-020-00217-6; Paz A, 2013, PEST MANAG SCI, V69, P444, DOI 10.1002/ps.3289; Pedrini P, 2001, BIRD STUDY, V48, P194, DOI 10.1080/00063650109461218; Pendleton BA., 1987, SCI TECHNICAL SERIE, P215; Pennington DN, 2012, STUD AVIAN BIOL, V45, P9; Petty SJ, 1998, ECOLOGY CONSERVATION, V118; Piana RP, 2012, CONDOR, V114, P279, DOI 10.1525/cond.2012.100163; Pino J, 2000, LANDSCAPE URBAN PLAN, V49, P35, DOI 10.1016/S0169-2046(00)00053-0; Price TD, 2014, NATURE, V509, P222, DOI 10.1038/nature13272; QGIS Development Team, 2018, QGIS GEOGR INF SYST; R Core Team, 2021, R LANG ENV STAT; Real J, 1997, BIOL CONSERV, V79, P59, DOI 10.1016/S0006-3207(96)00100-0; Sanchez-Zapata JA, 2003, BIOL CONSERV, V111, P71, DOI 10.1016/S0006-3207(02)00251-3; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Sara M, 2016, J ZOOL, V299, P163, DOI 10.1111/jzo.12340; Sarasola JH, 2005, CAN J ZOOL, V83, P1353, DOI 10.1139/Z05-131; Sarasola JH, 2018, BIRDS PREY BIOL CONS, DOI DOI 10.1007/978-3-319-73745-4_9; Sarasola JH., 2018, CONSERVATION STATUS, P373; Savard JPL, 2000, LANDSCAPE URBAN PLAN, V48, P131, DOI 10.1016/S0169-2046(00)00037-2; Sekercioglu CH, 2012, J ORNITHOL, V153, pS153, DOI 10.1007/s10336-012-0869-4; Sergio F, 2005, NATURE, V436, P192, DOI 10.1038/436192a; Sergio F, 2007, ANIM BEHAV, V74, P1607, DOI 10.1016/j.anbehav.2006.10.022; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Shannon C.E, 1949, MATH THEORY COMMUNIC, V1st; Sharma Neeraj, 2018, Journal of Threatened Taxa, V10, P11869, DOI 10.11609/jott.3464.10.7.11869-11894; Simberloff D, 1998, BIOL CONSERV, V83, P247, DOI 10.1016/S0006-3207(97)00081-5; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smith SB, 2007, WILSON J ORNITHOL, V119, P419, DOI 10.1676/06-073.1; Socolar JB, 2016, TRENDS ECOL EVOL, V31, P67, DOI 10.1016/j.tree.2015.11.005; Sohil A, 2020, ECOL PROCESS, V9, DOI 10.1186/s13717-020-00250-9; SOLONEN T, 1993, ORNIS FENNICA, V70, P129; Stout WE, 2010, J RAPTOR RES, V44, P255, DOI 10.3356/JRR-09-26.1; Suhail I, 2020, BIODIVERSITY HIMALAY, V18, P897, DOI [10.1007/978-981-32-9174-4, DOI 10.1007/978-981-32-9174-4, 10.1007/978-981-32-9174-4_35, DOI 10.1007/978-981-32-9174-4_35]; Symes CT, 2012, GABAR, V23, P69; Tapia L., 2018, BIRDS PREY BIOL CONS, P63, DOI [10.1007/978-3-319-73745-4_3, DOI 10.1007/978-3-319-73745-4_3, 10.1007/978-3-319-73745-4, DOI 10.1007/978-3-319-73745-4]; TERBORGH J, 1992, BIOTROPICA, V24, P283, DOI 10.2307/2388523; The Cornell Lab of Ornithology, ALL BIRDS RAPT; Thiollay JM, 2006, IBIS, V148, P240, DOI 10.1111/j.1474-919X.2006.00531.x; Thiollay JM, 2002, BIOL CONSERV, V107, P111, DOI 10.1016/S0006-3207(02)00051-4; Thiollay JM, 1998, J RAPTOR RES, V32, P40; Thiollay JM., 1985, FALCONIFORMES TROPIC, P155, DOI [10.1007/BF00378906, DOI 10.1007/BF00378906]; Tinajero R., 2017, Tropical Conservation Science, V10, punpaginated, DOI 10.1177/1940082917712426; Tucker GM, 1994, BIRDS EUROPE THEIR C, V3; Van den Bergh E, 2005, HYDROBIOLOGIA, V540, P237, DOI 10.1007/s10750-004-7147-2; Vergara Pablo, 2010, Revista Catalana d'Ornitologia, V26, P22; Virani M, 1998, J RAPTOR RES, V32, P28; Virani MZ, 2009, OSTRICH, V80, P9, DOI 10.2989/OSTRICH.2009.80.1.2.760; Vogler B, 2015, EUR J WILDLIFE RES, V61, P611, DOI 10.1007/s10344-015-0914-8; Voskamp A, 2017, J BIOGEOGR, V44, P709, DOI 10.1111/jbi.12916; Watson J., 2010, GOLDEN EAGLE, V2; Watson RT, 1998, J RAPTOR RES, V32, P1; Watson RT., 2011, GYRFALCONS PTARMIGAN, VI; Whitacre D.F., 2012, NEOTROPICAL BIRDS PR; Whitacre DF., 1990, MAYA PROJECT USE RAP, P71; White CM, 1974, 39 N AM WILDL C WASH, P301; Whitfield DP, 2003, BIOL CONSERV, V114, P157, DOI 10.1016/S0006-3207(03)00019-3; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Witmer GW, 2005, WILDLIFE RES, V32, P259, DOI 10.1071/WR04003; Wu Yinyin, 2006, Ornithological Science, V5, P157, DOI 10.2326/1347-0558(2006)5[157:WLEACW]2.0.CO;2; Zhang Y, 2019, AMBIO, V48, P293, DOI 10.1007/s13280-018-1076-1	171	0	0	8	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0246555	10.1371/journal.pone.0246555	http://dx.doi.org/10.1371/journal.pone.0246555			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1D8GY	35482717	gold, Green Published			2022-12-26	WOS:000794035700100
J	Kumstel, S; Schreiber, T; Goldstein, L; Stenzel, J; Lindner, T; Joksch, M; Zhang, XB; Wendt, EHU; Schonrogge, M; Krause, B; Vollmar, B; Zechner, D				Kumstel, Simone; Schreiber, Tim; Goldstein, Lea; Stenzel, Jan; Lindner, Tobias; Joksch, Markus; Zhang, Xianbin; Wendt, Edgar Heinz Uwe; Schoenrogge, Maria; Krause, Bernd; Vollmar, Brigitte; Zechner, Dietmar			Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism	PLOS ONE			English	Article							DEHYDROGENASE INHIBITOR; PYRUVATE-DEHYDROGENASE; MYELOMA CELLS; MURINE MODEL; TUMOR-CELLS; IN-VITRO; GALLOFLAVIN; AGENT; ADENOCARCINOMA; GEMCITABINE	Pancreatic cancer is the fourth leading cause of cancer death, with a 5-year survival rate of 10%. A stagnant high mortality rate over the last decades highlights the need for innovative therapeutic approaches. Pancreatic tumors pursue an altered metabolism in order to maintain energy generation under low nutrient influx and hypoxic conditions. Targeting these metabolic strategies might therefore be a reasonable therapeutic approach for pancreatic cancer. One promising agent is CPI- 613, a potent inhibitor of two enzymes of the tricarboxylic acid cycle. The present study evaluated the anti-cancerous efficacy of CPI-613 in combination with galloflavin, a lactate dehydrogenase inhibitor or with alpha-cyano-4-hydroxycinnamic acid, an inhibitor of monocarboxylate transporters. The efficacy of both combination therapies was tested in vitro on one human and two murine pancreatic cancer cell lines and in vivo in an orthotopic pancreatic cancer model. Tumor progression was evaluated by MRI and F-18-FDG PET-CT. Both combinatorial treatments demonstrated in vitro a significant inhibition of pancreatic cancer cell proliferation and induction of cell death. In contrast to the in vitro results, both combination therapies did not significantly reduce tumor growth in vivo. The in vitro results suggest that a combined inhibition of different metabolic pathways might be a promising approach for cancer therapy. However, the in vivo experiments indicate that applying a higher dosage or using other drugs targeting these metabolic pathways might be more promising.	[Kumstel, Simone; Schreiber, Tim; Goldstein, Lea; Zhang, Xianbin; Wendt, Edgar Heinz Uwe; Schoenrogge, Maria; Vollmar, Brigitte; Zechner, Dietmar] Univ Med Ctr, Rudolf Zenker Inst Expt Surg, Rostock, Germany; [Stenzel, Jan; Lindner, Tobias; Joksch, Markus] Univ Med Ctr, Core Facil Multimodal Small Anim Imaging, Rostock, Germany; [Krause, Bernd] Univ Med Ctr, Dept Nucl Med, Rostock, Germany	University of Rostock; University of Rostock; University of Rostock	Kumstel, S (corresponding author), Univ Med Ctr, Rudolf Zenker Inst Expt Surg, Rostock, Germany.	simone.kumstel@uni-rostock.de		Zhang, Xianbin/0000-0002-0948-6698; Kumstel, Simone/0000-0001-6942-6294				Alistar A, 2017, LANCET ONCOL, V18, P770, DOI 10.1016/S1470-2045(17)30314-5; Baek G, 2014, CELL REP, V9, P2233, DOI 10.1016/j.celrep.2014.11.025; Benyahia Z, 2021, CANCERS, V13, DOI 10.3390/cancers13030569; Biancur DE, 2018, BBA-REV CANCER, V1870, P67, DOI 10.1016/j.bbcan.2018.04.011; Bove K, 2002, BIOCHEM BIOPH RES CO, V291, P1001, DOI 10.1006/bbrc.2002.6554; Choi IK, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00193; Critchlow SE, 2012, CANCER RES, V72, DOI 10.1158/1538-7445.AM2012-3224; Farabegoli F, 2012, EUR J PHARM SCI, V47, P729, DOI 10.1016/j.ejps.2012.08.012; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Ferriero R, 2018, J HEPATOL, V69, P325, DOI 10.1016/j.jhep.2018.03.016; Fujiwara S, 2015, EXP HEMATOL ONCOL, V4, DOI 10.1186/s40164-015-0008-z; Gaglio D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.56; Gao LX, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-01579-x; Gottfried E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066987; Grossberg AJ, 2020, CA-CANCER J CLIN, V70, P375, DOI 10.3322/caac.21626; Guan XW, 2020, AAPS J, V22, DOI 10.1208/s12248-020-00466-9; Guan XW, 2019, AAPS J, V21, DOI 10.1208/s12248-018-0261-2; Guillaumond F, 2013, P NATL ACAD SCI USA, V110, P3919, DOI 10.1073/pnas.1219555110; HALESTRAP AP, 1976, BIOCHEM J, V156, P193, DOI 10.1042/bj1560193; Hamdan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072953; Han XY, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-014-0097-x; Hanson DJ, 2015, ONCOTARGET, V6, P33568, DOI 10.18632/oncotarget.5598; Im HJ, 2018, NUCL MED MOLEC IMAG, V52, P5, DOI 10.1007/s13139-017-0493-6; Jeong KY, 2016, ONCOL LETT, V11, P1866, DOI 10.3892/ol.2016.4137; Killion JJ, 1998, CANCER METAST REV, V17, P279, DOI 10.1023/A:1006140513233; Kong SC, 2016, PANCREAS, V45, P1036, DOI 10.1097/MPA.0000000000000571; Koukourakis MI, 2005, NEOPLASIA, V7, P1, DOI 10.1593/neo.04373; Kumstel S, 2020, ANN NY ACAD SCI, V1473, P20, DOI 10.1111/nyas.14338; Kumstel S, 2020, J ADV RES, V21, P35, DOI 10.1016/j.jare.2019.09.002; Lee KC, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.05.08; Liang C, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.255; Manerba M, 2012, CHEMMEDCHEM, V7, P311, DOI 10.1002/cmdc.201100471; McFate T, 2008, J BIOL CHEM, V283, P22700, DOI 10.1074/jbc.M801765200; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; New J, 2017, CANCER RES, V77, P6679, DOI 10.1158/0008-5472.CAN-17-1077; Oz ES, 2012, ONCOL LETT, V3, P927, DOI 10.3892/ol.2012.559; Pardee TS, 2014, CLIN CANCER RES, V20, P5255, DOI 10.1158/1078-0432.CCR-14-1019; Partecke LI, 2011, EUR SURG RES, V47, P98, DOI 10.1159/000329413; Peterson JK, 2004, EUR J CANCER, V40, P837, DOI 10.1016/j.ejca.2004.01.003; Philip PA, 2019, FUTURE ONCOL, V15, P3189, DOI 10.2217/fon-2019-0209; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Russell WMS., 1959, MED J AUSTRALIA; Sadeghzadeh M, 2020, MOLECULES, V25, DOI 10.3390/molecules25102309; Schonrogge M, 2018, CELL SIGNAL, V47, P101, DOI 10.1016/j.cellsig.2018.03.015; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singh SS, 2006, CURR DRUG METAB, V7, P165, DOI 10.2174/138920006775541552; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; SPENCER TL, 1976, BIOCHEM J, V154, P405, DOI 10.1042/bj1540405; Stuart SD, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-4; Wang N, 2021, CELL, V184, P370, DOI 10.1016/j.cell.2020.11.043; Wendt EHU, 2020, ANTICANCER RES, V40, P153, DOI 10.21873/anticanres.13936; Wong H, 2012, CLIN CANCER RES, V18, P3090, DOI 10.1158/1078-0432.CCR-12-0445; WORTHLEY EG, 1969, TOXICOL APPL PHARM, V15, P275, DOI 10.1016/0041-008X(69)90027-1; Xu ZH, 2014, WORLD J GASTROENTERO, V20, P11216, DOI 10.3748/wjg.v20.i32.11216; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zachar Z, 2011, J MOL MED, V89, P1137, DOI 10.1007/s00109-011-0785-8; Zechner D, 2016, ONCOTARGET, V7, P56395, DOI 10.18632/oncotarget.10892; Zhang XB, 2019, J ADV RES, V20, P9, DOI 10.1016/j.jare.2019.04.006; Zhang XB, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00590; Zhao ZQ, 2014, CANCER LETT, V342, P150, DOI 10.1016/j.canlet.2013.08.042	60	0	0	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266601	10.1371/journal.pone.0266601	http://dx.doi.org/10.1371/journal.pone.0266601			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C1KV	35452495	gold, Green Published			2022-12-26	WOS:000792887700015
J	Moukenet, A; Richardson, S; Moundine, K; Laoukole, J; Ngarasta, N; Seck, I				Moukenet, Azoukalne; Richardson, Sol; Moundine, Kebfene; Laoukole, Jean; Ngarasta, Ngarkodje; Seck, Ibrahima			Knowledge and practices surrounding malaria and LLIN use among Arab, Dazagada and Fulani pastoral nomads in Chad	PLOS ONE			English	Article							CHEMOPREVENTION; COMMUNITIES	Background Chadian pastoral nomads are highly exposed to malaria due to their lifestyle and their mobility between various endemic areas. To inform strategies to reduce nomads' risk of malaria and associated morbidity and mortality, it is important to understand the factors associated to their knowledge of malaria transmission and prevention practices. Methods A cross-sectional study among Arab, Dazagada and Fulani pastoral nomadic groups was conducted in February and October 2021. A validated structured electronic questionnaire was administered to assess knowledge of malaria. Attitudes and malaria prevention practices were assessed on the basis of perception of the causes of malaria and the use of a long-lasting insecticide-treated net (LLIN) the day before the survey. Data were analyzed using Chi-square tests and multivariate logistic regression with covariates adjustment. Results A total of 278 nomads aged 20 to 65 years were included in the study. Overall, 90.7% of participants surveyed had a good knowledge of malaria. Fulani respondents were more likely to have a good knowledge of malaria than Arab respondents (Adjusted Odd ratio (AOR): 5.00, 95% CI: 1.04-24.03) and households possessing a LLIN were more likely to have a good knowledge of malaria (AOR: 9.66, 95% CI: 1.24-75.36). Most nomad households surveyed reported sleeping under a mosquito net the night before the survey (87.1%) while 98.9% owned a LLIN. Daza respondents (AOR: 0.23, 95% CI: 0.09-0.56) were less likely to use LLINs than Arab respondents. The middle (AOR: 2.78, 95% CI: 1.17-6.62) and wealthier households (AOR: 6.68, 95% CI: 3.19-14.01) were more likely to use LLINs. Knowledge of malaria was associated with the use of LLIN (AOR: 12.77, 95% CI: 1.58-102.99). Conclusion There remains a need to improve nomads' understanding of Plasmodium falciparum-carrying mosquitoes as the vector for malaria transmission and the quality of information provided. Knowledge of malaria and its prevention strategies in nomadic setting lead to the use of LLINs. Further reductions in malaria morbidity can be achieved by improving nomads' access to LLINs. This study can inform on the design policies to improve nomadic communities' knowledge of malaria prevention and promoting LLIN use as requested by the national policy against malaria.	[Moukenet, Azoukalne; Seck, Ibrahima] Cheikh Anta Diop Univ, Dakar, Senegal; [Moukenet, Azoukalne; Ngarasta, Ngarkodje] Univ Ndjamena, Ndjamena, Chad; [Richardson, Sol] Malaria Consortium, London, England; [Richardson, Sol] Tsinghua Univ, Vanke Sch Publ Hlth, Beijing, Peoples R China; [Moundine, Kebfene] StraDEC Training, Res & Innovat Dept, Ndjamena, Chad; [Laoukole, Jean] Natl Malaria Control Program, Ndjamena, Chad	University Cheikh Anta Diop Dakar; Tsinghua University	Moukenet, A (corresponding author), Cheikh Anta Diop Univ, Dakar, Senegal.; Moukenet, A (corresponding author), Univ Ndjamena, Ndjamena, Chad.	azoukalne07@yahoo.fr		Richardson, Sol/0000-0003-0863-1061; Moukenet, Azoukalne/0000-0001-7780-366X				Adhikari B, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1593-y; [Anonymous], 2012, ET CULT LUT MOUST IM; Bechir M, 2012, ECOHEALTH, V9, P122, DOI 10.1007/s10393-011-0727-5; Beer N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-606; Bojang K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011225; Brieger W., 2011, Africa Health, V33, P14; Chatio S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216486; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; Clanet J, 1994, GOGRAPHIE PASTORALE; CTA, 1996, ATL DLEV BASS LAC TC; Demarest S., 2018, METHODOLOGIE ENQUETE; Dicko A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000407; Druetz T, 2018, AM J TROP MED HYG, V98, P524, DOI 10.4269/ajtmh.17-0599; Esse C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-224; Fikrie A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250981; Fuchs P., 1996, NOMAD PEOPLES, P151; Fuge TG, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0755-7; Gamble C, 2006, Cochrane Database Syst Rev, pCD003755; Graves PM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-354; INSEED, 2012, DEUX RCENS GNRAL POP, P121; INSEED, 2009, REC GNRAL POP HAB; INSEED ICF International., 2016, ENQ DMOGR SANT IND M; Kajeechiwa L, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1528-7; Kanyangarara M, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2178-8; Koenker H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097496; Konate AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000408; Lengeler C., 2004, INSECTICIDE TREATED; Maslove DM, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-26; Maude RJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-385; Ministre de la Sant Publique, 2017, ANN STAT, P183; Moto DD., 2004, MED TROP MARS, V64, P469; Moukenet A., 2021, SEASONAL MALARIA CHE, V57; Newby G, 2015, AM J TROP MED HYG, V93, P125, DOI 10.4269/ajtmh.14-0254; Nguon Chea, 2018, Glob Bioeth, V29, P16, DOI 10.1080/11287462.2017.1411762; Noor AM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-369; Okeibunor JC, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-24; Panter-Brick C, 2006, SOC SCI MED, V62, P2810, DOI 10.1016/j.socscimed.2005.10.009; Pell CL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214280; Peto TJ, 2018, T ROY SOC TROP MED H, V112, P264, DOI 10.1093/trstmh/try053; Plucinski MM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-427; Programme National de Lutte contre le Paludisme, 2013, PLAN STRATG NAT LUTT; Programme National de Lutte contre le Paludisme, 2014, POL NAT LUTT PAL, P25; Programme National de Lutte contre le Paludisme INSEED, 2018, RAPP ENQ NAT IND PAL, P165; Rapport du procureur general, 2019, MINISTERE JUSTICE IS, P77; Rek J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243303; Richard V, 2004, Med Trop (Mars), V64, P421; Richardson S, 2021, AM J TROP MED HYG, V105, P1712, DOI 10.4269/ajtmh.21-0314; Sahan K, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1718-y; Sanogo Y., 2020, THESIS U SCI TECHNIQ; Schelling E, 2005, ACTA TROP, V95, P16, DOI 10.1016/j.actatropica.2005.03.006; Seck MC, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2055-x; Serengbe Gustave Bobossi, 2015, BMC Res Notes, V8, P162, DOI 10.1186/s13104-015-1124-x; Sesay S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-2; Tagbor H, 2016, TROP MED INT HEALTH, V21, P224, DOI 10.1111/tmi.12642; The Harvard Humanitarian Initiative, 2021, KOBOTOOLBOX; Nguyen TN, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1662-2; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Warsame M, 1991, MALARIA DEV AFRICA C; Wiese M, 2004, Med Trop (Mars), V64, P486; Wiese M., 2004, HLTH VULNERABILITY C; Yaya S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180508	61	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266900	10.1371/journal.pone.0266900	http://dx.doi.org/10.1371/journal.pone.0266900			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421160	Green Published, gold			2022-12-26	WOS:000795453600079
J	Musters, SCW; van Noort, HHJ; Bakker, CA; Degenhart, I; van Dieren, S; Geelen, SJ; van der Lee, M; Smith, R; Maaskant, JM; Bemelman, WA; van Dijkum, EJMN; Besselink, MG; Eskes, AM				Musters, Selma C. W.; van Noort, Harm H. J.; Bakker, Chris A.; Degenhart, Isabel; van Dieren, Susan; Geelen, Sven J.; van der Lee, Michele; Smith, Reggie; Maaskant, Jolanda M.; Bemelman, Willem A.; van Dijkum, Els J. M. Nieveen; Besselink, Marc G.; Eskes, Anne M.		Amsterdam UMC Peri-operative Surg	Impact of a surgical ward breakfast buffet on nutritional intake in postoperative patients: A prospective cohort pilot study	PLOS ONE			English	Article							PROTECTED MEALTIMES; ENHANCED RECOVERY; SAMPLE-SIZE; CARE; COMPLICATIONS; SURGERY; PREVALENCE; GUIDELINES; STAY; RISK	BackgroundAn early return to normal intake and early mobilization enhances postoperative recovery. However, one out of six surgical patients is undernourished during hospitalization and approximately half of the patients eat 50% or less of the food provided to them. We assessed the use of newly introduced breakfast buffets in two wards for gastrointestinal and oncological surgery and determined the impact on postoperative protein and energy intake. MethodsA prospective pilot cohort study was conducted to assess the impact of the introduction of breakfast buffets in two surgical wards. Adult patients had the opportunity to choose between an attractive breakfast buffet and regular bedside breakfast service. Primary outcomes were protein and energy intake during breakfast. We asked patients to report the type of breakfast service and breakfast intake in a diary over a seven-day period. Prognostic factors were used during multivariable regression analysis. ResultsA total of 77 patients were included. The median percentage of buffet use per patient during the seven-day study period was 50% (IQR 0-83). Mean protein intake was 14.7 g (SD 8.4) and mean energy intake 332.3 kcal (SD 156.9). Predictors for higher protein intake included the use of the breakfast buffet (beta = 0.06, p = 0.01) and patient weight (beta = 0.13, p = 0.01). Both use of the breakfast buffet (beta = 1.00, p = 0.02) and Delirium Observation Scale scores (beta = -246.29, p = 0.02) were related to higher energy intake. ConclusionIntroduction of a breakfast buffet on a surgical ward was associated with higher protein and energy intake and it could be a promising approach to optimizing such intake in surgical patients. Large, prospective and preferably randomized studies should confirm these findings.	[Musters, Selma C. W.; Bakker, Chris A.; Degenhart, Isabel; van Dieren, Susan; van der Lee, Michele; Smith, Reggie; Bemelman, Willem A.; van Dijkum, Els J. M. Nieveen; Besselink, Marc G.; Eskes, Anne M.] Univ Amsterdam, Canc Ctr Amsterdam, Dept Surg, Amsterdam UMC, Amsterdam, Noord Holland, Netherlands; [van Noort, Harm H. J.] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Med Ctr, IQ Healthcare, Nijmegen, Gelderland, Netherlands; [van Noort, Harm H. J.] Radboud Univ Nijmegen, Dept Surg, Med Ctr, Nijmegen, Gelderland, Netherlands; [Geelen, Sven J.] Univ Amsterdam, Dept Rehabil, Amsterdam Movement Sci, Amsterdam UMC, Amsterdam, Noord Holland, Netherlands; [Maaskant, Jolanda M.] Univ Amsterdam, Emma Childrens Hosp, Amsterdam UMC, Amsterdam, Noord Holland, Netherlands; [Eskes, Anne M.] Griffith Univ, Menzies Hlth Inst Queensland, Brisbane, Qld, Australia; [Eskes, Anne M.] Griffith Univ, Sch Nursing & Midwifery, Brisbane, Qld, Australia	University of Amsterdam; Vrije Universiteit Amsterdam; Radboud University Nijmegen; Radboud University Nijmegen; University of Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Griffith University; Menzies Health Institute Queensland; Griffith University	Musters, SCW; Eskes, AM (corresponding author), Univ Amsterdam, Canc Ctr Amsterdam, Dept Surg, Amsterdam UMC, Amsterdam, Noord Holland, Netherlands.; Eskes, AM (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Brisbane, Qld, Australia.; Eskes, AM (corresponding author), Griffith Univ, Sch Nursing & Midwifery, Brisbane, Qld, Australia.	s.c.musters@amsterdamUMC.nl; a.m.eskes@amsterdamUMC.nl	; van Noort, Harm/C-2368-2018	Geelen, Sven/0000-0001-9443-8211; van Noort, Harm/0000-0001-9467-8434; Musters, Selma/0000-0002-8568-5496	Amsterdam UMC in Amsterdam, the Netherlands	Amsterdam UMC in Amsterdam, the Netherlands(Netherlands Government)	This work is supported by an unrestricted innovation grant of the Amsterdam UMC in Amsterdam, the Netherlands. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal E., MALNUTRITION POOR FO; Beck M, 2017, INT J QUAL STUD HEAL, V12, DOI 10.1080/17482631.2017.1360699; Beck M, 2017, J ADV NURS, V73, P1947, DOI 10.1111/jan.13278; Beerens HC, 2018, AGING MENT HEALTH, V22, P26, DOI 10.1080/13607863.2016.1227766; Bonetti L, 2017, J CLIN NURS, V26, P5082, DOI 10.1111/jocn.14051; Castel H, 2006, J AM COLL NUTR, V25, P128, DOI 10.1080/07315724.2006.10719523; Chan J, 2015, CAN J DIET PRACT RES, V76, P81, DOI 10.3148/cjdpr-2014-035; Connolly A., 2011, Journal of Human Nutrition and Dietetics, V24, P279; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Dijxhoorn DN., NOVEL IN HOSP MEAL S; Edwards JSA., COMP ENERGY INTAKE E; Gibney MJ, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101540; Gjorgjievski M, 2020, INJURY, V51, pS23, DOI 10.1016/j.injury.2019.12.027; Huxtable S., EFFICACY PROTECTED M; Julious SA, 2005, PHARM STAT, V4, P287, DOI 10.1002/pst.185; Khan NA, 2006, J GEN INTERN MED, V21, P177, DOI 10.1111/j.1525-1497.2006.00319.x; Knudsen AW, 2015, SCAND J GASTROENTERO, V50, P1191, DOI 10.3109/00365521.2015.1028994; Kruizenga H, 2016, AM J CLIN NUTR, V103, P1026, DOI 10.3945/ajcn.115.126615; Lassen K, 2012, CLIN NUTR, V31, P817, DOI 10.1016/j.clnu.2012.08.011; McCray S., ROOM SERVICE IMPROVE; Morris MS, 2014, JAMA SURG, V149, P348, DOI 10.1001/jamasurg.2013.4064; Mudge AM., HELPING UNDERSTAND N; Naseer Benazir, 2017, JBI Database System Rev Implement Rep, V15, P1209, DOI 10.11124/JBISRIR-2016-003038; Nieuwenhuizen WF., 2010, OLDER ADULTS PATIENT, P9; Norman K., PROGNOSTIC IMPACT DI; Ozkalkanli MY, 2009, NUTR CLIN PRACT, V24, P274, DOI 10.1177/0884533609332087; Palmer M, 2015, EUR J CLIN NUTR, V69, P961, DOI 10.1038/ejcn.2015.87; Porter J, 2020, RISK MANAG HEALTHC P, V13, P713, DOI 10.2147/RMHP.S224901; Rasmussen HH, 2004, CLIN NUTR, V23, P1009, DOI 10.1016/j.clnu.2004.01.001; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Tannen A., CARE PROBLEMS NURSIN; Varadhan KK, 2010, CLIN NUTR, V29, P434, DOI 10.1016/j.clnu.2010.01.004; Viechtbauer W, 2015, J CLIN EPIDEMIOL, V68, P1375, DOI 10.1016/j.jclinepi.2015.04.014; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Weiser TG, 2016, B WORLD HEALTH ORGAN, V94, P201, DOI 10.2471/BLT.15.159293; Young AM, 2018, CLIN NUTR ESPEN, V24, P140, DOI 10.1016/j.clnesp.2017.12.009; Zhang ZH, 2016, ANN TRANSL MED, V4, DOI 10.3978/j.issn.2305-5839.2015.12.63	37	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267087	10.1371/journal.pone.0267087	http://dx.doi.org/10.1371/journal.pone.0267087			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D8GY	35482733	gold, Green Published			2022-12-26	WOS:000794035700106
J	Stamenova, V; Chu, CRY; Pang, AD; Fang, JM; Shakeri, A; Cram, P; Bhattacharyya, OF; Bhatia, RSF; Tadrous, MF				Stamenova, Vess; Chu, Cherry; Pang, Andrea; Fang, Jiming; Shakeri, Ahmad; Cram, Peter; Bhattacharyya, Onil F.; Bhatia, R. Sacha F.; Tadrous, Mina F.			Virtual care use during the COVID-19 pandemic and its impact on healthcare utilization in patients with chronic disease: A population-based repeated cross-sectional study	PLOS ONE			English	Article							TELEMEDICINE	PurposeIt is currently unclear how the shift towards virtual care during the 2019 novel coronavirus (COVID-19) pandemic may have impacted chronic disease management at a population level. The goals of our study were to provide a description of the levels of use of virtual care services relative to in-person care in patients with chronic disease across Ontario, Canada and to describe levels of healthcare utilization in low versus high virtual care users. MethodsWe used linked health administrative data to conduct a population-based, repeated cross-sectional study of all ambulatory patient visits in Ontario, Canada (January 1, 2018 to January 16, 2021). Further stratifications were also completed to examine patients with COPD, heart failure, asthma, hypertension, diabetes, mental illness, and angina. Patients were classified as low (max 1 virtual care visit) vs. high virtual care users. A time-series analysis was done using interventional autoregressive integrated moving average (ARIMA) modelling on weekly hospitalizations, outpatient visits, and diagnostic tests. ResultsThe use of virtual care increased across all chronic disease patient populations. Virtual care constituted at least half of the total care in all conditions. Both low and high virtual care user groups experienced a statistically significant reduction in hospitalizations and laboratory testing at the start of the pandemic. Hospitalization volumes increased again only among the high users, while testing increased in both groups. Outpatient visits among high users remained unaffected by the pandemic but dropped in low users. ConclusionThe decrease of in-person care during the pandemic was accompanied by an increase in virtual care, which ultimately allowed patients with chronic disease to return to the same visit rate as they had before the onset of the pandemic. Virtual care was adopted across various chronic conditions, but the relative adoption of virtual care varied by condition with highest rates seen in mental health.	[Stamenova, Vess; Chu, Cherry; Shakeri, Ahmad; Bhattacharyya, Onil F.; Bhatia, R. Sacha F.; Tadrous, Mina F.] Womens Coll Hosp, Womens Coll Hosp Inst Hlth Syst Solut & Virtual Ca, Toronto, ON, Canada; [Pang, Andrea; Fang, Jiming; Cram, Peter; Bhatia, R. Sacha F.] ICES, Toronto, ON, Canada; [Cram, Peter] Univ Texas Med Branch Galveston, Galveston, TX USA; [Bhattacharyya, Onil F.] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Tadrous, Mina F.] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Texas System; University of Texas Medical Branch Galveston; University of Toronto; University of Toronto	Stamenova, V (corresponding author), Womens Coll Hosp, Womens Coll Hosp Inst Hlth Syst Solut & Virtual Ca, Toronto, ON, Canada.	vess.stamenova@wchospital.ca	Tadrous, Mina/E-9136-2018; Stamenova, Vess/H-1712-2013	Tadrous, Mina/0000-0003-1911-6129; Stamenova, Vess/0000-0003-3252-7766	Ontario Ministry of Health	Ontario Ministry of Health(Ministry of Health and Long-Term Care, Ontario)	This work was funded through the Ontario Ministry of Health as funds provided to the Centre for Digital Health Evaluation at Women's College Hospital, Toronto, Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GC, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.21476; Bhatia R Sacha, 2021, CMAJ Open, V9, pE107, DOI 10.9778/cmajo.20200311; Bhatia RS, 2021, BMJ QUAL SAF, V30, P236, DOI 10.1136/bmjqs-2020-011624; Blecker S, 2021, JAMA INTERN MED, V181, P269, DOI 10.1001/jamainternmed.2020.3978; Butt JH, 2022, EUR HEART J-QUAL CAR, V8, P14, DOI 10.1093/ehjqcco/qcab021; Chudasama YV, 2020, DIABETES METAB SYND, V14, P965, DOI 10.1016/j.dsx.2020.06.042; De Filippo O, 2020, NEW ENGL J MED, V383, P88, DOI 10.1056/NEJMc2009166; Glazier RH, 2021, CAN MED ASSOC J, V193, pE200, DOI 10.1503/cmaj.202303; Mehrotra A, 2021, JAMA-J AM MED ASSOC, V325, P431, DOI 10.1001/jama.2020.25706; Ongur D, 2020, JAMA-J AM MED ASSOC, V324, P1149, DOI 10.1001/jama.2020.14294; Patel SY, 2021, HEALTH AFFAIR, V40, P349, DOI 10.1377/hlthaff.2020.01786; Saglietto A, 2020, LANCET, V395, P1110, DOI 10.1016/S0140-6736(20)30690-5; Schaffer AL, 2021, BMC MED RES METHODOL, V21, DOI 10.1186/s12874-021-01235-8; Schull MJ., 2019, INT J POPULATION DAT, V4; Smithson R, 2021, AUST HEALTH REV, V45, P311, DOI 10.1071/AH20190; Stephenson E, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0255992; Weiner JP, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.2618; Wright A, 2020, J GEN INTERN MED, V35, P2816, DOI 10.1007/s11606-020-06025-4; Yuan N, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.4157	19	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267218	10.1371/journal.pone.0267218	http://dx.doi.org/10.1371/journal.pone.0267218			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D9PO	35468168	Green Published, gold			2022-12-26	WOS:000794129600016
J	Akasu, R; Miyazaki, T; Elhussiny, MZ; Sugiura, Y; Tomitsuka, Y; Haraguchi, S; Otsu, K; Chowdhury, VS; Miyazaki, A				Akasu, Risako; Miyazaki, Takuro; Elhussiny, Mohamed Z.; Sugiura, Yuki; Tomitsuka, Yuki; Haraguchi, Shogo; Otsu, Kinya; Chowdhury, Vishwajit S.; Miyazaki, Akira			Calpain-mediated proteolytic production of free amino acids in vascular endothelial cells augments obesity-induced hepatic steatosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEM-L; MOUSE; DEGRADATION; METABOLISM; DISEASES	Free amino acids that accumulate in the plasma of patients with diabetes and obesity influence lipid metabolism and protein synthesis in the liver. The stress-inducible intracellular protease calpain proteolyzes various substrates in vascular endothelial cells (ECs), although its contribution to the supply of free amino acids in the liver microenvironment remains enigmatic. In the present study, we showed that calpains are associated with free amino acid production in cultured ECs. Furthermore, conditioned media derived from calpain-activated ECs facilitated the phosphorylation of ribosomal protein S6 kinase (S6K) and de novo lipogenesis in hepatocytes, which were abolished by the amino acid transporter inhibitor, JPH203, and the mammalian target of rapamycin complex 1 inhibitor, rapamycin. Meanwhile, calpain-overexpressing capillary-like ECs were observed in the livers of high-fat diet-fed mice. Conditional KO of EC/hematopoietic Capns1, which encodes a calpain regulatory subunit, diminished levels of branched-chain amino acids in the hepatic microenvironment without altering plasma amino acid levels. Concomitantly, conditional KO of Capns1 mitigated hepatic steatosis without normalizing body weight and the plasma lipoprotein profile in an amino acid transporter-dependent manner. Mice with targeted Capns1 KO exhibited reduced phosphorylation of S6K and maturation of lipogenic factor sterol regulatory elementbinding protein 1 in hepatocytes. Finally, we show that bone marrow transplantation negated the contribution of hematopoietic calpain systems. We conclude that overactivation of calpain systems may be responsible for the production of free amino acids in ECs, which may be sufficient to potentiate S6K/sterol regulatory element-binding protein 1-induced lipogenesis in surrounding hepatocytes.	[Akasu, Risako; Miyazaki, Takuro; Tomitsuka, Yuki; Haraguchi, Shogo; Miyazaki, Akira] Showa Univ, Dept Biochem, Sch Med, Tokyo, Japan; [Elhussiny, Mohamed Z.; Chowdhury, Vishwajit S.] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka, Japan; [Elhussiny, Mohamed Z.] Aswan Univ, Fac Vet Med, Dept Anim & Poultry Behav & Management, Aswan, Egypt; [Sugiura, Yuki] Keio Univ, Dept Biochem, Sch Med, Tokyo, Japan; [Otsu, Kinya] Kings Coll London, Sch Cardiovasc Med & Sci, British Heart Fdn Ctr Excellence, London, England; [Chowdhury, Vishwajit S.] Kyushu Univ, Fac Arts & Sci, Fukuoka, Japan	Showa University; Kyushu University; Egyptian Knowledge Bank (EKB); Aswan University; Keio University; University of London; King's College London; Kyushu University	Miyazaki, T (corresponding author), Showa Univ, Dept Biochem, Sch Med, Tokyo, Japan.	taku@pharm.showa-u.ac.jp	Elhussiny, Mohamed Z./AAM-9418-2021	Elhussiny, Mohamed Z./0000-0003-1177-9315; Miyazaki, Takuro/0000-0003-3354-0292	Japan Society for the Promotion of Science KAKENHI grant [JP21K08585, JP19K08590, JP22H03520, JP19H03110]; Bristol-Myers Squibb; British Heart Foundation [CH/11/3/29051, RG/16/15/32294]; Suzuken Memorial Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Naito Memorial Foundation	Japan Society for the Promotion of Science KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Bristol-Myers Squibb(Bristol-Myers Squibb); British Heart Foundation(British Heart Foundation); Suzuken Memorial Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Naito Memorial Foundation(Naito Memorial Foundation)	This study was supported in part by the Japan Society for the Promotion of Science KAKENHI grant (grant nos.: JP21K08585 [to A. M.], JP19K08590 [to T. M.], JP22H03520 [to T. M.], and JP19H03110 [to V. S. C.]), research grant from Bristol-Myers Squibb (to T. M.), personal chair grant from the British Heart Foundation (grant nos.: CH/11/3/29051 and RG/16/15/32294 [to K. O.]), research grant from the Suzuken Memorial Foundation (to T. M.), and research grant from the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to T. M.), and a research grant from the Naito Memorial Foundation (to T. M.).	Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Chen H, 2003, P NATL ACAD SCI USA, V100, P14908, DOI 10.1073/pnas.2136625100; Cheng Q, 2016, J MOL ENDOCRINOL, V56, P175, DOI 10.1530/JME-15-0212; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Dyachok J, 2016, J BIOL CHEM, V291, P22414, DOI 10.1074/jbc.M116.732511; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; FOLCH J, 1957, J BIOL CHEM, V226, P497; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Han G, 2020, ANIMAL, V14, P1701, DOI 10.1017/S1751731120000464; Ito K, 2015, COMP BIOCHEM PHYS A, V187, P13, DOI 10.1016/j.cbpa.2015.04.010; Javed K, 2019, BIOCHEM SOC T, V47, P571, DOI 10.1042/BST20180250; Kigawa Y, 2014, ARTERIOSCL THROM VAS, V34, P2413, DOI 10.1161/ATVBAHA.114.303086; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Le Couteur DG, 2020, AGEING RES REV, V64, DOI 10.1016/j.arr.2020.101198; Lynch CJ, 2014, NAT REV ENDOCRINOL, V10, P723, DOI 10.1038/nrendo.2014.171; Marcu R, 2018, ISCIENCE, V4, P20, DOI 10.1016/j.isci.2018.05.003; Miyao M, 2015, LAB INVEST, V95, P1130, DOI 10.1038/labinvest.2015.95; Miyazaki T., 2016, J CLIN INVEST; Miyazaki T, 2007, AM J PHYSIOL-CELL PH, V293, pC1216, DOI 10.1152/ajpcell.00083.2007; Miyazaki T, 2020, INFLAMM REGEN, V40, DOI 10.1186/s41232-020-00114-x; Miyazaki T, 2019, FASEB J, V33, P2037, DOI 10.1096/fj.201800588RR; Miyazaki T, 2018, J ATHEROSCLER THROMB, V25, P1, DOI 10.5551/jat.RV17008; Miyazaki T, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00079; Miyazaki T, 2015, CIRC RES, V116, P1170, DOI 10.1161/CIRCRESAHA.116.305363; Miyazaki T, 2013, J ATHEROSCLER THROMB, V20, P228, DOI 10.5551/jat.14787; Miyazaki T, 2011, CIRCULATION, V124, P2522, DOI 10.1161/CIRCULATIONAHA.111.021675; Newgard CB, 2017, CELL METAB, V25, P43, DOI 10.1016/j.cmet.2016.09.018; Oka M, 2017, J CELL SCI, V130, P3568, DOI 10.1242/jcs.200519; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; Scalia R, 2007, DIABETES, V56, P1842, DOI 10.2337/db06-1198; Shimano H, 2017, NAT REV ENDOCRINOL, V13, P710, DOI 10.1038/nrendo.2017.91; Shinkai-Ouchi F, 2016, MOL CELL PROTEOMICS, V15, P1262, DOI 10.1074/mcp.M115.053413; Son SM, 2019, CELL METAB, V29, P192, DOI 10.1016/j.cmet.2018.08.013; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; Taki M, 2021, ACS MATER LETT, V3, P42, DOI 10.1021/acsmaterialslett.0c00451; Taneike M., 2011, J BIOL UDAYANA; Tomita T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16003-3; Uno K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8940; Verrey F, 2003, PFLUG ARCH EUR J PHY, V445, P529, DOI 10.1007/S00424-002-0973-Z; Wempe MF, 2012, DRUG METAB PHARMACOK, V27, P155, DOI 10.2133/dmpk.DMPK-11-RG-091; White PJ, 2019, SCIENCE, V363, P582, DOI 10.1126/science.aav0558; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Yothaisong S, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317694545; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200	47	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101953	10.1016/j.jbc.2022.101953	http://dx.doi.org/10.1016/j.jbc.2022.101953			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3R4NR	35447117	Green Published, gold			2022-12-26	WOS:000838892100009
J	Mostofa, G; Tran, M; Gilling, S; Lee, GC; Fraher, O; Jin, L; Kang, HYJ; Park, YK; Lee, JY; Wang, L; Shin, DJ				Mostofa, Golam; Tran, Melanie; Gilling, Shaynian; Lee, Grace; Fraher, Ondine; Jin, Lei; Kang, Hyunju; Park, Young-Ki; Lee, Ji-Young; Wang, Li; Shin, Dong-Ju			MicroRNA-200c coordinates HNF1 homeobox B and apolipoprotein O functions to modulate lipid homeostasis in alcoholic fatty liver disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA HIGH-DENSITY; ETHANOL; METABOLISM; EXPRESSION; MICE; PHOSPHATIDYLCHOLINE; ALPHA; TRANSCRIPTION; PATHOGENESIS; INHIBITION	Hepatic steatosis is an initial manifestation of alcoholic liver disease. An imbalance of hepatic lipid processes including fatty acid uptake, esterification, oxidation, and triglyceride secretion leads to alcoholic fatty liver (AFL). However, the precise molecular mechanisms underlying the pathogenesis of AFL remain elusive. Here, we show that mice deficient in microRNAs (miRs)-141 and -200c display resistance to the development of AFL. We found that miR-200c directly targets HNF1 homeobox B (Hnf1b), a transcriptional activator for microsomal triglyceride transfer protein (Mttp), as well as apolipoprotein O (ApoO), an integral component of the mitochondrial contact site and cristae organizing system complex. We show that expression of these miRs is significantly induced by chronic ethanol exposure, which is accompanied by reduced HNF1B and APOO levels. Furthermore, miR-141/200c deficiency normalizes ethanol-mediated impairment of triglyceride secretion, which can be attributed to the restored levels of HNF1B and MTTP, as well as phosphatidylcholine abundance. Moreover, we demonstrate that miR-141/200c deficiency restores ethanol-mediated inhibition of APOO expression and mitochondrial dysfunction, improving mitochondrial antioxidant defense capacity and fatty acid oxidation. Taken together, these results suggest that miR-200c contributes to the modulation of lipid homeostasis in AFL disease by cooperatively regulating Hnf1b and ApoO functions.	[Kang, Hyunju; Park, Young-Ki; Lee, Ji-Young] Yale Univ, Dept Physiol & Neurobiol, Sect Digest Dis, New Haven, CT 06520 USA; [Wang, Li] Univ Connecticut, Dept Nutr Sci, Storrs, CT USA; [Tran, Melanie] Yale Univ, Yale Univ, Dept Internal Med, Sect Digest Dis, New Haven, CT USA; [Shin, Dong-Ju] Univ Connecticut Hlth Ctr, Dept ofMedicine, Div Nephrol, Farmington, CT 06030 USA	Yale University; University of Connecticut; Yale University; University of Connecticut	Shin, DJ (corresponding author), Univ Connecticut Hlth Ctr, Dept ofMedicine, Div Nephrol, Farmington, CT 06030 USA.	dong-ju-shin@uconn.edu		Mostofa, Md./0000-0002-0488-9121	National Institutes of Health [R01AA026322]; American Heart Association postdoctoral fellowship [18POST33960183]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association postdoctoral fellowship(American Heart Association)	This study was supported by the National Institutes of Health (R01AA026322 to D.-J. S.) . M. T. was supported by an American Heart Association postdoctoral fellowship (18POST33960183) .	Attal N, 2021, TRANSL ONCOL, V14, DOI 10.1016/j.tranon.2020.100975; BARAONA E, 1979, J LIPID RES, V20, P289; BARAONA E, 1970, J CLIN INVEST, V49, P769, DOI 10.1172/JCI106290; Belgardt BF, 2015, NAT MED, V21, P619, DOI 10.1038/nm.3862; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; BORENSZTAJN J, 1976, BIOCHEM J, V156, P539, DOI 10.1042/bj1560539; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cao HJ, 2013, DEVELOPMENT, V140, P3348, DOI 10.1242/dev.089193; Carr RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097118; Charlton M, 2009, HEPATOLOGY, V49, P1375, DOI 10.1002/hep.22927; Chen L, 2017, BIOMED PHYS ENG EXPR, V3, DOI 10.1088/2057-1976/aa7efa; Clugston RD, 2014, J LIPID RES, V55, P239, DOI 10.1194/jlr.M041863; Das S, 2012, PFLUG ARCH EUR J PHY, V464, P101, DOI 10.1007/s00424-012-1100-4; Feng XL, 2014, CANCER LETT, V344, P166, DOI 10.1016/j.canlet.2013.11.004; Feng YY, 2014, CELL PHYSIOL BIOCHEM, V34, P1983, DOI 10.1159/000366394; Fischer M, 2003, J BIOL CHEM, V278, P27997, DOI 10.1074/jbc.M302140200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gaemers IC, 2011, BBA-MOL BASIS DIS, V1812, P447, DOI 10.1016/j.bbadis.2011.01.003; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; GORDON ER, 1972, BIOCHEM PHARMACOL, V21, P2991, DOI 10.1016/0006-2952(72)90192-X; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; Han XY, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-81; Hasuwa H, 2013, SCIENCE, V341, P71, DOI 10.1126/science.1237999; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hoek JB, 2002, GASTROENTEROLOGY, V122, P2049, DOI 10.1053/gast.2002.33613; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Hussain MM, 2011, CLIN LIPIDOL, V6, P293, DOI 10.2217/CLP.11.21; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Jandacek RJ, 2017, HEALTHCARE-BASEL, V5, DOI 10.3390/healthcare5020025; Kennell JA, 2008, P NATL ACAD SCI USA, V105, P15417, DOI 10.1073/pnas.0807763105; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Ki SH, 2010, HEPATOLOGY, V52, P1291, DOI 10.1002/hep.23837; Koob S, 2015, BBA-MOL CELL RES, V1853, P1551, DOI 10.1016/j.bbamcr.2015.03.004; Koob S, 2014, BIOL CHEM, V395, P285, DOI 10.1515/hsz-2013-0274; Kornfeld JW, 2013, NATURE, V494, P111, DOI 10.1038/nature11793; Lamant M, 2006, J BIOL CHEM, V281, P36289, DOI 10.1074/jbc.M510861200; Lee YK, 2016, BMB REP, V49, P424, DOI 10.5483/BMBRep.2016.49.8.081; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; LIEBER CS, 1994, ALCOHOL CLIN EXP RES, V18, P592, DOI 10.1111/j.1530-0277.1994.tb00915.x; Lin MCM, 1997, FASEB J, V11, P1145, DOI 10.1096/fasebj.11.13.9367349; Long Z, 2017, FREE RADICAL BIO MED, V113, P71, DOI 10.1016/j.freeradbiomed.2017.09.016; LOSOWSKY MS, 1963, AM J MED, V35, P794, DOI 10.1016/0002-9343(63)90241-9; MAVRELIS PG, 1983, HEPATOLOGY, V3, P226; MORLAND J, 1974, BIOCHEM PHARMACOL, V23, P21, DOI 10.1016/0006-2952(74)90310-4; Nijstad N, 2011, BBA-MOL CELL BIOL L, V1811, P294, DOI 10.1016/j.bbalip.2011.01.008; Noga AA, 2003, J BIOL CHEM, V278, P21851, DOI 10.1074/jbc.M301982200; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; ONTKO JA, 1973, J LIPID RES, V14, P78; Sampath H, 2005, LIPIDS, V40, P1187, DOI 10.1007/s11745-005-1484-z; SCHAPIRO RH, 1964, J CLIN INVEST, V43, P1338, DOI 10.1172/JCI105009; SCHAPIRO RH, 1965, NEW ENGL J MED, V272, P610, DOI 10.1056/NEJM196503252721203; Smathers RL, 2013, J LIPID RES, V54, P1335, DOI 10.1194/jlr.M034892; Sugimoto T, 2002, J HEPATOL, V36, P157, DOI 10.1016/S0168-8278(01)00263-X; Thumser AE, 2014, CURR OPIN CLIN NUTR, V17, P124, DOI 10.1097/MCO.0000000000000031; Tian F, 2017, BIOCHEM BIOPH RES CO, V491, P8, DOI 10.1016/j.bbrc.2017.06.128; Tran M, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.96094; VANCE DE, 1990, BIOCHEM CELL BIOL, V68, P1151, DOI 10.1139/o90-172; VENKATESAN S, 1988, BIOCHIM BIOPHYS ACTA, V960, P61, DOI 10.1016/0005-2760(88)90009-4; Xu MJ, 2015, GASTROENTEROLOGY, V149, P1030, DOI 10.1053/j.gastro.2015.06.009; YAO ZM, 1988, J BIOL CHEM, V263, P2998; You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200; Yu JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep29352; Zaqout S, 2020, FRONT NEUROANAT, V14, DOI 10.3389/fnana.2020.582218; Zhang GX, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0858-x	65	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101966	10.1016/j.jbc.2022.101966	http://dx.doi.org/10.1016/j.jbc.2022.101966			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9DZ	35460694	Green Published, gold			2022-12-26	WOS:000807750700002
J	Jamieson, JJ; Lin, YY; Malloy, NA; Soto, D; Searson, PC; Gerecht, S				Jamieson, John J.; Lin, YingYu; Malloy, Nora A.; Soto, Daniel; Searson, Peter C.; Gerecht, Sharon			Hypoxia-induced blood-brain barrier dysfunction is prevented by pericyte-conditioned media via attenuated actomyosin contractility and claudin-5 stabilization	FASEB JOURNAL			English	Article						blood-brain barrier; brain microvascular endothelial cells; contractility; hypoxia; induced pluripotent stem cells; pericytes; tissue engineering; transendothelial electrical resistance	CAPILLARY ENDOTHELIAL-CELLS; PLURIPOTENT STEM-CELLS; FIBRONECTIN FIBRILLOGENESIS; EXTRACELLULAR-MATRIX; PERMEABILITY; INHIBITION; INCREASES; HIF-1	The blood-brain barrier (BBB) regulates molecular and cellular entry from the cerebrovasculature into the surrounding brain parenchyma. Many diseases of the brain are associated with dysfunction of the BBB, where hypoxia is a common stressor. However, the contribution of hypoxia to BBB dysfunction is challenging to study due to the complexity of the brain microenvironment. In this study, we used a BBB model with brain microvascular endothelial cells and pericytes differentiated from iPSCs to investigate the effect of hypoxia on barrier function. We found that hypoxia-induced barrier dysfunction is dependent upon increased actomyosin contractility and is associated with increased fibronectin fibrillogenesis. We propose a role for actomyosin contractility in mediating hypoxia-induced barrier dysfunction through modulation of junctional claudin-5. Our findings suggest pericytes may protect brain microvascular endothelial cells from hypoxic stresses and that pericyte-derived factors could be candidates for treatment of pathological barrier-forming tissues.	[Jamieson, John J.; Lin, YingYu; Gerecht, Sharon] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Jamieson, John J.; Lin, YingYu; Searson, Peter C.; Gerecht, Sharon] Johns Hopkins Univ, Inst Nanobiotechnol, 100 Croft Hall,3400 North Charles St, Baltimore, MD 21218 USA; [Malloy, Nora A.; Soto, Daniel] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Sch Med, Baltimore, MD 21218 USA; [Searson, Peter C.; Gerecht, Sharon] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Searson, Peter C.; Gerecht, Sharon] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA; [Gerecht, Sharon] Duke Univ, Dept Biomed Engn, Duke, NC USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Duke University	Searson, PC; Gerecht, S (corresponding author), Johns Hopkins Univ, Inst Nanobiotechnol, 100 Croft Hall,3400 North Charles St, Baltimore, MD 21218 USA.	searson@jhu.edu; sharon.gerecht@duke.edu	Gerecht, Sharon/HCH-8629-2022	Gerecht, Sharon/0000-0002-8542-4835	DOD \ Defense Threat Reduction Agency (DTRA) [HDTRA1-15-1-0046]; HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [R61 HL154252]; HHS \ NIH \ National Institute of Neurological Disorders and Stroke (NINDS) [R01NS106008]; Maryland Stem Cell Research Fund (MSCRF) [MSCRFI-2784]; HHS \ NIH \ National Cancer Institute (NCI) [U54CA210173]; American Heart Association (AHA) [19PRE34380896]; Air Force Office of Scientific Research [FA9550-20-1-0356]	DOD \ Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI); HHS \ NIH \ National Institute of Neurological Disorders and Stroke (NINDS); Maryland Stem Cell Research Fund (MSCRF); HHS \ NIH \ National Cancer Institute (NCI); American Heart Association (AHA)(American Heart Association); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	DOD vertical bar Defense Threat Reduction Agency (DTRA), Grant/Award Number: HDTRA1-15-1-0046; HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: R61 HL154252; HHS vertical bar NIH vertical bar National Institute of Neurological Disorders and Stroke (NINDS), Grant/Award Number: R01NS106008; Maryland Stem Cell Research Fund (MSCRF), Grant/Award Number: MSCRFI-2784; HHS vertical bar NIH vertical bar National Cancer Institute (NCI), Grant/Award Number: U54CA210173; American Heart Association (AHA), Grant/Award Number: 19PRE34380896; Air Force Office of Scientific Research, Grant/Award Number: FA9550-20-1-0356	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Al Ahmad A, 2009, J CELL PHYSIOL, V218, P612, DOI 10.1002/jcp.21638; Baumann J, 2019, EXP CELL RES, V383, DOI 10.1016/j.yexcr.2019.111503; BENSON P F, 1961, Cereb Palsy Bull, V3, P510; Brillault J, 2002, J NEUROCHEM, V83, P807, DOI 10.1046/j.1471-4159.2002.01186.x; Chi AY, 2010, ANTIOXID REDOX SIGN, V12, P603, DOI 10.1089/ars.2009.2861; Citi Sandra, 2019, Biophys Rev, V11, P783, DOI 10.1007/s12551-019-00582-7; Davidson CD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37044-1; DeStefano JG, 2018, FLUIDS BARRIERS CNS, V15, DOI 10.1186/s12987-018-0117-2; Engelhardt S, 2014, BRIT J PHARMACOL, V171, P1210, DOI 10.1111/bph.12489; Engelhardt S, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/2045-8118-12-4; Engelhardt S, 2014, J CELL PHYSIOL, V229, P1096, DOI 10.1002/jcp.24544; Faal T, 2019, STEM CELL REP, V12, P451, DOI 10.1016/j.stemcr.2019.01.005; Griggs LA, 2017, MATRIX BIOL, V60-61, P157, DOI 10.1016/j.matbio.2017.01.001; Gudzenko T, 2015, MOL BIOL CELL, V26, P3190, DOI [10.1091/mbc.E14-05-1026, 10.1091/mbc.E15-06-0421]; Hayashi K, 2004, REGUL PEPTIDES, V123, P77, DOI 10.1016/j.regpep.2004.05.023; Hicks K, 2010, AM J PHYSIOL-CELL PH, V298, pC1583, DOI 10.1152/ajpcell.00458.2009; Hielscher A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147600; Hocking DC, 2000, J BIOL CHEM, V275, P10673, DOI 10.1074/jbc.275.14.10673; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; Jamieson JJ, 2019, FLUIDS BARRIERS CNS, V16, DOI 10.1186/s12987-019-0136-7; Kuhlmann CRW, 2007, J NEUROCHEM, V102, P501, DOI 10.1111/j.1471-4159.2007.04506.x; Kuntz M, 2014, MICROVASC RES, V91, P44, DOI 10.1016/j.mvr.2013.12.002; Kusuma S, 2013, P NATL ACAD SCI USA, V110, P12601, DOI 10.1073/pnas.1306562110; Kusuma S, 2012, FASEB J, V26, P4925, DOI 10.1096/fj.12-209296; Lee TH, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0529-6; Lippmann ES, 2020, FLUIDS BARRIERS CNS, V17, DOI 10.1186/s12987-020-00222-3; Lippmann ES, 2014, SCI REP-UK, V4, DOI 10.1038/srep04160; Lu JY, 2020, DEV CELL, V52, P631, DOI 10.1016/j.devcel.2020.01.007; Luissint AC, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-23; Merali Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171558; Nzou G, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66487-8; Ogunshola OO, 2012, HIGH ALT MED BIOL, V13, P153, DOI 10.1089/ham.2012.1052; Page S, 2019, NEUROMOL MED, V21, P414, DOI 10.1007/s12017-019-08531-z; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Qi HB, 2011, CELL PHYSIOL BIOCHEM, V27, P251, DOI 10.1159/000327951; Rana MK, 2015, J CELL SCI, V128, P1083, DOI 10.1242/jcs.155036; Sabatier L, 2009, MOL BIOL CELL, V20, P846, DOI 10.1091/mbc.E08-08-0830; Saunders JT, 2019, MOL BIOL CELL, V30, P2218, DOI 10.1091/mbc.E19-03-0140; Scott LE, 2015, INTEGR BIOL-UK, V7, P1454, DOI 10.1039/c5ib00217f; Stebbins MJ, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau7375; Tornabene E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221103; Underly RG, 2017, J NEUROSCI, V37, P129, DOI 10.1523/JNEUROSCI.2891-16.2016; Varadaraj A, 2017, MOL BIOL CELL, V28, P1195, DOI 10.1091/mbc.E16-08-0601; Wang P, 2013, CELL PHYSIOL BIOCHEM, V32, P859, DOI 10.1159/000354488; Witt KA, 2008, MICROVASC RES, V75, P91, DOI 10.1016/j.mvr.2007.06.004; Wong Andrew D, 2013, Front Neuroeng, V6, P7, DOI 10.3389/fneng.2013.00007; Yamashita M, 2020, FLUIDS BARRIERS CNS, V17, DOI 10.1186/s12987-020-00197-1; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067; Zieseniss A, 2014, HYPOXIA, V2, P11, DOI 10.2147/HP.S53575	50	0	0	7	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22331	10.1096/fj.202200010RR	http://dx.doi.org/10.1096/fj.202200010RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0U8EI	35476363				2022-12-26	WOS:000787879900001
J	Osada, Y; Motojima, N; Kobayashi, Y; Yamamoto, S				Osada, Yuji; Motojima, Naoyuki; Kobayashi, Yousuke; Yamamoto, Sumiko			Differences in mediolateral dynamic stability during gait initiation according to whether the non-paretic or paretic leg is used as the leading limb	PLOS ONE			English	Article							INDIVIDUALS; HEALTHY; BALANCE; RELIABILITY; STROKE; HIP	We investigated mediolateral dynamic stability at first foot off and first initial contact during gait initiation according to whether the paretic or non-paretic leg was used as the leading limb. Thirty-eight individuals with stroke initiated gait with the paretic and non-paretic legs as the leading limb, and their movements were measured using a 3D motion analysis system. Margin of stability (i.e., the length between the extrapolated center of mass and lateral border of the stance foot) was used as an index of dynamic stability, with a large value indicating dynamic stability in the lateral direction. However, an excessively large margin of stability value (i.e., when the extrapolated center of mass is outside the medial border of the stance foot) indicates dynamic instability in the medial direction. Differences in the margin of stability between tasks were compared using the Wilcoxon signed-rank test. The minimum margin of stability was observed just before first foot off. When the non-paretic leg was used as the leading limb, the margin of stability tended to be excessively large at first foot off compared with when the paretic leg was used (p < 0.001). In other words, the extrapolated center of mass was outside the medial border of the paretic stance foot. In conclusion, lateral stability was achieved when using the non-paretic leading limb because the extrapolated center of mass was located outside the medial border of the stance foot. However, medial dynamic stability was lower for the non-paretic leading limb compared with the paretic leading limb.	[Osada, Yuji] Tokushima Bunri Univ, Dept Hlth & Welf, Tokushima, Japan; [Motojima, Naoyuki] Showa Univ, Sch Nursing & Rehabil Sci, Yokohama, Kanagawa, Japan; [Kobayashi, Yousuke] Nakaizu Rehabil Ctr, Shizuoka, Japan; [Yamamoto, Sumiko] Int Univ Hlth & Welf, Grad Sch, Tokyo, Japan	Tokushima Bunri University; Showa University; International University of Health & Welfare	Osada, Y (corresponding author), Tokushima Bunri Univ, Dept Hlth & Welf, Tokushima, Japan.	osada@tks.bunri-u.ac.jp		Yamamoto, Sumiko/0000-0001-6402-873X				Bensoussan L, 2006, J REHABIL MED, V38, P287, DOI 10.1080/16501970600694859; BRUNT D, 1991, AM J PHYS MED REHAB, V70, P206, DOI 10.1097/00002060-199108000-00009; BRUNT D, 1995, ARCH PHYS MED REHAB, V76, P627, DOI 10.1016/S0003-9993(95)80631-8; Caderby T, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00127; Caderby T, 2014, J BIOMECH, V47, P417, DOI 10.1016/j.jbiomech.2013.11.011; Ceccato JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008193; Chen BL, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052696; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cruz TH, 2009, J BIOMECH, V42, P1673, DOI 10.1016/j.jbiomech.2009.04.015; DEMPSTER WILFRED TAYLOR, 1955, U S A F WRIGHT AIR DEVELOPMENT CENTER TECH REPT, V55/159, P1; Eng JJ, 2002, ARCH PHYS MED REHAB, V83, P1138, DOI 10.1053/apmr.2002.33644; Hesse S, 1997, ARCH PHYS MED REHAB, V78, P719, DOI 10.1016/S0003-9993(97)90079-4; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Jiang N, 2015, CLIN NEUROPHYSIOL, V126, P154, DOI 10.1016/j.clinph.2014.05.003; Kirker SGB, 2000, J NEUROL NEUROSUR PS, V68, P458, DOI 10.1136/jnnp.68.4.458; Ko M, 2011, TOP STROKE REHABIL, V18, P258, DOI 10.1310/tsr1803-258; Kozinc Z, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10090667; Osada Yuji, 2015, J Jpn Phys Ther Assoc, V18, P7, DOI 10.1298/jjpta.Vol18_002; RADOMSKI MV, 1986, AM J OCCUP THER, V40, P55, DOI 10.5014/ajot.40.1.55b; Rektor I, 2001, CLIN NEUROPHYSIOL, V112, P2146, DOI 10.1016/S1388-2457(01)00662-9; Robertson DGE, 2003, J ELECTROMYOGR KINES, V13, P569, DOI 10.1016/S1050-6411(03)00080-4; Rocchi L, 2006, NEUROSCI LETT, V406, P128, DOI 10.1016/j.neulet.2006.07.027; Rosenthal R., 2008, ESSENTIALS BEHAV RES; Sharma S, 2015, CLIN BIOMECH, V30, P689, DOI 10.1016/j.clinbiomech.2015.05.004; Sivakumaran S, 2018, HUM MOVEMENT SCI, V57, P366, DOI 10.1016/j.humov.2017.09.014; Sousa ASP, 2015, J APPL BIOMECH, V31, P349, DOI 10.1123/jab.2014-0222; Stackhouse C, 2007, GAIT POSTURE, V26, P301, DOI 10.1016/j.gaitpost.2006.09.076; Tisserand R, 2018, HUM MOVEMENT SCI, V58, P175, DOI 10.1016/j.humov.2018.01.012; Tokuno CD, 2006, GAIT POSTURE, V24, P424, DOI 10.1016/j.gaitpost.2005.09.012; van Dijk MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183020; Vistamehr A, 2016, J BIOMECH, V49, P396, DOI 10.1016/j.jbiomech.2015.12.047; WIDAJEWICZ W, 1994, J NEUROPHYSIOL, V72, P2070, DOI 10.1152/jn.1994.72.5.2070; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6; Yiou E, 2017, WORLD J ORTHOP, V8, P815, DOI 10.5312/wjo.v8.i11.815	34	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267577	10.1371/journal.pone.0267577	http://dx.doi.org/10.1371/journal.pone.0267577			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476702	Green Published, gold			2022-12-26	WOS:000840124300053
J	Liu, Y; Luo, YW; Yan, SM; Lian, YF; Wu, SY; Xu, M; Feng, L; Zhang, X; Li, R; Zhang, XT; Feng, QS; Zeng, YX; Zhang, H				Liu, Yang; Luo, Yuewen; Yan, Shumei; Lian, Yi-Fan; Wu, Shiyu; Xu, Miao; Feng, Lin; Zhang, Xu; Li, Rong; Zhang, Xiantao; Feng, Qi-Sheng; Zeng, Yi-Xin; Zhang, Hui			CRL2(KLHDC3) mediates p14ARF N-terminal ubiquitylation degradation to promote non-small cell lung carcinoma progression	ONCOGENE			English	Article							UBIQUITIN LIGASE; CANCER; MUTATIONS; RESISTANCE; PROTEIN; DICHLOROACETATE; EXPRESSION; GEFITINIB; MDM2	Kelch superfamily involves a variety of proteins containing multiple kelch motif and is well characterized as substrate adaptors for CUL3 E3 ligases, which play critical roles in carcinogenesis. However, the role of kelch proteins in lung cancer remains largely unknown. In this study, the non-small cell lung cancer (NSCLC) patients with higher expression of a kelch protein, kelch domain containing 3 (KLHDC3), showed worse overall survival. KLHDC3 deficiency affected NSCLC cell lines proliferation in vitro and in vivo. Further study indicated that KLHDC3 mediated CUL2 E3 ligase and tumor suppressor p14ARF interaction, facilitating the N-terminal ubiquitylation and subsequent degradation of p14ARF. Interestingly, Gefitinib-resistant NSCLC cell lines displayed higher KLHDC3 protein levels. Gefitinib and Osimertinib medications were capable of upregulating KLHDC3 expression to promote p14ARF degradation in the NSCLC cell lines. KLHDC3 shortage significantly increased the sensitivity of lung cancer cells to epidermal growth factor receptor (EGFR)-targeted drugs, providing an alternative explanation for the development of Gefitinib and Osimertinib resistance in NSCLC therapy. Our works suggest that CRL2(KLHDC3) could be a valuable target to regulate the abundance of p14ARF and postpone the occurrence of EGFR-targeted drugs resistance.	[Liu, Yang; Xu, Miao; Feng, Lin; Feng, Qi-Sheng; Zeng, Yi-Xin] Sun Yat Sen Univ Canc Ctr, Dept Expt Res, State Key Lab Oncol South China, Guangzhou 510060, Peoples R China; [Luo, Yuewen; Wu, Shiyu; Zhang, Xu; Li, Rong; Zhang, Xiantao; Zhang, Hui] Sun Yat Sen Univ, Guangdong Engn Res Ctr Antimicrobial Agent & Immu, Zhongshan Sch Med, Inst Human Virol,Key Lab Trop Dis Control,Minist, Guangzhou, Guangdong, Peoples R China; [Luo, Yuewen] Sun Yat Sen Univ, Sch Med, Guangzhou 510080, Peoples R China; [Yan, Shumei] Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Pathol, State Key Lab Oncol South China, Guangzhou, Peoples R China; [Lian, Yi-Fan] Sun Yat Sen Univ, Guangdong Prov Key Lab Liver Dis Res, Affiliated Hosp 3, Guangzhou, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Zeng, YX (corresponding author), Sun Yat Sen Univ Canc Ctr, Dept Expt Res, State Key Lab Oncol South China, Guangzhou 510060, Peoples R China.; Zhang, H (corresponding author), Sun Yat Sen Univ, Guangdong Engn Res Ctr Antimicrobial Agent & Immu, Zhongshan Sch Med, Inst Human Virol,Key Lab Trop Dis Control,Minist, Guangzhou, Guangdong, Peoples R China.	zengyx@sysucc.org.cn; zhangh92@mail.sysu.edu.cn			Special Reserach Program of Sun Yat-sen University Cancer Center; National Special Research Program of China for Important Infectious Diseases [2018ZX10302103, 2017ZX10202102]; Important Key Program of NSFC [81730060]; Joint-Innovation Program in Healthcare for Special Scientific Research Projects of Guangzhou [201803040002]; Natural Science Foundation of Guangdong, China (Excellent Youth Foundation); Fundamental Research Funds for the Central Universities	Special Reserach Program of Sun Yat-sen University Cancer Center; National Special Research Program of China for Important Infectious Diseases; Important Key Program of NSFC; Joint-Innovation Program in Healthcare for Special Scientific Research Projects of Guangzhou; Natural Science Foundation of Guangdong, China (Excellent Youth Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	We thank Dr Li Zhang for kindly providing lung cancer cell lines. This work was supported by the Special Reserach Program of Sun Yat-sen University Cancer Center to Y-XZ; the National Special Research Program of China for Important Infectious Diseases (2018ZX10302103 and 2017ZX10202102), the Important Key Program of NSFC (81730060), and the Joint-Innovation Program in Healthcare for Special Scientific Research Projects of Guangzhou (201803040002) to HZ; the Natural Science Foundation of Guangdong, China (Excellent Youth Foundation) and the Fundamental Research Funds for the Central Universities to MX.	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; Chen DL, 2010, NATURE, V464, P624, DOI 10.1038/nature08820; Chen J, 2018, NATURE, V557, P585, DOI 10.1038/s41586-018-0128-9; Cross DAE, 2014, CANCER DISCOV, V4, P1046, DOI 10.1158/2159-8290.CD-14-0337; Dhanoa BS, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-13; Ettinger DS, 2017, J NATL COMPR CANC NE, V15, P504, DOI 10.6004/jnccn.2017.0050; Garon EB, 2014, J CANCER RES CLIN, V140, P443, DOI 10.1007/s00432-014-1583-9; Guo Y, 2015, FREE RADICAL BIO MED, V88, P337, DOI 10.1016/j.freeradbiomed.2015.06.013; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; ITO N, 1994, J MOL BIOL, V238, P794, DOI 10.1006/jmbi.1994.1335; Juan O, 2017, THER ADV MED ONCOL, V9, P201, DOI 10.1177/1758834016687262; Kamijo T, 1999, CANCER RES, V59, P2217; Khazaei Z, 2019, ADV HUM BIOL, V9, P245, DOI 10.4103/2321-8568.262891; Ko A, 2012, JNCI-J NATL CANCER I, V104, P1660, DOI 10.1093/jnci/djs424; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Kwon YT, 2017, TRENDS BIOCHEM SCI, V42, P873, DOI 10.1016/j.tibs.2017.09.002; Lian YF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152820; Luo YW, 2019, J IMMUNOL, V203, P269, DOI 10.4049/jimmunol.1900125; Mahrour N, 2008, J BIOL CHEM, V283, P8005, DOI 10.1074/jbc.M706987200; Maione P, 2015, THER ADV MED ONCOL, V7, P263, DOI 10.1177/1758834015595048; Nacak TG, 2007, CIRC RES, V100, P1155, DOI 10.1161/01.RES.0000265844.56493.ac; Ohinata Y, 2003, FEBS LETT, V537, P1, DOI 10.1016/S0014-5793(03)00036-X; Olszewski U, 2010, CLIN PHARMACOL-ADV A, V2, P177, DOI 10.2147/CPAA.S11795; Ozenne P, 2010, INT J CANCER, V127, P2239, DOI 10.1002/ijc.25511; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Recondo G, 2018, NAT REV CLIN ONCOL, V15, P694, DOI 10.1038/s41571-018-0081-4; Reinstein E, 2000, ONCOGENE, V19, P5944, DOI 10.1038/sj.onc.1203989; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Schwaederle M, 2015, CANCER RES, V75, P1187, DOI 10.1158/0008-5472.CAN-14-2305; Senga SS, 2021, OPEN BIOL, V11, DOI 10.1098/rsob.200358; Shibata S, 2013, P NATL ACAD SCI USA, V110, P7838, DOI 10.1073/pnas.1304592110; Stogios PJ, 2004, TRENDS BIOCHEM SCI, V29, P634, DOI 10.1016/j.tibs.2004.10.003; Strutt H, 2013, DEVELOPMENT, V140, P1693, DOI 10.1242/dev.089656; Takezawa K, 2012, CANCER DISCOV, V2, P922, DOI 10.1158/2159-8290.CD-12-0108; Wang D, 2017, CANCER METAST REV, V36, P683, DOI 10.1007/s10555-017-9703-z; Wang XW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2533; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; XUE FY, 1993, CELL, V72, P681, DOI 10.1016/0092-8674(93)90397-9; Yan SM, 2016, J CANCER, V7, P618, DOI 10.7150/jca.14030; Yu WS, 2008, MOL CELLS, V26, P443; Zhang P, 2010, MOL CANCER THER, V9, P336, DOI 10.1158/1535-7163.MCT-09-0589; Zhong WZ, 2018, ANN ONCOL, V29, P738	50	0	0	4	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 27	2022	41	22					3104	3117		10.1038/s41388-022-02318-6	http://dx.doi.org/10.1038/s41388-022-02318-6		APR 2022	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	1U7PG	35468939				2022-12-26	WOS:000787133900002
J	Gao, P; Hao, JL; Xie, QW; Han, GQ; Xu, BB; Hu, H; Sa, NE; Du, XW; Tang, HL; Yan, J; Dong, XM				Gao, Ping; Hao, Jing-Lan; Xie, Qian-Wen; Han, Gui-Qin; Xu, Bin-Bing; Hu, Hang; Sa, Na-Er; Du, Xiao-Wen; Tang, Hai-Long; Yan, Jian; Dong, Xiao-Ming			PELO facilitates PLK1-induced the ubiquitination and degradation of Smad4 and promotes the progression of prostate cancer	ONCOGENE			English	Article							INHIBITORS	PLK1 and Smad4 are two important factors in prostate cancer initiation and progression. They have been reported to play the opposite role in Pten-deleted mice, one is an oncogene, the other is a tumor suppressor. Moreover, they could reversely regulate the PI3K/AKT/mTOR pathway and the activation of MYC. However, the connections between PLK1 and Smad4 have never been studied. Here, we showed that PLK1 could interact with Smad4 and promote the ubiquitination and degradation of Smad4 in PCa cells. PLK1 and PELO could bind to different domains of Smad4 and formed a protein complex. PELO facilitated the degradation of Smad4 through cooperating with PLK1, thereby resulting in proliferation and metastasis of prostate cancer cell. Changes in protein levels of Smad4 led to the alteration of biological function that caused by PLK1 in prostate cancer cells. Further studies showed that PELO upregulation was positively associated with high grade PCa and knockdown of PELO expression significantly decreased PCa cell proliferation and metastasis in vitro and vivo. PELO knockdown in PCa cells could enhance the tumor suppressive role of PLK1 inhibitor. In addition, blocking the interaction between PELO and Smad4 by using specific peptide could effectively inhibit PCa cell metastasis ability in vitro and vivo. Overall, these findings identified a novel regulatory relationship among PLK1, Smad4 and PELO, and provided a potential therapeutic strategy for advanced PCa therapy by co-targeting PLK1 and PELO.	[Gao, Ping; Hao, Jing-Lan; Xie, Qian-Wen; Han, Gui-Qin; Xu, Bin-Bing; Hu, Hang; Sa, Na-Er; Du, Xiao-Wen; Dong, Xiao-Ming] Shaanxi Normal Univ, Coll Life Sci, Xian 710119, Peoples R China; [Tang, Hai-Long] Fourth Mil Med Univ, Xijing Hosp, Dept Hematol, Xian 710032, Peoples R China; [Yan, Jian] Northwest Univ, Sch Med, Xian 710069, Peoples R China; [Yan, Jian] City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Peoples R China	Shaanxi Normal University; Air Force Military Medical University; Northwest University Xi'an; City University of Hong Kong	Gao, P; Dong, XM (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Xian 710119, Peoples R China.	ping.gao2016@outlook.com; xiaomingdong@snnu.edu.cn	; Yan, Jian/B-2631-2018	Dong, xiao-ming/0000-0003-2413-8541; Yan, Jian/0000-0002-1267-2870; gao, ping/0000-0003-1383-3290	College of Life Sciences at Shaanxi Normal University - National Natural Science Foundation of China [81972417]; "1000 Young Scholars" Program of Shaanxi Province; Natural Science Foundation of Shaanxi Province [2020JM-292, 2020JQ-430]; Fundamental Research Funds for the Central Universities [GK201902002, GK201903061]; College Students' Innovative Entrepreneurial Training Plan Program [S202110718036]	College of Life Sciences at Shaanxi Normal University - National Natural Science Foundation of China; "1000 Young Scholars" Program of Shaanxi Province; Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); College Students' Innovative Entrepreneurial Training Plan Program	We thank the College of Life Sciences at Shaanxi Normal University for the sharing platform of laboratory apparatus. This work was funded by the National Natural Science Foundation of China (81972417), The "1000 Young Scholars" Program of Shaanxi Province, Natural Science Foundation of Shaanxi Province (2020JM-292, 2020JQ-430), Fundamental Research Funds for the Central Universities (GK201902002, GK201903061) and College Students' Innovative Entrepreneurial Training Plan Program (S202110718036).	Adham IM, 2003, MOL CELL BIOL, V23, P1470, DOI 10.1128/MCB.23.4.1470-1476.2003; Garcia IA, 2020, MUTAT RES-FUND MOL M, V821, DOI 10.1016/j.mrfmmm.2020.111693; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen SQ, 2012, BIOORG MED CHEM LETT, V22, P1247, DOI 10.1016/j.bmcl.2011.11.052; Davis L, 1998, GENETICS, V149, P45; Demagny H, 2014, CELL REP, V9, P688, DOI 10.1016/j.celrep.2014.09.020; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Dong XM, 2020, FASEB J, V34, P8416, DOI 10.1096/fj.201902946R; Drucker DJ, 2020, NAT REV DRUG DISCOV, V19, P277, DOI 10.1038/s41573-019-0053-0; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fosgerau K, 2015, DRUG DISCOV TODAY, V20, P122, DOI 10.1016/j.drudis.2014.10.003; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gheghiani L, 2021, CANCER RES, V81, P1293, DOI 10.1158/0008-5472.CAN-20-1377; Goroshchuk O, 2019, ONCOGENE, V38, P1, DOI 10.1038/s41388-018-0443-5; Kleeff J, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.22; KUMAR S, 2015, BIOMED RES INT, V2015, DOI DOI 10.1155/2015/705745; Liakath-Ali K, 2018, NATURE, V556, P376, DOI 10.1038/s41586-018-0032-3; Liu XS, 2011, J BIOL CHEM, V286, P35795, DOI 10.1074/jbc.C111.269050; Ogawa R, 2019, CLIN CANCER RES, V25, P2887, DOI 10.1158/1078-0432.CCR-18-3684; Olmos D, 2011, CLIN CANCER RES, V17, P3420, DOI 10.1158/1078-0432.CCR-10-2946; Pedersen K, 2014, ONCOGENE, V33, P1190, DOI 10.1038/onc.2013.35; Roelen BAJ, 2003, AM J PHYSIOL-CELL PH, V285, pC823, DOI 10.1152/ajpcell.00053.2003; Shi CX, 2021, ONCOGENE, V40, P937, DOI 10.1038/s41388-020-01580-w; Song B, 2019, J CLIN INVEST, V129, P569, DOI 10.1172/JCI122367; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Tan J, 2013, CANCER DISCOV, V3, P1156, DOI 10.1158/2159-8290.CD-12-0595; van der Toom EE, 2019, NAT REV UROL, V16, P7, DOI 10.1038/s41585-018-0119-5; Weichert W, 2004, PROSTATE, V60, P240, DOI 10.1002/pros.20050; Whittaker SR, 2017, PHARMACOL THERAPEUT, V173, P83, DOI 10.1016/j.pharmthera.2017.02.008; Yao YS, 2020, EXP BIOL MED, V245, P777, DOI 10.1177/1535370220916709; Zhang M, 2017, CANCER LETT, V392, P71, DOI 10.1016/j.canlet.2017.01.024; Zhang Z, 2014, CANCER RES, V74, P6635, DOI 10.1158/0008-5472.CAN-14-1916	33	1	1	5	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 20	2022	41	21					2945	2957		10.1038/s41388-022-02316-8	http://dx.doi.org/10.1038/s41388-022-02316-8		APR 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	1L8MU	35437307	Green Submitted			2022-12-26	WOS:000784068300001
J	Alif, Z; Dunning, J; Chik, HYJ; Burke, T; Schroeder, J				Alif, Ziva; Dunning, Jamie; Chik, Heung Ying Janet; Burke, Terry; Schroeder, Julia			What is the best fitness measure in wild populations? A case study on the power of short-term fitness proxies to predict reproductive value	PLOS ONE			English	Article							HOUSE SPARROWS; INDIVIDUAL FITNESS; ANCESTORS; SELECTION; PARENTS; GROWTH	Fitness is at the core of evolutionary theory, but it is difficult to measure accurately. One way to measure long-term fitness is by calculating the individual's reproductive value, which represents the expected number of allele copies an individual passes on to distant future generations. However, this metric of fitness is scarcely used because the estimation of individual's reproductive value requires long-term pedigree data, which is rarely available in wild populations where following individuals from birth to death is often impossible. Wild study systems therefore use short-term fitness metrics as proxies, such as the number of offspring produced. This study compared two frequently used short-term metrics for fitness obtained at different offspring life stages (eggs, hatchlings, fledglings and recruits), and compared their ability to predict reproductive values derived from the genetic pedigree of a wild passerine bird population. We used twenty years of precise field observations and a near-complete genetic pedigree to calculate reproductive success, individual growth rate and de-lifed fitness as lifetime fitness measures, and as annual de-lifed fitness. We compared the power of these metrics to predict reproductive values and lineage survival to the end of the study period. The three short-term fitness proxies predict the reproductive values and lineage survival only when measured at the recruit stage. There were no significant differences between the different fitness proxies at the same offspring stages in predicting the reproductive values and lineage survival. Annual fitness at one year old predicted reproductive values equally well as lifetime de-lifed fitness. However, none of the short-term fitness proxies were strongly associated with the reproductive values. The commonly used short-term fitness proxies best predict long-term fitness when measured at recruitment stage. Thus, because lifetime fitness measured at recruit stage and annual fitness in the first year of life were the best proxies of long-term fitness in short-lived birds, we encourage their future use.	[Alif, Ziva; Dunning, Jamie; Schroeder, Julia] Imperial Coll London, Dept Life Sci, Silwood Pk, Ascot, Berks, England; [Chik, Heung Ying Janet] Univ Groningen, Groningen Inst Evolutionary Life Sci, Groningen, Netherlands; [Burke, Terry] Univ Sheffield, Dept Anim & Plant Sci, Sheffield, S Yorkshire, England	Imperial College London; University of Groningen; University of Sheffield	Alif, Z (corresponding author), Imperial Coll London, Dept Life Sci, Silwood Pk, Ascot, Berks, England.	ziva.alif@gmail.com		Chik, Heung Ying Janet/0000-0003-4646-4444	Public Scholarship, Development, Disability and Maintenance Fund of the Republic of Slovenia; Volkswagen Foundation; German Research Foundation: Deutsche Forschungsgemeinschaft [CIG PCIG12-GA-2012-333096]; European Research Council; UK Natural Envirronment Research Council [NE/F006071/1, NE/J024597/1, NE/M005941/1]	Public Scholarship, Development, Disability and Maintenance Fund of the Republic of Slovenia; Volkswagen Foundation(Volkswagen); German Research Foundation: Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); UK Natural Envirronment Research Council	VZA received Ad Futura scholarship from the Public Scholarship, Development, Disability and Maintenance Fund of the Republic of Slovenia (https://www.srips-rs.si/en). JS was supported by the Volkswagen Foundation (https://www.volkswagenstiftung.de/en), a grant from the German Research Foundation: Deutsche Forschungsgemeinschaft (https://www.dfg.de/en/), and CIG PCIG12-GA-2012-333096 from the European Research Council (https://erc.europa.eu). TB was supported by UK Natural Envirronment Research Council grants NE/F006071/1, NE/J024597/1 and NE/M005941/1 (https://nerc.ukri.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton NH, 2011, GENETICS, V188, P953, DOI 10.1534/genetics.111.127555; Brommer JE, 2004, AM NAT, V163, P505, DOI 10.1086/382547; Brommer JE, 2002, ECOL LETT, V5, P802, DOI 10.1046/j.1461-0248.2002.00369.x; Chang JT, 1999, ADV APPL PROBAB, V31, P1002, DOI 10.1239/aap/1029955256; Chen N, 2019, P NATL ACAD SCI USA, V116, P2158, DOI 10.1073/pnas.1813852116; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; Coulson T, 2006, P ROY SOC B-BIOL SCI, V273, P547, DOI 10.1098/rspb.2005.3357; Dobson FS, 2020, FRONT ECOL EVOL, V8, DOI 10.3389/fevo.2020.00216; Dobson FS, 2016, ECOL EVOL, V6, P5614, DOI 10.1002/ece3.2279; Engen S, 2009, AM NAT, V174, P795, DOI 10.1086/647930; Fisher, 1930, GENETICAL THEORY NAT; Grafen A., 1988, REPROD SUCCESS, P454, DOI DOI 10.1098/RSTB.2007.0011; Grafen A, 2006, J MATH BIOL, V53, P15, DOI 10.1007/s00285-006-0376-4; Grafen A, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0356; Gratten J, 2008, SCIENCE, V319, P318, DOI 10.1126/science.1151182; Gravel S, 2015, THEOR POPUL BIOL, V101, P47, DOI 10.1016/j.tpb.2015.02.002; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; HILL WG, 1993, HEREDITY, V71, P652, DOI 10.1038/hdy.1993.190; Hunter DC, 2019, J HERED, V110, P433, DOI 10.1093/jhered/esz033; Kaar P, 1998, P ROY SOC B-BIOL SCI, V265, P2415, DOI 10.1098/rspb.1998.0592; KOZLOWSKI J, 1993, TRENDS ECOL EVOL, V8, P84, DOI 10.1016/0169-5347(93)90056-U; MACCLUER JW, 1986, ZOO BIOL, V5, P147, DOI 10.1002/zoo.1430050209; McGraw JB, 1996, AM NAT, V147, P47, DOI 10.1086/285839; Moorad JA, 2014, ECOLOGY, V95, P1087, DOI 10.1890/13-0778.1; Nakagawa S, 2007, OECOLOGIA, V153, P749, DOI 10.1007/s00442-007-0765-4; Ockendon N, 2009, BEHAV ECOL, V20, P305, DOI 10.1093/beheco/arp006; Orr HA, 2009, NAT REV GENET, V10, P531, DOI 10.1038/nrg2603; R Core Team, 2021, R LANG ENV STAT; Reid JM, 2019, EVOL LETT, V3, P271, DOI 10.1002/evl3.118; Roff DA, 2008, J GENET, V87, P339, DOI 10.1007/s12041-008-0056-9; Rubach KK, 2020, J MAMMAL, V101, P1302, DOI 10.1093/jmammal/gyaa086; Saether BE, 2015, TRENDS ECOL EVOL, V30, P273, DOI 10.1016/j.tree.2015.03.007; Schroeder J, 2012, J EVOLUTION BIOL, V25, P149, DOI 10.1111/j.1420-9101.2011.02412.x; Schroeder J, 2015, P NATL ACAD SCI USA, V112, P4021, DOI 10.1073/pnas.1422715112; Schroeder J, 2011, J AVIAN BIOL, V42, P271, DOI 10.1111/j.1600-048X.2010.05271.x; Simons MJP, 2015, ECOL EVOL, V5, P3500, DOI 10.1002/ece3.1623; Wolak ME, 2012, METHODS ECOL EVOL, V3, P792, DOI 10.1111/j.2041-210X.2012.00213.x; Wolf JB, 2001, J EVOLUTION BIOL, V14, P347, DOI 10.1046/j.1420-9101.2001.00277.x	38	2	2	6	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0260905	10.1371/journal.pone.0260905	http://dx.doi.org/10.1371/journal.pone.0260905			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C1KV	35452482	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000792887700041
J	Fernandes, LD; Mata, AS; Godoy, WAC; Reigada, C				Fernandes, Lucas D.; Mata, Angelica S.; Godoy, Wesley A. C.; Reigada, Carolina			Refuge distributions and landscape connectivity affect host-parasitoid dynamics: Motivations for biological control in agroecosystems	PLOS ONE			English	Article							HABITAT FRAGMENTATION; SCALE DRIVERS; PATCH SIZE; AGGREGATION; DIVERSITY; BEETLE	Species distributions are affected by landscape structure at different spatial scales. Here we study how the interplay between dispersal at different spatial scales and landscape connectivity and composition affect local species dynamics. Using a host-parasitoid model, we assessed host density and host occupancy on the landscape, under different parasitoid dispersal ranges and three local distributions of non-crop habitats, areas where hosts are unable to grow but parasitoids are provided with alternative hosts and food resources. Our results show distinct responses of host density to increases in non-crop area, measured by differences in slopes for different distributions of non-crop habitats, and that the effect of local landscape composition on species dynamics depends on the landscape connectivity at the regional scale. Moreover, we show how host density and occupancy are affected by increasing parasitoid dispersal ranges depending on landscape structure. Our results demonstrate the role of local and regional scales on species distributions and the importance of the combined effects of species biological parameters and landscape structure on species dynamics. Finally, we highlight the relevance of these aspects for the development of better strategies of biological control.	[Fernandes, Lucas D.] Imperial Coll London, Dept Life Sci, Silwood Pk, Ascot, Berks, England; [Fernandes, Lucas D.; Godoy, Wesley A. C.] Univ Sao Paulo, Dept Entomol & Acarol, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil; [Mata, Angelica S.] Univ Fed Lavras UFLA, Dept Fis, Lavras, MG, Brazil; [Reigada, Carolina] Univ Fed Sao Carlos UFSCar, Dept Ecol & Biol Evolut, Rodovia Washington Luis, Sao Carlos, SP, Brazil	Imperial College London; Universidade de Sao Paulo; Universidade Federal de Lavras; Universidade Federal de Sao Carlos	Fernandes, LD (corresponding author), Imperial Coll London, Dept Life Sci, Silwood Pk, Ascot, Berks, England.; Fernandes, LD (corresponding author), Univ Sao Paulo, Dept Entomol & Acarol, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil.	ldiasfer@imperial.ac.uk	D. Fernandes, Lucas/Q-1792-2015	D. Fernandes, Lucas/0000-0001-6053-2277; Sousa da Mata, Angelica/0000-0002-3892-5274	Brazilian agency FAPESP; Brazilian agency CAPES; Brazilian agency FAPEMIG; Sao Paulo Research Foundation (FAPESP) [2015/26989-4, 2014/16609-7, 2019/11672-6]; FAPEMIG [APQ-02482-18]; CNPq [423185/2018-7]	Brazilian agency FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian agency CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian agency FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was partially supported by the Brazilian agencies FAPESP (https://fapesp.br/), CAPES (https://www.gov.br/capes/pt-br), FAPEMIG (http://www.fapemig.br/pt/), and CNPq (https://www.gov.br/cnpq/pt-br).L.D.F., W.A.C.G. and C.R. acknowledge funding provided by the Sao Paulo Research Foundation (FAPESP -grants \#2015/26989-4, \#2014/16609-7, and \#2019/11672-6). A.S.M. acknowledges computational time at DFI-UFLA and support by FAPEMIG (Grant No. APQ-02482-18) and CNPq (Grant No. 423185/2018-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermatt F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019525; Amarasekare P, 2000, J ANIM ECOL, V69, P201, DOI 10.1046/j.1365-2656.2000.00378.x; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Barbosa Pedro, 1998, P55, DOI 10.1016/B978-012078147-8/50050-5; Bellone D., 2019, BASIC APPL ECOL, V43; Beverton R.J.H., 1957, FISH INVEST LONDON S, V19; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Briggs CJ, 2004, THEOR POPUL BIOL, V65, P299, DOI 10.1016/j.tpb.2003.11.001; Chaplin-Kramer R, 2012, ECOL APPL, V22, P1936, DOI 10.1890/11-1844.1; Fahrig L, 2019, BIOL CONSERV, V230, P179, DOI 10.1016/j.biocon.2018.12.026; Fahrig L, 2017, ANNU REV ECOL EVOL S, V48, P1, DOI 10.1146/annurev-ecolsys-110316-022612; Fletcher RJ, 2018, BIOL CONSERV, V226, P9, DOI 10.1016/j.biocon.2018.07.022; Fortuna MA, 2006, P ROY SOC B-BIOL SCI, V273, P1429, DOI 10.1098/rspb.2005.3448; Fraser SEM, 2007, J APPL ECOL, V44, P352, DOI 10.1111/j.1365-2664.2006.01266.x; Gonzalez E, 2022, BIOL CONSERV, V265, DOI 10.1016/j.biocon.2021.109409; Haan NL, 2020, TRENDS ECOL EVOL, V35, P175, DOI 10.1016/j.tree.2019.10.003; Karp DS, 2018, P NATL ACAD SCI USA, V115, pE7863, DOI 10.1073/pnas.1800042115; Le Gal A, 2020, ECOL MODEL, V420, DOI 10.1016/j.ecolmodel.2019.108912; Letourneau DK, 2011, ECOL APPL, V21, P9, DOI 10.1890/09-2026.1; Lustig A, 2017, LANDSCAPE ECOL, V32, P2311, DOI 10.1007/s10980-017-0570-3; Malard JJ, 2020, ECOL MODEL, V421, DOI 10.1016/j.ecolmodel.2020.108961; Martin EA, 2019, ECOL LETT, V22, P1083, DOI 10.1111/ele.13265; MAY RM, 1981, J ANIM ECOL, V50, P855, DOI 10.2307/4142; Medeiros HR, 2019, BIOL CONSERV, V238, DOI 10.1016/j.biocon.2019.07.038; MURDOCH WW, 1992, AM NAT, V140, P41, DOI 10.1086/285402; Newman EA, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00293; NICHOLSON A. J., 1935, Proceedings of the Zoological Society of London, P551; Pareja M, 2008, BASIC APPL ECOL, V9, P701, DOI 10.1016/j.baae.2007.10.008; Perez-Alvarez R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45041-1; QUINN JF, 1988, OECOLOGIA, V75, P132, DOI 10.1007/BF00378826; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; REIGADA C., 2014, ECOLOGICAL MODELLING, P11; Reigada C, 2012, OIKOS, V121, P1665, DOI 10.1111/j.1600-0706.2011.20259.x; Roderick GK, 2003, NAT REV GENET, V4, P889, DOI 10.1038/nrg1201; Rusch A, 2010, ADV AGRON, V109, P219, DOI 10.1016/S0065-2113(10)09006-1; Schmidt MH, 2004, ECOLOGICAL ENGINEERING FOR PEST MANAGEMENT: ADVANCES IN HABITAT MANIPULATION FOR ARTHROPODS, P55; Seidl R, 2016, J APPL ECOL, V53, P530, DOI 10.1111/1365-2664.12540; Senf C, 2017, LANDSCAPE ECOL, V32, P501, DOI 10.1007/s10980-016-0460-0; Sober V, 2020, AGR ECOSYST ENVIRON, V298, DOI 10.1016/j.agee.2020.106961; Souza B, 2019, NATURAL ENEMIES INSE; Thies C, 1999, SCIENCE, V285, P893, DOI 10.1126/science.285.5429.893; THOMAS CD, 1994, CONSERV BIOL, V8, P373, DOI 10.1046/j.1523-1739.1994.08020373.x; Thompson SED, 2019, ECOL LETT, V22, P2087, DOI 10.1111/ele.13398; Tscharntke T, 2002, ECOL RES, V17, P229, DOI 10.1046/j.1440-1703.2002.00482.x; Tscharntke T, 2008, BIOL CONTROL, V45, P238, DOI 10.1016/S1049-9644(08)00082-0; Urban D, 2001, ECOLOGY, V82, P1205, DOI 10.1890/0012-9658(2001)082[1205:LCAGTP]2.0.CO;2; Vandermeer J, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2489; Veres A, 2013, AGR ECOSYST ENVIRON, V166, P110, DOI 10.1016/j.agee.2011.05.027; Wajnberg E., 2008, BEHAV ECOLOGY INSECT; Wildemeersch M, 2019, ECOL MODEL, V409, DOI 10.1016/j.ecolmodel.2019.108745; Zhao ZH, 2012, ECOL RES, V27, P303, DOI 10.1007/s11284-011-0903-7	51	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267037	10.1371/journal.pone.0267037	http://dx.doi.org/10.1371/journal.pone.0267037			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421182	Green Published, gold			2022-12-26	WOS:000795453600097
J	Georgi, TW; Zieschank, A; Kornrumpf, K; Kurch, L; Sabri, O; Korholz, D; Mauz-Korholz, C; Kluge, R; Posch, S				Georgi, Thomas W.; Zieschank, Axel; Kornrumpf, Kevin; Kurch, Lars; Sabri, Osama; Koerholz, Dieter; Mauz-Koerholz, Christine; Kluge, Regine; Posch, Stefan			Automatic classification of lymphoma lesions in FDG-PET-Differentiation between tumor and non-tumor uptake	PLOS ONE			English	Article							INTERNATIONAL WORKSHOP; HODGKIN; SEGMENTATION; MULTICENTER; MANAGEMENT	IntroductionThe automatic classification of lymphoma lesions in PET is a main topic of ongoing research. An automatic algorithm would enable the swift evaluation of PET parameters, like texture and heterogeneity markers, concerning their prognostic value for patients outcome in large datasets. Moreover, the determination of the metabolic tumor volume would be facilitated. The aim of our study was the development and evaluation of an automatic algorithm for segmentation and classification of lymphoma lesions in PET. MethodsPre-treatment PET scans from 60 Hodgkin lymphoma patients from the EuroNet-PHL-C1 trial were evaluated. A watershed algorithm was used for segmentation. For standardization of the scan length, an automatic cropping algorithm was developed. All segmented volumes were manually classified into one of 14 categories. The random forest method and a nested cross-validation was used for automatic classification and evaluation. ResultsOverall, 853 volumes were segmented and classified. 203/246 tumor lesions and 554/607 non-tumor volumes were classified correctly by the automatic algorithm, corresponding to a sensitivity, a specificity, a positive and a negative predictive value of 83%, 91%, 79% and 93%. In 44/60 (73%) patients, all tumor lesions were correctly classified. In ten out of the 16 patients with misclassified tumor lesions, only one false-negative tumor lesion occurred. The automatic classification of focal gastrointestinal uptake, brown fat tissue and composed volumes consisting of more than one tissue was challenging. ConclusionOur algorithm, trained on a small number of patients and on PET information only, showed a good performance and is suitable for automatic lymphoma classification.	[Georgi, Thomas W.; Kurch, Lars; Sabri, Osama; Kluge, Regine] Univ Leipzig, Dept Nucl Med, Leipzig, Germany; [Zieschank, Axel; Kornrumpf, Kevin; Posch, Stefan] Martin Luther Univ Halle & Wittenberg, Inst Comp Sci, Halle, Saale, Germany; [Koerholz, Dieter; Mauz-Koerholz, Christine] Justus Liebig Univ, Dept Pediat Oncol, Giessen, Germany	Leipzig University; Martin Luther University Halle Wittenberg; Justus Liebig University Giessen	Georgi, TW (corresponding author), Univ Leipzig, Dept Nucl Med, Leipzig, Germany.	Thomas.Georgi@medizin.uni-leipzig.de			foundation "Mitteldeutsche Kinderkrebsforschung" ("Children's cancer research of central germany")	foundation "Mitteldeutsche Kinderkrebsforschung" ("Children's cancer research of central germany")	The study was supported by the foundation "Mitteldeutsche Kinderkrebsforschung" ("Children's cancer research of central germany") https://www.kinderkrebsforschung.net The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrington SF, 2021, J NUCL MED, V62, P332, DOI 10.2967/jnumed.119.238923; Barrington SF, 2017, EUR J NUCL MED MOL I, V44, pS97, DOI 10.1007/s00259-017-3690-8; Blanc-Durand P, 2021, EUR J NUCL MED MOL I, V48, P1362, DOI 10.1007/s00259-020-05080-7; Breiman L., 2001, RANDOM FORESTS, V45, P5; Capobianco N, 2021, J NUCL MED, V62, P30, DOI 10.2967/jnumed.120.242412; Cheson BD, 2014, J CLIN ONCOL, V32, P3059, DOI 10.1200/JCO.2013.54.8800; Cheson BD, 2011, J CLIN ONCOL, V29, P1844, DOI 10.1200/JCO.2010.32.5225; Duhrsen U, 2018, J CLIN ONCOL, V36, P2024, DOI 10.1200/JCO.2017.76.8093; Frood R, 2021, EUR J NUCL MED MOL I, V48, P3198, DOI 10.1007/s00259-021-05233-2; Hsu CY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22319-4; Kurch L, 2013, KLIN PADIATR, V225, P357, DOI 10.1055/s-0033-1354416; Lopci E, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-041252; Lue KH, 2019, CLIN NUCL MED, V44, pE559, DOI 10.1097/RLU.0000000000002732; Mauz-Korholz C, 2015, J CLIN ONCOL, V33, P2975, DOI 10.1200/JCO.2014.59.4853; Mayerhoefer ME, 2021, METHODS, V188, P105, DOI 10.1016/j.ymeth.2020.06.020; Meignan M, 2009, LEUKEMIA LYMPHOMA, V50, P1257, DOI 10.1080/10428190903040048; Mikhaeel NG, 2019, INT J RADIAT ONCOL, V104, P501, DOI 10.1016/j.ijrobp.2019.02.001; Nanni C, 2017, LEUKEMIA LYMPHOMA, V58, P2298, DOI 10.1080/10428194.2017.1298752; Nguyen NC, 2011, ACTA ONCOL, V50, P670, DOI 10.3109/0284186X.2010.550933; Pfaehler E, 2021, EJNMMI RES, V11, DOI 10.1186/s13550-020-00744-9; Pinochet P, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.628179; Shankland KR, 2012, LANCET, V380, P848, DOI 10.1016/S0140-6736(12)60605-9; Sibille L, 2020, RADIOLOGY, V294, P445, DOI 10.1148/radiol.2019191114; Townsend W, 2012, LANCET, V380, P836, DOI 10.1016/S0140-6736(12)60035-X; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Wang YB, 2007, MOL IMAGING BIOL, V9, P83, DOI 10.1007/s11307-006-0075-y	26	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267275	10.1371/journal.pone.0267275	http://dx.doi.org/10.1371/journal.pone.0267275			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7MW	35436321	gold, Green Published			2022-12-26	WOS:000791258900006
J	Ieki, T; Yamanaka, Y; Yoshikawa, K				Ieki, Takashi; Yamanaka, Yuki; Yoshikawa, Keiichi			Functional analysis of human olfactory receptors with a high basal activity using LNCaP cell line	PLOS ONE			English	Article							ODORANT RECEPTOR; EXPRESSION; IDENTIFICATION; ACTIVATION; LIGAND; SPECIFICITY; SENSITIVITY; ANTAGONISM; BEHAVIOR; FAMILY	Humans use a family of more than 400 olfactory receptors (ORs) to detect odorants. However, deorphanization of ORs is a critical issue because the functional properties of more than 80% of ORs remain unknown, thus, hampering our understanding of the relationship between receptor function and perception. HEK293 cells are the most commonly used heterologous expression system to determine the function of a given OR; however, they cannot functionally express a majority of ORs probably due to a lack of factor(s) required in cells in which ORs function endogenously. Interestingly, ORs have been known to be expressed in a variety of cells outside the nose and play critical physiological roles. These findings prompted us to test the capacity of cells to functionally express a specific repertoire of ORs. In this study, we selected three cell lines that endogenously express functional ORs. We demonstrated that human prostate carcinoma (LNCaP) cell lines successfully identified novel ligands for ORs that were not recognized when expressed in HEK293 cells. Further experiments suggested that the LNCaP cell line was effective for functional expression of ORs, especially with a high basal activity, which impeded the sensitive detection of ligand-mediated activity of ORs. This report provides an efficient functional assay system for a specific repertoire of ORs that cannot be characterized in current cell systems.	[Ieki, Takashi; Yamanaka, Yuki; Yoshikawa, Keiichi] Kao Corp, Sensory Sci Res, Haga, Tochigi, Japan	KAO Corporation	Yoshikawa, K (corresponding author), Kao Corp, Sensory Sci Res, Haga, Tochigi, Japan.	yoshikawa.keiichi@kao.com		Yoshikawa, Keiichi/0000-0003-4790-4114	Kao Corporation	Kao Corporation	This work was supported by Kao Corporation. The Kao Corporation provided support in the form of salaries for the authors. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaffy T, 2006, J NEUROCHEM, V97, P1506, DOI 10.1111/j.1471-4159.2006.03859.x; Bautze V, 2012, CHEM SENSES, V37, P479, DOI 10.1093/chemse/bjr130; Bellono NW, 2017, CELL, V170, DOI 10.1016/j.cell.2017.05.034; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chang AJ, 2015, NATURE, V527, P240, DOI 10.1038/nature15721; Charlier L, 2012, CELL MOL LIFE SCI, V69, P4205, DOI 10.1007/s00018-012-1116-0; Cheret J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05973-0; D'Hulst C, 2016, CELL REP, V16, P1115, DOI 10.1016/j.celrep.2016.06.047; Dewan A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05129-0; Dodd S, 2021, NEUROSCI BIOBEHAV R, V120, P537, DOI 10.1016/j.neubiorev.2020.09.028; Fei AM, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23823-4; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Flegel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055368; Fukuda N, 2004, J CELL SCI, V117, P5835, DOI 10.1242/jcs.01507; Gisladottir RS, 2020, CURR BIOL, V30, P4643, DOI 10.1016/j.cub.2020.09.012; Gonzalez-Kristeller DC, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00035; Griffin CA, 2009, DEV CELL, V17, P649, DOI 10.1016/j.devcel.2009.09.004; Haga S, 2010, NATURE, V466, P118, DOI 10.1038/nature09142; Horio N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07940-1; Inagaki S, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107814; Jaeger SR, 2013, CURR BIOL, V23, P1601, DOI 10.1016/j.cub.2013.07.030; Jia L, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101268; Jiang Y, 2015, NAT NEUROSCI, V18, P1446, DOI 10.1038/nn.4104; Katada S, 2003, BIOCHEM BIOPH RES CO, V305, P964, DOI 10.1016/S0006-291X(03)00863-5; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Lee SJ, 2019, NAT REV DRUG DISCOV, V18, P116, DOI 10.1038/s41573-018-0002-3; Li YR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001230; Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x; Mainland JD, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.2; Mainland JD, 2014, NAT NEUROSCI, V17, P114, DOI 10.1038/nn.3598; Malik B, 2019, CHEM SENSES, V44, P289, DOI 10.1093/chemse/bjz019; Massberg D, 2015, ARCH BIOCHEM BIOPHYS, V566, P100, DOI 10.1016/j.abb.2014.12.004; McClintock TS, 2014, J NEUROSCI, V34, P15669, DOI 10.1523/JNEUROSCI.3625-14.2014; Menashe I, 2007, PLOS BIOL, V5, P2462, DOI 10.1371/journal.pbio.0050284; Murrell JR, 1999, J NEUROSCI, V19, P8260; Nakashima A, 2013, CELL, V154, P1314, DOI 10.1016/j.cell.2013.08.033; Nara K, 2011, J NEUROSCI, V31, P9179, DOI 10.1523/JNEUROSCI.1282-11.2011; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; Niimura Y, 2014, GENOME RES, V24, P1485, DOI 10.1101/gr.169532.113; Oka Y, 2004, EMBO J, V23, P120, DOI 10.1038/sj.emboj.7600032; Oka Y, 2006, NEURON, V52, P857, DOI 10.1016/j.neuron.2006.10.019; Olender T, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2960-3; Peterlin Z, 2008, CHEM BIOL, V15, P1317, DOI 10.1016/j.chembiol.2008.10.014; Pfister P, 2020, CURR BIOL, V30, P2574, DOI 10.1016/j.cub.2020.04.086; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Pronin A, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100475; Raka RN, 2022, CRIT REV FOOD SCI, V62, P5424, DOI 10.1080/10408398.2021.1885007; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Saito N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195263; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Sato-Akuhara N, 2016, J NEUROSCI, V36, P4482, DOI 10.1523/JNEUROSCI.3259-15.2016; Shah A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23824-3; Sharma R, 2017, ELIFE, V6, DOI 10.7554/eLife.21895; Shirasu M, 2014, NEURON, V81, P165, DOI 10.1016/j.neuron.2013.10.021; Shirokova E, 2005, J BIOL CHEM, V280, P11807, DOI 10.1074/jbc.M411508200; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Trimmer C, 2019, P NATL ACAD SCI USA, V116, P9475, DOI 10.1073/pnas.1804106115; Tsunoda M, 2018, CURR BIOL, V28, P1213, DOI 10.1016/j.cub.2018.02.060; Von Dannecker LEC, 2006, P NATL ACAD SCI USA, V103, P9310, DOI 10.1073/pnas.0600697103; von der Weid B, 2015, NAT NEUROSCI, V18, P1455, DOI 10.1038/nn.4100; Wainscott DB, 2007, J PHARMACOL EXP THER, V320, P475, DOI 10.1124/jpet.106.112532; Wakisaka N, 2017, CURR BIOL, V27, P1437, DOI 10.1016/j.cub.2017.04.014; Wallrabenstein I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144704; Wu C, 2015, INT J BIOCHEM CELL B, V64, P75, DOI 10.1016/j.biocel.2015.03.008; Wu LF, 2012, J BIOL CHEM, V287, P22287, DOI 10.1074/jbc.M112.345884; Yabuki Y, 2016, NAT NEUROSCI, V19, P897, DOI 10.1038/nn.4314; Yasi EA, 2019, BIOCHEMISTRY-US, V58, P2160, DOI 10.1021/acs.biochem.8b01208; Yoshikawa K, 2013, NAT CHEM BIOL, V9, P160, DOI [10.1038/NCHEMBIO.1164, 10.1038/nchembio.1164]; Yoshikawa K, 2009, CHEM SENSES, V34, P15, DOI 10.1093/chemse/bjn047; Yu YQ, 2015, P NATL ACAD SCI USA, V112, P14966, DOI 10.1073/pnas.1517510112; Zhang JJ, 2013, J NEUROSCI, V33, P3228, DOI 10.1523/JNEUROSCI.4299-12.2013; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237	75	0	0	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267356	10.1371/journal.pone.0267356	http://dx.doi.org/10.1371/journal.pone.0267356			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446888	Green Published, gold			2022-12-26	WOS:000795468200002
J	Kilic, OM; Budak, M; Gunal, E; Acir, N; Halbac-Cotoara-Zamfir, R; Alfarraj, S; Ansari, MJ				Kilic, Orhan Mete; Budak, Mesut; Gunal, Elif; Acir, Nurullah; Halbac-Cotoara-Zamfir, Rares; Alfarraj, Saleh; Ansari, Mohammad Javed			Soil salinity assessment of a natural pasture using remote sensing techniques in central Anatolia, Turkey	PLOS ONE			English	Article							RANGE EXPANSION; INDEXES; IMAGERY	Soil salinity is a major land degradation process reducing biological productivity in arid and semi-arid regions. Therefore, its effective monitoring and management is inevitable. Recent developments in remote sensing technology have made it possible to accurately identify and effectively monitor soil salinity. Hence, this study determined salinity levels of surface soils in 2650 ha agricultural and natural pastureland located in an arid region of central Anatolia, Turkey. The relationship between electrical conductivity (EC) values of 145 soil samples and the dataset created using Landsat 5 TM satellite image was investigated. Remote sensing dataset for 23 variables, including visible, near infrared (NIR) and short-wave infrared (SWIR) spectral ranges, salinity, and vegetation indices were created. The highest correlation between EC values and remote sensing dataset was obtained in SWIR1 band (r = -0.43). Linear regression analysis was used to reveal the relationship between six bands and indices selected from the variables with the highest correlations. Coefficient of determination (R-2 = 0.19) results indicated that models obtained using satellite image did not provide reliable results in determining soil salinity. Microtopography is the major factor affecting spatial distribution of soil salinity and caused heterogeneous distribution of salts on surface soils. Differences in salt content of soils caused heterogeneous distribution of halophytes and led to spectral complexity. The dark colored slickpots in small-scale depressions are common features of sodic soils, which are responsible for spectral complexity. In addition, low spatial resolution of Landsat 5 TM images is another reason decreasing the reliability of models in determining soil salinity.	[Kilic, Orhan Mete] Tokat Gaziosmanpasa Univ, Fac Arts & Sci, Dept Geog, Tokat, Turkey; [Budak, Mesut] Siirt Univ, Fac Agr, Dept Soil Sci & Plant Nutr, Siirt, Turkey; [Gunal, Elif] Tokat Gaziosmanpasa Univ, Fac Agr, Dept Soil Sci & Plant Nutr, Tokat, Turkey; [Acir, Nurullah] Kirsehir Ahi Evran Univ, Fac Agr, Dept Soil Sci & Plant Nutr, Kirsehir, Turkey; [Halbac-Cotoara-Zamfir, Rares] Politehn Univ Timisoara, Fdn & Cadastral Survey, Dept Overland Commun Ways, Timisoara, Romania; [Alfarraj, Saleh] King Saud Univ, Coll Sci, Zool Dept, Riyadh, Saudi Arabia; [Ansari, Mohammad Javed] Mahatma Jyotiba Phule Rohilkhand Univ Bareilly, Hindu Coll Moradabad, Dept Bot, Bareilly, Uttar Pradesh, India	Gaziosmanpasa University; Siirt University; Gaziosmanpasa University; Ahi Evran University; Polytechnic University of Timisoara; King Saud University	Kilic, OM (corresponding author), Tokat Gaziosmanpasa Univ, Fac Arts & Sci, Dept Geog, Tokat, Turkey.	orhanmete.kilic@gop.edu.tr	Ansari, Muhammad/GQI-1517-2022; Ansari, Mohammad Javed/E-9303-2014; kilic, orhan mete/AGF-0216-2022	Ansari, Mohammad Javed/0000-0002-8718-3078; kilic, orhan mete/0000-0002-6723-1984	King Saud University, Riyadh, Saudi Arabia [RSP-2022R7]	King Saud University, Riyadh, Saudi Arabia(King Saud University)	This project was supported by Researchers Supporting Project Number (RSP-2022R7) King Saud University, Riyadh, Saudi Arabia.	Abbas A, 2007, MODSIM 2007: INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION, P2632; Ahmed I, 1997, INT GEOSCI REMOTE SE, P1627, DOI 10.1109/IGARSS.1997.608989; Akramkhanov A, 2012, ENVIRON MONIT ASSESS, V184, P2475, DOI 10.1007/s10661-011-2132-5; Alhammadi MS, 2008, INT J REMOTE SENS, V29, P1745, DOI 10.1080/01431160701395195; Allbed A, 2014, GEODERMA, V230, P1, DOI 10.1016/j.geoderma.2014.03.025; Allbed A, 2018, GEOCARTO INT, V33, P830, DOI 10.1080/10106049.2017.1303090; Bannari A, 2008, COMMUN SOIL SCI PLAN, V39, P2795, DOI 10.1080/00103620802432717; Bannari A, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10060855; Ben-Dor E, 2003, SOIL SCI SOC AM J, V67, P289, DOI 10.2136/sssaj2003.0289; Ben-Dor E, 2008, REMOTE SENS SOIL SAL, P3960; Bouaziz M, 2011, CR GEOSCI, V343, P795, DOI 10.1016/j.crte.2011.09.003; Budak M., 2015, Ege Universitesi Ziraat Fakultesi Dergisi, V52, P191; Budak M., 2012, GENESIS CLASSIFICATI; Casas S., 1995, SALINITY ASSESSMENT; CHAPMAN JE, 1989, INT J REMOTE SENS, V10, P245, DOI 10.1080/01431168908903860; Cheng YB, 2008, REMOTE SENS ENVIRON, V112, P363, DOI 10.1016/j.rse.2007.01.023; Cullu Mehmet Ali, 2003, Turkish Journal of Agriculture and Forestry, V27, P23; Dehni A, 2012, PROCEDIA ENGINEER, V33, P188, DOI 10.1016/j.proeng.2012.01.1193; Delavar MA, 2020, GEODERMA REG, V22, DOI 10.1016/j.geodrs.2020.e00317; Douaoui AEK, 2006, GEODERMA, V134, P217, DOI 10.1016/j.geoderma.2005.10.009; Eldeiry AA, 2008, SOIL SCI SOC AM J, V72, P201, DOI 10.2136/sssaj2007.0013; Elhag M, 2017, GEOSCI INSTRUM METH, V6, P149, DOI 10.5194/gi-6-149-2017; Elhag M, 2016, J SENSORS, V2016, DOI 10.1155/2016/7596175; Fan XW, 2015, REMOTE SENS-BASEL, V7, P488, DOI 10.3390/rs70100488; Farifteh J, 2006, GEODERMA, V130, P191, DOI 10.1016/j.geoderma.2005.02.003; Farifteh J., 2007, IMAGING SPECTROSCOPY; Farooq S, 2021, AGRONOMY-BASEL, V11, DOI 10.3390/agronomy11061123; Farooq S, 2017, ACTA OECOL, V84, P23, DOI 10.1016/j.actao.2017.08.004; Fischer J., 1999, SOIL TAXONOMY BASIC; Gorji T, 2017, ECOL INDIC, V74, P384, DOI 10.1016/j.ecolind.2016.11.043; Guide EF, 2003, LEICA GEOSYSTEMS GIS; Gunal E, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0259695; Gunal E, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256355; IBM C IBM SPSS Inc, 2012, SPSS STAT WIND; Judkins G, 2012, ENVIRON MANAGE, V50, P478, DOI 10.1007/s00267-012-9889-3; Khan NM, 2001, 22 AS C REM SENS; Liang SL, 2001, IEEE T GEOSCI REMOTE, V39, P2490, DOI 10.1109/36.964986; Madani A.A., 2005, GISCI REMOTE SENS, V42, P171, DOI [10.2747/1548-1603.42.2.171, DOI 10.2747/1548-1603.42.2.171]; Majeed A., 2019, PLANT ABIOTIC STRESS, P83, DOI DOI 10.1007/978-3-030-06118-0_3; Metternicht GI, 2003, REMOTE SENS ENVIRON, V85, P1, DOI 10.1016/S0034-4257(02)00188-8; Mougenot B., 1993, REMOTE SENSING REV, V7, DOI [10.1080/02757259309532180, DOI 10.1080/02757259309532180]; Nelson, 2012, REMOTE SENS-BASEL; Nguyen KA, 2020, PROG EARTH PLANET SC, V7, DOI 10.1186/s40645-019-0311-0; Omuto C.T., 2020, MAPPING SALT AFFECTE; Onen H, 2018, WEED SCI, V66, P494, DOI 10.1017/wsc.2018.20; Peng J, 2019, GEODERMA, V337, P1309, DOI 10.1016/j.geoderma.2018.08.006; QI J, 1994, REMOTE SENS ENVIRON, V48, P119, DOI 10.1016/0034-4257(94)90134-1; RICHARDS L. A., 1954, Diagnosis and Improvement of Saline and Alkali Soils.; Shammi M, 2019, HEALTHCARE-BASEL, V7, DOI 10.3390/healthcare7010050; Sidike A., 2014, INT J APPL EARTH OBS, DOI [10.1016/j.jag.2014.05.011, DOI 10.1016/J.JAG.2014.05.011]; Sonmez B., 2003, GUIDE SALINITY CONTR; Sparks DL., 2003, ENV SOIL CHEM, DOI [10.1002/chem.200304920, DOI 10.1002/CHEM.200304920]; Tilley DR, 2007, J ENVIRON QUAL, V36, P780, DOI 10.2134/jeq2005.0327; VERMA KS, 1994, INT J REMOTE SENS, V15, P1901, DOI 10.1080/01431169408954215; Wang JZ, 2020, SCI TOTAL ENVIRON, V707, DOI 10.1016/j.scitotenv.2019.136092; Wardlow BD, 2008, REMOTE SENS ENVIRON, V112, P1096, DOI 10.1016/j.rse.2007.07.019; [翁永玲 WENG YongLing], 2006, [地理科学, Scientia Geographica Sinica], V26, P369; Yang ZP, 2011, J GEOGR SCI, V21, P979, DOI 10.1007/s11442-011-0894-x; Zhang M, 1997, ECOL APPL, V7, P1039, DOI 10.1890/1051-0761(1997)007[1039:MPCSMU]2.0.CO;2; Zhang TT, 2011, ECOL INDIC, V11, P1552, DOI 10.1016/j.ecolind.2011.03.025	60	2	2	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266915	10.1371/journal.pone.0266915	http://dx.doi.org/10.1371/journal.pone.0266915			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7MW	35436285	Green Published, gold			2022-12-26	WOS:000791258900013
J	Lin, CY; Tong, YX; Bai, YY; Zhao, ZX; Quan, WX; Liu, ZR; Wang, JJ; Song, YP; Tian, J; Dong, WT				Lin, Chenyang; Tong, Yuxin; Bai, Yaying; Zhao, Zixi; Quan, Wenxiang; Liu, Zhaorui; Wang, Jiuju; Song, Yanping; Tian, Ju; Dong, Wentian			Prevalence and correlates of depression and anxiety among Chinese international students in US colleges during the COVID-19 pandemic: A cross-sectional study	PLOS ONE			English	Article							INSOMNIA SEVERITY INDEX; MENTAL-HEALTH OUTCOMES; DISORDERS; PHQ-9; MOTIVATION; VALIDITY; RISK	Background Previous studies showed that the COVID-19 outbreak increased the levels of depression and anxiety in heterogeneous populations. However, none has explored the prevalence and correlates of depression and anxiety among Chinese international students studying in US colleges during the pandemic. Objective This study examines the prevalence of depression and anxiety among Chinese international students enrolled in US universities during the COVID-19 pandemic and identifies the associated factors, including habits, social and psychological support, sleep quality, and remote learning. Methods Between June and July 2020, we conducted a cross-sectional study through Wenjuanxing, a web-based survey platform. Participants were recruited with snowball sampling through 21 Chinese international student associations in US universities. The survey consisted of demographic questions, the Social Support Rating Scale (SSRS), the Insomnia Severity Index (ISI), the Patient Health Questionnaire-9 (PHQ-9), the General Anxiety Disorder-7 (GAD-7), and self-constructed questions on academic performance, financial concerns, use of social media, physical exercise, and psychological support. Cut-off scores of 10 were used for both PHQ-9 and GAD-7 to determine the binary outcomes of depression and anxiety, respectively. Bivariant analyses and multivariable logistic regression analyses were performed to identify the associated factors. Results Among 1881 participants, we found a prevalence of depression (PHQ-9 score >= 10) at 24.5% and that of anxiety (GAD-7 score >= 10) at 20.7%. A higher risk of depression was associated with recent exposure to traumatic events, agreement to pandemic's negative impacts on financial status, agreement and strong agreement to the negative impacts of remote learning on personal relationships, and a higher ISI score. A lower risk of depression was associated with disagreement to the negative impacts of remote learning on academic performance and future careers, strong willingness to seek professional help with emotional issues, and a higher SSRS score. In addition, a higher risk of anxiety was associated with recent exposure to traumatic events, a lot of workloads, often staying up for online classes, agreement and strong agreement to the negative impacts of remote learning on personal relationships, and a higher ISI score. A lower risk of anxiety was associated with the willingness and strong willingness to seek professional help with emotional issues, and a higher SSRS score. Conclusion This study showed a high prevalence of depression and anxiety among Chinese international students studying in US colleges during the COVID-19 pandemic. Multiple correlates -including recent exposure to traumatic events, pandemic-related financial concerns, workload, social support, remote learning, willingness to seek professional help, and sleep quality-were identified. It is critical for future studies to further investigate this student population and for universities to provide more flexible learning options and more access to psychological services.	[Lin, Chenyang] Univ Calif Los Angeles, Neurosci Interdept Program, Los Angeles, CA 90095 USA; [Tong, Yuxin] Boston Univ, Dept Psychol & Brain Sci, Boston, MA 02215 USA; [Bai, Yaying] Columbia Univ, Dept Art Hist & Archaeol, New York, NY USA; [Zhao, Zixi] Ohio State Univ, Dept Psychol, Columbus, OH USA; [Quan, Wenxiang; Liu, Zhaorui; Wang, Jiuju; Song, Yanping; Tian, Ju; Dong, Wentian] Peking Univ Sixth Hosp, Beijing, Peoples R China; [Quan, Wenxiang; Liu, Zhaorui; Wang, Jiuju; Song, Yanping; Tian, Ju; Dong, Wentian] Peking Univ, Inst Mental Hlth, Beijing, Peoples R China; [Quan, Wenxiang; Liu, Zhaorui; Wang, Jiuju; Song, Yanping; Tian, Ju; Dong, Wentian] Peking Univ, Peking Univ Sixth Hosp, Natl Clin Res Ctr Mental Disorders, NHC Key Lab Mental Hlth, Beijing, Peoples R China	University of California System; University of California Los Angeles; Boston University; Columbia University; University System of Ohio; Ohio State University; Peking University; Peking University	Lin, CY (corresponding author), Univ Calif Los Angeles, Neurosci Interdept Program, Los Angeles, CA 90095 USA.; Quan, WX (corresponding author), Peking Univ Sixth Hosp, Beijing, Peoples R China.; Quan, WX (corresponding author), Peking Univ, Inst Mental Hlth, Beijing, Peoples R China.; Quan, WX (corresponding author), Peking Univ, Peking Univ Sixth Hosp, Natl Clin Res Ctr Mental Disorders, NHC Key Lab Mental Hlth, Beijing, Peoples R China.	clin25@g.ucla.edu; quanwenxiang@bjmu.edu.cn		Lin, Leo Chenyang/0000-0002-6222-518X				[Anonymous], READ 2020 SEVIS NUMB; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; BRACKNEY BE, 1995, J COUNS PSYCHOL, V42, P456, DOI 10.1037/0022-0167.42.4.456; [陈曼曼 Chen ManMan], 2015, [中国心理卫生杂志, Chinese Mental Health Journal], V29, P241; Chen X, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-021-01271-4; Chung KF, 2011, SLEEP MED, V12, P463, DOI 10.1016/j.sleep.2010.09.019; Douglas Pamela K, 2009, Int J Emerg Ment Health, V11, P137; Gerber MM, 2018, J PSYCHOPATHOL BEHAV, V40, P645, DOI 10.1007/s10862-018-9682-6; Guo Y, 2020, J MED INTERNET RES, V22, DOI 10.2196/20328; Hefner J, 2009, AM J ORTHOPSYCHIAT, V79, P491, DOI 10.1037/a0016918; Hertenstein E, 2019, SLEEP MED REV, V43, P96, DOI 10.1016/j.smrv.2018.10.006; Hou FS, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09738-7; Hyde JS, 2020, HARVARD REV PSYCHIAT, V28, P4, DOI 10.1097/HRP.0000000000000230; Islam MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238162; Jang K L, 1999, J Gend Specif Med, V2, P39; Johnson EO, 2006, J PSYCHIATR RES, V40, P700, DOI 10.1016/j.jpsychires.2006.07.008; Kendler KS, 2001, PSYCHOL MED, V31, P605, DOI 10.1017/S0033291701003907; Keyes CLM, 2012, J AM COLL HEALTH, V60, P126, DOI 10.1080/07448481.2011.608393; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lee S, 2009, BRIT J PSYCHIAT, V194, P411, DOI 10.1192/bjp.bp.108.054841; Lei XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153454; Li Y, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.669119; Liu J, 2008, J XINJIANG MED U, V31, P1, DOI DOI 10.3969/J.ISSN.1009-5551.2008.01.001; Lui M., 2009, ADV SOC WORK, V10, P69, DOI [10.18060/164, DOI 10.18060/164]; Mojtabai R, 2015, SOC PSYCH PSYCH EPID, V50, P1657, DOI 10.1007/s00127-015-1097-z; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Oswalt SB, 2020, J AM COLL HEALTH, V68, P41, DOI 10.1080/07448481.2018.1515748; Overstreet C, 2017, PSYCHIAT RES, V247, P296, DOI 10.1016/j.psychres.2016.10.047; Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017; Purnama A., 2021, OPEN ACCESS MACED J, V9, P205, DOI [10.3889/oamjms.2021.5841, DOI 10.3889/OAMJMS.2021.5841]; Son C, 2020, J MED INTERNET RES, V22, DOI 10.2196/21279; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Tao Y., 2014, POPUL EC, V3, P3, DOI DOI 10.3969/J.ISSN.1000-4149.2014.03.001; Tian ZR, 2021, PEERJ, V9, DOI 10.7717/peerj.11037; Tong X, 2016, EPILEPSY RES, V120, P31, DOI 10.1016/j.eplepsyres.2015.11.019; Usher K, 2020, INT J MENT HEALTH NU, V29, P315, DOI 10.1111/inm.12726; Wang CY, 2021, J AM COLL HEALTH, DOI 10.1080/07448481.2021.1960849; Wang WZ, 2014, GEN HOSP PSYCHIAT, V36, P539, DOI 10.1016/j.genhosppsych.2014.05.021; Wang XM, 2020, J MED INTERNET RES, V22, DOI 10.2196/22817; who.int, 2020, MENT HLTH PSYCH CONS; Wise SL, 2005, APPL MEAS EDUC, V18, P163, DOI 10.1207/s15324818ame1802_2; Woon LSC, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252481; World Health Organization, 2011, IMPACT EC CRISES MEN, DOI [10.2174/138161211795656729, DOI 10.2174/138161211795656729]; Wright HM, 2021, J PSYCHIATR RES, V137, P673, DOI 10.1016/j.jpsychires.2020.10.045; Wright KM, 2011, J CLIN PSYCHOL, V67, P1240, DOI 10.1002/jclp.20845; Wu KK, 2005, J TRAUMA STRESS, V18, P39, DOI 10.1002/jts.20004; Xiao S., 1994, J CLIN PSYCHIAT, V4, P98, DOI DOI 10.1186/S12913-016-1423-5; Xie XY, 2020, JAMA PEDIATR, V174, P898, DOI 10.1001/jamapediatrics.2020.1619; Xiong JQ, 2020, J AFFECT DISORDERS, V277, P55, DOI 10.1016/j.jad.2020.08.001; Yeung TS, 2022, J AM COLL HEALTH, V70, P2470, DOI 10.1080/07448481.2020.1865980; Yu DSF, 2010, J ADV NURS, V66, P2350, DOI 10.1111/j.1365-2648.2010.05394.x; Yu H, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-02826-3; Zhai YS, 2020, LANCET PSYCHIAT, V7, pE22, DOI 10.1016/S2215-0366(20)30089-4; Zhang C, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.648755; Zhang YY, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.697642	56	4	4	7	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267081	10.1371/journal.pone.0267081	http://dx.doi.org/10.1371/journal.pone.0267081			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421199	Green Published, gold			2022-12-26	WOS:000795453600106
J	Mabunda, N; Augusto, O; Zicai, AF; Duaja, A; Oficiano, S; Ismael, N; Vubil, A; Mussa, T; Moraes, M; Jani, I				Mabunda, Nedio; Augusto, Orvalho; Zicai, Ana Flora; Duaja, Ana; Oficiano, Sandra; Ismael, Nalia; Vubil, Adolfo; Mussa, Tufaria; Moraes, Milton; Jani, Ilesh			Nucleic acid testing identifies high prevalence of blood borne viruses among approved blood donors in Mozambique	PLOS ONE			English	Article							TRANSFUSION-TRANSMISSIBLE INFECTIONS; HUMAN-IMMUNODEFICIENCY-VIRUS; 1ST-TIME; SAFETY; RISK; IMPLEMENTATION; DONATIONS; AFRICA; MAPUTO; YIELD	BackgroundAlthough blood transfusion is an intervention that saves lives, it poses significant risks to the blood receivers, including the transmission of bloodborne pathogens. We aimed at determining the prevalence of Human Immunodeficiency Virus (HIV), Hepatitis B virus (HBV), and Hepatitis C virus (HCV) in candidates approved for blood donation, and in samples considered to be negative in reference blood banks in Mozambique. MethodsA cross-sectional study was performed between November 2014 and October 2015 in Maputo and Beira cities. Demographic information was obtained from all consenting blood donors using a structured questionnaire. Plasma samples were screened for HIVAb/Ag combinations, HBsAg and Anti-HCV. Blood donors considered to be negative by serological testing were re-tested in pools of six plasma samples using nucleic acid testing (NAT). ResultsMost blood donors were male 2,320 (83.4%) with an age range of 18 to 34 years. The overall seroprevalence of HIV, HBV and HCV infections among blood donors approved for donation was 4.6% (127; 95% CI 3.8-5.4), 4.5% (124; 95% CI 3.7-5.3) and 0.4% (11; 95% CI 0.2-0.7), respectively. The overall frequency by NAT of HIV RNA, HBV DNA, and HCV RNA in serologically negative blood donor samples was 2.6 per 1000 blood donors (7; 95% CI 1.1-5.4); 12.5 per 1000 blood donors (33; 95% CI 8.6-17.5) and 2.6 per 1000 blood donors (6; 95% CI 1.0-5.7), respectively. ConclusionOur results show high seroprevalence of HIV and HBV infections in blood donors approved for donation, and high frequency of molecular biomarkers of HIV, HBV, and HCV in blood considered to be safe. These results suggest the need for a new blood screening policy in Mozambique, including the use of NAT to detect infectious blood donations during the immunologically negative window.	[Mabunda, Nedio; Zicai, Ana Flora; Duaja, Ana; Ismael, Nalia; Vubil, Adolfo; Jani, Ilesh] Inst Nacl Saude, Marracuene, Mozambique; [Mabunda, Nedio; Moraes, Milton] Fiocruz MS, Inst Oswaldo Cruz, Lab Hanseniase, Rio De Janeiro, Brazil; [Augusto, Orvalho; Mussa, Tufaria] Univ Eduardo Mondlane, Fac Med, Maputo, Mozambique; [Duaja, Ana] Hosp Cent Beira, Sofala, Mozambique; [Oficiano, Sandra] Hosp Cent Maputo, Maputo, Mozambique	Fundacao Oswaldo Cruz; Eduardo Mondlane University	Mabunda, N (corresponding author), Inst Nacl Saude, Marracuene, Mozambique.; Mabunda, N (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Hanseniase, Rio De Janeiro, Brazil.	nedio.jonas@ins.gov.mz	Moraes, Milton Ozório/G-9753-2011; Augusto, Orvalho/J-8767-2019	Moraes, Milton Ozório/0000-0003-2653-0037; Augusto, Orvalho/0000-0002-0005-3968; Jani, Ilesh/0000-0002-6880-6655; Mabunda, Nedio/0000-0002-1848-4627; Mussa, Tufaria/0000-0002-9635-3585	Flandres Government	Flandres Government	This work was supported by The Flandres Government, BICMINS project.	Rios-Ocampo WA, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0206-z; Allain JP, 2010, TRANSFUSION, V50, P340, DOI 10.1111/j.1537-2995.2009.02444.x; [Anonymous], 2017, GLOBAL STATUS REPORT; Bagot KL, 2016, TRANSFUS MED REV, V30, P81, DOI 10.1016/j.tmrv.2016.02.002; Boutayeb A., 2010, IMPACT INFECT DIS DE, P1171; Butler EK, 2018, TRANSFUSION, V58, P854, DOI 10.1111/trf.14497; Candotti D, 2017, TRANSFUS CLIN BIOL, V24, P189, DOI 10.1016/j.tracli.2017.06.014; Cunha L, 2007, J MED VIROL, V79, P1832, DOI 10.1002/jmv.21010; Fang CT, 2003, VOX SANG, V85, P9, DOI 10.1046/j.1423-0410.2003.00311.x; Galel SA, 2018, TRANSFUSION, V58, P649, DOI [10.1111/trf.14457, 10.1111/trf.15014]; Goncalez TT, 2019, TRANSFUSION, V59, P2334, DOI 10.1111/trf.15286; Gudo ES, 2009, TRANSFUSION, V49, P1146, DOI 10.1111/j.1537-2995.2009.02100.x; Kafando E., 2017, J HEMATOL BLOOD TRAN, V4, P015; Kanagasabai U, 2018, MMWR-MORBID MORTAL W, V67, P1392, DOI 10.15585/mmwr.mm6750a4; Laperche S, 2013, TRANSFUSION, V53, P816, DOI 10.1111/j.1537-2995.2012.03797.x; Lourençon Adriana de Fátima, 2011, Rev. Bras. Hematol. Hemoter., V33, P190, DOI 10.5581/1516-8484.20110052; Mabunda N, 2020, MEM I OSWALDO CRUZ, V115, DOI 10.1590/0074-02760200006; Mapako T, 2013, TRANSFUSION, V53, P2413, DOI 10.1111/trf.12311; Ministrio da Sade (MISAU) Instituto Nacional de Estatstica (INE) e ICF, 2015, INQ IND IM MALR HIV; Mohamed Z, 2019, J VIRAL HEPATITIS, V26, P750, DOI 10.1111/jvh.13073; Oluyinka OO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131912; Owusu-Ofori S, 2005, TRANSFUSION, V45, P133, DOI 10.1111/j.1537-2995.2004.04279.x; Prugger C, 2016, VOX SANG, V110, P196, DOI 10.1111/vox.12327; Roth WK, 2012, VOX SANG, V102, P82, DOI 10.1111/j.1423-0410.2011.01506.x; Salles N.A., 2019, REV SOC BRAS MED TRO, V52, pe20180432, DOI [10.1590/0037-8682-0432-2018, DOI 10.1590/0037-8682-0432-2018]; Stokx J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-141; Stramer SL, 2004, NEW ENGL J MED, V351, P760, DOI 10.1056/NEJMoa040085; Vermeulen M, 2009, TRANSFUSION, V49, P1115, DOI 10.1111/j.1537-2995.2009.02110.x; Viegas EO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121452; Ware AD, 2018, VOX SANG, V113, P3, DOI 10.1111/vox.12620; World Health Organization, 2015, 19 WHO MOD LIST ESS	31	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267472	10.1371/journal.pone.0267472	http://dx.doi.org/10.1371/journal.pone.0267472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D8GY	35482726	Green Published, gold			2022-12-26	WOS:000794035700004
J	Maneerat, P; Nakjai, P; Niwitpong, SA				Maneerat, Patcharee; Nakjai, Pisit; Niwitpong, Sa-Aat			Bayesian interval estimations for the mean of delta-three parameter lognormal distribution with application to heavy rainfall data	PLOS ONE			English	Article								Flash flooding is caused by heavy rainfall that frequently occurs during a tropical storm, and the Thai population has been subjected to this problem for a long time. The key to solving this problem by planning and taking action to protect the population and infrastructure is the motivation behind this study. The average weekly rainfall in northern Thailand during Tropical Storm Wipha are approximated using interval estimations for the mean of a delta-three parameter lognormal distribution. Our proposed methods are Bayesian confidence intervals-based noninformative (NI) priors (equal-tailed and highest posterior density (HPD) intervals based on NI1 and NI2 priors). Our numerical evaluation shows that the HPD-NI1 prior was closer to the nominal confidence level and possessed the narrowest expected length when the variance was small-to-medium for a large threshold. The efficacy of the methods was illustrated by applying them to weekly natural rainfall data in northern Thailand to examine their abilities to indicate flooding occurrence.	[Maneerat, Patcharee] Uttaradit Rajabhat Univ, Dept Appl Math, Uttaradit, Thailand; [Nakjai, Pisit] Uttaradit Rajabhat Univ, Dept Comp Sci, Uttaradit, Thailand; [Niwitpong, Sa-Aat] King Mongkuts Univ Technol North Bangkok, Dept Appl Stat, Bangkok, Thailand	Uttaradit Rajabhat University; Uttaradit Rajabhat University; King Mongkuts University of Technology North Bangkok	Niwitpong, SA (corresponding author), King Mongkuts Univ Technol North Bangkok, Dept Appl Stat, Bangkok, Thailand.	sa-aat.n@sci.kmutnb.ac.th		Niwitpong, Sa-aat/0000-0001-8269-3397; maneerat, Patcharee/0000-0003-2145-9657; Nakjai, Pisit/0000-0001-8471-4390	King Mongkut's University of Technology North Bangkok [KMUTBNB-65-KNOW-09]; Thailand Science Research and Innovation (TSRI); Uttaradit Rajabhat University	King Mongkut's University of Technology North Bangkok; Thailand Science Research and Innovation (TSRI); Uttaradit Rajabhat University	This research was funded by King Mongkut's University of Technology North Bangkok, Contract no. KMUTBNB-65-KNOW-09. Dr. Patcharee Maneerat and Dr. Pisit Nakjai were appreciated funding by Thailand Science Research and Innovation (TSRI) and Uttaradit Rajabhat University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J., 1963, LOGNORMAL DISTRIBUTI; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Banerjee S., 2014, HIERARCHICAL MODELIN; Basak P, 2009, COMPUT STAT DATA AN, V53, P3580, DOI 10.1016/j.csda.2009.03.015; Box GE, 1992, BAYESIAN INFERENCE S; BURGES SJ, 1975, WATER RESOUR RES, V11, P229, DOI 10.1029/WR011i002p00229; CHARBENEAU RJ, 1978, WATER RESOUR RES, V14, P149, DOI 10.1029/WR014i001p00149; Cheng ZL, 2012, INT J PHOTOENERGY, V2012, DOI 10.1155/2012/608298; COHEN AC, 1985, J QUAL TECHNOL, V17, P92, DOI 10.1080/00224065.1985.11978942; COHEN AC, 1951, J AM STAT ASSOC, V46, P206, DOI 10.2307/2279920; COHEN AC, 1980, J AM STAT ASSOC, V75, P399, DOI 10.2307/2287466; Gelman A., 2014, BAYESIAN DATA ANAL, VThird; Jin SB, 2017, AM STAT, V71, P106, DOI 10.1080/00031305.2016.1208630; Krstanovic P. F., 1992, Water Resources Management, V6, P279, DOI 10.1007/BF00872281; Maneerat P, 2020, BIOMETRICAL J, V62, P1769, DOI 10.1002/bimj.201900079; Maneerat P, 2020, PEERJ, V8, DOI 10.7717/peerj.8502; Maneerat P, 2021, COMMUN STAT-SIMUL C, V50, P2906, DOI 10.1080/03610918.2019.1616095; Nguyen HT, 2019, THAIL STATIST, V17, pI; Pang WK, 2005, EUR J OPER RES, V164, P367, DOI 10.1016/j.ejor.2003.04.005; RODRIGUEZ-ITURBE I, 1974, WATER RESOUR RES, V10, P713, DOI 10.1029/WR010i004p00713; ROYSTON P, 1992, STAT MED, V11, P897, DOI 10.1002/sim.4780110707; SANGAL BP, 1970, WATER RESOUR RES, V6, P505, DOI 10.1029/WR006i002p00505; Singh V. P., 1986, HYDROLOGICAL SCI TEC, V2, P33; SINGH VP, 1990, COMPUT STAT DATA AN, V10, P71, DOI 10.1016/0167-9473(90)90104-P; SINGH VP, 1987, WATER RESOUR BULL, V23, P1185; STONE M, 1979, J ROY STAT SOC B MET, V41, P276; Thai Meteorological Department, 2018, MET AC KNOWL DOC; Thai Meteorological Department, 2019, WEEKL WEATH REP 29 J; WEERAHANDI S, 1993, J AM STAT ASSOC, V88, P899, DOI 10.2307/2290779; Wu WH, 2014, J APPL STAT, V41, P1471, DOI 10.1080/02664763.2014.881780; Zou GY, 2008, STAT MED, V27, P1693, DOI 10.1002/sim.3095; Zou GY, 2009, COMPUT STAT DATA AN, V53, P3755, DOI 10.1016/j.csda.2009.03.016	32	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266455	10.1371/journal.pone.0266455	http://dx.doi.org/10.1371/journal.pone.0266455			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421161	gold, Green Published			2022-12-26	WOS:000795453600048
J	Mustafa, Z; Kalbacher, H; Burster, T				Mustafa, Zhadyra; Kalbacher, Hubert; Burster, Timo			Occurrence of a novel cleavage site for cathepsin G adjacent to the polybasic sequence within the proteolytically sensitive activation loop of the SARS-CoV-2 Omicron variant: The amino acid substitution N679K and P681H of the spike protein	PLOS ONE			English	Article							NEUTROPHIL ELASTASE; CORONAVIRUS; DELTA	The serine proteases neutrophil elastase (NE), proteinase 3 (PR3), cathepsin G (CatG), and neutrophil serine protease 4 (NSP4) are secreted by activated neutrophils as a part of the innate immune response against invading pathogens. However, these serine proteases might be adopted by viruses to mediate viral surface protein priming resulting in host cell entrance and productive infection. Indeed, NE and PR3 hydrolyze the scissile peptide bond within the proteolytically sensitive polybasic sequence of the activation loop of SARS-CoV-2 located at the S1/S2 interface of the Spike (S) protein; an amino acid motif which differs from SARS-CoV-1. The occurrence of novel SARS-CoV-2 variants and substitution of distinct amino acids at the polybasic sequence prompts serious concerns regarding increased transmissibility. We propose that a novel cleavage site by CatG of the Omicron variant and the increased substrate turnover of the Delta variant by furin within the polybasic sequence should be considered for increased transmission of SARS-CoV-2 variants.	[Mustafa, Zhadyra; Burster, Timo] Nazarbayev Univ, Sch Sci & Humanities, Dept Biol, Nur Sultan, Kazakhstan; [Kalbacher, Hubert] Eberhard Karls Univ Tubingen, Inst Clin Anat & Cell Anal, Fac Med, Tubingen, Germany	Nazarbayev University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Burster, T (corresponding author), Nazarbayev Univ, Sch Sci & Humanities, Dept Biol, Nur Sultan, Kazakhstan.	timo.burster@nu.edu.kz		Burster, Timo/0000-0002-9596-6558	Nazarbayev University Faculty-Development Competitive Research Grants Program [280720FD1907]	Nazarbayev University Faculty-Development Competitive Research Grants Program	We appreciate the support of Reinhold Schirmbeck (University Hospital Ulm, Internal Medicine I, Ulm, Germany) regarding TMPRSS2 and Jozef Oleksyszyn for Suc-Val-Pro-PheP(OPh) (Wroclaw University of Science and Technology, Faculty of Chemistry, Wroclaw, Poland).	Akgun E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240012; Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; Andreano E, 2021, NAT MED, V27, P759, DOI 10.1038/s41591-021-01347-0; Bestle D, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.202000786; Van Dorp CH, 2021, medRxiv, DOI 10.1101/2021.03.29.21254233; Callaway E, 2021, NATURE, V595, P17, DOI 10.1038/d41586-021-01696-3; Eichelberger KR, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1009054; Goettig P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17121969; Hoffmann M, 2020, CELL, DOI [DOI 10.1016/J.CELL.2020.02.052, 10.1016/j.cell.2020.02.052]; Jaimes J., 2020, PROTEOLYTIC CLEAVAGE, DOI [10.2139/ssrn.3581359, DOI 10.2139/SSRN.3581359]; Kasperkiewicz P, 2014, P NATL ACAD SCI USA, V111, P2518, DOI 10.1073/pnas.1318548111; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Liu J, 2020, EBIOMEDICINE, V55, DOI 10.1016/j.ebiom.2020.102763; Matsuyama S, 2005, P NATL ACAD SCI USA, V102, P12543, DOI 10.1073/pnas.0503203102; Mishra SK, 2021, ACTA TROP, V214, DOI 10.1016/j.actatropica.2020.105778; Mohammadi M, 2021, BRAZ J INFECT DIS, V25, DOI 10.1016/j.bjid.2021.101606; Mustafa Z, 2021, ACS OMEGA, V6, P7181, DOI 10.1021/acsomega.1c00363; Mykytyn AZ, 2021, ELIFE, V10, DOI 10.7554/eLife.64508; OLEKSYSZYN J, 1991, BIOCHEMISTRY-US, V30, P485, DOI 10.1021/bi00216a026; Ramanathan Muthukumar, 2021, Lancet Infect Dis, V21, P1070, DOI [10.1101/2021.02.22.432359, 10.1016/S1473-3099(21)00262-0]; Scudellari M, 2021, NATURE, V595, P640, DOI 10.1038/d41586-021-02039-y; Shi YF, 2020, CELL DEATH DIFFER, V27, P1451, DOI 10.1038/s41418-020-0530-3; Singh J, 2021, NAT MED, V27, P1131, DOI 10.1038/s41591-021-01397-4; Socher E, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9050525; Tang JLW, 2021, J INFECTION, V82, pE27, DOI 10.1016/j.jinf.2020.12.024; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	28	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0264723	10.1371/journal.pone.0264723	http://dx.doi.org/10.1371/journal.pone.0264723			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7MW	35436320	gold, Green Published			2022-12-26	WOS:000791258900007
J	Stoto, MA; Schlageter, S; Kraemer, JD				Stoto, Michael A.; Schlageter, Samantha; Kraemer, John D.			COVID-19 mortality in the United States: It's been two Americas from the start	PLOS ONE			English	Article								During the summer of 2021, a narrative of "two Americas" emerged: one with high demand for the COVID-19 vaccine and the second with widespread vaccine hesitancy and opposition to masks and vaccines. We analyzed "excess mortality" rates (the difference between total deaths and what would have been expected based on earlier time periods) prepared by the CDC for the United States from January 3, 2020 to September 26, 2021. Between Jan. 3, 2020 and Sept. 26, 2021, there were 895,693 excess deaths associated with COVID-19, 26% more than reported as such. The proportion of deaths estimated by the excess mortality method that was reported as COVID-19 was highest in the Northeast (92%) and lowest in the West (72%) and South (76%). Of the estimated deaths, 43% occurred between Oct. 4, 2020 and Feb. 27, 2021. Before May 31, 2020, approximately 56% of deaths were in the Northeast, where 17% of the population resides. Subsequently, 48% of deaths were in the South, which makes up 38% of the population. Since May 31, 2020, the South experienced COVID-19 mortality 26% higher than the national rate, whereas the Northeast's rate was 42% lower. If each region had the same mortality rate as the Northeast, more than 316,234 COVID-19 deaths between May 31, 2020 and Sept. 26, 2021 were "avoidable." More than half (63%) of the avoidable deaths occurred between May 31, 2020 and February, 2021, and more than half (60%) were in the South. Regional differences in COVID-19 mortality have been strong throughout the pandemic. The South has had higher mortality rates than the rest of the U.S. since May 31, 2020, and experienced 62% of the avoidable deaths. A comprehensive COVID-19 policy, including population-based restrictions as well as vaccines, is needed to control the pandemic.	[Stoto, Michael A.; Schlageter, Samantha; Kraemer, John D.] Georgetown Univ, Dept Hlth Syst Adm, Washington, DC 20057 USA	Georgetown University	Stoto, MA (corresponding author), Georgetown Univ, Dept Hlth Syst Adm, Washington, DC 20057 USA.	stotom@georgetown.edu						Anand S, 2020, LANCET, V396, P1335, DOI 10.1016/S0140-6736(20)32009-2; [Anonymous], 2022, EXC DEATHS ASS COVID; Barndollar H., 2022, PROVIDENCE J; Baumgaertner, 2021, LOS ANGELES TIMES; Bump Philip, 2021, WASH POST; Bump Philip., 2022, WASH POST; CDC, 2020, COVID DAT TRACK TREN; Fricker Ronald D Jr, 2021, Signif (Oxf), V18, P12, DOI 10.1111/1740-9713.01485; Havers FP, 2020, JAMA INTERN MED, V180, P1576, DOI 10.1001/jamainternmed.2020.4130; Jarvie J., 2021, LOS ANGELES TIMES; Kasakove S., 2021, NEW YORK TIMES; Krugman Paul, 2021, NEW YORK TIMES; Leonhardt D., 2021, NEW YORK TIMES; Mathieu E, 2021, NAT HUM BEHAV, V5, P947, DOI 10.1038/s41562-021-01122-8; National Vital Statistics System, 2020, VITAL STAT REPORT GU, V3; Panebianco, 2020, EV DAT TYP GUID DEC; Rubin Jennifer, 2021, WASH POST; Schneider E, RESPONDING OMICRON A; Schneider EC, 2021, COMMONWEALTH FUND, DOI [10.26099/3542-5n54, DOI 10.26099/3542-5N54]; Shamus K., 2022, AGE ED VOTING TRUMP; Stoto MA, 2021, AM J PUBLIC HEALTH, V111, pS93, DOI 10.2105/AJPH.2021.306334; Tingley K., 2022, NEW YORK TIMES; Wood D, 2021, NPR; Woolf SH., 2021, JAMA-J AM MED ASSOC; Woolf SH, 2022, JAMA-J AM MED ASSOC, V327, P1331, DOI 10.1001/jama.2022.3785	25	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0265053	10.1371/journal.pone.0265053	http://dx.doi.org/10.1371/journal.pone.0265053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D8GY	35482643	Green Published, Green Submitted, gold			2022-12-26	WOS:000794035700005
J	Umar, A; Khan, MS; Sehgal, SA; Jafar, K; Ahmad, S; Waheed, A; Aslam, MW; Wajid, M; Rehman, TU; Khan, T; Ditta, A; Akmal, H; Ashfaq, M; Javed, T; Tahir, R				Umar, Ali; Khan, Muhammad Saleem; Sehgal, Sheikh Arslan; Jafar, Kamran; Ahmad, Shabbir; Waheed, Ahmad; Aslam, Muhammad Waseem; Wajid, Muhammad; Rehman, Tanzil Ur; Khan, Tehmina; Ditta, Allah; Akmal, Hasnain; Ashfaq, Muhammad; Javed, Tariq; Tahir, Rida			Epidemiological studies of sleep disorder in educational community of Pakistani population, its major risk factors and associated diseases	PLOS ONE			English	Article								Sleep is one of the most important functions of the life. The disturbance in sleep or quality of sleep leads to several dysfunctions of the human body. This study aimed to investigate the prevalence of sleep disorders, their possible risk factors and their association with other health problems. The data was collected from the educational community of the Pakistani population. The Insomnia Severity Index (ISI) was used to evaluate the insomnia and the sleep apnea was evaluated through a simple questionnaire method. The blood samples were collected to perform significant blood tests for clinical investigations. Current research revealed that the individuals in the educational community had poor sleep quality. A total of 1998 individuals from the educational community were surveyed, 1584 (79.28%) of whom had a sleep disorders, including insomnia (45.20%) and sleep apnea (34.08%). The measured onset of age for males and females was 30.35 years and 31.07 years respectively. The Clinical investigations showed that the sleep had significant impact on the hematology of the patients. Higher levels of serum uric acid and blood sugar were recorded with a sleep disorder. The individuals of the educational community were using the sleeping pills. The other associated diseases were mild tension, headaches, migraines, depression, diabetes, obesity, and myopia. The use of beverage, bad mood, medical condition, mental stress, disturbed circadian rhythms, workload and extra use of smartphone were major risk factors of sleep disorders. It was concluded that the insomnia was more prevalent than the sleep apnea. Furthermore, life changes events were directly linked with disturbance of sleep. Tension, depression, headaches, and migraine were more associated with sleep disorders than all other health issues.	[Umar, Ali; Khan, Muhammad Saleem; Jafar, Kamran; Ahmad, Shabbir; Waheed, Ahmad; Aslam, Muhammad Waseem; Wajid, Muhammad; Rehman, Tanzil Ur; Khan, Tehmina; Ditta, Allah; Akmal, Hasnain; Ashfaq, Muhammad; Javed, Tariq; Tahir, Rida] Univ Okara, Fac Life Sci, Dept Zool, Okara, Pakistan; [Sehgal, Sheikh Arslan] Univ Okara, Fac Life Sci, Dept Bioinformat, Okara, Pakistan		Khan, MS (corresponding author), Univ Okara, Fac Life Sci, Dept Zool, Okara, Pakistan.; Sehgal, SA (corresponding author), Univ Okara, Fac Life Sci, Dept Bioinformat, Okara, Pakistan.	samiikhan@uo.edu.pk; arslansehgal@yahoo.com	; Khan, Muhammad Saleem/P-9208-2016	Waheed, Ahmad/0000-0001-5810-3369; Khan, Muhammad Saleem/0000-0003-2653-402X				Abrishami A, 2010, CAN J ANAESTH, V57, P423, DOI 10.1007/s12630-010-9280-x; Akerstedt T, 2002, J PSYCHOSOM RES, V53, P741, DOI 10.1016/S0022-3999(02)00333-1; Albasheer OB, 2020, COGENT PSYCHOL, V7, DOI 10.1080/23311908.2020.1789424; Nigro CA, 2018, SLEEP BREATH, V22, P683, DOI 10.1007/s11325-017-1612-4; Alotaibi AD., J FAMILY COMMUNITY M, P23; [Anonymous], 2020, MUCH SLEEP REALL NEE; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bhaskar Swapna, 2016, J Family Med Prim Care, V5, P780, DOI 10.4103/2249-4863.201153; Boudjeltia KZ, 2008, VASC HEALTH RISK MAN, V4, P1467; Bruni O, 1997, CEPHALALGIA, V17, P492, DOI 10.1046/j.1468-2982.1997.1704492.x; Brzecka A, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00330; Chen X, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-02866-9; Chen YY, 2005, J EPIDEMIOL COMMUN H, V59, P488, DOI 10.1136/jech.2004.020511; Chiu HY, 2017, SLEEP MED REV, V36, P57, DOI 10.1016/j.smrv.2016.10.004; Crowley K, 2011, NEUROPSYCHOL REV, V21, P41, DOI 10.1007/s11065-010-9154-6; Cuadros JL, 2012, MATURITAS, V72, P367, DOI 10.1016/j.maturitas.2012.05.012; Di Mauro P, 2021, CHILDREN-BASEL, V8, DOI 10.3390/children8100921; Dragioti E, 2017, ANN GEN PSYCHIATR, V16, DOI 10.1186/s12991-017-0137-3; Dyken ME, 2012, CHEST, V141, P528, DOI 10.1378/chest.11-0773; Eckert DJ, 2020, J CLIN SLEEP MED, V16, P341, DOI 10.5664/jcsm.8268; Elliott JE, 2020, SLEEP, V43, DOI 10.1093/sleep/zsz237; Engeda J, 2013, DIABETIC MED, V30, P676, DOI 10.1111/dme.12165; Fan L, 2019, J AM MED DIR ASSOC, V20, P1480, DOI 10.1016/j.jamda.2019.06.009; Fang H, 2019, J CELL MOL MED, V23, P2324, DOI 10.1111/jcmm.14170; Foley D, 2004, J PSYCHOSOM RES, V56, P497, DOI 10.1016/j.jpsychores.2004.02.010; FOLEY DJ, 1995, SLEEP, V18, P425, DOI 10.1093/sleep/18.6.425; Foley DJ, 1999, SLEEP, V22, pS366; Fu WN, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-00913-3; Gabbay IE, 2012, SLEEP BREATH, V16, P453, DOI 10.1007/s11325-011-0523-z; Gonzaga C, 2015, J HUM HYPERTENS, V29, P705, DOI 10.1038/jhh.2015.15; Gu DN, 2010, SLEEP, V33, P601, DOI 10.1093/sleep/33.5.601; Hirotsu C, 2017, BRAIN BEHAV IMMUN, V59, P211, DOI 10.1016/j.bbi.2016.09.005; Ibrahim JM., 2011, J COUNTRY EGYPT, V29, P31; Jiang W, 2018, ANN HUM BIOL, V45, P457, DOI 10.1080/03014460.2018.1535661; Jiang XL, 2015, PUBLIC HEALTH, V129, P1579, DOI 10.1016/j.puhe.2015.07.030; Kalimo R, 2000, STRESS MEDICINE, V16, P65, DOI 10.1002/(SICI)1099-1700(200003)16:2<65::AID-SMI834>3.0.CO;2-8; Kerkhofs M, 2007, MATURITAS, V56, P212, DOI 10.1016/j.maturitas.2006.07.007; Khalil M, 2020, DIABETES RES CLIN PR, V161, DOI 10.1016/j.diabres.2020.108035; Khalyfa A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094301; Khorasani ZM, 2021, CURR DIABETES REV, V17, P214, DOI 10.2174/1573399816666200527140340; Kim G, 2016, ANN OCCUP ENVIRON ME, V28, DOI 10.1186/s40557-016-0131-2; Kim SJ, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15122648; Krause AJ, 2017, NAT REV NEUROSCI, V18, P404, DOI 10.1038/nrn.2017.55; Li X, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16183316; Liak C, 2011, CAN RESPIR J, V18, P338, DOI 10.1155/2011/924629; Liang Y, 2019, AGING CLIN EXP RES, V31, P309, DOI 10.1007/s40520-018-1005-y; Litsfeldt S, 2020, J SCH NURS, V36, P458, DOI 10.1177/1059840520901335; Loprinzi PD, 2015, AM J HEALTH BEHAV, V39, P471, DOI 10.5993/AJHB.39.4.3; Maniaci A, 2021, ANN IG MED PREV COMU, V33, P615, DOI 10.7416/ai.2021.2439; McCall W Vaughn, 2004, Prim Care Companion J Clin Psychiatry, V6, P9; Medic G, 2017, NAT SCI SLEEP, V9, P151, DOI 10.2147/NSS.S134864; Morgan D, 2015, CRIT CARE CLIN, V31, P403, DOI 10.1016/j.ccc.2015.03.004; Mulgrew AT, 2007, SLEEP MED, V9, P42, DOI 10.1016/j.sleep.2007.01.009; Naufel MF, 2018, MENOPAUSE, V25, P139, DOI 10.1097/GME.0000000000000962; Nauman S, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02292; Neikrug AB, 2010, GERONTOLOGY, V56, P181, DOI 10.1159/000236900; Pace A, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56090454; PASQUALI R, 1990, INT J OBESITY, V14, P207; Pavlova MK, 2019, AM J MED, V132, P292, DOI 10.1016/j.amjmed.2018.09.021; Perogamvros L, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101701; Pollicina I, 2021, BEHAV SCI-BASEL, V11, DOI 10.3390/bs11120180; RASMUSSEN BK, 1993, PAIN, V53, P65, DOI 10.1016/0304-3959(93)90057-V; Roberts RE, 2014, SLEEP, V37, P239, DOI 10.5665/sleep.3388; Roche Johanna., MEDRXIV 2020; Roepke SK., 2010, INDIAN J MED RES, V131; Saccomano SJ, 2014, J GERONTOL NURS, V40, P38, DOI 10.3928/00989134-20131029-06; Sancisi E, 2010, HEADACHE, V50, P1464, DOI 10.1111/j.1526-4610.2010.01711.x; Sateia MJ, 2014, CHEST, V146, P1387, DOI 10.1378/chest.14-0970; Seguin L, 2020, ANESTH ANALG, V131, P1025, DOI 10.1213/ANE.0000000000004909; Sivertsen B, 2009, J PSYCHOSOM RES, V67, P109, DOI 10.1016/j.jpsychores.2009.05.001; Sokucu SN, 2014, PULM MED, V2014, DOI 10.1155/2014/754839; Somers VK., J AM COLL CARDIOL; Stevens M, 2008, NORMAL SLEEP SLEEP P; Ursin R, 2009, SCAND J WORK ENV HEA, V35, P193, DOI 10.5271/sjweh.1325; Vance DE, 2011, J NEUROSCI NURS, V43, P261, DOI 10.1097/JNN.0b013e318227efb2; Wang XF, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2302-5; Yaremchuk K, 2018, CLIN GERIATR MED, V34, P205, DOI 10.1016/j.cger.2018.01.008; Zhou ZQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121796	78	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266739	10.1371/journal.pone.0266739	http://dx.doi.org/10.1371/journal.pone.0266739			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1F9GM	35446890	gold, Green Published			2022-12-26	WOS:000795468200015
J	Zuniga-Montanez, R; Coil, DA; Eisen, JA; Pechacek, R; Guerrero, RG; Kim, M; Shapiro, K; Bischel, HN				Zuniga-Montanez, Rogelio; Coil, David A.; Eisen, Jonathan A.; Pechacek, Randi; Guerrero, Roque G.; Kim, Minji; Shapiro, Karen; Bischel, Heather N.			The challenge of SARS-CoV-2 environmental monitoring in schools using floors and portable HEPA filtration units: Fresh or relic RNA?	PLOS ONE			English	Article							WASTE-WATER SURVEILLANCE; CONTAMINATION; OPPORTUNITIES; EPIDEMIOLOGY; TRANSMISSION; QUARANTINE; SURFACES; VIRUS	Testing surfaces in school classrooms for the presence of SARS-CoV-2, the virus that causes COVID-19, can provide public-health information that complements clinical testing. We monitored the presence of SARS-CoV-2 RNA in five schools (96 classrooms) in Davis, California (USA) by collecting weekly surface-swab samples from classroom floors and/or portable high-efficiency particulate air (HEPA) units (n = 2,341 swabs). Twenty-two surfaces tested positive, with qPCR cycle threshold (Ct) values ranging from 36.07-38.01. Intermittent repeated positives in a single room were observed for both floor and HEPA filter samples for up to 52 days, even following regular cleaning and HEPA filter replacement after a positive result. We compared the two environmental sampling strategies by testing one floor and two HEPA filter samples in 57 classrooms at Schools D and E. HEPA filter sampling yielded 3.02% and 0.41% positivity rates per filter sample collected for Schools D and E, respectively, while floor sampling yielded 0.48% and 0% positivity rates. Our results indicate that HEPA filter swabs are more sensitive than floor swabs at detecting SARS-CoV-2 RNA in interior spaces. During the study, all schools were offered weekly free COVID-19 clinical testing through Healthy Davis Together (HDT). HDT also offered on-site clinical testing in Schools D and E, and upticks in testing participation were observed following a confirmed positive environmental sample. However, no confirmed COVID-19 cases were identified among students associated with classrooms yielding positive environmental samples. The positive samples detected in this study appeared to contain relic viral RNA from individuals infected before the monitoring program started and/or RNA transported into classrooms via fomites. High-Ct positive results from environmental swabs detected in the absence of known active infections supports this conclusion. Additional research is needed to differentiate between fresh and relic SARS-CoV-2 RNA in environmental samples and to determine what types of results should trigger interventions.	[Zuniga-Montanez, Rogelio; Pechacek, Randi; Guerrero, Roque G.; Kim, Minji; Bischel, Heather N.] Univ Calif Davis, Dept Civil & Environm Engn, One Shields Ave, Davis, CA 95616 USA; [Coil, David A.; Eisen, Jonathan A.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Eisen, Jonathan A.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Eisen, Jonathan A.] Univ Calif Davis, Dept Evolut & Ecol, Davis, CA 95616 USA; [Shapiro, Karen] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Bischel, HN (corresponding author), Univ Calif Davis, Dept Civil & Environm Engn, One Shields Ave, Davis, CA 95616 USA.	hbischel@ucdavis.edu	Eisen, Jonathan A./H-2706-2019	Eisen, Jonathan A./0000-0002-0159-2197; Zuniga-Montanez, Rogelio/0000-0002-2931-1721; Coil, David/0000-0001-6049-8240				Abrahao JS, 2021, SCI TOTAL ENVIRON, V766, DOI 10.1016/j.scitotenv.2020.142645; Ang AXY, 2022, INDOOR AIR, V32, DOI 10.1111/ina.12930; [Anonymous], 2020, HLTH DAV TOG WORK PR; Barbieri P, 2021, ENVIRON RES, V198, DOI 10.1016/j.envres.2021.111200; Betancourt WQ, 2021, SCI TOTAL ENVIRON, V779, DOI 10.1016/j.scitotenv.2021.146408; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Coil DA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253578; Curtius J, 2021, AEROSOL SCI TECH, V55, P586, DOI 10.1080/02786826.2021.1877257; Dumont-Leblond N, 2021, AM J INFECT CONTROL, V49, P701, DOI 10.1016/j.ajic.2021.02.004; FDA, 2020, K202641 FDA; Fernandez-de-Mera IG, 2021, TRANSBOUND EMERG DIS, V68, P1487, DOI 10.1111/tbed.13817; Gendron L, 2010, AEROSOL SCI TECH, V44, P893, DOI 10.1080/02786826.2010.501351; Goodwin L, 2021, J GLOB HEALTH, V11, DOI 10.7189/jogh.11.10002; Hart OE, 2020, SCI TOTAL ENVIRON, V730, DOI 10.1016/j.scitotenv.2020.138875; Harvey AP, 2021, ENVIRON SCI TECH LET, V8, P168, DOI 10.1021/acs.estlett.0c00875; Horve PF, 2021, INDOOR AIR, V31, P1826, DOI 10.1111/ina.12898; Hubler S., 2021, NEW YORK TIMES; Jiang FC, 2020, EMERG INFECT DIS, V26, P2162, DOI 10.3201/eid2609.201435; Kasloff S.B., 2020, MEDRXIV, DOI [10.1101/2020.06.11.20128884, DOI 10.1101/2020.06.11.20128884]; Krambrich J, 2021, VIROL J, V18, DOI 10.1186/s12985-021-01556-6; Liu J, 2021, INT J INFECT DIS, V105, DOI 10.1016/j.ijid.2021.02.025; Maestre JP, 2021, SCI TOTAL ENVIRON, V778, DOI 10.1016/j.scitotenv.2021.146201; Marshall DL, 2020, MICROB RISK ANAL, V16, DOI 10.1016/j.mran.2020.100137; McElfish PA, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052278; Medema Gertjan, 2020, Current Opinion in Environmental Science & Health, V17, P49, DOI 10.1016/j.coesh.2020.09.006; Moreno T, 2021, ENVIRON INT, V147, DOI 10.1016/j.envint.2020.106326; Mouchtouri VA, 2020, INT J HYG ENVIR HEAL, V230, DOI 10.1016/j.ijheh.2020.113599; Nissen K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76442-2; Redmond SN, 2021, INFECT CONT HOSP EP, V42, P215, DOI 10.1017/ice.2020.416; Renninger N, 2021, MSYSTEMS, V6, DOI 10.1128/mSystems.01350-20; Riddell S, 2020, VIROL J, V17, DOI 10.1186/s12985-020-01418-7; Rodriguez M, 2021, SCI TOTAL ENVIRON, V785, DOI 10.1016/j.scitotenv.2021.147300; Baral S, 2021, medRxiv, DOI 10.1101/2021.01.07.21249419; Safford H., 2022, BIORXIV, DOI [10.1101/2022.01.28.22269911, DOI 10.1101/2022.01.28.22269911]; Santarpia JL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69286-3; Sousan S, 2022, AM J INFECT CONTROL, V50, P330, DOI 10.1016/j.ajic.2021.10.009; Thompson JR, 2020, WATER RES, V184, DOI 10.1016/j.watres.2020.116181; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; Vo V, 2022, SCI TOTAL ENVIRON, V805, DOI 10.1016/j.scitotenv.2021.149930; Vandenberg O, 2021, NAT REV MICROBIOL, V19, P171, DOI 10.1038/s41579-020-00461-z; Wang X, 2000, T ASAE, V43, P1877, DOI 10.13031/2013.3092; Wu FQ, 2021, WATER RES, V202, DOI 10.1016/j.watres.2021.117400; Zhou J, 2021, CLIN INFECT DIS, V73, pE1870, DOI 10.1093/cid/ciaa905	43	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267212	10.1371/journal.pone.0267212	http://dx.doi.org/10.1371/journal.pone.0267212			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C1KV	35452479	Green Published, gold, Green Submitted			2022-12-26	WOS:000792887700001
J	Zechner, C; Henne, WM; Sathe, AA; Xing, C; Hernandez, G; Sun, SY; Cheong, MC				Zechner, Christoph; Henne, W. Mike; Sathe, Adwait A.; Xing, Chao; Hernandez, Genaro; Sun, Shengyi; Cheong, Mi Cheong			Cellular abundance of sodium phosphate cotransporter SLC20A1/PiT1 and phosphate uptake are controlled post-transcriptionally by ESCRT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APE LEUKEMIA-VIRUS; COMPLEX; PROTEIN; UBIQUITIN; EXPRESSION; TRANSPORT; RECRUITMENT; RETROVIRUS; MACHINERY; RECEPTORS	Inorganic phosphate is essential for human life. The widely expressed mammalian sodium/phosphate cotransporter SLC20A1/PiT1 mediates phosphate uptake into most cell types; however, while SLC20A1 is required for development, and elevated SLC20A1 expression is associated with vascular calcification and aggressive tumor growth, the mechanisms regulating SLC20A1 protein abundance are unknown. Here, we found that SLC20A1 protein expression is low in phosphate-replete cultured cells but is strikingly induced following phosphate starvation, whereas mRNA expression is high in phosphate-replete cells and only mildly increased by phosphate starvation. To identify regulators of SLC20A1 protein levels, we performed a genome-wide CRISPR-based loss-of-function genetic screen in phosphate-replete cells using SLC20A1 protein induction as readout. Our screen revealed that endosomal sorting complexes required for transport (ESCRT) machinery was essential for proper SLC20A1 protein downregulation in phosphate-replete cells. We show that SLC20A1 colocalizes with ESCRT and that ESCRT deficiency increases SLC20A1 protein and phosphate uptake into cells. We also found numerous additional candidate regulators of mammalian phosphate homeostasis, including genes modifying protein ubiquitination and the Krebs cycle and oxidative phosphorylation pathways. Many of these targets have not been previously implicated in this process. We present here a model in which SLC20A1 protein abundance and phosphate uptake are tonically negatively regulated post-transcriptionally in phosphate-replete cells through direct ESCRT-mediated SLC20A1 degradation. Moreover, our screening results provide a comprehensive resource for future studies to elucidate the mechanisms governing cellular phosphate homeostasis. We conclude that genome-wide CRISPR-based genetic screening is a powerful tool to discover proteins and pathways relevant to physiological processes.	[Zechner, Christoph] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Endocrinol, Dallas, TX 75390 USA; [Zechner, Christoph] Univ Texas Southwestern Med Ctr Dallas, Charles & Jane Pak Ctr Mineral Metab & Clin Res, Dallas, TX 75390 USA; [Zechner, Christoph; Hernandez, Genaro; Sun, Shengyi; Cheong, Mi Cheong] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Henne, W. Mike] Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Sathe, Adwait A.; Xing, Chao] Univ Texas Southwestern Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Xing, Chao] Univ Texas Southwestern Med Ctr Dallas, Dept Bioinformat, Dallas, TX 75390 USA; [Xing, Chao] Univ Texas Southwestern Med Ctr Dallas, Dept Populat & Data Sci, Dallas, TX 75390 USA; [Hernandez, Genaro] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Sun, Shengyi] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Wayne State University	Zechner, C (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Endocrinol, Dallas, TX 75390 USA.; Zechner, C (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Charles & Jane Pak Ctr Mineral Metab & Clin Res, Dallas, TX 75390 USA.; Zechner, C (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	christoph.zechner@utsouthwestern.edu	Zechner, Christoph/AAW-7249-2021	Zechner, Christoph/0000-0002-2829-9935; Sun, Shengyi/0000-0002-1734-3902; Xing, Chao/0000-0002-1838-0502	National Institutes of Health, United States [K08DK106569]; O'Brien Kidney Research Center [P30DK079328, R01DK081423, R01DK115703, R01DK091392, R01DK126887]; Welch Foundation, United States [I-1873]; Ford Foundation Fellowship, United States; UT Southwestern Department of Internal Medicine (Division Chief Nominated Pilot and Feasibility Project in Biomedical Research); Howard Hughes Medical Institute, United States; Charles and Jane Pak Center for Mineral Metabolism and Clinical Research at UT Southwestern, United States	National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); O'Brien Kidney Research Center; Welch Foundation, United States(The Welch Foundation); Ford Foundation Fellowship, United States; UT Southwestern Department of Internal Medicine (Division Chief Nominated Pilot and Feasibility Project in Biomedical Research); Howard Hughes Medical Institute, United States(Howard Hughes Medical Institute); Charles and Jane Pak Center for Mineral Metabolism and Clinical Research at UT Southwestern, United States	This project was supported by the National Institutes of Health, United States (grant no.: K08DK106569 [to C. Z.]); O'Brien Kidney Research Center (grant nos.: P30DK079328, R01DK081423, R01DK115703, and R01DK091392 [to O. W. M.] and R01DK126887 [to W. M. H.]), The Welch Foundation, United States (grant no.: I-1873 [to W. M. H.]), a Ford Foundation Fellowship, United States (to G. H.), the UT Southwestern Department of Internal Medicine (Division Chief Nominated Pilot and Feasibility Project in Biomedical Research [to C. Z.]), the Howard Hughes Medical Institute, United States (to D. J. M.), and the Charles and Jane Pak Center for Mineral Metabolism and Clinical Research at UT Southwestern, United States. None of these funding sources influenced design and execution of this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agromayor M, 2012, STRUCTURE, V20, P414, DOI 10.1016/j.str.2011.12.013; Ali N, 2013, CURR BIOL, V23, P453, DOI 10.1016/j.cub.2013.02.033; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Beck L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009148; Beck L, 2009, J BIOL CHEM, V284, P31363, DOI 10.1074/jbc.M109.053132; Bergwitz C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056753; Bon N, 2018, J BIOL CHEM, V293, P2102, DOI 10.1074/jbc.M117.807339; Bookout Angie L, 2006, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1508s73; Chande S, 2018, NAT REV ENDOCRINOL, V14, P637, DOI 10.1038/s41574-018-0076-3; Clague MJ, 2012, DEV CELL, V23, P457, DOI 10.1016/j.devcel.2012.08.011; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Florenzano P, 2020, LANCET DIABETES ENDO, V8, P163, DOI 10.1016/S2213-8587(19)30426-7; Golden RJ, 2017, NATURE, V542, P197, DOI 10.1038/nature21025; Gonzalez-Parra E, 2012, CARDIOVASC PATHOL, V21, P372, DOI 10.1016/j.carpath.2012.02.008; Green J, 2001, KIDNEY INT, V60, P1182, DOI 10.1046/j.1523-1755.2001.0600031182.x; Hasegawa J, 2019, J CELL SCI, V132, DOI 10.1242/jcs.229179; Helbig I, 2019, AM J HUM GENET, V104, P1060, DOI 10.1016/j.ajhg.2019.04.001; Hernando N, 2021, PHYSIOL REV, V101, P1, DOI 10.1152/physrev.00008.2019; JOHANN SV, 1992, J VIROL, V66, P1635, DOI 10.1128/JVI.66.3.1635-1640.1992; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; Kolb AR, 2014, MOL BIOL CELL, V25, P276, DOI 10.1091/mbc.E13-07-0394; Kolmus K, 2021, J CELL SCI, V134, DOI 10.1242/jcs.250951; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Krebs EG, 2000, ADV ENZYME REGUL, V40, P441, DOI 10.1016/S0065-2571(99)00030-8; Kumari D, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11081185; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Li XW, 2006, CIRC RES, V98, P905, DOI 10.1161/01.RES.0000216409.20863.e7; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Masuda M, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88646; McNally KE, 2017, NAT CELL BIOL, V19, P1214, DOI 10.1038/ncb3610; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; OLAH Z, 1994, J BIOL CHEM, V269, P25426; Onaga C, 2021, ANTICANCER RES, V41, P43, DOI 10.21873/anticanres.14750; Printsev I, 2017, J MEMBRANE BIOL, V250, P379, DOI 10.1007/s00232-016-9931-0; Ritter CS, 2016, CLIN J AM SOC NEPHRO, V11, P1088, DOI 10.2215/CJN.11901115; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sato Keiko, 2017, Clin Breast Cancer, V17, pe135, DOI 10.1016/j.clbc.2016.11.005; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schoneberg J, 2018, SCIENCE, V362, P1423, DOI 10.1126/science.aat1839; Schuh AL, 2014, CRIT REV BIOCHEM MOL, V49, P242, DOI 10.3109/10409238.2014.881777; Stefani F, 2011, CURR BIOL, V21, P1245, DOI 10.1016/j.cub.2011.06.028; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; Tenenhouse HS, 1998, AM J PHYSIOL-RENAL, V275, pF527, DOI 10.1152/ajprenal.1998.275.4.F527; Uckert W, 1998, HUM GENE THER, V9, P2619, DOI 10.1089/10430349850019454; Vance JE, 2015, TRAFFIC, V16, P1, DOI 10.1111/tra.12230; Vietri M, 2020, NAT REV MOL CELL BIO, V21, P25, DOI 10.1038/s41580-019-0177-4; Wood KM, 2021, BIOCHEM J, V478, P3099, DOI 10.1042/BCJ20200740; Yorikawa C, 2005, BIOCHEM J, V387, P17, DOI 10.1042/BJ20041227	53	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101945	10.1016/j.jbc.2022.101945	http://dx.doi.org/10.1016/j.jbc.2022.101945			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3R4NR	35447110	gold, Green Published			2022-12-26	WOS:000838892100005
J	Lariviere, C; Rabhi, K; Preuss, R; Coutu, MF; Roy, N; Henry, SM				Lariviere, Christian; Rabhi, Khalil; Preuss, Richard; Coutu, Marie-France; Roy, Nicolas; Henry, Sharon M.			Derivation of clinical prediction rules for identifying patients with non-acute low back pain who respond best to a lumbar stabilization exercise program at post-treatment and six-month follow-up	PLOS ONE			English	Article							JOINT HYPERMOBILITY SYNDROME; SHORT-TERM IMPROVEMENT; PHYSICAL-THERAPY; SEGMENTAL INSTABILITY; CLASSIFYING PATIENTS; PRIMARY-CARE; TESTS; INTERVENTIONS; SPINE; CLASSIFICATION	Low back pain (LBP) remains one of the most common and incapacitating health conditions worldwide. Clinical guidelines recommend exercise programs after the acute phase, but clinical effects are modest when assessed at a population level. Research needs to determine who is likely to benefit from specific exercise interventions, based on clinical presentation. This study aimed to derive clinical prediction rules (CPRs) for treatment success, using a lumbar stabilization exercise program (LSEP), at the end of treatment and at six-month follow-up. The eight-week LSEP, including clinical sessions and home exercises, was completed by 110 participants with non-acute LBP, with 100 retained at the six-month follow-up. Physical (lumbar segmental instability, motor control impairments, posture and range of motion, trunk muscle endurance and physical performance tests) and psychological (related to fear-avoidance and home-exercise adherence) measures were collected at a baseline clinical exam. Multivariate logistic regression models were used to predict clinical success, as defined by >= 50% decrease in the Oswestry Disability Index. CPRs were derived for success at program completion (T8) and six-month follow-up (T34), negotiating between predictive ability and clinical usability. The chosen CPRs contained four (T8) and three (T34) clinical tests, all theoretically related to spinal instability, making these CPRs specific to the treatment provided (LSEP). The chosen CPRs provided a positive likelihood ratio of 17.9 (T8) and 8.2 (T34), when two or more tests were positive. When applying these CPRs, the probability of treatment success rose from 49% to 96% at T8 and from 53% to 92% at T34. These results support the further development of these CPRs by proceeding to the validation stage.	[Lariviere, Christian] Inst Rech Robert Sauve Sante & Securite Travail I, Montreal, PQ, Canada; [Lariviere, Christian; Preuss, Richard; Coutu, Marie-France; Roy, Nicolas] Ctr Integre Univ Sante & Serv Soc Ctr Sud de Ille, IURDPM, Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada; [Preuss, Richard] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Coutu, Marie-France] Univ Sherbrooke, Charles Le Moyne Hosp Res Ctr, Longueuil, PQ, Canada; [Henry, Sharon M.] Univ Vermont, Dept Neurol Sci, Burlington, VT USA	Universite de Montreal; McGill University; University of Sherbrooke; University of Vermont	Lariviere, C (corresponding author), Inst Rech Robert Sauve Sante & Securite Travail I, Montreal, PQ, Canada.; Lariviere, C (corresponding author), Ctr Integre Univ Sante & Serv Soc Ctr Sud de Ille, IURDPM, Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada.	Christian.lariviere@irsst.qc.ca		Lariviere, Christian/0000-0003-4299-4755	Institut de recherche Robert-Sauve en sante et en securite du travail (IRSST) [2016-0013, 2010-0022]	Institut de recherche Robert-Sauve en sante et en securite du travail (IRSST)	This study was funded by Institut de recherche Robert-Sauve en sante et en securite du travail (IRSST) (2016-0013, 2010-0022 to CL). The funder provided support in the form of salaries for authors [CL, KR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Alqarni AM, 2011, J ORTHOP SPORT PHYS, V41, P130, DOI 10.2519/jospt.2011.3457; Alrwaily M, 2017, PHYS THER, V97, P1147, DOI 10.1093/ptj/pzx087; Barr KP, 2007, AM J PHYS MED REHAB, V86, P72, DOI 10.1097/01.phm.0000250566.44629.a0; Beinart NA, 2013, SPINE J, V13, P1940, DOI 10.1016/j.spinee.2013.08.027; Beneciuk JM, 2009, PHYS THER, V89, P114, DOI 10.2522/ptj.20080239; Biely SA, 2014, J ORTHOP SPORT PHYS, V44, P262, DOI 10.2519/jospt.2014.4988; BIERINGSORENSEN F, 1984, SPINE, V9, P106, DOI 10.1097/00007632-198403000-00002; Boucher JA, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-0875-4; Burton AK, 1999, SPINE, V24, P2484, DOI 10.1097/00007632-199912010-00010; Cai CC, 2009, EUR SPINE J, V18, P554, DOI 10.1007/s00586-009-0909-9; Childs JD, 2006, PHYS THER, V86, P122, DOI 10.1093/ptj/86.1.122; Cholewicki J, 1996, CLIN BIOMECH, V11, P1, DOI 10.1016/0268-0033(95)00035-6; Cleland JA, 2007, PHYS THER, V87, P9, DOI 10.2522/ptj.20060155; Davarian S, 2012, J BACK MUSCULOSKELET, V25, P123, DOI 10.3233/BMR-2012-0320; Demidenko E, 2007, STAT MED, V26, P3385, DOI 10.1002/sim.2771; Denteneer L, 2017, ARCH PHYS MED REHAB, V98, P151, DOI 10.1016/j.apmr.2016.07.020; Deyo RA, 2015, PHYS THER, V95, P159, DOI 10.2522/ptj.2015.95.2.e1; Enthoven P, 2003, J REHABIL MED, V35, P168, DOI 10.1080/16501970310013517; Fairbank J C, 1980, Physiotherapy, V66, P271; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Ferrari S, 2015, CHIROPR MAN THER, V23, DOI 10.1186/s12998-015-0058-7; Fitzgerald GK, 2010, PHYS THER, V90, P855, DOI 10.2522/ptj.20090233.ic; Flynn T, 2002, SPINE, V27, P2835, DOI 10.1097/00007632-200212150-00021; Freidin MB, 2021, PAIN, V162, P1176, DOI 10.1097/j.pain.0000000000002100; Fritz JM, 2009, SPINE, V34, P2803, DOI 10.1097/BRS.0b013e3181ae2bd4; George SZ, 2021, J ORTHOP SPORT PHYS, V51, pCPG1, DOI 10.2519/jospt.2021.0304; Ghezelbash F, 2022, COMPUT METHOD BIOMEC, V25, P1156, DOI 10.1080/10255842.2021.2004399; Granata KP, 2001, J BIOMECH, V34, P1117, DOI 10.1016/S0021-9290(01)00081-1; Hall AM, 2010, PHYS THER, V90, P1099, DOI 10.2522/ptj.20090245; Hartvigsen J, 2018, LANCET, V391, P2356, DOI 10.1016/S0140-6736(18)30480-X; Hayden JA, 2005, ANN INTERN MED, V142, P776, DOI 10.7326/0003-4819-142-9-200505030-00014; Hebert JJ, 2010, ARCH PHYS MED REHAB, V91, P78, DOI 10.1016/j.apmr.2009.08.146; Hicks GE, 2005, ARCH PHYS MED REHAB, V86, P1753, DOI 10.1016/j.apmr.2005.03.033; Hicks GE, 2012, CLIN J PAIN, V28, P195, DOI 10.1097/AJP.0b013e318226c411; Hill JC, 2008, ARTHRIT RHEUM-ARTHR, V59, P632, DOI 10.1002/art.23563; HSIEH FY, 1989, STAT MED, V8, P795, DOI 10.1002/sim.4780080704; Jack K, 2010, MANUAL THER, V15, P220, DOI 10.1016/j.math.2009.12.004; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Jensen MP, 1996, PAIN, V67, P35, DOI 10.1016/0304-3959(96)03078-3; Jordan JL, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005956.pub2; Lariviere C, 2016, DEV PRELIMINAIRE PRE; Lariviere C, 2019, J ELECTROMYOGR KINES, V46, P55, DOI 10.1016/j.jelekin.2019.03.001; Lee WC, 1999, INT J EPIDEMIOL, V28, P521, DOI 10.1093/ije/28.3.521; Liebenson C, 2009, PM&R, V1, P530, DOI 10.1016/j.pmrj.2009.03.007; Lyles RH, 2007, STAT MED, V26, P1632, DOI 10.1002/sim.2617; Mannion AF, 2000, EUR SPINE J, V9, P273, DOI 10.1007/s005860000189; Mannion AF, 2009, EUR SPINE J, V18, P1881, DOI 10.1007/s00586-009-1093-7; Marks R, 2005, HEALTH PROMOT PRACT, V6, P37, DOI 10.1177/1524839904266790; McGill S, 2002, LOW BACK DISORDERS E; Niederer D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227423; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Preuss R, 2005, MANUAL THER, V10, P14, DOI 10.1016/j.math.2004.08.006; Rabin A, 2014, J ORTHOP SPORT PHYS, V44, P6, DOI 10.2519/jospt.2014.4888; Remvig L, 2007, J RHEUMATOL, V34, P804; Richardson C, 2004, THERAPEUTIC EXERCISE, V2nd; Searle A, 2015, CLIN REHABIL, V29, P1155, DOI 10.1177/0269215515570379; Simmonds MJ, 1998, SPINE, V23, P2412, DOI 10.1097/00007632-199811150-00011; Smidt N, 2005, AUST J PHYSIOTHER, V51, P71, DOI 10.1016/S0004-9514(05)70036-2; Smith TO, 2013, RHEUMATOL INT, V33, P2709, DOI 10.1007/s00296-013-2790-4; Stanton TR, 2010, PHYS THER, V90, P843, DOI 10.2522/ptj.20090233; Stolze LR, 2012, J ORTHOP SPORT PHYS, V42, P425, DOI 10.2519/jospt.2012.3826; Teyhen DS, 2007, PHYS THER, V87, P313, DOI 10.2522/ptj.20060253; Thompson EL, 2016, CLIN J PAIN, V32, P164, DOI 10.1097/AJP.0000000000000235; Tsao H, 2010, EUR J PAIN, V14, P832, DOI 10.1016/j.ejpain.2010.01.001; van Dieen JH, 2017, EXERC SPORT SCI REV, V45, P223, DOI 10.1249/JES.0000000000000121; Van Dillen LR, 1998, PHYS THER, V78, P979, DOI 10.1093/ptj/78.9.979; van Meulenbroek T, 2021, SCAND J PAIN, V21, P22, DOI 10.1515/sjpain-2020-0023; van Tulder M, 2000, SPINE, V25, P2784, DOI 10.1097/00007632-200011010-00011; Vanti C, 2016, J MANIP PHYSIOL THER, V39, P359, DOI 10.1016/j.jmpt.2016.04.003; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; Vuori IM, 2001, MED SCI SPORT EXER, V33, pS551, DOI 10.1097/00005768-200106001-00026; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	72	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0265970	10.1371/journal.pone.0265970	http://dx.doi.org/10.1371/journal.pone.0265970			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476707	gold, Green Published			2022-12-26	WOS:000840124300006
J	Li, ZX; Zhang, MQ; Yang, ZB; Yu, JX; Liu, Y; Wang, HW				Li, Zongxiang; Zhang, Mingqian; Yang, Zhibin; Yu, Jingxiao; Liu, Yu; Wang, Haiwen			Division of coal spontaneous combustion stages and selection of indicator gases	PLOS ONE			English	Article							INDEX GASES; PRODUCTS; BEHAVIOR; MODEL; RISK; FIRE	Investigating the division of coal spontaneous combustion stages and the selection of indicator gases is significant to the safe production of coal mines. In this study, the characteristic temperature of coal spontaneous combustion, the generation law of indicator gases, the combustion process, and the division of the combustion stages of coal samples taken from Hongqingliang (HQL) and Dayan (DY) mines were investigated using thermogravimetric analysis experiment, indicator gas detection experiment, and coal oxidation spontaneous combustion experiment. The results of the thermogravimetric analysis experiment showed that the pyrolysis temperatures of the HQL and DY coals were 115.76 degrees C and 131.80 degrees C, and the ignition temperatures were 337.74 degrees C and 360.18 degrees C, respectively. The indicator gas detection results showed that the first-appearance temperature of C2H4 was 85 degrees C for the HQL and DY coals, whereas the first-appearance temperature of C2H6 varied: 115 degrees C for the HQL coal and 130 degrees C for the DY coal. The first-appearance temperatures of C2H2 were 180 degrees C and 195 degrees C for the HQL and DY coals, respectively. The experiments on coal oxidation spontaneous combustion showed that the spontaneous combustion period of the HQL and DY coals were 35.45 and 42.3 days, respectively. The heating process during combustion could be divided into four stages: a latent period of spontaneous combustion, a slow spontaneous heating period, an accelerated spontaneous heating period, and a period of combustion. The critical temperature of each stage showed a good correlation with the incipient temperature of the indicator gases, namely C2H2, C2H4, and C2H6, and the appearance of the above gases can be used to characterize the degree of spontaneous combustion of coal.	[Li, Zongxiang; Zhang, Mingqian; Yang, Zhibin; Yu, Jingxiao; Liu, Yu; Wang, Haiwen] Liaoning Tech Univ, Coll Safety Sci & Engn, Fuxing, Liaoning, Peoples R China; [Li, Zongxiang] Liaoning Tech Univ, Key Lab Mine Thermodynam Disaster & Control, Minist Educ, Huludao, Liaoning, Peoples R China	Liaoning Technical University; Liaoning Technical University	Zhang, MQ (corresponding author), Liaoning Tech Univ, Coll Safety Sci & Engn, Fuxing, Liaoning, Peoples R China.	zmq1991@126.com			National Natural Science Foundation of China [51774170]; National Key R&D Program of China [2018YFC0807900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China	The author Zongxiang Li received each award.This research was supported by the National Natural Science Foundation of China (Grant No. 51774170) and the National Key R&D Program of China (2018YFC0807900). There was no additional external funding received for this study.	Adamus A, 2011, FUEL PROCESS TECHNOL, V92, P663, DOI 10.1016/j.fuproc.2010.11.025; Beamish BB, 2000, THERMOCHIM ACTA, V362, P79, DOI 10.1016/S0040-6031(00)00588-8; Civeira MS, 2016, SCI TOTAL ENVIRON, V544, P892, DOI 10.1016/j.scitotenv.2015.12.026; Deng J, 2016, PROCESS SAF ENVIRON, V104, P218, DOI 10.1016/j.psep.2016.09.007; Deng J, 2015, FUEL, V157, P261, DOI 10.1016/j.fuel.2015.04.063; Di JY, 2014, ADV MATER RES-SWITZ, V852, P821, DOI 10.4028/www.scientific.net/AMR.852.821; Guo J, 2019, PROCESS SAF ENVIRON, V126, P223, DOI 10.1016/j.psep.2019.04.014; Guo XY, 2019, ENERG SOURCE PART A, V41, P626, DOI 10.1080/15567036.2018.1520345; Li L, 2020, ENERGY, V203, DOI 10.1016/j.energy.2020.117855; Liang YT, 2019, J LOSS PREVENT PROC, V57, P208, DOI 10.1016/j.jlp.2018.12.003; Liu W, 2017, FUEL, V188, P553, DOI 10.1016/j.fuel.2016.10.049; Niu HY, 2016, J CENT SOUTH UNIV, V23, P2321, DOI 10.1007/s11771-016-3290-y; Nyashina GS, 2018, ENERG CONVERS MANAGE, V174, P175, DOI 10.1016/j.enconman.2018.08.048; Onifade M, 2020, INT J MIN SCI TECHNO, V30, P303, DOI 10.1016/j.ijmst.2020.03.001; Onifade M, 2021, PROCESS SAF ENVIRON, V148, P1019, DOI 10.1016/j.psep.2021.02.017; Onifade M, 2020, INT J MIN SCI TECHNO, V30, P691, DOI 10.1016/j.ijmst.2020.03.006; Parsa MR, 2017, FUEL, V193, P54, DOI 10.1016/j.fuel.2016.12.016; Pone JDN, 2007, INT J COAL GEOL, V72, P124, DOI 10.1016/j.coal.2007.01.001; Ren J, 2014, ENERG FUEL, V28, P3688, DOI 10.1021/ef500446j; Shi GQ, 2021, PROCESS SAF ENVIRON, V149, P631, DOI 10.1016/j.psep.2021.03.010; Sipila J, 2012, J LOSS PREVENT PROC, V25, P617, DOI 10.1016/j.jlp.2012.01.006; Song ZY, 2014, INT J COAL GEOL, V133, P72, DOI 10.1016/j.coal.2014.09.004; Sun Y, 2019, PROCESS SAF ENVIRON, V131, P223, DOI 10.1016/j.psep.2019.09.013; Taraba B, 2011, FUEL PROCESS TECHNOL, V92, P712, DOI 10.1016/j.fuproc.2010.12.003; Tripathi DD, 2008, FIRE TECHNOL, V44, P185, DOI 10.1007/s10694-007-0034-4; Wen H, 2017, APPL THERM ENG, V114, P583, DOI 10.1016/j.applthermaleng.2016.12.022; Xiao Y, 2018, FUEL, V227, P325, DOI 10.1016/j.fuel.2018.04.070; Xie J, 2011, INT J COAL GEOL, V85, P123, DOI 10.1016/j.coal.2010.10.007; Zeng Q, 2018, SCI TOTAL ENVIRON, V640, P1478, DOI 10.1016/j.scitotenv.2018.05.135; Zhang LJ, 2018, FUEL, V222, P350, DOI 10.1016/j.fuel.2018.02.157; Zhang YT, 2018, FUEL, V233, P68, DOI 10.1016/j.fuel.2018.06.052; Zhao JY, 2019, ENERGY, V181, P136, DOI 10.1016/j.energy.2019.05.158	32	0	0	14	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267479	10.1371/journal.pone.0267479	http://dx.doi.org/10.1371/journal.pone.0267479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476715	Green Published, gold			2022-12-26	WOS:000840124300046
J	MacIntyre, AM; Meline, V; Gorman, Z; Augustine, SP; Dye, CJ; Hamilton, CD; Iyer-Pascuzzi, AS; Kolomiets, MV; McCulloh, KA; Allen, C				MacIntyre, April M.; Meline, Valerian; Gorman, Zachary; Augustine, Steven P.; Dye, Carolyn J.; Hamilton, Corri D.; Iyer-Pascuzzi, Anjali S.; Kolomiets, Michael V.; McCulloh, Katherine A.; Allen, Caitilyn			Trehalose increases tomato drought tolerance, induces defenses, and increases resistance to bacterial wilt disease	PLOS ONE			English	Article							INDUCED SYSTEMIC RESISTANCE; RALSTONIA-SOLANACEARUM; SALICYLIC-ACID; ABSCISIC-ACID; GENE-EXPRESSION; JASMONIC ACID; WATER-STRESS; HYPERSENSITIVE RESPONSE; ARABIDOPSIS-THALIANA; REDOX ACTIVATION	Ralstonia solanacearum causes bacterial wilt disease, leading to severe crop losses. Xylem sap from R. solanacearum-infected tomato is enriched in the disaccharide trehalose. Water-stressed plants also accumulate trehalose, which increases drought tolerance via abscisic acid (ABA) signaling. Because R. solanacearum-infected plants suffer reduced water flow, we hypothesized that bacterial wilt physiologically mimics drought stress, which trehalose could mitigate. We found that R. solanacearum-infected plants differentially expressed drought-associated genes, including those involved in ABA and trehalose metabolism, and had more ABA in xylem sap. Consistent with this, treating tomato roots with ABA reduced both stomatal conductance and stem colonization by R. solanacearum. Treating roots with trehalose increased xylem sap ABA and reduced plant water use by lowering stomatal conductance and temporarily improving water use efficiency. Trehalose treatment also upregulated expression of salicylic acid (SA)-dependent tomato defense genes; increased xylem sap levels of SA and other antimicrobial compounds; and increased bacterial wilt resistance of SA-insensitive NahG tomato plants. Additionally, trehalose treatment increased xylem concentrations of jasmonic acid and related oxylipins. Finally, trehalose-treated plants were substantially more resistant to bacterial wilt disease. Together, these data show that exogenous trehalose reduced both water stress and bacterial wilt disease and triggered systemic disease resistance, possibly through a Damage Associated Molecular Pattern (DAMP) response pathway. This suite of responses revealed unexpected linkages between plant responses to biotic and abiotic stress and suggested that R. solanacearum-infected plants increase trehalose to improve water use efficiency and increase wilt disease resistance. The pathogen may degrade trehalose to counter these efforts. Together, these results suggest that treating tomatoes with exogenous trehalose could be a practical strategy for bacterial wilt management.	[MacIntyre, April M.; Dye, Carolyn J.; Hamilton, Corri D.; Allen, Caitilyn] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [MacIntyre, April M.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Meline, Valerian; Iyer-Pascuzzi, Anjali S.] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; [Gorman, Zachary; Kolomiets, Michael V.] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; [Augustine, Steven P.; McCulloh, Katherine A.] Univ Wisconsin, Dept Bot, Madison, WI USA; [MacIntyre, April M.] Valent Biosci, Libertyville, IL USA; [Dye, Carolyn J.] Soil Carbon Co, Minneapolis, MN USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Texas A&M University System; Texas A&M University College Station; University of Wisconsin System; University of Wisconsin Madison	Allen, C (corresponding author), Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA.	callen@wisc.edu		MacIntyre, April/0000-0002-1867-6661	USDANIFA Predoctoral Fellowship; University of Wisconsin-Madison College of Agricultural and Life Sciences	USDANIFA Predoctoral Fellowship; University of Wisconsin-Madison College of Agricultural and Life Sciences	This research was supported by a USDANIFA Predoctoral Fellowship to AMM and by the University of Wisconsin-Madison College of Agricultural and Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd el-Rahim MF, 1998, PLANT PATHOL, V47, P216, DOI 10.1046/j.1365-3059.1998.00211.x; Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; Almeras E, 2003, PLANT J, V34, P202, DOI 10.1046/j.1365-313X.2003.01718.x; Alvarez B, 2010, TECHNOLOGY ED TOPICS, P267; An CF, 2011, J INTEGR PLANT BIOL, V53, P412, DOI 10.1111/j.1744-7909.2011.01043.x; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2020, R R R PROJECT STAT C; Asaf S, 2017, MICROBIOL RES, V205, P135, DOI 10.1016/j.micres.2017.08.009; Avonce N, 2004, PLANT PHYSIOL, V136, P3649, DOI 10.1104/pp.104.052084; B. Ingel, 2021, bioRxiv, DOI 10.1101/2021.03.19.436187; Bae HH, 2005, PHYSIOL PLANTARUM, V125, P114, DOI 10.1111/j.1399-3054.2005.00537.x; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; BEATTIE GA, 1995, ANNU REV PHYTOPATHOL, V33, P145, DOI 10.1146/annurev.py.33.090195.001045; Beattie GA, 2011, ANNU REV PHYTOPATHOL, V49, P533, DOI 10.1146/annurev-phyto-073009-114436; Beckman CH, 2000, PHYSIOL MOL PLANT P, V57, P101, DOI 10.1006/pmpp.2000.0287; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bian CH, 2020, MOL PLANT MICROBE IN, V33, P1424, DOI 10.1094/MPMI-08-20-0211-R; Block A, 2005, PLANT PHYSIOL, V138, P1481, DOI 10.1104/pp.105.059246; Boatwright JL, 2013, MOL PLANT PATHOL, V14, P623, DOI 10.1111/mpp.12035; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolouri Moghaddam MR, 2012, J EXP BOT, V63, P3989, DOI 10.1093/jxb/ers129; Brading PA, 2000, PLANT J, V23, P305, DOI 10.1046/j.1365-313x.2000.00778.x; Brown DG, 2007, APPL ENVIRON MICROB, V73, P2777, DOI 10.1128/AEM.00984-06; Cao J, 2015, PLANTA, V241, P757, DOI 10.1007/s00425-014-2215-y; Chen K, 2020, J INTEGR PLANT BIOL, V62, P25, DOI 10.1111/jipb.12899; Chen YY, 2009, PHYSIOL PLANTARUM, V136, P324, DOI 10.1111/j.1399-3054.2009.01226.x; Chen ZX, 2009, PLANT SIGNAL BEHAV, V4, P493, DOI 10.4161/psb.4.6.8392; Choudhary Devendra K., 2007, Indian Journal of Microbiology, V47, P289, DOI 10.1007/s12088-007-0054-2; Cortina C, 2005, PLANT SCI, V169, P75, DOI 10.1016/j.plantsci.2005.02.026; Daugherty MP, 2010, EUR J PLANT PATHOL, V127, P333, DOI 10.1007/s10658-010-9598-9; De Lorenzo G, 2018, TRENDS IMMUNOL, V39, P937, DOI 10.1016/j.it.2018.09.006; Denance N, 2013, PLANT J, V73, P225, DOI 10.1111/tpj.12027; Denny TP, 2006, PLANT-ASSOCIATED BACTERIA, P573; Derksen H, 2013, PLANT SCI, V207, P79, DOI 10.1016/j.plantsci.2013.03.004; Deslandes L, 2002, P NATL ACAD SCI USA, V99, P2404, DOI 10.1073/pnas.032485099; Deslandes L, 2014, CURR OPIN PLANT BIOL, V20, P110, DOI 10.1016/j.pbi.2014.05.002; Digonnet C, 2012, PLANTA, V236, P1419, DOI 10.1007/s00425-012-1694-y; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Elphinstone J. G., 2005, Bacterial wilt disease and the Ralstonia solanacearum species complex, P9; Flores-Cruz Z, 2009, MOL PLANT MICROBE IN, V22, P773, DOI 10.1094/MPMI-22-7-0773; French E, 2018, MOL PLANT MICROBE IN, V31, P432, DOI 10.1094/MPMI-08-17-0209-R; Garg AK, 2002, P NATL ACAD SCI USA, V99, P15898, DOI 10.1073/pnas.252637799; Ge SX, 2020, BIOINFORMATICS, V36, P2628, DOI 10.1093/bioinformatics/btz931; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; GODOY JA, 1990, PLANT MOL BIOL, V15, P695, DOI 10.1007/BF00016120; Gomez LD, 2010, PLANT J, V64, P1, DOI 10.1111/j.1365-313X.2010.04312.x; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Hamilton CD, 2021, MOL PLANT MICROBE IN, V34, P669, DOI 10.1094/MPMI-10-20-0298-R; Hase S, 2008, PLANT PATHOL, V57, P870, DOI 10.1111/j.1365-3059.2008.01858.x; Hassan MAE, 2013, EUR J PLANT PATHOL, V136, P145, DOI 10.1007/s10658-012-0149-4; He YH, 2002, PLANT PHYSIOL, V128, P876, DOI 10.1104/pp.010843; He YM, 2020, PHYTOCHEMISTRY, V174, DOI 10.1016/j.phytochem.2020.112334; HENDRICK CA, 1984, APPL ENVIRON MICROB, V48, P94, DOI 10.1128/AEM.48.1.94-101.1984; Hernandez-Blanco C, 2007, PLANT CELL, V19, P890, DOI 10.1105/tpc.106.048058; Hirsch J, 2002, PHYTOPATHOLOGY, V92, P1142, DOI 10.1094/PHYTO.2002.92.10.1142; Hou SG, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00646; Hu J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002589; Iordachescu M, 2008, J INTEGR PLANT BIOL, V50, P1223, DOI 10.1111/j.1744-7909.2008.00736.x; Ishihara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046763; Ishikawa R, 2005, PHYTOPATHOLOGY, V95, P1209, DOI 10.1094/PHYTO-95-1209; Ishikawa Ryo, 1996, Annals of the Phytopathological Society of Japan, V62, P478, DOI 10.3186/jjphytopath.62.478; Jackson M, 1997, TRENDS PLANT SCI, V2, P22, DOI 10.1016/S1360-1385(96)10050-9; Jacobs JM, 2013, MBIO, V4, DOI 10.1128/mBio.00875-13; Jacobs JM, 2012, MBIO, V3, DOI 10.1128/mBio.00114-12; Jakab G, 2001, EUR J PLANT PATHOL, V107, P29, DOI 10.1023/A:1008730721037; Ji K, 2014, J EXP BOT, V65, P5243, DOI 10.1093/jxb/eru288; JOOSTEN MHAJ, 1989, PLANT PHYSIOL, V89, P945, DOI 10.1104/pp.89.3.945; Kaiser E, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.01317; Kapilan R, 2018, BIOL RES, V51, DOI 10.1186/s40659-018-0152-0; Khater MA., 2018, MIDDLE E J AGR RES, V7, P782; Khokhani D, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.3028; Khokhani D, 2017, MBIO, V8, DOI [10.1128/mBio.00895-17, 10.1128/mbio.00895-17]; Kissoudis C, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02009; Kolbe A, 2005, P NATL ACAD SCI USA, V102, P11118, DOI 10.1073/pnas.0503410102; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; LANAHAN MB, 1994, PLANT CELL, V6, P521, DOI 10.1105/tpc.6.4.521; Leyman B, 2001, TRENDS PLANT SCI, V6, P510, DOI 10.1016/S1360-1385(01)02125-2; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lin QF, 2020, J EXP BOT, V71, P4285, DOI 10.1093/jxb/eraa173; Lin QF, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1986-5; Lin YC, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1207-z; Ling QH, 2011, PHOTOSYNTH RES, V107, P209, DOI 10.1007/s11120-010-9606-0; Liu HL, 2005, MOL PLANT MICROBE IN, V18, P1296, DOI 10.1094/MPMI-18-1296; Lopez-Gresa MP, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0166938, 10]; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lowe TM, 2015, MOL PLANT MICROBE IN, V28, P286, DOI 10.1094/MPMI-09-14-0292-FI; Lowe-Power TM, 2018, TRENDS MICROBIOL, V26, P929, DOI 10.1016/j.tim.2018.06.002; Lowe-Power TM, 2018, ENVIRON MICROBIOL, V20, P1330, DOI 10.1111/1462-2920.14020; Lowe-Power TM, 2016, MBIO, V7, DOI 10.1128/mBio.00656-16; Lunn JE, 2006, BIOCHEM J, V397, P139, DOI 10.1042/BJ20060083; Lunn JE, 2007, FUNCT PLANT BIOL, V34, P550, DOI 10.1071/FP06315; Lunn JE, 2014, PLANT J, V79, P544, DOI 10.1111/tpj.12509; Lyu JI, 2013, PLANT CELL TISS ORG, V112, P257, DOI 10.1007/s11240-012-0225-7; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; MacIntyre AM, 2020, MOL PLANT MICROBE IN, V33, P462, DOI 10.1094/MPMI-08-19-0218-R; Mandal S, 2013, SCI WORLD J, DOI 10.1155/2013/561056; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Marcos R, 2015, PLANT PHYSIOL, V169, P2324, DOI 10.1104/pp.15.00992; McElrone AJ, 2003, J EXP BOT, V54, P419, DOI 10.1093/jxb/erg046; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Milling A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015853; Montillet JL, 2002, PLANT PHYSIOL BIOCH, V40, P633, DOI 10.1016/S0981-9428(02)01402-X; Mori Y, 2016, MOL PLANT PATHOL, V17, P890, DOI 10.1111/mpp.12335; Muller M, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-37; ORGAMBIDE G, 1991, J BIOL CHEM, V266, P8312; Osakabe Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00086; Park J, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0443-x; Patel J, 2021, PHYSIOL PLANTARUM, V172, P1030, DOI 10.1111/ppl.13324; Paul M, 2007, CURR OPIN PLANT BIOL, V10, P303, DOI 10.1016/j.pbi.2007.04.001; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Paul MJ, 2018, PLANT PHYSIOL, V177, P12, DOI 10.1104/pp.17.01634; PENACORTES H, 1995, P NATL ACAD SCI USA, V92, P4106, DOI 10.1073/pnas.92.10.4106; Piazza A, 2015, J EXP BOT, V66, P2795, DOI 10.1093/jxb/erv095; Potnis N, 2014, APPL ENVIRON MICROB, V80, P3173, DOI 10.1128/AEM.00345-14; Poueymiro M, 2014, MBIO, V5, DOI 10.1128/mBio.02065-14; Pradhanang PM, 2005, PLANT DIS, V89, P989, DOI 10.1094/PD-89-0989; Prost I, 2005, PLANT PHYSIOL, V139, P1902, DOI 10.1104/pp.105.066274; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Raivo Kolde, 2019, PHEATMAP PRETTY HEAT, DOI DOI 10.1128/AEM.01151-09; Ranf S, 2011, PLANT J, V68, P100, DOI 10.1111/j.1365-313X.2011.04671.x; Rau A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-91; Reignault P, 2001, NEW PHYTOL, V149, P519, DOI 10.1046/j.1469-8137.2001.00035.x; RETIG N, 1974, PHYSIOL PLANT PATHOL, V4, P469, DOI 10.1016/0048-4059(74)90032-0; Reuscher S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079052; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romero C, 1997, PLANTA, V201, P293, DOI 10.1007/s004250050069; Sade N, 2009, NEW PHYTOL, V181, P651, DOI 10.1111/j.1469-8137.2008.02689.x; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Savatin DV, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00470; Schluepmann H, 2003, P NATL ACAD SCI USA, V100, P6849, DOI 10.1073/pnas.1132018100; Schluepmann H, 2012, J EXP BOT, V63, P3379, DOI 10.1093/jxb/err311; Seo S, 2016, PLANT CELL PHYSIOL, V57, P1932, DOI 10.1093/pcp/pcw114; Shi YC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217204; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Signorelli S, 2019, TRENDS PLANT SCI, V24, P413, DOI 10.1016/j.tplants.2019.02.001; Singh V, 2012, PLANT SIGNAL BEHAV, V7, P605, DOI 10.4161/psb.20066; Sinha R, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00333; Sinha R, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00902; Smart CD, 2003, MOL PLANT MICROBE IN, V16, P141, DOI 10.1094/MPMI.2003.16.2.141; Smeekens S, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.23; Song L, 2016, SCIENCE, V354, DOI 10.1126/science.aag1550; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; TAL M, 1966, PLANT PHYSIOL, V41, P1387, DOI 10.1104/pp.41.8.1387; Tanaka K, 2021, ANNU REV PHYTOPATHOL, V59, P53, DOI 10.1146/annurev-phyto-082718-100146; Tans-Kersten J, 2001, J BACTERIOL, V183, P3597, DOI 10.1128/JB.183.12.3597-3605.2001; Thompson AJ, 2004, PLANT CELL ENVIRON, V27, P459, DOI 10.1111/j.1365-3040.2003.01164.x; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Tian T, 2017, NUCLEIC ACIDS RES, V45, pW122, DOI 10.1093/nar/gkx382; Tornero P, 1997, MOL PLANT MICROBE IN, V10, P624, DOI 10.1094/MPMI.1997.10.5.624; Tran TM, 2016, ENVIRON MICROBIOL, V18, P4103, DOI 10.1111/1462-2920.13446; Tran TM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005686; Umezawa T, 2006, PLANT J, V46, P171, DOI 10.1111/j.1365-313X.2006.02683.X; Vallad GE, 2004, CROP SCI, V44, P1920, DOI 10.2135/cropsci2004.1920; Vandesteene L, 2012, PLANT PHYSIOL, V160, P884, DOI 10.1104/pp.112.201400; Vandesteene L, 2010, MOL PLANT, V3, P406, DOI 10.1093/mp/ssp114; VASSE J, 1995, MOL PLANT MICROBE IN, V8, P241, DOI 10.1094/MPMI-8-0241; Vicente J, 2012, MOL PLANT, V5, P914, DOI 10.1093/mp/ssr105; Walters DR, 2006, ANN BOT-LONDON, V97, P779, DOI 10.1093/aob/mcl034; Wang KD, 2020, PLANT CELL, V32, P166, DOI 10.1105/tpc.19.00487; Wang WJ, 2020, J INTEGR PLANT BIOL, V62, P1518, DOI 10.1111/jipb.12925; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Widhalm JR, 2015, MOL PLANT, V8, P83, DOI 10.1016/j.molp.2014.12.001; YAMAGUCHISHINOZAKI K, 1993, MOL GEN GENET, V238, P17, DOI 10.1007/BF00279525; Yao J, 2007, J BACTERIOL, V189, P6415, DOI 10.1128/JB.00398-07; Yao J, 2006, J BACTERIOL, V188, P3697, DOI 10.1128/JB.188.10.3697-3708.2006; Yu WQ, 2019, PLANTA, V250, P643, DOI 10.1007/s00425-019-03195-2; Zhang HJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01176; Zhao CZ, 2019, MOL PLANT MICROBE IN, V32, P813, DOI 10.1094/MPMI-10-18-0268-R; Zhao YF, 2003, PLANT J, V36, P485, DOI 10.1046/j.1365-313X.2003.01895.x; Zhou R, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1982-9; ZIMMERMAN DC, 1979, PLANT PHYSIOL, V63, P536, DOI 10.1104/pp.63.3.536	173	2	2	15	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0266254	10.1371/journal.pone.0266254	http://dx.doi.org/10.1371/journal.pone.0266254			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476629	gold, Green Published			2022-12-26	WOS:000840124300010
J	Svendsen, CD; Kuiper, KKJ; Ostridge, K; Larsen, TH; Nielsen, R; Hodneland, V; Nordeide, E; Bakke, PS; Eagan, TM				Svendsen, Christina D.; Kuiper, Karel K. J.; Ostridge, Kristoffer; Larsen, Terje H.; Nielsen, Rune; Hodneland, Vidar; Nordeide, Eli; Bakke, Per S.; Eagan, Tomas M.			Factors associated with coronary heart disease in COPD patients and controls	PLOS ONE			English	Article							ARTERY CALCIFICATION; CALCIUM SCORE; INFLAMMATORY MARKERS; LUNG-FUNCTION; CARDIAC CT; ATHEROSCLEROSIS; QUANTIFICATION; COMORBIDITIES; POPULATION; MORBIDITY	Background COPD and coronary heart disease (CHD) frequently co-occur, yet which COPD phenotypes are most prone to CHD is poorly understood. The aim of this study was to see whether COPD patients did have a true higher risk for CHD than subjects without COPD, and to examine a range of potential factors associated with CHD in COPD patients and controls. Methods 347 COPD patients and 428 non-COPD controls, were invited for coronary computed tomography angiography (CCTA) and pulmonary CT. Arterial blood gas, bioelectrical impedance and lung function was measured, and a detailed medical history taken. The CCTA was evaluated for significant coronary stenosis and calcium score (CaSc), and emphysema defined as >10% of total area <-950 Hounsfield units. Results 12.6% of the COPD patients and 5.7% of the controls had coronary stenosis (p<0.01), whereas 55.9% of the COPD patients had a CaSc>100 compared to 31.6% of the controls (p<0.01). In a multivariable model adjusting for sex, age, body composition, pack-years, CRP, cholesterol/blood pressure lowering medication use and diabetes mellitus, the OR (95% CI) for having significant stenosis was 1.80 (0.86-3.78) in COPD patients compared with controls. In a similar model, the OR (95% CI) for having CaSc>100 was 1.68 (1.12-2.53) in COPD patients compared with controls. Examining the risk of significant stenosis and CaSc>100 among COPD patients, no variable was associated with significant stenosis, whereas male sex [OR 2.85 (1.56-5.21)], age [OR 3.74 (2.42-5.77)], statin use [OR 2.23 (1.23-4.50)] were associated with CaSc>100, after adjusting for body composition, pack-years, C-reactive protein, use of angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), diabetes, emphysema score, GOLD category, exacerbation frequency, eosinophilia, and hypoxemia. Conclusion COPD patients were more likely to have CHD, but neither emphysema score, lung function, exacerbation frequency, nor hypoxemia predicted presence of either coronary stenosis or CaSc>100.	[Svendsen, Christina D.; Nielsen, Rune; Nordeide, Eli; Eagan, Tomas M.] Haukeland Hosp, Dept Thorac Med, Bergen, Norway; [Kuiper, Karel K. J.; Larsen, Terje H.; Hodneland, Vidar] Haukeland Hosp, Dept Heart Dis, Bergen, Norway; [Ostridge, Kristoffer] Univ Southampton, Fac Med Clin & Expt Sci, Southampton, Hants, England; [Ostridge, Kristoffer] AstraZeneca, Translat Sci & Expt Med, Res & Early Dev, Resp & Immunol,BioPharmaceut R&D, Gothenburg, Sweden; [Larsen, Terje H.] Univ Bergen, Dept Biomed, Bergen, Norway; [Nielsen, Rune; Bakke, Per S.; Eagan, Tomas M.] Univ Bergen, Dept Clin Sci, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Southampton; AstraZeneca; University of Bergen; University of Bergen	Svendsen, CD (corresponding author), Haukeland Hosp, Dept Thorac Med, Bergen, Norway.	chne@helse-bergen.no	Eagan, Tomas ML/P-3554-2014	Eagan, Tomas ML/0000-0001-8725-9960				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Barr RG, 2012, EUR RESPIR J, V39, P846, DOI 10.1183/09031936.00165410; Bhatt SP, 2013, TRANSL RES, V162, P237, DOI 10.1016/j.trsl.2013.05.001; Cerqueira MD, 2002, INT J CARDIOVAS IMAG, V18, P539; Chen WJ, 2015, LANCET RESP MED, V3, P631, DOI 10.1016/S2213-2600(15)00241-6; Eagan TML, 2010, EUR RESPIR J, V35, P540, DOI 10.1183/09031936.00088209; Feary JR, 2010, THORAX, V65, P956, DOI 10.1136/thx.2009.128082; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fragoso CAV, 2018, RESP MED, V137, P40, DOI 10.1016/j.rmed.2018.02.018; Gaisl T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126613; GEVENOIS PA, 1995, AM J RESP CRIT CARE, V152, P653, DOI 10.1164/ajrccm.152.2.7633722; Gronseth R, 2014, EUR CLIN RESPIR J, V1, DOI 10.3402/ecrj.v1.26196; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Henein M, 2015, INT J CARDIOL, V184, P581, DOI 10.1016/j.ijcard.2015.02.072; Hong YZ, 2019, COPD, V16, P66, DOI 10.1080/15412555.2019.1566894; Jenny NS, 2010, ATHEROSCLEROSIS, V209, P226, DOI 10.1016/j.atherosclerosis.2009.08.037; Johannessen A, 2006, AM J RESP CRIT CARE, V173, P1316, DOI 10.1164/rccm.200601-023OC; Kim YJ, 2012, EUR HEART J-CARD IMG, V13, P776, DOI 10.1093/ehjci/jes060; Lange P, 2010, COPD, V7, P5, DOI 10.3109/15412550903499506; Lee MS, 2013, INT J CARDIOVAS IMAG, V29, P29, DOI 10.1007/s10554-013-0257-z; Lin T, 2010, ATHEROSCLEROSIS, V212, P501, DOI 10.1016/j.atherosclerosis.2010.06.017; Lopez-Campos JL, 2020, ARCH BRONCONEUMOL, V56, P65, DOI 10.1016/j.arbres.2019.06.001; Maclay JD, 2013, CHEST, V143, P798, DOI 10.1378/chest.12-0938; Mota IL, 2018, INT J CHRONIC OBSTR, V13, P1999, DOI 10.2147/COPD.S162713; Park HY, 2010, RESP MED, V104, P1326, DOI 10.1016/j.rmed.2010.02.024; Rabe KF, 2018, EUR RESPIR REV, V27, DOI 10.1183/16000617.0057-2018; Reed RM, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2012.05.018; Ronit A, 2018, INT J CHRONIC OBSTR, V13, P3321, DOI 10.2147/COPD.S172695; RUMBERGER JA, 1995, CIRCULATION, V92, P2157, DOI 10.1161/01.CIR.92.8.2157; Rumberger JA, 2010, VASC HEALTH RISK MAN, V6, P579; Schroeder EB, 2003, AM J EPIDEMIOL, V158, P1171, DOI 10.1093/aje/kwg276; Schutz Y, 2002, INT J OBESITY, V26, P953, DOI 10.1038/sj.ijo.0802037; Sin DD, 2006, EUR RESPIR J, V28, P1245, DOI 10.1183/09031936.00133805; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; Sorheim IC, 2010, THORAX, V65, P480, DOI 10.1136/thx.2009.122002; Soriano JB, 2005, CHEST, V128, P2099, DOI 10.1378/chest.128.4.2099; StataCorp, 2015, STAT STAT SOFTW REL; Sverzellati N, 2012, RADIOLOGY, V262, P460, DOI 10.1148/radiol.11110364; Wang ZM, 2013, EUR RADIOL, V23, P975, DOI 10.1007/s00330-012-2683-z; Williams MC, 2014, THORAX, V69, P718, DOI 10.1136/thoraxjnl-2012-203151; World Health Organization, 2018, GLOB HLTH EST 2016 D	41	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0265682	10.1371/journal.pone.0265682	http://dx.doi.org/10.1371/journal.pone.0265682			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476713	Green Published, gold			2022-12-26	WOS:000840124300004
J	Tsang, JLY; Fowler, R; Cook, DJ; Burns, KEA; Hunter, K; Forcina, V; Hwang, A; Duan, E; Patterson, L; Binnie, A				Tsang, Jennifer L. Y.; Fowler, Robert; Cook, Deborah J.; Burns, Karen E. A.; Hunter, Kylee; Forcina, Victoria; Hwang, Anna; Duan, Erick; Patterson, Lisa; Binnie, Alexandra			Motivating factors, barriers and facilitators of participation in COVID-19 clinical research: A cross-sectional survey of Canadian community intensive care units	PLOS ONE			English	Article							OUTCOMES; CANCER	Only a small proportion of COVID-19 patients in Canada have been recruited into clinical research studies. One reason is that few community intensive care units (ICUs) in Canada participate in research. The objective of this study was to examine the motivating factors, barriers and facilitators to research participation amongst Canadian community ICU stakeholders. A cross-sectional online survey was distributed between May and November 2020. The survey focused on 6 domains: participant demographics, ICU characteristics, ICU research infrastructure, motivating factors, perceived barriers, and perceived facilitators. Responses were received from 73 community ICU stakeholders, representing 18 ICUs. 7/18 ICUs had a clinical research program. Participants rated their interest in pandemic research at a mean of 5.2 (Standard Deviation [SD] = 1.9) on a 7-point Likert scale from 'not interested' to 'very interested'. The strongest motivating factor for research participation was the belief that research improves clinical care and outcomes. The most significant facilitators of research involvement were the availability of an experienced research coordinator and dedicated external funding to cover start-up costs, while the most significant barriers to research involvement were a lack of start-up funding for a research coordinator and a lack of ICU research experience. Canadian Community ICU stakeholders are interested in participating in pandemic research but lack basic infrastructure, research personnel, research experience and start-up funding. Evolution of a research support model at community hospitals, where most patients receive acute care, may increase research participation and improve the generalizability of funded research in Canada.	[Tsang, Jennifer L. Y.; Duan, Erick] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Tsang, Jennifer L. Y.; Forcina, Victoria; Hwang, Anna] McMaster Univ, Michael G DeGroote Sch Med, Niagara Reg Campus, St Catharines, ON, Canada; [Tsang, Jennifer L. Y.; Duan, Erick; Patterson, Lisa] Niagara Hlth, St Catharines, ON, Canada; [Fowler, Robert; Burns, Karen E. A.] Univ Toronto, Interdept Div Crit Care, Temerty Sch Med, Toronto, ON, Canada; [Fowler, Robert] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Cook, Deborah J.; Burns, Karen E. A.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Cook, Deborah J.; Duan, Erick] St Josephs HealthCare, Hamilton, ON, Canada; [Burns, Karen E. A.] St Michaels Hosp, Toronto, ON, Canada; [Hunter, Kylee] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Binnie, Alexandra] William Osler Hlth Syst, Etobicoke, ON, Canada	McMaster University; McMaster University; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McMaster University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Ottawa	Tsang, JLY (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.; Tsang, JLY (corresponding author), McMaster Univ, Michael G DeGroote Sch Med, Niagara Reg Campus, St Catharines, ON, Canada.; Tsang, JLY (corresponding author), Niagara Hlth, St Catharines, ON, Canada.	Jennifer.tsang@mcmaster.ca		Binnie, Alexandra/0000-0003-2969-8177	Canadian Critical Care Trials Group Early Career Research Award	Canadian Critical Care Trials Group Early Career Research Award	JT received the Canadian Critical Care Trials Group Early Career Research Award to support this study. https://www.ccctg.ca/Home The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus DC., 2020, JAMA-J AM MED ASSOC, V324, P1317, DOI 10.1001/jama.2020.17022; Canadian Institute for Health Information, 2018, NUMB HOSP BEDS STAFF; Challen R, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n579; DiDiodato G, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2517-4; Downing A, 2017, GUT, V66, P89, DOI 10.1136/gutjnl-2015-311308; du Bois A, 2005, INT J GYNECOL CANCER, V15, P183, DOI 10.1136/ijgc-00009577-200503000-00001; Gehrke P, 2019, CAN MED ASSOC J, V191, pE962, DOI 10.1503/cmaj.190055; Gordon AC, 2021, NEW ENGL J MED, V384, P1491, DOI 10.1056/NEJMoa2100433; Government of Canada, 2022, COVID 19 DAIL EP UPD; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Krzyzanowska MK, 2011, ANN ONCOL, V22, P10, DOI 10.1093/annonc/mdr420; Majumdar SR, 2008, ARCH INTERN MED, V168, P657, DOI 10.1001/archinternmed.2007.124; Murthy S., 2021, CATCO CANADIAN SITES; Ontario Institute for Cancer Research, CAN CANC CLIN TRIALS; Rochon J, 2011, ANN ONCOL, V22, P16, DOI 10.1093/annonc/mdr421; Snihur Adrian, 2020, Healthc Q, V23, P30, DOI 10.12927/hcq.2020.26277	16	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0266770	10.1371/journal.pone.0266770	http://dx.doi.org/10.1371/journal.pone.0266770			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476678	Green Published, gold			2022-12-26	WOS:000840124300015
J	Lukeneder, P; Lukeneder, A				Lukeneder, Petra; Lukeneder, Alexander			Mineralized belemnoid cephalic cartilage from the late Triassic Polzberg Konservat-Lagerstatte (Austria)	PLOS ONE			English	Article							INVERTEBRATE CARTILAGES; SEPIA-OFFICINALIS; CEPHALOPODS; EVOLUTION; ULTRASTRUCTURE; CHONDROCYTES; COMPONENTS; DIVERSITY; HISTOLOGY; MOLLUSCA	Although hyaline cartilage is widely distributed in various invertebrate groups such as sabellid polychaetes, molluscs (cephalopods, gastropods) and a chelicerate arthropod group (horseshoe crabs), the enigmatic relationship and distribution of cartilage in taxonomic groups remains to be explained. It can be interpreted as a convergent trait in animal evolution and thus does not seem to be a vertebrate invention. Due to the poor fossil record of cartilaginous structures, occurrences of mineralized fossil cartilages are important for evolutionary biology and paleontology. Although the biochemical composition of recent cephalopod cartilage differs from vertebrate cartilage, histologically the cartilages of these animal groups resemble one another remarkably. In this study we present fossil material from the late Triassic Polzberg Konservat-Lagerstatte near Lunz am See (Lower Austria, Northern Calcareous Alps). A rich Carnian fauna is preserved here, whereby a morphogroup (often associated with belemnoid remains) of black, amorphous appearing fossils still remained undetermined. These multi-elemental, symmetrical fossils show remarkable similarities to recent cartilage. We examined the conspicuous micro- and ultrastructure of these enigmatic fossils by thin-sectioning and Scanning Electron Microscopy (SEM). The geochemical composition analyzed by Microprobe and Energy Dispersive X-ray Spectroscopy (SEM-EDX) revealed carbonization as the taphonomic pathway for this fossil group. Mineralization of soft tissues permits the 3D preservation of otherwise degraded soft tissues such as cartilage. We examined eighty-one specimens from the Polzberg locality and seven specimens from Cave del Predil (formerly Raibl, Julian Alps, Italy). The study included morphological examinations of these multi-elemental fossils and a focus on noticeable structures like grooves and ridges. The detected grooves are interpreted to be muscular attachment areas, and the preserved branched system of canaliculi is comparable to a channel system that is also present in recent coleoid cartilage. The new findings on these long-known enigmatic structures strongly point to the preservation of cephalic cartilage belonging to the belemnoid Phragmoteuthis bisinuata and its homologization to the cephalic cartilage of modern coleoids.	[Lukeneder, Petra] Univ Vienna, Doctoral Sch Ecol & Evolut, Vienna, Austria; [Lukeneder, Alexander] Museum Nat Hist Vienna, Vienna, Austria	University of Vienna	Lukeneder, P (corresponding author), Univ Vienna, Doctoral Sch Ecol & Evolut, Vienna, Austria.	a0501032@unet.univie.ac.at		Lukeneder, Alexander/0000-0002-8384-3366	Austrian Academy of Sciences (OAW); Federal Government of Lower Austria (Department Science and Research) [K3-F964/001-2020]; University of Vienna	Austrian Academy of Sciences (OAW); Federal Government of Lower Austria (Department Science and Research); University of Vienna	This work was created in the course of projects funded by the Austrian Academy of Sciences (OAW), represented by the National Committee for Geo/Hydro-Sciences (Earth Sciences Program), project Polzberg Lukeneder and the Federal Government of Lower Austria (Department Science and Research) project K3-F964/001-2020. Project funding was acquired by AL. Open access funding for publication provided by University of Vienna (acquired by PL). Study design, field work and data collection was funded by the above projects. The authors are responsible for the contents of this publication. The funder had no impact on conceptualization, design, data collection, analysis, decision to publish, or preparation of the manuscript.	Bailleul AM, 2020, NATL SCI REV, V7, P815, DOI 10.1093/nsr/nwz206; Bailleul AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036112; BAIRATI A, 1987, TISSUE CELL, V19, P673, DOI 10.1016/0040-8166(87)90074-7; Bairati A, 1998, TISSUE CELL, V30, P340, DOI 10.1016/S0040-8166(98)80047-5; BUDELMANN BU, 1993, PHILOS T ROY SOC B, V340, P93, DOI 10.1098/rstb.1993.0051; Clements T, 2017, PALAEONTOLOGY, V60, P1, DOI 10.1111/pala.12267; Cole AG, 2011, EUR CELLS MATER, V21, P122, DOI 10.22203/eCM.v021a10; Cole AG, 2004, ZOOLOGY, V107, P261, DOI 10.1016/j.zool.2004.05.001; Cole AG, 2004, ACTA ZOOL-STOCKHOLM, V85, P69, DOI 10.1111/j.0001-7272.2004.00159.x; Cole AG, 2009, ZOOLOGY, V112, P2, DOI 10.1016/j.zool.2008.01.003; Doguzhaeva LA, 2007, CEPHALOPODS PRESENT AND PAST: NEW INSIGHTS AND FRESH PERSPECTIVES, P221, DOI 10.1007/978-1-4020-6806-5_11; Doguzhaeva LA, 2018, ACTA PALAEONTOL POL, V63, P341, DOI 10.4202/app.00393.2017; Doguzhaeva Larisa A., 2010, Ferrantia, V59, P37; Doguzhaeva Larisa A., 2007, Palaeoworld, V16, P272, DOI 10.1016/j.palwor.2007.08.002; Donovan DT, 2006, PALAEONTOLOGY, V49, P673, DOI 10.1111/j.1475-4983.2006.00552.x; Donovan Desmond T., 2016, Treatise Online, V73, P1; EILBERG RG, 1975, CALC TISS RES, V19, P85, DOI 10.1007/BF02563993; Focareta L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157821; Forchielli A, 2013, AUSTRIAN J EARTH SCI, V106, P46; Fraas E., 1889, JAHRESH VEREINS VATE, V45, P217; FRANC S, 1995, EUR J BIOCHEM, V234, P125, DOI 10.1111/j.1432-1033.1995.125_c.x; Fuchs D, 2021, SWISS J PALAEONTOL, V140, DOI 10.1186/s13358-021-00241-z; Fuchs D, 2013, PALAEONTOL Z, V87, P431, DOI 10.1007/s12542-013-0182-4; Fuchs D, 2013, NEUES JAHRB GEOL P-A, V269, P241, DOI 10.1127/0077-7749/2013/0347; Fuchs D, 2011, J PALEONTOL, V85, P234, DOI 10.1666/10-089.1; Hall B.K., 2015, BONES CARTILAGE DEV; Hall BK, 2013, J ANAT, V222, P19, DOI 10.1111/j.1469-7580.2012.01495.x; Hoffmann R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57731-2; Hoffmann R, 2017, PALEOBIOLOGY, V43, P304, DOI 10.1017/pab.2016.44; Hornung Thomas, 2007, Bulletin of the New Mexico Museum of Natural History and Science, V41, P59; Hu YZ, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.201033; Johanson Z, 2010, SEMIN CELL DEV BIOL, V21, P414, DOI 10.1016/j.semcdb.2009.10.011; Kaucka M, 2019, SEMIN CELL DEV BIOL, V91, P2, DOI 10.1016/j.semcdb.2017.12.007; Klinghardt F., 1932, Palaeontologische Zeitschrift, V14, P160; Klug C, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0523-2; Klug C, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0877; Klug C, 2012, PALAEONTOLOGY, V55, P1307, DOI 10.1111/j.1475-4983.2012.01196.x; Kroger B, 2011, BIOESSAYS, V33, P602, DOI 10.1002/bies.201100001; Kruta I, 2020, PALAEONTOLOGY, V63, P301, DOI 10.1111/pala.12457; Lemanis R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151404; Leone F, 2004, EUR J HISTOCHEM, V48, P159; Levett A, 2019, GEOSCI FRONT, V10, P1125, DOI 10.1016/j.gsf.2018.06.006; LIBBIN RM, 1976, CALC TISS RES, V22, P67; Lukeneder A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-96052-w; Lukeneder A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77017-x; Mojsisovics E., 1882, ABHANDLUNGEN KAISERL, V10, P1; Munster G., 1846, BEITR GE PETREFAKTEN, V6, P51; Naef A., 1922, FOSSIL DIBRANCHIATE, P1; Nasdala L., 2004, EMU NOTES MINERALOGY, V6, P281; NOJIMA T, 1990, Scientific Reports of Cetacean Research, P39; PERSON P, 1969, BIOL REV, V44, P1, DOI 10.1111/j.1469-185X.1969.tb00819.x; Person P., 1983, CARTILAGE VOLUME 1 S, V1, P31; PHILPOTT DE, 1970, J MORPHOL, V131, P417, DOI 10.1002/jmor.1051310405; RABINOWITZ JL, 1976, BIOL BULL-US, V150, P69, DOI 10.2307/1540590; Schaffer J., 1930, HDB MIKROSKOPISCHEN, P1; Smith CPA, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-89998-4; Stur D., 1874, VERHANDLUNGEN KAISER, V1, P271; Suess E., 1865, SITZUNGSBERICHTE K A, V51, P225; Tanner AR, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2818; Tarazona OA, 2016, NATURE, V533, P86, DOI 10.1038/nature17398; Wacey D, 2014, SCI REP-UK, V4, DOI 10.1038/srep05841; WANG A, 1989, CARBON, V27, P209, DOI 10.1016/0008-6223(89)90125-5; Wild E, 2015, ORG DIVERS EVOL, V15, P37, DOI 10.1007/s13127-014-0184-4; Wright GM, 2001, CELL TISSUE RES, V304, P165, DOI 10.1007/s004410100374; Ziegler A, 2018, AM MALACOL BULL, V36, P248, DOI 10.4003/006.036.0205	65	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0264595	10.1371/journal.pone.0264595	http://dx.doi.org/10.1371/journal.pone.0264595			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35442996	Green Published, gold			2022-12-26	WOS:000822608900008
J	Negret, PJ; Atkinson, SC; Woodworth, BK; Tor, MC; Allan, JR; Fuller, RA; Amano, T				Negret, Pablo Jose; Atkinson, Scott C.; Woodworth, Bradley K.; Tor, Marina Corella; Allan, James R.; Fuller, Richard A.; Amano, Tatsuya			Language barriers in global bird conservation	PLOS ONE			English	Article							DISSEMINATION	Multiple languages being spoken within a species' distribution can impede communication among conservation stakeholders, the compilation of scientific information, and the development of effective conservation actions. Here, we investigate the number of official languages spoken within the distributions of 10,863 bird species to identify which species might be particularly affected by consequences of language barriers. We show that 1587 species have 10 languages or more spoken within their distributions. Threatened and migratory species have significantly more languages spoken within their distributions, when controlling for range size. Particularly high numbers of species with many languages within their distribution are found in Eastern Europe, Russia and central and western Asia. Global conservation efforts would benefit from implementing guidelines to overcome language barriers, especially in regions with high species and language diversity.	[Negret, Pablo Jose] Univ Queensland, Sch Earth & Environm Sci, Brisbane, Qld, Australia; [Negret, Pablo Jose; Woodworth, Bradley K.; Tor, Marina Corella; Fuller, Richard A.; Amano, Tatsuya] Univ Queensland, Ctr Biodivers & Conservat Sci, Brisbane, Qld, Australia; [Atkinson, Scott C.] United Nations Dev Programme, New York, NY USA; [Woodworth, Bradley K.; Tor, Marina Corella; Fuller, Richard A.; Amano, Tatsuya] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Allan, James R.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands	University of Queensland; University of Queensland; University of Queensland; University of Amsterdam	Negret, PJ (corresponding author), Univ Queensland, Sch Earth & Environm Sci, Brisbane, Qld, Australia.; Negret, PJ (corresponding author), Univ Queensland, Ctr Biodivers & Conservat Sci, Brisbane, Qld, Australia.	p.negret@uq.edu.au	Fuller, Richard/B-7971-2008	Fuller, Richard/0000-0001-9468-9678; Negret, Pablo Jose/0000-0002-4683-839X; CORELLA TOR, Marina/0000-0003-3961-3165	Colombian Administrative Department of Science, Technology and Innovation (Colciencias); Australian Research Council Future Fellowship [FT180100354]; University of Queensland	Colombian Administrative Department of Science, Technology and Innovation (Colciencias)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Australian Research Council Future Fellowship(Australian Research Council); University of Queensland(University of Queensland)	This work was supported by the Colombian Administrative Department of Science, Technology and Innovation (Colciencias), the Australian Research Council Future Fellowship FT180100354, and the University of Queensland strategic funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JR, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau7668; Allan JR, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000158; Amano T, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001296; Amano Tatsuya, 2016, PLoS Biol, V14, pe2000933, DOI 10.1371/journal.pbio.2000933; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BirdLife International, 2018, STAT WORLDS BIRDS TA; BirdLife-International and NatureServe, 2020, BIRD SPEC DISTR MAPS; Ceballos G., 2010, J COSMOL, V8, P1821; Chen BX, 2018, URBAN FOR URBAN GREE, V31, P79, DOI 10.1016/j.ufug.2017.12.011; Cheung H, 2020, METHODS ECOL EVOL, V11, P1379, DOI 10.1111/2041-210X.13465; Council of Europe. Council for Cultural Co-operation, 2001, COMM EUR FRAM REF LA, DOI 10.1002/9781118784235.eelt0114.pub2; Ens Emilie J., 2012, Ecological Management & Restoration, V13, P26, DOI 10.1111/j.1442-8903.2011.00627.x; ESRI, 2011, ARC GIS DESKT; Fernandez-Llamazares A, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12398; Harrison ME, 2020, PEOPLE NAT, V2, P4, DOI 10.1002/pan3.10060; Hirsenberger H, 2019, J CULT HERIT, V37, P215, DOI 10.1016/j.culher.2018.10.006; Hua X, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09842-2; IUCN, 2020, IUCN RED LIST THREAT; Job H, 2017, J SUSTAIN TOUR, V25, P1697, DOI 10.1080/09669582.2017.1377432; Kamp J, 2015, CONSERV BIOL, V29, P1684, DOI 10.1111/cobi.12537; Karam-Gemael M, 2018, PERSPECT ECOL CONSER, V16, P125, DOI 10.1016/j.pecon.2018.06.002; Kark S, 2015, CURR OPIN ENV SUST, V12, P12, DOI 10.1016/j.cosust.2014.08.005; Kellenberg D, 2013, NATL BUR EC RES; Konno K, 2020, ECOL EVOL, V10, P6373, DOI 10.1002/ece3.6368; Lee DCA, 2019, AUST J CAREER DEV, V28, P197, DOI 10.1177/1038416219849645; LOH J, 2014, BIOCULTURAL DIVERSIT; Lynch AJ, 2021, ONE EARTH, V4, P269, DOI 10.1016/j.oneear.2021.01.002; Macpherson H, 2017, GATEWAYS, V10, P298, DOI 10.5130/ijcre.v10i1.5436; Marquez MC, 2020, FRONT COMMUN, V5, DOI 10.3389/fcomm.2020.00031; Martini E, 2017, AGROFOREST SYST, V91, P811, DOI 10.1007/s10457-016-0011-3; Mason N, 2020, NAT ECOL EVOL, V4, P694, DOI 10.1038/s41559-020-1160-3; Matthews KRW, 2020, ACCOUNT RES, V27, P477, DOI 10.1080/08989621.2020.1774373; Mattsson BJ, 2019, LAND USE POLICY, V83, P282, DOI 10.1016/j.landusepol.2019.01.040; Mazor T, 2013, DECCISION POINT, V73, P8; Nations United., 2019, NATURES DANGER DECLI, DOI [10.1016/j.gloenvcha.2014.04.002, DOI 10.1016/J.GLOENVCHA.2014.04.002]; Nunez MA, 2021, NAT ECOL EVOL, V5, P264, DOI 10.1038/s41559-020-01369-w; Nunez MA, 2019, J APPL ECOL, V56, P4, DOI 10.1111/1365-2664.13319; R Core Team, 2021, R LANG ENV STAT; Reagan Timothy, 2001, LANG PROBL LANG PLAN, V25, P51, DOI 10.1075/lplp.25.1.04rea; Rose DC, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12564; Schubert SC, 2019, EMU, V119, P364, DOI 10.1080/01584197.2019.1609340; Strobl C., 2008, ENCY GIS, P891, DOI [10.1007/springerreference_62666, DOI 10.1007/SPRINGERREFERENCE_62666, 10.1007/978-0-387-35973-11012, DOI 10.1007/978-0-387-35973-11012]; Teo HC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239009; Turvey ST, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1644; UNEP/CMS (UN Environment Programme/Convention on the Conservation of Migratory Species of Wild Animals) Secretariat, 2012, BIRDS EYE VIEW FLYW; United States Central Intelligence Agency, 2020, WORLD FACTBOOK; Webb TJ, 2008, J APPL ECOL, V45, P1198, DOI 10.1111/j.1365-2664.2008.01495.x; Yesou P., 2011, 13 MEDMARAVIS PAN ME	48	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0267151	10.1371/journal.pone.0267151	http://dx.doi.org/10.1371/journal.pone.0267151			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35442973	gold, Green Submitted, Green Published			2022-12-26	WOS:000822608900042
J	Abdullahi, T; Nitschke, G; Sweijd, N				Abdullahi, Tassallah; Nitschke, Geoff; Sweijd, Neville			Predicting diarrhoea outbreaks with climate change	PLOS ONE			English	Article							DISEASE; NETWORKS; BURDEN	BackgroundClimate change is expected to exacerbate diarrhoea outbreaks across the developing world, most notably in Sub-Saharan countries such as South Africa. In South Africa, diseases related to diarrhoea outbreak is a leading cause of morbidity and mortality. In this study, we modelled the impacts of climate change on diarrhoea with various machine learning (ML) methods to predict daily outbreak of diarrhoea cases in nine South African provinces. MethodsWe applied two deep Learning DL techniques, Convolutional Neural Networks (CNNs) and Long-Short term Memory Networks (LSTMs); and a Support Vector Machine (SVM) to predict daily diarrhoea cases over the different South African provinces by incorporating climate information. Generative Adversarial Networks (GANs) was used to generate synthetic data which was used to augment the available data-set. Furthermore, Relevance Estimation and Value Calibration (REVAC) was used to tune the parameters of the ML methods to optimize the accuracy of their predictions. Sensitivity analysis was also performed to investigate the contribution of the different climate factors to the diarrhoea prediction method. ResultsOur results showed that all three ML methods were appropriate for predicting daily diarrhoea cases with respect to the selected climate variables in each South African province. However, the level of accuracy for each method varied across different experiments, with the deep learning methods outperforming the SVM method. Among the deep learning techniques, the CNN method performed best when only real-world data-set was used, while the LSTM method outperformed the other methods when the real-world data-set was augmented with synthetic data. Across the provinces, the accuracy of all three ML methods improved by at least 30 percent when data augmentation was implemented. In addition, REVAC improved the accuracy of the CNN method by about 2.5% in each province. Our parameter sensitivity analysis revealed that the most influential climate variables to be considered when predicting outbreak of diarrhoea in South Africa were precipitation, humidity, evaporation and temperature conditions. ConclusionsOverall, experiments indicated that the prediction capacity of our DL methods (Convolutional Neural Networks) was found to be superior (with statistical significance) in terms of prediction accuracy across most provinces. This study's results have important implications for the development of automated early warning systems for diarrhoea (and related disease) outbreaks across the globe.	[Abdullahi, Tassallah; Nitschke, Geoff] Univ Cape Town, Dept Comp Sci, Cape Town, Western Cape, South Africa; [Sweijd, Neville] Appl Ctr Climate & Earth Syst Sci, Council Sci Ind Res, Cape Town, South Africa	University of Cape Town	Abdullahi, T (corresponding author), Univ Cape Town, Dept Comp Sci, Cape Town, Western Cape, South Africa.	abdtas008@myuct.ac.za	Nitschke, Geoff/ABC-9948-2021	Nitschke, Geoff/0000-0001-9058-852X	South African National Research Foundation (NRF) [403, 118557]	South African National Research Foundation (NRF)(National Research Foundation - South Africa)	The authors would like to extend their gratitude to the Applied Center for Climate and Earth Systems Research (ACCESS) under the Council for Scientific Research (CSIR), South Africa and Clicks Pharmaceuticals, South Africa for providing data that was relevant to this study.	Abdiansah A., 2015, INT J COMPUT APPL, V128, P28, DOI DOI 10.5120/IJCA2015906480; Alexander KA, 2013, INT J ENV RES PUB HE, V10, P1202, DOI 10.3390/ijerph10041202; Bradshaw D, 2003, SAMJ S AFR MED J, V93, P682; Davis C., 2017, CLIMATE RISK VULNERA, V2nd; Dhimal M, 2016, FINAL REPORT ASSESSM; Ding CW, 2017, 50TH ANNUAL IEEE/ACM INTERNATIONAL SYMPOSIUM ON MICROARCHITECTURE (MICRO), P395, DOI 10.1145/3123939.3124552; Esteban C, 2017, REAL VALUED MEDICAL; Fang XY, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-4930-2; Fawaz HI, 2018, IEEE INT CONF BIG DA, P1367, DOI 10.1109/BigData.2018.8621990; Fuhad KMF, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10050329; Gevrey M, 2003, ECOL MODEL, V160, P249, DOI 10.1016/S0304-3800(02)00257-0; Guo YH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237750; Ikeda T, 2019, ATMOSPHERE-BASEL, V10, DOI 10.3390/atmos10090522; Jia Wenxiao, 2019, AMIA Jt Summits Transl Sci Proc, V2019, P680; Jia Wu, 2019, Journal of Electronic Science and Technology, V17, P26, DOI 10.11989/JEST.1674-862X.80904120; Kamai T, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007354; Kapwata T, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081665; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Kullin B, 2015, SAMJ S AFR MED J, V105, P121, DOI [10.7196/SAMJ.8654, 10.7196/samj.8654]; Lara-Benitez P, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10072322; LeCun Y., 2015, DEEP LEARNING NATURE, V521, P436, DOI [DOI 10.1038/NATURE14539, 10.1038/nature14539]; Musengimana G, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090859; Nannen V, 2007, 2007 IEEE C EVOLUTIO; OMahony N, 2019, SCI INFORM C; Pelanek R., 2015, J ED DATA MIN, V7, P1; SAFAVIAN SR, 1991, IEEE T SYST MAN CYB, V21, P660, DOI 10.1109/21.97458; Sak H., 2014, P INT; Sapankevych NL, 2009, IEEE COMPUT INTELL M, V4, P24, DOI 10.1109/MCI.2009.932254; Smit S, 2009, 2009 IEEE C EVOLUTIO; Smit S, 2010, IEEE C EV COMP IEEE, P18; Sola J, 1997, IEEE T NUCL SCI, V44, P1464, DOI 10.1109/23.589532; Pham T, 2017, J BIOMED INFORM, V69, P218, DOI 10.1016/j.jbi.2017.04.001; Troeger C, 2018, LANCET INFECT DIS, V18, P1211, DOI 10.1016/S1473-3099(18)30362-1; Ul Abideen Z, 2020, IEEE ACCESS, V8, P22812, DOI 10.1109/ACCESS.2020.2970023; Nguyen V, 2017, IEEE DATA MINING, P347, DOI 10.1109/ICDM.2017.44; Wang YM, 2015, APPL SOFT COMPUT, V35, P280, DOI 10.1016/j.asoc.2015.05.047; Wen Q., ARXIV PREPRINT ARXIV; WHO, 1996, WORLD HLTH REPORT 19; WHO, 2009, PROTECTING HLTH CLIM; Yan L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182937; Yang S, 2020, 2020 INT WORKSH EL C, P98101	41	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0262008	10.1371/journal.pone.0262008	http://dx.doi.org/10.1371/journal.pone.0262008			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7VA	35439258	gold, Green Published			2022-12-26	WOS:000791280100032
J	Banack, SA; Stark, AC; Cox, PA				Banack, Sandra Anne; Stark, Aleksandra C.; Cox, Paul Alan			A possible blood plasma biomarker for early-stage Alzheimer's disease	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; PHOSPHOETHANOLAMINE; ETHANOLAMINE	We sought to identify a usable biomarker from blood samples to characterize early-stage Alzheimer's disease (AD) patients, in order to facilitate rapid diagnosis, early therapeutic intervention, and monitoring of clinical trials. We compared metabolites from blood plasma in early-stage Alzheimer's disease patients with blood plasma from healthy controls using two different analytical platforms: Amino Acid Analyzer and Tandem Mass-Spectrometer. Early-stage Alzheimer's patient blood samples were obtained during an FDA-approved Phase IIa clinical trial (Clinicaltrial.gov NCT03062449). Participants included 25 early-stage Alzheimer's patients and 25 healthy controls in the United States. We measured concentrations of 2-aminoethyl dihydrogen phosphate and taurine in blood plasma samples. We found that plasma concentrations of a phospholipid metabolite, 2-aminoethyl dihydrogen phosphate, normalized by taurine concentrations, distinguish blood samples of patients with early-stage AD. This possible new Alzheimer's biomarker may supplement clinical diagnosis for early detection of the disease.	[Banack, Sandra Anne; Cox, Paul Alan] Brain Chem Labs, Jackson, WY 83001 USA; [Stark, Aleksandra C.] Dartmouth Hitchock Med Ctr, Lebanon, NH USA	Dartmouth College	Cox, PA (corresponding author), Brain Chem Labs, Jackson, WY 83001 USA.	paul@ethnomedicine.org		Cox, Paul/0000-0001-6401-2981				Banack SA, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.200116; Bayram Ece, 2018, Alzheimers Dement (N Y), V4, P395, DOI 10.1016/j.trci.2018.04.007; Duan JJ, 2015, J BIOL CHEM, V290, P15380, DOI 10.1074/jbc.R115.658823; ELLISON DW, 1987, BRAIN RES, V417, P389, DOI 10.1016/0006-8993(87)90471-9; Feng L, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-017-1008-x; Ferreira AK, 2013, BIOMED PHARMACOTHER, V67, P481, DOI 10.1016/j.biopha.2013.01.012; Fransquet PD, 2018, CLIN BIOCHEM, V58, P5, DOI 10.1016/j.clinbiochem.2018.05.020; Hattingen E, 2009, BRAIN, V132, P3285, DOI 10.1093/brain/awp293; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; KAMITANI T, 1992, J BIOL CHEM, V267, P24611; Koroshetz WJ, 1997, ANN NEUROL, V41, P160, DOI 10.1002/ana.410410206; Lawrence E, 2017, J ALZHEIMERS DIS, V59, P1359, DOI 10.3233/JAD-170261; Lovell MA, 2002, NEUROBIOL AGING, V23, P179, DOI 10.1016/S0197-4580(01)00281-0; MCGALE EHF, 1977, J NEUROCHEM, V29, P291, DOI 10.1111/j.1471-4159.1977.tb09621.x; MENON AK, 1993, EMBO J, V12, P1907, DOI 10.1002/j.1460-2075.1993.tb05839.x; Moscoso A, 2021, JAMA NEUROL, V78, P396, DOI 10.1001/jamaneurol.2020.4986; Mullane K, 2018, BIOCHEM PHARMACOL, V158, P359, DOI 10.1016/j.bcp.2018.09.026; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Olsson B, 2016, LANCET NEUROL, V15, P673, DOI [10.1016/S1474-4422(16)00070-3, 10.1016/s1474-4422(16)00070-3]; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; PERRY TL, 1969, CLIN CHIM ACTA, V25, P53, DOI 10.1016/0009-8981(69)90226-5; Salles Jean Pierre, 2020, Clin Biochem Rev, V41, P13, DOI 10.33176/AACB-19-00031; Serpente M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061443; Sheng BY, 2012, J NEUROCHEM, V120, P419, DOI 10.1111/j.1471-4159.2011.07581.x; Slocum RH., 1991, AMINO ACID ANAL PHYS, P87; Swarbrick S, 2019, MOL NEUROBIOL, V56, P6156, DOI 10.1007/s12035-019-1500-y; Takousis P, 2019, ALZHEIMERS DEMENT, V15, P1468, DOI 10.1016/j.jalz.2019.06.4952; Tan IK, 2006, ANN ACAD MED SINGAP, V35, P468; US Department of Health and Human Services and GL49 V.I.C.H., 2015, GUID IND STUD EV MET, P1; van Echten-Deckert G, 1998, J BIOL CHEM, V273, P1184, DOI 10.1074/jbc.273.2.1184; Zetterberg H, 2021, MOL NEURODEGENER, V16, DOI 10.1186/s13024-021-00430-x	31	1	1	6	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267407	10.1371/journal.pone.0267407	http://dx.doi.org/10.1371/journal.pone.0267407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446894	gold, Green Published			2022-12-26	WOS:000795468200060
J	Che, S; Wang, C; Varga, C; Barbut, S; Susta, L				Che, Sunoh; Wang, Chaoyue; Varga, Csaba; Barbut, Shai; Susta, Leonardo			Prevalence of breast muscle myopathies (spaghetti meat, woody breast, white striping) and associated risk factors in broiler chickens from Ontario Canada	PLOS ONE			English	Article							PECTORALIS-MAJOR; GROWTH-RATE; QUALITY; MORTALITY; STRAINS; FEMALE; IMPACT; TIME	Spaghetti meat (SM), woody breast (WB), and white striping (WS) are myopathies that affect the pectoral muscle of fast-growing broiler chickens. The prevalence and possible risk factors of these myopathies have been reported in other countries, but not yet in Canada. Thus, the objective of this study was to assess the prevalence and risk factors associated with these myopathies in a representative population of Canadian broilers. From May 2019 to March 2020, 250 random breast fillets from each of 37 flocks (total, 9,250) were obtained from two processing plants and assessed for the presence and severity of myopathies. Demographic data (e.g., sex and average live weight), environmental conditions during the grow-out period (e.g., temperature), and husbandry parameters (e.g., vaccination) were collected for each flock. Associations between these factors and the myopathies were tested using logistic regression analyses. The prevalence of SM, severe WB, and mild or moderate WS was 36.3% (95% CI: 35.3-37.3), 11.8% (95% CI: 11.2-12.5), and 96.0% (95% CI: 95.6-96.4), respectively. Most (85.1%) of the fillets showed multiple myopathies. Regression analyses showed that the odds of SM increased with live weight (OR = 1.30, 95% CI 1.01-1.69) and higher environmental temperature during the grow-out period (OR = 1.75, 95% CI 1.31-2.34). The odds of WB increased with live weight (OR = 1.23, 95% CI 1.03-1.47) and when flocks were not vaccinated against coccidia (OR = 1.86, 95% CI 1.51-2.29). This study documents for the first time a high prevalence of myopathies in Ontario broilers, and suggests that these lesions may have a significant economic impact on the Canadian poultry industry. Our results indicate that environmental conditions and husbandry are associated with the development of breast myopathies, in agreement with the current literature. Future studies are needed to determine how risk factors can promote the occurrence of these conditions, in order to implement possible mitigating strategies.	[Che, Sunoh; Susta, Leonardo] Univ Guelph, Dept Pathobiol, Guelph, ON, Canada; [Wang, Chaoyue; Barbut, Shai] Univ Guelph, Dept Food Sci, Guelph, ON, Canada; [Varga, Csaba] Univ Illinois, Dept Pathobiol, Champaign, IL USA	University of Guelph; University of Guelph; University of Illinois System; University of Illinois Urbana-Champaign	Susta, L (corresponding author), Univ Guelph, Dept Pathobiol, Guelph, ON, Canada.	lsusta@uoguelph.ca	Susta, Leonardo/I-2968-2019; Varga, Csaba/Y-1006-2018	Susta, Leonardo/0000-0002-4578-6145; Varga, Csaba/0000-0003-2751-3677	Ontario Ministry of Agriculture, Food and Rural Affairs [UofG2017-2922]	Ontario Ministry of Agriculture, Food and Rural Affairs	Initials of the author who received the award: L.S. -Grant numbers awarded to each author: OMAFRA grant #(UofG2017-2922) - The full name of the funder: Ontario Ministry of Agriculture, Food and Rural Affairs - URL of the funder website: http://www.omafra.gov.on.ca/english/-The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agriculture and Agri-Food Canada, 2021, CAN HATCH EGGS IND; Aguirre ME, 2020, POULTRY SCI, V99, P3723, DOI 10.1016/j.psj.2020.03.026; Alnahhas N, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0369-2; Bailey RA, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.01041; Bailey RA, 2015, POULTRY SCI, V94, P2870, DOI 10.3382/ps/pev304; Baldi G, 2018, ANIMAL, V12, P164, DOI 10.1017/S1751731117001069; Baldi G, 2019, FOOD RES INT, V115, P369, DOI 10.1016/j.foodres.2018.11.020; Barbut S, 2008, MEAT SCI, V79, P46, DOI 10.1016/j.meatsci.2007.07.031; Barbut S, 2019, WORLD POULTRY SCI J, V75, P559, DOI 10.1017/S0043933919000436; Bodle BC, 2018, POULTRY SCI, V97, P3298, DOI 10.3382/ps/pey166; Bowker B, 2016, POULTRY SCI, V95, P1957, DOI 10.3382/ps/pew115; Calini F, 2007, BRAZ J POULTRY SCI, V9, P77, DOI 10.1590/S1516-635X2007000200001; Canadian Food Inspection Agency, 2021, FOOD AN INF DOC POUL; Canadian Food Inspection Agency, 2019, METH PROD CLAIMS; Canadian Food Inspection Agency, 2018, POULTR DISP; Canadian Food Inspection Agency, 2021, VET BIOL; de Carvalho LM, 2020, LWT-FOOD SCI TECHNOL, V131, DOI 10.1016/j.lwt.2020.109809; Chang A, 2016, ANIM PROD SCI, V56, P1254, DOI 10.1071/AN15381; Chen H., 2020, GENERATE HIGH RESOLU; Chen LR, 2019, AVIAN PATHOL, V48, P319, DOI 10.1080/03079457.2019.1598541; Chung ELT, 2021, BRIT POULTRY SCI, V62, P32, DOI 10.1080/00071668.2020.1817327; Clark DL, 2017, POULTRY SCI, V96, P4085, DOI 10.3382/ps/pex202; Dalgaard LB, 2018, INT J FOOD SCI TECH, V53, P1744, DOI 10.1111/ijfs.13759; de Jong IC., 2017, BROILER BREEDING FLO, V211, P230, DOI [10.19103/as.2016.0011.26, DOI 10.19103/AS.2016.0011.26]; DICKENS JA, 1992, POULTRY SCI, V71, P560, DOI 10.3382/ps.0710560; Diop SA, 2022, J APPL STAT, V49, P2570, DOI 10.1080/02664763.2021.1911966; Dohoo IR., 2014, AVC INCORPORATED CHA; Gao J, 2008, POULTRY SCI, V87, P1609, DOI 10.3382/ps.2007-00007; Gardner Tyler, 2020, J Sports Med (Hindawi Publ Corp), V2020, P7059057, DOI 10.1155/2020/7059057; Gautier AE, 2020, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00468; Geronimo BC, 2022, J FOOD SCI TECH MYS, V59, P1185, DOI 10.1007/s13197-021-05123-3; Government of Canada, 2020, HIST DAT; Griffin JR, 2018, AVIAN PATHOL, V47, P2, DOI 10.1080/03079457.2017.1356908; Health Canada, 2009, CAT ANT DRUGS BAS IM; Heier BT, 2002, PREV VET MED, V53, P147, DOI 10.1016/S0167-5877(01)00266-5; Kuttappan VA, 2016, POULTRY SCI, V95, P2724, DOI 10.3382/ps/pew216; Kuttappan VA, 2013, POULTRY SCI, V92, P811, DOI 10.3382/ps.2012-02506; Kuttappan VA, 2013, POULTRY SCI, V92, P331, DOI 10.3382/ps.2012-02646; Kuttappan VA, 2012, POULTRY SCI, V91, P3230, DOI 10.3382/ps.2012-02397; Kuttappan VA, 2012, POULTRY SCI, V91, P2677, DOI 10.3382/ps.2012-02259; Kuttappan VA, 2012, POULTRY SCI, V91, P1240, DOI 10.3382/ps.2011-01947; Lee JW, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10030481; Hai L, 2006, COMP BIOCHEM PHYS A, V144, P11, DOI 10.1016/j.cbpa.2006.01.032; Livingston ML, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04400; Livingston ML, 2019, POULTRY SCI, V98, P2813, DOI 10.3382/ps/pez015; Livingston ML, 2019, POULTRY SCI, V98, P217, DOI 10.3382/ps/pey333; Lorenzi M, 2014, J APPL POULTRY RES, V23, P754, DOI 10.3382/japr.2014-00968; Malila Y, 2018, ASIAN AUSTRAL J ANIM, V31, P1807, DOI 10.5713/ajas.18.0355; Meloche KJ, 2018, POULTRY SCI, V97, P3311, DOI 10.3382/ps/pey171; Meloche KJ, 2018, POULTRY SCI, V97, P1786, DOI 10.3382/ps/pex453; Meloche KJ, 2018, POULTRY SCI, V97, P1794, DOI 10.3382/ps/pex454; Mudalal S, 2015, ANIMAL, V9, P728, DOI 10.1017/S175173111400295X; Naing L, 2006, ARCH OROFAC SCI, V1, P9; National Research Council Canada, 2021, DO SEAS START; Office of the United States Trade Representative, 2020, US MEX CAN AGR; Pampouille E., 2019, DIFFERENTIAL EXPRESS, V1, P17, DOI [10.1038/s41598-019-51521-1, DOI 10.1038/S41598-019-51521-1]; Pascual A, 2020, ITAL J ANIM SCI, V19, P1135, DOI 10.1080/1828051X.2020.1824590; Petracci M, 2019, COMPR REV FOOD SCI F, V18, P565, DOI 10.1111/1541-4337.12431; Petracci M, 2015, WORLD POULTRY SCI J, V71, P363, DOI 10.1017/S0043933915000367; Petracci M, 2014, ITAL J ANIM SCI, V13, DOI 10.4081/ijas.2014.3138; Purswell J. L., 2012, 9th International Livestock Environment Symposium (ILES IX), Valencia, Spain, 8-12 July 2012, pILES12; Russo E, 2015, POULTRY SCI, V94, P1843, DOI 10.3382/ps/pev172; Sihvo HK, 2018, J COMP PATHOL, V161, P1, DOI 10.1016/j.jcpa.2018.04.002; Sihvo HK, 2017, VET PATHOL, V54, P119, DOI 10.1177/0300985816658099; Sommet N, 2017, INT REV SOC PSYCHOL, V30, P203, DOI 10.5334/irsp.90; Suarez ME, 1997, POULTRY SCI, V76, P1029, DOI 10.1093/ps/76.7.1029; Torrey S, 2021, POULTRY SCI, V100, DOI 10.1016/j.psj.2020.12.052; Velleman SG, 2017, AVIAN DIS, V61, P481, DOI 10.1637/11738-080217-Reg.1; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Willemsen H, 2008, POULTRY SCI, V87, P2358, DOI 10.3382/ps.2008-00095; Winkler T, 2011, ACTA ORTHOP, V82, P102, DOI 10.3109/17453674.2010.539498; Wold JP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173384; Xing T, 2019, COMPR REV FOOD SCI F, V18, P380, DOI 10.1111/1541-4337.12417; Zampiga M, 2018, J ANIM SCI BIOTECHNO, V9, DOI 10.1186/s40104-018-0294-5	74	3	3	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267019	10.1371/journal.pone.0267019	http://dx.doi.org/10.1371/journal.pone.0267019			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1E2NP	35427383	gold, Green Published			2022-12-26	WOS:000794332400031
J	Hailu, AW; Degarege, A; Petros, B; Costa, D; Ayene, YY; Villier, VC; Mouhajir, A; Favennec, L; Razakandrainibe, R; Adamu, H				Hailu, Ambachew W.; Degarege, Abraham; Petros, Beyene; Costa, Damien; Ayene, Yonas Yimam; Villier, Ven-Ceslas; Mouhajir, Abdelmounaim; Favennec, Loic; Razakandrainibe, Romy; Adamu, Haileeysus			Genetic diversity of Cryptosporidium spp. in non-human primates in rural and urban areas of Ethiopia	PLOS ONE			English	Article							PATHOGENIC ENTEROCYTOZOON-BIENEUSI; IMPENETRABLE NATIONAL-PARK; GIARDIA-DUODENALIS; MOLECULAR-DETECTION; ENTERIC PARASITES; INFECTIONS; PREVALENCE; TRANSMISSION; CUNICULUS; RESPONSES	Non-Human Primates (NHPs) harbor Cryptosporidium genotypes that can infect humans and vice versa. NHPs Chlorocebus aethiops and Colobus guereza and humans have overlapping territories in some regions of Ethiopia, which may increase the risk of zoonotic transmission of Cryptosporidium. This cross-sectional study examined the molecular prevalence and subtypes of Cryptosporidium spp. from 185 fecal samples of Chlorocebus aethiops and Colobus guereza in rural and urban areas in Ethiopia. Samples were tested for Cryptosporidium infection using nested polymerase chain reaction (PCR), and subtypes were determined by sequencing a fragment of the 60-kDa glycoprotein gene (gp60). Of the 185 samples, fifty-one (27.56%) tested positive for Cryptosporidium infection. The species detected were C. parvum (n = 34), C. hominis (n = 12), and C. cuniculus (n = 3). Mixed infection with C. parvum and C. hominis were detected in 2 samples. Four C. hominis family subtypes (Ia, Ib, Id, and Ie) and one C. parvum family subtype (IIa) were identified. C. hominis IaA20 (n = 7) and C. parvum IIaA17G1R1 (n = 6) were the most prevalent subtypes detected. These results confirm that Chlorocebus aethiops and Colobus guereza can be infected with diverse C. parvum and C. hominis subtypes that can also potentially infect humans. Additional studies could help to understand the role of NHPs in the zoonotic transmission of Cryptosporidium in Ethiopia.	[Hailu, Ambachew W.; Petros, Beyene] Biomed Sci Stream Addis Ababa Univ, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia; [Degarege, Abraham] Univ Nebraska Med Ctr, Coll Publ Hlth, Dept Epidemiol, Omaha, NE USA; [Costa, Damien; Villier, Ven-Ceslas; Mouhajir, Abdelmounaim; Favennec, Loic; Razakandrainibe, Romy] Univ Med Pharm Rouen, EA ESCAPE 7510, Rouen, France; [Costa, Damien; Favennec, Loic; Razakandrainibe, Romy] Sante Publ France, CNR LE Cryptosporidiosis, Rouen, France; [Ayene, Yonas Yimam] Univ Tehran Med Sci, Sch Publ Hlth, Dept Med Parasitol & Mycol, Tehran, Iran; [Adamu, Haileeysus] Addis 12 Ababa Univ, Inst Biotechnol, Addis Ababa, Ethiopia	University of Nebraska System; University of Nebraska Medical Center; Universite de Reims Champagne-Ardenne; Institute of Public Health Surveillance; Tehran University of Medical Sciences	Hailu, AW (corresponding author), Biomed Sci Stream Addis Ababa Univ, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia.	ambalake@gmail.com		Woreta, Ambachew/0000-0003-2958-5471	Rouen University Hospital (France); Addis Ababa University (Ethiopia)	Rouen University Hospital (France); Addis Ababa University (Ethiopia)	The authors are grateful, Rouen University Hospital (France), and Addis Ababa University (Ethiopia) support.	Adamu H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002831; Amenu Kebede, 2015, Comparative Clinical Pathology, V24, P1491, DOI 10.1007/s00580-015-2105-0; Bhat S A, 2014, J Parasit Dis, V38, P101, DOI 10.1007/s12639-012-0201-5; Bouzid M, 2013, CLIN MICROBIOL REV, V26, P115, DOI 10.1128/CMR.00076-12; Chalmers RM, 2011, EMERG INFECT DIS, V17, P536, DOI 10.3201/eid1703.100410; Chalmers RM, 2011, PARASITOL RES, V108, P1321, DOI 10.1007/s00436-010-2199-x; Chalmers RM, 2009, EMERG INFECT DIS, V15, P829, DOI 10.3201/eid1505.081419; Chen L, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3604-7; Colford JM, 1996, AM J EPIDEMIOL, V144, P807, DOI 10.1093/oxfordjournals.aje.a009015; de Almeida-Rocha JM, 2017, BIOL CONSERV, V215, P30, DOI 10.1016/j.biocon.2017.08.018; Dixon AB, 2009, GEOGRAPHY, V94, P38; DUNBAR RIM, 1974, FOLIA PRIMATOL, V21, P36, DOI 10.1159/000155595; Efstratiou A, 2017, WATER RES, V114, P14, DOI 10.1016/j.watres.2017.01.036; Ekanayake DK, 2006, AM J TROP MED HYG, V74, P322, DOI 10.4269/ajtmh.2006.74.322; Gibson AR, 2018, CURR BIOL, V28, pR193, DOI 10.1016/j.cub.2017.11.070; Gillespie TR, 2008, YEARB PHYS ANTHROPOL, V51, P53, DOI 10.1002/ajpa.20949; Gracenea M, 2002, VET PARASITOL, V104, P19, DOI 10.1016/S0304-4017(01)00611-2; Hailu AW, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253186; Innes EA, 2020, TRENDS PARASITOL, V36, P290, DOI 10.1016/j.pt.2019.12.016; Karim MR, 2014, INT J PARASITOL, V44, P1039, DOI 10.1016/j.ijpara.2014.07.006; Koehler AV, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2462-4; Koehler AV, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0492-8; Kvac M., 2014, CRYPTOSPORIDIUM PARA, P237, DOI DOI 10.1007/978-3-7091-1562-6_5; Li W, 2011, J CLIN MICROBIOL, V49, P4326, DOI 10.1128/JCM.05051-11; McLennan MR, 2017, INT J PRIMATOL, V38, P105, DOI 10.1007/s10764-017-9962-0; Mesele Yihune, 2009, Sinet, Ethiopian Journal of Science, V32, P57; Moens MAJ, 2016, INT J PARASITOL, V46, P41, DOI 10.1016/j.ijpara.2015.08.001; Mynarova A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152771; Nizeyi JB, 2002, PARASITOL RES, V88, P380, DOI 10.1007/s00436-001-0543-x; Nizeyi JB, 1999, J PARASITOL, V85, P1084, DOI 10.2307/3285672; Nolan MJ, 2013, WATER RES, V47, P1726, DOI 10.1016/j.watres.2012.12.027; Nolan MJ, 2010, INFECT GENET EVOL, V10, P1179, DOI 10.1016/j.meegid.2010.07.020; Parsons MB, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003529; Ryan U, 2018, INT J PARASITOL, V48, P1, DOI 10.1016/j.ijpara.2017.09.004; Sak B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109751; Sak B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071840; Salyer SJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001597; Santin M, 2013, NEW ZEAL VET J, V61, P1, DOI 10.1080/00480169.2012.731681; Sharbatkhori M, 2015, IRAN J PARASITOL, V10, P441; Smith RP, 2010, PREV VET MED, V94, P9, DOI 10.1016/j.prevetmed.2009.12.005; Sricharern W, 2016, INFECT GENET EVOL, V40, P310, DOI 10.1016/j.meegid.2016.02.004; Sulaiman IM, 2005, J CLIN MICROBIOL, V43, P2805, DOI 10.1128/JCM.43.6.2805-2809.2005; Troeger C, 2017, LANCET INFECT DIS, V17, P909, DOI 10.1016/S1473-3099(17)30276-1; Valeix N, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8091450; Vieira PM, 2015, FOLIA PARASIT, V62, DOI 10.14411/fp.2015.002; Widmer G, 2020, INT J PARASITOL, V50, P253, DOI 10.1016/j.ijpara.2020.01.005; Ye JB, 2014, PARASITOL INT, V63, P132, DOI 10.1016/j.parint.2013.10.007; Ye JB, 2012, EMERG INFECT DIS, V18, P1640, DOI 10.3201/eid1810.120653	48	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267103	10.1371/journal.pone.0267103	http://dx.doi.org/10.1371/journal.pone.0267103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421188	gold, Green Published			2022-12-26	WOS:000795453600108
J	Shukla, AM; Welch, KM; Villa, AM				Shukla, Anubhuti M.; Welch, Kelly M.; Villa, Alessandro M.			Assessment of the willingness of dentists in the state of Indiana to administer vaccines	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; UNITED-STATES; IMMUNIZATION; PHARMACISTS; RECOMMENDATIONS; VACCINATION; EXPERIENCES; ADOLESCENTS; ATTITUDES; BELIEFS	BackgroundHuman Papillomavirus associated oropharyngeal cancers have been on the rise in the past three decades. Dentists are uniquely positioned to discuss vaccination programs with their patients. The goal of this project was to assess the readiness of dentists in the state of Indiana in being able to administer vaccines. MethodsAn 18-question online survey was sent to licensed dentists in the state of Indiana. Mantel-Haenszel chi-square tests, followed by multivariable analyses using ordinal logistic regression were conducted to assess providers' comfort levels and willingness to administer vaccines in both children and adults, by provider characteristics (practice type, location, and years in practice). ResultsA total of 569 completed surveys were included for data analyses. Most dentists (58%) responded positively when asked if they would consider offering vaccinations in their office, if allowed by state legislation. In general, dentists working in academic settings and federally qualified health centers were more agreeable to offering vaccination in their practice. The level of agreement with "Dentists should be allowed to administer HPV, Influenza, Hep A and COVID 19 vaccines" for both children and adults decreased with increased years of practice. More than half of the respondents (55%) agreed that dental providers were competent to administer vaccines and needed no further training. ConclusionThe study results suggest the willingness of dentists in the state of Indiana to offer vaccinations in their practices, if allowed by legislation. Practical implicationsDental providers can be a unique resource to add to workforce for improving vaccination efforts.	[Shukla, Anubhuti M.] Indiana Univ, Sch Dent, Dept Cariol Operat Dent & Dent Publ Hlth, Indianapolis, IN USA; [Welch, Kelly M.] Team Maureen, N Falmouth, MA USA; [Villa, Alessandro M.] Univ Calif San Francisco, Sch Dent, Dept Orofacial Sci, San Francisco, CA USA	Indiana University System; Indiana University-Purdue University Indianapolis; University of California System; University of California San Francisco	Shukla, AM (corresponding author), Indiana Univ, Sch Dent, Dept Cariol Operat Dent & Dent Publ Hlth, Indianapolis, IN USA.	anshukla@iu.edu						[Anonymous], 2020, J AM DENT ASSOC, V151, P303, DOI 10.1016/j.adaj.2020.01.027; Chau NG, 2014, CURR TREAT OPTION ON, V15, P595, DOI 10.1007/s11864-014-0309-1; Daley E, 2011, J PUBLIC HEALTH DENT, V71, P136, DOI 10.1111/j.1752-7325.2011.00212.x; Dempsey AF, 2015, VACCINE, V33, pD106, DOI 10.1016/j.vaccine.2015.09.032; Ducatman BS, 2018, ARCH PATHOL LAB MED, V142, P715, DOI 10.5858/arpa.2018-0083-RA; Gambhir Ramandeep Singh, 2015, J Family Med Prim Care, V4, P13, DOI 10.4103/2249-4863.152239; Gerges S, 2018, HUM VACC IMMUNOTHER, V14, P471, DOI 10.1080/21645515.2017.1403695; GRABENSTEIN JD, 1992, MED CARE, V30, P503, DOI 10.1097/00005650-199206000-00004; Indiana Dental Association,, IND DENT APPR ADM VA; ISDH,, IND HEP OUTBR; Isenor JE, 2018, PHARM PRACT-GRANADA, V16, DOI [10.18549/pharmpract.2018.04.1310, 10.18549/PharmPract.2018.04.1310]; Isenor JE, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5697-x; Isenor Jennifer E, 2016, J Pharm Policy Pract, V9, P32; Kao CM, 2014, CURR OPIN PEDIATR, V26, P383, DOI 10.1097/MOP.0000000000000093; MacDougall D, 2016, HUM VACC IMMUNOTHER, V12, P623, DOI 10.1080/21645515.2015.1093714; Maxey H., 2020, 2020 INDIANA DENT WO; Meites E, 2019, MMWR-MORBID MORTAL W, V68, P698, DOI [10.15585/mmwr.mm6832a3, 10.1111/ajt.15633]; NEDERHOF AJ, 1985, EUR J SOC PSYCHOL, V15, P263, DOI 10.1002/ejsp.2420150303; Nusair MB, 2020, RISK MANAG HEALTHC P, V13, P2179, DOI 10.2147/RMHP.S265133; Pampena E, 2020, J CANCER EDUC, V35, P689, DOI 10.1007/s13187-019-01512-7; Poland GA, 2013, VACCINE, V31, P4689, DOI 10.1016/j.vaccine.2013.03.031; Salous MH, 2020, HUM VACC IMMUNOTHER, V16, P3131, DOI 10.1080/21645515.2020.1752595; Shukla A, 2019, J CANCER EDUC, V34, P890, DOI 10.1007/s13187-018-1391-z; Simon L., 2020, JAMA HLTH FORUM; Temoka E, 2013, S MED; Vazquez-Otero C, 2018, J AM DENT ASSOC, V149, P9, DOI 10.1016/j.adaj.2017.08.021; Villa A, 2021, J AM DENT ASSOC, V152, P184, DOI 10.1016/j.adaj.2020.09.025; Walker TY, 2019, MMWR-MORBID MORTAL W, V68, P718, DOI 10.15585/mmwr.mm6833a2; You EL, 2019, CURR ONCOL, V26, P119, DOI 10.3747/co.26.4819	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267167	10.1371/journal.pone.0267167	http://dx.doi.org/10.1371/journal.pone.0267167			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7VA	35439280	Green Published, gold			2022-12-26	WOS:000791280100016
J	Michell, DL; Allen, RM; Cavnar, AB; Contreras, DM; Yu, MZ; Semler, EM; Massick, C; Raby, CA; Castleberry, M; Ramirez, MA; Zhu, WY; May-Zhang, LD; Ifrim, A; Carr, JJ; Terry, JG; Schwendeman, A; Davies, SS; Sheng, QH; Linton, MF; Vickers, KC				Michell, Danielle L.; Allen, Ryan M.; Cavnar, Ashley B.; Contreras, Danielle M.; Yu, Minzhi; Semler, Elizabeth M.; Massick, Clark; Raby, Chase A.; Castleberry, Mark; Ramirez, Marisol A.; Zhu, Wanying; May-Zhang, Linda; Ifrim, Anca; Carr, John Jeffrey; Terry, James G.; Schwendeman, Anna; Davies, Sean S.; Sheng, Quanhu; Linton, MacRae F.; Vickers, Kasey C.			Elucidation of physico-chemical principles of high-density lipoprotein-small RNA binding interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY-ARTERY CALCIUM; DIETARY TRANS FAT; HDL; STRESS; DNA; IDENTIFICATION; TRANSLATION; METHYLATION; CONSUMPTION; MICRORNAS	Extracellular small RNAs (sRNAs) are abundant in many biofluids, but little is known about their mechanisms of transport and stability in RNase-rich environments. We previously reported that high-density lipoproteins (HDLs) in mice were enriched with multiple classes of sRNAs derived from the endogenous transcriptome, but also from exogenous organisms. Here, we show that human HDL transports tRNA-derived sRNAs (tDRs) from host and nonhost species, the profiles of which were found to be altered in human atherosclerosis. We hypothesized that HDL binds to tDRs through apolipoprotein A-I (apoA-I) and that these interactions are conferred by RNAspecific features. We tested this using microscale thermophoresis and electrophoretic mobility shift assays and found that HDL binds to tDRs and other single-stranded sRNAs with strong affinity but did not bind to double-stranded RNA or DNA. Furthermore, we show that natural and synthetic RNA modifications influenced tDR binding to HDL. We demonstrate that reconstituted HDL bound to tDRs only in the presence of apoA-I, and purified apoA-I alone were able to bind sRNA. Conversely, phosphatidylcholine vesicles did not bind tDRs. In summary, we conclude that HDL binds to singlestranded sRNAs likely through nonionic interactions with enable extracellular RNA communication and provide a foundation for future studies to manipulate HDL-sRNA interactions for therapeutic approaches to prevent or treat disease.	[Michell, Danielle L.; Allen, Ryan M.; Cavnar, Ashley B.; Contreras, Danielle M.; Massick, Clark; Raby, Chase A.; Castleberry, Mark; Zhu, Wanying; Ifrim, Anca; Linton, MacRae F.; Vickers, Kasey C.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Yu, Minzhi; Schwendeman, Anna] Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA; [Semler, Elizabeth M.; Vickers, Kasey C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Ramirez, Marisol A.; Sheng, Quanhu] Vanderbilt Univ, Dept Biostat, Med Ctr, Nashville, TN USA; [May-Zhang, Linda; Davies, Sean S.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Carr, John Jeffrey; Terry, James G.] Vanderbilt Univ, Med Ctr, Dept Radiol & Radiol Sci, Nashville, TN 37232 USA	Vanderbilt University; University of Michigan System; University of Michigan; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Michell, DL; Vickers, KC (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA.; Vickers, KC (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	danielle.michell@vumc.org; kasey.c.vickers@vumc.org	; Carr, John/A-1938-2012	Michell, Danielle/0000-0002-2048-4191; Yu, Minzhi/0000-0002-3141-7285; Terry, James/0000-0001-6659-3441; allen, ryan/0000-0002-8057-3436; Carr, John/0000-0002-4398-8237	American Heart Association, United States [16POST26630003]; Keck Foundation Medical Research Program; National Institutes of Health, United States [P01HL116263, P01CA229123, UH3CA241685, R01HL128996, R01CA260958]	American Heart Association, United States(American Heart Association); Keck Foundation Medical Research Program; National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the American Heart Association, United States 16POST26630003 (D. L.M.); W. M. Keck Foundation Medical Research Program (K. C. V.);and the National Institutes of Health, United States: P01HL116263(M. F. L, K. C. V.), P01CA229123 (K. C. V.), UH3CA241685 (K. C.V.), R01HL128996 (K. C. V.), and R01CA260958 (K. C. V.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Aggarwal G, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101019; Akat KM, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127317; Akiyama Y, 2020, RNA BIOL, V17, P1116, DOI 10.1080/15476286.2020.1732702; Allen RM, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1506198; Asztalos BF, 2011, CURR OPIN LIPIDOL, V22, P176, DOI 10.1097/MOL.0b013e3283468061; Axmann M, 2019, JOVE-J VIS EXP, DOI 10.3791/59573; Axmann M, 2018, GENES-BASEL, V9, DOI 10.3390/genes9110533; Ben-Aicha S, 2020, CARDIOVASC RES, V116, P1288, DOI 10.1093/cvr/cvz239; Camont L, 2011, TRENDS MOL MED, V17, P594, DOI 10.1016/j.molmed.2011.05.013; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Carr JJ, 2017, JAMA CARDIOL, V2, P391, DOI 10.1001/jamacardio.2016.5493; Chan PP, 2016, NUCLEIC ACIDS RES, V44, pD184, DOI 10.1093/nar/gkv1309; Cozen AE, 2015, NAT METHODS, V12, P879, DOI [10.1038/NMETH.3508, 10.1038/nmeth.3508]; Desgagne V, 2017, EPIGENOMICS-UK, V9, P669, DOI 10.2217/epi-2016-0177; Desgagne V, 2017, CLIN CHEM LAB MED, V55, P667, DOI 10.1515/cclm-2016-0575; Desgagne V, 2016, EPIGENETICS-US, V11, P438, DOI 10.1080/15592294.2016.1176816; Dhahbi JM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-298; Dhahbi JM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00074; Di Bartolo BA, 2011, ATHEROSCLEROSIS, V217, P395, DOI 10.1016/j.atherosclerosis.2011.04.001; Drino A, 2020, RNA BIOL, V17, P1104, DOI 10.1080/15476286.2020.1733798; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Florijn BW, 2019, DIABETES, V68, P2287, DOI 10.2337/db18-1360; Fu HJ, 2009, FEBS LETT, V583, P437, DOI 10.1016/j.febslet.2008.12.043; Geary RS, 2009, EXPERT OPIN DRUG MET, V5, P381, DOI [10.1517/17425250902877680, 10.1517/17425250902877680 ]; Gordon SM, 2010, J PROTEOME RES, V9, P5239, DOI 10.1021/pr100520x; Gromelski S, 2006, LANGMUIR, V22, P6293, DOI 10.1021/la0531796; Guo LL, 2015, ANTIOXID REDOX SIGN, V22, P1633, DOI 10.1089/ars.2014.6078; Guzzi N, 2018, CELL, V173, P1204, DOI 10.1016/j.cell.2018.03.008; Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810; Herster F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13756-4; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Kang M, 2016, CURR OPIN COLLOID IN, V26, P58, DOI 10.1016/j.cocis.2016.09.006; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Li HM, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101642; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu DM, 2002, BBA-BIOMEMBRANES, V1563, P45, DOI 10.1016/S0005-2736(02)00384-X; May-Zhang LS, 2019, J BIOL CHEM, V294, P19022, DOI 10.1074/jbc.RA119.009424; May-Zhang LS, 2018, J BIOL CHEM, V293, P9176, DOI 10.1074/jbc.RA117.001099; Megel C, 2015, INT J MOL SCI, V16, P1873, DOI 10.3390/ijms16011873; Mengistu DH, 2009, J PHYS CHEM B, V113, P12277, DOI 10.1021/jp904986j; Michanek A, 2010, BBA-BIOMEMBRANES, V1798, P829, DOI 10.1016/j.bbamem.2009.12.009; Michell DL, 2016, JOVE-J VIS EXP, DOI 10.3791/54488; Navab M, 2009, J LIPID RES, V50, pS145, DOI 10.1194/jlr.R800036-JLR200; Niculescu LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140958; Tosar JP, 2020, NUCLEIC ACIDS RES, V48, P12874, DOI 10.1093/nar/gkaa674; Raabe CA, 2014, NUCLEIC ACIDS RES, V42, P1414, DOI 10.1093/nar/gkt1021; Raina M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00171; Saikia M, 2012, J BIOL CHEM, V287, P42708, DOI 10.1074/jbc.M112.371799; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Scicali R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56857-2; Sedgeman LR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40338-7; Seo Minguk, 2019, Curr Protoc Nucleic Acid Chem, V76, pe70, DOI 10.1002/cpnc.70; Shi JC, 2021, NAT CELL BIOL, V23, P424, DOI 10.1038/s41556-021-00652-7; Shigematsu M, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00562; Sobala A, 2013, RNA BIOL, V10, P553, DOI 10.4161/rna.24285; Suleymanoglu Erhan, 2006, PDA J Pharm Sci Technol, V60, P218; Tabet F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151061; Tabet F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4292; Talbot CPJ, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800027; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Thompson DM, 2009, CELL, V138, P215, DOI 10.1016/j.cell.2009.07.001; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Torres LFC, 2019, ATHEROSCLEROSIS, V286, P20, DOI 10.1016/j.atherosclerosis.2019.04.227; Tosar JP, 2018, NUCLEIC ACIDS RES, V46, P9081, DOI 10.1093/nar/gky495; Tsujita M, 2021, FEBS LETT, V595, P773, DOI 10.1002/1873-3468.13950; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wagner J, 2013, ARTERIOSCL THROM VAS, V33, P1392, DOI 10.1161/ATVBAHA.112.300741; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283; Zhang YF, 2018, NAT CELL BIOL, V20, P535, DOI 10.1038/s41556-018-0087-2; Zhang YF, 2014, J MOL CELL BIOL, V6, P172, DOI 10.1093/jmcb/mjt052	72	0	0	7	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101952	10.1016/j.jbc.2022.101952	http://dx.doi.org/10.1016/j.jbc.2022.101952			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9OQ	35447119	Green Submitted, Green Published, gold			2022-12-26	WOS:000807778400003
J	Theisen, FF; Salladini, E; Davidsen, R; Rasmussen, CJ; Staby, L; Kragelund, BB; Skriver, K				Theisen, Frederik Friis; Salladini, Edoardo; Davidsen, Rikke; Rasmussen, Christina Jo; Staby, Lasse; Kragelund, Birthe B.; Skriver, Karen			alpha alpha-hub coregulator structure and flexibility determine transcription factor binding and selection in regulatory interactomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-CAPACITY; DISORDER; TAF4; COACTIVATOR; ACTIVATION; MOTIF; SPECTROSCOPY; SPECIFICITY; PROTEINS; ANAC013	Formation of transcription factor (TF)-coregulator complexes is a key step in transcriptional regulation, with coregulators having essential functions as hub nodes in molecular networks. How specificity and selectivity are maintained in these nodes remain open questions. In this work, we addressed specificity in transcriptional networks using complexes formed between TFs and alpha alpha-hubs, which are defined by a common alpha alpha hairpin secondary structure motif, as a model. Using NMR spectroscopy and binding thermodynamics, we analyzed the structure, dynamics, stability, and ligand-binding properties of the Arabidopsis thaliana RST domains from TAF4 and known binding partner RCD1, and the TAFH domain from human TAF4, allowing comparison across species, functions, and architectural contexts. While these alpha alpha-hubs shared the alpha alpha hairpin motif, they differed in length and orientation of accessory helices as well as in their thermodynamic profiles of ligand binding. Whereas biologically relevant RCD1-ligand pairs displayed high affinity driven by enthalpy, TAF4-ligand interactions were entropy driven and exhibited less binding induced structuring. We in addition identified a thermal unfolding state with a structured core for all three domains, although the temperature sensitivity differed. Thermal stability studies suggested that initial unfolding of the RCD1-RST domain localized around helix 1, lending this region structural malleability, while effects in TAF4-RST were more stochastic, suggesting variability in structural adaptability upon binding. Collectively, our results support a model in which hub structure, flexibility, and binding thermodynamics contribute to alpha alpha hub-TF binding specificity, a finding of general relevance to the understanding of coregulator-ligand interactions and interactome sizes.	[Theisen, Frederik Friis; Salladini, Edoardo; Davidsen, Rikke; Rasmussen, Christina Jo; Staby, Lasse; Kragelund, Birthe B.; Skriver, Karen] Univ Copenhagen, REPIN & Linderstrom Lang Ctr Prot Sci, Copenhagen, Denmark; [Staby, Lasse; Kragelund, Birthe B.] Univ Copenhagen, Dept Biol, Struct Biol & NMR Lab, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Kragelund, BB; Skriver, K (corresponding author), Univ Copenhagen, REPIN & Linderstrom Lang Ctr Prot Sci, Copenhagen, Denmark.; Kragelund, BB (corresponding author), Univ Copenhagen, Dept Biol, Struct Biol & NMR Lab, Copenhagen, Denmark.	bbk@bio.ku.dk; kskriver@bio.ku.dk	; Skriver, Karen/K-9860-2014	Theisen, Frederik Friis/0000-0002-3412-4242; Skriver, Karen/0000-0003-2225-4012	Novo Nordisk Foundation challenge grant REPIN [NNF18OC0033926]; Novo Nordisk Founda-tion, Denmark grant [NNF18OC0052177]	Novo Nordisk Foundation challenge grant REPIN; Novo Nordisk Founda-tion, Denmark grant	This work was supported by the Novo Nordisk Foundation challenge grant REPIN, rethinking protein interactions (grant no.: NNF18OC0033926; to B. B. K. and K. S.) . Support was also achieved from the Novo Nordisk Founda-tion, Denmark grant (grant no.: NNF18OC0052177; to K. S.) .	A.Shapiguzov, 2020, bioRxiv, DOI 10.1101/2020.07.02.184937; Adams GE, 2018, BIOCHEM J, V475, P3921, DOI 10.1042/BCJ20170314; Ahlfors R, 2004, PLANT CELL, V16, P1925, DOI 10.1105/tpc.021832; Alhindi T, 2017, SCI REP-UK, V7, DOI 10.1038/srep44948; Berlow RB, 2019, BIOCHEMISTRY-US, V58, P1354, DOI 10.1021/acs.biochem.8b01290; Berlow RB, 2017, NATURE, V543, P447, DOI 10.1038/nature21705; Borgia A, 2018, NATURE, V555, P61, DOI 10.1038/nature25762; Brosche M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004112; Bugge K, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.REV120.012928; Bugge K, 2018, STRUCTURE, V26, P734, DOI 10.1016/j.str.2018.03.013; Chen WY, 2013, GENE DEV, V27, P1596, DOI 10.1101/gad.216192.113; Christensen LF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55385-3; De Clercq I, 2013, PLANT CELL, V25, P3472, DOI 10.1105/tpc.113.117168; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dyson HJ, 2016, J BIOL CHEM, V291, P6714, DOI 10.1074/jbc.R115.692020; EFIMOV AV, 1991, PROTEIN ENG, V4, P245, DOI 10.1093/protein/4.3.245; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Erkina TY, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0092-2; Ferreira RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056579; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Gianni S, 2019, PROTEIN ENG DES SEL, V32, P355, DOI 10.1093/protein/gzz020; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Had Zi, 2021, P NATL ACAD SCI USA, V118; Hamborg L, 2020, ANAL BIOCHEM, V605, DOI 10.1016/j.ab.2020.113863; Henley MJ, 2020, P NATL ACAD SCI USA, V117, P27346, DOI 10.1073/pnas.2013244117; Jaspers P, 2010, PLANT SIGNAL BEHAV, V5, P78, DOI 10.4161/psb.5.1.10293; Jaspers P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-170; Jaspers P, 2009, PLANT J, V60, P268, DOI 10.1111/j.1365-313X.2009.03951.x; Jemth P, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau4130; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Kjaergaard M, 2011, J BIOMOL NMR, V50, P157, DOI 10.1007/s10858-011-9508-2; Kneller JM, 2002, J AM CHEM SOC, V124, P1852, DOI 10.1021/ja017461k; Kragelund BB, 2012, TRENDS PLANT SCI, V17, P625, DOI 10.1016/j.tplants.2012.06.010; Kundu TK, 2000, MOL CELL, V6, P551, DOI 10.1016/S1097-2765(00)00054-X; Lago C, 2004, GENE, V342, P231, DOI 10.1016/j.gene.2004.08.023; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lawit SJ, 2007, PLANT MOL BIOL, V64, P73, DOI 10.1007/s11103-007-9135-1; Lawrence CW, 2014, J PHYS CHEM LETT, V5, P833, DOI 10.1021/jz402729x; Lawrence EJ, 2019, CURR BIOL, V29, P2676, DOI 10.1016/j.cub.2019.06.084; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; Marr MT, 2009, P NATL ACAD SCI USA, V106, P1295, DOI 10.1073/pnas.0812990106; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Narayan A, 2019, BIOCHEMISTRY-US, V58, P2519, DOI 10.1021/acs.biochem.9b00089; Nettels D, 2009, P NATL ACAD SCI USA, V106, P20740, DOI 10.1073/pnas.0900622106; O'Shea C, 2017, J BIOL CHEM, V292, P512, DOI 10.1074/jbc.M116.753426; O'Shea C, 2015, BIOCHEM J, V465, P281, DOI 10.1042/BJ20141045; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Orekhov VY, 2011, PROG NUCL MAG RES SP, V59, P271, DOI 10.1016/j.pnmrs.2011.02.002; Park S, 2009, BLOOD, V113, P3558, DOI 10.1182/blood-2008-06-161307; Prabhu NV, 2005, ANNU REV PHYS CHEM, V56, P521, DOI 10.1146/annurev.physchem.56.092503.141202; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Ravarani CNJ, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20188190; Reeves WM, 2005, MOL CELL BIOL, V25, P9092, DOI 10.1128/MCB.25.20.9092-9102.2005; Rohl CA, 1997, BIOCHEMISTRY-US, V36, P8435, DOI 10.1021/bi9706677; Sanborn AL, 2021, ELIFE, V10, DOI 10.7554/eLife.68068; Shapiguzov A, 2019, ELIFE, V8, DOI 10.7554/eLife.43284; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shirdel SA, 2019, EUR BIOPHYS J BIOPHY, V48, P305, DOI 10.1007/s00249-019-01362-7; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SIGLER PB, 1988, NATURE, V333, P210, DOI 10.1038/333210a0; Staby L, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2021.167320; Staby L, 2021, CELL COMMUN SIGNAL, V19, DOI 10.1186/s12964-020-00686-8; Staby L, 2017, BIOCHEM J, V474, P2509, DOI 10.1042/BCJ20160631; Theisen FF, 2021, J AM CHEM SOC, V143, P14540, DOI 10.1021/jacs.1c04214; Tian Y, 2014, J MAGN RESON, V243, P54, DOI 10.1016/j.jmr.2014.03.011; Tuttle LM, 2018, CELL REP, V22, P3251, DOI 10.1016/j.celrep.2018.02.097; Vainonen JP, 2012, BIOCHEM J, V442, P573, DOI 10.1042/BJ20111739; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang XP, 2007, P NATL ACAD SCI USA, V104, P7839, DOI 10.1073/pnas.0608570104; Wang Y, 2008, PLANT PHYSIOL, V148, P1201, DOI 10.1104/pp.108.126375; Warfield L, 2014, P NATL ACAD SCI USA, V111, pE3506, DOI 10.1073/pnas.1412088111; Wirthmueller L, 2018, NEW PHYTOL, V220, P232, DOI 10.1111/nph.15277; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103	74	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101963	10.1016/j.jbc.2022.101963	http://dx.doi.org/10.1016/j.jbc.2022.101963			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9DZ	35452682	gold, Green Published			2022-12-26	WOS:000807750700004
J	Komatsu, A; Iida, I; Nasu, Y; Ito, G; Harada, F; Kishikawa, S; Moss, SJ; Maeda, T; Terunuma, M				Komatsu, Ayaka; Iida, Izumi; Nasu, Yusuke; Ito, Genki; Harada, Fumiko; Kishikawa, Sari; Moss, Stephen J.; Maeda, Takeyasu; Terunuma, Miho			Ammonia induces amyloidogenesis in astrocytes by promoting amyloid precursor protein translocation into the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; ALZHEIMERS-DISEASE; GLUTAMINE-SYNTHETASE; CELL-SURFACE; SECRETASE CLEAVAGE; HUMAN MICROGLIA; TRAFFICKING; HYPERAMMONEMIA; DEGRADATION; ENDOCYTOSIS	Hyperammonemia is known to cause various neurological dysfunctions such as seizures and cognitive impairment. Several studies have suggested that hyperammonemia may also be linked to the development of Alzheimer's disease (AD). However, the direct evidence for a role of ammonia in the pathophysiology of AD remains to be discovered. Herein, we report that hyperammonemia increases the amount of mature amyloid precursor protein (mAPP) in astrocytes, the largest and most prevalent type of glial cells in the central nervous system that are capable of metabolizing glutamate and ammonia, and promotes amyloid beta (A beta) production. We demonstrate the accumulation of mAPP in astrocytes was primarily due to enhanced endocytosis of mAPP from the plasma membrane. A large proportion of internalized mAPP was targeted not to the lysosome, but to the endoplasmic resite APP cleaving enzyme 1) and gamma-secretase presenilin-1 are expressed, and mAPP is cleaved to produce A beta. Finally, we show the ammonia-induced production of A beta in astrocytic endoplasmic reticulum was specific to A beta 42, a principal component of senile plaques in AD patients. Our studies uncover a novel mechanism of A beta 42 production in astrocytes and also provide the first evidence that ammonia induces the pathogenesis of AD by regulating astrocyte function.	[Komatsu, Ayaka; Iida, Izumi; Nasu, Yusuke; Ito, Genki; Harada, Fumiko; Kishikawa, Sari; Terunuma, Miho] Niigata Univ, Fac Dent, Div Oral Biochem, Niigata, Japan; [Harada, Fumiko; Maeda, Takeyasu] Niigata Univ, Fac Dent, Ctr Adv Oral Sci, Niigata, Japan; [Moss, Stephen J.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA USA; [Harada, Fumiko; Maeda, Takeyasu] Niigata Univ, Grad Sch Med & Dent Sci, Niigata, Japan	Niigata University; Niigata University; Tufts University; Niigata University	Terunuma, M (corresponding author), Niigata Univ, Fac Dent, Div Oral Biochem, Niigata, Japan.	mterunuma@dent.niigata-u.ac.jp		Terunuma, Miho/0000-0003-1876-9726; Maeda, Takeyasu/0000-0001-5317-7510				Adlimoghaddam A, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00057; Assentoft M, 2016, J BIOL CHEM, V291, P19184, DOI 10.1074/jbc.M116.740217; ATANASSOV CL, 1995, NEUROCHEM INT, V27, P417, DOI 10.1016/0197-0186(95)00023-2; Beitz E, 2006, P NATL ACAD SCI USA, V103, P269, DOI 10.1073/pnas.0507225103; BRANCONNIER RJ, 1986, AM J PSYCHIAT, V143, P1313, DOI 10.1176/ajp.143.10.1313; Chang GHF, 2000, NEURO-ONCOLOGY, V2, P174, DOI 10.1093/neuonc/2.3.174; Choy RWY, 2012, P NATL ACAD SCI USA, V109, pE2077, DOI 10.1073/pnas.1208635109; Dai HL, 2013, NEUROCHEM INT, V63, P610, DOI 10.1016/j.neuint.2013.09.005; Dong CM, 2007, CELL SIGNAL, V19, P2388, DOI 10.1016/j.cellsig.2007.07.017; El Ayadi A, 2012, P NATL ACAD SCI USA, V109, P13416, DOI 10.1073/pnas.1206786109; Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200; Fellner L, 2013, GLIA, V61, P349, DOI 10.1002/glia.22437; FISMAN M, 1985, AM J PSYCHIAT, V142, P71; FISMAN M, 1989, J AM GERIATR SOC, V37, P1102, DOI 10.1111/j.1532-5415.1989.tb06935.x; Gouras GK, 2015, NEUROTHERAPEUTICS, V12, P3, DOI 10.1007/s13311-014-0313-y; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Haussinger D, 2008, GUT, V57, P1156, DOI 10.1136/gut.2007.122176; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Hiltunen M, 2006, J BIOL CHEM, V281, P32240, DOI 10.1074/jbc.M603106200; Holm LM, 2005, PFLUG ARCH EUR J PHY, V450, P415, DOI 10.1007/s00424-005-1399-1; HOYER S, 1990, NEUROSCI LETT, V117, P358, DOI 10.1016/0304-3940(90)90691-2; JAMES JH, 1979, LANCET, V2, P772, DOI 10.1016/S0140-6736(79)92119-6; Jayakumar AR, 2008, J BIOL CHEM, V283, P33874, DOI 10.1074/jbc.M804016200; Jin YY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050564; Jones RS, 2013, J NEUROIMMUNE PHARM, V8, P301, DOI 10.1007/s11481-012-9427-3; Jung ES, 2015, SCI REP-UK, V5, DOI 10.1038/srep08805; Kelly T, 2010, J NEUROCHEM, V115, P1123, DOI 10.1111/j.1471-4159.2010.07009.x; Koo EH, 1996, J CELL SCI, V109, P991; Lah JJ, 2000, MOL CELL NEUROSCI, V16, P111, DOI 10.1006/mcne.2000.0861; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lemberg A, 2009, ANN HEPATOL, V8, P95, DOI 10.1016/S1665-2681(19)31785-5; Li ZY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153526; Lie PPY, 2019, NEUROBIOL DIS, V122, P94, DOI 10.1016/j.nbd.2018.05.015; Linde CI, 2011, AM J PHYSIOL-CELL PH, V300, pC1502, DOI 10.1152/ajpcell.00379.2010; Mader S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020090; Murphy MP, 2010, J ALZHEIMERS DIS, V19, P311, DOI [10.3233/JAD-2009-1221, 10.3233/JAD-2010-1221]; Nagele RG, 2003, BRAIN RES, V971, P197, DOI 10.1016/S0006-8993(03)02361-8; Nixon RA, 2017, FASEB J, V31, P2729, DOI 10.1096/fj.201700359; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; Orre M, 2014, NEUROBIOL AGING, V35, P1, DOI 10.1016/j.neurobiolaging.2013.07.008; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Pinnix I, 2001, J BIOL CHEM, V276, P481, DOI 10.1074/jbc.M005968200; Placido AI, 2014, BBA-MOL BASIS DIS, V1842, P1444, DOI 10.1016/j.bbadis.2014.05.003; Potokar M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071121; Robinson SR, 2000, NEUROCHEM INT, V36, P471, DOI 10.1016/S0197-0186(99)00150-3; Seiler N, 2002, NEUROCHEM INT, V41, P189, DOI 10.1016/S0197-0186(02)00041-4; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Sosa LJ, 2017, J NEUROCHEM, V143, P11, DOI 10.1111/jnc.14122; TANAKA RD, 1986, J LIPID RES, V27, P261; Terunuma M, 2004, J NEUROSCI, V24, P7074, DOI 10.1523/JNEUROSCI.1323-04.2004; Terunuma M, 2015, NEUROPHARMACOLOGY, V88, P74, DOI 10.1016/j.neuropharm.2014.09.015; Terunuma M, 2010, P NATL ACAD SCI USA, V107, P13918, DOI 10.1073/pnas.1000853107; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Thrane VR, 2013, NAT MED, V19, P1643, DOI 10.1038/nm.3400; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; Van Nguyen T, 2016, MOL CELL, V61, P809, DOI 10.1016/j.molcel.2016.02.032; Vasquez KO, 2017, J PHARMACOL EXP THER, V361, P87, DOI 10.1124/jpet.116.238378; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Verkman AS, 2017, EXPERT OPIN THER TAR, V21, P1161, DOI 10.1080/14728222.2017.1398236; Wu HT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7239; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748	62	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101933	10.1016/j.jbc.2022.101933	http://dx.doi.org/10.1016/j.jbc.2022.101933			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L7CP	35427648	gold, Green Published			2022-12-26	WOS:000817175700009
J	Moradi, S; Kamal, A; Es, HA; Farhadi, F; Ebrahimi, M; Chitsaz, H; Sharifi-Zarchi, A; Baharvand, H				Moradi, Sharif; Kamal, Aryan; Es, Hamidreza Aboulkheyr; Farhadi, Farnoosh; Ebrahimi, Marzieh; Chitsaz, Hamidreza; Sharifi-Zarchi, Ali; Baharvand, Hossein			Pan-cancer analysis of microRNA expression profiles highlights microRNAs enriched in normal body cells as effective suppressors of multiple tumor types: A study based on TCGA database	PLOS ONE			English	Article							DLK1-DIO3 LOCUS; STEM; DISEASE; GROWTH; MOUSE; RNA; DETERMINANTS; DEREGULATION; SKELETAL	Background MicroRNAs (miRNAs) are frequently deregulated in various types of cancer. While antisense oligonucleotides are used to block oncomiRs, delivery of tumour-suppressive miRNAs holds great potential as a potent anti-cancer strategy. Here, we aim to determine, and functionally analyse, miRNAs that are lowly expressed in various types of tumour but abundantly expressed in multiple normal tissues. Methods The miRNA sequencing data of 14 cancer types were downloaded from the TCGA dataset. Significant differences in miRNA expression between tumor and normal samples were calculated using limma package (R programming). An adjusted p value < 0.05 was used to compare normal versus tumor miRNA expression profiles. The predicted gene targets were obtained using TargetScan, miRanda, and miRDB and then subjected to gene ontology analysis using Enrichr. Only GO terms with an adjusted p < 0.05 were considered statistically significant. All data from wet-lab experiments (cell viability assays and flow cytometry) were expressed as means SEM, and their differences were analyzed using GraphPad Prism software (Student's t test, p < 0.05). Results By compiling all publicly available miRNA profiling data from The Cancer Genome Atlas (TCGA) Pan-Cancer Project, we reveal a small set of tumour-suppressing miRNAs (which we designate as 'normomiRs') that are highly expressed in 14 types of normal tissues but poorly expressed in corresponding tumour tissues. Interestingly, muscle-enriched miRNAs (e.g. miR-133a/b and miR-206) and miRNAs from DLK1-DIO3 locus (e.g. miR-381 and miR-411) constitute a large fraction of the normomiRs. Moreover, we define that the CCCGU motif is absent in the oncomiRs' seed sequences but present in a fraction of tumour-suppressive miRNAs. Finally, the gain of function of candidate normomiRs across several cancer cell types indicates that miR-206 and miR-381 exert the most potent inhibition on multiple cancer types in vitro. Conclusion Our results reveal a pan-cancer set of tumour-suppressing miRNAs and highlight the potential of miRNA-replacement therapies for targeting multiple types of tumour.	[Moradi, Sharif; Es, Hamidreza Aboulkheyr; Ebrahimi, Marzieh; Baharvand, Hossein] ACECR, Royan Inst Stem Cell Biol & Technol, Dept Stem Cells & Dev Biol, Cell Sci Res Ctr, Tehran, Iran; [Kamal, Aryan] Saarland Univ, Ctr Bioinformat, Saarbrucken, Germany; [Es, Hamidreza Aboulkheyr] Univ Technol Sydney, Fac Engn & Informat Technol, Sch Biomed Engn, Sydney, NSW, Australia; [Farhadi, Farnoosh; Sharifi-Zarchi, Ali] Sharif Univ Technol, Dept Comp Engn, Tehran, Iran; [Chitsaz, Hamidreza] Colorado State Univ, Dept Comp Sci, Ft Collins, CO 80523 USA; [Baharvand, Hossein] Univ Sci & Culture, Dept Dev Biol, Tehran, Iran	Academic Center for Education, Culture & Research (ACECR); Saarland University; University of Technology Sydney; Sharif University of Technology; Colorado State University	Baharvand, H (corresponding author), ACECR, Royan Inst Stem Cell Biol & Technol, Dept Stem Cells & Dev Biol, Cell Sci Res Ctr, Tehran, Iran.; Sharifi-Zarchi, A (corresponding author), Sharif Univ Technol, Dept Comp Engn, Tehran, Iran.; Chitsaz, H (corresponding author), Colorado State Univ, Dept Comp Sci, Ft Collins, CO 80523 USA.; Baharvand, H (corresponding author), Univ Sci & Culture, Dept Dev Biol, Tehran, Iran.	chitsaz@chitsazlab.org; asharifi@ce.sharif.edu; h.baharvand@royan-rc.ac.ir		Baharvand, Hossein/0000-0001-6528-3687	Royan Institute, Sharif University of Technology; Colorado State University	Royan Institute, Sharif University of Technology; Colorado State University	HB, ASZ, and HC are supported by funds from Royan Institute, Sharif University of Technology, and Colorado State University, respectively. The funding bodies had no role in the study design, collection, analysis, and interpretation of data, or in writing the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ahmadi A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-89605-6; Akhtari FS, 2021, PLOS GENET, V17, DOI 10.1371/journal.pgen.1009732; Anastasiadou E, 2018, NAT REV CANCER, V18, P5, DOI 10.1038/nrc.2017.99; Bader AG, 2010, CANCER RES, V70, P7027, DOI 10.1158/0008-5472.CAN-10-2010; Benetatos L, 2013, CELL MOL LIFE SCI, V70, P795, DOI 10.1007/s00018-012-1080-8; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Castagnino A, 2018, ONCOGENE, V37, P6425, DOI 10.1038/s41388-018-0422-x; Chen X, 2018, MOL THER-NUCL ACIDS, V13, P568, DOI 10.1016/j.omtn.2018.10.005; Chen YH, 2020, NUCLEIC ACIDS RES, V48, pD127, DOI 10.1093/nar/gkz757; Cui SY, 2014, J CELL MOL MED, V18, P1913, DOI 10.1111/jcmm.12358; Cui W, 2015, MOL BIOL CELL, V26, P1416, DOI 10.1091/mbc.E14-11-1576; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Enterina JR, 2017, EXPERT REV RESP MED, V11, P749, DOI 10.1080/17476348.2017.1355241; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Fidler MM, 2017, LANCET ONCOL, V18, P1579, DOI 10.1016/S1470-2045(17)30677-0; Fu XN, 2017, ONCOL REP, V38, P1851, DOI 10.3892/or.2017.5839; Greve TS, 2013, ANNU REV CELL DEV BI, V29, P213, DOI 10.1146/annurev-cellbio-101512-122343; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grottke A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146370; Gutierrez-Aranda I, 2010, STEM CELLS, V28, P1568, DOI 10.1002/stem.471; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Haga CL, 2012, J BIOL CHEM, V287, P42695, DOI 10.1074/jbc.M112.387761; Hamilton MP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3730; Harafuji N, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-55; Hitachi K, 2017, ONCOTARGET, V8, P5943, DOI 10.18632/oncotarget.13966; Hung CS, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103096; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Jiang YS, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2072-5; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Kawamura A, 2016, SCI REP-UK, V6, DOI 10.1038/srep19464; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lever J, 2019, NAT METHODS, V16, P505, DOI 10.1038/s41592-019-0422-y; Liao M, 2020, CELL MOL BIOL LETT, V25, DOI 10.1186/s11658-020-00216-x; Lim JP, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3187-7; Liu B, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0260-7; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Mohammadi P, 2021, J DERMATOL SCI, V101, P49, DOI 10.1016/j.jdermsci.2020.11.002; Moradi S, 2020, BIOESSAYS, V42, DOI 10.1002/bies.202000042; Moradi S, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1455-y; Moradi S, 2018, CELL J, V20, P61, DOI 10.22074/cellj.2018.4846; Moradi S, 2017, STEM CELL REP, V9, P2081, DOI 10.1016/j.stemcr.2017.10.009; Moradi S, 2014, STEM CELLS, V32, P3, DOI 10.1002/stem.1576; Morii I, 2019, CANCER SCI, V110, P1044, DOI 10.1111/cas.13941; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Nohata N, 2012, ONCOTARGET, V3, P9; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; Pan JY, 2017, MOL THER-NUCL ACIDS, V8, P442, DOI 10.1016/j.omtn.2017.06.002; Radmanesh F, 2021, ANGIOGENESIS, V24, P657, DOI 10.1007/s10456-021-09778-6; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Rupaimoole R, 2016, CANCER DISCOV, V6, P235, DOI 10.1158/2159-8290.CD-15-0893; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Senanayake U, 2012, CARCINOGENESIS, V33, P1014, DOI 10.1093/carcin/bgs126; Shahriari F, 2020, EXP EYE RES, V190, DOI 10.1016/j.exer.2019.107883; Svoronos AA, 2016, CANCER RES, V76, P3666, DOI 10.1158/0008-5472.CAN-16-0359; Takeshita F, 2010, MOL THER, V18, P181, DOI 10.1038/mt.2009.207; Tang H, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1190-3; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Wang L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161859; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Wust S, 2018, CELL METAB, V27, P1026, DOI 10.1016/j.cmet.2018.02.022; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Xu Q, 2012, NUCLEIC ACIDS RES, V40, P761, DOI 10.1093/nar/gkr730; Yang X, 2017, AM J CANCER RES, V7, P913; Ye YL, 2019, MOL CARCINOGEN, V58, P279, DOI 10.1002/mc.22926	71	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267291	10.1371/journal.pone.0267291	http://dx.doi.org/10.1371/journal.pone.0267291			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476804	gold, Green Published			2022-12-26	WOS:000840124300032
J	Richards, HL; Eustace, J; O' Dwyer, A; Wormald, A; Curtin, Y; Fortune, DG				Richards, Helen L.; Eustace, Joseph; O' Dwyer, Amanda; Wormald, Andrew; Curtin, Yvonne; Fortune, Donal G.			Healthcare workers use of psychological support resources during COVID-19; a mixed methods approach utilising Pillar Integration Analysis	PLOS ONE			English	Article							MENTAL-HEALTH; STAFF	Objectives We sought to examine healthcare workers (HCWs) utilisation of formal and informal psychological support resources in the workplace during the first and third waves of the COVID-19 pandemic in Ireland. Methods A convergent mixed methods approach was undertaken. Four hundred and thirty HCWs in the Mid West and South of Ireland responded to an online survey in terms of their use of psychological support resources during Wave 1 (April/May 2020) of COVID-19. Thirty-nine HCWs undertook in depth interviews at Wave 3 (January/February 2021), and a further quantitative survey was distributed and completed by 278 HCWs at this time. Quantitative data arising at Wave 1 and Wave 3, were synthesised with Qualitative data collected at Wave 3. A Pillar Integration Process (PIP) was utilised in the analysis of the quantitative and qualitative data. Results Five pillars were identified from the integration of results. These were: a) the primacy of peer support, b) the importance of psychologically informed management, c) a need to develop the organisational well-being ethos, d) support for all HCWs, and e) HCWs ideas for developing the well-being path. These pillars encapsulated a strong emphasis on collegial support, an emphasis on the need to support managers, a questioning of the current supports provided within the healthcare organisations and critical reflections on what HCWs viewed as most helpful for their future support needs. Conclusions HCWs who utilised supportive resources indicated 'in house' supports, primarily collegial resources, were the most frequently used and perceived as most helpful. While formal psychological supports were important, the mechanism by which such psychological support is made available, through utilising peer support structures and moving towards psychologically informed supervisors and workplaces is likely to be more sustainable and perceived more positively by HCWs.	[Richards, Helen L.; Curtin, Yvonne] Mercy Univ Hosp, Dept Clin Psychol, Cork, Ireland; [Richards, Helen L.; O' Dwyer, Amanda; Wormald, Andrew; Curtin, Yvonne; Fortune, Donal G.] Univ Limerick, Dept Psychol, Limerick, Ireland; [Eustace, Joseph] Cork Univ Hosp, Dept Nephrol, Cork, Ireland; [Eustace, Joseph] Univ Coll Cork, HRB Clin Res Facil, Cork, Ireland	University College Cork; University of Limerick; University College Cork; Health Research Board - Ireland; University College Cork	Fortune, DG (corresponding author), Univ Limerick, Dept Psychol, Limerick, Ireland.	Donal.fortune@ul.ie		O'Dwyer, Amanda/0000-0001-9557-4450	Irish Health Research Board [COV19-2020042]	Irish Health Research Board	The work reported in the current manuscript was supported by a grant from the Irish Health Research Board to HLR JE, DGF. https://www.hrb.ie Grant number COV19-2020042. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhanemhe R, 2021, OCCUP MED-OXFORD, V71, P127, DOI 10.1093/occmed/kqab023; Albott CS, 2020, ANESTH ANALG, V131, P43, DOI 10.1213/ANE.0000000000004912; Alden LE, 2021, WORK STRESS, V35, P193, DOI 10.1080/02678373.2020.1758833; Blake H, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17092997; Braun V., 2021, THEMATIC ANAL PRACTI; Brooks SK, 2019, BRIT MED BULL, V129, P25, DOI 10.1093/bmb/ldy040; Brooks SK, 2018, J OCCUP ENVIRON MED, V60, P248, DOI 10.1097/JOM.0000000000001235; Buselli R, 2021, PSYCHIAT RES, V299, DOI 10.1016/j.psychres.2021.113847; Cag Y, 2021, GEN HOSP PSYCHIAT, V68, P90, DOI 10.1016/j.genhosppsych.2020.12.010; Cenat JM, 2021, PSYCHIAT RES, V295, DOI 10.1016/j.psychres.2020.113599; Chen QN, 2020, LANCET PSYCHIAT, V7, pE15, DOI 10.1016/S2215-0366(20)30078-X; Chen R, 2021, INT J MENT HEALTH NU, V30, P102, DOI 10.1111/inm.12796; Chung J P Y, 2020, East Asian Arch Psychiatry, V30, P34, DOI 10.12809/eaap2014; Clark VLP, 2019, CONTEMP EDUC PSYCHOL, V57, P106, DOI 10.1016/j.cedpsych.2019.01.007; DePierro J, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113426; Edwards JL, 2017, AUST J PSYCHOL, V69, P218, DOI 10.1111/ajpy.12146; Fetters MD, 2013, HEALTH SERV RES, V48, P2134, DOI 10.1111/1475-6773.12117; Ffrench-O'Carroll R, 2021, BRIT J ANAESTH, V126, pE39, DOI 10.1016/j.bja.2020.09.040; Flanagan P, 2020, J ADV NURS, V76, P1746, DOI 10.1111/jan.14360; Gilleen J, 2021, BJPSYCH OPEN, V7, DOI 10.1192/bjo.2021.42; Greenberg N, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1211; Hedderman E, 2021, IRISH J PSYCHOL MED, V38, P154, DOI 10.1017/ipm.2020.59; Huang YE, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112954; Ivankova NV, 2006, FIELD METHOD, V18, P3, DOI 10.1177/1525822X05282260; Jiang XX, 2020, PSYCHIAT RES, V286, DOI 10.1016/j.psychres.2020.112903; Johnson RE, 2019, J MIX METHOD RES, V13, P301, DOI 10.1177/1558689817743108; Jones N, 2012, PSYCHIATRY, V75, P49, DOI 10.1521/psyc.2012.75.1.49; Junker NM, 2022, GROUP ORGAN MANAGE, V47, P41, DOI 10.1177/10596011211004789; Kisely S, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1642; Knaak Stephanie, 2017, Healthc Manage Forum, V30, P111, DOI 10.1177/0840470416679413; Krug H, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.684475; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Lamb D, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-051687; Lamb D, 2021, OCCUP ENVIRON MED, V78, P801, DOI 10.1136/oemed-2020-107276; Lefevre H, 2021, J PAIN SYMPTOM MANAG, V61, P416, DOI 10.1016/j.jpainsymman.2020.09.023; Malik M, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.669009; Mellins CA, 2020, GEN HOSP PSYCHIAT, V67, P62, DOI 10.1016/j.genhosppsych.2020.08.013; Muller AE, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113441; Naldi A, 2021, BJPSYCH OPEN, V7, DOI 10.1192/bjo.2020.161; Petrella AR, 2021, GEN PSYCHIAT, V34, DOI 10.1136/gpsych-2020-100458; Pollock A, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013779; Price J, 2021, FAM SYST HEALTH, V39, P493, DOI 10.1037/fsh0000600; Procaccia R, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.624176; Rodriguez-Vega B, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.562578; Schubert M, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18126183; Schulte EE, 2020, J PEDIATR-US, V222, P13, DOI 10.1016/j.jpeds.2020.04.057; Sharma M, 2021, CLIN INFECT DIS, V72, pE566, DOI 10.1093/cid/ciaa1311; Sulaiman AH, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8030228; Taylor S, 2020, J ANXIETY DISORD, V75, DOI 10.1016/j.janxdis.2020.102289; Vajpeyee M, 2022, INT J SOC PSYCHIATR, V68, P798, DOI 10.1177/00207640211006742; Vindrola-Padros C, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-040503; Walton M, 2020, EUR HEART J-ACUTE CA, V9, P241, DOI 10.1177/2048872620922795; Wanigasooriya K, 2020, BJPSYCH OPEN, V7, DOI 10.1192/bjo.2020.150; Zace D, 2021, J PSYCHIATR RES, V136, P319, DOI 10.1016/j.jpsychires.2021.02.019	54	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267458	10.1371/journal.pone.0267458	http://dx.doi.org/10.1371/journal.pone.0267458			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476796	Green Published, gold			2022-12-26	WOS:000840124300044
J	Alatrany, SSJ; Ogden, R; Falaiyah, AM; ALdrraji, HAS; Alatrany, ASS				Alatrany, Saad S. J.; Ogden, Ruth; Falaiyah, Ashraf Muwafa; ALdrraji, Hasan Ali Sayyid; Alatrany, Abbas S. S.			The passage of time in Iraq during the covid-19 pandemic	PLOS ONE			English	Article							EXPERIENCE	The covid-19 global pandemic has influenced the day-to-day lives of people across the world. One consequence of this has been significant distortion to the subjective speed at which people feel like time is passing. To date, temporal distortions during covid-19 have mainly been studied in Europe. The current study therefore sought to explore experiences of the passage of time in Iraq. An online questionnaire was used to explore the passage of time during the day, week and the 11 months since the first period of covid-19 restrictions were imposed in Iraq. The questionnaire also measured affective and demographic factors, and task-load. The results showed that distortions to the passage of time were widespread in Iraq. Participants consistently reported a slowing of the passage of time for the day and the week during the pandemic in comparison to normal (i.e. before the pandemic). Participants also reported that it felt like longer than 11-months since the first lockdown began. The passage of time during the day and week were not predicted by any demographic, affective or task-load measures taken in the study. The perceived length of time since the first lockdown was however predicted by stress and change of life due to covid, with greater stress and greater change of life being associated with greater subjective lengthening of the pandemic. The findings indicate that whilst distortions to the passage of time during covid-19 appear to be a global phenomenon, the factors which predict temporal experience during the pandemic differ between countries and cultures.	[Alatrany, Saad S. J.] Imam Jaafar Al Sadiq Univ, Baghdad, Iraq; [Ogden, Ruth] Liverpool John Moores Univ, Sch Psychol, Liverpool, Merseyside, England; [Falaiyah, Ashraf Muwafa; ALdrraji, Hasan Ali Sayyid] Univ Baghdad, Coll Educ Human Sci Ibn Reshed, Baghdad, Iraq; [Alatrany, Abbas S. S.] Univ Informat Technol & Commun, Baghdad, Iraq; [Alatrany, Abbas S. S.] Liverpool John Moores Univ, Sch Comp Sci & Math, Liverpool, Merseyside, England	Imam Jaa'far al-Sadiq University; Liverpool John Moores University; University of Liverpool; University of Baghdad; University of Information Technology & Communication; Liverpool John Moores University	Ogden, R (corresponding author), Liverpool John Moores Univ, Sch Psychol, Liverpool, Merseyside, England.	r.s.ogden@ljmu.acuk		Alatrany, Saad/0000-0002-0778-6750; Ogden, Ruth/0000-0002-0931-1986				[Anonymous], 2020, BBC 0305; BECH P, 1975, ACTA PSYCHIAT SCAND, V51, P42, DOI 10.1111/j.1600-0447.1975.tb00211.x; BLEWETT AE, 1992, BRIT J PSYCHIAT, V161, P195, DOI 10.1192/bjp.161.2.195; Block RA, 1997, PSYCHON B REV, V4, P184, DOI 10.3758/BF03209393; Cellini N, 2020, J SLEEP RES, V29, DOI 10.1111/jsr.13074; Cravo A. M., 2021, PSYARXIV, DOI [10.31234/osf.io/6jg4r, DOI 10.31234/OSF.IO/6JG4R]; Droit-Volet S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236465; Droit-Volet S, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00176; Droit-Volet S, 2015, ACTA PSYCHOL, V156, P77, DOI 10.1016/j.actpsy.2015.01.006; FLAHERTY MG, 1991, SOC PSYCHOL QUART, V54, P76, DOI 10.2307/2786790; FLAHERTY MG, 1993, SOCIOL INQ, V63, P394, DOI 10.1111/j.1475-682X.1993.tb00320.x; Hall E, 1973, SILENT LANGUAGE; Hall Edward Twitchell, 1989, LENGUAJE SILENCIOSO; HART S G, 1988, P139; Ismael NB, 2021, ANN ROMANIAN SOC CEL, P2496; Jebril N., 2020, INT J PSYCHOSOCIAL R, P10, DOI DOI 10.2139/SSRN.3597426; Kamal N. M., 2020, Kurdistan Journal of Applied Research, V5, P37, DOI 10.24017/covid.5; Knight DM, 2016, CAMB J ANTHROPOL, V34, P32, DOI 10.3167/ca.2016.340105; Loose T, 2022, TIME SOC, V31, P110, DOI 10.1177/0961463X211027420; Mahmood KI, 2022, J INTERPERS VIOLENCE, V37, pNP11811, DOI 10.1177/0886260521997929; Martinelli N, 2021, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.616169; MEZEY AG, 1961, J NEUROL NEUROSUR PS, V24, P269, DOI 10.1136/jnnp.24.3.269; Moussa MT, 2017, RES SOCIAL WORK PRAC, V27, P375, DOI 10.1177/1049731516662916; Ogden R., 2021, COGNITIVE PSYCHOL B, V6; Ogden R, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250412; Ogden RS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235871; Sackett AM, 2010, PSYCHOL SCI, V21, P111, DOI 10.1177/0956797609354832; Torboli D, 2021, CURR PSYCHOL, DOI 10.1007/s12144-021-01811-7; Wearden J., 2016, PSYCHOL TIME PERCEPT; Wearden JH, 2015, CONSCIOUS COGN, V38, P165, DOI 10.1016/j.concog.2015.06.005; Wittmann M, 2020, KRONOSCOPE, V20, P260, DOI 10.1163/15685241-12341471; World Bank, 2020, IR YOUTH UN RAT 1999; World Bank, 2021, WORLD BANK IR; World Bank, 2020, SHAR POV HEADC IR 20; World Health Organisation, 2021, WHO COR DASHB	35	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266877	10.1371/journal.pone.0266877	http://dx.doi.org/10.1371/journal.pone.0266877			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421167	gold, Green Accepted, Green Published			2022-12-26	WOS:000795453600074
J	Daily, A; Ravishankar, P; Harms, S; Klimberg, VS				Daily, Anna; Ravishankar, Prashanth; Harms, Steve; Klimberg, V. Suzanne			Using tears as a non-invasive source for early detection of breast cancer	PLOS ONE			English	Article							MASS-SPECTROMETRY; BIOMARKERS; PROTEOMICS; FLUID; S100A8; CELLS; ELISA	The changing expression levels of ocular proteins in response to systemic disease has been well established in literature. In this study, we examined the ocular proteome to identify protein biomarkers with altered expression levels in women diagnosed with breast cancer. Tear samples were collected from 273 participants using Schirmer strip collection methods. Following protein elution, proteome wide trypsin digestion with Liquid chromatography/tandem mass spectrometry (LC-MS/MS) was used to identify potential protein biomarkers with altered expression levels in breast cancer patients. Selected biomarkers were further validated by enzyme linked immunosorbent assay (ELISA). A total of 102 individual tear samples (51 breast cancer, 51 control) were analyzed by LC-MS/MS which identified 301 proteins. Spectral intensities between the groups were compared and 14 significant proteins (p-value <0.05) were identified as potential biomarkers in breast cancer patients. Three biomarkers, S100A8 (p-value = 0.0069, 7.8-fold increase), S100A9 (p-value = 0.0048, 10.2-fold increase), and Galectin-3 binding protein (p-value = 0.01, 3.0-fold increase) with an increased expression in breast cancer patients were selected for validation using ELISA. Validation by ELISA was conducted using 171 individual tear samples (75 Breast Cancer and 96 Control). Similar to the observed LC-MS/MS results, S100A8 (p-value <0.0001) and S100A9 (p-value <0.0001) showed significantly higher expression in breast cancer patients. However, galectin-3 binding protein had increased expression in the control group. Our results provide further support for using tear proteins to detect non-ocular systemic diseases such as breast cancer. Our work provides crucial details to support the continued evaluation of tear samples in the screening and diagnosis of breast cancer and paves the way for future evaluation of the tear proteome for screening and diagnosis of systemic diseases.	[Daily, Anna; Ravishankar, Prashanth; Harms, Steve; Klimberg, V. Suzanne] Namida Lab Inc, Fayetteville, AR USA; [Harms, Steve] Breast Ctr Med Associates Northwest Arkansas, Fayetteville, AR USA; [Klimberg, V. Suzanne] Univ Texas, Dept Surg, Med Branch, Galveston, TX USA; [Klimberg, V. Suzanne] Univ Texas, MD Anderson Canc Ctr, Breast Surg Oncol, Houston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; UTMD Anderson Cancer Center	Daily, A (corresponding author), Namida Lab Inc, Fayetteville, AR USA.	anna@namidalab.com	Ravishankar, Prashanth/Q-3806-2019	Ravishankar, Prashanth/0000-0001-9841-8939				Allgower C, 2020, CANCERS, V12, DOI 10.3390/cancers12082037; Aslebagh R, 2019, ADV EXP MED BIOL, V1140, P451, DOI 10.1007/978-3-030-15950-4_26; Azkargorta M, 2017, J PROTEOMICS, V150, P359, DOI 10.1016/j.jprot.2016.05.006; Bachhuber F, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-89514-8; Bao Y, 2016, ONCOL LETT, V11, P1936, DOI 10.3892/ol.2016.4134; Barmada A, 2020, EYE, V34, P1731, DOI 10.1038/s41433-020-0930-0; Beretov J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141876; Bergenfelz C, 2015, BRIT J CANCER, V113, P1234, DOI 10.1038/bjc.2015.346; Bohm D, 2012, ONCOL REP, V28, P429, DOI 10.3892/or.2012.1849; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bresnick AR, 2015, NAT REV CANCER, V15, P96, DOI 10.1038/nrc3893; Comoglu SS, 2013, NEUROSCI LETT, V553, P63, DOI 10.1016/j.neulet.2013.08.019; Denburg MR, 2016, J BONE MINER RES, V31, P1128, DOI 10.1002/jbmr.2829; Devos D, 2001, J NEUROL, V248, P672, DOI 10.1007/PL00007833; Evans V, 2001, CLIN EXP OPHTHALMOL, V29, P161, DOI 10.1046/j.1442-9071.2001.00408.x; Feigenbaum D., 2018, TEAR PROTEINS POSSIB; Gijs M, 2019, INVEST OPHTH VIS SCI, V60; Hagan S, 2016, EPMA J, V7, DOI 10.1186/s13167-016-0065-3; Inubushi S, 2020, ANTICANCER RES, V40, P3091, DOI 10.21873/anticanres.14290; Kallo G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158000; Kennedy RD, 2005, CANCER RES, V65, P10265, DOI 10.1158/0008-5472.CAN-05-1841; Kharazmi E, 2014, BREAST CANCER RES TR, V144, P185, DOI 10.1007/s10549-014-2848-3; Lebrecht Antje, 2009, Cancer Genomics & Proteomics, V6, P177; Li E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111217; Li JW, 2020, CANCERS, V12, DOI 10.3390/cancers12102767; Li N, 2005, J PROTEOME RES, V4, P2052, DOI 10.1021/pr0501970; Li YH, 2018, HUM PATHOL, V74, P156, DOI 10.1016/j.humpath.2018.01.004; Benitez-del-Castillo JM, 2021, MOL VIS, V27, P243; MARTINO G, 1993, J NEUROIMMUNOL, V44, P149, DOI 10.1016/0165-5728(93)90036-X; McKiernan E, 2011, TUMOR BIOL, V32, P441, DOI 10.1007/s13277-010-0137-2; Nattinen J, 2020, TRANSL VIS SCI TECHN, V9, DOI 10.1167/tvst.9.3.16; Nishtala K, 2016, EYE VISION, V3, DOI 10.1186/s40662-016-0051-9; Parris TZ, 2014, INT J CANCER, V134, P1617, DOI 10.1002/ijc.28497; Pieragostino D, 2015, PROTEOM CLIN APPL, V9, P169, DOI 10.1002/prca.201400084; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Ponzini E, 2022, MASS SPECTROM REV, V41, P842, DOI 10.1002/mas.21691; Raju KSR, 2013, BIOMED CHROMATOGR, V27, P1354, DOI 10.1002/bmc.2996; Ravishankar P, 2022, APPL SCI-BASEL, V12, DOI 10.3390/app12062884; Reynolds NM, 2018, CELL MOL BIOENG, V11, P37, DOI 10.1007/s12195-017-0512-9; Sahay P, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249759; Salvisberg C, 2014, PROTEOM CLIN APPL, V8, P185, DOI 10.1002/prca.201300053; Shaheed SU, 2018, CLIN PROTEOM, V15, DOI 10.1186/s12014-017-9179-4; Shieh Y, 2016, NAT REV CLIN ONCOL, V13, P550, DOI 10.1038/nrclinonc.2016.50; Shiyanbola OO, 2017, CANCER EPIDEM BIOMAR, V26, P1753, DOI 10.1158/1055-9965.EPI-17-0531; Spjuth O, 2017, J AM MED INFORM ASSN, V24, P950, DOI 10.1093/jamia/ocx038; Stanifer R., 1983, BIOCH EYE, P7; Takeuchi T, 2020, J AM CHEM SOC, V142, P6617, DOI 10.1021/jacs.9b13874; Tarver T, 2012, J CONS HLTH INTERNET, V16, P366, DOI 10.1080/15398285.2012.701177; Tikkanen R., 2020, US HLTH CARE GLOBAL, P1; Traini S, 2014, MOL CANCER THER, V13, P916, DOI 10.1158/1535-7163.MCT-12-1117; VANHAERINGEN NJ, 1981, SURV OPHTHALMOL, V26, P84, DOI 10.1016/0039-6257(81)90145-4; Wang DJ, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00496; White MJV, 2015, J IMMUNOL, V195, P1858, DOI 10.4049/jimmunol.1500365; Winters S, 2017, PROG MOL BIOL TRANSL, V151, P1, DOI 10.1016/bs.pmbts.2017.07.002; Yin CG, 2016, BREAST CANCER RES TR, V156, P407, DOI 10.1007/s10549-016-3754-7; Yin CG, 2013, BREAST CANCER RES TR, V142, P297, DOI 10.1007/s10549-013-2737-1; Zhou L, 2017, EXPERT REV PROTEOMIC, V14, P189, DOI 10.1080/14789450.2017.1285703; Zhou L, 2012, PROG RETIN EYE RES, V31, P527, DOI 10.1016/j.preteyeres.2012.06.002	58	2	2	8	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267676	10.1371/journal.pone.0267676	http://dx.doi.org/10.1371/journal.pone.0267676			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35471994	Green Published, gold			2022-12-26	WOS:000816171900013
J	Ho, HL; Jiang, YQ; Chiang, CL; Karwowska, S; Yerram, R; Sharma, K; Scudder, S; Chiu, CH; Tsai, CM; Palma, JF; Sharma, A; Chou, TY				Ho, Hsiang-Ling; Jiang, Yuqiu; Chiang, Chi-Lu; Karwowska, Sylwia; Yerram, Ranga; Sharma, Keerti; Scudder, Sidney; Chiu, Chao-Hua; Tsai, Chun-Ming; Palma, John F.; Sharma, Abha; Chou, Teh-Ying			Efficacy of liquid biopsy for disease monitoring and early prediction of tumor progression in EGFR mutation-positive non-small cell lung cancer	PLOS ONE			English	Article							DNA; NSCLC; HETEROGENEITY; RESISTANCE; GEFITINIB; EVOLUTION; AFATINIB	15-40% of non-small cell lung cancer (NSCLC) patients harbor epidermal growth factor receptor (EGFR)-sensitizing mutations. Tyrosine kinase inhibitors (TKIs) provide significant clinical benefit in this population, yet all patients will ultimately progress. Liquid biopsy can reliably identify somatic tumor-associated EGFR mutations in plasma. This study aimed to assess the feasibility and value of the quantitative assessment of EGFR driver mutations in plasma in EGFR-mutated NSCLC patients treated with EGFR-TKIs as a tool to evaluate therapeutic response to TKIs and monitor for disease progression. The study included 136 patients with tissue biopsy-confirmed EGFR-sensitizing, mutation-positive lung adenocarcinoma with plasma collected prior to TKI treatment and at least two post-initiation TKI treatment/follow-up blood samples. Plasma samples were tested with the cobas(R) EGFR Mutation Test v2 (cobas EGFR Test), and semi-quantitative index (SQI) values for each identified mutation were reported by the assay software. The most common baseline EGFR mutations detected in tissue were L858R (53.7%) and exon 19 deletion (39.7%). Plasma cell-free DNA analysis detected EGFR mutations in 74% of the baseline samples. Objective response rate by RECIST 1.1 was achieved in 72% of patients, while 93% had a molecular response (defined as disappearance of the EGFR mutation from plasma). 83% of patients had molecular progression (MP; 1.5X SQI increase or new T790M mutation), and 82% who had a clinical response had clinical progression. On average, MP occurred 42 days prior to clinical progression. Patients who progressed while on first-line TKI showed MP of the original EGFR-sensitizing mutations prior to the emergence of a T790M mutation, which was detected in 27% of the EGFR plasma-positive patients. Longitudinal monitoring of EGFR mutational load in plasma is feasible and can predict both response and clinical progression in EGFR-mutated NSCLC patients treated with EGFR-TKIs, as well as detect treatment-emergent EGFR mutations.	[Ho, Hsiang-Ling; Chou, Teh-Ying] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan; [Jiang, Yuqiu; Karwowska, Sylwia; Yerram, Ranga; Sharma, Keerti; Scudder, Sidney; Palma, John F.; Sharma, Abha] Roche Diagnost Solut, Clin Dev & Med Affairs, Pleasanton, CA 94588 USA; [Chiang, Chi-Lu; Chiu, Chao-Hua; Tsai, Chun-Ming] Taipei Vet Gen Hosp, Dept Chest Med, Div Thorac Oncol, Taipei, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital	Chou, TY (corresponding author), Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan.; Sharma, A (corresponding author), Roche Diagnost Solut, Clin Dev & Med Affairs, Pleasanton, CA 94588 USA.	abha.sharma@roche.com; tehying@gmail.com			Roche Molecular Systems, Inc. [L22339]; Taipei Veterans General Hospital	Roche Molecular Systems, Inc.; Taipei Veterans General Hospital(Taipei Veterans General Hospital)	The study was funded by Roche Molecular Systems, Inc. (https://diagnostics.roche.com/global/en/products/product-category/molecular-diagnostics.html) under contract L22339. The grant/contract was awarded to TehYing Chou and Taipei Veterans General Hospital. The sponsors played a role in data collection and analysis, decision to publish and preparation of the manuscript.	Aldea M, 2020, J THORAC ONCOL, V15, P383, DOI 10.1016/j.jtho.2019.11.024; Arriola E, 2018, CLIN TRANSL ONCOL, V20, P1261, DOI 10.1007/s12094-018-1855-y; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Chabon JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11815; Chaudhuri AA, 2017, CANCER DISCOV, V7, P1394, DOI 10.1158/2159-8290.CD-17-0716; Cohen JD, 2018, SCIENCE, V359, P926, DOI 10.1126/science.aar3247; Sebastien S, 2014, CLIN CANCER RES, V20, P4613, DOI 10.1158/1078-0432.CCR-13-3063; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Devarakonda S, 2017, ANN ONCOL, V28, P1690, DOI 10.1093/annonc/mdx313; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gray JE, 2019, CLIN CANCER RES, V25, P6644, DOI 10.1158/1078-0432.CCR-19-1126; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Jenkins S, 2017, J THORAC ONCOL, V12, P1061, DOI 10.1016/j.jtho.2017.04.003; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marchetti A, 2015, J THORAC ONCOL, V10, P1437, DOI 10.1097/JTO.0000000000000643; Mok T, 2015, CLIN CANCER RES, V21, P3196, DOI 10.1158/1078-0432.CCR-14-2594; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Reck M, 2016, J THORAC ONCOL, V11, P1682, DOI 10.1016/j.jtho.2016.05.036; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1; Yatabe Y, 2015, J THORAC ONCOL, V10, P438, DOI 10.1097/JTO.0000000000000422	27	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267362	10.1371/journal.pone.0267362	http://dx.doi.org/10.1371/journal.pone.0267362			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D8GY	35482671	gold, Green Published			2022-12-26	WOS:000794035700107
J	Iizuka, T; Kawamorita, T; Handa, T; Ishikawa, H				Iizuka, Tatsuya; Kawamorita, Takushi; Handa, Tomoya; Ishikawa, Hitoshi			Refractive and visual function changes in twilight conditions	PLOS ONE			English	Article							NIGHT MYOPIA; BLUR; TOLERANCE; ACUITY; FOCUS; ROD	PurposeWe investigated the effect of luminance on refraction and visual function under twilight conditions. MethodsTwenty young adults (mean age 20.5 +/- 0.5 years) without ocular diseases and 20 eyes were included in the study. Subjective and objective spherical equivalent power (SE), logMAR, pupil diameter, ocular aberration, and ocular axial length were evaluated. Measurements were conducted in a light room with high luminance (300 cd/m(2)) targets (photopic), in a dark room with low luminance (10 cd/m(2)) targets (twilight), and a dark room after 15 min of adaptation to low luminance (10 cd/m(2)) targets (after adaptation: AA). Differences between the three conditions were analyzed using the Friedman test and Scheffe's multiple comparisons. ResultsThe results of logMAR were -0.20 +/- 0.07, -0.08 +/- 0.08, and -0.11 +/- 0.08 in photopic, twilight, and AA, respectively, with significant differences between photopic and twilight (p < 0.001) and between photopic and AA (p < 0.001). Then subjective SE were -3.58 +/- 2.04 D, -3.75 +/- 2.08 D, and -3.74 +/- 2.04 D in photopic, twilight, and AA, respectively, with significant differences between photopic and twilight (p = 0.007) and photopic and AA (p = 0.023). However, none of the other objective SEs produced a significant difference (p = 0.63). The pupil diameter and ocular aberration changed significantly in all conditions (p < 0.001). ConclusionsSubjective myopic refraction increased and visual resolution decreased in younger subjects. However, this change in refraction is less than one level (+/- 0.25 D) in clinical optometry, so fully corrected eyeglasses are important when assuming refraction in twilight, and there is no need for additional correction.	[Iizuka, Tatsuya] Kitasato Univ, Grad Sch Med Sci, Sagamihara, Kanagawa, Japan; [Kawamorita, Takushi; Handa, Tomoya; Ishikawa, Hitoshi] Kitasato Univ, Dept Orthopt & Visual Sci, Sch Allied Hlth Sci, Sagamihara, Kanagawa, Japan; [Ishikawa, Hitoshi] Kitasato Univ, Dept Ophthalmol, Sch Med, Sagamihara, Kanagawa, Japan	Kitasato University; Kitasato University; Kitasato University	Iizuka, T (corresponding author), Kitasato Univ, Grad Sch Med Sci, Sagamihara, Kanagawa, Japan.	mm20002@st.kitasato-u.ac.jp		Iizuka, Tatsuya/0000-0002-9311-3842				Artal P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040239; Buck S. L., 2004, VISUAL NEUROSCIENCES, V1, P863; Charman WN, 1996, OPHTHAL PHYSL OPT, V16, P474, DOI 10.1016/0275-5408(96)00024-5; Chirre E, 2016, J VISION, V16, DOI 10.1167/16.8.16; DEGROOT SG, 1952, J OPT SOC AM, V42, P492, DOI 10.1364/JOSA.42.000492; Enke K., 1979, 7 INT TECHN C EXP SA; FRUMKES TE, 1972, SCIENCE, V175, P913, DOI 10.1126/science.175.4024.913; Gonzalez-Hernandez B., 2020, TRANSP RES PROCEDIA, V45, P827, DOI [10.1016/j.trpro.2020.02.087, DOI 10.1016/J.TRPRO.2020.02.087]; Heinrich SP, 2020, GRAEF ARCH CLIN EXP, V258, P2791, DOI 10.1007/s00417-020-04867-6; Institute for Traffic Accident Research and Data Analysis, TRAFF STAT, V2019; Kline DW, 1999, HUM FACTORS, V41, P356, DOI 10.1518/001872099779611049; KOOMEN M, 1949, J OPT SOC AM, V39, P370, DOI 10.1364/JOSA.39.000370; LEGGE GE, 1987, J OPT SOC AM A, V4, P851, DOI 10.1364/JOSAA.4.000851; LEIBOWITZ HW, 1975, J OPT SOC AM, V65, P1121, DOI 10.1364/JOSA.65.001121; Lin RJ, 2015, OPTOMETRY VISION SCI, V92, P559, DOI 10.1097/OPX.0000000000000584; Marcos S, 2006, Bull Soc Belge Ophtalmol, P197; National Police Agency, 2019, WHIT PAP POL; National Police Agency, 2020, FAT ACC; OTERO JM, 1951, J OPT SOC AM, V41, P942, DOI 10.1364/JOSA.41.000942; Pesudovs K, 2004, J REFRACT SURG, V20, pS508; Puell MC, 2004, J REFRACT SURG, V20, P484, DOI 10.3928/1081-597X-20040901-12; Schwiegerling J, 2002, J OPT SOC AM A, V19, P1937, DOI 10.1364/JOSAA.19.001937; TUCKER J, 1975, AM J OPTOM PHYS OPT, V52, P3; Wilcox WW, 1932, P NATL ACAD SCI USA, V18, P47, DOI 10.1073/pnas.18.1.47; Wood JM, 2015, INVEST OPHTH VIS SCI, V56, P4480, DOI 10.1167/iovs.14-16096; Wood JM, 2014, INVEST OPHTH VIS SCI, V55, P2284, DOI 10.1167/iovs.13-13369; Woods RL, 2010, INVEST OPHTH VIS SCI, V51, P6077, DOI 10.1167/iovs.09-5013; World Health Organization, 2020, GLOBAL STATUS REPORT, DOI DOI 10.1037/COU0000248; Zele AJ, 2013, J VISION, V13, DOI 10.1167/13.1.21	29	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267149	10.1371/journal.pone.0267149	http://dx.doi.org/10.1371/journal.pone.0267149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1E2NP	35427398	Green Published, gold			2022-12-26	WOS:000794332400019
J	Lennie, JL; Mondick, JT; Gastonguay, MR				Lennie, Janelle L.; Mondick, John T.; Gastonguay, Marc R.			Bayesian modeling and simulation to inform rare disease drug development early decision-making: Application to Duchenne muscular dystrophy	PLOS ONE			English	Article							6-MINUTE WALK TEST; CLINICAL-TRIALS; END-POINTS	Rare disease clinical trials are constrained to small sample sizes and may lack placebo-control, leading to challenges in drug development. This paper proposes a Bayesian model-based framework for early go/no-go decision making in rare disease drug development, using Duchenne muscular dystrophy (DMD) as an example. Early go/no-go decisions were based on projections of long-term functional outcomes from a Bayesian model-based analysis of short-term trial data informed by prior knowledge based on 6MWT natural history literature data in DMD patients. Frequentist hypothesis tests were also applied as a reference analysis method. A number of combinations of hypothetical trial designs, drug effects and cohort comparison methods were assessed. The proposed Bayesian model-based framework was superior to the frequentist method for making go/no-go decisions across all trial designs and cohort comparison methods in DMD. The average decision accuracy rates across all trial designs for the Bayesian and frequentist analysis methods were 45.8 and 8.98%, respectively. A decision accuracy rate of at least 50% was achieved for 42 and 7% of the trial designs under the Bayesian and frequentist analysis methods, respectively. The frequentist method was limited to the short-term trial data only, while the Bayesian methods were informed with both the short-term data and prior information. The specific results of the DMD case study were limited due to incomplete specification of individual-specific covariates in the natural history literature data and should be reevaluated using a full natural history dataset. These limitations aside, the framework presented provides a proof of concept for the utility of Bayesian model-based methods for decision making in rare disease trials.	[Lennie, Janelle L.; Gastonguay, Marc R.] Univ Connecticut, Biomed Engn, Storrs, CT 06269 USA; [Lennie, Janelle L.; Mondick, John T.; Gastonguay, Marc R.] Metrum Res Grp, Tariffville, CT 06081 USA	University of Connecticut	Lennie, JL (corresponding author), Univ Connecticut, Biomed Engn, Storrs, CT 06269 USA.; Lennie, JL (corresponding author), Metrum Res Grp, Tariffville, CT 06081 USA.	janellelennie@gmail.com						[Anonymous], 2021, RARE FACTS; [Anonymous], 2021, FDA ADEQUATE WELL CO; Baron KT, 2015, J PHARMACOKINET PHAR, V42, pS84; Beal SL., 2018, NONMEM USERS GUIDE; Bell SA, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0170-0; Berry SA, 2020, GENET MED, V22, P219, DOI 10.1038/s41436-019-0616-9; Brehm MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115200; Bushby K, 2014, MUSCLE NERVE, V50, P477, DOI 10.1002/mus.24332; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Center for Drug Evaluation and Research, 2016, ET SUMM REV; Center for Drug Evaluation and Research Center for Biologics Evaluation and Research, 2019, RAR DIS COMM ISS DRU; Clemens PR, 2020, JAMA NEUROL, V77, P982, DOI 10.1001/jamaneurol.2020.1264; FDA, 2016, FDA GRANTS ACC APPR; Frank DE, 2020, NEUROLOGY, V94, pE2270, DOI 10.1212/WNL.0000000000009233; Frewer P, 2016, PHARM STAT, V15, P255, DOI 10.1002/pst.1746; Gelman A., 2013, BAYESIAN DATA ANAL C; Goemans N, 2013, NEUROMUSCULAR DISORD, V23, P618, DOI 10.1016/j.nmd.2013.05.006; Gregory W., 2014, NONPARAMETRIC STAT N, V2nd ed; Hoffman E, 2016, VARIABLE DYSTROPHINC; Kjellsson Maria C, 2004, AAPS J, V6, pe19; Lennie JL, 2020, J PHARMACOKINET PHAR, V47, P91, DOI 10.1007/s10928-020-09671-7; Mcdonald CM, 2013, MUSCLE NERVE, V48, P343, DOI 10.1002/mus.23902; McDonald CM, 2013, MUSCLE NERVE, V48, P357, DOI 10.1002/mus.23905; McDonald CM, 2010, MUSCLE NERVE, V42, P966, DOI 10.1002/mus.21808; Mendell JR, 2013, ANN NEUROL, V74, P637, DOI 10.1002/ana.23982; Mercuri E, 2016, NEUROMUSCULAR DISORD, V26, P576, DOI 10.1016/j.nmd.2016.05.016; Saint-Hilary G, 2018, PHARM STAT, V17, P555, DOI 10.1002/pst.1870; Sekhar KS, 2013, NAT J COMMUNITY MED, V4, P175; Warner RM., 2007, APPL STAT BIVARIATE; Whitehead J, 2003, STAT MED, V22, P677, DOI 10.1002/sim.1429	30	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0247286	10.1371/journal.pone.0247286	http://dx.doi.org/10.1371/journal.pone.0247286			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D8GY	35482633	gold, Green Published, Green Submitted			2022-12-26	WOS:000794035700042
J	Lipman, D; Safo, SE; Chekouo, T				Lipman, Danika; Safo, Sandra E.; Chekouo, Thierry			Multi-omic analysis reveals enriched pathways associated with COVID-19 and COVID-19 severity	PLOS ONE			English	Article								COVID-19 is a disease characterized by its seemingly unpredictable clinical outcomes. In order to better understand the molecular signature of the disease, a recent multi-omics study was done which looked at correlations between biomolecules and used a tree- based machine learning approach to predict clinical outcomes. This study specifically looked at patients admitted to the hospital experiencing COVID-19 or COVID-19 like symptoms. In this paper we examine the same multi-omics data, however we take a different approach, and we identify stable molecules of interest for further pathway analysis. We used stability selection, regularized regression models, enrichment analysis, and principal components analysis on proteomics, metabolomics, lipidomics, and RNA sequencing data, and we determined key molecules and biological pathways in disease severity, and disease status. In addition to the individual omics analyses, we perform the integrative method Sparse Multiple Canonical Correlation Analysis to analyse relationships of the different view of data. Our findings suggest that COVID-19 status is associated with the cell cycle and death, as well as the inflammatory response. This relationship is reflected in all four sets of molecules analyzed. We further observe that the metabolic processes, particularly processes to do with vitamin absorption and cholesterol are implicated in COVID-19 status and severity.	[Lipman, Danika; Chekouo, Thierry] Univ Calgary, Dept Math & Stat, Calgary s, Calgary, AB, Canada; [Safo, Sandra E.] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [Chekouo, Thierry] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada	University of Calgary; University of Minnesota System; University of Minnesota Twin Cities; University of Calgary	Chekouo, T (corresponding author), Univ Calgary, Dept Math & Stat, Calgary s, Calgary, AB, Canada.; Safo, SE (corresponding author), Univ Minnesota, Div Biostat, Minneapolis, MN USA.; Chekouo, T (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.	ssafo@umn.edu; thierry.chekouotekou@ucalgary.ca		Chekouo, Thierry/0000-0002-3594-9182; Safo, Sandra/0000-0001-9593-4778	New Frontier in Research Fund [NFRFE-2018-00748]; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2019-04810]; University of Calgary; National Institutes of Health (NIH) [5KL2TR002492-04, 1R35GM142695-01]	New Frontier in Research Fund; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Calgary; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the New Frontier in Research Fund [NFRFE-2018-00748], the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant [RGPIN-2019-04810], and the Vice-President (Research) Grant for Covid-19 at the University of Calgary in the form of funds to TC. This study was also funded by the National Institutes of Health (NIH) in the form of grants to SES [5KL2TR002492-04, 1R35GM142695-01].	Abu-Farha M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103544; Berlit Peter, 2020, Neurol Res Pract, V2, P51, DOI 10.1186/s42466-020-00097-7; Bouhaddou M, 2020, CELL, V182, P685, DOI 10.1016/j.cell.2020.06.034; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Dai MY, 2020, CANCER DISCOV, V10, P783, DOI 10.1158/2159-8290.CD-20-0422; Ding T, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.635255; Dinglasan, 2021, NICLOSAMIDE REVERSES; Don BR, 2004, SEMIN DIALYSIS, V17, P432, DOI 10.1111/j.0894-0959.2004.17603.x; Fibrinogen [Internet], FIBRINOGEN LAB TESTS; Gibson PG, 2020, MED J AUSTRALIA, V213, P54, DOI 10.5694/mja2.50674; Hastie T., 2019, IMPUTE IMPUTATION MI; Hipp R. D., 2020, SQLITE; hmpgloballearningnetwork.com, LONG HAULER PATIENTS; IPA QIAGEN Inc, PRODUCTS INGENUITYPA; Kang SJ, 2020, INFECT CHEMOTHER, V52, P154, DOI 10.3947/ic.2020.52.2.154; Lee W, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00292-7; Li R, 2020, AGING-US, V12, P15784, DOI 10.18632/aging.103888; LIPEA software Cybernetics B., HOME; LIPID MAPS, US; Mehta V, 2020, CANCER DISCOV, V10, P935, DOI 10.1158/2159-8290.CD-20-0516; Meinshausen N, 2010, J R STAT SOC B, V72, P417, DOI 10.1111/j.1467-9868.2010.00740.x; Miners S, 2020, ALZHEIMERS RES THER, V12, DOI 10.1186/s13195-020-00744-w; Overmyer Katherine A, 2020, medRxiv, DOI 10.1101/2020.07.17.20156513; Shah RD, 2013, J R STAT SOC B, V75, P55, DOI 10.1111/j.1467-9868.2011.01034.x; Taquet M, 2021, LANCET PSYCHIAT, V8, P416, DOI 10.1016/S2215-0366(21)00084-5; Target Explorer [Internet], TARGET EXPLORER SEAR; Vinciguerra M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9072095; Witten DM, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1470; Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017	29	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267047	10.1371/journal.pone.0267047	http://dx.doi.org/10.1371/journal.pone.0267047			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D9PO	35468151	Green Published, gold			2022-12-26	WOS:000794129600020
J	Neitzke-Montinelli, V; Gomes, PDFC; Pascutti, PG; Moura-Neto, RS; Silva, R				Neitzke-Montinelli, Vanessa; Figueiredo Celestino Gomes, Priscila da Silva; Pascutti, Pedro G.; Moura-Neto, Rodrigo S.; Silva, Rosane			Genetic diversity of the melanocortin-1 receptor in an admixed population of Rio de Janeiro: Structural and functional impacts of Cys35Tyr variant	PLOS ONE			English	Article							MC1R VARIANTS; CONVERGENT EVOLUTION; MALIGNANT-MELANOMA; PARKINSONS-DISEASE; PROTEIN STABILITY; HAIR COLOR; R-PACKAGE; RED HAIR; SKIN; POLYMORPHISMS	The melanocortin-1 receptor (MC1R) is one of the key proteins involved in the regulation of melanin production and several polymorphisms have been associated with different phenotypes of skin and hair color in human and nonhuman species. Most of the knowledge is centered on more homogeneous populations and studies involving an admixed group of people should be encouraged due to the great importance of understanding the human color variation. This work evaluates the MC1R diversity and the possible impacts of MC1R variants in an admixed sample population of Rio de Janeiro, Brazil, which is a product of Native American, African, and European miscegenation. Sequencing of complete coding region and part of the 3 ' UTR of MC1R gene identified 31 variants including one insertion and three novel synonymous substitutions in sample population grouped according to skin, hair and eye pigmentation levels. In nonmetric multidimensional scaling analysis (NMDS), three main clusters were identified, in which the Brazilian dark skin group remained in the African cluster whereas the intermediate and the light skin color phenotype in the European one. None gathered with Asians since their immigration to Brazil was a recent event. In silico analyses demonstrated that Cys35Tyr, Ile155Thr and Pro256Ser, found in our population, have a negative effect on receptor function probably due to changes on the receptor structure. Notably, Cys35Tyr mutation could potentially impair agonist binding. Altogether, this work contributes to the understanding of the genetic background of color variation on an admixed population and gives insights into the damaging effects of MC1R variants.	[Neitzke-Montinelli, Vanessa; Figueiredo Celestino Gomes, Priscila da Silva; Pascutti, Pedro G.; Silva, Rosane] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Moura-Neto, Rodrigo S.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil; [Neitzke-Montinelli, Vanessa] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Figueiredo Celestino Gomes, Priscila da Silva] Auburn Univ, Phys Dept, Auburn, AL 36849 USA	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Cedars Sinai Medical Center; Auburn University System; Auburn University	Silva, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.	silvaros@biot.ufrj.br	Silva, Rosane/C-1427-2013	Silva, Rosane/0000-0002-2998-6999; da Silva Figueiredo Celestino Gomes, Priscila/0000-0001-7370-9596	CAPES (PSFCG) [23038.006844/2014-46]; FAPERJ [E-26/260043/2019, 202847/2018, 202532/2019]; CNPq [304156/2016-7, 312905/2018-1]; CAPES [23038006844/2014-46]	CAPES (PSFCG)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	(VNM) Pro-Forense Fellowship Grant n degrees 23038.006844/2014-46 CAPES (PSFCG) FAPERJ, E-26/260043/2019 (RS) was supported by CNPq Grant n degrees 304156/2016-7, FAPERJ Grant n degrees 202847/2018. (RSMN) was supported by CAPES ProForense Grant n degrees 23038006844/2014-46, CNPq Grant n degrees 312905/2018-1, FAPERJ Grant n degrees 202532/2019. URL: CAPES -Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior (https://www.gov.br/capes/pt-br/assuntos/editaiscapes) CNPq -Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnologico (https://www.gov.br/cnpq/pt-br/acesso-a-informa cao/bolsas-e-auxilios) FAPERJ-Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (http://www.faperj.br)	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Adhikari K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08147-0; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; Andersen JD, 2020, INT J LEGAL MED, V134, P1569, DOI 10.1007/s00414-020-02307-y; Bateman A, 2021, NUCLEIC ACIDS RES, V49, pD480, DOI 10.1093/nar/gkaa1100; Beaumont KA, 2007, HUM MOL GENET, V16, P2249, DOI 10.1093/hmg/ddm177; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Box NF, 1997, HUM MOL GENET, V6, P1891, DOI 10.1093/hmg/6.11.1891; Capriotti E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S2; Case D. A., 2018, AMBER 2019; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chaplin G, 2004, AM J PHYS ANTHROPOL, V125, P292, DOI 10.1002/ajpa.10263; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clarke L, 2017, NUCLEIC ACIDS RES, V45, pD854, DOI 10.1093/nar/gkw829; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Dario P, 2015, INT J LEGAL MED, V129, P1191, DOI 10.1007/s00414-015-1248-5; de Meeus T, 2007, INFECT GENET EVOL, V7, P731, DOI 10.1016/j.meegid.2007.07.005; de Souza AM, 2019, GENET MOL BIOL, V42, P495, DOI [10.1590/1678-4685-GMB-2018-0076, 10.1590/1678-4685-gmb-2018-0076]; Deng L, 2017, HEREDITAS, V155, DOI 10.1186/s41065-017-0036-2; Elincx-Benizri S, 2014, J MOL NEUROSCI, V54, P820, DOI 10.1007/s12031-014-0425-1; Fernandez LP, 2007, CARCINOGENESIS, V28, P1659, DOI 10.1093/carcin/bgm084; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Frandberg PA, 2001, BIOCHEM BIOPH RES CO, V281, P851, DOI 10.1006/bbrc.2001.4429; Gao X, 2009, ANN NEUROL, V65, P76, DOI 10.1002/ana.21535; Goncalves VF, 2008, HUM HERED, V65, P23, DOI 10.1159/000106059; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; Hepp D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121812; Horrell EMW, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00095; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ibarrola-Villava M, 2014, J INVEST DERMATOL, V134, P1146, DOI 10.1038/jid.2013.469; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; John PR, 2003, ANN NY ACAD SCI, V994, P299, DOI 10.1111/j.1749-6632.2003.tb03193.x; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Lott M. T., 2013, CURR PROTOC BIOINFOR, V123, P1, DOI [10.1002/0471250953.bi0123s44, DOI 10.1002/0471250953.BI0123S44]; Mahmoud AH, 2017, ASIAN AUSTRAL J ANIM, V30, P154, DOI 10.5713/ajas.16.0138; Marano LA, 2017, GENET MOL BIOL, V40, P530, DOI [10.1590/1678-4685-GMB-2016-0180, 10.1590/1678-4685-gmb-2016-0180]; Neitzke-Montinelli V, 2012, AM J HUM BIOL, V24, P853, DOI 10.1002/ajhb.22301; Manta FSN, 2013, ANN HUM BIOL, V40, P94, DOI 10.3109/03014460.2012.742138; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Pires DEV, 2014, NUCLEIC ACIDS RES, V42, pW314, DOI 10.1093/nar/gku411; Potapov V, 2009, PROTEIN ENG DES SEL, V22, P553, DOI 10.1093/protein/gzp030; Raimann PE, 2012, INT J LEGAL MED, V126, P337, DOI 10.1007/s00414-011-0606-1; Raimondi S, 2008, INT J CANCER, V122, P2753, DOI 10.1002/ijc.23396; Riera C, 2016, HUM MUTAT, V37, P1013, DOI 10.1002/humu.23048; Rodrigues CHM, 2018, NUCLEIC ACIDS RES, V46, pW350, DOI 10.1093/nar/gky300; Rosenkranz AA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1228, DOI 10.1134/S0006297913110035; Ruiz-Linares A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004572; Sakai C, 1997, EMBO J, V16, P3544, DOI 10.1093/emboj/16.12.3544; Savage SA, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-31; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Silva WA, 2006, HUM BIOL, V78, P29, DOI 10.1353/hub.2006.0028; Suzuki I, 1997, J INVEST DERMATOL, V108, P838, DOI 10.1111/1523-1747.ep12292572; Tagliabue E, 2018, CANCER MANAG RES, V10, P1143, DOI 10.2147/CMAR.S155283; Carratto TMT, 2020, FORENSIC SCI INT-GEN, V48, DOI 10.1016/j.fsigen.2020.102335; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wheatley M, 2012, BRIT J PHARMACOL, V165, P1688, DOI 10.1111/j.1476-5381.2011.01629.x; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Yang GL, 2013, SCI WORLD J, DOI 10.1155/2013/675382; ZAGO MA, 1992, AM J PHYS ANTHROPOL, V88, P295, DOI 10.1002/ajpa.1330880304; Zanna PT, 2008, BIOCHEM BIOPH RES CO, V368, P211, DOI 10.1016/j.bbrc.2008.01.060	66	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267286	10.1371/journal.pone.0267286	http://dx.doi.org/10.1371/journal.pone.0267286			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1C1KV	35452484	gold, Green Published			2022-12-26	WOS:000792887700028
J	Razak, MR; Aris, AZ; Yusoff, FM; Yusof, ZNB; Kim, SD; Kim, KW				Razak, Muhammad Raznisyafiq; Aris, Ahmad Zaharin; Yusoff, Fatimah Md; Yusof, Zetty Norhana Balia; Kim, Sang Don; Kim, Kyoung Woong			Assessment of RNA extraction protocols from cladocerans	PLOS ONE			English	Article							ADVERSE OUTCOME PATHWAYS; HIGH-QUALITY RNA; MOINA-MICRURA KURZ; DAPHNIA-MAGNA; GENE-EXPRESSION; ACUTE TOXICITY; PRESERVATION; ZOOPLANKTON; ECOTOXICOLOGY; OPTIMIZATION	The usage of cladocerans as non-model organisms in ecotoxicological and risk assessment studies has intensified in recent years due to their ecological importance in aquatic ecosystems. The molecular assessment such as gene expression analysis has been introduced in ecotoxicological and risk assessment to link the expression of specific genes to a biological process in the cladocerans. The validity and accuracy of gene expression analysis depends on the quantity, quality and integrity of extracted ribonucleic acid (RNA) of the sample. However, the standard methods of RNA extraction from the cladocerans are still lacking. This study evaluates the extraction of RNA from tropical freshwater cladocerans Moina micrura using two methods: the phenol-chloroform extraction method (QIAzol) and a column-based kit (Qiagen Micro Kit). Glycogen was introduced in both approaches to enhance the recovery of extracted RNA and the extracted RNA was characterised using spectrophotometric analysis (NanoDrop), capillary electrophoresis (Bioanalyzer). Then, the extracted RNA was analysed with reverse transcription polymerase chain reaction (RT-PCR) to validate the RNA extraction method towards downstream gene expression analysis. The results indicate that the column-based kit is most suitable for the extraction of RNA from M. micrura, with the quantity (RNA concentration = 26.90 +/- 6.89 ng/mu l), quality (A260:230 = 1.95 +/- 0.15, A280:230 = 1.85 +/- 0.09) and integrity (RNA integrity number, RIN = 7.20 +/- 0.16). The RT-PCR analysis shows that the method successfully amplified both alpha tubulin and actin gene at 33-35 cycles (i.e. Ct = 32.64 to 33.48). The results demonstrate that the addition of glycogen is only suitable for the phenol-chloroform extraction method. RNA extraction with high and comprehensive quality control assessment will increase the accuracy and reliability of downstream gene expression, thus providing more ecotoxicological data at the molecular biological level on other freshwater zooplankton species.	[Razak, Muhammad Raznisyafiq; Aris, Ahmad Zaharin] Univ Putra Malaysia, Fac Forestry & Environm, Dept Environm, Seri Kembangan, Selangor, Malaysia; [Aris, Ahmad Zaharin; Yusoff, Fatimah Md] Univ Putra Malaysia, Int Inst Aquaculture & Aquat Sci, Seri Kembangan, Negeri Sembilan, Malaysia; [Yusoff, Fatimah Md] Univ Putra Malaysia, Fac Agr, Dept Aquaculture, Seri Kembangan, Selangor, Malaysia; [Yusof, Zetty Norhana Balia] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Biochem, Seri Kembangan, Selangor, Malaysia; [Yusof, Zetty Norhana Balia] Univ Putra Malaysia, Inst Biosci, Seri Kembangan, Selangor, Malaysia; [Kim, Sang Don; Kim, Kyoung Woong] Gwangju Inst Sci & Technol, Sch Earth Sci & Environm Engn, Gwangju, South Korea	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Gwangju Institute of Science & Technology (GIST)	Aris, AZ (corresponding author), Univ Putra Malaysia, Fac Forestry & Environm, Dept Environm, Seri Kembangan, Selangor, Malaysia.; Aris, AZ (corresponding author), Univ Putra Malaysia, Int Inst Aquaculture & Aquat Sci, Seri Kembangan, Negeri Sembilan, Malaysia.	zaharin@upm.edu.my	Razak, Muhammad Raznisyafiq/X-3978-2019	Razak, Muhammad Raznisyafiq/0000-0001-7358-050X	GIST Research Institute (GRI); Gwangju Institute of Science and Technology (GIST)	GIST Research Institute (GRI); Gwangju Institute of Science and Technology (GIST)	Funding: This work was supported by GIST Research Institute (GRI) grant funded by the <ITALIC><BOLD> </BOLD></ITALIC>Gwangju Institute of Science and Technology (GIST) in 2021.	A.Geary-Teeter, 2019, bioRxiv, DOI 10.1101/745232; Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34; Archer E, 2017, CHEMOSPHERE, V174, P437, DOI 10.1016/j.chemosphere.2017.01.101; Asai S, 2015, MAR GENOM, V24, P115, DOI 10.1016/j.margen.2014.12.004; Asselman J, 2019, ENVIRON SCI TECHNOL, V53, P3850, DOI 10.1021/acs.est.8b06720; Astrid T, 2016, LIMNOL OCEANOGR-METH, V14, P186, DOI 10.1002/lom3.10079; Azuraidi OM, 2013, AQUACULTURE, V412, P131, DOI 10.1016/j.aquaculture.2013.06.034; Ban E, 2017, ANAL BIOANAL CHEM, V409, P6397, DOI 10.1007/s00216-017-0580-7; Black AR, 2003, LIMNOL OCEANOGR-METH, V1, P45, DOI 10.4319/lom.2003.1.45; Boonthai C., 2011, PESTICIDES MODERN WO, DOI [10.5772/18275, DOI 10.5772/18275]; Bopp SK, 2019, CRIT REV TOXICOL, V49, P174, DOI 10.1080/10408444.2019.1579169; Brown RAM, 2018, BMC BIOTECHNOL, V18, DOI 10.1186/s12896-018-0421-6; Burden N, 2015, J APPL TOXICOL, V35, P971, DOI 10.1002/jat.3165; Ching T, 2014, RNA, V20, P1684, DOI 10.1261/rna.046011.114; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; Cozigou G, 2015, J AM ASSOC LAB ANIM, V54, P209; Dahms HU, 2016, AQUAT TOXICOL, V180, P282, DOI 10.1016/j.aquatox.2016.10.013; de Oliveira LLD, 2018, WATER AIR SOIL POLL, V229, DOI 10.1007/s11270-018-3765-6; De Wever J, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00992; DeLeo Danielle M, 2018, Biol Methods Protoc, V3, pbpy012, DOI 10.1093/biomethods/bpy012; Doke SK, 2015, SAUDI PHARM J, V23, P223, DOI 10.1016/j.jsps.2013.11.002; Ebele Anekwe Jennifer, 2017, Emerging Contaminants, V3, P1, DOI 10.1016/j.emcon.2016.12.004; Elias-Gutierrez M, 2019, LIMNETICA, V38, P227, DOI 10.23818/limn.38.18; Fattorini P, 2020, ELECTROPHORESIS, V41, P386, DOI 10.1002/elps.201900200; Ferrao AD, 2017, ENVIRON TOXICOL CHEM, V36, P2689, DOI 10.1002/etc.3819; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Ford KL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213685; Gayral P, 2011, MOL ECOL RESOUR, V11, P650, DOI 10.1111/j.1755-0998.2011.03010.x; Ghose SL, 2014, ENVIRON TOXICOL CHEM, V33, P2114, DOI 10.1002/etc.2665; Giraudo M, 2017, AQUAT TOXICOL, V190, P142, DOI 10.1016/j.aquatox.2017.07.003; Goetze E, 2013, J PLANKTON RES, V35, P972, DOI 10.1093/plankt/fbt035; Gorokhova E, 2005, LIMNOL OCEANOGR-METH, V3, P143, DOI 10.4319/lom.2005.3.143; Hamm J, 2017, TOXICOL IN VITRO, V41, P245, DOI 10.1016/j.tiv.2017.01.004; Heckmann LH, 2007, ECOTOXICOLOGY, V16, P445, DOI 10.1007/s10646-007-0148-y; Icoglu Aksakal F, 2019, TURK J ZOOL, V43, P554, DOI 10.3906/zoo-1909-8; Imhof HK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187590; Jeong TY, 2018, ENVIRON POLLUT, V241, P869, DOI 10.1016/j.envpol.2018.06.026; Kim Haeyeon, 2017, Toxicology and Environmental Health Sciences, V9, P41, DOI 10.1007/s13530-017-0302-8; Kim HY, 2017, ENVIRON SCI TECHNOL, V51, P12898, DOI 10.1021/acs.est.7b05050; Kim RO, 2019, ECOTOXICOLOGY, V28, P167, DOI 10.1007/s10646-018-2009-2; Kobari T, 2016, PLANKTON BENTHOS RES, V11, P1; Kono N, 2016, MOL ECOL RESOUR, V16, P662, DOI 10.1111/1755-0998.12485; Krupp G., 2005, STRINGENT RNA QUALIT; Lee JW, 2015, J ENVIRON SCI, V35, P115, DOI 10.1016/j.jes.2015.05.002; Liu Y, 2017, AQUAT TOXICOL, V183, P104, DOI 10.1016/j.aquatox.2016.12.020; Gama-Flores JL, 2017, DOSE-RESPONSE, V15, DOI 10.1177/1559325817723732; Macedo NJ, 2014, ASEE 2014 ZON C; Mathay C, 2012, BIOPRESERV BIOBANK, V10, P532, DOI 10.1089/bio.2012.0030; McCarthy A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121659; Monteiro MB, 2016, CLIN CHIM ACTA, V462, P158, DOI 10.1016/j.cca.2016.09.018; Padhi Bhaja K, 2018, Biomol Detect Quantif, V15, P18, DOI 10.1016/j.bdq.2018.02.001; Pan Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep40385; Parmar TK, 2016, FRONT LIFE SCI, V9, P110, DOI 10.1080/21553769.2016.1162753; Perez-Portela R, 2013, MOL ECOL RESOUR, V13, P884, DOI 10.1111/1755-0998.12122; Perkins EJ, 2015, TOXICOL SCI, V148, P14, DOI 10.1093/toxsci/kfv181; Pham TL, 2018, J CHEM-NY, V2018, DOI 10.1155/2018/9217815; Ravindran SP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47226-0; Razak MR, 2021, ECOTOX ENVIRON SAFE, V211, DOI 10.1016/j.ecoenv.2021.111905; Reiman M, 2017, FASEB J, V31, P3298, DOI 10.1096/fj.201601031RR; Rietzler AC, 2014, BRAZ J BIOL, V74, P518, DOI 10.1590/1519-6984.14113; Ruocco N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172171; Russell WMS., 1959, MED J AUSTRALIA; Semenova AS, 2018, RUSS J BIOL INVASION, V9, P175, DOI 10.1134/S207511171802011X; Sharma Rahul, 2020, STAR Protoc, V1, P100006, DOI 10.1016/j.xpro.2019.100006; Sinev AY, 2015, ZOOTAXA, V4006, P569, DOI 10.11646/zootaxa.4006.3.9; Stanta G, 2011, GUIDELINES FOR MOLECULAR ANALYSIS IN ARCHIVE TISSUES, P1, DOI 10.1007/978-3-642-17890-0; Sulata Kar, 2017, AACL Bioflux, V10, P1210; Tiam SK, 2017, WATER QUAL RES J CAN, V52, P109, DOI 10.2166/wqrj.2017.030; Toni LS, 2018, METHODSX, V5, P599, DOI 10.1016/j.mex.2018.05.011; Vijverberg Jacobus, 2018, Sri Lanka Journal of Aquatic Sciences, V23, P3; White K, 2018, BIOPRESERV BIOBANK, V16, P148, DOI 10.1089/bio.2017.0099; Winnebeck EC, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14119; Wuerz M, 2019, J PLANKTON RES, V41, P393, DOI 10.1093/plankt/fbz025; Xiong B, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1682-7; Xiong W, 2020, ENVIRON SCI ECOTECH, V1, DOI 10.1016/j.ese.2019.100008; Zhang H, 2013, J EXP MAR BIOL ECOL, V446, P57, DOI 10.1016/j.jembe.2013.04.021	76	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0264989	10.1371/journal.pone.0264989	http://dx.doi.org/10.1371/journal.pone.0264989			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35472091	gold, Green Published			2022-12-26	WOS:000816171900039
J	Shen, KR				Shen, Karen			Relationship between nursing home COVID-19 outbreaks and staff neighborhood characteristics	PLOS ONE			English	Article							QUALITY; DISPARITIES	The COVID-19 pandemic has been particularly deadly for residents of nursing homes and other long-term care facilities. This paper analyzes COVID-19 deaths at nursing homes during the first wave of the pandemic in the United States during the spring and early summer 2020. By combining data on facility-level COVID-19 deaths during this period with data on the neighborhoods where nursing home staff reside for a sample of eighteen states, this paper finds that staff neighborhood characteristics were a large and significant predictor of COVID-19 nursing home deaths. Even after controlling for the county where a facility is located, one standard deviation increases in average staff neighborhood (Census tract) population density, public transportation use, and non-white share were associated with 1.3 (p < .001), 1.4 (p < .001), and 0.9 (p < .001) additional deaths per 100 beds, respectively. These effects are larger than all facility management or quality variables, and larger than the effect of the nursing home's own neighborhood characteristics. These results suggest COVID-19 outbreaks in staff communities can have large consequences for the facilities where they work, even in highly-rated facilities, and that disparities in nursing home outbreaks may be related to differences in the types of neighborhoods nursing home staff live in.	[Shen, Karen] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA	Harvard University	Shen, KR (corresponding author), Harvard Univ, Dept Econ, Cambridge, MA 02138 USA.	kshen10@jh.edu		Shen, Karen/0000-0002-5931-9513				Abrams HR, 2020, J AM GERIATR SOC, V68, P1653, DOI 10.1111/jgs.16661; Alonso-Zaldivar R, 2020, HARROWING BLAME GAME; Chatterjee P, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16930; Chen MK, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2015455118; Dean A, 2020, HEALTH AFFAIR, V39, P1993, DOI 10.1377/hlthaff.2020.01011; Dingel J.I., 2020, MANY JOBS CAN BE DON, DOI [10.3386/w26948, DOI 10.3386/W26948, 10.3386/w26948.]; Fashaw SA, 2020, J AM MED DIR ASSOC, V21, P233, DOI 10.1016/j.jamda.2019.07.004; Gandhi A, 2021, HEALTH AFFAIR, V40, P384, DOI 10.1377/hlthaff.2020.00957; Gebeloff R., 2020, NEW YORK TIMES; Gorges RJ, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.37431; Khimm S., 2020, NBC NEWS; Knittel CR., 2020, MEDRXIV; Konetzka RT, 2021, J AM GERIATR SOC, V69, P46, DOI 10.1111/jgs.16951; Konetzka RT, 2015, HEALTH AFFAIR, V34, P819, DOI 10.1377/hlthaff.2014.1084; Lau-Ng R., 2020, J AM GERIATR SOC; Millett GA, 2020, ANN EPIDEMIOL, V47, P37, DOI 10.1016/j.annepidem.2020.05.003; Mor V, 2004, MILBANK Q, V82, P227, DOI 10.1111/j.0887-378X.2004.00309.x; Oppel R.A., 2020, NEW YORK TIMES; Rau J., 2020, KAISER HLTH NEWS; Sharma H, 2020, J APPL GERONTOL, V39, P981, DOI 10.1177/0733464819838447; Smith DB, 2007, HEALTH AFFAIR, V26, P1448, DOI 10.1377/hlthaff.26.5.1448; Tomer A, 2020, PROTECT ESSENTIAL WO; Wen LS., 2020, HLTH AFF BLOG, DOI [10.1377/hblog20200716.620294, DOI 10.1377/HBLOG20200716.620294]; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548	24	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267377	10.1371/journal.pone.0267377	http://dx.doi.org/10.1371/journal.pone.0267377			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7VA	35439279	gold, Green Submitted, Green Published			2022-12-26	WOS:000791280100002
J	Thepsilvisut, O; Chutimanukul, P; Sae-Tan, S; Ehara, H				Thepsilvisut, Ornprapa; Chutimanukul, Preuk; Sae-Tan, Sudathip; Ehara, Hiroshi			Effect of chicken manure and chemical fertilizer on the yield and qualities of white mugwort at dissimilar harvesting times	PLOS ONE			English	Article							ARTEMISIA-LACTIFLORA; ANTIOXIDANT ACTIVITY; CHLOROPHYLL CONTENT; PHENOLIC CONTENT; VEGETABLES; NITROGEN; NITRATE; OPTIMIZATION; GROWTH	One of the key components that affects soil productiveness, plant growth, and crop quality is fertilization. The effect of fertilizer, both organic and chemical, on the extremely acidic (pH 4.10) sandy loam soil chemical properties, yield, and quality of white mugwort grown were evaluated in this study. The field experiment arranged in a randomized complete block design, with four replications was conducted in Prachin Buri province, Thailand. There were six treatments, no fertilization (control), chemical fertilizer (25-7-7 + 46-0-0) applied at 187.50 (66.56 N:6.77 P2O5:6.77 K2O kg ha(-1)) kg ha(-1) and applied at 375.00 (133.12 N:13.13 P2O5:13.13 K2O kg ha(-1)) kg ha(-1), chicken manure applied at 3.36, 6.72, and 10.08 t ha(-1). After harvesting, application of chicken manure tended to increase soil organic matter compared to the control, however, the application of chemical fertilizer did not show the same effect. The fresh weight of white mugwort increased with the rise in both fertilizer levels. Chicken manure application at 10.08 t ha(-1) produced the highest fresh weight at all times. The level of accumulated nitrate was significantly greater when fertilizer rates increased. In addition, the total phenolic content of the white mugwort fertilized with chicken manure was higher than that fertilized with chemical fertilizer. However, there was no association between the DPPH radical scavenging capacity at harvesting times and different fertilization. Based on the results, chicken manure applied at 10.08 t ha(-1) gave the best yield and higher total phenolic content of white mugwort, which was probably due to the improved soil organic matter.	[Thepsilvisut, Ornprapa; Chutimanukul, Preuk] Thammasat Univ, Fac Sci & Technol, Dept Agr Technol, Pathum Thani, Thailand; [Sae-Tan, Sudathip] Kasetsart Univ, Fac Agroind, Dept Food Sci & Technol, Bangkok, Thailand; [Ehara, Hiroshi] Nagoya Univ, Int Ctr Res & Educ Agr, Nagoya, Japan	Thammasat University; Kasetsart University; Nagoya University	Thepsilvisut, O (corresponding author), Thammasat Univ, Fac Sci & Technol, Dept Agr Technol, Pathum Thani, Thailand.	ornprapa@hotmail.com		Ehara, Hiroshi/0000-0001-5367-1332	Thammasat University Center of Excellence in Agriculture Innovation Center through Supply Chain and Value Chain and Major of Agricultural Technology, Faculty of Science and Technology, Thammasat University	Thammasat University Center of Excellence in Agriculture Innovation Center through Supply Chain and Value Chain and Major of Agricultural Technology, Faculty of Science and Technology, Thammasat University	The authors would like to Thammasat University Center of Excellence in Agriculture Innovation Center through Supply Chain and Value Chain and Major of Agricultural Technology, Faculty of Science and Technology, Thammasat University for providing experimental and laboratory facility.	Amarowicz R, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10081215; Anugoolprasert O., 2015, TJST, V4, P81; Azmi F.M., 2019, ENV CONTAM REV, V2, P19, DOI [DOI 10.26480/ECR.01.2019.19.22, 10.26480/ecr.01.2019.19.22]; Bender I., 2009, Agronomy Research, V7, P572; Chang EH, 2014, SOIL SCI PLANT NUTR, V60, P499, DOI 10.1080/00380768.2014.917333; Davies MJ, 2009, ANN BOT-LONDON, V104, P315, DOI 10.1093/aob/mcp126; de Santiago A, 2019, LAND DEGRAD DEV, V30, P1121, DOI 10.1002/ldr.3298; Lima JRD, 2021, AGRICULTURE-BASEL, V11, DOI 10.3390/agriculture11040290; Du YD, 2020, CATENA, V193, DOI 10.1016/j.catena.2020.104617; Dumas Y, 2003, J SCI FOOD AGR, V83, P369, DOI 10.1002/jsfa.1370; Elhanafi L, 2019, J FOOD QUALITY, DOI 10.1155/2019/9428092; European Community, 2011, OFF J EUR UNION, VL320, P15; Ferreira JFS, 2007, J AGR FOOD CHEM, V55, P1686, DOI 10.1021/jf063017v; Ghimire BK, 2021, AGRONOMY-BASEL, V11, DOI 10.3390/agronomy11071327; Guadagnin SG, 2005, FOOD ADDIT CONTAM A, V22, P1203, DOI 10.1080/02652030500239649; Horwitz W., 1980, METHODS ANAL, P554; Hossain M. B., 2017, SAARC Journal of Agriculture, V15, P93, DOI 10.3329/sja.v15i2.35158; Ibrahim MH, 2013, MOLECULES, V18, P10973, DOI 10.3390/molecules180910973; Iqbal A, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9020178; Ishiwata H, 2002, EUR FOOD RES TECHNOL, V215, P367, DOI 10.1007/s00217-002-0577-z; Jin L, 2016, IND CROP PROD, V87, P198, DOI 10.1016/j.indcrop.2016.04.044; Kaluzewicz A, 2017, HORTIC SCI, V44, P178, DOI 10.17221/60/2016-HORTSCI; Kruger E, 2011, J APPL BOT FOOD QUAL, V84, P40; Kulprachakarn K., 2019, Walailak Journal of Science and Technology, V16, P185; Lata B, 2014, SCI HORTIC-AMSTERDAM, V168, P38, DOI 10.1016/j.scienta.2014.01.009; Li J, 2008, J PLANT NUTR, V31, P1642, DOI 10.1080/01904160802244860; Li Y, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00064; Lin Fu-Di, 2014, Zhongguo Zhong Yao Za Zhi, V39, P2531; Liu XF, 2007, LWT-FOOD SCI TECHNOL, V40, P552, DOI 10.1016/j.lwt.2005.09.007; MacKinney G, 1941, J BIOL CHEM, V140, P315; Nakamura Y, 1998, J AGR FOOD CHEM, V46, P5031, DOI 10.1021/jf980521u; Natural Resources Conservation Service, 2004, SOIL SURVEY LAB METH; Office of Soil Survey and Land Use Planning, 2005, MIR SOIL SOIL SER EC; Oloyede FM, 2012, SCI WORLD J, DOI 10.1100/2012/808196; Omer EA., 2014, PLANT INT RES J HORT, V2, P11; Pavlou GC, 2007, SCI HORTIC-AMSTERDAM, V111, P319, DOI 10.1016/j.scienta.2006.11.003; Rezaei E., 2015, Advances in Bio Research, V6, P119; Rodnuch N., 2019, CURRENT APPL SCI TEC, V19, P297; Santamaria P, 2006, J SCI FOOD AGR, V86, P10, DOI 10.1002/jsfa.2351; Soil Survey Staff, 2017, NAT SOIL SURV HDB SO; Taokaenchan Narin, 2020, Chiang Mai University Journal of Natural Sciences, V19, P1029, DOI 10.12982/CMUJNS.2020.0064; Thai Meteorological Department, 2016, STAT PRACH BUR WEATH; Thepsilvisut O., 2017, TSTJ, V25, P615; WALKLEY A, 1947, SOIL SCI, V63, P251, DOI 10.1097/00010694-194704000-00001; Wang QH, 2014, CARBOHYD POLYM, V102, P460, DOI 10.1016/j.carbpol.2013.11.068; Worthington V, 2001, J ALTERN COMPLEM MED, V7, P161, DOI 10.1089/107555301750164244; Yeboah S., 2012, African Journal of Agricultural Research, V7, P177	47	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266190	10.1371/journal.pone.0266190	http://dx.doi.org/10.1371/journal.pone.0266190			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35472063	gold, Green Published			2022-12-26	WOS:000816171900042
J	Vanleeuw, L; Zembe-Mkabile, W; Atkins, S; Medina-Marino, A				Vanleeuw, Lieve; Zembe-Mkabile, Wanga; Atkins, Salla; Medina-Marino, Andrew			"I'm suffering for food": Food insecurity and access to social protection for TB patients and their households in Cape Town, South Africa	PLOS ONE			English	Article							TUBERCULOSIS PATIENTS; RESISTANT TUBERCULOSIS; DISABILITY GRANT; ECONOMIC BURDEN; WESTERN CAPE; COMMUNITY; HIV; POVERTY; SUPPORT; EASTERN	BackgroundTuberculosis (TB) is a major health concern and the number one cause of death in South Africa. Social protection programmes can strengthen the resilience of TB patients, their families and households. This study aimed to get a better understanding of the role of social protection and other forms of support in relation to the burden of TB on patients and their households in South Africa. MethodsThis is a cross-sectional exploratory qualitative study using a phenomenological approach to focus on the lived experiences and perceptions of TB patients and healthcare workers. We interviewed 16 patients and six healthcare workers and analysed data thematically. ResultsThe challenges faced by participants were closely related to household challenges. Participants reported a heavy physical burden, aggravated by a lack of nutritious food and that households could not provide the food they needed. Some needed to resort to charity. At the same time, households were significantly affected by the burden of caring for the patient-and remained the main source of financial, emotional and physical support. Participants reported challenges and costs associated with the application process and high levels of discretion by the assessing doctor allowing doctors' opinions and beliefs to influence their assessment. ConclusionAccess to adequate nutritious food was a key issue for many patients and this need strained already stretched households and budgets. Few participants reported obtaining state social protection support during their illness, but many reported challenges and high costs of trying to access it. Further research should be conducted on support mechanisms and interventions for TB patients, but also their households, including food support, social protection and contact tracing. In deciding eligibility for grants, the situation of the household should be considered in addition to the individual patient.	[Vanleeuw, Lieve; Zembe-Mkabile, Wanga] South African Med Res Council, Hlth Syst Res unit, Tygerberg, South Africa; [Vanleeuw, Lieve; Atkins, Salla] Tampere Univ, Fac Social Sci, New Social Res & Global Hlth & Dev, Tampere, Finland; [Zembe-Mkabile, Wanga] Univ South Afr, Archie Mafeje Social Policy Res Inst, Sch Transdisciplinary Res & Grad, Studies, Pretoria, South Africa; [Atkins, Salla] Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden	South African Medical Research Council; Tampere University; University of South Africa; Karolinska Institutet	Vanleeuw, L (corresponding author), South African Med Res Council, Hlth Syst Res unit, Tygerberg, South Africa.; Vanleeuw, L (corresponding author), Tampere Univ, Fac Social Sci, New Social Res & Global Hlth & Dev, Tampere, Finland.	lieve.vanleeuw@mrc.ac.za		Vanleeuw, Lieve/0000-0002-9012-3308				Adu PA, 2021, GLOBALIZATION HEALTH, V17, DOI 10.1186/s12992-020-00657-1; [Anonymous], 2019, GLOB TUB REP; [Anonymous], 2018, MORT CAUS DEATH S AF; Balinda IG, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz102; Barter DM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-980; Boccia D, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P37, DOI 10.5588/ijtld.10.0438; Booysen F, 2004, SAHARA J, V1, P45; Booysen F, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10214-z; Caesar MCJ., 2017, TRIPLE BURDEN HIV TB; Chen B, 2016, PATIENT PREFER ADHER, V10, P1063, DOI 10.2147/PPA.S105655; Chihota VN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138149; Claros JM, 2014, AIDS BEHAV, V18, pS459, DOI 10.1007/s10461-014-0870-4; Classen CN, 1999, THORAX, V54, P136, DOI 10.1136/thx.54.2.136; de Paoli MM, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-6; de Pee S, 2014, AIDS BEHAV, V18, pS531, DOI 10.1007/s10461-014-0730-2; Deshmukh R D, 2018, Indian J Tuberc, V65, P41, DOI 10.1016/j.ijtb.2017.05.003; Erlinger S, 2019, INT J TUBERC LUNG D, V23, P1205, DOI 10.5588/ijtld.18.0814; Escott Sarah, 2007, J Health Organ Manag, V21, P506, DOI 10.1108/14777260710834300; Foster N, 2015, SOC SCI MED, V130, P42, DOI 10.1016/j.socscimed.2015.01.046; Gentilini U, 2016, REVIVAL CASH VERSUS; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Grobler L, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006086.pub4; Kelly, 2018, INFLUENCE DISABILITY; Kelly G., 2013, 330 U CAP TOWN CTR S; Kweza PF, 2018, INT J TUBERC LUNG D, V22, P264, DOI 10.5588/ijtld.17.0491; Loeb M, 2008, DISABIL SOC, V23, P311, DOI 10.1080/09687590802038803; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Lutge EE, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007952.pub3; MacGregor H, 2006, J BIOSOC SCI, V38, P43, DOI 10.1017/S0021932005000957; Masquillier C, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18802; Massyn N, 2016, TUBERCULOSIS; Mauch V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-43; Meghji J, LONG TERM EFFECT PUL; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Patterson JM, 2002, J MARRIAGE FAM, V64, P349, DOI 10.1111/j.1741-3737.2002.00349.x; Paz-Soldan VA, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-290; Phaswana-Mafuya N, 2009, SOC WORK HEALTH CARE, V48, P533, DOI 10.1080/00981380802595156; Ramma L, 2015, INT J TUBERC LUNG D, V19, P1513, DOI 10.5588/ijtld.15.0341; Rudgard WE, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5962-z; Semba RD, 2010, FOOD NUTR BULL, V31, pS345, DOI 10.1177/15648265100314S404; Simchowitz B., 2004, SOCIAL SECURITY HIV; Statistics South Africa, 2021, LANG; Tanimura T, 2014, EUR RESPIR J, V43, P1763, DOI 10.1183/09031936.00193413; Thorpe J, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002425; Ukwaja KN, 2012, INT J TUBERC LUNG D, V16, P733, DOI 10.5588/ijtld.11.0193; United Nations, 2015, SUSTAINABLE DEV GOAL, DOI DOI 10.1163/157180910X12665776638740; van der Walt M., 2021, 1 NATL TB PREVALENCE; Watthananukul T, 2020, INT J TUBERC LUNG D, V24, P686, DOI 10.5588/ijtld.19.0353; WHO, 2015, IMPLEMENTING END TB; Wingfield T, 2017, LANCET, V389, P16; Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC; Woolgar HL, 2014, J ASSOC NURSE AIDS C, V25, P589, DOI 10.1016/j.jana.2014.07.001; World Health Organization, 2005, WHOHTMTB2005352; World Health Organization, 2020, GLOBAL TUBERCULOSIS	54	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266356	10.1371/journal.pone.0266356	http://dx.doi.org/10.1371/journal.pone.0266356			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35472210	Green Published, gold			2022-12-26	WOS:000816171900035
J	de Hoog, E; Spencer, GE				de Hoog, Eric; Spencer, Gaynor E.			Activity-dependent modulation of neuronal K-V channels by retinoic acid enhances Ca-V channel activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITORY SYNAPTIC-TRANSMISSION; U-TYPE INACTIVATION; CALCIUM-CHANNELS; PLASTICITY; GAMMA; LTP	The metabolite of vitamin A, retinoic acid (RA), is known to affect synaptic plasticity in the nervous system and to play an important role in learning and memory. A ubiquitous mechanism by which neuronal plasticity develops in the nervous system is through modulation of voltage-gated Ca2+ (CaV) and voltage-gated K+ channels. However, how retinoids might regulate the activity of these channels has not been determined. Here, we show that RA modulates neuronal firing by inducing spike broadening and complex spiking in a dose-dependent manner in peptidergic and dopaminergic cell types. Using patch-clamp electrophysiology, we show that RA-induced complex spiking is activity dependent and involves enhanced inactivation of delayed rectifier voltage-gated K+ channels. The prolonged depolarizations observed during RA-modulated spiking lead to an increase in Ca2+ influx through CaV channels, though we also show an opposing effect of RA on the same neurons to inhibit Ca2+ influx. At physiological levels of Ca2+, this inhibition is specific to CaV2 (not CaV1) channels. Examining the interaction between the spike-modulating effects of RA and its inhibition of CaV channels, we found that inhibition of CaV2 channels limits the Ca2+ influx resulting from spike modulation. Our data thus provide novel evidence to suggest that retinoid signaling affects both delayed rectifier K+ channels and CaV channels to fine-tune Ca2+ influx through CaV2 channels. As these channels play important roles in synaptic function, we propose that these modulatory effects of retinoids likely contribute to synaptic plasticity in the nervous system.	[de Hoog, Eric; Spencer, Gaynor E.] Brock Univ, Dept Biol Sci, St Catharines, ON, Canada	Brock University	Spencer, GE (corresponding author), Brock Univ, Dept Biol Sci, St Catharines, ON, Canada.	gspencer@brocku.ca			Natural Sciences and Engineering Research Council of Canada [02825]; Ontario Graduate Scholarship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	Funding and additional information-This work was supported by a Discovery Grant from The Natural Sciences and Engineering Research Council of Canada (02825; to G. E. S.) . E. d. H. was sup-ported by an Ontario Graduate Scholarship.	Aoto J, 2008, NEURON, V60, P308, DOI 10.1016/j.neuron.2008.08.012; Arendt KL, 2015, P NATL ACAD SCI USA, V112, pE5744, DOI 10.1073/pnas.1510239112; Arendt KL, 2015, NEURON, V86, P442, DOI 10.1016/j.neuron.2015.03.009; Balind SR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09767-w; Bett GCL, 2011, BIOPHYS J, V100, P11, DOI 10.1016/j.bpj.2010.11.011; Byrne JH, 1996, J NEUROSCI, V16, P425; Carrillo E, 2013, CHANNELS, V7, P97, DOI 10.4161/chan.23569; Chang CW, 2017, ELIFE, V6, DOI 10.7554/eLife.26278; Chen L, 2014, NEUROPHARMACOLOGY, V78, P3, DOI 10.1016/j.neuropharm.2012.12.004; Cheong E, 2013, PHYSIOL REV, V93, P961, DOI 10.1152/physrev.00010.2012; Chiang MY, 1998, NEURON, V21, P1353, DOI 10.1016/S0896-6273(00)80654-6; Cho IH, 2020, P NATL ACAD SCI USA, V117, P29937, DOI 10.1073/pnas.2000790117; Cocco S, 2002, NEUROSCIENCE, V115, P475, DOI 10.1016/S0306-4522(02)00423-2; Cunningham TJ, 2015, NAT REV MOL CELL BIO, V16, P110, DOI 10.1038/nrm3932; de Hoog E, 2019, J BIOL CHEM, V294, P10076, DOI 10.1074/jbc.RA118.006444; de Hoog E, 2018, CELL CALCIUM, V72, P51, DOI 10.1016/j.ceca.2018.02.001; Dmetrichuk JM, 2008, J NEUROSCI, V28, P13014, DOI 10.1523/JNEUROSCI.3192-08.2008; Epsztein J, 2011, NEURON, V70, P109, DOI 10.1016/j.neuron.2011.03.006; Fourcaudot E, 2009, NAT NEUROSCI, V12, P1093, DOI 10.1038/nn.2378; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Hsu IU, 2020, P NATL ACAD SCI USA, V117, P29914, DOI 10.1073/pnas.2009224117; Hsu YT, 2019, P NATL ACAD SCI USA, V116, P7113, DOI 10.1073/pnas.1820690116; Klemic KG, 1998, BIOPHYS J, V74, P1779, DOI 10.1016/S0006-3495(98)77888-9; Klemic KG, 2001, BIOPHYS J, V81, P814, DOI 10.1016/S0006-3495(01)75743-8; Liou JC, 2005, J CELL SCI, V118, P4721, DOI 10.1242/jcs.02603; Nanou E, 2018, NEURON, V98, P466, DOI 10.1016/j.neuron.2018.03.017; Nomoto M, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-8; Ochoa WF, 2003, BIOCHEMISTRY-US, V42, P8774, DOI 10.1021/bi034713g; Rothwell CM, 2017, J NEUROPHYSIOL, V117, P692, DOI 10.1152/jn.00737.2016; Rothwell CM, 2014, NEUROBIOL LEARN MEM, V114, P251, DOI 10.1016/j.nlm.2014.07.007; Rothwell CM, 2014, NEUROBIOL LEARN MEM, V114, P127, DOI 10.1016/j.nlm.2014.05.010; Sakakibara M, 2005, J NEUROPHYSIOL, V94, P3884, DOI 10.1152/jn.01163.2004; Sarti F, 2013, J NEUROSCI, V33, P11440, DOI 10.1523/JNEUROSCI.1710-13.2013; SIDELL N, 1986, BIOCHEM BIOPH RES CO, V138, P560, DOI 10.1016/S0006-291X(86)80533-2; Spafford JD, 2006, J NEUROPHYSIOL, V95, P42, DOI 10.1152/jn.00658.2005; Upreti C, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84943-x; Vesprini ND, 2015, J NEUROPHYSIOL, V113, P172, DOI 10.1152/jn.00458.2014; Vesprini ND, 2014, J NEUROPHYSIOL, V111, P1318, DOI 10.1152/jn.00434.2013; Wang HL, 2011, J NEUROSCI, V31, P17764, DOI 10.1523/JNEUROSCI.3964-11.2011; Wheeler DG, 2012, CELL, V149, P1112, DOI 10.1016/j.cell.2012.03.041; Wietrzych M, 2005, LEARN MEMORY, V12, P318, DOI 10.1101/lm.89805; Xu W, 2012, NEURON, V73, P990, DOI 10.1016/j.neuron.2011.12.036; Yee AX, 2016, SYNAPSE, V70, P445, DOI 10.1002/syn.21921; Zhong LR, 2018, J NEUROSCI, V38, P10454, DOI 10.1523/JNEUROSCI.1133-18.2018; Zhou YD, 2005, P NATL ACAD SCI USA, V102, P19121, DOI 10.1073/pnas.0509856103	46	1	1	3	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101959	10.1016/j.jbc.2022.101959	http://dx.doi.org/10.1016/j.jbc.2022.101959			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T5WI	35452677	gold, Green Published			2022-12-26	WOS:000804798000001
J	Yuan, YW; Li, KL; Teng, F; Wang, WW; Zhou, B; Zhou, X; Lin, JY; Ye, XR; Deng, YJ; Liu, WH; Luo, SJ; Zhang, PZ; Liu, DY; Zheng, MH; Li, J; Lu, Y; Zhang, HJ				Yuan, Youwen; Li, Kangli; Teng, Fei; Wang, Weiwei; Zhou, Bing; Zhou, Xuan; Lin, Jiayang; Ye, Xueru; Deng, Yajuan; Liu, Wenhui; Luo, Shenjian; Zhang, Peizhen; Liu, Deying; Zheng, Minghua; Li, Jin; Lu, Yan; Zhang, Huijie			Leukemia inhibitory factor protects against liver steatosis in nonalcoholic fatty liver disease patients and obese mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; SELF-RENEWAL; LIF; THERAPY; CANCER	Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide. However, the molecular mechanisms that promote dysregulation of hepatic triglyceride metabolism and lead to NAFLD are poorly understood, and effective treatments are limited. Leukemia inhibitory factor (LIF) is a member of the interleukin-6 cytokine family and has been shown to regulate a variety of physiological processes, although its role in hepatic triglyceride metabolism remains unknown. In the present study, we measured circulating LIF levels by ELISA in 214 patients with biopsy-diagnosed NAFLD as well as 314 normal control patients. We further investigated the potential role and mechanism of LIF on hepatic lipid metabolism in obese mice. We found that circulating LIF levels correlated with the severity of liver steatosis. Patients with ballooning, fibrosis, lobular inflammation, and abnormally elevated liver injury markers alanine transaminase and aspartate aminotransferase also had higher levels of serum LIF than control patients. Furthermore, animal studies showed that white adipose tissue-derived LIF could ameliorate liver steatosis through activation of hepatic LIF receptor signaling pathways. Together, our results suggested that targeting LIF-LIF receptor signaling might be a promising strategy for treating NAFLD.	[Yuan, Youwen; Li, Kangli; Teng, Fei; Wang, Weiwei; Zhou, Xuan; Lin, Jiayang; Ye, Xueru; Deng, Yajuan; Liu, Wenhui; Luo, Shenjian; Zhang, Peizhen; Liu, Deying; Zhang, Huijie] Southern Med Univ, Nanfang Hosp, Dept Endocrinol & Metab, Guangzhou, Peoples R China; [Yuan, Youwen; Li, Kangli; Teng, Fei; Wang, Weiwei; Zhou, Xuan; Lin, Jiayang; Ye, Xueru; Deng, Yajuan; Liu, Wenhui; Luo, Shenjian; Zhang, Peizhen; Liu, Deying; Zhang, Huijie] Southern Med Univ, Nanfang Hosp, Guangdong Prov Key Lab Shock & Microcirculat, Guangzhou, Peoples R China; [Zhou, Bing; Lu, Yan] Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Key Lab Metab & Mol Med,Minist Educ, Shanghai, Peoples R China; [Zheng, Minghua] Wenzhou Med Univ, Affiliated Hosp 1, MAFLD Res Ctr, Dept Hepatol, Wenzhou, Zhejiang, Peoples R China; [Zheng, Minghua] Key Lab Diag & Treatment Dev Chron Liver Dis, Wenzhou, Zhejiang, Peoples R China; [Li, Jin] Shanxi Med Univ, Affiliated Hosp 2, Dept Med, Div Endocrinol, Taiyuan, Peoples R China	Southern Medical University - China; Southern Medical University - China; Fudan University; Wenzhou Medical University; Shanxi Medical University	Zhang, HJ (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Endocrinol & Metab, Guangzhou, Peoples R China.; Zhang, HJ (corresponding author), Southern Med Univ, Nanfang Hosp, Guangdong Prov Key Lab Shock & Microcirculat, Guangzhou, Peoples R China.; Lu, Y (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Key Lab Metab & Mol Med,Minist Educ, Shanghai, Peoples R China.	lu.yan2@zs-hospital.sh.cn; huijiezhang2005@126.com	Zhang, Hui/HHN-8494-2022; zhang, hui/GXH-6098-2022	Zheng, Ming-Hua/0000-0003-4984-2631	National Key Research and Development Project [2018YFA0800404]; Natural Science Foundation [2018B030311031]; Key-Area Research and Development Program of Guangdong Province [2018B030311031]; National Natural Science Foundation of China [81970736, 81974119, 82070588]; Program of Shanghai Academic Research Leader by Shanghai Municipal Science and Technology Committee [21XD1423400]; Distinguished Young Scholars Training Program of Nanfang Hospital	National Key Research and Development Project; Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Key-Area Research and Development Program of Guangdong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Academic Research Leader by Shanghai Municipal Science and Technology Committee; Distinguished Young Scholars Training Program of Nanfang Hospital	This study was supported by the National Key Research and Development Project (No.2018YFA0800404), Natural Science Foundation and Key-Area Research and Development Program of Guangdong Province (No.2018B030311031), National Natural Science Foundation of China (Nos.81970736, 81974119 and 82070588), and the Program of Shanghai Academic Research Leader by Shanghai Municipal Science and Technology Committee (No. 21XD1423400). Dr Huijie Zhang was partially supported by Distinguished Young Scholars Training Program of Nanfang Hospital.	Ahmadian M, 2010, INT J BIOCHEM CELL B, V42, P555, DOI 10.1016/j.biocel.2009.12.009; Arora GK, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121221; Auernhammer CJ, 2000, ENDOCR REV, V21, P313, DOI 10.1210/er.21.3.313; Beretta E, 2002, PEPTIDES, V23, P975, DOI 10.1016/S0196-9781(02)00021-9; Brandt N, 2015, AM J PHYSIOL-ENDOC M, V309, pE142, DOI 10.1152/ajpendo.00313.2014; Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012; Cai JJ, 2020, CIRC RES, V126, P679, DOI 10.1161/CIRCRESAHA.119.316337; Carobbio S, 2013, DIABETES, V62, P3697, DOI 10.2337/db12-1748; Chen Z, 2019, TRENDS ENDOCRIN MET, V30, P903, DOI 10.1016/j.tem.2019.08.006; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; Fioravante M, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0956-9; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Florholmen G, 2006, DIABETOLOGIA, V49, P724, DOI 10.1007/s00125-006-0150-6; Francque S, 2021, NAT REV GASTRO HEPAT, V18, P24, DOI 10.1038/s41575-020-00366-5; Gallego-Escuredo JM, 2015, INT J OBESITY, V39, P121, DOI 10.1038/ijo.2014.76; Graf U, 2011, GENES-BASEL, V2, P280, DOI 10.3390/genes2010280; Inoue H, 2004, NAT MED, V10, P168, DOI 10.1038/nm980; Jansson JO, 2006, EUR J ENDOCRINOL, V154, P349, DOI 10.1530/eje.1.02082; Kane H, 2019, TRENDS IMMUNOL, V40, P857, DOI 10.1016/j.it.2019.07.006; Khan RS, 2019, HEPATOLOGY, V70, P711, DOI 10.1002/hep.30429; Li HT, 2010, J HEPATOL, V53, P934, DOI 10.1016/j.jhep.2010.05.018; Li XY, 2014, ONCOTARGET, V5, P788, DOI 10.18632/oncotarget.1772; Liu SC, 2013, J CLIN INVEST, V123, P5269, DOI 10.1172/JCI63428; Nicola NA, 2015, CYTOKINE GROWTH F R, V26, P533, DOI 10.1016/j.cytogfr.2015.07.001; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Rosado-Olivieri EA, 2020, CELL METAB, V31, P327, DOI 10.1016/j.cmet.2019.12.009; Rotman Y, 2017, GUT, V66, P180, DOI 10.1136/gutjnl-2016-312431; Shi Y, 2019, NATURE, V569, P131, DOI 10.1038/s41586-019-1130-6; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Wu T, 2021, J EXP MED, V218, DOI 10.1084/jem.20201203; Yki-Jarvinen H, 2021, NAT REV GASTRO HEPAT, V18, P770, DOI 10.1038/s41575-021-00472-y; Younossi Z, 2019, HEPATOLOGY, V69, P2672, DOI 10.1002/hep.30251; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zarei M, 2020, TRENDS PHARMACOL SCI, V41, P199, DOI 10.1016/j.tips.2019.12.005; Zhang C, 2021, PHARMACOL THERAPEUT, V221, DOI 10.1016/j.pharmthera.2020.107754	36	1	1	4	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101946	10.1016/j.jbc.2022.101946	http://dx.doi.org/10.1016/j.jbc.2022.101946			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3R4NR	35447114	Green Published, gold			2022-12-26	WOS:000838892100006
J	Liang, LYY; Takamiya, R; Miki, Y; Heike, K; Taketomi, Y; Sugimoto, N; Yamaguchi, M; Shitara, H; Nishito, Y; Kobayashi, T; Hirabayashi, T; Murakami, M				Liang, Luyiyun; Takamiya, Rina; Miki, Yoshimi; Heike, Kanako; Taketomi, Yoshitaka; Sugimoto, Nao; Yamaguchi, Midori; Shitara, Hiroshi; Nishito, Yasumasa; Kobayashi, Tetsuyuki; Hirabayashi, Tetsuya; Murakami, Makoto			Group IVE cytosolic phospholipase A(2) limits psoriatic inflammation by mobilizing the anti-inflammatory lipid N-acylethanolamine	FASEB JOURNAL			English	Article						keratinocyte; lipidomics; N-acylethanolamine; phospholipase A(2); psoriasis	ONE-STEP GENERATION; BARRIER FUNCTION; CELL PATHWAY; DISEASE; MODEL; PALMITOYLETHANOLAMIDE; GENE; IDENTIFICATION; CPLA(2)DELTA; ACYLCERAMIDE	Psoriasis is an inflammatory disorder characterized by keratinocyte hyper-proliferation and Th17-type immune responses. However, the roles of bioactive lipids and the regulation of their biosynthesis in this chronic skin disease are not fully understood. Herein, we show that group IVE cytosolic phospholipase A(2) (cPLA(2)epsilon/PLA2G4E) plays a counterregulatory role against psoriatic inflammation by producing the anti-inflammatory lipid N-acylethanolamine (NAE). Lipidomics analysis of mouse skin revealed that NAE species and their precursors (N-acyl-phosphatidylethanolamine and glycerophospho-N-acylethanolamine) were robustly increased in parallel with the ongoing process of imiquimod (IMQ)-induced psoriasis, accompanied by a marked upregulation of cPLA(2)epsilon in epidermal keratinocytes. Genetic deletion of cPLA(2)epsilon exacerbated IMQ-induced ear swelling and psoriatic marker expression, with a dramatic reduction of NAE-related lipids in IMQ-treated, and even normal, skin. Stimulation of cultured human keratinocytes with psoriatic cytokines concomitantly increased PLA2G4E expression and NAE production, and supplementation with NAEs significantly attenuated the cytokine-induced upregulation of the psoriatic marker S100A9. Increased expression of cPLA(2)epsilon was also evident in the epidermis of psoriatic patients. These findings reveal for the first time the in vivo role of cPLA(2)epsilon, which is highly induced in the keratinocytes of the psoriatic skin, promotes the biosynthesis of NAE-related lipids, and contributes to limiting psoriatic inflammation.	[Liang, Luyiyun; Takamiya, Rina; Miki, Yoshimi; Taketomi, Yoshitaka; Sugimoto, Nao; Murakami, Makoto] Univ Tokyo, Ctr Dis Biol & Integrat Med, Grad Sch Med, Lab Microenvironm & Metab Hlth Sci, Tokyo, Japan; [Heike, Kanako; Kobayashi, Tetsuyuki] Ochanomizu Univ, Fac Sci, Dept Biol, Tokyo, Japan; [Yamaguchi, Midori; Shitara, Hiroshi; Nishito, Yasumasa] Tokyo Metropolitan Inst Med Sci, Ctr Basic Technol Res, Lab Transgen Technol, Tokyo, Japan; [Hirabayashi, Tetsuya] Tokyo Metropolitan Inst Med Sci, Dept Basic Med Sci, Lab Biomembrane, Tokyo, Japan; [Murakami, Makoto] Japan Agcy Med Res & Dev, AMED, CREST, Tokyo, Japan	University of Tokyo; Ochanomizu University; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST)	Murakami, M (corresponding author), Univ Tokyo, Ctr Dis Biol & Integrat Med, Grad Sch Med, Lab Microenvironm & Metab Hlth Sci,Bunkyo Ku, Tokyo 1138655, Japan.	makmurak@m.u-tokyo.ac.jp		Miki, Yoshimi/0000-0002-8587-0333	Japan Agency for Medical Research and Development (AMED) [18gm0710006, 20gm1210013, 20gm4010005, 20ek0410052, 20gm0910002]; MEXT \ Japan Society for the Promotion of Science (JSPS) [JP15H05905, JP16H02613, JP20H04939, JP20H05691, JP19K08597, JP19K07042, JP18K06624, JP21K08315]; Hoyu Science Foundation	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hoyu Science Foundation	Japan Agency for Medical Research and Development (AMED), Grant/Award Number: 18gm0710006, 20gm1210013, 20gm4010005, 20ek0410052 and 20gm0910002; MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP15H05905, JP16H02613, JP20H04939, JP20H05691, JP19K08597, JP19K07042, JP18K06624 and JP21K08315; Hoyu Science Foundation	Asai K, 2003, J BIOL CHEM, V278, P8809, DOI 10.1074/jbc.M212117200; Azfar RS, 2008, CURR OPIN RHEUMATOL, V20, P416, DOI 10.1097/BOR.0b013e3283031c99; Bandyopadhyay M, 2020, IMMUNITY, V53, P16, DOI 10.1016/j.immuni.2020.06.015; Biro T, 2009, TRENDS PHARMACOL SCI, V30, P411, DOI 10.1016/j.tips.2009.05.004; Blauvelt A, 2018, CLIN REV ALLERG IMMU, V55, P379, DOI 10.1007/s12016-018-8702-3; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Botelho SC, 2011, EMBO J, V30, P1003, DOI 10.1038/emboj.2011.29; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Chiba H, 2004, J BIOL CHEM, V279, P12890, DOI 10.1074/jbc.M305801200; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; Everard A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08051-7; Gaire BP, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9081753; Garg P, 2010, NEUROSCIENCE, V166, P252, DOI 10.1016/j.neuroscience.2009.11.069; Ghafouri N, 2013, PAIN, V154, P1649, DOI 10.1016/j.pain.2013.05.002; Ghomashchi F, 2010, J BIOL CHEM, V285, P36100, DOI 10.1074/jbc.M110.165647; Greenberg R, 2021, J AM ACAD DERMATOL, V84, P639, DOI 10.1016/j.jaad.2020.03.112; Gruber F, 2019, FREE RADICAL BIO MED, V144, P256, DOI 10.1016/j.freeradbiomed.2019.04.019; Guo YM, 2021, MOLECULES, V26, DOI 10.3390/molecules26175213; Herbert D, 2018, J INVEST DERMATOL, V138, P1999, DOI 10.1016/j.jid.2018.03.1522; Hirabayashi T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14609; Honda T, 2019, INT IMMUNOL, V31, P589, DOI 10.1093/intimm/dxy087; Hussain Z, 2017, BBA-MOL CELL BIOL L, V1862, P1546, DOI 10.1016/j.bbalip.2017.08.006; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; IMOKAWA G, 1994, J CLIN INVEST, V94, P89, DOI 10.1172/JCI117352; Inoue M, 2017, J BIOCHEM, V162, P449, DOI 10.1093/jb/mvx054; Kang H, 2017, BRIT J DERMATOL, V176, P713, DOI 10.1111/bjd.15008; Kemeny L, 2007, SKIN PHARMACOL PHYS, V20, P155, DOI 10.1159/000098702; Kendall AC, 2016, BRIT J DERMATOL, V175, P163, DOI 10.1111/bjd.14521; Kiezel-Tsugunova M, 2018, BIOCHEM SOC T, V46, P119, DOI 10.1042/BST20160469; Kim HJ, 2015, INT J DERMATOL, V54, pE401, DOI 10.1111/ijd.12841; Kondo N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6338; Laleh P, 2019, J CELL PHYSIOL, V234, P7893, DOI 10.1002/jcp.27913; Lebrero P, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080799; Lee HC, 2015, BIOCHEMISTRY-US, V54, P2539, DOI 10.1021/acs.biochem.5b00207; Lessard JC, 2013, P NATL ACAD SCI USA, V110, P19537, DOI 10.1073/pnas.1309576110; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; McGinley AM, 2020, IMMUNITY, V52, P342, DOI 10.1016/j.immuni.2020.01.002; Miki Y, 2016, J BIOL CHEM, V291, P15588, DOI 10.1074/jbc.M116.734624; Miki Y, 2013, J EXP MED, V210, P1217, DOI 10.1084/jem.20121887; Murakami M, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10101457; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Mustafiz SSB, 2019, BBA-MOL CELL BIOL L, V1864, DOI 10.1016/j.bbalip.2019.158515; Ogura Y, 2016, NAT CHEM BIOL, V12, P669, DOI 10.1038/nchembio.2127; Ohto T, 2005, J BIOL CHEM, V280, P24576, DOI 10.1074/jbc.M413711200; Omland SH, 2017, J EUR ACAD DERMATOL, V31, P1161, DOI 10.1111/jdv.14128; Park KD, 2021, INT IMMUNOPHARMACOL, V98, DOI 10.1016/j.intimp.2021.107883; Patel DD, 2015, IMMUNITY, V43, P1040, DOI 10.1016/j.immuni.2015.12.003; Perez-Gonzalez M, 2020, PROG NEUROBIOL, V191, DOI 10.1016/j.pneurobio.2020.101818; Pohla L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59996-z; Prinz I, 2020, J EXP MED, V217, DOI 10.1084/jem.20191397; Rastelli M, 2020, AM J PHYSIOL-ENDOC M, V319, pE647, DOI 10.1152/ajpendo.00146.2020; Saito-Sasaki N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23623-9; Sasso O, 2018, J INVEST DERMATOL, V138, P562, DOI 10.1016/j.jid.2017.07.853; Sawada Y, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.623052; Sawada Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30373-1; Schlosburg JE, 2009, J PHARMACOL EXP THER, V329, P314, DOI 10.1124/jpet.108.150136; Schonthaler HB, 2013, IMMUNITY, V39, P1171, DOI 10.1016/j.immuni.2013.11.011; Shao S, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.151911; Singh TP, 2011, AM J PATHOL, V178, P699, DOI 10.1016/j.ajpath.2010.10.008; Sorokin AV, 2018, J CLIN LIPIDOL, V12, P1047, DOI 10.1016/j.jacl.2018.03.091; Sumida H, 2014, J IMMUNOL, V192, P4361, DOI 10.4049/jimmunol.1302959; Sumitomo A, 2019, J INVEST DERMATOL, V139, P1010, DOI 10.1016/j.jid.2018.10.034; Swindell WR, 2016, J INVEST DERMATOL, V136, P1820, DOI 10.1016/j.jid.2016.04.035; Takeichi T, 2020, J CLIN INVEST, V130, P890, DOI 10.1172/JCI130675; Trinchese G, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00032; Tronino D, 2016, COLLOID SURFACE B, V141, P311, DOI 10.1016/j.colsurfb.2016.01.058; Tronino D, 2015, MOL PHARMACEUT, V12, P3369, DOI 10.1021/acs.molpharmaceut.5b00397; Tsuboi K, 2021, BBA-MOL CELL BIOL L, V1866, DOI 10.1016/j.bbalip.2021.158972; Tsuboi K, 2011, BBA-MOL CELL BIOL L, V1811, P565, DOI 10.1016/j.bbalip.2011.07.009; Ueda N, 2005, LIFE SCI, V77, P1750, DOI 10.1016/j.lfs.2005.05.018; Ueda N, 2010, PROG LIPID RES, V49, P299, DOI 10.1016/j.plipres.2010.02.003; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Uyama T, 2012, J BIOL CHEM, V287, P2706, DOI 10.1074/jbc.M111.267575; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yamamoto K, 2017, METHOD ENZYMOL, V583, P101, DOI 10.1016/bs.mie.2016.09.007; Yamamoto K, 2015, J EXP MED, V212, P1901, DOI 10.1084/jem.20141904; Yamashita A, 2009, BBA-MOL CELL BIOL L, V1791, P1011, DOI 10.1016/j.bbalip.2009.05.008; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022	80	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22301	10.1096/fj.202101958R	http://dx.doi.org/10.1096/fj.202101958R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	1E1JF	35478358				2022-12-26	WOS:000794251300001
J	Tang, SC; Horter, L; Bosh, K; Kassem, AM; Kahn, EB; Ricaldi, JN; Pao, LZ; Kang, GJ; Singleton, CM; Liu, TB; Thomas, I; Rao, CY				Tang, Shichao; Horter, Libby; Bosh, Karin; Kassem, Ahmed M.; Kahn, Emily B.; Ricaldi, Jessica N.; Pao, Leah Zilversmit; Kang, Gloria J.; Singleton, Christa-Marie; Liu, Tiebin; Thomas, Isabel; Rao, Carol Y.			Change in unemployment by social vulnerability among United States counties with rapid increases in COVID-19 incidence-July 1-October 31, 2020	PLOS ONE			English	Article							DISPARITIES	Objective During the COVID-19 pandemic, the unemployment rate in the United States peaked at 14.8% in April 2020. We examined patterns in unemployment following this peak in counties with rapid increases in COVID-19 incidence. Method We used CDC aggregate county data to identify counties with rapid increases in COVID-19 incidence (rapid riser counties) during July 1-October 31, 2020. We used a linear regression model with fixed effect to calculate the change of unemployment rate difference in these counties, stratified by the county's social vulnerability (an indicator compiled by CDC) in the two months before the rapid riser index month compared to the index month plus one month after the index month. Results Among the 585 (19% of U.S. counties) rapid riser counties identified, the unemployment rate gap between the most and least socially vulnerable counties widened by 0.40 percentage point (p<0.01) after experiencing a rapid rise in COVID-19 incidence. Driving the gap were counties with lower socioeconomic status, with a higher percentage of people in racial and ethnic minority groups, and with limited English proficiency. Conclusion The widened unemployment gap after COVID-19 incidence rapid rise between the most and least socially vulnerable counties suggests that it may take longer for socially and economically disadvantaged communities to recover. Loss of income and benefits due to unemployment could hinder behaviors that prevent spread of COVID-19 (e.g., seeking healthcare) and could impede response efforts including testing and vaccination. Addressing the social needs within these vulnerable communities could help support public health response measures.	[Tang, Shichao; Horter, Libby; Bosh, Karin; Kassem, Ahmed M.; Kahn, Emily B.; Ricaldi, Jessica N.; Pao, Leah Zilversmit; Kang, Gloria J.; Singleton, Christa-Marie; Liu, Tiebin; Thomas, Isabel; Rao, Carol Y.] Ctr Dis Control & Prevent, COVID 19 Response Team, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Tang, SC (corresponding author), Ctr Dis Control & Prevent, COVID 19 Response Team, Atlanta, GA 30333 USA.	stang2@cdc.gov	Tang, Shichao/HDN-4205-2022	Thomas, Isabel/0000-0001-6878-9704; Kang, Gloria/0000-0002-7918-0379; Kassem, Ahmed/0000-0003-4053-7841				Acs G., 2020, URBAN I, P1, DOI [10.20955/es.2020.33, DOI 10.20955/ES.2020.33]; Canilang S., 2020, BOARD GOVERNORS FEDE; Centers for Disease Control and Prevention, COVID DAT TRACK 2021; Centers for Disease Control and Prevention, CDC SOC VULN IND 202; Chen JY, 2007, J COMMUN HEALTH, V32, P5, DOI 10.1007/s10900-006-9031-7; Congressional Research Service, UN RAT COVID 19 PAND; Cornwell B, 2012, INFLUENZA OTHER RESP, V6, P63, DOI 10.1111/j.1750-2659.2011.00270.x; Couch KA, 2020, J PUBLIC ECON, V192, DOI 10.1016/j.jpubeco.2020.104287; Dasgupta S, 2021, ANN EPIDEMIOL, V57, P46, DOI 10.1016/j.annepidem.2021.02.006; Dasgupta S, 2020, MMWR-MORBID MORTAL W, V69, P1535, DOI 10.15585/mmwr.mm6942a3; Department of Labor, UN INS WEEKL CLAIMS; Diamond LC, 2020, PATIENT EDUC COUNS, V103, P1451, DOI 10.1016/j.pec.2020.05.028; Driscoll Anne K, 2012, NCHS Data Brief, P1; Flanagan BE, 2011, J HOMEL SECUR EMERG, V8, DOI 10.2202/1547-7355.1792; Gold JAW, 2020, MMWR-MORBID MORTAL W, V69, P1517, DOI 10.15585/mmwr.mm6942e1; Hughes MM, 2021, MMWR-MORBID MORTAL W, V70, P431, DOI 10.15585/mmwr.mm7012e1; Killerby ME, 2020, MMWR-MORBID MORTAL W, V69, P790, DOI 10.15585/mmwr.mm6925e1; Moore JT, 2020, MMWR-MORBID MORTAL W, V69, P1122, DOI 10.15585/mmwr.mm6933e1; Niles MT, 2020, NUTRIENTS, V12, DOI 10.3390/nu12072096; Stokes EK, 2020, MMWR-MORBID MORTAL W, V69, P759, DOI 10.15585/mmwr.mm6924e2; U.S. Bureau of Labor Statistics,, LAB FORC DAT COUNT N; U.S. Bureau of Labor Statistics, LOC AR UN STAT 2020; United States Bureau of Labor Statistics CPS, 2019, LAB FORC CHAR RAC ET; Velasquez D, 2020, EQUITABLE ACCESS HLT, DOI [10.1377/hblog20200331.77927/full/?utm_campaign=HASU+4-5-20&utm_medium=email&utm_content=COVID-19%3A+Federal+Reinsurance%2C+Untested+Treatments%2C+Ensuring+Vaccine+Affordability%3B+Advanced+Primary+Care%3B+What+, DOI 10.1377/HBLOG20200331.77927/FULL/?UTM_CAMPAIGN=HASU+4-5-20&UTM_MEDIUM=EMAIL&UTM_CONTENT=COVID-19%3A+FEDERAL+REINSURANCE%2C+UNTESTED+TREATMENTS%2C+ENSURING+VACCINE+AFFORDABILITY%3B+ADVANCED+PRIMARY+CARE%3B+WHAT+]; Woolhandler S, 2020, ANN INTERN MED, V173, P63, DOI 10.7326/M20-1491	25	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0265888	10.1371/journal.pone.0265888	http://dx.doi.org/10.1371/journal.pone.0265888			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35442951	Green Published, gold			2022-12-26	WOS:000822608900013
J	Tan, Z; Shi, S; Xu, J; Liu, XM; Lei, YB; Zhang, B; Hua, J; Meng, QC; Wang, W; Yu, XJ; Liang, C				Tan, Zhen; Shi, Si; Xu, Jin; Liu, Xiaomeng; Lei, Yubin; Zhang, Bo; Hua, Jie; Meng, Qingcai; Wang, Wei; Yu, Xianjun; Liang, Chen			RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m(6)A-YTHDF2-dependent manner	ONCOGENE			English	Article							GROWTH-FACTOR-C; OBESITY	RNA N6-methyladenosine (m(6)A) is an emerging regulator of mRNA modifications and represents a novel player in tumorigenesis. Although it has functional significance in both pathological and physiological processes, the role of m(6)A modification in pancreatic ductal cancer (PDAC) remains elusive. Here, we showed that high fat mass and obesity-associated gene (FTO) expression was associated with a poor prognosis in PDAC patients and that suppression of FTO expression inhibited cell proliferation. Here, m(6)A sequencing (m(6)A-seq) was performed to screen genes targeted by FTO. The effects of FTO stimulation on the biological characteristics of pancreatic cancer cells, including proliferation and colony formation, were investigated in vitro and in vivo. The results indicate that FTO directly targets platelet-derived growth factor C (PDGFC) and stabilizes its mRNA expression in an m(6)A-YTHDF2-dependent manner. m(6)A-methylated RNA immunoprecipitation-qPCR (MeRIP-qPCR), RNA immunoprecipitation (RIP), and luciferase reporter assays were employed to validate the specific binding of FTO to PDGFC. PDGFC upregulation led to reactivation of the Akt signaling pathway, promoting cell growth. Overall, our study reveals that FTO downregulation leads to increased m(6)A modifications in the 3MODIFIER LETTER PRIME UTR of PDGFC and then modulates the degradation of its transcriptional level in an m(6)A-YTHDF2-dependent manner, highlighting a potential therapeutic target for PDAC treatment and prognostic prediction.	[Tan, Zhen; Shi, Si; Xu, Jin; Liu, Xiaomeng; Lei, Yubin; Zhang, Bo; Hua, Jie; Meng, Qingcai; Wang, Wei; Yu, Xianjun; Liang, Chen] Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, Shanghai 200032, Peoples R China; [Tan, Zhen; Shi, Si; Xu, Jin; Liu, Xiaomeng; Lei, Yubin; Zhang, Bo; Hua, Jie; Meng, Qingcai; Wang, Wei; Yu, Xianjun; Liang, Chen] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China; [Tan, Zhen; Shi, Si; Xu, Jin; Liu, Xiaomeng; Lei, Yubin; Zhang, Bo; Hua, Jie; Meng, Qingcai; Wang, Wei; Yu, Xianjun; Liang, Chen] Shanghai Pancreat Canc Inst, Shanghai 200032, Peoples R China; [Tan, Zhen; Shi, Si; Xu, Jin; Liu, Xiaomeng; Lei, Yubin; Zhang, Bo; Hua, Jie; Meng, Qingcai; Wang, Wei; Yu, Xianjun; Liang, Chen] Fudan Univ, Pancreat Canc Inst, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Fudan University	Wang, W; Yu, XJ; Liang, C (corresponding author), Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, Shanghai 200032, Peoples R China.; Wang, W; Yu, XJ; Liang, C (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China.; Wang, W; Yu, XJ; Liang, C (corresponding author), Shanghai Pancreat Canc Inst, Shanghai 200032, Peoples R China.; Wang, W; Yu, XJ; Liang, C (corresponding author), Fudan Univ, Pancreat Canc Inst, Shanghai 200032, Peoples R China.	wangwei@fudanpci.org; yuxianjun@fudanpci.org; liangchen@fudanpci.org			National Natural Science Foundation of China [81802352, 81902428, 82002541, U21A20374]; Shanghai Municipal Science and Technology Major Project [21JC1401500]; Scientific Innovation Project of Shanghai Education Committee [2019-01-07-00-07-E00057]; Clinical Research Plan of Shanghai Hospital Development Center [SHDC2020CR1006A]; Shanghai Sailing Program [19YF1409400]; Xuhui District Artificial Intelligence Medical Hospital Cooperation Project [2021-011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology Major Project; Scientific Innovation Project of Shanghai Education Committee; Clinical Research Plan of Shanghai Hospital Development Center; Shanghai Sailing Program; Xuhui District Artificial Intelligence Medical Hospital Cooperation Project	This study was jointly funded by the National Natural Science Foundation of China (No. 81802352, 81902428, 82002541 and U21A20374), Shanghai Municipal Science and Technology Major Project (21JC1401500), Scientific Innovation Project of Shanghai Education Committee (2019-01-07-00-07-E00057), Clinical Research Plan of Shanghai Hospital Development Center (SHDC2020CR1006A), and Xuhui District Artificial Intelligence Medical Hospital Cooperation Project (2021-011), the Shanghai Sailing Program (No. 19YF1409400).	Anderson AC, 2011, DRUG DISCOV TODAY, V16, P755, DOI 10.1016/j.drudis.2011.07.001; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Cao YH, 2013, TRENDS MOL MED, V19, P460, DOI 10.1016/j.molmed.2013.05.002; Chen JL, 2019, J CANCER RES CLIN, V145, P19, DOI 10.1007/s00432-018-2796-0; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Christenson ES, 2020, LANCET ONCOL, V21, pE135, DOI 10.1016/S1470-2045(19)30795-8; Cui Q, 2017, CELL REP, V18, P2622, DOI 10.1016/j.celrep.2017.02.059; Deng XL, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00396; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Grossberg AJ, 2020, CA-CANCER J CLIN, V70, P375, DOI 10.3322/caac.21626; He CA, 2010, NAT CHEM BIOL, V6, P863, DOI 10.1038/nchembio.482; He LE, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1109-9; Hirayama M, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.028; Huang XY, 2017, EUR J CANCER CARE, V26, DOI 10.1111/ecc.12464; Huang Y, 2019, CANCER CELL, V35, P677, DOI 10.1016/j.ccell.2019.03.006; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kramer F, 2020, HAEMATOLOGICA, V105, P2083, DOI 10.3324/haematol.2019.226332; Lei H, 2008, EXP EYE RES, V86, P711, DOI 10.1016/j.exer.2007.08.007; Li Q, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-020-00453-8; Li Zejuan, 2017, Cancer Cell, V31, P127, DOI 10.1016/j.ccell.2016.11.017; Liang C, 2020, GUT, V69, P888, DOI 10.1136/gutjnl-2018-317163; Liu J, 2018, NAT CELL BIOL, V20, P1074, DOI 10.1038/s41556-018-0174-4; Liu T, 2020, J CELL PHYSIOL, V235, P548, DOI 10.1002/jcp.28994; Lurie G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016756; Mizrahi JD, 2020, LANCET, V395, P2008, DOI 10.1016/S0140-6736(20)30974-0; Niu Y, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1004-4; Pietras K, 2002, CANCER RES, V62, P5476; Reigstad LJ, 2003, J BIOL CHEM, V278, P17114, DOI 10.1074/jbc.M301728200; Salgado-Montilla Jeannette L, 2017, Arch Cancer Res, V5, DOI 10.21767/2254-6081.1000148; Shi HL, 2019, MOL CELL, V74, P640, DOI 10.1016/j.molcel.2019.04.025; Son D, 2014, J BIOL CHEM, V289, P6225, DOI 10.1074/jbc.M113.508994; Su R, 2018, CELL, V172, P90, DOI 10.1016/j.cell.2017.11.031; Tang XD, 2019, ONCOL LETT, V17, P2473, DOI 10.3892/ol.2018.9873; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vu LP, 2017, NAT MED, V23, P1369, DOI 10.1038/nm.4416; Wang TY, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01204-7; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Yang S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10669-0; Zaccara S, 2019, NAT REV MOL CELL BIO, V20, P608, DOI 10.1038/s41580-019-0168-5; Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zhou ZJ, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01216-3	44	5	5	4	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 13	2022	41	20					2860	2872		10.1038/s41388-022-02306-w	http://dx.doi.org/10.1038/s41388-022-02306-w		APR 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	1F4TJ	35422475	Green Published, hybrid			2022-12-26	WOS:000782543300001
J	Aoyagi, M; Oshima, M; Oishi, M; Kita, S; Fujita, K; Imai, H; Oishi, S; Ohmori, H; Ono, T				Aoyagi, Misaki; Oshima, Marie; Oishi, Masamichi; Kita, Soma; Fujita, Koichi; Imai, Haruki; Oishi, Shuji; Ohmori, Hiroko; Ono, Takashi			Computational fluid dynamic analysis of the nasal respiratory function before and after postero-superior repositioning of the maxilla	PLOS ONE			English	Article							PHARYNGEAL AIRWAY SPACE; MANDIBULAR SETBACK SURGERY; LE-FORT-I; ORTHOGNATHIC SURGERY; SLEEP-APNEA; CONDYLAR RESORPTION; MORPHOLOGY; SEVERITY; FLOW; OSTEOTOMY	Morphological changes in the upper airway and the resulting alteration in the nasal respiratory function after jawbone repositioning during orthognathic surgery have garnered attention recently. In particular, nasopharyngeal stenosis, because of the complex influence of both jaws, the effects of which have not yet been clarified owing to postero-superior repositioning of the maxilla, may significantly impact sleep and respiratory function, necessitating further functional evaluation. This study aimed to perform a functional evaluation of the effects of surgery involving maxillary repositioning, which may result in a larger airway resistance if the stenosis worsens the respiratory function, using CFD for treatment planning. A model was developed from CT images obtained preoperatively (PRE) and postoperatively (POST) in females (n = 3) who underwent maxillary postero-superior repositioning using Mimics and ICEM CFD. Simultaneously, a model of stenosis (STENOSIS) was developed by adjusting the severity of stenosis around the PNS to simulate greater repositioning than that in the POST. Inhalation at rest and atmospheric pressure were simulated in each model using Fluent, whereas pressure drop (Delta P) was evaluated using CFD Post. In this study, Delta P was proportional to airway resistance because the flow rate was constant. Therefore, the magnitude of Delta P was evaluated as the level of airway resistance. The Delta P in the airway was lower in the POST compared to the PRE, indicating that the analysis of the effects of repositioning on nasal ventilation showed that current surgery is appropriate with respect to functionality, as it does not compromise respiratory function. The rate of change in the cross-sectional area of the mass extending pharynx (alpha) was calculated as the ratio of each neighboring section. The closer the alpha-value is to 1, the smaller the Delta P, so ideally the airway should be constant. This study identified airway shapes that are favorable from the perspective of fluid dynamics.	[Aoyagi, Misaki; Kita, Soma; Fujita, Koichi; Imai, Haruki; Oishi, Shuji; Ohmori, Hiroko; Ono, Takashi] Tokyo Med & Dent Univ TMDU, Dept Orthodont Sci, Grad Sch Med & Dent Sci, Tokyo, Japan; [Oshima, Marie; Oishi, Masamichi] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Fujita, Koichi; Imai, Haruki] Yokohama City Univ Med Ctr, Dept Oral & Maxillofacial Surg, Yokohama, Kanagawa, Japan	Tokyo Medical & Dental University (TMDU); University of Tokyo; Yokohama City University	Oshima, M (corresponding author), Univ Tokyo, Inst Ind Sci, Tokyo, Japan.	marie@iis.u-tokyo.ac.jp		Aoyagi, Misaki/0000-0002-8404-6270	Japan Society for the Promotion of Science (JSPS) [19K19261, 19K21364]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Names of the authors who received each award: Soma Kita, Shuji Oishi circle Grant numbers awarded to each author: 19K19261, 19K21364 circle The full name of each funder: Japan Society for the Promotion of Science (JSPS) circle URL of funder website: https://www.jsps.go.jp/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydemir H, 2012, ANGLE ORTHOD, V82, P993, DOI 10.2319/091911-597.1; Battagel JM, 1996, EUR J ORTHODONT, V18, P557; Chen FS, 2007, AM J ORTHOD DENTOFAC, V131, P372, DOI 10.1016/j.ajodo.2005.06.028; Cui XG, 2011, J BIOMECH, V44, P2768, DOI 10.1016/j.jbiomech.2011.08.019; Cutbirth M, 1998, J ORAL MAXIL SURG, V56, P178, DOI 10.1016/S0278-2391(98)90863-1; De Clercq C A, 1994, Int J Adult Orthodon Orthognath Surg, V9, P233; Engboonmeskul Thanyaphat, 2020, J Oral Biol Craniofac Res, V10, P597, DOI 10.1016/j.jobcr.2020.08.008; Haarmann S, 2009, INT J ORAL MAX SURG, V38, P321, DOI 10.1016/j.ijom.2009.01.006; HAHN I, 1993, J APPL PHYSIOL, V75, P2273, DOI 10.1152/jappl.1993.75.5.2273; Harada K, 2002, EUR J ORTHODONT, V24, P471, DOI 10.1093/ejo/24.5.471; HILBERG O, 1989, J APPL PHYSIOL, V66, P295, DOI 10.1152/jappl.1989.66.1.295; Hong JS, 2011, J ORAL MAXIL SURG, V69, pE401, DOI 10.1016/j.joms.2011.02.011; Hoppenreijs TJM, 1999, INT J ORAL MAX SURG, V28, P411, DOI 10.1034/j.1399-0020.1999.280602.x; Hsieh YJ, 2015, PLAST RECONSTR SURG, V135, p361E, DOI 10.1097/PRS.0000000000000913; Ishiguro K, 2009, ORAL SURG ORAL MED O, V107, P343, DOI 10.1016/j.tripleo.2008.08.021; KARABOUTA I, 1985, J MAXILLOFAC SURG, V13, P185, DOI 10.1016/S0301-0503(85)80045-X; Kita S, 2020, BRIT J ORAL MAX SURG, V58, P57, DOI 10.1016/j.bjoms.2019.10.309; Kita S, 2016, J ORAL MAXIL SURG, V74, P2241, DOI 10.1016/j.joms.2016.06.171; Kleinstreuer C, 2010, ANNU REV FLUID MECH, V42, P301, DOI 10.1146/annurev-fluid-121108-145453; Lan ZJ, 2006, AURIS NASUS LARYNX, V33, P433, DOI 10.1016/j.anl.2006.03.009; Landes CA, 2008, J ORAL MAXIL SURG, V66, P657, DOI 10.1016/j.joms.2007.06.633; Launder B. E., 1974, Letters in Heat and Mass Transfer, V1, P131, DOI 10.1016/0094-4548(74)90150-7; Lee JH, 2010, RESP PHYSIOL NEUROBI, V172, P136, DOI 10.1016/j.resp.2010.05.010; McLean HA, 2005, EUR RESPIR J, V25, P521, DOI 10.1183/09031936.05.00045004; Mehra P, 2001, AM J ORTHOD DENTOFAC, V120, P154, DOI 10.1067/mod.2001.114647; Mirmohamadsadeghi H, 2020, BRIT J ORAL MAX SURG, V58, P807, DOI 10.1016/j.bjoms.2020.04.020; Omura S, 2015, J CRANIOFAC SURG, V26, P1613, DOI 10.1097/SCS.0000000000001787; Park JW, 2010, AM J ORTHOD DENTOFAC, V138, P292, DOI 10.1016/j.ajodo.2009.10.036; Song BL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219642; Tselnik M, 2000, J ORAL MAXIL SURG, V58, P282, DOI 10.1016/S0278-2391(00)90053-3; Tseng YC, 2021, J DENT SCI, V16, P51, DOI 10.1016/j.jds.2020.07.015; TURVEY TA, 1984, AM J ORTHOD DENTOFAC, V85, P109, DOI 10.1016/0002-9416(84)90002-2; Vos WG, 2010, CURR OPIN ALLERGY CL, V10, P26, DOI 10.1097/ACI.0b013e328334f659; Watanabe T, 2002, AM J RESP CRIT CARE, V165, P260, DOI 10.1164/ajrccm.165.2.2009032; White DP, 2012, COMPR PHYSIOL, V2, P2541, DOI 10.1002/cphy.c110064; Woodson BT, 2015, LARYNGOSCOPE, V125, P1233, DOI 10.1002/lary.24972; Xu C, 2006, J BIOMECH, V39, P2043, DOI 10.1016/j.jbiomech.2005.06.021; Yajima Y, 2017, INT J ORAL MAX SURG, V46, P839, DOI 10.1016/j.ijom.2017.03.028; Yu CC, 2012, J CRANIOFAC SURG, V23, P401, DOI 10.1097/SCS.0b013e318240feed	39	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267677	10.1371/journal.pone.0267677	http://dx.doi.org/10.1371/journal.pone.0267677			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D8GY	35482658	Green Published, gold			2022-12-26	WOS:000794035700075
J	Barden, LEB; Gaschen, L; Hampton, CDC; Takawira, C; Liu, CC; Nourbakhsh, A; Lopez, MJ				Barden, Lelia E. B.; Gaschen, Lorrie; Hampton, Chiara De Caro Carella; Takawira, Catherine; Liu, Chin-Chi; Nourbakhsh, Ali; Lopez, Mandi J.			Computed tomography myelography technique and spinal morphometry in healthy Yucatan pigs	PLOS ONE			English	Article							GRADED COMPRESSION; CAUDA-EQUINA; MODELS; CORD	Porcine models of spinal cord injury (SCI) have an irreplaceable role in the development of experimental therapies. There is little literature regarding CT myelogram (CTM) techniques in swine and morphometry in miniature swine has not been established. A CT-guided method for performing myelography as well as reference values for spinal morphometry in healthy Yucatan miniature swine is lacking. The goal of this study is to describe a CT-guided method of performing CTM in a porcine model of SCI and to establish spinal morphometric reference values in mature Yucatan pigs. Six healthy, Yucatan sows, 9 months of age, weighing between 39-57.7kg, with no history of spinal disease, spinal injury, or neurologic deficits on physical exam were used in this study. CT myelography was performed in each sow under general anesthesia. CT scout images were used to guide needle placement at the L3-L4 intervertebral site. Once correct needle placement was confirmed using a 1ml test injection, a full dose of iodinated contrast (0.3ml/kg) was injected slowly over a 2-minute time period. Morphometry was performed using area measurements of the spinal cord (SC), vertebral body (VB), dural sac (DS), and vertebral canal (VC) at the mid-body and the intervertebral disc space of each spinal segment. Of the quantitative measurements, the spinal cord surface area had the widest range of values and the greatest coefficient of variance (CV) while those parameters for the vertebral canal had a low CV. Of the morphometric ratios, the DS:VC, had the lowest CV while the spinal cord ratios to DS and VC had the highest (>30). The vertebral canal surface area and the dural space: vertebral canal ratio may serve as reference values in future studies using this animal model.	[Barden, Lelia E. B.; Gaschen, Lorrie; Hampton, Chiara De Caro Carella; Takawira, Catherine; Liu, Chin-Chi; Lopez, Mandi J.] LSU Sch Vet Med, Dept Vet Clin Sci, Baton Rouge, LA 70803 USA; [Nourbakhsh, Ali] WellStar Atlanta Med Ctr, Atlanta, GA USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; WellStar Atlanta Medical Center	Gaschen, L (corresponding author), LSU Sch Vet Med, Dept Vet Clin Sci, Baton Rouge, LA 70803 USA.	lgaschen@lsu.edu	Hampton, Chiara/GZM-1336-2022	Hampton, Chiara/0000-0002-8344-8569; Liu, Chin-Chi/0000-0003-0723-8313	WellStar Atlanta Medical Center, Atlanta, GA, USA	WellStar Atlanta Medical Center, Atlanta, GA, USA	ML WellStar Atlanta Medical Center, Atlanta, GA, USA https://www.wellstar.org/ locations/hospital/atlanta-medical-center The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi Mihyun, 2010, [Korean J. of Veterinary Research, 대한수의학회지], V50, P37; de Freitas RMC, 2015, SPINE J, V15, P992, DOI 10.1016/j.spinee.2015.01.017; Cuellar CA, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00082; Dennison SE., 2010, EVALUATION DIFFERENT, V51, P254; Dyce KM SW., 2010, TXB VET ANATOMY, V4th. ed, P762; JONES JC, 1995, AM J VET RES, V56, P1125; Jones Jeryl C, 2005, J Vet Sci, V6, P341; Mazensky D, 2017, ANAT REC, V300, P2091, DOI 10.1002/ar.23694; Newcomb B, 2012, VET SURG, V41, P207, DOI 10.1111/j.1532-950X.2011.00911.x; OLMARKER K, 1989, SPINE, V14, P569, DOI 10.1097/00007632-198906000-00003; OLMARKER K, 1991, SPINE, V16, P61, DOI 10.1097/00007632-199101000-00012; Pleticha J, 2013, J NEUROSCI METH, V216, P10, DOI 10.1016/j.jneumeth.2013.03.006; Ricciardi M, 2018, OPEN VET J, V8, P265, DOI 10.4314/ovj.v8i3.6; Schomberg DT, 2017, J NEUROTRAUM, V34, P541, DOI 10.1089/neu.2016.4567; Swindle M. M., 1994, ILAR News, V36, P1; Wilson S, 2020, J INVEST SURG, V33, P240, DOI 10.1080/08941939.2018.1492048; Wright J A, 1984, In Pract, V6, P25	17	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266396	10.1371/journal.pone.0266396	http://dx.doi.org/10.1371/journal.pone.0266396			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D8GY	35482719	Green Published, gold			2022-12-26	WOS:000794035700104
J	Duttmann, C; Flores, B; Sheleby-Elias, J; Castillo, G; Rodriguez, D; Maggi, M; Demedio, J				Duttmann, Christiane; Flores, Byron; Sheleby-Elias, Jessica; Castillo, Gladys; Rodriguez, Daymara; Maggi, Matias; Demedio, Jorge			Africanized honeybee population (Apis mellifera L.) in Nicaragua: Forewing length and mitotype lineages	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; EVOLUTIONARY HISTORY; GENETIC-STRUCTURE; LARGE-SCALE; BEE; IDENTIFICATION; HYBRIDIZATION; INSIGHTS; GENOME	Various subspecies of Apis mellifera L. were introduced to Central America since colonization 500 years ago. Hybridization increased with the entrance of the Africanized bee in Nicaragua in 1984. Rustic beekeeping activities and numerous feral swarms define the genetic pattern, reflected in phenotypic heterogeneity and remarkable differences in the behaviour of the bee colonies, especially the nest defence. Due to these facts, the question emerge about the degree of Africanization of honeybee colonies in Nicaragua. In this study, we identified Africanized honeybee colonies based on the single character "mean forewing length" and we corroborated our results by determining mitotypes using mtDNA analysis. Morphometric and genetic approaches were realized in three different geographical zones of Nicaragua and related to beehive characteristics and management. Worker bee samples were taken from the inside of 146 hives from 26 apiaries. Abdominal colour as phenotypic character was the first examination, followed by measurement of 1460 right forewings to determine corresponding probability of Africanization. More than 60% of the beehives showed phenotypic heterogeneity and mean forewing length of 8.74 mm (SD 0.16 mm) indicated a high degree of Africanization. Those results provided a selection of 96 worker bees to perform PCR of two worker bees per hive. For mitochondrial DNA analysis 14 samples from sentinel apiaries were added. Three from 61 beehives presented bees with different mtDNA. Throughout, three mitotypes of the African (A) lineage were detected; one mitotype is still unidentified. Mitotype A1 A. mellifera iberiensis was represented by 88 bees and mitotype A4 A. mellifera scutellata by 21 bees. Phylogenetic analysis confirmed the PCR findings. No associations were found between mitotypes, forewing length, beehive characteristics and management. A high degree of Africanization in A. mellifera colonies represented by two predominating mitotypes from the A lineage, prevail in Neotropical Nicaragua, with mitotype A4 predominating at higher altitudes.	[Duttmann, Christiane; Flores, Byron; Sheleby-Elias, Jessica; Castillo, Gladys] Univ Nacl Autonoma Nicaragua Leon, Escuela Ciencias Agr & Vet, Ctr Vet Diagnost & Invest CEVEDI, Leon, Nicaragua; [Rodriguez, Daymara; Demedio, Jorge] Univ Agr La Habana, Fac Med Vet, Havana, Cuba; [Maggi, Matias] UNMdP, CONICET, Inst Invest Produce & Sanidad & Ambiente IIPROSAM, Mar Del Plata, Argentina; [Maggi, Matias] UNMdP, Fac Ciencias Exactas & Nat, Mar Del Plata, Argentina; [Maggi, Matias] Consejo Nacl Invest Cient & Tecn, Ctr Cient Tecnol Mar del Plata, Mar Del Plata, Argentina; [Maggi, Matias] Ctr Assoc Simple CIC PBA, Mar Del Plata, Argentina; [Maggi, Matias] Univ Nacl Mar del Plata, Ctr Invest Abejas Sociales, Fac Ciencias Exactas & Nat, Mar Del Plata, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Mar del Plata; National University of Mar del Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Mar del Plata	Flores, B (corresponding author), Univ Nacl Autonoma Nicaragua Leon, Escuela Ciencias Agr & Vet, Ctr Vet Diagnost & Invest CEVEDI, Leon, Nicaragua.	byronfloressomarriba@gmail.com	Flores, Byron/AAD-5434-2020; Sheleby-Elias, Jessica/GLV-4129-2022	Flores, Byron/0000-0002-1932-3227; Sheleby-Elias, Jessica/0000-0001-7370-5763; Duttmann, Christiane/0000-0001-8214-5059; Rodriguez Alfonso, Daymara/0000-0002-2089-5281				Amakpe F, 2018, J APIC SCI, V62, P47, DOI [10.2478/JAS-2018-0006, 10.2478/jas-2018-0006]; Bustos M., 1992, ARCH ZOOTEC, V41, P563; Chavez-Galarza J, 2017, APIDOLOGIE, V48, P533, DOI 10.1007/s13592-017-0498-2; Clarke KE, 2002, EVOLUTION, V56, P1462; Collet T, 2006, HEREDITY, V97, P329, DOI 10.1038/sj.hdy.6800875; Cridland JM, 2017, GENOME BIOL EVOL, V9, P457, DOI 10.1093/gbe/evx009; da Silva FL, 2015, COMPUT ELECTRON AGR, V114, P68, DOI 10.1016/j.compag.2015.03.012; DALY HV, 1982, ANN ENTOMOL SOC AM, V75, P591, DOI 10.1093/aesa/75.6.591; Direccin General de Meteorologa, 2020, CLIM NIC; Dominguez-Ayala R, 2016, APIDOLOGIE, V47, P642, DOI 10.1007/s13592-015-0414-6; Duttmann C, 2021, EXP APPL ACAROL, V83, P527, DOI 10.1007/s10493-021-00603-9; Evans JD, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.11; Franck P, 2001, HEREDITY, V86, P420, DOI 10.1046/j.1365-2540.2001.00842.x; Francoy TM, 2009, GENET MOL RES, V8, P709, DOI 10.4238/vol8-2kerr019; Francoy TM, 2008, APIDOLOGIE, V39, P488, DOI 10.1051/apido:2008028; Galataud J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242053; GARNERY L, 1993, EXPERIENTIA, V49, P1016, DOI 10.1007/BF02125651; Garnery L, 1992, MOL ECOL, V1, P145, DOI 10.1111/j.1365-294X.1992.tb00170.x; Guzman-Novoa E, 2004, APIDOLOGIE, V35, P15, DOI 10.1051/apido:2003061; Guzman-Novoa E, 2020, FRONT ECOL EVOL, V8, DOI 10.3389/fevo.2020.608091; Guzman-Novoa E, 2011, VET MEXICO, V42, P149; HALL HG, 1991, P NATL ACAD SCI USA, V88, P4548, DOI 10.1073/pnas.88.10.4548; Han F, 2012, ECOL EVOL, V2, P1949, DOI 10.1002/ece3.312; Henriques D., 2019, POPULAR TRNALEU COX2; Henriques D, 2020, INSECTS, V11, DOI 10.3390/insects11020089; Ilyasov RA, 2020, SAUDI J BIOL SCI, V27, P3615, DOI 10.1016/j.sjbs.2020.08.001; Kerr W., 1967, S AFR BEE J, V39, P33; Kraus FB, 2007, HEREDITY, V99, P233, DOI 10.1038/sj.hdy.6800988; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Leclercq G, 2018, ENTOMOL FAUN, DOI [10.25518/2030-6318.4050, DOI 10.25518/2030-6318.4050]; Tibata VM, 2018, J APICULT RES, V57, P219, DOI 10.1080/00218839.2017.1409065; Meixner MD, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.05; Agra MN, 2018, ENTOMOL EXP APPL, V166, P724, DOI 10.1111/eea.12719; RINDERER TE, 1993, APIDOLOGIE, V24, P569, DOI 10.1051/apido:19930605; RINDERER TE, 1986, APIDOLOGIE, V17, P33, DOI 10.1051/apido:19860104; Ruttner F., 1988, BIOGEOGRAPHY TAXONOM, DOI [10.1007/978-3-642-72649-1, DOI 10.1007/978-3-642-72649-1]; Schneider SS, 2004, ANNU REV ENTOMOL, V49, P351, DOI 10.1146/annurev.ento.49.061802.123359; Schneider SS, 2003, EVOLUTION, V57, P2350, DOI 10.1111/j.0014-3820.2003.tb00247.x; Schroder S, 2002, NEW KEY BEES AUTOMAT; Segura JAL, 2000, GENET MOL BIOL, V23, P317; Sousa ATO, 2012, REV ENFERM UFPE LINE, P2563; Spivak M., 1981, AFRICAN HONEY BEE, P137; Szalanski AL, 2010, J APICULT RES, V49, P177, DOI 10.3896/IBRA.1.49.2.06; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Techer MA, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0520-8; Tihelka E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71393-0; Wallberg A, 2014, NAT GENET, V46, P1081, DOI 10.1038/ng.3077; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260	48	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267600	10.1371/journal.pone.0267600	http://dx.doi.org/10.1371/journal.pone.0267600			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D9PO	35468163	Green Published, gold			2022-12-26	WOS:000794129600033
J	LaGier, AJ; Elbe, A; Thamke, A; Anderson, P				LaGier, Adriana J.; Elbe, Andrew; Thamke, Amanda; Anderson, Payton			Vibration, a treatment for migraine, linked to calpain driven changes in actin cytoskeleton	PLOS ONE			English	Article							WHOLE-BODY VIBRATION; EPITHELIAL-MESENCHYMAL TRANSITION; KINETIC OSCILLATION STIMULATION; CALCIUM-DEPENDENT PROTEASE; FILOPODIA; BUNDLES; CELLS; MECHANISMS; ATTACHMENT; SPASTICITY	Understanding how a human cell reacts to external physical stimuli is essential to understanding why vibration can elicit localized pain reduction. Stimulation of epithelial cells with external vibration forces has been shown to change cell shape, particularly in regards to structures involved in non-muscle cell motility. We hypothesized that epithelial cells respond to vibration transduction by altering proteins involved in remodeling cytoskeleton. Epithelial cells were exposed to vibration and assessed by microscopy, cytoskeletal staining, immunoblotting and quantitative RT-PCR. Here, we report that epithelial cell lines exposed to 15 minutes of vibration retract filopodia and concentrate actin at the periphery of the cell. In particular, we show an increased expression of the calcium-dependent, cysteine protease, calpain. The discovery that cell transitions are induced by limited exposure to natural forces, such as vibration, provides a foundation to explain how vibrational treatment helps migraine patients.	[LaGier, Adriana J.; Elbe, Andrew; Thamke, Amanda; Anderson, Payton] Grand View Univ, Coll Social & Nat Sci, Dept Biol, Des Moines, IA 50316 USA		LaGier, AJ (corresponding author), Grand View Univ, Coll Social & Nat Sci, Dept Biol, Des Moines, IA 50316 USA.	alagier@grandview.edu		LAGIER, ADRIANA/0000-0002-6135-1424				Ahmad M, 2017, ANN DERMATOL RES, V1, P001; Bornschlogl T, 2013, CYTOSKELETON, V70, P590, DOI 10.1002/cm.21130; Breitsprecher D, 2011, J CELL SCI, V124, P3305, DOI 10.1242/jcs.086934; Burns DM, 2004, AM J PHYSIOL-CELL PH, V287, pC457, DOI 10.1152/ajpcell.00274.2003; Cheng HYK, 2015, HUM MOVEMENT SCI, V39, P65, DOI 10.1016/j.humov.2014.11.003; Davis FM, 2014, ONCOGENE, V33, P2307, DOI 10.1038/onc.2013.187; Dove AW, 2003, J CELL BIOL, V160, P285; Ebersbach G, 2008, ARCH PHYS MED REHAB, V89, P399, DOI 10.1016/j.apmr.2007.09.031; Geppetti Pierangelo, 2005, J Headache Pain, V6, P61, DOI 10.1007/s10194-005-0153-6; Heckman CA, 2013, CELL SIGNAL, V25, P2298, DOI 10.1016/j.cellsig.2013.07.006; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Huttenlocher A, 1997, J BIOL CHEM, V272, P32719, DOI 10.1074/jbc.272.52.32719; Ito Y, 2011, BIO-MED MATER ENG, V21, P149, DOI 10.3233/BME-2011-0664; Juto JE, 2015, HEADACHE, V55, P117, DOI 10.1111/head.12485; Khurana S, 2011, CELL ADHES MIGR, V5, P409, DOI 10.4161/cam.5.5.17644; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li TQ, 2016, NEUROIMAGE-CLIN, V12, P451, DOI 10.1016/j.nicl.2016.08.014; MACPHERSON I. A., 1958, JOUR HYGIENE, V56, P29; MAGOS L, 1961, BRIT J IND MED, V18, P157; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; McRobert EA, 2012, FEBS J, V279, P3240, DOI 10.1111/j.1742-4658.2012.08710.x; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Nussenzveig HM, 2018, EUR BIOPHYS J BIOPHY, V47, P499, DOI 10.1007/s00249-017-1268-9; Naoz M, 2008, BIOPHYS J, V95, P5706, DOI 10.1529/biophysj.108.143453; Nemethova M, 2008, J CELL BIOL, V180, P1233, DOI 10.1083/jcb.200709134; Nishitani WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026181; OHNO S, 1984, NATURE, V312, P566, DOI 10.1038/312566a0; Oldenbourg R, 2000, BIOPHYS J, V78, P1176, DOI 10.1016/S0006-3495(00)76675-6; Olsson AR, 2004, OCCUP ENVIRON MED, V61, P233, DOI 10.1136/oem.2003.007971; ONO K, 1989, NATURE, V340, P721, DOI 10.1038/340721a0; Park C, 2017, ANN REHABIL MED-ARM, V41, P273, DOI 10.5535/arm.2017.41.2.273; Partridge MA, 2006, MOL BIOL CELL, V17, P4237, DOI 10.1091/mbc.E06-06-0496; Perl K, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3683-9; Perrin BJ, 2002, INT J BIOCHEM CELL B, V34, P722, DOI 10.1016/S1357-2725(02)00009-2; Pollard TD, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018226; Potter DA, 1998, J CELL BIOL, V141, P647, DOI 10.1083/jcb.141.3.647; Puech PH, 2021, OPEN BIOL, V11, DOI 10.1098/rsob.210256; Romero S, 2012, J CELL SCI, V125, P4999, DOI 10.1242/jcs.104778; Sackmann Erich, 2021, Biophys Rev, V13, P123, DOI 10.1007/s12551-021-00781-1; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Serrano K, 2004, CELL MOTIL CYTOSKEL, V58, P242, DOI 10.1002/cm.20011; SHUBSACHS S, 1950, BRIT MED J, V2, P415, DOI 10.1136/bmj.2.4675.415-c; Small JV, 1998, BBA-MOL CELL RES, V1404, P271, DOI 10.1016/S0167-4889(98)00080-9; Smith Kevin C, 2004, Dermatol Online J, V10, P1; Sun SD, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.758026; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Tan WJ, 2017, AM J TRANSL RES, V9, P1402; Thammanichanon P, 2020, IN VIVO, V34, P2389, DOI 10.21873/invivo.12052; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Vigo L, 2021, J OPHTHALMOL, V2021, DOI 10.1155/2021/1370002; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang Z Q, 2016, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V34, P443, DOI 10.3760/cma.j.issn.1001-9391.2016.06.011	54	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0262058	10.1371/journal.pone.0262058	http://dx.doi.org/10.1371/journal.pone.0262058			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D8GY	35482731	gold, Green Published			2022-12-26	WOS:000794035700025
J	Lovas, M; Tanka-Salamon, A; Beinrohr, L; Voszka, I; Szabo, L; Molnar, K; Kolev, K				Lovas, Miklos; Tanka-Salamon, Anna; Beinrohr, Laszlo; Voszka, Istvan; Szabo, Laszlo; Molnar, Kinga; Kolev, Krasimir			Polyphosphate nanoparticles enhance the fibrin stabilization by histones more efficiently than linear polyphosphates	PLOS ONE			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; DNA; PLASMA; RESISTANCE; STABILITY	IntroductionBeyond the three-dimensional fibrin network, the mechanical and lytic stability of thrombi is supported by the matrix of neutrophil extracellular traps (NETs) composed of polyanionic DNA meshwork with attached proteins including polycationic histones. Polyphosphates represent another type of polyanions, which in their linear form are known to enhance the fibrin stabilizing effects of DNA and histones. However, in vivo polyphosphates are also present in the form of nanoparticles (PolyP-NP), the interference of which with the fibrin/NET matrix is poorly characterized. AimsTo compare the effects of linear and nanoparticulate polyphosphates, and their combinations with relevant NET components (DNA, histone H3) on fibrin formation, structure, and lysis in in vitro assays focusing on histone-polyphosphate interactions. MethodsTransmission electron microscopy and dynamic light scattering for stability of the PolyP-NP preparations. Turbidimetry for kinetics of fibrinogen clotting by thrombin and fibrin dissolution by tissue-type plasminogen activator/plasminogen. Scanning electron microscopy for fibrin structure. Surface plasmon resonance for strength of histone-PolyP interactions. ResultsBoth linear PolyP and PolyP-NP accelerated the fibrin formation and slowed down its dissolution and these effects were strongly dependent on the number of individual PolyP particles and not on their size. Addition of DNA did not modify significantly the PolyP-NP effects on fibrin formation and lysis. Both linear and nanoparticulate PolyP counteracted the effect of histone in the acceleration of fibrinogen clotting by thrombin. PolyP-NP, but not linear PolyP enhanced the prolongation of lysis time in fibrin containing histone and caused more pronounced thickening of the fibrin fibers than the linear form. Finally, PolyP-NP bound weaker to histone than the linear form. ConclusionsThe interaction of PolyP with histone was a stronger modulator of fibrin formation and lysis than its interaction with DNA. In addition, the PolyP nanoparticles enhanced the thrombus stabilizing effects of histone more effectively than linear PolyP.	[Lovas, Miklos; Tanka-Salamon, Anna; Beinrohr, Laszlo; Szabo, Laszlo; Kolev, Krasimir] Semmelwe Univ, Dept Biochem, Budapest, Hungary; [Voszka, Istvan] Semmelwe Univ, Dept Biophys & Radiat Biol, Budapest, Hungary; [Szabo, Laszlo] Hungarian Acad Sci, Inst Mat & Environm Chem, Res Ctr Nat Sci, Dept Funct & Struct Mat, Budapest, Hungary; [Molnar, Kinga] Eotvos Lorand Univ, Dept Anat Cell & Dev Biol, Budapest, Hungary	Semmelweis University; Semmelweis University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Eotvos Lorand University	Kolev, K (corresponding author), Semmelwe Univ, Dept Biochem, Budapest, Hungary.	Krasimir.Kolev@eok.sote.hu	Kolev, Krasimir/J-7648-2019	Kolev, Krasimir/0000-0002-5612-004X	Ministry of Innovation and Technology in Hungary [TKP2021-EGA-24]; Hungarian National Research, Development and Innovation Office [137563]; UNKP Scholarship of the Ministry of Innovation and Technology, Hungary	Ministry of Innovation and Technology in Hungary; Hungarian National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); UNKP Scholarship of the Ministry of Innovation and Technology, Hungary	This study was funded by the Thematic Institutional Excellence funding scheme of the Ministry of Innovation and Technology in Hungary for the Molecular Biology thematic programme of Semmelweis University (https://nkfih.gov.hu/) [TKP2021-EGA-24] and the Hungarian National Research, Development and Innovation Office (https://nkfih.gov.hu/) [137563] in the form of funds to KK, and the UNKP Scholarship of the Ministry of Innovation and Technology, Hungary in the form of funds to ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas I, 2018, ARTERIOSCL THROM VAS, V38, P1868, DOI 10.1161/ATVBAHA.118.311165; BLOMBACK B, 1994, THROMB RES, V75, P521, DOI 10.1016/0049-3848(94)90227-5; Bocskei-Antal B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47841-x; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; BRYAN RK, 1990, EUR BIOPHYS J, V18, P165, DOI 10.1007/BF02427376; Collet JP, 2000, ARTERIOSCL THROM VAS, V20, P1354, DOI 10.1161/01.ATV.20.5.1354; de Boer OJ, 2013, THROMB HAEMOSTASIS, V109, P290, DOI 10.1160/TH12-06-0425; Donovan AJ, 2014, BIOMACROMOLECULES, V15, P3976, DOI 10.1021/bm501046t; Fiske CH, 1925, J BIOL CHEM, V66, P375; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Gould TJ, 2015, J THROMB HAEMOST, V13, pS82, DOI 10.1111/jth.12977; Isozaki S, 2021, MEDIAT INFLAMM, V2021, DOI 10.1155/2021/5582943; Khan SH, 2012, ANAL BIOCHEM, V421, P385, DOI 10.1016/j.ab.2011.12.006; KOLEV K, 1994, J BIOL CHEM, V269, P17030; Komorowicz E, 2021, J THROMB HAEMOST, V19, P1307, DOI 10.1111/jth.15258; Komorowicz E, 2020, J MECH BEHAV BIOMED, V102, DOI 10.1016/j.jmbbm.2019.103459; Kudela D, 2015, ANGEW CHEM INT EDIT, V54, P4018, DOI 10.1002/anie.201409639; Locke M, 2021, THROMB HAEMOSTASIS, V121, P464, DOI 10.1055/s-0040-1718760; Locke M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68584-0; Longstaff C, 2018, J THROMB HAEMOST, V16, P652, DOI 10.1111/jth.13957; Longstaff C, 2015, J THROMB HAEMOST, V13, pS98, DOI 10.1111/jth.12935; Longstaff C, 2013, J BIOL CHEM, V288, P6946, DOI 10.1074/jbc.M112.404301; Lundblad RL., 1976, METHODS ENZYMOLOGY, V45, pp156; McEvoy GK, 1992, AM HOSP FORMULARY SE, V1992, P276; Nikolova N.D., 2013, THEORY APPL MONTE CA, P1, DOI DOI 10.5772/53049; Rangaswamy C, 2021, THROMB HAEMOSTASIS, V121, P1021, DOI 10.1055/a-1336-0526; Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; Smith SA, 2008, BLOOD, V112, P2810, DOI 10.1182/blood-2008-03-145755; Szymusiak M, 2016, BIOCONJUGATE CHEM, V27, P102, DOI 10.1021/acs.bioconjchem.5b00524; Varju I, 2011, J THROMB HAEMOST, V9, P979, DOI 10.1111/j.1538-7836.2011.04203.x; Varju I, 2019, THROMB RES, V182, P1, DOI 10.1016/j.thromres.2019.08.003; Varju I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23725-4; Varju I, 2015, THROMB HAEMOSTASIS, V113, P1289, DOI 10.1160/TH14-08-0669; Verhoef JJF, 2017, BLOOD, V129, P1707, DOI 10.1182/blood-2016-08-734988; Weisel J. W., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P161, DOI 10.2174/187152508784871963; Weisel JW, 2017, SUBCELL BIOCHEM, V82, P405, DOI 10.1007/978-3-319-49674-0_13; Yeon JH, 2017, SCI REP-UK, V7, DOI 10.1038/srep42119	38	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266782	10.1371/journal.pone.0266782	http://dx.doi.org/10.1371/journal.pone.0266782			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D9PO	35468161	gold, Green Published			2022-12-26	WOS:000794129600001
J	Mameno, K; Kubo, T				Mameno, Kota; Kubo, Takahiro			Socio-economic drivers of irrigated paddy land abandonment and agro-ecosystem degradation: Evidence from Japanese agricultural census data	PLOS ONE			English	Article							FARMLAND ABANDONMENT; RICE FIELDS; WOMENS PARTICIPATION; CROPLAND ABANDONMENT; MOUNTAINOUS AREAS; URBAN FRINGE; CONSERVATION; LANDSCAPE; BIODIVERSITY; SATOYAMA	The abandonment of irrigated paddy land has increased in Japan, which can cause a decline in food security and biodiversity. Despite the importance of individual decisions, most studies have only examined regional or community-based determinants of paddy land abandonment. This study aimed to uncover the socio-economic determinants affecting individual landowners' decisions to abandon paddy land, using Japanese agricultural census data (2005, 2010, and 2015) composed of over one million unique paddy landowners. Results showed that low agricultural benefits are a key driver of abandonment, similar to European countries. Conversely, there is a positive correlation between the population of full-time cultivators in a household and paddy land abandonment, which contradicts previous evidence. Although some mosaics of socio-ecological landscapes with high biodiversity formed through long-term human influence (i.e., the Satoyama landscapes) are less-favored agricultural areas, the paddy land in some of these landscapes tends not to be abandoned. These findings support effective policymaking that balances biodiversity conservation and the provision of agroecosystem services in semi-natural landscapes.	[Mameno, Kota] Tohoku Univ, Grad Sch Agr Sci, Dept Resource & Environm Econ, Sendai, Miyagi, Japan; [Kubo, Takahiro] Natl Inst Environm Studies, Biodivers Div, Tsukuba, Ibaraki, Japan; [Kubo, Takahiro] Univ Kent, Sch Anthropol & Conservat, Canterbury, Kent, England; [Kubo, Takahiro] Univ Oxford, Dept Zool, Oxford, England	Tohoku University; National Institute for Environmental Studies - Japan; University of Kent; University of Oxford	Mameno, K (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Dept Resource & Environm Econ, Sendai, Miyagi, Japan.	kota.mameno@gmail.com	Mameno, Kota/AAF-2197-2020	Mameno, Kota/0000-0001-8866-7421	Japan Society for the Promotion of Science [19H03095]; SOMPO Environment Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); SOMPO Environment Foundation	TK; Project/Area Number: 19H03095 & Overseas Research Fellowships; Japan Society for the Promotion of Science; https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-19H03095/https://www.jsps.go.jp/j-ab/ab_list/list_h31.html KM; Grant Program for Doctoral Course Students; SOMPO Environment Foundation; https://www.sompo-ef.org/academic/academic.html Finally, it notes that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal B, 2009, ECOL ECON, V68, P2785, DOI 10.1016/j.ecolecon.2009.04.025; Aoki K, 2019, FOOD QUAL PREFER, V75, P28, DOI 10.1016/j.foodqual.2018.11.021; Aoki M., 2001, COMP I ANAL; Beilin R, 2014, LAND USE POLICY, V36, P60, DOI 10.1016/j.landusepol.2013.07.003; Burel F, 1996, CRIT REV PLANT SCI, V15, P169, DOI 10.1080/713608130; BUTLER JS, 1982, ECONOMETRICA, V50, P761, DOI 10.2307/1912613; Cameron A.C., 2009, MICROECONOMETRICS US; Cernusca A, 1996, PIRINEOS, V147-148, P145, DOI DOI 10.3989/PIRINEOS.1996.V147-148.141; Chen XD, 2009, BIOL CONSERV, V142, P1740, DOI 10.1016/j.biocon.2009.03.012; Corbelle-Rico E, 2012, LAND USE POLICY, V29, P493, DOI 10.1016/j.landusepol.2011.08.008; Dayer AA, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12394; Deininger K., 2003, LAND SALES RENTAL MA; Deng X, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10113909; Elphick CS, 2000, CONSERV BIOL, V14, P181, DOI 10.1046/j.1523-1739.2000.98314.x; Fernandez N, 2017, CONSERV LETT, V10, P276, DOI 10.1111/conl.12374; Filho WL, 2017, INT J SUST DEV WORLD, V24, P554, DOI 10.1080/13504509.2016.1240113; Fujioka M, 2010, WATERBIRDS, V33, P8, DOI 10.1675/063.033.s102; Fukamachi K, 2017, J ENVIRON MANAGE, V202, P543, DOI 10.1016/j.jenvman.2016.11.061; Greene H., 2003, ECONOMETRIC ANAL; HARTUP BK, 1994, BIOL CONSERV, V69, P235, DOI 10.1016/0006-3207(94)90422-7; Hattori T., 1998, Journal of Rural Planning Association, V16, P325, DOI 10.2750/arp.16.325; Henningsen A., 2019, PACKAGE CENSREG; Ichikawa K, 2006, LANDSCAPE URBAN PLAN, V78, P398, DOI 10.1016/j.landurbplan.2005.12.001; Diaz GI, 2011, LANDSCAPE URBAN PLAN, V99, P207, DOI 10.1016/j.landurbplan.2010.11.005; Ito J, 2019, ECOL ECON, V160, P62, DOI 10.1016/j.ecolecon.2019.01.036; Kamada M, 1997, LANDSCAPE URBAN PLAN, V37, P85, DOI 10.1016/S0169-2046(96)00372-6; Kamal S, 2015, J ENVIRON PLANN MAN, V58, P576, DOI 10.1080/09640568.2013.875463; Katayama N, 2015, AGR SYST, V132, P73, DOI 10.1016/j.agsy.2014.09.001; Katoh K, 2009, BIOL CONSERV, V142, P1930, DOI 10.1016/j.biocon.2009.02.030; Kawashima S., 2016, Journal of Rural Economics, V88, P287; Kidido JK, 2017, LAND USE POLICY, V60, P254, DOI 10.1016/j.landusepol.2016.10.040; Kobori H, 2003, AMBIO, V32, P307, DOI 10.1639/0044-7447(2003)032[0307:PCAFST]2.0.CO;2; Koshida C, 2018, CONSERV BIOL, V32, P1392, DOI 10.1111/cobi.13156; Kurihara S., 2020, JAPANESE J FARM MANA, V58, P71, DOI [10.11300/fmsj.58.2_71, DOI 10.11300/FMSJ.58.2_71]; Kutner M., 2005, APPL LINEAR STAT MOD; Lau JD, 2020, CONSERV BIOL, V34, P1589, DOI 10.1111/cobi.13487; Lawler SP, 2001, ISR J ZOOL, V47, P513, DOI 10.1560/X7K3-9JG8-MH2J-XGX1; Li SF, 2017, J GEOGR SCI, V27, P1123, DOI 10.1007/s11442-017-1426-0; Lieskovsky J, 2015, J RURAL STUD, V37, P75, DOI 10.1016/j.jrurstud.2014.12.007; Lindsey PA, 2005, BIOL CONSERV, V125, P113, DOI 10.1016/j.biocon.2005.03.015; Ma XL, 2015, LAND USE POLICY, V42, P293, DOI 10.1016/j.landusepol.2014.07.020; MacDonald D, 2000, J ENVIRON MANAGE, V59, P47, DOI 10.1006/jema.1999.0335; Maclean J.L., 2002, RICE ALMANAC SOURCE; Mameno K, 2021, CONSERV SCI PRACT, V3, DOI 10.1111/csp2.417; Ministry of Agriculture Forestry and Fisheries, 2019, IMPL STAT DIR PAYM S; Ministry of Agriculture Forestry and Fisheries , 2010, LIST RICE IKIMONO LA; Ministry of Agriculture Forestry and Fisheries, 2016, ANN REP FOOD AGR RUR; Natuhara Y, 2013, ECOL ENG, V56, P97, DOI 10.1016/j.ecoleng.2012.04.026; Normile D., 2016, NATURE NURTURE; Norris K, 2010, BIOL CONSERV, V143, P2341, DOI 10.1016/j.biocon.2009.12.032; Osawa T, 2016, SCI TOTAL ENVIRON, V542, P478, DOI 10.1016/j.scitotenv.2015.10.067; Ostrom Elinor, 1990, GOVERNING COMMONS EV; Perino A, 2019, SCIENCE, V364, P351, DOI 10.1126/science.aav5570; Poor EE, 2021, CONSERV SCI PRACT, V3, DOI 10.1111/csp2.395; Queiroz C, 2014, FRONT ECOL ENVIRON, V12, P288, DOI 10.1890/120348; R Core Team, 2021, R LANG ENV STAT COMP; Ramsdell CP, 2016, ENVIRON CONSERV, V43, P34, DOI 10.1017/S0376892915000302; Rey Benayas J. M., 2007, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V2, DOI 10.1079/PAVSNNR20072057; Rola-Rubzen MF, 2020, APPL ECON PERSPECT P, V42, P113, DOI 10.1002/aepp.13011; Ruskule A, 2013, LANDSCAPE URBAN PLAN, V115, P49, DOI 10.1016/j.landurbplan.2013.03.012; Salazar-Ordonez M, 2021, LAND USE POLICY, V107, DOI 10.1016/j.landusepol.2019.104348; Satyavathi CT, 2010, GEND TECHNOL DEV, V14, P441, DOI 10.1177/097185241001400308; Selinske MJ, 2015, CONSERV LETT, V8, P282, DOI 10.1111/conl.12154; Senda T., 1998, JAPANESE J FARM MANA, V36, P57, DOI [10.11300/fmsj1963.36.1_57, DOI 10.11300/FMSJ1963.36.1_57]; Shao JA, 2015, J GEOGR SCI, V25, P701, DOI 10.1007/s11442-015-1197-4; Su GD, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10103676; Takagishi Y., 2010, Journal of Rural Economics, P260; Takayama T, 2021, AUST J AGR RESOUR EC, V65, P658, DOI 10.1111/1467-8489.12425; Takayama T, 2020, EUR REV AGRIC ECON, V47, P157, DOI 10.1093/erae/jbz008; Takayama T, 2018, LAND USE POLICY, V77, P116, DOI 10.1016/j.landusepol.2018.05.033; Takayama T, 2018, AGR WATER MANAGE, V206, P113, DOI 10.1016/j.agwat.2018.04.031; Uchida K, 2014, ECOL MONOGR, V84, P637, DOI 10.1890/13-2170.1; Uematsu Y, 2010, AGR ECOSYST ENVIRON, V135, P304, DOI 10.1016/j.agee.2009.10.010; Ustaoglu E, 2018, ENVIRON REV, V26, P396, DOI 10.1139/er-2018-0001; Walls M, 2015, LAND ECON, V91, P1; WHO, 2018, FAO STATS; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; Yamaoka K., 2006, WATER AGR, P287; Yan JZ, 2016, LAND USE POLICY, V57, P459, DOI 10.1016/j.landusepol.2016.06.014; Yokohari M, 1997, LANDSCAPE URBAN PLAN, V38, P1, DOI 10.1016/S0169-2046(97)00010-8; Yoshida S., 2004, Journal of Rural Planning Association, V23, P277, DOI 10.2750/arp.23.23-suppl_277; Zhang Y, 2014, LAND USE POLICY, V41, P186, DOI 10.1016/j.landusepol.2014.05.011	82	0	0	18	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266997	10.1371/journal.pone.0266997	http://dx.doi.org/10.1371/journal.pone.0266997			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421175	Green Published, gold			2022-12-26	WOS:000795453600093
J	Monceau, A; Delacroix, C; Lemaitre, M; Revet, G; Furling, D; Agbulut, O; Klein, A; Ferry, A				Monceau, Alexandra; Delacroix, Clement; Lemaitre, Megane; Revet, Gaelle; Furling, Denis; Agbulut, Onnik; Klein, Arnaud; Ferry, Arnaud			The beneficial effect of chronic muscular exercise on muscle fragility is increased by Prox1 gene transfer in dystrophic mdx muscle	PLOS ONE			English	Article							CONTRACTION-INDUCED INJURY; INDUCED FORCE LOSS; SKELETAL-MUSCLE; MOLECULAR-MECHANISMS; UTROPHIN; PROTECTS; MICE; SUSCEPTIBILITY; ADAPTATIONS; ACTIVATION	PurposeGreater muscle fragility is thought to cause the exhaustion of the muscle stem cells during successive degeneration/repair cycles, leading to muscle wasting and weakness in Duchenne muscular dystrophy. Chronic voluntary exercise can partially reduce the susceptibility to contraction induced-muscle damage, i.e., muscle fragility, as shown by a reduced immediate maximal force drop following lengthening contractions, in the dystrophic mdx mice. Here, we studied the effect of Prospero-related homeobox factor 1 gene (Prox1) transfer (overexpression) using an AAV on fragility in chronically exercised mdx mice, because Prox1 promotes slower type fibres in healthy mice and slower fibres are less fragile in mdx muscle. MethodsBoth tibialis anterior muscles of the same mdx mouse received the transfer of Prox1 and PBS and the mice performed voluntary running into a wheel during 1 month. We also performed Prox1 transfer in sedentary mdx mice. In situ maximal force production of the muscle in response to nerve stimulation was assessed before, during and after 10 lengthening contractions. Molecular muscle parameters were also evaluated. ResultsInterestingly, Prox1 transfer reduced the isometric force drop following lengthening contractions in exercised mdx mice (p < 0.05 to 0.01), but not in sedentary mdx mice. It also increased the muscle expression of Myh7 (p < 0.001), MHC-2x (p < 0.01) and Trpc1 (p < 0.01), whereas it reduced that one of Myh4 (p < 0.001) and MHC-2b (p < 0.01) in exercised mdx mice. Moreover, Prox1 transfer decreased the absolute maximal isometric force (p < 0.01), but not the specific maximal isometric force, before lengthening contraction in exercised (p < 0.01) and sedentary mdx mice. ConclusionOur results indicate that Prox1 transfer increased the beneficial effect of chronic exercise on muscle fragility in mdx mice, but reduced absolute maximal force. Thus, the potential clinical benefit of the transfer of Prox1 into exercised dystrophic muscle can merit further investigation.	[Monceau, Alexandra; Delacroix, Clement; Furling, Denis; Klein, Arnaud; Ferry, Arnaud] Sorbonne Univ, Assoc Myol Inst, Myol Ctr Res, UMRS974, Paris, France; [Lemaitre, Megane] Sorbonne Univ, UMS 28, Paris, France; [Revet, Gaelle; Agbulut, Onnik] Sorbonne Univ, Inst Paris Seine Biol, Biol Adaptat & Ageing, UMR CNRS 8256,Inserm ERL U1164, Paris, France; [Ferry, Arnaud] Univ Paris Cite, Paris, France	UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Ferry, A (corresponding author), Sorbonne Univ, Assoc Myol Inst, Myol Ctr Res, UMRS974, Paris, France.; Ferry, A (corresponding author), Univ Paris Cite, Paris, France.	arnaud.ferry@upmc.fr	ferry, arnaud/D-2816-2019	ferry, arnaud/0000-0002-6050-4556; Agbulut, Onnik/0000-0003-1923-8871				Agbulut O, 1996, BIOL CELL, V88, P131, DOI 10.1016/S0248-4900(97)83528-9; Al-Rewashdy H, 2015, HUM MOL GENET, V24, P1243, DOI 10.1093/hmg/ddu535; Allard B, 2018, NEUROMUSCULAR DISORD, V28, P394, DOI 10.1016/j.nmd.2018.03.004; Baltgalvis KA, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-32; Baumann CW, 2020, MED SCI SPORT EXER, V52, P354, DOI 10.1249/MSS.0000000000002126; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Call JA, 2013, J PHYSIOL-LONDON, V591, P3765, DOI 10.1113/jphysiol.2013.254656; Chakkalakal JV, 2004, HUM MOL GENET, V13, P379, DOI 10.1093/hmg/ddh037; Chalkiadaki A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004490; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Consolino CM, 2004, J APPL PHYSIOL, V96, P633, DOI 10.1152/japplphysiol.00587.2003; Deconinck N, 1998, NEUROMUSCULAR DISORD, V8, P362, DOI 10.1016/S0960-8966(98)00048-0; Delacroix C, 2018, AM J PATHOL, V188, P2662, DOI 10.1016/j.ajpath.2018.07.015; Dellorusso C, 2001, J MUSCLE RES CELL M, V22, P467, DOI 10.1023/A:1014587918367; Dumonceaux J, 2010, MOL THER, V18, P881, DOI 10.1038/mt.2009.322; Ferry A, 2020, J PHYSIOL-LONDON, V598, P3667, DOI 10.1113/JP279282; Ferry A, 2015, AM J PATHOL, V185, P2012, DOI 10.1016/j.ajpath.2015.03.027; Gao YF, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00235; Gehrig SM, 2008, EXP PHYSIOL, V93, P1190, DOI 10.1113/expphysiol.2008.042838; Gehrig SM, 2010, AM J PATHOL, V176, P29, DOI 10.2353/ajpath.2010.090760; Hourde C, 2013, AM J PATHOL, V182, P1509, DOI 10.1016/j.ajpath.2013.01.020; Hughes DC, 2015, AM J PHYSIOL-ENDOC M, V309, pE1, DOI 10.1152/ajpendo.00095.2015; Khairallah RJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002829; Kivela R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13124; Leyva-Leyva M, 2018, J MEMBRANE BIOL, V251, P535, DOI 10.1007/s00232-018-0036-9; Lindsay A, 2020, SKELET MUSCLE, V10, DOI 10.1186/s13395-020-0221-2; Lindsay A, 2019, FEBS J, V286, P2562, DOI 10.1111/febs.14831; Lindsay A, 2019, J APPL PHYSIOL, V126, P363, DOI 10.1152/japplphysiol.00948.2018; Ljubicic V, 2011, HUM MOL GENET, V20, P3478, DOI 10.1093/hmg/ddr265; Lynch GS, 2000, AM J PHYSIOL-CELL PH, V279, pC1290, DOI 10.1152/ajpcell.2000.279.4.C1290; Matsakas A, 2013, FASEB J, V27, P4004, DOI 10.1096/fj.13-228296; Matsumura CY, 2011, AM J PHYSIOL-CELL PH, V301, pC1344, DOI 10.1152/ajpcell.00056.2011; Miura P, 2009, HUM MOL GENET, V18, P4640, DOI 10.1093/hmg/ddp431; Olthoff JT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07639-3; Petchey LK, 2014, P NATL ACAD SCI USA, V111, P9515, DOI 10.1073/pnas.1406191111; Roy P, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0096-4; Ruegg MA, 2011, ANNU REV PHARMACOL, V51, P373, DOI 10.1146/annurev-pharmtox-010510-100537; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Schertzer JD, 2006, AM J PHYSIOL-ENDOC M, V291, pE499, DOI 10.1152/ajpendo.00101.2006; Selsby JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030063; Stupka N, 2006, J PHYSIOL-LONDON, V575, P645, DOI 10.1113/jphysiol.2006.108472; Whitehead NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015354	42	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0254274	10.1371/journal.pone.0254274	http://dx.doi.org/10.1371/journal.pone.0254274			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7MW	35436319	gold, Green Submitted, Green Published			2022-12-26	WOS:000791258900034
J	Sasse, SL; Harrington, BB; DiPrete, B; Chagomerana, MD; Klyn, LL; Wallie, SN; Maliwichi, MF; Jumbe, AE; Hoffman, IH; Rosenberg, NC; Tang, J; Hosseinipour, M				Sasse, Simone L.; Harrington, Bryna B.; DiPrete, Bethany; Chagomerana, Maganizo D.; Klyn, Laura Limarzi; Wallie, Shaphil N.; Maliwichi, Madalitso F.; Jumbe, Allan E.; Hoffman, Irving H.; Rosenberg, Nora C.; Tang, Jennifer; Hosseinipour, Mina		S4Study	Factors associated with a history of treatment interruption among pregnant women living with HIV in Malawi: A cross-sectional study	PLOS ONE			English	Article							OPTION B PLUS; BREAST-FEEDING WOMEN; TO-CHILD TRANSMISSION; ANTIRETROVIRAL THERAPY; FOLLOW-UP; REPRODUCTIVE INTENTIONS; TREATMENT ADHERENCE; POSITIVE WOMEN; RETENTION; PROGRAM	IntroductionLong-term care engagement of women on antiretroviral therapy (ART) is essential to effective HIV public health measures. We sought to explore factors associated with a history of HIV treatment interruption among pregnant women living with HIV presenting to an antenatal clinic in Lilongwe, Malawi. MethodsWe performed a cross-sectional study of pregnant women living with HIV who had a history of ART interruption presenting for antenatal care. Women were categorized as either retained in HIV treatment or reinitiating care after loss-to-follow up (LTFU). To understand factors associated with treatment interruption, we surveyed socio-demographic and partner relationship characteristics. Crude and adjusted prevalence ratios (aPR) for factors associated with ART interruption were estimated using modified Poisson regression with robust variance. We additionally present patients' reasons for ART interruption. ResultsWe enrolled 541 pregnant women living with HIV (391 retained and 150 reinitiating). The median age was 30 years (interquartile range (IQR): 25-34). Factors associated with a history of LTFU were age <30 years (aPR 1.46; 95% CI: 1.33-1.63), less than a primary school education (aPR 1.25; CI: 1.08-1.46), initiation of ART during pregnancy or breastfeeding (aPR 1.49, CI: 1.37-1.65), nondisclosure of HIV serostatus to their partner (aPR 1.39, CI: 1.24-1.58), lack of awareness of partner's HIV status (aPR 1.41, CI: 1.27-1.60), and no contraception use at conception (aPR 1.60, CI 1.40-1.98). Access to care challenges were the most common reasons reported by women for treatment interruption (e.g., relocation, transport costs, or misplacing health documentation). ConclusionsInterventions that simplify the ART clinic transfer process, facilitate partner disclosure, and provide counseling about the importance of lifelong ART beyond pregnancy and breastfeeding should be further evaluated for improving retention in ART treatment of women living with HIV in Malawi.	[Sasse, Simone L.] NYU, Dept Obstet & Gynecol, New York, NY USA; [Sasse, Simone L.; Harrington, Bryna B.; DiPrete, Bethany; Chagomerana, Maganizo D.; Klyn, Laura Limarzi; Wallie, Shaphil N.; Maliwichi, Madalitso F.; Jumbe, Allan E.; Hoffman, Irving H.; Rosenberg, Nora C.; Tang, Jennifer; Hosseinipour, Mina] Univ North Carolina Project Malawi, Kamuzu Cent Hosp, Lilongwe, Malawi; [Harrington, Bryna B.] Johns Hopkins Univ, Dept Gynecol & Obstet, Baltimore, MD USA; [DiPrete, Bethany] Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC USA; [Hoffman, Irving H.; Hosseinipour, Mina] Univ North Carolina Chapel Hill, Dept Med, Chapel Hill, NC USA; [Rosenberg, Nora C.] Univ North Carolina Chapel Hill, Dept Hlth Behav, Chapel Hill, NC USA; [Tang, Jennifer] Univ North Carolina Chapel Hill, Dept Obstet & Gynecol, Chapel Hill, NC USA	New York University; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sasse, SL (corresponding author), NYU, Dept Obstet & Gynecol, New York, NY USA.; Sasse, SL (corresponding author), Univ North Carolina Project Malawi, Kamuzu Cent Hosp, Lilongwe, Malawi.	simone.sasse@nyulangone.org		Sasse, Simone/0000-0003-0168-2771	National Institutes of Health [R01HD080485, D43TW010060]; Doris Duke Charitable Foundation International Clinical Research Fellows Program; UNC Medical Scientist Training Program [T32GM008719]; NIMH individual fellowship [F30MH111370]; Fulbright-Fogarty U.S. Student fellowship; NIH Fogarty International Center [R25TW009340]; UNC Center for AIDS Research [P30AI50410]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation International Clinical Research Fellows Program; UNC Medical Scientist Training Program; NIMH individual fellowship; Fulbright-Fogarty U.S. Student fellowship; NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); UNC Center for AIDS Research	Funding: This research was made possible through funding by the National Institutes of Health (R01HD080485, D43TW010060, MH, URL: https:// www.nih.gov), the Doris Duke Charitable Foundation International Clinical Research Fellows Program (SAS, URL: https://www.ddcf.org), the UNC Medical Scientist Training Program (T32GM008719, BJH), the NIMH individual fellowship (F30MH111370, BJH, URL: https:// www.nimh.nih.gov), the Fulbright-Fogarty U.S. Student fellowship (BJH, URL: https://us. fulbrightonline.org), and the NIH Fogarty International Center (R25TW009340, BJH, URL: https://www.fic.nih.gov). Regulatory support was provided through the UNC Center for AIDS Research	Aluisio A, 2011, JAIDS-J ACQ IMM DEF, V56, P76, DOI 10.1097/QAI.0b013e3181fdb4c4; Atanga PN, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2058-9; Audet CM, 2016, AIDS BEHAV, V20, P2090, DOI 10.1007/s10461-016-1341-x; Barr BAT, 2018, LANCET HIV, V5, pE688, DOI 10.1016/S2352-3018(18)30316-3; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bengtson AM, 2020, AIDS BEHAV, V24, P551, DOI 10.1007/s10461-019-02748-6; Bhushan NL, 2019, AIDS CARE, V31, P199, DOI 10.1080/09540121.2018.1510102; Black S, 2014, AIDS CARE, V26, P736, DOI 10.1080/09540121.2013.855300; Cataldo F, 2017, JAIDS-J ACQ IMM DEF, V74, P517, DOI 10.1097/QAI.0000000000001273; Clouse K, 2014, JAIDS-J ACQ IMM DEF, V67, pE12, DOI 10.1097/QAI.0000000000000263; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Colombini M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20766; Colvin CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108150; Cooper D, 2007, SOC SCI MED, V65, P274, DOI 10.1016/j.socscimed.2007.03.019; Dzangare J, 2016, TROP MED INT HEALTH, V21, P202, DOI 10.1111/tmi.12637; Elwell K, 2016, AIDS CARE, V28, P971, DOI 10.1080/09540121.2016.1153586; Erlwanger AS, 2017, JAIDS-J ACQ IMM DEF, V75, pS198, DOI [10.1097/QAI.0000000000001347, 10.1097/qai.0000000000001347]; Flax VL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175590; Gibbs GR., 2007, ANAL QUALITATIVE DAT, V703, P38, DOI [DOI 10.4135/9781849208574, 10.4135/9781849208574]; Gill MM, 2017, AIDS PATIENT CARE ST, V31, P153, DOI 10.1089/apc.2016.0234; Haas AD, 2016, LANCET HIV, V3, pE175, DOI 10.1016/S2352-3018(16)00008-4; Kalembo FW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066517; Katirayi L, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20919; Kim MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149527; Kiwanuka G, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3450-9; Krakowiak D, 2016, JAIDS-J ACQ IMM DEF, V72, pS167, DOI 10.1097/QAI.0000000000001053; Landes M, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25290; Llenas-Garcia J, 2016, TROP MED INT HEALTH, V21, P1003, DOI 10.1111/tmi.12728; Luebbert J, 2012, CLIN INFECT DIS, V55, P441, DOI 10.1093/cid/cis438; Malawi Ministry of Health, 2014, MAL GUID CLIN MAN HI; Manda-Taylor L, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1523-1; Masters SH, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002166; Mphonda SM, 2014, AFR J REPROD HEALTH, V18, P97; National Statistics Office Malawi the Inner City Fund, 2017, 201516 MAL NAT DEM H; Nyondo AL, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/s12914-014-0030-y; O'Shea MS, 2016, AIDS CARE, V28, P1027, DOI 10.1080/09540121.2016.1140891; Phiri N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222138; Phiri N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.019785; Phiri S, 2017, JAIDS-J ACQ IMM DEF, V75, pS140, DOI 10.1097/qai.0000000000001357; Rosenberg NE, 2015, LANCET HIV, V2, pE483, DOI 10.1016/S2352-3018(15)00182-4; Schouten EJ, 2011, LANCET, V378, P282, DOI 10.1016/S0140-6736(10)62303-3; Sennott C, 2012, INT PERSPECT SEX R H, V38, P34, DOI 10.1363/3803412; Shattuck D, 2011, AM J PUBLIC HEALTH, V101, P1089, DOI 10.2105/AJPH.2010.300091; Sinunu MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100741; StataCorp, 2017, STATA STAT SOFTWARE; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; Tweya H., 2018, PLOS ONE, V13, P1; Tweya H, 2014, TROP MED INT HEALTH, V19, P1360, DOI 10.1111/tmi.12369; Wang BX, 2011, SAMJ S AFR MED J, V101, P253, DOI 10.7196/SAMJ.4078; Wesevich A, 2017, AIDS CARE, V29, P1417, DOI 10.1080/09540121.2017.1308464; Wilkinson LS, 2015, TROP MED INT HEALTH, V20, P365, DOI 10.1111/tmi.12434; Zhou A, 2016, SOC SCI MED, V158, P52, DOI 10.1016/j.socscimed.2016.04.013; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	53	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267085	10.1371/journal.pone.0267085	http://dx.doi.org/10.1371/journal.pone.0267085			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7VA	35439264	gold, Green Published			2022-12-26	WOS:000791280100020
J	Bibo-Verdugo, B; Joglekar, I; Giridhar, MNK; Ramirez, ML; Snipas, SJ; Clark, AC; Poreba, M; Salvesen, GS				Bibo-Verdugo, Betsaida; Joglekar, Isha; Giridhar, Mithun N. Karadi; Ramirez, Monica L.; Snipas, Scott J.; Clark, A. Clay; Poreba, Marcin; Salvesen, Guy S.			Resurrection of an ancient inflammatory locus reveals switch to caspase-1 specificity on a caspase-4 scaffold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASDERMIN-D; MAMMALIAN CASPASES; IL-1 FAMILY; ACTIVATION; PYROPTOSIS; INFLAMMASOMES; MECHANISMS; REGULATORS; SECRETION; EVOLUTION	Pyroptosis is a mechanism of inflammatory cell death mediated by the activation of the prolytic protein gasdermin D by caspase-1, caspase-4, and caspase-5 in human, and caspase-1 and caspase-11 in mouse. In addition, caspase-1 amplifies inflammation by proteolytic activation of cytokine interleukin-1 beta (IL-1 beta). Modern mammals of the order Carnivora lack the caspase-1 catalytic domain but express an unusual version of caspase-4 that can activate both gasdermin D and IL-1 beta. Seeking to understand the evolutionary origin of this caspase, we utilized the large amount of data available in public databases to perform ancestral sequence reconstruction of an inflammatory caspase of a Carnivora ancestor. We expressed the catalytic domain of this putative ancestor in Escherichia coli, purified it, and compared its substrate specificity on synthetic and protein substrates to extant caspases. We demonstrated that it activates gasdermin D but has reduced ability to activate IL-1 beta. Our reconstruction suggests that caspase-1 was lost in a Carnivora ancestor, perhaps upon a selective pressure for which the generation of biologically active IL-1 beta by caspase-1 was detrimental. We speculate that later, a Carnivora encountered selective pressures that required the production of IL-1 beta, and caspase-4 subsequently gained this activity. This hypothesis would explain why extant Carnivora possess an inflammatory caspase with caspase-1 catalytic function placed on a caspase-4 scaffold.	[Bibo-Verdugo, Betsaida; Snipas, Scott J.; Salvesen, Guy S.] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA; [Joglekar, Isha; Giridhar, Mithun N. Karadi; Clark, A. Clay] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Ramirez, Monica L.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Poreba, Marcin] Wroclaw Univ Sci & Technol, Dept Bioorgan Chem, Wroclaw, Poland	Sanford Burnham Prebys Medical Discovery Institute; University of Texas System; University of Texas Arlington; University of California System; University of California San Diego; Wroclaw University of Science & Technology	Salvesen, GS (corresponding author), Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA.	gsalvesen@sbpdiscovery.org		Karadi Giridhar, Mithun Nag/0000-0003-0520-5921; Joglekar, Isha/0000-0001-7930-5533; Clark, Allan/0000-0003-4371-4102	National Institutes of Health [R01 GM99040, P30 CA30199, RO1 GM127654]; National Science Centre in Poland [UMO-2018/29/B/NZ1/02249]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Centre in Poland(National Science Centre, Poland)	This work was supported by the National Institutes of Health grants R01 GM99040 and P30 CA30199 (to G. S. S.) and RO1 GM127654 (to A. C. C.). M. P. laboratory is supported by the National Science Centre in Poland (grant OPUS, UMO-2018/29/B/NZ1/02249). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonina IS, 2015, IMMUNITY, V42, P991, DOI 10.1016/j.immuni.2015.06.003; Akita K, 1997, J BIOL CHEM, V272, P26595, DOI 10.1074/jbc.272.42.26595; Albalat R, 2016, NAT REV GENET, V17, P379, DOI 10.1038/nrg.2016.39; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bibo-Verdugo B, 2022, MOL ASPECTS MED, V88, DOI 10.1016/j.mam.2022.101085; Bibo-Verdugo B, 2020, J BIOL CHEM, V295, P11292, DOI 10.1074/jbc.RA120.014259; Cookson BT, 2001, TRENDS MICROBIOL, V9, P113, DOI 10.1016/S0966-842X(00)01936-3; Cui HR, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.592622; Denault Jean-Bernard, 2003, Curr Protoc Protein Sci, VChapter 21, DOI 10.1002/0471140864.ps2113s30; Devant P, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abh3567; Digby Z, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109614; Dinarello CA, 2018, IMMUNOL REV, V281, P8, DOI 10.1111/imr.12621; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Dondelinger Y, 2016, TRENDS CELL BIOL, V26, P721, DOI 10.1016/j.tcb.2016.06.004; Eckhart L, 2008, MOL BIOL EVOL, V25, P831, DOI 10.1093/molbev/msn012; Eick GN, 2017, MOL BIOL EVOL, V34, P247, DOI 10.1093/molbev/msw223; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Fischer H, 2020, APOPTOSIS, V25, P474, DOI 10.1007/s10495-020-01614-4; Fischer H, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00939; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Goh G, 2020, P NATL ACAD SCI USA, V117, P28939, DOI 10.1073/pnas.2003352117; Grinshpon RD, 2019, BIOCHEM J, V476, P3475, DOI 10.1042/BCJ20190625; Grinshpon RD, 2018, PROTEIN SCI, V27, P1857, DOI 10.1002/pro.3494; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Harms MJ, 2010, CURR OPIN STRUC BIOL, V20, P360, DOI 10.1016/j.sbi.2010.03.005; Heilig R, 2018, EUR J IMMUNOL, V48, P584, DOI 10.1002/eji.201747404; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Man SM, 2017, IMMUNOL REV, V277, P61, DOI 10.1111/imr.12534; Martin L.D., 1989, P536; Martin SJ, 2012, MOL CELL, V46, P387, DOI 10.1016/j.molcel.2012.04.026; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Monteleone M, 2018, CELL REP, V24, P1425, DOI 10.1016/j.celrep.2018.07.027; Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12; MOSLEY B, 1987, J BIOL CHEM, V262, P2941; Pei JM, 2014, METHODS MOL BIOL, V1079, P263, DOI 10.1007/978-1-62703-646-7_17; Poreba M, 2014, CELL DEATH DIFFER, V21, P1482, DOI 10.1038/cdd.2014.64; Ramirez MLG, 2018, J BIOL CHEM, V293, P7058, DOI 10.1074/jbc.RA117.001329; Ramirez MLG, 2018, SEMIN CELL DEV BIOL, V82, P79, DOI 10.1016/j.semcdb.2018.01.002; Ruhl S, 2015, EUR J IMMUNOL, V45, P2927, DOI 10.1002/eji.201545772; Salvesen GS, 2016, FEBS J, V283, P2577, DOI 10.1111/febs.13616; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Stennicke HR, 2000, METHOD ENZYMOL, V322, P91; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Van Opdenbosch N, 2019, IMMUNITY, V50, P1352, DOI 10.1016/j.immuni.2019.05.020; Vigano E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9761; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wong JP, 2017, FUTURE MED CHEM, V9, P169, DOI 10.4155/fmc-2016-0181; Xia SY, 2021, NATURE, V593, P607, DOI 10.1038/s41586-021-03478-3; Xie JZ, 2018, CELL HOST MICROBE, V23, P297, DOI 10.1016/j.chom.2018.01.006	56	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101931	10.1016/j.jbc.2022.101931	http://dx.doi.org/10.1016/j.jbc.2022.101931			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9FR	35427646	gold, Green Published			2022-12-26	WOS:000807755100009
J	Tyagi, A; Wu, SY; Sharma, S; Wu, KR; Zhao, D; Deshpande, R; Singh, R; Li, WC; Topaloglu, U; Ruiz, J; Watabe, K				Tyagi, Abhishek; Wu, Shih-Ying; Sharma, Sambad; Wu, Kerui; Zhao, Dan; Deshpande, Ravindra; Singh, Ravi; Li, Wencheng; Topaloglu, Umit; Ruiz, Jimmy; Watabe, Kounosuke			Exosomal miR-4466 from nicotine-activated neutrophils promotes tumor cell stemness and metabolism in lung cancer metastasis	ONCOGENE			English	Article							CIGARETTE-SMOKING; LYMPHOCYTE RATIO; BRAIN METASTASES; SERUM COTININE; SURVIVAL; PROTEIN; GLIOBLASTOMA; PROLIFERATION; COLONIZATION; INFLAMMATION	Smoking is associated with lung cancer and has a profound impact on tumor immunity. Nicotine, the addictive and non-carcinogenic smoke component, influences various brain cells and the immune system. However, how long-term use of nicotine affects brain metastases is poorly understood. We, therefore, examined the mechanism by which nicotine promotes lung cancer brain metastasis. In this study, we conducted a retrospective analysis of 810 lung cancer patients with smoking history and assessed brain metastasis. We found that current smoker's lung cancer patients have significantly higher brain metastatic incidence compared to the never smokers. We also found that chronic nicotine exposure recruited STAT3-activated N2-neutrophils within the brain pre-metastatic niche and secreted exosomal miR-4466 which promoted stemness and metabolic switching via SKI/SOX2/CPT1A axis in the tumor cells in the brain thereby enabling metastasis. Importantly, exosomal miR-4466 levels were found to be elevated in serum/urine of cancer-free subjects with a smoking history and promote tumor growth in vivo, suggesting that exosomal miR-4466 may serve as a promising prognostic biomarker for predicting increased risk of metastatic disease among smoker(s). Our findings suggest a novel pro-metastatic role of nicotine-induced N2-neutrophils in the progression of brain metastasis. We also demonstrated that inhibiting nicotine-induced STAT3-mediated neutrophil polarization effectively abrogated brain metastasis in vivo. Our results revealed a novel mechanistic insight on how chronic nicotine exposure contributes to worse clinical outcome of metastatic lung cancer and implicated the risk of using nicotine gateway for smoking cessation in cancer patients.	[Tyagi, Abhishek; Wu, Shih-Ying; Sharma, Sambad; Wu, Kerui; Zhao, Dan; Deshpande, Ravindra; Singh, Ravi; Li, Wencheng; Topaloglu, Umit; Ruiz, Jimmy; Watabe, Kounosuke] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center	Watabe, K (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.	kwatabe@wakehealth.edu	Zhao, Dan/Y-8065-2019; Tyagi, Abhishek/AFZ-6213-2022; Tyagi, Abhishek/CAF-1274-2022; Singh, Ravi/A-5740-2011	Zhao, Dan/0000-0002-5120-6725; Tyagi, Abhishek/0000-0002-0155-2099; Tyagi, Abhishek/0000-0002-0155-2099; Singh, Ravi/0000-0003-0750-1804	NIH [R01CA173499, R01CA185650, R01CA205067]; Comprehensive Cancer Center of Wake Forest University, National Institutes of Health [P30CA012197]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Comprehensive Cancer Center of Wake Forest University, National Institutes of Health	This work was supported by NIH grant R01CA173499, R01CA185650 and R01CA205067 (to KW). This study used various Shared Resources including Tumor Tissue and Pathology, Cancer Genomics, Flow Cytometry, Biostatistics and Cell Engineering that are supported by the Comprehensive Cancer Center of Wake Forest University, National Institutes of Health Grant (P30CA012197).	Ali A, 2013, CURR ONCOL, V20, pE300, DOI 10.3747/co.20.1481; Aoshiba K, 1996, J LAB CLIN MED, V127, P186, DOI 10.1016/S0022-2143(96)90077-3; Asakura K, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0863-y; Bambury RM, 2013, J NEURO-ONCOL, V114, P149, DOI 10.1007/s11060-013-1164-9; Benhammou K, 2000, NEUROPHARMACOLOGY, V39, P2818, DOI 10.1016/S0028-3908(00)00153-2; Bleesing JJH, 2003, CYTOM PART B-CLIN CY, V51B, P1, DOI 10.1002/cyto.b.10007; Boire A, 2017, CELL, V168, P1101, DOI 10.1016/j.cell.2017.02.025; Caraballo RS, 1998, JAMA-J AM MED ASSOC, V280, P135, DOI 10.1001/jama.280.2.135; Caraballo RS, 2004, NICOTINE TOB RES, V6, P19, DOI 10.1080/14622200310001656821; Souto JC, 2011, MED RES REV, V31, P311, DOI 10.1002/med.20185; Ceccarelli SM, 2011, J MED CHEM, V54, P3109, DOI 10.1021/jm100809g; Chawla K, 2013, BIOINFORMATICS, V29, P2519, DOI 10.1093/bioinformatics/btt432; Cheng L, 2019, IMMUNOBIOLOGY, V224, P388, DOI 10.1016/j.imbio.2019.02.009; Chou YT, 2013, STEM CELLS, V31, P2607, DOI 10.1002/stem.1518; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; Cui P, 2020, CELL SIGNAL, V71, DOI 10.1016/j.cellsig.2020.109598; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; DeJarnette JB, 1998, P NATL ACAD SCI USA, V95, P14909, DOI 10.1073/pnas.95.25.14909; Deng C, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016875; Deng JH, 2012, CANCER CELL, V21, P642, DOI 10.1016/j.ccr.2012.03.039; Doi H, 2019, IN VIVO, V33, P195, DOI 10.21873/invivo.11459; Dong Y, 2018, ANN NEUROL, V83, P387, DOI 10.1002/ana.25159; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Fuchs J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253601; Gong JN, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00941; Haftchenary S, 2013, ACS MED CHEM LETT, V4, P1102, DOI 10.1021/ml4003138; Han SJ, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01201; Hawkins BT, 2004, BRAIN RES, V1027, P48, DOI 10.1016/j.brainres.2004.08.043; Horwitz M, 1999, NAT GENET, V23, P433, DOI 10.1038/70544; Hsiao SH, 2013, LUNG CANCER, V82, P319, DOI 10.1016/j.lungcan.2013.08.004; Cuartero MI, 2013, STROKE, V44, P3498, DOI 10.1161/STROKEAHA.113.002470; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Karachaliou N, 2013, TRANSL LUNG CANCER R, V2, P172, DOI 10.3978/j.issn.2218-6751.2013.01.01; Kazuyori TTN., 2017, J CANC SCI RES, V3, P1; Kim S, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121236; Kobayashi H, 2018, ONCOL LETT, V16, P4243, DOI 10.3892/ol.2018.9225; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kudo Y, 2019, ANN ONCOL, V30, P1521, DOI 10.1093/annonc/mdz207; Laughney AM, 2020, NAT MED, V26, P259, DOI 10.1038/s41591-019-0750-6; Lauterstein DE, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13040417; Lee W, 2019, J EXP MED, V216, P176, DOI 10.1084/jem.20181170; Lehuede C, 2016, CANCER RES, V76, P5201, DOI 10.1158/0008-5472.CAN-16-0266; Li TW, 2020, NUCLEIC ACIDS RES, V48, pW509, DOI 10.1093/nar/gkaa407; Li YPD, 2019, J NEURO-ONCOL, V143, P337, DOI 10.1007/s11060-019-03169-0; Lin H, 2017, NEURO-ONCOLOGY, V19, P43, DOI 10.1093/neuonc/now128; Liu Y, 2013, NEURO-ONCOLOGY, V15, P891, DOI 10.1093/neuonc/not031; Liu YF, 2016, CANCER CELL, V30, P243, DOI 10.1016/j.ccell.2016.06.021; Loeffler JS, 2020, EPIDEMIOLOGY CLIN MA; Luke Florian, 2018, Oncotarget, V9, P18844, DOI 10.18632/oncotarget.24787; Mansouri Sheila, 2016, CNS Oncol, V5, P159, DOI 10.2217/cns-2016-0001; Maru Y, 2020, CSH PERSPECT MED, V10, DOI 10.1101/cshperspect.a036897; Mashimo T, 2014, CELL, V159, P1603, DOI 10.1016/j.cell.2014.11.025; Mitsuya K, 2017, J NEUROSURG, V127, P433, DOI 10.3171/2016.8.JNS16899; Morad G, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1627164; O'Keeffe LM, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-021611; O'Loughlin J, 2008, NICOTINE TOB RES, V10, P525, DOI 10.1080/14622200801901997; Ohsawa K, 2004, J NEUROCHEM, V88, P844, DOI 10.1046/j.1471-4159.2003.02213.x; Panopoulos AD, 2006, BLOOD, V108, P3682, DOI 10.1182/blood-2006-02-003012; Peinado H, 2017, NAT REV CANCER, V17, P302, DOI 10.1038/nrc.2017.6; Piccard H, 2012, CRIT REV ONCOL HEMAT, V82, P296, DOI 10.1016/j.critrevonc.2011.06.004; Rodrigues G, 2019, NAT CELL BIOL, V21, P1403, DOI 10.1038/s41556-019-0404-4; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Sacks P, 2020, NEUROSURG CLIN N AM, V31, P481, DOI 10.1016/j.nec.2020.06.001; Schaal CM, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0901-2; Shaul ME, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1232221; Shenker RF, 2017, CANCER MED-US, V6, P944, DOI 10.1002/cam4.1058; Shigdar S, 2014, CANCER LETT, V345, P271, DOI 10.1016/j.canlet.2013.07.031; Sifat AE, 2018, J NEUROCHEM, V147, P204, DOI 10.1111/jnc.14561; Singh S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-73; Singh SP, 2000, TOXICOL APPL PHARM, V164, P65, DOI 10.1006/taap.2000.8897; Sodja E, 2016, RADIOL ONCOL, V50, P188, DOI 10.1515/raon-2015-0027; Stapleton JM, 2003, NEUROPSYCHOPHARMACOL, V28, P765, DOI 10.1038/sj.npp.1300106; Szczerba BM, 2019, NATURE, V566, P553, DOI 10.1038/s41586-019-0915-y; TOTTI N, 1984, SCIENCE, V223, P169, DOI 10.1126/science.6318317; Tyagi A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20733-9; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang TY, 2018, CELL METAB, V27, P1357, DOI 10.1016/j.cmet.2018.04.018; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140; Wingrove E, 2019, CELL REP, V27, P1277, DOI 10.1016/j.celrep.2019.03.085; Yeung CLA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11150; Zhang HY, 2010, BLOOD, V116, P2462, DOI 10.1182/blood-2009-12-259630; Zhang L, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaz5387	82	2	2	4	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 27	2022	41	22					3079	3092		10.1038/s41388-022-02322-w	http://dx.doi.org/10.1038/s41388-022-02322-w		APR 2022	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	1U7PG	35461327	Green Published, hybrid			2022-12-26	WOS:000785962300001
J	Heimbuch, IS; Fan, TK; Wu, AD; Faas, GC; Charles, AC; Iacoboni, M				Heimbuch, Ian S.; Fan, Tiffany K.; Wu, Allan D.; Faas, Guido C.; Charles, Andrew C.; Iacoboni, Marco			Ultrasound stimulation of the motor cortex during tonic muscle contraction	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; POWER-LAW ABSORPTION; FOCUSED ULTRASOUND; ABERRATION CORRECTION; BRAIN-STIMULATION; EVOKED-POTENTIALS; NEURON DENSITIES; CONTACT HEAT; EMG ACTIVITY; FREQUENCY	Transcranial ultrasound stimulation (tUS) shows potential as a noninvasive brain stimulation (NIBS) technique, offering increased spatial precision compared to other NIBS techniques. However, its reported effects on primary motor cortex (M1) are limited. We aimed to better understand tUS effects in human M1 by performing tUS of the hand area of M1 (M1(hand)) during tonic muscle contraction of the index finger. Stimulation during muscle contraction was chosen because of the transcranial magnetic stimulation-induced phenomenon known as cortical silent period (cSP), in which transcranial magnetic stimulation (TMS) of M1(hand) involuntarily suppresses voluntary motor activity. Since cSP is widely considered an inhibitory phenomenon, it presents an ideal parallel for tUS, which has often been proposed to preferentially influence inhibitory interneurons. Recording electromyography (EMG) of the first dorsal interosseous (FDI) muscle, we investigated effects on muscle activity both during and after tUS. We found no change in FDI EMG activity concurrent with tUS stimulation. Using single-pulse TMS, we found no difference in M1 excitability before versus after sparsely repetitive tUS exposure. Using acoustic simulations in models made from structural MRI of the participants that matched the experimental setups, we estimated in-brain pressures and generated an estimate of cumulative tUS exposure experienced by M1(hand) for each subject. We were unable to find any correlation between cumulative M1(hand) exposure and M1 excitability change. We also present data that suggest a TMS-induced MEP always preceded a near-threshold cSP.	[Heimbuch, Ian S.; Faas, Guido C.; Charles, Andrew C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Heimbuch, Ian S.; Iacoboni, Marco] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Heimbuch, Ian S.; Iacoboni, Marco] Univ Calif Los Angeles, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA; [Fan, Tiffany K.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Wu, Allan D.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Evanston, IL USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Northwestern University; Feinberg School of Medicine	Heimbuch, IS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.; Heimbuch, IS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA.; Heimbuch, IS (corresponding author), Univ Calif Los Angeles, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA.	heimbuch@ucla.edu		Heimbuch, Ian/0000-0002-4821-7888; Iacoboni, Marco/0000-0002-0035-5413; Fan, Tiffany/0000-0003-4646-6378	Arline and Seymour Kreshek Family Fund	Arline and Seymour Kreshek Family Fund	This work was funded by The Arline and Seymour Kreshek Family Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai L, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0456-6; Ai L, 2016, IEEE ENG MED BIO, P1758, DOI 10.1109/EMBC.2016.7591057; [Anonymous], 2012, SAFE USE ULTRASOUND; Atapour N, 2019, CEREB CORTEX, V29, P3836, DOI 10.1093/cercor/bhy263; Baumgartner U, 2012, NEUROPHYSIOL CLIN, V42, P267, DOI 10.1016/j.neucli.2012.06.002; BEAULIEU C, 1989, J COMP NEUROL, V279, P228, DOI 10.1002/cne.902790206; Butler JE, 2012, CLIN NEUROPHYSIOL, V123, P1409, DOI 10.1016/j.clinph.2011.11.034; CANTELLO R, 1992, NEUROLOGY, V42, P1951; CHAPMAN IV, 1980, ULTRASOUND MED BIOL, V6, P47, DOI 10.1016/0301-5629(80)90063-0; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Christov-Moore L, 2017, SOC NEUROSCI-UK, V12, P174, DOI 10.1080/17470919.2016.1154105; CLASSEN J, 1995, ELECTROMYOGR MOTOR C, V97, P264, DOI 10.1016/0924-980X(95)00099-2; Collins CE, 2011, BRAIN BEHAV EVOLUT, V78, P37, DOI 10.1159/000327319; Collins CE, 2010, P NATL ACAD SCI USA, V107, P15927, DOI 10.1073/pnas.1010356107; D. T.Nguyen, 2020, bioRxiv, DOI 10.1101/2020.11.26.400580; DAVEY NJ, 1994, J PHYSIOL-LONDON, V477, P223, DOI 10.1113/jphysiol.1994.sp020186; Deffieux T, 2013, CURR BIOL, V23, P2430, DOI 10.1016/j.cub.2013.10.029; Deffieux T, 2010, IEEE T ULTRASON FERR, V57, P2637, DOI 10.1109/TUFFC.2010.1738; Desideri D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208747; Di Lazzaro V, 2008, BRAIN STIMUL, V1, P345, DOI 10.1016/j.brs.2008.07.004; Duck F A, 1990, PHYS PROPERTIES TISS; Estebanez L, 2017, CELL REP, V20, P308, DOI 10.1016/j.celrep.2017.06.044; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; Folloni D, 2019, NEURON, V101, P1109, DOI 10.1016/j.neuron.2019.01.019; Fomenko A, 2020, ELIFE, V9, DOI 10.7554/eLife.54497; FRY FJ, 1958, SCIENCE, V127, P83, DOI 10.1126/science.127.3289.83; Garvey MA, 2001, CLIN NEUROPHYSIOL, V112, P1451, DOI 10.1016/S1388-2457(01)00581-8; Gavrilov L R, 1976, Prog Brain Res, V43, P279; Gavrilov LR, 1996, ULTRASOUND MED BIOL, V22, P179, DOI 10.1016/0301-5629(96)83782-3; Gibson BC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01007; Gordon PC, 2018, BRAIN STIMUL, V11, P1322, DOI 10.1016/j.brs.2018.08.003; Greffrath W, 2007, PAIN, V132, P301, DOI 10.1016/j.pain.2007.04.026; Guo HS, 2018, NEURON, V98, P1020, DOI 10.1016/j.neuron.2018.04.036; Hayner M, 2001, J ACOUST SOC AM, V110, P3319, DOI 10.1121/1.1410964; Heimbuch IS., 2021, BIORXIV, DOI [10.1101/2021.06.03.446963, DOI 10.1101/2021.06.03.446963]; HESS CW, 1987, NEUROSCI LETT, V82, P47, DOI 10.1016/0304-3940(87)90169-8; HESS CW, 1987, J PHYSIOL-LONDON, V388, P397, DOI 10.1113/jphysiol.1987.sp016621; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Hupfeld KE, 2020, J NEUROSCI METH, V346, DOI 10.1016/j.jneumeth.2020.108950; Hynynen K, 1998, ULTRASOUND MED BIOL, V24, P275, DOI 10.1016/S0301-5629(97)00269-X; Ilic TV, 2002, J PHYSIOL-LONDON, V545, P153, DOI 10.1113/jphysiol.2002.030122; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jones RM, 2016, PHYS MED BIOL, V61, P23, DOI 10.1088/0031-9155/61/1/23; Kallioniemi E, 2015, J CLIN NEUROPHYSIOL, V32, P346, DOI 10.1097/WNP.0000000000000177; Kaufman MT, 2013, J NEUROPHYSIOL, V110, P817, DOI 10.1152/jn.00892.2011; Kim H, 2014, BRAIN STIMUL, V7, P748, DOI 10.1016/j.brs.2014.06.011; Kwon JH, 2006, J NEUROIMAGING, V16, P347, DOI 10.1111/j.1552-6569.2006.00064.x; Lee W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178476; Lee W, 2016, SCI REP-UK, V6, DOI 10.1038/srep34026; Lee W, 2015, SCI REP-UK, V5, DOI 10.1038/srep08743; Lefaucheur JP, 2014, CLIN NEUROPHYSIOL, V125, P2150, DOI 10.1016/j.clinph.2014.05.021; Legon W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28320-1; Legon W, 2018, HUM BRAIN MAPP, V39, P1995, DOI 10.1002/hbm.23981; Legon W, 2014, NAT NEUROSCI, V17, P322, DOI 10.1038/nn.3620; Liebetanz D, 2003, J PSYCHIATR RES, V37, P277, DOI 10.1016/S0022-3956(03)00017-7; Lutkenhoff ES, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115551; Mayka MA, 2006, NEUROIMAGE, V31, P1453, DOI 10.1016/j.neuroimage.2006.02.004; McGregor KM, 2011, BEHAV BRAIN RES, V222, P158, DOI 10.1016/j.bbr.2011.03.042; McIntyre CC, 2002, J NEUROPHYSIOL, V88, P1592, DOI 10.1152/jn.2002.88.4.1592; Menz MD, 2013, J NEUROSCI, V33, P4550, DOI 10.1523/JNEUROSCI.3521-12.2013; Miller GW, 2015, MED PHYS, V42, P2223, DOI 10.1118/1.4916656; Moller C, 2009, CLIN NEUROPHYSIOL, V120, P1003, DOI 10.1016/j.clinph.2009.03.001; Mohammadjavadi M, 2019, BRAIN STIMUL, V12, P901, DOI 10.1016/j.brs.2019.03.005; MORTIMER AJ, 1988, ULTRASOUND MED BIOL, V14, P499, DOI 10.1016/0301-5629(88)90111-1; Mueller J, 2014, BRAIN STIMUL, V7, P900, DOI 10.1016/j.brs.2014.08.008; Murty O.P., 2009, J FORENSIC MED TOXIC, V26, P26; Nakamura H, 1997, J PHYSIOL-LONDON, V498, P817, DOI 10.1113/jphysiol.1997.sp021905; Nowak LG, 1998, EXP BRAIN RES, V118, P477, DOI 10.1007/s002210050304; O'Brien WD, 2007, PROG BIOPHYS MOL BIO, V93, P212, DOI 10.1016/j.pbiomolbio.2006.07.010; Oberman L, 2011, J CLIN NEUROPHYSIOL, V28, P67, DOI 10.1097/WNP.0b013e318205135f; Pichardo S, 2011, PHYS MED BIOL, V56, P219, DOI 10.1088/0031-9155/56/1/014; Plaksin M, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0136-15.2016; Premoli I, 2014, NEUROIMAGE, V103, P152, DOI 10.1016/j.neuroimage.2014.09.028; Priori A, 1998, NEUROREPORT, V9, P2257, DOI 10.1097/00001756-199807130-00020; R Core Team, 2020, R LANG ENV STAT COMP; RINALDI PC, 1991, BRAIN RES, V558, P36, DOI 10.1016/0006-8993(91)90711-4; Robertson JLB, 2017, J ACOUST SOC AM, V141, P1726, DOI 10.1121/1.4976339; Roth Y, 2007, J CLIN NEUROPHYSIOL, V24, P31, DOI 10.1097/WNP.0b013e31802fa393; Sato T, 2018, NEURON, V98, P1031, DOI 10.1016/j.neuron.2018.05.009; Sen T, 2015, ANATOL J CARDIOL, V15, P334, DOI 10.5152/akd.2015.6061; Shattuck DW, 2002, MED IMAGE ANAL, V6, P129, DOI 10.1016/S1361-8415(02)00054-3; Spagnolo F, 2013, BRAIN STIMUL, V6, P892, DOI 10.1016/j.brs.2013.05.004; Strauss S, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00012; ter Haar G, 2011, ULTRASOUND MED BIOL, V37, P177, DOI 10.1016/j.ultrasmedbio.2010.10.021; Thut G, 2009, TRENDS COGN SCI, V13, P182, DOI 10.1016/j.tics.2009.01.004; Treeby BE, 2014, J ACOUST SOC AM, V136, P1499, DOI 10.1121/1.4894790; Treeby BE, 2012, J ACOUST SOC AM, V131, P4324, DOI 10.1121/1.4712021; Treeby BE, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3360308; Tufail Y, 2010, NEURON, V66, P681, DOI 10.1016/j.neuron.2010.05.008; Tyler WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003511; Vance J, 2004, J MOTOR BEHAV, V36, P450, DOI 10.3200/JMBR.36.4.450-459; Verhagen L, 2019, ELIFE, V8, DOI 10.7554/eLife.40541; Wagner T, 2007, ANNU REV BIOMED ENG, V9, P527, DOI 10.1146/annurev.bioeng.9.061206.133100; Warbrick T, 2009, J CLIN NEUROPHYSIOL, V26, P117, DOI 10.1097/WNP.0b013e31819d8016; WASSERMANN EM, 1993, ELECTROEN CLIN NEURO, V89, P424, DOI 10.1016/0168-5597(93)90116-7; Werhahn KJ, 1999, J PHYSIOL-LONDON, V517, P591, DOI 10.1111/j.1469-7793.1999.0591t.x; White PJ, 2006, PHYS MED BIOL, V51, P2293, DOI 10.1088/0031-9155/51/9/013; WILSON SA, 1995, ELECTROMYOGR MOTOR C, V97, P55, DOI 10.1016/0924-980X(94)00274-B; Wolters A., 2012, OXFORD HDB TRANSCRAN; Xia X, 2021, NEUROIMAGE, V243, DOI 10.1016/j.neuroimage.2021.118557; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Yu K, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22743-7; Zachry T, 2005, BRAIN RES BULL, V67, P304, DOI 10.1016/j.brainresbull.2005.06.035; Zeng K, 2022, ANN NEUROL, V91, P238, DOI 10.1002/ana.26294; Ziemann U, 2015, CLIN NEUROPHYSIOL, V126, P1847, DOI 10.1016/j.clinph.2014.08.028	107	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0267268	10.1371/journal.pone.0267268	http://dx.doi.org/10.1371/journal.pone.0267268			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35442956	Green Submitted, Green Published, gold			2022-12-26	WOS:000822608900049
J	Zhang, CZ; Li, W; Li, XY; Wan, DB; Mack, S; Zhang, JJ; Wagner, K; Wang, C; Tan, BW; Chen, J; Wu, CW; Tsuji, K; Takeuchi, M; Chen, ZP; Hammock, BD; Pinkerton, KE; Yang, J				Zhang, Chuanzhen; Li, Wei; Li, Xiyuan; Wan, Debin; Mack, Savannah; Zhang, Jingjing; Wagner, Karen; Wang, Chang; Tan, Bowen; Chen, Jason; Wu, Ching-Wen; Tsuji, Kaori; Takeuchi, Minoru; Chen, Ziping; Hammock, Bruce D.; Pinkerton, Kent E.; Yang, Jun			Novel aerosol treatment of airway hyper-reactivity and inflammation in a murine model of asthma with a soluble epoxide hydrolase inhibitor	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; IN-VITRO; TARGET; HYPERRESPONSIVENESS; BIOSYNTHESIS; ACIDS	Asthma currently affects more than 339 million people worldwide. In the present preliminary study, we examined the efficacy of a new, inhalable soluble epoxide hydrolase inhibitor (sEHI), 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU), to attenuate airway inflammation, mucin secretion, and hyper-responsiveness (AHR) in an ovalbumin (OVA)-sensitized murine model. Male BALB/c mice were divided into phosphate-buffered saline (PBS), OVA, and OVA+TPPU (2- or 6-h) exposure groups. On days 0 and 14, the mice were administered PBS or sensitized to OVA in PBS. From days 26-38, seven challenge exposures were performed with 30 min inhalation of filtered air or OVA alone. In the OVA+TPPU groups, a 2- or 6-h TPPU inhalation preceded each 30-min OVA exposure. On day 39, pulmonary function tests (PFTs) were performed, and biological samples were collected. Lung tissues were used to semi-quantitatively evaluate the severity of inflammation and airway constriction and the volume of stored intracellular mucosubstances. Bronchoalveolar lavage (BAL) and blood samples were used to analyze regulatory lipid mediator profiles. Significantly (p < 0.05) attenuated alveolar, bronchiolar, and pleural inflammation; airway resistance and constriction; mucosubstance volume; and inflammatory lipid mediator levels were observed with OVA+TPPU relative to OVA alone. Cumulative findings indicated TPPU inhalation effectively inhibited inflammation, suppressed AHR, and prevented mucosubstance accumulation in the murine asthmatic model. Future studies should determine the pharmacokinetics (i.e., absorption, distribution, metabolism, and excretion) and pharmacodynamics (i.e., concentration/dose responses) of inhaled TPPU to explore its potential as an asthma-preventative or -rescue treatment.	[Zhang, Chuanzhen; Chen, Ziping] Shandong First Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Jinan, Shandong, Peoples R China; [Zhang, Chuanzhen; Chen, Ziping] Shandong Prov Qianfoshan Hosp, Jinan, Shandong, Peoples R China; [Zhang, Chuanzhen; Li, Xiyuan; Mack, Savannah; Zhang, Jingjing; Chen, Jason; Wu, Ching-Wen; Pinkerton, Kent E.] Univ Calif Davis, Ctr Hlth & Environm, Davis, CA 95616 USA; [Li, Wei; Li, Xiyuan] Shandong Univ, Sch Control Sci & Engn, Jinan, Shandong, Peoples R China; [Wan, Debin; Wagner, Karen; Wang, Chang; Tan, Bowen; Hammock, Bruce D.; Yang, Jun] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA; [Wan, Debin; Wagner, Karen; Wang, Chang; Tan, Bowen; Hammock, Bruce D.; Yang, Jun] Univ Calif Davis, Comprehens Canc Ctr, Davis, CA 95616 USA; [Tsuji, Kaori; Takeuchi, Minoru] Kyoto Sangyo Univ, Dept Anim Med Sci, Kyoto, Japan	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; University of California System; University of California Davis; Shandong University; University of California System; University of California Davis; University of California System; University of California Davis; Kyoto Sangyo University	Pinkerton, KE (corresponding author), Univ Calif Davis, Ctr Hlth & Environm, Davis, CA 95616 USA.; Li, W (corresponding author), Shandong Univ, Sch Control Sci & Engn, Jinan, Shandong, Peoples R China.; Yang, J (corresponding author), Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA.; Yang, J (corresponding author), Univ Calif Davis, Comprehens Canc Ctr, Davis, CA 95616 USA.	cindy@sdu.edu.cn; kepinkerton@ucdavis.edu; junyang@ucdavis.edu	Zhang, Jing/HII-4294-2022	D'Evelyn, Savannah M/0000-0002-2003-0245; Tan, Bowen/0000-0003-3036-2881	American Asthma Foundation [15-Hamm-Ex1]; NIEHS/Superfund Research Program P42 [ES004699]; NIH/NIEHS R35 [ES030443]; National Institute for Occupational Safety and Health [OHO7550]; National Institute of Environmental Health Sciences [ES023513, OD011107]	American Asthma Foundation; NIEHS/Superfund Research Program P42; NIH/NIEHS R35; National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by grants from the American Asthma Foundation 15-Hamm-Ex1, NIEHS/Superfund Research Program P42 (ES004699), NIH/NIEHS R35 (ES030443), National Institute for Occupational Safety and Health (OHO7550), and the National Institute of Environmental Health Sciences P30 (ES023513) and P51 (OD011107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, GLOB STRAT ASTHM MAN; [Anonymous], 2018, GLOB ASTHM REP 2018; Arnold WR, 2016, BIOCHEMISTRY-US, V55, P6969, DOI 10.1021/acs.biochem.6b01037; Bastan I, 2018, J LEUKOCYTE BIOL, V104, P109, DOI 10.1002/JLB.3MA1017-423R; Boulet LP, 2018, CURR OPIN PULM MED, V24, P56, DOI 10.1097/MCP.0000000000000441; Carr TF, 2021, ANN ALLERG ASTHMA IM, V127, P530, DOI 10.1016/j.anai.2021.05.027; Chandel A, 2019, BIOMED PHARMACOTHER, V112, DOI 10.1016/j.biopha.2019.108601; Chong Jasmine, 2019, Curr Protoc Bioinformatics, V68, pe86, DOI 10.1002/cpbi.86; Devos FC, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0610-1; Dharmage SC, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00246; Dileepan M, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01118; Fehrenbach H, 2017, CELL TISSUE RES, V367, P551, DOI 10.1007/s00441-016-2566-8; Gras D, 2013, PHARMACOL THERAPEUT, V140, P290, DOI 10.1016/j.pharmthera.2013.07.008; Gur ZT, 2018, EUR J MED CHEM, V153, P34, DOI 10.1016/j.ejmech.2017.07.019; Hajimohammadi B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01940; Hammad H, 2021, CELL, V184, P2521, DOI 10.1016/j.cell.2021.04.019; Hammock BD, 2021, J MED CHEM, V64, P1856, DOI 10.1021/acs.jmedchem.0c01886; He JL, 2016, J DIABETES, V8, P305, DOI 10.1111/1753-0407.12358; Hildreth K, 2020, J NUTR BIOCHEM, V86, DOI 10.1016/j.jnutbio.2020.108484; Holguin F, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00588-2019; Hu J, 2017, NATURE, V552, P248, DOI 10.1038/nature25013; Jakiela B, 2013, PROSTAG OTH LIPID M, V106, P116, DOI 10.1016/j.prostaglandins.2013.05.001; Jiang JX, 2020, RESP RES, V21, DOI 10.1186/s12931-020-1281-x; Jiang JX, 2020, EUR J PHARMACOL, V868, DOI 10.1016/j.ejphar.2019.172874; Karra L, 2015, MUCOSAL IMMUNOL, V8, P852, DOI 10.1038/mi.2014.116; Kim DI, 2019, BMC PULM MED, V19, DOI 10.1186/s12890-019-1001-9; Ku SK, 2012, ARCH PHARM RES, V35, P1073, DOI 10.1007/s12272-012-0615-8; Kundu S, 2013, J LIPID RES, V54, P436, DOI 10.1194/jlr.M031914; Lazaar AL, 2016, BRIT J CLIN PHARMACO, V81, P971, DOI 10.1111/bcp.12855; Lee KSS, 2014, J MED CHEM, V57, P7016, DOI 10.1021/jm500694p; Lee-Sarwar KA, 2020, METABOLITES, V10, DOI 10.3390/metabo10030097; Levan SR, 2019, NAT MICROBIOL, V4, P1851, DOI 10.1038/s41564-019-0498-2; Levy BD, 2005, AM J RESP CRIT CARE, V172, P824, DOI 10.1164/rccm.200410-1413OC; Lu KD, 2016, PEDIATR EXERC SCI, V28, P264, DOI 10.1123/pes.2015-0122; Matsumoto N, 2019, BIOCHEM BIOPH RES CO, V515, P248, DOI 10.1016/j.bbrc.2019.05.088; Meshram D, 2020, RECENT PATENTS INFLA, V14, P15, DOI 10.2174/1872213X14666200130095040; Miles C, 2017, NPJ PRIM CARE RESP M, V27, DOI 10.1038/s41533-017-0056-4; Morin C, 2010, AM J RESP CELL MOL, V43, P564, DOI 10.1165/rcmb.2009-0155OC; Morin C, 2009, AM J PHYSIOL-LUNG C, V296, pL130, DOI 10.1152/ajplung.90436.2008; Nayeem MA, 2018, ACTA PHARMACOL SIN, V39, P1142, DOI 10.1038/aps.2018.24; Newman JW, 2005, PROG LIPID RES, V44, P1, DOI 10.1016/j.plipres.2004.10.001; NICE, 2021, ASTHM DIAGN MON CHRO; Norton SK, 2012, J ALLERGY CLIN IMMUN, V130, P761, DOI 10.1016/j.jaci.2012.04.023; Ono E, 2014, AM J RESP CRIT CARE, V190, P886, DOI 10.1164/rccm.201403-0544OC; Rand AA, 2019, J LIPID RES, V60, P1996, DOI 10.1194/jlr.M094219; Russell RJ, 2017, CLIN SCI, V131, P1723, DOI 10.1042/CS20160253; Sisemore MF, 2001, ARCH BIOCHEM BIOPHYS, V392, P32, DOI 10.1006/abbi.2001.2434; Song GH, 2019, PHYTOTHER RES, V33, P2702, DOI 10.1002/ptr.6444; Viswanathan S, 2003, J AM COLL NUTR, V22, P502, DOI 10.1080/07315724.2003.10719328; Wagner KM, 2017, PHARMACOL THERAPEUT, V180, P62, DOI 10.1016/j.pharmthera.2017.06.006; Wan DB, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00464; Wang H, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0522-6; Wang L, 2012, AM J RESP CELL MOL, V46, P614, DOI 10.1165/rcmb.2011-0359OC; Whelan J, 2013, ADV NUTR, V4, P311, DOI 10.3945/an.113.003772; Wu CW, 2020, TOXICOL PATHOL, V48, P422, DOI 10.1177/0192623319893312; Yang J, 2015, AM J RESP CELL MOL, V52, P46, DOI 10.1165/rcmb.2013-0440OC; Yang J, 2009, ANAL CHEM, V81, P8085, DOI 10.1021/ac901282n; Zeki AA, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12352; Zhou Y, 2017, SHOCK, V47, P638, DOI 10.1097/SHK.0000000000000767; Zhou Y, 2016, CELL TISSUE RES, V363, P399, DOI 10.1007/s00441-015-2262-0	60	0	0	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0266608	10.1371/journal.pone.0266608	http://dx.doi.org/10.1371/journal.pone.0266608			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35443010	Green Published, gold			2022-12-26	WOS:000822608900027
J	Carvalho, GR; Faria, WR; Nardy, VPDR; Betarelli, AA				Carvalho, Glauco Rodrigues; Faria, Weslem Rodrigues; Nardy, Vinicius Pimenta Delgado Ribeiro; Betarelli Junior, Admir Antonio			Hedonic pricing analysis for semen of dairy bulls in Brazil	PLOS ONE			English	Article							SEXED SEMEN; ARTIFICIAL-INSEMINATION; MILK; SELECTION; QUALITY; CATTLE; FAT; ECONOMICS; PREMIUMS; INDEXES	Dairy farming is an important aspect of the Brazilian agricultural sector. The presence of numerous producers has created a large number of jobs in this field, contributing significantly to the rural economy. Artificial insemination (AI), used as one of the main means of reproduction, is increasingly gaining importance in the genetic improvement of animals. Given this scenario, the semen of bulls has become extremely marketable and an important aspect of the animal industry. This study aims to develop a hedonic model for the price of semen doses of dairy bulls based on the information from the main sellers of the product in the Brazilian market. The main findings reveal that there is an additional premium for proven bulls. Semen doses from Gir bulls proved to be more expensive, and the AI firm ALTA has a discount compared to the other firms. From the characteristics obtained in the tests, there is a premium only for the Predicted Transmitting Ability-Milk (volume). The most valued feature found is the dose being sexed, that is, the dose that guarantees the gestation of a female from its use. Semen doses from dead bulls has proved to be more expensive.	[Carvalho, Glauco Rodrigues] Empresa Brasileira Pesquisa Agr EMBRAPA, Juiz De Fora, MG, Brazil; [Faria, Weslem Rodrigues; Nardy, Vinicius Pimenta Delgado Ribeiro; Betarelli Junior, Admir Antonio] Univ Fed Juizde Fora, Fac Econ, Campus Univ, Juiz De Fora, MG, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Faria, WR (corresponding author), Univ Fed Juizde Fora, Fac Econ, Campus Univ, Juiz De Fora, MG, Brazil.	weslem.faria@ufjf.edu.br		Nardy, Vinicius/0000-0002-4461-0244	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [302792/2019-8]; EMBRAPA Gado de Leite -Juiz de Fora; Universidade Federal de Juiz de For a (UFJF)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); EMBRAPA Gado de Leite -Juiz de Fora(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Universidade Federal de Juiz de For a (UFJF)	Grants: 1) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). Award number: 302792/2019-8. Recipient: Weslem Rodrigues Faria. 2) EMBRAPA Gado de Leite -Juiz de Fora. There is no Award number. Recipient: Glauco Rodrigues Carvalho. 3) Universidade Federal de Juiz de For a (UFJF). There is no Award number. Recipient: Weslem Rodrigues Faria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acciani C, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13010185; Alvarez R. H, 2008, ARTIGO HYPERTEXTO; ASBIAAssociao Brasileira de Inseminao Artificial, 2018, REL INDEX; Ballco P, 2018, SPAN J AGRIC RES, V16, DOI 10.5424/sjar/2018162-12130; Bimbo F, 2016, J DAIRY SCI, V99, P1095, DOI 10.3168/jds.2015-10018; Bittante G, 2021, J DAIRY SCI, V104, P3210, DOI 10.3168/jds.2020-18436; BOWMAN KR, 1992, AM J AGR ECON, V74, P991, DOI 10.2307/1243197; Buccola S, 1997, AM J AGR ECON, V79, P452, DOI 10.2307/1244143; Butler ST, 2014, ANIMAL, V8, P165, DOI 10.1017/S1751731114000664; Carlucci D, 2013, AGRIBUSINESS, V29, P194, DOI 10.1002/agr.21332; Clasen JB, 2021, J DAIRY SCI, V104, P8062, DOI 10.3168/jds.2020-20028; Costanigro M., 2011, The Oxford Handbook of the economics of food consumption and policy, P152; da Costa MD, 2021, TROP ANIM HEALTH PRO, V53, DOI 10.1007/s11250-020-02462-9; De Vries A, 2020, ANIM REPROD, V17, DOI [10.1590/1984-3143-AR2020-0020, 10.1590/1984-3143-ar2020-0020]; Ettema JF, 2017, J DAIRY SCI, V100, P4161, DOI 10.3168/jds.2016-11333; Gaya G.L., 2014, REV BRAS SAUDE PROD, V15; Gillmeister W. J., 1996, Review of Agricultural Economics, V18, P181, DOI 10.2307/1349431; HILLERS JK, 1980, J DAIRY SCI, V63, P322, DOI 10.3168/jds.S0022-0302(80)82933-X; Hossein-Zadeh NG, 2010, ANIM REPROD SCI, V121, P17, DOI 10.1016/j.anireprosci.2010.05.012; IBGE-Instituto Brasileiro de Geografia e Estatistica, 2019, CONH CID EST BRAS; IBGEInstituto Brasileiro de Geografia e Estatstica, 2018, PESQ PEC MUN 2018; Jiang RZ, 2021, FOOD RES INT, V141, DOI 10.1016/j.foodres.2020.110006; KENNEDY PE, 1981, AM ECON REV, V71, P801; KIRKLAND JJ, 1986, AM J AGR ECON, V68, P44, DOI 10.2307/1241648; LADD GW, 1976, AM J AGR ECON, V58, P504, DOI 10.2307/1239267; LANCASTER KJ, 1966, J POLIT ECON, V74, P132, DOI 10.1086/259131; Leitch H. W, 1994, P ANN INT ANN M OTT; LENZ JE, 1994, AM J AGR ECON, V76, P492, DOI 10.2307/1243660; LENZ JE, 1991, J DAIRY SCI, V74, P1803, DOI 10.3168/jds.S0022-0302(91)78345-8; Lima FS, 2010, J DAIRY SCI, V93, P4404, DOI 10.3168/jds.2009-2789; Loke MK, 2015, J DAIRY SCI, V98, P2824, DOI 10.3168/jds.2014-8867; Madalena FE, 2000, REV BRAS ZOOTECN, V29, P678, DOI 10.1590/S1516-35982000000300006; Madalena Fernando Enrique, 1996, Revista da Sociedade Brasileira de Zootecnia, V25, P428; McConnell KE, 2000, AM J AGR ECON, V82, P133, DOI 10.1111/0002-9092.00011; McCullock K, 2013, J DAIRY SCI, V96, P6366, DOI 10.3168/jds.2013-6672; Miglior F, 2005, J DAIRY SCI, V88, P1255, DOI 10.3168/jds.S0022-0302(05)72792-2; Nightingale C, 2008, J DAIRY SCI, V91, P1236, DOI 10.3168/jds.2007-0609; Oczkowski E, 2001, ECON REC, V77, P374, DOI 10.1111/1475-4932.00030; Osada M, 2019, ANIM SCI J, V90, P597, DOI 10.1111/asj.13156; Prata MA, 2015, GENET MOL RES, V14, P12585, DOI 10.4238/2015.October.19.2; Qi X, 2021, FOOD QUAL PREFER, V92, DOI 10.1016/j.foodqual.2021.104229; Richards TJ, 1996, CAN J AGR ECON, V44, P251, DOI 10.1111/j.1744-7976.1996.tb00149.x; Rosewarne S, 2019, J AUST POLIT ECON, P5; Rudstrom M, 2004, REV AGR ECON, V26, P552, DOI 10.1111/j.1467-9353.2004.00199.x; Seidel GE, 2014, ANIMAL, V8, P160, DOI 10.1017/S1751731114000202; Severo N.C., 2009, REV VET ZOOTECNIA MI, V101, P16; Vishwanath R, 2003, THERIOGENOLOGY, V59, P571, DOI 10.1016/S0093-691X(02)01241-4; Vleck L. D. Van, 1981, New technologies in animal breeding, P221; Walsh DP, 2021, J DAIRY SCI, V104, P3181, DOI 10.3168/jds.2020-18676; Waugh FV, 1928, J FARM ECON, V10, P185, DOI 10.2307/1230278; WILMINK JBM, 1988, LIVEST PROD SCI, V20, P299, DOI 10.1016/0301-6226(88)90025-5; Yang TY, 2020, FOOD SCI NUTR, V8, P5362, DOI 10.1002/fsn3.1757; Yim ES, 2014, INT J HOSP MANAG, V39, P11, DOI 10.1016/j.ijhm.2014.01.010; Zhang Y, 2020, INT FOOD AGRIBUS MAN, V23, P487, DOI 10.22434/IFAMR2019.0212	54	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267109	10.1371/journal.pone.0267109	http://dx.doi.org/10.1371/journal.pone.0267109			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7VA	35439267	Green Published, gold			2022-12-26	WOS:000791280100024
J	Cheetham, AG; Plunkett, S; Campbell, P; Hilldrup, J; Coffa, BG; Gilliland, S; Eckard, S				Cheetham, Andrew G.; Plunkett, Susan; Campbell, Preston; Hilldrup, Jacob; Coffa, Bonnie G.; Gilliland, Stan, III; Eckard, Steve			Analysis and differentiation of tobacco-derived and synthetic nicotine products: Addressing an urgent regulatory issue	PLOS ONE			English	Article							ENANTIOMERIC COMPOSITION; GAS-CHROMATOGRAPHY; UNITED-STATES; NORNICOTINE; ANABASINE; ANATABINE	There is significant regulatory and economic need to distinguish analytically between tobacco-derived nicotine (TDN) and synthetic nicotine (SyN) in commercial products. Currently, commercial e-liquid and oral pouch products are available that contain tobacco-free nicotine, which could be either extracted from tobacco or synthesized. While tobacco products that contain TDN are regulated by FDA Center for Tobacco Products, those with SyN are currently not in the domain of any regulatory authority. This regulatory difference provides an economic incentive to use or claim the use of SyN to remain on the market without submitting a Premarket Tobacco Product Application. TDN is similar to 99.3% (S)-nicotine, whereas SyN can vary from racemic (50/50 (R)/(S)) to >= 99% (S)-nicotine, i.e., chemically identical to the tobacco-derived compound. Here we report efforts to distinguish between TDN and SyN in various samples by characterizing impurities, (R)/(S)-nicotine enantiomer ratio, (R)/(S)nornicotine enantiomer ratio, and carbon-14 (C-14) content. Only C-14 analysis accurately and precisely differentiated TDN (100% C-14) from SyN (35-38% C-14) in all samples tested. C-14 quantitation of nicotine samples by accelerator mass spectrometry is a reliable determinate of nicotine source and can be used to identify misbranded product labelled as containing SyN. This is the first report to distinguish natural, bio-based nicotine from synthetic, petroleum-based nicotine across a range of pure nicotine samples and commercial e-liquid products.	[Cheetham, Andrew G.; Plunkett, Susan; Hilldrup, Jacob; Coffa, Bonnie G.; Eckard, Steve] Enthalpy Analyt LLC, Richmond, VA 23237 USA; [Plunkett, Susan; Campbell, Preston; Gilliland, Stan, III] Consilium Sci LLC, Richmond, VA USA		Cheetham, AG (corresponding author), Enthalpy Analyt LLC, Richmond, VA 23237 USA.	andrew.cheetham@enthalpy.com		Cheetham, Andrew/0000-0002-9933-9877; Gilliland III, Stanley/0000-0002-5335-0886				[Anonymous], 2009, FAMILY SMOKING PREVE; [Anonymous], PUFF BAR HOMEPAGE 20; [Anonymous], 2021, CHAIRMAN KRISHNAMOOR; [Anonymous], FIRMS EMBRACE SYNTHE; [Anonymous], 2020, FDA NOTIFIES CO INCL; Armstrong DW, 1998, CHIRALITY, V10, P587, DOI 10.1002/(SICI)1520-636X(1998)10:7<587::AID-CHIR6>3.3.CO;2-R; Armstrong DW, 1999, CHIRALITY, V11, P82, DOI 10.1002/(SICI)1520-636X(1999)11:1&lt;82::AID-CHIR14&gt;3.0.CO;2-C; Arnold M., 2017, Patent No. [US9,556,142B2, 9556142]; ASTM International, 2021, D686621 ASTM; Cai B, 2012, J BIOL CHEM, V287, P42804, DOI 10.1074/jbc.M112.413807; Cai B, 2012, J AGR FOOD CHEM, V60, P11586, DOI 10.1021/jf303681u; Caruso RV, 2014, INT J ENV RES PUB HE, V11, P202, DOI 10.3390/ijerph110100202; Viana GFD, 2011, ENVIRON MONIT ASSESS, V181, P255, DOI 10.1007/s10661-010-1827-3; Divi MKP, 2013, Patent No. [US8,378,111B2, 8378111]; Downey G., 2016, ADV FOOD AUTHENTICIT; Ducharme Jamie, 2021, TIME; Duell AK, 2021, CHEM RES TOXICOL, V34, P1718, DOI 10.1021/acs.chemrestox.1c00192; Food and Drug Administration, 2021, FDA MAK SIGN PROGR S; Hellinghausen G, 2018, TALANTA, V181, P132, DOI 10.1016/j.talanta.2017.12.060; Jordt SE, 2021, TOB CONTROL, DOI 10.1136/tobaccocontrol-2021-056626; Liu BZ, 2008, J CHROMATOGR B, V865, P13, DOI 10.1016/j.jchromb.2008.01.034; McCague R., 2021, Patent No. [US10,913,962B2, 10913962]; Next Generation Labs, 2021, AUTH CAS STUD HILIQN; Norcia A., 2021, FILTER MAGAZINE; O'Connor RJ, 2010, TOB CONTROL, V19, DOI 10.1136/tc.2009.030163; Park-Lee E, 2021, MMWR-MORBID MORTAL W, V70, P1387, DOI 10.15585/mmwr.mm7039a4; Rep. Sherrill Tours Superfund Sites With EPA Regional Administrator, 2021, 11 C DISTRICT; Rodrigues C, 2013, COMP ANAL C, V60, P77, DOI 10.1016/B978-0-444-59562-1.00004-9; United States Pharmacopoeial Convention, 2020, US PHARM NAT FORM US; Willis B., 2017, Patent No. [US9,809,567B2, 9809567]; Wilson Megan, 2022, POLITICO; Zeller MR, 2021, TOBACCO NICOTINE PRO	32	3	3	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267049	10.1371/journal.pone.0267049	http://dx.doi.org/10.1371/journal.pone.0267049			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421170	gold, Green Published			2022-12-26	WOS:000795453600100
J	Chen, J; Yang, YY; Yu, NN; Sun, WX; Yang, YY; Zhao, M				Chen, Jing; Yang, Yuying; Yu, Ningning; Sun, Wanxiao; Yang, Yuanyuan; Zhao, Mei			Relationship between gut microbiome characteristics and the effect of nutritional therapy on glycemic control in pregnant women with gestational diabetes mellitus	PLOS ONE			English	Article							PROBIOTIC SUPPLEMENTATION; GLUCOSE; METABOLISM; INSULIN; INTERVENTION; METAANALYSIS; SYNBIOTICS; BUTYRATE; DISEASE; IMPACT	The purpose of this study was to explore the relationship between the characteristics of gut microbiome and the effect of medical nutrition therapy (MNT) on glycemic control in pregnant women with gestational diabetes mellitus (GDM). Seventy-four pregnant women newly diagnosed with GDM received MNT for one-week. The effect of glycemic control was evaluated by fasting and 2-hour postprandial blood glucose; and stool samples of pregnant women were collected to detect the gut microbiome before and after MNT. We used a nested case-control study design, with pregnant women with GDM who did not meet glycemic standards after MNT as the ineffective group and those with an age difference of <= 5 years, matched for pre-pregnancy body mass index (BMI) 1:1, and meeting glycemic control criteria as the effective group. Comparison of the gut microbiome characteristics before MNT showed that the ineffective group was enriched in Desulfovibrio, Aeromonadales, Leuconostocaceae, Weissella, Prevotella, Bacillales_Incertae Sedis XI, Gemella and Bacillales, while the effective group was enriched in Roseburia, Clostridium, Bifidobacterium, Bifidobacteriales, Bifidobacteriaceae, Holdemania and Proteus. After treatment, the effective group was enriched in Bifidobacterium and Actinomycete, while the ineffective group was enriched in Holdemania, Proteus, Carnobacteriaceae and Granulicatella. In conclusion, the decrease in the abundance of characteristic gut microbiome positively correlated with blood glucose may be a factor influencing the poor hypoglycemic effect of MNT in pregnant women with GDM. Abundance of more characteristic gut microbiome negatively correlated with blood glucose could help control blood glucose in pregnant women with GDM.	[Chen, Jing; Yu, Ningning; Sun, Wanxiao; Zhao, Mei] Anhui Med Univ, Sch Nursing, Hefei, Anhui, Peoples R China; [Yang, Yuying] Univ Sci & Technol China, Affiliated Hosp USTC 1, Hefei Ion Med Ctr, Dept Nursing,Div Life Sci & Med, Hefei, Anhui, Peoples R China; [Yang, Yuanyuan] Anhui Med Univ, Dept Obstet & Gynecol, Affiliated Hosp 1, Hefei, Anhui, Peoples R China	Anhui Medical University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical University	Zhao, M (corresponding author), Anhui Med Univ, Sch Nursing, Hefei, Anhui, Peoples R China.	zhapmei@ahmu.edu.cn		Zhao, Mei/0000-0003-3530-0233; Chen, Jing/0000-0003-0764-969X	National Natural Science Foundation of China [81671471]; Major projects of Humanities and social sciences research projects in Colleges and universities in Anhui Province [SK2021ZD0030]; Scientific research cultivation project of Nursing College of Anhui Medical University [hlzd2020003]; Young seedling cultivation project of Nursing College of Anhui Medical University [hlqm20201903, hlqm2021037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major projects of Humanities and social sciences research projects in Colleges and universities in Anhui Province; Scientific research cultivation project of Nursing College of Anhui Medical University; Young seedling cultivation project of Nursing College of Anhui Medical University	This study was supported by National Natural Science Foundation of China (81671471), Major projects of Humanities and social sciences research projects in Colleges and universities in Anhui Province (SK2021ZD0030), Scientific research cultivation project of Nursing College of Anhui Medical University(hlzd2020003), and Young seedling cultivation project of Nursing College of Anhui Medical University (hlqm20201903, hlqm2021037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagawa S, 2021, METABOLITES, V11, DOI 10.3390/metabo11120887; Amaretti A, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02614; Aranaz P, 2021, INT J OBESITY, V45, P2261, DOI 10.1038/s41366-021-00904-4; Asgharian H, 2020, EUR J NUTR, V59, P205, DOI 10.1007/s00394-019-01900-1; Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V303, pG675, DOI 10.1152/ajpgi.00152.2012; Balsells M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h102; Barandouzi ZA, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00541; Barka EA, 2016, MICROBIOL MOL BIOL R, V80, P1, DOI 10.1128/MMBR.00019-15; Blumer I, 2013, J CLIN ENDOCR METAB, V98, P4227, DOI 10.1210/jc.2013-2465; Callaway LK, 2019, DIABETES CARE, V42, P364, DOI 10.2337/dc18-2248; Casarin RCV, 2013, J PERIODONTAL RES, V48, P30, DOI 10.1111/j.1600-0765.2012.01498.x; Caughey AB, 2017, OBSTET GYNECOL, V130, pE17, DOI 10.1097/AOG.0000000000002159; Chen MY, 2020, INT J BIOL MACROMOL, V155, P890, DOI 10.1016/j.ijbiomac.2019.11.047; Chesdachai S, 2022, J INFECTION, V84, P511, DOI 10.1016/j.jinf.2022.01.039; Cuevas-Sierra A, 2021, NUTRIENTS, V13, DOI 10.3390/nu13082710; D'Anna R, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88329-x; Dodd JM, 2019, LANCET DIABETES ENDO, V7, P15, DOI [10.1016/s2213-8587(18)30310-3, 10.1016/S2213-8587(18)30310-3]; Ericson U, 2020, J NUTR, V150, P861, DOI 10.1093/jn/nxz293; Gao CH, 2019, J DIABETES INVEST, V10, P154, DOI 10.1111/jdi.12854; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Hamilton AL, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00085-17; Han SS, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009275.pub3; Hasain Z, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.680622; Heym N, 2019, PSYCHOPHARMACOLOGY, V236, P1459, DOI 10.1007/s00213-019-05230-2; Hughes RCE, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018493; Jiang HY, 2021, J CLIN LAB ANAL, V35, DOI 10.1002/jcla.23650; Jose PA, 2021, MICROBIOL RES, V246, DOI 10.1016/j.micres.2021.126708; Kapur K., 2021, NUTR MANAGEMENT GEST, V1, P1, DOI [10.1159/000509900, DOI 10.1159/000509900]; Karamali M, 2016, DIABETES METAB, V42, P234, DOI 10.1016/j.diabet.2016.04.009; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kimber-Trojnar Z, 2014, CURR PHARM BIOTECHNO, V15, P100, DOI 10.2174/1389201015666140330200254; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Kuang YS, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix058; Lee Kyoung-Hee, 2020, Obstet Gynecol Sci, V63, P19, DOI 10.5468/ogs.2020.63.1.19; Li MX, 2020, INT J BIOL MACROMOL, V149, P717, DOI 10.1016/j.ijbiomac.2020.01.305; Lippert K, 2017, BENEF MICROBES, V8, P545, DOI 10.3920/BM2016.0184; Lu RY, 2021, INQUIRY-J HEALTH CAR, V58, DOI 10.1177/00469580211012491; Martin-Pelaez S, 2022, NUTRIENTS, V14, DOI 10.3390/nu14020341; McNabney SM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121348; Mistry SK, 2021, ENDOCRIN DIAB METAB, V4, DOI 10.1002/edm2.285; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Nie K, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.757718; Nikbakht E, 2018, EUR J NUTR, V57, P95, DOI 10.1007/s00394-016-1300-3; Olsson LM, 2020, GUT, V69, P1229, DOI 10.1136/gutjnl-2019-319322; Pan YS, 2022, J GASTROEN HEPATOL, V37, P7, DOI 10.1111/jgh.15713; Pellonpera O, 2019, DIABETES CARE, V42, P1009, DOI 10.2337/dc18-2591; Ponzo V, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020330; Qi WW, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.016352; Qian YW, 2018, BRAIN BEHAV IMMUN, V70, P194, DOI 10.1016/j.bbi.2018.02.016; Reigadas E, 2020, ANAEROBE, V61, DOI 10.1016/j.anaerobe.2019.102079; Rus M, 2022, MEDICINA-LITHUANIA, V58, DOI 10.3390/medicina58020271; Saleh S, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201800435; Sanmiguel C, 2015, CURR OBES REP, V4, P250, DOI 10.1007/s13679-015-0152-0; Sayavedra L, 2021, ENVIRON MICROBIOL, V23, P3164, DOI 10.1111/1462-2920.15538; Shaik A, 2020, IDCases, V21, DOI 10.1016/j.idcr.2020.e00792; Sung JJY, 2020, GUT, V69, P1572, DOI 10.1136/gutjnl-2019-319826; Tarry-Adkins JL, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002848; Teixeira CG, 2021, PROBIOTICS ANTIMICRO, V13, P915, DOI 10.1007/s12602-021-09751-1; Tett A, 2021, NAT REV MICROBIOL, V19, P585, DOI 10.1038/s41579-021-00559-y; The Chinese medical association branch of obstetrics and gynaecology obstetric group, 2014, CHIN J OBSTET GYNECO, V49, P561; Tims S, 2013, ISME J, V7, P707, DOI 10.1038/ismej.2012.146; Tremblay A, 2021, J DIET SUPPL, V18, P227, DOI 10.1080/19390211.2020.1749751; Wang JK, 2020, FOOD CHEM TOXICOL, V135, DOI 10.1016/j.fct.2019.110965; Wang JF, 2018, GUT, V67, P1614, DOI 10.1136/gutjnl-2018-315988; Wang T, 2020, EUR J NUTR, V59, P2709, DOI 10.1007/s00394-019-02117-y; Wang Y, 2020, PHARMACOL RES, V157, DOI 10.1016/j.phrs.2020.104784; Wickens KL, 2017, BRIT J NUTR, V117, P804, DOI [10.1017/S0007114517000289, 10.1017/s0007114517000289]; Yamamoto JM, 2018, DIABETES CARE, V41, P1346, DOI 10.2337/dc18-0102; Yang YH, 2019, FOOD FUNCT, V10, P5952, DOI [10.1039/c9fo00766k, 10.1039/C9FO00766K]; Zhang CJ, 2021, BMC PREGNANCY CHILDB, V21, DOI 10.1186/s12884-021-04039-2; Zhang L, 2022, BIOENGINEERED, V13, P5625, DOI 10.1080/21655979.2021.2023789; Zhang MX, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2343-2; Zhang W, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109131; Zheng J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197771; Zheng JP, 2020, J ETHNOPHARMACOL, V246, DOI 10.1016/j.jep.2019.112225; Zhou LY, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00985	76	2	2	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267045	10.1371/journal.pone.0267045	http://dx.doi.org/10.1371/journal.pone.0267045			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1E2NP	35427393	Green Published, gold			2022-12-26	WOS:000794332400035
J	Hu, SS; Zhang, JY; Guo, GQ; Zhang, L; Dai, J; Gao, Y				Hu, Shangshang; Zhang, Jinyan; Guo, Guoqing; Zhang, Li; Dai, Jing; Gao, Yu			Comprehensive analysis of GSEC/miR-101-3p/SNX16/PAPOLG axis in hepatocellular carcinoma	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; LONG NONCODING RNAS; GENE-EXPRESSION; ENDOGENOUS RNA; CANCER; CERNA; PROLIFERATION; PROGNOSIS; MIGRATION; PROMOTES	Hepatocellular carcinoma (HCC) is one of the most lethal malignancies. A growing number of studies have shown that competitive endogenous RNA (ceRNA) regulatory networks might play important roles during HCC process. The present study aimed to identify a regulatory axis of the ceRNA network associated with the development of HCC. The roles of SNX16 and PAPOLG in HCC were comprehensively analyzed using bioinformatics tools. Subsequently, the "mRNA-miRNA-lncRNA" model was then used to predict the upstream miRNAs and lncRNAs of SNX16 and PAPOLG using the miRNet database, and the miRNAs with low expression and good prognosis in HCC and the lncRNAs with high expression and poor prognosis in HCC were screened by differential expression and survival analysis. Finally, the risk-prognosis models of ceRNA network axes were constructed by univariate and multifactorial Cox proportional risk analysis, and the immune correlations of ceRNA network axes were analyzed using the TIMER and GEPIA database. In this study, the relevant ceRNA network axis GSEC/miR-101-3p/SNX16/PAPOLG with HCC prognosis was constructed, in which GSEC, SNX16, and PAPOLG were highly expressed in HCC with poor prognosis, while miR-101-3p was lowly expressed in HCC with good prognosis. The risk-prognosis model predicted AUC of 0.691, 0.623, and 0.626 for patient survival at 1, 3, and 5 years, respectively. Immuno-infiltration analysis suggested that the GSEC/miR-101-3p/SNX16/PAPOLG axis might affect macrophage polarization. The GSEC/miR-101-3p/SNX16/PAPOLG axis of the ceRNA network axis might be an important factor associated with HCC prognosis and immune infiltration.	[Hu, Shangshang] Bengbu Med Coll, Res Ctr Clin Lab Sci, Sch Lab Med, Bengbu, Peoples R China; [Zhang, Jinyan; Guo, Guoqing; Zhang, Li; Dai, Jing; Gao, Yu] Bengbu Med Coll, Sch Life Sci, Bengbu, Peoples R China; [Zhang, Jinyan; Gao, Yu] Bengbu Med Coll, Anhui Prov Key Lab Translat Canc Res, Bengbu, Peoples R China	Bengbu Medical College; Bengbu Medical College; Bengbu Medical College	Gao, Y (corresponding author), Bengbu Med Coll, Sch Life Sci, Bengbu, Peoples R China.; Gao, Y (corresponding author), Bengbu Med Coll, Anhui Prov Key Lab Translat Canc Res, Bengbu, Peoples R China.	gaoyu@bbmc.edu.cn	Gao, Yu/AAU-9530-2021	Gao, Yu/0000-0002-4210-7338	Research Foundation for Advanced Talents of Bengbu Medical College [15190016]; Graduate Innovation Project of Bengbu Medical College [Byycxz20002]	Research Foundation for Advanced Talents of Bengbu Medical College; Graduate Innovation Project of Bengbu Medical College	This research was funded by Research Foundation for Advanced Talents of Bengbu Medical College (grant number 15190016, Yu Gao) and Graduate Innovation Project of Bengbu Medical College (grant number Byycxz20002, Shangshang Hu). The funder website is http://www.bbmc.edu.cn Funders didn't play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Alfa GK, 2018, NEW ENGL J MED, V379, P54, DOI 10.1056/NEJMoa1717002; Balogh J, 2016, J HEPATOCELL CARCINO, V3, P41, DOI 10.2147/JHC.S61146; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, 2017, Cell, V169, P1327, DOI 10.1016/j.cell.2017.05.046; Cao Z, 2018, BIOINFORMATICS, V34, P2185, DOI 10.1093/bioinformatics/bty085; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Chang L, 2020, NUCLEIC ACIDS RES, V48, pW244, DOI 10.1093/nar/gkaa467; Chao YJ, 2019, MED SCI MONITOR, V25, P6581, DOI 10.12659/MSM.915100; Cui MY, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00626; Ding W, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223971; Golabi P, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005904; Hilmi M, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0824-5; Ivanovska I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024582; Kong CQ, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/6638915; Kursun D, 2019, TURK J BIOL, V43, P124, DOI 10.3906/biy-1810-2; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; Lei FC, 2019, PEERJ, V7, DOI 10.7717/peerj.7135; Li BG, 2018, LIFE SCI, V197, P122, DOI 10.1016/j.lfs.2018.02.006; Li CY, 2017, AM J TRANSL RES, V9, P2088; Li H, 2020, AGING-US, V12, P3451, DOI 10.18632/aging.102821; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Li TW, 2020, NUCLEIC ACIDS RES, V48, pW509, DOI 10.1093/nar/gkaa407; Li XN, 2019, BIOMED PHARMACOTHER, V112, DOI 10.1016/j.biopha.2019.108611; Liu RF, 2020, BIOCHEM BIOPH RES CO, V532, P300, DOI 10.1016/j.bbrc.2020.08.056; Liu ZK, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1188-x; Lv L, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01575-3; Matsumura K, 2017, ONCOGENE, V36, P1191, DOI 10.1038/onc.2016.282; Pan WD, 2019, MOL ONCOL, V13, P2246, DOI 10.1002/1878-0261.12553; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sammarco G, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041176; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Shen ZY, 2020, MOL ONCOL, V14, P387, DOI 10.1002/1878-0261.12626; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Strillacci A, 2013, J PATHOL, V229, P379, DOI 10.1002/path.4097; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Teasdale RD, 2012, BIOCHEM J, V441, P39, DOI 10.1042/BJ20111226; Tian XH, 2020, MOL ONCOL, V14, P462, DOI 10.1002/1878-0261.12606; Wan SS, 2014, GASTROENTEROLOGY, V147, P1393, DOI 10.1053/j.gastro.2014.08.039; Wang H, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0680-1; Xu JX, 2017, STRUCTURE, V25, P1251, DOI 10.1016/j.str.2017.06.015; Yang Q, 2014, J MOL BIOL, V426, P43, DOI 10.1016/j.jmb.2013.09.025; Yang WW, 2012, J BIOL CHEM, V287, P40140, DOI 10.1074/jbc.M112.348763; Yao RR, 2018, WORLD J SURG ONCOL, V16, DOI 10.1186/s12957-018-1312-y; Zhang Y, 2020, INT J MOL MED, V46, P159, DOI 10.3892/ijmm.2020.4586; Zhao XX, 2017, ONCOTARGET, V8, P30576, DOI 10.18632/oncotarget.15736	45	3	3	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267117	10.1371/journal.pone.0267117	http://dx.doi.org/10.1371/journal.pone.0267117			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D8GY	35482720	Green Published, gold			2022-12-26	WOS:000794035700010
J	Li, K; Wei, HT; He, XH; Tian, ZH				Li, Ke; Wei, Haitao; He, Xiaohui; Tian, Zhihui			Relational POI recommendation model combined with geographic information	PLOS ONE			English	Article							PERSONALIZED POINT; FACTORIZATION; PREFERENCE	Point of interest (POI) recommendation is a popular personalized location-based service. This paper proposes a Geographic Personal Matrix Factorization (GPMF) model that makes effective use of geographic information from the perspective of the relationship between POIs and users. This model considers the role of geographic information from multiple perspectives based on the locational relationship among users, the distributional relationship between users and POIs, and the proximity and clustering relationship among POIs. The GPMF mines the influence of geographic information on different objects and carries out unique modeling through cosine similarity, non-linear function, and k nearest neighbor (KNN). This study explored the influence of geographic information on POI recommendation through extensive experiments with data from Foursquare. The result shows that GPMF performs better than the commonly used POI recommendation algorithm in terms of both precision and recall. Geographic information through proximity relations effectively improves the recommendation algorithm.	[Li, Ke; Wei, Haitao; He, Xiaohui; Tian, Zhihui] Zhengzhou Univ, Sch Geosci & Technol, Zhengzhou, Henan, Peoples R China; [Li, Ke; Wei, Haitao; He, Xiaohui; Tian, Zhihui] Zhengzhou Univ, Chinese Acad Meteorol Sci, Joint Lab Ecometeorol, Zhengzhou, Henan, Peoples R China	Zhengzhou University; Chinese Academy of Meteorological Sciences (CAMS); Zhengzhou University	Wei, HT (corresponding author), Zhengzhou Univ, Sch Geosci & Technol, Zhengzhou, Henan, Peoples R China.; Wei, HT (corresponding author), Zhengzhou Univ, Chinese Acad Meteorol Sci, Joint Lab Ecometeorol, Zhengzhou, Henan, Peoples R China.	zzu_wei@zzu.edu.cn			National Key Research and Development Program of China [2018YFB0505000]; Key Research and Development and Promotion Special Projects of Henan Province (Science and Technology Tackling Key Problems) [192102210124]	National Key Research and Development Program of China; Key Research and Development and Promotion Special Projects of Henan Province (Science and Technology Tackling Key Problems)	X.H was received the National Key Research and Development Program of China under grant (number 2018YFB0505000); URL: https://service.most.gov.cn/The funder support this word in study design and data collection and analysis. Z.T was received the Key Research and Development and Promotion Special Projects of Henan Province (Science and Technology Tackling Key Problems) under grant (number 192102210124). URL:http://kjt.henan.gov.cn/The funder support this word in study design and data collection and analysis.	[Anonymous], 2020, IEEE T IND INFORM, DOI DOI 10.1109/TII.2019.2958696; Bobadilla J, 2013, KNOWL-BASED SYST, V46, P109, DOI 10.1016/j.knosys.2013.03.012; [柴彦威 Chai Yanwei], 2015, [城市规划学刊, Urban Planning Forum], P61; Chang S., 2020, Point-of-Interest Recommendation based on Geographical Influence and Extended Pairwise Ranking, P966; Chen J., 2018, COMPLEXITY; Cheng C, 2016, ACM T INTEL SYST TEC, V8, DOI 10.1145/2901299; Davtalab M, 2021, KNOWL INF SYST, V63, P65, DOI 10.1007/s10115-020-01509-5; Gao R, 2018, NEUROCOMPUTING, V273, P159, DOI 10.1016/j.neucom.2017.08.020; Gunawardana A., 2009, A survey of accuracy evaluation metrics of recommendation tasks, V10; Guo JP, 2018, J MANAGE INFORM SYST, V35, P1121, DOI 10.1080/07421222.2018.1523564; Guo L, 2019, SOFT COMPUT, V23, P11935, DOI 10.1007/s00500-018-03748-9; Hao PY, 2019, NEUROCOMPUTING, V349, P1, DOI 10.1016/j.neucom.2019.04.022; Hao W, 2020, MODELING POI SPECIFI, P130; He J., 2016, Inferring a Personalized Next Point-of-Interest Recommendation Model with Latent Behavior Patterns, P137; Hu L, P 37 INT ACM SIGIR C, P345; Hu L, 2019, NEUROCOMPUTING, V363, P58, DOI 10.1016/j.neucom.2019.07.040; Hu Y, P26372; Jiao X, 2019, FUTURE GENER COMP SY, V100, P982, DOI 10.1016/j.future.2019.05.065; Koren Y, 2009, COMPUTER, V42, P30, DOI 10.1109/MC.2009.263; Li X, P433; Li X W, 2007, CHINESE J NATURE, V29, P69; Li X, 2017, ACM T INFORM SYST, V35, DOI 10.1145/3057283; Lian DF, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P831, DOI 10.1145/2623330.2623638; Liu C., 2019, ISPRS INT J GEO-INF, V8, DOI DOI 10.1016/j.knosys.2018.08.031; Lu J, 2015, DECIS SUPPORT SYST, V74, P12, DOI 10.1016/j.dss.2015.03.008; Ma C, 2018, CIKM'18: PROCEEDINGS OF THE 27TH ACM INTERNATIONAL CONFERENCE ON INFORMATION AND KNOWLEDGE MANAGEMENT, P697, DOI 10.1145/3269206.3271733; Pan R, P50211; Pan ZG, 2019, IEEE ACCESS, V7, P99496, DOI 10.1109/ACCESS.2019.2930311; Qian TY, 2019, ACM T INFORM SYST, V37, DOI 10.1145/3295499; Rahmani Hossein A., 2020, Advances in Information Retrieval, 42nd European Conference on IR Research, ECIR 2020. Proceedings. Lecture Notes in Computer Science (LNCS 12035), P205, DOI 10.1007/978-3-030-45439-5_14; Si YL, 2019, KNOWL-BASED SYST, V163, P267, DOI 10.1016/j.knosys.2018.08.031; Wang H, 2018; Wu RZ, 2018, IEEE ACCESS, V6, P10675, DOI 10.1109/ACCESS.2018.2805831; Xing SN, 2018, APPL INTELL, V48, P2458, DOI 10.1007/s10489-017-1103-0; Yang Y, 2019, IEEE T KNOWL DATA EN, V31, P757, DOI 10.1109/TKDE.2018.2842190; Yao L., 2018, ACM T INTERNET TECHN, V18, DOI DOI 10.1016/j.neucom.2017.08.020; Ye M, 2011, PROCEEDINGS OF THE 34TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL (SIGIR'11), P325; Yuan Q, 2013, SIGIR'13: THE PROCEEDINGS OF THE 36TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH & DEVELOPMENT IN INFORMATION RETRIEVAL, P363; Zeng J, 2019, INT J WEB SERV RES, V16, P40, DOI 10.4018/IJWSR.2019100103; Zhang ZB, 2019, NEUROCOMPUTING, V357, P53, DOI 10.1016/j.neucom.2019.04.079	40	1	1	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266340	10.1371/journal.pone.0266340	http://dx.doi.org/10.1371/journal.pone.0266340			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1E2NP	35427385	gold, Green Published			2022-12-26	WOS:000794332400005
J	Owolabi, EO; Adeloye, D; Ajayi, AI; McCaul, M; Davies, J; Chu, KM				Owolabi, Eyitayo Omolara; Adeloye, Davies; Ajayi, Anthony Idowu; McCaul, Michael; Davies, Justine; Chu, Kathryn M.			Lower limb amputations among individuals living with diabetes mellitus in low- and middle-income countries: A systematic review protocol	PLOS ONE			English	Review							METAANALYSIS	Background The burden of diabetes mellitus (DM) and its associated complications continue to burgeon, particularly in low- and middle-income countries (LMICs). Lower limb amputation (LLA) is one of the most life-altering complications of DM, associated with significant morbidity, mortality and socio-economic impacts. High-income countries have reported a decreasing incidence of DM-associated LLA, but the situation in many LMICs is unknown. We aim to conduct a systematic review to determine the incidence and prevalence of DM-associated LLA in LMICs to better inform appropriate interventions and health system response. Methods and analysis A systematic search of the literature will be conducted on five databases: MEDLINE, Embase, Cumulative Index of Nursing and Allied Health Literature (CINAHL), Scopus and African Journal Online (AJOL). Only observational, quantitative studies reporting the incidence and/or prevalence of DM-related LLA will be considered. A validated study design-specific critical appraisal tool will be used to assess the risk of bias in individual studies. We will determine the incidence of LLA by examining the number of new cases of LLA among individuals with confirmed DM diagnosis during the specified period, while the prevalence will be based on the total number of all new and existing LLAs in a population. LLA will be considered as the resection of the lower limb from just above the knee to any point down to the toe. If heterogeneity is low to moderate, a random-effects meta-analysis will be conducted on extracted crude prevalence/incidence rates, with the median and interquartile range also reported. The systematic review will be performed in accordance with the JBI guideline for prevalence and incidence review. Study reporting will follow the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) guideline.	[Owolabi, Eyitayo Omolara; Chu, Kathryn M.] Stellenbosch Univ, Ctr Global Surg, Dept Global Hlth, Cape Town, South Africa; [Adeloye, Davies] Univ Edinburgh, Ctr Global Hlth, Usher Inst, Edinburgh, Midlothian, Scotland; [Ajayi, Anthony Idowu] Africa Populat & Hlth Res Ctr, Populat Dynam & Sexual & Reprod Hlth Unit, Nairobi, Kenya; [McCaul, Michael] Stellenbosch Univ, Dept Global Hlth, Div Epidemiol & Biostat, Cape Town, South Africa; [Davies, Justine] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England	Stellenbosch University; University of Edinburgh; African Population & Health Research Centre; Stellenbosch University; University of Birmingham	Ajayi, AI (corresponding author), Africa Populat & Hlth Res Ctr, Populat Dynam & Sexual & Reprod Hlth Unit, Nairobi, Kenya.	ajayianthony@gmail.com	; Ajayi, Anthony Idowu/N-4272-2016	Adeloye, Davies/0000-0003-1316-8139; Ajayi, Anthony Idowu/0000-0002-6004-3972				Adler AI, 2010, DIABETOLOGIA, V53, P840, DOI 10.1007/s00125-009-1638-7; Agu Thaddeus Chika, 2016, J Clin Orthop Trauma, V7, P242; Amer Diabet Assoc, 2006, DIABETES CARE, V29, pS43; Baidoo R.O., 2016, POSTGRAD MED J GHANA, V5, P80; Bommer C, 2018, DIABETES CARE, V41, P963, DOI 10.2337/dc17-1962; Collaboration C, 2011, COCHRANE CONSUMERS C; Creager MA, 2021, CIRCULATION, V143, pE875, DOI 10.1161/CIR.0000000000000967; De Klerk C, 2017, S AFR FAM PRACT, V59, DOI 10.1080/20786190.2016.1248145; Deeks JJ., 2019, COCHRANE HDB SYSTEMA, P241, DOI [DOI 10.1002/9780470712184.CH9, 10.1002/9781119536604.ch10, DOI 10.1002/9781119536604.CH10]; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Flood D, 2021, LANCET HEALTH LONGEV, V2, pE340, DOI [10.1016/S2666-7568(21)00089-1, 10.1016/s2666-7568(21)00089-1]; Frykberg Robert G, 2006, J Foot Ankle Surg, V45, pS1; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; International Diabetes Federation, 2019, IDF DIABETES ATLAS, V9th ed.; Kontopantelis E, 2012, STAT METHODS MED RES, V21, P409, DOI 10.1177/0962280210392008; Lambert AP, 2003, DIABETES CARE, V26, P333, DOI 10.2337/diacare.26.2.333; Mapa-Tassou C, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1124-7; Moher D, 2015, SYST REV, V4, DOI [10.1186/s13643-015-0087-2, 10.1186/2046-4053-4-1]; Moxey PW, 2011, DIABETIC MED, V28, P1144, DOI 10.1111/j.1464-5491.2011.03279.x; Munn Z, 2017, JOANN BRIGGS I REV M, P51; Narres M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182081; Ogbera A O, 2006, Int J Low Extrem Wounds, V5, P244, DOI 10.1177/1534734606294538; Page MJ, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n160; Sahu Anamika, 2016, Ind Psychiatry J, V25, P4, DOI 10.4103/0972-6748.196041; Sarfo-Kantanka O, 2019, BMC ENDOCR DISORD, V19, DOI 10.1186/s12902-019-0353-8; Schaper NC, 2012, DIABETOLOGIA, V55, P1869, DOI 10.1007/s00125-012-2588-z; The World Bank, WORLD BANK LEND GROU; Thiruvoipati T, 2015, WORLD J DIABETES, V6, P961, DOI 10.4239/wjd.v6.i7.961; Wells G, 2014, NEWCASTLE OTTAWA QUA; World Health Organization, DIAB 2021; Zhang YQ, 2020, DIABETES CARE, V43, P964, DOI 10.2337/dc19-1614; Zidarov D, 2009, ARCH PHYS MED REHAB, V90, P634, DOI 10.1016/j.apmr.2008.11.003	32	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266907	10.1371/journal.pone.0266907	http://dx.doi.org/10.1371/journal.pone.0266907			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421192	gold, Green Published			2022-12-26	WOS:000795453600080
J	Pronk, AC; Seppala, LJ; Trajanoska, K; Stringa, N; van de Loo, B; de Groot, LCPGM; van Schoor, NM; Koskeridis, F; Markozannes, G; Ntzani, E; Uitterlinden, AG; Rivadeneira, F; Stricker, BH; van der Velde, N				Pronk, A. C.; Seppala, L. J.; Trajanoska, K.; Stringa, N.; van de Loo, B.; de Groot, L. C. P. G. M.; van Schoor, N. M.; Koskeridis, F.; Markozannes, G.; Ntzani, E.; Uitterlinden, A. G.; Rivadeneira, F.; Stricker, B. H.; van der Velde, N.			Candidate genetic variants and antidepressant-related fall risk in middle-aged and older adults	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; CYTOCHROME-P450 ENZYMES; ABCB1 MDR1; POPULATION; POLYMORPHISMS; METAANALYSIS; CYP2C19; CYP2D6; IMPACT; PHARMACOGENETICS	Background Antidepressant use has been associated with increased fall risk. Antidepressant-related adverse drug reactions (e.g. orthostatic hypotension) depend partly on genetic variation. We hypothesized that candidate genetic polymorphisms are associated with fall risk in older antidepressant users. Methods The association between antidepressant use and falls was cross-sectionally investigated in a cohort of Dutch older adults by logistic regression analyses. In case of significant interaction product term of antidepressant use and candidate polymorphism, the association between the variant genotype and fall risk was assessed within antidepressant users and the association between antidepressant use and fall risk was investigated stratified per genotype. Secondly, a look-up of the candidate genes was performed in an existing genome-wide association study on drug-related falls in antidepressant users within the UK Biobank. In antidepressant users, genetic associations for our candidate polymorphisms for fall history were investigated. Results In antidepressant users(n = 566), for rs28371725 (CYP2D6* 41) fall risk was decreased in TC/variant allele carriers compared to CC/non-variant allele carriers (OR = 0.45, 95% CI 0.26-0.80). Concerning rs1057910 (CYP2C9* 3), fall risk was increased in CA/variant allele carriers compared to AA/non-variant allele carriers (OR = 1.95, 95% CI 1.17-3.27). Regarding, rs1045642 (ABCB1), fall risk was increased in AG/variant allele carriers compared to GG/non-variant allele carriers (OR = 1.69, 95% CI 1.07-2.69). Concerning the ABCB1-haplotype (rs1045642/rs1128503), fall risk was increased in AA-AA/variant allele carriers compared to GG-GG/non-variant allele carriers (OR = 1.86, 95% CI 1.05-3.29). In the UK Biobank, in antidepressant users(n = 34,000) T/variant-allele of rs28371725 (CYP2D* 41) was associated with increased fall risk (OR = 1.06, 95% CI 1.01-1.12). G/non-variant-allele of rs4244285 (CY2C19* 2) was associated with decreased risk (OR = 0.96, 95% CI 0.92-1.00). Conclusion This is the first study showing that certain genetic variants modify antidepressant-related fall risk. The results were not always consistent across the studies and should be validated in a study with a prospective design. However, pharmacogenetics might have value in antidepressant (de)prescribing in falls prevention.	[Pronk, A. C.; Seppala, L. J.; van de Loo, B.; van der Velde, N.] Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Amsterdam UMC, Dept Internal Med,Sect Geriatr Med, Amsterdam, Netherlands; [Trajanoska, K.; Uitterlinden, A. G.; Rivadeneira, F.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Stringa, N.; van de Loo, B.; van Schoor, N. M.] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Amsterdam UMC, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [de Groot, L. C. P. G. M.] Wageningen Univ, Dept Human Nutr & Hlth, Wageningen, Netherlands; [Koskeridis, F.; Markozannes, G.; Ntzani, E.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Ioannina, Greece; [Ntzani, E.] Brown Univ, Ctr Res Synth Hlth, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA; [Ntzani, E.] Brown Univ, Ctr Evidence Synth Hlth, Sch Publ Hlth, Providence, RI 02912 USA; [Stricker, B. H.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Vrije Universiteit Amsterdam; Wageningen University & Research; University of Ioannina; Brown University; Brown University; Erasmus University Rotterdam; Erasmus MC	Pronk, AC (corresponding author), Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Amsterdam UMC, Dept Internal Med,Sect Geriatr Med, Amsterdam, Netherlands.	a.c.pronk@amsterdamumc.nl	Markozannes, Georgios/GXM-3556-2022; Markozannes, Georgios/AAS-7269-2020	Markozannes, Georgios/0000-0001-8481-579X; Markozannes, Georgios/0000-0001-8481-579X; Pronk, anouschka/0000-0001-5154-2369; Koskeridis, Fotios/0000-0002-1253-7556; de Groot, Lisette/0000-0003-2778-2789	Clementine Brigitta Maria Dalderup fund, Amsterdam University fund [20713, 7303]; Netherlands Organization for Health Research and Development (ZonMw), The Hague [6130.0031]; NZO (Dutch Dairy Association), Zoetermeer; Orthica, Almere; Netherlands Consortium Healthy Ageing (NCHA) Leiden/Rotterdam; Ministry of Economic Affairs, Agriculture and Innovation, The Hague [KB-15-004003]; Wageningen University, Wageningen; VUmc, Amsterdam; Erasmus Medical Center, Rotterdam; Netherlands Ministry of Health, Welfare and Sports, Directorate of Long-Term Care; Netherlands Organization for Scientific Research (NWO) [480-10-014]; Erasmus MC University Medical Center Rotterdam; Erasmus University Rotterdam; Netherlands Organisation for Scientific Research (NWO); The Netherlands Organisation for Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Netherlands Genomics Initiative (NGI); Ministry of Education, Culture and Science; Ministry of Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; Welsh Government; British Heart Foundation; Cancer Research UK; Diabetes UK; National Health Service (NHS); Wellcome Trust; MRC; NIHR; Department of Health; Medical Research Council	Clementine Brigitta Maria Dalderup fund, Amsterdam University fund; Netherlands Organization for Health Research and Development (ZonMw), The Hague(Netherlands Organization for Health Research and Development); NZO (Dutch Dairy Association), Zoetermeer; Orthica, Almere; Netherlands Consortium Healthy Ageing (NCHA) Leiden/Rotterdam; Ministry of Economic Affairs, Agriculture and Innovation, The Hague; Wageningen University, Wageningen; VUmc, Amsterdam; Erasmus Medical Center, Rotterdam; Netherlands Ministry of Health, Welfare and Sports, Directorate of Long-Term Care; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Erasmus MC University Medical Center Rotterdam; Erasmus University Rotterdam; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); The Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Netherlands Genomics Initiative (NGI); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Welsh Government; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Diabetes UK(Diabetes UK); National Health Service (NHS); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR(National Institute for Health Research (NIHR)); Department of Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Clementine Brigitta Maria Dalderup fund (project numbers 20713 and 7303, receiver N. van der Velde), which is an Amsterdam University fund (https://www.auf.nl/en/about-the-fund/about.html).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The initial B-PROOF study has received funding so far by the Netherlands Organization for Health Research and Development (ZonMw, Grant 6130.0031), The Hague; unrestricted grant from NZO (Dutch Dairy Association), Zoetermeer; Orthica, Almere; Netherlands Consortium Healthy Ageing (NCHA) Leiden/Rotterdam; Ministry of Economic Affairs, Agriculture and Innovation (project KB-15-004003), The Hague; Wageningen University, Wageningen; VUmc, Amsterdam; Erasmus Medical Center, Rotterdam. The Longitudinal Aging Study Amsterdam (LASA) is largely supported by a grant from the Netherlands Ministry of Health, Welfare and Sports, Directorate of Long-Term Care. The data collection in 2012-2013 was financially supported by the Netherlands Organization for Scientific Research (NWO) in the framework of the project "New Cohorts of young old in the 21st century" (File Number 480-10-014). The Rotterdam Study is supported by the Erasmus MC University Medical Center and Erasmus University Rotterdam; The Netherlands Organisation for Scientific Research (NWO); The Netherlands Organisation for Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); The Netherlands Genomics Initiative (NGI); the Ministry of Education, Culture and Science; the Ministry of Health, Welfare and Sports; the European Commission (DG XII); and the Municipality of Rotterdam. The UK Biobank was established by the Wellcome Trust medical charity, Medical Research Council, Department of Health, Scottish Government and the Northwest Regional Development Agency. It has also received funding from the Welsh Government, British Heart Foundation, Cancer Research UK and Diabetes UK. UK Biobank is supported by the National Health Service (NHS). UK Biobank is open to bona fide researchers anywhere in the world, including those funded by academia and industry. The medical research project is a non-profit charity which has received core funding of around 133 pound Million. Core funding continues to be received from the Wellcome Trust, the MRC, and more recently, from Cancer Research UK and NIHR. UK Biobank has received additional funding for: genotyping of all 500,000 participants (from the Department of Health, Medical Research Council, British Heart Foundation) The sponsors have no role in the design or implementation of the study, data collection, data management, data analysis, data interpretation, or in the review, or approval of the manuscript.	Aarts N, 2016, INT J CLIN PHARM-NET, V38, P1311, DOI 10.1007/s11096-016-0371-9; Amsterdam LAS, 2019, LONGITUDINAL AGING S; [Anonymous], PHARMACOGENOMICS KNO; [Anonymous], ONDERZOEKSLIJN GEPER; Bertilsson L, 2007, CLIN PHARMACOL THER, V82, P606, DOI 10.1038/sj.clpt.6100358; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Carroll Norman V, 2005, J Manag Care Pharm, V11, P307; Coupland C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4551; Darowski A, 2009, DRUG AGING, V26, P381, DOI 10.2165/00002512-200926050-00002; de Klerk OL, 2013, PHARMACOGENOMICS J, V13, P349, DOI 10.1038/tpj.2012.16; de Vries M, 2018, J AM MED DIR ASSOC, V19, DOI 10.1016/j.jamda.2017.12.013; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Fabbri C, 2020, CLIN PSYCHOPHARM NEU, V18, P1, DOI 10.9758/cpn.2020.18.1.1; Fabbri C, 2018, EUR NEUROPSYCHOPHARM, V28, P945, DOI 10.1016/j.euroneuro.2018.05.009; Ham AC, 2017, J AM MED DIR ASSOC, V18, DOI 10.1016/j.jamda.2016.09.021; Ham AC, 2014, DRUG AGING, V31, P917, DOI 10.1007/s40266-014-0225-x; Hartholt KA, 2016, THER ADV DRUG SAF, V7, P39, DOI 10.1177/2042098615627806; Hartholt KA, 2011, J TRAUMA, V71, P748, DOI 10.1097/TA.0b013e3181f6f5e5; Hicks JK, 2017, CLIN PHARMACOL THER, V102, P37, DOI 10.1002/cpt.597; Hicks JK, 2015, CLIN PHARMACOL THER, V98, P127, DOI 10.1002/cpt.147; Hiemke C, 2018, PHARMACOPSYCHIATRY, V51, pE1, DOI [10.1055/s-0037-1600991, 10.1055/s-0043-116492]; Hodges LM, 2011, PHARMACOGENET GENOM, V21, P152, DOI 10.1097/FPC.0b013e3283385a1c; Hoogendijk EO, 2020, EUR J EPIDEMIOL, V35, P61, DOI 10.1007/s10654-019-00541-2; Huisman M, 2011, INT J EPIDEMIOL, V40, P868, DOI 10.1093/ije/dyq219; Ikram MA, 2020, EUR J EPIDEMIOL, V35, P483, DOI 10.1007/s10654-020-00640-5; Ikram MA, 2017, EUR J EPIDEMIOL, V32, P807, DOI 10.1007/s10654-017-0321-4; Just KS, 2017, PHARMACOGENOMICS, V18, P1281, DOI 10.2217/pgs-2017-0018; Kirchheiner J, 2004, MOL PSYCHIATR, V9, P442, DOI 10.1038/sj.mp.4001494; KNMP, GEN BACKGR TEXT PHAR; Leschziner GD, 2007, PHARMACOGENOMICS J, V7, P154, DOI 10.1038/sj.tpj.6500413; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Milat Andrew J, 2011, N S W Public Health Bull, V22, P43, DOI 10.1071/NB10065; Mrazek David A, 2010, Dialogues Clin Neurosci, V12, P69; National Center for Biotechnology Information National Library of Medicine, DATABASE SINGLE NUCL; Nevado-Holgado AJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012177; Peles AM, 2008, PROG NEURO-PSYCHOPH, V32, P1439, DOI 10.1016/j.pnpbp.2008.03.018; pharmvar, PHARMACOGENE VARIATI; Phillips KA, 2001, JAMA-J AM MED ASSOC, V286, P2270, DOI 10.1001/jama.286.18.2270; Porcelli S, 2011, EXPERT OPIN DRUG MET, V7, P1101, DOI 10.1517/17425255.2011.597740; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roberts R. L., 2002, Pharmacogenomics Journal, V2, P191, DOI 10.1038/sj.tpj.6500099; Royal Dutch Pharmacists Association (KNMP), DUTCH PHARM WORK GRO; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Samer CF, 2013, MOL DIAGN THER, V17, P165, DOI 10.1007/s40291-013-0028-5; Sarginson JE, 2010, PHARMACOGENET GENOM, V20, P467, DOI 10.1097/FPC.0b013e32833b593a; Steimer W, 2005, CLIN CHEM, V51, P376, DOI 10.1373/clinchem.2004.041327; Steimer W, 2004, CLIN CHEM, V50, P1623, DOI 10.1373/clinchem.2003.030825; Stel VS, 2004, AGE AGEING, V33, P58, DOI 10.1093/ageing/afh028; Sterke CS, 2012, BRIT J CLIN PHARMACO, V73, P812, DOI 10.1111/j.1365-2125.2011.04124.x; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Uhr M, 2008, NEURON, V57, P203, DOI 10.1016/j.neuron.2007.11.017; ukbiobank, UK BIOBANK RES ETHIC; van Poelgeest EP, 2021, EUR GERIATR MED, V12, P585, DOI 10.1007/s41999-021-00475-7; van Wijngaarden JP, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-80; Welsh S, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3391-x; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wolking S, 2015, CLIN PHARMACOKINET, V54, P709, DOI 10.1007/s40262-015-0267-1; Woolcott JC, 2009, ARCH INTERN MED, V169, P1952, DOI 10.1001/archinternmed.2009.357; Zhou SF, 2009, DRUG METAB REV, V41, P89, DOI 10.1080/03602530902843483; Zhou Y, 2017, CLIN PHARMACOL THER, V102, P688, DOI 10.1002/cpt.690	60	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266590	10.1371/journal.pone.0266590	http://dx.doi.org/10.1371/journal.pone.0266590			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421149	gold, Green Published			2022-12-26	WOS:000795453600053
J	Riley, P; Riley, A; Turtle, J; Ben-Nun, M				Riley, Pete; Riley, Allison; Turtle, James; Ben-Nun, Michal			COVID-19 deaths: Which explanatory variables matter the most?	PLOS ONE			English	Article								More than a year since the appearance of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), many questions about the disease COVID-19 have been answered; however, many more remain poorly understood. Although the situation continues to evolve, it is crucial to understand what factors may be driving transmission through different populations, both for potential future waves, as well as the implications for future pandemics. In this report, we compiled a database of more than 28 potentially explanatory variables for each of the 50 U.S. states through early May 2020. Using a combination of traditional statistical and modern machine learning approaches, we identified those variables that were the most statistically significant, and, those that were the most important. These variables were chosen to be fiduciaries of a range of possible drivers for COVID-19 deaths in the USA. We found that population-weighted population density (PWPD), some "stay at home" metrics, monthly temperature and precipitation, race/ethnicity, and chronic low-respiratory death rate, were all statistically significant. Of these, PWPD and mobility metrics dominated. This suggests that the biggest impact on COVID-19 deaths was, at least initially, a function of where you lived, and not what you did. However, clearly, increasing social distancing has the net effect of (at least temporarily) reducing the effective PWPD. Our results strongly support the idea that the loosening of "lock-down" orders should be tailored to the local PWPD. In contrast to these variables, while still statistically significant, race/ethnicity, health, and climate effects could only account for a few percent of the variability in deaths. Where associations were anticipated but were not found, we discuss how limitations in the parameters chosen may mask a contribution that might otherwise be present.	[Riley, Pete; Riley, Allison; Turtle, James; Ben-Nun, Michal] Predict Sci Inc, San Diego, CA 92121 USA		Riley, P (corresponding author), Predict Sci Inc, San Diego, CA 92121 USA.	pete@predsci.com		Riley, Pete/0000-0002-1859-456X	National Science Foundations (NSF) RAPID program [2031536]; NSF	National Science Foundations (NSF) RAPID program(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	This study was funded through a grant from the National Science Foundations (NSF) RAPID program (2031536). All authors are or were employed at Predictive Science Inc. (PSI), a commercial company, when this research was performed. The funder (NSF) provided support in the form of salaries for all authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Armitage R, 2020, LANCET PUBLIC HEALTH, V5, pE256, DOI 10.1016/S2468-2667(20)30061-X; Bansal M, 2020, DIABETES METAB SYND, V14, P247, DOI 10.1016/j.dsx.2020.03.013; Ben-Nun M, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007013; BENDEL RB, 1976, AM STAT, V30, P85, DOI 10.2307/2683800; Brettschneider B, OH HUMIDITY WHICH ST; BUCKLAND ST, 1993, J APPL ECOL, V30, P478, DOI 10.2307/2404188; CDC, STATS STAT CHRON LOW; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; CurrentResults, AV ANN PREC US STAT; Dave D, 2021, ECON INQ, V59, P29, DOI 10.1111/ecin.12944; Davies NG, 2020, NAT MED, V26, P1205, DOI 10.1038/s41591-020-0962-9; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Google, COVID 19 COMM MOB RE; Gromping U, 2006, J STAT SOFTW, V17, DOI 10.18637/jss.v017.i01; Gross CP, 2020, J GEN INTERN MED, V35, P3097, DOI 10.1007/s11606-020-06081-w; Heavey L, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.21.2000903; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; James G, 2013, SPRINGER TEXTS STAT, V103, P15, DOI 10.1007/978-1-4614-7138-7_2; jhu, COVID 19 US CAS COUN; Jin JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00152; Lau H, 2020, J MICROBIOL IMMUNOL, V53, P467, DOI 10.1016/j.jmii.2020.03.026; Liu JT, 2020, SCI TOTAL ENVIRON, V726, DOI 10.1016/j.scitotenv.2020.138513; LiveScience, MOST LEAST OB STAT S; Lotfi M, 2020, CLIN CHIM ACTA, V508, P254, DOI 10.1016/j.cca.2020.05.044; Ndairoua F, 2020, CHAOS SOLITON FRACT, V135, DOI 10.1016/j.chaos.2020.109846; R Core Team, 2021, R LANG ENV STAT; Raifman MA, 2020, AM J PREV MED, V59, P137, DOI 10.1016/j.amepre.2020.04.003; Riley P., 2017, BIORXIV172817, P172817; Riley P, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004392; Riley P, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003064; Sajadi MM, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.11834; Singh AK, 2020, DIABETES METAB SYND, V14, P303, DOI 10.1016/j.dsx.2020.04.004; Tamara A, 2020, DIABETES METAB SYND, V14, P655, DOI 10.1016/j.dsx.2020.05.020; Tuite AR, 2020, CAN MED ASSOC J, V192, pE497, DOI 10.1503/cmaj.200476; Turtle J., 2019, MEDRXIV19012807, P19012807; USCensus, CENS TABL RES; USEPA, UV IND SUN SAF; USNews, USNEWS; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Wang J., 2020, SSRN ELECT J, DOI [10.2139/ssrn.3551767, DOI 10.2139/SSRN.3551767]; Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598; Wikipedia, US STAT LOC GOV RESP; Worldpop, WORLDPOP POP; wrapper SMDfmbTHaRTUAMFuwTLl, 2019, EARTH MULTIVARIATE A; Wu X, 2020, MANAGEMENT TRANSFORMATION OF HUAWEI, P1, DOI 10.1017/9781108550987; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548; Zhang CH, 2020, J RURAL HEALTH, V36, P433, DOI 10.1111/jrh.12476; Zhu H, 2020, ESTIMATING NUMBER IN, DOI [10.25561/77731, DOI 10.25561/77731]	50	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266330	10.1371/journal.pone.0266330	http://dx.doi.org/10.1371/journal.pone.0266330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446873	gold, Green Published, Green Submitted			2022-12-26	WOS:000795468200021
J	Udomsinprasert, W; Ungsudechachai, T; Vejchapipat, P; Poovorawan, Y; Honsawek, S				Udomsinprasert, Wanvisa; Ungsudechachai, Tachatra; Vejchapipat, Paisarn; Poovorawan, Yong; Honsawek, Sittisak			Systemic cytokine profiles in biliary atresia	PLOS ONE			English	Article							LIVER; SERUM; EXPRESSION; FIBROSIS; PATHOGENESIS; INFLAMMATION; CHILDREN; INFANTS	BackgroundInflammation and immune dysregulation persuade biliary duct injury in biliary atresia (BA), a leading cause of pediatric liver transplantation given lack of specific biomarkers. We aimed to determine associations between systemic cytokine profiles and clinical parameters in BA patients and to identify potential BA biomarkers. MethodsSystemic levels of 27 cytokines were measured in 82 BA patients and 25 healthy controls using a multiplex immunoassay. Relative mRNA expressions of candidate cytokines in 20 BA livers and 5 non-BA livers were assessed using quantitative real-time PCR. ResultsHigher levels of 17 cytokines including IL-1 beta, IL-6, IL-7, IL-8, IL-9, IL-2, IL-15, eotaxin, IP-10, MCP-1, MIP-1 alpha, MIP-1 beta, G-CSF, IL-1ra, IL-4, IL-5, and IL-10 and lower levels of IFN-alpha and PDGF were significantly associated with BA. In BA patients, increased levels of IL-7, eotaxin, IP-10, and IL-13 were significantly associated with unfavorable outcomes including jaundice, fibrosis, and portal hypertension. Indeed, systemic levels of those cytokines were significantly correlated with clinical parameters indicating jaundice, fibrosis, and hepatic dysfunction in BA patients. Out of 27 cytokines, 4 (IL-8, IP-10, MCP-1, and PDGF) had potential as sensitive and specific biomarkers of BA. Of these, higher IL-8 levels were significantly associated with reduced survival of BA. In BA livers, relative mRNA expressions of IL-8, IP-10, and MCP-1 were significantly up-regulated. ConclusionsHigher levels of several cytokines including inflammatory cytokines, immunomodulatory cytokines, chemokines, and anti-inflammatory cytokines and lower levels of growth factors would reflect inflammatory and immune responses related to BA development. Among 27 cytokines, plasma IL-8 might have great potential as a diagnostic and prognostic biomarker for BA.	[Udomsinprasert, Wanvisa; Ungsudechachai, Tachatra] Mahidol Univ, Fac Pharm, Dept Biochem, Bangkok, Thailand; [Vejchapipat, Paisarn] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Fac Med, Dept Surg,Thai Red Cross Soc, Bangkok, Thailand; [Poovorawan, Yong] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Fac Med, Ctr Excellence Clin Virol,Dept Pediat, Bangkok, Thailand; [Honsawek, Sittisak] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Fac Med, Dept Biochem,Thai Red Cross Soc,Osteoarthrit & Mu, Bangkok, Thailand	Mahidol University; Chulalongkorn University; Thai Red Cross Society; Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society	Udomsinprasert, W (corresponding author), Mahidol Univ, Fac Pharm, Dept Biochem, Bangkok, Thailand.; Honsawek, S (corresponding author), Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Fac Med, Dept Biochem,Thai Red Cross Soc,Osteoarthrit & Mu, Bangkok, Thailand.	wanvisa.udo@mahidol.th; sittisak.h@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	Udomsinprasert, Wanvisa/0000-0002-1132-7442	Mahidol University; Osteoarthritis and Musculoskeleton Research Unit, Faculty of Medicine, Ratchadapiseksompotch Fund, Chulalongkorn University [CUGR63953002]	Mahidol University; Osteoarthritis and Musculoskeleton Research Unit, Faculty of Medicine, Ratchadapiseksompotch Fund, Chulalongkorn University	This research project is supported by Mahidol University (Basic Research Fund: fiscal year 2021) and Osteoarthritis and Musculoskeleton Research Unit, Faculty of Medicine, Ratchadapiseksompotch Fund, Chulalongkorn University (CUGR63953002). The funders had no role in study design, data collection and analysis,<ITALIC><BOLD> </BOLD></ITALIC>decision to publish, or preparation of the manuscript.	Aron JH, 2009, SEMIN IMMUNOPATHOL, V31, P383, DOI 10.1007/s00281-009-0154-7; Asai A, 2015, NAT REV GASTRO HEPAT, V12, P342, DOI 10.1038/nrgastro.2015.74; Bednarek J, 2018, HEPATOLOGY, V68, P1890, DOI 10.1002/hep.30051; Bonkovsky HL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206389; Deng YQ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002003; Ding XC, 2012, HEPATO-GASTROENTEROL, V59, P2357, DOI 10.5754/hge12388; El-Faramawy Amel A M, 2011, Trop Gastroenterol, V32, P50; Feldman AG, 2012, SEMIN PEDIATR SURG, V21, P192, DOI 10.1053/j.sempedsurg.2012.05.003; Holterman A, 2021, J PEDIATR SURG, V56, P1179, DOI 10.1016/j.jpedsurg.2021.03.038; Huang YH, 2007, LAB INVEST, V87, P66, DOI 10.1038/labinvest.3700490; Jian ZH, 2015, WORLD J PEDIATR, V11, P352, DOI 10.1007/s12519-015-0023-5; Jun YK, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76880-y; Kim BK, 2012, J GASTROEN HEPATOL, V27, P781, DOI 10.1111/j.1440-1746.2011.06962.x; Kobayashi H, 1999, J PEDIATR SURG, V34, P308, DOI 10.1016/S0022-3468(99)90197-5; Kobayashi H, 2006, J PEDIATR SURG, V41, P1967, DOI 10.1016/j.jpedsurg.2006.08.018; Madadi-Sanjani O, 2021, J CLIN MED, V10, DOI 10.3390/jcm10091978; Molina MF, 2019, CYTOKINE, V124, DOI 10.1016/j.cyto.2018.07.028; Narayanaswamy B, 2007, HEPATOLOGY, V46, P180, DOI 10.1002/hep.21701; Nobili V, 2004, J PEDIATR GASTR NUTR, V39, P540, DOI 10.1097/00005176-200411000-00017; Saito T, 2017, EUR J PEDIATR SURG, V27, P280, DOI 10.1055/s-0036-1592136; Santetti D, 2015, WORLD J GASTROENTERO, V21, P8927, DOI 10.3748/wjg.v21.i29.8927; Saxena V, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002069; Fratta LXS, 2015, J HEPATO-BIL-PAN SCI, V22, P846, DOI 10.1002/jhbp.297; Steuerwald NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081974; Uchida K, 2006, J PEDIATR SURG, V41, P1657, DOI 10.1016/j.jpedsurg.2006.05.058; Weng HL, 2007, HEPATOLOGY, V46, P1257, DOI 10.1002/hep.21806; Wong VWS, 2010, HEPATOLOGY, V51, P454, DOI 10.1002/hep.23312; Wu JF, 2012, LIVER INT, V32, P1557, DOI 10.1111/liv.12001; Zagory JA, 2015, CURR OPIN PEDIATR, V27, P389, DOI 10.1097/MOP.0000000000000214	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267363	10.1371/journal.pone.0267363	http://dx.doi.org/10.1371/journal.pone.0267363			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C1KV	35452452	Green Published, gold			2022-12-26	WOS:000792887700029
J	Lovern, SB; Van Hart, R				Lovern, Sarah B.; Van Hart, Rochelle			Impact of oxytetracycline exposure on the digestive system microbiota of Daphnia magna	PLOS ONE			English	Article							WASTE-WATER; ANTIBIOTIC-RESISTANCE; ENVIRONMENTAL-IMPACT; PHARMACEUTICALS; LIVESTOCK; TOXICITY; BACTERIA; REMOVAL; RISK	Antibiotics are used to treat serious illness, but may also be used extraneously or as a preventative measure in many farm animals. This usage increases the potential for unintentional exposure to a variety of organisms. When antibiotics enter aquatic environments, Daphnia magna are especially vulnerable as they filter-feed in freshwater environments. Oxytetracycline (OTC) is a commonly-used broad-spectrum antibiotic used to treat a variety of mammalian diseases. In this study, the impact of OTC on D. magna mortality and gut biota were studied using both cultivation and sequencing-based approaches. Mortality rates were extremely low with the LD50 >2,000ppm. However, OTC impacted abundance and species diversity of intestinal microorganisms in the gut of the D. magna in abundance as well as species diversity. In control organisms, Pseudomonas putida and Aeromonas hydrophila were both present while only P. putida was found in OTC-exposed organisms. Disruption of the intestinal biota in D. magna could have implications on long-term survival, energy expenditure, and reproduction.	[Lovern, Sarah B.; Van Hart, Rochelle] Concordia Univ Wisconsin, Dept Life & Earth Sci, Mequon, WI 53097 USA		Lovern, SB (corresponding author), Concordia Univ Wisconsin, Dept Life & Earth Sci, Mequon, WI 53097 USA.	sarah.lovern@cuw.edu			Mick A. Naulin Foundation; Concordia University Earth and Life Science Department	Mick A. Naulin Foundation; Concordia University Earth and Life Science Department	Funding for this research was provided by the Mick A. Naulin Foundation and Concordia University Earth and Life Science Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar S., 1992, US EPA ARCH, P5; Agwuh KN, 2006, J ANTIMICROB CHEMOTH, V58, P256, DOI 10.1093/jac/dkl224; Akbar S, 2020, SCI TOTAL ENVIRON, V705, DOI 10.1016/j.scitotenv.2019.135827; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; [Anonymous], 2011, PFIZ MAT SAF DAT SHE; ATT Bioquest Inc, 2017, ATT BIOQUEST INC; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Barkema HW, 2009, J DAIRY SCI, V92, P4717, DOI 10.3168/jds.2009-2347; Callens M, 2020, FEMS MICROBIOL ECOL, V96, DOI 10.1093/femsec/fiaa128; Coetzee JF, 2005, VET PARASITOL, V127, P61, DOI 10.1016/j.vetpar.2004.08.017; Compassion in World Farming, 2011, ANT FARM AN PROD; Croswell A, 2009, INFECT IMMUN, V77, P2741, DOI 10.1128/IAI.00006-09; Doi AM, 2000, J AQUAT ANIM HEALTH, V12, P246, DOI 10.1577/1548-8667(2000)012&lt;0246:TKOODI&gt;2.0.CO;2; Ebele Anekwe Jennifer, 2017, Emerging Contaminants, V3, P1, DOI 10.1016/j.emcon.2016.12.004; ELMUND GK, 1971, B ENVIRON CONTAM TOX, V6, P129, DOI 10.1007/BF01540093; Flaherty CM, 2005, CHEMOSPHERE, V61, P200, DOI 10.1016/j.chemosphere.2005.02.016; Genewiz Inc, 2019, US; Gorokhova E, 2015, ENVIRON SCI TECHNOL, V49, P5779, DOI 10.1021/acs.est.5b00833; GUSTAFSON RH, 1991, J DAIRY SCI, V74, P1428, DOI 10.3168/jds.S0022-0302(91)78299-4; Han GH, 2006, ENVIRON TOXICOL CHEM, V25, P265, DOI 10.1897/05-193R.1; Hellweger FL, 2011, INT J ENV RES PUB HE, V8, P480, DOI 10.3390/ijerph8020480; Huang MH, 2012, PROCESS SAF ENVIRON, V90, P141, DOI 10.1016/j.psep.2011.08.008; Jaimes-Duenez J, 2018, TICKS TICK-BORNE DIS, V9, P1286, DOI 10.1016/j.ttbdis.2018.05.009; JONES JG, 1977, FRESHWATER BIOL, V7, P67, DOI 10.1111/j.1365-2427.1977.tb01659.x; JURGENS K, 1994, MARINE MICROBIAL FOOD WEBS, 1994, VOL 8, NO 1 AND 2, P295; Kemper N, 2008, ECOL INDIC, V8, P1, DOI 10.1016/j.ecolind.2007.06.002; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Li D, 2008, ENVIRON TOXICOL CHEM, V27, P80, DOI 10.1897/07-080.1; Li D, 2010, APPL ENVIRON MICROB, V76, P3444, DOI 10.1128/AEM.02964-09; Li Y, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091803; Lovern SB, 2006, ENVIRON TOXICOL CHEM, V25, P1132, DOI 10.1897/05-278R.1; McMAHON J. W., 1965, LIMNOL OCEANOGR, V10, P105; Meinertz JR, 2011, B ENVIRON CONTAM TOX, V87, P621, DOI 10.1007/s00128-011-0415-8; Muuka G. M., 2017, Journal of Veterinary Medicine and Animal Health, V9, P110, DOI 10.5897/jvmah2017.0573; Om C, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0147-y; Pereira AMPT, 2015, ENVIRON RES, V136, P108, DOI 10.1016/j.envres.2014.09.041; Qiting J., 1988, WATER TREATMENT, V3, P285; Ruhl JB, 2000, ECOL LAW QUART, V27, P263; Simon NS, 2005, ENVIRON SCI TECHNOL, V39, P3480, DOI 10.1021/es049039k; Stumpf M, 1999, SCI TOTAL ENVIRON, V225, P135, DOI 10.1016/S0048-9697(98)00339-8; Thorp JH, 2010, AQUAT ECOL SER, P1; Tullo E, 2019, SCI TOTAL ENVIRON, V650, P2751, DOI 10.1016/j.scitotenv.2018.10.018; Turker G, 2018, ECOTOX ENVIRON SAFE, V147, P349, DOI 10.1016/j.ecoenv.2017.08.044; U.S. Environmental Protection Agency, 1994, STANDARD OPERATING P; Watkinson AJ, 2009, SCI TOTAL ENVIRON, V407, P2711, DOI 10.1016/j.scitotenv.2008.11.059; Zhou SYD, 2020, ENVIRON INT, V136, DOI 10.1016/j.envint.2019.105359	46	1	1	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0265944	10.1371/journal.pone.0265944	http://dx.doi.org/10.1371/journal.pone.0265944			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476627	Green Published, gold			2022-12-26	WOS:000840124300005
J	Said, EA; Al-Dughaishi, S; Al-Hatmi, W; Al-Reesi, I; Al-Riyami, M; Al-Balushi, MS; Al-Bimani, A; Al-Busaidi, JZ; Al-Khabori, M; Al-Kindi, S; Procopio, FA; Al-Rashdi, A; Al-Ansari, A; Babiker, H; Koh, CY; Al-Naamani, K; Pantaleo, G; Al-Jabri, AA				Said, Elias A.; Al-Dughaishi, Sumaya; Al-Hatmi, Wadha; Al-Reesi, Iman; Al-Riyami, Marwa; Al-Balushi, Mohammed S.; Al-Bimani, Atika; Al-Busaidi, Juma Z.; Al-Khabori, Murtadha; Al-Kindi, Salam; Procopio, Francesco A.; Al-Rashdi, Afrah; Al-Ansari, Aliyaa; Babiker, Hamza; Koh, Crystal Y.; Al-Naamani, Khalid; Pantaleo, Giuseppe; Al-Jabri, Ali A.			Human macrophages and monocyte-derived dendritic cells stimulate the proliferation of endothelial cells through midkine production	PLOS ONE			English	Article							NF-KAPPA-B; GROWTH-FACTOR MIDKINE; CYTOKINE MIDKINE; NUCLEAR-FACTOR; SERUM MIDKINE; T-CELLS; DIFFERENTIATION; ACTIVATION; CANCER; PROGRESSION	The cytokine midkine (MK) is a growth factor that is involved in different physiological processes including tissue repair, inflammation, the development of different types of cancer and the proliferation of endothelial cells. The production of MK by primary human macrophages and monocyte-derived dendritic cells (MDDCs) was never described. We investigated whether MK is produced by primary human monocytes, macrophages and MDDCs and the capacity of macrophages and MDDCs to modulate the proliferation of endothelial cells through MK production. The TLR stimulation of human monocytes, macrophages and MDDCs induced an average of approximate to 200-fold increase in MK mRNA and the production of an average of 78.2, 62, 179 pg/ml MK by monocytes, macrophages and MDDCs respectively (p < 0.05). MK production was supported by its detection in CD11c(+) cells, CLEC4C(+) cells and CD68(+) cells in biopsies of human tonsils showing reactive lymphoid follicular hyperplasia. JSH-23, which selectively inhibits NF-kappa B activity, decreased the TLR-induced production of MK in PMBCs, macrophages and MDDCs compared to the control (p < 0.05). The inhibition of MK production by macrophages and MDDCs using anti-MK siRNA decreased the capacity of their supernatants to stimulate the proliferation of endothelial cells (p = 0.01 and 0.04 respectively). This is the first study demonstrating that the cytokine MK is produced by primary human macrophages and MDDCs upon TLR triggering, and that these cells can stimulate endothelial cell proliferation through MK production. Our results also suggest that NF-kappa B plays a potential role in the production of MK in macrophages and MDDCs upon TLR stimulation. The production of MK by macrophages and MDDCs and the fact that these cells can enhance the proliferation of endothelial cells by producing MK are novel immunological phenomena that have potentially important therapeutic implications.	[Said, Elias A.; Al-Dughaishi, Sumaya; Al-Hatmi, Wadha; Al-Reesi, Iman; Al-Balushi, Mohammed S.; Al-Bimani, Atika; Al-Busaidi, Juma Z.; Koh, Crystal Y.; Al-Jabri, Ali A.] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Microbiol & Immunol, Muscat, Oman; [Al-Riyami, Marwa; Al-Rashdi, Afrah] Sultan Qaboos Univ, Dept Pathol, Coll Med & Hlth Sci, Muscat, Oman; [Al-Khabori, Murtadha; Al-Kindi, Salam] Sultan Qaboos Univ, Dept Hematol, Coll Med & Hlth Sci, Muscat, Oman; [Procopio, Francesco A.; Pantaleo, Giuseppe] Univ Lausanne, CHUV, Dept Med, Lab AIDS Immunopathogenesis, Lauzane, Switzerland; [Al-Ansari, Aliyaa] Sultan Qaboos Univ, Coll Sci, Dept Biol, Muscat, Oman; [Babiker, Hamza] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Biochem, Muscat, Oman; [Al-Naamani, Khalid] Armed Force Hosp, Dept Med, Muscat, Oman	Sultan Qaboos University; Sultan Qaboos University; Sultan Qaboos University; University of Lausanne; Sultan Qaboos University; Sultan Qaboos University	Said, EA (corresponding author), Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Microbiol & Immunol, Muscat, Oman.	Elias.Said@gmail.com			Sultan Qaboos University [IG/MED/MICR/18/02]	Sultan Qaboos University	Author funded EAS. Grant number IG/MED/MICR/18/02. Funder: Sultan Qaboos University (https://www.squ.edu.om/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIDOME K, 1995, JPN J CANCER RES, V86, P655, DOI 10.1111/j.1349-7006.1995.tb02449.x; Biriken D, 2018, MIKROBIYOL BUL, V52, P147, DOI 10.5578/mb.66745; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Bosisio D, 2018, CURR OPIN IMMUNOL, V53, P180, DOI 10.1016/j.coi.2018.05.011; Bosshart H, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.08.53; Cai YQ, 2020, CYTOKINE, V135, DOI 10.1016/j.cyto.2020.155242; Cao Y, 2017, J APPL TOXICOL, V37, P1359, DOI 10.1002/jat.3470; Cerezo-Wallis D, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1073-3; Chang W, 2020, J INTENSIVE CARE MED, V35, P1290, DOI 10.1177/0885066619861580; Choudhuri R, 1997, CANCER RES, V57, P1814; Cohen S, 2012, J IMMUNOL, V188, P259, DOI 10.4049/jimmunol.1101468; Collin M, 2018, IMMUNOLOGY, V154, P3, DOI 10.1111/imm.12888; Dalton HJ, 2014, CANCER RES, V74, P1287, DOI 10.1158/0008-5472.CAN-13-2825; Deng H, 2021, NEURAL REGEN RES, V16, P1582, DOI 10.4103/1673-5374.303036; Eiz-Vesper B, 2020, TRANSFUS MED HEMOTH, V47, P429, DOI 10.1159/000512729; Fan NG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088299; Filippou PS, 2020, ONCOGENE, V39, P2040, DOI 10.1038/s41388-019-1124-8; Friedl P, 2001, TRENDS IMMUNOL, V22, P187, DOI 10.1016/S1471-4906(01)01869-5; Golinski ML, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00032; Gong XT, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/6656622; Guo XF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15770-3; Hallissey CM, 2014, J INFECT DIS, V209, P1847, DOI 10.1093/infdis/jit819; Hassan WA, 2019, EGYPT RHEUMATOL, V41, P189, DOI 10.1016/j.ejr.2018.11.001; Homme RP, 2021, AM J PATHOL, V191, P947, DOI 10.1016/j.ajpath.2021.01.016; Hung YJ, 2011, AM J CLIN PATHOL, V136, P594, DOI 10.1309/AJCPWT70XOVXSVGE; Ikematsu S, 2000, BRIT J CANCER, V83, P701, DOI 10.1054/bjoc.2000.1339; Inazumi T, 1997, ARCH DERMATOL RES, V289, P471, DOI 10.1007/s004030050223; Jakubzick CV, 2017, NAT REV IMMUNOL, V17, P349, DOI 10.1038/nri.2017.28; Jones DR, 2014, BRIT J PHARMACOL, V171, P2925, DOI 10.1111/bph.12601; KADOMATSU K, 1990, J CELL BIOL, V110, P607, DOI 10.1083/jcb.110.3.607; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kosugi T, 2007, LAB INVEST, V87, P903, DOI 10.1038/labinvest.3700599; Krzystek-Korpacka M, 2010, INFLAMM BOWEL DIS, V16, P208, DOI 10.1002/ibd.21011; Kumar A, 2011, DIABETES OBES METAB, V13, P750, DOI 10.1111/j.1463-1326.2011.01402.x; Land Walter G, 2015, Sultan Qaboos Univ Med J, V15, pe157; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Marongiu L, 2019, J LEUKOCYTE BIOL, V106, P147, DOI 10.1002/JLB.3MIR1218-483RR; Marpaung Blondina, 2018, Open Access Maced J Med Sci, V6, P1323, DOI 10.3889/oamjms.2018.315; Maruyama K, 2004, ARTHRITIS RHEUM-US, V50, P1420, DOI 10.1002/art.20175; Masuda T, 2017, AM J PATHOL, V187, P740, DOI 10.1016/j.ajpath.2016.12.006; Miller RL, 2008, DRUG NEWS PERSPECT, V21, P69, DOI 10.1358/dnp.2008.21.2.1188193; Muramatsu T, 2010, P JPN ACAD B-PHYS, V86, P410, DOI 10.2183/pjab.86.410; Narita H, 2008, J VASC SURG, V47, P1322, DOI 10.1016/j.jvs.2007.12.037; Nordin SL, 2013, J INNATE IMMUN, V5, P519, DOI 10.1159/000346709; Patel AA, 2017, J EXP MED, V214, P1913, DOI 10.1084/jem.20170355; Pereira TF, 2020, BMC RES NOTES, V13, DOI 10.1186/s13104-020-4914-8; Pham LV, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00147; Rathnasamy G, 2014, INVEST OPHTH VIS SCI, V55, P5878, DOI 10.1167/iovs.13-13718; Said EA, 2002, J BIOL CHEM, V277, P37492, DOI 10.1074/jbc.M201194200; Said EA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158265; Said EA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153191; Schroder M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157387; Segura E, 2013, TRENDS IMMUNOL, V34, P440, DOI 10.1016/j.it.2013.06.001; Shaheen KYA, 2015, INT J HEPATOL, V2015, DOI 10.1155/2015/146389; Shaygannejad V, 2014, IRAN J IMMUNOL, V11, P134, DOI IJIv11i2A8; Shin HM, 2004, FEBS LETT, V571, P50, DOI 10.1016/j.febslet.2004.06.056; Shindo E, 2017, MOD RHEUMATOL, V27, P54, DOI 10.1080/14397595.2016.1179860; Stent G, 2002, CYTOMETRY, V48, P167, DOI 10.1002/cyto.10118; Stoica GE, 2002, J BIOL CHEM, V277, P35990, DOI 10.1074/jbc.M205749200; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; Takeuchi H, 2014, BRIT J PHARMACOL, V171, P931, DOI 10.1111/bph.12499; Tsai SL, 2020, ELIFE, V9, DOI 10.7554/eLife.50765; Ud-Din S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124502; UEHARA K, 1992, J BIOCHEM-TOKYO, V111, P563, DOI 10.1093/oxfordjournals.jbchem.a123797; Vangeti S, 2019, J IMMUNOL, V202, P2069, DOI 10.4049/jimmunol.1801191; Vaure C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00316; Vrankova S, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9814038; Wagar LE, 2021, NAT MED, V27, P125, DOI 10.1038/s41591-020-01145-0; Wang JY, 2008, P NATL ACAD SCI USA, V105, P3915, DOI 10.1073/pnas.0709592105; Wang P, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00110; Wang Q, 2018, PHARMACOL BIOCHEM BE, V169, P59, DOI 10.1016/j.pbb.2018.04.005; Weckbach LT, 2012, AM J PHYSIOL-HEART C, V303, pH429, DOI 10.1152/ajpheart.00934.2011; Wu GC, 2017, ONCOTARGET, V8, P40181, DOI 10.18632/oncotarget.13658; Wykes M, 2000, IMMUNOLOGY, V100, P1, DOI 10.1046/j.1365-2567.2000.00044.x; You ZB, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-6; Zhang YW, 2016, SCI REP-UK, V6, DOI 10.1038/srep29447	77	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267662	10.1371/journal.pone.0267662	http://dx.doi.org/10.1371/journal.pone.0267662			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476724	Green Published, gold			2022-12-26	WOS:000840124300063
J	Yu, HG; Bijian, K; da Silva, SD; Su, J; Morand, G; Spatz, A; Alaoui-Jamali, MA				Yu, Henry G.; Bijian, Krikor; da Silva, Sabrina D.; Su, Jie; Morand, Gregoire; Spatz, Alan; Alaoui-Jamali, Moulay A.			NEDD9 links anaplastic thyroid cancer stemness to chromosomal instability through integrated centrosome asymmetry and DNA sensing regulation	ONCOGENE			English	Article							PROGNOSTIC IMPLICATIONS; METASTASIS; CELLS; ACTIVATION; CARCINOMA; EVOLUTION; HETEROGENEITY; AMPLIFICATION; ASSOCIATION; MECHANISMS	Stemness and chromosomal instability (CIN) are two common contributors to intratumor heterogeneity and therapy relapse in advanced cancer, but their interplays are poorly defined. Here, in anaplastic thyroid cancer (ATC), we show that ALDH+ stem-like cancer cells possess increased CIN-tolerance owing to transcriptional upregulation of the scaffolding protein NEDD9. Thyroid patient tissues and transcriptomic data reveals NEDD9/ALDH1A3 to be co-expressed and co-upregulated in ATC. Compared to bulk ALDH- cells, ALDH+ cells were highly efficient at propagating CIN due to their intrinsic tolerance of both centrosome amplification and micronuclei. ALDH+ cells mitigated the fitness-impairing effects of centrosome amplification by partially inactivating supernumerary centrosomes. Meanwhile, ALDH+ cells also mitigated cell death caused by micronuclei-mediated type 1 interferon secretion by suppressing the expression of the DNA-sensor protein STING. Both mechanisms of CIN-tolerance were lost upon RNAi-mediated NEDD9 silencing. Both in vitro and in vivo, NEDD9-depletion attenuated stemness, CIN, cell/tumor growth, while enhancing paclitaxel effectiveness. Collectively, these findings reveal that ATC progression can involve an ALDH1A3/NEDD9-regulated program linking their stemness to CIN-tolerance that could be leveraged for ATC treatment.	[Yu, Henry G.; Bijian, Krikor; da Silva, Sabrina D.; Su, Jie; Morand, Gregoire; Spatz, Alan; Alaoui-Jamali, Moulay A.] McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Lady Davis Inst Med Res, Dept Med, Montreal, PQ, Canada; [Yu, Henry G.; Bijian, Krikor; da Silva, Sabrina D.; Su, Jie; Morand, Gregoire; Spatz, Alan; Alaoui-Jamali, Moulay A.] McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ, Canada; [da Silva, Sabrina D.; Morand, Gregoire] McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Lady Davis Inst Med Res, Dept Otolaryngol Head & Neck Surg, Montreal, PQ, Canada; [Spatz, Alan] McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Lady Davis Inst Med Res, Dept Pathol, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University; Lady Davis Institute; McGill University; Lady Davis Institute; McGill University	Alaoui-Jamali, MA (corresponding author), McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Lady Davis Inst Med Res, Dept Med, Montreal, PQ, Canada.; Alaoui-Jamali, MA (corresponding author), McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ, Canada.	moulay.alaoui-jamali@mcgill.ca		Spatz, Alan/0000-0003-3020-1420; Morand, Gregoire/0000-0002-6150-6772	Canadian Institutes of Health Research [178116]; McGill Interdisciplinary Initiative in Infection and Immunity (MI4); Swiss Cancer League [BIL KFS-3002-082012]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); McGill Interdisciplinary Initiative in Infection and Immunity (MI4); Swiss Cancer League	This study was supported by the Canadian Institutes of Health Research (Grant#178116) and in part by McGill Interdisciplinary Initiative in Infection and Immunity (MI4); GB Morand was supported by the Swiss Cancer League (BIL KFS-3002-082012).	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Ahn J, 2012, J CELL SCI, V125, P1814, DOI 10.1242/jcs.101444; Bajar BT, 2016, NAT METHODS, V13, P993, DOI [10.1038/NMETH.4045, 10.1038/nmeth.4045]; Bakhoum SF, 2018, NATURE, V553, P467, DOI 10.1038/nature25432; Bakhoum SF, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a029611; Bible KC, 2021, THYROID, V31, P337, DOI 10.1089/thy.2020.0944; Binder JX, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau012; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan JY, 2011, INT J BIOL SCI, V7, P1122, DOI 10.7150/ijbs.7.1122; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chen H, 2016, MOL BIOL EVOL, V33, P4, DOI 10.1093/molbev/msv212; Cosenza MR, 2017, CELL REP, V20, P1906, DOI 10.1016/j.celrep.2017.08.005; Feng Y, 2012, CANCER RES, V72, P6502, DOI 10.1158/0008-5472.CAN-12-1909; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gabbasov R, 2018, ONCOGENE, V37, P4854, DOI 10.1038/s41388-018-0296-y; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Ganly I, 2014, THYROID, V24, P662, DOI 10.1089/thy.2013.0503; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gentili M, 2019, CELL REP, V26, P2377, DOI 10.1016/j.celrep.2019.01.105; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; Heiden KB, 2014, J CLIN ENDOCR METAB, V99, pE2178, DOI 10.1210/jc.2014-1844; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Hopfner KP, 2020, NAT REV MOL CELL BIO, V21, P501, DOI 10.1038/s41580-020-0244-x; Isham CR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004358; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Izumchenko E, 2009, CANCER RES, V69, P7198, DOI 10.1158/0008-5472.CAN-09-0795; Jin YJ, 2014, INT J CANCER, V134, P2294, DOI 10.1002/ijc.28568; JOHNSON TL, 1988, AM J SURG PATHOL, V12, P22, DOI 10.1097/00000478-198801000-00003; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Knutson DC, 2008, ARCH BIOCHEM BIOPHYS, V477, P163, DOI 10.1016/j.abb.2008.06.005; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Li W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065095; Lin RY, 2011, NAT REV ENDOCRINOL, V7, P609, DOI 10.1038/nrendo.2011.127; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Lohard S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13689-y; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; Malta TM, 2018, CELL, V173, P338, DOI 10.1016/j.cell.2018.03.034; Marcato P, 2011, CELL CYCLE, V10, P1378, DOI 10.4161/cc.10.9.15486; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Mariappan A, 2019, EMBO J, V38, DOI 10.15252/embj.201899876; McGranahan N, 2017, CELL, V168, P613, DOI 10.1016/j.cell.2017.01.018; Miao YX, 2019, CELL, V177, P1172, DOI 10.1016/j.cell.2019.03.025; Milunovic-Jevtic A, 2016, CURR OPIN BIOTECH, V40, P113, DOI 10.1016/j.copbio.2016.03.011; Miranda A, 2019, P NATL ACAD SCI USA, V116, P9020, DOI 10.1073/pnas.1818210116; Molinaro E, 2017, NAT REV ENDOCRINOL, V13, P644, DOI 10.1038/nrendo.2017.76; Morel AP, 2017, NAT MED, V23, P568, DOI 10.1038/nm.4323; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Nagayama Y, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00020; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Paludan SR, 2019, NAT REV IMMUNOL, V19, P141, DOI 10.1038/s41577-018-0117-0; Pillai S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10072; Prabakaran T, 2018, EMBO J, V37, DOI 10.15252/embj.201797858; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Quintyne NJ, 2005, SCIENCE, V307, P127, DOI 10.1126/science.1104905; Ranjan R, 2019, CELL STEM CELL, V25, P666, DOI 10.1016/j.stem.2019.08.014; Reeb N., 2015, J THYROID DISORD THE, V4, P2, DOI [10.4172/2167-7948.1000e179, DOI 10.4172/2167-7948.1000E179]; Shagisultanova E, 2015, GENE, V567, P1, DOI 10.1016/j.gene.2015.04.086; Shah JV, 2000, CELL, V103, P997, DOI 10.1016/S0092-8674(00)00202-6; Shimamura M, 2014, ENDOCR J, V61, P481, DOI 10.1507/endocrj.EJ13-0526; Shiraiwa K, 2019, THYROID, V29, P674, DOI 10.1089/thy.2018.0212; Singh MK, 2007, CELL BIOCHEM BIOPHYS, V48, P54, DOI 10.1007/s12013-007-0036-3; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; Todaro M, 2010, CANCER RES, V70, P8874, DOI 10.1158/0008-5472.CAN-10-1994; Visciano C, 2015, ONCOGENE, V34, P5175, DOI 10.1038/onc.2014.441; Wang ZP, 2017, ONCOTARGET, V8, P1714, DOI 10.18632/oncotarget.13852; Wilkens L, 2004, P NATL ACAD SCI USA, V101, P1309, DOI 10.1073/pnas.0305817101; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2008, J CELL BIOL, V180, P261, DOI 10.1083/jcb.200707083; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910; Zhou W, 2014, LEUKEMIA, V28, P1155, DOI 10.1038/leu.2013.383; Zhu XG, 2019, ENDOCR-RELAT CANCER, V26, P739, DOI 10.1530/ERC-19-0107; Zierhut C, 2019, CELL, V178, P302, DOI 10.1016/j.cell.2019.05.035	74	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 20	2022	41	21					2984	2999		10.1038/s41388-022-02317-7	http://dx.doi.org/10.1038/s41388-022-02317-7		APR 2022	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	1L8MU	35449243				2022-12-26	WOS:000784606800001
J	Chen, P; Callisaya, M; Wills, K; Greenaway, T; Winzenberg, T				Chen, Pamela; Callisaya, Michele; Wills, Karen; Greenaway, Timothy; Winzenberg, Tania			Cognition, educational attainment and diabetes distress predict poor health literacy in diabetes: A cross-sectional analysis of the SHELLED study	PLOS ONE			English	Article							OLDER-ADULTS; DEPRESSION; OUTCOMES; RISK; TOOL	Objectives To identify factors that predict poor health literacy amongst people with diabetes. Design Cross-sectional analysis of baseline data from a prospective study of diabetic foot disease. Setting Patients attending a tertiary hospital diabetes outpatient clinic in Tasmania, Australia. Participants 222 people with diabetes mellitus, aged >40 years, with no history of foot ulceration, psychotic disorders or dementia. Outcome measures Health literacy was measured using the short form Test of Functional Health Literacy in Adults (functional health literacy), and the Health Literacy Questionnaire (HLQ), which measures nine domains of health literacy. Predictors included demographic characteristics, cognition, diabetes distress, depression, and educational attainment. Results In multivariable analysis, greater educational attainment (OR 0.88, 95% CI 0.76, 0.99) and poorer cognition (OR 0.71, 95% CI 0.63, 0.79) were associated with poorer functional health literacy. Age was negatively associated with domains of appraisal of health information and ability to find good health information (both beta = -0.01). Educational attainment was positively associated with four domains, namely having sufficient information to manage my health, actively managing my health, appraisal of and ability to find good health information (beta ranging from +0.03 to 0.04). Diabetes distress was negatively associated with five domains: having sufficient information to manage my health, social support for health, ability to actively engage with healthcare providers, navigating the healthcare system and ability to find good health information (beta ranging from -0.14 to -0.18). Conclusion Poorer cognition and poorer educational attainment may be detrimental for an individual's functional health literacy, and education, diabetes distress and older age detrimental across multiple health literacy domains. Clinicians and policy makers should be attuned to these factors when communicating with people with diabetes and in designing healthcare systems to be more health-literacy friendly in order to improve diabetes outcomes.	[Chen, Pamela; Greenaway, Timothy; Winzenberg, Tania] Univ Tasmania, Sch Med, Hobart, Tas, Australia; [Callisaya, Michele; Wills, Karen; Winzenberg, Tania] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia	University of Tasmania; University of Tasmania; Menzies Institute for Medical Research	Chen, P (corresponding author), Univ Tasmania, Sch Med, Hobart, Tas, Australia.	pamelachen@iinet.net.au		Chen, Pamela/0000-0001-8082-5050	Australian Podiatry Education and Research Fund [CNT05006]	Australian Podiatry Education and Research Fund	This study has been funded by the Australian Podiatry Education and Research Fund (CNT05006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216402; ABS, 2008, HLTH LITERACY AUSTR; Al Sayah F, 2013, J GEN INTERN MED, V28, P444, DOI 10.1007/s11606-012-2241-z; Ancker JS, 2020, J GEN INTERN MED, V35, P2427, DOI 10.1007/s11606-019-05472-y; Baker DW, 2008, J GEN INTERN MED, V23, P723, DOI 10.1007/s11606-008-0566-4; Baker DW, 1999, PATIENT EDUC COUNS, V38, P33, DOI 10.1016/S0738-3991(98)00116-5; Barber MN, 2009, HEALTH PROMOT INT, V24, P252, DOI 10.1093/heapro/dap022; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Callisaya ML, 2019, DIABETOLOGIA, V62, P448, DOI 10.1007/s00125-018-4778-9; Chen P, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025349; Cheng G, 2012, INTERN MED J, V42, P484, DOI 10.1111/j.1445-5994.2012.02758.x; Chew BH, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011469.pub2; de Camargo KR, 2011, GLOB PUBLIC HEALTH, V6, P102, DOI 10.1080/17441692.2010.514617; Department of Health and Human Services, SOL WRITT COMM UPD H; Eichler K, 2009, INT J PUBLIC HEALTH, V54, P313, DOI 10.1007/s00038-009-0058-2; Federman AD, 2009, J AM GERIATR SOC, V57, P1475, DOI 10.1111/j.1532-5415.2009.02347.x; Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Hambleton RK., 1985, ITEM RESPONSE THEORY; Jeppesen KM, 2009, ANN FAM MED, V7, P24, DOI 10.1370/afm.919; LeRoith D, 2019, J CLIN ENDOCR METAB, V104, P1520, DOI 10.1210/jc.2019-00198; Maneze D, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/3458969; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nguyen HT, 2013, DIABETES RES CLIN PR, V101, P141, DOI 10.1016/j.diabres.2013.05.012; Nutbeam D, 1998, HEALTH PROMOT INT, V13, P349, DOI 10.1093/heapro/13.4.349; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; Osborne RH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-658; Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626; Schillinger D, 2002, JAMA-J AM MED ASSOC, V288, P475, DOI 10.1001/jama.288.4.475; Schinckus L, 2018, PATIENT EDUC COUNS, V101, P324, DOI 10.1016/j.pec.2017.08.006; Wahl AK, 2021, HEART LUNG, V50, P417, DOI 10.1016/j.hrtlng.2021.02.007; WILLIAMS MV, 1995, JAMA-J AM MED ASSOC, V274, P1677; Wolf MS, 2012, J GEN INTERN MED, V27, P1300, DOI 10.1007/s11606-012-2079-4	33	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0267265	10.1371/journal.pone.0267265	http://dx.doi.org/10.1371/journal.pone.0267265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35442990	gold, Green Published, Green Accepted			2022-12-26	WOS:000822608900048
J	Jo, H; Lee, HH; Kim, DH; Kong, ID				Jo, Hoon; Lee, Ho Hee; Kim, Dong-Hyun; Kong, In Deok			Satisfaction with the walking-related environment during COVID-19 in South Korea	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; EXERCISE	This study aimed to examine the satisfaction level differences between urban and rural areas with regard to their walking environment during the COVID-19 pandemic in South Korea. This online cross-sectional research was conducted using a mobile health application. Overall, 1,032 local residents who participated in the mobile healthcare program of a public health center were classified as being from either urban (n = 481, 46.6%) or rural areas (n = 551, 53.4%) for the purpose of this study. The Walkability Checklist, which includes sociodemographic information, was employed using a Chi-square test and a multivariate logistic regression to investigate whether or not the participants were satisfied with the environmental factors associated with walking. It was found that both urban and rural areas were more likely to be unsatisfied with walking comfort (adjusted OR: 24.472, 95% CI: 14.937-40.096). Regarding the walking comfort aspects of the walking environment, urban residents chose poor landscape ("needed more grass, flowers, or trees"; aOR: 13.561, 95% CI: 3.619-50.823) as their primary dissatisfaction, and rural residents chose messy streets ("dirty, lots of litter or trash"; aOR: 29.045, 95% CI: 6.202-136.015). Compared with urban residents, rural residents were more discontented with the walking environment. Thus, to promote walking activities at the community level, it is necessary to focus on walking comfort, and implement efforts related to environmental beautification.	[Jo, Hoon] Yonsei Univ, Artificial Intelligence Big Data Med Ctr, Wonju Coll Med, Wonju, South Korea; [Jo, Hoon] Hallym Univ, Grad Sch Hlth Sci, Dept Rehabil Therapy, Chunchon, South Korea; [Lee, Ho Hee] Yonsei Univ, Wonju Coll Med, Dept Prevent Med, Wonju, South Korea; [Kim, Dong-Hyun] Hallym Univ, Coll Med, Dept Social & Prevent Med, Chunchon, South Korea; [Kong, In Deok] Yonsei Univ, Wonju Coll Med, Dept Physiol, Wonju, South Korea; [Kong, In Deok] Yonsei Univ, Ctr Exercise Med, Wonju Coll Med, Wonju, South Korea	Yonsei University; Hallym University; Yonsei University; Hallym University; Yonsei University; Yonsei University	Kim, DH (corresponding author), Hallym Univ, Coll Med, Dept Social & Prevent Med, Chunchon, South Korea.; Kong, ID (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Physiol, Wonju, South Korea.; Kong, ID (corresponding author), Yonsei Univ, Ctr Exercise Med, Wonju Coll Med, Wonju, South Korea.	dhkims@hallym.ac.kr; kong@yonsei.ac.kr	Jo, Hoon/AAS-4235-2021	Jo, Hoon/0000-0003-3762-1540	Gangwon Provincial Office under the support team of the Integrated Health Promotion Program in South Korea [B0080118002323]; Korea Disease Control and Prevention Agency [2021-1128]	Gangwon Provincial Office under the support team of the Integrated Health Promotion Program in South Korea; Korea Disease Control and Prevention Agency	The study was funded by the Gangwon Provincial Office under the support team of the Integrated Health Promotion Program (Project No. B0080118002323) in South Korea (https://www.provin.gangwon.kr/gw/portal), and awarded by Kim, D. H.. Additionally, this work was supported by the Research Program (Fund Code. 2021-1128) funded by the Korea Disease Control and Prevention Agency (https://www.kdca.go.kr/index.es?sid=a2), and awarded by Kong, I. D.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AW, 2007, TRANSPORT RES D-TR E, V12, P548, DOI 10.1016/j.trd.2007.07.005; Ali G, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-99546-9; Ali G, 2021, J CLEAN PROD, V291, DOI 10.1016/j.jclepro.2021.125806; Ball K, 2001, PREV MED, V33, P434, DOI 10.1006/pmed.2001.0912; Castaneda-Babarro A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186878; Chen PJ, 2020, J SPORT HEALTH SCI, V9, P103, DOI 10.1016/j.jshs.2020.02.001; DAVISON RCR, 1993, SPORTS MED, V16, P369, DOI 10.2165/00007256-199316060-00002; Fatality Analysis Reporting System (FARS), 2022, TRAFF SAF FACTS; Iacono M., 2008, ACCESS DESTINATIONS; Iwamoto J, 2001, J Orthop Sci, V6, P128; Ju MJ, 2021, SCI TOTAL ENVIRON, V750, DOI 10.1016/j.scitotenv.2020.141521; Kahn EB, 2002, AM J PREV MED, V22, P73, DOI 10.1016/S0749-3797(02)00434-8; Katzmarzyk PT, 2000, CAN MED ASSOC J, V163, P1435; Lee HS, 2015, ASIAN WOMEN, V31, P1; Lee M-S., 2005, J AGR MED COMMUN HLT, V30, P227; Marques M, 2022, ENVIRON RES, V203, DOI 10.1016/j.envres.2021.111930; Martin MY, 2006, J AGING PHYS ACTIV, V14, P392, DOI 10.1123/japa.14.4.392; Morimoto T, 2006, QUAL LIFE RES, V15, P537, DOI 10.1007/s11136-005-3033-2; Natalucci V, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.602020; Nieman DC, 2019, J SPORT HEALTH SCI, V8, P201, DOI 10.1016/j.jshs.2018.09.009; Park J, 2018, J PHYS ACT HEALTH, V15, P763, DOI 10.1123/jpah.2017-0428; Park Y, 2021, HERD-HEALTH ENV RES, V14, P43, DOI 10.1177/19375867211026571; Parks SE, 2003, J EPIDEMIOL COMMUN H, V57, P29, DOI 10.1136/jech.57.1.29; R Core Team, 2013, R LANG ENV STAT COMP; Roux L, 2008, AM J PREV MED, V35, P578, DOI 10.1016/j.amepre.2008.06.040; Sallis J.F., 2015, HLTH BEHAV THEORY RE, V5, P43; Sallis JF, 1998, PHYS ACTIVITY BEHAV; Samarasekara GN, 2011, ENVIRON BEHAV, V43, P501, DOI 10.1177/0013916510379350; VOLOSHIN AS, 1988, J AM PODIAT MED ASSN, V78, P295, DOI 10.7547/87507315-78-6-295; WHO WHO, WHO DIR GEN OP REM M; Yang Y, 2012, AM J PREV MED, V43, P11, DOI 10.1016/j.amepre.2012.03.015	31	1	1	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0266183	10.1371/journal.pone.0266183	http://dx.doi.org/10.1371/journal.pone.0266183			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35442995	Green Published, gold			2022-12-26	WOS:000822608900019
J	Pinit, S; Ruengchaijatuporn, N; Sriswasdi, S; Buaboocha, T; Chadchawan, S; Chaiwanon, J				Pinit, Sompop; Ruengchaijatuporn, Natthanan; Sriswasdi, Sira; Buaboocha, Teerapong; Chadchawan, Supachitra; Chaiwanon, Juthamas			Hyperspectral and genome-wide association analyses of leaf phosphorus status in local Thai indica rice	PLOS ONE			English	Article							DEFICIENCY TOLERANCE; PHOSPHATE STARVATION; TOOL; RESPONSES; GROWTH; QTLS; ROOT	Phosphorus (P) is an essential mineral nutrient and one of the key factors determining crop productivity. P-deficient plants exhibit visual leaf symptoms, including chlorosis, and alter spectral reflectance properties. In this study, we evaluated leaf inorganic phosphate (Pi) contents, plant growth and reflectance spectra (420-790 nm) of 172 Thai rice landrace varieties grown hydroponically under three different P supplies (overly sufficient, mildly deficient and severely deficient conditions). We reported correlations between Pi contents and reflectance ratios computed from two wavebands in the range of near infrared (720-790 nm) and visible energy (green-yellow and red edge) (r > 0.69) in Pi-deficient leaves. Artificial neural network models were also developed which could classify P deficiency levels with 85.60% accuracy and predict Pi content with R-2 of 0.53, as well as highlight important waveband sections. Using 217 reflectance ratio indices to perform genome-wide association study (GWAS) with 113,114 SNPs, we identified 11 loci associated with the spectral reflectance traits, some of which were also associated with the leaf Pi content trait. Hyperspectral measurement offers a promising non-destructive approach to predict plant P status and screen large germplasm for varieties with high P use efficiency.	[Pinit, Sompop; Chadchawan, Supachitra; Chaiwanon, Juthamas] Chulalongkorn Univ, Fac Sci, Ctr Excellence Environm & Plant Physiol, Dept Bot, Bangkok, Thailand; [Pinit, Sompop] Chulalongkorn Univ, Fac Sci, Program Biotechnol, Bangkok, Thailand; [Ruengchaijatuporn, Natthanan; Sriswasdi, Sira] Chulalongkorn Univ, Fac Med, Computat Mol Biol Grp, Bangkok, Thailand; [Sriswasdi, Sira] Chulalongkorn Univ, Fac Med, Res Affairs, Bangkok, Thailand; [Buaboocha, Teerapong] Chulalongkorn Univ, Fac Sci, Omics Sci & Bioinformat Ctr, Bangkok, Thailand; [Buaboocha, Teerapong] Chulalongkorn Univ, Fac Sci, Dept Biochem, Mol Crop Res Unit, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University	Chaiwanon, J (corresponding author), Chulalongkorn Univ, Fac Sci, Ctr Excellence Environm & Plant Physiol, Dept Bot, Bangkok, Thailand.	juthamas.c@chula.ac.th		Chaiwanon, Juthamas/0000-0002-4802-0428; Pinit, Sompop/0000-0003-2546-6061	Development and Promotion of Science and Technology Talents Project (DPST) grant fund of Institute for the Promotion of Teaching Science and Technology (IPST) [024/2558]; Chulalongkorn University [DNS 61_048_23_016-2]; Royal Golden Jubilee Ph.D. Scholarship Grant (RGJ-Ph.D.) of Thailand Research Fund (TRF) [PHD/0188/2558-2.B.CU/58/AC.1.O.XX]	Development and Promotion of Science and Technology Talents Project (DPST) grant fund of Institute for the Promotion of Teaching Science and Technology (IPST); Chulalongkorn University(Chulalongkorn University); Royal Golden Jubilee Ph.D. Scholarship Grant (RGJ-Ph.D.) of Thailand Research Fund (TRF)	This research was funded by the Development and Promotion of Science and Technology Talents Project (DPST) grant fund of Institute for the Promotion of Teaching Science and Technology (IPST) (024/2558) and partially funded by Grants for Development of New Faculty Staff, Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (DNS 61_048_23_016-2) to J.C. S.P. was supported by the Royal Golden Jubilee Ph.D. Scholarship Grant (RGJ-Ph.D.) of Thailand Research Fund (TRF) (PHD/0188/2558-2.B.CU/58/AC.1.O.XX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alewell C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18326-7; Ansari M. S., 2016, International Journal of Bio-resource and Stress Management, V7, P653; Brachi B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-232; Cabrera-Bosquet L, 2011, CEREAL RES COMMUN, V39, P147, DOI 10.1556/CRC.39.2011.1.15; Carstensen A, 2018, PLANT PHYSIOL, V177, P271, DOI 10.1104/pp.17.01624; Chen YB, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01186; Chiera J, 2002, J EXP BOT, V53, P473, DOI 10.1093/jexbot/53.368.473; Choi J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16021-1; Cordell D, 2015, FOOD SECUR, V7, P337, DOI 10.1007/s12571-015-0442-0; Czarnecki O, 2013, INT J MOL SCI, V14, P7681, DOI 10.3390/ijms14047681; Frydenvang J, 2015, PLANT PHYSIOL, V169, P353, DOI 10.1104/pp.15.00823; Ge YF, 2019, PLANT METHODS, V15, DOI 10.1186/s13007-019-0450-8; Irfan M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61147-3; Jewel ZA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040900; Jiang CF, 2007, PLANT PHYSIOL, V145, P1460, DOI 10.1104/pp.107.103788; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; LAUER MJ, 1989, PLANT PHYSIOL, V89, P1331, DOI 10.1104/pp.89.4.1331; Lekklar C, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-018-5317-2; Li JZ, 2009, J GENET GENOMICS, V36, P173, DOI 10.1016/S1673-8527(08)60104-6; MERTENS E, 1990, PLANT PHYSIOL, V93, P584, DOI 10.1104/pp.93.2.584; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Ni JJ, 1998, THEOR APPL GENET, V97, P1361, DOI 10.1007/s001220051030; Penuelas J, 1998, TRENDS PLANT SCI, V3, P151, DOI 10.1016/S1360-1385(98)01213-8; Pinit S, 2020, APPL PLANT SCI, V8, DOI 10.1002/aps3.11395; Plaxton WC, 2011, PLANT PHYSIOL, V156, P1006, DOI 10.1104/pp.111.175281; Secco D, 2013, PLANT CELL, V25, P4285, DOI 10.1105/tpc.113.117325; Sun DW, 2019, PLANT METHODS, V15, DOI 10.1186/s13007-019-0432-x; Turner S.D., 2018, BIORXIV, V3, P731, DOI [10.1101/005165, 10.21105/joss.00731, DOI 10.1101/005165.V1]; UWASAWA M, 1988, SOIL SCI PLANT NUTR, V34, P41, DOI 10.1080/00380768.1988.10415578; Wissuwa M, 1998, THEOR APPL GENET, V97, P777, DOI 10.1007/s001220050955; Xu HX, 2007, RUSS J PLANT PHYSL+, V54, P741, DOI 10.1134/S1021443707060040; Yao W, 2017, GIGASCIENCE, V7, DOI 10.1093/gigascience/gix119; Yin YL, 2012, PLANT PHYSIOL BIOCH, V55, P77, DOI 10.1016/j.plaphy.2012.03.009; YOSHIDA S., 1971, Laboratory manual for physiological studies of rice.; Yu FH, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.573272; Zhang ZL, 2014, J INTEGR PLANT BIOL, V56, P192, DOI 10.1111/jipb.12163; Zhao DL, 2003, PLANT SOIL, V257, P205, DOI 10.1023/A:1026233732507; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	38	0	0	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0267304	10.1371/journal.pone.0267304	http://dx.doi.org/10.1371/journal.pone.0267304			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35443012	Green Published, gold			2022-12-26	WOS:000822608900051
J	He, RS; Xhabija, B; Gopi, LK; Kurup, JT; Xu, ZS; Liu, Z; Kidder, BL				He, Runsheng; Xhabija, Besa; Gopi, Lijin K.; Kurup, Jiji T.; Xu, Zhishan; Liu, Zhe; Kidder, Benjamin L.			H3K4 demethylase KDM5B regulates cancer cell identity and epigenetic plasticity	ONCOGENE			English	Article							GENE-EXPRESSION; STEM-CELLS; DRUG-RESISTANCE; MESSENGER-RNA; BREAST-CANCER; SELF-RENEWAL; JARID1B; METHYLATION; PATTERNS; PROLIFERATION	The H3K4 demethylase KDM5B is overexpressed in multiple cancer types, and elevated expression levels of KDM5B is associated with decreased survival. However, the underlying mechanistic contribution of dysregulated expression of KDM5B and H3K4 demethylation in cancer is poorly understood. Our results show that loss of KDM5B in multiple types of cancer cells leads to increased proliferation and elevated expression of cancer stem cell markers. In addition, we observed enhanced tumor formation following KDM5B depletion in a subset of representative cancer cell lines. Our findings also support a role for KDM5B in regulating epigenetic plasticity, where loss of KDM5B in cancer cells with elevated KDM5B expression leads to alterations in activity of chromatin states, which facilitate activation or repression of alternative transcriptional programs. In addition, we define KDM5B-centric epigenetic and transcriptional patterns that support cancer cell plasticity, where KDM5B depleted cancer cells exhibit altered epigenetic and transcriptional profiles resembling a more primitive cellular state. This study also provides a resource for evaluating associations between alterations in epigenetic patterning upon depletion of KDM5B and gene expression in a diverse set of cancer cells.	[He, Runsheng; Xhabija, Besa; Gopi, Lijin K.; Kurup, Jiji T.; Xu, Zhishan; Kidder, Benjamin L.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48202 USA; [He, Runsheng; Xhabija, Besa; Gopi, Lijin K.; Kurup, Jiji T.; Xu, Zhishan; Kidder, Benjamin L.] Wayne State Univ, Karmanos Canc Inst, Sch Med, Detroit, MI 48202 USA; [Xu, Zhishan] Xinxiang Med Univ, Inst Precis Med, Xinxiang 453000, Henan, Peoples R China; [Xu, Zhishan] Shandong Normal Univ, Coll Chem Chem Engn & Mat Sci, Jinan 250014, Shandong, Peoples R China; [Liu, Zhe] Qufu Normal Univ, Dept Chem & Chem Engn, Qufu 273165, Shandong, Peoples R China; [Xhabija, Besa] Univ Michigan, Dept Chem & Biochem, Flint, MI 48503 USA; [Kurup, Jiji T.] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Xinxiang Medical University; Shandong Normal University; Qufu Normal University; University of Michigan System; University of Michigan; University of Michigan Flint; Columbia University	Kidder, BL (corresponding author), Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48202 USA.; Kidder, BL (corresponding author), Wayne State Univ, Karmanos Canc Inst, Sch Med, Detroit, MI 48202 USA.	benjamin.kidder@wayne.edu	LIU, zhe/HGD-6875-2022; Xhabija, Besa/GOP-2447-2022	Xhabija, Besa/0000-0002-4784-2454	Wayne State University, Karmanos Cancer Institute; Elsa U. Pardee Foundation	Wayne State University, Karmanos Cancer Institute; Elsa U. Pardee Foundation	This work was supported by Wayne State University, Karmanos Cancer Institute, and a grant from the Elsa U. Pardee Foundation awarded to BLK.	Abaan OD, 2013, CANCER RES, V73, P4372, DOI 10.1158/0008-5472.CAN-12-3342; Albert M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003461; Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016; Barrett A, 2002, INT J CANCER, V101, P581, DOI 10.1002/ijc.10644; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Benayoun BA, 2014, CELL, V158, P673, DOI 10.1016/j.cell.2014.06.027; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Catchpole S, 2011, INT J ONCOL, V38, P1267, DOI 10.3892/ijo.2011.956; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chen KF, 2015, NAT GENET, V47, P1149, DOI 10.1038/ng.3385; Cheng CJ, 2009, CANCER RES, V69, P3634, DOI 10.1158/0008-5472.CAN-08-3615; Cutcliffe C, 2005, CLIN CANCER RES, V11, P7986, DOI 10.1158/1078-0432.CCR-05-1354; Dai B, 2014, BIOCHEM BIOPH RES CO, V454, P221, DOI 10.1016/j.bbrc.2014.10.078; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dey BK, 2008, MOL CELL BIOL, V28, P5312, DOI 10.1128/MCB.00128-08; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Evertts AG, 2013, MOL BIOL CELL, V24, P3025, DOI 10.1091/mbc.E12-07-0529; Facompre ND, 2016, CANCER RES, V76, P5538, DOI 10.1158/0008-5472.CAN-15-3377; Frankenberg S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-8; Gopi LK, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21707-1; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hayami S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-59; He RS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29074-6; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hinohara K, 2018, CANCER CELL, V34, P939, DOI 10.1016/j.ccell.2018.10.014; Hu GQ, 2014, METHODS MOL BIOL, V1150, P175, DOI 10.1007/978-1-4939-0512-6_11; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Khan A, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1708-7; Kidder BL, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0115-7; Kidder BL, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r32; Kidder BL, 2013, MOL CELL BIOL, V33, P4793, DOI 10.1128/MCB.00692-13; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li X, 2013, INT J MOL SCI, V14, P7866, DOI 10.3390/ijms14047866; Liu HF, 2010, MOL CANCER THER, V9, P1080, DOI 10.1158/1535-7163.MCT-09-0965; Lu PJ, 1999, J BIOL CHEM, V274, P15633, DOI 10.1074/jbc.274.22.15633; McGranahan N, 2017, CELL, V168, P613, DOI 10.1016/j.cell.2017.01.018; Medema JP, 2013, NAT CELL BIOL, V15, P338, DOI 10.1038/ncb2717; Min MW, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000178; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muntean AG, 2009, AM J PATHOL, V175, P1353, DOI 10.2353/ajpath.2009.081142; O'Brien CA, 2010, CLIN CANCER RES, V16, P3113, DOI 10.1158/1078-0432.CCR-09-2824; Ohta K, 2013, INT J ONCOL, V42, P1212, DOI 10.3892/ijo.2013.1799; Oshimori N, 2015, CELL, V160, P963, DOI 10.1016/j.cell.2015.01.043; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Reinhold WC, 2019, CANCER RES, V79, P3514, DOI 10.1158/0008-5472.CAN-18-2047; Reinhold WC, 2012, CANCER RES, V72, P3499, DOI 10.1158/0008-5472.CAN-12-1370; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roesch A, 2006, J INVEST DERMATOL, V126, P1850, DOI 10.1038/sj.jid.5700324; Roesch A, 2013, CANCER CELL, V23, P811, DOI 10.1016/j.ccr.2013.05.003; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schmitz SU, 2011, EMBO J, V30, P4586, DOI 10.1038/emboj.2011.383; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Shibue T, 2017, NAT REV CLIN ONCOL, V14, P611, DOI 10.1038/nrclinonc.2017.44; Shigekawa Yoshinobu, 2018, Oncotarget, V9, P34320, DOI 10.18632/oncotarget.26144; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; STINSON SF, 1992, ANTICANCER RES, V12, P1035; Stuelten CH, 2010, STEM CELLS, V28, P649, DOI 10.1002/stem.324; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Taylor-Papadimitriou J, 2017, EXPERT OPIN THER TAR, V21, P5, DOI 10.1080/14728222.2017.1263616; Timp W, 2013, NAT REV CANCER, V13, P497, DOI 10.1038/nrc3486; Vinogradova M, 2016, NAT CHEM BIOL, V12, P531, DOI 10.1038/nchembio.2085; Wang LS, 2015, TUMOR BIOL, V36, P2465, DOI 10.1007/s13277-014-2859-z; Wang ZR, 2015, AM J CANCER RES, V5, P87; Xhabija B, 2019, SEMIN CANCER BIOL, V57, P79, DOI 10.1016/j.semcancer.2018.11.001; Xiang Y, 2007, P NATL ACAD SCI USA, V104, P19226, DOI 10.1073/pnas.0700735104; Xie LQ, 2011, EMBO J, V30, P1473, DOI 10.1038/emboj.2011.91; Xu J, 2018, BIOL OPEN, V7, DOI 10.1242/bio.031245; Yamamoto S, 2014, CANCER CELL, V25, P762, DOI 10.1016/j.ccr.2014.04.024; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340	84	0	0	2	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 20	2022	41	21					2958	2972		10.1038/s41388-022-02311-z	http://dx.doi.org/10.1038/s41388-022-02311-z		APR 2022	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	1L8MU	35440714	Green Accepted			2022-12-26	WOS:000784875000001
J	Auma, AWN; Kowal, C; Shive, CL; Lange, A; Damjanovska, S; Zebrowski, E; Reyes, E; Calabrese, L; Kostadinova, L; Falck-Ytter, Y; Mattar, M; Anthony, DD				Auma, Ann W. N.; Kowal, Corinne; Shive, Carey L.; Lange, Alyssa; Damjanovska, Sofi; Zebrowski, Elizabeth; Reyes, Elane; Calabrese, Leonard; Kostadinova, Lenche; Falck-Ytter, Yngve; Mattar, Maya; Anthony, Donald D.			Transient elastography score is elevated during rheumatoid factor-positive chronic hepatitis C virus infection and rheumatoid factor decline is highly variable over the course of direct-acting antiviral therapy	PLOS ONE			English	Article							PLASMA INTERLEUKIN-18 LEVELS; MIXED CRYOGLOBULINEMIA; IMMUNE ACTIVATION; LIVER STIFFNESS; ASSOCIATION; ACCURACY	BackgroundElevated rheumatoid factor (RF) levels and systemic immune activation are highly prevalent during chronic hepatitis C virus (HCV) infection. Direct-acting antiviral (DAA) therapy has been associated with normalization of various soluble immune activation parameters. Whether the RF levels relate to soluble immune activation markers during chronic HCV infection, and over what time frame RF levels normalize during and after DAA treatment is unknown and was investigated here. MethodsIn a longitudinal study, plasma and serum was obtained from HCV infected RF positive (RF+) and RF negative (RF-) participants. The levels of RF, HCV RNA and soluble markers of inflammation were determined before (week 0), during (weeks 4, 8 and 12) and after (week 24) treatment with HCV DAA therapy. In a subset of RF+ participants, the analysis was extended to over 70 weeks after therapy initiation. Hepatic and other clinical parameters were determined at baseline (week 0) in all participants. ResultsBefore therapy, transient elastography (TE) score was greater in RF+ compared to RF- HCV infected participants, while the systemic levels of soluble inflammatory markers were comparable. Following DAA therapy initiation, HCV RNA levels became undetectable within 4 weeks in both the RF+ and RF- groups. RF levels declined in the first 6 months in most RF+ persons but most commonly remained positive. The levels of some soluble inflammatory markers declined, mainly within 4 weeks of DAA therapy start, in both the RF+ and RF- groups. The baseline (week 0) TE score correlated with RF levels before, during and after DAA therapy, while plasma IL-18 levels correlated with RF level after DAA therapy. ConclusionDuring chronic HCV infection, TE score is elevated in RF+ HCV infected individuals and factors other than HCV viremia (including liver stiffness or fibrosis and select markers of inflammation) likely contribute to persistence of RF after treatment of HCV with DAA.	[Auma, Ann W. N.; Shive, Carey L.; Lange, Alyssa; Anthony, Donald D.] Case Western Reserve Univ, Dept Pathol, Dept Med, Cleveland, OH 44106 USA; [Kowal, Corinne; Shive, Carey L.; Lange, Alyssa; Damjanovska, Sofi; Zebrowski, Elizabeth; Reyes, Elane; Kostadinova, Lenche; Falck-Ytter, Yngve; Mattar, Maya; Anthony, Donald D.] Cleveland VA Med Ctr, Cleveland, OH 44106 USA; [Kowal, Corinne; Shive, Carey L.; Lange, Alyssa; Damjanovska, Sofi; Zebrowski, Elizabeth; Reyes, Elane; Kostadinova, Lenche; Falck-Ytter, Yngve; Mattar, Maya; Anthony, Donald D.] VA GRECC, Cleveland, OH 44106 USA; [Calabrese, Leonard] Cleveland Clin Fdn, Dept Rheumatol & Immunol Dis, Cleveland, OH USA; [Anthony, Donald D.] MetroHlth Med Ctr, Div Rheumatol, Cleveland, OH 44109 USA	Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Geriatric Research Education & Clinical Center; Cleveland Clinic Foundation; MetroHealth System	Anthony, DD (corresponding author), Case Western Reserve Univ, Dept Pathol, Dept Med, Cleveland, OH 44106 USA.; Anthony, DD (corresponding author), Cleveland VA Med Ctr, Cleveland, OH 44106 USA.; Anthony, DD (corresponding author), VA GRECC, Cleveland, OH 44106 USA.; Anthony, DD (corresponding author), MetroHlth Med Ctr, Div Rheumatol, Cleveland, OH 44109 USA.	dda3@case.edu	Falck-Ytter, Yngve/GZH-0993-2022	Lange, Alyssa/0000-0001-9956-4858; AUMA, Ann/0000-0002-0094-4007; Damjanovska, Sofi/0000-0001-6036-9190	DDA BLRD [BX001894]; CSRD grants US department of Veterans Affairs [CLS IK2CX001471]; US department of Veterans Affairs [DDA CX001791, AWA D43 TW010319]; Fogarty International Center of the National Institutes of Health	DDA BLRD; CSRD grants US department of Veterans Affairs(US Department of Veterans Affairs); US department of Veterans Affairs(US Department of Veterans Affairs); Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	DDA BX001894 BLRD and CSRD grants US department of Veterans Affairs CLS IK2CX001471 US department of Veterans Affairs DDA CX001791 US department of Veterans Affairs AWA D43 TW010319 Fogarty International Center of the National Institutes of Health The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL G, 1993, ARTHRITIS RHEUM, V36, P1341, DOI 10.1002/art.1780361003; Afdhal NH, 2015, CLIN GASTROENTEROL H, V13, P772, DOI 10.1016/j.cgh.2014.12.014; AGNELLO V, 1992, NEW ENGL J MED, V327, P1490, DOI 10.1056/NEJM199211193272104; Agnello V, 1997, ARTHRITIS RHEUM, V40, P2007, DOI 10.1002/art.1780401113; Auma AWN, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.641230; Auma AWN, 2021, OPEN FORUM INFECT DI, V8, DOI 10.1093/ofid/ofab079; Batsaikhan B, 2018, J GASTROEN HEPATOL, V33, P1897, DOI 10.1111/jgh.14275; BOMBARDIERI S, 1979, Ricerca in Clinica e in Laboratorio, V9, P361; Bonacci M, 2017, CLIN GASTROENTEROL H, V15, P575, DOI 10.1016/j.cgh.2016.09.158; Cacoub P, 2015, AM J MED, V128, P950, DOI 10.1016/j.amjmed.2015.02.017; Charles ED, 2009, KIDNEY INT, V76, P818, DOI 10.1038/ki.2009.247; Chattergoon MA, 2011, J INFECT DIS, V204, P1730, DOI 10.1093/infdis/jir642; Csepregi Antal, 1997, Orvosi Hetilap, V138, P651; Dammacco F, 2013, NEW ENGL J MED, V369, P1035, DOI 10.1056/NEJMra1208642; Dorner T, 2004, CURR OPIN RHEUMATOL, V16, P246; Falasca K, 2007, CLIN INVEST MED, V30, pE167; Fan C, 2020, J MED MICROBIOL, V69, P759, DOI 10.1099/jmm.0.001185; FERRI C, 1991, CLIN EXP RHEUMATOL, V9, P621; Ganne-Carrie N, 2006, HEPATOLOGY, V44, P1511, DOI 10.1002/hep.21420; Ingegnoli F, 2013, DIS MARKERS, V2013, P727, DOI 10.1155/2013/726598; KARLSBERG PL, 1995, ARCH DERMATOL, V131, P1119, DOI 10.1001/archderm.131.10.1119; Kessel A, 2007, CURR MED CHEM, V14, P547, DOI 10.2174/092986707780059652; Kostadinova Lenche, 2018, Pathog Immun, V3, P149, DOI 10.20411/pai.v3i1.242; Kostadinova L, 2016, J INFECT DIS, V214, P1438, DOI 10.1093/infdis/jiw372; Lauletta G, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1280-6; Lauletta G, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/502156; Loffreda S, 2003, J HEPATOL, V38, P230, DOI 10.1016/S0168-8278(02)00353-7; Lorey SL, 2004, CLIN EXP IMMUNOL, V136, P456, DOI 10.1111/j.1365-2249.2004.02465.x; LUNEL F, 1994, GASTROENTEROLOGY, V106, P1291, DOI 10.1016/0016-5085(94)90022-1; Marquez M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119568; McMurray RW, 1997, SEMIN ARTHRITIS RHEU, V26, P689, DOI 10.1016/S0049-0172(97)80005-4; Medrano LM, 2018, AIDS, V32, P1095, DOI 10.1097/QAD.0000000000001787; MISIANI R, 1992, ANN INTERN MED, V117, P573, DOI 10.7326/0003-4819-117-7-573; MONTI G, 1986, RES CLIN LAB, V16, P367; Reyes-Aviles E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144629; Sansonno D., 1996, DETECTION DISTRIBUTI; Sharma A, 2009, IMMUNOLOGY, V128, pe514, DOI 10.1111/j.1365-2567.2008.03021.x; Sise ME, 2016, HEPATOLOGY, V63, P408, DOI 10.1002/hep.28297; Szabo G, 2012, J HEPATOL, V57, P642, DOI 10.1016/j.jhep.2012.03.035; Tiwari V, 2022, ACR OPEN RHEUMATOL, V4, P119, DOI 10.1002/acr2.11358; Trejo O, 2001, MEDICINE, V80, P252, DOI 10.1097/00005792-200107000-00004; Turan Y, 2010, TURK J RHEUMATOL, V25, P63, DOI 10.5152/tjr.2010.03; Vecchiet J, 2005, ANN CLIN LAB SCI, V35, P415; Zignego AL, 2007, DIGEST LIVER DIS, V39, P2, DOI 10.1016/j.dld.2006.06.008; Zimmermann HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011049	45	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267512	10.1371/journal.pone.0267512	http://dx.doi.org/10.1371/journal.pone.0267512			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D8GY	35482664	gold, Green Published			2022-12-26	WOS:000794035700013
J	Buechner, A; Bardt, M; Haumann, S; Geissler, G; Salcher, R; Lenarz, T				Buechner, Andreas; Bardt, Michael; Haumann, Sabine; Geissler, Gunnar; Salcher, Rolf; Lenarz, Thomas			Clinical experiences with intraoperative electrocochleography in cochlear implant recipients and its potential to reduce insertion trauma and improve postoperative hearing preservation	PLOS ONE			English	Article							ROUND WINDOW ELECTROCOCHLEOGRAPHY; OUTCOMES; ELECTRODES; FREQUENCY; SYSTEM	Access to low-frequency acoustic information in cochlear implant patients leads to better speech understanding in noise. Electrocochleography (ECochG) can provide real-time feedback about the health of the cochlea during the insertion process with the potential to reduce insertion trauma. We describe our experiences of using this technique. Data from 47 adult subjects with measurable residual hearing and an Advanced Bionics (Valencia, CA) SlimJ (46) or MidScala (1) electrode array were analyzed. ECochGs were recorded intraoperatively via the implant. The surgeon adjusted the course of the electrode insertion based on drops in the ECochG. The final array position was assessed using postoperative imaging and pure tone thresholds were measured before and after surgery. Three different patterns of ECochG response amplitude were observed: Growth, Fluctuating and Total Loss. Subjects in the growth group showed the smallest postoperative hearing loss. However, the group with fluctuating amplitudes showed no meaningful correlation between the ECochG responses and the postoperative hearing loss, indicating that amplitude alone is insufficient for detecting damage. Considering the phase of the signal additionally to the amplitude and reclassifying the data by both the phase and amplitude of the response into three groups Type I-Type III produced statistically significant correlations between postoperative hearing loss and the grouping based on amplitude and phase respectively. We showed significantly better hearing preservation for Type I (no drop in amplitude) and Type II (drop with a concurrent phase shift), while Type III (drop without concurrent phase shift) had more surgery induced hearing loss. ECochG potentials measured through the implant could provide valuable feedback during the electrode insertion. Both the amplitude and phase of the ECochG response are important to consider. More data needs to be evaluated to better understand the impact of the different signal components to design an automated system to alert the surgeon ahead of damaging the cochlea.	[Buechner, Andreas; Bardt, Michael; Haumann, Sabine; Salcher, Rolf; Lenarz, Thomas] Hannover Med Sch, Dept Otolaryngol, Hannover, Germany; [Geissler, Gunnar] Adv Bion GmbH, European Res Ctr, Hannover, Germany	Hannover Medical School	Buechner, A (corresponding author), Hannover Med Sch, Dept Otolaryngol, Hannover, Germany.	buechner.andreas@mh-hannover.de		Haumann, Sabine/0000-0002-9138-0277; Buechner, Andreas/0000-0001-6788-3985				Adunka O, 2006, LARYNGOSCOPE, V116, P1017, DOI 10.1097/01.mlg.0000217224.94804.bb; Adunka OF, 2016, LARYNGOSCOPE, V126, P1193, DOI 10.1002/lary.25602; Avci E, 2014, J COMP NEUROL, V522, P3245, DOI 10.1002/cne.23594; Bester C, 2020, HEARING RES, V398, DOI 10.1016/j.heares.2020.108094; Brant Jason A, 2016, World J Otorhinolaryngol Head Neck Surg, V2, P157, DOI 10.1016/j.wjorl.2016.08.002; Buchner A, 2009, AUDIOL NEURO-OTOL, V14, P8, DOI 10.1159/000206490; Campbell L, 2016, OTOL NEUROTOL, V37, P332, DOI 10.1097/MAO.0000000000000972; Dalbert A, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00018; Dalbert A, 2016, OTOL NEUROTOL, V37, P446, DOI 10.1097/MAO.0000000000000998; Dalbert A, 2015, AUDIOL NEURO-OTOL, V20, P339, DOI 10.1159/000438742; Dees G, 2016, FRONT SURG, V3, DOI 10.3389/fsurg.2016.00002; Dietz A, 2016, EUR ARCH OTO-RHINO-L, V273, P4135, DOI 10.1007/s00405-016-4099-x; Fitzpatrick DC, 2014, OTOL NEUROTOL, V35, P64, DOI 10.1097/MAO.0000000000000219; Formeister EJ, 2015, EAR HEARING, V36, P249, DOI 10.1097/AUD.0000000000000106; Gantz Bruce J, 2006, Audiol Neurootol, V11 Suppl 1, P63, DOI 10.1159/000095616; Giardina CK, 2019, EAR HEARING, V40, P833, DOI 10.1097/AUD.0000000000000659; Gibson WP, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00274; Harris Robert, 2011, Cochlear Implants Int, V12, P209, DOI 10.1179/146701011X12950038111657; Haumann S, 2019, TRENDS HEAR, V23, DOI 10.1177/2331216519833567; Huarte RM, 2014, CURR OPIN OTOLARYNGO, V22, P349, DOI 10.1097/MOO.0000000000000089; Jurawitz MC, 2014, AUDIOL NEURO-OTOL, V19, P293, DOI 10.1159/000360601; Kim JS, 2018, HEARING RES, V370, P304, DOI 10.1016/j.heares.2018.10.016; KOHLLOFFEL LU, 1970, J SOUND VIB, V11, P325, DOI 10.1016/S0022-460X(70)80036-0; Koka K, 2018, OTOL NEUROTOL, V39, pE654, DOI 10.1097/MAO.0000000000001906; Koka K, 2017, EAR HEARING, V38, pE161, DOI 10.1097/AUD.0000000000000385; Lenarz T, 2009, AUDIOL NEURO-OTOL, V14, P22, DOI 10.1159/000206492; Mandala M, 2012, OTOLARYNG HEAD NECK, V146, P774, DOI 10.1177/0194599811435895; Miranda Priscila Carvalho, 2014, Int J Otolaryngol, V2014, P468515, DOI 10.1155/2014/468515; O'Connell BP, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00291; Pappa AK, 2019, J NEUROPHYSIOL, V121, P2163, DOI 10.1152/jn.00006.2019; Radeloff A, 2012, OTOL NEUROTOL, V33, P348, DOI 10.1097/MAO.0b013e318248ea86; RUBEN R. J., 1960, ANN OTOL RHINOL AND LARYNGOL, V69, P459; Scott WC, 2016, OTOL NEUROTOL, V37, P1654, DOI 10.1097/MAO.0000000000001224; SNYDER RL, 1984, HEARING RES, V15, P261, DOI 10.1016/0378-5955(84)90033-9; SOHMER H, 1980, ELECTROEN CLIN NEURO, V49, P506, DOI 10.1016/0013-4694(80)90393-4; Stakhovskaya O, 2007, JARO-J ASSOC RES OTO, V8, P220, DOI 10.1007/s10162-007-0076-9; Verbist BM, 2010, OTOL NEUROTOL, V31, P722, DOI 10.1097/MAO.0b013e3181d279e0; von Ilberg C, 1999, ORL J OTO-RHINO-LARY, V61, P334, DOI 10.1159/000027695; Weder S, 2020, EAR HEARING, V41, P1560, DOI 10.1097/AUD.0000000000000871; Wever EG, 1930, J EXP PSYCHOL, V13, P373, DOI 10.1037/h0075820; Zheng XY, 1997, HEARING RES, V113, P76, DOI 10.1016/S0378-5955(97)00127-5	41	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266077	10.1371/journal.pone.0266077	http://dx.doi.org/10.1371/journal.pone.0266077			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C1KV	35452461	Green Published, gold			2022-12-26	WOS:000792887700022
J	Chen, HA; Hsu, ST; Hsieh, MJ; Sim, SS; Chu, SE; Yang, WS; Chien, YC; Wang, YC; Lee, BC; Huang, EPC; Lin, HY; Ma, MHM; Chiang, WC; Sun, JT				Chen, Hsuan-An; Hsu, Shuo-Ting; Hsieh, Ming-Ju; Sim, Shyh-Shyong; Chu, Sheng-En; Yang, Wen-Shuo; Chien, Yu-Chun; Wang, Yao-Cheng; Lee, Bin-Chou; Huang, Edward Pei-Chuan; Lin, Hao-Yang; Ma, Matthew Huei-Ming; Chiang, Wen-Chu; Sun, Jen-Tang			Influence of advanced life support response time on out-of-hospital cardiac arrest patient outcomes in Taipei	PLOS ONE			English	Article							ADVANCED AIRWAY MANAGEMENT; SURVIVAL; RESUSCITATION; INTERVENTIONS; ASSOCIATION; INTUBATION; IMPROVE; RHYTHM	Background The association between out-of-hospital cardiac arrest patient survival and advanced life support response time remained controversial. We aimed to test the hypothesis that for adult, non-traumatic, out-of-hospital cardiac arrest patients, a shorter advanced life support response time is associated with a better chance of survival. We analyzed Utstein-based registry data on adult, non-traumatic, out-of-hospital cardiac arrest patients in Taipei from 2011 to 2015. Methods Patients without complete data, witnessed by emergency medical technicians, or with response times of >= 15 minutes, were excluded. We used logistic regression with an exposure of advanced life support response time. Primary and secondary outcomes were survival to hospital discharge and favorable neurological outcomes (cerebral performance category <= 2), respectively. Subgroup analyses were based on presenting rhythms of out-of-hospital cardiac arrest, bystander cardiopulmonary resuscitation, and witness status. Results A total of 4,278 cases were included in the final analysis. The median advanced life support response time was 9 minutes. For every minute delayed in advanced life support response time, the chance of survival to hospital discharge would reduce by 7% and chance of favorable neurological outcome by 9%. Subgroup analysis showed that a longer advanced life support response time was negatively associated with the chance of survival to hospital discharge among out-of-hospital cardiac arrest patients with shockable rhythm and pulse electrical activity groups. Conclusions In non-traumatic, adult, out-of-hospital cardiac arrest patients in Taipei, a longer advanced life support response time was associated with declining odds of survival to hospital discharge and favorable neurologic outcomes, especially in patients presenting with shockable rhythm and pulse electrical activity.	[Chen, Hsuan-An; Hsu, Shuo-Ting; Sim, Shyh-Shyong; Chu, Sheng-En; Sun, Jen-Tang] Far Eastern Mem Hosp, Dept Emergency Med, New Taipei, Taiwan; [Hsieh, Ming-Ju; Lin, Hao-Yang; Ma, Matthew Huei-Ming; Chiang, Wen-Chu] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Emergency Med, Taipei, Taiwan; [Yang, Wen-Shuo; Wang, Yao-Cheng] Taipei City Fire Dept, Emergency Med Serv Div, Taipei, Taiwan; [Chien, Yu-Chun] Minist Interior, Emergency Med Serv Div, Natl Fire Agcy, New Taipei, Taiwan; [Lee, Bin-Chou] Natl Taiwan Univ Hosp, Taipei City Hosp, Dept Emergency Med, Zhongxiao Branch, Taipei, Taiwan; [Huang, Edward Pei-Chuan] Natl Taiwan Univ Hosp, Dept Emergency Med, Hsin Chu Branch, Hsinchu, Taiwan; [Ma, Matthew Huei-Ming; Chiang, Wen-Chu] Natl Taiwan Univ Hosp, Dept Emergency Med, Yun Lin Branch, Touliu, Taiwan; [Sun, Jen-Tang] Tzu Chi Univ, Sch Med, Hualien, Taiwan	Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Taipei City Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Tzu Chi University	Sun, JT (corresponding author), Far Eastern Mem Hosp, Dept Emergency Med, New Taipei, Taiwan.; Chiang, WC (corresponding author), Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Emergency Med, Taipei, Taiwan.; Chiang, WC (corresponding author), Natl Taiwan Univ Hosp, Dept Emergency Med, Yun Lin Branch, Touliu, Taiwan.; Sun, JT (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.	drchiang.tw@gmail.com; tangtang05231980@gmail.com		MA, MATTHEW HUEI-MING/0000-0002-4388-9984; HSIEH, MING-JU/0000-0003-3636-6250; yang, wen shuo/0000-0002-6905-9049; Hsu, Shuoting/0000-0003-2753-0346; CHEN, HSUAN-AN/0000-0003-0701-1944; CHIANG, WEN-CHU/0000-0001-8620-7982; Pei-Chuan Huang, Edward/0000-0002-4800-2561; Chu, Sheng-En/0000-0002-0453-9973	Taiwan Ministry of Science and Technology [MOST 1082314-B-002-130-MY3, MOST 105-2314-B-002200-MY3, MOST 109-2314-B-002 -154 -MY2]	Taiwan Ministry of Science and Technology	This study was funded by the Taiwan Ministry of Science and Technology (MOST 1082314-B-002-130-MY3, MOST 105-2314-B-002200-MY3, MOST 109-2314-B-002 -154 -MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON NS, 1991, NEW ENGL J MED, V324, P1225; Andrew E, 2014, RESUSCITATION, V85, P1633, DOI 10.1016/j.resuscitation.2014.07.015; Benoit JL, 2019, PREHOSP EMERG CARE, V23, P838, DOI 10.1080/10903127.2019.1595236; Bergstrom M, 2018, RESUSCITATION, V133, P147, DOI 10.1016/j.resuscitation.2018.10.018; Chiang WC, 2018, ANN EMERG MED, V71, P387, DOI 10.1016/j.annemergmed.2017.08.008; Chiang WC, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0181-4; Chiang WC, 2009, RESUSCITATION, V80, P9, DOI 10.1016/j.resuscitation.2008.10.010; Coppler PJ, 2016, RESUSCITATION, V98, P9, DOI 10.1016/j.resuscitation.2015.09.399; De Maio VJ, 2003, ANN EMERG MED, V42, P242, DOI 10.1067/mem.2003.266; Earnest A, 2012, PREHOSP EMERG CARE, V16, P256, DOI 10.3109/10903127.2011.615974; Fukuda T, 2014, INT J CARDIOL, V176, P910, DOI 10.1016/j.ijcard.2014.08.057; Gaspari R, 2016, RESUSCITATION, V109, P33, DOI 10.1016/j.resuscitation.2016.09.018; Gold LS, 2010, RESUSCITATION, V81, P622, DOI 10.1016/j.resuscitation.2010.02.004; Gold LS, 2009, PREHOSP EMERG CARE, V13, P341, DOI 10.1080/10903120902935389; Goto Y, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007568; Grunau B, 2019, RESUSCITATION, V135, P137, DOI 10.1016/j.resuscitation.2018.12.003; Hanif MA, 2010, ACAD EMERG MED, V17, P926, DOI 10.1111/j.1553-2712.2010.00829.x; Hansen M, 2018, CIRCULATION, V137, P2032, DOI 10.1161/CIRCULATIONAHA.117.033067; Hasegawa K, 2013, JAMA-J AM MED ASSOC, V309, P257, DOI 10.1001/jama.2012.187612; Hawkes C, 2017, RESUSCITATION, V110, P133, DOI 10.1016/j.resuscitation.2016.10.030; Herlitz J, 2008, RESUSCITATION, V76, P31, DOI 10.1016/j.resuscitation.2007.06.027; Holzer M, 2002, NEW ENGL J MED, V346, P549; Homma Y, 2019, AM J EMERG MED, V37, P241, DOI 10.1016/j.ajem.2018.05.037; Izawa J, 2018, RESUSCITATION, V128, P16, DOI 10.1016/j.resuscitation.2018.04.024; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Jacobs IG, 2011, RESUSCITATION, V82, P1138, DOI 10.1016/j.resuscitation.2011.06.029; Ko DT, 2016, AM HEART J, V177, P129, DOI 10.1016/j.ahj.2016.04.018; Ko Y-C., 2019, RESUSCITATION, V142, pe101; Kurz MC, 2018, RESUSCITATION, V128, P132, DOI 10.1016/j.resuscitation.2018.04.031; Larsen JM, 2012, RESUSCITATION, V83, P1427, DOI 10.1016/j.resuscitation.2012.08.337; Lee AF, 2022, JAMA NETW OPEN, V5, DOI 10.1001/jamanetworkopen.2021.48871; Lee DW, 2019, AM J EMERG MED, V37, P1999, DOI 10.1016/j.ajem.2019.02.021; Ma MHM, 2007, RESUSCITATION, V74, P461, DOI 10.1016/j.resuscitation.2007.02.006; McNally B., 2011, MMWR SURVEILL SUMM, V60; Michelland L, 2020, J EVAL CLIN PRACT, V26, P1013, DOI 10.1111/jep.13268; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; O'Keeffe C, 2011, EMERG MED J, V28, P703, DOI 10.1136/emj.2009.086363; Olasveengen TM, 2009, JAMA-J AM MED ASSOC, V302, P2222, DOI 10.1001/jama.2009.1729; Ono Y, 2016, RESUSCITATION, V107, P65, DOI 10.1016/j.resuscitation.2016.08.005; Pell JP, 2001, BRIT MED J, V322, P1385, DOI 10.1136/bmj.322.7299.1385; Perkins GD, 2018, NEW ENGL J MED, V379, P711, DOI 10.1056/NEJMoa1806842; Perkins GD, 2020, INTENS CARE MED, V46, P426, DOI 10.1007/s00134-019-05836-2; Perkins GD, 2015, RESUSCITATION, V96, P328, DOI 10.1016/j.resuscitation.2014.11.002; Flato UAP, 2015, RESUSCITATION, V92, P1, DOI 10.1016/j.resuscitation.2015.03.024; Ran LY, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.014330; Sanghavi P, 2015, JAMA INTERN MED, V175, P196, DOI 10.1001/jamainternmed.2014.5420; Sigal AP, 2019, RESUSCITATION, V139, P182, DOI 10.1016/j.resuscitation.2019.04.018; Stiell IG, 2004, NEW ENGL J MED, V351, P647, DOI 10.1056/NEJMoa040325; Sun JT, 2018, RESUSCITATION, V122, P48, DOI 10.1016/j.resuscitation.2017.11.048; Tsai BM, 2020, PLOS ONE, V15, DOI [10.1371/journal.pone.0235315, 10.1371/journal.pone.0235315.r001, 10.1371/journal.pone.0235315.r002, 10.1371/journal.pone.0235315.r003, 10.1371/journal.pone.0235315.r004]; Tuttle JE, 2018, WEST J EMERG MED, V19, P654, DOI 10.5811/westjem.2018.3.37051; Valenzuela TD, 1997, CIRCULATION, V96, P3308; Wang CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122675; Wang CH, 2020, ANN EMERG MED, V75, P627, DOI 10.1016/j.annemergmed.2019.12.003; Wang HE, 2018, JAMA-J AM MED ASSOC, V320, P769, DOI 10.1001/jama.2018.7044; Wang HE, 2010, ANN EMERG MED, V55, P527, DOI 10.1016/j.annemergmed.2009.12.020; Wu CS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191636	57	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266969	10.1371/journal.pone.0266969	http://dx.doi.org/10.1371/journal.pone.0266969			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421162	gold, Green Published			2022-12-26	WOS:000795453600089
J	Chen, Q; Li, F; Zuo, XB; Chen, J; Qin, PW; Wang, CH; Xu, J; Yang, DY; Xing, BG; Liu, Y; Jia, P; Li, LL; Yang, CM; Yu, DM				Chen, Qun; Li, Fang; Zuo, Xiaobing; Chen, Jin; Qin, Peiwu; Wang, Chuhui; Xu, Jin; Yang, Danyu; Xing, Baogang; Liu, Ying; Jia, Peng; Li, Linling; Yang, Chengming; Yu, Dongmei			Reversible domain closure modulates GlnBP ligand binding affinity	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; GLUTAMINE; PROTEIN; DYNAMICS	Glutamine binding protein (GlnBP) is an Escherichia Coli periplasmic binding protein, which binds and carries glutamine to the inner membrane ATP-binding cassette (ABC) transporter. GlnBP binds the ligand with affinity around 0.1 mu M measured by isothermal titration calorimetry (ITC) and ligand binding stabilizes protein structure shown by its increase in thermodynamic stability. However, the molecular determinant of GlnBP ligand binding is not known. Electrostatic and hydrophobic interaction between GlnBP and glutamine are critical factors. We propose that the freedome of closure movement is also vital for ligand binding. In order to approve this hypothesis, we generate a series of mutants with different linker length that has different magnitude of domain closure. Mutants show different ligand binding affinity, which indicates that the propensity of domain closure determines the ligand binding affinity. Ligand binding triggers gradual ensemble conformational change. Structural changes upon ligand binding are monitored by combination of small angle x-ray scattering (SAXS) and NMR spectroscopy. Detailed structure characterization of GlnBP contributes to a better understanding of ligand binding and provides the structural basis for biosensor design.	[Chen, Qun; Li, Fang; Qin, Peiwu; Wang, Chuhui] Tsinghua Berkeley Shenzhen Inst, Ctr Precis Med & Healthcare, Shenzhen, Guangdong, Peoples R China; [Zuo, Xiaobing] Argonne Natl Lab, Xray Sci Div, 9700 S Cass Ave, Argonne, IL 60439 USA; [Chen, Jin] Univ Macau, Inst Chinese Med Sci, Macau, Peoples R China; [Xu, Jin; Yang, Danyu] Shenzhen Aier Eye Hosp, Shenzhen, Guangdong, Peoples R China; [Xing, Baogang; Yang, Chengming] Univ Sci & Technol Hosp, Shenzhen, Guangdong, Peoples R China; [Liu, Ying; Jia, Peng] Shenzhen Custom, Food Inspect & Quarantine Ctr, Shenzhen, Guangdong, Peoples R China; [Li, Linling] Southern Med Univ, Shenzhen Matern & Child Healthcare Hosp, Shenzhen, Guangdong, Peoples R China; [Yu, Dongmei] Shandong Univ, Sch Mech Elect & Informat Engn, Weihai, Shandong, Peoples R China	United States Department of Energy (DOE); Argonne National Laboratory; University of Macau; Southern Medical University - China; Shandong University	Yang, CM (corresponding author), Univ Sci & Technol Hosp, Shenzhen, Guangdong, Peoples R China.; Yu, DM (corresponding author), Shandong Univ, Sch Mech Elect & Informat Engn, Weihai, Shandong, Peoples R China.	hanks281128@163.com; yudongmei@sdu.edu.cn			National Natural Science Foundation of China [31970742, 81972854, 81802626]; Science, Technology and Innovation Commission of Shenzhen Municipality [JSGG20191129110812]; Southern University of Science and Technology Hospital Dean Research Fund [2020-A4]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science, Technology and Innovation Commission of Shenzhen Municipality; Southern University of Science and Technology Hospital Dean Research Fund	The use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE.	Bermejo GA, 2010, BIOCHEMISTRY-US, V49, P1893, DOI 10.1021/bi902045p; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fenton AW, 2010, BIOCHEMISTRY-US, V49, P7202, DOI 10.1021/bi100147w; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Grunau A, 2007, BIOCHEMISTRY-US, V46, P8244, DOI 10.1021/bi700596s; Henzl MT, 2007, BIOCHEMISTRY-US, V46, P23, DOI 10.1021/bi061421h; Hsiao CD, 1996, J MOL BIOL, V262, P225, DOI 10.1006/jmbi.1996.0509; Hu YL, 2008, J MOL BIOL, V382, P99, DOI 10.1016/j.jmb.2008.06.091; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jung YS, 2004, J BIOMOL NMR, V30, P11, DOI 10.1023/B:JNMR.0000042954.99056.ad; Linton KJ, 2007, PHYSIOLOGY, V22, P122, DOI 10.1152/physiol.00046.2006; Loeffler HH, 2009, BIOPHYS J, V97, P2541, DOI 10.1016/j.bpj.2009.08.019; Ma JH, 2009, J AM CHEM SOC, V131, P9884, DOI 10.1021/ja903552q; Pang A, 2003, FEBS LETT, V550, P168, DOI 10.1016/S0014-5793(03)00866-4; Sun YJ, 1998, J MOL BIOL, V278, P219, DOI 10.1006/jmbi.1998.1675; Yu JH, 1997, J BIOMOL NMR, V9, P167, DOI 10.1023/A:1018606304131	16	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0263102	10.1371/journal.pone.0263102	http://dx.doi.org/10.1371/journal.pone.0263102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446849	Green Submitted, gold, Green Published			2022-12-26	WOS:000795468200031
J	Koehn, RR; Roelker, SA; Pan, XL; Schmitt, LC; Chaudhari, AMW; Siston, RA				Koehn, Rebekah R.; Roelker, Sarah A.; Pan, Xueliang; Schmitt, Laura C.; Chaudhari, Ajit M. W.; Siston, Robert A.			Is modular control related to functional outcomes in individuals with knee osteoarthritis and following total knee arthroplasty?	PLOS ONE			English	Article							MUSCLE SYNERGIES; MOTOR MODULES; GAIT ANALYSIS; PERFORMANCE; ACTIVATION; WALKING; PATTERNS; INSTABILITY; BALANCE; HIP	BackgroundIndividuals who undergo total knee arthroplasty (TKA) for treatment of knee osteoarthritis often experience suboptimal outcomes. Investigation of neuromuscular control strategies in these individuals may reveal factors that contribute to these functional deficits. The purpose of this pilot study was to determine the relationship between patient function and modular control during gait before and after TKA. MethodsElectromyography data from 36 participants (38 knees) were collected from 8 lower extremity muscles on the TKA-involved limb during >= 5 over-ground walking trials before (n = 30), 6-months after (n = 26), and 24-months after (n = 13) surgery. Muscle modules were estimated using non-negative matrix factorization. The number of modules was determined from 500 resampled trials. ResultsA higher number of modules was related to better performance-based and patient-reported function before and 6-months after surgery. Participants with organization similar to healthy, age-matched controls trended toward better function 24-months after surgery, though these results were not statistically significant. We also observed plasticity in the participants' modular control strategies, with 100% of participants who were present before and 24-months after surgery (10/10) demonstrating changes in the number of modules and/or organization of at least 1 module. ConclusionsThis pilot work suggests that functional improvements following TKA may initially present as increases in the number of modules recruited during gait. Subsequent improvements in function may present as improved module organization. NoteworthyThis work is the first to characterize motor modules in TKA both before and after surgery and to demonstrate changes in the number and organization of modules over the time course of recovery, which may be related to changes in patient function. The plasticity of modular control following TKA is a key finding which has not been previously documented and may be useful in predicting or improving surgical outcomes through novel rehabilitation protocols.	[Koehn, Rebekah R.; Chaudhari, Ajit M. W.; Siston, Robert A.] Ohio State Univ, Dept Mech & Aerosp Engn, Columbus, OH 43210 USA; [Roelker, Sarah A.] Univ Massachusetts, Dept Kinesiol, Amherst, MA 01003 USA; [Pan, Xueliang] Ohio State Univ, Ctr Biostat & Bioinformat, Columbus, OH 43210 USA; [Schmitt, Laura C.; Chaudhari, Ajit M. W.; Siston, Robert A.] Ohio State Univ, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA; [Schmitt, Laura C.; Chaudhari, Ajit M. W.; Siston, Robert A.] Ohio State Univ, Sports Med Res Inst, Wexner Med Ctr, Columbus, OH 43210 USA; [Schmitt, Laura C.; Chaudhari, Ajit M. W.] Ohio State Univ, Sch Hlth & Rehabil Sci, Div Phys Therapy, Columbus, OH 43210 USA; [Chaudhari, Ajit M. W.; Siston, Robert A.] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Chaudhari, Ajit M. W.; Siston, Robert A.] Ohio State Univ, Dept Orthopaed, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University of Massachusetts System; University of Massachusetts Amherst; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Siston, RA (corresponding author), Ohio State Univ, Dept Mech & Aerosp Engn, Columbus, OH 43210 USA.; Siston, RA (corresponding author), Ohio State Univ, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA.; Siston, RA (corresponding author), Ohio State Univ, Sports Med Res Inst, Wexner Med Ctr, Columbus, OH 43210 USA.; Siston, RA (corresponding author), Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA.; Siston, RA (corresponding author), Ohio State Univ, Dept Orthopaed, Columbus, OH 43210 USA.	siston.1@osu.edu			National Science Foundation Graduate Research Fellowship Program [DGE-1343012, DGE-0822215]; Ohio State University; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR056700]	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Ohio State University(Ohio State University); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by the National Science Foundation Graduate Research Fellowship Program under Grant Nos. DGE-1343012 (SAR)and DGE-0822215 (EJC), a fellowship from The Ohio State University (RRK; https://gradsch.osu.edu/fellowships), and by Grant Number R01AR056700 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. The content is solely the responsibility of the authors and does not necessarily representthe officialviewsof the NationalInstituteof ArthritisandMusculoskeletaland Skin Diseasesnor theNationalInstitutesof Health.The fundershad norole in studydesign,data collectionand analysis,decisionto publish,or preparationof themanuscript.	Allen JL, 2019, J NEUROPHYSIOL, V122, P277, DOI 10.1152/jn.00561.2018; Allen JL, 2017, J NEUROPHYSIOL, V118, P363, DOI 10.1152/jn.00813.2016; Almeida GJ, 2010, ARCH PHYS MED REHAB, V91, P932, DOI 10.1016/j.apmr.2010.02.003; Ardestani MM, 2017, J ELECTROMYOGR KINES, V37, P90, DOI 10.1016/j.jelekin.2017.09.006; Bade MJ, 2010, J ORTHOP SPORT PHYS, V40, P559, DOI 10.2519/jospt.2010.3317; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Benedetti MG, 2003, CLIN BIOMECH, V18, P871, DOI 10.1016/S0268-0033(03)00146-3; BERMAN AT, 1987, J BONE JOINT SURG AM, V69A, P1340; Brough LG, 2019, J BIOMECH, V82, P361, DOI 10.1016/j.jbiomech.2018.11.011; Chaudhari AMW, 2019, J ORTHOP SPORT PHYS, V49, P513, DOI 10.2519/jospt.2019.8619; Clark DJ, 2010, J NEUROPHYSIOL, V103, P844, DOI 10.1152/jn.00825.2009; Davidson BS, 2013, J ELECTROMYOGR KINES, V23, P1485, DOI 10.1016/j.jelekin.2013.06.008; Dobson F, 2013, OSTEOARTHR CARTILAGE, V21, P1042, DOI 10.1016/j.joca.2013.05.002; Ferreira CL, 2020, J BIOMECH, V110, DOI 10.1016/j.jbiomech.2020.109981; Freisinger GM, 2017, J ORTHOP RES, V35, P1644, DOI 10.1002/jor.23447; Hayes HB, 2014, CLIN NEUROPHYSIOL, V125, P2024, DOI 10.1016/j.clinph.2014.02.001; Hubley-Kozey CL, 2010, CLIN BIOMECH, V25, P995, DOI 10.1016/j.clinbiomech.2010.07.008; Ivanenko YP, 2004, J PHYSIOL-LONDON, V556, P267, DOI 10.1113/jphysiol.2003.057174; Jacobs DA, 2018, J NEUROENG REHABIL, V15, DOI 10.1186/s12984-017-0343-x; JEFFERY RS, 1991, J BONE JOINT SURG BR, V73, P709, DOI 10.1302/0301-620X.73B5.1894655; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kennedy DM, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-3; Kieliba P, 2018, IEEE T NEUR SYS REH, V26, P882, DOI 10.1109/TNSRE.2018.2810859; Kubota K, 2021, IEEE T NEUR SYS REH, V29, P239, DOI 10.1109/TNSRE.2020.3043831; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; LEE WA, 1984, J MOTOR BEHAV, V16, P135; Marmon AR, 2014, INT J SPORTS PHYS TH, V9, P329; MUSSAIVALDI FA, 1994, P NATL ACAD SCI USA, V91, P7534, DOI 10.1073/pnas.91.16.7534; OLREE KS, 1995, BIOL CYBERN, V73, P409, DOI 10.1007/BF00201475; REJESKI WJ, 1995, OSTEOARTHR CARTILAGE, V3, P157, DOI 10.1016/S1063-4584(05)80050-0; Roelker S. A., 2021, MEDRXIV P 2020052220, DOI [10.1371/journal.pone.0261862, DOI 10.1371/JOURNAL.PONE.0261862]; Roelker SA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0261862; Roos Ewa M, 2003, Health Qual Life Outcomes, V1, P64, DOI 10.1186/1477-7525-1-64; Safavynia Seyed A, 2011, Top Spinal Cord Inj Rehabil, V17, P16; Santuz A, 2017, INT J NEURAL SYST, V27, DOI 10.1142/S0129065717500071; Sawers A, 2015, J NEUROPHYSIOL, V114, P3359, DOI 10.1152/jn.00758.2015; Serrancoli G, 2016, CLIN BIOMECH, V31, P65, DOI 10.1016/j.clinbiomech.2015.09.019; Shuman BR, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-019-0502-3; Shuman BR, 2018, ARCH PHYS MED REHAB, V99, P2175, DOI 10.1016/j.apmr.2018.03.006; Singh JA, 2010, OSTEOARTHR CARTILAGE, V18, P515, DOI 10.1016/j.joca.2009.12.001; Sloan M, 2018, J BONE JOINT SURG AM, V100, P1455, DOI 10.2106/JBJS.17.01617; Smith AJ, 2004, J ORTHOP RES, V22, P260, DOI 10.1016/S0736-0266(03)00184-0; Steele KM, 2015, DEV MED CHILD NEUROL, V57, P1176, DOI 10.1111/dmcn.12826; Stulberg SD, 2002, J BONE JOINT SURG AM, V84A, P90, DOI 10.2106/00004623-200200002-00011; Su FC, 1998, CLIN BIOMECH, V13, P176, DOI 10.1016/S0268-0033(97)00039-9; Ting LH, 2007, CURR OPIN NEUROBIOL, V17, P622, DOI 10.1016/j.conb.2008.01.002; Ting LH, 2015, NEURON, V86, P38, DOI 10.1016/j.neuron.2015.02.042; Torres-Oviedo G, 2007, J NEUROPHYSIOL, V98, P2144, DOI 10.1152/jn.01360.2006; Weiss JM, 2002, CLIN ORTHOP RELAT R, P172, DOI 10.1097/01.blo.0000036536.46246.d9; Wilson SA, 1996, J ARTHROPLASTY, V11, P359, DOI 10.1016/S0883-5403(96)80023-4; Yercan HS, 2005, KNEE, V12, P257, DOI 10.1016/j.knee.2005.01.004; Zeni JA, 2010, PHYS THER, V90, P43, DOI 10.2522/ptj.20090089	52	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267340	10.1371/journal.pone.0267340	http://dx.doi.org/10.1371/journal.pone.0267340			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C1KV	35452480	gold, Green Published, Green Submitted			2022-12-26	WOS:000792887700026
J	Komenda, M; Jarkovsky, J; Klimes, D; Panoska, P; Sanca, O; Gregor, J; Muzik, J; Karolyi, M; Majek, O; Blaha, M; Mackova, B; Razova, J; Adamkova, V; Cerny, V; Blatny, J; Dusek, L				Komenda, Martin; Jarkovsky, Jiri; Klimes, Daniel; Panoska, Petr; Sanca, Ondrej; Gregor, Jakub; Muzik, Jan; Karolyi, Matej; Majek, Ondrej; Blaha, Milan; Mackova, Barbora; Razova, Jarmila; Adamkova, Vera; Cerny, Vladimir; Blatny, Jan; Dusek, Ladislav			Sharing datasets of the COVID-19 epidemic in the Czech Republic	PLOS ONE			English	Article								At the time of the COVID-19 pandemic, providing access to data (properly optimised regarding personal data protection) plays a crucial role in providing the general public and media with up-to-date information. Open datasets also represent one of the means for evaluation of the pandemic on a global level. The primary aim of this paper is to describe the methodological and technical framework for publishing datasets describing characteristics related to the COVID-19 epidemic in the Czech Republic (epidemiology, hospital-based care, vaccination), including the use of these datasets in practice. Practical aspects and experience with data sharing are discussed. As a reaction to the epidemic situation, a new portal COVID-19: Current Situation in the Czech Republic (https://onemocneni-aktualne.mzcr.cz/covid-19)& nbsp;was developed and launched in March 2020 to provide a fully-fledged and trustworthy source of information for the public and media. The portal also contains a section for the publication of (i) public open datasets available for download in CSV and JSON formats and (ii) authorised-access-only section where the authorised persons can (through an online generated token) safely visualise or download regional datasets with aggregated data at the level of the individual municipalities and regions. The data are also provided to the local open data catalogue (covering only open data on healthcare, provided by the Ministry of Health) and to the National Catalogue of Open Data (covering all open data sets, provided by various authorities/publishers, and harversting all data from local catalogues). The datasets have been published in various authentication regimes and widely used by general public, scientists, public authorities and decision-makers. The total number of API calls since its launch in March 2020 to 15 December 2020 exceeded 13 million. The datasets have been adopted as an official and guaranteed source for outputs of third parties, including public authorities, non-governmental organisations, scientists and online news portals. Datasets currently published as open data meet the 3-star open data requirements, which makes them machine-readable and facilitates their further usage without restrictions. This is essential for making the data more easily understandable and usable for data consumers. In conjunction with the strategy of the MH in the field of data opening, additional datasets meeting the already implemented standards will be also released, both on COVID-19 related and unrelated topics.	[Komenda, Martin; Jarkovsky, Jiri; Klimes, Daniel; Panoska, Petr; Sanca, Ondrej; Gregor, Jakub; Muzik, Jan; Karolyi, Matej; Majek, Ondrej; Blaha, Milan; Dusek, Ladislav] Inst Hlth Informat & Stat Czech Republ, Prague, Czech Republic; [Komenda, Martin; Jarkovsky, Jiri; Klimes, Daniel; Panoska, Petr; Gregor, Jakub; Muzik, Jan; Karolyi, Matej; Majek, Ondrej; Blaha, Milan; Dusek, Ladislav] Masaryk Univ, Fac Med, Inst Biostat & Anal, Brno, Czech Republic; [Komenda, Martin] Masaryk Univ, Fac Med, Med Simulat Ctr, Brno, Czech Republic; [Karolyi, Matej] Masaryk Univ, Fac Informat, Brno, Czech Republic; [Mackova, Barbora] Natl Inst Publ Hlth, Prague, Czech Republic; [Razova, Jarmila; Blatny, Jan] Minist Hlth Czech Republ, Prague, Czech Republic; [Adamkova, Vera] Inst Clin & Expt Med, Dept Prevent Cardiol, Prague, Czech Republic; [Adamkova, Vera] Charles Univ Prague, Fac Med 1, Dept Nephrol, Prague, Czech Republic; [Adamkova, Vera] Czech Tech Univ, Fac Biomed Engn, Kladno, Czech Republic; [Cerny, Vladimir] Masaryk Hosp Usti Nad Labem, Dept Anaesthesiol Perioperat Med & Intens Care, Usti Nad Labem, Czech Republic; [Cerny, Vladimir] Univ JE Purkyne, Usti Nad Labem, Czech Republic	Institute of Biostatistics & Analyses; Masaryk University Brno; Masaryk University Brno; Masaryk University Brno; National Institute of Public Health (SZU) - Czech Republic; Institute for Clinical & Experimental Medicine (IKEM); Charles University Prague; Czech Technical University Prague; Masaryk Hospital; University of Jan Evangelista Purkyne	Komenda, M (corresponding author), Inst Hlth Informat & Stat Czech Republ, Prague, Czech Republic.; Komenda, M (corresponding author), Masaryk Univ, Fac Med, Inst Biostat & Anal, Brno, Czech Republic.; Komenda, M (corresponding author), Masaryk Univ, Fac Med, Med Simulat Ctr, Brno, Czech Republic.	martin.komenda@uzis.cz	Gregor, Jakub/HCI-7621-2022	Gregor, Jakub/0000-0003-2431-7873; Komenda, Martin/0000-0003-0572-5767	Ministry of Health of the Czech Republic; Institute of Health information and statistics of the Czech Republic	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Institute of Health information and statistics of the Czech Republic	a) All sources of funding (financial or material support) related to this manuscript are covered by Ministry of Health of the Czech Republic and Institute of Health information and statistics of the Czech Republic. There are no particular grants or other organizations that supported this study. b) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. c) The authors received no specific funding for this work.	Alamo T, 2020, ELECTRONICS-SWITZ, V9, DOI 10.3390/electronics9050827; Altayar MS, 2018, GOV INFORM Q, V35, P633, DOI 10.1016/j.giq.2018.09.006; [Anonymous], OPEN DATA INITIATIVE; [Anonymous], GOLEMIO DATA PLATFOR; [Anonymous], LEGISLATIVN PROSTED; [Anonymous], 2020, COVID 19 DATA HUB; Boeckhout M, 2018, EUR J HUM GENET, V26, P931, DOI 10.1038/s41431-018-0160-0; CSSEGISandData, 2020, COVID 19 DAT REP CTR; D'Agostino M, 2018, REV PANAM SALUD PUBL, V42, DOI 10.26633/RPSP.2018.66; Dagliati A, 2021, BRIEF BIOINFORM, V22, P812, DOI 10.1093/bib/bbaa418; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Etalab, 2020, COR EP MON DASHB FRA; European Centre for Disease Prevention and Control, 2020, COVID 19 COR DATAWEE; European Commission, EU IMPL G8 OP DAT CH; Government of Canada, OP DAT; Komenda M, 2020, COVID 19 OVERVIEW CU; Komenda M., 2020, COVID 19 OVERVIEW CU; Komenda M, 2020, J MED INTERNET RES, V22, DOI 10.2196/19367; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Majek O., 2020, MODELLING 1 WAVE COV, DOI [10.1101/2020.09.10.20192070v1, DOI 10.1101/2020.09.10.20192070V1]; Ministry of Health of the Czech Republic, 2020, COVID 19 CZECH REP O; Ministry of Health of the Czech Republic, 2020, COVID 19 DASHB; Ministry of Health of the Czech Republic, 2019, OPEN DATA CATALOGUE; Ministry of Interior of the Czech Republic, 2018, NAT CAT OP DAT; Our World in Data, 2020, COR PAND COVID 19E D; Park JJH, 2021, LANCET GLOB HEALTH, V9, pE711, DOI 10.1016/S2214-109X(20)30542-8; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Public Health England, COR COVID 19 UK; Rios RS, 2020, EXPERT REV GASTROENT, V14, P1125, DOI 10.1080/17474124.2020.1815533; Robert Koch Institute, 2020, COVID 19 COR SARS CO; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18	31	1	1	7	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267397	10.1371/journal.pone.0267397	http://dx.doi.org/10.1371/journal.pone.0267397			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446896	gold, Green Published			2022-12-26	WOS:000795468200003
J	Liu, YB; Fu, JY; Wang, LL; Zhao, ZJ; Wang, HH; Han, SN; Sun, XY; Pan, CM				Liu, Yanbo; Fu, Junying; Wang, Linlin; Zhao, Zhijun; Wang, Huihui; Han, Suna; Sun, Xiyu; Pan, Chunmei			Isolation, identification, and whole-genome sequencing of high-yield protease bacteria from Daqu of ZhangGong Laojiu	PLOS ONE			English	Article							FERMENTATION; RESISTANCE; COMMUNITY; FINDER	A total of 296 strains of protease-producing bacteria were isolated and purified from medium-temperature Daqu produced by ZhangGong LaoJiu Wine Co. Ltd. After calculating the ratio of transparent ring diameter to colony diameter and measuring the protease activities, a strain of high-yield protease bacteria, called DW-7, was screened out with a protease activity of 99.54 U/mL. Through morphological observation, 16S rDNA sequence analysis, and physiological and biochemical tests, the isolated bacteria DW-7 was determined to be Bacillus velezensis. In addition, whole-genome sequencing (WGS), using PacBio and the Illumina platform, was performed. Gene annotation was then conducted using the Clusters of Orthologous Groups (COG), Kyoto Encyclopedia of Genes and Genomes (KEGG), Non-Redundant Protein Sequence Database (NR), and Gene Ontology (GO) databases. The results showed that the genome of DW-7 was 3,942,829 bp long with a GC content of 46.45%. A total of 3,662 protein-encoding genes were predicted, with a total length of 3,402,822 bp. Additionally, 2,283; 2,796; and 2,127 genes were annotated in the COG, KEGG, and GO databases, respectively. A total of 196 high-yield protease genes were mainly enriched in the metabolism of alanine, aspartic acid, glutamate, glycine, serine, and threonine, as well as ABC transporter and transporter pathways.	[Liu, Yanbo; Fu, Junying; Wang, Linlin; Zhao, Zhijun; Wang, Huihui; Sun, Xiyu; Pan, Chunmei] Henan Univ Anim Husb & Econ, Coll Food & Biol Engn, Liquor Coll, Zhengzhou, Henan, Peoples R China; [Liu, Yanbo; Han, Suna] Henan Yangshao Distillery Co Ltd, Postdoctoral Programme, Mianchi, Henan, Peoples R China; [Liu, Yanbo; Fu, Junying; Wang, Linlin; Zhao, Zhijun; Wang, Huihui; Sun, Xiyu; Pan, Chunmei] Henan Univ Anim Husb & Econ, Henan Liquor Style Engn Technol Res Ctr, Zhengzhou, Henan, Peoples R China; [Liu, Yanbo; Fu, Junying; Wang, Linlin; Zhao, Zhijun; Wang, Huihui; Pan, Chunmei] Henan Univ Anim Husb & Econ, Zhengzhou Key Lab Liquor Brewing Microbial Techno, Zhengzhou, Henan, Peoples R China; [Sun, Xiyu] ZhangGongLaoJiu Wine Co Ltd, Ningling, Henan, Peoples R China	Henan University of Animal Husbandry & Economy; Henan University of Animal Husbandry & Economy; Henan University of Animal Husbandry & Economy	Pan, CM (corresponding author), Henan Univ Anim Husb & Econ, Coll Food & Biol Engn, Liquor Coll, Zhengzhou, Henan, Peoples R China.; Pan, CM (corresponding author), Henan Univ Anim Husb & Econ, Henan Liquor Style Engn Technol Res Ctr, Zhengzhou, Henan, Peoples R China.; Pan, CM (corresponding author), Henan Univ Anim Husb & Econ, Zhengzhou Key Lab Liquor Brewing Microbial Techno, Zhengzhou, Henan, Peoples R China.	sige518888@163.com	wang, huimin/HDM-8421-2022; Fu, JY/GRR-6179-2022; wang, hui/GRS-4730-2022; Fu, Terrence/GPS-8331-2022		Major Science and Technology Projects of Henan Province of China [181100211400]; Key Technologies Research and Development Program of Henan Province of China [202102110130]; Scientific Research Foundation for Docotors of Henan University of Animal Husbandry and Economy [2018HNUAHEDF011]; Key Subject Projects of Henan University of Animal Husbandry and Economy [C3060020]	Major Science and Technology Projects of Henan Province of China; Key Technologies Research and Development Program of Henan Province of China; Scientific Research Foundation for Docotors of Henan University of Animal Husbandry and Economy; Key Subject Projects of Henan University of Animal Husbandry and Economy	We thank ZhangGong LaoJiu Wine Co. Ltd. for providing the samples and the distillery staff for their help in sampling. We also thank the members of the subject group for supporting this study and contributing to the experimental work. We would like to thank Editage (www.editage.cn) for English language editing.	Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bertelli C, 2018, BIOINFORMATICS, V34, P2161, DOI 10.1093/bioinformatics/bty095; Chen YR, 2021, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.592421; Chu WH, 2007, J IND MICROBIOL BIOT, V34, P241, DOI 10.1007/s10295-006-0192-2; Deng L, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.588117; DVORAK HF, 1977, J IMMUNOL, V119, P38; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Faja OM, 2019, VET WORLD, V12, P1140, DOI 10.14202/vetworld.2019.1140-1149; Fan GS, 2018, J AM SOC BREW CHEM, V76, P209, DOI 10.1080/03610470.2018.1424402; Fan GS, 2019, J BIOSCI BIOENG, V127, P309, DOI 10.1016/j.jbiosc.2018.08.005; Fan WY, 2021, THESIS JIANGNAN U, DOI [10.27169/d.cnki.gwqgu.2021.000945, DOI 10.27169/D.CNKI.GWQGU.2021.000945]; Feng LF, 2018, THESIS SHANXI NORMAL; Fouts DE, 2006, NUCLEIC ACIDS RES, V34, P5839, DOI 10.1093/nar/gkl732; Haas B., 2007, TRANSPOSONPSI APPL P; Harish BS, 2018, INT J BIOL MACROMOL, V107, P1373, DOI 10.1016/j.ijbiomac.2017.09.115; Hu BD., 2016, MODERN FOOD SCI TECH, V33, P99, DOI [10.13982/j.mfst.1673-9078.2017.2.016, DOI 10.13982/J.MFST.1673-9078.2017.2.016]; Huang YG, 2014, J I BREWING, V120, P268, DOI 10.1002/jib.135; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Li DN, 2019, MICROBIOLOGYOPEN, V8, DOI 10.1002/mbo3.922; Li FH, 2016, CHIN J OCEANOL LIMN, V34, P153, DOI 10.1007/s00343-015-4149-z; Liu JJ, 2018, J SCI FOOD AGR, V98, P113, DOI 10.1002/jsfa.8445; Lowe TM, 2016, NUCLEIC ACIDS RES, V44, pW54, DOI 10.1093/nar/gkw413; Lu Z., 2016, HEILONGJIANG AGR SCI, P110; Mamo J, 2018, J FOOD QUALITY, DOI 10.1155/2018/7957269; McDermott PF, 2016, ANTIMICROB AGENTS CH, V60, P5515, DOI 10.1128/AAC.01030-16; Ming HM., 2013, LIQUOR MAKING SCI TE, P57, DOI [10.13746/j.njkj.2013.12.022, DOI 10.13746/J.NJKJ.2013.12.022]; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Nie HF., 2015, LIQUOR MAKING SCI TE, P41, DOI [10.13746/j.njkj.2015157, DOI 10.13746/J.NJKJ.2015157]; Prajapati VS, 2017, 3 BIOTECH, V7, DOI 10.1007/s13205-017-1005-1; Ronholm J, 2016, CLIN MICROBIOL REV, V29, P837, DOI 10.1128/CMR.00056-16; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Sun JX., 2012, MODERN FOOD SCI TECH, V28, P1541, DOI [10.13982/j.mfst.1673-9078.2012.11.033, DOI 10.13982/J.MFST.1673-9078.2012.11.033]; Thevarajoo S, 2015, MAR GENOM, V23, P49, DOI 10.1016/j.margen.2015.04.009; Tyler AD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29334-5; Wang, 2018, FEED REV, P4; Wang, 2010, THESIS HENAN AGR U; Wang HL, 2021, APPL ENVIRON MICROB, V87, DOI 10.1128/AEM.01203-21; Wang J., 2015, CHINA BREWING, V34, P43; [卫春会 Wei Chunhui], 2014, [食品与机械, Food and Machinery], V30, P24; Wu Q, 2013, INT J FOOD MICROBIOL, V166, P323, DOI 10.1016/j.ijfoodmicro.2013.07.003; Wu XY, 2021, ARCH MICROBIOL, V203, P5831, DOI 10.1007/s00203-021-02552-8; Xiao W., 2014, LIQUOR MAKING SCI TE, P50, DOI [10.13746/j.njkj.2014216, DOI 10.13746/J.NJKJ.2014216]; Yang JG, 2018, J I BREWING, V124, P498, DOI 10.1002/jib.528; Yin X, 2020, J BIOSCI BIOENG, V129, P315, DOI 10.1016/j.jbiosc.2019.09.017; Yuan XL., 2012, LIQUOR MAKING SCI TE, P51, DOI [10.13746/j.njkj.2012.09.021, DOI 10.13746/J.NJKJ.2012.09.021]; Zhang, 2012, CHINA BREWING, V31, P35; Zhang Y, 2021, CHINESE J CHEM, V39, P550, DOI 10.1002/cjoc.202000515; Zhao QL., 2015, LIQUOR MAKING SCI TE, P41, DOI [10.13746/j.njkj.2015105, DOI 10.13746/J.NJKJ.2015105]; [钟晓敏 Zhong Xiaomin], 2009, [食品与发酵工业, Food and Fermentation Industries], V35, P40	49	0	0	24	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0264677	10.1371/journal.pone.0264677	http://dx.doi.org/10.1371/journal.pone.0264677			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35472204	gold, Green Published			2022-12-26	WOS:000816171900029
J	Nehe, A; King, J; King, IP; Murchie, EH; Foulkes, MJ				Nehe, Ajit; King, Julie; King, Ian P.; Murchie, Erik H.; Foulkes, M. John			Identifying variation for N-use efficiency and associated traits in amphidiploids derived from hybrids of bread wheat and the genera Aegilops, Secale, Thinopyrum and Triticum	PLOS ONE			English	Article							DROUGHT-ADAPTIVE TRAITS; NITROGEN-USE EFFICIENCY; GRAIN-YIELD; PROTEIN-CONCENTRATION; LEAF PHOTOSYNTHESIS; GENETIC-VARIATION; WILD RELATIVES; IDENTIFICATION; SENESCENCE; FERTILIZER	Future genetic progress in wheat grain yield will depend on increasing biomass and this must be achieved without commensurate increases in nitrogen (N) fertilizer inputs to minimize environmental impacts. In recent decades there has been a loss of genetic diversity in wheat through plant breeding. However, new genetic diversity can be created by incorporating genes into bread wheat from wild wheat relatives. Our objectives were to investigate amphidiploids derived from hybrids of bread wheat (Triticum aestivum L.) and related species from the genera Aegilops, Secale, Thinopyrum and Triticum for expression of higher biomass, N-use efficiency (NUE) and leaf photosynthesis rate compared to their bread wheat parents under high and low N conditions. Eighteen amphidiploid lines and their bread wheat parents were examined in high N (HN) and low N (LN) treatments under glasshouse conditions in two years. Averaged across years, grain yield reduced by 38% under LN compared to HN conditions (P = 0.004). Three amphidiploid lines showed positive transgressive segregation compared to their bread wheat parent for biomass per plant under HN conditions. Positive transgressive segregation was also identified for flag-leaf photosynthesis both pre-anthesis and post-anthesis under HN and LN conditions. For N uptake per plant at maturity positive transgressive segregation was identified for one amphidiploid line under LN conditions. Our results indicated that introgressing traits from wild relatives into modern bread wheat germplasm offers scope to raise biomass and N-use effciency in both optimal and low N availability environments.	[Nehe, Ajit; King, Julie; King, Ian P.; Murchie, Erik H.; Foulkes, M. John] Univ Nottingham, Sch Biosci, Div Plant & Crop Sci, Loughborough, Leics, England	University of Nottingham	Foulkes, MJ (corresponding author), Univ Nottingham, Sch Biosci, Div Plant & Crop Sci, Loughborough, Leics, England.	John.Foulkes@nottingham.ac.uk		Nehe, Ajit/0000-0002-1409-9297	United Kingdom Biotechnology and Biological Sciences Research Council [BB/J011827/1]	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the United Kingdom Biotechnology and Biological Sciences Research Council [grant number BB/J011827/1],	Aisawi KAB, 2015, CROP SCI, V55, P1749, DOI 10.2135/cropsci2014.09.0601; Atkinson JA, 2015, J EXP BOT, V66, P2283, DOI 10.1093/jxb/erv006; AUSTIN RB, 1982, ANN BOT-LONDON, V49, P177, DOI 10.1093/oxfordjournals.aob.a086238; Bai CH, 2013, J EXP BOT, V64, P1745, DOI 10.1093/jxb/ert041; Barraclough PB, 2010, EUR J AGRON, V33, P1, DOI 10.1016/j.eja.2010.01.005; Bogard M, 2011, J EXP BOT, V62, P3621, DOI 10.1093/jxb/err061; BYRNES BH, 1990, FERT RES, V26, P209, DOI 10.1007/BF01048758; CARVER BF, 1989, PHOTOSYNTH RES, V20, P105, DOI 10.1007/BF00034120; del Blanco IA, 2000, CROP SCI, V40, P1257, DOI 10.2135/cropsci2000.4051257x; Dreccer F., 2004, P 4 INT CROP SCI C B; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Dumas J. B. A, 1831, ANN CHIM PHYS, V2, P198; Ehdaie B, 2010, J AGRON CROP SCI, V196, P455, DOI 10.1111/j.1439-037X.2010.00433.x; EVANS LT, 1970, AUST J BIOL SCI, V23, P725, DOI 10.1071/BI9700725; Flintham JE, 1997, J AGR SCI-CAMBRIDGE, V128, P11, DOI 10.1017/S0021859696003942; Foulkes MJ, 2009, FIELD CROP RES, V114, P329, DOI 10.1016/j.fcr.2009.09.005; Foulkes MJ, 2011, J EXP BOT, V62, P469, DOI 10.1093/jxb/erq300; Gaju O, 2011, FIELD CROP RES, V123, P139, DOI 10.1016/j.fcr.2011.05.010; Gaju O, 2016, FIELD CROP RES, V193, P1, DOI 10.1016/j.fcr.2016.04.018; Gaju O, 2014, FIELD CROP RES, V155, P213, DOI 10.1016/j.fcr.2013.09.003; Genard M, 1999, J HORTIC SCI BIOTECH, V74, P772, DOI 10.1080/14620316.1999.11511187; Gouis J. le, 2010, Aspects of Applied Biology, P151; Hawkesford M. J., 2012, Better Crops with Plant Food, V96, P10; Hawkesford MJ, 2014, J CEREAL SCI, V59, P276, DOI 10.1016/j.jcs.2013.12.001; JOHNSON RC, 1987, PLANT PHYSIOL, V83, P1014, DOI 10.1104/pp.83.4.1014; Kamal NM, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235837; King IP, 1997, NEW PHYTOL, V137, P75, DOI 10.1046/j.1469-8137.1997.00828.x; King JL, 2017, PLANT BIOTECHNOL J, V15, P217, DOI 10.1111/pbi.12606; Kishii M, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00585; Longin CFH, 2012, THEOR APPL GENET, V125, P1087, DOI 10.1007/s00122-012-1967-7; Lopes MS, 2011, CROP SCI, V51, P1617, DOI 10.2135/cropsci2010.07.0445; Machefert SE, 2004, WATER AIR SOIL POLL, V4, P427, DOI DOI 10.1023/B:WAF0.0000028369.86947.9F; Merchuk-Ovnat L, 2016, PLANT SCI, V251, P23, DOI 10.1016/j.plantsci.2016.05.003; MOLL RH, 1982, AGRON J, V74, P562, DOI 10.2134/agronj1982.00021962007400030037x; Moore G, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.18, 10.1038/nplants.2015.18]; Muurinen S, 2006, CROP SCI, V46, P561, DOI 10.2135/cropsci2005-05-0046; Nehe AS, 2020, FIELD CROP RES, V251, DOI 10.1016/j.fcr.2020.107778; Nehe AS, 2018, FIELD CROP RES, V225, P152, DOI 10.1016/j.fcr.2018.06.002; Nemeth C, 2015, GENOME, V58, P71, DOI 10.1139/gen-2015-0002; Ogbonnaya FC, 2007, EUPHYTICA, V157, P321, DOI 10.1007/s10681-007-9381-y; OrtizMonasterio JI, 1997, CROP SCI, V37, P892, DOI 10.2135/cropsci1997.0011183X003700030032x; Panday US., 2020, DRONES-BASEL, V4; Pask AJD, 2012, FIELD CROP RES, V126, P104, DOI 10.1016/j.fcr.2011.09.021; Prins A, 2016, J EXP BOT, V67, P1827, DOI 10.1093/jxb/erv574; Ren T, 2019, J EXP BOT, V70, P1153, DOI 10.1093/jxb/ery448; Reynolds M, 2007, J EXP BOT, V58, P177, DOI 10.1093/jxb/erl250; Serrago RA, 2013, FIELD CROP RES, V150, P42, DOI 10.1016/j.fcr.2013.05.016; Shavrukov Y, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01950; Song QF, 2017, PLANT CELL ENVIRON, V40, P2946, DOI 10.1111/pce.13041; Subbarao GV, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2106595118; Sybesma C., 1983, ADV PHOTOSYNTHESIS R, V2, DOI [10.1128/AEM.03566-12, DOI 10.1128/AEM.03566-12]; Tilly N, 2014, J APPL REMOTE SENS, V8, DOI 10.1117/1.JRS.8.083671; Waines JG, 2007, ANN BOT-LONDON, V100, P991, DOI 10.1093/aob/mcm180; Warburton ML, 2006, EUPHYTICA, V149, P289, DOI 10.1007/s10681-005-9077-0; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x	55	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266924	10.1371/journal.pone.0266924	http://dx.doi.org/10.1371/journal.pone.0266924			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1E2NP	35427365	Green Published, gold			2022-12-26	WOS:000794332400029
J	Squara, PA; Luu, VP; Perol, D; Coudert, B; Machuron, V; Bachot, C; Samelson, L; Florentin, V; Pinguet, JM; Yahia, BB				Squara, Pierre-Alexandre; Luu, Vinh-Phuc; Perol, David; Coudert, Bruno; Machuron, Valerie; Bachot, Camille; Samelson, Laurence; Florentin, Virginie; Pinguet, Jean-Marc; Ben Hadj Yahia, Bechir			Personalized Reimbursement Model (PRM) program: A real-world data platform of cancer drugs use to improve and personalize drug pricing and reimbursement in France	PLOS ONE			English	Article							HEALTH TECHNOLOGY-ASSESSMENT; TASK-FORCE; SECONDARY DATA; RECOMMENDATIONS; POLICIES; DESIGN	ObjectiveThis article describes the Personalized Reimbursement Model (PRM) program methodology, limitations, achievement and perspectives in using real-world data of cancer drugs use to improve and personalize drug pricing and reimbursement in France. Materials and methodsPRM platform aggregates Electronic Pharmacy Records (EPR) data from French medical centers (PRM centers) to build retrospective cohorts of patients treated with injectable cancer drugs in a hospital setting. Data extracted on January 1(st), 2020, from breast cancer (BC) patients who received trastuzumab, trastuzumab emtansin or pertuzumab since January 1st, 2011, and from lung cancer (LC) patients who received bevacizumab or atezolizumab since January 1(st), 2015, enabled recovering their injectable cancer drugs history from diagnosis date until December 30(th), 2019, and served as dataset for assessment. Results123 PRM centers provided data from 30,730 patients (25,660 BC and 5,070 LC patients respectively). Overall, 20,942 (82%) of BC and 4,716 (93%) of LC patients were analyzed. Completion rate was above 98% for patients characteristics, diagnostic and treatment related data. PRM centers cover 48% and 33% of BC and LC patients in-hospital therapeutic management in France, respectively. Distribution of BC and LC patients therapeutic management, by medical center category and geographic location, was similar in PRM centers to all French medical centers, ensuring the representativeness of the PRM platform. ConclusionPRM Platform enabled building a national database generating on demand Real-World Evidence based on EPR. This enabled the first performance-based risk-sharing arrangements based on PRM data, between the CEPS and Roche, for atezolizumab cancer immunotherapy in metastatic non-small cell lung cancer indication.	[Squara, Pierre-Alexandre] Univ Paris, Dept Med, Paris, France; [Luu, Vinh-Phuc; Ben Hadj Yahia, Bechir] Med Affairs Dept, Boulogne Billancourt, France; [Perol, David] Ctr Leon Berard Comprehens Canc Ctr, Med Oncol Dept, Lyon, France; [Coudert, Bruno] Georges Francois Leclerc Comprehens Canc Ctr, Med Oncol Dept, Dijon, France; [Machuron, Valerie; Bachot, Camille] Med Evidence Dept, Boulogne Billancourt, France; [Samelson, Laurence; Florentin, Virginie] Market Access Dept, Boulogne Billancourt, France; [Pinguet, Jean-Marc] Personalized Healthcare Dept, Boulogne Billancourt, France	Sanofi-Aventis; Sanofi France; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Centre Georges-Francois Leclerc	Yahia, BB (corresponding author), Med Affairs Dept, Boulogne Billancourt, France.	bechir.ben_hadj_yahia@roche.com	d, p/GWC-4283-2022	Squara, Pierre-Alexandre/0000-0001-5998-8285				[Anonymous], 2020, OECD HLTH POLICY STU, DOI [10.1787/4b2-9cb9-en, DOI 10.1787/4B2-9CB9-EN]; [Anonymous], 2020, ACC PERS ONC EUR; [Anonymous], 2018, OECD HLTH POLICY STU; [Anonymous], 2019, EFPIA PAT WAIT IND 2; [Anonymous], 2019, PUBLIC HLTH FRANCE; [Anonymous], 2020, EUR CANC INF SYST; [Anonymous], 2020, EUR HLTH DAT SPAC; [Anonymous], 2019, IN HOSP SPEND REL CA; Berger ML, 2017, VALUE HEALTH, V20, P1003, DOI 10.1016/j.jval.2017.08.3019; Berger ML, 2012, VALUE HEALTH, V15, P217, DOI 10.1016/j.jval.2011.12.010; Cave A, 2019, CLIN PHARMACOL THER, V106, P36, DOI 10.1002/cpt.1426; Chouaid C, 2016, TARGET ONCOL, V11, P515, DOI 10.1007/s11523-015-0411-8; Cottu P, 2020, EUR J CANCER, V141, P209, DOI 10.1016/j.ejca.2020.10.012; Cox E, 2009, VALUE HEALTH, V12, P1053, DOI 10.1111/j.1524-4733.2009.00601.x; Cuggia Marc, 2019, Yearb Med Inform, V28, P195, DOI 10.1055/s-0039-1677917; Donia M, 2017, EUR J CANCER, V74, P89, DOI 10.1016/j.ejca.2016.12.017; Garrison LP, 2007, VALUE HEALTH, V10, P326, DOI 10.1111/j.1524-4733.2007.00186.x; Garrison LP, 2013, VALUE HEALTH, V16, P703, DOI 10.1016/j.jval.2013.04.011; Kerr D, 2020, ONCOLOGIST, V25, pE1, DOI 10.1634/theoncologist.2019-0337; Lancry PJ, 2001, PHARMACOECONOMICS, V19, P39, DOI 10.2165/00019053-200119002-00007; Makady A, 2015, VALUE HEALTH, V18, pA567, DOI 10.1016/j.jval.2015.09.1863; Makady A, 2017, VALUE HEALTH, V20, P520, DOI 10.1016/j.jval.2016.12.003; Moulis G, 2015, REV MED INTERNE, V36, P411, DOI 10.1016/j.revmed.2014.11.009; Orsini LS, 2020, PHARMACOEPIDEM DR S, V29, P1504, DOI 10.1002/pds.5079; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Scherpereel A, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4958-5; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Sherman RE, 2016, NEW ENGL J MED, V375, P2293, DOI 10.1056/NEJMsb1609216; Skovlund E, 2018, EUR J CANCER, V101, P69, DOI 10.1016/j.ejca.2018.06.036; Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919; Wang T, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.594549; Woolmore A, 2020, ONCOLOGIST, V25, pE1428, DOI 10.1634/theoncologist.2019-0855	32	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267242	10.1371/journal.pone.0267242	http://dx.doi.org/10.1371/journal.pone.0267242			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7VA	35439247	gold, Green Published			2022-12-26	WOS:000791280100019
J	Tang, KY; Hsiao, CH; Hwang, GJ				Tang, Kai-Yu; Hsiao, Chun-Hua; Hwang, Gwo-Jen			A scholarly network of AI research with an information science focus: Global North and Global South perspectives	PLOS ONE			English	Article							BIG DATA ANALYTICS; ARTIFICIAL-INTELLIGENCE; KNOWLEDGE MANAGEMENT; DECISION-MAKING; STRATEGIC VALUE; VALUE CREATION; SYSTEM; MODEL; COCITATION; ADOPTION	This paper primarily aims to provide a citation-based method for exploring the scholarly network of artificial intelligence (AI)-related research in the information science (IS) domain, especially from Global North (GN) and Global South (GS) perspectives. Three research objectives were addressed, namely (1) the publication patterns in the field, (2) the most influential articles and researched keywords in the field, and (3) the visualization of the scholarly network between GN and GS researchers between the years 2010 and 2020. On the basis of the PRISMA statement, longitudinal research data were retrieved from the Web of Science and analyzed. Thirty-two AI-related keywords were used to retrieve relevant quality articles. Finally, 149 articles accompanying the follow-up 8838 citing articles were identified as eligible sources. A co-citation network analysis was adopted to scientifically visualize the intellectual structure of AI research in GN and GS networks. The results revealed that the United States, Australia, and the United Kingdom are the most productive GN countries; by contrast, China and India are the most productive GS countries. Next, the 10 most frequently co-cited AI research articles in the IS domain were identified. Third, the scholarly networks of AI research in the GN and GS areas were visualized. Between 2010 and 2015, GN researchers in the IS domain focused on applied research involving intelligent systems (e.g., decision support systems); between 2016 and 2020, GS researchers focused on big data applications (e.g., geospatial big data research). Both GN and GS researchers focused on technology adoption research (e.g., AI-related products and services) throughout the investigated period. Overall, this paper reveals the intellectual structure of the scholarly network on AI research and several applications in the IS literature. The findings provide research-based evidence for expanding global AI research.	[Tang, Kai-Yu] Ming Chuan Univ, Dept Int Business, Taipei, Taiwan; [Hsiao, Chun-Hua] Kainan Univ, Sch Business, Taoyuan, Taiwan; [Hwang, Gwo-Jen] Natl Taiwan Univ Sci & Technol, Grad Inst Digital Learning & Educ, Taipei, Taiwan	Ming Chuan University; Nan Kai University Technology; National Taiwan University of Science & Technology	Tang, KY (corresponding author), Ming Chuan Univ, Dept Int Business, Taipei, Taiwan.	ky.nctu@gmail.com	Tang, Kai-Yu/GQQ-6162-2022	Tang, Kai-Yu/0000-0002-3965-3055	Ministry of Science and Technology, Taiwan [MOST 110-2511-H-130-001, MOST 109-2410-H-424-003, MOST 109-2511-H-011-002-MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study is partially supported by the Ministry of Science and Technology, Taiwan, under contract numbers MOST 110-2511-H-130-001 (Kai-Yu Tang), MOST 109-2410-H-424-003 (ChunHua Hsiao), and MOST 109-2511-H-011-002-MY3 (Gwo-Jen Hwang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar AM, 2019, INT J INFORM MANAGE, V49, P45, DOI 10.1016/j.ijinfomgt.2019.02.006; Acharya A, 2018, INT J INFORM MANAGE, V42, P90, DOI 10.1016/j.ijinfomgt.2018.06.008; Aloini D, 2020, INT J INFORM MANAGE, V51, DOI 10.1016/j.ijinfomgt.2019.03.012; Arroyo-Machado W, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228713; Baig MI, 2019, INFORM PROCESS MANAG, V56, DOI 10.1016/j.ipm.2019.102095; Bohlouli M, 2015, J INF SCI, V41, P779, DOI 10.1177/0165551515602846; Boldosova V, 2019, INFORM SYST J, V29, P1126, DOI 10.1111/isj.12244; Botsis T, 2012, J AM MED INFORM ASSN, V19, P1011, DOI 10.1136/amiajnl-2012-000881; Botsis T, 2011, J AM MED INFORM ASSN, V18, P631, DOI 10.1136/amiajnl-2010-000022; Calvard TS, 2018, INT J INFORM MANAGE, V43, P159, DOI 10.1016/j.ijinfomgt.2018.07.011; Cebrino J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242781; Chae B, 2019, INT J INFORM MANAGE, V45, P83, DOI 10.1016/j.ijinfomgt.2018.10.023; Chen DQ, 2015, J MANAGE INFORM SYST, V32, P4, DOI 10.1080/07421222.2015.1138364; Chen HC, 2012, MIS QUART, V36, P1165; Chen XL, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0255184; Chen XL, 2022, NEURAL COMPUT APPL, V34, P11295, DOI 10.1007/s00521-020-05588-x; Chen XL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231192; Cheng KH, 2022, ETR&D-EDUC TECH RES, V70, P169, DOI 10.1007/s11423-021-10070-z; Cocos A, 2017, J AM MED INFORM ASSN, V24, P813, DOI 10.1093/jamia/ocw180; Confraria H, 2017, RES POLICY, V46, P265, DOI 10.1016/j.respol.2016.11.004; Constantiou ID, 2015, J INF TECHNOL-UK, V30, P44, DOI 10.1057/jit.2014.17; De Mauro A, 2018, INFORM PROCESS MANAG, V54, P807, DOI 10.1016/j.ipm.2017.05.004; de Sousa WG, 2019, GOV INFORM Q, V36, DOI 10.1016/j.giq.2019.07.004; Del Vecchio P, 2018, INFORM PROCESS MANAG, V54, P847, DOI 10.1016/j.ipm.2017.10.006; Demoulin NTM, 2020, INFORM MANAGE-AMSTER, V57, DOI 10.1016/j.im.2018.10.006; Dremel C, 2017, MIS Q EXEC, V16, P81; Duan YQ, 2019, INT J INFORM MANAGE, V48, P63, DOI 10.1016/j.ijinfomgt.2019.01.021; Dwivedi YK, 2021, INT J INFORM MANAGE, V57, DOI 10.1016/j.ijinfomgt.2019.08.002; Fahmy C, 2015, J CRIM JUSTICE EDUC, V26, P423, DOI 10.1080/10511253.2015.1051999; Frizzo-Barker J, 2016, INT J INFORM MANAGE, V36, P403, DOI 10.1016/j.ijinfomgt.2016.01.006; Galetsi P, 2020, INT J INFORM MANAGE, V50, P206, DOI 10.1016/j.ijinfomgt.2019.05.003; Gandomi A, 2015, INT J INFORM MANAGE, V35, P137, DOI 10.1016/j.ijinfomgt.2014.10.007; GARFIELD E, 1955, SCIENCE, V122, P108, DOI 10.1126/science.122.3159.108; Giannakis M, 2016, J ENTERP INF MANAG, V29, P706, DOI 10.1108/JEIM-06-2015-0050; Grover V, 2018, J MANAGE INFORM SYST, V35, P388, DOI 10.1080/07421222.2018.1451951; Gupta M, 2016, INFORM MANAGE-AMSTER, V53, P1049, DOI 10.1016/j.im.2016.07.004; Hashem IAT, 2016, INT J INFORM MANAGE, V36, P748, DOI 10.1016/j.ijinfomgt.2016.05.002; He W, 2013, INT J INFORM MANAGE, V33, P464, DOI 10.1016/j.ijinfomgt.2013.01.001; Heintzelman NH, 2013, J AM MED INFORM ASSN, V20, P898, DOI 10.1136/amiajnl-2012-001076; Huang TCK, 2012, INT J INFORM MANAGE, V32, P257, DOI 10.1016/j.ijinfomgt.2011.11.006; Hull G, 2015, ETHICS INF TECHNOL, V17, P89, DOI 10.1007/s10676-015-9363-z; Hwang GJ, 2021, MATHEMATICS-BASEL, V9, DOI 10.3390/math9060584; Intezari A, 2017, J KNOWL MANAG, V21, P71, DOI 10.1108/JKM-07-2015-0293; Kallinikos J, 2015, J INF TECHNOL-UK, V30, P70, DOI 10.1057/jit.2014.36; Khan S, 2017, INFORM PROCESS MANAG, V53, P923, DOI 10.1016/j.ipm.2017.03.006; Kitchens B, 2018, J MANAGE INFORM SYST, V35, P540, DOI 10.1080/07421222.2018.1451957; Kshetri N, 2014, TELECOMMUN POLICY, V38, P1134, DOI 10.1016/j.telpol.2014.10.002; Kwon O, 2014, INT J INFORM MANAGE, V34, P387, DOI 10.1016/j.ijinfomgt.2014.02.002; Lee CH, 2013, J INF SCI, V39, P523, DOI 10.1177/0165551513478738; Lehrer C, 2018, J MANAGE INFORM SYST, V35, P424, DOI 10.1080/07421222.2018.1451953; Li WF, 2016, J MANAGE INFORM SYST, V33, P1059, DOI 10.1080/07421222.2016.1267528; Liebana-Cabanillas F, 2017, INT J INFORM MANAGE, V37, P14, DOI 10.1016/j.ijinfomgt.2016.10.008; Liu CH, 2017, J KNOWL MANAG, V21, P213, DOI 10.1108/JKM-07-2015-0298; Loebbecke C, 2015, J STRATEGIC INF SYST, V24, P149, DOI 10.1016/j.jsis.2015.08.002; Lugmayr A, 2017, J KNOWL MANAG, V21, P197, DOI 10.1108/JKM-07-2016-0307; Jimenez-Marquez JL, 2019, INT J INFORM MANAGE, V44, P1, DOI 10.1016/j.ijinfomgt.2018.09.003; Maireder A, 2017, SOC SCI COMPUT REV, V35, P126, DOI 10.1177/0894439315617262; Margolis R, 2014, J AM MED INFORM ASSN, V21, P957, DOI 10.1136/amiajnl-2014-002974; Martin KE, 2015, MIS Q EXEC, V14, P67; Menon S, 2016, MIS QUART, V40, P963, DOI 10.25300/MISQ/2016/40.4.08; Miah SJ, 2017, INFORM MANAGE-AMSTER, V54, P771, DOI 10.1016/j.im.2016.11.011; Mikalef P, 2020, INFORM MANAGE-AMSTER, V57, DOI 10.1016/j.im.2019.05.004; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Muller O, 2018, J MANAGE INFORM SYST, V35, P488, DOI 10.1080/07421222.2018.1451955; Nishant R, 2020, INT J INFORM MANAGE, V53, DOI 10.1016/j.ijinfomgt.2020.102104; O'Connor C, 2017, J KNOWL MANAG, V21, P156, DOI 10.1108/JKM-08-2016-0357; Ortega F, 2018, IEEE ACCESS, V6, P48543, DOI 10.1109/ACCESS.2018.2867731; Osborne JD, 2016, J AM MED INFORM ASSN, V23, P1077, DOI 10.1093/jamia/ocw006; Poole D., 1998, COMPUTATIONAL INTELL; Qi SJ, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254988; Raguseo E, 2018, INT J INFORM MANAGE, V38, P187, DOI 10.1016/j.ijinfomgt.2017.07.008; Rehman MHU, 2016, INT J INFORM MANAGE, V36, P917, DOI 10.1016/j.ijinfomgt.2016.05.013; Rothberg HN, 2017, J KNOWL MANAG, V21, P92, DOI 10.1108/JKM-07-2015-0300; Russell S.J., 2010, ARTIFICIAL INTELLIGE; Saboo AR, 2016, MIS QUART, V40, P911, DOI 10.25300/MISQ/2016/40.4.06; Saggi MK, 2018, INFORM PROCESS MANAG, V54, P758, DOI 10.1016/j.ipm.2018.01.010; Sahoo SS, 2014, J AM MED INFORM ASSN, V21, P263, DOI 10.1136/amiajnl-2013-002156; Sax M, 2016, ETHICS INF TECHNOL, V18, P25, DOI 10.1007/s10676-016-9394-0; Shin DH, 2016, TELECOMMUN POLICY, V40, P837, DOI 10.1016/j.telpol.2015.03.007; Shirazi F, 2019, INT J INFORM MANAGE, V48, P238, DOI 10.1016/j.ijinfomgt.2018.10.005; SMALL H, 1973, J AM SOC INFORM SCI, V24, P265, DOI 10.1002/asi.4630240406; Strauss JA, 2013, J AM MED INFORM ASSN, V20, P349, DOI 10.1136/amiajnl-2012-000928; Sumbal MS, 2019, J KNOWL MANAG, V23, P1566, DOI 10.1108/JKM-02-2019-0084; Sumbal MS, 2017, J KNOWL MANAG, V21, P180, DOI 10.1108/JKM-07-2016-0262; Surbakti FPS, 2020, INFORM MANAGE-AMSTER, V57, DOI 10.1016/j.im.2019.02.001; Tang KY, 2021, COMPUT EDUC, V175, DOI 10.1016/j.compedu.2021.104323; van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3; Verma S, 2018, INFORM PROCESS MANAG, V54, P791, DOI 10.1016/j.ipm.2018.01.004; Verma S, 2017, J ENTERP INF MANAG, V30, P354, DOI 10.1108/JEIM-10-2015-0099; Wang YC, 2018, INFORM MANAGE-AMSTER, V55, P64, DOI 10.1016/j.im.2017.04.001; WHITE HD, 1981, J AM SOC INFORM SCI, V32, P163, DOI 10.1002/asi.4630320302; Wolfe AW, 1997, AM ETHNOL, V24, P219, DOI 10.1525/ae.1997.24.1.219; Wu J, 2016, INFORM MANAGE-AMSTER, V53, P1020, DOI 10.1016/j.im.2016.07.003; Xie JH, 2018, J AM MED INFORM ASSN, V25, P72, DOI 10.1093/jamia/ocx045; Ye Y, 2014, J AM MED INFORM ASSN, V21, P815, DOI 10.1136/amiajnl-2013-001934; Zhang TT, 2017, J KNOWL MANAG, V21, P623, DOI 10.1108/JKM-12-2016-0522; Zhou ZJ, 2016, INFORM MANAGE-AMSTER, V53, P964, DOI 10.1016/j.im.2016.04.004	97	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266565	10.1371/journal.pone.0266565	http://dx.doi.org/10.1371/journal.pone.0266565			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1E2NP	35427381	gold, Green Published			2022-12-26	WOS:000794332400030
J	Fort, PE; Losiewicz, MK; Elghazi, L; Kong, DJ; Cras-Meneur, C; Fingar, DC; Kimball, SR; Rajala, RVS; Smith, AJ; Ali, RR; Abcouwer, SF; Gardner, TW				Fort, Patrice E.; Losiewicz, Mandy K.; Elghazi, Lynda; Kong, Dejuan; Cras-Meneur, Corentin; Fingar, Diane C.; Kimball, Scot R.; Rajala, Raju V. S.; Smith, Alexander J.; Ali, Robin R.; Abcouwer, Steven F.; Gardner, Thomas W.			mTORC1 regulates high levels of protein synthesis in retinal ganglion cells of adult mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEIN; SECONDARY REDUCTION; SKELETAL-MUSCLE; MECHANISMS; METABOLISM; MODEL; PHOSPHORYLATION; EXPRESSION; MIGRATION; DEFECTS	Mechanistic target of rapamycin (mTOR) and mTOR complex 1 (mTORC1), linchpins of the nutrient sensing and protein synthesis pathways, are present at relatively high levels in the ganglion cell layer (GCL) and retinal ganglion cells (RGCs) of rodent and human retinas. However, the role of mTORCs in the control of protein synthesis in RGC is unknown. Here, we applied the SUrface SEnsing of Translation (SUnSET) method of nascent protein labeling to localize and quantify protein synthesis in the retinas of adult mice. We also used intravitreal injection of an adeno-associated virus 2 vector encoding Cre recombinase in the eyes of mtor-or rptor-floxed mice to conditionally knockout either both mTORCs or only mTORC1, respectively, in cells within the GCL. A novel vector encoding an inactive Cre mutant (Cre & UDelta;C) served as control. We found that retinal protein synthesis was highest in the GCL, particularly in RGC. Negation of both complexes or only mTORC1 significantly reduced protein synthesis in RGC. In addition, loss of mTORC1 function caused a significant reduction in the panRGC marker, RNA-binding protein with multiple splicing, with little decrease of the total number of cells in the RGC layer, even at 25 weeks after adeno-associated virus-Cre injection. These findings reveal that mTORC1 signaling is necessary for maintaining the high rate of protein synthesis in RGCs of adult rodents, but it may not be essential to maintain RGC viability. These findings may also be relevant to understanding the pathophysiology of RGC disorders, including glaucoma, diabetic retinopathy, and optic neuropathies.	[Fort, Patrice E.; Losiewicz, Mandy K.; Elghazi, Lynda; Kong, Dejuan; Abcouwer, Steven F.; Gardner, Thomas W.] Univ Michigan, Ophthalmol & Visual Sci, Med Sch, Ann Arbor, MI 48109 USA; [Fort, Patrice E.; Gardner, Thomas W.] Univ Michigan, Mol & Integrat Physiol, Med Sch, Ann Arbor, MI USA; [Gardner, Thomas W.] Univ Michigan, MEND Div, Internal Med, Med Sch, Ann Arbor, MI USA; [Fingar, Diane C.] Univ Michigan, Cell & Dev Biol, Med Sch, Ann Arbor, MI USA; [Kimball, Scot R.] Penn State Coll Med, Cellular & Mol Physiol, Hershey, PA USA; [Rajala, Raju V. S.] Univ Oklahoma, Dept Ophthalmol, Hlth Sci Ctr, Oklahoma City, OK USA; [Rajala, Raju V. S.] Univ Oklahoma, Dept Physiol, Hlth Sci Ctr, Oklahoma City, OK USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Abcouwer, SF (corresponding author), Univ Michigan, Ophthalmol & Visual Sci, Med Sch, Ann Arbor, MI 48109 USA.	sabcouwe@umich.edu		Elghazi, Lynda/0000-0003-1755-9217	National Institutes of Health (NIH) [R01EY031961, R01EY020582, R01EY020823, R01EY029349, R24-DK-082841, R01DK100722, DK15658]; Juvenile Diabetes Research Foundation Center of Excellence at the University of Michigan; Research to Prevent Blindness; Core Grant for Vision Research at the University of Michigan [NIH P30EY007003]; Michigan Diabetes Research Center [NIH P30DK020572]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation Center of Excellence at the University of Michigan; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Core Grant for Vision Research at the University of Michigan; Michigan Diabetes Research Center	This work was supported by the National Institutes of Health (NIH) grants R01EY031961 (to S. F. A. and P. E. F.) , R01EY020582 (to S. F. A. and T. W. G.) , R01EY020823 (to S. F. A.) , R01EY029349 (to S. F. A.) , R24-DK-082841 (to S. F. A., P. E. F., and T. W. G.) , R01DK100722 (to D. C. F.) , DK15658 (to S. R. K.) ; the Juvenile Diabetes Research Foundation Center of Excellence at the University of Michigan (to T. W. G. and P. E. F.) ; and Research to Prevent Blindness (to T. W. G.) , NIH P30EY007003 (Core Grant for Vision Research at the University of Michigan) , and NIH P30DK020572 (Michigan Diabetes Research Center) .	Assouvie A, 2018, METHODS MOL BIOL, V1784, P29, DOI 10.1007/978-1-4939-7837-3_3; Aurnhammer C, 2012, HUM GENE THER METHOD, V23, P18, DOI 10.1089/hgtb.2011.034; Boutouja F, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010018; CHIHARA E, 1981, J NEUROCHEM, V37, P247, DOI 10.1111/j.1471-4159.1981.tb05316.x; CHIHARA E, 1982, BRAIN RES, V250, P363, DOI 10.1016/0006-8993(82)90432-2; Choi JH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04774-9; Dennis MD, 2011, J BIOL CHEM, V286, P8287, DOI 10.1074/jbc.M110.209171; Elghazi L, 2017, MOL METAB, V6, P560, DOI 10.1016/j.molmet.2017.03.010; Farazi TA, 2014, RNA, V20, P1090, DOI 10.1261/rna.045005.114; Fort PE, 2014, DIABETES, V63, P3077, DOI 10.2337/db14-0235; Fu ZJ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041503; Gardner TW, 2015, AM J PHYSIOL-ENDOC M, V309, pE546, DOI 10.1152/ajpendo.00180.2015; Garza-Lombo C, 2016, FRONT CELL NEUROSCI, V10, DOI [10.1101/GAD.1212704, 10.3389/fncel.2016.00157]; Georgiadis A, 2016, GENE THER, V23, P857, DOI 10.1038/gt.2016.66; Goodman CA, 2013, EXERC SPORT SCI REV, V41, P107, DOI 10.1097/JES.0b013e3182798a95; Guggenhuber S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015707; Ha YJ, 2018, INVEST OPHTH VIS SCI, V59, P4670, DOI 10.1167/iovs.18-24427; Hartung M, 1998, J BIOL CHEM, V273, P22884, DOI 10.1074/jbc.273.36.22884; HODSON S, 1967, J CELL BIOL, V35, P722, DOI 10.1083/jcb.35.3.722; Hornberg H, 2013, J NEUROSCI, V33, P10384, DOI 10.1523/JNEUROSCI.5858-12.2013; Hornberg H, 2016, J NEUROSCI, V36, P12697, DOI 10.1523/JNEUROSCI.2400-16.2016; Jhanwar-Uniyal Meena, 2017, Advances in Biological Regulation, V64, P39, DOI 10.1016/j.jbior.2016.12.001; Jones I, 2019, BIOL OPEN, V8, DOI 10.1242/bio.044370; Jones I, 2015, DIS MODEL MECH, V8, P1517, DOI 10.1242/dmm.021972; KARLSSON JO, 1971, J NEUROCHEM, V18, P749, DOI 10.1111/j.1471-4159.1971.tb12005.x; Kelleher AR, 2013, AM J PHYSIOL-ENDOC M, V304, pE229, DOI 10.1152/ajpendo.00409.2012; Kim J, 2019, NAT CELL BIOL, V21, P63, DOI 10.1038/s41556-018-0205-1; Kimball SR, 2002, J APPL PHYSIOL, V93, P1168, DOI 10.1152/japplphysiol.00221.2002; Koley S, 2019, NEUROSCI RES, V139, P26, DOI 10.1016/j.neures.2018.10.003; Kurtoglu M, 2007, ANTIOXID REDOX SIGN, V9, P1383, DOI 10.1089/ars.2007.1714; Kwong JMK, 2010, INVEST OPHTH VIS SCI, V51, P1052, DOI 10.1167/iovs.09-4098; Lam C, 2019, MOL MED REP, V20, P2734, DOI 10.3892/mmr.2019.10525; LEON JA, 1990, INVEST OPHTH VIS SCI, V31, P1709; Leveillard T, 2017, CELL MOL LIFE SCI, V74, P3649, DOI 10.1007/s00018-016-2318-7; Lindsay KJ, 2014, P NATL ACAD SCI USA, V111, P15579, DOI 10.1073/pnas.1412441111; Losiewicz MK, 2020, EXP EYE RES, V197, DOI 10.1016/j.exer.2020.108131; Ma S, 2015, EXP EYE RES, V135, P1, DOI 10.1016/j.exer.2015.04.006; MARAINI G., 1962, OPHTHALMOLOGICA, V144, P141; MARAINL G., 1962, OPHTHALMOLOGICA, V144, P13; Masin L, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80308-y; Maus M, 2006, J NEUROCHEM, V96, P815, DOI 10.1111/j.1471-4159.2005.03601.x; Metea MR, 2007, EXP PHYSIOL, V92, P635, DOI 10.1113/expphysiol.2006.036376; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Newman EA, 2013, J CEREBR BLOOD F MET, V33, P1685, DOI 10.1038/jcbfm.2013.145; Nishiguchi KM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7006; NOVER A, 1960, Albrecht Von Graefes Arch Ophthalmol, V161, P554, DOI 10.1007/BF00686431; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pereiro X, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21239330; Petit L, 2015, ONCOTARGET, V6, P16786, DOI 10.18632/oncotarget.4466; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Rajala RVS, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00266; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Rodriguez AR, 2014, J COMP NEUROL, V522, P1411, DOI 10.1002/cne.23521; Romano GL, 2020, BIOCHEM PHARMACOL, V180, DOI 10.1016/j.bcp.2020.114199; Saha S, 2016, NEUROSCIENCE, V329, P1, DOI 10.1016/j.neuroscience.2016.04.032; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schiapparelli LM, 2019, CELL REP, V28, P1935, DOI 10.1016/j.celrep.2019.07.037; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; SCHULTZE B, 1959, Beitr Pathol Anat, V120, P58; Seigel GM, 2014, MOL VIS, V20, P301; Shah SH, 2018, DEV NEUROBIOL, V78, P998, DOI 10.1002/dneu.22630; Shigeoka T, 2016, CELL, V166, P181, DOI 10.1016/j.cell.2016.05.029; Shigeoka T, 2013, J CELL BIOL, V202, P991, DOI 10.1083/jcb.201305139; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Sindelar DK, 2004, ENDOCRINOLOGY, V145, P3363, DOI 10.1210/en.2003-1727; Starr CR, 2019, INVEST OPHTH VIS SCI, V60, P4849, DOI 10.1167/iovs.19-27512; Starr CR, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0513-1; STEINMAN L, 1974, TISSUE CELL, V6, P137, DOI 10.1016/0040-8166(74)90028-7; Su B, 2011, CRIT REV BIOCHEM MOL, V46, P527, DOI 10.3109/10409238.2011.618113; Switon K, 2017, NEUROSCIENCE, V341, P112, DOI 10.1016/j.neuroscience.2016.11.017; Tailler M, 2019, CELL DEATH DIFFER, V26, P1766, DOI 10.1038/s41418-018-0244-y; Tee AR, 2016, SEMIN CELL DEV BIOL, V52, P12, DOI 10.1016/j.semcdb.2016.01.040; Thoreen CC, 2017, BIOCHEM SOC T, V45, P213, DOI 10.1042/BST20160072; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Umegaki Y, 2018, J NEUROSCI, V38, P4985, DOI 10.1523/JNEUROSCI.2370-17.2018; Usui V, 2015, J CLIN INVEST, V125, P2335, DOI 10.1172/JCI80297; Wangsa-Wirawan ND, 2003, ARCH OPHTHALMOL-CHIC, V121, P547, DOI 10.1001/archopht.121.4.547; Wong-Riley M, 2010, EYE BRAIN, V2, P99; Xie J, 2014, TRANSLATION, V2, DOI 10.4161/trla.28174; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Zhang J, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00558; Zieger M, 2016, ONCOTARGET, V7, P9620, DOI 10.18632/oncotarget.7330; Zuiderveld K.J., 1994, GRAPHICS GEMS, P474, DOI DOI 10.1016/B978-0-12-336156-1.50061-6	85	0	0	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101944	10.1016/j.jbc.2022.101944	http://dx.doi.org/10.1016/j.jbc.2022.101944			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T5WI	35447116	Green Published, gold			2022-12-26	WOS:000804798000004
J	Shen, WC; Borchert, AJ; Downs, DM				Shen, Wangchen; Borchert, Andrew J.; Downs, Diana M.			2-Aminoacrylate stress damages diverse PLP-dependent enzymes in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALMONELLA-TYPHIMURIUM; THREONINE DEAMINASE; TRANSAMINASE-B; SERINE; MECHANISM; FAMILY; YJGF; PHOSPHORIBOSYLAMINE; AMINOTRANSFERASE; INACTIVATION	Pyridoxal 50-phosphate (PLP) is an essential cofactor for a class of enzymes that catalyze diverse reactions in central metabolism. The catalytic mechanism of some PLP-dependent enzymes involves the generation of reactive enamine intermediates like 2-aminoacrylate (2AA). 2AA can covalently modify PLP in the active site of some PLP-dependent enzymes and subsequently inactivate the enzyme through the formation of a PLP-pyruvate adduct. In the absence of the enamine/imine deaminase RidA, Salmonella enterica experiences 2AA-mediated metabolic stress. Sur-prisingly, PLP-dependent enzymes that generate endogenous 2AA appear to be immune to its attack, while other PLP-dependent enzymes accumulate damage in the presence of 2AA stress; however, structural determinants of 2AA sensi-tivity are unclear. In this study, we refined a molecular method to query proteins from diverse systems for their sensitivity to 2AA in vivo. This method was then used to examine active site residues of Alr, a 2AA-sensitive PLP-dependent enzyme, that affect its sensitivity to 2AA in vivo. Unexpectedly, our data also showed that a low level of 2AA stress can persist even in the presence of a functional RidA. In summary, this study expands our understanding of 2AA metabolism and takes an initial step toward characterizing the structural determinants influencing enzyme susceptibility to damage by free 2AA.	[Shen, Wangchen; Borchert, Andrew J.; Downs, Diana M.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Downs, Diana M.] Renewable Resources & Enabling Sci Ctr, Natl Renewable Energy Lab, Golden, CO USA	University System of Georgia; University of Georgia; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Downs, DM (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	dmdowns@uga.edu		Borchert, Andrew/0000-0003-1435-3643; Shen, Wangchen/0000-0002-8296-2822	NIH [GM095837]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by an award from the competitive grants program at the NIH (GM095837) to D. M. D. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ARFIN SM, 1971, J BACTERIOL, V105, P519, DOI 10.1128/JB.105.2.519-522.1971; BADET B, 1984, BIOCHEMISTRY-US, V23, P5188, DOI 10.1021/bi00317a016; BALCH WE, 1976, APPL ENVIRON MICROB, V32, P781, DOI 10.1128/AEM.32.6.781-791.1976; Bazurto JV, 2016, MBIO, V7, DOI 10.1128/mBio.01840-15; Borchert AJ, 2019, TRENDS BIOCHEM SCI, V44, P849, DOI 10.1016/j.tibs.2019.04.011; Borchert AJ, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00140-17; BURNS RO, 1979, J BIOL CHEM, V254, P1074; Casasnovas R, 2012, J PHYS CHEM B, V116, P10665, DOI 10.1021/jp303678n; Chargaff E, 1943, J BIOL CHEM, V151, P273; Chen GJ, 2000, BIOTECHNIQUES, V28, P498, DOI 10.2144/00283st08; CROUT DHG, 1980, EUR J BIOCHEM, V106, P97; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Enos-Berlage JL, 1998, J BACTERIOL, V180, P6519, DOI 10.1128/JB.180.24.6519-6528.1998; Ernst DC, 2018, MBIO, V9, DOI 10.1128/mBio.00084-18; Ernst DC, 2016, MOL MICROBIOL, V101, P210, DOI 10.1111/mmi.13384; Ernst DC, 2016, J BACTERIOL, V198, P536, DOI 10.1128/JB.00804-15; Ernst DC, 2014, J BACTERIOL, V196, P3335, DOI 10.1128/JB.01960-14; FLAVIN M, 1964, BIOCHEMISTRY-US, V3, P885, DOI 10.1021/bi00895a004; Flynn JM, 2013, MOL MICROBIOL, V89, P751, DOI 10.1111/mmi.12313; Flynn JM, 2013, J BACTERIOL, V195, P3603, DOI 10.1128/JB.00463-13; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; HAYASHI H, 1995, J BIOCHEM-TOKYO, V118, P463, DOI 10.1093/oxfordjournals.jbchem.a124931; Hunter GA, 2009, CELL MOL BIOL, V55, P102, DOI 10.1170/T844; Irons J, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02058; Irons J, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00434-18; Irons JL, 2020, MICROBIOL MOL BIOL R, V84, DOI 10.1128/MMBR.00024-20; Islam MM, 2010, J BIOL CHEM, V285, P265, DOI 10.1074/jbc.M109.048777; Jhee KH, 1998, BIOCHEMISTRY-US, V37, P14591, DOI 10.1021/bi981325j; Lambrecht JA, 2013, MBIO, V4, DOI 10.1128/mBio.00033-13; Lambrecht JA, 2013, ACS CHEM BIOL, V8, P242, DOI 10.1021/cb300364k; Lambrecht JA, 2012, J BIOL CHEM, V287, P3454, DOI 10.1074/jbc.M111.304477; Lambrecht JA, 2010, J BIOL CHEM, V285, P34401, DOI 10.1074/jbc.M110.160515; Liang J, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00004; LIKOS JJ, 1982, BIOCHEMISTRY-US, V21, P4377, DOI 10.1021/bi00261a029; McKinney J, 2002, J BACTERIOL, V184, P6056, DOI 10.1128/JB.184.21.6056-6059.2002; Niehaus TD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1584-3; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; PHILLIPS AT, 1965, J BIOL CHEM, V240, P4703; Schmitz G, 2004, J BACTERIOL, V186, P803, DOI 10.1128/JB.186.3.803-810.2004; SCHNACKERZ KD, 1979, BIOCHEMISTRY-US, V18, P3557, DOI 10.1021/bi00583a019; Schulze JO, 2006, J MOL BIOL, V358, P1212, DOI 10.1016/j.jmb.2006.02.064; Singh R, 2013, J ENZYM INHIB MED CH, V28, P183, DOI 10.3109/14756366.2011.643305; UENO H, 1982, BIOCHEMISTRY-US, V21, P4387, DOI 10.1021/bi00261a030; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Whitaker GH, 2021, YEAST, V38, P615, DOI 10.1002/yea.3670; Yennawar NH, 2002, BIOCHEMISTRY-US, V41, P11592, DOI 10.1021/bi020221c	46	2	2	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101970	10.1016/j.jbc.2022.101970	http://dx.doi.org/10.1016/j.jbc.2022.101970			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9DZ	35460692	Green Published, gold			2022-12-26	WOS:000807750700010
J	Carvalho, C; Serrao, FV; Pisani, GK; Martinez, AF; Serrao, PRMD				Carvalho, Cristiano; Serrao, Fabio Viadanna; Pisani, Giulia Keppe; Martinez, Adalberto Felipe; Mendes da Silva Serrao, Paula Regina			Frontal plane biomechanics during single-leg squat and hip strength in patients with isolated patellofemoral osteoarthritis compared to matched controls: A cross-sectional study	PLOS ONE			English	Article							JOINT COORDINATE SYSTEM; KNEE KINEMATICS; LATERAL TRUNK; STAIR DESCENT; PAIN; FEMALES; MOTION; PROGRESSION; RUNNERS; WALKING	The patellofemoral compartment of the knee is the most frequently affected by osteoarthritis. However, there is a lack of biomechanics studies on patellofemoral osteoarthritis (PFOA). This study's purpose was to compare the frontal plane biomechanics of the trunk and lower limb during the single-leg squat and isometric hip abductor torque in individuals with isolated PFOA and controls. Frontal plane kinematics during the single-leg squat were evaluated using a three-dimensional (3-D) motion analysis system. Isometric hip abductor torque was determined using a handheld dynamometer. Twenty individuals participated in the study (10 with PFOA and 10 controls). No significant differences between groups were found regarding age (mean +/- SD, PFOA group = 51.8 +/- 6.9 versus control group = 47.8 +/- 5.5; mean difference = 4, 95% confidence interval [CI] = -1.9 to 9.9, p = 0.20) or body mass index (PFOA group = 27.6 +/- 2.2 versus control group = 25.5 +/- 2.5; mean difference = 2.1, 95% confidence interval [CI] = -0.1 to 4.3, p = 0.06). Compared to control, the PFOA group presented greater hip adduction in the descending and ascending phases of the single-leg squat at 45 degrees (mean difference [95% CI] = 6.44 degrees [0.39-12.48 degrees], p = 0.04; mean difference [95% CI] = 5.33 degrees [0.24-10.42 degrees], p = 0.045, respectively) and 60 degrees (mean difference [95% CI] = 8.44 degrees [2.15-14.73 degrees], p = 0.01; mean difference [95% CI] = 7.58 degrees [2.1-13.06 degrees], p = 0.009, respectively) of knee flexion. No significant differences between groups were found for the frontal plane kinematics of the trunk, pelvis or knee (p > 0.05). The PFOA group exhibited lower isometric hip abductor torque (mean difference [95% CI] = -0.34 Nm/kg [-0.67 to -0.01 Nm/kg], p = 0.04). The individuals with PFOA presented greater hip adduction than the control group, which could increase lateral patellofemoral joint stress at 45 degrees and 60 degrees of knee flexion in the descending and ascending phases of the single-leg squat. These individuals also exhibited hip abductor weakness in comparison to healthy controls.	[Carvalho, Cristiano; Serrao, Fabio Viadanna; Pisani, Giulia Keppe; Martinez, Adalberto Felipe; Mendes da Silva Serrao, Paula Regina] Univ Fed Sao Carlos, Dept Phys Therapy, Sao Carlos, SP, Brazil; [Carvalho, Cristiano; Serrao, Fabio Viadanna; Pisani, Giulia Keppe; Martinez, Adalberto Felipe; Mendes da Silva Serrao, Paula Regina] Univ Fed Sao Carlos, Phys Therapy Postgrad Program, Sao Carlos, SP, Brazil	Universidade Federal de Sao Carlos; Universidade Federal de Sao Carlos	Serrao, PRMD (corresponding author), Univ Fed Sao Carlos, Dept Phys Therapy, Sao Carlos, SP, Brazil.; Serrao, PRMD (corresponding author), Univ Fed Sao Carlos, Phys Therapy Postgrad Program, Sao Carlos, SP, Brazil.	paula.serrao@ufscar.br	Serrão, Paula/F-8755-2015; Carvalho, Cristiano/W-6989-2019	Serrão, Paula/0000-0002-4547-9161; Carvalho, Cristiano/0000-0003-1174-0015	Sao Paulo Research Foundation [2017/20057-8, 2017/25959-0, 2018/10329-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [001]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	AFM, CC -Finance Code 001 Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br).CC -grant #2017/20057-8 -Sao Paulo Research Foundation (www.fapesp.br).GKP -grant #2017/25959-0 Sao Paulo Research Foundation (www.fapesp.br).PRMSS -grant #2018/10329-3-Sao Paulo Research Foundation (www.fapesp.br).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bolgla LA, 2008, J ORTHOP SPORT PHYS, V38, P12, DOI 10.2519/jospt.2008.2462; Bolgla LA, 2010, J ELECTROMYOGR KINES, V20, P142, DOI 10.1016/j.jelekin.2008.11.008; Carvalho C, 2021, THER ADV CHRONIC DIS, P12, DOI [DOI 10.1177/20406223211028764, 10.1177/20406223211028764]; Crossley KM, 2011, OSTEOARTHR CARTILAGE, V19, P765, DOI 10.1016/j.joca.2011.05.005; Crossley KM, 2018, ARTHRIT CARE RES, V70, P309, DOI 10.1002/acr.23261; Dierks TA, 2008, J ORTHOP SPORT PHYS, V38, P448, DOI 10.2519/jospt.2008.2490; Duncan R, 2008, RHEUMATOLOGY, V47, P1704, DOI 10.1093/rheumatology/ken339; Duncan R, 2011, ANN RHEUM DIS, V70, P1944, DOI 10.1136/ard.2011.151050; Duncan R, 2009, OSTEOARTHR CARTILAGE, V17, P1151, DOI 10.1016/j.joca.2009.03.016; Duncan RC, 2006, RHEUMATOLOGY, V45, P757, DOI 10.1093/rheumatology/kei270; Fernandes MI, 2003, TRANSLATION VALIDATI; Ford KR, 2003, MED SCI SPORT EXER, V35, P1745, DOI 10.1249/01.MSS.0000089346.85744.D9; Fredericson M, 2000, CLIN J SPORT MED, V10, P169, DOI 10.1097/00042752-200007000-00004; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136, DOI 10.1115/1.3138397; Gross KD, 2009, MED CLIN N AM, V93, P179, DOI 10.1016/j.mcna.2008.09.007; Hamel KA, 2005, ERGONOMICS, V48, P1047, DOI 10.1080/00140130500193665; Hart HF, 2012, OSTEOARTHR CARTILAGE, V20, P863, DOI 10.1016/j.joca.2012.04.009; Hewett TE, 2009, BRIT J SPORT MED, V43, P417, DOI 10.1136/bjsm.2009.059162; Hinman RS, 2007, RHEUMATOLOGY, V46, P1057, DOI 10.1093/rheumatology/kem114; Hinman RS, 2002, ARCH PHYS MED REHAB, V83, P1080, DOI 10.1053/apmr.2002.33068; Hogiund LT, 2014, J APPL BIOMECH, V30, P82, DOI 10.1123/jab.2012-0244; Hoglund Lisa T, 2018, Pilot Feasibility Stud, V4, P70, DOI 10.1186/s40814-018-0262-z; Hunt MA, 2008, OSTEOARTHR CARTILAGE, V16, P591, DOI 10.1016/j.joca.2007.10.017; Hurwitz DE, 1998, J BIOMECH, V31, P423, DOI 10.1016/S0021-9290(98)00028-1; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Komistek RD, 1999, J ARTHROPLASTY, V14, P738, DOI 10.1016/S0883-5403(99)90230-9; Macri Erin M, 2020, BMJ Open Sport Exerc Med, V6, pe000877, DOI 10.1136/bmjsem-2020-000877; Martinez AF, 2018, J STRENGTH COND RES, V32, P1902, DOI 10.1519/JSC.0000000000002564; MCALINDON TE, 1992, ANN RHEUM DIS, V51, P844, DOI 10.1136/ard.51.7.844; Miyazaki T, 2002, ANN RHEUM DIS, V61, P617, DOI 10.1136/ard.61.7.617; Nakagawa TH, 2012, J ORTHOP SPORT PHYS, V42, P491, DOI 10.2519/jospt.2012.3987; Nakagawa TH, 2012, MED SCI SPORT EXER, V44, P1747, DOI 10.1249/MSS.0b013e318256903a; Pohl MB, 2013, GAIT POSTURE, V37, P440, DOI 10.1016/j.gaitpost.2012.08.017; Powers CM, 2010, J ORTHOP SPORT PHYS, V40, P42, DOI 10.2519/jospt.2010.3337; Powers CM, 2003, J ORTHOP SPORT PHYS, V33, P639, DOI 10.2519/jospt.2003.33.11.639; Rathleff MS, 2014, BRIT J SPORT MED, V48, P1088, DOI 10.1136/bjsports-2013-093305; Reeves ND, 2008, J ELECTROMYOGR KINES, V18, P218, DOI 10.1016/j.jelekin.2007.06.003; Reeves ND, 2011, NAT REV RHEUMATOL, V7, P113, DOI 10.1038/nrrheum.2010.212; Self BP, 2000, ARTHRIT CARE RES, V13, P191, DOI 10.1002/1529-0131(200008)13:4<191::AID-ANR3>3.0.CO;2-C; Stefanik JJ, 2016, OSTEOARTHR CARTILAGE, V24, P1160, DOI 10.1016/j.joca.2016.01.981; Thomas MJ, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-201; Utting MR, 2005, KNEE, V12, P362, DOI 10.1016/j.knee.2004.12.006; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; WASSERTHEIL S, 1970, BIOMETRICS, V26, P588, DOI 10.2307/2529115; Willson JD, 2006, MED SCI SPORT EXER, V38, P945, DOI 10.1249/01.mss.0000218140.05074.fa; Winter D. A, 2009, BIOMECHANICS MOTOR C; World Health O, 2020, WHO GUID PHYS ACT SE, DOI DOI 10.4324/9780203795002; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6; Zazulak BT, 2005, J ORTHOP SPORT PHYS, V35, P292, DOI 10.2519/jospt.2005.35.5.292	52	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0267446	10.1371/journal.pone.0267446	http://dx.doi.org/10.1371/journal.pone.0267446			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476842	Green Published, gold			2022-12-26	WOS:000840124300043
J	Fetene, G; Tesfaye, T; Negesse, Y; Dulla, D				Fetene, Gossa; Tesfaye, Tamirat; Negesse, Yilkal; Dulla, Dubale			Factors associated with preterm birth among mothers who gave birth at public Hospitals in Sidama regional state, Southeast Ethiopia: Unmatched case-control study	PLOS ONE			English	Article							CENTRAL ZONE; INTIMATE PARTNER; DETERMINANTS; PREGNANCY; TIGRAY; OUTCOMES; VIOLENCE	Background Preterm birth remains the commonest cause of neonatal mortality, and morbidity representing one of the principal targets of neonatal health care. Ethiopia is one of the countries which shoulder the highest burden of preterm birth. Therefore, this study was aimed to assess factors associated with preterm birth at public hospitals in Sidama regional state. Methods Facility-based case-control study was conducted at public hospitals in Sidama regional state, from 1st June to 1st September/2020. In this study, a total of 135 cases and 270 controls have participated. To recruit cases and controls consecutive sampling methods and simple random sampling techniques were used respectively. Data were collected using pretested structured interviewer-administered questionnaire, and checklist via chart review. Data were entered using EpiData version 3.1 and exported to SPSS version 20 for analysis. Independent variables with P-value < 0.25 in the bivariate logistic regression were candidates for multivariable logistic regression analysis. Finally, statistical significance was declared at P-value < 0.05. Results The response rate was 100%. Rural resident (AOR = 2.034; 95%CI: 1.242, 3.331), no antenatal care service utilization (AOR = 2.516; 95%CI: 1.406, 4.503), pregnancy-induced hypertension (AOR = 2.870; 95%CI: 1.519, 5.424), chronic medical problem during pregnancy (AOR = 2.507; 95%CI: 1.345, 4.676), urinary tract infections (AOR = 3.023; 95%CI: 1.657, 5.513), birth space less than 2 years (AOR = 3.029; 95%CI: 1.484, 6.179), and physical intimate violence (AOR = 2.876; 95%CI: 1.534, 5.393) were significantly associated with preterm birth. Conclusion Most of the risk factors of preterm birth were found to be modifiable. Community mobilization on physical violence during pregnancy and antenatal care follow-up are the ground for the prevention of preterm birth because attentive and critical antenatal care screening practice could early identify risk factors. Besides, information communication education about preterm birth prevention was recommended.	[Fetene, Gossa; Negesse, Yilkal] Mizan Tepi Univ, Coll Med & Hlth Sci, Mizan Teferi, Ethiopia; [Tesfaye, Tamirat; Dulla, Dubale] Hawassa Univ, Coll Med & Hlth Sci, Hawassa, Ethiopia	Hawassa University	Fetene, G (corresponding author), Mizan Tepi Univ, Coll Med & Hlth Sci, Mizan Teferi, Ethiopia.	Feteneg2119@gmail.com	Abebe, Gossa Fetene/GPK-1234-2022; Abebe, Gossa/AAD-3316-2022; Dulla, Dubale/AAC-7552-2019	Abebe, Gossa/0000-0002-8495-3022; 				Abaraya M, 2018, PEDIATR HEALTH MED T, V9, P101, DOI 10.2147/PHMT.S174789; Abdollahi F, 2015, J FAM COMMUNITY MED, V22, P13, DOI 10.4103/2230-8229.149577; Aregawi G., 2019, BMC RES NOTES, V12, P1, DOI [10.1186/s13104-018-4038-6, DOI 10.1186/S13104-018-4038-6]; Aregawi G, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4650-0; Assembly, 2015, SDGS TRANSFORM OUR W, DOI DOI 10.1186/S12916-015-0342-3; Ayebare E, 2018, PAN AFR MED J, V30, DOI 10.11604/pamj.2018.30.272.13531; Bekele I., 2017, J WOMENS HLTH CARE, V6, P356; Berhe T, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4307-z; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Brhane M, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4439-1; Brown HK, 2014, INT J EPIDEMIOL, V43, P802, DOI 10.1093/ije/dyt251; Chawanpaiboon S, 2019, LANCET GLOB HEALTH, V7, pE37, DOI 10.1016/S2214-109X(18)30451-0; Edwards KI., 2019, ESTIMATED DATE DELIV; Ethiopian Public Health Institute (EPHI) [Ethiopia] and ICF, 2019, ETH MIN DEM HLTH SUR; FMOH, 2015, HLTH SECT TRANSF PLA, P184; Gabbe SG, 2016, OBSTET NORMAL PROBLE, DOI DOI 10.1016/C2013-0-00408-2; Gebreslasie K., 2016, ADV IN NURSING, V2016; Glaser AP, 2015, UROL CLIN N AM, V42, P547, DOI 10.1016/j.ucl.2015.05.004; Laelago T, 2020, ITAL J PEDIATR, V46, DOI 10.1186/s13052-020-0772-1; Laelago T, 2017, AFR HEALTH SCI, V17, P681, DOI 10.4314/ahs.v17i3.10; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Mokuolu OA, 2010, PEDIATRIC REP, V2, P11, DOI 10.4081/pr.2010.e3; Nabavizadeh SH, 2012, INT J GEN MED, V5, P1013, DOI 10.2147/IJGM.S33385; Patel RM, 2016, AM J PERINAT, V33, P318, DOI 10.1055/s-0035-1571202; Pettker CM, 2017, OBSTET GYNECOL, V129, pE150, DOI 10.1097/AOG.0000000000002046; Purisch SE, 2017, SEMIN PERINATOL, V41, P387, DOI 10.1053/j.semperi.2017.07.009; Quinn JA, 2016, VACCINE, V34, P6047, DOI 10.1016/j.vaccine.2016.03.045; Riyanto DL, 2017, ADV SCI LETT, V23, P6828, DOI 10.1166/asl.2017.9408; Ruducha J, 2017, LANCET GLOB HEALTH, V5, pE1142, DOI 10.1016/S2214-109X(17)30331-5; Schmidt U, 2013, DIS MARKERS, V2013, P43, DOI 10.1155/2013/835876; Seyom E, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-015-0135-5; Sigalla GN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172540; Smits LJM, 2001, LANCET, V358, P2074, DOI 10.1016/S0140-6736(01)07105-7; Teklay Girmay, 2018, BMC Res Notes, V11, P571, DOI 10.1186/s13104-018-3693-y; Hoang TN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162844; Urquia ML, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-42; USAID, 2016, RWAND PROF PRET LOW; Wagura PM, 2014, THESIS; WHO, 2016, MARCH DIM GLOB ACT R; Woday A., 2018, INTIMATE PARTNER VIO; Woday A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225060; Woldeyohannes D., 2019, CLIN MOTHER CHILD HL, V16, P2; World Health Organization, 2017, PRET BIRTH FACT SHEE; Wudie FT, 2019, S AFR J CHILD HEALTH, V13, P108, DOI 10.7196/SAJCH.2019.v13i3.1479	44	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0265594	10.1371/journal.pone.0265594	http://dx.doi.org/10.1371/journal.pone.0265594			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35442955	Green Published, gold			2022-12-26	WOS:000822608900011
J	Lin, PC; Yang, YCSH; Lin, SC; Lu, MC; Tsai, YT; Lu, SC; Chen, SH; Chen, SY				Lin, Pei-Chun; Yang, Yu-Chen S. H.; Lin, Sheng-Chieh; Lu, Meng-Che; Tsai, Yin-Tai; Lu, Shou-Cheng; Chen, Shu-Huey; Chen, Shih-Yen			Clinical significance and intestinal microbiota composition in immunocompromised children with norovirus gastroenteritis	PLOS ONE			English	Article							GENE	Background Norovirus (NoV) infection is common in pediatric patients with immunodeficiency and is more likely to cause severe disease. Objective Our study aims to figure out the clinical differences and distribution of intestinal microbiota in immunocompromised children with NoV gastroenteritis. Methods Pediatric patients admitted to Shang-Ho Hospital with diagnosis of acute gastroenteritis including different immune status were enrolled and their medical records were reviewed. NoV gastroenteritis was validated using RT-PCR molecular methods. Viral shedding period was determined by real-time RT-PCR assays. Intestinal microbiota enrichment analysis was carried out by next generation sequencing after fecal DNA extraction and subsequent Linear Discriminant Analysis (LDA) Effect Size (LEfSe) method. Results Significantly higher frequency of diarrhea [mean, (IQR), 3.8 (3-5) /day] and longer viral shedding time [mean, IQR, 8.5 (5-13) days] was found in immunocompromised NoV infections than in immunocompetent patients without NoV infections (p = 0.013*) and immunocompetent patients with NoV infections (p = 0.030**). The fever prevalence was significantly lower in immunocompromised NoV infections than in different immune or infection status. Intestinal microbiota metagenomics analysis showed no significant community richness difference while the LEfSe analysis showed a significant difference in commensal richness at the phylum level, the family level, and the genus level in patients under different immune status. Conclusion We evaluated the clinical significances and microbiota composition in immunocompromised children with norovirus gastroenteritis. This will further facilitate studies of the interaction between the intestinal microbiota in such patients with precise determination of their bacterial infection control and probiotic supplements strategy.	[Lin, Pei-Chun; Chen, Shih-Yen] Taipei Med Univ, Shuang Ho Hosp, Dept Pediat, Div Pediat Gastroenterol, Taipei, Taiwan; [Yang, Yu-Chen S. H.] Taipei Med Univ, Off Human Res, Joint Biobank, Taipei, Taiwan; [Lin, Sheng-Chieh; Lu, Meng-Che] Taipei Med Univ, Shuang Ho Hosp, Dept Pediat, Div Allergy Asthma & Immunol, Taipei, Taiwan; [Lin, Sheng-Chieh] Taipei Med Univ, Coll Med, Sch Med, Dept Pediat, Taipei, Taiwan; [Tsai, Yin-Tai; Lu, Shou-Cheng] Taipei Med Univ, Shuang Ho Hosp, Dept Med Lab, New Taipei, Taiwan; [Chen, Shu-Huey] Taipei Med Univ, Shuang Ho Hosp, Dept Pediat, Div Pediat Hematol & Oncol, Taipei, Taiwan	Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Shuang Ho Hospital	Chen, SY (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Pediat, Div Pediat Gastroenterol, Taipei, Taiwan.; Chen, SH (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Pediat, Div Pediat Hematol & Oncol, Taipei, Taiwan.	shu117@tmu.edu.tw; cd1075@ms17.hinet.net		Lu, Meng-Che/0000-0001-9185-6645	 [MOST 106-2314-B-182A-142-MY2];  [MOST 108-2314B-038-097-]	; 	Corresponding author Shih Yen Chen received study supported by grants from MOST 106-2314-B-182A-142-MY2 and MOST 108-2314B-038 -097 -, Taiwan.	Almand EA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173124; Asnicar F, 2015, PEERJ, V3, DOI 10.7717/peerj.1029; Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025; Basic M, 2014, INFLAMM BOWEL DIS, V20, P431, DOI 10.1097/01.MIB.0000441346.86827.ed; Bok K, 2009, J VIROL, V83, P11890, DOI 10.1128/JVI.00864-09; Bull RA, 2012, J VIROL, V86, P3219, DOI 10.1128/JVI.06712-11; Callahan Ben J, 2016, F1000Res, V5, P1492; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Chen J, 2012, BIOINFORMATICS, V28, P2106, DOI 10.1093/bioinformatics/bts342; Chen SY, 2017, SCI REP-UK, V7, DOI 10.1038/srep46130; Chen SY, 2013, PEDIATR INFECT DIS J, V32, P1335, DOI 10.1097/INF.0b013e3182a5f5b6; Cheng HY, 2021, MEDICINE, V100, DOI 10.1097/MD.0000000000025123; Grytdal SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148395; Grytdal SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126733; He TJ, 2017, J MOL DIAGN, V19, P836, DOI 10.1016/j.jmoldx.2017.06.006; Iritani N, 2008, J VIROL, V82, P7336, DOI 10.1128/JVI.02371-07; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Nelson AM, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-7; Pietsch C, 2018, J CLIN VIROL, V108, P96, DOI 10.1016/j.jcv.2018.09.013; Pu LZCT, 2020, J GASTROEN HEPATOL, V35, P433, DOI 10.1111/jgh.14868; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rodriguez-Diaz J, 2017, SCI REP-UK, V7, DOI 10.1038/srep45559; Rupprom K, 2017, VIROL SIN, V32, P139, DOI 10.1007/s12250-016-3863-9; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Veloo ACM, 2011, ANTIMICROB AGENTS CH, V55, P1199, DOI 10.1128/AAC.01771-09; Yang Y, 2010, J VIROL, V84, P9595, DOI 10.1128/JVI.02614-09; Yang YCSH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57612-8; Yu WJ, 2018, J FORMOS MED ASSOC, V117, P720, DOI 10.1016/j.jfma.2017.09.009	29	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0266876	10.1371/journal.pone.0266876	http://dx.doi.org/10.1371/journal.pone.0266876			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35443009	Green Submitted, gold, Green Published			2022-12-26	WOS:000822608900036
J	Melku, M; Gesesew, HA; Ward, PR				Melku, Mulugeta; Gesesew, Hailay Abrha; Ward, Paul R.			Magnitude and predictors of HIV-Drug resistance in Africa: A protocol for systematic review and meta-analysis	PLOS ONE			English	Review							ANTIRETROVIRAL TREATMENT; VIROLOGICAL FAILURE; CHILDREN; ACCUMULATION; ADHERENCE; MUTATIONS	Introduction Human Immunodeficiency Virus (HIV) is continued to be a major public health problem in low-income countries and more importantly in Africa. For the last decade, access to Antiretroviral Therapy (ART) and its impact in improving quality of life and reducing HIV-related morbidity and mortality has significantly been improved in Africa. Nevertheless, the emergency of HIV drug resistance (HIVDR) has posed challenges in achieving optimal ART treatment outcomes and is alarmingly increasing globally in general and in Africa in particular. Comprehensive epidemiological data on the magnitude of HIVDR and HIVDR mutations, and predictors of HIVDR are, however, limited in Africa. Objective The main objective of this systematic review will be to estimate the pooled proportion of HIVDR and HIVDR mutations, and identify factors associated with HIVDR among people living with HIV/AIDS (PLWH) in Africa. Method Published Literature from 2000 until 30 October 2021 will be searched in PubMed/Medline Ovid, HINARI, SCOPUS, EMBASE, CINAHL, Web of Sciences, and Cochrane electronic databases. Initially, the literature will be screened based on title/abstract and followed by full-text appraisal for methodological quality using JBI critical appraisal tools. Data will be extracted from eligible articles after the full-text appraisal. Heterogeneity will be qualitatively assessed by a visual Funnel plot and quantitatively measured by an index of heterogeneity (I-2 statistics). Random-effects model will be fitted to estimate the proportion of HIVDR and each HIVDR mutations. Sub-group and sensitivity analyses will be conducted to reduce heterogeneity. Meta-regression will be done by median year of sampling per study to observe the pattern of changes over time. Publication bias will be assessed by egger's statistics. In case of publication bias, Trim and Fill analysis will be conducted to overcome small-study effect. Data analysis will be performed using Stata version 14. Ethics and dissemination As the data sources are published papers, the protocol will not require an ethical approval letter. The final report of the review will be published in a peer-reviewed journal.	[Melku, Mulugeta] Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Gondar, Ethiopia; [Melku, Mulugeta] Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia; [Gesesew, Hailay Abrha] Mekelle Univ, Sch Publ Hlth, Mekelle, Ethiopia; [Gesesew, Hailay Abrha; Ward, Paul R.] Torrens Univ, Res Ctr Publ Hlth Policy, Adelaide, SA, Australia	University of Gondar; Flinders University South Australia; Mekelle University; Torrens University Australia	Melku, M (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Gondar, Ethiopia.; Melku, M (corresponding author), Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia.	mulugeta.melku@gmail.com		Ward, Paul/0000-0002-5559-9714				Avert, INF HIV HIV DRUG RES; Boender TS, 2016, J ANTIMICROB CHEMOTH, V71, P2918, DOI 10.1093/jac/dkw218; Boerma RS, 2017, J ANTIMICROB CHEMOTH, V72, P365, DOI 10.1093/jac/dkw463; Boyd AT, 2021, AIDS, V35, P1127, DOI 10.1097/QAD.0000000000002858; CLINICAL INFO.HIV.GOV, NONN REV TRANSCR INH; Deletsu SD, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000018777; Diseases and Injuries Collaborators, 2020, LANCET, V396, P1204, DOI [10.1016/S0140-6736(20)30925-9, DOI 10.1016/S0140-6736(20)30925-9]; Etta EM, 2017, AIDS RES THER, V14, DOI 10.1186/s12981-017-0161-z; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; JBI, 2020, CRIT APPR TOOLS US J; Joanna Briggs Institute, 2020, CHECKL AN CROSS SECT; Johnson LF, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002468; Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK ENDING AI; Jordan MR, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000021661; Kiros M, 2020, RETROVIROLOGY, V17, DOI 10.1186/s12977-020-00542-0; Kityo C, 2016, AIDS RES HUM RETROV, V32, P628, DOI [10.1089/AID.2015.0215, 10.1089/aid.2015.0215]; Koigi Peter, 2014, BMC Res Notes, V7, P890, DOI 10.1186/1756-0500-7-890; Kouamou V, 2020, AIDS RES HUM RETROV, V36, P566, DOI [10.1089/aid.2019.0232, 10.1089/AID.2019.0232]; Makwaga O., 2020, AFR J HLTH SCI, V33, P56; Makwaga O, 2020, PAN AFR MED J, V37, DOI 10.11604/pamj.2020.37.311.25909; Masikini P, 2015, CLIN CASE REP, V3, P353, DOI 10.1002/ccr3.254; Michael HU, 2021, AIDS BEHAV, V25, P492, DOI 10.1007/s10461-020-03008-8; Nachega Jean B., 2011, Infectious Disorders - Drug Targets, V11, P167; Obasa AE, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00438; Pennings PS, 2013, INFECT DIS REP, V5, P21, DOI 10.4081/idr.2013.s1.e5; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7647; Sigaloff KCE, 2011, JAIDS-J ACQ IMM DEF, V58, P23, DOI 10.1097/QAI.0b013e318227fc34; Skhosana L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118145; Ssemwanga D, 2015, AIDS REV, V17, P3; Stockdale AJ, 2018, CLIN INFECT DIS, V66, P1846, DOI 10.1093/cid/cix1108; Stoneburner R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100431; Tadesse BT, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11090877; Taffa N, 2018, J ANTIMICROB CHEMOTH, V73, P3137, DOI 10.1093/jac/dky278; United Nations/Africa Renewal, HIV DRUG RES GROW WH; Vaz P, 2020, J PEDIAT INF DIS SOC, V9, P6, DOI 10.1093/jpids/piy102; Wallis CL, 2012, ANTIVIR THER, V17, P313, DOI 10.3851/IMP1985; WHO, TACKL HIV DRUG RES; WHO, 2015, GLOB ACT PLAN ABT RE; WHO, 2020, WHO HLTH TOP HIV AID; WHO, KEY FACTS MILL DEV G; WHO, 2021, HIV DRUG RES REP 202; World Health Organization, 2020, WHO FACT SHEETS; World Health Organization, 2019, HIV DRUG RES REP 201; World Health Organization, 2018, WHO HIV AIDS	44	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0267159	10.1371/journal.pone.0267159	http://dx.doi.org/10.1371/journal.pone.0267159			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35442975	Green Published, gold			2022-12-26	WOS:000822608900043
J	Liu, ZL; Liu, JL; Chen, TL; Wang, Y; Shi, AD; Li, KS; Li, XY; Qiu, B; Zheng, LJ; Zhao, LM; Shu, LZ; Lian, S; Huang, SH; Zhang, ZL; Xu, YF				Liu, Zengli; Liu, Jialiang; Chen, Tianli; Wang, Yue; Shi, Anda; Li, Kangshuai; Li, Xingyong; Qiu, Bo; Zheng, Lijie; Zhao, Liming; Shu, Lizhuang; Lian, Shuo; Huang, Shaohui; Zhang, Zongli; Xu, Yunfei			Wnt-TCF7-SOX9 axis promotes cholangiocarcinoma proliferation and pemigatinib resistance in a FGF7-FGFR2 autocrine pathway	ONCOGENE			English	Article							BETA-CATENIN; INVASION; TARGETS; GROWTH; CANCER; SOX9	Cholangiocarcinoma (CCA) is a type of highly malignant tumor originating from bile ducts. The prognosis of CCA is poor and the treatment options are limited. The biomarker study of CCA has made little progresses in recent years because of the difficulty to obtain CCA specimens. SOX9 is an important regulator of cholangiocyte proliferation and differentiation. We performed mRNA sequencing of CCA, retrieved TCGA data, and detected SOX9 expression in a large CCA cohort. With WNT3A stimulation, SOX9 expression and transcription was elevated by TCF7. Moreover, SOX9 was substantially up-regulated in CCA tissues and was identified as a prognostic biomarker of CCA. With mRNA sequencing and in vitro/vivo validation, we demonstrated that SOX9 enhanced the transcription and expression of FGF7 and FGFR2. FGF7 was significantly up-regulated in the bile and serum of CCA patients, and may promote CCA proliferation by activating FGFR2 in an autocrine pathway. co-expression of FGF7 and FGFR2 was a more sensitive marker for poor prognosis. SOX9-induced overexpression of FGF7 and FGFR2 was the key reason of SOX9-involved pemigatinib resistance. In conclusion, SOX9 and FGF7 were prognostic biomarkers of CCA. WNT3A-TCF7-SOX9 axis could induce pemigatinib resistance in two independent pathways: (1)SOX9 directly promotes FGFR2 transcription and expression; (2)SOX9 elevates FGF7 expression, which could be secreted from CCA cells and activates FGFR2 phosphorylation in an autocrine pathway.	[Liu, Zengli; Liu, Jialiang; Chen, Tianli; Wang, Yue; Shi, Anda; Li, Kangshuai; Qiu, Bo; Zheng, Lijie; Zhao, Liming; Shu, Lizhuang; Lian, Shuo; Huang, Shaohui; Zhang, Zongli; Xu, Yunfei] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Gen Surg, Jinan 250012, Shandong, Peoples R China; [Li, Xingyong] Shandong Univ, Shandong Prov Hosp 3, Cheeloo Coll Med, Dept Hepatobiliary Surg, Jinan 250012, Shandong, Peoples R China	Shandong University; Shandong University	Zhang, ZL; Xu, YF (corresponding author), Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Gen Surg, Jinan 250012, Shandong, Peoples R China.	zzlzzl1900@163.com; xuyunfei1988@126.com			Shandong University Multidisciplinary Research and Innovation Team of Young Scholars [2020QNQT002]; Shandong Province Key RD Program [,2021CXGC011105]; National Natural Science Foundation of China [82072676, 82172791]; China Postdoctoral Science Foundation [2020M682190, 2020M682195]; Clinical Research Foundation of Shandong University [2020SDUCRCA018]; Natural Science Foundation of Shandong Province [ZR2019MH008]; Jinan City Science and Technology Development Program [201805017, 201805013]; Clinical Research Innovation Fund Project [CXPJJH11800001-2018240]; Hengrui Hepatobiliary and Pancreatic Foundation; Key Research and Development Program of Shandong Province [2019GSF108254]; Beijing Medical Award Foundation [YXJL-2020-0785-0967, YXJL-2020-0785-0968]	Shandong University Multidisciplinary Research and Innovation Team of Young Scholars; Shandong Province Key RD Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Clinical Research Foundation of Shandong University; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Jinan City Science and Technology Development Program; Clinical Research Innovation Fund Project; Hengrui Hepatobiliary and Pancreatic Foundation; Key Research and Development Program of Shandong Province; Beijing Medical Award Foundation	Our study was supported by Shandong University Multidisciplinary Research and Innovation Team of Young Scholars (Grant No. 2020QNQT002), Shandong Province Key R&D Program(Major Scientific Innovation Projects,2021CXGC011105), National Natural Science Foundation of China (Grant No. 82072676, 82172791), China Postdoctoral Science Foundation (Grant No. 2020M682190, 2020M682195), Clinical Research Foundation of Shandong University (Grant No. 2020SDUCRCA018), Natural Science Foundation of Shandong Province (ZR2019MH008), Jinan City Science and Technology Development Program (Grant No. 201805017, 201805013), Clinical Research Innovation Fund Project(CXPJJH11800001-2018240), Hengrui Hepatobiliary and Pancreatic Foundation (Grant No.Y-2017-144), Key Research and Development Program of Shandong Province (Grant No. 2019GSF108254), Beijing Medical Award Foundation (YXJL-2020-0785-0967, YXJL-2020-0785-0968).	Abou-Alfa GK, 2020, LANCET ONCOL, V21, P671, DOI 10.1016/S1470-2045(20)30109-1; Andersen JB, 2012, GASTROENTEROLOGY, V142, P1021, DOI 10.1053/j.gastro.2011.12.005; Antoniou A, 2009, GASTROENTEROLOGY, V136, P2325, DOI 10.1053/j.gastro.2009.02.051; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Chen TL, 2021, ONCOGENE, V40, P4941, DOI 10.1038/s41388-021-01850-1; Chen TL, 2021, MOL THER, V29, P2134, DOI 10.1016/j.ymthe.2021.02.017; Davis K, 1990, Int J Technol Assess Health Care, V6, P203; Fan EW, 2015, J UROLOGY, V194, P223, DOI 10.1016/j.juro.2015.01.073; Goyal L, 2021, CANCER TREAT REV, V95, DOI 10.1016/j.ctrv.2021.102170; Hoy SM, 2020, DRUGS, V80, P923, DOI 10.1007/s40265-020-01330-y; Huang TT, 2017, INT J ONCOL, V50, P1501, DOI 10.3892/ijo.2017.3927; Katoh M, 2014, MED RES REV, V34, P280, DOI 10.1002/med.21288; Kawaguchi Y, 2013, J CLIN INVEST, V123, P1881, DOI 10.1172/JCI66022; Lau WM, 2018, MOL CANCER THER, V17, P232, DOI 10.1158/1535-7163.MCT-17-0367; Li ZP, 2021, J EXP CLIN CANC RES, V40, DOI 10.1186/s13046-021-01890-1; Liu PCC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231877; Liu ZL, 2019, EBIOMEDICINE, V45, P181, DOI 10.1016/j.ebiom.2019.06.023; Pai R, 2008, CANCER RES, V68, P5086, DOI 10.1158/0008-5472.CAN-07-2325; Poncy A, 2015, DEV BIOL, V404, P136, DOI 10.1016/j.ydbio.2015.05.012; Qiu B, 2019, EBIOMEDICINE, V50, P166, DOI 10.1016/j.ebiom.2019.11.021; Rizvi S, 2018, NAT REV CLIN ONCOL, V15, P95, DOI 10.1038/nrclinonc.2017.157; Ropiquet F, 1999, INT J CANCER, V82, P237, DOI 10.1002/(SICI)1097-0215(19990719)82:2<237::AID-IJC14>3.0.CO;2-Q; Sarabipour S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10262; Shimokawa T, 2003, CANCER RES, V63, P6116; Silverman IM, 2021, CANCER DISCOV, V11, P326, DOI 10.1158/2159-8290.CD-20-0766; Sun RQ, 2019, EBIOMEDICINE, V47, P142, DOI 10.1016/j.ebiom.2019.08.062; Valle JW, 2021, LANCET, V397, P428, DOI 10.1016/S0140-6736(21)00153-7; Xie YL, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00222-7; Xu YF, 2019, ONCOGENE, V38, P868, DOI 10.1038/s41388-018-0485-8; Xu YF, 2014, BIOCHEM BIOPH RES CO, V446, P54, DOI 10.1016/j.bbrc.2014.02.050; Yuan XD, 2018, BRIT J CANCER, V119, P1358, DOI 10.1038/s41416-018-0338-9	31	5	5	2	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 13	2022	41	20					2885	2896		10.1038/s41388-022-02313-x	http://dx.doi.org/10.1038/s41388-022-02313-x		APR 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	1F4TJ	35428876				2022-12-26	WOS:000782705700001
J	Begum, MY; Osmani, RAM; Alqahtani, A; Ghazwani, M; Hani, U; Ather, H; Atiya, A; Rahamathulla, M; Siddiqua, A				Begum, M. Yasmin; M. Osmani, Riyaz Ali; Alqahtani, Ali; Ghazwani, Mohammed; Hani, Umme; Ather, Hissana; Atiya, Akhtar; Rahamathulla, Mohamed; Siddiqua, Ayesha			Development of stealth liposomal formulation of celecoxib: In vitro and in vivo evaluation	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; SKIN PERMEATION; PLASMA; PHARMACOKINETICS; OSTEOARTHRITIS; MICROEMULSION; STABILITY; COMPLEX	Celecoxib (CLB) is a highly hydrophobic selective cyclo-oxygenase inhibitor with high plasma protein binding and undergoes extensive hepatic metabolism. CLB is highly effective in the treatment of osteo and rheumatoid arthritis as first line therapy but produces severe gastro-intestinal toxicities and cardiovascular side effects. In this research, stealth liposomes of CLB were developed with the intention to reduce the side effects and increase the accumulation of drug in the sites of inflammation. Stealth liposomes were prepared by thin film hydration technique using distearoylphosphatidylcholine and PE-PEG 2000 with variable amounts of cholesterol and characterized. The effects of various lipids such as hydrogenated soy phosphatidylcholine, dipalmitoyl phosphatidylcholine, distearoylphosphatidylcholine and cholesterol content on % drug encapsulation was investigated. The optimized stealth liposomes were characterized by FT-IR and DSC for possible drug excipients interaction. Pharmacokinetics, pharmacodynamics and biodistribution studies were carried out for the stealth liposomes. The results revealed that the stealth liposomes reduced the inflammation to the larger magnitude and have also sustained the magnitude when compared to free drug along with maximum analgesic response. Higher elimination half-life, AUC, MRT and lowered clearance rate denotes the extended bioavailability of the drug in blood. Biodistribution studies revealed that stealth liposomes extend the circulation time of liposomes in blood by decreasing opsonisation and be less concentrated in kidney, thereby reducing the toxicities to RES and renal organs and facilitate the drug accumulation in the area of inflammation. Our results indicated that CLB, without the requirement of modifications to enhance solubilisation, can be encapsulated and released from liposomal formulations. This new-fangled drug delivery approach may be used to circumvent the low bioavailability and toxic side effects of oral CLB formulations.	[Begum, M. Yasmin; Hani, Umme; Rahamathulla, Mohamed] King Khalid Univ, Coll Pharm, Dept Pharmaceut, Abha, Saudi Arabia; [M. Osmani, Riyaz Ali] JSS Acad Higher Educ & Res, JSS Coll Pharm, Dept Pharmaceut, Mysuru, Karnataka, India; [Alqahtani, Ali] King Khalid Univ, Coll Pharm, Dept Pharmacol, Abha, Saudi Arabia; [Ghazwani, Mohammed; Ather, Hissana] King Khalid Univ, Coll Pharm, Dept Pharmaceut Chem, Abha, Saudi Arabia; [Atiya, Akhtar] King Khalid Univ, Coll Pharm, Dept Pharmacognosy, Abha, Saudi Arabia; [Siddiqua, Ayesha] King Khalid Univ, Coll Pharm, Dept Clin Pharm, Abha, Saudi Arabia	King Khalid University; JSS Academy of Higher Education & Research; JSS College of Pharmacy, Mysuru; King Khalid University; King Khalid University; King Khalid University; King Khalid University	Begum, MY (corresponding author), King Khalid Univ, Coll Pharm, Dept Pharmaceut, Abha, Saudi Arabia.	yaminimp47@gmail.com	Alqahtani, Ali M/AAW-5226-2020; Osmani, Riyaz Ali/B-7455-2017; hani, umme/CAJ-4228-2022; Rahamathulla, Mohamed/ABC-7450-2021; hani, Umme/CAJ-4227-2022; Ghazwani, Mohammed/CDJ-7608-2022	Alqahtani, Ali M/0000-0002-2240-4757; Osmani, Riyaz Ali/0000-0002-2333-0817; Rahamathulla, Mohamed/0000-0001-8826-3718; 	King Khalid University [RGP.1/330/42]	King Khalid University	The grant was received by M.Yasmin Begum (The corresponding author). It was funded by the Deanship of Scientific Research through Research Group (Small) [Project number RGP.1/ 330/42] of King Khalid University, Abha-61421, Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begum MY., 2011, RES J PHARM TECHNOL, V4, P1766; Bhatia A, 2004, J PHARM PHARM SCI, V7, P252; Clemett D, 2000, DRUGS, V59, P957, DOI 10.2165/00003495-200059040-00017; Costa P, 2001, EUR J PHARM SCI, V13, P123, DOI 10.1016/S0928-0987(01)00095-1; Dave Vivek, 2019, Nano-Structures & Nano-Objects, V18, P43, DOI 10.1016/j.nanoso.2019.100288; Davies NM, 2000, CLIN PHARMACOKINET, V38, P225, DOI 10.2165/00003088-200038030-00003; Er Y, 2009, J LIPOSOME RES, V19, P29, DOI 10.1080/08982100802673940; Flaten GE, 2006, EUR J PHARM SCI, V28, P336, DOI 10.1016/j.ejps.2006.03.008; GRAEME ML, 1966, J PHARMACOL EXP THER, V153, P373; Hathout RM, 2007, AAPS PHARMSCITECH, V8; Hoekman JD, 2014, J PHARM SCI-US, V103, P2231, DOI 10.1002/jps.24022; Immordino ML, 2006, INT J NANOMED, V1, P297; Jain SK, 2007, DRUG DELIV, V14, P327, DOI 10.1080/10717540601098740; Layek Buddhadev, 2010, Sci Pharm, V78, P507, DOI 10.3797/scipharm.0911-11; Manosroi A, 2004, INT J PHARMACEUT, V270, P279, DOI 10.1016/j.ijpharm.2003.10.031; Mohammed AR, 2004, INT J PHARMACEUT, V285, P23, DOI 10.1016/j.ijpharm.2004.07.010; Nasr M, 2010, AAPS PHARMSCITECH, V11, P85, DOI 10.1208/s12249-009-9364-5; Okur NU, 2011, INT J PHARMACEUT, V416, P136, DOI 10.1016/j.ijpharm.2011.06.026; Pai RS., 2009, INT J PHARM SCI NANO, V1, P317; Paradkar AR, 2003, DRUG DEV IND PHARM, V29, P739, DOI 10.1081/DDC-120021773; Park KM, 1999, INT J PHARM, V181, P173, DOI 10.1016/S0378-5173(99)00029-0; Paulson SK, 2001, J PHARMACOL EXP THER, V297, P638; Paulson SK, 1999, BIOPHARM DRUG DISPOS, V20, P293, DOI 10.1002/(SICI)1099-081X(199909)20:6<293::AID-BDD188>3.0.CO;2-X; Ramana M. V., 2007, Indian Journal of Pharmaceutical Sciences, V69, P390; Rathod S, 2010, INDIAN J PHARM SCI, V72, P155, DOI 10.4103/0250-474X.65014; Saraswat AL, 2020, J DRUG DELIV SCI TEC, V55, DOI 10.1016/j.jddst.2019.101477; Segale L, 2015, J DRUG DELIV SCI TEC, V26, P35, DOI 10.1016/j.jddst.2015.02.001; Shakeel Faiyaz, 2008, Journal of Nanobiotechnology, V6, P8, DOI 10.1186/1477-3155-6-8; Shinde CG, 2016, RSC ADV, V6, P12913, DOI 10.1039/c5ra22672d; Simon LS, 1998, ARTHRITIS RHEUM-US, V41, P1591, DOI 10.1002/1529-0131(199809)41:9<1591::AID-ART9>3.0.CO;2-J; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; SUBCZYNSKI WK, 1994, BIOCHEMISTRY-US, V33, P7670, DOI 10.1021/bi00190a022; Ventura CA, 2005, EUR J MED CHEM, V40, P624, DOI 10.1016/j.ejmech.2005.03.001; Vijayakumar MR, 2016, J DRUG DELIV SCI TEC, V33, P125, DOI 10.1016/j.jddst.2016.02.009; Walter MF, 2004, ATHEROSCLEROSIS, V177, P235, DOI 10.1016/j.atherosclerosis.2004.10.001; Zhang JA, 2005, EUR J PHARM BIOPHARM, V59, P177, DOI 10.1016/j.ejpb.2004.06.009	36	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0264518	10.1371/journal.pone.0264518	http://dx.doi.org/10.1371/journal.pone.0264518			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2K2KP	35472207	Green Published, gold			2022-12-26	WOS:000816171900019
J	Derian, N; Pham, HP; Nehar-Belaid, D; Tchitchek, N; Klatzmann, DJ; Eric, VJ; Six, AJ				Derian, Nicolas; Pham, Hang-Phuong; Nehar-Belaid, Djamel; Tchitchek, Nicolas; Klatzmann, David J.; Eric, Vicaut J.; Six, Adrien J.			The Tsallis generalized entropy enhances the interpretation of transcriptomics datasets	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; DIVERSITY; EXPRESSION	BackgroundIdentifying differentially expressed genes between experimental conditions is still the gold-standard approach to interpret transcriptomic profiles. Alternative approaches based on diversity measures have been proposed to complement the interpretation of such datasets but are only used marginally. MethodsHere, we reinvestigated diversity measures, which are commonly used in ecology, to characterize mice pregnancy microenvironments based on a public transcriptome dataset. Mainly, we evaluated the Tsallis entropy function to explore the potential of a collection of diversity measures for capturing relevant molecular event information. ResultsWe demonstrate that the Tsallis entropy function provides additional information compared to the traditional diversity indices, such as the Shannon and Simpson indices. Depending on the relative importance given to the most abundant transcripts based on the Tsallis entropy function parameter, our approach allows appreciating the impact of biological stimulus on the inter-individual variability of groups of samples. Moreover, we propose a strategy for reducing the complexity of transcriptome datasets using a maximation of the beta diversity. ConclusionsWe highlight that a diversity-based analysis is suitable for capturing complex molecular events occurring during physiological events. Therefore, we recommend their use through the Tsallis entropy function to analyze transcriptomics data in addition to differential expression analyses.	[Derian, Nicolas; Nehar-Belaid, Djamel; Tchitchek, Nicolas; Klatzmann, David J.; Six, Adrien J.] Sorbonne Univ, INSERM, UMR S 959, Immunol Immunopathol Immunotherapy i3, Paris, France; [Derian, Nicolas; Nehar-Belaid, Djamel; Tchitchek, Nicolas; Klatzmann, David J.; Six, Adrien J.] Hop La Pitie Salpetriere, AP HP, Biotherapy CIC BTi, Paris, France; [Pham, Hang-Phuong] IL TOO Pharma, Paris, France; [Nehar-Belaid, Djamel] Jackson Lab Genom Med, Farmington, CT USA; [Eric, Vicaut J.] Univ Paris 07, Hop St Louis Lariboisiere, APHP, Unite Rech Clin,UMR 942, Paris, France; [Derian, Nicolas; Nehar-Belaid, Djamel; Tchitchek, Nicolas; Klatzmann, David J.; Six, Adrien J.] Hop La Pitie Salpetriere, AP HP, Inflammat Immunopathol Biotherapy Dept i2B, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Jackson Laboratory; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Six, AJ (corresponding author), Sorbonne Univ, INSERM, UMR S 959, Immunol Immunopathol Immunotherapy i3, Paris, France.; Six, AJ (corresponding author), Hop La Pitie Salpetriere, AP HP, Biotherapy CIC BTi, Paris, France.; Six, AJ (corresponding author), Hop La Pitie Salpetriere, AP HP, Inflammat Immunopathol Biotherapy Dept i2B, Paris, France.	adrien.six@sorbonne-universite.fr	Nehar-Belaid, Djamel/GQZ-4299-2022	Nehar-Belaid, Djamel/0000-0001-6002-5021; PHAM, Hang-Phuong/0000-0002-7896-7401; Tchitchek, Nicolas/0000-0003-3307-0446	Assistance Publique-Hopitaux de Paris, Sorbonne University, Inserm, LabEx Transimmunom [ANR-11-IDEX-0004-02]	Assistance Publique-Hopitaux de Paris, Sorbonne University, Inserm, LabEx Transimmunom	This work has been funded by Assistance Publique-Hopitaux de Paris, Sorbonne University, Inserm, LabEx Transimmunom (ANR-11-IDEX-0004-02).	Derian N, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004801; Griffith M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004393; Guo MZ, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004575; Habbeddine M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107267; Hunt JS, 2000, SEMIN CELL DEV BIOL, V11, P127, DOI 10.1006/scdb.2000.0158; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Kim BR, 2017, J MICROBIOL BIOTECHN, V27, P2089, DOI 10.4014/jmb.1709.09027; Kondratyeva A, 2019, BIOL REV, V94, P1317, DOI 10.1111/brv.12504; Kosch R, 2019, RES SYNTH METHODS, V10, P99, DOI 10.1002/jrsm.1337; Liu Q, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006687; Ma Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15298-6; Marcon E, 2015, J STAT SOFTW, V67, P1; Marcon E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090289; Martinez O, 2008, P NATL ACAD SCI USA, V105, P9709, DOI 10.1073/pnas.0803479105; Masi M, 2005, PHYS LETT A, V338, P217, DOI 10.1016/j.physleta.2005.01.094; Negishi Y, 2018, J OBSTET GYNAECOL RE, V44, P2025, DOI 10.1111/jog.13759; Nehar-Belaid D, 2016, J IMMUNOL, V196, P678, DOI 10.4049/jimmunol.1501834; Ogata N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144822; Ruocco MG, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00389; Seweryn MT, 2020, COMPUT STRUCT BIOTEC, V18, P1830, DOI 10.1016/j.csbj.2020.05.005; Shobeiri SS., 2015, J IMMUNOL RES, V2015, P1, DOI [10.1155/2015/692198, DOI 10.1155/2015/692198]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TOTHMERESZ B, 1995, J VEG SCI, V6, P283, DOI 10.2307/3236223; TSALLIS C, 1988, J STAT PHYS, V52, P479, DOI 10.1007/BF01016429; Zambelli F, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky055; Zhou GY, 2019, NUCLEIC ACIDS RES, V47, pW234, DOI 10.1093/nar/gkz240	26	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266618	10.1371/journal.pone.0266618	http://dx.doi.org/10.1371/journal.pone.0266618			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446844	Green Published, gold			2022-12-26	WOS:000795468200014
J	Garuglieri, E; Booth, JM; Fusi, M; Yang, XY; Marasco, R; Mbobo, T; Clementi, E; Sacchi, L; Daffonchio, D				Garuglieri, Elisa; Booth, Jenny Marie; Fusi, Marco; Yang, Xinyuan; Marasco, Ramona; Mbobo, Tumeka; Clementi, Emanuela; Sacchi, Luciano; Daffonchio, Daniele			Morphological characteristics and abundance of prokaryotes associated with gills in mangrove brachyuran crabs living along a tidal gradient	PLOS ONE			English	Article							EVOLUTION; OXYGEN; LAND; METAORGANISMS; COMMUNICATION; MECHANISMS; NANOTUBES; BACTERIA; ANIMALS; GENES	Due to the chemico-physical differences between air and water, the transition from aquatic life to the land poses several challenges for animal evolution, necessitating morphological, physiological and behavioural adaptations. Microbial symbiosis is known to have played an important role in eukaryote evolution, favouring host adaptation under changing environmental conditions. We selected mangrove brachyuran crabs as a model group to investigate the prokaryotes associated with the gill of crabs dwelling at different tidal levels (subtidal, intertidal and supratidal). In these animals, the gill undergoes a high selective pressure, finely regulating multiple physiological functions during both animal submersion under and emersion from the periodical tidal events. We hypothesize that similarly to other marine animals, the gills of tidal crabs are consistently colonized by prokaryotes that may quantitatively change along the environmental gradient driven by the tides. Using electron microscopy techniques, we found a thick layer of prokaryotes over the gill surfaces of all of 12 crab species from the mangrove forests of Saudi Arabia, Kenya and South Africa. We consistently observed two distinct morphotypes (rod- and spherical-shaped), positioned horizontally and/or perpendicularly to the gill surface. The presence of replicating cells indicated that the prokaryote layer is actively growing on the gill surface. Quantitative analysis of scanning electron microscopy images and the quantification of the bacterial 16S rRNA gene by qPCR revealed a higher specific abundance of prokaryote cells per gill surface area in the subtidal species than those living in the supratidal zone. Our results revealed a correlation between prokaryote colonization of the gill surfaces and the host lifestyle. This finding indicates a possible role of prokaryote partnership within the crab gills, with potential effects on animal adaptation to different levels of the intertidal gradient present in the mangrove ecosystem.	[Garuglieri, Elisa; Booth, Jenny Marie; Fusi, Marco; Yang, Xinyuan; Marasco, Ramona; Daffonchio, Daniele] King Abdullah Univ Sci & Technol KAUST, Red Sea Res Ctr, Biol & Environm Sci & Engn Div BESE, Thuwal, Saudi Arabia; [Fusi, Marco] Joint Nat Conservat Comm, Peterborough, England; [Mbobo, Tumeka] South African Inst Aquat Biodivers Inst, Natl Res Fdn, Makhanda, South Africa; [Mbobo, Tumeka] Kirstenbosch Res Ctr, South African Natl Biodivers Inst, Cape Town, South Africa; [Mbobo, Tumeka] Stellenbosch Univ, Ctr Invas Biol, Dept Bot & Zool, Stellenbosch, South Africa; [Clementi, Emanuela; Sacchi, Luciano] Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, Pavia, Italy	King Abdullah University of Science & Technology; National Research Foundation - South Africa; South African National Biodiversity Institute; Stellenbosch University; University of Pavia	Fusi, M; Daffonchio, D (corresponding author), King Abdullah Univ Sci & Technol KAUST, Red Sea Res Ctr, Biol & Environm Sci & Engn Div BESE, Thuwal, Saudi Arabia.; Fusi, M (corresponding author), Joint Nat Conservat Comm, Peterborough, England.	marco.fusi@kaust.edu.sa; daniele.daffonchio@kaust.edu.sa	Marasco, Ramona/ABF-3088-2021	Marasco, Ramona/0000-0003-4776-7519; Daffonchio, Daniele/0000-0003-0947-925X	King Abdullah University of Science and Technology (KAUST) through the Competitive Research Grant [CRG-7-3739]	King Abdullah University of Science and Technology (KAUST) through the Competitive Research Grant	D.D. acknowledges the financial support of King Abdullah University of Science and Technology (KAUST) through the Competitive Research Grant (CRG-7-3739), "The role of the bacterial symbiome at the gill-water (air) interface in the evolution towards terrestrialisation (Microlanding)," 1 April 2019 to 31 March 2022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Bach HJ, 2002, J MICROBIOL METH, V49, P235, DOI 10.1016/S0167-7012(01)00370-0; Baidya AK, 2018, CURR OPIN MICROBIOL, V42, P1, DOI 10.1016/j.mib.2017.08.006; Belting M, 2008, J CELL BIOL, V183, P1187, DOI 10.1083/jcb.200810038; BLISS DE, 1968, AM ZOOL, V8, P673; Board WE, World Register of Marine Species, DOI 10.14284/170; Bordenstein SR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002226; Bosch TCG, 2011, ZOOLOGY, V114, P185, DOI 10.1016/j.zool.2011.04.001; Buggren WW., 1988, BIOL LAND CRABS; Callegari M, 2021, NPJ BIOFILMS MICROBI, V7, DOI 10.1038/s41522-021-00212-9; Cannicci S, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.575372; CAVEY MJ, 1992, T AM MICROSC SOC, V111, P16, DOI 10.2307/3226722; Chen F, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11071829; Chown SL, 2004, PLOS BIOL, V2, P1701, DOI 10.1371/journal.pbio.0020406; Dembowski JB, 1926, BIOL BULL-US, V50, P179, DOI 10.2307/1536668; Dubey GP, 2011, CELL, V144, P590, DOI 10.1016/j.cell.2011.01.015; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Duke NC., 2015, TROPICAL FORESTRY HD, DOI [10.1007/978-3-642-41554-8, DOI 10.1007/978-3-642-41554-8]; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Fluck M, 2007, INTEGR COMP BIOL, V47, P524, DOI 10.1093/icb/icm080; Friel AD, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01398; Fusi M, 2015, OIKOS, V124, P784, DOI 10.1111/oik.01757; Gao JG, 2021, GENE, V769, DOI 10.1016/j.gene.2020.145203; Giomi F, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2927; Greenaway P., 1999, CRUSTACEANS BIODIVER, V1; Henry RP, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00431; Hogarth P, 2007, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198568704.001.0001; Hsia CCW, 2013, COMPR PHYSIOL, V3, P849, DOI 10.1002/cphy.c120003; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; HUGHES GM, 1969, J EXP BIOL, V51, P203; Jaspers C, 2019, ZOOLOGY, V133, P81, DOI 10.1016/j.zool.2019.02.007; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Kysela DT, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002565; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Li Y, 2008, J PLANT PHYSIOL, V165, P1783, DOI 10.1016/j.jplph.2007.12.007; Louca S, 2016, SCIENCE, V353, P1272, DOI 10.1126/science.aaf4507; Lozano-Fernandez J, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0133; Luque J, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abj5689; Minelli A, 2016, ARTHROPOD BIOL EVOLU; Morris J Jeffrey, 2018, F1000Res, V7, DOI 10.12688/f1000research.14385.1; Motone K, 2020, MBIO, V11, DOI 10.1128/mBio.01019-19; Naruse T, 2003, CRUSTACEANA, V76, P1211, DOI 10.1163/156854003773123447; Rich MK, 2021, SCIENCE, V372, P864, DOI 10.1126/science.abg0929; Ripley B., 2016, SUPPORT FUNCTIONS DA; Rodesney CA, 2017, P NATL ACAD SCI USA, V114, P5906, DOI 10.1073/pnas.1703255114; Sacchi L, 2004, TISSUE CELL, V36, P43, DOI 10.1016/j.tice.2003.08.004; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Selden P., 2012, ENCY LIFE SCI, DOI [10.1002/9780470015902.a0001641.pub3, DOI 10.1002/9780470015902.A0001641.PUB3, 10.1002/9780470015902]; Singh BK, 2020, ENVIRON MICROBIOL, V22, P564, DOI 10.1111/1462-2920.14900; Sun DL, 2013, APPL ENVIRON MICROB, V79, P5962, DOI 10.1128/AEM.01282-13; TOMLINSON P B, 1986; van Kessel MAHJ, 2016, ENV MICROBIOL REP, V8, P590, DOI 10.1111/1758-2229.12407; Vecoli M, 2010, GEOL SOC SPEC PUBL, V339, P1, DOI 10.1144/SP339.1; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Voolstra CR, 2020, BIOESSAYS, V42, DOI 10.1002/bies.202000004; Wagner-Dobler I, 2006, ANNU REV MICROBIOL, V60, P255, DOI 10.1146/annurev.micro.60.080805.142115; Wale M, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.770245; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Willmer P., ENV PHYSL ANIMALS; WOLCOTT TG, 1984, PHYSIOL ZOOL, V57, P161, DOI 10.1086/physzool.57.1.30155978; Young KD, 2007, CURR OPIN MICROBIOL, V10, P596, DOI 10.1016/j.mib.2007.09.009; Zhang ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148135; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x; Zimmer Martin, 2006, Acta Biologica Benrodis, V13, P127	63	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266977	10.1371/journal.pone.0266977	http://dx.doi.org/10.1371/journal.pone.0266977			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421185	gold, Green Published			2022-12-26	WOS:000795453600091
J	Geremew, D; Geremew, H; Tamir, M; Adem, M; Tegene, B; Bayleyegn, B				Geremew, Demeke; Geremew, Habtamu; Tamir, Mebratu; Adem, Mohammed; Tegene, Birhanemeskel; Bayleyegn, Biruk			Tuberculosis and isoniazid prophylaxis among adult HIV positive patients on ART in Northwest Ethiopia	PLOS ONE			English	Article							PREVENTIVE THERAPY; INFECTED PATIENTS; TB; DETERMINANTS; INDIVIDUALS; PREVALENCE; HAART	BackgroundAlthough antiretroviral therapy (ART) can avert tuberculosis (TB) incidence among human immunodeficiency virus (HIV) infected patients, the concomitant use of ART with isoniazid (INH) has a paramount effect. Despite this evidence, there is a paucity of data regarding TB incidence among HIV patients on ART with and without isoniazid prophylaxis and its predictors. Thus, this study sought to assess the incidence and predictors of TB among adult HIV positive patients on ART. MethodsThis was a hospital based retrospective study including 368 adult HIV positive patients on ART in Gondar comprehensive specialized hospital between January 1, 2016, and April 30, 2019. Data was extracted from clinical laboratory and HIV care ART follow up clinic. The bi-variable and multivariable regression models were used to ascertain predictors of incident TB. Data was analyzed using SPSS version 20 software. ResultsA total of 335 adult HIV positive patients were included in the analysis, of whom, 56 (16.7%) were developed incident TB. Being ambulatory and bedridden (AOR: 2.2, 95% CI: 1.1, 4.6), advanced WHO clinical HIV disease stage (III and IV) (AOR: 3.2, 95% CI: 1.6, 6.1), not taking INH (AOR: 2.8, 95% CI: 1.3, 5.9), and baseline CD4(+) T cell count <= 200 cell/mm(3) (AOR: 3.6, 95% CI: 1.8, 7.2) were found to be the predictors of tuberculosis incidence. ConclusionThe study indicated a high TB incidence among HIV positive patients in Gondar. Therefore, scaling up the isoniazid preventive therapy program and its strict compliance is necessary to avert HIV fueled tuberculosis in HIV endemic areas.	[Geremew, Demeke] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Immunol & Mol Biol Unit, Bahir Dar, Ethiopia; [Geremew, Habtamu] Oda Bultum Univ, Coll Hlth Sci, Chiro, Ethiopia; [Tamir, Mebratu] Univ Gondar, Sch Biomed & Lab Sci, Dept Med Parasitol, Gondar, Ethiopia; [Adem, Mohammed] Univ Gondar, Sch Biomed & Lab Sci, Dept Immunol & Mol Biol, Gondar, Ethiopia; [Tegene, Birhanemeskel] Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Dept Med Microbiol, Gondar, Ethiopia; [Bayleyegn, Biruk] Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Dept Hematol & Immunohematol, Gondar, Ethiopia	Bahir Dar University; University of Gondar; University of Gondar; University of Gondar; University of Gondar	Geremew, D (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Immunol & Mol Biol Unit, Bahir Dar, Ethiopia.	deme2112@gmail.com	Geremew, Demeke/ABE-5034-2020	Geremew, Demeke/0000-0001-8493-1512; Geremew, Habtamu/0000-0002-9027-9847; Maru, Abiy/0000-0002-6032-8978				Aemro A, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-04959-y; Al Abri S, 2020, INT J INFECT DIS, V92, pS60, DOI 10.1016/j.ijid.2020.02.042; Alemu A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232426; Alemu A, 2020, INT J INFECT DIS, V95, P59, DOI 10.1016/j.ijid.2020.02.053; [Anonymous], 2017, FMOH NATL GUIDELINES; Assebe LF, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-036892; Assebe LF, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1719-0; Aung ZZ, 2019, INT J INFECT DIS, V80, P10, DOI 10.1016/j.ijid.2018.12.008; Ayele HT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1089-3; Bayabil S, 2021, HIV AIDS-RES PALLIAT, V13, P527, DOI 10.2147/HIV.S307069; Belew H, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05290-2; Dalbo M., 2016, ADV INFECT DIS, V06, P70, DOI 10.4236/aid.2016.62010; Fekadu S, 2015, J INFECT DEV COUNTR, V9, P898, DOI 10.3855/jidc.5667; Fenta A, 2020, INT J GEN MED, V13, P1529, DOI 10.2147/IJGM.S278758; Gelaw YA, 2020, HIV AIDS-RES PALLIAT, V12, P839, DOI 10.2147/HIV.S284722; Geremew D, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05040-4; Geremew D, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4031-2; Giri PA, 2013, N AM J MED SCI, V5, P37, DOI [10.4103/1947-2714.114169, 10.4103/1947-2714.106193, 10.4103/1947-2714.107537]; Gunda DW, 2018, CAN J INFECT DIS MED, V2018, DOI 10.1155/2018/1346104; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Mama Mohammedaman, 2018, Open Microbiol J, V12, P163, DOI 10.2174/1874285801812010163; Mengesha Y, 2020, INTEGR PHARM RES PRA, V9, P127, DOI 10.2147/IPRP.S268924; Mohammed S., 2015, INT J PHARMA SCI RES, V6, P1406; Okoye AA, 2013, IMMUNOL REV, V254, P54, DOI 10.1111/imr.12066; Pathmanathan I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173309; Sabasaba A, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3696-x; Temesgen B, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7912-9; WHO: Joint HIV and TB Department Meeting, 2008, REP WHO 3 1 M INT CA; Wondimeneh Yitayih, 2012, BMC Res Notes, V5, P331, DOI 10.1186/1756-0500-5-331	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266803	10.1371/journal.pone.0266803	http://dx.doi.org/10.1371/journal.pone.0266803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1C1KV	35452463	gold, Green Published			2022-12-26	WOS:000792887700009
J	Hagiya, H; Otsuka, Y; Tokumasu, K; Honda, H; Nishimura, Y; Obika, M; Otsuka, F				Hagiya, Hideharu; Otsuka, Yuki; Tokumasu, Kazuki; Honda, Hiroyuki; Nishimura, Yoshito; Obika, Mikako; Otsuka, Fumio			Interest in Infectious Diseases specialty among Japanese medical students amidst the COVID-19 pandemic: A web-based, cross-sectional study	PLOS ONE			English	Article							IMPACT; EDUCATION; SARS	IntroductionThe emergence of the novel coronavirus disease of 2019 (COVID-19) has led to huge disruptions in the medical field and society. The significance of training and education for experts has been increasingly acknowledged in Japan, where the number of infectious disease (ID) specialists is reportedly insufficient. In this paper, we report the results of a web-based survey that was conducted to reveal the ways in which the COVID-19 pandemic has influenced medical students' awareness of ID specialists and future career choices. MethodThis cross-sectional descriptive study was conducted in March 2021 and targeted 717 medical students belonging to Medical School of Okayama University, Japan. The questionnaire consisted of four questions meant to assess students' knowledge and future intentions of becoming ID specialists. ResultsWe obtained 328 eligible questionnaires (response rate: 45.7%). Of 227 (69.2%) students who were aware of ID specialists, 99 (43.6%) answered that they came to know about them only after the pandemic, 12 (3.7%) answered that their interest in being an ID specialist arose during the pandemic, while 36 (11.0%) responded that they would rather not become ID specialists. At the time of the survey, 5 students (1.5%) were aiming to become ID specialists. ConclusionWe observed a very low rate of interest to be an ID specialist among medical students. The experience of the pandemic does not seem to have influenced Japanese medical students to choose ID as a specialty for their careers. Continuous efforts to increase the number of ID specialists are necessary in Japan as a countermeasure against the coming pandemic.	[Hagiya, Hideharu; Otsuka, Yuki; Tokumasu, Kazuki; Honda, Hiroyuki; Nishimura, Yoshito; Obika, Mikako; Otsuka, Fumio] Okayama Univ, Dept Gen Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan	Okayama University	Hagiya, H (corresponding author), Okayama Univ, Dept Gen Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	hagiya@okayama-u.ac.jp	Nishimura, Yoshito/ABF-6713-2020; Tokumasu, Kazuki/ABF-9651-2021	Nishimura, Yoshito/0000-0003-0224-7501; Hagiya, Hideharu/0000-0002-5086-1891				Althwanay A, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.10775; [Anonymous], LANCET COVID 19 RESO; Association for Fire Ecology, 2021, AFE CERT AC PROGR; Bongomin F, 2021, ADV MED EDUC PRACT, V12, P253, DOI 10.2147/AMEP.S300265; Byrnes YM, 2020, MED EDUC ONLINE, V25, DOI 10.1080/10872981.2020.1798088; Calhoun KE, 2020, AM J SURG, V220, P44, DOI 10.1016/j.amjsurg.2020.04.024; Hagiya Hideharu, 2021, Cureus, V13, pe16643, DOI 10.7759/cureus.16643; Harvey WT, 2021, NAT REV MICROBIOL, V19, P409, DOI 10.1038/s41579-021-00573-0; Hu B, 2021, NAT REV MICROBIOL, V19, P141, DOI 10.1038/s41579-020-00459-7; Hu LY, 2020, TRANSL PEDIATR, V9, P243, DOI 10.21037/tp-20-100; Lee K, 2009, GLOB INST, P1; Lim ECH, 2009, ANN ACAD MED SINGAP, V38, P724; Loh LC, 2006, MALAYS J MED SCI, V13, P30; Magazine N, 2022, VIRUSES-BASEL, V14, DOI 10.3390/v14030640; McGugan S, 2003, CLIN INVEST MED, V26, P106; National Resident Matching Program, RESULTS DATA SPECIAL; Park Seung Won, 2016, Korean J Med Educ, V28, P209, DOI 10.3946/kjme.2016.30; Patil NG, 2003, MED EDUC, V37, P1127, DOI 10.1046/j.1365-2923.2003.01723.x; Peiffer-Smadja N, 2020, BMC MED EDUC, V20, DOI 10.1186/s12909-020-02317-9; Rose S, 2020, JAMA-J AM MED ASSOC, V323, P2131, DOI 10.1001/jama.2020.5227; The Japanese Society of Internal Medicine, 2021, NUMB SOC MEMB; Wright S, 1997, J GEN INTERN MED, V12, P53, DOI 10.1007/s11606-006-0007-1; Yoon John D, 2018, J Grad Med Educ, V10, P149, DOI 10.4300/JGME-D-17-00063.1	23	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267587	10.1371/journal.pone.0267587	http://dx.doi.org/10.1371/journal.pone.0267587			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9GM	35446911	gold, Green Published			2022-12-26	WOS:000795468200022
J	Hayashi, R; Kogiso, T; Kikuchi, N; Yamamoto, K; Nakamura, S; Egawa, H; Hagiwara, N; Tokushige, K				Hayashi, Ryoko; Kogiso, Tomomi; Kikuchi, Noriko; Yamamoto, Kana; Nakamura, Shinichi; Egawa, Hiroto; Hagiwara, Nobuhisa; Tokushige, Katsutoshi			Portopulmonary hypertension and the risk of high right ventricular systolic pressure in liver transplant candidates	PLOS ONE			English	Article							PULMONARY-HYPERTENSION; DIAGNOSIS; SURVIVAL; CLASSIFICATION; GUIDELINES; CIRRHOSIS; MODEL	AimPortopulmonary hypertension (PoPH) is a rare and serious complication of liver cirrhosis and portal hypertension that can interfere with liver transplantation (LT). We evaluated the prevalence of PoPH and the clinical features of right ventricular systolic pressure (RVSP), which is equivalent to pulmonary artery systolic pressure, in LT candidates. MethodsThis was a single-center retrospective study. A total of 157 Japanese patients with decompensated liver cirrhosis or portal hypertension (76 men, median age = 52 years [range: 18-68 years]) were enrolled. The relationships between RVSP and clinical parameters, and the prevalence of PoPH in LT candidates, were evaluated. ResultsThe cardiological parameters were as follows: brain natriuretic peptide (BNP), 39.1 (4.0-780.5) pg/mL; RVSP, 31.2 (16.0-122.4) mmHg; ejection fraction, 58% (28-72%); and mean peak tricuspid regurgitation velocity, 2.3 (1.5-5.3) m/s. The RVSP was significantly higher in females (p = 0.02) and primary biliary cholangitis (PBC) patients (p = 0.01), and was weakly correlated with the BNP level (r = 0.40, p = 0.01). For RVSPs of < 36 and >= 36 mmHg, the 5-year survival rates were 36.1% versus 34.1%, and 85.4% versus 85.3%, in non-LT and LT cases, respectively (p = 0.47 and 0.69, respectively). Among six patients with an RVSP >= 50 mmHg, three (1.9%) were diagnosed with PoPH and treated with vasodilators. ConclusionsPoPH was observed in 3 cases (1.9%) in 157 LT candidates. In patients with suspected mild pulmonary hypertension (RVSP, 36 - 50 mmHg), LT was successfully performed.	[Hayashi, Ryoko; Kogiso, Tomomi; Yamamoto, Kana; Nakamura, Shinichi; Tokushige, Katsutoshi] Tokyo Womens Med Univ, Inst Gastroenterol, Dept Internal Med, Shinjuku Ku, Tokyo, Japan; [Kikuchi, Noriko; Hagiwara, Nobuhisa] Tokyo Womens Med Univ, Dept Cardiol, Shinjuku Ku, Tokyo, Japan; [Egawa, Hiroto] Tokyo Womens Med Univ, Inst Gastroenterol, Dept Surg, Shinjuku Ku, Tokyo, Japan	Tokyo Women's Medical University; Tokyo Women's Medical University; Tokyo Women's Medical University	Kogiso, T (corresponding author), Tokyo Womens Med Univ, Inst Gastroenterol, Dept Internal Med, Shinjuku Ku, Tokyo, Japan.	kogiso.tomomi@twmu.ac.jp	Kikuchi, Noriko/HGA-4821-2022	Kikuchi, Noriko/0000-0002-2760-8927				Ashfaq M, 2007, AM J TRANSPLANT, V7, P1258, DOI 10.1111/j.1600-6143.2006.01701.x; Atsukawa M, 2020, HEPATOL RES, V50, P1244, DOI 10.1111/hepr.13560; Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; Benjaminov FS, 2003, GUT, V52, P1355, DOI 10.1136/gut.52.9.1355; Cholongitas E, 2005, ALIMENT PHARM THERAP, V22, P1079, DOI 10.1111/j.1365-2036.2005.02691.x; Colle IO, 2003, HEPATOLOGY, V37, P401, DOI 10.1053/jhep.2003.50060; DuBrock HM, 2020, TRANSPLANT DIRECT, V6, DOI 10.1097/TXD.0000000000001085; Foocharoen C, 2011, INT J RHEUM DIS, V14, P282, DOI 10.1111/j.1756-185X.2011.01625.x; Galie N, 2004, EUR HEART J, V25, P2243, DOI 10.1016/j.ehj.2004.09.014; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; HADENGUE A, 1991, GASTROENTEROLOGY, V100, P520, DOI 10.1016/0016-5085(91)90225-A; Hoeper MM, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00740-2017; Hoeper MM, 2004, LANCET, V363, P1461, DOI 10.1016/S0140-6736(04)16107-2; Humbert M, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01887-2018; Kawut SM, 2005, LIVER TRANSPLANT, V11, P1107, DOI 10.1002/lt.20459; Kawut SM, 2008, HEPATOLOGY, V48, P196, DOI 10.1002/hep.22275; Khaderi S, 2014, LIVER TRANSPLANT, V20, P724, DOI 10.1002/lt.23870; Kodama K Serizawa N., 2020, EC GASTROENTEROLOGY, P63; Korbitz PM, 2020, CLIN TRANSPLANT, V34, DOI 10.1111/ctr.13995; Krowka MJ, 2006, HEPATOLOGY, V44, P1502, DOI 10.1002/hep.21431; Krowka MJ, 2016, TRANSPLANTATION, V100, P1440, DOI 10.1097/TP.0000000000001229; Krowka MJ, 2012, CHEST, V141, P906, DOI 10.1378/chest.11-0160; LEBREC D, 1979, AM REV RESPIR DIS, V120, P849; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Mandell MS, 2000, LIVER TRANSPLANT, V6, pS36, DOI 10.1002/lt.500060509; MCDONNELL PJ, 1983, AM REV RESPIR DIS, V127, P437, DOI 10.1164/arrd.1983.127.4.437; Medarov BI, 2014, RESP MED, V108, P943, DOI 10.1016/j.rmed.2014.04.004; Ramsay M A, 1997, Liver Transpl Surg, V3, P494, DOI 10.1002/lt.500030503; Savale L, 2020, J HEPATOL, V73, P130, DOI 10.1016/j.jhep.2020.02.021; Simonneau G, 2004, J AM COLL CARDIOL, V43, p5S, DOI 10.1016/j.jacc.2004.02.037; Swanson KL, 2008, AM J TRANSPLANT, V8, P2445, DOI 10.1111/j.1600-6143.2008.02384.x; Tajiri T, 2010, DIGEST ENDOSC, V22, P1, DOI 10.1111/j.1443-1661.2009.00929.x; Yoshimaru K, 2018, PEDIATR TRANSPLANT, V22, DOI 10.1111/petr.13203	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267125	10.1371/journal.pone.0267125	http://dx.doi.org/10.1371/journal.pone.0267125			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0Z7VA	35439259	Green Published, gold			2022-12-26	WOS:000791280100014
J	Prabakaran, DS; Chaturvedi, PK; Krishnamoorthy, D; Seo, YS; Thippana, M; Park, WY				Prabakaran, D. S.; Chaturvedi, Pankaj Kumar; Krishnamoorthy, Dineshkumar; Seo, Young-Seok; Thippana, Mallikarjuna; Park, Woo-Yoon			Fused toes homolog, a potential molecular regulator of human papillomavirus type 16 E6 and E7 oncoproteins in cervical cancer	PLOS ONE			English	Article							PROTEIN-STRUCTURE; EXPRESSION; MIGRATION; PROMOTES; SERVER; CELLS; DEGRADATION; INHIBITION; ACTIVATION; PI3K	Human papillomavirus type 16 (HPV16) plays a major role in the development of cervical cancer. The oncogenic potential of HPV16 is attributed to E6 and E7 oncoproteins. Here, we investigated the relationship between fused toes homolog (FTS) and HPV16 E6 and E7 in cervical cancer cells. HPV16-positive CaSki and SiHa cell lines were used for in vitro studies. FTS silencing was performed using a small interfering RNA (siRNA)-based approach, and western blotting was performed to determine the protein expression of tumor suppressors and cell survival markers. Immunoprecipitation, immunofluorescence, in silico analysis, and immunohistochemistry were performed to determine the interaction between, and intracellular co-localization of, FTS and both the E6 and E7 proteins. Silencing of FTS reduced the expression of the E6 and E7 proteins in cervical cancer cell lines and conversely increased the expression of the tumor suppressor proteins p53 and retinoblastoma protein. However, the primary transcripts of HPV16 E6 and E7 were unaffected by FTS silencing; furthermore, FTS transcription was unaffected by silencing of either E6 or E7, suggesting their interaction occurs post-translationally. Immunofluorescence and immunohistochemistry analysis demonstrated co-localization of FTS with the HPV16 E6 and E7 proteins, while immunoprecipitation results suggested that FTS interacts with both E6 and E7. Furthermore, in silico structural analysis identified putative residues involved in the binding of FTS with E6 and E7. Taken together, these results show that FTS affects both HPV16 E6 and E7 oncogenes in cervical cancer. We propose FTS as a target for the prevention of cervical cancer development and progression.	[Prabakaran, D. S.; Chaturvedi, Pankaj Kumar; Seo, Young-Seok; Park, Woo-Yoon] Chungbuk Natl Univ Hosp, Dept Radiat Oncol, Cheongju, South Korea; [Krishnamoorthy, Dineshkumar] Cent Univ Kerala, Sch Biol Sci, Dept Plant Sci, Periye, Kerala, India; [Thippana, Mallikarjuna] Univ Hyderabad, Sch Life Sci, Dept Biotechnol & Bioinformat, Hyderabad, India; [Park, Woo-Yoon] Chungbuk Natl Univ, Dept Radiat Oncol, Coll Med, Cheongju, South Korea	Chungbuk National University; Chungbuk National University Hospital; Central University of Kerala; University of Hyderabad; Chungbuk National University	Park, WY (corresponding author), Chungbuk Natl Univ Hosp, Dept Radiat Oncol, Cheongju, South Korea.; Park, WY (corresponding author), Chungbuk Natl Univ, Dept Radiat Oncol, Coll Med, Cheongju, South Korea.	wynpark@chungbuk.ac.kr	Prabakaran, D.S/GLN-3671-2022	Prabakaran, D.S/0000-0002-2486-5290; K, Dineshkumar/0000-0002-2675-1879; Chaturvedi, Pankaj Kumar/0000-0002-4389-1443	National Research Foundation of Korea (NRF) [2015R1D1A1A01060061]; Regional Innovation Strategy (RIS) through the NRF - Ministry of Education (MOE) [2021RIS0829]; Korea Medical Device Development Fund - Korea government [KMDFKMDF_PR_20200901_0042-2021-04]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Regional Innovation Strategy (RIS) through the NRF - Ministry of Education (MOE); Korea Medical Device Development Fund - Korea government	This study was supported by the National Research Foundation of Korea (NRF) [2015R1D1A1A01060061], Regional Innovation Strategy (RIS) through the NRF funded by the Ministry of Education (MOE) [2021RIS0829], and the Korea Medical Device Development Fund grant funded by the Korea government KMDFKMDF_PR_20200901_0042-2021-04] in the form of funds to W-YP. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajay AK, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-2; Anandharaj A, 2011, MOL BIOL REP, V38, P5361, DOI 10.1007/s11033-011-0688-3; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Boulenouar S, 2010, CARCINOGENESIS, V31, P473, DOI 10.1093/carcin/bgp281; Cattani P, 2009, J CLIN MICROBIOL, V47, P3895, DOI 10.1128/JCM.01275-09; Chang JTC, 2010, CANCER GENE THER, V17, P827, DOI 10.1038/cgt.2010.38; Chen JZ, 2014, CURR MED CHEM, V21, P3070, DOI 10.2174/0929867321666140414095605; Cinghu S, 2011, J CELL PHYSIOL, V226, P1564, DOI 10.1002/jcp.22486; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Ghittoni R, 2010, VIRUS GENES, V40, P1, DOI 10.1007/s11262-009-0412-8; Hampson L, 2001, FASEB J, V15, P1445, DOI 10.1096/fj.00-0728fje; Ho CM, 2010, INT J CANCER, V127, P622, DOI 10.1002/ijc.25078; Jung YS, 2013, BIOCHEM BIOPH RES CO, V435, P339, DOI 10.1016/j.bbrc.2013.04.060; Kim YW, 2015, ONCOL REP, V33, P1675, DOI 10.3892/or.2015.3760; Ko J, 2012, NUCLEIC ACIDS RES, V40, pW294, DOI 10.1093/nar/gks493; Kong LH, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-07483-z; Lau L, 2015, SCIENCE, V350, P568, DOI 10.1126/science.aab3291; Lesche R, 1997, MAMM GENOME, V8, P879, DOI 10.1007/s003359900604; Liao XH, 2014, FEBS J, V281, P927, DOI 10.1111/febs.12658; Martinez-Zapien D, 2016, NATURE, V529, P541, DOI 10.1038/nature16481; Muthusami S, 2014, CANCER LETT, V351, P252, DOI 10.1016/j.canlet.2014.06.007; Pal A, 2020, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.03116; Prabakaran DS, 2019, INT J BIOL MACROMOL, V126, P1318, DOI 10.1016/j.ijbiomac.2018.09.114; Rodon J, 2013, NAT REV CLIN ONCOL, V10, P143, DOI 10.1038/nrclinonc.2013.10; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Subramanian PD, 2016, CANCER CHEMOTH PHARM, V78, P753, DOI 10.1007/s00280-016-3110-y; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Yeo-Teh NSL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061706; Yeung CLA, 2017, ONCOTARGET, V8, P12158, DOI 10.18632/oncotarget.14555; Zhang JF, 2016, MOL CELL, V62, P929, DOI 10.1016/j.molcel.2016.04.023; Zhu DJ, 2015, INT J CLIN EXP PATHO, V8, P4981	36	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266532	10.1371/journal.pone.0266532	http://dx.doi.org/10.1371/journal.pone.0266532			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421154	gold, Green Published			2022-12-26	WOS:000795453600050
J	Saleh, EM; Hamdy, GM; Hassan, RE				Saleh, Eman M.; Hamdy, Germine M.; Hassan, Rasha E.			Neuroprotective effect of sodium alginate against chromium-induced brain damage in rats	PLOS ONE			English	Article							ACID PHENETHYL ESTER; HEXAVALENT CHROMIUM; IN-VITRO; OXIDATIVE STRESS; CELL-DEATH; TOXICITY; PROTECTS; CANCER; GENOTOXICITY; FUCOIDAN	Oral exposure to chromium hexavalent [Cr(VI)] has disastrous impacts and affects many people worldwide. Cr(VI) triggers neurotoxicity via its high oxidation potential by generating high amount of ROS. Meanwhile, alginates are known by their chelating activity and ability to bind heavy metals and toxins, in addition to their antioxidant, anti-inflammatory, and anti-apoptotic activities. So, this study aimed to explore the neuroprotective potential of sodium alginate (SA) against cellular injury, DNA damage, macromolecule alterations, and apoptosis induced by oral ingestion of Cr. Forty Wistar male rats were divided into 4 groups; group I: standard control ingested with the vehicle solution, group II: Cr-intoxicated group received 10 mg/kg b.w. of potassium dichromate orally by gavage and kept without treatment, group III: SA group in which rats were orally exposed to 200 mg/kg b.w. of SA only, and group IV: SA-treated group that received 200 mg/kg b.w. of SA along with Cr for 28 consecutive days. Neurotransmitters such as Acetyl choline esterase (AchE), Monoamine oxidase A (MAOA) concentrations, Dopamine (DA) and 5-Hydroxytryptamine (5-HT) levels were assessed in brain homogenate tissues. Neurobiochemical markers; NAD(+) and S100B protein were investigated in the brain tissues and serum, respectively. Levels of HSP70, caspase-3, protein profiling were evaluated. DNA damage was determined using the Comet assay. Results revealed a significant reduction in the AchE and MAOA concentrations, DA, 5-HT, and NAD(+) levels, with an increase in the S100B protein levels. Cr(VI) altered protein pattern and caused DNA damage. High levels of HSP70 and caspase-3 proteins were observed. Fortunately, oral administration of SA prevented the accumulation of Cr in brain homogenates and significantly improved all investigated parameters. SA attenuated the ROS production and relieved the oxidative stress by its active constituents. SA can protect against cellular and DNA damage and limit apoptosis. SA could be a promising neuroprotective agent against Cr(VI)-inducing toxicity.	[Saleh, Eman M.; Hamdy, Germine M.; Hassan, Rasha E.] Ain Shams Univ, Fac Sci, Dept Biochem, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Ain Shams University	Hamdy, GM (corresponding author), Ain Shams Univ, Fac Sci, Dept Biochem, Cairo, Egypt.	germinemohsen@sci.asu.edu.eg	Saleh, Eman M./AFH-0426-2022	Hamdy, Germine/0000-0002-4419-7875				Abd Eldaim MA, 2019, BIOMED PHARMACOTHER, V115, DOI 10.1016/j.biopha.2019.108908; Achmad R.T., 2017, ANN RES REV BIOL, P1; Aggarwal V, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9110735; Akhtar N, 2008, J ENVIRON SCI, V20, P231, DOI 10.1016/S1001-0742(08)60036-4; Akinyemi AJ, 2019, TOXICOL REP, V6, P833, DOI 10.1016/j.toxrep.2019.08.001; Alquezar C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-56930-w; Atashrazm F, 2015, MAR DRUGS, V13, P2327, DOI 10.3390/md13042327; Balali-Mood M, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.643972; Basha DC, 2014, NEUROSCI RES, V78, P81, DOI 10.1016/j.neures.2013.09.007; Briffa J, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04691; Bylund J, 2006, J BIOL CHEM, V281, P2526, DOI 10.1074/jbc.M510692200; Casalegno C., 2017, EFSA SUPPORT PUBL, V12, DOI [10.2903/sp.efsa.2015.en-478, DOI 10.2903/SP.EFSA.2015.EN-478]; Catelas I, 2003, BIOMATERIALS, V24, P383, DOI 10.1016/S0142-9612(02)00351-4; Cengiz M, 2016, INDIAN J PHARMACOL, V48, P407, DOI 10.4103/0253-7613.186213; Chen JY, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00623; Ciacci C, 2012, AQUAT TOXICOL, V120, P109, DOI 10.1016/j.aquatox.2012.04.015; Costa LG, 2006, CLIN CHIM ACTA, V366, P1, DOI 10.1016/j.cca.2005.10.008; Cuenoud B, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.609517; Dimitrova-Shumkovska J, 2020, MAR DRUGS, V18, DOI 10.3390/md18050242; Eftekharzadeh B, 2010, CARBOHYD POLYM, V79, P1063, DOI 10.1016/j.carbpol.2009.10.040; Ergen K, 2013, BALK MED J, V30, P105, DOI 10.5152/balkanmedj.2012.093; Ericsson C, 2011, METHODS MOL BIOL, V675, P307, DOI 10.1007/978-1-59745-423-0_17; Fang ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103194; Ferraz AC, 2008, NEUROCHEM RES, V33, P1238, DOI 10.1007/s11064-007-9575-7; Hao P, 2017, BIOL TRACE ELEM RES, V178, P127, DOI 10.1007/s12011-016-0915-9; Hentati F, 2020, MOLECULES, V25, DOI 10.3390/molecules25143152; HILL CH, 1970, FED PROC, V29, P1474; Husni A., 2016, Journal of Biological Sciences, V16, P58, DOI 10.3923/jbs.2016.58.64; Imbs TI, 2016, CARBOHYD POLYM, V135, P162, DOI 10.1016/j.carbpol.2015.08.062; Katsyuba E, 2020, NAT METAB, V2, P9, DOI 10.1038/s42255-019-0161-5; Kim JY, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9092020; Kim JH, 2016, ECOTOX ENVIRON SAFE, V125, P78, DOI 10.1016/j.ecoenv.2015.12.001; Kulathunga MRDL, 2019, ENVIRON GEOCHEM HLTH, V41, P2329, DOI 10.1007/s10653-019-00264-z; Kumar P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52479-w; Kumari K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/782493; Leite-Silva C, 2007, GENET MOL BIOL, V30, P105, DOI 10.1590/S1415-47572007000100019; Li YK, 2000, J NEUROCHEM, V74, P143; Loomis D, 2018, OCCUP ENVIRON MED, V75, P593, DOI 10.1136/oemed-2017-104944; Lou JL, 2021, ENVIRON INT, V153, DOI 10.1016/j.envint.2021.106525; Mahmoud AM, 2017, BIOMED PHARMACOTHER, V91, P303, DOI 10.1016/j.biopha.2017.04.073; Momo CMM, 2019, VET SCI, V6, DOI 10.3390/vetsci6010030; Moriya C, 2013, CLIN EXP HYPERTENS, V35, P607, DOI 10.3109/10641963.2013.776568; Moshtaghie A., 2004, IRAN J PHARM RES, V3, P149, DOI [10.22037/ijpr.2010.592, DOI 10.22037/IJPR.2010.592]; Nakamura S, 2006, J ORTHOP RES, V24, P733, DOI 10.1002/jor.20077; Naoi M, 2006, J NEURAL TRANSM-SUPP, P67; Nickens KP, 2010, CHEM-BIOL INTERACT, V188, P276, DOI 10.1016/j.cbi.2010.04.018; Niranjan R, 2014, MOL NEUROBIOL, V49, P28, DOI 10.1007/s12035-013-8483-x; Pan H, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/6623328; Patlolla AK, 2009, ENVIRON TOXICOL, V24, P66, DOI 10.1002/tox.20395; Piotrowska A, 2020, BIOL TRACE ELEM RES, V196, P359, DOI 10.1007/s12011-019-01924-y; Ponnan A, 2020, ENVIRON SCI POLLUT R, V27, P31760, DOI 10.1007/s11356-020-09472-y; Ravichandran V, 2018, INT J BIOL MACROMOL, V108, P1101, DOI 10.1016/j.ijbiomac.2017.11.030; Rizfa MS., 2020, J KELAUT TROP, V23, P284, DOI [10.14710/jkt.v23i3.8946, DOI 10.14710/JKT.V23I3.8946]; Sachan N. K., 2009, J PHARM RES, V2, P1191; Selcho M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005897; Shekhawat K., 2015, INT J ADV RES, V3, P167; Singh P, 2017, MOL NEUROBIOL, V54, P3368, DOI 10.1007/s12035-016-9909-z; Soudani N, 2012, J PHYSIOL BIOCHEM, V68, P397, DOI 10.1007/s13105-012-0152-4; Sun Hong, 2015, Curr Environ Health Rep, V2, P295, DOI 10.1007/s40572-015-0054-z; Sutirman ZA, 2021, INT J BIOL MACROMOL, V174, P216, DOI 10.1016/j.ijbiomac.2021.01.150; Szekalska M, 2016, INT J POLYM SCI, V2016, DOI 10.1155/2016/7697031; Szekalska M, 2016, INT J POLYM SCI, V2016, DOI 10.1155/2016/8635408; Tchounwou Paul B, 2012, Exp Suppl, V101, P133, DOI 10.1007/978-3-7643-8340-4_6; Thakur A.K., 2021, CASE STUD CHEM ENV E, V3, DOI DOI 10.1016/J.CSCEE.2021.100100; Thompson CM, 2013, CRIT REV TOXICOL, V43, P244, DOI 10.3109/10408444.2013.768596; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Tusi SK, 2011, BIOMATERIALS, V32, P5438, DOI 10.1016/j.biomaterials.2011.04.024; Urbano AM, 2012, CURR DRUG METAB, V13, P284; Vallejos-Vidal E, 2016, FISH SHELLFISH IMMUN, V56, P34, DOI 10.1016/j.fsi.2016.06.028; Nguyen VT, 2016, INT J BIOL MACROMOL, V93, P1620, DOI 10.1016/j.ijbiomac.2016.05.078; Vincent JB, 2019, CURR OPIN CLIN NUTR, V22, P483, DOI 10.1097/MCO.0000000000000604; Wan J, 2018, J ANIM SCI BIOTECHNO, V9, DOI 10.1186/s40104-018-0273-x; Wood Patrick B, 2008, Expert Rev Neurother, V8, P781, DOI 10.1586/14737175.8.5.781; Yaacob EN, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.03162; Zagrodzka J, 2000, ACTA NEUROBIOL EXP, V60, P333; Zhao JX, 2021, INT J BIOL MACROMOL, V167, P921, DOI 10.1016/j.ijbiomac.2020.11.048; Zhitkovich A, 2011, CHEM RES TOXICOL, V24, P1617, DOI 10.1021/tx200251t	77	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266898	10.1371/journal.pone.0266898	http://dx.doi.org/10.1371/journal.pone.0266898			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1F9AX	35421180	gold, Green Published			2022-12-26	WOS:000795453600078
J	Ha Nguyen, TV				Thi Vinh Ha Nguyen			Welfare impact of climate change on capture fisheries in Vietnam	PLOS ONE			English	Article							SMALL PELAGIC FISHES; ECONOMIC-IMPACT; MARINE; OCEAN; SEA; TEMPERATURE; ESTUARINE; SHELLFISH; TAIWAN	Fisheries are forecasted to shrink in the tropics due to climate change. In Vietnam, fisheries are a pro-poor economic sector and essential nutrition source; however, welfares of producers and consumers in the climate change context are not well understood. While most studies focus on the gains or losses of total products and revenues, this paper pays additional attention to the changes in surpluses of market players in the long run. A combination of the production function, demand and supply functions, and partial equilibrium analysis is employed to measure the production and welfare impacts based on time series data from 1976 to 2018 and a Vietnam household living standards survey in 2018. The results show that relative to the present, catch yield is likely to reduce 35%-45% by mid-century and 45%-80% by the end of the century. Consumers may lose their surplus of 7-9 billion USD (PPP, 2018) by 2035 and 10-18 billion USD by 2065 due to supply reduction, while producers may gain additional profit of 3.5-4.5 billion USD by 2035 and 5-9 billion USD by 2065 owing to a price increase. The research findings suggest that Vietnam could impose measures to limit capture effort, as set out in the Law of Fisheries 2017, without harming fisher welfare. The expansion of aquaculture could reduce the gap between supply and demand of wild fish to mitigate consumer welfare loss; however, this impact is still ambiguous.	[Thi Vinh Ha Nguyen] Vietnam Natl Univ, Univ Econ & Business, Hanoi, Vietnam	Vietnam National University Hanoi	Ha Nguyen, TV (corresponding author), Vietnam Natl Univ, Univ Econ & Business, Hanoi, Vietnam.	ntvha@vnu.edu.vn		Thi Vinh Ha, Nguyen/0000-0003-4612-5813				Ibarra AA, 2013, ECONOMICS-KIEL, V7, DOI 10.5018/economics-ejournal.ja.2013-36; Alessi C, 2019, SCI TOTAL ENVIRON, V693, DOI 10.1016/j.scitotenv.2019.07.282; Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; Allison EH, 2005, R4778J DFID; Allsopp M., 2008, CHALLENGING AQUACULT; Alnafissa M, 2021, J KING SAUD UNIV SCI, V33, DOI 10.1016/j.jksus.2021.101458; Altieri AH, 2021, TRENDS ECOL EVOL, V36, P227, DOI 10.1016/j.tree.2020.11.003; [Anonymous], 2021, DECISION 339 QD TTG; [Anonymous], 2012, VIN KINH T QUY HOCH; Barange Manuel, 2018, FAO Fisheries and Aquaculture Technical Paper, V627, P611; Barbier EB, 2000, ECOL ECON, V35, P47, DOI 10.1016/S0921-8009(00)00167-1; Bassett TJ, 2013, GEOFORUM, V48, P42, DOI 10.1016/j.geoforum.2013.04.010; Belkin I.M., 2016, IOC UNESCO UNEP 2016, P101; Brander K, 2010, J MARINE SYST, V79, P389, DOI 10.1016/j.jmarsys.2008.12.015; Caviedes C.N., 1992, P355, DOI 10.1017/CBO9780511565625.015; CHENG H, 1988, AM J AGR ECON, V70, P533, DOI 10.2307/1241491; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; CIA, 2022, WORLD FACTBOOK; Conrad J.M., 1999, RESOURCE EC; DARA, 2012, CLIMATE VULNERABILIT, V2nd; Davis TR, 2020, REG STUD MAR SCI, V36, DOI 10.1016/j.rsma.2020.101295; Dey MM, 2016, MAR POLICY, V67, P164, DOI 10.1016/j.marpol.2015.12.023; Garza-Gil MD, 2011, REG ENVIRON CHANGE, V11, P87, DOI 10.1007/s10113-010-0121-9; Drupp MA, 2018, AM ECON J-ECON POLIC, V10, P109, DOI 10.1257/pol.20160240; Eakin C., 2008, GLOBAL CLIMATE CHANG; Edenhofer O., 2015, CLIMATE CHANGE 2014; Elisio M, 2020, J MARINE SYST, V212, DOI 10.1016/j.jmarsys.2020.103445; FAO, 2020, FAO Yearbook of Fishery Statistics, DOI 10.4060/cb1213t; FAO, 2016, STATE WORLD FISHERIE; Foden WB, 2019, WIRES CLIM CHANGE, V10, DOI 10.1002/wcc.551; GSO, 2021, STAT YB VIET NAM 202; GSO, 2019, RES VIETN HOUS LIV S; Guerra TP, 2021, FISH RES, V234, DOI 10.1016/j.fishres.2020.105815; Ha NTV., 2017, INT C YOUNG RES EC B; Haarr A, 2021, SCI TOTAL ENVIRON, V774, DOI 10.1016/j.scitotenv.2021.145652; Hernroth BE, 2018, ENVIRON RES, V161, P425, DOI 10.1016/j.envres.2017.11.032; Heron S., 2008, STATUS CORAL REEFS W, P35; Hollowed AB, 2013, ICES J MAR SCI, V70, P1023, DOI 10.1093/icesjms/fst081; Huang MR, 2021, ECOL INDIC, V121, DOI 10.1016/j.ecolind.2020.106976; Hussain SV, 2021, REG STUD MAR SCI, V44, DOI 10.1016/j.rsma.2021.101773; Jardine SL, 2020, ECOL ECON, V176, DOI 10.1016/j.ecolecon.2020.106691; Kelleher K., SUNKEN BILLIONS EC J; Kibria G, 2021, MAR POLLUT BULL, V167, DOI 10.1016/j.marpolbul.2021.112364; Kishida T., 2003, RELATIONSHIP FISHING; Lam VWY, 2016, SCI REP-UK, V6, DOI 10.1038/srep32607; Lee H., 2020, THESIS SEOUL NATL U; Li JT, 2019, SOCIO-ECON PLAN SCI, V67, P69, DOI 10.1016/j.seps.2018.09.004; Liu XR, 2018, STUD AGRIC ECON, V120, P97, DOI 10.7896/j.1806; Lunduka RW, 2019, CLIM DEV, V11, P35, DOI 10.1080/17565529.2017.1372269; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; McPhaden MJ, 2020, NINO SO OSCILLATION; MENDELSOHN R, 1994, AM ECON REV, V84, P753; Meynecke JO, 2012, ESTUAR COAST SHELF S, V100, P93, DOI 10.1016/j.ecss.2012.01.001; MONRE, CLIM CHANG SEA LEV R; Monteclaro H, 2018, OCEAN COAST MANAGE, V158, P128, DOI 10.1016/j.ocecoaman.2018.03.032; Mora C, 2001, MAR BIOL, V139, P765; Narita D, 2012, CLIMATIC CHANGE, V113, P1049, DOI 10.1007/s10584-011-0383-3; Ngo AT., 2013, 50 YEARS FISHERIES V; Nguyen NT, 2015, IMPACTS CLIMATE CHAN; Nkoro E., 2016, J STAT ECONOMETRIC M, V5, P63; Nong D, 2019, ECON ANAL POLICY, V62, P213, DOI 10.1016/j.eap.2019.04.004; Nordhaus WD., 1999, M ABR CLIM CHANG ROL; OECD, 2010, EC ADAPTING FISHERIE; Oktavilia S., 2020, IOP C SERIES EARTH E, DOI [10.1088/1755-1315/474/7/072047, DOI 10.1088/1755-1315/474/7/072047]; Parry ML, 2007, CLIMATE CHANGE 2007; Plaganyi E, 2019, SCIENCE, V363, P930, DOI 10.1126/science.aaw5824; PROVIA, 2013, PROVIA GLOB PROGR RE; Punzon A, 2021, ECOL INDIC, V121, DOI 10.1016/j.ecolind.2020.107142; Roessig JM, 2004, REV FISH BIOL FISHER, V14, P251, DOI 10.1007/s11160-004-6749-0; Franco ACS, 2021, SCI TOTAL ENVIRON, V761, DOI 10.1016/j.scitotenv.2020.143296; Shrestha M.B., 2018, J FINANC DATA SCI, DOI [DOI 10.1016/J.JFDS.2017.11.001, 10.1016/j. jfds.2017.11.001]; Sumaila UR, 2011, NAT CLIM CHANGE, V1, P449, DOI 10.1038/NCLIMATE1301; Sumaila UR., 2010, WORLD BANK DISCUSSIO, V5; Sumaila UR., 2019, CLIMATE CHANGE IMPAC; Sumby J, 2021, MAR POLICY, V123, DOI 10.1016/j.marpol.2020.104284; Sun CH, 2006, ECOL ECON, V56, P268, DOI 10.1016/j.ecolecon.2005.02.001; Tol RSJ, 2009, J ECON PERSPECT, V23, P29, DOI 10.1257/jep.23.2.29; Tseng WC, 2008, ECOL ECON, V65, P282, DOI 10.1016/j.ecolecon.2007.06.015; Whiteley NM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34089-0; Williams J.E., 2015, REFERENCE MODULE EAR, V1, P10, DOI [10.1016/B978-0-12-409548-9.09505-1, DOI 10.1016/B978-0-12-409548-9.09505-1]; Williams L., 2010, FISHERIES THEMATIC P; Williamson P., 2021, IMPACTS CLIMATE CHAN, P115, DOI DOI 10.1016/B978-0-12-822373-4.00024-0; Yasumiishi EM, 2020, DEEP-SEA RES PT II, V181, DOI 10.1016/j.dsr2.2020.104907; Zhang QC, 2020, AGR WATER MANAGE, V228, DOI 10.1016/j.agwat.2019.105869; Zhu YG, 2020, SCI TOTAL ENVIRON, V737, DOI 10.1016/j.scitotenv.2020.140258	85	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0264997	10.1371/journal.pone.0264997	http://dx.doi.org/10.1371/journal.pone.0264997			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D9PO	35468138	gold, Green Published			2022-12-26	WOS:000794129600026
J	Wang, JH; Zhang, Q; Chen, EG; Zhao, PQ; Xu, Y				Wang, Jianhui; Zhang, Qi; Chen, Enguang; Zhao, Peiquan; Xu, Yu			Elabela promotes the retinal angiogenesis by inhibiting ferroptosis during the vaso-obliteration phase in mouse oxygen-induced retinopathy model	FASEB JOURNAL			English	Article						angiogenesis; Elabela; ferroptosis; OIR; ROP	PREECLAMPSIA; PREMATURITY; MANAGEMENT; DEATH	Retinopathy of prematurity (ROP) is a leading cause of childhood blindness associated with retinal vaso-obliteration in phase 1 and pathological neovascularization (NV) in phase 2; however, effective and safe treatments for ROP definitive treatment are yet to be determined. Anti-vascular endothelial growth factor (VEGF) therapy mainly focuses on reducing abnormal NV in phase 2 but with high risks of late recurrence and systemic side effects. Previous studies have established that the severity of vaso-obliteration in phase 1 largely influences subsequent stages, suggesting that prevention of vessels loss may be a potential therapeutic target for ROP. Herein, the therapeutic potential and safety of early Elabela intervention treatment in treating phase 1 ROP and the possible underlying mechanisms were investigated using an oxygen-induced retinopathy (OIR) mouse model. It was observed that intraperitoneal injection of Elabela remarkably reduced the avascular retinal area and increased the vascular density in phase 1 of OIR mice. Further investigation revealed that mitochondrion-dependent ferroptosis was involved in oxidative stress-mediated vascular protection loss in phase 1 OIR. Furthermore, we demonstrated that Elabela could rescue mitochondria-dependent ferroptosis via mediating the xCT/GPX4 axis. Collectively, our study revealed that ferroptosis may play a significant role in early ROP, while Elabela may be a safe and promising strategy for the early intervention of ROP.	[Wang, Jianhui; Chen, Enguang; Zhao, Peiquan; Xu, Yu] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Ophthalmol, Shanghai 200092, Peoples R China; [Zhang, Qi] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Inst Dev & Regenerat Cardiovasc Med, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhao, PQ; Xu, Y (corresponding author), Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Ophthalmol, Shanghai 200092, Peoples R China.	zhaopeiquan@126.com; xuyu01@xinhuamed.com.cn		Wang, Jianhui/0000-0002-4878-5850	Science and Technology Commission of Shanghai Municipality [20Z11900400]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	The study was supported by the Science and Technology Commission of Shanghai Municipality (20Z11900400).	Bai T, 2020, FREE RADICAL BIO MED, V160, P92, DOI 10.1016/j.freeradbiomed.2020.07.026; Chen H, 2017, J AM SOC NEPHROL, V28, P2695, DOI 10.1681/ASN.2016111210; Chng SC, 2013, DEV CELL, V27, P672, DOI 10.1016/j.devcel.2013.11.002; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Di Fiore JM, 2021, EXP NEUROL, V342, DOI 10.1016/j.expneurol.2021.113753; Dixon SJ, 2019, ANNU REV CANC BIOL, V3, P35, DOI 10.1146/annurev-cancerbio-030518-055844; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Feng H, 2020, CELL REP, V30, P3411, DOI 10.1016/j.celrep.2020.02.049; Fielder AR, 2019, OPHTHALMOLOGY, V126, P652, DOI 10.1016/j.ophtha.2018.12.034; Filippi L, 2020, EXPERT OPIN DRUG SAF, V19, P1409, DOI 10.1080/14740338.2020.1826927; Fu JY, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-02063-1; Hadian K, 2020, CELL, V181, P1188, DOI 10.1016/j.cell.2020.04.039; Hartnett ME, 2012, NEW ENGL J MED, V367, P2515, DOI 10.1056/NEJMra1208129; Hartnett ME, 2017, SURV OPHTHALMOL, V62, P257, DOI 10.1016/j.survophthal.2016.12.004; Ho LN, 2017, SCIENCE, V357, P707, DOI 10.1126/science.aam6607; Huang Z, 2019, J CELL PHYSIOL, V234, P61, DOI 10.1002/jcp.27047; Jiang XJ, 2021, NAT REV MOL CELL BIO, V22, P266, DOI 10.1038/s41580-020-00324-8; Kajarabille N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194968; Li L, 2021, CELL DEATH DISCOV, V7, DOI 10.1038/s41420-021-00610-0; Liet B, 2021, BBA-MOL CELL RES, V1868, DOI 10.1016/j.bbamcr.2021.119065; Liu W, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.02.07; Ma Z, 2021, HEART FAIL REV, V26, P1249, DOI 10.1007/s10741-020-09957-5; Palmer EA, 2020, OPHTHALMOLOGY, V127, pS84, DOI 10.1016/j.ophtha.2020.01.034; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Schmidt B, 2013, JAMA-J AM MED ASSOC, V309, P2111, DOI 10.1001/jama.2013.5555; Seibt TM, 2019, FREE RADICAL BIO MED, V133, P144, DOI 10.1016/j.freeradbiomed.2018.09.014; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Stone WL, 2016, FRONT BIOSCI-LANDMRK, V21, P165, DOI 10.2741/4382; Tadokoro T, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.132747; Wang XJ, 2020, CLIN EXP PHARMACOL P, V47, P1953, DOI 10.1111/1440-1681.13382; Xu CM, 2021, J HYPERTENS, V39, P12, DOI 10.1097/HJH.0000000000002591; Xu J, 2018, J CELL PHYSIOL, V233, P6472, DOI 10.1002/jcp.26492; Yang PR, 2017, CIRCULATION, V135, P1160, DOI 10.1161/CIRCULATIONAHA.116.023218; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Zhou YQ, 2021, FREE RADICAL BIO MED, V171, P55, DOI 10.1016/j.freeradbiomed.2021.05.009; Zielonka J, 2012, J BIOL CHEM, V287, P2984, DOI 10.1074/jbc.M111.309062	36	0	0	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22257	10.1096/fj.202101785RRR	http://dx.doi.org/10.1096/fj.202101785RRR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0U0DH	35471770				2022-12-26	WOS:000787329800001
J	Hudson, SM; Pears, B; Jacques, D; Fonville, T; Hughes, P; Alsos, I; Snape, L; Lang, A; Brown, A				Hudson, Samuel M.; Pears, Ben; Jacques, David; Fonville, Thierry; Hughes, Paul; Alsos, Inger; Snape, Lisa; Lang, Andreas; Brown, Antony			Life before Stonehenge: The hunter-gatherer occupation and environment of Blick Mead revealed by sedaDNA, pollen and spores	PLOS ONE			English	Article							ENGLISH CHALKLANDS; VEGETATION; DISTURBANCE; SEQUENCE; HISTORY; AGE; DNA	The Neolithic and Bronze Age construction and habitation of the Stonehenge Landscape has been extensively explored in previous research. However, little is known about the scale of pre-Neolithic activity and the extent to which the later monumental complex occupied an 'empty' landscape. There has been a long-running debate as to whether the monumental archaeology of Stonehenge was created in an uninhabited forested landscape or whether it was constructed in an already partly open area of pre-existing significance to late Mesolithic hunter-gatherers. This is of significance to a global discussion about the relationship between incoming farmers and indigenous hunter-gatherer societies that is highly relevant to both Old and New World archaeology. Here we present the results of plant sedaDNA, palynological and geoarchaeological analysis at the Late hunter-gatherer site complex of Blick Mead at the junction of the drylands of Salisbury Plain and the floodplain of the River Avon, on the edge of the Stonehenge World Heritage Site. The findings are placed within a chronological framework built on OSL, radiocarbon and relative archaeological dating. We show that Blick Mead existed in a clearing in deciduous woodland, exploited by aurochsen, deer and hunter-gatherers for approximately 4000 years. Given its rich archaeology and longevity this strongly supports the arguments of continuity between the Late Mesolithic hunter-gatherers activity and Neolithic monument builders, and more specifically that this was a partially open environment important to both groups. This study also demonstrates that sediments from low-energy floodplains can provide suitable samples for successful environmental assaying using sedaDNA, provided they are supported by secure dating and complementary environmental proxies.	[Hudson, Samuel M.; Pears, Ben; Fonville, Thierry; Hughes, Paul; Brown, Antony] Univ Southampton, Dept Geog & Environm Sci, Southampton, Hants, England; [Jacques, David] Univ Buckingham, Sch Humanities, Buckingham, England; [Alsos, Inger; Brown, Antony] Arctic Univ Tromso, Tromso Univ Museum, Dept Nat Sci, Tromso, Norway; [Snape, Lisa; Lang, Andreas] Univ Salzburg, Dept Geog & Geol, Salzburg, Austria	University of Southampton; University of Buckingham; UiT The Arctic University of Tromso; Salzburg University	Hudson, SM (corresponding author), Univ Southampton, Dept Geog & Environm Sci, Southampton, Hants, England.	S.M.Hudson@Soton.ac.uk		Lang, Andreas/0000-0002-1604-4898; Hughes, Paul/0000-0002-8447-382X; Hudson, Samuel/0000-0001-8914-0998	University of Southampton	University of Southampton	The author(s) received no specific funding for this work. However, the corresponding author did receive funding from the University of Southampton for general fieldwork costs.	Allen M., 2009, PLANTS NEOLITHIC BRI, P9; Allen M., 2009, PAPERS MEMORY JG EVA, P49; Allen MJ., 2017, MOLLUSCS ARCHAEOLOGY, P144; Allen MJ., 2002, LANDSCAPES, V3, P55; Alsos IG, 2020, QUATERNARY SCI REV, V239, DOI 10.1016/j.quascirev.2020.106364; Alsos IG, 2021, QUATERNARY SCI REV, V259, DOI 10.1016/j.quascirev.2021.106903; Alsos IG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195403; Baker AG, 2013, QUATERNARY SCI REV, V62, P21, DOI 10.1016/j.quascirev.2012.11.018; BALL DF, 1964, J SOIL SCI, V15, P84, DOI 10.1111/j.1365-2389.1964.tb00247.x; Barton R.N.E., 1995, P PREHIST SOC, V61, P81, DOI [10.1017/S0079497X00003042, DOI 10.1017/S0079497X00003042]; BENNETT KD, 1990, J ARCHAEOL SCI, V17, P635, DOI 10.1016/0305-4403(90)90045-7; Bowden M., 2015, HIST ENGLAND; Boyer F, 2016, MOL ECOL RESOUR, V16, P176, DOI 10.1111/1755-0998.12428; Brown T., 1997, OXFORD J ARCHAEOL, V16, P133, DOI DOI 10.1111/1468-0092.00030; Bullock P., 1985, HDB SOIL THIN SECTIO; BUSH MB, 1988, J ARCHAEOL SCI, V15, P453, DOI 10.1016/0305-4403(88)90042-8; Capo E, 2021, QUATERNARY, V4, DOI 10.3390/quat4010006; Cleal R.M.J., 1995, STONEHENGE ITS LANDS; Coissac E, 2016, MOL ECOL, V25, P1423, DOI 10.1111/mec.13549; Courty M.A., 1989, SOILS MICROMORPHOLOG; Croudace IW, 2006, GEOL SOC SPEC PUBL, V267, P51, DOI 10.1144/GSL.SP.2006.267.01.04; Davies P, 2005, ANTIQUITY, V79, P280, DOI 10.1017/S0003598X00114085; DAVISON W, 1993, EARTH-SCI REV, V34, P119, DOI 10.1016/0012-8252(93)90029-7; DIMBLEBY G. W., 1957, NEW PHYTOL, V56, P12, DOI 10.1111/j.1469-8137.1957.tb07446.x; DIMBLEBY GW, 1974, J ARCHAEOL SCI, V1, P117, DOI 10.1016/0305-4403(74)90038-7; Edmonds M, 1999, J QUATERNARY SCI, V14, P485, DOI 10.1002/(SICI)1099-1417(199910)14:6<485::AID-JQS483>3.0.CO;2-D; Edwards ME, 2018, HOLOCENE, V28, P2006, DOI 10.1177/0959683618798095; Ellis CJ., 2003, P PREHIST SOC, V69, P107; Enevold R, 2019, VEG HIST ARCHAEOBOT, V28, P105, DOI 10.1007/s00334-018-0687-6; Entwistle R., 1990, MOLLUSCAN STUDIES, V254; Etienne D, 2014, VEG HIST ARCHAEOBOT, V23, P743, DOI 10.1007/s00334-014-0439-1; Evans C, 1988, ARCHAEOLOGY CONTEXT, P85; Evans C., 1999, OXFORD J ARCHAEOL, V18, P241; Evans JG., 1993, CLIMATE CHANGE HUMAN, P147; Fitzpatrick EA., 1993, SOIL MICROSCOPY MICR; Fox C., 1932, PERSONALITY BRITAIN; French C, 2005, GEOARCHAEOLOGY, V20, P109, DOI 10.1002/gea.20039; French C., 2003, P PREHIST SOC, P201; French C, 2012, ANTIQ J, V92, P1, DOI 10.1017/S0003581512000704; Grime J. P., 1979, Plant strategies and vegetation processes.; Gron K., 2018, P PREHIST SOC, V84, P111; Innes J, 2010, VEG HIST ARCHAEOBOT, V19, P439, DOI 10.1007/s00334-010-0266-y; Innes JB, 2013, QUATERNARY SCI REV, V77, P80, DOI 10.1016/j.quascirev.2013.07.012; Jacques D., 2014, WILTSHIRE ARCHAEOLOG, V107, P7; Lewis J, 2019, ARCHAEOL J, V176, P1, DOI 10.1080/00665983.2019.1551507; Lewis JSC., 2011, MUSEUM LONDON ARCHAE; Long DJ, 1999, J ARCHAEOL SCI, V26, P45, DOI 10.1006/jasc.1998.0308; Lyons T., 2018, BLICK MEAD EXPLORING; MONTGOMERY W I, 1975, Mammal Review, V5, P23, DOI 10.1111/j.1365-2907.1975.tb00184.x; Overton NJ, 2018, J WORLD PREHIST, V31, P385, DOI 10.1007/s10963-018-9116-0; Pearson MP, 2007, ANTIQUITY, V81, P617, DOI 10.1017/S0003598X00095624; Preece RC, 1999, QUATERNARY SCI REV, V18, P1075, DOI 10.1016/S0277-3791(98)00066-3; Rowley-Conwy P., 2020, FARMERS FRONTIER PAN, P401, DOI DOI 10.2307/J.CTV13GVH1G.23; Serjeantson D, 2014, ENVIRON ARCHAEOL, V19, P256, DOI 10.1179/1749631414Y.0000000020; Shumilovskikh LS, 2022, VEG HIST ARCHAEOBOT, V31, P323, DOI 10.1007/s00334-021-00849-8; Sonstebo JH, 2010, MOL ECOL RESOUR, V10, P1009, DOI 10.1111/j.1755-0998.2010.02855.x; Stevens CJ, 2012, ANTIQUITY, V86, P707, DOI 10.1017/S0003598X00047864; Stoops G., 2003, Guidelines for analysis and description of soil and regolith thin sections; Tansley AG, 1939, BRIT ISLANDS THEIR V; Thomas J, 2009, ANTIQUITY, V83, P40, DOI 10.1017/S0003598X00098070; Tilley C.Y, 1994, PHENOMENOLOGY LANDSC; Tipping R, 2009, J ARCHAEOL SCI, V36, P140, DOI 10.1016/j.jas.2008.07.016; Treasure E.R., 2019, P PREHIST SOC, V85, P193, DOI [10.1017/ppr.2019.12, DOI 10.1017/PPR.2019.12]; van Vuure Cis (T.), 2002, Lutra, V45, P3; VANGEEL B, 1978, REV PALAEOBOT PALYNO, V25, P377, DOI 10.1016/0034-6667(78)90021-0; VANGEEL B, 1981, REV PALAEOBOT PALYNO, V31, P367; Vatcher F de M., 1973, WILTSHIRE ARCHAEOLOG, V68, P57; Vera F. W. M., 2000, Grazing ecology and forest history, DOI 10.1079/9780851994420.0000; Waller MP, 2000, J QUATERNARY SCI, V15, P253, DOI 10.1002/(SICI)1099-1417(200003)15:3<253::AID-JQS481>3.0.CO;2-8; Waton PV., 1986, INT FLINT S, V4, P169; Whitehouse Nicki J., 2004, Environmental Archaeology, V9, P199, DOI 10.1179/env.2004.9.2.199; Whitehouse NJ, 2010, QUATERNARY SCI REV, V29, P539, DOI 10.1016/j.quascirev.2009.10.010; Whittle A., 1993, Proceedings of the Prehistoric Society, V59, P197; WYMER J, 1962, P PREHIST SOC, V28, P329, DOI 10.1017/S0079497X00015759	74	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2022	17	4							e0266789	10.1371/journal.pone.0266789	http://dx.doi.org/10.1371/journal.pone.0266789			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3T2PZ	35476794	gold, Green Accepted, Green Published			2022-12-26	WOS:000840124300017
J	Kaushik, S; Selvanathan, P; Soni, GV				Kaushik, Saurabh; Selvanathan, Prabhakaran; Soni, Gautam Vivek			Customized low-cost high-throughput amplifier for electro-fluidic detection of cell volume changes in point-of-care applications	PLOS ONE			English	Article							FLOW-CYTOMETRY; HEALTH; PARTICLES; DIAGNOSIS; ALCOHOLS; SYSTEMS; DEATHS	Physical parameters of the pathogenic cells, like its volume, shape, and stiffness, are important biomarkers for diseases, chemical changes within the cell, and overall cell health. The response of pathogenic bacteria and viruses to different chemical disinfectants is studied widely. Some of the routinely employed techniques to measure these changes require elaborate and expensive equipment which limits any study to a non-mobile research lab facility. Recently, we showed a micropore-based electro-fluidic technique to have great promise in measuring subtle changes in cell volumes at high throughput and resolution. This method, however, requires commercial amplifiers, which makes this technique expensive and incompatible for in-field use. In this paper, we develop a home-built amplifier to make this technique in-field compatible and apply it to measure changes in bacterial volumes upon exposure to alcohol. First, we introduce our low-cost and portable transimpedance amplifier and characterize the maximum range, absolute error percentage, and RMS noise of the amplifier in the measured current signal, along with the amplifier's bandwidth, and compared these characteristics with the commercial amplifiers. Using our home-built amplifier, we demonstrate a high throughput detection of similar to 1300 cells/second and resolve cell diameter changes down to 1 mu m. Finally, we demonstrate measurement of cell volume changes in E. coli bacteria when exposed to ethanol (5% v/v), which is otherwise difficult to measure via imaging techniques. Our low-cost amplifier (similar to 100-fold lower than commercial alternatives) is battery-run, completely portable for point-of-care applications, and the electro-fluidic devices are currently being tested for in-field applications.	[Kaushik, Saurabh; Selvanathan, Prabhakaran; Soni, Gautam Vivek] Raman Res Inst, Bangalore, Karnataka, India	Department of Science & Technology (India); Raman Research Institute (RRI)	Soni, GV (corresponding author), Raman Res Inst, Bangalore, Karnataka, India.	gvsoni@rri.res.in		Kaushik, Saurabh/0000-0002-9728-9853; Soni, Gautam/0000-0002-0134-5583; Selvanathan, Prabhakaran/0000-0003-1971-8744	RRI; BDTD, DST [TDP/BDT/08/2019];  [GCElndia/R2/2017l003]	RRI; BDTD, DST; 	The project was funded by RRI's internal funding. Partial funding for the project came from BDTD (TDP/BDT/08/2019), DST and from GCElndia/R2/2017l003 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi U, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54006-3; Aria MM, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00395; Bafna JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157399; Bearden A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205132; Betters Dawn M, 2015, J Adv Pract Oncol, V6, P435; Boyce JM, 2018, INFECT CONT HOSP EP, V39, P323, DOI 10.1017/ice.2017.301; Brundage JF, 2008, EMERG INFECT DIS, V14, P1193, DOI 10.3201/eid1408.071313; Bruno Paul, 2011, J Can Chiropr Assoc, V55, P69; Chan CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072498; Chen H., 2013, AGENTS, V14, P13469, DOI [10.1039/c2cp41858d.Advances, DOI 10.1039/C2CP41858D.ADVANCES]; Ciotti C, 2021, INFECT DIS NOW, V51, P77, DOI 10.1016/j.medmal.2020.10.002; Cook TM, 2001, BRIT J ANAESTH, V87, P477, DOI 10.1093/bja/87.3.477; Croft P, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0265-4; Cyr ME, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4815-5; Daniel E Shumer NJNNPS, 2017, PHYSIOL BEHAV, V176, P139, DOI [10.1016/j.physbeh.2017.03.040, DOI 10.1016/J.PHYSBEH.2017.03.040]; DEBLOIS RW, 1970, REV SCI INSTRUM, V41, P909, DOI 10.1063/1.1684724; Fair RJ, 2014, PERSPECT MED CHEM, V6, P25, DOI 10.4137/PMC.S14459; Forchelet D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32314-4; Goel AK, 2015, WORLD J CLIN CASES, V3, P20, DOI 10.12998/wjcc.v3.i1.20; GROVER NB, 1972, BIOPHYS J, V12, P1099, DOI 10.1016/S0006-3495(72)86147-2; Gu Z, 2017, SCI BULL, V62, P1245, DOI 10.1016/j.scib.2017.09.005; Hisham R, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018933; Hu ZL, 2020, J CHEM EDUC, V97, P4345, DOI 10.1021/acs.jchemed.0c00389; Huffer S, 2011, APPL ENVIRON MICROB, V77, P6400, DOI 10.1128/AEM.00694-11; INGRAM LO, 1981, J BACTERIOL, V146, P331, DOI 10.1128/JB.146.1.331-336.1981; Kao LY, 2014, AM J ROENTGENOL, V202, P904, DOI 10.2214/AJR.13.10644; Kaushik S, 2020, ACS SENSORS, V5, P3892, DOI 10.1021/acssensors.0c01302; Koltai K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081803; Kowalczyk SW, 2010, NANO LETT, V10, P324, DOI 10.1021/nl903631m; Kruk ME, 2018, LANCET, V392, P2203, DOI [10.1016/S0140-6736(18)31668-4, 10.1016/s0140-6736(18)31668-4]; Kyu HH, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4111-4; Land KJ, 2019, NAT MICROBIOL, V4, P46, DOI 10.1038/s41564-018-0295-3; Maheshwaram SK, 2021, NANOSCALE, V13, P320, DOI 10.1039/d0nr06219g; Martin MJA., 2022, ADV LAB MED MED LAB, V2, P149, DOI [DOI 10.1515/ALMED-2021-0011, 10.1515/almed-2021-0011]; Murray JF, 2004, AM J RESP CRIT CARE, V169, P1181, DOI 10.1164/rccm.200402-140OE; Newman-Toker DE, 2021, DIAGNOSIS, V8, P67, DOI 10.1515/dx-2019-0104; Nwugo CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051936; Ochwoto M, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-017-0174-3; Paiva B, 2009, HAEMATOL-HEMATOL J, V94, P1599, DOI 10.3324/haematol.2009.009100; Perez P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27295-3; Phelps M, 2018, J INFECT DIS, V217, P641, DOI 10.1093/infdis/jix602; Pidot SJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar6115; Ribeiro MM, 2015, REV LAT-AM ENFERM, V23, P741, DOI 10.1590/0104-1169.0266.2611; Rod AMK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06006-4; Rouzrokh A, 2009, ADV PHYSIOL EDUC, V33, P121, DOI 10.1152/advan.90205.2008; Ruiz-Garcia R, 2014, J ALLERGY CLIN IMMUN, V134, P218, DOI 10.1016/j.jaci.2014.01.023; Smith-Bindman R, 2019, JAMA-J AM MED ASSOC, V322, P843, DOI 10.1001/jama.2019.11456; Soni GV, 2012, NANO LETT, V12, P3180, DOI 10.1021/nl301163m; Soni GV, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3277116; Soufi B, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00103; Steinbock LJ, 2010, NANO LETT, V10, P2493, DOI 10.1021/nl100997s; Stratmann J, 2019, CLIN APPL THROMB-HEM, V25, DOI 10.1177/1076029619885184; Takashima T, 2017, J CLIN IMMUNOL, V37, P486, DOI 10.1007/s10875-017-0405-7; Tekkesin N, 2012, J CLIN LAB ANAL, V26, P125, DOI 10.1002/jcla.21497; Thomson PS, 1935, ECTION TBE LBTITORP, P5; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; Turnbull PCB., 2002, KOEHLER TM ANTHRAX C, V271, P1, DOI [10.1007/978-3-662-05767-4_1, DOI 10.1007/978-3-662-05767-4_1]; Vlachos L., 1990, RESONANCE IMAGING DI, V106, P102; Watanabe M, 2008, J JAPANESE ASS CRYST, V34, P240, DOI [10.19009/jjacg.34.4_240, DOI 10.19009/JJACG.34.4_240]; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Wurcel V, 2019, PUBLIC HEALTH GENOM, V22, P8, DOI 10.1159/000501832; Yan BY, 2015, CHINESE J ANAL CHEM, V43, P971, DOI 10.1016/S1872-2040(15)60843-X; Yusko EC, 2011, NAT NANOTECHNOL, V6, P253, DOI 10.1038/nnano.2011.12	63	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0267207	10.1371/journal.pone.0267207	http://dx.doi.org/10.1371/journal.pone.0267207			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35442970	gold, Green Published			2022-12-26	WOS:000822608900045
J	Shetty, NH; Elliott, RM; Wang, M; Palmer, MI; Culligan, PJ				Shetty, Nandan H.; Elliott, Robert M.; Wang, Mark; Palmer, Matthew, I; Culligan, Patricia J.			Comparing the hydrological performance of an irrigated native vegetation green roof with a conventional Sedum spp. green roof in New York City	PLOS ONE			English	Article							LEAF-AREA INDEX; STORMWATER RETENTION; SUBSTRATE DEPTH; LONG-TERM; RUNOFF; EVAPOTRANSPIRATION; DIVERSITY; MEDIA; CONFIGURATION; MANAGEMENT	The objective of this study was to compare the hydrological performance of an irrigated, 127 mm deep green roof, planted with vegetation native to the New York City area, to a conventional, non-irrigated, 100 mm deep green roof, planted with drought-tolerant Sedum spp. Four years of climate and runoff data from both green roofs were analyzed to determine seasonal stormwater retention. Empirical relationships between rainfall and runoff were developed for both roofs, and applied to historical rainfall data in order to compare stormwater retention values for different rainfall depths. Crop coefficients for the vegetation on each green roof were estimated using the soil moisture extraction function. This function was also used to estimate monthly evapotranspiration. Despite being irrigated, the green roof with native vegetation retained more stormwater per annum (64%) than the non-irrigated green roof planted with Sedum spp. (54%). The green roof planted with native vegetation also had approximately twice the crop coefficient (1.13) than the green roof planted with Sedum spp. (0.57), indicating that the New York City native plants transpire more stormwater than the Sedum spp. plants given certain climate and substrate moisture conditions. Overall, the results of the study indicate that, for the New York City climate region, irrigated green roofs of native vegetation have the capacity to better manage stormwater than non-irrigated green roofs planted with drought-tolerant succulents.	[Shetty, Nandan H.] The Citadel, Dept Civil & Environm Engn, Charleston, SC 29409 USA; [Elliott, Robert M.; Wang, Mark] Columbia Univ, Dept Civil Engn & Engn Mech, New York, NY 10027 USA; [Palmer, Matthew, I] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA; [Culligan, Patricia J.] Univ Notre Dame, Dept Civil & Environm Engn & Earth Sci, Notre Dame, IN 46556 USA	Columbia University; Columbia University; University of Notre Dame	Shetty, NH (corresponding author), The Citadel, Dept Civil & Environm Engn, Charleston, SC 29409 USA.	nshetty@citadel.edu		Shetty, Nandan/0000-0002-1025-1992	National Science Foundation [CMMI-1325676]; Environmental Protection Agency [EP-15-C-000016]; South Carolina Sea Grant [2004324]; National Fish and Wildlife Foundation; New York State Office of the Attorney General	National Science Foundation(National Science Foundation (NSF)); Environmental Protection Agency(United States Environmental Protection Agency); South Carolina Sea Grant; National Fish and Wildlife Foundation; New York State Office of the Attorney General	This work was funded, in part, by the National Science Foundation grant CMMI-1325676 (PC) (https://www.nsf.gov/), Environmental Protection Agency contract EP-15-C-000016 (PC) (https://www.epa.gov/), and South Carolina Sea Grant 2004324 (NS) (https://www.scseagrant.org/).The authors wish to thank the New York City Department of Parks & Recreation for constructing and monitoring the Ranaqua green roof through a grant from the National Fish and Wildlife Foundation and the New York State Office of the Attorney General. Any opinions, findings, and conclusions expressed in this paper are those of the authors and not meant to represent the views of any supporting institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisio JM, 2016, ECOL ENG, V88, P20, DOI 10.1016/j.ecoleng.2015.12.022; Berndtsson JC, 2010, ECOL ENG, V36, P351, DOI 10.1016/j.ecoleng.2009.12.014; Berretta C, 2014, J HYDROL, V511, P374, DOI 10.1016/j.jhydrol.2014.01.036; Berthier E, 2011, 2 INT C URBAN DRAINA; Boyd NS, 2002, POTATO RES, V45, P117, DOI 10.1007/BF02736107; Butler C, 2012, URBAN FOR URBAN GREE, V11, P1, DOI 10.1016/j.ufug.2011.11.002; Carson TB, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024036; Carson TB., 2014, EVALUATING GREEN ROO; Cascone S, 2019, BUILD ENVIRON, V147, P337, DOI 10.1016/j.buildenv.2018.10.024; Currie Beth Anne, 2008, Urban Ecosystems, V11, P409, DOI 10.1007/s11252-008-0054-y; DiGiovanni K, 2013, J HYDROL ENG, V18, P99, DOI 10.1061/(ASCE)HE.1943-5584.0000572; Edinger G.J, 2014, ECOLOGICAL COMMUNITI; Elliott RM, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/7/074020; Fassman-Beck E, 2013, J HYDROL, V490, P11, DOI 10.1016/j.jhydrol.2013.03.004; George BA, 2000, AGR WATER MANAGE, V46, P121, DOI 10.1016/S0378-3774(00)00083-4; Gordon R, 1997, POTATO RES, V40, P251, DOI 10.1007/BF02358007; Graceson A, 2013, ECOL ENG, V61, P328, DOI 10.1016/j.ecoleng.2013.09.030; Guo DL, 2016, ENVIRON MODELL SOFTW, V78, P216, DOI 10.1016/j.envsoft.2015.12.019; Hakimdavar R, 2016, ECOL ENG, V93, P207, DOI 10.1016/j.ecoleng.2016.05.023; Hardin M., 2008, COMP ANAL GREENROOF; Hardin M, 2012, WATER-SUI, V4, P914, DOI 10.3390/w4040914; Hargreaves G. H., 1985, Applied Engineering in Agriculture, V1, P96; Harper GE, 2015, ECOL ENG, V78, P127, DOI 10.1016/j.ecoleng.2014.06.004; Heim A., 2017, CITIES ENV, V9; Hill J, 2017, J HYDROL ENG, V22, DOI 10.1061/(ASCE)HE.1943-5584.0001534; Hill J, 2016, ECOL ENG, V94, P418, DOI 10.1016/j.ecoleng.2016.05.045; Kiniry JR, 2013, BIOENERG RES, V6, P276, DOI 10.1007/s12155-012-9254-7; Li YL, 2014, WATER SCI TECHNOL, V69, P727, DOI 10.2166/wst.2013.770; Lundholm J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009677; MacIvor JS, 2013, J ENVIRON MANAGE, V130, P297, DOI 10.1016/j.jenvman.2013.09.014; Madakadze IC, 1998, BIOMASS BIOENERG, V15, P475, DOI 10.1016/S0961-9534(98)00060-9; Marasco DE, 2014, ENVIRON SCI TECHNOL, V48, P10273, DOI 10.1021/es501699h; Mentens J, 2006, LANDSCAPE URBAN PLAN, V77, P217, DOI 10.1016/j.landurbplan.2005.02.010; Mitchell RB, 1998, AGRON J, V90, P47, DOI 10.2134/agronj1998.00021962009000010009x; Mobilia Mirka, 2015, WSEAS Transactions on Environment and Development, V11, P264; Nagase A, 2012, LANDSCAPE URBAN PLAN, V104, P356, DOI 10.1016/j.landurbplan.2011.11.001; Palla A, 2009, J HYDROL, V379, P193, DOI 10.1016/j.jhydrol.2009.10.008; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Poe S, 2015, J HYDROL, V523, P356, DOI 10.1016/j.jhydrol.2015.02.002; Redfearn DD, 1997, AGRON J, V89, P262, DOI 10.2134/agronj1997.00021962008900020018x; Sandstrom UG, 2006, LANDSCAPE URBAN PLAN, V77, P39, DOI 10.1016/j.landurbplan.2005.01.004; Schneider D., 2011, WORLD ENV WATER RESO, P3629, DOI [10.1061/41173(414)380, DOI 10.1061/41173(414)380]; Schroll E, 2011, ECOL ENG, V37, P595, DOI 10.1016/j.ecoleng.2010.12.020; Schultz I, 2018, J HYDROL-REG STUD, V18, P110, DOI 10.1016/j.ejrh.2018.06.008; Shafique M, 2018, RENEW SUST ENERG REV, V90, P757, DOI 10.1016/j.rser.2018.04.006; Shetty NH, 2018, THESIS COLUMBIA U NE; Soulis KX, 2017, ECOL ENG, V102, P80, DOI 10.1016/j.ecoleng.2017.01.031; Starry O, 2013, THESIS U MARYLAND; Stovin V, 2015, ECOL ENG, V85, P159, DOI 10.1016/j.ecoleng.2015.09.076; Stovin V, 2013, J ENVIRON MANAGE, V131, P206, DOI 10.1016/j.jenvman.2013.09.026; Tabares-Velasco PC, 2011, INT J HEAT MASS TRAN, V54, P5149, DOI 10.1016/j.ijheatmasstransfer.2011.08.034; Talebi A, 2019, ECOL ENG, V126, P1, DOI 10.1016/j.ecoleng.2018.10.006; Theodosiou TG, 2003, ENERG BUILDINGS, V35, P909, DOI 10.1016/S0378-7788(03)00023-9; Van Mechelen C, 2015, SUSTAIN CITIES SOC, V19, P74, DOI 10.1016/j.scs.2015.07.007; Vanuytrecht E, 2014, LANDSCAPE URBAN PLAN, V122, P68, DOI 10.1016/j.landurbplan.2013.11.001; VanWoert ND, 2005, J ENVIRON QUAL, V34, P1036, DOI 10.2134/jeq2004.0364; Volder A, 2014, SUSTAIN CITIES SOC, V10, P59, DOI 10.1016/j.scs.2013.05.005; Voyde E., 2011, THESIS, V1994, P224; Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI 10.1899/04-020.1; Whittinghill LJ, 2015, URBAN ECOSYST, V18, P13, DOI 10.1007/s11252-014-0386-8; Zeri M, 2011, AGR ECOSYST ENVIRON, V144, P319, DOI 10.1016/j.agee.2011.09.006; Zhao LL, 2013, J GEOGR SCI, V23, P359, DOI 10.1007/s11442-013-1015-9	62	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2022	17	4							e0266593	10.1371/journal.pone.0266593	http://dx.doi.org/10.1371/journal.pone.0266593			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	2T6VD	35443016	gold, Green Published			2022-12-26	WOS:000822608900026
J	Elhadi, M; Msherghi, A; Khaled, A; Alsoufi, A; Alhadi, A; Kareem, A; Ashini, A; Alsharif, T; Alhodiri, A; Altaeb, E; Hamed, M; Itrunbah, A; Mohmmed, S; Alameen, H; Idheiraj, H; Shuwayyah, A; Alhudhairy, S; Alansari, A; Abraheem, W; Akl, H; Nagib, T; Almugaddami, A; Aljameel, B; Muamr, S; Alsuwiyah, S; Alsghair, A; Soula, E; Buzreg, A; Alagelli, F; Aldireewi, A; Bareem, A; Alshareea, E; Gemberlo, A; Zaid, A				Elhadi, Muhammed; Msherghi, Ahmed; Khaled, Ahmed; Alsoufi, Ahmed; Alhadi, Abdulmueti; Kareem, Asraa; Ashini, Aimen; Alsharif, Tahani; Alhodiri, Alarabi; Altaeb, Emtenan; Hamed, Mona; Itrunbah, Ahmed; Mohmmed, Soha; Alameen, Hind; Idheiraj, Hanadi; Shuwayyah, Anshirah; Alhudhairy, Sara; Alansari, Arowa; Abraheem, Wisam; Akl, Hend; Nagib, Taha; Almugaddami, Ayman; Aljameel, Basheer; Muamr, Siba; Alsuwiyah, Suhir; Alsghair, Ateka; Soula, Enas; Buzreg, Anis; Alagelli, Fatma; Aldireewi, Abdulfatah; Bareem, Ahmed; Alshareea, Entisar; Gemberlo, Asmhan; Zaid, Ahmed			Impact of lockdown due to the COVID-19 pandemic on mental health among the Libyan population	PLOS ONE			English	Article							SERVICES	BackgroundThe coronavirus disease 2019 (COVID-19) pandemic may have a potentially serious effect on mental health and increase the risk of anxiety, depression, and post-traumatic stress disorders in people. In this study, we aimed to determine the prevalence of psychological illness and the impact of the COVID-19 pandemic on the Libyan population's mental health. MethodA cross-sectional survey, conducted in both online and paper modes and consisting of five sections, was completed in more than 30 cities and towns across Libya. The first section consisted of questions on basic demographic characteristics. The second section contained a survey related to the lockdown status, activities, related stress levels, and quarantine. The third section comprised the self-administered 9-item Patient Health Questionnaire (PHQ-9). The fourth section contained the 7-item Generalized Anxiety Disorder Scale (GAD-7), and the fifth section contained the Impact of Event Scale-Revised (IES-R). ResultOf the 31,557 respondents, 4,280 (13.6%) reported severe depressive symptoms, with a mean [standard deviation (SD)] PHQ-9 score of 8.32 (5.44); 1,767 (5.6%) reported severe anxiety symptoms, with a mean (SD) GAD-7 score of 6 (4.6); and 6,245 (19.8%) of the respondents reported post-traumatic stress disorder (PTSD), with a mean (SD) score of 15.3 (18.85). In multivariate analysis, young age, being female, unmarried, educated, or victims of domestic violence or abuse, work suspension during the pandemic, and having increased workload, financial issues, suicidal thoughts, or a family member with or hospitalized due to COVID-19 were significantly associated with a high likelihood of depressive and anxiety symptoms, as well as PTSD. Internal displacement due to civil war was also associated with PTSD. ConclusionTo our knowledge, this is the first study to analyze the psychological impacts of the COVID-19 pandemic and civil war in Libya. Further study on the development of strategies and interventions aimed at reducing the mental disease burden on the Libyan population is warranted.	[Elhadi, Muhammed; Msherghi, Ahmed; Khaled, Ahmed; Alsoufi, Ahmed; Kareem, Asraa; Ashini, Aimen; Alsharif, Tahani; Altaeb, Emtenan; Alameen, Hind; Shuwayyah, Anshirah; Nagib, Taha; Almugaddami, Ayman; Muamr, Siba; Alsuwiyah, Suhir; Alsghair, Ateka; Soula, Enas; Buzreg, Anis; Alagelli, Fatma; Aldireewi, Abdulfatah; Bareem, Ahmed; Alshareea, Entisar; Gemberlo, Asmhan; Zaid, Ahmed] Univ Tripoli, Fac Med, Tripoli, Libya; [Alhadi, Abdulmueti; Itrunbah, Ahmed] Univ Zawia, Fac Med, Az Zawiyah, Libya; [Alhodiri, Alarabi; Hamed, Mona; Alansari, Arowa] Univ Gharyan, Fac Med, Gharyan, Libya; [Mohmmed, Soha; Akl, Hend] Al Arab Med Univ, Fac Med, Benghazi, Libya; [Idheiraj, Hanadi; Alhudhairy, Sara] Univ Sebha, Fac Med, Sebha, Libya; [Abraheem, Wisam] Omar Al Mukhtar Univ, Fac Med, Albayda, Libya; [Aljameel, Basheer] Univ Al Mergib, Fac Med, Al Khums, Libya	Sebha University; Omar Al Mukhtar University	Elhadi, M (corresponding author), Univ Tripoli, Fac Med, Tripoli, Libya.	Muhammed.elhadi.uot@gmail.com	Alagelli, Fatma/ABQ-0517-2022; Alhadi, Abdulmueti/ABG-3342-2020; Elhadi, Muhammed/AAU-5641-2020	Alagelli, Fatma/0000-0002-5277-8733; Elhadi, Muhammed/0000-0001-6406-4212; Ebrahim, Wesam/0000-0003-0116-9628; hamed, mona/0000-0002-4560-7653; Younis, Soha/0000-0001-8480-3529; Zaid, Ahmed/0000-0002-1063-2883				Abuazza Adel, 2013, Int Psychiatry, V10, P56; Beck JG, 2008, J ANXIETY DISORD, V22, P187, DOI 10.1016/j.janxdis.2007.02.007; Charlson FJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040593; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Gonzalez-Sanguino C., 2020, BRAIN BEHAV IMMUN, V87, P172, DOI [DOI 10.1016/J.BBI.2020.05.040, 10.1016/j.bbi.2020.05.040]; Hammarstrom A, 2019, J PUBLIC HEALTH RES, V8, P56, DOI 10.4081/jphr.2019.1504; Haro JM, 2006, MED CLIN-BARCELONA, V126, P445, DOI 10.1157/13086324; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Levis B., 2019, ACCURACY PATIENT HLT, V365, pl1476, DOI [10.1136/bmj.l1476%JBMJ, DOI 10.1136/BMJ.L1476%JBMJ]; Li W, 2020, INT J BIOL SCI, V16, P1732, DOI 10.7150/ijbs.45120; Morina N, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00433; Musisi S, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00020; Okasha A., 2003, WORLD PSYCHIATRY, V25, P39, DOI [10.1016/j.wpsyc.2012.01.008, DOI 10.1016/J.WPSYC.2012.01.008]; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; Rajkumar RP, 2020, ASIAN J PSYCHIATR, V52, DOI 10.1016/j.ajp.2020.102066; Rauch SAM, 2020, DEPRESS ANXIETY, V37, P505, DOI 10.1002/da.23058; Rhouma Abdul Hakim, 2016, BJPsych Int, V13, P70; Rossi R, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00790; Siriwardhana C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064742; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Tian FY, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112992; WANG CY, 2020, INT J ENV RES PUB HE, V17, DOI [10.3390/ijerph17051729, DOI 10.3390/IJERPH17051729]	23	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267426	10.1371/journal.pone.0267426	http://dx.doi.org/10.1371/journal.pone.0267426			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	1D8GY	35482687	Green Published, gold			2022-12-26	WOS:000794035700088
J	Nageeb, WM; Hetta, HF				Nageeb, Wedad M.; Hetta, Helal F.			The predictive potential of different molecular markers linked to amikacin susceptibility phenotypes in Pseudomonas aeruginosa	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; GENTAMICIN; TESTS; DIAGNOSTICS; DATABASE; DOCKING; GUIDE; GENE	Informed antibiotic prescription offers a practical solution to antibiotic resistance problem. With the increasing affordability of different sequencing technologies, molecular-based resistance prediction would direct proper antibiotic selection and preserve available agents. Amikacin is a broad-spectrum aminoglycoside exhibiting higher clinical efficacy and less resistance rates in Ps. aeruginosa due to its structural nature and its ability to achieve higher serum concentrations at lower therapeutic doses. This study examines the predictive potential of molecular markers underlying amikacin susceptibility phenotypes in order to provide improved diagnostic panels. Using a predictive model, genes and variants underlying amikacin resistance have been statistically and functionally explored in a large comprehensive and diverse set of Ps. aeruginosa completely sequenced genomes. Different genes and variants have been examined for their predictive potential and functional correlation to amikacin susceptibility phenotypes. Three predictive sets of molecular markers have been identified and can be used in a complementary manner, offering promising molecular diagnostics. armR, nalC, nalD, mexR, mexZ, ampR, rmtD, nalDSer32Asn, fusA1Y552C, fusA1D588G, arnAA170T, and arnDG206C have been identified as the best amikacin resistance predictors in Ps. aeruginosa while faoAT385A, nuoGA890T, nuoGA574T, lptAT55A, lptAR62S, pstBR87C, gidBE126G, gidBQ28K, amgSE108Q, and rplYQ41L have been identified as the best amikacin susceptibility predictors. Combining different measures of predictive performance together with further functional analysis can help design new and more informative molecular diagnostic panels. This would greatly inform and direct point of care diagnosis and prescription, which would consequently preserve amikacin functionality and usefulness.	[Nageeb, Wedad M.] Suez Canal Univ, Fac Med, Med Microbiol & Immunol Dept, Ismailia, Egypt; [Hetta, Helal F.] Assiut Univ, Fac Med, Med Microbiol & Immunol Dept, Assiut, Egypt	Egyptian Knowledge Bank (EKB); Suez Canal University; Egyptian Knowledge Bank (EKB); Assiut University	Nageeb, WM (corresponding author), Suez Canal Univ, Fac Med, Med Microbiol & Immunol Dept, Ismailia, Egypt.	wedad_saleh@med.suez.edu.eg						Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; [Anonymous], 2022, EUR COMM ANT SUSC TE, P116; Bains M, 2012, APPL ENVIRON MICROB, V78, P6762, DOI 10.1128/AEM.01015-12; Barbosa C, 2017, MOL BIOL EVOL, V34, P2229, DOI 10.1093/molbev/msx158; Bauer KA, 2014, CLIN INFECT DIS, V59, pS134, DOI 10.1093/cid/ciu547; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bolard A, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01835-17; Burnham CAD, 2017, NAT REV MICROBIOL, V15, P697, DOI 10.1038/nrmicro.2017.103; Caliendo AM, 2013, CLIN INFECT DIS, V57, pS139, DOI 10.1093/cid/cit578; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; CDC Antibiotic Resistance, 2019, ANTIBIOTIC RESISTANC; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Cock PJA, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0080-7; Committee JF, 2020, BRIT NATL FORMULARY; Dallakyan S, 2015, METHODS MOL BIOL, V1263, P243, DOI 10.1007/978-1-4939-2269-7_19; Doi Y, 2007, ANTIMICROB AGENTS CH, V51, P852, DOI 10.1128/AAC.01345-06; Dubois W, 2002, ANTIMICROB AGENTS CH, V46, P638, DOI 10.1128/AAC.46.3.638-645.2002; Earle SG, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.41, 10.1038/nmicrobiol.2016.41]; Ehsan Z, 2015, FUTURE MICROBIOL, V10, P1901, DOI 10.2217/fmb.15.117; El'Garch F, 2007, ANTIMICROB AGENTS CH, V51, P1016, DOI 10.1128/AAC.00704-06; Feng YF, 2016, ANTIMICROB AGENTS CH, V60, P4229, DOI 10.1128/AAC.00434-16; Fischer JE, 2003, INTENS CARE MED, V29, P1043, DOI 10.1007/s00134-003-1761-8; Garcia Coralith, 2011, BMC Clin Pharmacol, V11, P18, DOI 10.1186/1472-6904-11-18; GILBERT DN, 1977, AM J MED, V62, P924, DOI 10.1016/0002-9343(77)90662-3; Gonzalez MD, 2018, INFECT DIS CLIN N AM, V32, P19, DOI 10.1016/j.idc.2017.11.006; Hanson KE, 2016, CLIN INFECT DIS, V63, P1361, DOI 10.1093/cid/ciw494; IBM Corp, IBM SPSS STAT W VERS; Kim JS, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/1081536; Kim YA, 2018, ANN LAB MED, V38, P176, DOI 10.3343/alm.2018.38.2.176; KLUGE RM, 1974, ANTIMICROB AGENTS CH, V6, P442, DOI 10.1128/AAC.6.4.442; Kordes A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11414-3; Kosack CS, 2017, B WORLD HEALTH ORGAN, V95, P639, DOI 10.2471/BLT.16.187468; Krahn T, 2012, ANTIMICROB AGENTS CH, V56, P5591, DOI 10.1128/AAC.01446-12; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LAU WK, 1977, PEDIATRICS, V60, P372; Liu CX, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0592-5; Lopez-Causape C, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.02583-17; Miao RX, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000018714; Mikheil DM, 2012, J ANTIBIOT, V65, P185, DOI 10.1038/ja.2012.5; Mustafa RA, 2017, J CLIN EPIDEMIOL, V92, P18, DOI 10.1016/j.jclinepi.2017.09.003; Nageeb W, 2021, ANTIBIOTICS-BASEL, V10, DOI 10.3390/antibiotics10010035; Nyfeler B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042657; Ozongwu C, 2017, Biomol Detect Quantif, V13, P1, DOI 10.1016/j.bdq.2017.06.001; Poole K, 2005, ANTIMICROB AGENTS CH, V49, P479, DOI 10.1128/AAC.49.2.479-487.2005; Poritz MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026047; Rybenkov VV, 2014, FEMS MICROBIOL LETT, V356, P154, DOI 10.1111/1574-6968.12478; Sanz-Garcia F, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00451; Schmitz JE, 2018, FUTURE MICROBIOL, V13, P1697, DOI 10.2217/fmb-2018-0258; Schniederjans M, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.01178-17, 10.1128/AAC.01178-17]; Semper C, 2020, PROTEIN SCI, V29, P758, DOI 10.1002/pro.3815; Sutherland CA, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0155-z; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; van Belkum A, 2013, J CLIN MICROBIOL, V51, P2018, DOI 10.1128/JCM.00313-13; Wardell SJT, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01619-19; Wattam AR, 2017, NUCLEIC ACIDS RES, V45, pD535, DOI 10.1093/nar/gkw1017; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861; Yokoyama K, 2003, LANCET, V362, P1888, DOI 10.1016/S0140-6736(03)14959-8; Zhang R., 2004, RCSB PDB 1XDZ CRYSTA	59	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0267396	10.1371/journal.pone.0267396	http://dx.doi.org/10.1371/journal.pone.0267396			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D9PO	35468158	gold, Green Published			2022-12-26	WOS:000794129600008
J	Sun, Y; Umer, M; Wu, P; Guo, Y; Ren, WD; Han, X; Li, Q; Wu, BL; Shen, KP; Xia, TT; Zang, LP; Wang, SX; He, YJ				Sun, Yan; Umer, Muhammud; Wu, Pan; Guo, Yun; Ren, Wenda; Han, Xu; Li, Qing; Wu, Bangli; Shen, Kaiping; Xia, Tingting; Zang, Lipeng; Wang, Shixiong; He, Yuejun			Indigenous microorganisms offset the benefits of growth and nutrition regulated by inoculated arbuscular mycorrhizal fungi for four pioneer herbs in karst soil	PLOS ONE			English	Article							HELPER BACTERIA; NUTRIENT ACQUISITION; CONTEXT-DEPENDENCY; PLANT COMMUNITY; WATER; RHIZOSPHERE; VEGETATION; PHOSPHORUS; RESPONSES; ECOSYSTEM	Arbuscular mycorrhizal (AM) fungi, as beneficial soil microorganisms, inevitably interact with indigenous microorganisms, regulating plant growth and nutrient utilization in natural habitats. However, how indigenous microorganisms affect the benefits of growth and nutrition regulated by inoculated AM fungi for plants in karst ecosystem habitats remains unclear today. In this experiment, the Gramineae species Setaria viridis vs. Arthraxon hispidus and the Compositae species Bidens pilosa vs. Bidens tripartita exist in the initial succession stage of the karst ecosystem. These plant species were planted into different soil microbial conditions, including AM fungi soil (AMF), AM fungi interacting with indigenous microorganisms soil (AMI), and a control soil without AM fungi and indigenous microorganisms (CK). The plant biomass, nitrogen (N), and phosphorus (P) were measured; the effect size of different treatments on these variables of plant biomass and N and P were simultaneously calculated to assess plant responses. The results showed that AMF treatment differently enhanced plant biomass accumulation, N, and P absorption in all species but reduced the N/P ratio. The AMI treatment also significantly increased plant biomass, N and P, except for the S. viridis seedlings. However, regarding the effect size, the AM fungi effect on plant growth and nutrition was greater than the interactive effect of AM fungi with indigenous microorganisms. It indicates that the indigenous microorganisms offset the AM benefits for the host plant. In conclusion, we suggest that the indigenous microorganisms offset the benefits of inoculated AM fungi in biomass and nutrient accumulation for pioneer plants in the karst habitat.	[Sun, Yan; Guo, Yun; Ren, Wenda; Han, Xu; Li, Qing; Wu, Bangli; Shen, Kaiping; Xia, Tingting; Zang, Lipeng; Wang, Shixiong; He, Yuejun] Guizhou Univ, Forestry Coll, Res Ctr Forest Ecol, Guiyang, Peoples R China; [Umer, Muhammud; He, Yuejun] Guizhou Univ, Inst Forest Resources & Environm Guizhou, Guiyang, Peoples R China; [Wu, Pan] Guizhou Univ, Key Lab Karst Georesources & Environm, Minist Educ, Guiyang, Peoples R China	Guizhou University; Guizhou University; Guizhou University	He, YJ (corresponding author), Guizhou Univ, Forestry Coll, Res Ctr Forest Ecol, Guiyang, Peoples R China.; He, YJ (corresponding author), Guizhou Univ, Inst Forest Resources & Environm Guizhou, Guiyang, Peoples R China.	hyj1358@163.com		He, Yuejun/0000-0002-7653-0265; Umer, Muhammad/0000-0002-3957-0196	National Natural Science Foundation of China [NSFC: 31660156, 31360106]; Science and Technology Project of Guizhou Province [[2021] General-455, [2016] Supporting-2805]; Guizhou Hundred-level Innovative Talents Project (Qian-ke-he platform talents) [[2020] 6004]; First-class Disciplines Program on Ecology of Guizhou Province [GNYL[2017]007]; Talentplatform Program of Guizhou Province [[2017] 5788, [2018]5781]; Basic Research Program in Guizhou Province [[2019]1060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Guizhou Province; Guizhou Hundred-level Innovative Talents Project (Qian-ke-he platform talents); First-class Disciplines Program on Ecology of Guizhou Province; Talentplatform Program of Guizhou Province; Basic Research Program in Guizhou Province	This research was funded by the National Natural Science Foundation of China (NSFC: 31660156; 31360106), the Science and Technology Project of Guizhou Province ([2021] General-455; [2016] Supporting-2805), the Guizhou Hundred-level Innovative Talents Project (Qian-ke-he platform talents [2020] 6004), the First-class Disciplines Program on Ecology of Guizhou Province (GNYL[2017]007), the Talentplatform Program of Guizhou Province ([2017] 5788; [2018]5781), The Basic Research Program in Guizhou Province ([2019]1060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MF, 2011, J ARID LAND, V3, P155, DOI 10.3724/SP.J.1227.2011.00155; Anding L, 2017, APPL ECOL ENV RES, V15, P1167, DOI 10.15666/aeer/1504_11671183; Artursson V, 2006, ENVIRON MICROBIOL, V8, P1, DOI 10.1111/j.1462-2920.2005.00942.x; Auge RM, 2015, MYCORRHIZA, V25, P13, DOI 10.1007/s00572-014-0585-4; AzconAguilar C, 1996, MYCORRHIZA, V6, P457, DOI 10.1007/s005720050147; Bao S.D, 2000, SOIL AGRO CHEM ANAL, P49; Battini F, 2016, MICROBIOL RES, V183, P68, DOI 10.1016/j.micres.2015.11.012; Bender SF, 2019, AGR ECOSYST ENVIRON, V273, P13, DOI 10.1016/j.agee.2018.12.003; Bever JD, 2003, NEW PHYTOL, V157, P465, DOI 10.1046/j.1469-8137.2003.00714.x; Biro B, 2000, APPL SOIL ECOL, V15, P159, DOI 10.1016/S0929-1393(00)00092-5; Bona E, 2017, MYCORRHIZA, V27, P1, DOI [10.1007/s00572-016-0727-y, 10.1]; Cao JianHua, 2015, Journal of Resources and Ecology, V6, P247, DOI 10.5814/j.issn.1674-764x.2015.04.008; Cappellazzo G, 2008, PLANT PHYSIOL, V147, P429, DOI 10.1104/pp.108.117820; Chen XB, 2012, WORLD J MICROB BIOT, V28, P205, DOI 10.1007/s11274-011-0809-0; Dabrowska G, 2014, J PLANT NUTR SOIL SC, V177, P459, DOI 10.1002/jpln.201300115; de Boer W, 2003, APPL ENVIRON MICROB, V69, P835, DOI 10.1128/AEM.69.2.835-844.2003; Diagne N, 2018, ARID LAND RES MANAG, V32, P212, DOI 10.1080/15324982.2017.1406413; Doumbou CL, 2001, PHYTOPROTECTION, V82, P85, DOI 10.7202/706219ar; Elbon A, 2015, BIOL AGRIC HORTIC, V31, P73, DOI 10.1080/01448765.2014.966147; Ferrol N, 2019, PLANT SCI, V280, P441, DOI 10.1016/j.plantsci.2018.11.011; Fester T, 1999, MYCORRHIZA, V8, P241, DOI 10.1007/s005720050240; Frey-Klett P, 2007, NEW PHYTOL, V176, P22, DOI 10.1111/j.1469-8137.2007.02191.x; Frey-Klett P, 2005, NEW PHYTOL, V168, P4, DOI 10.1111/j.1469-8137.2005.01553.x; Gahan J, 2015, APPL SOIL ECOL, V89, P113, DOI 10.1016/j.apsoil.2014.12.008; GARBAYE J, 1994, NEW PHYTOL, V128, P197, DOI 10.1111/j.1469-8137.1994.tb04003.x; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Giovannini L, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10010106; Green SM, 2019, CHEM GEOL, V527, DOI 10.1016/j.chemgeo.2019.03.018; Guo Y, 2022, J PLANT ECOL, V15, P399, DOI 10.1093/jpe/rtab110; Hartmann A, 2014, REV GEOPHYS, V52, P218, DOI 10.1002/2013RG000443; Hausmann NT, 2010, ECOLOGY, V91, P2333, DOI 10.1890/09-0924.1; He YJ, 2019, ENVIRON SCI POLLUT R, V26, P8828, DOI 10.1007/s11356-019-04385-x; He YJ, 2017, SAINS MALAYS, V46, P1701, DOI 10.17576/jsm-2017-4610-05; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.2307/177062; Hodge A, 2001, NATURE, V413, P297, DOI 10.1038/35095041; Hoeksema JD, 2010, ECOL LETT, V13, P394, DOI 10.1111/j.1461-0248.2009.01430.x; Jiang ZC, 2014, EARTH-SCI REV, V132, P1, DOI 10.1016/j.earscirev.2014.01.005; Johnson NC, 2010, P NATL ACAD SCI USA, V107, P2093, DOI 10.1073/pnas.0906710107; Kaiser C, 2015, NEW PHYTOL, V205, P1537, DOI 10.1111/nph.13138; Kardol P, 2010, TRENDS ECOL EVOL, V25, P670, DOI 10.1016/j.tree.2010.09.001; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; Larimer AL, 2014, ECOLOGY, V95, P1045, DOI 10.1890/13-0025.1; Leff JW, 2015, P NATL ACAD SCI USA, V112, P10967, DOI 10.1073/pnas.1508382112; Leigh J, 2011, FEMS MICROBIOL ECOL, V76, P428, DOI 10.1111/j.1574-6941.2011.01066.x; Li XG, 2020, ENVIRON MICROBIOL, V22, P1025, DOI 10.1111/1462-2920.14808; Linderman RG., 1997, PLANT RELATIONSHIPS, P117; Liu RJ, 2003, MYCORRHIZA, V13, P123, DOI 10.1007/s00572-002-0207-4; Liu WX, 2007, BIOL FERT SOILS, V44, P259, DOI 10.1007/s00374-007-0198-6; Liu YG, 2020, FORESTS, V11, DOI 10.3390/f11080797; Long ZF., 2005, GUIZHOU AGR SCI, V33, P69; Lugtenberg B, 2013, MOL MICROBIAL ECOLOG, P561, DOI DOI 10.1002/9781118297674.CH53; Marulanda A, 2006, MICROB ECOL, V52, P670, DOI 10.1007/s00248-006-9078-0; Micallef SA, 2009, J EXP BOT, V60, P1729, DOI 10.1093/jxb/erp053; Miransari M, 2011, APPL MICROBIOL BIOT, V89, P917, DOI 10.1007/s00253-010-3004-6; Mortimer PE, 2013, PLANT SOIL, V366, P229, DOI 10.1007/s11104-012-1421-2; Nie YP, 2014, PLANT ECOL, V215, P1099, DOI 10.1007/s11258-014-0369-0; Niwa R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25701-4; Ortiz N, 2015, J PLANT PHYSIOL, V174, P87, DOI 10.1016/j.jplph.2014.08.019; Pang DB, 2018, ECOL ENG, V123, P151, DOI 10.1016/j.ecoleng.2018.09.001; Peng T, 2012, CATENA, V90, P53, DOI 10.1016/j.catena.2011.11.001; Richardson AE, 2011, PLANT PHYSIOL, V156, P989, DOI 10.1104/pp.111.175448; Rillig MC, 2006, NEW PHYTOL, V171, P41, DOI 10.1111/j.1469-8137.2006.01750.x; Rousk J, 2008, FEMS MICROBIOL ECOL, V63, P350, DOI 10.1111/j.1574-6941.2008.00440.x; Shen KP, 2020, FRONT ECOL EVOL, V8, DOI 10.3389/fevo.2020.00125; Shi ZY, 2015, J ARID LAND, V7, P414, DOI 10.1007/s40333-014-0046-0; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Smith SE, 2011, ANNU REV PLANT BIOL, V62, P227, DOI 10.1146/annurev-arplant-042110-103846; Srivastava R, 2010, BIOL CONTROL, V53, P24, DOI 10.1016/j.biocontrol.2009.11.012; Tan K.H., 2005, SOIL SAMPLING PREPAR, Vsecond, DOI [10.1201/9781482274769, DOI 10.1201/9781482274769]; Tawaraya K, 2006, J PLANT NUTR, V29, P657, DOI 10.1080/01904160600564428; van der Heijden MGA, 1998, ECOLOGY, V79, P2082, DOI 10.1890/0012-9658(1998)079[2082:DAMFSA]2.0.CO;2; Vazquez MM, 2000, APPL SOIL ECOL, V15, P261, DOI 10.1016/S0929-1393(00)00075-5; Vigo C, 2000, PLANT PATHOL, V49, P509, DOI 10.1046/j.1365-3059.2000.00473.x; Wang XM, 2018, PLANT ECOL, V219, P759, DOI 10.1007/s11258-018-0832-4; Wilson GWT, 2009, ECOL LETT, V12, P452, DOI 10.1111/j.1461-0248.2009.01303.x; Wu F, 2021, CAN J MICROBIOL, V67, P349, DOI 10.1139/cjm-2020-0227; Xia TT, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234410; Xiao Y, 2020, APPL SOIL ECOL, V149, DOI 10.1016/j.apsoil.2019.103485; Yang HS, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-50; [曾馥平 ZENG FuPing], 2007, [生态学报, Acta Ecologica Sinica], V27, P5110, DOI 10.1016/S1872-2032(08)60016-5; Zhang FJ, 2018, MYCORRHIZA, V28, P703, DOI 10.1007/s00572-018-0866-4; Zhang LX, 2004, ACTA BOT SIN, V46, P259	82	1	1	12	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266526	10.1371/journal.pone.0266526	http://dx.doi.org/10.1371/journal.pone.0266526			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1D9PO	35468152	gold, Green Published			2022-12-26	WOS:000794129600012
